0001171843-24-002288.txt : 20240426 0001171843-24-002288.hdr.sgml : 20240426 20240426160638 ACCESSION NUMBER: 0001171843-24-002288 CONFORMED SUBMISSION TYPE: 20-F PUBLIC DOCUMENT COUNT: 100 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240426 DATE AS OF CHANGE: 20240426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALMADEN MINERALS LTD CENTRAL INDEX KEY: 0001015647 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] ORGANIZATION NAME: 01 Energy & Transportation IRS NUMBER: 981204631 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-32702 FILM NUMBER: 24883624 BUSINESS ADDRESS: STREET 1: SUITE 210 - 1333 JOHNSTON STREET CITY: VANCOUVER STATE: A1 ZIP: V6H 3R9 BUSINESS PHONE: (604) 689-7644 MAIL ADDRESS: STREET 1: SUITE 210 - 1333 JOHNSTON STREET CITY: VANCOUVER STATE: A1 ZIP: V6H 3R9 20-F 1 f20f_042624.htm FORM 20-F
false 2023 FY 0001015647 0001015647 2023-01-01 2023-12-31 0001015647 dei:BusinessContactMember 2023-01-01 2023-12-31 0001015647 2023-12-31 0001015647 2022-12-31 0001015647 2022-01-01 2022-12-31 0001015647 2021-01-01 2021-12-31 0001015647 2021-12-31 0001015647 2020-12-31 0001015647 ifrs-full:IssuedCapitalMember 2020-12-31 0001015647 ifrs-full:ReserveOfSharebasedPaymentsMember 2020-12-31 0001015647 ifrs-full:WarrantsMember 2020-12-31 0001015647 aau:TotalReservesMember 2020-12-31 0001015647 aau:DeficitMember 2020-12-31 0001015647 ifrs-full:IssuedCapitalMember 2021-12-31 0001015647 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-12-31 0001015647 ifrs-full:WarrantsMember 2021-12-31 0001015647 aau:TotalReservesMember 2021-12-31 0001015647 aau:DeficitMember 2021-12-31 0001015647 ifrs-full:IssuedCapitalMember 2022-12-31 0001015647 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-12-31 0001015647 ifrs-full:WarrantsMember 2022-12-31 0001015647 aau:TotalReservesMember 2022-12-31 0001015647 aau:DeficitMember 2022-12-31 0001015647 ifrs-full:IssuedCapitalMember 2021-01-01 2021-12-31 0001015647 ifrs-full:ReserveOfSharebasedPaymentsMember 2021-01-01 2021-12-31 0001015647 ifrs-full:WarrantsMember 2021-01-01 2021-12-31 0001015647 aau:TotalReservesMember 2021-01-01 2021-12-31 0001015647 aau:DeficitMember 2021-01-01 2021-12-31 0001015647 ifrs-full:IssuedCapitalMember 2022-01-01 2022-12-31 0001015647 ifrs-full:ReserveOfSharebasedPaymentsMember 2022-01-01 2022-12-31 0001015647 ifrs-full:WarrantsMember 2022-01-01 2022-12-31 0001015647 aau:TotalReservesMember 2022-01-01 2022-12-31 0001015647 aau:DeficitMember 2022-01-01 2022-12-31 0001015647 ifrs-full:IssuedCapitalMember 2023-01-01 2023-12-31 0001015647 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-01-01 2023-12-31 0001015647 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001015647 aau:TotalReservesMember 2023-01-01 2023-12-31 0001015647 aau:DeficitMember 2023-01-01 2023-12-31 0001015647 ifrs-full:IssuedCapitalMember 2023-12-31 0001015647 ifrs-full:ReserveOfSharebasedPaymentsMember 2023-12-31 0001015647 ifrs-full:WarrantsMember 2023-12-31 0001015647 aau:TotalReservesMember 2023-12-31 0001015647 aau:DeficitMember 2023-12-31 0001015647 aau:PueblaHoldingsIncMember 2023-01-01 2023-12-31 0001015647 aau:MineraGorrionSAdeCVMember 2023-01-01 2023-12-31 0001015647 aau:FurnitureFixturesAndFittingsMember 2023-01-01 2023-12-31 0001015647 ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001015647 aau:GeologicalLibraryMember 2023-01-01 2023-12-31 0001015647 aau:FieldEquipmentMember 2023-01-01 2023-12-31 0001015647 aau:MillEquipmentMember 2023-01-01 2023-12-31 0001015647 aau:TuligticProjectMember 2023-12-31 0001015647 aau:TuligticProjectMember 2022-12-31 0001015647 ifrs-full:NotLaterThanOneYearMember 2023-12-31 0001015647 ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember 2023-12-31 0001015647 ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember 2023-12-31 0001015647 ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember 2023-12-31 0001015647 ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FurnitureFixturesAndFittingsMember 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:GeologicalLibraryMember 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FieldEquipmentMember 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:MillEquipmentMember 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FurnitureFixturesAndFittingsMember 2023-01-01 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:GeologicalLibraryMember 2023-01-01 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FieldEquipmentMember 2023-01-01 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:MillEquipmentMember 2023-01-01 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember 2023-01-01 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FurnitureFixturesAndFittingsMember 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:GeologicalLibraryMember 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FieldEquipmentMember 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:MillEquipmentMember 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FurnitureFixturesAndFittingsMember 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerSoftwareMember 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:GeologicalLibraryMember 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FieldEquipmentMember 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:MillEquipmentMember 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FurnitureFixturesAndFittingsMember 2023-01-01 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2023-01-01 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerSoftwareMember 2023-01-01 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:GeologicalLibraryMember 2023-01-01 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FieldEquipmentMember 2023-01-01 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:MillEquipmentMember 2023-01-01 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2023-01-01 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FurnitureFixturesAndFittingsMember 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerSoftwareMember 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:GeologicalLibraryMember 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FieldEquipmentMember 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:MillEquipmentMember 2023-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2023-12-31 0001015647 aau:FurnitureFixturesAndFittingsMember 2022-12-31 0001015647 ifrs-full:ComputerEquipmentMember 2022-12-31 0001015647 ifrs-full:ComputerSoftwareMember 2022-12-31 0001015647 aau:GeologicalLibraryMember 2022-12-31 0001015647 aau:FieldEquipmentMember 2022-12-31 0001015647 aau:MillEquipmentMember 2022-12-31 0001015647 aau:FurnitureFixturesAndFittingsMember 2023-12-31 0001015647 ifrs-full:ComputerEquipmentMember 2023-12-31 0001015647 ifrs-full:ComputerSoftwareMember 2023-12-31 0001015647 aau:GeologicalLibraryMember 2023-12-31 0001015647 aau:FieldEquipmentMember 2023-12-31 0001015647 aau:MillEquipmentMember 2023-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FurnitureFixturesAndFittingsMember 2021-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2021-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:GeologicalLibraryMember 2021-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FieldEquipmentMember 2021-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:MillEquipmentMember 2021-12-31 0001015647 ifrs-full:GrossCarryingAmountMember 2021-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FurnitureFixturesAndFittingsMember 2022-01-01 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:GeologicalLibraryMember 2022-01-01 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:FieldEquipmentMember 2022-01-01 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember aau:MillEquipmentMember 2022-01-01 2022-12-31 0001015647 ifrs-full:GrossCarryingAmountMember 2022-01-01 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FurnitureFixturesAndFittingsMember 2021-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2021-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerSoftwareMember 2021-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:GeologicalLibraryMember 2021-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FieldEquipmentMember 2021-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:MillEquipmentMember 2021-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2021-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FurnitureFixturesAndFittingsMember 2022-01-01 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerEquipmentMember 2022-01-01 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember ifrs-full:ComputerSoftwareMember 2022-01-01 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:GeologicalLibraryMember 2022-01-01 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:FieldEquipmentMember 2022-01-01 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember aau:MillEquipmentMember 2022-01-01 2022-12-31 0001015647 ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember 2022-01-01 2022-12-31 0001015647 aau:FurnitureFixturesAndFittingsMember 2021-12-31 0001015647 ifrs-full:ComputerEquipmentMember 2021-12-31 0001015647 ifrs-full:ComputerSoftwareMember 2021-12-31 0001015647 aau:GeologicalLibraryMember 2021-12-31 0001015647 aau:FieldEquipmentMember 2021-12-31 0001015647 aau:MillEquipmentMember 2021-12-31 0001015647 aau:TuligticMember 2022-12-31 0001015647 ifrs-full:OtherPropertyPlantAndEquipmentMember 2022-12-31 0001015647 aau:TuligticMember 2023-01-01 2023-12-31 0001015647 ifrs-full:OtherPropertyPlantAndEquipmentMember 2023-01-01 2023-12-31 0001015647 aau:TuligticMember 2023-12-31 0001015647 ifrs-full:OtherPropertyPlantAndEquipmentMember 2023-12-31 0001015647 aau:TuligticMember 2021-12-31 0001015647 ifrs-full:OtherPropertyPlantAndEquipmentMember 2021-12-31 0001015647 aau:TuligticMember 2022-01-01 2022-12-31 0001015647 ifrs-full:OtherPropertyPlantAndEquipmentMember 2022-01-01 2022-12-31 0001015647 aau:LoganPropertyLocatedInTheYukonTerritoryCanadaMember 2022-05-25 2022-05-26 0001015647 aau:LoganPropertyLocatedInTheYukonTerritoryCanadaMember 2022-05-26 0001015647 aau:GoldLoanMember 2019-05-14 0001015647 aau:GoldLoanMember 2019-05-01 2019-05-14 0001015647 ifrs-full:WarrantsMember 2019-05-01 2019-05-14 0001015647 ifrs-full:WarrantsMember 2019-05-14 0001015647 aau:GoldLoanDerivativeInstrumentsMember 2019-05-01 2019-05-14 0001015647 aau:GoldLoanDerivativeInstrumentsMember 2023-01-01 2023-12-31 0001015647 aau:GoldLoanDerivativeInstrumentsMember 2022-01-01 2022-12-31 0001015647 aau:GoldLoanMember 2023-12-31 0001015647 aau:GoldLoanMember 2022-12-31 0001015647 aau:GoldLoanMember 2021-12-31 0001015647 aau:GoldLoanMember 2023-01-01 2023-12-31 0001015647 aau:GoldLoanMember 2022-01-01 2022-12-31 0001015647 aau:GoldLoanDerivativeInstrumentsMember 2022-12-31 0001015647 aau:GoldLoanDerivativeInstrumentsMember 2021-12-31 0001015647 aau:GoldLoanDerivativeInstrumentsMember 2023-12-31 0001015647 aau:DerivativeFinancialLiabilityMember 2023-01-01 2023-12-31 0001015647 aau:DerivativeFinancialLiabilityMember 2022-01-01 2022-12-31 0001015647 ifrs-full:WarrantsMember 2023-01-01 2023-12-31 0001015647 aau:WarrantsExpiryMember 2023-01-01 2023-12-31 0001015647 aau:WarrantsExpiryMember 2023-12-31 0001015647 aau:WarrantsExpiryMember 2022-12-31 0001015647 aau:WarrantsExpiryOneMember 2023-01-01 2023-12-31 0001015647 aau:WarrantsExpiryOneMember 2023-12-31 0001015647 aau:WarrantsExpiryOneMember 2022-12-31 0001015647 aau:WarrantsExpiryTwoMember 2023-01-01 2023-12-31 0001015647 aau:WarrantsExpiryTwoMember 2023-12-31 0001015647 aau:WarrantsExpiryTwoMember 2022-12-31 0001015647 aau:WarrantsExpiryThreeMember 2023-01-01 2023-12-31 0001015647 aau:WarrantsExpiryThreeMember 2023-12-31 0001015647 aau:WarrantsExpiryThreeMember 2022-12-31 0001015647 aau:WarrantsExpiryFourMember 2023-01-01 2023-12-31 0001015647 aau:WarrantsExpiryFourMember 2023-12-31 0001015647 aau:WarrantsExpiryFourMember 2022-12-31 0001015647 aau:WarrantsExpiryFiveMember 2022-01-01 2022-12-31 0001015647 aau:WarrantsExpiryFiveMember 2022-12-31 0001015647 aau:WarrantsExpiryFiveMember 2021-12-31 0001015647 aau:WarrantsExpiryMember 2022-01-01 2022-12-31 0001015647 aau:WarrantsExpiryMember 2021-12-31 0001015647 aau:WarrantsExpiryOneMember 2022-01-01 2022-12-31 0001015647 aau:WarrantsExpiryOneMember 2021-12-31 0001015647 aau:WarrantsExpiryTwoMember 2022-01-01 2022-12-31 0001015647 aau:WarrantsExpiryTwoMember 2021-12-31 0001015647 aau:WarrantsExpiryThreeMember 2022-01-01 2022-12-31 0001015647 aau:WarrantsExpiryThreeMember 2021-12-31 0001015647 aau:WarrantsExpiryFourMember 2022-01-01 2022-12-31 0001015647 aau:WarrantsExpiryFourMember 2021-12-31 0001015647 aau:WarrantsExpiryFiveMember 2021-01-01 2021-12-31 0001015647 aau:WarrantsExpiryFiveMember 2020-12-31 0001015647 aau:WarrantsExpiryMember 2021-01-01 2021-12-31 0001015647 aau:WarrantsExpiryMember 2020-12-31 0001015647 aau:WarrantsExpiryOneMember 2021-01-01 2021-12-31 0001015647 aau:WarrantsExpiryOneMember 2020-12-31 0001015647 aau:WarrantsExpiryTwoMember 2021-01-01 2021-12-31 0001015647 aau:WarrantsExpiryTwoMember 2020-12-31 0001015647 aau:WarrantsExpiryThreeMember 2021-01-01 2021-12-31 0001015647 aau:WarrantsExpiryThreeMember 2020-12-31 0001015647 aau:WarrantsExpiryFourMember 2021-01-01 2021-12-31 0001015647 aau:WarrantsExpiryFourMember 2020-12-31 0001015647 2020-01-01 2020-12-31 0001015647 aau:WarrantsIssuedOnMarch182021Member 2022-01-01 2022-12-31 0001015647 aau:February92023Member 2023-01-01 2023-12-31 0001015647 aau:February92023Member 2023-12-31 0001015647 aau:February92023Member 2022-12-31 0001015647 aau:March32023Member 2023-01-01 2023-12-31 0001015647 aau:March32023Member 2023-12-31 0001015647 aau:March32023Member 2022-12-31 0001015647 aau:March312023Member 2023-01-01 2023-12-31 0001015647 aau:March312023Member 2023-12-31 0001015647 aau:March312023Member 2022-12-31 0001015647 aau:May82023Member 2023-01-01 2023-12-31 0001015647 aau:May82023Member 2023-12-31 0001015647 aau:May82023Member 2022-12-31 0001015647 aau:May282023Member 2023-01-01 2023-12-31 0001015647 aau:May282023Member 2023-12-31 0001015647 aau:May282023Member 2022-12-31 0001015647 aau:July82023Member 2023-01-01 2023-12-31 0001015647 aau:July82023Member 2023-12-31 0001015647 aau:July82023Member 2022-12-31 0001015647 aau:September182023Member 2023-01-01 2023-12-31 0001015647 aau:September182023Member 2023-12-31 0001015647 aau:September182023Member 2022-12-31 0001015647 aau:March72027Member 2023-01-01 2023-12-31 0001015647 aau:March72027Member 2023-12-31 0001015647 aau:March72027Member 2022-12-31 0001015647 aau:June102027Member 2023-01-01 2023-12-31 0001015647 aau:June102027Member 2023-12-31 0001015647 aau:June102027Member 2022-12-31 0001015647 aau:October42027Member 2023-01-01 2023-12-31 0001015647 aau:October42027Member 2023-12-31 0001015647 aau:October42027Member 2022-12-31 0001015647 aau:December162027Member 2023-01-01 2023-12-31 0001015647 aau:December162027Member 2023-12-31 0001015647 aau:December162027Member 2022-12-31 0001015647 aau:February142028Member 2023-01-01 2023-12-31 0001015647 aau:February142028Member 2023-12-31 0001015647 aau:February142028Member 2022-12-31 0001015647 aau:April32028Member 2023-01-01 2023-12-31 0001015647 aau:April32028Member 2023-12-31 0001015647 aau:April32028Member 2022-12-31 0001015647 aau:July102028Member 2023-01-01 2023-12-31 0001015647 aau:July102028Member 2023-12-31 0001015647 aau:July102028Member 2022-12-31 0001015647 aau:September192028Member 2023-01-01 2023-12-31 0001015647 aau:September192028Member 2023-12-31 0001015647 aau:September192028Member 2022-12-31 0001015647 aau:March42022Member 2022-01-01 2022-12-31 0001015647 aau:March42022Member 2022-12-31 0001015647 aau:March42022Member 2021-12-31 0001015647 aau:April302022Member 2022-01-01 2022-12-31 0001015647 aau:April302022Member 2022-12-31 0001015647 aau:April302022Member 2021-12-31 0001015647 aau:April302022OneMember 2022-01-01 2022-12-31 0001015647 aau:April302022OneMember 2022-12-31 0001015647 aau:April302022OneMember 2021-12-31 0001015647 aau:May312022Member 2022-01-01 2022-12-31 0001015647 aau:May312022Member 2022-12-31 0001015647 aau:May312022Member 2021-12-31 0001015647 aau:June92022Member 2022-01-01 2022-12-31 0001015647 aau:June92022Member 2022-12-31 0001015647 aau:June92022Member 2021-12-31 0001015647 aau:October32022Member 2022-01-01 2022-12-31 0001015647 aau:October32022Member 2022-12-31 0001015647 aau:October32022Member 2021-12-31 0001015647 aau:December152022Member 2022-01-01 2022-12-31 0001015647 aau:December152022Member 2022-12-31 0001015647 aau:December152022Member 2021-12-31 0001015647 aau:February92023Member 2022-01-01 2022-12-31 0001015647 aau:February92023Member 2021-12-31 0001015647 aau:March32023Member 2022-01-01 2022-12-31 0001015647 aau:March32023Member 2021-12-31 0001015647 aau:March312023Member 2022-01-01 2022-12-31 0001015647 aau:March312023Member 2021-12-31 0001015647 aau:May82023Member 2022-01-01 2022-12-31 0001015647 aau:May82023Member 2021-12-31 0001015647 aau:May282023Member 2022-01-01 2022-12-31 0001015647 aau:May282023Member 2021-12-31 0001015647 aau:July82023Member 2022-01-01 2022-12-31 0001015647 aau:July82023Member 2021-12-31 0001015647 aau:September182023Member 2022-01-01 2022-12-31 0001015647 aau:September182023Member 2021-12-31 0001015647 aau:March72027Member 2022-01-01 2022-12-31 0001015647 aau:March72027Member 2021-12-31 0001015647 aau:June102027Member 2022-01-01 2022-12-31 0001015647 aau:June102027Member 2021-12-31 0001015647 aau:October42027Member 2022-01-01 2022-12-31 0001015647 aau:October42027Member 2021-12-31 0001015647 aau:December162027Member 2022-01-01 2022-12-31 0001015647 aau:December162027Member 2021-12-31 0001015647 aau:February72021Member 2021-01-01 2021-12-31 0001015647 aau:February72021Member 2021-12-31 0001015647 aau:February72021Member 2020-12-31 0001015647 aau:February72021OneMember 2021-01-01 2021-12-31 0001015647 aau:February72021OneMember 2021-12-31 0001015647 aau:February72021OneMember 2020-12-31 0001015647 aau:March292021Member 2021-01-01 2021-12-31 0001015647 aau:March292021Member 2021-12-31 0001015647 aau:March292021Member 2020-12-31 0001015647 aau:March292021OneMember 2021-01-01 2021-12-31 0001015647 aau:March292021OneMember 2021-12-31 0001015647 aau:March292021OneMember 2020-12-31 0001015647 aau:May62021Member 2021-01-01 2021-12-31 0001015647 aau:May62021Member 2021-12-31 0001015647 aau:May62021Member 2020-12-31 0001015647 aau:July72021Member 2021-01-01 2021-12-31 0001015647 aau:July72021Member 2021-12-31 0001015647 aau:July72021Member 2020-12-31 0001015647 aau:August132021Member 2021-01-01 2021-12-31 0001015647 aau:August132021Member 2021-12-31 0001015647 aau:August132021Member 2020-12-31 0001015647 aau:September162021Member 2021-01-01 2021-12-31 0001015647 aau:September162021Member 2021-12-31 0001015647 aau:September162021Member 2020-12-31 0001015647 aau:December122021Member 2021-01-01 2021-12-31 0001015647 aau:December122021Member 2021-12-31 0001015647 aau:December122021Member 2020-12-31 0001015647 aau:March42022Member 2021-01-01 2021-12-31 0001015647 aau:March42022Member 2020-12-31 0001015647 aau:April302022Member 2021-01-01 2021-12-31 0001015647 aau:April302022Member 2020-12-31 0001015647 aau:April302022OneMember 2021-01-01 2021-12-31 0001015647 aau:April302022OneMember 2020-12-31 0001015647 aau:May312022Member 2021-01-01 2021-12-31 0001015647 aau:May312022Member 2020-12-31 0001015647 aau:June92022Member 2021-01-01 2021-12-31 0001015647 aau:June92022Member 2020-12-31 0001015647 aau:October32022Member 2021-01-01 2021-12-31 0001015647 aau:October32022Member 2020-12-31 0001015647 aau:December152022Member 2021-01-01 2021-12-31 0001015647 aau:December152022Member 2020-12-31 0001015647 aau:February92023Member 2021-01-01 2021-12-31 0001015647 aau:February92023Member 2020-12-31 0001015647 aau:March32023Member 2021-01-01 2021-12-31 0001015647 aau:March32023Member 2020-12-31 0001015647 aau:March312023Member 2021-01-01 2021-12-31 0001015647 aau:March312023Member 2020-12-31 0001015647 aau:May82023Member 2021-01-01 2021-12-31 0001015647 aau:May82023Member 2020-12-31 0001015647 aau:May282023Member 2021-01-01 2021-12-31 0001015647 aau:May282023Member 2020-12-31 0001015647 aau:July82023Member 2021-01-01 2021-12-31 0001015647 aau:July82023Member 2020-12-31 0001015647 aau:September182023Member 2021-01-01 2021-12-31 0001015647 aau:September182023Member 2020-12-31 0001015647 aau:GrantOneMember 2023-01-01 2023-12-31 0001015647 aau:GrantTwoMember 2023-01-01 2023-12-31 0001015647 aau:GrantThreeMember 2023-01-01 2023-12-31 0001015647 aau:GrantFourMember 2023-01-01 2023-12-31 0001015647 aau:GrantFiveMember 2023-01-01 2023-12-31 0001015647 aau:GrantSixMember 2023-01-01 2023-12-31 0001015647 aau:GrantSevenMember 2023-01-01 2023-12-31 0001015647 aau:GrantEightMember 2023-01-01 2023-12-31 0001015647 aau:GrantNineMember 2023-01-01 2023-12-31 0001015647 aau:GrantTenMember 2023-01-01 2023-12-31 0001015647 aau:GrantElevenMember 2023-01-01 2023-12-31 0001015647 aau:GrantTwelveMember 2023-01-01 2023-12-31 0001015647 aau:GrantThirteenMember 2023-01-01 2023-12-31 0001015647 aau:GrantFourteenMember 2023-01-01 2023-12-31 0001015647 aau:GrantFifteenMember 2023-01-01 2023-12-31 0001015647 aau:AzucarMember 2023-01-01 2023-12-31 0001015647 aau:AzucarMember 2022-01-01 2022-12-31 0001015647 aau:AzucarMember 2021-01-01 2021-12-31 0001015647 aau:AlmadexMember 2023-01-01 2023-12-31 0001015647 aau:AlmadexMember 2022-01-01 2022-12-31 0001015647 aau:AlmadexMember 2021-01-01 2021-12-31 0001015647 aau:AzucarMember 2023-12-31 0001015647 aau:AzucarMember 2022-12-31 0001015647 aau:AlmadexMember 2023-12-31 0001015647 aau:AlmadexMember 2022-12-31 0001015647 aau:AlmadexMember aau:DrillEquipmentMember 2023-12-31 0001015647 aau:AlmadexMember aau:DrillEquipmentMember 2022-12-31 0001015647 aau:ChairmansDaughterMember 2023-12-31 0001015647 aau:ChairmansDaughterMember 2022-12-31 0001015647 aau:ChairmansDaughterMember 2021-12-31 0001015647 aau:NoncapitalLossCarryForwardsMember 2023-12-31 0001015647 aau:NoncapitalLossCarryForwardsMember 2022-12-31 0001015647 aau:CapitalLossCarryForwardsMember 2023-12-31 0001015647 aau:CapitalLossCarryForwardsMember 2022-12-31 0001015647 aau:ExplorationAndEvaluationAssetsDeductibleDifferencesMember 2023-12-31 0001015647 aau:ExplorationAndEvaluationAssetsDeductibleDifferencesMember 2022-12-31 0001015647 aau:ShareIssueCostsMember 2023-12-31 0001015647 aau:ShareIssueCostsMember 2022-12-31 0001015647 aau:PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember 2023-12-31 0001015647 aau:PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember 2022-12-31 0001015647 aau:DonationsMember 2023-12-31 0001015647 aau:DonationsMember 2022-12-31 0001015647 aau:InvestmentTaxCreditMember 2023-12-31 0001015647 aau:InvestmentTaxCreditMember 2022-12-31 0001015647 aau:CountryOfCanadaMember 2023-12-31 0001015647 aau:CountryOfCanadaMember 2022-12-31 0001015647 aau:CountryOfMexicoMember 2023-12-31 0001015647 aau:CountryOfMexicoMember 2022-12-31 0001015647 ifrs-full:Level1OfFairValueHierarchyMember 2023-12-31 0001015647 ifrs-full:Level2OfFairValueHierarchyMember 2023-12-31 0001015647 ifrs-full:Level3OfFairValueHierarchyMember 2023-12-31 0001015647 aau:CountryOfUnitedStatesMember 2023-12-31 0001015647 aau:CountryOfUnitedStatesMember 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD iso4217:CAD xbrli:shares iso4217:MXN aau:Integer utr:oz

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 20-F

 

REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

 

SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of event requiring this shell company report

 

For the transition period from _____________________ to ____________________

 

 

Commission file number 001-32702

 

ALMADEN MINERALS LTD.

(Exact name of Registrant as specified in its charter)

 

British Columbia, Canada

(Jurisdiction of incorporation or organization)

 

1333 Johnston Street, #210, Vancouver, British Columbia V6H 3R9

(Address of principal executive offices)

 

Korm Trieu, ktrieu@almadenminerals.com, 1333 Johnston Street, #210, Vancouver, BC V6H 3R9

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

 
Securities registered or to be registered pursuant to Section 12(b) of the Act.
Title of each class Trading symbol Name of each exchange on which registered
     
Common shares without Par Value AAUAF OTCQB Markets

 

Securities registered or to be registered pursuant to Section 12(g) of the Act.

 

None

(Title of Class)

 

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.

 

None

 

 

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common shares as of the close of the period covered by the annual report.

 

137,221,408

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

☐ Yes ☒ No

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

☐ Yes ☒ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).

 

Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Emerging Growth Company

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 1

 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐1

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

 

U.S. GAAP ☐   International Financial Reporting Standards as issued ☒   Other ☐
    by the International Accounting Standards Board    

 

 

 

 

 

 

 

__________________________

1 Checkboxes are blank pending adoption of the underlying rules.

 

 2

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.

 

☐ Item 17 ☐ Item 18

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

☐ Yes ☒ No

 

(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDS DURING THE PAST FIVE YEARS)

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

☐ Yes ☐ No

 

 

Under the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), Almaden is classified as an "Emerging Growth Company". The Company will continue to be deemed an emerging growth company until the earliest on the last day of our fiscal year during which (i) annual gross revenue exceeds $1.07 billion or (ii) the Company issues more than $1.0 billion in non-convertible debt in a three-year period. Almaden will lose its status as an emerging growth company on the last day of its fiscal year following the fifth anniversary of the date of the first sale of common equity securities pursuant to an effective registration statement. The Company will also lose its status as an emerging growth company if at any time it is deemed to be a large accelerated filer.

 

As an emerging growth company, Almaden is exempt from Section 404(b) of the Sarbanes-Oxley Act of 2002, as amended (the “Sarbanes-Oxley Act”), which requires a public company’s auditor to attest to, and report on, management’s assessment of its internal controls. The Company is also exempt from Sections 14A(a) and (b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which require companies to hold shareholder advisory votes on executive compensation and golden parachute compensation.

 

Almaden has elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(2) of the Jobs Act, that allows the Company to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result of this election, Almaden’s financial statements may not be comparable to companies that comply with public company effective dates.

 

 3

 

 

TABLE OF CONTENTS

 

  Page
Glossary of Geologic and Mining Terms 5
Note Regarding Mineral Resource and Mineral Reserve Estimates 12
Cautionary Note Regarding Forward-Looking Statements 13
     
  PART I  
Item 1 Identity of Directors, Senior Management and Advisors 15
     
Item 2 Offer Statistics and Expected Timetable 15
     
Item 3 Key Information 15
     
Item 4 Information on the Company 24
Item 4A Unresolved Staff Comments 48
     
Item 5 Operating and Financial Review and Prospects 48
     
Item 6 Directors, Senior Management and Employees 52
     
Item 7 Major Shareholders and Related Party Transactions 76
     
Item 8 Financial Information 78
     
Item 9 The Offer and Listing of Securities 81
     
Item 10 Additional Information 82
     
Item 11 Quantitative and Qualitative Disclosures About Market Risk 92
     
Item 12 Description of Securities Other than Equity Securities 92
     
  PART II  
Item 13 Defaults, Dividend Arrearages and Delinquencies 92
     
Item 14 Material Modifications to the Rights of Securities Holders 92
     
Item 15 Controls and Procedures 92
     
Item 16 Reserved 93
Item 16A Audit Committee Financial Expert 93
Item 16B Code of Ethics 93
Item 16C Principal Accountant Fees and Services 94
Item 16D Exemptions from the Listing Standards for Audit Committees 94
Item 16E Purchases of Equity Securities by the Issuer and Affiliated Purchasers 94
Item 16F Change in Registrant’s Certifying Accountant 94
Item 16G Corporate Governance 94
Item 16H Mine Safety Disclosure 94
Item 16I Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 95
Item 16J Insider Trading Policies 95
Item 16K Cybersecurity 95
     
  PART III  
Item 17 Financial Statements 95
     
Item 18 Financial Statements 95
     
Item 19 Exhibits 95
     
Signature 98

 

  4

 

 

Glossary of Geologic and Mining Terms

 

Adularia: A colourless, moderate to low-temperature variety of orthoclase feldspar typically with a relatively high barium content. It is a prominent constituent of low sulphidation epithermal veins.

 

Alkalic Intrusive: An igneous rock emplaced below ground level in which the feldspar is dominantly sodic and or potassic.

 

Alkalinity: The chemical nature of solutions characterized by a high concentration of hydroxyl ions.

 

Alteration: Usually referring to chemical reactions in a rock mass resulting from the passage of hydrothermal fluids.

 

Andesite: A dark-coloured, fine-grained extrusive rock that, when porphyritic, contains phenocrysts composed primarily of zoned sodic plagioclase (esp. andesine) and one or more of the mafic minerals (eg. Biotite, horn-blende, pyroxene), with a ground-mass composed generally of the same minerals as the phenocrysts; the extrusive equivalent of diorite. Andesite grades into latite with increasing alkali feldspar content, and into dacite with more alkali feldspar and quartz. It was named by Buch in 1826 from the Andes Mountains, South America.

 

Anomalous: A geological feature, often subsurface, distinguished by geological, geochemical or geophysical means, which is detectably different than the general surroundings and is often of potential economic value.

 

Anomaly: Any concentration of metal noticeably above or below the average background concentration.

 

Argillic: A form of alteration characterized by the alteration of original minerals to clays.

 

Arsenopyrite: A sulphide of arsenic and iron with the chemical composition FeAsS.

 

Assay: An analysis to determine the presence, absence or quantity of one or more components.

 

Axis: An imaginary hinge line about which the fold limbs are bent. The axis of a fold can be at the top or bottom of the fold, can be tilted or horizontal.

 

Batholith: An intrusion, usually granitic, which has a large exposed surface area and no observable bottom. Usually associated with orogenic belts.

 

Breccia: Rock consisting of more or less angular fragments in a matrix of finer-grained material or cementing material.

 

Brecciated: Rock broken up by geological forces.

 

Bulk sample: A very large sample, the kind of sample to take from broken rock or of gravels and sands when testing placer deposits.

 

Calc-silicate: Calcium-bearing silicate minerals. These minerals are commonly formed as a result of the interaction of molten rock and its derived, hot hydrothermal fluids with very chemically reactive calcium carbonate (limestone). Calc-silicate minerals include garnet, pyroxene, amphibole and epidote. These minerals are commonly described as skarn and are genetically and spatially associated with a wide range of metals.

 

Chert: A very fine grained siliceous rock. Many limestones contain nodules and thin lenses of chert.

 

Chip sample: A sample composed of discontinuous chips taken along a surface across a given line.

 

Claim: That portion of public mineral lands, which a party has staked or marked out in accordance with provincial or state mining laws, to acquire the right to explore for the minerals under the surface.

 

Clastic: Consisting of rock material that has been mechanically derived, transported, and deposited. Such material is also called detrital.

 

  5

 

Cleavage: The tendency of a crystal to split, or break, along planes of structural weakness.

 

Concordant Bodies: Intrusive igneous bodies whose contacts are parallel to the bedding of the intruded rock.

 

Conglomerate: Rock composed of mostly rounded fragments which are of gravel size or larger in a finer grained matrix.

 

Craton: A central stable region common to nearly all continents and composed chiefly of highly metamorphosed Precambrian rocks.

 

Cretaceous: Geological time period between 136 and 64 million years ago.

 

Crystalline: Means the specimen is made up of one or more groups of crystals.

 

Cut-off grade: The minimum grade of mineralization used to establish quantitative and qualitative estimates of total mineralization.

 

Dacite: A fine grained acid volcanic rock, similar to rhyolite in which the feldspar is predominantly plagioclase.

 

Degradation: The ongoing process of erosion in a stream.

 

Diagenesis: The changes that occur in a sediment during and after lithification. These changes include compaction, cementation, replacement, and recrystallization.

 

Diamond drill: A type of rotary drill in which the cutting is done by abrasion using diamonds embedded in a matrix rather than by percussion. The drill cuts a core of rock which is recovered in long cylindrical sections.

 

Dilution: Results from the mixing in of unwanted gangue or waste rock with the ore during mining.

 

Dip: Geological measurement of the angle of maximum slope of planar elements in rocks. Can be applied to beddings, jointing, fault planes, etc.

 

Discordant Bodies: Intrusive igneous bodies whose contacts cut across the bedding, or other pre-existing structures, to the intruded rock.

 

Disseminated deposit: Deposit in which the mineralization is scattered through a large volume of host rock, sometimes as separate mineral grains, or sometimes along joint or fault surfaces.

 

Dyke: A tabular, discordant, intrusive igneous body.

 

Earn in: The right to acquire an interest in a property pursuant to an Option Agreement.

 

Ejecta: Pyroclastic material thrown out or ejected by a volcano. It includes ash, volcanic bombs, and lapilli.

 

Epithermal: Epithermal deposits are a class of ore deposits that form generally less than 1 km from surface. These deposits, which can host economic quantities of gold, silver, copper, lead and zinc are formed as a result of the precipitation of ore minerals from up-welling hydrothermal fluids. There are several classes of epithermal deposits that are defined on the basis of fluid chemistry and resulting alteration and ore mineralogy. Fluid chemistry is largely controlled by the proximity to igneous intrusive rocks and as a result igneous fluid content.

 

Extrusive Rock: Igneous rock that has solidified on the earth’s surface from volcanic action.

 

Fault: A fracture in a rock where there had been displacement of the two sides.

 

Faults: Breaks in rocks with noticeable movement or displacement of the rocks on either side of the break.

 

  6

 

Feldspar: A group of aluminum silicate minerals closely related in chemical composition and physical properties. There are two major chemical varieties of feldspar: the potassium aluminum, or potash, feldspars and the sodium-calcium-aluminum, or plagioclase, feldspars. The feldspars possess a tetrahedral framework of silicon and oxygen, with the partial substitution of aluminum for the silicon. They make up about 60 percent of the earth’s crust.

 

Felsic: Light colored silicate minerals, mainly quartz and feldspar, or an igneous rock comprised largely of felsic minerals (granite, rhyolite).

 

Fluid inclusion: Fluid inclusions are "bubbles" of fluid trapped within the host mineral during its deposition from its parent hydrothermal fluid. They are tiny remnants of the exact fluid from which the host mineral and its associated ore minerals deposited and they provide direct information about the fluid composition, temperature and pressure at which the hydrothermal deposit formed.

 

Folds: Are flexures in bedded or layered rocks. They are formed when forces are applied gradually to rocks over a long period of time.

 

Fracture: Breaks in a rock, usually due to intensive folding or faulting.

 

Gangue: Term used to describe worthless minerals or rock waste mixed in with the valuable minerals.

 

Geochemical Anomaly: An area of elevated values of a particular element in soil or rock samples collected during the preliminary reconnaissance search for locating favourable metal concentrations that could indicate the presence of surface or drill targets.

 

Geochemistry: The study of the chemistry of rocks, minerals, and mineral deposits.

 

Geophysics: The study of the physical properties of rocks, minerals, and mineral deposits.

 

Gouge: The finely ground rock that results from the abrasion along a fault surface.

 

Grade: The concentration of each ore metal in a rock sample, usually given as weight percent. Where extremely low concentrations are involved, the concentration may be given in grams per tonne (g/t) or ounces per ton (oz/t). The grade of an ore deposit is calculated, often using sophisticated statistical procedures, as an average of the grades of a very large number of samples collected from throughout the deposit.

 

Granite: A coarse grained, plutonic igneous rock that is normally pale pink, pale pink-brown, or pale grey, and composed of quartz, alkali feldspar, micas and accessory minerals.

 

Granodiorite: A course grained, plutonic igneous rock that is normally pale grey, and composed of quartz, calc-alkali feldspar, micas and accessory minerals.

 

Grid: A network composed of two sets of uniformly spaced parallel lines, usually intersecting at right angles and forming squares, superimposed on a map, chart, or aerial photograph, to permit identification of ground locations by means of a system or coordinates and to facilitate computation of direction and distance and size of geologic, geochemical or geophysical features.

 

Hectare: A square of 100 meters on each side.

 

Host rock: The rock within which the ore deposit occurs.

 

Hydrothermal: Of or pertaining to hot water, to the action of hot water, or to the products of this action, such as a mineral deposit precipitated from a hot aqueous solution; also, said of the solution itself. “Hydrothermal” is generally used for any hot water, but has been restricted by some to water of magmatic origin.

 

Igneous: Means a rock formed by the cooling of molten silicate material.

 

  7

 

Induced polarization (I.P.) method: The method used to measure various electrical responses to the passage of alternating currents of different frequencies through near-surface rocks or to the passage of pulses of electricity.

 

Intermediate: An igneous rock made up of both felsic and mafic minerals (diorite).

 

Intrusion: General term for a body of igneous rock formed below the surface.

 

Intrusive Rock: Any igneous rock solidified from magma beneath the earth’s surface.

 

Joint venture agreement: An agreement where the parties agree to the terms on which a property will be jointly explored, developed, and mined. (See also “Option agreement” and “Earn in”).

 

Jurassic: Geological time period between 195 and 136 million years ago.

 

Kriging: (a) A statistical technique employed in calculating grade and tonnage of ore reserves from sampling data. The data are handled by computer. (b) A technique for interpolating which honors data points exactly. An output point is calculated as a linear combination of known data points. Kriging attempts to produce the best linear unbiased estimate. Used to interpolate between drill holes.

 

K-silicate: Potassium-bearing silicates. Potassium silicates are very common rock-forming minerals, however they are also formed by the interaction of hydrothermal fluids derived from the cooling intrusive rocks that are genetically and spatially associated with porphyry and epithermal deposits. Potassium feldspar (orthoclase) and potassium mica (biotite) are both commonly closely associated with copper-molybdenum ore in porphyry copper deposits.

 

K-spar: Potassium feldspar.

 

Lava: Means an igneous rock formed by the cooling of molten silicate material which escapes to the earth’s surface or pours out onto the sea floor.

 

Limestone: Sedimentary rock that is composed mostly of carbonates, the two most common of which are calcium and magnesium carbonates.

 

Lithosphere: The crust and upper mantle, located above the asthenosphere and composing the rigid plates.

 

Mafic: A general term used to describe ferromagnesian minerals. Rocks composed mainly of ferromagnesian minerals are correctly termed melanocratic.

 

Magma: Naturally occurring molten rock material, generated within the earth and capable of intrusion and extrusion, from which igneous rocks have been derived through solidification and related processes. It may or may not contain suspended solids (such as crystals and rock fragments) and/or gas phases.

 

Massive: Implies large mass. Applied in the context of hand specimens of, for example, sulphide ores, it usually means the specimen is composed essentially of sulphides with few, if any, other constituents.

 

Metamorphic: Means any rock which is altered within the earth’s crust by the effects of heat and/or pressure and/or chemical reactions. Pertains to the process of metamorphism or to its results.

 

Metasediment: A sediment or sedimentary rock that shows evidence of having been subjected to metamorphism.

 

Metavolcanic: An informal term for volcanic rocks that show evidence of having been subject to metamorphism.

 

Mineral claim: A legal entitlement to minerals in a certain defined area of ground.

 

Mineral Deposit or Mineralized Material: A mineralized underground body which has been intersected by sufficient closely spaced drill holes and/or underground sampling to support sufficient tonnage and average grade of metal(s) to warrant further exploration-development work. This deposit does not qualify as a commercially mineable ore body (Reserves), as prescribed under Commission standards, until a final and comprehensive economic, technical, and legal feasibility study based upon the test results is concluded.

 

  8

 

Mineral: A naturally occurring, inorganic, solid element or compound that possesses an orderly internal arrangement of atoms and a unique set of physical and chemical properties.

 

Mineralization: Usually implies minerals of value occurring in rocks.

 

Net profits interest: A contractual granted right to some portion of the profits after deduction of expenses sometimes expressed as a form of royalty.

 

Net smelter returns: Means the amount actually paid to the mine or mill owner from the sale of ore, minerals and other materials or concentrates mined and removed from mineral properties. A royalty based on net smelter returns usually provides cash flow that is free of any operating or capital costs and environmental liabilities.

 

Option agreement: An agreement where the optionee can exercise certain options to acquire or increase an interest in a property by making periodic payments or share issuances or both to the optionor or by exploring, developing or producing from the optionor’s property or both. Usually upon the acquisition of such interest, unless it is a 100% interest, all operations thereafter are on a joint venture basis.

 

Ordinary kriging: The basic technique of kriging and uses a weighted average of neighboring samples to estimate the 'unknown' value at a given location. Weights are optimized using the semi-variogram model, the location of the samples and all the relevant inter-relationships between known and unknown values. The technique also provides a "standard error" which may be used to quantify confidence levels.

 

Ore: A natural aggregate of one or more minerals which may be mined and sold at a profit, or from which some part may be profitably separated.

 

Ore reserve: The measured quantity and grade of all or part of a mineralized body in a mine or undeveloped mineral deposit for which the mineralization is sufficiently defined and measured on three sides to form the basis of at least a preliminary mine production plan for economically viable mining.

 

Orogeny: The process of forming mountains by folding and thrusting.

 

Outcrop: An in situ exposure of bedrock.

 

Overburden: A general term for any material covering or obscuring rocks from view.

 

oz/t or opt: Ounces per ton.

 

Paleozoic: An era of geologic time, from the end of the Precambrian to the beginning of the Mesozoic, or from about 570 to about 225 million years ago.

 

Phenocrysts: An unusually large crystal in a relatively finer grained matrix.

 

Pluton: Term for an igneous intrusion, usually formed from magma.

 

Porphyry: An igneous rock composed of larger crystals set within a finer ground mass.

 

Pyroclastic rock: A rock of volcanic origin consisting of highly variable mixture of rock fragments, cinders and ashes and bits of crystals and glass.

 

Quartz monzonite: A course grained, plutonic igneous rock that is normally pale pink, and composed of quartz, alkali feldspar, micas and accessory minerals.

 

Rare Earth: A group of rare metallic chemical elements with consecutive atomic numbers of 57 to 71.

 

  9

 

Reclamation bond: A bond usually required by governmental mining regulations when mechanized work on a property is contemplated. Proceeds of the bond are used to reclaim any workings or put right any damage if reclamation undertaken does not satisfy the requirements of the regulations.

 

Reserve: That part of a mineral deposit which could be economically extracted or produced at the time of the reserve determination.

 

Reserves: A natural aggregate of one or more minerals which, at a specified time and place, may be mined and sold at a profit, or from which some part may be profitably separated.

 

Reverse circulation drill: A rotary percussion drill in which the drilling mud and cuttings return to the surface through the drill pipe.

 

Rhyolite: The fine grained equivalent of granite.

 

Royalty interest: A royalty, the calculation and payment of which is tied to some production unit such as ton of concentrate or ounce of gold or silver produced. A common form of royalty interest is based on the net smelter return.

 

Sample: Small amount of material that is supposed to be absolutely typical or representative of the object being sampled.

 

Sandstone: Composed of sand-sized fragments cemented together. As a rule the fragments contain a high percentage of quartz.

 

Sedimentary: A rock formed from cemented or compacted sediments.

 

Sediments: Are composed of the debris resulting from the weathering and breakup of other rocks that have been deposited by or carried to the oceans by rivers, or left over from glacial erosion or sometimes from wind action.

 

Selvage: A marginal zone, as in a dyke or vein, having some distinctive feature of fabric or composition.

 

Sericite: A fine-grained variety of mica occurring in small scales, especially in schists.

 

Shale: An argillaceous rock consisting of silt or clay-sized particles cemented together. Most shales are quite soft, because they contain large amounts of clay minerals.

 

Silicate: Most rocks are made up of a small number of silicate minerals ranging from quartz (SiO2) to more complex minerals such as orthoclase feldspar (KAlSi3O8) or hornblende (Ca2Na(Mg,Fe)4(Al,Fe,Ti)Si8)22(OH)2).

 

Sill: Tabular intrusion which is sandwiched between layers in the host rock.

 

Skarn: A thermally altered impure limestone in which material has been added to the original rock. Skarns are generally characterized by the presence of calcium and silica rich minerals. Many skarns contain sulphide minerals which in some cases can be of economic value.

 

Stock: An igneous intrusive body of unknown depth with a surface exposure of less than 104 square kilometres. The sides, or contacts, of a stock, like those of a batholith, are usually steep and broaden with depth.

 

Stockwork: A mineral deposit consisting of a three-dimensional network of closely spaced planar or irregular veinlets.

 

Strike: The bearing, or magnetic compass direction, of an imaginary line formed by the intersection of a horizontal plane with any planar surface, most commonly with bedding planes or foliation planes in rocks.

 

  10

 

Sulphide minerals: A mineral compound characterized by the linkage of sulfur with a metal or semimetal; e.g., galena.

 

Syncline: A fold in which the bed has been forced down in the middle or up on the sides to form a trough.

 

Tailings: Material rejected from a mill after recoverable valuable minerals have been extracted.

 

Tailings pond: A pond where tailings are disposed of.

 

Tonne: Metric ton – 1,000 kilograms – equivalent to 1.1023 tons.

 

Triassic: Geological time period between 225 and 195 million years ago.

 

Tuff: A finer grained pyroclastic rock made up mostly of ash and other fine grained volcanic material.

 

Veins: The mineral deposits that are found filling openings in rocks created by faults or replacing rocks on either side of faults.

 

Vuggy silica: In a high sulphidation epithermal environment, the highly acidic waters have dissolved everything but silica resulting in a highly porous and pox marker rock which is a good host for gold deposition. It is an indicator mineralization typical of epithermal rocks.

 

Waste: Rock which is not ore. Usually referred to that rock which has to be removed during the normal course of mining in order to get at the ore.

 

Glossary of Abbreviations

 

Ag: Silver

Ag g/t:   Silver grade measured in grams per metric ton
  Converts to ounces per ton by dividing by 34.286

Au: Gold

Au g/t:   Gold grade measured in grams per metric ton
  Converts to ounces per ton by dividing by 34.286

Cu: Copper

g/t: grams per tonne

IP: Induced Polarization geophysical survey

masl: meters above sea level

MPa: Megapascal or one million pascals.

NGO: Non-governmental organization

NSR: net smelter returns royalty

Oz: Troy ounce

Pa: one pascal

QA/QC: Quality Assurance/Quality Control

tpd: Tonnes per day

ton: Short ton (2,000 pounds)

tonne: Metric ton (1000 kilograms - 2204.62 pounds)

Conversion Table

Metric / Imperial

1.0 millimeter (mm) = 0.039 inches (in)

1.0 meter (m) = 3.28 feet (ft)

1.0 kilometer (km) = 0.621 miles (mi)

1.0 hectare (ha) = 2.471 acres (ac)

1.0 gram (g) = 0.032 troy ounces (oz)

1.0 metric tonne (t) = 1.102 short tons (ton)

1.0 g/t = 0.029 oz/ton

 

Unless otherwise indicated, all dollar ($) amounts referred to herein are in Canadian dollars.

  11

 


NOTE REGARDING MINERAL RESOURCE AND MINERAL RESERVE ESTIMATES

 

The U.S. Securities and Exchange Commission (the “SEC”) has adopted final rules to amend and modernize the mineral property disclosure requirements for issuers whose securities are registered with the SEC. These new rules have rescinded the historical property disclosure guidance for mining registrants included in SEC Industry Guide 7 and replaced them with the disclosure requirements in subpart 1300 of SEC Regulation S-K (“S-K 1300”).

 

The SEC now recognizes estimates of Mineral Resources categories “Measured Mineral Resources,” “Indicated Mineral Resources” and “Inferred Mineral Resources” in addition to the Mineral Reserve categories of “Proven Mineral Reserves” and “Probable Mineral Reserves”.

 

Mineral reserve is an estimate of tonnage and grade or quality of indicated and measured mineral resources that, in the opinion of the qualified person, can be the basis of an economically viable project. More specifically, it is the economically mineable part of a measured or indicated mineral resource, which includes diluting materials and allowances for losses that may occur when the material is mined or extracted.

 

· Proven mineral reserve is the economically mineable part of a measured mineral resource and can only result from conversion of a measured mineral resource.

 

· Probable mineral reserve is the economically mineable part of an indicated and, in some cases, a measured mineral resource.

 

Mineral resource is a concentration or occurrence of material of economic interest in or on the Earth's crust in such form, grade or quality, and quantity that there are reasonable prospects for economic extraction. A mineral resource is a reasonable estimate of mineralization, taking into account relevant factors such as cut-off grade, likely mining dimensions, location or continuity, that, with the assumed and justifiable technical and economic conditions, is likely to, in whole or in part, become economically extractable. Mineral Resources that are not Mineral Reserves do not meet the threshold for reserve modifying factors, such as estimated economic viability, that would allow for conversion to Mineral Reserves. There is no certainty that all or any part of a Mineral Resource will be converted into a Mineral Reserve.

 

· Measured mineral resource is that part of a mineral resource for which quantity and grade or quality are estimated on the basis of conclusive geological evidence and sampling. The level of geological certainty associated with a measured mineral resource is sufficient to allow a qualified person to apply modifying factors in sufficient detail to support detailed mine planning and final evaluation of the economic viability of the deposit. Because a measured mineral resource has a higher level of confidence than the level of confidence of either an indicated mineral resource or an inferred mineral resource, a measured mineral resource may be converted to a proven mineral reserve or to a probable mineral reserve.

 

· Indicated mineral resource is that part of a mineral resource for which quantity and grade or quality are estimated on the basis of adequate geological evidence and sampling. The level of geological certainty associated with an indicated mineral resource is sufficient to allow a qualified person to apply modifying factors in sufficient detail to support mine planning and evaluation of the economic viability of the deposit. Because an indicated mineral resource has a lower level of confidence than the level of confidence of a measured mineral resource, an indicated mineral resource may only be converted to a probable mineral reserve.

 

· Inferred mineral resource is that part of a mineral resource for which quantity and grade or quality are estimated on the basis of limited geological evidence and sampling. The level of geological uncertainty associated with an inferred mineral resource is too high to apply relevant technical and economic factors likely to influence the prospects of economic extraction in a manner useful for evaluation of economic viability. Because an inferred mineral resource has the lowest level of geological confidence of all mineral resources, which prevents the application of the modifying factors in a manner useful for evaluation of economic viability, an inferred mineral resource may not be considered when assessing the economic viability of a mining project, and may not be converted to a mineral reserve.

 

  12

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Statements contained in this Annual Report on Form 20-F (the “Annual Report”) of Almaden Minerals Ltd. (“Almaden” or the “Company”), and the exhibits attached hereto that are not historical facts are forward-looking statements and forward-looking information (collectively, “forward-looking statements”) within the meaning of U.S. and Canadian securities legislation and the U.S. Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties.

 

Such forward-looking statements include, but are not limited to, statements regarding the permitting review process for the Ixtaca Gold-Silver Project (“Ixtaca” or the “Ixtaca Project”) and the outcome of legal actions in Mexico that are based on assumptions about: the permitting and legal regimes in Mexico; economic and political conditions; success of exploration, development and environmental protection and remediation activities; the impact of legal actions in Mexico including the impact of the TFJA proceedings and SCJN decision, the timing, outcome, impact, and procedures relating to consultations under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) and the possible initiation of legal proceedings under the CPTPP; the timing, procedures and impact for any consultation and related activities by Economia with indigenous communities and the timing and procedures for Economia to issue mineral titles to Almaden, the impact and timing of any decisions relating to the Decree; Almaden’s belief that Mexico’s Ministry of Economy submission to the District Court is inconsistent with the Mexican Mining Law, the SCJN decision, and international law; the Company’s plans to re-submit a revised environmental permit application (“MIA”) to the Secretaría de Medio Ambiente y Recurso Naturales’ (“SEMARNAT”); the potential timing of a MIA resubmission; the Company’s belief that Ixtaca could, long after final closure, make meaningful and enduring positive contributions to surrounding communities and beyond; the Company’s expectation that the Ixtaca Project would create approximately 600 direct jobs during the peak of construction and 420 jobs during operations; the impact of the Ixtaca Project’s proposed dry-stack tailing facilities; the Company’s belief that the Company’s cash resources are sufficient to meet its working capital and mineral exploration requirements for the year ended December 31, 2024 (“Fiscal 2024”); the Company’s expectation to advance further elements of the community social investment plan as mining and construction advance; and the Company’s belief that the Ixtaca deposit can be an economically robust project that could provide the basis for further investment in the area. These statements relate to analyses and other information that are based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. Statements concerning Mineral Reserve and Mineral Resource estimates may also be deemed to constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if a property is developed, and in the case of Mineral Reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (often, but not always, using words or phrases such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates” or “intends”, or stating that certain actions, events or results “may”, “could”, “would”, “might” or “will” (or the negative and grammatical variations of any of these terms and similar expressions) be taken, occur or be achieved) are not statements of historical fact and may be forward-looking statements. Forward-looking statements are not a guarantee of future performance and are based upon a number of estimates and assumptions of management, in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this document including, without limitation, assumptions about: both Almaden’s and the applicable Mexican authorities’ legal positions; our assumption that our applications preserve our mineral rights and that mineral title will eventually be issued to Almaden; the permitting and legal regimes in Mexico; future economic and political conditions; the timing and costs of future activities on the Company’s properties, including but not limited to development and operating costs in the event that a production decision is made; success, timing, accuracy and results of exploration and drilling programs (including metallurgical testing), development and environmental protection and remediation activities; stability and predictability in Mexico’s mineral tenure, mining, environmental and agrarian laws and regulations, as well as their application and judicial decisions thereon; continued respect for the rule of law in Mexico; prices for gold, silver and base metals remaining as estimated; future currency exchange rates remaining as estimated; availability of funds; capital, decommissioning and reclamation estimates; prices for energy inputs, labour, materials, supplies and services (including transportation); no labour-related disruptions; the ability to secure and maintain mineral rights and ownership to properties and the surface rights necessary for operations; community support for the Ixtaca Project; the ability to comply with environmental, health and safety laws; favourable equity and debt capital markets; the ability to raise any

  13

 

necessary capital on reasonable terms to advance the development of the Ixtaca Project; expectations about the ability to acquire resources and/or reserves through acquisition and/or development; future metal prices; the current exploration, development, environmental and other objectives concerning the Ixtaca Project being achieved and other corporate activities proceeding as expected; that third party contractors and equipment, including the Rock Creek mill, will be available and operate as anticipated; the accuracy of any mineral reserve and mineral resource estimates; the timing and reliability of sampling and assay data; the accuracy of budgeted exploration and development costs and expenditures; the cut-off grades; the taxation policies which will apply to the Ixtaca Project being consistent with the Company’s expectations; the price of other commodities such as fuel; rates and interest rates; operating conditions being favourable, including whereby the Company is able to operate in a safe, efficient and effective manner; political and regulatory stability; that all necessary governmental and third party approvals, licences and permits for the planned exploration, development and environmental protection activities will be obtained in a timely manner and on favourable terms; obtaining required renewals for existing approvals; sustained labour stability; positive relations with local groups and the Company’s ability to meet any obligations under agreements with such groups; stability in financial and capital goods markets; and availability of equipment. While the Company considers these assumptions to be reasonable, the assumptions are inherently subject to significant business, social, economic, political, legal, regulatory, competitive and other risks and uncertainties, contingencies and other factors that could cause actual actions, events, conditions, results, performance or achievements to be materially different from those projected in the forward-looking information. Many assumptions are based on factors and events that are not within the control of the Company and there is no assurance they will prove to be correct. Some of the important risks, uncertainties and other factors that could affect forward-looking statements include, but are not limited to, those described further in the sections entitled “ITEM 3. KEY INFORMATION - Risk Factors”, “ITEM 4. INFORMATION ON THE COMPANY - Business Overview”, “ITEM 4. INFORMATION ON THE COMPANY – Principal Property Interests” and “ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS” and in the exhibits attached to this Annual Report. Should one or more of these risks, uncertainties and other factors materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the Company’s forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The forward-looking statements are based on beliefs, expectations and opinions of the Company’s management on the date of this Annual Report and speak only as of the date hereof and the Company does not undertake any obligation to publicly update forward-looking statements contained herein to reflect events or circumstances after the date hereof, except as required by law. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.

 

Forward-looking statements and other information contained herein concerning the mining industry and the Company’s expectations concerning the mining industry are based on estimates prepared by the Company using data from publicly available sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. However, this data is inherently imprecise, although generally indicative of relative market positions, market shares and performance characteristics. While the Company is not aware of any misstatements regarding any mining industry data presented herein, the industry involves risks and uncertainties and is subject to change based on various factors.

 

Certain historical and forward-looking statements contained in this Annual Report has been provided by, or derived from information provided by, certain persons other than the Company. Although the Company does not have any knowledge that would indicate that any such information is untrue or incomplete, the Company assumes no responsibility for the accuracy and completeness of such information or the failure by such other persons to disclose events which may have occurred or may affect the completeness or accuracy of such information, but which is unknown to the Company.

 

Please consult the Company’s public filings at www.sec.gov for further, more detailed information concerning these matters.

 

  14

 

PART I

 

Item 1. Identity of Directors, Senior Management and Advisors

 

Not applicable

 

Item 2. Offer Statistics and Expected Timetable

 

Not applicable

 

Item 3. Key Information

 

A. [Reserved]

 

B. Capitalization and Indebtedness

 

Not applicable.

 

C. Reasons for the Offer and Use of Proceeds

 

Not applicable.

 

D. Risk Factors

 

Speculative Nature of Resource Exploration and Development

Resource exploration and development is a speculative business, characterized by a number of significant risks including, among other things, unprofitable efforts resulting not only from the failure to discover mineral deposits but from finding mineral deposits which, though present, are insufficient in quantity and quality to return a profit from production. The marketability of minerals acquired or discovered by the Company may be affected by numerous factors which are beyond the control of the Company and which cannot be accurately predicted, such as market fluctuations, the proximity and capacity of milling facilities, mineral markets and processing equipment, and other factors such as government regulations, including regulations relating to royalties, allowable production, importing and exporting of minerals, and environment protection, the combination of which factors may result in the Company not receiving an adequate return on investment capital.

 

Presently, the Company is in the exploration and development stage and there is no assurance that a commercially viable ore deposit or mining operation will result in any of its properties or prospects until further work is done and a comprehensive economic evaluation based upon that work is concluded. In recent years the Company has financed its operations principally through the sale of equity securities. In the past, it has also financed its activities by entering into joint venture arrangements and through the sale of an inventory of gold. A commercially viable ore deposit and mining operation is dependent on the establishment of economically recoverable reserves, the ability of the Company to obtain the necessary financing and permitting to complete development and ultimately upon future profitable production or the realization of proceeds from the disposition of the properties.

 

Title to mineral properties

Almaden does not currently hold title to the mining concessions underlying the Ixtaca Deposit and there is no guarantee that it will in the future. The Mineral Rights may be materially adversely affected by the Amparo, the decision of the SCJN and the Economia Submission as discussed in Item 8 under the heading “Legal Proceedings”, and below under the title “Legal Dispute with Mexico Regarding Mineral Concessions Over Ixtaca Project”. There are significant risks that the impact of the decision of the SCJN and the Economia Submission may not be known for an extended period of time, and that the Company may lose all of its interest in some or all of its mineral claims and/or Mineral Rights. The properties may be subject to prior unregistered agreements or transfers and title may be affected by undetected defects. Furthermore, the Mineral Rights may be subject to prior unregistered agreements or transfers and title may be affected by undetected defects.

 

There is a risk that Mineral Rights or title to the mining concessions, the surface rights and access rights comprising Ixtaca and the necessary infrastructure, may be deficient or subject to additional disputes. The procurement or enforcement of such rights, or any dispute with respect to such rights, can be costly and time consuming. In areas where there are local populations or landowners, it may be necessary, as a practical matter, to negotiate surface access. Even in the event that the Company has the legal right to access the surface and carry on construction and mining activities, the Company may not be able to negotiate satisfactory agreements with existing landowners/occupiers for such access, and therefore it may be unable to carry out activities as planned. In addition, in circumstances where such access is denied, or no agreement can be reached, this could have a material adverse effect on the Company and the Company may need to rely on the assistance of local officials or the courts in such jurisdictions or pursue other alternatives, which may suspend, delay or impact mining activities as planned.

 

  15

 

There is also a risk that the Company’s exploration, development and mining authorizations and surface rights may be challenged or impugned by third parties. In addition, there is a risk that the Company will not be able to renew some or all its licenses in the future. Inability to renew a license could result in the loss of any project located within that license.

 

Legal Dispute with Mexico Regarding Mineral Concessions Over Ixtaca Project

On July 4, 2022, the Company reported that Economia was officially notified of the final decision of the Supreme Court of Justice of Mexico (“SCJN”) relating to the Mineral Title Lawsuit, and in turn notified Almaden that the Company’s mineral titles relating to the Ixtaca Project are “ineffective”, or void. The Company understood this to mean that the mineral title had reverted to application status, and that these applications preserved the mineral rights for Almaden but did not allow the Company to engage in exploration (the “Mineral Rights”), until such time as Economia completed the steps required in the court-ordered indigenous consultation in the area covered by the mineral title applications.

 

On February 22, 2023, the Company announced that Economia had made a submission to the second district court in Puebla State (the “District Court”), seeking to deny the two mineral title applications which were first made by Almaden in 2002 and 2008 (the “Submission”) and which underpin the Ixtaca deposit. The Submission claimed that the mineral title applications contained technical faults, despite Economia’s previous statements to the contrary and its acceptance of the mineral title applications and grant of the mineral titles in 2003 and 2009. By alleging technical faults in the mineral title applications, Economia appeared to be arbitrarily seeking to deny the grant of the mineral titles and avoid the indigenous consultation ordered by the February 2022 decision of the SCJN.

 

Later, on April 13, 2023, the Company announced that the District Court ruled that the Submission formally complied with the SCJN decision. The Company and some local community members filed separate appeals of the District Court decision with the Federal Appeals Court (“TCC”), and on October 16, 2023 the Company reported that the TCC dismissed all of the appeals filed by the Parties, and ruled the Submission is compliant with the 2022 decision of the SCJN, since the SCJN decision did not formally prevent Economia from reviewing the technical aspects of the mineral title applications. The TCC ruling did not address the validity of the Submission and therefore safeguarded the Company’s right to challenge the substance and legality of the Submission through the Mexican Federal Administrative Court (“TFJA”).

 

Subsequent to the Submission, the Company had initiated legal action in the TFJA and on October 16, 2023 announced that the TFJA granted a definitive injunction in relation to the Submission, which prevents Economia from releasing the mineral rights covered by Almaden’s mineral title applications to third parties while the trial continues, anticipated to last approximately 18 months in total.

 

If the Company’s legal proceedings are unsuccessful, it could result in the loss of the property which would have a negative effect on the Company’s operations and business plan.

 

Further information regarding this legal dispute is provided in Item 8 below under the heading “Legal Proceedings”.

 

Risk related to potential proceedings under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”)

On December 13, 2023 the Company delivered to the United Mexican States (“Mexico”) a Request for Consultations in accordance with the CPTPP relating to an investment dispute with Mexico, and on March 14, 2024, the Company delivered to Mexico notice of its intention to submit a claim to arbitration against Mexico in accordance with Article 9.19.3 of the CPTPP. The Company notes its desire for all parties to reach a mutually acceptable outcome swiftly and amicably. If such an outcome is not achieved within the six months time frame for consultations, the Company expects it will have no alternative but to commence legal proceedings before an arbitral tribunal and seek full compensation for damages the Company has suffered as a result of Mexico’s acts and omissions. In the event the Company commences legal proceedings and they are decided adversely to us, these legal proceedings, or others that could be brought against the Company in the future, could have a material adverse effect on our financial position or prospects. While the Company believes it has valid reasons to commence legal proceedings, litigation matters are inherently uncertain and there is no guarantee that if proceedings commence they will be successful, or that the likely outcome of this matter will be consistent with the ultimate resolution of the matter. Any legal proceedings would require the Company to incur significant expense, devote significant resources, and may generate adverse publicity, which could materially, and possibly adversely, affect its business. The Company’s inability to enforce its rights and the enforcement of rights on a prejudicial basis by foreign courts or international arbitral tribunals could have an adverse effect on the Company’s outlook. Outcomes in any legal proceedings and the process for recovering funds even if there is a successful outcome in any legal proceedings can be lengthy and unpredictable. Furthermore, there is a risk that the Company will be unable to secure the necessary funding to advance any legal proceedings.

 

  16

 

History of Net Losses, Lack of Cash Flow and Assurance of Profitability; Need for Additional Capital

The Company had net losses in a number of years since its date of incorporation. Due to the nature of the Company’s business, there can be no assurance that the Company will be profitable. The Company had net losses of $63,620,232 for the year ended December 31, 2023 (“Fiscal 2023”), $11,846,560 for the year ended December 31, 2022 (“Fiscal 2022”), and $2,668,254 for the year ended December 31, 2021 (“Fiscal 2021”).

 

The Company currently has no revenues from operations as all of its properties and prospects are in the exploration and development stage. There is no assurance that the Company will receive revenues from operations at any time in the near future. During Fiscal 2023, 2022 and 2021, the Company earned interest income and other income from Administrative service fees charged to Azucar Minerals Ltd. (“Azucar”) and Almadex Minerals Ltd. (“Almadex”).

 

At December 31, 2023, the Company had working capital of $4,830,735 including cash and cash equivalents of $4,245,983. Management estimates that the current cash position and potential future cash flows will be sufficient for the Company to carry out its business for the upcoming year.

 

The Company has not paid dividends on its shares since incorporation and the Company does not anticipate doing so in the foreseeable future.

 

Uncertainty of Obtaining Additional Funding Requirements

If the Company’s exploration and development programs are successful, additional capital will be required for the further development of an economic ore body and to place it in commercial production. The only material sources of future funds presently available to the Company are the sale of its equity capital, the incurring of debt, or the offering by the Company of an interest in its properties and prospects to be earned by another party or parties carrying out further development thereof.

 

Failure to obtain additional financing on a timely basis could cause the Company to forfeit its interest in such properties, dilute its interests in the properties and/or reduce or terminate its operations.

 

The Company is Subject to Numerous Laws and Regulations

The Company’s exploration activities are subject to extensive federal, provincial, state and local laws and regulations governing prospecting, development, production, exports, taxes, labour standards, occupational health and safety, mine safety and other matters in all the jurisdictions in which it operates. These laws and regulations are subject to change, can become more stringent and compliance can therefore become more costly. These factors may affect both the Company’s ability to undertake exploration and development activities in respect of future properties in the manner contemplated, as well as its ability to continue to explore, develop and operate those properties in which it currently has an interest or in respect of which it has obtained exploration and development rights to date. The Company applies the expertise of its management, advisors, employees and contractors to ensure compliance with current laws and relies on its land men and legal counsel in both Mexico and Canada.

 

Failure to comply with applicable laws and regulations may result in civil or criminal fines or penalties or enforcement actions, including orders issued by regulatory or judicial authorities enjoining, curtailing or closing operations or requiring corrective measures, installation of additional equipment or remedial actions, any of which could result in the Company incurring significant expenditures. The Company may also be required to compensate private parties suffering loss or damage by reason of a breach of such laws, regulations or permitting requirements. It is also possible that future laws and regulations, or a more stringent enforcement of current laws and regulations by governmental authorities, could cause additional expense, capital expenditures, restrictions on or suspensions of our operations and delays in the exploration and development of Ixtaca.

 

  17

 

Risks related to International Labour Organization (“ILO”) Convention 169 Compliance

The Company may, or may in the future, operate in areas presently or previously inhabited or used by indigenous peoples. As a result, the Company’s operations are subject to national and international laws, codes, resolutions, conventions, guidelines and other similar rules respecting the rights of indigenous peoples, including the provisions of ILO Convention 169. ILO Convention 169 mandates, among other things, that governments consult with indigenous peoples who may be impacted by mining projects prior to granting rights, permits or approvals in respect of such projects. Therefore, consultation with indigenous communities by Mexican authorities and the Company may be required for the Ixtaca Project.

 

ILO Convention 169 has been ratified by Mexico and indigenous consultation is a requirement of the SCJN decision. However, to date Mexico has not implemented procedures to ensure their compliance with ILO Convention 169.

 

As noted in Item 8. Financial Information, sub-heading “Legal Proceedings”, the SCJN has recently determined, that before issuing Almaden’s mineral titles, Economia should have provided for a consultation procedure with relevant Indigenous communities. Amongst other things, the decision orders Economia to declare Almaden’s mineral titles ineffective, or void (‘insubsistentes’) and to issue them again only following Economia’s review of the file and compliance with its obligation to carry out the necessary procedures to consult with Indigenous communities. Until the court-ordered consultation has been completed, for which there is significant uncertainty about time and outcome, the Company cannot proceed to construction and operation of the Ixtaca Project and is not able to engage in exploration. As reported above, Economia is seeking to deny the feasibility of the Ixtaca mineral title applications, which the Company is appealing in Mexican courts. If the Economia Submission stands, then indigenous consultation would be pre-empted and the Company will not have any Mineral Rights over the Ixtaca project. On the other hand, if the Company’s appeal is successful, Economia is likely to be required to proceed to indigenous consultation prior to any formal grant of mineral title at Ixtaca.

 

The standards for local implementation of the obligations assumed by Mexico under ILO Convention 169 regarding the human right to free, prior, informed consultation of indigenous communities are currently evolving. The SCJN decision has halted and at best is expected to result in a significant delay in project development notwithstanding the extensive engagement already conducted by the Company in relevant communities.

 

Government compliance with ILO Convention 169 can result in delays and significant additional expenses to the Company arising from the consultation process with indigenous peoples in relation to the Company’s exploration, mining or development projects. Moreover, any actual or perceived past contraventions, or potential future actual or perceived contraventions, of ILO Convention 169 by Mexico creates a risk that the permits, rights, approvals, and other governmental authorizations that the Company has relied upon, or may in the future rely upon, to carry out its operations or plans could be challenged by or on behalf of indigenous peoples.

 

Such challenges may result in, without limitation, additional expenses with respect to the Company’s operations, the suspension, revocation or amendment of the Company’s rights or mining, environmental or export permits, a delay or stoppage of the Company’s development, exploration or mining operations, the refusal by governmental authorities to grant new permits or approvals required for the Company’s continuing operations until the settlement of such challenges, or the requirement for the responsible government to undertake the requisite consultation process in accordance with ILO Convention 169.

 

As a result of the inherent uncertainty in respect of such proceedings, the Company is unable to predict what the results of any such challenges would be; however, any ILO Convention 169 proceedings relating to the Company’s operations in Mexico may have a material adverse effect on the business, operations, and financial condition of the Company.

 

  18

 

Political, economic and social environment

The Company’s mineral properties may be adversely affected by political, economic and social uncertainties which could have a material adverse effect on the Company’s results of operations and financial condition. Areas in which the Company holds or may acquire properties may experience local political unrest and disruption which could potentially affect the Company’s projects or interests. Changes in leadership, social or political disruption or unforeseen circumstances affecting political, economic and social structure could adversely affect the Company’s property interests or restrict its operations. The Company’s mineral exploration and development activities may be affected by changes in government regulations relating to the mining industry and may include regulations on production, price controls, labour, export controls, income taxes, expropriation of property, environmental legislation and safety factors.

 

Any shifts in political attitudes or changes in laws that may result in, among other things, significant changes to mining laws or any other national legal body of regulations or policies are beyond the control of the Company and may adversely affect its business. The Company faces the risk that governments may adopt substantially different policies, which might extend to the expropriation of assets or increased government participation in the mining sector. In addition, changes in resource development or investment policies, increases in taxation rates, higher mining fees and royalty payments, revocation or cancellation of mining concession rights or shifts in political attitudes in Mexico may adversely affect the Company’s business.

 

The Company’s relationship with communities in which it operates is critical to the development of the Ixtaca Project. Local communities may be influenced by external entities, groups or organizations opposed to mining activities. In recent years, anti-mining NGO activity in Mexico has increased. These NGOs have taken such actions as road closures, work stoppages and lawsuits for damages. These actions relate not only to current activities but often in respect to the mining activities by prior owners of mining properties. Such actions by NGOs may have a material adverse effect on the Company’s operations at the Ixtaca Project and on its financial position, cash flow and results of operations.

 

The Company may be subject to legal proceedings that arise in the ordinary course of business

Due to the nature of its business, the Company may be subject to regulatory investigations, claims, lawsuits and other proceedings in the ordinary course of its business. The Company’s operations are subject to the risk of legal claims by employees, unions, contractors, lenders, suppliers, joint venture partners, shareholders, governmental agencies or others through private actions, class actions, administrative proceedings, regulatory actions or other litigation. Plaintiffs may seek recovery of very large or indeterminate amounts, and the magnitude of the potential loss relating to such lawsuits may remain unknown for substantial periods of time. Defense and settlement costs can be substantial, even with respect to claims that have no merit. The results of these legal proceedings cannot be predicted with certainty due to the uncertainty inherent in litigation, including the effects of discovery of new evidence or advancement of new legal theories, the difficulty of predicting decisions of judges and juries and the possibility that decisions may be reversed on appeal. The litigation process could, as a result, take away from the time and effort of the Company’s management and could force the Company to pay substantial legal fees or penalties. There can be no assurances that the resolutions of any such matters will not have a material adverse effect on the Company’s business, financial condition and results of operations.

 

Environmental, Climate Change, Health and Safety Regulation Compliance

The Company’s exploration and development activities are subject to extensive laws and regulations governing environmental protection and employee health and safety promulgated by governments and government agencies.

 

Environmental (inclusive of climate change) and health and safety laws and regulations are complex and have become more stringent over time. Failure to comply with applicable environmental and health and safety laws may result in injunctions, damages, suspension or revocation of permits and imposition of penalties. Environmental regulation is evolving in a manner resulting in stricter standards and the enforcement of, and fines and penalties for, non-compliance are becoming more stringent.

 

The Company is also subject to various reclamation-related conditions. Reclamation requirements are designed to minimize long-term effects of mining exploitation and exploration disturbance by requiring the operating company to control possible deleterious effluents and to re-establish to some degree pre-disturbance land forms and vegetation. The Company is subject to such requirements in connection with its activities at Ixtaca. Any significant environmental issues that may arise, however, could lead to increased reclamation expenditures and could have a material adverse impact on the Company’s financial resources.

 

  19

 

There can also be no assurance that closure estimates prove to be accurate. The amounts recorded for reclamation costs are estimates unique to a property based on estimates provided by independent consulting engineers and the Company’s assessment of the anticipated timing of future reclamation and remediation work required to comply with existing laws and regulations. Actual costs incurred in future periods could differ from amounts estimated. Additionally, future changes to environmental laws and regulations could affect the extent of reclamation and remediation work required to be performed by the Company. Any such changes in future costs could materially impact the amounts charged to operations for reclamation and remediation.

 

Climate change regulations may become more onerous over time as governments implement policies to further reduce carbon emissions, including the implementation of taxation regimes based on aggregate carbon emissions. Some of the costs associated with reducing emissions can be offset by increased energy efficiency and technological innovation. However, the cost of compliance with environmental regulation and changes in environmental regulation has the potential to result in increased costs of operations, reducing the potential profitability of the Company’s future operations.

 

Due to increased global attention regarding the use of cyanide in mining operations, regulations may be imposed restricting or prohibiting the use of cyanide and other hazardous substances in mineral processing activities. If such legislation were to be adopted in a region in which the Company relies on the use of cyanide, it would have a significant adverse impact on the Company’s results of operations and financial condition as there are few, if any, substitutes for cyanide in extracting metals from certain types of ore.

 

While the Company intends to fully comply with all applicable environmental and health and safety regulations there can be no assurance that the Company has been or will at all times be in complete compliance with such laws, regulations and permits, or that the costs of complying with current and future environmental and health and safety laws and permits will not materially and adversely affect the Company’s future business, results of operations or financial condition.

 

Operating Hazards and Risks Associated with the Mining Industry

Mining operations generally involve a high degree of risk, which even a combination of experience, knowledge and careful evaluation may not be able to overcome. Hazards such as unusual or unexpected geological formations and other conditions are involved. Operations in which the Company has a direct or indirect interest will be subject to all the hazards and risks normally incidental to exploration, development and production of minerals, any of which could result in work stoppages, damage to or destruction of mines and other producing facilities, damage to or loss of life and property, environmental damage and possible legal liability for any or all damage or loss. The Company may become subject to liability for cave-ins and other hazards for which it cannot insure or against which it may elect not to insure where premium costs are disproportionate to the Company’s perception of the relevant risks. The payment of such insurance premiums and the incurring of such liabilities would reduce the funds available for exploration activities.

 

Uncertainty in Commercially Mineable Ore Deposits

There is no certainty that the expenditures to be made by the Company in the exploration of its properties as described herein will result in discoveries of mineralized material in commercial quantities. Most exploration projects do not result in the discovery of commercially mineable ore deposits and no assurance can be given that any particular level of recovery of ore reserves will in fact be realized or that any identified mineral deposit will ever qualify as a commercially mineable (or viable) ore body which can be legally and economically exploited. Estimates of reserves, mineral deposits and production costs can also be affected by such factors as environmental permitting regulations and requirements, weather, environmental factors, unforeseen technical difficulties, unusual or unexpected geological formations and work interruptions. In addition, the grade of ore ultimately mined may differ from that indicated by drilling results. Short term factors relating to ore reserves, such as the need for orderly development of ore bodies or the processing of new or different grades, may also have an adverse effect on mining operations and on the results of operations. There can be no assurance that minerals recovered in small-scale tests will be duplicated in large-scale tests under on-site conditions or in production scale. Material changes in ore reserves, grades, stripping ratios or recovery rates may affect the economic viability of any project.

 

  20

 

Uncertainty in Development of a Commercially Mineable Ore Deposit

The properties and prospects in which the Company has an interest are not in commercial production. A commercially viable ore deposit is dependent on the establishment of economically recoverable reserves, the ability of the Company to obtain the necessary financing and permitting to complete development, and ultimately upon future profitable production or the realization of proceeds from the disposition of the properties.

 

Uncertainty of Reserves and Mineralization Estimates

There are numerous uncertainties inherent in estimating proven and probable reserves and mineralization, including many factors beyond the control of the Company. The estimation of reserves and mineralization is a subjective process and the accuracy of any such estimates is a function of the quality of available data and of engineering and geological interpretation and judgment. Results of drilling, metallurgical testing and production and the evaluation of mine plans subsequent to the date of any estimate may justify revision of such estimates. No assurances can be given that the volume and grade of reserves recovered and rates of production will not be less than anticipated. Assumptions about prices are subject to greater uncertainty and metals prices have fluctuated widely in the past. Declines in the market price of base or precious metals also may render reserves or mineralization containing relatively lower grades of ore uneconomic to exploit. Changes in operating and capital costs and other factors including, but not limited to, short-term operating factors such as the need for sequential development of ore bodies and the processing of new or different ore grades, may materially and adversely affect reserves.

 

Mineral Prices May Not Support Corporate Profit

The mining industry in general is intensely competitive and there is no assurance that, even if commercial quantities of mineral resources are developed, a profitable market will exist for the sale of same. Factors beyond the control of the Company may affect the marketability of any substances discovered. The price of minerals is volatile over short periods of time and is affected by numerous factors beyond the control of the Company, including international economic and political trends, expectations of inflation, currency exchange fluctuations, interest rates and global or regional consumption patterns, speculative activities and increased production due to improved mining techniques. Material changes in mineral prices may affect the economic viability of any project.

 

Possible Dilution to Present and Prospective Shareholders

The Company’s plan of operation, in part, contemplates the financing of the conduct of its business by the issuance, for cash, of equity securities of the Company or incurring debt, or a combination of the two. Any transaction involving the issuance of previously authorized but unissued shares of common shares, or securities convertible into common shares, would result in dilution, possibly substantial, to present and prospective holders of common shares. The Company could also seek joint venture partners or funding sources such as royalties or streaming transactions. These approaches would dilute the Company’s interest in properties it has acquired.

 

Material Risk of Dilution Presented by Large Number of Outstanding Share Purchase Options and Warrants

As of April 26, 2024, there were share purchase options outstanding allowing the holders of these options to purchase 12,465,000 shares of the Company’s common shares and warrants allowing the holders of these warrants to purchase 500,000 shares of the Company’s common shares. Directors and officers of the Company in the aggregate hold 10,450,000 of these share purchase options. An additional 2,015,000 share purchase options are held by employees and consultants of the Company. Given the fact that as of April 26, 2024 there were 137,221,408 shares of common shares outstanding, the exercise of all of the existing share purchase options and warrants would result in dilution to the existing shareholders and could depress the price of the Company’s shares. The exercise of all outstanding share purchase options and warrants would cause the number of issued and outstanding common shares to rise 9%.

 

Dependence on Key Personnel

The Company depends highly on the business and technical expertise of its management and key personnel. There is little possibility that this dependence will decrease in the near term. As the Company’s operations expand, additional general management resources may be required. The Company maintains no “Key Man” insurance coverage, and the loss or unavailability of any of its key personnel could have a negative effect on the Company’s ability to operate effectively.

 

Conflict of Interest

Some of the Company’s directors and officers are directors and officers of other natural resource or mining-related companies. Duane Poliquin, Morgan Poliquin, Douglas McDonald, and Korm Trieu also serve as directors and/or officers of Azucar and Almadex. Almadex acts as a lender to the Company pursuant to a gold loan agreement dated as of May 14, 2019 (the “Gold Loan Agreement”). See the section entitled “Material Contracts. Elaine Ellingham also serves as a director of Alamos Gold Inc., and Omai Gold Mines Corp. Kevin O’Kane also serves on the Board of IAMGOLD Corporation (“IAMGOLD”) and NorthIsle Copper and Gold Inc. Ria Fitzgerald also serves as a director of Victoria Gold Corp. These associations may give rise from time to time to conflicts of interest, as a result of which, the Company may miss the opportunity to participate in certain transactions.

 

  21

 

The Ability to Manage Growth

Should the Company be successful in its efforts to develop its mineral properties or to raise capital for such development or for the development of other mining ventures it will experience significant growth in operations. If this occurs, management anticipates that additional expansion will be required in order to continue development. Any expansion of the Company’s business would place further demands on its management, operational capacity and financial resources. The Company anticipates that it will need to recruit qualified personnel in all areas of its operations. There can be no assurance that the Company will be effective in retaining its current personnel or attracting and retaining additional qualified personnel, expanding its operational capacity or otherwise managing growth. The failure to manage growth effectively could have a material adverse effect on the Company's business, financial condition and results of operations.

 

Foreign Operations

The Company currently has development projects located in Mexico. The Company’s foreign activities are subject to the risks normally associated with conducting business in foreign countries, including exchange controls and currency fluctuations, foreign taxation, laws or policies of particular countries, labor practices and disputes, and uncertain political and economic environments, as well as risks of war and civil disturbances, or other risks that could cause exploration or development difficulties or stoppages, restrict the movement of funds or result in the deprivation or loss of contract rights or the taking of property by nationalization or expropriation without fair compensation. Foreign operations could also be adversely impacted by laws and policies of the U.S. affecting foreign trade, investment and taxation.

 

Changes to Mexican Mining Taxes

In October 2013, the Mexican Congress approved a package of tax reforms which included significant changes to the country’s mining royalties and tax structure. These new laws had an effective date of January 1, 2014. The changes include a 7.5% special mining royalty on earnings before interest, taxes, depreciation and amortization and an additional 0.5% royalty on gross revenues from precious metal production. The new law also increases annual taxes on certain inactive exploration concessions by 50% to 100%. These changes may result in increased holding costs to the Company for its existing mineral concessions. These new taxes and royalties, any future increases to tax and royalty rates, or any new taxes imposed by the Mexican governmental authorities may materially and adversely affect the potential to define economic reserves on any Mexican properties and result in the Company’s Mexican properties being less attractive to potential optionees or joint-venture partners.

 

Foreign Incorporation and Civil Liabilities

The Company was created under amalgamation under the laws of the Province of British Columbia, Canada. With the exception of Alfredo Phillips, who is a resident of Mexico, all of the Company’s directors and officers are residents of Canada, and all of the Company’s assets and its subsidiaries are located outside the U.S. Consequently, it may be difficult for U.S. investors to affect service of process in the U.S. upon those directors and officers who are not residents of the U.S., or to realize in the U.S. upon judgments of U.S. courts predicated upon civil liabilities under applicable U.S. laws.

 

Competition

There is competition from other mining exploration companies with operations similar to those of the Company's. Many of the mining companies with which the Company competes have operations and financial strength many times greater than that of the Company. Such competitors could outbid the Company for such projects, equipment or personnel, or produce minerals at a lower cost which would have a negative effect on the Company’s operations and financial condition.

 

Volatility of Share Price

Market prices for shares of early stage companies are often volatile. Factors such as announcements of mineral discoveries, exploration and financial results, and other factors could have a significant effect on the price of the Company’s shares.

 

  22

 

Foreign Currency Fluctuations

At the present time, a majority of the Company’s activities are carried on outside of Canada. Accordingly, it is subject to risks associated with fluctuations of the rate of exchange between the Canadian dollar and foreign currencies.

 

The Company is currently not engaged in currency hedging to offset any risk of exchange rate fluctuation and currently has no plans to engage in currency hedging.

 

Lack of a Dividend Policy

The Company does not intend to pay cash dividends in the foreseeable future, as any earnings are expected to be retained for use in developing and expanding its business. However, the actual amount of dividends which the Company may pay will remain subject to the discretion of the Company’s Board of Directors (the “Board”) and will depend on results of operations, cash requirements and future prospects of the Company and other factors.

 

ESTMA Risks

The Extractive Sector Transparency Measures Act (Canada) (“ESTMA”) requires public disclosure of certain payments to governments by companies engaged in the commercial development of minerals which are publicly listed in Canada. Mandatory annual reporting is required for extractive companies with respect to payments made to foreign and domestic governments, including aboriginal groups. ESTMA requires reporting on the payments of any taxes, royalties, fees, production entitlements, bonuses, dividends, infrastructure reporting or structuring payments to avoid reporting. If the Company becomes subject to an enforcement action or is in violation of ESTMA, this may result in significant penalties or sanctions which may also have a material adverse effect on the Company’s reputation.

 

The Impacts of a Health Pandemic or Outbreak of Contagious Disease

The Company’s business could be significantly adversely affected by the effects of a widespread global outbreak of contagious disease, including the recent outbreak of respiratory illness caused by COVID-19. The Company cannot accurately predict the impact COVID-19 and its variants will have on third parties’ ability to meet their obligations with the Company, including due to uncertainties relating to the ultimate geographic spread of the virus, the severity of the disease, the duration of the outbreak, and the length of travel and quarantine restrictions imposed by governments of affected countries. In particular, the continued spread of COVID-19 and its variants globally could materially and adversely impact the Company’s business including without limitation, employee health, limitations on travel, the availability of industry experts and personnel, restrictions to planned exploration and drill programs, receipt of necessary government approvals, regulatory compliance, and other factors that will depend on future developments beyond the Company’s control. In addition, a significant outbreak of contagious diseases in the human population could result in a widespread health crisis that could adversely affect the economies and financial markets of many countries (including those in which the Company operates), resulting in an economic downturn that could negatively impact the Company’s operations and ability to raise capital.

 

Cybersecurity Risks

As is typical of modern businesses, the Company is reliant on the continuous and uninterrupted operation of its information technology (“IT”) systems. User access and security of all Company sites and IT systems can be critical elements to its operations, as is cloud security, security of all of the Company’s IT systems, and protection against cyber security incidents. Any IT failure pertaining to availability, access or system security could potentially result in disruption of the activities of the Company and its personnel, and could adversely affect the reputation, operations or financial performance of the Company.

 

Potential risks to the Company’s IT systems could include unauthorized attempts to extract business sensitive, confidential or personal information, denial of access extortion, corruption of information or disruption of business processes, or by inadvertent or intentional actions by the Company’s employees or vendors. A cybersecurity incident resulting in a security breach or failure to identify a security threat could disrupt business and could result in the loss of sensitive, confidential or personal information or other assets, as well as litigation, regulatory enforcement, violation of privacy or securities laws and regulations, and remediation costs, all of which could materially impact the Company’s business or reputation.

 

  23

 

As a result of social media and other web-based applications, companies today are at much greater risk of losing control over how they are perceived

Damage to the Company’s reputation can be the result of the actual or perceived occurrence of any number of events, and could include any negative publicity, whether true or not. Although the Company places a great emphasis on protecting its image and reputation, it does not ultimately have direct control over how it is perceived by others. Reputation loss may lead to increased challenges in developing and maintaining community relations, decreased investor confidence and act as an impediment to the Company’s overall ability to advance its projects, thereby having a material adverse impact on the Company’s business, financial condition or results of operations.

 

International Conflict

International conflict and other geopolitical tensions and events, including war, military action, terrorism, trade disputes, and international responses thereto have historically led to, and may in the future lead to, uncertainty or volatility in global commodity and financial markets. Russia’s recent invasion of Ukraine has led to sanctions being levied against Russia by the international community and may result in additional sanctions or other international action, any of which may have a destabilizing effect on commodity prices and global economies more broadly. Volatility in commodity prices may adversely affect the Company’s business, financial condition and results of operations. The extent and duration of the current Russian-Ukrainian conflict and related international action cannot be accurately predicted at this time and the effects of such conflict may magnify the impact of the other risks identified in this Annual Information Form, including those relating to commodity price volatility and global financial conditions. The situation is rapidly changing and unforeseeable impacts, including on our shareholders and counterparties on which we rely and transact with, may materialize and may have an adverse effect on the Company’s business, results of operation and financial condition.

 

Emerging Growth Company Transition Period

Pursuant to the JOBS Act of 2012 and Section 7(a)2(B) of the Securities Act, the Company is taking advantage of the extended transition period for Emerging Growth Companies. When an accounting standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the standard for the private company. This may make comparison of the Company’s financial statements with any other public company which is not either an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible as different or revised standards may be used.

 

The Company could be deemed a passive foreign investment company which could have negative consequences for U.S. investors.

The Company could be classified as a Passive Foreign Investment Company (“PFIC”) under the United States tax code. If the Company is a PFIC, then owners of the Company’s shares who are U.S. taxpayers generally will be required to include distributions or any gain realized upon a disposition or deemed disposition of shares, as ordinary income and to pay an interest charge on a portion of such distribution or gain, unless the taxpayer timely makes a qualified electing fund ("QEF") election or a mark-to-market election with respect to the Company’s shares.

 

Item 4. Information on the Company

 

A. History and Development of the Company

The head office of the Company is located at 1333 Johnston Street, Suite 210, Vancouver, British Columbia, Canada, V6H 3R9. The address of the registered office of the Company is 1177 West Hastings Street, Suite 1710, Vancouver, British Columbia, Canada, V6E 2L3.

 

Computershare Investor Services Inc., at its offices in Vancouver, B.C. and Toronto, Ontario, is the registrar and transfer agent of the Company’s Common Shares.

 

The contact person is Korm Trieu, Chief Financial Officer. The telephone number is (604) 689-7644. The fax number is (604) 689-7645. The email address is ktrieu@almadenminerals.com. The web-site address is www.almadenminerals.com.

 

The Company was formed by amalgamation under the laws of the Province of British Columbia of its predecessor companies, Almaden Resources Corporation and Fairfield Minerals Ltd., on February 1, 2002. The Company operates under the Business Corporations Act (British Columbia) (the “BCBCA”).

 

  24

 

Effective July 31, 2015, the Company effected a corporate reorganization pursuant to a statutory plan of arrangement (“Plan of Arrangement”) involving the Company’s then wholly owned subsidiary, Azucar, as described below.

 

The Company’s common shares began trading on the Toronto Stock Exchange (“TSX”) under the symbol “AMM” on February 11, 2002 and on the NYSE American (formerly the NYSE MKT), under the symbol “AAU” on December 19, 2005. The Company delisted from the NYSE American effective April 4, 2024 and concurrently began trading on the OTCQB Marketplace, under the symbol “AAUAF”. Almaden Resources Corporation’s initial public offering on the Vancouver Stock Exchange was pursuant to a prospectus dated October 10, 1986. The shares of Fairfield Minerals Ltd. began trading on the Vancouver Stock Exchange on July 18, 1986 and on the TSX on May 21, 1990.

 

There have been no public takeover offers by third parties in respect of the Company’s common shares and the Company has made no public takeover offers in respect of any other company’s shares.

 

Business of the Company

The Company is engaged in the business of the acquisition, exploration and when warranted, development of mineral properties. The Company currently has one material property in Mexico, which is at the exploration and development stage. The Company has not generated any revenues from operations.

 

Corporate Reorganization

The Company entered into an Arrangement Agreement dated May 11, 2015 involving the spinout, pursuant to a statutory Plan of Arrangement, of Almaden’s early stage exploration projects, royalty interests and other non-core assets into a new public company called Azucar (formerly Almadex Minerals Limited), which trades on the TSX Venture Exchange (the “TSXV”) under the symbol “AMZ” and the OTCQB marketplace under the symbol “AXDDF”, pursuant to which Azucar acquired the following key assets:

 

· a 100% interest in the El Cobre copper-gold porphyry exploration project in Mexico and the Willow copper-gold porphyry exploration project in Nevada, in addition to a portfolio of 20 other exploration projects;
· a 2% NSR on the Company’s Tuligtic property in Mexico, which hosts the Company’s Ixtaca gold-silver development project;
· a 1.5% NSR on the Caballo Blanco gold deposit in Mexico, a development project operated by Timmins Gold Corp.;
· a 2% NSR on the Elk gold deposit in Canada, an advanced exploration project operated by JDL Gold Corp. (formerly Gold Mountain Mining Corp.);
· a portfolio of 21 additional NSRs on exploration projects in Mexico, Canada and the United States identified through the Company’s past prospect generator activities;
· equity holdings in several publicly-listed companies;
· 1,597 ounces of gold bullion; and
· approximately $3 million in cash.

 

On July 31, 2015, all conditions to the statutory Plan of Arrangement regarding the spinout were satisfied or waived and the spinout was effective. Almaden’s shareholders approved the Plan of Arrangement and exchanged their existing common shares of Almaden for one “new” Almaden common share and 0.6 common share of Azucar.

 

The Company entered into an Administrative Services Agreement with Azucar dated May 15, 2015, as amended by First Amending Agreement dated December 16, 2015 (the “Agreement”). Under the Agreement, the Company is the sole and exclusive manager of Azucar, and provides Azucar with general management services and day-to-day operation of Azucar. These services include:

 

· Office space;
· Executive personnel and human resources;
· Geological technical support; and
· Accounting and financial services.

  25

 

Azucar compensates the Company 5% (2022 – 13%) of the Company’s actual monthly cost of rent for any shared facilities, and 5% (2022 – 13%) of any shared personnel’s fees and/or wages. Azucar pays the Company any reasonable fees or costs incurred on behalf of Azucar by the Company which were approved by Azucar.

 

Effective May 18, 2018, Azucar effected a corporate reorganization pursuant to a statutory plan of arrangement involving Azucar’s then wholly owned subsidiary, Almadex. Consequent upon this corporate reorganization the Company entered into an Administrative Services Agreement with Almadex dated March 29, 2018 (the “Almadex Agreement”). Under the Almadex Agreement, the Company is the sole and exclusive manager of Almadex, and provides Almadex with general management services and day-to-day operation of Almadex. These services include:

 

· Office space;
· Executive personnel and human resources;
· Geological technical support; and
· Accounting and financial services.

 

Almadex compensates the Company 66% (2022 – 49%) of the Company’s actual monthly cost of rent for any shared facilities, and 66% (2022 – 49%) of any shared personnel’s fees and/or wages. Almadex pays the Company any reasonable fees or costs incurred on behalf of Almadex by the Company which were approved by Almadex.

 

Both the Agreement and the Almadex Agreement (together, the “Administrative Services Agreements”) had initial 5-year terms, with subsequent automatic 1-year renewals unless terminated pursuant to the terms permitted under the Administrative Services Agreements. The Administrative Services Agreements include a Change of Control clause. If either party is subject to a Change of Control during the term of the respective Administrative Services Agreement, the Administrative Services Agreement shall automatically terminate within 48 hours of the Change of Control unless agreed to in writing by both parties. The target of the Change of Control shall then pay the other party $2 million as compensation for the unplanned termination of the Company’s engagement and significant disruption to the other party’s business. “Change of Control” means the date upon which, without the written concurrence of the target of the Change of Control, any person (as that term is defined in the Securities Act (British Columbia)) makes and does not withdraw a take-over bid (as that term is defined in the Securities Act (British Columbia)) or acquires, directly or indirectly, that number of common shares of the target which equals or exceeds twenty percent (20%) of the then issued common shares of the target.

 

Available Information

The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC on www.sec.gov. You can also find information on our website www.almadenminerals.com. The information contained on our website is not a part of this annual report.

 

B. Business Overview

 

The Company is engaged in the business of the acquisition, exploration and when warranted, development of mineral properties. The Company currently holds Mineral Rights to one material property in Mexico. The Company has not generated any revenues from operations.

 

Maintaining properties

 

The following is a general statement about government requirements for holding mineral properties in the jurisdictions where the Company currently holds material mineral property interests.

 

In Mexico, mining law is a federal matter and according to current legislation, derived from the legal reform published in the Official Gazette of the Federation on May 08, 2023, there are a series of obligations imposed by mining concessions, which are described in general terms as follows:

 

a. To present, prior to the granting of the concession title, a financial vehicle to guarantee the prevention measures.
b. To have the authorization of the Mine Restoration, Closure and Post-Closure Program, as provided in the General Law of Ecological Balance and Environmental Protection.

  26

 

c. Implement water reuse measures within the mining lot.
d. Incorporate a social impact study and indigenous consultation.
e. File assessment work reports.
f. To give notice of the beginning of its operations and to report various reports on permits, authorizations, and rulings on labor matters such as health and safety.
g. Pay mining rights.

 

With respect to mining rights payments, according to the Federal Law of Duties in Force, if a concession holder has not conducted exploration or exploitation activities during a two-year period, the concession holder would have to pay an additional 50% of the taxes payable per hectare if within the last 11 years, and an additional 100% of the taxes payable if after year 12. Land taxes per hectare also have to be paid by January 31 and July 31 each year. Both amounts are subject to inflation accounting and the inflation adjustment number for each fiscal period is published in the Official Gazette of the Federation.

 

Under the Mexican Constitution and the mining and environmental laws of Mexico, all mining projects are subject to Federal legal control. This control is exercised from the exploration phase through the closure phase of a mining project. Prior to the initiation of exploration activities, concession owners are required to file a notice of commencement of exploration activities in conformity with Mexican Official Norm 120 (NOM-120) or an Preventive Report (Informe Preventivo); prior to initiation of construction activities (and also in some more intrusive exploration activities), mining projects are required to apply for and obtain an environmental impact authorization and a land use permit from the Mexican Federal environmental agency SEMARNAT (Secretaria de Medio Ambiente y Recursos Naturales). This requires the presentation of an environmental impact manifest and a technical study which deals with the impacts, the environmental mitigation, and habitat compensation to the satisfaction of the authorities having environmental jurisdiction.

 

Competition

 

The mineral property exploration and development business, in general, is intensively competitive and there is not any assurance that even if commercial quantities of ore are discovered, a ready market will exist for sale of same. Numerous factors beyond the Company’s control may affect the marketability of any substances discovered. These factors include market fluctuations; the proximity and capacity of natural resource markets and processing equipment; and government regulations, including regulations relating to prices, taxes, royalties, land tenure, land use, importing and exporting of minerals and environmental protection. The exact effect of these factors cannot be accurately predicted, but the combination of these factors may make it difficult for the Company to receive an adequate return on investment.

 

The Company competes with many companies possessing greater financial resources and technical facilities for the acquisition of mineral concessions, claims, leases and other mineral interests as well as for the recruitment and retention of qualified employees.

 

Seasonality

 

The Company’s Ixtaca Project is in central Mexico. In Mexico, the climate in the project area is marked by dry, cold winters and a distinct rainy season. The rainy season typically begins in May or June and continues until late September to October. In most years, roads remain passable and exploration can be done throughout the rainy season. Seasonal changes do not have a material impact on the Company’s exploration expenditures.

 

Exploration Program Protocols

 

General Sample Handling and Quality Control Program for Exploration Programs

 

The Company employs a strict quality control program for samples taken during its exploration programs. For drilling programs, a quality control program is in place which includes the insertion of blanks, field duplicates and certified standards into the sample stream.

 

Chain of Custody

Samples of rock and drill core and cuttings are sealed by the sampler and kept under control of a qualified person until they are shipped to a laboratory.

 

  27

 

Sample Handling

Sample handling for drilling programs is described more fully below. Soil and stream sediment samplers have been trained to industry standard levels of sampling methodology. In general, the Company sieves stream sediment samples to -20 mesh in the field during preparation. Samplers are required to not wear any jewellery or clothing or use equipment which may contaminate the sample. All sample locations are geographically located at the time of sampling using the Global Positioning System. The Company has prepared standardized sample information cards for samplers to record information concerning the sample location, type and medium. Outcrop, float and dump rock samples are collected by geologists who record similarly ordered geologic information relating to the sample taken.

 

Blanks

Blank material, a sample of crushed and pulverized rock, known to contain very low or non-detectable concentration of gold and silver, is inserted as a pulp into the sample stream on an interval of every 20 samples. Blanks are intended to detect possible contamination.

 

Duplicates

During drill programs the Company routinely includes a field duplicate into the sample stream, spaced at 20 sample intervals. Field duplicate samples are splits of drill core or reverse circulation cuttings from the sample interval. The resulting two field duplicate samples are submitted with separate sample numbers “blind” to the assay lab and separately treated as normal samples. The samples are taken randomly with no regard to rock type, geographic position or degree of alteration or mineralization. These field duplicates are then used to detect the cumulative uncertainties associated with the entire sampling and analytical process.

 

Standards

During drill programs the Company routinely includes a certified standard into the sample stream, spaced at 20 sample intervals. Certified standards are purchased from CDN Resource Laboratories of Langley, BC and are prepared by this professional third-party lab according to industry standard and accepted methodologies. Standards are utilized to monitor the accuracy of the laboratory work.

 

Sample Handling for Drill Programs

 

Core Box Preparation

Plastic core boxes are used for the storage of core. Each box is labelled by the drillers at the drill rig with the drill-hole number, a box number and an arrow to mark the start of the tray and the down-hole direction. Wooden core blocks, with the meterage in black marker pen, are inserted by the drillers at the end of each core run (usually 3 m or less). These core run intervals are checked and recorded by the geologist during mark up (see below). When filled with core the boxes are sealed with a plastic lid by the drillers and transported to the core logging facility.

 

Sample and Core Box Markup

Once at the core logging facility, the core boxes are marked up with the starting and ending meterage, written at the ends of the trays with a marker. The start and end of each selected sample interval is marked with a red wax pencil mark across the core and sample numbers are written on the edge of the core box channels at the start and end of each sample interval. Intervals denoting the position in the sample tag sequence of field duplicate, blank and analytical standards are also marked on the core box. A cut line was marked on the core as a guide for sawing of half-core samples for assay. The cut line position is marked by fitting the ends of the core together, to align them as they came out of the hole, and using a ruler to draw a line down the core axis with a red wax pencil. This mark-up is done after the trays are photographed. Cut line positions are selected by the logging geologist to produce two halves with equal proportions of mineralization. Typically, this is done by marking the cut line down the long axis of the ellipses described by the intersection of the veins with the core circumference. Each tray is digitally photographed before core cutting and sampling.

 

Core Logging

Before cutting and sampling the core, the following tables of data are entered into the Company drill hole database system:

 

  28

 

Geotechnical Logging

1. Core box record sheet: Beginning and end from/to intervals for each core box.

 

2. For each core run (from and to) a record of the core size, meters of core recovered for the interval, RQD (the total length of pieces of core in the interval that are twice the width of the core divided by the length of the interval, times 100) and hardness (on a scale from 1 to 10, from hardest to softest).

 

3. A drilling daily control sheet showing the progress of the drill rig for each shift.

 

Geological Logging

1. Geology Log: Intervals selected by the geologist recording a detailed description of the lithology, texture, alteration, mineral assemblage and intensity and level of oxidation/weathering. Structural measurements (i.e. the angle of structures to the core axis) are also recorded. The cover sheet includes details such as surveyed collar co-ordinates, downhole survey data, core size depths, drilling dates and sample number series.

 

2. Veining and Mineralization: Estimates of the percent veining and the percentage of different minerals represented in either vein, breccia or disseminated form, i.e. quartz, carbonates, pyrite etc.

 

3. Sample Sheet: A record of the sample intervals, sample numbers and duplicate, blank and analytical standard numbers.

 

4. Hole Summary: An abbreviated hole log that summarizes the important features of a drill hole. A summary drill hole trace giving the geologist the opportunity to summarize the hole and sketch in structural orientations in a form easily transferred to sections. All logs are saved on the server along with the core photos and other data from each hole.

 

Sample Interval Selection

All strongly altered or mineralized intervals of core were sampled. Sampling always began at least 5 samples above the start of mineralization. Sample intervals were selected using the following criteria.

- Maximum sample length of 2 m in unmineralized lithologies.
- Maximum sample length of 1 m in mineralized lithologies.
- Minimum sample length of 50 cm. Geological changes in the core such as major mineralization/alteration intensity and lithology changes were used as sample breaks.
- Core size changes and any zones of core loss were used as sample breaks.
- Large discrete veins that might possibly be modeled or mined as separate structures were sampled separately.

 

The begin/end marks were placed so that the entire vein ended up in the sample(s) and the vein is not smeared into samples on either side.

 

Sampling Procedure

All samples were originally cut in half using custom-made, gasoline engine-powered diamond core saws. All were recently changed to electric powered saws. Each saw has sliding trays and customized “core cradles” sized for each core diameter in order to ensure a straight cut down the cut line and to minimize the loss of friable core during cutting. Areas of very soft rock (e.g. fault gouge), are cut with a machete, using the side of the core channel to ensure a straight cut. Areas of very broken core (pieces <1 cm) were sampled using spoons. The following standard sampling procedures were employed:

 

The right-hand side of the core (looking down the hole) was always sampled. After cutting, half the core was placed in a new plastic sample bag and half was placed back in the core box. Between each sample, the core saw and sampling table areas were washed to ensure no contamination between samples. Field duplicate, blank and analytical standards were added into the sample sequence as they were being cut. After cutting of samples containing visible gold, a piece of abrasive quartz sandstone was cut to clean the diamond blade. This was done to prevent contamination of the following sample with gold that may have become smeared onto the blade.

 

Sample numbers were written on the outside of the sample bags twice and the tag from the sample book was placed inside the bag with the half core. The bags were sealed using single-use plastic cable ties.

 

Sample numbers on the bags were checked against the numbers on the core box and the sample book.

 

  29

 

The core cutting area is within the core logging shed and the logging geologists regularly checked the precision of the core cutting and sampling. The sealed plastic sample bags were placed in large plastic twine (rice) sacks (usually between 8 and 10 samples per sack) and sealed using single-use plastic cable ties. The sacks were weighed and the sack number, sample numbers, sack weight and date written on the outside of the sacks.

 

C. Organizational Structure

 

The Company currently has three wholly-owned (direct or indirect) subsidiaries. These subsidiaries are:

 

Subsidiaries Jurisdiction   Nature of operations
Puebla Holdings Inc. Canada   Holding company
Minera Gorrion, S.A. de C.V. Mexico   Exploration company

 

D. Property, Plants and Equipment

 

Company’s Principal Property

 

The Tuligtic Project, which hosts the Ixtaca discovery, is the only project material to the Company. The Tuligtic Project property (the “Tuligtic Property” or the “Property”) is located in Puebla State, Mexico at 618,800m east and 2,176,100m north (UTM NAD83 Zone 14 coordinates).

 

The Tuligtic Property/Ixtaca Project – Mexico

 

Location and Access

The Ixtaca deposit, the epithermal gold-silver target within the Tuligtic Property, is located 8 km northwest of the town of San Francisco Ixtacamaxtitlán, the county seat of the municipality of Ixtacamaxtitlán, Puebla State. The Ixtaca Project is accessible by driving 40 km east along Highway 119 from Apizaco, an industrial center located approximately 50 km north of Puebla City by two-lane Highway, and then north approximately 2 km along a paved road to the town of Santa Maria. The trip from Apizaco to site can be driven in approximately 1.5 hours. There is also access to the Tuligtic Property using gravel roads from the northeast via Tezhuitan and Cuyoaco, from the south via Libres and from the northwest via Chignahuapan. The Xicohtencatl Industrial complex lies 30 km southwest by paved road from the Ixtaca Project, and houses agricultural, chemical, biomedical and industrial manufacturing facilities and is serviced by rail. Puebla, the fourth largest city in Mexico has a population in excess of 4 million people, and includes one of the largest Volkswagen automotive plants outside Germany.

 

The Topography on the Tuligtic Property is generally moderate to steep hills with incised stream drainages. Elevation ranges from 2,300 meters (m) above sea level in the south to 2,800 m in the north. Vegetation is dominantly cactus and pines and the general area is also somewhat cultivated with subsistence vegetables, bean and corn crops. The Ixtaca Zone (as defined below) exploration area has been previously cleared and logged. The region has a temperate climate with mean monthly temperatures ranging from 16°C in June to 12°C in January. The area experiences approximately 714 mm of precipitation annually with the majority falling during the rainy season, between June and September. Annual evapotranspiration is estimated to be 774 mm. Exploration can be conducted year-round within the Tuligtic Property; however, road building and drilling operations may be impacted by weather to some degree during the rainy season. Electricity is available on the Tuligtic Property from the national electricity grid that services nearby towns such as Santa Maria and Zacatepec. The surface rights locally are privately owned and Almaden has negotiated voluntary surface land use agreements with surface landowners within the exploration area prior to beginning activities. To date Almaden has secured through purchase agreements over 1,139 hectares, from numerous independent owners.

 

  30

 

 

 

Claims and Title

Almaden’s interest with respect to the Tuligtic Property is held by Minera Gorrion S.A. de C.V., a subsidiary of Almaden, through the holding company, Puebla Holdings Inc., and is subject to a 2% NSR in favour of Almadex.

 

To maintain a claim in good standing in Mexico, the holder is required to meet annual exploration or exploitation expenditure requirements. Given that the Original Concessions have reverted to application status, the Company has been advised that currently there are no taxes or expenditure requirements relating to them.

 

Almaden does not currently hold title to the mineral concessions underlying the Ixtaca Deposit and there is no guarantee that it will in the future. The Tuligtic Property was identified by Almaden in 2001, following the recognition of surficial clay deposits that were interpreted to represent high-level epithermal alteration. The Cerro Grande concession was granted to the Company in 2003, and the Cerro Grande 2 concession was granted to the Company in 2009. The Property originally consisted of approximately 14,000 hectares (the “Original Concessions”), as shown below:

 

  Claim Name Claim Number Area (hectares) Valid Until Date  
  Cerro Grande 219469 11,202 March 5, 2053  
  Cerro Grande 2 233434 3,028 February 23, 2059  
  Total   14,230    

 

Legal Dispute

 

On April 7, 2015, the Ejido Tecoltemi, a community granted communal agrarian lands by the Mexican Government and whose lands (the “Ejido Lands”) overlapped with the southeastern portion of the Company’s original mineral concessions, filed an Amparo in a lower court in Puebla State, claiming that Mexico’s mineral title system is unconstitutional because Indigenous consultation is not required before the granting of mineral title (the “Amparo” or “Mineral Title Lawsuit”). The Amparo was against the Mexican government (President, Congress, Ministry of Economy, Directorate of Mines, Mining Registry Office), and used the Company’s two Original Concessions covering the Ixtaca Project as the subject matter of the Amparo. Almaden, through its Mexican subsidiary Minera Gorrión, was therefore considered an interested party in the Amparo. The Original Concessions covered Almaden’s Ixtaca Project and the Ejido Lands. The Ejido Lands overlapped approximately 330 ha of the far southeastern corner of the Original Concessions.

 

  31

 

Shortly after the Amparo was filed in April 2015, the lower court in Puebla State ordered the suspension of Almaden from conducting exploration and exploitation work over those portions of the Original Concessions which overlap with the Ejido Lands.

 

Mineral tenure over the Ejido Lands is not material to the Ixtaca Project. The Ejido Lands do not overlap the Ixtaca Project or its environmental or social area of impact. Almaden has never tried to negotiate access to the Ejido Lands, never conducted exploration work on the Ejido Lands, and has no interest in conducting any future exploration or development work over the Ejido Lands. The Ejido Lands are in a different drainage basin than the Ixtaca Project and the Company does not need to travel though the Ejido Lands to access the Ixtaca Project.

 

On April 15, 2019, the lower court in Puebla State ruled that Mexico’s mineral title system is unconstitutional. The Company’s concessions were ruled to be illegal, but the mineral rights over that land were ordered to be held for Almaden until such time as indigenous consultation could be completed.

 

Under Mexican law, any decisions in the Amparo, such as the April 15, 2019 lower court ruling, are granted in a provisional manner and only become final once the decisions are no longer subject to further appeal. The Superior (Collegiate) Court accepted the appeals of each of the Mexican Congress, Senate, Secretary of Economy and mining authorities, as well as Almaden as an interested party, against the April 15, 2019 provisional lower court decision in the Amparo.

 

On April 14, 2021, the Company announced that the Collegiate Court issued its decision on the Amparo, stating that it does not have the necessary authority to rule on the appeals. The case passed directly to the Supreme Court of Justice of Mexico (“SCJN”).

 

In early 2022, the SCJN ruled that the Mexican mineral title law is constitutional, but that Economia should have provided for a consultation procedure with relevant indigenous communities prior to issuing mineral titles to the Company. The SCJN ordered Economia to declare Almaden’s mineral titles ineffective, or void, and to revert them to application status in order to facilitate indigenous consultation.

 

The SCJN decision provided guidance to Mexican authorities regarding the procedures required to be followed by those authorities in the follow-up to its decision and performance of indigenous consultation. The decision also clarified that unless there is a significant impact on the rights of an indigenous community caused by the granting of the mineral title, such as relocation or something similar, title issuance is not dependent upon the consent of any indigenous community. The lower court in Puebla State was responsible for ensuring that the SCJN decision was properly implemented.

 

On July 4, 2022, the Company announced that Economia was officially notified of the SCJN decision and in turn notified Almaden that the Company’s mineral titles relating to the Ixtaca Project were “ineffective”, or void. Almaden understood this to mean that the mineral title reverted to application status and that these applications remained effective and preserved the mineral rights for Almaden but did not allow the Company to engage in exploration until such time as Economia completed its court-ordered indigenous consultation.

 

On February 22, 2023, the Company announced that Economia made a submission to the lower court in Puebla State seeking to deny the two mineral title applications which were first made by Almaden in 2002 and 2008 (the “Submission”). The Submission claimed that the applications contained technical faults, despite Economia’s previous statements to the contrary and its acceptance of the mineral title applications and grant of the mineral titles in 2003 and 2009. By alleging technical faults in the mineral title applications, Economia appeared to be arbitrarily seeking to deny the grant of the mineral titles and avoid the indigenous consultation ordered by the 2022 decision of the SCJN. Such consultation would have been welcomed by both the Company and surrounding community members.

 

On April 13, 2023, Almaden reported that the lower court in Puebla State ruled that the Submission formally complied with the SCJN decision. However, the court ruling appeared to rely heavily on Economia’s Submission regarding the Company’s 2002 and 2008 title applications, and in its decision the court did not provide arguments to address the Company’s challenge of the Submission.

 

  32

 

Almaden and local community members filed separate appeals of this decision to the Federal Appeals court (“TCC”), which in October 2023 dismissed all of the appeals filed by the Parties and confirmed the Submission is compliant with the 2022 decision of the SCJN, since the SCJN decision did not formally prevent Economia from reviewing the technical aspects of the mineral title applications.

 

However, the TCC ruling did not address the validity of the Submission and therefore safeguarded the Company’s right to challenge the substance and legality of the Submission through the Mexican Federal Administrative Court (“TFJA”).

 

Subsequent to the Submission, the Company had initiated legal action in the TFJA and on October 16, 2023 announced that the TFJA granted a definitive injunction in relation to the Submission, which prevents Economia from releasing the mineral rights covered by Almaden’s mineral title applications to third parties while the trial continues, anticipated to last approximately 18 months in total.

 

On December 13, 2023, the Company delivered to Mexico a Request for Consultations in accordance with the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) relating to an investment dispute with Mexico. Almaden sent the Request for Consultations to Mexico’s General Directorate of Legal Consultancy for International Trade (Dirección General de Consultoría Jurídica de Comercio Internacional).

 

The Company has suffered substantial harm arising out of Mexico’s conduct in breach of its investment protection obligations under the CPTPP, including (without limitation):

 

· Economia’s declaration that the Project’s mineral titles were ineffective, or void;
· Economia’s reassessment of the original applications for the mineral titles holding them to be deficient and unfeasible, contradicting the position previously adopted by it, and violating the Company and its subsidiary’s right to amend or supplement the mineral title applications; and
· the Mexican Secretariat of Environment and Natural Resources’ (Secretaría del Medio Ambiente y Recursos Naturales, “SEMARNAT”) delay in issuance and ultimate refusal to issue the environmental permit (Manifiesto de Impacto Ambiental) for the Ixtaca project.

 

The Request for Consultations enables the Company to initiate arbitration should an amicable resolution of the dispute with the Mexican government not be reached. The filing of the Request for Consultations initiates a six-month consultation period between the parties, during which they are to attempt to amicably settle the dispute. If no settlement is reached in that six-month period, the Company may then initiate international arbitration proceedings against Mexico in accordance with the CPTPP after serving a notice of intent to submit claims to arbitration. On December 29, 2023, Mexico acknowledged receipt of the Request for Consultations and stated that it would propose dates for a consultation meeting in the near future, but never reverted with proposed dates, leaving the dispute unresolved.

 

Accordingly, on March 14, 2024, the Company delivered to Mexico written notice of its intention to submit a claim (“Claim”) to arbitration against Mexico (the “Notice”) in accordance with Article 9.19.3 of the CPTPP. This Notice was delivered by Almaden together with Almadex Minerals Ltd. (“Almadex”), on behalf of themselves and their Mexican subsidiaries.

 

Amongst other things, the Notice sets out the factual background of the dispute as well as the legal basis of the resulting Claim, the provisions of the CPTPP that Mexico has breached, and the relief sought. The damages relating to the Almaden and Almadex Claim will be for no less than US$200 million, in the aggregate.

 

The Notice enables the Company to initiate arbitration should an amicable resolution of the dispute with the Mexican government not be reached. The filing of the Notice must precede initiation of arbitration by a minimum of 90 days.

 

In good faith and in the spirit of cooperation, Almaden invited Mexico once again to engage in discussions and negotiations with a view to achieving an amicable resolution of the dispute. The Company confirms that it is taking all necessary actions to preserve its rights and protect its investments in Mexico. The Company’s desire is for all parties to reach a mutually acceptable outcome swiftly and amicably. If such an outcome is not achieved during consultations, the Company expects it will have no alternative but to pursue its claims before an arbitral tribunal and seek full compensation for damages the Company has suffered as a result of Mexico’s acts and omissions. The Company retained international arbitration counsel at Boies Schiller Flexner LLP to advise and will consider any other actions necessary to ensure its rights are preserved.

 

  33

 

Historic Claim Reduction Efforts

 

In 2015, after learning about the Amparo, Almaden commenced a process to voluntarily cancel approximately 7,000 ha of its Original Concessions, including the area covering the Ejido Lands, to assure the Ejido Tecoltemi that Almaden would not interfere with the Ejido Lands, and to reduce Almaden’s land holding costs.

 

Almaden divided the Original Concessions into nine smaller concessions, which included two smaller mining concessions which overlapped the Ejido Lands (the “Overlapping Concessions”) and then voluntarily cancelled the Overlapping Concessions. The applicable Mexican mining authorities issued the New Concessions and accepted the abandonment of the Overlapping Concessions in May and June of 2017 after the issuance of a court order.

 

In June 2017, the Ejido Tecoltemi, the complainant in the Amparo, filed a legal complaint about the court order leading to the New Concessions, and on February 1, 2018, the court reviewing the complaint ruled the Ejido Tecoltemi’s complaint was founded, and sent the ruling to the court hearing the Amparo.

 

On December 21, 2018, the General Directorate of Mines issued a resolution that the New Concessions were left without effect, and the Original Concessions were in full force and effect (the “December 2018 Communication”).

 

On February 13, 2019, the General Directorate of Mines delivered, to the court hearing the Amparo, mining certificates stating that the Original Concessions were valid and that the New Concessions were cancelled.

 

On June 10, 2019, Almaden’s subsidiary appealed the December 2018 Communication, and subsequent cancellation of the New Concessions. On September 26, 2019, the lower court refused to hear the appeal, but on October 14, 2019, a higher court agreed to hear the appeal.

 

On December 1, 2020, the higher court denied the Company’s October 14, 2019 appeal, which objected to the reinstatement by the Mexican mining authorities of the Company’s Original Concessions. This court decision upheld the action of Mexican mining authorities that reinstated the Original Concessions as the Company’s sole mineral claims over the Ixtaca Project, and which left the New Concessions the Company was awarded in 2017 as held without effect. However, the decision also stated that the Company had the right to defend the New Concessions through the applicable legal procedures (such as the administrative challenge referred to below).

 

In communications with the lower court and mineral title certificates issued by the General Directorate of Mines directly to Almaden on December 16, 2019 (the “December 2019 Certificates”), the applicable Mexican records reflected the position that the Original Concessions (the subject matter of the Amparo) were active and owned by Almaden (through its Mexican subsidiary) and the New Concessions were left without effect. The Mexican mining authorities also indicated in the December 2019 Certificates that their position was subject to the final resolution of the Amparo.

 

On January 21, 2020, the Company filed an administrative challenge against the Mexican mining authorities’ issuance of the December 2019 Certificates, which represented the first time that Almaden had been directly notified of any changes in its mineral tenure.

 

Almaden believes that the December 2018 Communication from the Mexican mining authorities is the basis for the recorded change in its mineral tenure. The Company’s Mexican counsel advised that the December 2018 Communication should have had no legal effect as it was only provided to the lower court, was never officially served on the Company and was not issued by an official possessing the necessary legal authority. While the December 2018 Communication was dated December 21, 2018, the Company first became aware of it in May 2019 through a review of court documents.

 

  34

 

On November 15, 2022, after Economia had reverted the Original Concessions to the application status pursuant to the SCJN Amparo ruling, the Company submitted amended title applications which substantially reduced the area being requested. To date the General Directorate of Mines has not responded to these amended mineral title applications.

 

In summary, the Company believes that any rights it holds relating to the Ixtaca project are now based on mineral title applications which have been denied by Economia, through its issuance of the Submission. The Company is in the process of disputing this denial through the TFJA and is seeking consultations with the Mexican government under the CPTPP.

 

Geological Setting of the Tuligtic Project and Ixtaca Zone

The Ixtaca Project is situated within the Trans Mexican Volcanic Belt (TMVB), a Tertiary to recent intrusive volcanic arc extending approximately east-west across Mexico from coast to coast and ranging in width from 10 to 300km. The TMVB is the most recent episode of a long lasting magmatic activity which, since the Jurassic, produced a series of partially overlapping arcs as a result of the eastward subduction of the Farallon plate beneath western Mexico (Ferrari, 2011). The basement rocks of the eastern half of the TMVB are Precambrian terranes, including biotite orthogneiss and granulite affected by granitic intrusions, grouped into the Oaxaquia microcontinent (Ferrari et al., 2011; Fuentes-Peralta and Calderon, 2008). These are overlain by the Paleozoic Mixteco terrane, consisting of a metamorphic sequence known as the Acatlan complex and a fan delta sedimentary sequence known as the Matzitzi formation. Another sedimentary complex is found on top of the Mixteco terrane, represented by various paleogeographic elements such as the Mesozoic basins of Tlaxiaco, Zongolica, Zapotitlan, and Tampico-Misantla (Fuentes-Peralta and Calderon, 2008). The subducting plates associated with the TMVB are relatively young, with the Rivera plate dated at 10Ma (million years) and the Cocos plate at 11 to 17Ma.

 

The stratigraphy of the Tuligtic area can be divided into two main sequences: a Mesozoic sedimentary rock sequence related to the Zongolica basin and a sequence of late Tertiary igneous extrusive rocks belonging to the TMVB (Fuentes-Peralta & Calderon, 2008; Tritlla et al., 2004). The sedimentary sequence is locally intruded by plutonic rocks genetically related to the TMVB. The sedimentary complex at Tuligtic corresponds to the Upper Tamaulipas formation (Reyes-Cortes 1997). This formation, Late Jurassic to Early Cretaceous in age, is regionally described (Reyes-Cortes, 1997) as a sequence of grey-to-white limestone, slightly argillaceous, containing bands and nodules of black chert. The drilling conducted by Almaden allows for more detailed characterisation of the Upper Tamaulipas Formation carbonate units in the Tuligtic area. The sequence on the Project consists of clastic calcareous rocks. The limestone unit variably bedded, generally light grey but locally dark grey to black, with local chert rich sections graded into what have been named transition units and shale (also black shale). The transition units are brown calcareous siltstones and grainstones. These rocks are not significant in the succession but mark the transition from limestone to underlying calcareous shale. Typical of the transition units are coarser grain sizes. The lower calcareous “shale” units exhibit pronounced laminated bedding and is typically dark grey to black in colour, although there are green coloured beds as well. The shale units appear to have been subjected to widespread calc-silicate alteration.

 

Both the shale and transition units have very limited surface exposure and may be recessive. The entire carbonate package of rocks has been intensely deformed by the Laramide orogeny, showing complex thrusting and chevron folding in the hinge zones of a series of thrust-related east verging anticlines in the Ixtaca area (Tritlla et al., 2004; Coller, 2011). The calcareous shale units appear to occupy the cores of the anticlines while the thick bedded limestone units occupy the cores of major synclines identified in the Ixtaca zone.

 

The Tamaulipas Formation carbonate rocks are intruded in the mid-Miocene by a series of magmatic rocks. The compositions are very variable, consisting of hornblende-biotite-bearing tonalites, quartz-plagioclase-hornblende diorites, and, locally, aphanitic diabase dykes (Carrasco-Nunez et al., 1997). In the central part of the Tuligtic Property porphyry mineralization is hosted by and associated with a hornblende-biotite-quartz phyric granodiorite body. The contact between the granodiorite and the limestone is marked by the development of a prograde skarn.

 

In the Ixtaca deposit epithermal area of the Project, the limestone basement units are crosscut by intermediate dykes that are often intensely altered. In the vicinity of the Ixtaca zone these dykes are well mineralized especially at their contacts with limestone country rock. Petrography has shown that epithermal alteration in the dykes, marked by illite, adularia, quartz and pyrite overprints earlier calc-silicate endoskarn mineralogies (Leitch, 2011). Two main orientations are identified for dykes in the Ixtaca area; 060 degrees (parallel to the Main Ixtaca and Ixtaca North zones) and 330 degrees (parallel to the Chemalaco Zone).

 

  35

 

An erosional unconformity surface has been formed subsequent to the intrusion of the porphyry mineralization-associated granodiorites. This paleo topographical surface locally approximates the current topography. Although not well exposed the unconformity is marked by depression localised accumulations of basal conglomerate comprised of intrusive and sedimentary boulders.

 

Two styles of alteration and mineralization have been identified in the area: (1) copper-molybdenum porphyry style alteration and mineralization hosted by diorite and quartz-diorite intrusions; (2) silver-gold low-sulphidation epithermal quartz-bladed calcite veins hosted primarily by carbonate rocks and spatially associated with overlying volcanic hosted texturally destructive clay alteration and replacement silicification.

 

Outcropping porphyry-style alteration and mineralization is observed in the bottoms of several drainages where the altered intrusive complex is exposed in erosional windows beneath post mineral unconsolidated ash deposits. Multiple late and post mineral intrusive phases have been identified crossing an early intensely altered and quartz-veined medium-grained feldspar phyric diorite named the Principal Porphyry. Other intrusive types include late and post mineral mafic dykes and an inter-mineral feldspar-quartz phyric diorite. Late mineral mafic dykes are fine grained and altered to chlorite with accessory pyrite. Calc-silicate (garnet-clinopyroxene) altered limestone occurs in proximity to the intrusive contacts and is crosscut by late quartz-pyrite veins. Early biotite alteration of the principal porphyry consists of biotite-orthoclase flooding of the groundmass. Quartz veins associated with early alteration have irregular boundaries and are interpreted to be representative of A-style porphyry veins. These are followed by molybdenite veins which are associated with the same wall rock alteration. Chalcopyrite appears late in the early alteration sequence. Late alteration is characterized by intense zones of muscovite-illite-pyrite overprinting earlier quartz-K-feldspar-pyrite ± chalcopyrite veining and replacing earlier hydrothermal orthoclase and biotite. Stockwork quartz-pyrite crosscuts the A-style veins and is associated with muscovite-illite alteration of biotite. The quartz-sericite alteration can be texturally destructive resulting in white friable quartz veined and pyrite rich rock. Pyrite is observed replacing chalcopyrite and in some instances chalcopyrite remains only as inclusions within late stage pyrite grains.

 

Epithermal mineralization on the Tuligtic Property is considered to have no genetic relationship to the porphyry alteration and mineralization described above. The epithermal system is well preserved and there is evidence of a paleosurface as steam heated kaolinite and replacement silica alteration occur at higher elevations where the upper part of the Coyoltepec pyroclastic deposit is preserved.

 

The Upper Tamaulipas formation carbonates (limestone and shale units), the dykes that crosscut it and the upper Coyoltepec volcanic subunit (variously referred to as volcanics, tuff or ash) are the host rocks to the epithermal system at Ixtaca. The epithermal alteration occurs over a roughly 5 by 5 kilometre area and occurs as intense kaolinite-alunite alteration and silicification in volcanic rocks. This alteration is interpreted to represent the upper portion of a well preserved epithermal system. The bulk of the mineralisation occurs in the carbonate (limestone and shale) as colloform banded epithermal vein zones. Unlike many epithermal vein systems in Mexico, the bulk of the veining in the Ixtaca zone has low base metal contents and gold and silver occur as electrum and other sulphides. SEM work has demonstrated that silver does not occur with galena or tetrahedrite in any significant way. In the main limestone unit (80% of recoverable metal in the FS) the silver to gold ratio of the mineralisation is roughly estimated to average ~65:1 while in the shale it is roughly estimated to be slightly higher at ~75:1.

 

History of Past Work

To the Company’s knowledge, no modern exploration has been conducted on the Ixtaca Project prior to Almaden’s acquisition of claims during 2001 and there is no record of previous mining; as such, this is a maiden discovery.

 

During January 2003, Almaden completed a program of geologic mapping, rock, stream silt sampling and induced polarization (IP) geophysical surveys at the Tuligtic Property (then known as the “Santa Maria Prospect”). The exploration identified both a porphyry copper and an epithermal gold target within an approximately 5 x 5km area of intensely altered rock. At the porphyry copper target, stockwork quartz-pyrite veins associated with minor copper mineralization overprint earlier potassic alteration within a multi-phase intrusive body. A single north-south oriented IP survey line identified a greater than 2km long elevated chargeability response coincident with the exposed altered and mineralized intrusive system. Volcanic rocks exposed 1km to the south of the mineralized intrusive display replacement silicification and sinter indicative of the upper parts of an epithermal system (the “Ixtaca Zone”). Quartz-calcite veins returning anomalous values in gold and silver and textural evidence of boiling have been identified within limestone roughly 100m below the sinter. The sinter and overlying volcanic rocks are anomalous in mercury, arsenic, and antimony.

 

  36

 

Additional IP surveys and soil sampling were conducted in January and February 2005, further defining the porphyry copper target as an area of high chargeability and elevated copper, molybdenum, silver and gold in soil. A total of eight (8) east-west oriented lines, 3km in length, spaced at intervals of 200m have been completed over mineralized intrusive rocks intermittently exposed within gullies cutting through the overlying unmineralized ash deposits.

 

The Tuligtic Property was optioned to Pinnacle Mines Ltd. in 2006 and the option agreement was terminated in 2007 without completing significant exploration.

 

The Property was subsequently optioned to Antofagasta Minerals S.A. (Antofagasta) on March 23, 2009. During 2009 and 2010 Antofagasta, under Almaden operation, carried out IP geophysical surveys and a diamond drill program targeting the copper porphyry prospect. Three additional IP survey lines were completed, and in conjunction with the previous nine (9) IP lines, a 2 x 2.5km chargeability high anomaly, open to the west and south, was defined. The 2009 drilling consisted of 2,973m within seven (7) holes that largely intersected skarn type mineralization.

 

On February 16, 2010, Almaden announced that Antofagasta terminated its option to earn an interest in the Property.

 

In July 2010, Almaden initiated a preliminary diamond drilling program to test epithermal alteration within the Tuligtic Property, resulting in the discovery of the Ixtaca Zone. The target was based on exploration data gathered by Almaden since 2001 including high gold and silver in soil and a chargeability and resistivity high anomaly (derived from an IP geophysical survey conducted by Almaden) topographically beneath Cerro Caolin, a prominent clay and silica altered hill. This alteration, barren in gold and silver, was interpreted by Almaden to represent the top of an epithermal system which required drill testing to depth. The first hole, TU-10-001 intersected 302.42 metres of 1.01g/t gold and 48g/t silver and multiple high grade intervals including 44.35 metres of 2.77g/t gold and 117.7g/t silver.

 

As at December 31, 2023, the net book value of the Ixtaca Project was $1 (December 31, 2022 - $63,115,076).

 

Present Condition of Project

 

Geology and Mineral Resources

 

The veining of Ixtaca epithermal system displays characteristics representative of low and intermediate sulphidation deposits. These include typical mill feed and gangue mineralogy (electrum Ag-sulphides, sphalerite, galena, adularia, quartz and carbonates), mineralization dominantly in open space veins (colloform banding, cavity filling).

 

At the base of the overlying clay altered volcanics disseminated gold-silver mineralisation occurs in association with pyrite and minor veining. Locally this mineralisation can be high grade but largely associated with lower Ag:Au ratios roughly estimated to average 20:1.

 

To date two main vein orientations have been identified in the Ixtaca deposit:

· 060 trending sheeted veins hosted by limestone;

· 330 trending veins hosted by shale;

 

The bulk of the resource and over 80% of the mill feed is hosted by the limestone in the Main Ixtaca and Ixtaca North zones as swarms of sheeted and anastomosing high grade banded epithermal veins. There is no disseminated mineralisation within the host rock to the vein swarms, which is barren and unaltered limestone. To the northeast of the limestone hosted mineralisation, the Chemalaco zone, a 330 striking and west dipping vein zone hosted by shale, also forms part of the deeper resource.

 

  37

 

Rock Creek Mill

Almaden entered into an option agreement to acquire the Rock Creek Mill in October 2015. The Rock Creek Mill is a completed mill that was located outside of Nome, Alaska and which only operated for several months before its owner suspended its mining operation in 2008. The mill has been kept in excellent condition on care and maintenance.

 

The Rock Creek Mill was built to process 7,000 tonnes per day. It includes a three-stage crushing plant, gravity circuit, ball mill, floatation cells and leaching facilities. Also included in the option agreement are conveyors, metallurgical and chemical fire assay laboratories, a water treatment plant, full electrical circuitry and generators, and spare parts.

 

Almaden exercised its right and option under the option agreement and has purchased the Rock Creek Mill and related assets for a total of US$6,500,000, subject to adjustment under certain circumstances.

 

In addition to the cash payments, Almaden also issued to the optionor 407,997 Almaden common shares valued at $273,358 upon receipt of regulatory approval, which were issued on November 25, 2016.

 

During the year ended December 31, 2018, Almaden obtained ownership and title to the mill equipment, which remains located in Nome, Alaska.

 

The Rock Creek Mill has been incorporated into the Ixtaca economic studies.

 

Amended Preliminary Economic Assessment

 

On January 22, 2016, Almaden’s independent consultants prepared a Technical Report titled "Preliminary Economic Assessment of the Ixtaca Project”, which provided further detail to its December 9, 2015 press release summarizing the results of integrating the optioned Rock Creek Mill and a smaller, higher grade, payback focused pit on potential mine economics. An amended technical report was completed on April 13, 2016 (the “Amended PEA”); however the amendments were not material changes and the Report’s data, inputs, interpretation, conclusions and results all remained unchanged. This report was prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects (“NI 43-101”). NI 43-101 is a rule developed by the Canadian Securities Administrators that establishes standards for all public disclosure an issuer makes of scientific and technical information concerning mineral projects. These standards differ from the mining property disclosure rules specified in Subpart 1300 of Regulation S-K under the United States Securities Act of 1933 (“Subpart 1300”) promulgated by the SEC.

 

The Amended PEA followed the historical PEAs released in 2014 and 2015 (“Historical PEAs”) which evaluated larger throughput development alternatives. The primary reasons for providing an update to the Historical PEAs were to show the impact of significantly reduced initial capital cost on project economics and, given the significant decrease in precious metals prices, to demonstrate the viability of a mine plan which focused on the near surface high grade limestone hosted portions of the Ixtaca Zone deposit.

 

This mine plan was a smaller higher grade scenario than those described in Almaden’s Historical PEA studies. In addition, the Amended PEA incorporated the optioned Rock Creek mill as well as results from various engineering studies related to the project which had been conducted since the Historical PEAs were completed. The Amended PEA incorporated:

 

· The same resource model as the Historical PEAs;

· The Rock Creek Mill, which was optioned by the Company in October 2015, with average throughput of 7,500 tonnes per day;

· A smaller, near surface and payback focussed pit;

· A mine production schedule which targets higher grades earlier;

· Optimised waste placement and tailings management facilities;

· A 2% NSR now held by Almadex.

 

  38

 

Pre-Feasibility Study (“PFS”)

 

Upon completion of the Amended PEA, Almaden began the work required for a Pre-Feasibility Study on the Ixtaca Project. During 2016, Almaden completed the necessary geotechnical, geomechanical, and hydrologic field programs, and also optimized site layout through updated waste placement and facilities locations. A new metallurgical program was also completed on the limestone domain, which represents approximately 82% of the total gold equivalent ounces produced over the life of the mine in the PFS. This report was also prepared in accordance with NI 43-101, the standards for which differ from the mining property disclosure rules specified in Subpart 1300 promulgated by the SEC.

 

The completed PFS is dated May 17, 2017 and included an updated resource model. The mine production schedule also included the optioned Rock Creek Mill while targeting higher grades earlier, using smaller, payback focused starter pits.

 

Feasibility Study (“Study”)

 

Upon completion of the PFS, Almaden began the work required for a Feasibility Study on the Ixtaca Project. The Study and resulting mine plan incorporate significant changes from the PFS including filtered (dry stack) tailings, ore sorting, increased throughput and an improved mine schedule. Collectively the changes result in a reduced project footprint and improved economics.

 

Almaden engaged a team of consultants led by Moose Mountain Technical Services (“MMTS”) to undertake this Study. As of the date of the Study and of the date hereof, the aforementioned Named Experts or, as applicable, Designated Professionals, to the best of the Company's knowledge, after reasonable inquiry, beneficially own, directly or indirectly, less than 1% of the Common Shares of the Company or any of the Company’s associates or affiliates, and none of them have any registered or beneficial ownership, direct or indirect, of property of the Company or any of the Company’s associates or affiliates.

 

The completed Study is dated January 24, 2019, and an update to the FS is dated October 3, 2019. The Study was prepared in accordance with NI 43-101, the standards for which differ from the mining property disclosure rules specified in Subpart 1300 promulgated by the SEC. A technical report summary which summarises the Study in a manner intended to be in accordance with Subpart 1300 of Regulation S-K (the “TRS”) has been filed as an exhibit to this Annual Report. The TRS is a review and summary of the previous technical work carried out up to the date of the Study. No significant technical work has been conducted subsequent to this Study and all exploration, legal, permitting and other project updates subsequent to the Study are provided elsewhere in this 20F. The Study was filed as a Feasibility Study under 43-101 standards. However, since Subpart 1300 standards are different than 43-101 standards, such as a lower range for cost estimates and contingencies, the Study likely would not meet Subpart 1300 requirements for a Feasibility-level study.

 

TRS HIGHLIGHTS

(All values shown in this section discussing the TRS are in $US unless noted otherwise. Base case uses $1275/oz gold and $17/oz silver prices. Gold and silver equivalency calculations assume 75:1 ratio).

· Average annual production of 108,500 ounces gold and 7.06 million ounces silver (203,000 gold equivalent ounces, or 15.2 million silver equivalent ounces) over first 6 years;
 
· After-tax internal rate of return (“IRR”) of 42% and after-tax payback period of 1.9 years;
 
· After-tax net present value (“NPV”) of $310 million at a 5% discount rate;
 
· Initial Capital of $174 million;
 
· Conventional open pit mining with a Proven and Probable Mineral Reserve of 1.39 million ounces of gold and 85.2 million ounces of silver;
 
· Pre-concentration uses ore sorting to produce a total of 48 million tonnes of mill feed averaging 0.77 g/t gold and 47.9 g/t silver (2.03 g/t gold equivalent over first 6 years, 1.41 g/t gold equivalent over life of mine);

  39

 

· Average life-of-mine (“LOM”) annual production of 90,800 ounces gold and 6.14 million ounces silver (173,000 gold equivalent ounces, or 12.9 million silver equivalent ounces);
 
· Operating cost $716 per gold equivalent ounce, or $9.55 per silver equivalent ounce;
 
· All-in Sustaining Costs (“AISC”), including operating costs, sustaining capital, expansion capital, private and public royalties, refining and transport of $850 per gold equivalent ounce, or $11.30 per silver equivalent ounce;
 
  · Elimination of tailings dam by using filtered tailings significantly reduces the project footprint and water usage

 

Capital and Operating Costs

 

Initial capital cost for the Ixtaca gold-silver project is $174 million and sustaining capital (including expansion capital) is $111 million over the LOM. The estimated expansion capital of $64.5 million will be funded from cashflow in Year 4 for the throughput ramp-up in Year 5. Estimated LOM operating costs are $26.8 per tonne mill feed. The following tables summarize the cost components:

 

Initial Capital Costs ($ millions)

 

Mining 22.2  
Process 80.2  
Onsite Infrastructure 24.3  
Offsite Infrastructure 7.5  
Indirects, EPCM, Contingency and Owner’s Costs 39.9  
Total  174.2  

 

Expansion Capital Costs ($ millions)

 

Mining $1.2  
Process $56.9  
Infrastructure $1.5  
Indirects, EPCM, Contingency and Owner’s Costs $5.0  
Total $64.5  

 

LOM Average Operating Costs ($)

 

Mining costs $/tonne milled $15.2  
Processing $/tonne milled $10.5  
G&A $/tonne milled $1.1  
Total $/tonne milled $26.8  

 

Economic Results and Sensitivities

 

A summary of financial outcomes comparing base case metal prices to alternative metal price conditions are presented below. The TRS base case prices are derived from current common peer usage, while the alternate cases consider the project’s economic outcomes at varying prices witnessed at some point over the three years prior to the Study.

 

Summary of Ixtaca Economic Sensitivity to Precious Metal Prices (Base Case is Bold)

 

Gold Price ($/oz) 1125 1200 1275 1350 1425
Silver Price ($/oz) 14 15.5 17 18.5 20
 
Pre-Tax NPV 5% ($million) 229 349 470 591 712
Pre-Tax IRR (%) 35% 46% 57% 67% 77%
Pre-Tax Payback (years) 2.0 1.8 1.6 1.4 1.3

  40

 

After-Tax NPV 5% ($million) 151 233 310 388 466
After-Tax IRR (%) 25% 34% 42% 49% 57%
After-Tax Payback (years) 2.6 2.1 1.9 1.7 1.5

 

Mineral Resource Estimate

 

On January 31, 2013 the Company announced a maiden resource on the Ixtaca Zone, which was followed by a resource update on January 22, 2014 and another on May 17, 2017. Since that time an additional 104 holes have been completed, and this data is also included in the Mineral Resource Estimate which is summarised in the table below. The data available for the resource estimation consisted of 649 drill holes assayed for gold and silver. Wireframes constraining mineralised domains were constructed based on geologic boundaries defined by mineralisation intensity and host rock type. Higher grade zones occur where there is a greater density of epithermal veining. These higher grade domains have good continuity and are cohesive in nature.

 

Of the total drill holes, 558 intersected the mineralised solids and were used to make the resource estimate. Capping was completed to reduce the effect of outliers within each domain. Uniform down hole 3-meter composites were produced for each domain and used to produce semivariograms for each variable. Grades were interpolated into blocks 10 x 10 x 6 meters in dimension by ordinary kriging. Specific gravities were determined for each domain from drill core. Estimated blocks were classified as either Measured, Indicated or Inferred based on drill hole density and grade continuity.

 

Table showing the Measured, Indicated and Inferred Mineral Resource Statement (exclusive of Reserves) with the Base Case 0.3 g/t AuEq Cut-Off highlighted. AuEq calculation is based on average prices of $1250/oz gold and $18/oz silver.

 

 

Ixtaca Zone Measured, Indicated and Inferred Mineral Resource Statement (exclusive of Reserves)

 

 

1. Ixtaca Mineral Resources Estimate have an effective date of 8 July 2018.

 

2. Base Case 0.3 g/t AuEq Cut-Off grade is highlighted. AuEq calculation based on average prices of $1250/oz gold and $18/oz silver. The Base Case cut-off grade includes consideration of the open pit mining method, 90% metallurgical recovery, mining costs of $1.82/t, average processing costs of $11.7, G&A costs of $1.81/t

 

3. Mineral Resources are reported exclusive of those Mineral Resources that have been converted to Mineral Reserves. Mineral Resources that are not Mineral Reserves do not have demonstrated economic viability.

 

4. The estimate of Mineral Resources may be materially affected by environmental, permitting, legal or other relevant issues. The Mineral Resources have been classified according to the definitions outlined in the SEC Disclosure by Registrants Engaged in Mining Operations.

 

5. All figures were rounded to reflect the relative accuracy of the estimates and may result in summation differences.

 

Mineral Reserve Estimate

 

Mineral Reserves in the table below have been developed by MMTS with an effective date of November 30, 2018, The Mineral Reserves are based on an engineered open pit mine plan.

 

  41

 

 

Mineral Reserves

  Tonnes

Diluted Average

Grades

Contained Metal  
  (millions) Au (g/t) Ag (g/t) Au - '000 ozs Ag - '000 ozs  
Proven 31.6 0.70 43.5 714 44,273  
Probable 41.4 0.51 30.7 673 40,887  
TOTAL 73.1 0.59 36.3 1,387 85,159  

 

· Mineral Reserves have an effective date of November 30, 2018. The qualified person responsible for the Mineral Reserves is Jesse Aarsen, P.Eng of Moose Mountain Technical Services.
 
· The cut-off grade used for ore/waste determination is NSR>=$14/t
 
· All Mineral Reserves in this table are Proven and Probable Mineral Reserves. The Mineral Reserves are not in addition to the Mineral Resources but are a subset thereof. All Mineral Reserves stated above account for mining loss and dilution.
 
· Associated metallurgical recoveries (gold and silver, respectively) have been estimated as 90% and 90% for limestone, 50% and 90% for volcanic, 50% and 90% for black shale.
 
· Reserves are based on a US$1,300/oz gold price, US$17/oz silver price and an exchange rate of US$1.00:MXP20.00.
 
· Reserves are converted from resources through the process of pit optimization, pit design, production schedule and supported by a positive cash flow model.
 
· Rounding as required by reporting guidelines may result in summation differences.
 

 

Legal, political, environmental, or other risks that could materially affect the potential development of the Mineral Reserves are provided in this Form 20-F under the heading “Risk Factors”.0

 

Mine Plan

 

The Ixtaca gold-silver project is planned as a typical open pit mining operation using contractor mining. Initial production will ramp up to a mill feed rate of 7,650 tonnes per day followed by an expansion to 15,300 tonnes per day from Year 5 onwards.

 

An ore control system is planned to provide field control for the loading equipment to selectively mine ore grade material separately from the waste.

 

Mining operations will be based on 365 operating days per year with three 8 hour shifts per day.

 

Processing

 

The TRS reflects the Rock Creek process plant which has been purchased by Almaden. Run of mine ore will be crushed in a three-stage crushing circuit to -9 mm.

 

The TRS also incorporates ore sorting, test work for which has shown the ability to separate barren or low grade limestone host rock encountered within the vein swarm from vein and veined material (see Almaden news release of July 16th 2018). Product from the secondary crusher will be screened in to coarse (+20mm), mid-size (12 to 20 mm), and fine (-12mm) fractions. Coarse and mid-size ore will be sorted by an XRT ore sort machine to eject waste rock. Fine ore will bypass the ore sorting and is sent directly to the mill.

 

Ore sort waste from Limestone and Black Shale is below waste/ore cutoff grade and is placed in the waste rock dump. Ore sort ‘waste’ from the Volcanic unit is low grade ore and will be stockpiled for processing later in the mine life. Ore sorting pre-concentration increases the mill feed gold and silver grades by 32% and 31% respectively compared to run of mine (ROM) grades. The table below shows ROM grades with ore sort waste removed from the ROM, and the resulting mill feed.

 

  42

 

Ore Sort Mill Feed grade improvement

    ROM Ore sort Mill  
    Ore Waste Feed  
Limestone million tonnes 51.5 18.8 32.7  
Au g/t 0.572 0.24 0.763  
Ag g/t 37.5 12.0 52.2  
Black Shale million tonnes 12.2 6.3 5.8  
Au g/t 0.517 0.25 0.806  
Ag g/t 44.4 20.0 70.8  
Volcanic million tonnes 9.4 - 9.4  
Au g/t 0.790 - 0.790  
Ag g/t 18.6 - 18.6  
TOTAL million tonnes 73.1 25.1 48.0  
Au g/t 0.591 0.24 0.773  
Ag g/t 36.3 14.0 47.9  

 

Crushed ore is transported to the grinding circuit by an over land conveyor. Grinding to 75 microns is carried out with ball milling in a closed circuit with cyclones. Cyclone underflow is screened and the screen undersize is treated in semi-batch centrifugal gravity separators to produce a gravity concentrate.

 

The gravity concentrate will be treated in an intensive leach unit with gold and silver recovered from electrowinning cells.

 

The cyclone overflow will be treated in a flotation unit to produce a flotation concentrate. After regrinding the flotation concentrate leaching will be carried out in 2 stages. CIL leaching for 24 hours will complete gold extraction, followed by agitated tank leaching to complete silver leaching. A carbon desorption process will recover gold and silver from the CIL loaded carbon, and a Merrill Crowe process will recover gold and silver from pregnant solution from the agitated leach circuit.

 

Cyanide destruction on leach residue is carried out using the SO2/Air process. Final tailings are thickened and filtered then dry stacked and co-disposed with mine waste rock.

 

Average process recoveries from mill feed to final product over the life of mine are summarized below for each ore type.

 

Average Life of Mine Process Recoveries from Mill Feed

 

  Gold Silver  
Limestone 88.5% 86.8%  
Volcanic 64.4% 76.3%  
Black Shale 54.5% 84.7%  

 

Water and Waste Management

 

One of Almaden’s top priorities at Ixtaca is water quality and a mine plan that provides a permanent and consistent long-term supply of water for residents. The plan outlined in the TRS has evolved through the open dialogue between the Company and residents over the past number of years and as part of the Social Investment Plan consultation (see section below on “Community”).

 

Rainfall in the Ixtaca vicinity falls primarily during a relatively short rainy season. With no local water storage facilities, the flash flows of water are currently lost to the communities. Under the TRS, rainwater will be captured during the rainy season in the water storage reservoir and slowly released during the dry season, for use by both the mining operation and local residents.

 

Extensive geochemical studies have evaluated the potential for acid rock drainage and metal leaching from the waste rock and tailings using globally accepted standardised methods of laboratory testing and in compliance with Mexican regulations. Most of the waste rock at Ixtaca is limestone, and the studies of both waste rock and tailings have consistently shown that there is more than enough neutralising potential present in the waste rock to neutralise any acid generated. Testing to date also indicates low potential for metal leaching. These results along with the excellent access to potential markets in the growing industrial state of Puebla, indicate the potential for rock waste and tailings from the Ixtaca deposit to be secondary resources such as aggregate and cement feedstock. These opportunities were examined in 2019 as part of the Company’s commitment to best sustainable practices.

 

  43

 

In consideration of these findings and the hydrologic conditions at Ixtaca, Almaden and its consultants reviewed Best Available Technology and Best Applicable Practice in the design and planning of tailings management at Ixtaca, which resulted in selecting a dry-stack tailings facility which would include co-disposal of waste with filtered tailings, use much less water than traditional slurry facilities, reduce the mine footprint, allow for better dust control, and enable earlier rehabilitation of the tailings and waste disposal areas.

 

Community Consultations

 

Almaden has a long history of engagement with communities in the region around the Ixtaca Project. Amongst many other initiatives, the Company has trained and employed drillers and driller helpers from the local area, held ten large-scale community meetings totalling over 4,500 people, taken 500 local adults on tours of operating mines in Mexico, and held monthly technical meetings on a diverse range of aspects relating to the mining industry and the Ixtaca Project. At the end of 2021, the Company convened an outdoor end of year gathering in a large open space and is very appreciative of the ongoing support and optimism from local communities regarding the future of the project and the tremendous value that we can collectively deliver to the local area through project development.

 

In 2017, Almaden engaged a third-party consultant to lead a community consultation and impact assessment at the Ixtaca Project. In Mexico, only the energy industry requires completion of such an assessment (known in Mexico as a Trámite Evaluación de Impacto Social, or “EVIS”) as part of the permitting process. The purpose of these studies is to identify the people in the area of influence of a project (“Focus Area”), and assess the potential positive and negative consequences of project development to assist in the development of mitigation measures and the formation of social investment plans. To Almaden’s knowledge, this is the first time a formal EVIS has been completed in the minerals industry in Mexico, and as such reflects the Company’s commitment to best national and international standards in Ixtaca project development.

 

The EVIS and subsequent work on the development of a Social Investment Plan were conducted according to Mexican and international standards such as the Guiding Principles on Business and Human Rights, the Equator Principles, and the OECD Guidelines for Multinational Enterprises and Due Diligence Guidance for Meaningful Stakeholder Engagement in the Extractive Sector.

 

Fieldwork for the EVIS was conducted by an interdisciplinary group of nine anthropologists, ethnologists and sociologists graduated from various universities, who lived in community homes within the Ixtaca Focus Area during the study to allow for ethnographic immersion and an appreciation for the local customs and way of life. This third-party consultation sought voluntary participation from broad, diverse population groups, with specific attention to approximately one thousand persons in the Focus Area.

 

This extensive consultation resulted in changes to some elements of the mine design, including the planned construction of a permanent water reservoir to serve the local area long after mine closure, and the shift to dry-stack filtered waste management.

 

In March 2020, the Company announced that it has partnered with a local community group focused on irrigation development, and together with them coordinated with the Federal Government water authority (“CONAGUA”), to co-fund a new water reservoir in Zacatepec, a community located close to the Ixtaca mine development area. Next steps will involve adding new pipelines, tanks, and other structures to enhance the irrigation potential in support of local agricultural production.

 

This reservoir is one of the projects identified which could bring immediate benefits to the local area even prior to Ixtaca development. The Company looks forward to advancing further elements of the community Social Investment Plan as mine permitting and construction advance.

 

  44

 

In October 2021, the Company announced its decision to conduct a Human Rights Impact Assessment (“HRIA”) at the Ixtaca Project. The HRIA is being led by an independent technical expert consulting group named Centro de Investigaciones Interculturales Juridicas y Ambientales (“CIIJA”).

 

The HRIA was commenced in 2021 (see press release of October 19, 2021) and aimed to predict, identify, characterize, and assess the potential positive and negative impacts that the Ixtaca project could have during its lifespan on the human rights of both indigenous and non-indigenous communities located within its areas of influence and on other identified project stakeholders. In the event potential impacts were identified, the HRIA proposed strategies to amplify the positive and mitigate or compensate for the negative. The HRIA was not confined to the area of the mineral title applications and defined three areas of influence of the project: core, direct, and indirect.

 

The Company believes that completion of an HRIA reflects best international standards and produces substantial long-term value for stakeholders as it is conducive to operational continuity, community integration with the project, and culturally pertinent sustainable development for all stakeholders. The Company expected that the HRIA would be an important consideration for Mexican authorities at the time of potential permitting of the Ixtaca project as currently envisaged, which the Company would likely proceed with barring legislative changes in Mexico and subject to receipt of the required mineral titles.

 

This important exercise involved extensive field work under the oversight of an independent Advisory Committee comprised of local community representatives and the following subject-matter experts:

 

Dr. S. James Anaya – Chair of Advisory Committee. Dr. Anaya is the former dean of the University of Colorado Law School. He is a graduate of the University of New Mexico (B.A., 1980) and Harvard Law School (J.D., 1983). He has taught and written extensively on international human rights and issues concerning indigenous peoples and has lectured in many countries throughout the world. Dr. Anaya served as the United Nations Special Rapporteur on the Rights of Indigenous Peoples from May 2008 to June 2014, where he participated in the drafting of the United Nations Declaration on the Rights of Indigenous Peoples.

 

Ms. Katya Puga – Ms. Puga holds a Bachelor's degree in Political Science from the Instituto Tecnológico y de Estudios Superiores of Monterrey (2006), and pursued an MPhil in Social Studies at the Universidad Nacional Autónoma of Mexico. She has served as the Under-Secretary for Planning and Environmental Policy at Mexico’s Ministry of the Environment (“SEMARNAT”) and Director of Social Impact and Surface Occupation at the Ministry of Energy. She has also gained significant experience at departments within the United Nations, most notably as Liaison with the UN program for development where she led projects around democratic dialogues and indigenous peoples rights.

 

Dr. María del Carmen Carmona - Dr. Carmona studied law at the Escuela Libre de Derecho in Mexico and later specialized in Natural Resources Law at the Universidad Iberoamericana, prior to receiving a Doctorate in Political Science from the Universidad Nacional Autónoma of Mexico in 1996. She is a full-time researcher at the prestigious Legal Research Institute at UNAM, as well as a Level II member of the National Research System. Her research focuses on Environmental Law, Natural Resource Law, Human Rights that are related to the right to a healthy environment, Water Law, regulatory status of underground water, Coastal Law, Indigenous Law and Energy Justice. She has served as Under Attorney General at SEMARNAT.

 

Dr. Sergio Puig - Dr. Puig studied law at the Instituto Technologico Autonomo de Mexico (LL.B., 2002) and received a doctoral degree (JSD) in International Economic Law from Stanford Law School in 2009. He is currently the Evo DeConcini Professor of Law and Director of the International Trade and Business Law Program at the University of Arizona, as well as the Co-Editor in Chief of the Journal of International Economic Law. Before joining the University of Arizona, Professor Puig was the teaching fellow of the Program in International Legal Studies (SPILS) at Stanford and served as a lecturer in law at Duke and Stanford Universities. Before entering academia, he practiced law in Mexico and the USA, and worked at the World Bank and International Centre for Settlement of Investment Disputes (ICSID).

 

The Advisory Committee was charged with ensuring the HRIA was conducted in an independent manner with a robust methodology, and also provided comments and proposed mitigation measures for the identified impacts.

 

  45

 

In their final comments regarding the HRIA, the committee stated that the HRIA was:

 

developed in accordance with sound procedures, based on international standards and good practices, as well as with professionalism, seriousness, and good faith.

 

The committee also emphasized the Company’s need to continue to exercise due diligence to ensure that the human rights of individuals and communities that might be affected by the Ixtaca project are protected.

 

The HRIA itself involved hundreds of interactions with individuals and groups throughout the areas of influence of the Ixtaca project. It identified four core communities that would receive the majority of both positive and negative impacts of the project – Santa Maria Zotoltepec (pop. 478), Zacatepec (pop. 285), Ixtacamaxtitlan (pop. 515), and Loma Larga (pop. 83). The HRIA concludes that:

 

the impacts identified, given the early stage of the Project, can be avoided or mitigated through actions that translate into plans and programs, which in turn will be aligned with the company's Human Rights Policy, which is very positive since it has the necessary time to design and implement them, and thus avoid their occurrence or reduce the magnitude of the impact so that compensation for violating human rights is not required.

 

“In accordance with the above we can mention that the state of compliance and enjoyment of human rights in the region of influence is reasonably high, taking into account that in reality the formal or official data regarding compliance and enjoyment of human rights in the region are extremely limited due to the absence of specific sources and therefore generating or obtaining reliable data in this regard has been complicated because the available data are usually general and present situations rather limited to the interaction with authorities; However, no specific data was obtained from the surveys, workshops and interviews that demonstrate facts or acts directly attributable to the company developing the Project that violate the human rights of individuals and communities surrounding the Project, and even when impacts on the enjoyment of the aforementioned rights are foreseen or can be foreseen, it should be noted that as long as the mining company that will develop the Project both in its construction phase and in its operation phase is in compliance with applicable laws and regulations as well as in accordance with the standards and practices commonly accepted in the mining industry, the violation or non-compliance with human rights is a minor possibility that can be addressed and resolved in most cases in accordance with the internal plans and policies of the Project as mentioned in this document.”

 

Almaden takes seriously the conduct of human rights due diligence and the planning, development, and implementation of policies and procedures as and if the Ixtaca project advances. This includes the understanding that ongoing dialogue may lead to changes in mine design, as it has in the past during feasibility stage mine design (e.g. see press release, March 21st, 2018).

 

On February 21, 2023, the Company announced that it signed a cooperation agreement with the Ejido Santa María Zotoltepec, the Ejido located closest to the Ixtaca Project. The agreement is similar to the one signed in 2022 with the United Ejidatarios for the Sustainable Development of Santa María Zotoltepec, A.C., but it is signed with the entire Ejido after a majority vote in favour under strict agrarian rules and signed through an Act of Assembly.

 

The agreement is initially focused on contributions to support an agro-technological package aimed at sustainable plant nutrition and soil enrichment. Longer term, the agreement commits the parties to work collaboratively under the Project’s Social Management Plan in pursuit of multiple United Nations Sustainable Development Goals. The agreement broadens the architecture needed to formulate and deliver Ixtaca’s Social Management Plan which was to evolve from the HRIA and be mindful of the United Nations’ Sustainable Development Goals.

 

Economic Contributions

 

The TRS anticipates that approximately 600 direct jobs will be created during the peak of construction, and 420 jobs will be generated during operations. Assuming base case metal prices, under this TRS Ixtaca is anticipated to generate approximately US$130 million in Federal taxes, US$50 million in State taxes and US$30 million in Municipal taxes.

 

  46

 

Closure and Reclamation

 

Mine waste areas will be reclaimed and re-vegetated at the end of mining activity. At closure, all buildings will be removed and remaining facilities, except for the water storage dam (WSD), will be reclaimed and re-vegetated. The WSD and the availability of this water to the local communities will remain after closure.

 

Opportunities

 

Several opportunities excluded from the base case economics have been identified in the TRS.

 

· Results from the ore sorting tests identified several opportunities to increase the ore sort efficiency and could result in a further increase in mill feed grades. These opportunities will be investigated with future test work.

 

· Gold extraction recoveries in the minor black shale unit are currently impeded by the presence of carbonaceous material. Recent test work including carbon pre-flotation and ultra-fine gravity separation has demonstrated that the carbon can be liberated and removed with a significant improvement in gold recovery. This test work is ongoing and is expected to improve the black shale gold recovery.

 

· Test work carried out on Ixtaca limestone waste rock samples concluded that Ixtaca limestone waste rock is suitable for many types of concrete use and other applications such as shotcrete, subgrade, asphalt aggregate or railroad ballast with little effort and processing. Concrete produced with tests on Ixtaca limestone aggregate performed very well, achieving the 28-day design compressive strength of 30 MPa already at 7 days, and more than 40 MPa at 28 and 56 days.

 

Ixtaca is connected by 60 km of paved road to the industrial city Apizaco, 120 km of paved road to the state capital of Puebla, and 170 km of paved road to Mexico City.

 

The sale of limestone ore sort rejects (a waste product) as an aggregate presents a very significant potential source of revenue to the Project at no additional capital or operating cost to the Project. There is also potential to sell some of the waste rock as an aggregate.

 

· Fine aggregate from crushing and grinding operations is also expected to perform in a similar way to the coarse aggregate. Chemical analysis of the fine aggregate indicates that it is also suitable as a raw material for the production of lime cement or Portland cement if properly processed and blended with suitable silica aluminates.

 

Next Engineering and Development Steps

 

In December 2020, the Company announced that it received notification from the Mexican federal permitting authority, SEMARNAT, that the Company’s initial MIA, a required permit in order to proceed to construction and operation of the Ixtaca Project, did not receive approval. The Company originally submitted the MIA in early 2019.

 

The reasons cited by SEMARNAT for not approving the MIA include insufficient technical information regarding the impacts of the Ixtaca Project on the environment, local and regional area. Although not formally vested with authority on indigenous matters under a specific local body of law, SEMARNAT also expressed its opinion that indigenous persons are present in the area affected by the Ixtaca Project and indicated that this needs to be addressed in the context of obligations assumed by Mexico under ILO Convention 169 regarding the human right to free, prior, informed consultation of indigenous communities.

 

The Company has prepared a revised MIA permit application and related documents which incorporate additional data presently available to the Company as well as data gathered in further field studies. The Company expects that the HRIA would also be an important consideration for Mexican authorities at the time of potential permitting of the Ixtaca project as currently envisaged, which the Company would likely proceed with barring legislative changes in Mexico and subject to receipt of the required mineral titles.

 

  47

 

Qualified Persons, Sample Preparation, Analyses, Quality Control and Assurance

 

The independent qualified person responsible for the TRS is Jesse Aarsen, P.Eng., of Moose Mountain Technical Services. A copy of the TRS, and Mr. Aarsen’s consent, are included as exhibits to this Annual Report.

 

The analyses used in the preparation of the mineral resource statement were carried out at ALS Chemex Laboratories of North Vancouver (“ALS”) using industry standard analytical techniques. All strongly altered or epithermal-mineralized intervals of core have been sampled. Almaden employs a maximum sample length of 2 to 3m in unmineralized lithologies, and a maximum sample length of 1m in mineralized lithologies. During the years 2010 and 2011, Almaden employed a minimum sample length of 20cm. The minimum sample length was increased to 50cm from 2012 onwards to ensure the availability of sufficient material for replicate analysis. Drill core is half-sawn using industry standard diamond core saws. After cutting, half the core is placed in a new plastic sample bag and half is placed back in the core box. Sample numbers are written on the outside of the sample bags and a numbered tag placed inside the bag. Sample bags are sealed using a plastic cable tie. Sample numbers are checked against the numbers on the core box and the sample book.

 

ALS sends its own trucks to the Ixtaca Project to take custody of the samples at the Santa Maria core facility and transports them to its sample preparation facility in Guadalajara or Zacatecas, Mexico. Prepared sample pulps are then forwarded by ALS personnel to the ALS North Vancouver, British Columbia laboratory, which is ISO/IEC 17025:2017 and ISO 9001: 2015 certified, for analysis.

 

For gold, samples are first analysed by fire assay and atomic absorption spectroscopy (“AAS”). Samples that return values greater than 10 g/t gold using this technique are then re-analysed by fire assay but with a gravimetric finish. Silver is first analysed by Inductively Coupled Plasma - Atomic Emission Spectroscopy (“ICP-AES”). Samples that return values greater than 100 g/t silver by ICP-AES are then re analysed by HF-HNO3-HCLO4 digestion with HCL leach and ICP-AES finish. Of these samples those that return silver values greater than 1,500 g/t are further analysed by fire assay with a gravimetric finish. Blanks, field duplicates and certified standards were inserted into the sample stream as part of Almaden’s quality assurance and control program. In addition to the in-house QAQC measures employed by Almaden, Kris Raffle, P.Geo. of APEX Geoscience Ltd., completed an independent review of blank, field duplicate and certified standard analyses.  All QAQC values falling outside the limits of expected variability were flagged and followed through to ensure completion of appropriate reanalyses.  No discrepancies were noted within the drill hole database, and all QAQC failures were dealt with and handled with appropriate reanalyses.  

 

Current Work

 

The Company has prepared a revised MIA permit application and related documents which incorporate additional data presently available to the Company as well as data gathered in further field studies. The Company expects that the HRIA that it completed in 2023 would also be an important consideration for Mexican authorities at the time of potential permitting of the Ixtaca project as currently envisaged, which the Company would likely proceed with barring legislative changes in Mexico and subject to receipt of the required mineral titles.

 

Upcoming / Outlook

 

Almaden has access to sufficient funding to conduct its anticipated operations for the next fiscal year. The Company would likely proceed to submit its MIA application and related documents, including the HRIA, barring legislative changes in Mexico and subject to the receipt of the mineral titles at the property.

 

Item 4A. Unresolved Staff Comments

 

Not applicable.

 

Item 5. Operating and Financial Review and Prospects

 

A. Operating Results

The following discussion and analysis of the results of operations and the Company’s financial position should be read in conjunction with the consolidated financial statements and related notes for the years ended December 31, 2023, 2022, and 2021 appearing under Item 18 – Financial Statements and listed under Item 19 – Exhibits.

 

  48

 

The Company’s consolidated financial statements are stated in Canadian Dollars and have been prepared in accordance and compliance with International Financial Reporting Standards as issued by the International Accounting Standards Board (“IASB”).

 

The Company is in the business of exploring its principal mineral property in Mexico with the aim of developing it to a stage where it can be exploited at a profit or to arrange joint ventures or other business transactions whereby other companies provide, in whole or in part, funding for development and exploitation. At that stage, the Company’s operations would, to some extent, be dependent on the world market prices of any minerals mined. The Company does not have producing properties or operations on its properties.

 

The Company receives other income from Administrative Services Agreements with Azucar and Almadex. Under those Agreements, the Company is the sole and exclusive manager of Azucar and Almadex. Azucar and Almadex compensate the Company 5% (2022 – 13%) and 66% (2022 – 49%), respectively, of the Company’s actual monthly overhead costs including any shared personnel fees and/or wages. Azucar and Almadex also pay the Company any reasonable fees or costs incurred on their behalf by the Company which were approved by Azucar or Almadex, respectively. The Administrative Services Agreements had an initial 5-year term, with subsequent automatic 1-year renewals unless terminated pursuant to the terms permitted under the respective Agreements. The Administrative Services Agreements include a Change of Control clause. If either party is subject to a Change of Control during the term of the respective Agreement, that Agreement shall automatically terminate within 48 hours of the Change of Control unless agreed to in writing by both parties. The target of the Change of Control shall then pay the other party $2 million as compensation for the unplanned termination of the Company’s engagement and significant disruption to the other party’s business. “Change of Control” means the date upon which, without the written concurrence of the target of the Change of Control, any person (as that term is defined in the Securities Act (British Columbia)) makes and does not withdraw a take-over bid (as that term is defined in the Securities Act (British Columbia)) or acquires, directly or indirectly, that number of common shares of the target which equals or exceeds twenty percent (20%) of the then issued common shares of the target.

 

Fiscal 2023 compared to Fiscal 2022

For Fiscal 2023, the Company recorded a comprehensive loss of $63,620,232, or $0.46 per common share, compared to a comprehensive loss of $11,846,560, or $0.09 per common share, for Fiscal 2022. The decrease in loss and comprehensive loss of $51,773,672 was primarily a result of a $468,714 decrease in operating expenses offset by a $56,673,779 decrease in other income.

 

As the Company is in development stage, it has no revenue from mining operations. Other loss of $61,573,366 (Fiscal 2022 – $4,899,587) during Fiscal 2023 relates primarily to the impairment of exploration and evaluation assets of $63,823,478 (2022 – $Nil) from Tuligtic property, the mill equipment the impairment of property, plant and equipment of $Nil (Fiscal 2022 – $7,441,293) from the mill equipment, the revaluation of the unrealized gain on warrant liability of $102,787 (Fiscal 2022 – $520,503). The impairment of exploration and evaluation assets is due to the Mexican government’s action to revoke the Company’s mineral concession title and to prevent any further exploration and development plans on the Tuligtic property. The impairment of the mill equipment is the result of management’s assertion that the fair value of the Rock Creek Mill has decreased during storage in Nome, Alaska. The change in unrealized gain on warrant liability is due to the decrease in the Company’s share price to calculate the fair value using the Black-Scholes option pricing model.

 

The Company has an administrative services agreement with these two companies whereby overhead and salary expenses are proportionally allocated as described under the heading “Transactions with Related Parties”. Amounts earned from administrative service fees depends on the business activities of each company. During Fiscal 2023, the Company had a decrease in administrative services fees earned from Azucar of $75,853 (Fiscal 2022 - $185,068), and an increase in administrative service fees from Almadex of $1,346,494 (Fiscal 2022 - $1,191,360) due to operational activities within each company.

 

Operating expenses were $5,137,074 during Fiscal 2023 (Fiscal 2022 - $5,605,788). Certain operating expenses were reported on a gross basis and recovered through other income from the Administrative Service Agreements. The decrease in operating expenses of $468,714 is mainly due to a decrease of $667,950 from a stock option grant in Fiscal 2023 compared to Fiscal 2022 in share-based payments.

 

  49

 

Fiscal 2022 compared to Fiscal 2021

For Fiscal 2022, the Company recorded a loss and comprehensive loss of $11,846,560, or $0.09 per common share, compared to a loss and comprehensive loss of $2,668,254, or $0.02 per common share, for Fiscal 2021. The increase in loss and comprehensive loss of $9,178,306 was primarily a result of $8,451,451 decrease in other income (loss) and $300,189 decrease in operating expenses.

 

As the Company is in development stage, it has no revenue from mining operations. Other loss of $4,899,587 (Fiscal 2021 – Other income of $3,551,864) during Fiscal 2022 relates primarily to the impairment of property, plant and equipment of $7,441,293 (Fiscal 2021 – $Nil) from the mill equipment, the revaluation of the unrealized gain on warrant liability of $520,503 (Fiscal 2021 – $1,747,884) and the decrease in administrative services fees earned from Azucar of $185,068 (Fiscal 2021 - $412,812), and Almadex of $1,191,360 (Fiscal 2021 - $969,532). The Company has Administrative Service Agreements with these two companies whereby overhead and salary expenses are proportionally allocated as described under the heading “Transactions with Related Parties”. Amounts earned from administrative service fees depends on the business activities of each company. The change in unrealized gain on warrant liability of $1,227,381 in 2022 compared to 2021 relates to the decrease in the Company’s share price to calculate the fair value using the Black-Scholes option pricing model. The gain on debt forgiveness of $177,200 relates to the Chair of the Company’s Board forfeiting his deferred salary owed from $256,000 to $78,800 recorded in accounts payable.

 

Operating expenses were $5,605,788 during Fiscal 2022 (Fiscal 2021 - $5,905,977). Certain operating expenses were reported on a gross basis and recovered through other income from the Administrative Service Agreements. The decrease in operating expenses of $300,189 is mainly due to a decrease of $392,700 from a stock option grant in Fiscal 2022 compared to Fiscal 2021 in share-based payments.

 

B. Liquidity and Capital Resources

As at December 31, 2023, the Company’s working capital position was $4,830,735. Management estimates that the current cash position and potential future cash flows will be sufficient for the Company to carry out its business for the upcoming year.

 

The Company has government requirements in work and/or taxes to maintain claims held. The decision to keep or abandon such claims is not contractual but at the discretion of the Company.

 

The Company is obligated under an operating lease for its office premises with the following aggregate minimum lease payments effective April 1, 2017 through to March 31, 2022 with an extension option exercisable only by the Company through to March 31, 2027. The lease extension was exercised on November 22, 2021 and now runs to March 31, 2027. The Company reassessed this significant event as a lease modification and has estimated that the potential future lease payments under the extended lease term would result in an increase in lease liability by $508,799.

 

Under the Administrative Services Agreements between the Company and each of Azucar and Almadex the Company provides management services to Azucar and Almadex. Azucar compensates the Company 5% (2022 – 13%) of any shared personnel remuneration and office overhead expenses, while Almadex compensates the Company 66% (2022 – 49%) of any shared personnel remuneration and office overhead expenses. Therefore, Almaden currently recovers 71% (2022 – 62%) of the contractual compensation amounts for the Chair, Chief Executive Officer (the “CEO”), CFO and Executive Vice-President.

 

  50

 

Contractual obligations of the Company disclosed above do not include future option payments required to maintain the Company’s interest in certain mineral properties.

 

Management believes that the Company’s cash resources are sufficient to meet its working capital and mineral exploration requirements for its next fiscal year, but the Company may decide to raise additional funds through the sale of equity in Fiscal 2024 depending upon favorable market conditions.

 

Fiscal 2023

At the end of Fiscal 2023, the Company had working capital of $4,830,735 including cash and cash equivalents of $4,245,983 compared to working capital of $7,463,140, including cash and cash equivalents of $6,658,076 at the end of Fiscal 2022. The decrease in working capital of $2,632,405 is due to cash balances being used for expenditures in exploration and evaluation assets and corporate affairs.

 

The Company has long term liabilities of $4,757,480 at the end of Fiscal 2023 compared to $7,805,729 at the end of Fiscal 2022 that relates to deferred income tax liability from the Mexican income tax and Special Mining Duty associated with the Ixtaca Project of $Nil (Fiscal 2022 - $3,090,208). Other components of long term liabilities relate to long-term portion of lease liabilities of $277,104 (Fiscal 2022 - $377,635) for office lease, gold loan payable of $4,371,456 (Fiscal 2022 - $3,929,015) entered with Almadex on May 14, 2019, warrant liability of $Nil (Fiscal 2022 - $102,787) for the warrants issued pursuant to the registered direct offering on March 18, 2021 and derivative financial liabilities of $108,830 (Fiscal 2022 - $306,084) related to the gold loan.

 

Net cash used in operating activities during Fiscal 2023, was $1,483,006 (Fiscal 2022 - $1,653,398), after adjusting for non-cash activities.

 

Net cash used in investing activities during Fiscal 2023, was $801,290 (Fiscal 2022 - $1,728,846) related to expenditures in exploration and evaluation assets while waiting for its development permits.

 

Net cash used financing activities during Fiscal 2023, was $127,797 (Fiscal 2022 - $130,056).

 

Management estimates that the current cash position will be sufficient for the Company to carry out its business for the upcoming year.

 

Fiscal 2022

At the end of Fiscal 2022, the Company had working capital of $7,463,140 including cash and cash equivalents of $6,658,076 compared to working capital of $10,651,264, including cash and cash equivalents of $10,170,376 at the end of Fiscal 2021. The decrease in working capital of $3,188,124 is due to cash balances being used for expenditures in exploration and evaluation assets and corporate affairs.

 

The Company has long term liabilities of $7,805,729 at the end of Fiscal 2022 compared to $6,457,408 at the end of Fiscal 2021 that relates to deferred income tax liability from the Mexican income tax and Special Mining Duty associated with the Ixtaca Project of $3,090,208 (Fiscal 2021 - $1,749,023). Other components of long term liabilities relate to long-term portion of lease liabilities of $377,635 (Fiscal 2021 - $465,930) for office lease, gold loan payable of $3,929,015 (Fiscal 2021 - $3,227,545) entered with Almadex on May 14, 2019, warrant liability of $102,787 (Fiscal 2021 - $623,290) for the warrants issued pursuant to the registered direct offering on March 18, 2021 and derivative financial liabilities of $306,084 (Fiscal 2021 - $391,620) related to the gold loan.

 

Net cash used in operating activities during Fiscal 2022, was $1,653,398 (Fiscal 2021 - $1,600,250), after adjusting for non-cash activities.

 

Net cash used in investing activities during Fiscal 2022, was $1,728,846 (Fiscal 2021 - $2,795,150) related to expenditures in exploration and evaluation assets while waiting for its development permits.

 

Net cash used financing activities during Fiscal 2022, was $130,056. Net cash from financing activities during Fiscal 2021, was $12,031,078 as a result of registered direct offer of $11,610,581, options exercised of $564,750, and repayment of leasing of $130,056 (Fiscal 2021- $144,253).

 

  51

 

Management estimates that the current cash position will be sufficient for the Company to carry out its business for the upcoming year. Longer term, should the Company receive the necessary permits and authorizations to proceed to construction of the Ixtaca Project, additional funding will need to be secured.

 

C. Research and Development, Patents and Licenses

The Company has not conducted any Research and Development activities for the last three years, nor is it dependent upon any patents or licenses.

 

D. Trend Information

The world is gradually coming out of the COVID panic although many restrictions such as those on travel to some countries remain in place. The large expenditures and deficits that many countries used to offset COVID restrictions are now having to be dealt with at the same time as the resulting inflation is causing worldwide difficulties. Central Banks in many countries are raising interest rates to combat this inflation while their governments are still creating huge deficits. Thus, monetary and fiscal policies seem to be at odds with each other and there is much debate whether interest rates should rise further to quell inflation or go down to prevent a worldwide recession. Recent high profile bank failures have added to the concern and fear of further such failures overhangs markets.

 

During the past year, some Central Banks have reportedly been adding significantly to their gold reserves. Recent volatility in crypto currencies seems to have caused some investors seeking a safe haven for part of their assets to consider investing in gold and silver again. When the Silicon Valley Bank and Credit Suisse collapsed, the gold and silver prices firmed and began trading closer to US$2000.00 and US$25.00 respectively. Whether the precious metals will settle in these price ranges, drop or rise depends on events to come but the trend does seem to be towards gradually rising prices.

 

Governments are gradually becoming aware that ambitious plans for climate related changes require more than talk. Metals are required to effect these plans. There is a shortage of the metals needed for all the electrified cars, homes, power lines etc. that are planned in order to be carbon neutral in 2050. Existing mines cannot supply all that is needed, and they are being steadily depleted so the need for replacement will grow. The year 2050 is twenty-seven years away but a new mine can take that many years to be identified, developed, permitted and built. If a discovery is made it will most likely be strongly opposed by well funded anti-development activists.

 

Major companies seem to prefer to only explore around their existing mines. For expansion they usually wait for some junior to make a new mine discovery then buy and develop it. Most exploration for new mines is done by junior companies and under current financial conditions these are finding funding exploration difficult. So, many such firms seek to minimise risk by recycling old properties hoping to improve or extend something known rather than take the greater risk of seeking something new.

 

Against this backdrop there could be a significant shortage of metals needed for a growing world population with a growing need for more metals. Prices should begin to reflect the scarcity. Opposition to mining and some governments unnecessarily stringent conditions on exploration and development may begin to be reconsidered in the light of the urgent need for new mines.

 

E. Critical Accounting Estimates

Not applicable.

 

Item 6. Directors, Senior Management and Employees

 

A. Directors and Senior Management

 

Table No. 1 lists the directors of the Company as of April 26, 2024. The directors have served in their respective capacities since their election and/or appointment and will serve until the next annual general meeting of the Company or until a successor is duly elected, unless the office is vacated in accordance with the Articles of the Company. All directors are residents and citizens of Canada with the exception of Alfredo Phillips, who is a resident and citizen of Mexico.

 

  52

 

Table No. 1

Directors of the Company

Name and Jurisdiction of Residence Age Date First Elected or Appointed
James Duane Poliquin, B.C. Canada 83 February 1, 2002(4)
Morgan Poliquin, B.C. Canada 52 February 1, 2002(4)
Elaine Ellingham(1)(2)(3) ON, Canada 65 February 27, 2018
Kevin O’Kane(1)(2)(3) MB. Canada 64 March 31, 2021
Alfredo Phillips(2) CDMX, Mexico 62 March 31, 2021
Ria Fitzgerald(1)(3) B.C. Canada 45 June 29, 2021
     

(1) Member of Audit Committee

(2) Member of Nominating and Corporate Governance Committee

(3) Member of Compensation Committee

(4) Date of issue of the Certificate of Amalgamation

 

Duane Poliquin was a director of Almaden Resources Corporation since September 1980 and Morgan Poliquin since June 1999.

 

Duane Poliquin was a director of Fairfield Minerals Ltd. since June 1996.

 

Table No. 2 lists the Executive Officers of the Company as of April 26, 2024. The Executive Officers serve at the pleasure of the Board, subject to the terms of executive compensation agreements hereinafter described. All Executive Officers are residents British Columbia, Canada and citizens of Canada.

 

Table No. 2

Executive Officers of the Company

Name Position Age Date First Appointed
James Duane Poliquin Chair of the Board 83 February 1, 2002 (1)
Morgan Poliquin President and Chief Executive Officer 52 March 1, 2007
Korm Trieu Chief Financial Officer & Corp. Secretary 58 May 30, 2011
Douglas McDonald Executive Vice-President 55 September 22, 2014
John A. Thomas Vice-President, Project Development 76 September 9, 2019

 

(1) Date of issue of the Certificate of Amalgamation

 

Duane Poliquin was appointed an Officer of Almaden Resources Corporation in September 1980 and of Fairfield Minerals Ltd. in June 1996.

 

Duane Poliquin is a registered professional geological engineer with over 50 years of experience in mineral exploration and he is the founding shareholder of Almaden Resources Corporation. He gained international experience working with major mining companies where he participated in the discovery of several important mineral deposits. Mr. Poliquin has held executive positions and directorships with several junior resource companies over his career. He was founder and President of Westley Mines Ltd. when that company discovered the Santa Fe gold deposit in Nevada. Mr. Poliquin spends virtually all of his time on the affairs of the Company, Azucar and Almadex, of which he also serves as Chair of the Board and a director, his principal occupation during the preceding five years.

 

Morgan Poliquin is a registered professional geological engineer with over 20 years’ experience in mineral exploration since graduating with a B.A.Sc. degree in geological engineering from the University of British Columbia (1994). In 1996 he earned a M.Sc. in geology from the University of Auckland, New Zealand studying geothermal and epithermal deposits in the South Pacific including the Emperor Gold Deposit, Fiji. In 2010, Dr. Poliquin earned his Ph.D. in Geology from the Camborne School of Mines, University of Exeter. He is President and CEO of the Company and oversees corporate matters as well as directing the Company’s exploration program. Dr. Poliquin spends virtually all of his time directing the exploration programs and the affairs of the Company, Azucar and Almadex, of which he also serves as President, CEO and a director, his principal occupation during the preceding five years.

  53

 

Elaine Ellingham is a professional geoscientist with over 35 years of experience in the mining industry, her principal occupation during the preceding five years, having held senior positions in several mining companies. Ms. Ellingham serves as President & CEO of Omai Gold Mines Corp. and is principal of Ellingham Consulting, providing corporate advisory services to international mining companies and private equity groups. She spent eight years with the TSX serving in various capacities, including four years as the TSX National Leader of Mining & International Business Development. Ms. Ellingham has also served as interim CEO and Director of Richmont Mines Inc. and Senior Vice President, Investor Relations at IAMGOLD, in addition to other corporate development experience with Campbell Resources and Rio Algom Limited. She is also a member of the Board of Directors of Alamos Gold Inc. and Omai Gold Mines Corp.

 

Kevin O'Kane is a registered professional engineer with more than 40 years of experience in the global mining industry, his principal occupation during the preceding five years. He has held executive positions with BHP in South America, including Project Director, Vice President of Health, Safety and Environment, and Asset President. Most recently, Mr. O’Kane held the position of Executive Vice-President and Chief Operating Officer for SSR Mining Inc (2018 - 2020). and is a former Director of SolGold PLC. He holds the ESG Competent Boards Certificate and Global Competent Boards Designation (GCB.D). He is fluent in Spanish and brings a wealth of technical, operational and HSCE leadership combined with Latin American knowledge to Almaden’s Board. Mr. O’Kane also serves on the Boards of IAMGOLD Corporation, NorthIsle Copper and Gold Inc and Compañía Minera Autlán, S.A.B. de C.V. (Mexico).

 

Alfredo Phillips is a seasoned business executive in Mexican primary industries, his principal occupation during the preceding five years. He is currently advising Argonaut Gold on the sale of their Mexican assets and permitting needs, NewGold on a program to build their reputation as a world class mine closure for their San Luis Potosí Cerro San Pedro project. Most recently he served as the Vice President of Corporate Affairs and National Director for Mexico at Argonaut Gold Inc. Prior to this position, he served as Head of Governmental Affairs in Mexico at Arcelor Mittal, the world’s largest steel producer and a similar capacity for Torex Gold for close to seven years. Mr. Phillips is Vice president of the Mining Task Force of the Canadian Chamber of Commerce in Mexico (previously President of the Task Force), continues to serve on the Board of the Chamber, and is founding Chairman of the Guerrero Mining Cluster since 2016. He is also currently Chair of the Communications Committee at the Liberal Arts College, Universidad de la Libertad in Mexico City where he also teaches Expressive Clarity. He also serves on the board of directors of the Latin American and Caribbean Council on Renewable Energy (LAC-CORE) and Naturalia AC, environmental NGO (partnering with the Nature Conservancy and the US National Park Service-Borderlands Restoration Network). Mr. Phillips received a B.Sc. in Actuarial Mathematics from Anahuac University in Mexico City and a Master’s in Public Administration from the Kennedy School of Government at Harvard University.

 

Ria Fitzgerald is a business development consultant with over twenty years of experience in equity capital markets, mergers and acquisitions, project financing and project development with global and start-up companies in the mining, infrastructure, and renewable power sectors, her principal occupation during the preceding five years. She is currently the Director of Mining at Solvest Inc., a renewable energy company and an Independent Director at Victoria Gold Corp., a gold producer in Yukon, Canada. Ms. Fitzgerald has ten years of experience as an investment banker focused on the mining industry, where she was involved in over 100 financings raising more than $7 billion in private and public equity for global mining companies. She has also supported mining companies in providing strategic analysis regarding mergers & acquisitions, and financings. Ms. Fitzgerald’s most recent experience is in project development and financing for sustainable and renewable energy projects at mines and remote communities with a focus on collaborative partnerships between the mines and the local communities. Ms. Fitzgerald holds a Bachelor of Commerce degree from the University of Saskatchewan, where she graduated with High Honours and Great Distinction in finance and holds both the Chartered Financial Analyst designation and the Certificate in ESG Investing from the CFA Institute.

 

Korm Trieu is a Chartered Professional Accountant (CPA, CA) and holds a Bachelor of Science degree from the University of British Columbia and has spent over 20 years in corporate finance, administration and tax services, primarily in the natural resource, financial service and real estate sectors. From 2008-2011, he served as Vice President Finance for Sprott Resource Lending Corp. where he oversaw the Finance and Administration departments of a natural resource lending company. Mr. Trieu spends all of his business time on the affairs of the Company along with Azucar and Almadex, of which he is also the CFO and Corporate Secretary, his principal occupation during the preceding five years.

 

  54

 

Douglas McDonald holds a Bachelor of Commerce degree and an M.A. Sc. specializing in mineral economics from the University of British Columbia and has over 25 years of experience in the resource, foreign trade and resource policy arenas. Prior to joining Almaden, he worked with an investment dealer where he advised numerous mineral resource companies regarding M&A opportunities and assisted them in accessing capital markets. He also spent 5 years as a Foreign Service officer with the Canadian government, where he focused on international trade issues, primarily concerning their impact on the resources industry. Mr. McDonald spends all of his business time on the affairs of the Company, along with Azucar and Almadex, of which he is also a director and the Executive Vice-President, his principal occupation during the preceding five years.

 

John A. Thomas is a professional engineer, who holds a BSc, an MSc and a PhD in chemical engineering from the University of Manchester in the United Kingdom. He also received a diploma in accounting and finance from the U.K. Association of Certified Accountants. He has over 45 years of experience in the mining industry, including both base metal and precious metal projects in several countries including Brazil, Venezuela, Costa Rica, Russia, Kazakhstan, Canada and Zambia, his principal occupation during the preceding five years. His experience covers a wide range of activities in the mining industry from process development, management of feasibility studies, engineering and management of construction, and operation of mines. He served as VP Projects for Atlantic Gold for six years during which time he acted as a Qualified Person for the construction of the Moose River Consolidated Mine.

 

There are no arrangements or understandings with major shareholders, customers, suppliers or others pursuant to which any such director or executive officer was selected as a director or executive officer. Duane Poliquin, Chair of the Board and Director, is the father of Morgan Poliquin, President, Chief Executive Officer and Director.

 

B. Compensation

For the purposes of this document, “executive officer” of the Company means an individual who at any time during the year was the CEO, President, Executive Vice President or CFO of the Company; any Vice-President in charge of a principal business unit, division or function; and any individual who performed a policy-making function in respect of the Company.

 

Set out below are particulars of compensation paid to the following persons (the “Named Executive Officers” or “NEOs”) for the fiscal year ended December 31, 2023:

 

1. the CEO;
2. the CFO;
3. each of the three most highly compensated executive officers, or the three most highly compensated individuals acting in a similar capacity, other than the CEO and CFO, at the end of the most recently completed financial year whose total compensation was, individually, more than $150,000 for that financial year; and
4. any individual who would be a NEO under paragraph (3) but for the fact that the individual was neither an executive officer of the Company, nor acting in a similar capacity, at the end of that financial year.

 

The Company has no pension, defined contribution, or deferred compensation plans for its directors, executive officers or employees.

 

During Fiscal 2023, the Chair was remunerated at his base salary of $144,000 per annum, and the CEO was remunerated at his base salary of $345,000 per annum. The CEO’s employment contract included terms for two additional successive terms of 24 months each (the “Extended Term”) ending January 29, 2019. Subsequently, both the CEO’s and Chair’s employment contracts were amended to remove the Extended Term thereby making their terms indefinite. On September 1, 2022, the Chair agreed to forfeit $177,200 of the total $256,000 unpaid deferred salary. The remaining amount of $78,800 was paid on December 15, 2022.

 

During Fiscal 2023, the CFO and the Executive Vice-President were remunerated at their base salary of $250,000 CAD and $250,000 CAD, respectively. Each of the CFO’s and Executive Vice-President’s employment agreements have indefinite terms.

 

Under Administrative Services Agreements between the Company and each of Azucar and Almadex, the Company provides management services to Azucar and Almadex. Azucar compensates the Company 5% (2022 – 13%) of any shared personnel remuneration and office overhead expenses, while Almadex compensates the Company 66% (2022 – 49%) of any shared personnel remuneration and office overhead expenses. Therefore, Almaden currently recovers 71% (2022 – 62%) of the contractual compensation amounts for the Chair, CEO, CFO and Executive Vice-President.

 

  55

 

All non-management Directors are compensated $30,000 (2022 - $30,000) yearly. The Chair of the Audit Committee and the Chair of the Compensation Committee are compensated an additional $10,000 (2022 - $10,000) and $5,000 (2022 - $5,000) per year respectively. The Chair of the Nominating and Corporate Governance Committee is not compensated (2022 - $Nil). The Compensation Committee also recommended that, with respect to Director stock options, up to 800,000 options be granted to each non-management Director. Directors are entitled to reimbursement for reasonable travel and other out-of-pocket expenses incurred in connection with attendance at meetings of the Board. The Board may award special remuneration to any director undertaking any special services on behalf of the Company other than services ordinarily required of a director. Other than as indicated in Table No. 3 below, no director received any compensation for their services as a director, including committee participation and/or special assignments, or will receive compensation on termination.

 

Total compensation paid by the Company directly and/or indirectly to all directors and executive officers during Fiscal 2023 was $588,895 (Fiscal 2022 - $689,435) after recovery by the Company of 71% (2022 - 62%) of executive officer compensation pursuant to the terms of the Administrative Services Agreements between the Company and each of Azucar and Almadex.

Table No. 3

Summary Compensation Table

Annual Compensation Long-Term Compensation Awards Total
          Restricted Options/        
Name, Fiscal     Other Annual Stock SARS LTIP All Other Total
Principle Position and Year Salary Bonus Compensation* Awards Granted Payouts Compensation Compensation
Jurisdiction of Residence           (#)      
Duane Poliquin 2023(1)(2) $21,600 Nil $103,500 Nil 915,000 Nil Nil $125,100
Chair of the Board & 2022(1)(2) $55,354(8) Nil $173,000 Nil 800,000 Nil Nil $228,354
Director, B.C, Canada 2021(1)(2) $82,000(8) Nil $155,450 Nil 615,000 Nil Nil $237,450
Morgan Poliquin 2023(1)(2) $38,813 $11,644 $113,500 Nil 865,000 Nil Nil $163,957
President, CEO 2022(1)(2) $132,618 $33,638 $481,250 Nil 2,075,000 Nil Nil $647,506
& Director, B.C, Canada 2021(1)(2) $117,875 $35,366 $344,950 Nil 1,165,000 Nil Nil $498,191
Elaine Ellingham(6) 2023 Nil Nil $66,000 Nil 450,000 Nil $40,000(3)(4) $106,000
Director, ON, Canada 2022 Nil Nil $86,000 Nil 350,000 Nil $40,000(3)(5) $126,000
  2021 Nil Nil $136,500 Nil 450,000 Nil $40,000(3)(5) $176,500
Kevin O’Kane(10) 2023 Nil Nil $81,000 Nil 550,000 Nil $30,000(3) $111,000
Director, B.C, Canada 2022 Nil Nil $55,000 Nil 250,000 Nil $30,000(3) $85,000
  2021 Nil Nil $167,500 Nil 550,000 Nil $22,500(3) $190,000
Alfredo Phillips(10) 2023 Nil Nil $81,000 Nil 550,000 Nil $35,000(3) $116,000
Director, CDMX, Mexico 2022 Nil Nil $55,000 Nil 250,000 Nil $40,000(3) $95,000
  2021 Nil Nil $167,500 Nil 550,000 Nil $22,500(3) $190,000
Ria Fitzgerald(10) 2023 Nil Nil $66,000 Nil 550,000 Nil $35,000(3)(5) $101,000
Director, B.C, Canada 2022 Nil Nil $55,000 Nil 250,000 Nil $35,000(3)(4) $90,000
  2021 Nil Nil $137,500 Nil 550,000 Nil $17,500(3)(4) $155,000
William J. Worrall(9) 2023 Nil Nil Nil Nil Nil Nil Nil $Nil
Former Director, B.C, 2022 Nil Nil Nil Nil Nil Nil Nil $Nil
Canada 2021 Nil Nil $12,500 Nil 50,000 Nil Nil $12,500
Korm Trieu 2023(1)(2) $75,000 $26,250 $76,000 Nil 540,000 Nil Nil $177,250
Chief Financial Officer, 2022(1)(2) $96,100 $22,500 $154,700 Nil 605,000 Nil Nil $273,300
B.C, Canada 2021(1)(2) $83,042 $25,628 $170,200 Nil 540,000 Nil Nil $278,870
Douglas McDonald 2023(1)(2) $150,000 $75,000 $73,000 Nil 525,000 Nil Nil $298,000
Executive Vice President 2022(1)(2) $96,100 $48,125 $152,350 Nil 625,000 Nil Nil $296,575
B.C, Canada 2021(1)(2) $80,983 $25,628 $157,750 Nil 525,000 Nil Nil $264,361
John A. Thomas (7) 2023 $50,588 Nil $42,000 Nil 300,000 Nil Nil $92,588
Vice President, Project 2022 $60,000 Nil Nil Nil Nil Nil Nil $60,000
Development, B.C, Canada 2021 $60,000 Nil $102,000 Nil 300,000 Nil Nil $162,000
                             
 * Other Annual Compensation is the fair value of options granted calculated using the Black-Scholes option pricing model at grant date.
 (1) Azucar has compensated the Company, 27% during Fiscal 2021, 13% during Fiscal 2022, and 5% during Fiscal 2023 of any shared personnel fees and/or wages. The above table reflects only the compensation for each individual paid by Almaden after recovery of such 27%, 13% or 5% from Azucar.
 (2) Almadex has compensated the Company, 39% during Fiscal 2021, 49% during Fiscal 2022 and 66% during Fiscal 2023 of any shared personnel’s fees and/or wages. The above table reflects only the compensation for each individual paid by Almaden after recovery of such 39%, 49% or 66% from Almadex.
 (3) Director’s fees.
 (4) Audit Committee Chair’s fees.

  56

 

 (5) Compensation Committee Chair’s fees.
 (6) Elaine Ellingham commenced as a Director of the Company effective February 27, 2018.
 (7) John A. Thomas is compensated at a rate of $5,000 per month pursuant to his Independent Contractor Agreement dated July 1, 2019. Effective December 1, 2023, Mr. Thomas has agreed suspend his fees until further notice.
 (8) Duane Poliquin has agreed to defer payment of $96,000, $96,000 and $64,000 of his $240,000 gross annual salary during Fiscals 2022, 2021 and 2020 respectively. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and pay out the remaining balance of $78,800 on December 15, 2022.
 (9) William J. Worrall ceased to be a Director on July 24, 2021.
 (10) Kevin O’Kane and Alfredo Phillips commenced as a Director of the Company effective March 31, 2021 and Ria Fitzgerald commenced as a Director effective June 29, 2021

 

Remuneration on Termination

 

The Company has the following termination clauses within its executive employment contracts.

 

(1) Chair

 

The Company entered into an Executive Employment Contract dated January 1, 2016, as amended by Amending Agreement dated April 1, 2016 and Second Amending Agreement made January 1, 2019 (the “DP Agreement”) between the Company and Duane Poliquin (the “Executive” under the DP Agreement) which replaced an expired Executive Compensation Contract dated January 29, 2013 (the “HMR Agreement”) between the Company and Hawk Mountain Resources Ltd. (“Management Company”), a private company of which Duane Poliquin (the “Executive” under the HMR Agreement) is a shareholder, which was terminated by mutual agreement on December 31, 2015. The DP Agreement will terminate or may be terminated for any one of the following reasons:

 

(a) voluntarily by the Executive, upon at least three (3) months prior written notice of termination by the Executive to the Company; or
(b) without Cause, upon at least three (3) months prior written notice of termination by the Company to the Executive; or
(c) by the Company for Cause; or
(d) upon the death or disability of the Executive; or
(e) upon retirement by the Executive.

 

Termination by the Executive Voluntarily or by the Company for Cause

 

If the Executive shall voluntarily terminate employment under the DP Agreement or if the employment of the Executive thereunder is terminated by the Company for cause, then all compensation and benefits as theretofore provided shall terminate immediately upon the effective date of termination and no special severance compensation will be paid.

 

Cause to terminate the Executive’s employment under the DP Agreement shall mean:

 

(a) the repeated and demonstrated failure by the Executive to perform the Executive’s material duties under the DP Agreement, after demand for substantial performance is delivered by the Company to the Executive that specifically identifies the manner in which the Company believes the Executive has not substantially performed by the Executive under the DP Agreement; or
(b) the willful engagement by the Executive in misconduct which is materially injurious to the Company, monetarily or otherwise; or
(c) any other willful violation by the Executive of the provisions of the DP Agreement; or
(d) the Executive is convicted of a criminal offence involving fraud or dishonesty.

 

Termination by the Company Without Cause

 

If the Company shall terminate the Executive’s employment under the DP Agreement for any reason except for cause or disability then, upon the effective date of termination, the Company shall pay the Executive in one lump sum an amount equal to two (2) times the Executive’s then current Base Salary, less all statutory withholdings and deductions. All the benefits theretofore provided to the Executive shall be continued as if the Executive was still an employee of the Company for a period of twelve (12) months from the date of termination or until equal or better benefits are provided by a new employer, whichever shall first occur.

 

  57

 

Termination by Death or Disability

 

If the Executive dies or becomes disabled before the Executive’s employment is otherwise terminated, the Company shall pay the Executive or the Executive’s estate, an amount of compensation equal to six (6) months of the Executive’s then current Base Salary and all the benefits theretofore provided to the Executive shall be continued, for a period of six (6) months from the date of death or disability as if the Executive were still an employee of the Company. If such termination is due to the Executive’s death, payment shall be made in one lump sum to the Executive’s designate within 60 days of the Executive’s death. If no designate survives the Executive, the entire amount shall be paid to the Executive’s estate. If such termination is due to the Executive’s disability, payment shall be made in one lump sum to the Executive within sixty (60) days of the Executive’s disability. The compensation provided under this paragraph shall be in addition to that payable from any insurance coverage providing compensation upon death or disability.

 

Termination Following Change in Control

 

For purposes of the DP Agreement, a Change in Control shall be deemed to have occurred if:

 

(i) any person or any person and such person’s associates or affiliates, as such terms are defined in the Securities Act (British Columbia) (the “Act”), makes a tender, take-over or exchange offer, circulates a proxy to shareholders or takes other steps to effect a takeover of the control of the Company, whether by way of a reverse take-over, formal bid, causing the election or appointment of a majority of directors of the Company or otherwise in any manner whatsoever; or

 

(ii) during any period of eighteen (18) consecutive months (not including any period prior to the Effective Date), individuals who at the beginning of such period constituted the Board of Directors and any new directors, whose appointment by the Board of Directors or nomination for election by the Company’s shareholders was approved by a vote of at least three quarters (3/4) of the Board of Directors then still in office who either were directors at the beginning of the period or whose appointment or nomination for election was previously so approved, cease for any reason to constitute a majority of the Board of Directors; or

 

(iii) the acquisition by any person or by any person and such person’s affiliates or associates, as such terms are defined in the Act, and whether directly or indirectly, of common shares of the Company at the time held by such person and such person’s affiliates and associates, totals for the first time, twenty percent (20%) or more of the outstanding common shares of the Company; or

 

(iv) the business or businesses of the Company for which the Executive’s services are principally performed, are disposed of by the Company pursuant to a partial or complete liquidation, dissolution, consolidation or merger of the Company, or a sale or transfer of all or a significant portion of the Company’s assets.

 

Notwithstanding any other provisions in the DP Agreement regarding termination, if any of the events described above constituting a Change in Control shall have occurred during the Term, upon the termination of the Executive’s employment (unless such termination is because of the Executive’s Death or Disability, by the Company for Cause or by the Executive other than for “Good Reason”, as defined below) the Executive shall be entitled to and will receive no later than the fifteenth (15th) day following the date of termination a lump sum payment equal to three (3) times the Executive’s then current Base Salary. In addition, all benefits then applicable to the Executive shall be continued for a period of eighteen (18) months after the date of termination.

 

For purposes of the DP Agreement, “Good Reason” shall mean, without the Executive’s express written consent, any of the following:

 

(i) the assignment to the Executive of any duties inconsistent with the status or authority of the Executive’s office, or the Executive’s removal from such position, or a substantial alteration in the nature or status of the Executive’s authorities or responsibilities from those in effect immediately prior to the Change in Control;

 

  58

 

(ii) a reduction by the Company of the Executive’s Base Salary as in effect on the date of the DP Agreement or as the same may have been increased from time to time, or a failure by the Company to increase the Executive’s Base Salary as provided for in the DP Agreement or at a rate commensurate with that of other key executives of the Company;

 

(iii) the relocation of the office of the Company where the Executive is employed at the time of the Change in Control (the “CIC Location”) to a location more than fifty (50) miles away from the CIC Location, or the Company’s requiring the Executive to be based more than fifty (50) miles away from the CIC Location (except for requiring travel on the Company’s business to an extent substantially consistent with the Executive’s business travel obligations prior to the Change in Control);

 

(iv) the failure by the Company to continue to provide the Executive with benefits at least as favourable as those enjoyed by the Executive prior to the Change in Control, the taking of any action by the Company which would directly or indirectly materially reduce any of such benefits or deprive the Executive of any material fringe benefit enjoyed by the Executive at the time of the Change in Control, or the failure by the Company to provide the Executive with the number of entitled vacation days to which the Executive has earned on the basis of years of services with the Company; or

 

(v) the failure of the Company to obtain a satisfactory agreement from any successor to assume and agree to perform the DP Agreement or, if the business of the Company for which the Executive’s services are principally performed is sold or transferred, the purchaser or transferee of such business shall fail to agree to provide the Executive with the same or a comparable position, duties, remuneration and benefits for the Executive as provided immediately prior to the Change in Control.

 

Following a Change in Control during the term, the Executive shall be entitled to terminate the Executive’s employment for Good Reason.

 

In the event the Executive is entitled to a severance payment under the DP Agreement, then in addition to such severance payment, the Executive shall be entitled to employment search assistance to secure other comparable employment for the Executive for a period not to exceed one (1) year or until such comparable employment is found, whichever is the sooner, with fees for such assistance to be paid by the Company.

 

The Executive’s right to receive the aforementioned payment and benefits is expressly contingent upon the signing of a waiver and release satisfactory to the Company which releases the Company and its affiliates from all claims and liabilities arising out of the Executive’s employment and termination thereof and including confidentiality provisions, which waiver and release is satisfactory to the Company with respect to form, substance and timeliness.

 

(2) President & CEO

 

The Executive Employment Contract dated January 29, 2013, as amended by Amending Agreement dated April 1, 2016 and Second Amending Agreement made January 1, 2019 (the “MP Agreement”) between the Company and Morgan Poliquin (the “Executive” under the MP Agreement) will terminate or may be terminated for any one of the following reasons:

 

(a) voluntarily by the Executive, upon at least three (3) months prior written notice of termination by the Executive to the Company; or
(b) without cause, upon at least three (3) months prior written notice of termination by the Company to the Executive; or
(c) by the Company for cause; or
(d) upon the death or disability of the Executive; or
(e) upon retirement by the Executive.

 

  59

 

Termination by the Executive Voluntarily or by the Company for Cause

 

If the Executive shall voluntarily terminate employment under the MP Agreement or if the employment of the Executive is terminated by the Company for cause, then all compensation and benefits as theretofore provided shall terminate immediately upon the effective date of termination and no special severance compensation will be paid.

 

Cause to terminate the Executive’s employment shall mean:

 

(a) the repeated and demonstrated failure by the Executive to perform the Executive’s material duties under the MP Agreement, after demand for substantial performance is delivered by the Company to the Executive that specifically identifies the manner in which the Company believes the Executive has not substantially performed the Executive’s duties under the MP Agreement; or
(b) the willful engagement by the Executive in misconduct which is materially injurious to the Company, monetarily or otherwise; or
(c) any other willful violation by the Executive of the provisions of the MP Agreement; or
(d) the Executive is convicted of a criminal offence involving fraud or dishonesty.

 

Termination by the Company Without Cause

 

If the Company shall terminate the Executive’s employment under the MP Agreement for any reason except for cause then, upon the effective date of termination, the Company shall pay the Executive in one lump sum an amount equal to two (2) times the Executive’s then current Base Salary, less all statutory withholdings and deductions. All the benefits theretofore provided to the Executive shall be continued as if the Executive was still an employee of the Company for a period of twelve (12) months from the date of termination or until equal or better benefits are provided by a new employer, whichever shall first occur.

 

Termination by Death or Disability

 

If the Executive dies or becomes disabled before the Executive’s employment is otherwise terminated, the Company shall pay the Executive or the Executive’s estate, an amount of compensation equal to six (6) months of the Executive’s then current Base Salary and all the benefits theretofore provided to the Executive shall be continued, for a period of six (6) months from the date of death or disability as if the Executive were still an employee of the Company. If such termination is due to the Executive’s death, payment shall be made in one lump sum to the Executive’s designate within sixty (60) days of the Executive’s death. If no Executive’s designate survives the Executive, the entire amount shall be paid to the Executive’s estate. If such termination is due to the Executive’s disability, payment shall be made in one lump sum to the Executive within sixty (60) days of the Executive’s disability. The compensation provided under this paragraph shall be in addition to that payable from any insurance coverage providing compensation upon death or disability.

 

Termination Following Change in Control

 

For purposes of the MP Agreement, a Change in Control shall be deemed to have occurred if:

 

(i) any person or any person and such person’s associates or affiliates, as such terms are defined in the Act, makes a tender, take-over or exchange offer, circulates a proxy to shareholders or takes other steps to effect a takeover of the control of the Company, whether by way of a reverse take-over, formal bid, causing the election or appointment of a majority of directors of the Company or otherwise in any manner whatsoever; or

 

(ii) during any period of eighteen (18) consecutive months (not including any period prior to the Effective Date), individuals who at the beginning of such period constituted the Board of Directors and any new directors, whose appointment by the Board of Directors or nomination for election by the Company’s shareholders was approved by a vote of at least three quarters (3/4) of the Board of Directors then still in office who either were directors at the beginning of the period or whose appointment or nomination for election was previously so approved, cease for any reason to constitute a majority of the Board of Directors; or

 

  60

 

(iii) the acquisition by any person or by any person and such person’s affiliates or associates, as such terms are defined in the Act, and whether directly or indirectly, of common shares of the Company at the time held by such person and such person’s affiliates and associates, totals for the first time, twenty percent (20%) or more of the outstanding common shares of the Company; or

 

(iv) the business or businesses of the Company for which the Executive’s services are principally performed, are disposed of by the Company pursuant to a partial or complete liquidation, dissolution, consolidation or merger of the Company, or a sale or transfer of all or a significant portion of the Company’s assets.

 

Notwithstanding any other provisions in the MP Agreement regarding termination, if any of the events described above constituting a Change in Control shall have occurred during the Term, upon the termination of the Executive’s employment (unless such termination is because of the Executive’s death or disability, by the Company for cause or by the Executive other than for “Good Reason”, as defined below) the Executive shall be entitled to and will receive no later than the fifteenth (15th) day following the date of termination a lump sum severance payment equal to three (3) times the Executive’s then current Base Salary. In addition, all benefits then applicable to the Executive shall be continued for a period of eighteen (18) months after the date of termination.

 

For purposes of the MP Agreement, “Good Reason” shall mean, without the Executive’s express written consent, any of the following:

 

(i) the assignment to the Executive of any duties inconsistent with the status or authority of the Executive’s office, or the Executive’s removal from such position, or a substantial alteration in the nature or status of the Executive’s authorities or responsibilities from those in effect immediately prior to the Change in Control;

 

(ii) a reduction by the Company in the Executive’s Base Salary as in effect on the date of the MP Agreement or as the same may have been increased from time to time, or a failure by the Company to increase the Executive’s Base Salary as provided for in the MP Agreement or at a rate commensurate with that of other key executives of the Company;

 

(iii) the relocation of the CIC Location to a location more than fifty (50) miles away from the CIC Location, or the Company’s requiring the Executive to be based more than fifty (50) miles away from the CIC Location (except for requiring travel on the Company’s business to an extent substantially consistent with the Executive’s business travel obligations prior to the Change in Control);

 

(iv) the failure by the Company to continue to provide the Executive with benefits at least as favourable as those enjoyed by the Executive prior to the Change in Control, the taking of any action by the Company which would directly or indirectly materially reduce any of such benefits or deprive the Executive of any material fringe benefit enjoyed by the Executive at the time of the Change in Control, or the failure by the Company to provide the Executive with the number of entitled vacation days to which the Executive has earned on the basis of years of service with the Company; or

 

(v) the failure of the Company to obtain a satisfactory agreement from any successor to assume and agree to perform the MP Agreement or, if the business of the Company for which the Executive’s services are principally performed is sold or transferred, the purchaser or transferee of such business shall fail to agree to provide the Executive with the same or a comparable position, duties, salary and benefits as provided to the Executive by the Company immediately prior to the Change in Control.

 

Following a Change in Control during the Term, the Executive shall be entitled to terminate the Executive’s employment for Good Reason.

 

In the event the Executive is entitled to a severance payment under the MP Agreement, then in addition to such severance payment, the Executive shall be entitled to employment search assistance to secure other comparable employment for a period not to exceed one (1) year or until such comparable employment is found, whichever is the sooner, with fees for such assistance to be paid by the Company.

 

  61

 

The Executive’s right to receive the aforementioned payment and benefits is expressly contingent upon the signing of a waiver and release satisfactory to the Company which releases the Company and its affiliates from all claims and liabilities arising out of the Executive’s employment and termination thereof and including confidentiality provisions, which waiver and release is satisfactory to the Company with respect to form, substance and timeliness.

 

(3) CFO

 

The Employment Agreement dated May 24, 2011 as amended April 1, 2016 (the “KT Agreement”) between the Company and Korm Trieu (the “Employee” under the KT Agreement) may be terminated for any one of the following reasons:

 

(a) voluntarily by the Employee, upon at least sixty (60) days prior written notice of termination by the Employee to the Company; or
(b) by the Company for cause; or
(c) without cause, upon payment of twelve (12) months of the Employee’s then current Base Salary to the Employee; or
(d) upon the physical and/or mental impairment of the Employee.

 

Termination by the Employee Voluntarily or by the Company for Cause

 

If the Employee shall voluntarily terminate employment under the KT Agreement or if the employment of the Employee is terminated by the Company for cause, then all compensation and benefits as theretofore provided shall terminate immediately upon the effective date of termination and no special severance compensation will be paid.

 

Cause to terminate the Employee’s employment shall mean:

 

(a) the repeated and demonstrated failure by the Executive to perform the Employee’s material duties under the KT Agreement, after demand for substantial performance is delivered by the Company to the Employee that specifically identifies the manner in which the Company believes the Employee has not substantially performed the Employee’s duties under the KT Agreement; or
(b) the willful engagement by the Employee in misconduct which is materially injurious to the Company, monetarily or otherwise; or
(c) any other willful violation by the Employee of the provisions of the KT Agreement; or
(d) the Employee is convicted of a criminal offence involving fraud or dishonesty.

 

Termination by the Company Without Cause

 

If the Company elects to terminate the Employee’s employment for reasons other than cause, the Company shall pay the Employee, in one lump sum or in installments at the Company’s discretion, a severance payment equal to twelve (12) months of the Employee’s then current Base Salary.

 

Termination upon the physical and/or mental impairment of the Employee

 

If the Company terminates the Employee’s employment for physical and/or mental impairment, the Company’s financial obligation to the Employee is limited to that which the Employee would otherwise receive if the Company terminated the Employee’s employment for no reason.

 

Termination Following Change in Control

 

For purposes of the KT Agreement, a change in control shall be deemed to have occurred if:

 

(i) any person or any person and such person’s associates or affiliates, as such terms are defined in the Act, makes a tender, take-over or exchange offer, circulates a proxy to shareholders or takes other steps to effect a takeover of the control of the Company, whether by way of a reverse take-over, formal bid, causing the election or appointment of a majority of directors of the Company or otherwise in any manner whatsoever; or

  62

 

(ii) during any period of eighteen (18) consecutive months (not including any period prior to the Effective Date), individuals who at the beginning of such period constituted the Board of Directors and any new directors, whose appointment by the Board of Directors or nomination for election by the Company’s shareholders was approved by a vote of at least three quarters (3/4) of the Board of Directors then still in office who either were directors at the beginning of the period or whose appointment or nomination for election was previously so approved, cease for any reason to constitute a majority of the Board of Directors; or

 

(iii) the acquisition by any person or by any person and such person’s affiliates or associates, as such terms are defined in the Act, and whether directly or indirectly, of common shares of the Company at the time held by such person and such person’s affiliates and associates, totals for the first time, twenty percent (20%) or more of the outstanding common shares of the Company; or

 

(iv) the business or businesses of the Company for which the Employee’s services are principally performed, are disposed of by the Company pursuant to a partial or complete liquidation, dissolution, consolidation or merger of the Company, or a sale or transfer of all or a significant portion of the Company’s assets.

 

Notwithstanding any other provisions in the KT Agreement regarding termination, if any of the events described above constituting a Change in Control shall have occurred during the course of the KT Agreement, upon the termination of the Employee’s employment (unless such termination is because of the Employee’s Death or Disability, by the Company for cause or by the Employee other than for “Good Reason”, as defined below) the Employee shall be entitled to and will receive no later than the fifteenth (15th) day following the date of termination a lump sum severance payment equal to two (2) times the Employee’s then current Base Salary.

 

For purposes of the KT Agreement, “Good Reason” shall mean, without the Employee’s express written consent, any of the following:

 

(i) the assignment to the Employee of any duties inconsistent with the status or authority of the Employee’s office, or the Employee’s removal from such position, or a substantial alteration in the nature or status of the Employee’s authorities or responsibilities from those in effect immediately prior to the Change in Control;

 

(ii) a reduction by the Company in the Employee’s Base Salary as in effect on the date of the KT Agreement or as the same may have been increased from time to time, or a failure by the Company to increase the Employee’s Base Salary as provided for in the KT Agreement or at a rate commensurate with that of other key employees of the Company;

 

(iii) the relocation of the CIC Location to a location more than fifty (50) miles away from the CIC Location, or the Company’s requiring the Employee to be based more than fifty (50) miles away from the CIC Location (except for requiring travel on the Company’s business to an extent substantially consistent with the Employee’s business travel obligations prior to the Change in Control);

 

(iv) the failure by the Company to continue to provide the Employee with benefits at least as favourable as those enjoyed by the Employee prior to the Change in Control, the taking of any action by the Company which would directly or indirectly materially reduce any of such benefits or deprive the Employee of any material fringe benefit enjoyed by the Employee at the time of the Change in Control, or the failure by the Company to provide the Employee with the number of entitled vacation days to which the Employee has earned on the basis of years of service with the Company; or

 

(v) the failure of the Company to obtain a satisfactory agreement from any successor to assume and agree to perform the KT Agreement or, if the business of the Company for which the Employee’s services are principally performed is sold or transferred, the purchaser or transferee of such business shall fail to agree to provide the Employee with the same or a comparable position, duties, salary and benefits as provided to the Employee by the Company immediately prior to the Change in Control.

 

  63

 

Following a Change in Control during the course of the KT Agreement, the Employee shall be entitled to terminate the Employee’s employment for Good Reason.

 

The Employee’s right to receive the aforementioned payment and benefits is expressly contingent upon the signing of a waiver and release satisfactory to the Company which releases the Company and its affiliates from all claims and liabilities arising out of the Employee’s employment and termination thereof and including confidentiality provisions, which waiver and release is satisfactory to the Company with respect to form, substance and timeliness.

 

(4) Executive Vice President

 

The Employment Agreement dated September 22, 2014 as amended April 1, 2016 (the “DM Agreement”) between the Company and Douglas McDonald (the “Employee” under the DM Agreement) may be terminated for any one of the following reasons:

 

(a) voluntarily by the Employee, upon at least sixty (60) days prior written notice of termination by the Employee to the Company; or
(b) by the Company for cause; or
(c) without cause, upon payment of twelve (12) months of the Employee’s then current Base Salary to the Employee; or
(d) upon the physical and/or mental impairment of the Employee.

 

Termination by the Employee Voluntarily or by the Company for Cause

 

If the Employee shall voluntarily terminate employment under the DM Agreement or if the employment of the Employee is terminated by the Company for cause, then all compensation and benefits as theretofore provided shall terminate immediately upon the effective date of termination and no special severance compensation will be paid.

 

Cause to terminate the Employee’s employment shall mean:

 

(a) the repeated and demonstrated failure by the Employee to perform the Employee’s material duties under the DM Agreement, after demand for substantial performance is delivered by the Company to the Employee that specifically identifies the manner in which the Company believes the Employee has not substantially performed the Employee’s duties under the DM Agreement; or
(b) the willful engagement by the Employee in misconduct which is materially injurious to the Company, monetarily or otherwise; or
(c) any other willful violation by the Employee of the provisions of the DM Agreement; or
(d) the Employee is convicted of a criminal offence involving fraud or dishonesty.

 

Termination by the Company Without Cause

 

If the Company elects to terminate the Employee’s employment for reasons other than cause, the Company shall pay the Employee, in one lump sum or in installments at the Company’s discretion, a severance payment equal to twelve (12) months of the Employee’s then current Base Salary.

 

Termination upon the physical and/or mental impairment of the Employee

 

If the Company terminates the Employee’s employment for physical and/or mental impairment, the Company’s financial obligation to the Employee is limited to that which the Employee would otherwise receive if the Company terminated the Employee’s employment for no reason.

 

  64

 

Termination Following Change in Control

 

For purposes of the DM Agreement, a change in control shall be deemed to have occurred if:

 

(i) any person or any person and such person’s associates or affiliates, as such terms are defined in the Act, makes a tender, take-over or exchange offer, circulates a proxy to shareholders or takes other steps to effect a takeover of the control of the Company, whether by way of a reverse take-over, formal bid, causing the election or appointment of a majority of directors of the Company or otherwise in any manner whatsoever; or

 

(ii) during any period of eighteen (18) consecutive months (not including any period prior to the Effective Date), individuals who at the beginning of such period constituted the Board of Directors and any new directors, whose appointment by the Board of Directors or nomination for election by the Company’s shareholders was approved by a vote of at least three quarters (3/4) of the Board of Directors then still in office who either were directors at the beginning of the period or whose appointment or nomination for election was previously so approved, cease for any reason to constitute a majority of the Board of Directors; or

 

(iii) the acquisition by any person or by any person and such person’s affiliates or associates, as such terms are defined in the Act, and whether directly or indirectly, of common shares of the Company at the time held by such person and such person’s affiliates and associates, totals for the first time, twenty percent (20%) or more of the outstanding common shares of the Company; or

 

(iv) the business or businesses of the Company for which the Employee’s services are principally performed, are disposed of by the Company pursuant to a partial or complete liquidation, dissolution, consolidation or merger of the Company, or a sale or transfer of all or a significant portion of the Company’s assets.

 

Notwithstanding any other provisions in the DM Agreement regarding termination, if any of the events described above constituting a Change in Control shall have occurred during the course of the DM Agreement, upon the termination of the Employee’s employment (unless such termination is because of the Employee’s Death or Disability, by the Company for cause or by the Employee other than for “Good Reason”, as defined below) the Employee shall be entitled to and will receive no later than the fifteenth (15th) day following the date of termination a lump sum severance payment equal to two (2) times the Employee’s then current Base Salary.

 

For purposes of the DM Agreement, “Good Reason” shall mean, without the Employee’s express written consent, any of the following:

 

(i) the assignment to the Employee of any duties inconsistent with the status or authority of the Employee’s office, or the Employee’s removal from such position, or a substantial alteration in the nature or status of the Employee’s authorities or responsibilities from those in effect immediately prior to the Change in Control;

 

(ii) a reduction by the Company in the Employee’s Base Salary as in effect on the date of the DM Agreement or as the same may have been increased from time to time, or a failure by the Company to increase the Employee’s Base Salary as provided for in the DM Agreement or at a rate commensurate with that of other key employees of the Company;

 

(iii) the relocation of the CIC Location to a location more than fifty (50) miles away from the CIC Location, or the Company’s requiring the Employee to be based more than fifty (50) miles away from the CIC Location (except for requiring travel on the Company’s business to an extent substantially consistent with the Employee’s business travel obligations prior to the Change in Control);

 

(iv) the failure by the Company to continue to provide the Employee with benefits at least as favourable as those enjoyed by the Employee prior to the Change in Control, the taking of any action by the Company which would directly or indirectly materially reduce any of such benefits or deprive the Employee of any material fringe benefit enjoyed by the Employee at the time of the Change in Control, or the failure by the Company to provide the Employee with the number of entitled vacation days to which the Employee has earned on the basis of years of service with the Company; or

  65

 

(v) the failure of the Company to obtain a satisfactory agreement from any successor to assume and agree to perform the DM Agreement or, if the business of the Company for which the Employee’s services are principally performed is sold or transferred, the purchaser or transferee of such business shall fail to agree to provide the Employee with the same or a comparable position, duties, salary and benefits as provided to the Employee by the Company immediately prior to the Change in Control.

 

Following a Change in Control during the course of the DM Agreement, the Employee shall be entitled to terminate the Employee’s employment for Good Reason.

 

The Employee’s right to receive the aforementioned payment and benefits is expressly contingent upon the signing of a waiver and release satisfactory to the Company which releases the Company and its affiliates from all claims and liabilities arising out of the Employee’s employment and termination thereof and including confidentiality provisions, which waiver and release is satisfactory to the Company with respect to form, substance and timeliness.

 

(5) Vice President, Project Development

 

The Independent Contractor Agreement dated July 1, 2019 (the “JT Agreement”) between the Company and John A. Thomas (the “Contractor” under the JT Agreement) may be terminated for any one of the following reasons:

 

a. by Contractor, at any time, without cause or reason, upon 30 days written notice to the Company;
b. by the Company, for cause, at any time in the event of a failure by Contractor to comply with any of the provisions of the JT Agreement, including, without limitation, a persistent failure on the part of Contractor to follow the directions of the Board or CEO or any act of gross negligence or willful misconduct on the part of Contractor, where the Company has communicated such failure to Contractor and a reasonable opportunity to cure the failure has been provided, or by the Company immediately upon the death or incapacity of Contractor or upon Contractor no longer being qualified, under applicable corporate or securities laws or stock exchange requirements, to be the Vice-President, Project Development of the Company;
c. by Contractor, for cause, at any time in the event of a failure by the Company to comply with any of the provisions of the JT Agreement, where such failure has been communicated to the Company and a reasonable opportunity to cure the failure has been provided; or
d. by the Company, at any time, without cause or reason, upon 30 days written notice to Contractor;

 

and upon any such termination, the Board shall be at liberty to remove Contractor from any office held by Contractor in the Company or any of its subsidiaries and to make or cause to be made whatever regulatory or stock exchange filings are required in the circumstances.

 

Stock options

Incentive stock options to purchase securities from the Company are granted to directors, executive officers, employees and consultants of the Company on terms and conditions acceptable to the regulatory authorities in Canada, notably the TSX, and in accordance with the requirements of the applicable Canadian securities commissions’ requirements and regulations.

 

The Company has a formal written stock option plan (“Plan”) which permits the issuance of up to 10% of the Company’s issued share capital from time to time during the term of the Plan and provides that stock options may be granted from time to time provided that incentive stock options in favor of any consultant or person providing investor relations services cannot exceed 2% in any 12 month period. No incentive stock option granted under the Plan is transferable by the optionee other than by will or the laws of descent and distribution, and each incentive stock option is exercisable during the lifetime of the optionee only by such optionee and by the optionee’s personal representatives in the event of death for a period ending on the earlier of the expiry date of the option and twelve months after the date of death.

 

  66

 

The exercise price of all incentive stock options granted under the Plan is determined in accordance with TSX guidelines and cannot be less than the Market Price on the date of the grant. Market Price is the volume weighted average trading price of the Company’s shares on the TSX for the five trading days immediately preceding the date of the grant. The maximum term of each incentive stock option is five years. Options granted to consultants or persons providing Investor Relations Activities (as defined in the Plan) shall vest in stages with no more than ¼ of such options being exercisable in any three-month period. All options granted during Fiscal 2023, Fiscal 2022 and Fiscal 2021 vested on the date granted. Under the requirements of the TSX, all unallocated options under the Plan must be approved by the Board, including a majority of the unrelated directors, and by the shareholders every three years after the institution of the Plan. Insiders and affiliates of insiders entitled to receive a benefit under the Plan are not entitled to vote for such approval. The Plan received its triennial approval in Fiscal 2023.

 

The names and titles of the directors and executive officers of the Company to whom outstanding stock options have been granted and the number of common shares subject to such options as of April 26, 2024 are set forth in Table No. 4, as well as the number of options granted to directors, executive officers, employees and consultants as a group.

 

Table No. 4

Stock Options Outstanding

Name # Options Outstanding &Exercisable Exercise Price CDN$ Expiry Date
Duane Poliquin 500,000 0.33 06/10/2027
Chair of the Board & Director 200,000 0.30 10/04/2027
  100,000 0.33 12/16/2027
  350,000 0.16 7/10/2028
  265,000 0.18 9/19/2028
Morgan Poliquin 375,000 0.38 03/07/2027
President, Director & 1,200,000 0.33 06/10/2027
Chief Executive Officer 200,000 0.30 10/04/2027
  300,000 0.33 12/16/2027
  250,000 0.30 02/14/2028
  600,000 0.16 7/10/2028
  315,000 0.18 9/19/2028
Alfredo Phillips 250,000 0.33 06/10/2027
Director 500,000 0.26 04/03/2028
  50,000 0.16 07/10/2028
Kevin O’Kane 250,000 0.33 06/10/2027
Director 500,000 0.26 04/03/2028
  50,000 0.16 07/10/2028
Ria Fitzgerald 250,000 0.33 06/10/2027
Director 550,000 0.16 07/10/2028
Elaine Ellingham 100,000 0.38 03/07/2027
Director 250,000 0.33 06/10/2027
  400,000 0.26 04/03/2028
  50,000 0.16 07/10/2028
Korm Trieu 250,000 0.38 03/07/2027
Chief Financial Officer & 225,000 0.33 06/10/2027
Corporate Secretary 100,000 0.30 10/04/2027
  30,000 0.33 12/16/2027
  125,000 0.30 02/14/2028
  200,000 0.26 04/03/2028
  100,000 0.16 07/10/2028
  115,000 0.18 09/19/2028
Douglas McDonald 250,000 0.38 03/07/2027
Executive Vice President 20,000 0.33 06/10/2027
  100,000 0.30 10/04/2027
  255,000 0.33 12/16/2027
  75,000 0.30 02/14/2028
  250,000 0.26 04/03/2028
  100,000 0.16 07/10/2028
  100,000 0.18 09/19/2028
John A. Thomas 150,000 0.30 02/14/2028
Vice President, Project Development 150,000 0.18 09/19/2028
Total Directors/Officers (9 persons) 10,450,000    
Total Employees/Consultants (9 persons) 2,015,000    
Total Directors/Officers/Employees/Consultants 12,465,000    

 

  67

 

No funds were set aside or accrued by the Company during Fiscal 2023 to provide pension, retirement or similar benefits for directors or executive officers.

 

General

 

The TSX and the applicable Canadian securities law and regulation require that the Company comply with National Instrument 58-101 (Disclosure of Corporate Governance Practices) or any replacement of that instrument. The Company is also, under applicable Canadian securities law and regulation, required to comply with National Policy 58-201 (Corporate Governance Guidelines). National Instrument 58-101 and National Policy 58-201 (for convenience referred to in the aggregate as the “guidelines”) deal with matters such as the constitution and independence of corporate boards, their functions, the effectiveness and education of the board members and other matters. The Company’s statement as to compliance with the guidelines and its approach to corporate governance is set forth below.

 

Corporate Governance

 

The Board and management are committed to the highest standards of corporate governance. The Company’s corporate governance practices are in accordance with the guidelines. The Company is also cognizant of and compliant with various corporate governance requirements in Canada and is in compliance with applicable U.S. requirements.

 

The Company’s prime objective in directing and managing its business and affairs is to enhance shareholder value. The Company views effective corporate governance as a means of improving corporate performance and accordingly of benefit to the Company and all shareholders.

 

The Company also believes that director and management honesty and integrity are essential factors in ensuring good and effective corporate governance. To that end the Company’s directors have adopted various codes and policies for the Company, its directors, officers, employees and consultants. The codes and policies adopted to date are as follows: Audit Committee Charter, Nominating and Corporate Governance Committee-Responsibilities and Duties, Compensation Committee-Responsibilities and Duties, Code of Business Ethics, Code of Business Conduct and Ethics for Directors, Communications Policy, Securities Trading Policy, Whistleblowers Policy and Privacy Policy (the “Codes”). The Codes may be viewed on the Company’s website at www.almadenminerals.com. The Codes may also be viewed as filed on EDGAR as an exhibit to the 2005 Annual Report on Form 20-F filed with the Commission on March 30, 2006. Any amendments to the Codes or waivers of the provision of any Codes will be posted on the Company’s website within 5 business days of such amendment or waiver.

 

Executive Officer Position Descriptions

 

Chair of the Board (‘Chair’)

 

Responsibilities:

 

- Leads the Board and also takes a hands-on role in the Company’s day-to-day management.
- Helps the CEO to oversee all the operational aspects involved in running the Company, including project selection and planning.
- Takes overall responsibility for the Company’s direction and growth, seeking to generate significant financial gains for the shareholders.
- Oversees relationships with the communities and stakeholders in the areas where the Company operates, with the intent of ensuring the Company’s activities are of benefit to all.

 

Chief Executive Officer (‘CEO’)

 

Reports to:

 

The Board of Directors of the Company

 

Function:

Provides overall leadership and vision in developing, in concert with the Board, the strategic direction of the Company and in developing the tactics and business plans necessary to increase shareholder value.

 

  68

 

Manages the overall business to ensure strategic and business plans are effectively implemented, the results are monitored and reported to the Board and financial and operational objectives are attained.

 

Authorities, Duties and Responsibilities:

 

(a) General Functions:

 

1. Provides effective leadership to the management and the employees of the Company and establishes an effective means of control and co-ordination for all operations and activities.
2. Fosters a corporate culture that promotes ethical practices, integrity and a positive work climate enabling the Company to attract, retain and motivate a diverse group of quality employees.
3. Keeps the Board fully informed on the Company`s operational and financial affairs.
4. Develops and maintains a sound, effective organization structure and plans for capable management succession, progressive employee training and development programs and reports to the Board on these matters.
5. Ensures that effective communications and appropriate relationships are maintained with the shareholders of the Company and other stakeholders.
6. Develops capital expenditure plans for approval by the Board.
7. Turns any strategic plan as may be developed by the Board into a detailed operating plan.

 

(b) Strategy and Risks

 

1. Develops and recommends to the Board strategic plans to ensure the Company`s profitable growth and overall success. This includes updating and making changes as required and involving the Board in the early stages of developing strategy.
2. Identifies in conjunction with the other senior officers and appropriate directors of the Company the key risks with respect to the Company and its businesses and reviews such risks and strategies for managing them with the Board.
3. Ensures that the assets of the Company are adequately safeguarded and maintained.

 

(c) Exploration and Development

 

Responsible for managing the day to day activities and operating management of the Company and as such shall be responsible for the design, operation and improvement of the systems that create the Company`s exploration and development opportunities. The CEO accordingly shall have the primary responsibility:

- To direct and oversee all operational activities of the Company including exploration, development, mining and other such functions.
- To initiate solutions to the key business challenges of the Company.
- To participate in sourcing and negotiating financial arrangements for the further expansion and development of the Company including joint ventures, mergers, acquisitions, debt and equity financing.
- Represent and speak for the Company with shareholders, potential investors and other members of the industry.

 

(d) Financial Reporting

 

Oversees the quality and timeliness of financial reporting. Reports to the Board in conjunction with the CFO on the fairness and adequacy of the financial reporting of the Company to its shareholders.

 

Chief Financial Officer (‘CFO’)

 

Reports to:

The CEO of the Company

  69

 

Responsibilities:

- Developing, analyzing and reviewing financial data.
- Reporting on financial performance.
- Monitoring expenditures and costs.
- Assisting the CEO in preparing budgets and in the communicating to the analyst and shareholder, community and securities regulators, the financial performance of the Company.
- Fulfilling the reporting requirements of the securities regulators, stock exchanges and shareholders.
- Monitoring filing of tax returns and payment of taxes.

 

The CFO shall assist the CEO in establishing effective means of control and co-ordination of the operations and activities of the Company and identifying, in conjunction with the CEO, the key risks with respect to the Company and its business and reviewing with the CEO the strategies for managing such risks and ensuring that the assets of the Company are adequately safeguarded and maintained.

 

The CFO, in conjunction with the CEO, shall design or supervise the design of and implement, maintain and periodically evaluate the effectiveness of internal controls to provide reasonable assurances that the financial statements of the Company are fairly presented in accordance with generally accepted financial standards and principles and that disclosure controls are in place to provide reasonable assurance that material information relating to the financial performance of the Company and any deficiencies are made known to the Audit Committee.

 

Executive Vice President (formerly Vice President, Corporate Development)

 

Reports to:

The CEO of the Company

 

Responsibilities:

The Executive Vice President is responsible for:

- Developing and managing relationships with current and prospective business partners, investment bankers, institutional investors, financial analysts and the media;
- Preparing and presenting comprehensive reviews and analysis regarding the business to senior management and to the Board;
- Coordinating execution of key strategic initiatives such as activities relating to business and project financing, permitting and litigation;
- Ensuring appropriate corporate disclosure of non technical matters, aside from matters which would normally fall under the purview of the CFO;
- Working with the CEO in preparing and presenting to investors, the executive team and the Board;
- Conducting technical and financial analysis to determine the impact of growth opportunities on various metrics and to establish an execution plan as needed.

 

The Executive Vice President shall work with the CEO in establishing and managing relationships with key stakeholders, identifying and analysing key strategic business opportunities, as well as the development, communication and implementation of corporate strategies related to executing the business plan of the Company.

 

Vice President, Project Development

 

Reports to:

The CEO of the Company

 

Responsibilities:

The Vice President, Project Development is responsible for:

- Planning and managing the construction of the Ixtaca Project;
- Developing and overseeing the implementation of all required Project execution systems and procedures including Project controls, procurement of contracts, engineering construction, quality assurance and quality control;
- Ensuring the Project objectives, scope and plan are well defined and understood by the Project team and stakeholders;
- Ensuring the compliance with health, safety, environmental and community regulations and corporate standards;

  70

 

- Developing and recommending production strategies, together with capital budget and operating budget requirements to optimize short and long-range production capabilities while minimizing exposure to economic and environmental risk;
- Overseeing all site activities, site services, construction, pre-commissioning and commissioning;
- Assisting the CEO in preparing and presenting to investors, the executive team and the Board;

 

The Vice President, Project Development shall assist the CEO in establishing and managing relationships with key stakeholders. The Vice President, Project Development shall also conduct technical and financial analysis to determine the impact of growth opportunities on various metrics and to establish an execution plan as needed.

 

Mandate of the Board

The mandate of the Board is to supervise the management of the business and affairs of the Company and to act with a view to the best interests of the Company. In fulfilling its mandate, the Board, among other matters, is responsible for:

 

(a) adopting a strategic planning process and approving, on at least an annual basis, a strategic plan, taking into account the risk and opportunities of the Company’s business;
(b) identifying the principal risks of the Company’s business and implementing appropriate systems to manage such risks;
(c) satisfying itself, to the extent reasonably feasible, of the integrity of the CEO and other executive officers (if any) and ensuring that all such officers create a culture of integrity throughout the Company and developing programs of succession planning (including appointing, training and monitoring senior management);
(d) creating the Company’s internal control and management information systems and creating appropriate policies for matters including communications, securities trading, privacy, audit, whistleblowing and codes of ethical conduct;
(e) managing its affairs including selecting its Chair, nomination of candidates for election to the Board, constituting committees of the Board and determining director compensation; and
(f) engaging any necessary internal and/or external advisors.

 

In the Fiscal year ended December 31, 2023 there were six (6) meetings of the Board. The frequency of meetings as well as the nature of agenda items change, depending upon the state of the Company’s affairs and in light of opportunities or risks which the Company is subject to. Table No. 5 indicates the number of meetings attended by each director.

 

Table No. 5

Meetings Attended

 

  Director Attended Meetings  
  Duane Poliquin 6 6  
  Morgan Poliquin 6 6  
  Elaine Ellingham 6 6  
  Alfredo Phillips 6 6  
  Kevin O’Kane 6 6  
  Ria Fitzgerald 6 6  

 

All directors of the Company attended all Board meetings held after they were appointed to the Board

 

The Chair is the chair of meetings of the Board of directors and is not an independent director. Meetings of the independent members of the Board may be held periodically as convened by the independent Board members. In Fiscal 2023, six (6) meetings of the independent Board members were convened.

 

In carrying out its mandate, the Board and each committee of the Board, relies primarily on management and its employees to provide it with regular detailed reports on the operations of the Company and its financial position. Certain members of management are also on the Board and provide the Board with direct access to information concerning their areas of responsibility. Management personnel are also regularly asked to attend Board meetings to provide information, answer questions and receive the direction of the Board. The reports and information provided to the Board enable them to monitor and manage the risks associated with the Company’s operations and its compliance with legal and safety requirements, environmental issues and the financial position and liquidity of the Company.

 

  71

 

The Board discharges its responsibilities directly and through committees. At regularly scheduled meetings, members of the Board and management discuss the broad range of matters and issues relevant to the Company’s business interests and the Board is responsible for the approval of the Company’s Strategic Plan. In addition, the Board receives reports from management on the Company’s operational and financial performance. Between scheduled meetings, matters requiring Board authorization are effected by means of signed Consent Resolutions.

 

Board Assessment

The Nomination and Corporate Governance Committee reports to the Board periodically on the evaluation of the Board’s performance and that of the individual directors. The Performance of the CEO is evaluated by the Compensation Committee.

 

Composition of the Board

The guidelines recommend that a board of directors be constituted with a majority of individuals who qualify as “independent” directors.

 

In deciding whether a particular director is independent, the Board examined the factual circumstances of each director and considered them in the context of many factors, including the definitions in the guidelines and the requirements and policies of NYSE American Company Guide Rules. The current Board is composed of six members. The Board has determined that a majority of directors, namely 4 directors, are independent - Elaine Ellingham, Kevin O’Kane, Alfredo Phillips and Ria Fitzgerald. Two directors – Duane Poliquin and Morgan Poliquin – are not independent because, in addition to their being the Chair and CEO/President of the Company, respectively, they each have Executive Employment Contracts with the Company and, therefore, they each have a material relationship with the Company. The basis for determination of independence is under Canadian Securities Administrators’ National Instrument NI 52-110 - Audit Committees (“NI 52-110”) and NYSE American Exchange Company Guide Rules.

 

The Company does not have a controlling or significant shareholder. The Board believes that the membership of the Board fairly reflects the investment in the Company by minority shareholders.

 

The Board considers its size and composition to be appropriate and effective for carrying out its responsibilities. However, the Board may consider adding an additional director if a suitable candidate can be found who may bring additional experience or knowledge to the Board.

 

Board Committees

The Board currently has three committees - the Audit Committee, the Nomination and Corporate Governance Committee and the Compensation Committee. Each member of each committee is an independent director. Each committee is responsible for determining its own rules of procedure and may, from time to time, develop written descriptions for the responsibilities of the chair of such committee. No written position descriptions have yet been developed.

 

Mandates of each of the committees and the Codes undergo review periodically (in some cases mandated as annually) to bring them into line with changing Canadian and U.S. securities and corporate governance requirements and to reflect amendments that may be considered appropriate to make them more effective. Any revisions to the mandates and Codes will be available on the Company’s website at www.almadenminerals.com.

 

Audit Committee

The full text of the initial Audit Committee Charter is an exhibit to the 2003 Annual Report on Form 20-F filed with the Commission on May 11, 2004. After review, the Charter was altered to more properly define the functions of the Audit Committee. The revised Audit Committee Charter is an exhibit to the 2005 Annual Report on Form 20-F filed with the Commission on March 30, 2006.

 

  72

 

The members of the Audit Committee are Elaine Ellingham, Kevin O’Kane and Ria Fitzgerald, all of whom are independent (on the basis determined as set forth above) and “financially literate” within the meaning of NI 52-110, in that each of them has the ability to read and understand a set of financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of the issues that can reasonably be expected to be raised by the Company’s financial statements. The members of the Audit Committee have the respective education and experience set out below that is relevant to the performance of such member’s responsibilities as an Audit Committee member:

 

Elaine Ellingham has an MBA and has over 25 years of financial and management experience for public companies and for private equity groups. She held responsibilities for financial due diligence on issuers and applicants during her tenure at the TSX. She has served on audit committees for TSX and TSXV companies for over 12 years.

 

Kevin O'Kane is a registered professional engineer with nearly 40 years of experience in the global mining industry. He has held executive positions with BHP in South America, including Project Director, Vice President of Health, Safety and Environment, and Asset President. Most recently, Mr. O'Kane held the position of Executive Vice-President and Chief Operating Officer for SSR Mining Inc. He holds the ESG Competent Boards Certificate and Global Competent Boards Designation (GCB.D), achieved in 2021. He is fluent in Spanish and brings a wealth of technical, operational and HSCE leadership combined with Latin American knowledge to Almaden's Board. Mr. O’Kane also serves on the Boards of IAMGOLD, NorthIsle Copper and Gold Inc. and Compañía Minera Autlán, S.A.B. de C.V. (Mexico).

 

Ria Fitzgerald holds a Bachelor of Commerce degree and the Chartered Financial Analyst designation. She has over 20 years of financial, investment and capital markets experience, primarily in the mining sector.

 

The Audit Committee met four (4) times during Fiscal 2023.

 

Nominating and Corporate Governance Committee

The members of the Nominating and Corporate Governance Committee are Elaine Ellingham, Kevin O’Kane, and Alfredo Phillips. The Nominating and Corporate Governance Committee met four (4) times during Fiscal 2023. The full text of the initial Corporate Governance Charter is an exhibit to the 2003 Annual Report on Form 20-F filed with the Commission on May 11, 2004. After review, the Responsibilities and Duties of the Nominating and Corporate Governance Committee were altered to more properly define the functions of the Nominating and Corporate Committee. The revised Responsibilities and Duties is an exhibit to the 2005 Annual Report on Form 20-F filed with the Commission on March 30, 2006.

 

Compensation Committee

The members of the Compensation Committee are Elaine Ellingham, Kevin O’Kane, and Ria Fitzgerald. The Compensation Committee met four (4) times during Fiscal 2023 with Elaine Ellingham, Kevin O’Kane and Ria Fitzgerald attending all four (4) meetings. The Responsibilities and Duties of the Compensation Committee is an exhibit to the 2005 Annual Report on Form 20-F filed with the Commission on March 30, 2006.

 

Orientation and Continuing Education

The Nomination and Corporate Governance Committee is responsible for recommending to the Board an orientation and education program for new directors.

 

Director Term Limits and other Mechanisms of Board Renewal

The Company has not adopted term limits or other mechanisms for Board renewal. The Company does not consider it is yet appropriate to force any term limits or other mechanisms of Board renewal at this time.

 

Policies Regarding the Representation of Women on the Board

There are currently two women on the Company’s Board representing 33.3% of the Board. The Company plans to adopt a written policy with respect to the identification and nomination of women directors (the “Diversity Policy”). The Diversity Policy will require that the Board consider diversity on the Board from a number of aspects, including but not limited to gender, age, ethnicity and cultural diversity. In addition, when assessing and identifying potential new members to join the Board or the Company’s executive team, the Board will consider the current level of diversity on the Board and the executive team. As the Diversity Policy has not yet been adopted, the Company is not yet able to measure its effectiveness.

  73

 

Consideration of the Representation of Women in the Director Identification and Selection Process

Pursuant to the Diversity Policy, the Board will consider and evaluate the representation of women on the Board when identifying and nominating candidates for election and re-election to the Board. The Company will focus its search for new directors purely based on the qualification of potential candidates, regardless of their gender, age, ethnicity or culture.

 

Consideration Given to the Representation of Women in Executive Officer Appointments

Pursuant to the Diversity Policy, the Board will consider and evaluate the representation of women in the Company’s executive officer positions when identifying and nominating candidates for appointment as executive officers. The Company will focus its search for new executive officers purely based on the qualification of potential candidates, regardless of their gender, age, ethnicity or culture.

 

The Company’s Targets Regarding the Representation of Women on the Board and in Executive Officer Positions

The Company has not established a target for the representation of women on the Board or in executive officer positions of the Company by a specific date. The Company does not think it is appropriate to set targets because the Company focuses its search for new directors and executive officers purely based on the qualification of potential candidates, regardless of their gender, age, ethnicity or culture.

 

Number of Women on the Board and in Executive Officer Positions

As at the date of this Annual Report, two of the Company’s directors (representing 33.3% of the Company’s six directors) are and none of the Company’s executive officers are women.

 

Decisions Requiring Board Approval

In addition to those matters which must by law be approved by the Board, management is also required to seek Board approval for any major acquisition, disposition or expenditure. Management is also required to consult with the Board before entering into any venture which is outside of the Company’s existing line of business.

 

Changes in officers are to be approved by the Board including changes in officers of the Company’s principal operating subsidiaries.

 

In certain circumstances it may be appropriate for an individual director to engage an outside advisor at the expense of the Company. The engagement of the outside advisor would be subject to the approval of the Nomination and Corporate Governance Committee.

 

Communications and Investor Relations

The Company has adopted a Communications Policy, the purpose and aim of which is as follows:

 

(a) Controls the communications between the Company and its external stakeholders;
(b) Complies with its continuous and timely disclosure obligations;
(c) Avoids selective disclosure of Company information;
(d) Protects and prevents the improper use or disclosure of material information and confidential information;
(e) Educates the Company’s personnel on the appropriate use and disclosure of material information and confidential information;
(f) Fosters and facilitates compliance with applicable laws; and
(g) Creates formal Disclosure Officers to help achieve the above objectives.

 

In accordance with the Communications Policy of the Company, designated Disclosure Officers receive and respond to shareholder enquiries. Shareholder enquiries and concerns are dealt with promptly by Disclosure Officers of the Company.

 

Ethical Business Conduct

The Company has adopted a Code of Business Conduct and Ethics for Directors (“Code”), a Code of Business Ethics (“COBE”), a Securities Trading Policy and a Privacy Policy. Employees and consultants are required as a term of employment or engagement to undertake to abide by the COBE. Directors are bound to observe the Code adopted by the Board.

 

  74

 

All Directors, Officers and Employees (“Individuals”) sign a Certification (“Certification”) stating they have read the Code of Business Ethics policy (“Ethics Policy”) of the Company and have complied with such Policy in all respects. The Certification further acknowledges that all members of the Individual’s family, all other persons who live with the Individual and all holding companies and other related entities of the Individual and all such persons or companies acting on behalf of or at the request of any of the foregoing also complied with such Policy. The Certification also states that any violation of such Policy may constitute grounds for immediate suspension or dismissal.

 

Each director is expected and required by statute to act honestly and in good faith with a view to the best interests of the Company and to exercise the care, diligence and skill that a reasonably prudent individual would exercise in comparable circumstances and in accordance with the BCBCA and the Company’s Articles.

 

D. Employees

As of December 31, 2023 and continued through to April 26, 2024, the Company operated with eight people in Canada, of which five are administrative personnel and three are exploration personnel. There are no full-time employees in the U.S. or Mexico. None of the Company’s employees are covered by a collective bargaining agreement.

 

E. Share Ownership

Table No. 6 lists, as of April 26, 2024, directors and executive officers who beneficially own the Company's voting securities (Common Shares) and the amount of the Company’s voting securities owned by the directors and executive officers as a group.

 

Table No. 6

Shareholdings of Directors and Executive Officers

Title of   Amounts and Nature of Percent of
Class Name of Beneficial Owner Beneficial Ownership Class*
Common Duane Poliquin 4,623,136(1)(10) 3.33%
Common Morgan Poliquin 5,001,893(2)(10) 3.56%
Common Elaine Ellingham 869,400(3) 0.63%
Common Kevin O’Kane 800,000(4) 0.58%
Common Alfredo Phillips 800,000(5) 0.58%
Common Ria Fitzgerald 800,000(6) 0.58%
Common Korm Trieu 1,225,144(7) 0.89%
Common Doug McDonald 1,274,401(8) 0.92%
Common John A. Thomas 300,000(9) 0.22%
  Total Directors/Officers as group 15,693,974 11.29%
 (1) Of these shares 1,415,000 represent currently exercisable stock options.
 (2) Of these shares 3,240,000 represent currently exercisable stock options. 83,600 of these shares are held indirectly through Kohima Pacific Gold Corp., a company owned by Mr. Poliquin.
 (3) Of these shares 800,000 represent currently exercisable stock options, 44,400 of these shares are held indirectly through Edward Kammermayer, the husband of Mrs. Ellingham.
 (4) Of these shares 800,000 represent currently exercisable stock options.
 (5) Of these shares 800,000 represent currently exercisable stock options.
 (6) Of these shares 800,000 represent currently exercisable stock options.
 (7) Of these shares 1,145,000 represent currently exercisable stock options. 7,500 of these shares are held indirectly by Mr. Trieu’s wife.
 (8) Of these shares, 1,150,000 represent currently exercisable stock options. 7,500 of these shares are held indirectly by Shari Investments, an entity controlled by Mr. McDonald.
 (9) Of these shares 300,000 represent currently exercisable stock options.
 (10) Pursuant to a Voting Trust Agreement (Exhibit 3 to this Annual Report on Form 20-F), Duane Poliquin and Morgan Poliquin (the “Trustees”) jointly hold voting power over any of the Company’s common shares legally and beneficially owned by Mr. Ernesto Echavarria, a resident of Mexico. On August 10, 2015, Mr. Echavarria, who is not an executive officer or director of the Company, made a filing with the System for Electronic Disclosure by Insiders (“SEDI”), Canada’s on-line, browser-based service for the filing and viewing of insider reports as required by various provincial securities rules and regulations, disclosing that his ownership of Almaden common shares had fallen below the 10% threshold for such reporting. Based on such filing, Mr. Echavarria holds less than 10% of the Company’s common shares.

*Based on 137,221,408 shares outstanding as of April 26, 2024 and stock options and warrants exercisable within 60 days held by each beneficial owner.

 

  75

 

 

F. Disclosure of a Registrant’s Action to Recover Erroneously Awarded Compensation

 

Not applicable.

 

Item 7. Major Shareholders and Related Party Transactions

 

A. Major Shareholders

 

The Company is a publicly owned Canadian company, the shares of which are owned by residents of the U.S., residents of Canada and other foreign residents. To the extent known by the directors and executive officers of the Company, the Company is not directly or indirectly owned or controlled by another company. Table No. 7 lists, as of April 26, 2024, the only persons or companies beneficially owning more than 5% of the Company’s voting securities (Common Shares).

 

Table No. 7

Shareholdings of Beneficial Owners

Title of   Amounts and Nature of Percent of
Class Name of Beneficial Owner Beneficial Ownership Class*
Common Duane Poliquin 4,623,136(1)(3) 3.33%
Common Morgan Poliquin 5,001,893(2)(3) 3.56%
 (1) Of these shares 1,415,000 represent currently exercisable stock options.
 (2) Of these shares 3,240,000 represent currently exercisable stock options. 83,600 of these shares are held indirectly through Kohima Pacific Gold Corp., a company owned by Mr. Poliquin.
 (3) Pursuant to a Voting Trust Agreement (Exhibit 3 to this Annual Report on Form 20-F), Duane Poliquin and Morgan Poliquin (the “Trustees”) jointly hold voting power over any of the Company’s common shares legally and beneficially owned by Mr. Ernesto Echavarria, a resident of Mexico. On August 10, 2015, Mr. Echavarria, who is not an executive officer or director of the Company, made a filing with SEDI, Canada’s on-line, browser-based service for the filing and viewing of insider reports as required by various provincial securities rules and regulations, disclosing that his ownership of Almaden common shares had fallen below the 10% threshold for such reporting. Based on such filing, Mr. Echavarria hold less than 10% of the Company’s common shares.

 

*Based on 137,221,408 shares outstanding as of April 26, 2024 and stock options and warrants exercisable within 60 days held by each beneficial owner.

 

The Company's common shares are issued in registered form and the following information is from the Company’s registrar and transfer agent, Computershare Investor Services Inc. located in Vancouver, British Columbia and Toronto, Ontario, Canada.

 

On February 29, 2024, the shareholders' list for the Company’s common shares showed 207 registered shareholders, including depositories, and 137,221,408 shares outstanding. 173 of these registered shareholders are U.S. residents, owning 38,493,539 shares representing 28% of the issued and outstanding common shares. 23 of these registered shareholders are Canadian residents, owning 93,882,490 shares representing 68% of the issued and outstanding common shares. 11 of these registered shareholders are of other countries, owning 4,845,379 shares representing 4% of the issued and outstanding common shares.

 

B. Related party transactions

 

Certain officers and directors of the Company are also officers or directors of companies with which the Company has agreements and may not be considered at arm's-length to such agreements. However, any agreement or any agreement to be negotiated between the Company and such other companies has been or will be approved by directors of the Company, in accordance with the common law and the provisions of the BCBCA.

 

(a) Compensation of key management personnel

Key management includes members of the Board, the Chair, the President and CEO, the CFO, the Executive Vice President and the Vice President, Project Development. The aggregate compensation paid or payable to key management for services is as follows, after recovery of 5% (2022 – 13%, 2021 – 27%) of executive officer compensation from Azucar and 66% (2022 – 49%, 2021 – 39%) of executive officer compensation from Almadex:

 

  76

 

    March 31,
2024
    December 31,
2023
    December 31,
2022
    December 31,
2021
 
Professional fees   $ -     $ 50,588     $ 60,000     $ 60,000  
Salaries and benefits (1)     70,275       398,307  (3)     484,435  (2)     450,522  
Share-based payments     -       702,000       1,212,300       1,551,850  
Directors’ fees     33,750       140,000       145,000       102,500  
    $ 104,025       1,290,895       1,901,735       2,164,872  

 

(1) As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.
(2) As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.
(3) As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.

 

(b) Administrative Services Agreements

 

The Company recovers a portion of rent, office and license expenses from Azucar pursuant to an Administrative Services Agreement dated May 15, 2015 and First Amending Agreement dated December 16, 2015 between the Company and Azucar.

 

The Company also recovers a portion of rent, office, and license expenses from Almadex pursuant to an Administrative Services Agreement dated March 29, 2018 between the Company and Almadex.

 

During the year ended December 31, 2023, the Company received $75,853 (2022 - $185,068; 2021 - $412,812) from Azucar for administrative services fees included in other income and received $1,346,494 (2022 - $1,191,360; 2021 - $969,532) from Almadex for administrative services fees included in other income.

 

At December 31, 2023, included in accounts receivable is $7,005 (2022 - $64,006) due from Azucar and $369,045 (2022 - $117,044) due from Almadex in relation to expenses recoveries.

 

At December 31, 2023, the Company accrued $Nil (2022 - $80,727) payable to Almadex for exploration and drilling services in Mexico.

 

(c) Other related party transactions

 

During the year ended December 31, 2023, the Company employed the Chair’s daughter for a salary of $45,300 less statutory deductions (2022 - $48,800; 2021 - $41,300) for marketing and administrative services provided to the Company.

 

Other than as disclosed above, there have been no transactions or proposed transactions, which have materially affected or will materially affect the Company in which any director, executive officer, or beneficial holder of more than 10% of the outstanding common shares, or any of their respective relatives, spouses, associates or affiliates has had or will have any direct or material indirect interest. As stated above, management believes the transactions referenced above were on terms at least as favorable to the Company as the Company could have obtained from unaffiliated parties.

 

C. Interests of Experts and Counsel

 

Not applicable.

 

  77

 

Item 8. Financial Information

 

A. Consolidated Statements and Other Financial Information

 

The financial statements as required under Item 8 are attached hereto and found immediately following the text of this Annual Report.

 

Legal Proceedings

 

On April 7, 2015, the Ejido Tecoltemi, a community granted communal agrarian lands by the Mexican Government and whose lands (the “Ejido Lands”) overlapped with the southeastern portion of the Company’s original mineral concessions, filed an Amparo in a lower court in Puebla State, claiming that Mexico’s mineral title system is unconstitutional because Indigenous consultation is not required before the granting of mineral title (the “Amparo”, or “Mineral Title Lawsuit”). The Amparo was against the Mexican government (President, Congress, Ministry of Economy, Directorate of Mines, Mining Registry Office), and used the Company’s two Original Concessions covering the Ixtaca Project as the subject matter of the Amparo. Almaden, through its Mexican subsidiary Minera Gorrión, was therefore considered an interested party in the Amparo. The Original Concessions covered Almaden’s Ixtaca Project and the Ejido Lands. The Ejido Lands overlapped approximately 330 ha of the far southeastern corner of the Original Concessions and are not considered material to the Ixtaca Project.

 

Shortly after the Amparo was filed in April 2015, the lower court in Puebla State ordered the suspension of Almaden from conducting exploration and exploitation work over those portions of the Original Concessions which overlap with the Ejido Lands.

 

Mineral tenure over the Ejido Lands is not material to the Ixtaca Project. The Ejido Lands do not overlap the Ixtaca Project or its environmental or social area of impact. Almaden has never tried to negotiate access to the Ejido Lands, never conducted exploration work on the Ejido Lands, and has no interest in conducting any future exploration or development work over the Ejido Lands. The Ejido Lands are in a different drainage basin than the Ixtaca Project and the Company does not need to travel though the Ejido Lands to access the Ixtaca Project.

 

On April 15, 2019, the lower court in Puebla State ruled that Mexico’s mineral title system is unconstitutional. The Company’s concessions were ruled to be illegal, but the mineral rights over that land were ordered to be held for Almaden until such time as indigenous consultation could be completed.

 

Under Mexican law, any decisions in the Amparo, such as the April 15, 2019 lower court ruling, are granted in a provisional manner and only become final once the decisions are no longer subject to further appeal. The Superior (Collegiate) Court accepted the appeals of each of the Mexican Congress, Senate, Secretary of Economy and mining authorities, as well as Almaden as an interested party, against the April 15, 2019 provisional lower court decision in the Amparo.

 

On April 14, 2021, the Company announced that the Collegiate Court issued its decision on the Amparo, stating that it does not have the necessary authority to rule on the appeals. The case passed directly to the Supreme Court of Justice of Mexico (“SCJN”).

 

In early 2022, the SCJN ruled that the Mexican mineral title law is constitutional, but that Economia should have provided for a consultation procedure with relevant indigenous communities prior to issuing mineral titles to the Company. The SCJN ordered Economia to declare Almaden’s mineral titles ineffective, or void, and to revert them to application status in order to facilitate indigenous consultation.

 

The SCJN decision provided guidance to Mexican authorities regarding the procedures required to be followed by those authorities in the follow-up to its decision and performance of indigenous consultation. The decision also clarified that unless there is a significant impact on the rights of an indigenous community caused by the granting of the mineral title, such as relocation or something similar, title issuance is not dependent upon the consent of any indigenous community. The lower court in Puebla State was responsible for ensuring that the SCJN decision was properly implemented.

 

On July 4, 2022, the Company announced that Economia was officially notified of the SCJN decision and in turn notified Almaden that the Company’s mineral titles relating to the Ixtaca Project were “ineffective”, or void. Almaden understood this to mean that the mineral title reverted to application status and that these applications remained effective and preserved the mineral rights for Almaden but did not allow the Company to engage in exploration until such time as Economia completed its court-ordered indigenous consultation.

 

  78

 

On February 22, 2023, the Company announced that Economia made a submission to the lower court in Puebla State seeking to deny the two mineral title applications which were first made by Almaden in 2002 and 2008 (the “Submission”). The Submission claimed that the applications contain technical faults, despite Economia’s previous statements to the contrary and its acceptance of the mineral title applications and grant of the mineral titles in 2003 and 2009. By alleging technical faults in the mineral title applications, Economia appeared to be arbitrarily seeking to deny the grant of the mineral titles and avoid the indigenous consultation ordered by the 2022 decision of the SCJN. Such consultation would have been welcomed by both the Company and surrounding community members.

 

On April 13, 2023, Almaden reported that the lower court in Puebla State ruled that the Submission formally complied with the SCJN decision. However, the court ruling appeared to rely heavily on Economia’s Submission regarding the Company’s 2002 and 2008 title applications, and in its decision the court did not provide arguments to address the Company’s challenge of the Submission.

 

Almaden and local community members filed separate appeals of this decision to the Federal Appeals court (“TCC”), which in October 2023 dismissed all of the appeals filed by the Parties and confirmed the Submission is compliant with the 2022 decision of the SCJN, since the SCJN decision did not formally prevent Economia from reviewing the technical aspects of the mineral title applications.

 

However, the TCC ruling did not address the validity of the Submission and therefore safeguarded the Company’s right to challenge the substance and legality of the Submission through the Mexican Federal Administrative Court (“TFJA”).

 

Subsequent to the Submission, the Company had initiated legal action in the TFJA and on October 16, 2023 announced that the TFJA granted a definitive injunction in relation to the Submission, which prevents Economia from releasing the mineral rights covered by Almaden’s mineral title applications to third parties while the trial continues, anticipated to last approximately 18 months in total.

 

On December 13, 2023, the Company delivered to Mexico a Request for Consultations in accordance with the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (“CPTPP”) relating to an investment dispute with Mexico. Almaden sent the Request for Consultations to Mexico’s General Directorate of Legal Consultancy for International Trade (Dirección General de Consultoría Jurídica de Comercio Internacional).

 

The Company has suffered substantial harm arising out of Mexico’s conduct in breach of its investment protection obligations under the CPTPP, including (without limitation):

 

· Economia’s declaration that the Project’s mineral titles were ineffective, or void;
· Economia’s reassessment of the original applications for the mineral titles holding them to be deficient and unfeasible, contradicting the position previously adopted by it, and violating the Company and its subsidiary’s right to amend or supplement the mineral title applications; and
· the Mexican Secretariat of Environment and Natural Resources’ (Secretaría del Medio Ambiente y Recursos Naturales, “SEMARNAT”) delay in issuance and ultimate refusal to issue the environmental permit (Manifiesto de Impacto Ambiental) for the Ixtaca project.

 

The Request for Consultations enables the Company to initiate arbitration should an amicable resolution of the dispute with the Mexican government not be reached. The filing of the Request for Consultations initiates a six-month consultation period between the parties, during which they are to attempt to amicably settle the dispute. If no settlement is reached in that six-month period, the Company may then initiate international arbitration proceedings against Mexico in accordance with the CPTPP after serving a notice of intent to submit claims to arbitration. On December 29, 2023, Mexico acknowledged receipt of that Request and stated that it would propose dates for a consultation meeting in the near future, but never reverted with proposed dates, leaving the dispute unresolved.

 

  79

 

Accordingly, on March 14, 2024, the Company delivered to Mexico written notice of its intention to submit a claim (“Claim”) to arbitration against Mexico (the “Notice”) in accordance with Article 9.19.3 of the CPTPP. This Notice was delivered by Almaden together with Almadex Minerals Ltd. (“Almadex”), on behalf of themselves and their Mexican subsidiaries.

 

Amongst other things, the Notice sets out the factual background of the dispute as well as the legal basis of the resulting Claim, the provisions of the CPTPP that Mexico has breached, and the relief sought. The damages relating to the Almaden and Almadex Claim will be for no less than US$200 million, in the aggregate.

 

The Notice enables the Company to initiate arbitration should an amicable resolution of the dispute with the Mexican government not be reached. The filing of the Notice must precede initiation of arbitration by a minimum of 90 days.

 

In good faith and in the spirit of cooperation, Almaden invited Mexico once again to engage in discussions and negotiations with a view to achieving an amicable resolution of the dispute. The Company confirms that it is taking all necessary actions to preserve its rights and protect its investments in Mexico. The Company’s desire is for all parties to reach a mutually acceptable outcome swiftly and amicably. If such an outcome is not achieved during consultations, the Company expects it will have no alternative but to pursue its claims before an arbitral tribunal and seek full compensation for damages the Company has suffered as a result of Mexico’s acts and omissions. The Company retained international arbitration counsel at Boies Schiller Flexner LLP to advise and will consider any other actions necessary to ensure its rights are preserved.

 

Historic Claim Reduction Efforts

 

In 2015, after learning about the Amparo, Almaden commenced a process to voluntarily cancel approximately 7,000 ha of its Original Concessions, including the area covering the Ejido Lands, to assure the Ejido Tecoltemi that Almaden would not interfere with the Ejido Lands, and to reduce Almaden’s land holding costs.

 

Almaden divided the Original Concessions into nine smaller concessions, which included two smaller mining concessions which overlapped the Ejido Lands (the “Overlapping Concessions”) and then voluntarily cancelled the Overlapping Concessions. The applicable Mexican mining authorities issued the New Concessions and accepted the abandonment of the Overlapping Concessions in May and June of 2017 after the issuance of a court order.

 

In June 2017, the Ejido Tecoltemi, the complainant in the Amparo, filed a legal complaint about the court order leading to the New Concessions, and on February 1, 2018, the court reviewing the complaint ruled the Ejido Tecoltemi’s complaint was founded, and sent the ruling to the court hearing the Amparo.

 

On December 21, 2018, the General Directorate of Mines issued a resolution that the New Concessions were left without effect, and the Original Concessions were in full force and effect (the “December 2018 Communication”).

 

On February 13, 2019, the General Directorate of Mines delivered, to the court hearing the Amparo, mining certificates stating that the Original Concessions were valid and that the New Concessions were cancelled.

 

On June 10, 2019, Almaden’s subsidiary appealed the December 2018 Communication, and subsequent cancellation of the New Concessions. On September 26, 2019, the lower court refused to hear the appeal, but on October 14, 2019, a higher court agreed to hear the appeal.

 

On December 1, 2020, the higher court denied the Company’s October 14, 2019 appeal, which objected to the reinstatement by the Mexican mining authorities of the Company’s Original Concessions. This court decision upheld the action of Mexican mining authorities that reinstated the Original Concessions as the Company’s sole mineral claims over the Ixtaca Project, and which left the New Concessions the Company was awarded in 2017 as held without effect. However, the decision also stated that the Company had the right to defend the New Concessions through the applicable legal procedures (such as the administrative challenge referred to below).

 

  80

 

In communications with the lower court and mineral title certificates issued by the General Directorate of Mines directly to Almaden on December 16, 2019 (the “December 2019 Certificates”), the applicable Mexican records reflected the position that the Original Concessions (the subject matter of the Amparo) were active and owned by Almaden (through its Mexican subsidiary) and the New Concessions were left without effect. The Mexican mining authorities also indicated in the December 2019 Certificates that their position was subject to the final resolution of the Amparo.

 

On January 21, 2020, the Company filed an administrative challenge against the Mexican mining authorities’ issuance of the December 2019 Certificates, which represented the first time that Almaden had been directly notified of any changes in its mineral tenure.

 

Almaden believes that the December 2018 Communication from the Mexican mining authorities is the basis for the recorded change in its mineral tenure. The Company’s Mexican counsel advised that the December 2018 Communication should have had no legal effect as it was only provided to the lower court, was never officially served on the Company and was not issued by an official possessing the necessary legal authority. While the December 2018 Communication was dated December 21, 2018, the Company first became aware of it in May 2019 through a review of court documents.

 

On November 15, 2022, after Economia had reverted the Original Concessions to the application status pursuant to the SCJN Amparo ruling, the Company submitted amended title applications which substantially reduced the area being requested. To date the General Directorate of Mines has not responded to these amended mineral title applications.

 

Dividends

The Company has not declared any dividends since inception and does not anticipate that it will do so in the foreseeable future. The present policy of the Company is to retain future earnings for use in its operations and the expansion of its business.

 

B. Significant Changes

 

There have been no significant changes of financial condition since the most recent audited financial statements included within this Annual Report.

 

Item 9. Offer and Listing of Securities

 

A. Offer and Listing Details

 

The Company's common shares trade on TSX in Toronto, Ontario, Canada having the symbol "AMM,” and on the NYSE American (formerly the NYSE MKT) in New York, New York, U.S.A. having the symbol “AAU” and CUSIP #020283107. On April 5, 2024 the Company announced that it had delisted from the NYSE American stock exchange, and its common shares began trading on the OTCQB Marketplace in the U.S., under symbol “AAUAF”.

 

B. Plan of Distribution

 

Not applicable.

 

C. Markets

See Item 9.A. - Offer and Listing Details.

 

On April 21, 2023, the Company announced receipt of a notification letter from the NYSE American LLC stating that Almaden is not in compliance with the continued listing standards because the Company’s securities have been selling for a low price per share for a substantial period of time which NYSE American determines to be a 30-trading-day average price of less than US$0.20 per share. Pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the NYSE American staff determined that the Company’s continued listing is predicated on it effecting a reverse stock split of its common stock or otherwise demonstrating sustained price improvement within a reasonable period of time which the staff determined to be no later than October 19, 2023 (the “Cure Deadline”). On October 25, 2023 the Company announced that the Cure Deadline had been extended to April 19, 2024. On March 14, 2024 the Company announced that although it had requested consultations with Mexico under the CPTPP, Mexico had not proposed a date for these consultations. In view of this, and the Company’s wish to provide predictability to shareholders, it determined to voluntarily delist from the NYSE American exchange, and anticipated that the delisting will become effective at the end of business on or about April 4, 2024. On April 5, 2024 the Company announced that it had delisted from the NYSE American stock exchange, and its common shares began trading on the OTCQB Marketplace in the U.S., under symbol “AAUAF”.

 

  81

 

Item 10. Additional Information

 

A. Memorandum and Articles

 

At the Annual and Special General meeting of the Company held on May 18, 2005, shareholders passed appropriate resolutions to complete the transition procedures in accordance with the BCBCA, to increase the number of common shares which the Company is authorized to issue to an unlimited number of common shares and to cancel the Company’s Articles and adopt new Articles to take advantage of provisions of the BCBCA. The BCBCA was adopted in British Columbia on March 29, 2004 replacing the Company Act (the “Former Act”). The BCBCA requires the provisions formerly required in the Memorandum to be in the Articles. The BCBCA eliminates the requirement for a Memorandum.

 

The revised Articles are an exhibit to the 2005 Annual Report on Form 20-F filed with the Commission on March 30, 2006, and replaced the Memorandum and Articles as filed with the Commission on May 17, 2002.

 

Articles

The Company was formed through the amalgamation of Fairfield Minerals Ltd. and Almaden Resources Corporation effective December 31, 2001 under the Company Act of British Columbia (the “Company Act”). On March 29, 2004, British Columbia adopted the BCBCA to replace the Company Act. Companies registered under the Company Act are required to transition to the BCBCA. At the Annual and Special General meeting of the Company held on May 18, 2005, shareholders passed appropriate resolutions to complete the transition procedures to cancel the Company’s Articles and adopt new Articles, which includes an increase of the number of common shares which the Company is authorized to issue to an unlimited number of common shares. The Company’s new Articles became effective in June 2005 (the “Articles”).

 

The Articles contain no restrictions on the business the Company may carry on.

 

Under the Articles, if a director has a disclosable interest in a contract or transaction, such director is liable to account to the Company for any profits that accrue to the director as a result of the contract or transaction unless disclosure is made thereof and the contract or transaction is approved in accordance with the provisions of the BCBCA and a director is not entitled to vote on any director’s resolution to approve that contract or transaction unless all of the directors have a disclosable interest in that contract or transaction, in which case all of those directors may vote on such resolution.

 

A director may hold any office or place of profit with the Company in conjunction with the office of director, and no director shall be disqualified by their office from contracting with the Company. A director or such director’s firm may act in a professional capacity for the Company and a director or such director’s firm shall be entitled to remuneration for professional services. A director may become a director or other officer or employee of, or otherwise interested in, any company or firm in which the Company may be interested as a shareholder or otherwise. The director shall not be accountable to the Company for any remuneration or other benefits received by the director from such other company or firm unless the Company in general meeting directs otherwise.

 

Under the Articles the directors must manage or supervise the management of the business and affairs of the Company and have the authority to exercise all such powers which are not required to be exercised by the shareholders, or as governed by the BCBCA. Under the Articles the directors may, by resolution, create and appoint one or more committees consisting of such member or members of their body as they think fit and may delegate to any such committee such powers of the Board as the Board may designate or prescribe.

 

The Articles provide that the quorum necessary for the transaction of the business of the directors may be fixed by the directors and if not so fixed shall be a majority of the directors. The continuing directors may, notwithstanding any vacancy in their body, but if and so long as their number is reduced below the number fixed pursuant to the Articles as the necessary quorum of directors, act only for the purpose of increasing the number of directors to that number, or of summoning a general meeting of the Company, but for no other purpose.

 

  82

 

The Articles provide that the directors may, on behalf of the Company:

 

· Borrow money in a manner and amount, on any security, from any source and upon any terms and conditions;
· Issue bonds, debentures, and other debt obligations either outright or as security for any liability or obligation of the Company or any other person;
· Guarantee the repayment of money by any other person or the performance of any obligation of any other person; and
· Mortgage, charge, or give other security, on the whole or any part of the property or assets of the Company, both present and future.

 

There are no age limit requirements pertaining to the retirement or non-retirement of directors.

 

A director need not be a shareholder of the Company.

 

The Articles provide for the mandatory indemnification of Directors, Officers, former officers and directors, alternate directors, as well as their respective heirs and personal or other legal representatives, or any other person, to the greatest extent permitted by the BCBCA. The indemnification includes the mandatory payment of expenses and, in furtherance thereof, the Company is party to indemnification agreements with such individuals. The directors may cause the Company to purchase and maintain insurance for the benefit of eligible parties.

 

The rights, preferences and restrictions attaching to each class of the Company’s shares are as follows:

 

Common Shares

The authorized share structure of the Company consists of an unlimited number of common shares without par value. All the common shares of the Company are of the same class and, once issued, rank equally as to dividends, voting powers, and participation in assets. Holders of common shares are entitled to one vote for each share held of record on all matters to be acted upon by the shareholders. Holders of common shares are entitled to receive such dividends as may be declared from time to time by the Board of Directors, in its discretion, out of funds legally available therefor.

 

Upon liquidation, dissolution or winding up of the Company, holders of common shares are entitled to receive pro rata the assets of the Company, if any, remaining after payments of all debts and liabilities. No shares have been issued subject to call or assessment. There are no pre-emptive or conversion rights and no provisions for redemption or purchase for cancellation, surrender, or sinking or purchase funds.

 

The Directors may by resolution make any changes in the authorized share structure as may be permitted under Section 54 of the BCBCA, and may by resolution make or authorize the making of any alterations to the Articles and the Notice of Articles as may be required by such changes.

 

The Company may by ordinary resolution, create or vary special rights and restrictions as provided in Section 58 of the BCBCA. No alteration will be valid as to any part of the issued shares of any class unless the holders of all the issued shares of that class consent to the alteration in writing or consent by special separate resolution.

 

An annual general meeting shall be held once every calendar year at such time (not being more than 15 months after holding the last preceding annual meeting under the BCBCA nor more than 6 months from its preceding fiscal year end under the policies of the TSX) and place as may be determined by the Directors. The Directors may, as they see fit, convene an extraordinary general meeting. An extraordinary general meeting, if requisitioned in accordance with the BCBCA, shall be convened by the Directors or, if not convened by the Directors, may be convened by the requisitionists as provided in the BCBCA.

 

There are no limitations upon the rights to own securities.

 

  83

 

There are no provisions in the Articles that would have the effect of delaying, deferring, or preventing a change in control of the Company.

 

There is no special ownership threshold above which an ownership position must be disclosed. However, any ownership level above 10% must be disclosed by news release and notices filed in accordance with Canadian Securities Laws and by notices to the TSX.

 

A copy of the Company’s new Articles is an exhibit to the 2005 Annual Report on Form 20-F filed with the Commission on March 30, 2006.

 

Shareholder Rights Plan

On April 13, 2011, the Company’s Board of Directors adopted a Shareholder Rights Plan Agreement (the “Rights Plan”) between the Company and Computershare Investor Services Inc. (“Computershare”) as Rights Agent. The Rights Plan was subsequently approved by the shareholders of the Company at the Annual General and Special Meeting held June 28, 2011, reconfirmed by the shareholders of the Company at the 2014 Annual General Meeting, amended and reconfirmed at the 2017 Annual General Meeting and reconfirmed at the 2020 Annual General Meeting. The primary objective of the Rights Plan is to ensure, to the extent possible, that all shareholders of the Company are treated fairly in connection with any take-over bid for the Company by (a) providing shareholders with adequate time to properly assess a take-over bid without undue pressure and (b) providing the Board with more time to fully consider an unsolicited take-over bid, and, if applicable, to explore other alternatives to maximize shareholder value.

 

The full text of the Rights Plan was filed under cover of Form 6-K with the Commission on April 15, 2011 and is also available on SEDAR and the Company’s website.

 

Advance Notice Policy

On January 28, 2013 the Company’s Board of Directors approved and adopted an Advance Notice Policy, as amended on May 1, 2015 (the “Policy”) which, among other things, includes a provision that requires advance notice to the Company in circumstances where nominations of persons for election to the Board of Directors are made by shareholders of the Company other than pursuant to: (i) a requisition of a meeting made pursuant to the provisions of the BCBCA: or (ii) a shareholder proposal made pursuant to the provisions of the BCBCA.

 

The Policy, among other things, fixes a deadline by which holders of record of common shares of the Company must submit director nominations to the Company prior to any annual or special meeting of shareholders and set forth the information that a shareholder must include in the notice to the Company for the notice to be in proper written form.

 

In the case of an annual meeting of shareholders, notice to the Company must be made not less than 30 nor more than 65 days prior to the date of the annual meeting; provided, however, that in the event the annual meeting is to be held on a date that is less than 50 days after the date on which the first public announcement of the date of the annual meeting was made, notice may be made not later than the close of business on the 10th day following such public announcement.

 

In the case of a special meeting of shareholders (which is not also an annual meeting), notice to the Company must be made not later than the close of business on the 15th day following the day on which the first public announcement of the date of the special meeting was made.

 

The full text of the Amended Advance Notice Policy is an exhibit to the 2017 Annual Report on Form 20-F filed with the Commission on March 29, 2018.

 

Multiple Voting Policy for Uncontested Elections of Directors

The Board believes that each of its members should carry the confidence and support of the Company’s shareholders and, accordingly, has adopted, effective May 15, 2017, an Amended Majority Voting Policy for the election of directors for non-contested meetings. The Amended Majority Voting Policy provides that, in a non-contested election of directors, voting will be by ballot and, if the number of shares “withheld” for any nominee exceeds the number of shares voted “for” the nominee, then, notwithstanding that such director is duly elected as a matter of corporate law, he or she shall, immediately following the date of the final scrutineer’s report on the ballot, tender his or her written resignation to the Chair of the Board. A “non-contested election” means an election where the number of nominees for director is not greater than the number of directors to be elected. Under the Amended Majority Voting Policy, the Board will consider such offer of resignation and shall make a determination whether or not to accept or reject the resignation no later than 90 days following the date of the applicable shareholders’ meeting and shall accept the resignation absent exceptional circumstances. The Board will promptly announce its decision via press release. If the Board determines not to accept the resignation, the press release must fully state the reasons for its decision. No director who is required to tender his or her resignation shall participate in any meeting of the Board at which the resignation is considered. If a resignation is accepted by the Board, and subject to any corporate law restrictions, the Board may leave any resulting vacancy unfilled until the Company’s next annual general meeting, or may appoint a new director to fill the vacancy who the Board considers to merit the confidence of the shareholders, or may call a special meeting of shareholders at which there will be presented a management nominee or nominees to fill the vacant position or positions.

 

  84

 

The full text of the Amended Multiple Voting Policy is an exhibit to 2017 Annual Report on Form 20-F filed with the Commission on March 29, 2018.

 

B. Material Contracts

 

The following is a summary of each material contract, other than contracts entered into in the ordinary course of business, to which we or any member of the group is a party, for the two years preceding the date of this Annual Report.

 

Gold Loan Agreement dated as of May 14, 2019 between the Company (the “Borrower”) and Almadex (the “Lender”). Almaden may borrow from Almadex up to 1,597 ounces of 99.99% purity gold bullion. Upon receiving a drawdown notice, the Lender will sell the requested gold and send the proceeds in US dollars to the Borrower. Interest will be at 10% per year, calculated monthly, either paid quarterly or accrued to the loan value. The loan, plus any accrued but unpaid interest, is due March 31, 2026 as the Borrower provided written notice to the Lender on March 12, 2024 to extend the maturity date. Repayment may be in the form of gold or common shares of Almaden, and may include voluntary prepayment, with the form of repayment selected at the sole discretion of the Lender. A maximum of 11,172,671 common shares of Almaden are issuable for repayment of principal and interest, with any additional amounts due payable in gold. Mandatory Prepayment of 100 ounces of gold is required on the last business day of each month following the date when Almaden’s Ixtaca Project begins commercial production. The full text of the Gold Loan Agreement is filed as an exhibit to the 2020 Annual Report on Form 20- F filed with the Commission on March 26, 2021.

 

C. Exchange controls

 

Except as discussed above, the Company is not aware of any Canadian federal or provincial laws, decrees or regulations that restrict the export or import of capital, including foreign exchange controls, or that affect the remittance of interest, dividends or other payments to non-Canadian holders of the Company's common shares. There are no limitations under the laws of Canada or in the organizing documents of the Company on the right of non-Canadians to hold or vote securities of the Company, except that the Investment Canada Act (Canada) may require that, if specified thresholds are exceeded, a "non-Canadian" not acquire "control" of the Company without prior review and approval by the Minister of Innovation, Science and Economic Development. The acquisition of one third or more of the voting shares of the Company would give rise to a rebuttable presumption of the acquisition of control, and the acquisition of more than fifty percent of the voting shares of the Company would be deemed to be an acquisition of control. In addition, the Investment Canada Act (Canada) provides the Canadian government with broad discretionary powers in relation to national security to review and potentially prohibit, condition or require the divestiture of, any investment in the Company by a non-Canadian, including non-control level investments. "Non-Canadian" generally means an individual who is neither a Canadian citizen nor a permanent resident of Canada within the meaning of the Immigration and Refugee Protection Act (Canada) who has been ordinarily resident in Canada for not more than one year after the time at which he or she first became eligible to apply for Canadian citizenship, or any entity that is not controlled or beneficially owned by Canadians.

 

D. Taxation

 

The following summary of the material Canadian federal income tax consequences generally applicable in respect of the common shares reflects the Company’s opinion. The tax consequences to any particular holder of common shares will vary according to the status of that holder as an individual, trust, company or member of a partnership, the jurisdiction in which that holder is subject to taxation, the place where that holder is resident and, generally, according to that holder’s particular circumstances. This summary is applicable only to holders who are resident in the U.S., have never been resident in Canada, deal at arm’s length with the Company, hold their common shares as capital property and who will not use or hold the common shares in carrying on business in Canada. Special rules, which are not discussed in this summary, may apply to a U.S. holder that is an issuer that carries on business in Canada and elsewhere.

 

  85

 

This summary is based upon the provisions of the Income Tax Act of Canada and the regulations thereunder (collectively, the “Canadian Tax Act" or “ITA”) and the Canada-United States Tax Convention (the “Convention”) as at the date of the Registration Statement and the current administrative practices of Canada Revenue Agency. This summary does not take into account Provincial income tax consequences.

 

Each holder should consult his own tax advisor with respect to the income tax consequences applicable to him in his own particular circumstances.

 

Certain Canadian Federal Income Tax Consequences

The discussion under this heading summarizes the principal Canadian federal income tax consequences of acquiring, holding and disposing of common shares of the Company for a shareholder of the Company who is not a resident of Canada but is a resident of the U.S. and who will acquire and hold common shares of the Company as capital property for the purposes of the Canadian Tax Act. This summary does not apply to a shareholder who carries on business in Canada through a “permanent establishment” situated in Canada or performs independent personal services in Canada through a fixed base in Canada if the shareholder’s holding in the Company is effectively connected with such permanent establishment or fixed base. This summary is based on the provisions of the Canadian Tax Act and the regulations thereunder and on an understanding of the administrative practices of Canada Revenue Agency, and takes into account all specific proposals to amend the Canadian Tax Act or regulations made by the Minister of Finance of Canada as of the date hereof. It has been assumed that there will be no other relevant amendment of any governing law although no assurance can be given in this respect. This discussion is general only and is not a substitute for independent advice from a shareholder’s own Canadian and U.S. tax advisors.

 

The provisions of the Canadian Tax Act are subject to income tax treaties to which Canada is a party, including the Convention.

 

Dividends on Common Shares and Other Income

Under the Canadian Tax Act, a non-resident of Canada is generally subject to Canadian withholding tax at the rate of 25 percent on dividends paid or deemed to have been paid to him or her by a company resident in Canada. The Company is responsible for withholding of tax at the source. The Convention limits the rate to 15 percent if the shareholder is a resident of the U.S. and the dividends are beneficially owned by and paid to such shareholder, and to 5 percent if the shareholder is also a company that beneficially owns at least 10 percent of the voting stock of the payor company.

The amount of a stock dividend (for tax purposes) would generally be equal to the amount by which the paid up or stated capital of the Company had increased by reason of the payment of such dividend. The Company will furnish additional tax information to shareholders in the event of such a dividend. Interest paid or deemed to be paid on the Company’s debt securities held by non-Canadian residents may also be subject to Canadian withholding tax, depending upon the terms and provisions of such securities and any applicable tax treaty. The Convention generally eliminates Canadian tax on interest paid or deemed to be paid by the Company to U.S. residents. The Convention generally exempts from Canadian income tax dividends paid to a religious, scientific, literary, educational or charitable organization or to an organization constituted and operated exclusively to administer a pension, retirement or employee benefit fund or plan, if the organization is a resident of the U.S. and is exempt from income tax under the laws of the U.S.

 

Dispositions of Common Shares

Under the Canadian Tax Act, a taxpayer’s capital gain or capital loss from a disposition of a common shares of the Company is the amount, if any, by which his or her proceeds of disposition exceed (or are exceeded by, respectively) the aggregate of his or her adjusted cost base of the share and reasonable expenses of disposition. The capital gain or loss must be computed in Canadian currency using a weighted average adjusted cost base for identical properties. There are special transitional rules to apply capital losses against capital gains that arose in different periods. The amount by which a shareholder’s capital loss exceeds the capital gain in a year may be deducted from a capital gain realized by the shareholder in the three previous years or any subsequent year, subject to certain restrictions in the case of a corporate shareholder.

 

  86

 

Under the Canadian Tax Act, a non-resident of Canada is subject to Canadian tax on taxable capital gains, and may deduct allowable capital losses, realized on a disposition of "taxable Canadian property." Common shares of the Company will constitute taxable Canadian property of a shareholder at a particular time if the shareholder used the shares in carrying on business in Canada, or if at any time in the five years immediately preceding the disposition 25% or more of the issued shares of any class or series in the capital stock of the Company belonged to one or more persons in a group comprising the shareholder and persons with whom the shareholder and persons with whom the shareholder did not deal at arm’s length and in certain other circumstances.

 

The Convention relieves U.S. residents from liability for Canadian tax on capital gains derived on a disposition of shares unless

 

(a) the value of the shares is derived principally from “real property” in Canada, including the right to explore for or exploit natural resources and rights to amounts computed by reference to production,

 

(b) the shareholder was resident in Canada for 120 months during any period of 20 consecutive years preceding, and at any time during the 10 years immediately preceding, the disposition and the shares were owned by him when he or she ceased to be resident in Canada, or

 

(c) the shares formed part of the business property of a “permanent establishment” that the holder has or had in Canada within the 12 months preceding the disposition.

 

Certain U.S. Federal Income Tax Consequences

The following is a discussion of material U.S. federal income tax consequences generally applicable to a U.S. Holder (as defined below) of shares of the Company. This discussion does not cover any state, local or foreign tax consequences.

 

The following discussion is based upon the sections of the Internal Revenue Code of 1986, as amended (“the Code”), Treasury Regulations, published Internal Revenue Service (“IRS”) rulings, published administrative positions of the IRS and court decisions that are currently applicable, any or all of which could be materially and adversely changed, possibly on a retroactive basis, at any time. In addition, the discussion does not consider the potential effects, both adverse and beneficial, or recently proposed legislation which, if enacted, could be applied, possibly on a retroactive basis, at any time. The following discussion is for general information only. It is not intended to be, nor should it be construed to be, legal or tax advice to any U.S. Holder or prospective holder and not an opinion or representation with respect to the U.S. Federal income tax consequences to any U.S. Holder or prospective holder is made. The following summary was not written and is not intended to be used, and cannot be used, by any person for the avoidance of any penalties with respect to taxes that may be imposed on such person. U.S. Holders and prospective holders of shares of the Company are urged to consult their own tax advisors about the federal, state, local, and foreign tax consequences of purchasing, owning and disposing of common shares of the Company.

 

U.S. Holders

As used herein, a U.S. Holder includes a holder of shares of the Company who is a citizen or resident of the U.S. (as defined under Treasury Regulation Section 301.7701(b) or any applicable income tax convention), a company (or an entity which has elected to be treated as a corporation under Treasury Regulation Sections 301.7701-3) created or organized in or under the laws of the U.S. or of any political subdivision thereof, any estate other than a foreign estate (as defined in Section 7701(a)(31)(A) of the Code or, a trust subject to the primary supervision of a court within the U.S. and control of a U.S. fiduciary as described in Section 7701(a)(30)(E) of the Code). This summary does not address the tax consequences to, and U.S. Holder does not include, persons subject to special provisions of Federal income tax law, such as tax-exempt organizations, qualified retirement plans, financial institutions, insurance companies, real estate investment trusts, regulated investment companies, broker-dealers, non-resident alien individuals, persons or entities that have a “functional currency” other than the U.S. dollar, shareholders who hold common shares as part of a straddle, hedging or conversion transaction, and shareholders who acquired their shares through the exercise of employee stock options or otherwise as compensation for services. This summary is limited to U.S. Holders who own shares as capital assets. This summary does not address the consequences to a person or entity holding an interest in a shareholder of the Company or the consequences to a person of the ownership, exercise or disposition of any options, warrants or other rights to acquire shares of the Company.

 

  87

 

Distributions on Shares of the Company

U.S. Holders receiving dividend distributions (including constructive dividends) with respect to shares of the Company are required to include in gross income for U.S. federal income tax purposes the gross amount of such distributions equal to the U.S. dollar value of such distributions on the date of receipt (based on the exchange rate on such date), to the extent that the Company has current or accumulated earnings and profits, without reduction for any Canadian income tax withheld from such distributions. Such Canadian tax withheld may be credited, subject to certain limitations, against the U.S. Holder’s U.S. federal income tax liability or, alternatively, may be deducted in computing the U.S. Holder’s U.S. federal taxable income. (See more detailed discussion at “Foreign Tax Credit” below). To the extent that distributions exceed current or accumulated earnings and profits of the Company, they will be treated first as a return of capital up to the U.S. Holder’s adjusted tax basis in the common shares and thereafter as gain from the sale or exchange of the common shares. Unless the distribution constitutes “qualified dividend income” as defined in Section 1(h)(11), dividend income will be taxed at marginal tax rates applicable to ordinary income.

 

In the case of foreign currency received as a dividend that is not converted by the recipient into U.S. dollars on the date of receipt, a U.S. Holder will have a tax basis in the foreign currency equal to its U.S. dollar value on the date of receipt. Gain or loss may be recognized upon a subsequent sale or other disposition of the foreign currency, including an exchange for U.S. dollars.

 

Dividends paid on the shares of the Company will not generally be eligible for the dividends received deduction provided to companies receiving dividends from certain U.S. corporations. A U.S. Holder which is a corporation may, under certain circumstances, be entitled to a 70% deduction of the U.S. source portion of dividends received from the Company (unless the Company qualifies as a “passive foreign investment company”, as defined below) if such U.S. Holder owns shares representing at least 10% of the voting power and value of the Company. The availability of this deduction is subject to several complex limitations which are beyond the scope of this discussion. In addition, as discussed under the Controlled Foreign Corporation section below, distributions from controlled foreign corporations to certain U.S. corporate shareholders may be entitled to a dividend received deduction for the foreign source portion of the dividend.

 

The so-called Tax Cuts and Jobs Act (the “Tax Act”) was enacted on December 22, 2017 by the U.S. government. The Tax Act broadly changes the taxation of foreign earnings attributable to certain U.S. Holders from a worldwide tax regime to a territorial regime. The Tax Act created a transition tax that creates a deemed repatriation of previously untaxed foreign earnings and profits. Certain U.S. Holders may be subject to this transition tax and recognize taxable income due to undistributed earnings and profits of the Company.

 

Foreign Tax Credit

A U.S. Holder who pays (or has withheld from distributions) Canadian income tax with respect to the ownership of shares of the Company may be entitled, at the option of the U.S. Holder, to either a deduction or a tax credit for such foreign tax paid or withheld. This election is made on a year-by-year basis and applies to all foreign income taxes (or taxes in lieu of income tax) paid by (or withheld from) the U.S. Holder during the year. There are significant and complex limitations which apply to a U.S. Holder’s ability to claim the foreign tax credit. Furthermore, a foreign tax credit may not be claimed when a U.S. Holder is entitled to a dividend received deduction. The availability of the foreign tax credit and the application of the limitations on the credit are fact specific and holders and prospective holders of shares of the Company should consult their own tax advisors regarding their individual circumstances.

 

Disposition of Shares of the Company

For U.S. tax purposes, a U.S. Holder will generally recognize gain or loss upon the sale of shares of the Company equal to the difference, if any, between (I) the amount of cash plus the fair market value of any property received, and (ii) the shareholder’s tax basis in his, her or its shares of the Company. This gain or loss will be capital gain or loss if the common shares are capital assets in the hands of the U.S. Holder. Capital gain will then be classified as a short-term or long-term capital gain or loss depending upon the holding period of the U.S. Holder. Preferential tax rates apply to long-term capital gains of U.S. Holders which are individuals, estates or trusts. Gains and losses are netted and combined according to special rules in arriving at the overall capital gain or loss for a particular tax year. Deductions for net capital losses are subject to significant limitations. For U.S. Holders which are not companies, any unused portion of such net capital loss may be carried over to be used in later tax years until such net capital loss is thereby exhausted, but individuals may not carry back capital losses. For U.S. Holders which are taxable corporations (other than companies subject to Subchapter S of the Code), an unused net capital loss may be carried back three years from the loss year and carried forward five years from the loss year to be offset against capital gains until such net capital loss is thereby exhausted.

 

  88

 

Net Investment Tax

U.S. Holders may also be subject to the Net Investment Income Tax, which is imposed on certain U.S. taxpayers’ income from investments, such as dividends, interest and capital gains. Individual taxpayers are liable for a 3.8 percent Net Investment Income Tax on the lesser of their net investment income, or the amount by which their modified adjusted gross income exceeds certain statutory thresholds based on their filing status. U.S. Holders or prospective U.S. Holders should consult their tax advisors to determine if the Net Investment Income Tax will apply in their individual circumstances.

 

Other Considerations

In the following circumstances, the above sections of the discussion may not describe the U.S. federal income tax consequences resulting from the holding and disposition of shares of the Company.

 

Passive Foreign Investment Company

As a foreign company with U.S. Holders, the Company could potentially be treated as a PFIC, as defined in Section 1297 of the Code. Section 1297 of the Code defines a PFIC as a company that is not formed in the U.S. and, for any taxable year, either (i) 75% or more of its gross income is “passive income”, which includes among other types of income, interest, dividends and certain rents and royalties or (ii) the average percentage, by fair market value (or, if the company is a controlled foreign company or makes an election, by adjusted tax basis), of its assets that produce or are held for the production of “passive income” is 50% or more.

 

The rules governing PFICs can have significant tax effects on U.S. shareholders of foreign companies. U.S. shareholder’s income or gain, with respect to a disposition or deemed disposition of PFIC shares or a distribution payable on such shares will generally be subject to tax at the highest marginal rates applicable to ordinary income and certain interest charges as discussed below, unless the U.S. shareholder has timely made a “qualified electing fund” election or a “mark-to-market” election for those shares. The elections available to U.S. shareholders of a PFIC are made on a shareholder-by-shareholder basis, and U.S. shareholders should consult with tax advisors as soon as possible to determine the what election, if any, such U.S. shareholder should make. The timing for making such election can have consequences on the U.S. shareholders tax position with respect to its ownership in a PFIC.

 

Under one method, a U.S. shareholder who elects in a timely manner to treat the PFIC as a QEF, as defined in the Code, (an "Electing U.S. Holder") will be required to currently include in his income for any taxable year in which the company qualifies as a PFIC his pro-rata share of the company's (i) "net capital gain" (the excess of net long-term capital gain over net short-term capital loss), which will be taxed as long-term capital gain to the Electing U.S. Holder, and (ii) "ordinary earnings" (the excess of earnings and profits over net capital gain), which will be taxed as ordinary income to the Electing U.S. Holder, in each case, for the U.S. Holder's taxable year in which (or with which) the Company’s taxable year ends, regardless of whether such amounts are actually distributed. A QEF election also allows the Electing U.S. Holder to (i) generally treat any gain realized on the disposition of his common shares (or deemed to be realized on the pledge of his common shares) as capital gain; (ii) treat his share of the company's net capital gain, if any, as long-term capital gain instead of ordinary income, and (iii) either avoid interest charges resulting from PFIC status altogether (see discussion of interest charge below), or make an annual election, subject to certain limitations, to defer payment of current taxes on his share of the company's annual realized net capital gain and ordinary earnings which will then be subject, however, to an interest charge.

 

The procedure a U.S. Holder must comply with in making a timely QEF election will depend on whether the year of the election is the first year in the U.S. Holder's holding period in which the Company is a PFIC. If the U.S. shareholder makes a QEF election in such first year, (sometimes referred to as a "Pedigreed QEF Election"), then the U.S. shareholder may make the QEF election by simply filing the appropriate documents at the time the U.S. Holder files its tax return for such first year. If, however, the company qualified as a PFIC in a prior year during the U.S. shareholder’s holding period, then the U.S. shareholder may make a retroactive QEF election, provided he has preserved his right to do so under the protective statement regime or he obtains IRS permission.

 

If a U.S. shareholder has not made a QEF Election at any time (a "Non-electing U.S. Holder"), then special taxation rules under Section 1291 of the Code will apply to (i) gains realized on the disposition (or deemed to be realized by reason of a pledge) of his common shares and (ii) certain "excess distributions" by the company. An excess distribution is a current year distribution received by the U.S. shareholder on PFIC stock to the extent that the distribution exceeds its ratable portion of 125% of the average amount received by the U.S. shareholder during the preceding three years.

 

  89

 

A Non-electing U.S. shareholder generally would be required to pro-rate all gains realized on the disposition of his common shares and all excess distributions over the entire holding period for the common shares. All gains or excess distributions allocated to prior years of the U.S. shareholder (other than years prior to the first taxable year of the Company during such U.S. Holder's holding period and beginning after January 1, 1987 for which it was a PFIC) would be taxed at the highest marginal tax rate for each such prior year applicable to ordinary income. The Non-electing U.S. shareholder also would be liable for interest on the foregoing tax liability for each such prior year calculated as if such liability had been due with respect to each such prior year. A Non-electing non-corporate U.S. shareholder must treat this interest charge as "personal interest" which is wholly non-deductible. The balance of the gain or the excess distribution will be treated as ordinary income in the year of the disposition or distribution, and no interest charge will be incurred with respect to such balance.

 

If a company is a PFIC for any taxable year during which a Non-electing U.S. shareholder holds shares, then the company will continue to be treated as a PFIC with respect to such shares, even if it is no longer by definition a PFIC. A Non-electing U.S. shareholder may terminate this deemed PFIC status by electing to recognize gain (which will be taxed under the rules discussed above for Non-Electing U.S. Holders) as if such shares had been sold on the last day of the last taxable year for which it was a PFIC. If the company no longer qualifies as a PFIC in a subsequent year, then normal Code rules and not the PFIC rules will apply with respect to a U.S. shareholder who has made a Pedigreed QEF election.

 

If a U.S. shareholder makes a QEF Election that is not a Pedigreed Election (i.e., it is made after the first year during which the company is a PFIC and the U.S. shareholder holds shares of the company) (a "Non-Pedigreed Election"), the QEF rules apply prospectively but do not apply to years prior to the year in which the QEF first becomes effective. U.S. Holders are encouraged to consult their tax advisors regarding the specific consequences of making or not making a QEF Election.

 

Under an alternative method, U.S. Holders who hold (actually or constructively) marketable stock of a PFIC may elect to mark such stock to the market annually (a “mark-to-market election”). If such an election is made, such U.S. Holder will generally not be subject to the special taxation rules of Section 1291 discussed above. However, if the mark-to-market election is made by a Non-Electing U.S. Holder after the beginning of the holding period for the PFIC stock, then the Section 1291 rules will apply to certain dispositions of, distributions on and other amounts taxable with respect to the Company shares. A U.S. Holder who makes the mark-to-market election will include in income for each taxable year for which the election is in effect an amount equal to the excess, if any, of the fair market value of the shares of the Company as of the close of such tax year over such U.S. Holder’s adjusted basis in such common shares. In addition, the U.S. Holder is allowed a deduction for the lesser of (i) the excess, if any, of such U.S. Holder’s adjusted tax basis in the shares over the fair market value of such shares as of the close of the tax year, or (ii) the excess, if any, of (a) the mark-to-market gains for the shares in the Company included by such U.S. Holder for prior tax years, including any amount which would have been treated as a mark-to-market gain for any prior tax year but for the Section 1291 rules discussed above with respect to Non-Electing U.S. Holders, over (b) the mark-to-market losses for shares that were allowed as deductions for prior tax years. A U.S. Holder’s adjusted tax basis in the shares of the Company will be adjusted to reflect the amount included in or deducted from income as a result of a mark-to-market election. A mark-to-market election applies to the taxable year in which the election is made and to each subsequent taxable year, unless the Company’s shares cease to be marketable, as specifically defined, or the IRS consents to revocation of the election. U.S. Holders should consult their tax advisors regarding the manner of making such an election.

 

Controlled Foreign Corporation

If more than 50% of the total combined voting power of all classes of stock entitled to vote or more than 50% of the total value of the stock of the Company is owned, directly, indirectly or constructively, by U.S. Holders, each of whom own actually or constructively 10% or more of the total combined voting power of all classes of stock or 10% or more of the total value of all classes of stock of the Company (“10% U.S. Holders”), the Company would be treated as a “controlled foreign corporation” or “CFC” under Subpart F of the Code. This classification would effect many complex results, one of which requires such 10% U.S. Holders to include in their current income their pro rata share of (i) Subpart F income of the CFC, (ii) the CFC’s earnings from certain investments in U.S. property, (iii) global intangible low-taxed income (“GILTI), and (iv) base erosion minimum tax amounts for certain 10% U.S. Holders with sufficient gross receipts that make deductible payments to related foreign parties in tax years after December 31. 2018. The foreign tax credit described above may reduce the U.S. tax on these amounts. In addition, under Section 1248 of the Code, gain from the sale or exchange of shares by a U.S. Holder of common shares of the Company which is or was a 10% U.S. Holder at any time during the five-year period ending with the sale or exchange will be treated as dividend income to the extent of earnings and profits of the Company (accumulated only while the shares were held by the 10% U.S. Holder and while the Company was a CFC attributable to the shares sold or exchanged. Certain U.S. corporations that are 10% U.S. Holders may be entitled to a dividend received deduction for the foreign source portion of dividends received from the Company as discussed above.

 

  90

 

If a foreign corporation is both a PFIC and a CFC, the foreign corporation generally will not be treated as a PFIC with respect to certain 10% U.S. Holders of the CFC. This rule generally will be effective for taxable years of 10% U.S. Holders beginning after 1997 and for taxable years of foreign company’s ending with or within such taxable years of 10% U.S. Holders. The PFIC provisions continue to apply in the case of a PFIC that is also a CFC with respect to the U.S. Holders that are less than 10% shareholders. Because of the complexity of Subpart F, a more detailed review of these rules is beyond the scope of this discussion.

 

Information Reporting and Backup Withholding

In general, unless a U.S. Holder belongs to a category of certain exempt recipients (such as corporations), information reporting requirements will apply to distributions as well as proceeds of sales from the sale of shares of the Company that are effected through the U.S. office of a broker or the non-U.S. office of a broker that has certain connections with the United States. Backup withholding may apply to these payments if a U.S. Holder fails to provide a correct taxpayer identification number or certification of exempt status, fails to report in full dividend and interest income or, in certain circumstances, fails to comply with applicable certification requirements. Any amounts withheld under the backup withholding rules will be allowed as a refund or credit against a U.S. Holder’s U.S. federal income tax, provided the U.S. Holder furnishes the required information to the IRS in a timely manner. Other filing requirements may also apply. U.S. Holders should consult with their own tax advisors concerning their particular reporting requirements.

 

U.S. Holder’s should consult with their tax advisors to determine if holding common shares in the Company will create any other disclosure or reporting requirements for U.S. tax purposes.

 

E. Dividends and Paying Agents

 

Not applicable.

 

F. Statement by Experts

 

Not applicable.

 

G. Documents on Display / Additional Information

 

Any of the documents referred to above can be viewed at the head office of the Company located at 1333 Johnston Street, Suite 210, Vancouver, British Columbia, Canada, V6H 3R9.

 

This Annual Report and the Company’s recent Form 6-K filings can be viewed on the EDGAR web-site at www.sec.gov./edgar/searchedgar/companysearch.html. As well, additional information is contained in the Company’s Information Circular for its most recent annual meeting of security holders that involved the election of directors held on June 28, 2023 and additional financial information is provided in the Company’s financial statements and MD&A for its most recently completed financial year.

 

H. Subsidiary Information

 

Not applicable.

 

 

  91

 

I. Annual Report to Security Holders

 

Not applicable.

 

Item 11. Quantitative and Qualitative Disclosures about Market Risk

 

Exchange Rate Risk

The Company’s primary mineral exploration properties are located in Mexico. As a Canadian company, Almaden’s cash balances are kept primarily in Canadian funds, while many exploration and property expenses are denominated in U.S. dollars or the Mexican peso. Therefore, the Company is exposed to some exchange rate risk. The Company considers the amount of risk to be manageable and does not currently, nor is likely in the foreseeable future to, conduct hedging to reduce its exchange rate risk. A 10% change in the U.S. dollar exchange rate relative to the Canadian dollar would change the Company’s net loss by $110,000. A 10% change in the Mexican peso exchange rate relative to the Canadian dollar would change the Company’s net loss by $44,000.

 

Interest Rate Risk

The Company has no derivative financial instruments or other debt bearing variable interest rate instruments. The Company is exposed to varying interest rates on its cash and cash equivalents. A 1% change in the interest rate would change the Company’s net loss by $42,000.

 

Item 12. Description of Securities Other than Equity Securities

 

Not applicable.

 

PART II

 

Item 13. Defaults, Dividend Arrearages and Delinquencies

 

Not applicable.

 

Item 14. Material Modifications to the Rights of Securities Holders and Use of Proceeds

 

Not applicable.

 

Item 15. Controls and Procedures

 

Disclosure Controls and Procedures

 

The Company conducted an evaluation of the effectiveness of the design and operation of its disclosure controls and procedures (as defined in Rules 13a-15(e) under the Exchange Act) as of December 31, 2023. This evaluation was conducted under the supervision and with the participation of management, including the Company’s CEO and CFO. Based upon this evaluation, the Company’s CEO and CFO have concluded that, as of December 31, 2023, the Company’s disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the rules and forms. The Company also concluded that its disclosure controls and procedures are effective to provide reasonable assurance that information required to be disclosed in the reports filed or submitted under the Exchange Act is accumulated and communicated to its management, including the Company’s CEO and CFO, to allow timely decisions regarding required disclosure.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is a process designed by, or under the supervision of, the Company’s principal executive and principal financial officers and effected by the Company’s board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS as issued by IASB.

 

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

  92

 

The Company’s management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2023. In making this assessment, the Company’s management used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013) published by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on its assessment, management concluded that, as of December 31, 2023, the Company’s internal control over financial reporting was effective.

 

There were no changes in the Company’s internal control over financial reporting that occurred during the year ended December 31, 2023 that has materially affected, or that is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

Attestation Report of the Registered Accounting Firm

 

This Annual Report does not include an attestation report of the Company's registered public accounting firm because emerging growth companies are exempt from this requirement for so long as they remain emerging growth companies.

 

Changes in Internal Controls Over Financial Reporting

 

There were no changes in the Company’s internal controls over financial reporting identified in connection with the evaluation required by paragraph (d) of 17 CFR 240.13a-15 or 240.15d-15 that occurred during the period covered by this Annual Report that has materially affected, or is reasonably likely to materially affect, the issuer’s internal control over financial reporting.

 

Item 16. [Reserved]

 

Item 16A. Audit Committee Financial Expert

The Company’s Board of Directors has determined that Ms. Elaine Ellingham is the Company's audit committee financial expert. Ms. Ellingham has extensive business and financial experience. She has served as a director of several other publicly traded companies over the past 15 years, and currently serves as a director of two other publicly traded mining companies. Ms. Ellingham is independent as defined by Section 803(A) of the NYSE American Listing Standards.

 

Item 16B. Code of Ethics

The Company adopted several codes of conduct, including a Code of Business Ethics, a Code of Business Conduct Ethics for Directors, a Communications Policy and an Audit Committee Charter, which may be viewed on the Company’s website at www.almadenminerals.com. The Codes may also be viewed as filed on EDGAR as an exhibit to the 2005 Annual Report on Form 20-F filed with the Commission on March 30, 2006. Any amendments to the Codes or waivers of the provision of any Codes will be summarized and posted on the Company’s website within 5 business days of such amendment or waiver.

 

The Company has adopted the Code, the COBE, a Securities Trading Policy and a Privacy Policy. Employees and consultants are required as a term of employment or engagement to undertake to abide by the COBE. Directors are bound to observe the Code adopted by the Board.

 

All Individuals sign a Certification stating they have read the Ethics Policy of the Company and have complied with such Policy in all respects. The Certification further acknowledges that all members of the Individual’s family, all other persons who live with the Individual and all holding companies and other related entities of the Individual and all such persons or companies acting on behalf of or at the request of any of the foregoing also complied with such Policy. The Certification also states that any violation of such Policy may constitute grounds for immediate suspension or dismissal.

 

Each director is expected and required by statute to act honestly and in good faith with a view to the best interests of the Company and to exercise the care, diligence and skill that a reasonably prudent individual would exercise in comparable circumstances and in accordance with the BCBCA and the Company’s Articles.

 

  93

 

Item 16C. Principal Accountant Fees and Services

 

Audit Committee's pre-approval policies and procedures

The Audit Committee nominates and engages the independent auditors to audit the financial statements, and approves all audit services, audit-related services, tax services and other services provided by Davidson & Company LLP. Any services provided by Davidson & Company LLP that are not specifically included within the scope of the audit must be preapproved by the Audit Committee prior to any engagement. The Audit Committee is permitted to approve certain fees for audit-related services, tax services and other services before the completion of the engagement.

 

Table No. 8 lists the aggregate fees billed for each of the last two fiscal years for professional services rendered by Davidson & Company LLP (PCAOB ID 731), the Company’s principal accountant, for the audit of the Company’s annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years.

 

Table No. 8

Principal Accountant Fees

         
   

December 31,

2023

December 31,

2022

 
  Audit fees $60,500 $45,000  
  Audit-related fees 797 4,901  
  Tax fees - -  
  All other fees - -  

 

Fiscal 2023 and Fiscal 2022 audit fees relate to the annual audit of the Company’s consolidated financial statements, effectiveness of the Company’s internal control over financial reporting and review of the Form 20-F. Audit-related fees relate to accounting advisory services. Tax fees relate to the completion of income tax returns and tax consulting services. Other fees relate to services other than audit fees, audit-related fees, and tax fees described above.

 

Item 16D. Exemptions from the Listing Standards for Audit Committees

 

Not applicable.

 

Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

Not applicable.

 

Item 16F. Change in Registrant’s Certifying Accountant

 

Not applicable.

 

Item 16G. Corporate Governance

 

As at year-end, 2023, the Company’s class of common shares were listed on the NYSE American and the TSX. Under the rules of the NYSE American, listed companies are generally required to have a majority of their Board of Directors be “independent” as defined by the NYSE American Company Guide Rules. Currently, as permitted under applicable Canadian regulations, the Company’s Board consists of 6 directors, of which 4 are considered to be “independent.” In the opinion of management, the Company’s corporate governance practices do not differ in any significant way from those required of U.S. domestic companies listed on the NYSE American.

 

Item 16H. Mine Safety Disclosure

 

Not applicable.

 

  94

 

Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

Not applicable.

 

Item 16J. Insider Trading Policies

 

The Company has adopted a Securities Trading Policy which applies to the trading and confidentiality obligations of employees, officers and directors of the Company and its subsidiaries.

 

A copy of the Securities Trading Policy was filed as an exhibit to the Company’s Annual Report on Form 20-F for the year ended December 31, 2005, as filed with the Commission on March 30, 2006.

 

Item 16K. Cybersecurity

 

Risk Management and Strategy

 

The Company recognizes the importance of maintaining the security of its information technology systems and assets. We have implemented comprehensive cybersecurity risk assessment procedures to ensure effectiveness in cybersecurity management, strategy and governance and reporting cybersecurity risks. We have also integrated cybersecurity risk management into our overall enterprise risk management system.

 

The Company currently manages our cybersecurity risk through our IT consultants in a variety of practices that are applicable to all users of our information technology and information assets, including our employees, vendors and contractors. The Company uses a combination of technology and monitoring to promote security awareness and prevent security incidents, including, without limitation, network and passwords protocols, required VPN access to our database systems, rotation of security measures and third party firewalls and antivirus protections.

 

We have not experienced any material cybersecurity incidents or identified any material cybersecurity threats that have affected or are reasonably likely to materially affect us, our business strategy, results of operations or financial condition.

 

Governance

 

Our board of directors is responsible for overseeing risks related to cybersecurity. The Company's senior management team, including the President and Chief Financial Officer, are responsible for assessing and managing risks and incidents relating to cybersecurity threats. They discuss quarterly with the Audit Committee of any material findings and recommendations if any. The Audit Committee will then report their conclusions and recommendations to the Board of Directors.

 

PART III

 

Item 17. Financial Statements

 

The Company has provided financial statements pursuant to Item 18 of this Form 20-F.

 

Item 18. Financial Statements

 

The Company’s consolidated financial statements and notes thereto are expressed in Canadian Dollars (CDN$) and are prepared in accordance and compliance with IFRS as issued by the IASB.

 

Item 19. Exhibits

 

A. The financial statements and notes thereto as required under Item 18 are attached hereto and found immediately following the text of this Annual Report.

 

Audited Financial Statements

Independent registered Public Accounting Firm reports on the consolidated financial statements, dated March 20, 2024

Consolidated statements of financial position at December 31, 2023 and 2022

Consolidated statements of comprehensive loss for the years ended December 31, 2023, 2022 and 2021

  95

 

Consolidated statements of changes in equity for the years ended December 31, 2023, 2022 and 2021

Consolidated statements of cash flows for the years ended December 31, 2023, 2022 and 2021

Summary of significant accounting policies and other explanatory information

 

B. Index to Exhibits

   
1. Certificate of Amalgamation
  Amalgamation Agreement
  - Incorporated by reference to the Company’s Form Annual Report on Form 20-F for the year ended December 31, 2001, as filed with the Commission on May 17, 2002.
   
1.1 Articles
  - Incorporated by reference to the Company’s Form Annual Report on Form 20-F for the year ended December 31, 2005, as filed with the Commission on March 30, 2006.
   
2. Instruments defining the rights of holders of equity or debt securities being registered
  - Refer to Exhibit No. 1.
   
3.

Voting trust agreements. The Voting Trust Agreement dated December 17, 2009 between Ernesto Echavarria, as grantor, and Messrs Duane and Morgan Poliquin, as voting trustees.

- Incorporated by reference to the Company’s Form 20-F for the year ended December 31, 2013 and filed with the Commission on March 31, 2014.

   
4.1 Arrangement Agreement dated May 11, 2015 in connection with the Company’s statutory Plan of Arrangement with Almadex and filed with the Commission on March 31, 2016.
4.2 Administrative Services Agreement between the Company and Almadex Minerals Limited dated May 15, 2015 and filed with the Commission on March 31, 2016.
4.3 First Amending Agreement to the May 15, 2015 Administrative Services Agreement between the Company and Almadex Minerals Limited dated December 16, 2015 and filed with the Commission on March 31, 2016.
4.4 Executive Employment Contract between the Company and Duane Poliquin dated effective January 1, 2016 and filed with the Commission on March 31, 2016.
4.5 Amending Agreement dated April 1, 2016 to the Executive Compensation Contract with Morgan Poliquin dated January 29, 2013 and filed with the Commission on March 30, 2017.
4.6 Amending Agreement dated April 1, 2016 to the Executive Employment Contract with Duane Poliquin dated January 1, 2016 and filed with the Commission on March 30, 2017.
4.7 Amending agreement to the Executive Compensation Contract with Morgan Poliquin dated January 1, 2019 and filed with the Commission on March 15, 2019.
4.8 Amending agreement to the Executive Compensation Contract with Duane Poliquin dated January 1, 2019 and filed with the Commission on March 15, 2019.
4.9 Administrative Services Agreement between the Company and Almadex Minerals Ltd. (formerly 1154229 B.C. Ltd.) dated March 29, 2018 and filed with the Commission on March 15, 2019.
4.10 Gold Loan Agreement between the Company and Almadex Minerals Ltd. dated effective May 14th, 2019 and filed with the commission on March 27, 2020.
4.11 Short Form Base Shelf Prospectus and filed with the commission on February 25, 2021
4.12

Form of Placement Agency Agreement dated March 16, 2021

- Incorporated by reference to the Form 6-K and filed with the Commission on March 16, 2021

4.13

Form of Securities Purchase Agreement

- Incorporated by reference to the Form 6-K and filed with the Commission on March 16, 2021

4.14 Salary Deferral and Amendment Agreement and filed with the Commission on April 27, 2023
5. List of foreign patents – N/A
   
6. Calculation of earnings per share – N/A
   
7. Explanation of calculation of ratios – N/A
   
8. List of subsidiaries
   
9. Statement pursuant to the instruction to Item 8.A.4, regarding the financial statement filed in registration

 

  96

 

   
  Statements for initial public offerings of securities – N/A
   
10. Any notice required by Rule 104 of Regulation BTR – N/A
   
11 Audit Committee Charter
11.1 Nominating and Corporate Governance Committee-Duties and Responsibility
11.2 Compensation Committee-Responsibilities and Duties
11.3 Code of Business Ethics
11.4 Code of Business Conduct and Ethics for Directors
11.5 Communications Policy
11.6 Securities Trading Policy
11.7 Whistleblower Policy
11.8 Privacy Policy
  - Incorporated by reference to the Company’s Annual Report on Form 20-F for the year ended December 31, 2005, as filed with the Commission on March 30, 2006.
11.9

Shareholder Rights Plan dated April 13, 2011, as amended and reconfirmed at the 2017 Annual General Meeting and as reconfirmed at the 2020 Annual General Meeting.

- Incorporated by reference to the Form 6-K filed with the Commission on April 15, 2011.

11.10 Amended Advance Notice Policy dated January 28, 2013, as amended May 1, 2015 as filed with the Commission on March 29, 2018.
11.11 Amended Majority Voting Policy – adopted by the Board of Directors on May 7, 2013, as amended effective May 15, 2017 as filed with the Commission on March 29, 2018.
   
12.1 Certification of CEO Pursuant to Securities Exchange Act, Rules 13a-14 and 15d-14 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
12.2 Certification of CFO Pursuant to Securities Exchange Act, Rules 13a-14 and 15d-14 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
13.1 Certification of CEO Pursuant to the Sarbanes-Oxley Act, 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
13.2 Certification of CFO Pursuant to the Sarbanes-Oxley Act, 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   
14.1 Consent of Jesse Aarsen as filed with the Commission on September 28, 2023
14.2 Amended S-K 1300 Technical Report Summary of the Ixtaca Gold-Silver Project as filed with the Commission on September 28, 2023.
101.INS Inline XBRL Instance Document
101.SCH Inline XBRL Taxonomy Extension Schema Documents
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 Cover Page Interactive Data File (embedded within Inline XBRL document)
   

 

 

 

  97

 

SIGNATURE

 

 

 

The Registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this Annual Report on its behalf.

 

 

 

 

Almaden Minerals Ltd.

Registrant

 

 

 

Dated: April 26, 2024 By /s/Morgan Poliquin  
    Morgan Poliquin, CEO  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Financial Statements of

 

 

Almaden Minerals Ltd.

 

For the years ended December 31, 2023, 2022 and 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Almaden Minerals Ltd.

December 31, 2023, 2022 and 2021

 

 

Table of contents

 

 

Report of independent registered public accounting firm F-1
   
Consolidated statements of financial position F-2
   
Consolidated statements of comprehensive loss F-3
   
Consolidated statements of cash flows F-4
   
Consolidated statements of changes in equity F-5
   
Notes to the consolidated financial statements F-6 - F-36

 

 

 

 

 

 

 

 

Report of Independent Registered Public Accounting Firm

 

To the Shareholders and Directors of

Almaden Minerals Ltd.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated statements of financial position of Almaden Minerals Ltd. (the “Company”) as of December 31, 2023 and 2022, and the related consolidated statements of comprehensive loss, changes in equity, and cash flows for the years ended December 31, 2023, 2022, and 2021, and the related notes and schedules (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for the years ended December 31, 2023, 2022, and 2021, in conformity with IFRS Accounting Standards as issued by the International Accounting Standards Board.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

We have served as the Company’s auditor since 2015.

 

 

/s/ DAVIDSON & COMPANY LLP

 

 

Vancouver, Canada  Chartered Professional Accountants

March 20, 2024

 

 F-1 

 

Almaden Minerals Ltd.

Consolidated statements of financial position

(Expressed in Canadian dollars)

 

           
   December 31,
2023
   December 31,
2022
 
    $    $ 
ASSETS          
Current assets          
Cash and cash equivalents (Note 13)   4,245,983    6,658,076 
Gold in trust (Note 8)   1,082,801    974,397 
Accounts receivable and prepaid expenses (Note 4)   453,640    259,471 
Total current assets   5,782,424    7,891,944 
           
Non-current assets          
Right-of-use assets (Note 5)   330,597    432,319 
Property, plant and equipment (Note 6)   6,601,742    6,610,871 
Exploration and evaluation assets (Note 7)   1    63,115,076 
Total non current assets   6,932,340    70,158,266 
TOTAL ASSETS   12,714,764    78,050,210 
           
LIABILITIES          
Current liabilities          
Trade and other payables (Note 11 (a))   851,158    340,509 
Current portion of lease liabilities (Note 5)   100,531    88,295 
Total current liabilities   951,689    428,804 
           
Non-current liabilities          
Long-term portion of lease liabilities (Note 5)   277,104    377,635 
Gold loan payable (Note 8)   4,371,546    3,929,015 
Warrant liability (Note 9)   -    102,787 
Derivative financial liabilities (Note 8)   108,830    306,084 
Deferred income tax liability (Note 14)   -    3,090,208 
Total non current liabilities   4,757,480    7,805,729 
Total liabilities   5,709,169    8,234,533 
           
EQUITY          
Share capital (Note 10)   141,040,654    141,040,654 
Reserves (Note 10)   23,356,523    22,546,373 
Deficit   (157,391,582)   (93,771,350)
Total equity   7,005,595    69,815,677 
TOTAL EQUITY AND LIABILITIES   12,714,764    78,050,210 

Nature of operations (Note 1)

Subsequent event (Note 18)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

These consolidated financial statements are authorized for issue by the Board of Directors on March 20, 2024.

They are signed on the Company’s behalf by:

 

 

 

/s/Duane Poliquin  /s/ Elaine Ellingham
Director  Director

 

 

 F-2 

 

Almaden Minerals Ltd.

Consolidated statements of comprehensive loss

(Expressed in Canadian dollars)

 

                
   Year ended December 31, 
   2023   2022   2021 
Expenses  $   $   $ 
Professional fees (Note 11(a))   1,113,336    864,051    772,887 
Salaries and benefits (Note 11(a))   1,811,073    1,923,952    1,876,911 
Travel and promotion   50,120    107,869    200,995 
Depreciation (Note 6)   11,166    14,424    16,638 
Office and other (Note 11(b))   182,457    156,686    218,879 
Amortization of right-of-use assets (Note 5)   101,722    106,791    121,479 
Occupancy expenses (Note 5)   39,858    42,655    40,542 
Interest expense on lease liabilities (Note 5)   39,502    47,379    13,330 
Interest, accretion and standby fees on gold loan payable (Note 8)   540,709    468,308    394,371 
Listing and filing fees   193,490    154,505    187,169 
Insurance   103,491    96,068    89,476 
Directors’ fees (Note 11(a))   140,000    145,000    102,500 
Share-based payments (Note 10(d) and 11(a))   810,150    1,478,100    1,870,800 
Total Expenses   5,137,074    5,605,788    5,905,977 
                
Other income (loss)               
Administrative services fees (Note 11(b))   1,422,347    1,376,428    1,382,344 
Interest and other income   370,741    253,869    490,245 
Impairment of property, plant and equipment (Note 6)   -    (7,441,293)   - 
Impairment of exploration and evaluation assets (Note 7)   (63,823,478)   -    - 
Unrealized gain (loss) on derivative financial liabilities (Note 8)   191,732    110,177    (18,156)
Unrealized gain (loss) on gold in trust (Note 8)   132,895    (6,518)   (35,775)
Unrealized foreign exchange gain (loss) on gold loan payable (Note 8)   103,700    (257,803)   11,535 
Unrealized foreign exchange gain (loss) on gold in trust (Note 8)   (24,491)   64,920    (4,011)
Unrealized gain on warrant liability (Note 9)   102,787    520,503    1,747,884 
Gain on debt forgiveness (Note 11(a))   -    177,200    - 
Foreign exchange gain (loss)   (49,599)   302,930    (22,202)
Total other income (loss)    (61,573,366)   (4,899,587)   3,551,864 
Loss before income taxes   (66,710,440)   (10,505,375)   (2,354,113)
Deferred income tax recovery (expense) (Note 14)   3,090,208    (1,341,185)   (314,141)
Net loss for the year   (63,620,232)   (11,846,560)   (2,668,254)
                
Total comprehensive loss for the year   (63,620,232)   (11,846,560)   (2,668,254)
                
Basic and diluted net loss per share (Note 12)   (0.46)   (0.09)   (0.02)

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 F-3 

 

Almaden Minerals Ltd.

Consolidated statements of cash flows

(Expressed in Canadian dollars)

 

 

                
   Year ended December 31, 
   2023   2022   2021 
    $    $    $ 
Operating activities               
Net loss for the year   (63,620,232)   (11,846,560)   (2,668,254)
Items not affecting cash               
Deferred income tax (recovery) expense   (3,090,208)   1,341,185    314,141 
Depreciation   11,166    14,424    16,638 
Amortization of right-of-use assets   101,722    106,791    121,479 
Impairment of property, plant and equipment   -    7,441,293    - 
Impairment of exploration and evaluation assets   63,823,478    -    - 
Interest expenses on lease liability   39,502    47,379    13,330 
Interest, accretion and standby fees on gold loan payable   540,709    468,308    394,371 
Unrealized (gain) loss on derivative financial liabilities   (191,732)   (110,177)   18,156 
Unrealized (gain) loss on gold in trust   (132,895)   6,518    35,775 
Unrealized foreign exchange (gain) loss on gold loan payable   (103,700)   257,803    (11,535)
Unrealized foreign exchange (gain) loss on gold in trust   24,491    (64,920)   4,011 
Unrealized gain on warrant liability   (102,787)   (520,503)   (1,747,884)
Share-based payments   810,150    1,478,100    1,870,800 
Changes in non-cash working capital components               
Accounts receivable and prepaid expenses   (194,169)   (103,833)   19,370 
Trade and other payables   601,499    (169,206)   19,352 
Net cash used in operating activities   (1,483,006)   (1,653,398)   (1,600,250)
Investing activities               
Property, plant and equipment – purchase   (2,037)   (47,056)   (10,505)
Exploration and evaluation assets – costs   (799,253)   (1,681,790)   (2,784,645)
Net cash used in investing activities   (801,290)   (1,728,846)   (2,795,150)
Financing activities               
Issuance of shares, net of share issue costs   -    -    11,610,581 
Options exercised   -    -    564,750 
Repayment of lease liabilities   (127,797)   (130,056)   (144,253)
Net cash from (used in) financing activities   (127,797)   (130,056)   12,031,078 
                
Change in cash and cash equivalents   (2,412,093)   (3,512,300)   7,635,678 
Cash and cash equivalents, beginning of year   6,658,076    10,170,376    2,534,698 
Cash and cash equivalents, end of year   4,245,983    6,658,076    10,170,376 
Supplemental cash flow information (Note 13)               
                

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 F-4 

 

Almaden Minerals Ltd.

Consolidated statements of changes in equity

(Expressed in Canadian dollars)

 

                                           
   Share capital   Reserves         
   Number of
shares
   Amount   Share-based
payments
   Warrants   Total
reserves
   Deficit  

 

Total

 
       $   $   $   $   $   $ 
Balance, January 1, 2021   120,650,254    131,189,978    18,528,024    715,968    19,243,992    (79,256,536)   71,177,434 
Share-based payments   -    -    1,870,800    -    1,870,800    -    1,870,800 
Private placements, net of share issue costs   15,846,154    11,610,581    -    -    -    -    11,610,581 
Warrant liability   -    (2,371,174)   -    -    -    -    (2,371,174)
Finders’ warrants issued pursuant to private placement   -    (130,731)   130,731    -    130,731    -    - 
Shares issued for cash on exercise of stock options   725,000    564,750    -    -    -    -    564,750 
Fair value of cash stock options transferred to share capital   -    177,250    (177,250)   -    (177,250)   -    - 
Total comprehensive loss for the year   -    -    -    -    -    (2,668,254)   (2,668,254)
Balance, December 31, 2021   137,221,408    141,040,654    20,352,305    715,968    21,068,273    (81,924,790)   80,184,137 
Share-based payments   -    -    1,478,100    -    1,478,100    -    1,478,100 
Total comprehensive loss for the year   -    -    -    -    -    (11,846,560)   (11,846,560)
Balance, December 31, 2022   137,221,408    141,040,654    21,830,405    715,968    22,546,373    (93,771,350)   69,815,677 
Share-based payments   -    -    810,150    -    810,150    -    810,150 
Total comprehensive loss for the year   -    -    -    -    -    (63,620,232)   (63,620,232)
Balance, December 31, 2023   137,221,408    141,040,654    22,640,555    715,968    23,356,523    (157,391,582)   7,005,595 
                                    

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 F-5 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

1.Nature of operations

 

Almaden Minerals Ltd. (the “Company” or “Almaden”) was formed by amalgamation under the laws of the Province of British Columbia, Canada on February 1, 2002. The Company is an advanced exploration stage public company that is engaged directly in the exploration and development of exploration and evaluation property in Mexico. The Company’s shares are trade on the TSX Exchange under the symbol “AMM”. The address of the Company’s registered office is Suite 1710 –1177 West Hastings Street, Vancouver, BC, Canada V6E 2L3.

 

The Company is in the business of exploring and developing mineral projects and its principal asset is the Ixtaca precious metals project located on its Tuligtic claim in Mexico. The Company has not yet determined whether this project has economically recoverable mineral reserves. The recoverability of amounts shown for mineral properties is dependent upon the establishment of a sufficient quantity of economically recoverable reserves, the ability of the Company to obtain the necessary financing or participation of joint venture partners to complete development of the properties, and upon future profitable production or proceeds from the disposition of exploration and evaluation assets.

 

These consolidated financial statements were prepared on a “going concern” basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. As of December 31, 2023, the Company had a working capital surplus of $4,830,735 (2022 – $7,463,140). The Company does not currently hold any revenue-generating properties and therefore continues to incur losses. The Company incurred a net loss for the year ended December 31, 2023, of $63,620,232 (2022 – $11,846,560) and negative cash flows from operations of $1,483,006 for the year ended December 31, 2023 (2022 – $1,653,398). As at December 31, 2023, the Company had an accumulated deficit of $157,391,582 (2022 – $93,771,350). The Company’s ability to continue as a going concern is dependent upon its ability in the future to achieve profitable operations and in the meantime, to obtain the necessary financing to repay its liabilities when they become due. Management estimates that there is sufficient working capital to sustain operations for the next twelve months. External financing will be sought to finance the operations of the Company and enable the Company to continue its efforts towards the exploration and development of its mineral properties. There can be no assurance that steps management is taking will be successful. These consolidated financial statements do not include adjustments to the amounts and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern and such adjustments could be material.

 

2.Basis of presentation

 

(a)       Statement of Compliance with International Financial Reporting Standards (“IFRS”)

 

These consolidated financial statements have been prepared in accordance and compliance with IFRS Accounting standards as issued by the International Accounting Standards Board (“IASB”).

 

(b)       Basis of preparation

 

These consolidated financial statements have been prepared on a historical cost basis except for the revaluation of certain financial assets and financial liabilities at fair value through profit or loss. In addition, these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.

 

 F-6 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

2.Basis of presentation (Continued)

 

These consolidated financial statements, including comparatives, have been prepared on the basis of IFRS standards that are effective as at December 31, 2023.

 

(c)       Functional currency

 

The functional and reporting currency of the Company and its subsidiaries is the Canadian dollar.

 

(d)       Significant accounting judgments and estimates

 

The preparation of these consolidated financial statements requires management to make judgements and estimates that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. Actual outcomes could differ from these judgements and estimates. The consolidated financial statements include judgements and estimates which, by their nature, are uncertain. The impacts of such judgements and estimates are pervasive throughout the consolidated financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and the revision affects both current and future periods.

 

Significant assumptions about the future and other sources of judgements and estimates that management has made at the statement of financial position dates, that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions made, relate to, but are not limited to, the following:

 

Critical Judgments

 

oThe analysis of the functional currency for each entity of the Company determined by conducting an analysis of the consideration factors identified in IAS 21, “The Effect of Changes in Foreign Exchange Rates”. In concluding that the Canadian dollar is the functional currency of the parent and its subsidiary companies, management considered the currency that mainly influences the cost of providing goods and services in each jurisdiction in which the Company operates. As no single currency was clearly dominant, the Company also considered secondary indicators including the currency in which funds from financing activities are denominated and the currency in which funds are retained.

 

Going Concern

 

oManagement makes an assessment about the Company’s ability to continue as a going concern by taking into the account the consideration of the various factors discussed in Note 1. Judgement is applied by management in determining whether or not the elements giving rise to factors that cause doubt about the ability of the Company to continue as a going concern are present.

 

 F-7 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

2.Basis of presentation (Continued)

 

(d)       Significant accounting judgments and estimates (Continued)

 

Estimates

 

oThe estimated useful lives of property, plant and equipment which are included in the consolidated statements of financial position and the related depreciation included in profit or loss;
oThe recoverability of the value of the exploration and evaluation assets which is recorded in the consolidated statements of financial position (Note 3(f));
oThe Company uses the Black-Scholes option pricing model to determine the fair value of options, warrants, and derivative financial liabilities in order to calculate share-based payments expense, warrant liability and the fair value of finders’ warrants and stock options. Certain inputs into the model are estimates that involve considerable judgment or could be affected by significant factors that are out of the Company’s control;
oThe provision for income taxes which is included in profit or loss and the composition of deferred income tax liability included in the consolidated statement of financial position and the evaluation of the recoverability of deferred tax assets based on an assessment of the Company’s ability to utilize the underlying future tax deductions against future taxable income prior to expiry of those deductions;
oThe assessment of indications of impairment of each exploration and evaluation asset and property plant and equipment and related determination of the net realizable value and write-down of those assets where applicable (Note 3(f));
oThe estimated incremental borrowing rate used to calculate the lease liabilities; and
oThe estimated fair value of gold in trust.

 

3.Material accounting policies

 

(a)       Basis of consolidation

 

These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries as follows:

 

       
    Jurisdiction   Nature of operations
         
  Puebla Holdings Inc. Canada   Holding company
  Minera Gorrion, S.A. de C.V. Mexico   Exploration company

 

Inter-company balances and transactions, including unrealized income and expenses arising from inter-company transactions, are eliminated in preparing these consolidated financial statements.

 

 F-8 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

3.Material accounting policies (Continued)

 

(b)       Foreign currencies

 

Transactions in currencies other than the functional currency are recorded at the rates of exchange prevailing on the transaction dates. At each financial position reporting date, monetary assets and liabilities that are denominated in foreign currencies are translated at the rates prevailing at the date of the statement of financial position. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

(c)       Financial instruments

 

A financial asset is classified as measured at: amortized cost, fair value through other comprehensive income (FVOCI), or fair value through profit or loss (FVTPL). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. Derivatives embedded in contracts where the host is a financial asset in the scope of the standard are never separated. Instead, the hybrid financial instrument as a whole is assessed for classification. The Company's financial assets consist primarily of cash and cash equivalents, and accounts receivable and are classified at amortized cost.

 

Financial liabilities comprise the Company’s trade and other payables. Financial liabilities are initially recognized on the date they are originated and are derecognized when the contractual obligations are discharged or cancelled or expire. Trade and other payables are recognized initially at fair value and subsequent are measured at amortized costs using the effective interest method, when materially different from the initial amount. Derivative financial liabilities are classified as FVTPL. Fair value is determined based on the present value of future cash flow, discounted at the market rate of interest.

 

(i)     Impairment of financial assets

 

An ‘expected credit loss’ (ECL) model applies to financial assets measured at amortized cost, contract assets and debt investments at FVOCI, but not to investments in equity instruments. The Company's financial assets measured at amortized cost and subject to the ECL model include cash and cash equivalents, and accounts receivable.

 

(ii)    Embedded derivatives

 

Derivatives may be embedded in other financial instruments (the “host instrument”). Embedded derivatives are treated as separate derivatives when their economic characteristics and risks are not clearly and closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the combined contract is not held for trading or designated at fair value. These embedded derivatives are measured at fair value with subsequent changes recognized in profit or loss.

 

The Company issues warrants exercisable in a currency other than the Company’s functional currency and as a result, the warrants are derivative financial instruments.

 

Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred.

 

 F-9 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

3.Material accounting policies (Continued)

 

(d)       Cash and cash equivalents

 

Cash equivalents include term deposits and money market instruments which are readily convertible into cash or have maturities at the date of purchase of less than ninety days.

 

(e)       Property, plant and equipment

 

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, and are depreciated annually on a declining-balance basis if available-for-use at the following rates:

 

   
  Furniture, fixtures and other 20%
  Computer hardware and software 30%
  Geological library 20%
  Field equipment 20%
  Mill equipment Straight line over mine life (11 years)

 

(f)       Exploration and evaluation assets

 

The Company is in the advanced exploration stage with respect to its investment in exploration and evaluation assets and, accordingly, follows the practice of capitalizing all costs relating to the acquisition of, exploration for and development of mineral claims to which the Company has rights and crediting all proceeds received from farm-out arrangements or recovery of costs against the cost of the related claims. Acquisition costs include, but are not exclusive to land surface rights acquired. Deferred exploration costs include, but are not exclusive to geological, geophysical studies, annual mining taxes, exploratory drilling and sampling. At such time as commercial production commences, these costs will be charged to profit or loss on a unit-of-production method based on proven and probable reserves. The aggregate costs related to abandoned mineral claims are charged to profit or loss at the time of any abandonment or when it has been determined that there is evidence of an impairment.

 

The Company considers the following facts and circumstances in determining if it should test exploration and evaluation assets for impairment:

 

(i)the period for which the Company has the right to explore in the specific area has expired during the period or will expire in the near future, and is not expected to be renewed;

 

(ii)substantive expenditure on further exploration for and evaluation of mineral resources in the specific area is neither budgeted nor planned;

 

(iii)exploration for and evaluation of mineral resources in the specific area have not led to the discovery of commercially viable quantities of mineral resources and the entity has decided to discontinue such activities in the specific area; and

 

(iv)sufficient data exists to indicate that, although a development in the specific area is likely to proceed, the carrying amount of the exploration and evaluation assets is unlikely to be recovered in full from successful development or by sale.

 

 F-10 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

3.Material accounting policies (Continued)

 

(f)       Exploration and evaluation assets (Continued)

 

An impairment charge may be reversed but only to the extent that this does not exceed the original carrying value of the property that would have resulted if no impairment had been recognized. General exploration costs in areas of interest in which the Company has not secured rights are expensed as incurred.

 

The recoverability of amounts shown for exploration and evaluation assets is dependent upon the discovery of economically recoverable reserves, the ability of the Company to obtain financing to complete development of the properties, and on future production or proceeds of disposition.

 

The Company recognizes in profit or loss costs recovered on exploration and evaluation assets when amounts received or receivable are in excess of the carrying amount.

 

Once the technical feasibility and commercial viability of the extraction of mineral resources in an area of interest are demonstrable, exploration and evaluation assets attributable to that area of interest are first tested for impairment and then reclassified to development asset within property, plant and equipment.

 

All capitalized exploration and evaluation expenditures are monitored for indications of impairment.

 

Where a potential impairment is indicated, assessments are performed for each area of interest. To the extent that exploration expenditure is not expected to be recovered, it is charged to profit or loss. Exploration areas where reserves have been discovered, but require major capital expenditure before production can begin, are continually evaluated to ensure that commercial quantities of reserves exist or to ensure that additional exploration work is underway as planned.

 

(g)       Impairment of property, plant and equipment

 

Property, plant and equipment are reviewed for impairment at least annually, or if there is any indication that the carrying amount may not be recoverable. If any such indication is present, the recoverable amount of the asset is estimated in order to determine whether impairment exists. Where the asset does not generate cash flows that are independent from other assets, the Company estimates the recoverable amount of the cash generating unit to which the asset belongs.

 

An asset’s recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value, using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset or cash generating unit is estimated to be less than its carrying amount, the carrying amount is reduced to the recoverable amount by way of recording an impairment charge to profit or loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously been recognized.

 

 F-11 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

3.Material accounting policies (Continued)

 

(h)       Income taxes

 

Income tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to items recognized directly in equity or in other comprehensive income.

 

Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted at the reporting date, and any adjustment to tax payable in respect of previous years.

 

Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss, and differences relating to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date.

 

Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously.

 

A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.

 

(i)       Share-based payments

 

The Company’s stock option plan allows Company employees, directors, officers and consultants to acquire shares of the Company. The fair value of options granted is recognized as share-based payment expense with a corresponding increase in equity reserves. An individual is classified as an employee when the individual is an employee for legal or tax purposes (direct employee) or provides services similar to those performed by a direct employee.

 

Fair value is measured at grant date, and each tranche is recognized using the graded vesting method over the period during which the options vest. The fair value of the options granted is measured using the Black-Scholes option-pricing model, taking into account the terms and conditions upon which the options were granted. At each financial position reporting date, the amount recognized as an expense is adjusted to reflect the actual number of stock options that are expected to vest. In situations where equity instruments are issued to consultants and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received.

 

 F-12 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

3.Material accounting policies (Continued)

 

(j)       Share capital

 

Proceeds from the exercise of stock options and warrants are recorded as share capital in the amount for which the option or warrant enabled the holder to purchase a share in the Company, in addition to the proportionate amount of reserves originally created at the issuance of the stock options or warrants. Share capital issued for non-monetary consideration is valued at the closing market price at the date of issuance. The proceeds from the issuance of units are allocated between common shares and common share purchase warrants based on the residual value method. Under this method, the proceeds are allocated to common shares based on the fair value of a common share at the announcement date of the unit offering and any residual remaining is allocated to common share purchase warrants.

 

Certain of the Company’s warrants are exercisable in a currency other than the functional currency of the Company. As a result, the fair value allocated to the warrant is recorded as a derivative financial liability with residual value being attributed to the equity unit. The fair value of the warrant is determined using the Black-Scholes Option Pricing Model and is marked to market at the end of each period. Upon exercise of the warrant, the fair value of the warrant at the date of exercise is transferred to share capital.

 

(k)       Reclamation and closure cost obligations

 

Decommissioning and restoration provisions are recorded when a present legal or constructive obligation exists as a result of past events where it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made.

 

The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation and discount rates. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows discounted for the market discount rate.

 

Over time, the discounted liability is increased for the changes in the present value based on the current market discount rates and liability risks. When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount receivable can be measured reliably.

 

When the Company enters into an option agreement on its exploration and evaluations assets, as part of the option agreement, responsibility for any reclamation and remediation becomes the responsibility of the optionee.

 

 F-13 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

3.Material accounting policies (Continued)

 

(l)       Net loss per share

 

The Company presents the basic and diluted net loss per share data for its common shares, calculated by dividing the loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net loss per share is determined by adjusting the net loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all dilutive potential common shares (Note 12).

 

(m)       Leases

 

At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether the right to obtain substantially all of the economic benefits from use of the asset during the term of the arrangement exists, and if the Company has the right to direct the use of the asset. At inception or on reassessment of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of their relative standalone prices.

 

As a lessee, the Company recognizes a right-of-use asset and a lease liability at the commencement date of a lease. The right-of-use asset is initially measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received.

 

The right-of-use asset is subsequently depreciated using the straight line method from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. In addition, the right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

 

A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by the interest rate implicit in the lease, or if that rate cannot be readily determined, the incremental borrowing rate. Lease payments included in the measurement of the lease liability are comprised of:

 

·fixed payments, including in-substance fixed payments, less any lease incentives receivable;
·variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;
·amounts expected to be payable under a residual value guarantee;
·exercise prices of purchase options if the Company is reasonably certain to exercise that option; and
·payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease.

 

 F-14 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

3.Material accounting policies (Continued)

 

(m)       Leases (Continued)

 

The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if there is a change in the estimate or assessment of the expected amount payable under a residual value guarantee, purchase, extension or termination option. Variable lease payments not included in the initial measurement of the lease liability are charged directly to profit or loss.

 

The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments associated with these leases are charged directly to profit or loss on a straight-line basis over the lease term.

 

(n)       Standards issued or amended but not yet effective

 

The Company has not applied the following revised IFRS that has been issued but was not yet effective at December 31, 2023. This accounting standard is not currently expected to have a significant effect on the Company’s accounting policies or financial statements.

 

IAS 1 –Presentation of Financial Statements (“IAS 1”) was amended in January 2020 to provide a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments clarify that the classification of liabilities as current or noncurrent is based solely on a company’s right to defer settlement at the reporting date. The right needs to be unconditional and must have substance. The amendments also clarify that the transfer of a company’s own equity instruments is regarded as settlement of a liability, unless it results from the exercise of a conversion option meeting the definition of an equity instrument. These amendments were further revised by the issuance of Non-current Liabilities with Covenants (Amendments to IAS 1) on October 31, 2022 which further narrowed the scope of the amendments. The amendments are effective for annual periods beginning on January 1, 2024.

 

4.Accounts receivable and prepaid expenses

 

Accounts receivable and prepaid expenses consist of the following:

 

          
   December 31,   December 31, 
   2023   2022 
Accounts receivable (Note 11(b))  $389,895   $198,942 
Prepaid expenses   63,745    60,529 
 Total  $453,640   $259,471 

 

At December 31, 2023, the Company has recorded value added taxes of $164,189 (2022 - $251,775) included in exploration and evaluation assets, as the value added tax relates to the Tuligtic project and is expected to be recovered when the asset is sold (Note 7).

 

 F-15 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

 

 

5.Right-of-use assets and lease liabilities

 

The Company has lease agreements for its headquarter office space in Vancouver, B.C.

 

One lease containing an extension option exercisable only by the Company was exercised on November 22, 2021. The lease was therefore extended from March 31, 2022 to March 31, 2027. The Company reassessed this significant event as a lease modification and has estimated that the potential future lease payments under the extended lease term would result in an increase in lease liability by $508,799.

 

The continuity of lease liabilities for the years ended December 31, 2023 and 2022 are as follows:

 

          
   December 31,
2023
   December 31,
2022
 
Opening balance  $465,930   $548,607 
Less: lease payments   (127,797)   (130,056)
Interest expense   39,502    47,379 
    377,635    465,930 
Less: current portion of lease liabilities   (100,531)   (88,295)
Long-term portion of lease liabilities  $277,104   $377,635 

 

The Company entered into a sublease arrangement with a third party to lease an office unit from May 1, 2021 to March 31, 2022 under the same terms of the Company’s lease. The Company remains beholden to the obligations set out in its lease dated October 31, 2018. The rental income during the year ended December 31, 2023 (2022 - $8,508; 2021 - $22,452) from this operating sublease was $Nil and is recorded in interest and other income.

 

The continuity of ROU assets for the years ended December 31, 2023 and 2022 are as follows:

 

          
   December 31,
2023
   December 31,
2022
 
Opening balance  $432,319   $539,110 
Less: amortization of ROU assets   (101,722)   (106,791)
   $330,597   $432,319 

 

During the year ended December 31, 2023, the Company recognized occupancy expenses of $39,858 (2022 - $42,655; 2021 - $40,542) related to short term leases.

 

As at December 31, 2023, the remaining payments for the operating lease are due as follows:

 

                        
   2024   2025   2026   2027   2028   Total 
Office lease  $170,672   $173,970   $177,268   $44,523    -   $566,433 

 

 

 F-16 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

 

6.Property, plant and equipment

 

                                   
   Furniture
and fixtures
and other
   Computer
hardware
   Computer
software
   Geological
library
   Field
equipment
   Mill
equipment
   Total 
   $   $   $   $   $   $   $ 
Cost                            
December 31, 2022   159,171    271,540    198,981    51,760    245,647    6,568,841    7,495,940 
Additions   1,770    267    -    -    -    -    2,037 
Impairment of property, plant and equipment   -    -    -    -    -    -    - 
December 31, 2023   160,941    271,807    198,981    51,760    245,647    6,568,841    7,497,977 
                                    
Accumulated depreciation                                   
December 31, 2022   153,203    251,441    192,138    50,975    237,312    -    885,069 
Depreciation   1,223    6,066    2,053    157    1,667    -    11,166 
December 31, 2023   154,426    257,507    194,191    51,132    238,979    -    896,235 
                                    
Carrying amounts                                   
December 31, 2022   5,968    20,099    6,843    785    8,335    6,568,841    6,610,871 
December 31, 2023   6,515    14,300    4,790    628    6,668    6,568,841    6,601,742 

 

   Furniture
and fixtures
and other
   Computer
hardware
   Computer
software
   Geological
library
   Field
equipment
   Mill
equipment
   Total 
   $   $   $   $   $   $   $ 
Cost                            
December 31, 2021   158,219    267,004    198,981    51,760    245,647    13,968,566    14,890,177 
Additions   952    4,536    -    -    -    41,568    47,056 
Impairment of property, plant and equipment   -    -    -    -    -    (7,441,293)   (7,441,293)
December 31, 2022   159,171    271,540    198,981    51,760    245,647    6,568,841    7,495,940 
                                    
Accumulated depreciation                                   
December 31, 2021   151,390    244,043    189,206    50,779    235,227    -    870,645 
Depreciation   1,813    7,398    2,932    196    2,085    -    14,424 
December 31, 2022   153,203    251,441    192,138    50,975    237,312    -    885,069 
                                    
Carrying amounts                                   
December 31, 2021   6,829    22,961    9,775    981    10,420    13,968,566    14,019,532 
December 31, 2022   5,968    20,099    6,843    785    8,335    6,568,841    6,610,871 

 

 F-17 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

6.Property, plant and equipment (Continued)

 

As at December 31, 2022, the Company recorded an impairment of $7,441,293 on mill equipment to its recoverable amount due to the delay in receiving development permit and the lack of available for use in Mexico.

 

 

7.Exploration and evaluation assets

 

               
   Tuligtic   Other Property   Total 
Exploration and evaluation assets  $   $   $ 
Acquisition costs:               
Opening balance - (December 31, 2022)   11,308,721    -    11,308,721 
Additions   -    -    - 
Deductions   -    -    - 
Impairment of acquisition costs   (11,308,720)   -    (11,308,720)
Closing balance - (December 31, 2023)   1    -    1 
Deferred exploration costs:               
Opening balance - (December 31, 2022)   51,806,355    -    51,806,355 
Costs incurred during the year               
Professional/technical fees   159,031    -    159,031 
Geochemical, metallurgy   1,022    -    1,022 
Travel and accommodation   70,324    -    70,324 
Geology, geophysics and exploration   172,455    -    172,455 
Supplies and miscellaneous   318,047    -    318,047 
Environmental and permit   384,421    -    384,421 
Value-added tax (Note 4)   164,189         164,189 
Refund - Value-added tax   (561,086)   -    (561,086)
Impairment of deferred exploration cost   (52,514,758)   -    (52,514,758)
Total deferred exploration costs during the year   (51,806,355)   -    (51,806,355)
Closing balance - (December 31, 2023)   -    -    - 
Total exploration and evaluation assets   1    -    1 

 

During the year ended December 31, 2023, the Company recorded an impairment of acquisition cost of $11,308,720 (2022 - $Nil) and deferred exploration costs of $52,514,758 (2022 - $Nil) with respect to Tuligtic property due to the Mexican government’s action to revoke the Company’s mineral concession title and to prevent any further exploration and development plans on the Tuligtic property.

 

Title to exploration and evaluation assets involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the potential for problems arising from the frequently ambiguous conveyancing history characteristic of many mineral claims.

 

 F-18 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

7.Exploration and evaluation assets (Continued)

 

   Tuligtic   Other Property   Total 
Exploration and evaluation assets  $   $   $ 
Acquisition costs:               
Opening balance - (December 31, 2021)   11,211,756    1    11,211,757 
Additions   96,965    -    96,965 
Deductions   -    (1)   (1)
Closing balance - (December 31, 2022)   11,308,721    -    11,308,721 
Deferred exploration costs:               
Opening balance - (December 31, 2021)   50,219,882    -    50,219,882 
Costs incurred during the year               
Professional/technical fees   143,075    -    143,075 
Claim maintenance/lease costs   169,651    -    169,651 
Geochemical, metallurgy   3,929    -    3,929 
Travel and accommodation   155,195    -    155,195 
Geology, geophysics and exploration   307,712    -    307,712 
Supplies and miscellaneous   310,804    -    310,804 
Environmental and permit   640,541    -    640,541 
Value-added tax (Note 4)   251,775         251,775 
Refund - Value-added tax   (396,209)   -    (396,209)
Total deferred exploration costs during the year   1,586,473    -    1,586,473 
Closing balance - (December 31, 2022)   51,806,355    -    51,806,355 
Total exploration and evaluation assets   63,115,076    -    63,115,076 

 

The following is a description of the Company’s most significant property interests:

 

(a)Tuligtic

 

The Tuligtic property consisted of two mineral concessions which the Company applied for in 2002 and 2008. The mineral concessions were granted in 2003 and 2009, respectively (“the “Concessions”). The Company held a 100% interest in the Concessions subject to a 2.0% NSR royalty held by Almadex Minerals Ltd (‘’Almadex”). The Concessions covered approximately 14,000 Ha, including certain endowed lands of the Ejido Tecoltemi, which comprise approximately 330 Ha. The Concessions are located in Puebla, Mexico and underpinned the discovery made by the Company in 2010, referred to as “Ixtaca”.

 

In 2015, the Ejido Tecoltemi initiated a lawsuit against the Mexican government (President, Congress, Ministry of Economy, Directorate of Mines, Mining Registry Office) asserting that the Mexican mining law is unconstitutional because it fails to include provisions requiring consultation of indigenous communities before granting mineral titles. This lawsuit ultimately came before Mexico’s Supreme Court (“SCJN”), and in early 2022, the SCJN ruled that the Mexican mineral title law is constitutional, but that the Ministry of Economy (“Economia”) should have provided for a consultation procedure with relevant indigenous communities prior to issuing the Concessions to the Company. The SCJN ordered Economia to declare the Concessions ineffective - to revert them to application status - and to conduct indigenous consultation prior to re-issuing them.

 F-19 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

7.Exploration and evaluation assets (Continued)

 

(a)Tuligtic (continued)

 

In July, 2022 the Company announced that Economia notified Almaden that the Concessions were “ineffective”. The Company understood that the mineral title had reverted to application status, and that these applications preserved the mineral rights for Almaden but did not allow the Company to engage in exploration, until such time as Economia completed its court-ordered process to properly issue the Concessions after conducting indigenous consultation in the area covered by the mineral title applications.

 

However, on February 22, 2023, Economia made a submission to Mexican courts seeking to deny the two mineral title applications which were first made by Almaden in 2002 and 2008 (the “Submission”). The Submission claimed that the applications contain technical faults, despite Economia’s previous statements to the contrary and its acceptance of the mineral title applications and grant of the Concessions in 2003 and 2009.

 

This Submission has been reviewed by the Mexican district and appeals courts, which have ruled that the Submission complies with the SCJN ruling. However, the appeals court’s ruling did not address the validity of the Submission and therefore safeguarded the Company’s right to challenge the substance and legality of the Submission through the Mexican Federal Administrative Court (“TFJA”), which the Company has done.

 

The TFJA has granted a definitive injunction to Almaden’s Mexican subsidiary, Minera Gorrión (“MG”), which prevents Economia from releasing the mineral rights covered by the Company’s mineral title applications to third parties while the TFJA trial regarding the substance and legality of the Submission continues.

 

In summary, the rights held by Almaden to the Ixtaca project are now based on two mineral title applications which have been denied by Economia, through its issuance of the Submission. The Company is in the process of disputing this denial through the Mexican Federal Administrative Court.

 

(b)Other Property

 

On May 26, 2022, the Company transferred the 40% carried interest in the Logan property located in the Yukon Territory, Canada to Almadex for a consideration of $1 equal to its carrying value. No gain or loss was recognized in the statement of comprehensive loss.

 

(c)Other

 

Expenditures incurred by the Company in Mexico are subject to Mexican Value added tax (“VAT”). The VAT is included in exploration and evaluation assets as incurred. Under Mexican law, VAT paid can be used in the future to offset amounts resulting from VAT charged on sales. Under certain circumstances and subject to approval from tax authorities, A Company can also apply for an early refund of VAT prior to generating sales. During 2023, the Company received a VAT recovery of $561,086 (2022 - 396,209; $2021 - $506,394) and other income of $173,876 (2022 - $139,313; 2021 - $446,184) related to a VAT refund from prior years which is recorded in interest and other income.

 

 F-20 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

 

8.Gold loan payable and gold in trust

 

The Company has entered into a secured gold loan agreement (“Gold Loan”) with Almadex or the “Lender” pursuant to which Almadex has agreed to loan up to 1,597 ounces of gold bullion to the Company. The approximate value of this gold as at May 14, 2019 was USD$2,072,060 or $2,790,858.

 

Under the terms of the Gold Loan, the Company will be entitled to draw-down the gold in minimum 400 ounce tranches. At any given time, the amount of gold ounces drawn multiplied by the London Bullion Market Association (“LBMA”) AM gold price in US dollars, plus any accrued interest or unpaid fees, shall constitute the Loan Value.

 

The maturity date for the Gold Loan is March 31, 2024, and can be extended by two years at the discretion of the Company (the “Term”). Repayment of the Loan Value shall be made either through delivery of that amount of gold drawn, or through the issuance of common shares of the Company (“Shares”), according to the Lender’s discretion. Mandatory prepayment shall be required in the event that the Company’s Ixtaca gold-silver project located in Puebla State, Mexico (the “Ixtaca Project”) enters into commercial production during the Term, requiring the Company to deliver 100 gold ounces per month to the Lender. In addition, the Company has the right to pre-pay the Loan Value at any time without penalty, in either gold bullion or Shares as chosen by the Lender, and the Lender has the right to convert the Loan Value into Shares at any time during the Term. The conversion rate is equal to 95% of the 5 trading day volume weighted average price of the Share on the Toronto Stock Exchange or an equivalent.

 

The interest rate of the Gold Loan is 10% of the Loan Value per annum, calculated monthly, paid in arrears. Interest payments can either be accrued to the Loan Value, or paid by the Company in cash or gold bullion. A standby fee of 1% per annum, accrued quarterly, will be applied to any undrawn amount on the Gold Loan.

 

In addition, the Company has issued Almadex 500,000 transferable share purchase warrants (“Warrants”), with an exercise price of $1.50 per Share and expiry date of May 14, 2024 as an arrangement fee to cover the administrative costs of setting up the credit facility. These warrants were valued at $50,000 using the Black-Scholes option-pricing model with the following assumptions: expected life of five years, risk-free interest rate of 1.54%, expected dividend yield of 0% and expected volatility of 44.25%.

 

Security for the loan is certain equipment related to the Rock Creek Mill, which is not required for the Ixtaca Project. The Gold Loan includes industry standard provisions in the event of default, material breach and change of control.

 

The Gold Loan was recorded at fair value at inception and is subsequently measured at amortized cost using the effective interest method, recognizing interest expense on an effective yield basis.

 

The Company has determined that the Gold Loan contains multiple derivatives which are embedded in the US dollar denominated debt instrument. As the convertible Gold Loan is denominated in US dollars and is convertible into common shares based upon a variable Canadian dollar conversion rate, the fixed for fixed criteria is not met. As such, the conversion option cannot be classified as an equity instrument and is deemed to have no value. The embedded derivative from indexation of the loan principal portion to the movement in the price of gold is classified as a derivate financial liability and is marked to market at each period end using the Black-Scholes option-pricing model.

 

 F-21 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

8.Gold loan payable and gold in trust (Continued)

 

At inception, the following assumptions were used: expected life of five years, risk-free interest rate of 1.57% and expected volatility of 11.06%. The fair value of the embedded derivative for the year ended December 31, 2023 decreased by $191,732 (December 31, 2022 decreased by $110,177) based on the following assumptions used in the Black-Scholes option-pricing model: expected life of 0.25 years, risk-free interest rate of 4.00% and expected volatility of 9.93% (December 31, 2022, expected life of 1.25 years, risk-free interest rate of 4.00% and expected volatility of 11.57%).

 

The continuity of gold loan payable and derivative financial liabilities are as follows:

 

          
   December 31,
2023
   December 31,
2022
 
Gold loan payable – opening balance  $3,929,015   $3,227,545 
Accrued interest expense   353,372    314,024 
Accrued standby fees   10,377    9,416 
Accretion expense   176,960    144,868 
Foreign exchange difference   (98,178)   233,162 
Gold loan payable  $4,371,546   $3,929,015 
           
Derivative financial liabilities – opening balance  $306,084   $391,620 
Change in fair value through profit & loss   (191,732)   (110,177)
Foreign exchange difference   (5,522)   24,641 
Derivative financial liabilities  $108,830   $306,084 

 

As at December 31, 2023, Almaden has 397 ounces (397 ounces at December 31, 2022) of gold bullion on its account at a fair value of $1,082,801 ($974,397 at December 31, 2022).

 

The continuity of gold in trust are as follows:

 

                    
   December 31, 2023   December 31, 2022 
   Ounces   $   Ounces   $ 
Gold in trust, opening balance   397    974,397    397    915,995 
Sale of gold in trust   -    -    -    - 
Gain on sale   -    -    -    - 
Change in fair value through profit & loss   -    132,895    -    (6,518)
Foreign exchange difference   0    (24,491)   0    64,920 
    397    1,082,801    397    974,397 

 

 

9.Warrant liability

 

In connection with the registered direct offering private placement completed during the year ended December 31, 2021, the Company issued a total of 7,923,077 warrants exercisable at US$0.80 per share. The fair value of these warrants on issuance was $2,371,174, valued using the Black-Scholes option-pricing model with the following assumptions:

 

 F-22 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

9.Warrant liability (Continued)

 

     
  Risk-free interest rate 0.53%  
  Expected life of warrants 3.00 years  
  Expected annualized volatility 72.42%  
  Dividend Nil  
  Forfeiture rate 0%  

 

The fair value is recorded as a derivative financial liability as these warrants are exercisable in US dollars, differing from the Company’s functional currency. The change in fair value resulted in an unrealized gain of $102,787 (December 31, 2022 - $520,503) and is recognized in the consolidated statements of comprehensive loss for the year ended December 31, 2023. The fair value warrants were re-valued at period end using the Black-Scholes option-pricing model with the following assumptions:

 

          
   December 31, 2023   December 31, 2022 
Risk-free interest rate   3.91%   3.99%
Expected life of warrants   0.21 years    1.21 years 
Expected annualized volatility   36.25%   69.83%
Dividend   Nil    Nil 
Forfeiture rate   0%   0%

 

 

10.Share capital and reserves

 

(a)Authorized share capital

 

At December 31, 2023, the authorized share capital comprised an unlimited number of common shares. The common shares do not have a par value. All issued shares are fully paid.

 

(b)Details of private placements and other issues of common shares in 2023, 2022 and 2021

 

On March 18, 2021, the Company closed a registered direct offering private placement for the purchase and sale of 15,846,154 common shares and common share warrants to purchase up to 7,923,077 common shares at a combined purchase price of US$0.65 per unit for aggregate gross proceeds of US$10.3 million (CAD$12,838,950). The common share warrants will be immediately exercisable, have an exercise price of US$0.80 per share and will expire three years from the date of issuance. Share issue costs included a finder’s fee of $834,532 in cash, and finders’ warrants to purchase up to 435,769 common shares at a price of US$0.80 per common share until March 18, 2024. The fair value of the finders’ warrants was $130,731. In connection with the registered direct offering, the Company also incurred $393,837 in share issue costs. These amounts were recorded as a reduction to share capital. The proceeds of the registered direct offering were allocated $10,467,776 to share capital and $2,371,174 to warrants.

 

Share issue costs of $40,990 was recorded for fees paid related to the Short Form Base Shelf Prospectus filed on February 25, 2021.

 

 F-23 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

10.Share capital and reserves (Continued)

 

(c)Warrants

 

The continuity of warrants for the years ended December 31, 2023, 2022 and 2021 are as follows:

 

                              
   Exercise   December 31,               December 31, 
Expiry date  price   2022   Issued   Exercised   Expired   2023 
March 27, 2023   $0.50    5,489,658    -    -    (5,489,658)   - 
August 6, 2023   $0.90    3,100,000    -    -    (3,100,000)   - 
March 18, 2024   USD$0.80    7,923,077    -    -    -    7,923,077 
March 18, 2024   USD$0.80    435,769    -    -    -    435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        17,448,504    -    -    (8,589,658)   8,858,846 
Weighted average exercise price       $0.88    -    -   $0.64   $1.08 

 

The weighted average remaining life of warrants outstanding at December 31, 2023 was 0.22 years (2022 – 0.80 years).

 

   Exercise   December 31,               December 31, 
Expiry date  price   2021   Issued   Exercised   Expired   2022 
June 7, 2022   $1.35    4,720,000    -    -    (4,720,000)   - 
March 27, 2023   $0.50    5,489,658    -    -    -    5,489,658 
August 6, 2023   $0.90    3,100,000    -    -    -    3,100,000 
March 18, 2024   USD$0.80    7,923,077    -    -    -    7,923,077 
March 18, 2024   USD$0.80    435,769    -    -    -    435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        22,168,504    -    -    (4,720,000)   17,448,504 
Weighted average exercise price       $0.95    -    -   $1.35   $0.88 

 

The weighted average remaining life of warrants outstanding at December 31, 2022 was 0.80 years (2021 – 1.51 years).

 

   Exercise   December 31,               December 31, 
Expiry date  price   2020   Issued   Exercised   Expired   2021 
June 7, 2022   $1.35    4,720,000    -    -    -    4,720,000 
March 27, 2023   $0.50    5,489,658    -    -    -    5,489,658 
August 6, 2023   $0.90    3,100,000    -    -    -    3,100,000 
March 18, 2024   USD$0.80    -    7,923,077    -    -    7,923,077 
March 18, 2024   USD$0.80    -    435,769              435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        13,809,658    8,358,846    -    -    22,168,504 
Weighted average exercise price       $0.92   $1.00    -    -   $0.95 

 

The weighted average remaining life of warrants outstanding at December 31, 2021 was 1.51 years (2020 – 2.08 years).

 

 F-24 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

10.Share capital and reserves (Continued)

 

(c)Warrants (Continued)

 

The weighted average fair value of finders’ warrants granted during the years ended December 31, 2023, 2022 and 2021 calculated using the Black-Scholes option-pricing model at the issue dates, are as follows:

 

Weighted average assumptions used

 

           
Number of
warrants
Date of issue Fair value
per share
Risk free
interest
rate

Expected life

(in years)

Expected
volatility
Expected
dividends
435,769 March 18, 2021 $ 0.30 0.53% 3 72.42% $Nil

 

(d)Share purchase option compensation plan

 

The Company’s stock option plan permits the issuance of options up to a maximum of 10% of the Company’s issued share capital. Stock options issued to any consultant or person providing investor relations services cannot exceed 2% of the issued and outstanding common shares in any twelve month period. At December 31, 2023, the Company had reserved 1,217,141 stock options that may be granted. The exercise price of any option cannot be less than the volume weighted average trading price of the shares for the five trading days immediately preceding the date of the grant.

 

The maximum term of all options is five years. The Board of Directors determines the term of the option (to a maximum of five years) and the time during which any option may vest. Options granted to consultants or persons providing investor relations services shall vest in stages with no more than 25% of such option being exercisable in any three month period. All options granted during the years ended December 31, 2023, 2022 and 2021 vested on the grant date.

 

The Company’s stock option plan permits the option holder to exercise cashless by surrendering a portion of the underlying option shares to pay for the exercise price and the corresponding withholding taxes, if applicable.

 

 F-25 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

10.Share capital and reserves (Continued)

 

(d)Share purchase option compensation plan (Continued)

 

The continuity of stock options for the years ended December 31, 2023, 2022 and 2021 are as follows:

 

                              
Expiry date  Exercise
price
   December 31,
2022
   Granted   Exercised   Expired   December 31,
2023
 
February 9, 2023  $0.97    350,000    -    -    (350,000)   - 
March 3, 2023  $0.96    250,000    -    -    (250,000)   - 
March 31, 2023  $0.68    1,975,000    -    -    (1,975,000)   - 
May 8, 2023  $0.69    100,000    -    -    (100,000)   - 
May 28, 2023  $0.65    100,000    -    -    (100,000)   - 
July 8, 2023  $0.62    2,420,000    -    -    (2,420,000)   - 
September 18, 2023  $0.51    960,000    -    -    (960,000)   - 
March 7, 2027  $0.38    1,125,000    -    -    -    1,125,000 
June 10, 2027  $0.33    3,640,000    -    -    -    3,640,000 
October 4, 2027  $0.30    755,000    -    -    -    755,000 
December 16, 2027  $0.33    855,000    -    -    -    855,000 
February 14, 2028  $0.30    -    600,000    -    -    600,000 
April 3, 2028  $0.26    -    1,975,000    -    -    1,975,000 
July 10, 2028  $0.16    -    2,520,000    -    -    2,520,000 
September 19, 2028  $0.18    -    1,035,000    -    -    1,035,000 
Options outstanding and exercisable        12,530,000    6,130,000    -    (6,155,000)   12,505,000 
Weighted average exercise price       $0.49   $0.21    -   $0.66   $0.27 

 

The weighted average remaining life of stock options outstanding at December 31, 2023 was 3.96 years (2022 – 2.53 years).

 F-26 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

10.Share capital and reserves (Continued)

 

(d)Share purchase option compensation plan (Continued)

 

Expiry date  Exercise
price
   December 31,
2021
   Granted   Exercised   Expired   December 31,
2022
 
March 4, 2022  $0.47    1,125,000    -    -    (1,125,000)   - 
April 30, 2022  $0.41    100,000    -    -    (100,000)   - 
April 30, 2022  $0.58    220,000    -    -    (220,000)   - 
May 31, 2022  $0.62    600,000    -    -    (600,000)   - 
June 9, 2022  $0.64    1,980,000    -    -    (1,980,000)   - 
October 3, 2022  $1.13    860,000    -    -    (860,000)   - 
December 15, 2022  $0.89    900,000    -    -    (900,000)   - 
February 9, 2023  $0.97    350,000    -    -    -    350,000 
March 3, 2023  $0.96    250,000    -    -    -    250,000 
March 31, 2023  $0.68    1,975,000    -    -    -    1,975,000 
May 8, 2023  $0.69    100,000    -    -    -    100,000 
May 28, 2023  $0.65    100,000    -    -    -    100,000 
July 8, 2023  $0.62    2,470,000    -    -    (50,000)   2,420,000 
September 18, 2023  $0.51    960,000    -    -    -    960,000 
March 7, 2027  $0.38    -    1,125,000    -    -    1,125,000 
June 10, 2027  $0.33    -    3,640,000    -    -    3,640,000 
October 4, 2027  $0.30    -    755,000    -    -    755,000 
December 16, 2027  $0.33    -    855,000    -    -    855,000 
Options outstanding and exercisable        11,990,000    6,375,000    -    (5,835,000)   12,530,000 
Weighted average exercise price       $0.68   $0.34    -   $0.71   $0.49 

 

The weighted average remaining life of stock options outstanding at December 31, 2022 was 2.53 years (2021 – 0.98 years).

 

 F-27 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

10.Share capital and reserves (Continued)

 

(d)Share purchase option compensation plan (Continued)

 

Expiry date  Exercise
price
   December 31,
2020
   Granted   Exercised   Expired   December 31,
2021
 
February 7, 2021  $1.11    300,000    -    -    (300,000)   - 
February 7, 2021  $0.84    425,000    -    (375,000)   (50,000)   - 
March 29, 2021  $1.08    400,000    -    -    (400,000)   - 
March 29, 2021  $0.90    100,000    -    -    (100,000)   - 
May 6, 2021  $0.69    557,000    -    (275,000)   (282,000)   - 
July 7, 2021  $0.80    1,612,000    -    (75,000)   (1,537,000)   - 
August 13, 2021  $1.01    150,000    -    -    (150,000)   - 
September 16, 2021  $0.90    1,155,000    -    -    (1,155,000)   - 
December 12, 2021  $1.00    200,000    -    -    (200,000)   - 
March 4, 2022  $0.47    1,125,000    -    -    -    1,125,000 
April 30, 2022  $0.41    100,000    -    -    -    100,000 
April 30, 2022  $0.58    220,000    -    -    -    220,000 
May 31, 2022  $0.62    700,000    -    -    (100,000)   600,000 
June 9, 2022  $0.64    2,180,000    -    -    (200,000)   1,980,000 
October 3, 2022  $1.13    1,346,000    -    -    (486,000)   860,000 
December 15, 2022  $0.89    972,000    -    -    (72,000)   900,000 
February 9, 2023  $0.97    -    450,000    -    (100,000)   350,000 
March 3, 2023  $0.96    -    325,000    -    (75,000)   250,000 
March 31, 2023  $0.68    -    1,975,000    -    -    1,975,000 
May 8, 2023  $0.69    -    100,000    -    -    100,000 
May 28, 2023  $0.65    -    100,000    -    -    100,000 
July 8, 2023  $0.62    -    2,470,000    -    -    2,470,000 
September 18, 2023  $0.51    -    960,000    -    -    960,000 
Options outstanding and exercisable        11,542,000    6,380,000    (725,000)   (5,207,000)   11,990,000 
Weighted average exercise price       $0.80   $0.67   $0.78   $0.90   $0.68 

 

The weighted average remaining life of stock options outstanding at December 31, 2021 was 0.98 years (2020 – 1.08 years).

 

 F-28 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

10.Share capital and reserves (Continued)

 

(d)Share purchase option compensation plan (Continued)

 

The fair value of options granted during the years ended December 31, 2023, 2022 and 2021, calculated using the Black-Scholes option-pricing model at grant date, are as follows:

 

                            
Number
of options
   Date of grant  Fair value
per share
   Risk free
interest
rate
   Expected
life
(in years)
   Expected
volatility
   Expected
dividends
1,035,000   September 19, 2023  $0.10    3.96%   5    71.15%  $Nil
2,520,000   July 10, 2023  $0.12    3.81%   5    70.98%  $Nil
1,975,000   April 3, 2023  $0.15    2.87%   5    68.52%  $Nil
600,000   February 13, 2023  $0.18    3.43%   5    68.61%  $Nil
855,000   December 16, 2022  $0.19    3.07%   5    66.04%  $Nil
755,000   October 4, 2022  $0.22    3.42%   5    82.02%  $Nil
3,640,000   June 10, 2022  $0.22    3.38%   5    82.61%  $Nil
1,125,000   March 7, 2022  $0.31    1.65%   5    85.37%  $Nil
960,000   September 17, 2021  $0.23    0.45%   2    82.96%  $Nil
2,470,000   July 8, 2021  $0.25    0.45%   2    84.98%  $Nil
100,000   May 28, 2021  $0.30    0.32%   2    86.03%  $Nil
100,000   May 7, 2021  $0.30    0.33%   2    86.33%  $Nil
1,975,000   March 31, 2021  $0.31    0.22%   2    85.85%  $Nil
325,000   March 2, 2021  $0.43    0.26%   2    85.48%  $Nil
450,000   February 9, 2021  $0.49    0.19%   2    84.04%  $Nil

 

Total share-based payments expenses as a result of options granted and vested during the year ended December 31, 2023 was $810,150 (2022 - $1,478,100; 2021 - $1,870,800).

 

11.Related party transactions and balances

 

(a)Compensation of key management personnel

 

Key management includes members of the Board, the Chair, the President and Chief Executive Officer, the Chief Financial Officer, the Executive Vice President, and the Vice President, Project Development. The net aggregate compensation paid or payable to key management for services after recovery from Azucar Minerals Ltd. (Azucar) and Almadex (Note 11 (b)) is as follows:

 

               
   December 31,   December 31,   December 31, 
   2023   2022   2021 
             
Professional fees  $50,588   $60,000   $60,000 
Salaries and benefits   398,307 (3)   484,435 (2)   450,522 (1)
Share-based payments   702,000    1,212,300    1,551,850 
Directors’ fees   140,000    145,000    102,500 
 Total  $1,290,895   $1,901,735   $2,164,872 

 

 F-29 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

11.Related party transactions and balances (Continued)

 

(a)Compensation of key management personnel (Continued)

 

 (1)As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.
 (2)As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.
 (3)As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.

 

(b)Administrative Services Agreements

 

The Company recovers a portion of rent, office and license expenses from Azucar pursuant to an Administrative Services Agreement dated May 15, 2015 and First Amending Agreement dated December 16, 2015 between the Company and Azucar.

 

The Company also recovers a portion of rent, office and license expenses from Almadex pursuant to an Administrative Services Agreement dated March 29, 2018 between the Company and Almadex.

 

During the year ended December 31, 2023, the Company received $75,853 (2022 - $185,068; 2021 - $412,812) from Azucar for administrative services fees included in other income and received $1,346,494 (2022 - $1,191,360; 2021 - $969,532) from Almadex for administrative services fees included in other income.

 

At December 31, 2023, included in accounts receivable is $7,005 (2022 - $64,006) due from Azucar and $369,045 (2022 - $117,044) due from Almadex in relation to expense recoveries.

 

Under the Administrative Services Agreements, the Company is the sole and exclusive manager of Azucar and Almadex that provides general management services, office space, executive personnel, human resources, geological technical support, accounting and financial services at cost with no mark-up or additional direct charge. The three companies are considered related parties though common officers.

 

(c)Other related party transactions

 

At December 31, 2023, the Company accrued $Nil (2022 - $80,727) payable to Almadex for exploration and drilling services in Mexico.

 

During the year ended December 31, 2023, the Company employed the Chair’s daughter for a salary of $45,300 less statutory deductions (2022 - $48,800; 2021 - $41,300) for marketing and administrative services provided to the Company.

 

 F-30 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

 

12.Net loss per share

 

Basic and diluted net loss per share

 

The calculation of basic net loss per share for the year ended December 31, 2023 was based on the loss attributable to common shareholders of $63,620,232 (2022 - $11,846,560; 2021 - $2,668,254) and a weighted average number of common shares outstanding of 137,221,408 (2022 - 137,221,408; 2021 – 133,842,894).

 

The calculation of diluted net loss per share for the year ended December 31, 2023, 2022 and 2021 did not include the effect of stock options and warrants, as they were considered to be anti-dilutive.

 

13.Supplemental cash flow information

 

Supplemental information regarding non-cash transactions is as follows:

 

               
Investing and financing activities  December 31,
2023
   December 31,
2022
   December 31,
2021
 
             
Exploration and evaluation assets expenditures included in trade and other payables   -   $90,850   $89,203 
Right-of-use assets   -    -    (508,799)
Warrant liability   -    -    2,371,174 
Fair value of finders’ warrants   -    -    130,731 
Lease liabilities   -    -    508,799 
Fair value of cash stock options transferred to share capital on exercise of options   -    -    177,250 
                

 

Supplemental information regarding the split between cash and cash equivalents is as follows:

 

          
   December 31,
2023
   December 31,
2022
 
         
Cash  $1,658,863   $1,542,956 
Term Deposits   2,587,120    5,115,120 
 Total cash and cash equivalents  $4,245,983   $6,658,076 

 

 

14.Income Taxes

 

(a)The provision for income taxes differs from the amounts computed by applying the Canadian statutory rates to the net loss before income taxes due to the following:

 

 F-31 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

14.Income Taxes (Continued)

 

               
   December 31,
2023
   December 31,
2022
   December 31,
2021
 
Loss before income taxes  $(66,710,410)  $(10,505,375)  $(2,354,113)
Statutory rate   27.00%   27.00%   27.00%
                
Expected income tax   (18,011,811)   (2,836,451)   (635,611)
Effect of different tax rates in foreign jurisdictions   (2,005,959)   (83,891)   5,281 
Non-deductible share-based payments   218,741    399,087    505,116 
Other permanent items   2,484,720    1,838,169    (620,413)
Change in deferred tax assets not recognized   15,403,428    2,471,723    733,447 
Share issuance costs   -    -    (331,660)
True-ups and other   (1,179,327)   (447,452)   657,981 
Deferred income tax (recovery) expense  $(3,090,208)  $1,341,185   $314,141 

 

(b)The Company’s deferred income tax liability relates to the Mexican income tax and Special Mining Duty (“SMD”) associated with the Tuligtic project.

 

The significant components of deferred income tax assets (liabilities) are as follows:

 

          
   December 31,
2023
   December 31,
2022
 
         
Deferred tax assets          
Non-capital losses  $-   $2,477,570 
Exploration and evaluation assets   1,434,880    - 
    1,434,880    2,477,570 
Deferred tax liabilities          
Exploration and evaluation assets   (1,434,880)   (5,567,778)
           
Net deferred tax liabilities  $-   $(3,090,208)

 

(c)Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:

 

          
   December 31,
2023
   December 31,
2022
 
         
Non-capital loss carry forwards  $32,616,394   $25,487,951 
Capital loss carry forwards   23,360,422    24,538,993 
Exploration and evaluation assets   39,102,815    8,188,922 
Share issue costs   551,134    858,548 
Property, plant and equipment   7,748,032    7,782,024 
Donations   32,960    32,960 
Investment tax credit   223,873    223,873 
   $103,635,630   $67,113,271 

 

 

 F-32 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

14.Income Taxes (Continued)

 

At December 31, 2023, the Company had operating loss carry forwards available for tax purposes in Canada of $27,592,166 (2022 - $25,487,951) which expire between 2032 and 2043 and in Mexico of $4,588,699 (2022 - $Nil) which expire between 2024 and 2026.

 

15.Financial instruments

 

The fair values of the Company’s cash and cash equivalents, accounts receivable and trade and other payables approximate their carrying values because of the short-term nature of these instruments.

 

Except for warrant liability and derivative financial liabilities, the Company does not carry any financial instruments at FVTPL.

 

The Company is exposed to certain financial risks, including currency risk, credit risk, liquidity risk, interest rate risk and commodity and equity price risk.

 

(a)Currency risk

 

The Company’s property interests in Mexico make it subject to foreign currency fluctuations and inflationary pressures which may adversely affect the Company’s financial position, results of operations and cash flows. The Company is affected by changes in exchange rates between the Canadian dollar, the US dollar and the Mexican peso. The Company does not invest in foreign currency contracts to mitigate the risks.

 

As at December 31, 2023, the Company is exposed to foreign exchange risk through the following monetary assets and liabilities denominated in currencies other than the functional currency of the applicable subsidiary:

 

          
All amounts in Canadian dollars  US dollar   Mexican peso 
Cash and cash equivalents  $2,343,681   $458,149 
Accounts receivable and prepaid expenses   4,703    113 
Gold in trust   1,082,801    - 
Total assets  $3,431,185   $458,262 
           
Trade and other payables  $53,348   $14,087 
Gold loan payable   4,371,546    - 
Derivative financial liabilities   108,830    - 
Total liabilities  $4,533,724   $14,087 
           
Net assets  $(1,102,539)  $444,175 

 

A 10% change in the US dollar exchange rate relative to the Canadian dollar would change the Company’s net loss by $110,000.

 

 F-33 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

15.Financial instruments (Continued)

 

(a)Currency risk (Continued)

 

A 10% change in the Mexican peso relative to the Canadian dollar would change the Company’s net loss by $44,000.

 

(b)Credit risk

 

The Company’s cash and cash equivalents are held in large financial institutions, located in both Canada and Mexico. Cash equivalents mature at less than ninety days during the twelve months following the statement of financial position date. The Company’s accounts receivable consist of amounts due from related parties which are subsequently collected.

 

To mitigate exposure to credit risk on cash and cash equivalents, the Company has established policies to limit the concentration of credit risk with any given banking institution where the funds are held, to ensure counterparties demonstrate minimum acceptable credit risk worthiness and ensure liquidity of available funds.

 

As at December 31, 2023, the Company’s maximum exposure to credit risk is the carrying value of its cash and cash equivalents, and accounts receivable.

 

(c)Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company manages liquidity risk through the management of its capital structure. Liquidity risk is considered low as the Company has sufficient cash and cash equivalent to meet its current liabilities.

 

Trade and other payables are due within twelve months of the statement of financial position date.

 

(d)Interest rate risk

 

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to varying interest rates on cash and cash equivalents. The Company has no debt bearing variable interest rate.

 

A 1% change in the interest rate would change the Company’s net loss by $42,000.

 

(e)Commodity and equity price risk

 

The ability of the Company to explore its exploration and evaluation assets and the future profitability of the Company are directly related to the market price of gold and other precious metals. The Company monitors gold prices to determine the appropriate course of action to be taken by the Company. Equity price risk is defined as the potential adverse impact on the Company’s performance due to movements in individual equity prices or general movements in the level of the stock market.

 

 F-34 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

15.Financial instruments (Continued)

 

(e)Commodity and equity price risk (Continued)

 

A 1% change in the commodity price would change the Company’s net loss by $11,000.

 

(f)Classification of financial instruments

 

IFRS 13 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value as follows:

 

Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities;

 

Level 2 – inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and

 

Level 3 – inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

The following table sets forth the Company’s financial assets and liabilities measured at fair value by level within the fair value hierarchy.

 

                    
   Level 1   Level 2   Level 3   Total 
    $    $    $    $ 
Derivative financial liabilities   -    108,830    -    108,830 

 

 

16.Management of capital

 

The Company considers its capital to consist of components of equity. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the exploration of its exploration and evaluation assets and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk.

 

The Company considers its capital to consist of components of equity. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the exploration of its exploration and evaluation assets and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk.

 

The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares and, acquire or dispose of assets.

 

In order to maximize ongoing exploration efforts, the Company does not pay out dividends. The Company’s investment policy is to invest its short-term excess cash in highly liquid short-term interest-bearing investments with short term maturities, selected with regards to the expected timing of expenditures from continuing operations.

 

 F-35 

Almaden Minerals Ltd.
Notes to the consolidated financial statements
For the years ended December 31, 2023, 2022 and 2021
Expressed in Canadian dollars

 

16.Management of capital (Continued)

 

The Company expects its current capital resources will be sufficient to carry its exploration plans and operations for the foreseeable future. There were no changes to the Company’s approach to the management of capital during the period. The Company has no externally imposed capital requirements.

 

 

17.Segmented information

 

The Company operates in one reportable operating segment, being the acquisition and exploration of mineral resource properties.

 

The Company’s non-current assets are located in the following geographic locations:

 

          
   December 31,
2023
   December 31,
2022
 
Canada  $361,967   $472,435 
United States   6,568,840    6,568,840 
Mexico   1,533    63,116,991 
   $6,932,340   $70,158,266 

 

 

18.Subsequent event

 

On March 12, 2024, the Company provided notice to Almadex that it is extending the maturity date from March 31, 2024 to March 31, 2026 pursuant to the Gold Loan.

 

 

 

 

 

 

 

F-36

 

EX-1 2 exh_1.htm EXHIBIT 1

Exhibit 1

 

 

 

EX-8 3 exh_8.htm EXHIBIT 8

Exhibit 8

 

Almaden Minerals Ltd.

Organization Chart December 31, 2023

 

EX-12.1 4 exh_121.htm EXHIBIT 12.1

Exhibit 12.1

 

SECTION 302 OF THE SARBANES-OXLEY ACT

CEO CERTIFICATION
 

I, Morgan Poliquin, certify that:

 

1.I have reviewed this annual report on Form 20-F of Almaden Minerals Ltd.;

 

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

4.           The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

(a)        Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)        Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)         Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)       Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

5.           The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

 

(a)           All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

(b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

Date: April 26, 2024 /s/Morgan Poliquin
   
  Morgan Poliquin
  Chief Executive Officer

 

EX-12.2 5 exh_122.htm EXHIBIT 12.2

Exhibit 12.2

 

SECTION 302 OF THE SARBANES-OXLEY ACT

CFO CERTIFICATION
 

I, Korm Trieu, certify that:

 

1.I have reviewed this annual report on Form 20-F of Almaden Minerals Ltd.;

 

2.           Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

 

4.           The Company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Company and have:

 

(a)        Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)        Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)         Evaluated the effectiveness of the Company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)         Disclosed in this report any change in the Company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting; and

 

5.           The Company’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company’s auditors and the audit committee of the Company’s board of directors (or persons performing the equivalent functions):

 

(a)         All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company’s ability to record, process, summarize and report financial information; and

 

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting.

 

Dated: April 26, 2024  /s/Korm Trieu
  Korm Trieu
  Chief Financial Officer

 

EX-13.1 6 exh_131.htm EXHIBIT 13.1

Exhibit 13.1

 

SECTION 906 OF THE SARBANES-OXLEY ACT

CEO CERTIFICATION

 

In connection with the annual report of Almaden Minerals Ltd. (the “Company”) on Form 20-F for the fiscal year ending December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Morgan Poliquin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

 1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
   
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/”Morgan Poliquin”

 

Name: Morgan Poliquin

Title: Chief Executive Officer

April 26, 2024

 

 

 

EX-13.2 7 exh_132.htm EXHIBIT 13.2

Exhibit 13.2

 

SECTION 906 OF THE SARBANES-OXLEY ACT

CFO CERTIFICATION

 

In connection with the annual report of Almaden Minerals Ltd. (the “Company”) on Form 20-F for the fiscal year ending December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Korm Trieu, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

 1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
   
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/”Korm Trieu”

 

Name: Korm Trieu

Title: Chief Financial Officer

April 26, 2024

 

 

 

EX-101.SCH 8 aau-20231231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated statements of financial position link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated statements of comprehensive loss link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated statements of cash flows link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated statements of changes in equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Disclosure - Nature of operations link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Basis of presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Material accounting policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Accounts receivable and prepaid expenses link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Right-of-use assets and lease liabilities link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property, plant and equipment link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Exploration and evaluation assets link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Gold loan payable and gold in trust link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Warrant liability link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Share capital and reserves link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Related party transactions and balances link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Net loss per share link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Supplemental cash flow information link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Financial instruments link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Management of capital link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Segmented information link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Subsequent event link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Material accounting policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Material accounting policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Accounts receivable and prepaid expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Right-of-use assets and lease liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Property, plant and equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Exploration and evaluation assets (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Gold loan payable and gold in trust (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Warrant liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Share capital and reserves (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Related party transactions and balances (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Supplemental cash flow information (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Financial instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Segmented information (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Nature of operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Material accounting policies (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Material accounting policies (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Accounts receivable and prepaid expenses (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Accounts receivable and prepaid expenses (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Right-of-use assets and lease liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Right-of-use assets and lease liabilities (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Right-of-use assets and lease liabilities (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Right-of-use assets and lease liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Property, plant and equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Property, plant and equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - Exploration and evaluation assets (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Exploration and evaluation assets (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Gold loan payable and gold in trust (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - Gold loan payable and gold in trust (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - Gold loan payable and gold in trust (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Warrant liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Warrant liability (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Warrant liability (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Share capital and reserves (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - Share capital and reserves (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Share capital and reserves (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - Share capital and reserves (Details 3) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - Share capital and reserves (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - Related party transactions and balances (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - Related party transactions and balances (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - Net loss per share (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - Supplemental cash flow information (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - Supplemental cash flow information (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - Income Taxes (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - Income Taxes (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - Income Taxes (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - Financial instruments (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - Financial instruments (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - Financial instruments (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - Segmented information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 aau-20231231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 aau-20231231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 aau-20231231_lab.xml XBRL LABEL FILE Entity Addresses, Address Type [Axis] Business Contact [Member] Components of equity [axis] Issued capital [member] Reserve of share-based payments [member] Warrants [member] Total Reserves [Member] Deficit [Member] Legal Entity [Axis] Puebla Holdings Inc. [Member] Minera Gorrion, S.A. de C.V. [Member] Classes of property, plant and equipment [axis] Furniture, fixtures and fittings [member] Computer equipment [member] Geological library [member] Field equipment [member] Mill Equipment [Member] Categories of related parties [axis] Tuligtic Project [Member] Maturity [axis] Not later than one year [member] Later than one year and not later than two years [member] Later than two years and not later than three years [member] Later than three years and not later than four years [member] Later than four years and not later than five years [member] Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] Gross carrying amount [member] Classes of intangible assets other than goodwill [axis] Computer software [member] Accumulated depreciation, amortisation and impairment [member] Tuligtic [Member] Other property, plant and equipment [member] Logan Property Located In The Yukon Territory Canada [Member] Borrowings by name [axis] Gold Loan [Member] Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis] Gold Loan Derivative Instruments [Member] Classes of financial instruments [axis] Derivative Financial Liability [Member] Warrants Expiry [Member] Warrants Expiry One [Member] Warrants Expiry Two [Member] Warrants Expiry Three [Member] Warrants Expiry Four [Member] Warrants Expiry Five [Member] Warrants Issued On March 182021 [Member] Stock Options Expiry Date February 09, 2023 [Member] Stock Options Expiry Date March 3, 2023 [Member] Stock Options Expiry Date March 31, 2023 [Member] Stock Option Expiry Date May 8, 2023 [Member] Stock Option Expiry Date May 28, 2023 [Member] Stock Option Expiry Date July 8, 2023 [Member] Stock Options Expiry Date September 18, 2023 [Member] Stock Options Expiry Date March 7, 2027 [Member] Stock Options Expiry Date June 10, 2027 [Member] Stock Options Expiry Date October 4, 2027 [Member] Stock Options Expiry Date December 16, 2027 [Member] Stock Options Expiry Date February 14, 2028 [Member] Stock Options Expiry Date April 3, 2028 [Member] Stock Options Expiry Date July 10, 2028 [Member] Stock Options Expiry Date September 19, 2028 [Member] Stock Options Expiry Date March 4, 2022 [Member] Stock Options Expiry Date April 30, 2022 [Member] Stock Options Expiry Date April 30, 2022 [Member] Stock Options Expiry Date May 31, 2022 [Member] Stock Options Expiry Date June 9, 2022 [Member] Stock Options Expiry Date October 3, 2022 [Member] Stock Options Expiry Date December 15, 2022 [Member] Stock Options Expiry Date February 7, 2021 [Member] Stock Options Expiry Date February 7, 2021 [Member] Stock Options Expiry Date March 29, 2021 [Member] Stock Options Expiry Date March 29, 2021 [Member] Stock Options Expiry Date May 6, 2021 [Member] Stock Options Expiry Date July 7, 2021 [Member] Stock Options Expiry Date August 13, 2021 [Member] Stock Options Expiry Date September 16, 2021 [Member] Stock Options Expiry Date December 12, 2021 [Member] Grant One [Member] Grant Two [Member] Grant Three [Member] Grant Four [Member] Grant Five [Member] Grant Six [Member] Grant Seven [Member] Grant Eight [Member] Grant Nine [Member] Grant Ten [Member] Grant Eleven [Member] Grant Twelve [Member] Grant Thirteen [Member] Grant Fourteen [Member] Grant Fifteen [Member] Azucar [Member] Almadex [Member] Drill Equipment [Member] Chairmans Daughter [Member] Temporary difference, unused tax losses and unused tax credits [axis] Noncapital Loss Carry Forwards [Member] Capital Loss Carry Forwards [Member] Exploration and Evaluation Assets [Member] Share Issue Costs [Member] Property, Plant and Equipment [Member] Donations [Member] Investment Tax Credit [Member] Geographical [Axis] Country Of Canada [Member] Country Of Mexico [Member] Levels of fair value hierarchy [axis] Level 1 of fair value hierarchy [member] Level 2 of fair value hierarchy [member] Level 3 of fair value hierarchy [member] Country Of United States [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name Contact Personnel Email Address ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Auditor Name Auditor Location Auditor Firm ID Statement of financial position [abstract] ASSETS Current assets Cash and cash equivalents (Note 13) Gold in trust (Note 8) Accounts receivable and prepaid expenses (Note 4) Total current assets Non-current assets Right-of-use assets (Note 5) Property, plant and equipment (Note 6) Exploration and evaluation assets (Note 7) Total non current assets TOTAL ASSETS LIABILITIES Current liabilities Trade and other payables (Note 11 (a)) Current portion of lease liabilities (Note 5) Total current liabilities Non-current liabilities Long-term portion of lease liabilities (Note 5) Gold loan payable (Note 8) Warrant liability (Note 9) Derivative financial liabilities (Note 8) Deferred income tax liability (Note 14) Total non current liabilities Total liabilities EQUITY Share capital (Note 10) Reserves (Note 10) Deficit Total equity TOTAL EQUITY AND LIABILITIES Profit or loss [abstract] Expenses Professional fees (Note 11(a)) Salaries and benefits (Note 11(a)) Travel and promotion Depreciation (Note 6) Office and other (Note 11(b)) Amortization of right-of-use assets (Note 5) Occupancy expenses (Note 5) Interest expense on lease liabilities (Note 5) Interest, accretion and standby fees on gold loan payable (Note 8) Listing and filing fees Insurance Directors’ fees (Note 11(a)) Share-based payments (Note 10(d) and 11(a)) Total Expenses Other income (loss) Administrative services fees (Note 11(b)) Interest and other income Impairment of property, plant and equipment (Note 6) Impairment of exploration and evaluation assets (Note 7) Unrealized gain (loss) on derivative financial liabilities (Note 8) Unrealized gain (loss) on gold in trust (Note 8) Unrealized foreign exchange gain (loss) on gold loan payable (Note 8) Unrealized foreign exchange gain (loss) on gold in trust (Note 8) Unrealized gain on warrant liability (Note 9) Gain on debt forgiveness (Note 11(a)) Foreign exchange gain (loss) Total other income (loss)  Loss before income taxes Deferred income tax recovery (expense) (Note 14) Net loss for the year Total comprehensive loss for the year Basic net loss per share Diluted net loss per share Statement of cash flows [abstract] Operating activities Net loss for the year Items not affecting cash Deferred income tax (recovery) expense Depreciation Amortization of right-of-use assets Impairment of property, plant and equipment Impairment of exploration and evaluation assets Interest expenses on lease liability Interest, accretion and standby fees on gold loan payable Unrealized (gain) loss on derivative financial liabilities Unrealized (gain) loss on gold in trust Unrealized foreign exchange (gain) loss on gold loan payable Unrealized foreign exchange (gain) loss on gold in trust Unrealized gain on warrant liability Share-based payments Changes in non-cash working capital components Accounts receivable and prepaid expenses Trade and other payables Net cash used in operating activities Investing activities Property, plant and equipment – purchase Exploration and evaluation assets – costs Net cash used in investing activities Financing activities Issuance of shares, net of share issue costs Options exercised Repayment of lease liabilities Net cash from (used in) financing activities Change in cash and cash equivalents Cash and cash equivalents, beginning of year Cash and cash equivalents, end of year Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Beginning balance, value Beginning balance, shares Share-based payments Private placements, net of share issue costs Private placements, net of share issue costs, shares Warrant liability Finders’ warrants issued pursuant to private placement Shares issued for cash on exercise of stock options Shares issued for cash on exercise of stock options, shares Fair value of cash stock options transferred to share capital Total comprehensive loss for the year Ending balance, value Ending balance, shares Notes and other explanatory information [abstract] Nature of operations Basis Of Presentation Basis of presentation Material Accounting Policies Material accounting policies Accounts Receivable And Prepaid Expenses Accounts receivable and prepaid expenses Right-of-use Assets And Lease Liabilities Right-of-use assets and lease liabilities Property Plant And Equipment Property, plant and equipment Exploration and evaluation assets Gold loan payable and gold in trust Warrant Liability Warrant liability Share capital and reserves Related Party Transactions And Balances Related party transactions and balances Net loss per share Supplemental Cash Flow Information Supplemental cash flow information Income Taxes Income Taxes Financial instruments Management of capital Segmented Information Segmented information Subsequent event Basis of consolidation Foreign currencies Financial instruments Cash and cash equivalents Property, plant and equipment Exploration and evaluation assets Impairment of property, plant and equipment Income taxes Share-based payments Share capital Reclamation and closure cost obligations Net loss per share Leases Standards issued or amended but not yet effective Schedule of consolidated financial statements Schedule of property, plant and equipment Schedule of accounts receivable and prepaid expenses Schedule of continuity of lease liabilities Schedule of continuity of ROU assets Schedule of remaining payments for the operating lease Schedule of property, plant and equipment Schedule of exploration and evaluation assets Schedule of gold loan payable Schedule of gold in trust Schedule of warrant assumptions Schedule of derivative financial liability Schedule of Continuity of Warrants Schedule of -Warrant Fair Value Assumptions Schedule of Share options Schedule of share option fair value assumptions Schedule of related party payments Schedule of supplemental information Schedule of supplemental information of cash and cash equivalents Schedule of deferred income taxes Schedule of deferred tax assets and liabilities Schedule of deductible temporary differences Schedule of assets and liabilities Schedule of assets and liabilities at fair value Schedule of non-current Assets Working capital surplus Net loss Negative cash flows from operations Accumulated deficit Statement [Table] Entity name Jurisdiction Nature of operations Disclosure of detailed information about property, plant and equipment [table] Property, plant and equipment Property, plant and equipment Accounts receivable (Note 11(b)) Prepaid expenses  Total Disclosure of transactions between related parties [table] Value added tax receivables Opening balance Less: lease payments Interest expense Ending balance Less: current portion of lease liabilities Long-term portion of lease liabilities Opening balance Less: amortization of ROU assets Ending balance Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table] Remaining payments for office lease Increase in lease liability Operating sublease income Occupancy expense Disclosure of reconciliation of changes in goodwill [table] Balance at beginning, cost Additions/reduction (1) Impairment of property, plant and equipment Balance at ending, cost Balance at beginning, accumulated depreciation Depreciation Balance at ending, accumulated depreciation Carrying amounts Impairment on mill equipment Opening balance Additions Deductions Impairment of acquisition costs Closing balance Opening balance Professional/technical fees Claim maintenance/lease costs Geochemical, metallurgy Travel and accommodation Geology, geophysics and exploration Supplies and miscellaneous Environmental and permit Value-added tax (Note 4) Refund - Value-added tax Impairment of deferred exploration cost Total deferred exploration costs during the year Closing balance Total exploration and evaluation assets Impairment of acquisition costs Impairment of deferred exploration cost Proportion of ownership interest in associate Carrying value of property VAT recovery VAT refund from prior years Disclosure of detailed information about borrowings [table] Gold loan payable, beginning balance Accrued interest expense Accrued standby fees Accretion expense Foreign exchange difference Gold loan payable, ending balance Derivative financial liabilities, beginning balance Change in fair value through profit & loss Foreign exchange difference Derivative financial liabilities, ending balance Gold in trust, beginning balance, ounces Gold in trust, amount Sale of gold in trust, ounces Sale of gold in trust, amount Gain on sale, amount Change in fair value through profit & loss, amount Foreign exchange difference, amount Gold in trust, ending balance, ounces Gold in trust, amount Loan payable, ounces, loaned to company Borrowings, metals, noncurrent Loan payable, extension period (Year) Loan payable, gold delivery payments per month, ounces Borrowings, interest rate Borrowings, standby fee Number of warrants issued (in shares) Warrants, exercise price (in CAD per share) Warrants, fair value Warrants, valuation assumptions, expected life (Year) Risk free interest rate, warrants granted Expected dividend, warrants granted Description of expected volatility warrants granted Deriviative liability, assumptions, expected life (Year) Derivative liability, assumptions, risk-free interest rate Derivative liability, assumptions, expected volatility Net gains (losses) on change in fair value of derivatives Loans payable, ounces of gold Trust assets, metals Disclosure of detailed information about financial instruments [table] Risk free interest rate Expected life of warrants Expected annualized volatility Forfeiture rate Expected life of warrants (in years) Warrants exercisable Warrants exercisable share price Fair value of warrants Change in fair value of derivative financial liability Expiry date Exercise price Balance Issued Exercised Issued Balance Balance, outstanding and exercisable Issued, outstanding and exercisable (in shares) Exercised, outstanding and exercisable (in shares) Expired, outstanding and exercisable (in shares) Balance, oustanding and exercisable Balance, weighted average exercise price Issued, weighted average exercise price Exercised, weighted average exercise price Expired, weighted average exercise price Balance, weighted average exercise price Number of warrants Fair value per share Risk free interest rate Expected life (Year) Expected volatility Stock Options, exercise price Stock options, balance Stock options, granted Stock options, exercised Stock options, expired Stock options, balance Stock options, balance, outstanding and exercisable (in shares) Stock options, granted, outstanding and exercisable (in shares) Stock options, exercised, outstanding and exercisable (in shares) Options outstanding and exercisable, expired (in shares) Stock options, balance, outstanding and exercisable (in shares) Stock options, balance, weighted average exercise price Weighted average exercise price, granted Stock options, exercised, weighted average exercise price Weighted average exercise price, expired Stock options, balance, weighted average exercise price Fair value per share, stock options (in CAD per share) Risk free interest rate, stock options Expected life, stock options Expected volatility, stock options Weighted average remaining contractual life of outstanding warrants (Year) Stock options issuance limitations, maximum percentage of allowed issuable options Stock options issuance limitations, maximum percentage of allowed issuable options for services rendered Number of shares authorised (in shares) Stock option limitations, maximum amount of stock options exercisable during a 3 month period Weighted average remaining contractual life of outstanding share options (Year) Expense from share-based payment transactions with employees Professional fees Salaries and benefits Share-based payments Directors’ fees  Total Administrative services fees included in other income Amounts receivable, related party transactions Outstanding commitments made on behalf of entity, related party transactions Related party, salary contracted Profit loss Weighted average number of ordinary shares outstanding (in shares) Exploration and evaluation assets expenditures included in trade and other payables Right-of-use assets Warrant liability Fair value of finders’ warrants Lease liabilities Fair value of cash stock options transferred to share capital on exercise of options Cash Term Deposits  Total cash and cash equivalents Loss before income taxes Statutory rate Expected income tax Effect of different tax rates in foreign jurisdictions Non-deductible share-based payments Other permanent items Change in deferred tax assets not recognized Share issuance costs True-ups and other Deferred income tax (recovery) expense Non-capital losses Exploration and evaluation assets, deferred tax assets Deferred tax assets Exploration and evaluation assets, deferred tax liabilities Net deferred tax liabilities Disclosure of temporary difference, unused tax losses and unused tax credits [table] Deductible temporary differences Operating loss carryforwards Cash and cash equivalents Accounts receivable and prepaid expenses Gold in trust Total assets Trade and other payables Gold loan payable Derivatives financial liabilities Total liabilities Net assets Disclosure of fair value measurement of assets [table] Derivative financial liabilities Possible effect of 10% change in exchange rate regarding the USD to the net income (loss) Possible effect of 10% change in exchange rate regarding the MXN to the net income (loss) Possible effect of 1% change in the interest rate to the net income (loss) Possible effect of 1% change in the commodity price to the net income (loss) Non-current assets The number of equity shares outstanding. This member stands for a class of property, plant and equipment representing furniture, fixtures and fittings that are not permanently attached to real property. This member stands for a class of plant, property and equipment representing a geological library. This member stands for a class of plant, property and equipment representing field equipment. The total cash outflow for payments of lease liabilities. Stock Options Expiry Date April 30, 2022 [Member] [Default Label] Stock Options Expiry Date February 7, 2021 [Member] [Default Label] Stock Options Expiry Date March 29, 2021 [Member] [Default Label] Current assets [Default Label] Non-current assets [Default Label] Assets Current liabilities [Default Label] Non-current liabilities [Default Label] Liabilities Equity Equity and liabilities Expenses, by nature OtherIncomeLoss Profit (loss) before tax UnrealizedGainOnWarrantLiability Cash flows from (used in) operating activities Purchase of property, plant and equipment, classified as investing activities Purchase of exploration and evaluation assets Cash flows from (used in) investing activities Payments of lease liabilities, classified as financing activities Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents after effect of exchange rate changes aau_EquitySharesOutstanding DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock WarrantlibilityTextBlock DisclosureOfIncomeTaxesExplanatory Description of accounting policy for financial instruments [text block] Description of accounting policy for property, plant and equipment [text block] Description of accounting policy for exploration and evaluation expenditures [text block] Description of accounting policy for impairment of assets [text block] Description of accounting policy for share-based payment transactions [text block] Description of accounting policy for earnings per share [text block] Disclosure of detailed information about property, plant and equipment [text block] NatureOfOperation Depreciation rate, property, plant and equipment Description of useful life, property, plant and equipment Lease liabilities [Default Label] Less: lease payments PropertyPlantAndEquipmentCost Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment PropertyPlantAndEquipmentAccumulatedDepreciation Depreciation, property, plant and equipment ExplorationAndEvaluationAssetsTransactionCosts ExplorationAndEvaluationAssetsDeferredExplorationCosts BorrowingsMetalNoncurrent Derivative financial liabilities GainsLossesOnChangesInFairValueOfDerivatives DerivativeLiabilitiesForeignExchangeDifferences Number of other equity instruments outstanding in share-based payment arrangement Number of other equity instruments exercised or vested in share-based payment arrangement Number of other equity instruments expired in share-based payment arrangement Number of other equity instruments exercisable in share-based payment arrangement WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement Number of share options outstanding in share-based payment arrangement Number of share options exercised in share-based payment arrangement Number of share options expired in share-based payment arrangement NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement AmountOfSharebasedPayments IncreaseDecreaseInWarrantLiability Cash equivalents AccountsReceivableAndPrepaidExpenses Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts EX-101.PRE 12 aau-20231231_pre.xml XBRL PRESENTATION FILE GRAPHIC 13 fig1.jpg GRAPHIC begin 644 fig1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" && ?L# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#[\^'_ (6T MOQ-J?CBYU6U^WSQ^(KF%'FD=BL:QQ;5'/ &3P/6IO&MQ\*OAS+8Q>)[K2=#F MOM_V6.\N"CS[,%R@SD[=RYQTR*T/A'_Q\>//^QGNO_1<-<-\4"!^U=\'3C)_ ML7Q#_P"@6M %@?$CX$MTU_0S_P!MWIEQ\3_@)9Q^9<>)/#]O'D+OFNF1M?"=OJDCW;S7EO!/>K*C0QVYC9B(V8G<%DVE@2FY"34WOL!Z M-_PM+X!#R<^)O#X\[_59NF_><9^7GYN.>.W-/_X69\!AU\0Z$#_U\-_C6)<> M)+3X@?&[2--O;74-)L_#.CRZF+34;49 GELPR7W8(6KW MQ8UK5/!L>BS:+-#&PT?WQ]M.4[\\\?C3%^,'[/#;=OB_PPV[[N+_.[Z?-S7+>,CX=^ VBF[UV\ MNM8UW7YSM@BBWW>ISX PL>=H"@JI9B%48R>U>?:9X@T_Q1>7-E9:)I]I?;E\ MC3]-TJ*[GF(7<6\^1EC0+T+&,#/3=2YGV ]LM_BU^SY=EA!XL\-SE#AO*O2^ MT^AP>*F;XF? 8#_D8M!'_;RW^->76MWXA\&LL=S?2>#A+DB[FTZRGL7(Z+(\ M42%6Y'4CZUVND_$34]&DL[77DT^YMK^18K?Q%9,XM5E;A8YT(_'&F7OA+XR>&_#&D"PE@;397=R\^'_?A01YI :/@ MG"[,X.:Y*2WTRQAMY)_CYX;TZ)8Y$$D]W+*MNS^8$4F3'V@DO%AI,,A3"@YK MWOXF>&=2U;0(4T*;9XKTV7[7I5_(Q5(9^CJY_N2(6C9<'ALXR!7+0^+CXJTO MQKI'B;0(+B_T:_AA;3+28:@CX2*XCV[@H,H8CL &4<]ZSE6C!7>B!-GF']FV M:^5CX[Z!:;89E4-///\ 9F;SMJG?C[1]^+]Y)AD\KY0&[7 M3?%WQ#\-ZKK,]Q,8&DU!VG'>M74 MULE<3:*W_"RO@/\ ]#!H?_@0_P#C56X^+W[/5G=I:S^+O#,%VZ[UMY;[;(R^ MH4G)'OBJ'C'X@:X/$>C>$]&,%AJ6IP37"ZIJ'SPPK"5WI&F0)9\-N"$A0JLQ MR!@[/@[PGI_@G3PMNDUU>SL9+G5;L":[NY"NA_M>]U*%?L3O+$>DY MD&UO]WUZ5Y%K%EKGA7Q?';:_XBU^Z\/:_>-#"ME?F/[+(P^5'X+A"0?FC88R M,CO34FPNF=RWQ0^ :W'D'Q+X?$^W?Y1NFW[?7;G./>G_ /"RO@1_T,&AXZ_\ M?#_XT_1_!VB^&=:.HVUDRWYA\EKN:XDFD"\?*"[' ./SKL#)'-\K74H'\.?N MY]LTO:7'<\/^+WBKX8>-O",VF>!?B7X?\,ZY%=1--=1W#LWECEH25RT98$'= MC.![YKS'6+72K%]4O+KX[^&[.VN4M]BW%_/;1!D0!Q&W_+!206./,9CP2H)% M?0G@WX6Z]X7TUM.B\>7;6#]1 MGF"&..VU)D>XP.6"QDF +D9\O<'Q\V,UZ)\,]<\!>&?&FI'Q;\7?#GB2WN+; M%O8>>Z2,X8'SA#G$05?DPF0V=QP:]:OO#_@+P?X1LI]9T7P_IVFVQ>&V6;3X MB=S2,WEPJ$+LS,2=B9))Z4_P_'JEO$9O"_@33O#4%P,_:=4=+.=QZO#"CN!_ MLNZGU IW HP_%/X SW$EM'XG\/27,6/,A2[8R)D9&Y9D."I12NX M-SZ5-9_$6QO+."ZT7QSXTCLV"R"7^R!?V\:D9PTKVY9E&>IM9*I>3C8=M M#8;XG? 59EA/B/01,REUB-RV\J" 6"YR0"0,^]%Q\3?@+:P///XCT&"!!EY9 M;ED11ZDDX KSO2?BM!X3\<>,=N>!= 6ZT"TU:XU?5/$3 M7%_'<:A<7*VZO,C0(BL2758$9/+E(#-*SYX KZJTV/5]&TV\FNM4F\4:@BM) M:K-'':(6 ^6,%!@ M_$0<9[UQ'PGU:ZL_$>K:9KMA?V?CK681KVHR3&+[/(J ME;<)"8Y' 2(!$ ;#,/F.23A\W81\^V-EIPNK2W/QY\.B>WD62>$74TSQ*?*S M*RMS*)/+GQ$^$3S?E)V"KFA:?IUC?:/+??&K0KBWM[N.6X@-Q)I9O$6@PQ+]Z22Y95'U).!3Q\1O@4W M37M$/_;=ZO\ QTN+&+X5:]:ZC%J%W'J:)IT-KIHWW,DT[K'%Y8)QD.0Q)X 4 MD\5QP\??%;X7:3J5]\0+:T\0V<4L:PWWAFW5+:WCP%+S[Y!(!NRS/M*J#Z#- M93K*.R;*L=%_PL;X%?\ 0>T3_O\ O0?B-\"O^@]HG_?YZT/AA\0M=\>:*^J, M^B7-JK>7LTZYF6>&3NDR."$(&""&(8$$$@@G9TKQAK>H7$UM?^%]5T94Z737 M%O=1/SC \J0L#CGYE%)UDKW6WD_Z^X1R:_$WX#-YF/$6@MY?#[;ECL_WN>/Q MJ&R^+7[/NI6JW-GXK\-WMLQ*B:VO3(A(ZC2RGE2*^?/B);^(M+\3W5]\,/"-[X M7^-7VA+J\\-Z=>QGP_XDLM_S73DXC)=00&Q%,'!!W!O0[X[_ ,/ZF#'=VDT9*RI@X\Q58%=Z97CM7:7'F31X\QB>WS&O7CAH MRU4M#DEB)1T<2A_PL[X"_P#0QZ#_ .!+?XUY3\0&^''B+6/$-_H/Q9L= CN= M,CM=/M;?5YUCBN#(#-.5(94;RU5$*J<%G8@G&/5V::$X9V'XFD,SGGS&_.M_ MJ"_F,/KK_E/G:6'2KO#"-)!% J?;)XOM#J(MT*Y)*,WES'SU)D/FGY M0%%2C3[ %O,^.WA^X'DQ*P^TSQ>=CR=T7R_ZK[DW^D+F0^;RHVU[?K&GVVI7 M6E2W=O'=2V=VMS;/,H8P2A&42(3]UL,PR.Q-:7G2V2.[U 3,GGR OYOP%]>?\OXG M>_\ "UOV?_\ H:?#O_@8?\:/^%K?L_GIXI\._P#@8?\ &O'%OY#GYV_.K]G/ M+*I.YOS-5_9R_F_ 7UY_R_B>J'XK?L_KU\4^'1];P_XTG_"V/V?O^AJ\.?\ M@8?\:\JUZ3IN;\S2C MEJDK\WX \>U]G\3+O/[&/VMU^/\ X7BC-V9E)O95"I^\(ESGY0H9/]''[L^7 MRW)J]X?T.T\8:W::5H?QX\-:EJ.I7I:RM;>]=GN/E=O,C /.%P?LRYC(0G=3 MIX1*Q^,GP'M+>-8+6#Q T<4,8PD:C M3[@!5'8 5E6R_P!E!SYKV-:6,]I)1Y=SZ%\'_ O4_!?AOQK/XKU>+Q$\L$DM MBR-*# 520LXR?DW93]VORILX/)KUKX8S27/PV\*2S2/-+)I-HSR2,69F,*$D MD\DGUJYXQ_Y$_7?^O&?_ -%M5#X5_P#),?"'_8'L_P#T2E>.>F8_PC_X^/'G M_8SW7_HN&O-_C5<:C:_M1?!U]+L8-0NO['\0#R;BY-NNW9:Y;<$<\>F*](^$ M?_'QX\_[&>Z_]%PUY9\?_%UAX(_:5^#VK:KYJ:;'I.OK<7$:;UMU*6O[V0#D M(.Y .,],4 =C<^#=:\:7VF3>*+VQM=+TV\BU"#1M&5V62YB;=&\\\@#,%;#! M$1 2 23TIOQ,L8+S6_A_)/&)%M_$D&6W$$%H9MO0_P!X*?PK/\7?&'PU8^'8 M/%.F>*'U#28I40IX*/$'Q@\,V!\#^'[ M72_$^D7=OJC2>-\6L&G1,'4?:-A?9(0=XB.6P 6 %3'V[4? D/G'=_'%_:%T66*$]#\X.,X4?=K1\$_LP:/H MG@M='\3ZG>7?SK+!I=A-NLM.8'.($E#*7/5I"O)R55.E)8BK*"7*TD]G;;NK M-_H_(?)%/F93\2? 7PVO@M?$FD^*+;6KVQM<6-QK&HQBT=2RF6W\\89$E*E- MV[@D$[L5W/@OQ-IOBV--7\/MHMMHD8^RS0Q1C[;:RJHW6TA!VAE8]B01@C(. M:BG^$/PYT'PQ>P7PU*VTU86ENKN37+JW&W!+,QB=%&!W '%>?_#GX+Z;)JEQ MK'@V'4/ NB6\BBPN)Q)=7VLK@EY+E+EB!;Y;"*RB0X+EER!4^TJJ,MF^E]K? MYDRC&74[[5/$OAK6;ZZ\/0^*=.37KB&39;I=I+<(,/<5PNA^*K'XO7/-?+_C22^\3>-[G1?&EDOV+[+#-/=6+ M9AN5FF+E4@RDNP^5B1%=R , D&MJ-"K.G*;?NK\_7M\C-RC&2A?5GJ/@7Q-\ M0OA7\/-+OO&>KVNL>%[>QC>522-6MMX0HCROA9SR5"* ^2HW/BO%[+]HCP%H MGPO^(,7A_6!X8\?ZYJ=Y<27$]M*;\,)0(TB5U9MXA4!=YPLA.<T^2XM-'TO2;J:SM=;=HU(?R]P>4A5?C.T+G/6NY\6>!= \ M#Z#:0^'M)_X1]4F0MIOA?1[=[^X8X"(LS _9P-O,F1T'S+W\]2CSM5'RRTV? MW+WHVU\DF7&SWN<=;Z'\/-0TVRT%=9A\4:WK:Y>T^V1KJ4F4#%IFP\Y.T8:0 M%4!SM*\5WWA?6M(\*^&;JS&FZ=H<-GJ,6AVWV)C'9-"EV), KNO,,X"G.5C(5NY(R#Q&I7S?#F M^TNSUK0K?6-/E\0V[1^)EMP+:TL@K.KS!% AFBD4+NV!&#@Y!SCJE7]MAW*< M>626EM+.^^MEMWC\KF'L_P!XFGIU_K7\SU/2[CQ!)&PUK1H["=" AMM4^T!A MSDD>6@7MZ]:H:/J&MM=:H-1TN#0M/6-/(FDU))VEY8R.P50$4 +RQ/4],T&AF1770-+8R1SJISBYG=0T@) )C544@8.X9J)4^:5V]/Z[?K'XW&Q9E8>7)?MD9Q(-R1C_GGEN2XQZI:JMU;LC-ME0@ M!FXVD'L*S(C))(UTHC+$A47R]VT= .@ %33W$6GNS?:1+=LV6++D_X 5;WN M!EV/@@Z)=W?_ C&N77A[3KV5KB2PCM(9X$E))>2 2 ^3O)RR@%20+<0 Z'XGM&GAD5V4.L5TN/JEGN?&I6[IDG+7"*..> 3GIVKD=/\!-XAL;*7QE(WB'6FC5[A7G*6 M"38RRQ01[5* Y 9PS$ 9/-:4/PO\.:A"ROH>F36LCJ)4DM%+,01T.,^U4^60 M7&:/\8O#.M77V2#4)$\XLEO-'[;2-%T;5+>*&'1O#]XCW=C M&@%L+.5##)*5'>$.)5.#C:>.:D^!?B.PL?"MKX9U#5+6WUJP>2W2SD_=3LH? MY6*YPQ(^;Y..1Q3TY=!G9>#_ +9:')%K=U<3ZYX@"LO]K:DPDF0$G*Q #9 MA_NQJOOFNTMK@R,S$L0H[GBN4G\6:%X=TF&6^U&*(+)Y))?L M/'?BCP;9>'V_M_4-.UB.YE6UC>6VBC4$.TKXV#'.,DG/:O1?AR=7M=,UG3M4 MM[6V73]4N(;%+'A&LBP: E,_(VUB".GRY'!J_I>EQ:#I=I:6UI;VT42JK0VJ M"./..<*.V>:Y:\_LKPY\9-/N7COA?^,M/-D)(V)M#)9!I4# ?=D:.1\'N$([ M"L:J]Z$UTT^3_)7L^I<7NC&^-VFQ>-O$G@7P);6MK/=76IQZ]J+S!1]GTVT8 M&1E[EI))(X@!V=\\4[Q9X,A\"^$]3U'PMJ6O:0VGV\DUO8VMV\]N^!G;Y4F[ M@>@X%8_@/4K;QE^U%\1;U["Y:?P[H]IHVG:F/^/7R9&,ERD;CAG\Y&WE9-3AUC0;^,U=U;XO^#[ M&&"8^(K"\\U2T4-BYN20.I*QAB<>F*9XB\=:G<>+I/"'A:PL[[5K:TCN]1OM M2D866G)(2(D<(-TDK@,P0;?E&2PR,Y<>@^)]'O+B=-.\+^(#<1^7H5\RJP_P!XJ?>C2VHCH_"_C?1O&4;S:1JT&I;6VM)&X&PC&5*GE3ST(KG? MAC-;:M\1?B9J$L\IP.%8'8\*R!U!;D,."V,FO0K+PWX[^(A_MO4 MFTGP]J=C-#=:'?26:K>@JO[I, M_FU6-QCXBC!)/8UQ&A^/($\0S:;XBLU\,:S)Y<4,$L_FVUX26P;:? #YZ;&" MN#P5[UTVLZG9Z79R-<3-:FW#(3,8A_$D8*KOZ%BP'W3736M]'>0K/:2+<1 MMD+)"X9#C@X8$C\JX.'XA:+X4AA\,:%#J'B:YTN,6LK0RJZPLH *SW,C*AE/ M4J"SY)RHKA_#]CX_U[QU+J7A;PM;?#/1OWB:E-JDAFAU1BNU'CLHPFV1" ?. MRH8#:=XP1STN2GS-_$]7;7R]>A36NYTGQ,^&EHNJV?C6R\2KX#N]-3;(!+KMWJ++<:IJ\DKQW5S= M@#$ZR*=T3*0/+"$! !QUUO /@^?PW)XBU&_U"'4M8UV\6]O'M83%;0[(DAC MBB4DL55$'S,26))XX ZI9D"L2_05L[;(7J?./CGX4PZ-K%C9ZC%K$FEW3 OX MUT^1)9K>Z 2:^A(!5R !]LAVL3@2<&K6H:GXW^"6BF_\82KX_\ !T0WOXFT M.R9;^RA[2W5LI831@=983N'4IC)KZ 5RRF61<(H(52/O<8.?:O._^$!O/A?' MK.K^ [2;4%NG-W+X/EO?+M7E/+M:,^1;R-DDKGRV;LN2:(5*F'?NZKMN[W\W MM^)S2@FK-77X_F+I&L:?XFT:RU33+RWU+2[Z)9[:[MG$D4T;#(96'4&J\UO+ M')@MA,]:\Z;P9K6BI-XT^#5B1;73&XU[X6:T/L3>>W+O:YR+2Y/)*H^&WQ:\/?%.SO/[*DGM-6T]_*U30=4B-OJ&FR]-D\)Y7GHPRK=B:][#8N% M97BSSJM&VJU1KW2!6M@#G]Z/Y&I:=JT'E_9W08'FC*CZ&HXY"6QL)KTHR4MC MB:L.QNXILENC1D,Q /'RU*S%5R5Q49;=U%624I;-(X\(23[UBZAI?]J812%' M>NE8 ]JKFV\MF9!CG.*I,3,"T\&VZ3 EEQ_M5'KT%MX?18X71I6_A K8N%DW M<,5K"UC3?.^8G><55R3(_P"$@CO(_*E167IC%9&N75KH]C(D4$LQ/H #4#J+>9E[YKYV_;*USQ=XG\/VOPQ\ Z/?ZUK.M*)M3:RC)6W MM ?E1WX5/,8=R/E7WJ:E1THN2W+IP]I)1/-?@7^V--XR_:/UO3]6N&A\+^(I M5MM(BE.%M'CR(?IY@R&_VF%?:K0_/S^5?F7K'[!OQ<\+Z7;ZI;6MC?:A&1(U MAI]Z#=0D'((R K'_ '6/2ONS]G_XBZC\1/A[:R:_97.E^*M-Q9:O9WD+0R"9 M0,2;6 .'&&STSGTKGP=2IK3JK7='3BJ<-)TGIU/2'4+&^/2L*S7_ (O;\#6_ MZF23_P!-]S6Z^2C?0UAVK?\ %[/@:/\ J99/_3?N?M"?"" MQO\ 2Y]9MI=-UPFSM[J.V9B!:D'S)'0 9]#GTKV/X1_\?'CS_L9[K_T7#7C? M[3WA6S\8?M$_!S3[ZUTV]B73==F$.K60NX2RI:X.PL,'GA@5>_SL@E\X9[2JXKXK\/^&?C_P",_'GBK4]' MN]$\67MM"-=N+2$VQM/,D#*(&MG5@;H&%DVNHVF,8*@U]2>//@+<>+FLKV'4 M3I.I66T0-H^I:CIT6W>"RO'%.5?*@C)&?>J?C;]F_6_$UTVJZ!\3;SP!>OM- MT^B6\G^G+&I"F=C,"Q12=O!(RCQY'O7)]:H?$ZP: MR\16=SX'\(7NU)!JUG(MW?Q[@VPR$>3;*V!G)9\'^$UZA=^,/#46G)?1^)M& MCM)G\I9?ML>UY!WOM>O+^?PA;Z;X@AMQ#:ZZB>9LOAV[_UNE?#WX(W%A/+XF\<33^(/$=T M[216U]()4TR%ONPCL\@'WGZ9)"C R?/(O"MYHOCK3="U"6QU2?6(Y/[4M[N& M2ZM)88R,!Y)V:260D]6P#_=7 %>M^'M*U[P?JL@\.C^UO#,\04Z'J>H-&;"8 M'[]M,ZN?*8'!B;A2 5(R5KLM[O++_A_D5':S-#7/">G:Q?\ GRVLMO>+:/80 MW5K(89H+=R"Z1.N#$&*KDK@\#FJDGAG3?!_A^+3-$L8=.ME=28X@3QN!+,Q. M6)/)+$DGK6AJ'C+5]'D0:AH?A_396&4_M#Q.D98=B!Y'(K.O_%'B34M-N)+7 M0]!UF$ -C2?$*RN>1TW0JOMRPJ%34=4-Q:)VQJ%TC^9+.<[3M 5%Y[G%9OQ! MNM!TWPIJB:]*MEI,T313RQNZ2A6&U?+9?F$A.-NWYB<8!K@KOXHZAJVH'1+B M9O!VK1ONF\.Z3I\E]K*QG/S+(5,(C;!_?*K+P0"&JYI_AG4=8UZRN[/2]2FF MLPTL6K>-Y'D2V'AX'U MZQLX+W^V[Z)8;_6M.#[9$EC@"PEB>'20ET+APJDU[K;V_P!MR\LF5V@C&0H_ M/K7#^)]!\7VMYH=TGB2PF\B^C>YTT:88XKBVZ3*96D=@V""I&!D#/!KH]>\/ M6?B@0_;1=PE0?LRZ=?RVLJGIOW1D=,#J"*SI5$Y2IW^'SO\ ?Y_IKU"70UDA M-JY/GA9&7!12#Q^59^KZQH^A8?7M8L],A"&8F\N$C4(!R>2"<>U6/Q(TF M%(]+U+2=7LTSNFOK94U(#' 5MRP2$>K*A/N:HZ"@TF:_O[KPMK.N^(+VX$]U M?ZFEC"Q9%"HB/YA6.- !M6-3W/))-;BL6+6XU+XD:=W=L#A9;B8_/%Y@&[RTVD*1N;)('8Z/I-KH>D16&GZ;;Z%HUN!L@A0*" M/8#N>Y/)K/AU;Q(ZF>;PW9N#\P0:\"P[]# 3[Y-B/1=-N/,9Y!$HWL<,Q).WW-68[E+>TFAC625V M;Y1&#W[9->::+J5OXFN3!_PLG[==RM_QZ:/=6EGS_=5-C2D?\")]ZZ!/ K07 M0\[Q'XK:USN:WDU,A0X':15\T#/.T/MSVJHQL%S4\3>!+7QIX?N-)U*ZN+19 M)(YA):D;H7C<2(QW JR@J"58%2,@\5Y+X9\(:O\ &S2=!\9S:Q##/>00S2VT MD*_M>D:@\9E;4;!FO( MXUD5WB,J.BRHP7;\ZY(8@EJ](M])CLX_)LU6U"CY548$:]E4= .G85=^785 M^QP?@GX6:;HMP=1N5CU[7I;B6^FU2: 1,K,2 J 'IQ@$Y('>O0X_M,:JS-R% MPO' /I530U>QL4.W=NW88\D_,<9/K5VZF6=3F/.TX^9R%^N!6;UW*(YKH1S, MDK\$3P2]UH-W!INM6$D5[;W%TNZ$HC@S(W!PK1>8NX#C.>U M:+L\D>Q0N#D%8UVBJ\DAW16\BF8,K*\*KN+CI@C^[BHG:4'"6S!.SNDW"7=K:.T1FE,D$@=,2M*K@(5&#D8SD]=?\ MBKQ?X5TB?4-9T32M:L+*-IKR;1;J2*?RE!+RI!*NTD %B@ESP0"3@'&^"_@_ M0/AYI=_I'ARQCT^U:Y5GVNS^9M18T/S$X 50H . %XKO-2MUU#3;VS=V-O/& M\$FS@A74JV/0X)K'!UE7H1JK52N^G=]KHTEH[%J'5X-2L;6\LYUEM+J-)H)E M4_,CJ&5AGU!!K#\<>*[;P'X5U;Q!?))=06,/F);(<-/*2%CB'N[LJ_\ J\] MM-4\6_"?P19:1<^%Y/%ZZ1:Q65IJ6BSJHEC4!$>>!AYB%4 +^4)!_L( L2+T"QK6!XZ^*]_#=W_ M (>\&:+>>(?$4>$N9(5V16)894NY!4MCD)QZDU8\9_%33= M9K718X]?UDH\ MHM;>=0D*(,O)/)G;$BX.6/I7FW@CQU!HOBB#Q7>:)?7^M^,A)%I.D^&[8N)K M>)0SWLA=E"1M\@WR'CY>!NQ4RJ1IZSZ[>?HMV-79ZM\-?A39^'=-M]0\06MK MJGBZ8^==ZE,!+)YG8*S=,#CY<#K@5V3:UID=XMF]]9+=$$I;F9/-QW(7.2/? M%>6:79_%/Q9X@NKG4;[1_#6BN3#;Z6B?:YHD)'SR,I"O)_P/8,_=/6M:S^ _ MA:S<2R175_-&I7S'E^SKC)R%6 1JJ\GY<'K5N>'(?#5YXAGU33U6"99H+>RAF#,8VDE>:-E*,JOE,D$#!S7RSX4^,'QW^ M-]U9>&CX*?7]8\'S1ZE)K_\ QX3PR,I1"Z2%4,IC,NV1%;[VY5!PU?='AWP= MX<\-:D5TC0M/M)MB8D2V3S *IMJ'LY1NVUK=IJU]NZ?9FD9I0<>77N>,_!+7O#? MPR\-SVVN6_B71KO4-0NKZ>Y\0:5/&B7$C9>%&+2.!GD%S^\)9LDG ]>\.?$# MP[KVI1:39ZD#J4ENUU#9W$$L$LL*L TD:R(OF*I8 LN<9&:HWWQ(MKR26U\* MVK>,=2BKV['[!KEEB.ZMN>@/\2'^*-P48=1WKF8/ M%WC?0;ZY3Q79WCZ0H9H;BUTDSM&<]Y[9W#*!_$T$9]:V8?C%X3ABMI9];ACM MYV\L7>XRPQ-TQ*R ^3UZR;1[U*JI3Y-?N=OOV&UILO_ "Q) 6/;UD"*[8RN?09C+=7'EQH( MUC'W6!*^^*VNN@ATDHD:1%)(RIW#'R MXR?IZ58O#%%='+&1@N2!_2A[6'U.+^(7PKTWQ[]DN6O+W1=9LF5[?5--F:*4 M '(CE XDB/=3SZ$&O)?$O@7_ (3SQEINF^*]/U#PUX_LPT.A_$+P^ DS1?PA MI2/+N$;'S6TH)&>G.ZOH1[I",$AY&;>43GZ#/X55\0>%['QAH5QI&N6"7VEW MB-'-:ME=P/HRD,I'9@00>151G.$6H_*]]/->?].YSU*2E+G@[/\ !^J_4\'T M?XDZMX?\27_A/Q_!;P:CH][;VI\3Z>I32[YIHM\(<,E MM9E=Q7Y7[KBO/-'TK4?@#9:UI7BW2+CQAX O=0FO;GQ5,W]H7?DNH54OX"#) M(L: (9%# )&&/?&A<-:_#T>'-3\-ZNNL_##6IUMUG>?[3#I)=28'AN023;N^ MV,*^0C,N& ^6O1PN,[&7,CRI1Y6)QZ4S=FI&7;28-421R6ZS+\PY[&J%YI;-&5ZYZXK3W%> M,TUESSG%.XCSO5-#2UFSQN%55U!%_=\+SR.GYUVE]I+3R2.5WD]*XF_T2?[2 MSA.,\@5HA$EY;I>QAEP)0.#Z^QK)*D2$2##C@YZ_2MV)EC4#C..1535+?[0N M^,?O%].XK6,K:$-%!]JQ-SV-<[:X/QL^!I'7_A))/_3?,__HMJH?"O_DF/ MA#_L#V?_ *)2K_C'_D3]=_Z\9_\ T6U4/A7_ ,DQ\(?]@>S_ /1*5\@?3GSO MK7[2W_"E?%?C#2AX?36/.UJ[O7D^WK$8UVQ+\R[&V+Q_K'VIUYX-=1\2)H]9 M_:6^"EVZ[8Y= UZ ?E#J-Q.#@U$_A=@/5-4\>Z:=4O;"U-Q)]@C:6]O_ "_+L+,* M 2);I\1@XYPI;'?%>2?$3XD>)/!_ANP\7'Q+'<>'[^4)INB^']*/]H:N[.!# M%;M.P9M^?GE*J /N(?O5EZ+\1OB5XTN9V;PO:6OAB\"217OB.U6VMX8N2HBL M=[37,A..'*H, [14'BSPG':^+/"WR?%4QE&FU%2U?S^Z MQSWPE\!Z7I?B;6-%^)OAN]\"&&]@U'2Y!?17UMIR70+1PRM(CI'B4S1K+C;D M;"RG&?K'3?!_AKP?=). M]5TR"Z;1XFLO$&F6X,RW^EW)5+B#:1\Y1BDJ@_W6'\5U^S6I.V"&\9D+)+&#LW8Y"#."33>$IQ=K:]]_Q_I'9#W5 M>)T_COQ=X9\*_$S3U7P;/XB\430Y@N]\4LMNN>@\QB8ADXW* .V:M:/'\2_$ M.I:AJ=Q>6>A)N\JVTNXLDN(ECX(G6HA!F'\;2$ES]!@?6M_5M= MM/#-A>:KJ-PME96R&:>>?Y8HD'4D^G3\ZZ*S\16NHS/'9WVF7TL:;REM=+*P M'3.%SQ[XKA?C;X?N/$7PTUP-=6MB]BB:LD]WDPAK61;A1*,XT'35D1@ZW44 @G&6'W98\.OX&J/PZ\=P?$#0+75;2T^SWS MQI)>Z7=!ENK"9E#&*5,9! .03PP((X-=/J5T?S(TQ\G((!((/4Y MWC'XE>*?A-X+UCQEXATS1YM#TB+[5>:;8RW$MZ8<@,8Y2JH7&<[2@4X/S#K7 MJ'BGQ1!X/TF?5-:N(K*U5UC7;N=Y'8X6.) I:21CP%4$DUQ'BG2?$'Q+T1-- MU/3QX9T&^7_3=*,OFZA>P?\ /&5U&R!&XWA2[8RNY$=<\(_$K M37\>>'Y-4>;5+=+8)JD4\+0QQDD(L#_*F2VXLN=QPMU=W,Z MVFF:7:D)+J%U)Q'$">@X)9\8559CTKI(IIK:&&W@M;=KR49QN)V_4XKAO&<$ MVA_$/P#XDN6@N46\N=$D:1B8HGNHAY4HXX;?%Y>1VDQWI1C=C+EUX"GUTVT_ MC35UU9 OS:%IX:#30X_O_,9+C!Z;R%XSLKXMPZXQ@MNQD'W!!'KFLUO"'BCPI";C0==N=9:$#R]*\ M2*LPD 'W$N0!(AQP&?S.<9SR:^7O'CW_ (D^/GC335U2Z7_B>5F8#S,Y^N,5\<:+\,_% M?B)KA-/2^NY;>1XGCCUERQ91DA1YOS8'<<'L:3P!X"U'X@:M?6MIJMY:RV=I M)>R/)>WY]3>-KR'PY;6<"3WT>JREFCL[&V6>69 M57<[E&(VHHZN64 D#)) /#0C7/BIHEA'=>"_$:6?VA;A;?5KN/3DOXQRGVE8 MFDD2/)SY.WWGCMXG&?/69U9%# M'<-W'<52M_AIXLN%B: 7LC3B1K:./6W,EVJ9WM"OG9E48/*Y!QQFDZ4GF1QJ/*,C2(1R%SM'D MGBKX<:CI7AG1=5U>Z-U9:H[-!;MJLLS*T3\%EWD9##((S@@<@XKT;]EWP?;^ M(/!DFJ:TLFOM;:Q?VFG6FIW+S6]I$DQ^Y&V0#DGDGIZ4.+BKW [#X4_#G2/B M1\.;/_A)/$)\5:'J&Y)=+TV-M,TQD+3'IL%M,T4-G#DG;&$57(!PS2$XKLO$C6VB>!]:+Z MA#X5M(;.8?VG:J$%C\I'FHNWEE)! PV4[B YR(Y/BQ=:"VL_\ "-PW%HL^CO:VL=T-0$8S<>8\BML:,L!Y M8"Y4AMS<@2^(?!;:UHEY!XP\5:I+IHVS7#)<0V5NJQNLBL56/"895._.X$=1 M57Z!U+GP_P!!U3X5KK&EMX>D?3KW6+S5+>[T9$-K''*P*1- "KQ%455PJLI( M)SSBO0$UBWO+6RO//22WD561DR=P/?\ ^M7GNF_$#4/B#=7=S+K&E:!X5DN' M@T^&3GXFW+>)NOK:8=]<3=^!9?&NJW3ZZFDM:2 M92"'3[)DO(EXVR->E@ZR#TC"@9ZFNH36)IKZ.PDLQ:W90RK%(05<#@E&7(;& M1D<$9Z4^[\1#3G^SV<<-_J0^]#"QRGN[8P@^O/H#6(=.^'.H3>*!+I U36)O%-T8M/MO*1LI/=+LYO%VJZPWB>[@2ZN="\2W$FEM;;AD)':HZQF,9X93)G MNQ-7I);WQA\0?$&E^)9X6\/^&OL$JZ3 S"&ZNY5:8/.2,RH@$>U#A=X+%3@8 M[[7-/L/$EO$NHV5I>AOF6*\C$JDD,4HP5K#DTQUOX<@\+V\,/A MYELK?:66RD9I+=LG.5R2RY]5)'M3)KZ:0,][I]Y;(OWO)07"$=^5.?S7\*Y? M0?"=]X%UJ:;PY:0R>&;I6>[T596(LI^OG6P(PJMSOA&!G#* <@]A;ZY;72QL M+ZR9U/,29 O+5]I/L0%PX]F_2J&@WD M^I:':7DEM;Q2RH5;RV(7<&*DCC/)!(YJHS;ERS):TO$V#)%YEFFYFD6< YZ M[37CWQ"_9[T6:"_N/!GA3PY.]Y*SZOH-V'M+758W_P!:$EB(,$S9R&(*L1AE MYW#O]8CNH[RUW3PQ1&0;@KG=T/M4IUJ;[.(;>$"%/9L'/'?BAH8UGPUJD=];*WESQD;)K:0=8YHS\T;CT/X9I/&_V[PKKEO\0= M$\-+K&JQB#3-76UDVW$NF>829 "/G,#,9 #@[=X![5D_'3X 1>)K?_A/O!UU M8^#_ !W9O'=2:_:S-!%?6:\RI+?O?F=;<,\(;Y"S!20@/WN. /K7!VGC;7BWFSZ+/*GD>9+!' M:21^1(64",NQRQ&220F"%)%4K7XL:KX*:UTWXJ:)_P (^DKQQ6/C&T_>Z'J' MF8\K,R9%O(V1\L@523P1G%>ES0SV[$,D9 /756P]2+W ML<5+XI\0:AJ26^FZ-]GMFF$0NK^.0#;O;,N!C V(3M/=TYJWJWBS4;&ZO8;7 M0;F\, <(1N'F$1[E?[N-C-A.&W9SQQ72&27ILC_[Z/\ A1F;^['_ -]'_"NE MU(-_ OQ.?V*YY M?%7B&?9%?>&Y8)+B5B9(B0D<6]E&20)S^(-593*NAW:!9&5PP.2@QA^G .X$ M=3@-QD8JQ9^(KUKV& Z5*%9U4R?, 5.>!7HMQI[I_PKEH[/4X/VA?@A(\-HNE/X@?;(LCF M?S?L%QD%=NT+COG/M7G8J7[B2\CNPR_?1/<_B5^U"-)\;ZWX#_X1^.6/+:>V MI?VD@4-)#N!/R[5;YO\ 5,X<\8'(KVGX6J'GA%:(Y.7'S8^T/A;_R3+PC_P!@BT_]$I7R MO0^D/GW4/@#>?%;Q-\0M4M=3TNRD^WWFG1)?:<\["0K&P?S4E1T&&X\LHW7) M93MJO\;OA38>+OCA^S_X"RU!M(T?5KB#[5"9+;[1!%:!)&B)^< _,%;(R M 3G%>X_"/_CX\>?]C/=?^BX:\E_:(7Q#/^TI\&;7PPELNIW6FZ[ UY>?-%90 ME;7S)S'_ ,M64#"Q]"S#/ -%[:B:N2>.M(U'2];T33K'6[6\\1>(;_R3XN"NX9"*JJJ\+N=0?2N]\'?"O1/"NI+K#-<:QX@,;0_VMJ^UN]4+QFN:/8 M^(-)O--NTF%K=Q-#*T+F-RI&#AA7A-MX U'_ (6#JN@^'?$5U:/X7T"(Z=JD MD4(>UFN'?;;3%4S+&R1AR#G'!QD@U[IJ-Y;Z/IMSJ-]=PV5K:0M+P !)->;^"-+U+Q9XLM?B!:VS>&-(U*+;/8W!=[K6K=5*VTL\?"0,!A MDZR;"%;&<#F5SL*_@'XI+X3AN-+\=1S:7XKB1Y99+;36V3VJ-@3@0J1L[DXX MR"<5Z',-#\46$.HQ0:7K5M=('BOO)BN$=?[RO@Y_.N5\?^$SKVM6.L6%Y-I& MNZ:&%K?1Y(0'JKK_ !*>,BO'_$5CXN\&0ZKXAT^YT;3]07%W/'I/F6\5V WS MB6W)*.6 QN(5N3\PP*FZEL*Y[!J?P[TW45BGLT@T+6[-_-L-5TVVCCFMY.G( M DC(X:-OE8''!P1!J7A3Q/\1X;?2/%T.D6?AA?GU*'2KF5VUAE8%(R&4&"# M(W.NYR_"9VY)S=%^)FIIJ'A5M3T2UTS1_$5P;2"X-Z7G@F\EYD,@V! K"-E M#$@XJ_XB^/W@CP[K9T>74Y=2O(U9IO['MS=QP,N#MD=?E4X.>3C@Y(I+:XT; M?BGP3H&N:@ES>Z!:W=VJA4N "D^T=%$BD/@=AG KB/%FGWO@>5(O!NI33ZS( MRAO"-Y=RW=K*I8?,S,6>S Z^;G;V*,2*ZR&QN/B!"M[<:C/HF@31I):0:7>+ M]KN<_,)9+B,L$0C&(XV.0"=+L6UPQ+-/$>O>)?$/@.:3Q+HVHSZ/:V M$.JVLEMI*HJEC$S,I,DH<,TNT':548 .>EUC_A+M;M[Q))[/P?#,-KSVDAO; MY%]$.6X\P$2/+$'\[);+;6YSBNDUGP+JNAZU9ZQX2NOM=I-; M&*YTC4+ZY-O>!BKQS1R,9#$X&1G:0P?G&!6]\8+&.U\+^'I_L+WFBVFMVMUK MD*+OWV*!][/&.9(UVMVESJD=E=31^9IUY-D#[=$ZR6X0 %F8RHHPH).3Q5KXD:?H-WX5U+4 M/$@C:RTJTEO%OY [2V3*I/F1LA$BL"!]P@GI7D-Y;^$O ?PM\->)OBM?W^F> M*A'%/%?SW[3ZTU\%./L@!.&^8GRU&T!MKCK27D([NW^/VEZJMNTNB:UI>J21 MJ\MAK446GO%(5^= +B5-V#D C(KQ;XF?M0>(=0NI/#O@73H;75;J1K6/&*/#4?Q+_:LL]2L-?U)O"/@?3[LV-W!<6HCOM2P% M<"6+[@.QDW#B/<3\C]![!X?^!'AKP99A/"L>H>'M5,)M?^$@@N/,N;A1T61' MRDB _P#+/:%'0!:?NQWW&?+OA#P'XN\%WQ4YKT2/Q)\5 UZ4\/^(-NI327%XG]@G9>.XPQE&S#C'0'A>V*] MT\+:OXH:WCL-8\%WS:S;R-#-<69A6SO-IPLTL\.>*( M_&GAVQUFSL9M/MTFFMWMIRI>.2*1HI%RI*D;D.&!((YK7G=KV"Y\B7WQ,\9> M#+S28M0TW5=*G@LVTVUDO="9$-NW6%I63;CT#,".U;CZ]\4=3W2R^'-;U"VN M[:&)HI-"\VWFBB),1V[-IVY.&'K7U;M=8I05$D#SZUY1XFO;' MPSXRM_"WA'1]:7QA>0-?SV_ANYBM[6*('AIXY%:')/(4)NQSGD92J.6EAGD/ MASQU\2[>YO+'2=&UHW.FW!NIH8M!YM9)DSG'EX4,H/3C .,5S'@?5_$MQ-J9 M\+:1KEU+=V31W1M-*E?-M*Q7.2O 8H<$>F1QS7>KX.^-5_XXOSKE_P"&+:R\ M2V;11:#%R7WPQUO6]#\/Q:CXBN/#T M^C2).LWAY5BN96";7\R; 3##^ 1[% Y S6SN&_LB5S)"^-R\J>N!SUJ5O$7Q \%:78^?H>M:?!8![> MSNKK1CYUJK9WI%*R;DSD\#IDXQ7OU]XI-YJUG!IL/B;XC:'+N6ZNM%U+RX[9 MQT#D"**1.Q\N4L#U0CFL^XTOQ)-J"6O@#PGX5\,W$EW_ *;J.JM_:%S9*P!E ME9$8*'(P%CWL22"VUXT"QM],M=. MDLY+=[D/")"(6F!7.YG;@X'/2LB#XW:NK>)4DCOKJ/39X;_5H;W0'EAL96&V M*5E>+;&2, $<$8ZBOKNP^ FGJMV9=3NKUKB[75)E>UMHHKF^0?N9[A8XU,WE ML%98V;8"HXXJGX2T^3PG=)X'\3V%H^H:U!+>2ZM'*T\7B&8 +<>:9%#+-M*M MY1W#R^$.$P-U-VO8#Y5USQ;XAU#POX?BU'2]6N='G:6;2)H=&>0S;R7<0M&A M+ GG:.F.G%>Z_LCP33?"&1UCEMIH]>U)I(+B,Q3P[ILJ)(V :-B.<, <'.*= MXG\"Z9X1^+'A/2O VC:)I$\<$FHIITI>"UDN%88W;>4=@7PZ@\G+!J]5NM'\ M*^+/&%T4NI-.\906D?VR/3[^2TO3 3\OF;&'G1@@@,0P'0$9Q6 E2-L=/E&QBN] M5G7:V-L#+UOY;3P&\R2R? MO OLS-CM5Y9!PK28.?NQMN)_+&?SK5CN/L\:HZE=XW* ?F_'%0I$-V/+I?#T MG@/XP3^+]=.M>(K&325L8=2CF-P]AO;=,9;:,#$;%$VM$A" '<,G=5#XT>+K M2WNOAWXE%I9>*_ \%S>22K#?QBUDNO(+6YD8AE.-L@4,#^\91PV*]:AU V^K M3H"2QB3:J_CBRYF##_ %5P M%R!)@AOE##@$/FNRKECX)Z7J>B^#[?7=;T*%_&>K!]1U&:[G4S^;*2Z0>9M+ M(J(4C"@ *%QCKGJ])\3ZXLES)JVA65C=*Q,<-MJ#W ?(_B?R5VGVP:GT_4&N M=+LKF([([N))T29"K@.H8;^.#R,^]&V.WF;S)!+<')+6#&C32; NXYQ44BRWDC27)),*?= M0;<'T]R:?)[SE??\!\SM8\[\$W'B*R^('CG0;VSTR[FDNU\0R:I#?2?:;BWG M+);QF-H@ (5A$9(; 7'+&NNNM4\4W&N6]LEAH\.E1CS/M37LK7"ICKY?E;0 M<_[1XI?'GAJ?7M%74=+NH-%\0Z1&]SIFKSJ +9\?-'*QP#!(/E=3Q@YZ@$6/ M ?CS3O'_ (3TW78+2ZBENH0)X%M)&,$B\21[MN& 8$!AD$8(.#525[RYG;;^ MO,$F^AT6EW=Q%;LK2>8Y9MW!"G/(.*K+J NIS#*T;Q*=K;HPWX3RD+=MW)'6O0 MHH8;>QA%BBQV: +#' -Y"#N,' %6$:V 5VD@,BO&[' 0D8^ M9?O?*1CD'G&*Y^;X?^%Y/$FE6T>AP6*['N;@Z:C6Q95 54)B*\%FY]<8H52* MNU&W3U+U>C9Z%JUC"T-G).ZPHUQ]UDW-T/)K/>S\["P&215&[D!54 ]2,]:P M]2^'?AN2."*RM]1T6;S 5O;34[E)$8 D,,R,I(]&5@>A!%31^%M8OE5+GQWK MF47$1L;>SMQOQ]YT6 ^8?8X7VKLY4S)ZG36*QZ:K1QQ"?/#*W1\CD'VKSKP7 M+8>!M2E^$NIW5[J%KJ5K>:AI']J;I?,L7R$N/G,/F8"DEO+9>H%;[:3XP MGA$#^)-)MBHVF\M]#D-P_OY;3&,,?H1[=JY_Q]\$)/$'A&\&GW]Q=^++1/.T MZ_\ $EQ+=1M<=0LD(81B.3[K*J+@'('%92IR7O+H9RBU9QW1H>&!H^O_ KU MSP7K5DWA[1[%+GPN\.HS+^\MD3RXIHWDX=3&RLI.>1@\BO,?A#XTO_"H7X7^ M-I)4\7:!:[+*^N>$U_3D.R&]A;H[;-GF*"2IY^G5>$M+\)V_CZPU-HM!MX]= ML/[./AUK6&3['JEKN>X$;%<\HV&4@'"(W?%8'Q\_9]T_7?"UGJG@N:XTO7O! M]VVNZ1:R7LS6&5&ZXMHXMQ6(2H&4%1A2<8P2*VP&(C!)Q=UMU_7?U%44:\-. MNJ/1HY R;@0*[*7574,%;!(R,X/N* MN?:DN&_=[0O^SS7V2:DKH^?<7' 31D'H:Y?5-) M9E*MROKZUUE0SVHFC*L.#33$<"FCFU#LBY7!_E7.:@ OQ>^!(]/$S_\ ION: M],FA$,;J5Z UYUK8/_"Y?@4=FT?\),_/_?]C/=?\ HN&N#^*TOE?M6_!L[68G M1O$ 49/W+6@"'PA\:K;XF+'<>%=.L;M6+*ZZMK<%M@V]:C\J/J#SPPKS[Q=J6B_#*V-I=P7_AO7F ^ MQKH6MR16-UDX#;9&981DC*NG^Z6K'T*,CXD>%QI/Q$\/Z3JMYK]_H&J^7'!* M;@WK27F_.V1)V,>W SPA(VYXKO/$WA/Q?;0LUG\2M822.1 _GV=N1''NR>0H MR_.,G/':N6NO#?BK2?B=X%AN?$BW/BC4K6]GN;BZL([N*WAAC3$<"G858O(F M7!7(W>U=_):^,X6 G_X1K7E4_P"JA>XL6#>N2)E)_2B_85CS35-9\61>*+#P MWJGB.&P@N+9GBUJ.P5?M4N\CRSN.T/C!X'/85OV/PO\ "K 33VL.M3A]TEY? M/]IFD ./NC@5TNN3-K%BMCXA^'6HW5JCK((;.>UO8PPZ.")5?.>?N@U MQMYX%\*6JQQ:5\/_ !);D;MD26;*(]QRQ7,WRY]L5+0FB[\1[>V\7:?9_#Z" MUL&.L(TKR7UK%<6]O;PLGF8C;(:8!QL4=,[B0!SHZ;>>!_A7X;&@Z3>Z3H5K M:0^6T2SJ'Y&-\G)=R2>2V37F'B+PCI7AO5O#-OIOACQ;I4LNH&)[>TA8O-;% M2;F0/'*[JRJ0Q8-OAG\,?"MU<6@L])6PC:5K6\MY(+J>0GY8U M\]0S2.Y ZGELU'+T%K8\\\#_ !6O],^$?AG1M%M&LKFQA&DR:E<1K-YMQ&2" MEE #_I#$#<&(M:\O6/%4Y>_N)+=Q/;6L\A9MD07Y?W:M MY88=0N>]7_'_ (JL?">BSMJ-XJ7L@$=IIR#=/<2D\(B3Y&.?X6'8CO69J'CR&WUR[T?3M-U#7K^P"F]&FQ+Y M5J74,D2:;)J$CEV M+$JB.JJ 3_$6]Q7HWPQ\0>#]#C30;;4KE]4O;N2[N+G5H6BGOKISEY"655). M J\!54#@4N741/+XC\8:E;2)I?AEM,O74QQ7VK7-K:2\N[/0].O/$,]G,T%TVG1QQV\,J_>C:>5T1G7/*J6(/!P:\C_: M2\+VOQ7^&^J6%Q\)9-:\3-"8M)OM2A@F2PE;CS_-@D:8! 2VU1\Q &.:JQI& M,;KF>APWQF^.EI\0F\>>$? LNG_VOX'FAUB[U;6+J-=-E6V_>.D<>=UU\ZF, MI\J!@"6Z ^C_ P^"'AN'4(?'4VH7/CKQ?J$$M?(,@3+!*(WR/G M7[X4;MN>#BON/X=_$KP79QV&@V6BS?#R.$^1:Z3?Z;_9UNWM;O@12G_=.[U% M12524/WD;/R=ST\RH8&A54Q<]=R)#+QP-Y%=4+R5I"YC\HL,!AGE-T M]3R;&9I+207P6.-F8X^51A1^/4FL#X06MO!:^+/#)?;#X?URY@L[&5_](AMW M*R*\O=E=Y)2CGJN!DD&NYOKZ339<01JO'WPFYF]NG>O(?BEJ0U'7=/@\.P7% MY\0]+N+2ZMY+*WPA>N MS "CTS7S'\5H=8T'XH>(_B78:I)867@[5-+CO]-ALO.$MI-:K&UX/G5FD02$ M%-P1T3[NX U]*7EXTR2ML9B7P-RD#&>OO7A'C2XT#QOXU^+/@*_UZ/1FUBVT M^*YOUB61=/6WM2\\\A;Y8^'BC5F())(7D5/,HWDT5'<[SX=VWB[Q5--XSNM' M\+F:42Z?I=_,;B">;35E+)+@>8$69OWFT'IL)/8=%JGA+Q!XP:.P\17&FV_A MP.'N=/TGS7:^PP3V5O9>#U@V1R-*6N] M0D;&3M'$4(&1@Y9R<_*!S#:I>ZE>6KMW[[ONR[7U97NK[4KWQ):Z#I&E%-(B M@)O-:,BPPV^.$M[= "7D]@IIFCPBSM$=Y&7)=Y9&. M7DD=B6D=BPBM;*U2TM;>(1PPP( J # Z 5'JGB'3M#TF M;4M5NXM/LK=-TLURX55]O'9 5B\/03@&Z4]6N77D@_\ /,''K6UK M;@>/:W!#X4\2:7KT&N6OBR+2',MFNH:B+DVJG(,4[EC(#R=LY+!3@,N.1]!^ M&KK0OBAI]CKL5NINK-GAC:>()>Z9,0/,B)ZQMTR =K#!Y!!J^O@/PY-Y*S:# MI;K$FR/=9QDA<8QG;6/X^TB?PCY_C;PW:M)J.GVX_M'2[=?EU:RC&3'M'_+: M-EZ;JVI'Y1)#/9R6T48)4Y#!C*HP?>H_%/CK3_A5JMO -6T'_ (1:.!;< MZ%'YGVVVD7./($0<,"-J^2P7&,ANU8R3C:^JU^7^?YE2CS.Z-F&7[*)'BC#3 M?=+N<@>V>_T'I6!XF\6#1=4TK2$MYMYTJ[\=^?8)JH !;[.B1-RH(+*S MJX'.S'-,^(/@_P"*7C+1(+ ^'=,T'6K:59+;6+#4U1[5?NR&&3?N^="RG='W MY' (<4KV,7%G4M<^-TDG=X_#.@IY2GZ; M'J*_$C7!,)KF.\NRNCZZT7 M:OO(\9@#$^OECW[U=AV.@L_'5Q!?)I_B;2Y-"EN)-MOJ%JYN;"X/4*) H:)S MS\LJJ#CAFKHFDLYH3);O'/$Q_P!>C;LGT)_I5'1_&VD7<$S/.M@\%O\ :9X+ MW;&RPXSYN)IG_ DD;?9H9+PQ MF00M'(H+< +O((W,%[YK-\U_=12L]SH[OQA%X;U#3[!+:\U+5-3\W['862KY MDBQ@&20L[*B1J&7+,>K #).*76M8\>R0>;I/AO0;*Y'W!K>L.P^I$$+?EN_& ML'QDMUX;^(/PVUF9VNXVU"ZT0_Z-L?;@'7->BK,'17:%LYSN M?O\ G6D7HKHGX>IYKH>FWWC#Q5>:9XY\O5]=TM(KO^PYCY>DF%R?+NK=5!$W MS*R'SPS*R\8R"?29]2U%9P;BP?RHUV V?]AL-^-,_L MU+6-IFN#;0J,NQ(C7ZY_K5B'PS8K!)!+;03'/)DC#LQ]2QRQ)^M9U]I>CZ:T M+W31VTR/N3[5<%AC_9#,>GKCBK_>17O6,_=>UQTS7.K2!K&W>6# Q<7DACC; M'H/O,/P ]ZQ-0:\TW7-+N9IX9(Y%DL#'#"R["^&4Y).#6A-=RR3 QQ+$N1\S>W0^U8-OJ#K M-!8ZE$+746.YHR?W&-!N3YR M ?++1NPQU7=D) MN593P:\X\/VFFZGX$\4?"^RUN[FUW0;!M&EOKB4_:5\Z F&0R 9R$=>?8VO!*!*V) -OF*[L'7.5R!VS7T%H>B)86?SR%B.O&37C'PZCU'X)ZAJ\.KZ2 M+.W6&WGUNSL_WJVJ)$L":G;%1^]M&V;95QOB9=Q&TFO>([E;JVCE@D66"5 Z M21L&5E(R"".H([U]I1JQ4>1.]CQJU-\W,U:Y2=@K<=*8WS'-&PJ>1@T[:6Z\ M5V'$-Z4,_ M_HMJH?"O_DF/A#_L#V?_ *)2K_C'_D3]=_Z\9_\ T6U4/A7_ ,DQ\(?]@>S_ M /1*5\V?0&/\(_\ CX\>?]C/=?\ HN&O&OVH=*O]8_: ^$4&F:':^([O^R]= M8:==WC6BR+MM=Q$JG*D#IUKT;P+\0/#/A'4O&]MK>OZ;I-Q+XDNI$BO+I(F* M;(ANP3]W/?I7)_&?6O[+_:;^#=];V5YJR-HVOXCTQ$ED*E+7YP"P!'T.>1BD M!G1^&/L.ARW6J_!>_L;F.0-'#X;UJ*\N^PW%C)'N;.3C)&,=^*-/\6Z!\/?" MNLZ]<^!_%%G!L::^N-?T\W%T(T&&+AI')55R< XQFNUD^*5A;7C3:I#K&EVZ M\F;4-(N88HQZL^PJH'J3BNC\1:6GQ \!ZQIMEJ$(M-;TR:V@U"$B6/$L942 MJ<,O.>#S7-[]M)=>O;\!^I\\>#O&.FW5^_Q'T66\@TS3[>XL]-\.:E;SK&D$ MA0RRFL>"_C]X)\7RBSM]9L+#5EA$LUG<7"H8R3@[6 M.%D7/1D)!]JT=%\8RZ:FD>'O&FC+I%Y)%'907PE6ZTV]E50OEI*0"C-C*QRJ MI;. 6-:VJ> ?#NK:->6":5:Z?'>J4DFT^W6VF7C&Y64 AAZ_S%#:J7.I6MC;S7=Q(L=O"I>2 M:;Y0 .]>0:)\&K/X/6=_'X>M;FP@NG6277='#R79922#>6N2LZ\D,\(5L?PK MC-7?")UB\ANIK:[/B#1'C"MJ-]XEBNM.,H8[U3?"TBD8&5?[N<9XS3N[NZNO M)ZO[]B>FFX_QSXBTGQ1J'A$17%_IMS:ZQ'/]N^>!([?8YF+,.JR*!'M8CEP< M<"M;QU:IXJ^)W@+PS= 2:3']J\1W$$@W),UL$C@C*GC DG\SGO&M><^#-(\0 MWOC?4M7U/3M3UOP;[KUK?$3H)_N8R MM;K;[E;6_P O0QH>WM^_:^5SU>^^%O@V\F>67PWIJN1ES;1>1N]V\LKG\:0> M"O"_@^SGGT[0]/TZZD4*9H+=?.8;AQOY;'U-5T M(Q(%.0:YE--V_1G0=Q<:2;RZ:9\R!B<+P% [5F^(? FG>+-+;3-27,&Y95F$ MFTP,AW*ZG^$J1G/;%8VI?'/38-<728_#OB%-8F(CMX=4L_[/MY'(RJ^=(=H_ M ,?;M3H]/TSQ&[Z;X[\8:7=372@GPKIM\MK:!&X$; L)KG/+8_">H7WAZ33]3T/5+ZXU"TU/799(KB[#,%\TQQC"JX3< M#QNR&*C-=1I_BCQ9X6NIQXG\-OK*@AX;SP^GF(%;^$PN^_*^O?L*]-AMTBL8 MX+"UC2"$!%2%0(XU P J@8X '%!6M^R$<3X(\81>,OB)K'C.2YBL?LM@-#L-,D?\ TN.,3&2:>5,?NS(R MH G) CY.3@=GK%[!XBM9;74[.*\L+A?+DM[J 21NOH58$&O./AKX$EA\0^(/ M&5[+;QG69O-CTZTF$R6[9RP+KPS9].!^=>BS2KS+(Q1\_+N'+'TQ_A64KWT) M.,T>27X/Z]HFBVC8^'VJ2#3["*Z/F-HUX7(T;0[>R$.D6LK0I>-/&TC33,A#,HP$5"P V,2#D5 MUGAO2[?PUO@T72;;2HYV#3"UMPIE;LSD#+''&23BN1^"WAMU\!:9K-Y)OUS7 MHUUG5;YBKM//,H; (XPJ[8U4<*$ %=MK_CKP]\.]#AU#Q'K-GHD$LJV\,EX< MR3RL<+%%&/FDD/95!)IC1B_M!>.;CPA\.;JTT[6X_#_BC6$>UTW4G,>RQ*J& MEO)-X*^5"F6;(.>(;F(K M*$E1@&S*[F9ED &%"<#BL:ZT_P :6^L^(?B)K7AFX\7:[J:0Z;X:^']J(4?3 M;)7\P2WDTAVQL[@2R#D*510&91CTOP?\*MWC![> MS^(&A06UHTS36FAVMRS?9<,?*>1E(1ITSN&T%$8 KD@-6K\']?U+7/"-W%K- MX-3O]%U.[T6;5 H7[;]GDV"<@&;_Q/X36'3M* ML$6:]\+R _8[[YE3=$>3!<,2/WG*N<>8I/S#IC%132Z@>N2X4#:.3UYKQW]H M.SN6L?#-Q)M&AP:M&^HIR"1_RS;(Y.&QQC!YS7KY5MJ,\94G&>^">V?6N>^) M7@ZT\=>$[S0)WFAN+E=UM-&K9@G7F*0X[*V"1W -4MQ&C;:/9I>&]CM8$N9$ M4/<+&/,9<< MC) S5X1A>-O Z5X/^SW\:;CQ%;75IXFU2*'%K'<6MQ>3Q_,5 M+13IYG 8K(C'!&[!!-=MXP_:"\!^"='N-1N-;CU-85W-#I?^DN.=HW;>%R>. M2/;-%F!Z#=W5KI=G+>7<\-I:PKOEN)W"(B^I8\ 5RNJ?%G1]+6&>&WU*]M6W M$ZA%9M%:0X&09)YMD:@\X;=CCKR,\=INE^//B%KRZSJ>GP^'M(C<2:=I6N[; M@6S #_2#;Q[3)+G.WS7"IGA2>:Y'QYXHO/"?QHL?"D'A.X^+GBZ;0)/$%K-J M^HK$%9+E(3#%"4^SV_#%Q)C("X)/6@9\_P"B_%2"_P#VA-9\'Z?I>MZ5HUX! M8:#:,K&&V2>8W$[J;8^?);F10\:Q%5 )#2!%Q7W!X)^%NC>!9ENPXU;7?+$; M:I:X/6/VDOAY'#K/BB[T#4+N?PG>?V;-J7]FH\ MT%R9UM7AB=B'!WR@,KT%)3]IEM ME,I.3SO W?K6 WP]T^:S:RMM7\16]BRE1:IJTCQJ#QA?,W,H]@V/I64HR5W! M_)[?YBT&>+/@OX'U/.KR/=>%S;!VE_LF4);,K,K2![=U>,*Q1=P15SWZG/3Z MEX&N_%5G);ZIXOU'4])/[R6&2TLE8=\F;R&?'7@BQA\2:J= \2 MV=K#]H.J21JE\S9'F0D'YCG&X;1@GIS7F_[8WPATW4-5?QQX8FT)K6.!+2[T M&TMA%(LZ!Y6N)64;8N,_$+2X;JV$-Y]@TBS M6_MD# -Y$=2^%EO;ZSK7A7P3XZ\%Z5\@E@TI+'4M,68A))E+%D,9+9D.1A M=QZ"MB&;X?>$=0M[/4O@OJOAV./9=1WT'AR"[L5,:>6LBS6S2 %8R0#@':3C MBOD&U*/OZ+^NO^1X"]UZ&Q:_M(>%=2D$%MXGL#-N"*;%)YTA#*&"' 'I[TZ57F(R^%QV&,?E2VMJ(U M9%@Q66[S+/&,/< ,&#-USL/ X!^;KBMTQI#* MH 4J_<]/7TK,\4:;-JFE1VT<@BN//62&;'^KD7+(V!Z$#\,T\ZT(K)S?VMQ9 ME&WM*$,L( Y/S)G Z]0*QC^[D^;9]?T-?BBK;HVKK?<7$<;%0BGHO Z9S^%5 M;:8EW52TBC(_=\EN?RJMIGB32M>L;>YTS5K2[MYD#K/;SHYE!&0P8'H:O,\5 MLK/%/#%$B_-(9!CGU/:ME*-]R+,K73/)=)&J[EBY95.%'MGN:\:^)&@W&F_% MK0?&V@Z5=1M:V%S/J5[I1_>WRPH%^Q31_P#+4-$S-&PRRO$ ,;J]'_M!+<^._"OACQ_X M/U>1_#^KZ)-I,EU!,80+(1^4UFT?R-;LG\#1D%"O;%>8>/O'2V_PZ\3W5G=:?+\.?'-FEEH M9GC-O+I=_--Y%U%,#CY$),P!^93&ZXQS7K?BSX8SVVJ2^(O!M_#:^()(HQ>6 MMUG[#K6Q0%:8+DQS$=)T!XP&#@#'JX/%.UI+;\.O9=SBJ0]JO[RZ%BZC:2/ M /?WJ@'/X53\-^,;77KB:QN(+C1=?M5#7FB:B EU![@=)(SVD0E3Z]JT+I0D MPP.&YKZ2E)26AY52+6Y&W//:DI=W&,4?>' KS_\ 1*5G>./B'X7MM-UO1)?$6F1Z MP;2:+["UV@EWF,D(5SD,( LRQE-0O&D4%"=F8^6X!5?]IS*G_3/KN]Y^*WBC2/"OQ\^ U]JU_#86 M3Z#K,*32$%2[16@5054#GV4#V%>>_$KPT-=^(?BV6?1M4U'3;6^O[FZN+6RO M[N.!@D:QND4$JJTHW,054NAV,>,$>K^+)3N23GJ.\T27;(OHRBYQ[Y&,$ C%5]%^'LVFZ3':ZGX^\1Z MNT9(B9;W[,L29R$!0>8X'0-([M@9Z'XPD\ ZY?Z)XKU:9M'><2Z+XDOS^[>)U^:UN9@ J2QN&VO)CS$9>2P- M;/BCX;>&O%MJZ+)'9K,4>;[*JM:WRKRHG@QYH]C7$W_P /_#'AFVN-2M+RY\#VJ*9)KC2]1-C:IWRT3$PX'NM+ M0HLP:[K_ (65A?VUGJ^C1*L<&[QM1U[6X(]0TW4+64"+34AG0K?O(0=HCD4!4 +,P*[<;B,+6/BUXD MT_QE:^'X=3O=9TO^REUA]8T/P[Y]TT;R^7$L@9O(C4@._F@ ,%X4=_G[PY\/ M?B%X,^+6I>,+SXI7T?FZB^CPV5C]GNI;I9I3*T;Q(%BA92#+(L9W?*Q)!.*E M5*;AS\WIN[^ED_4I1O?6UC['TSX>^$[&(C^R[/4KISNGU+6(A=W=PYZL\LH9 MN?08 Z <5S_ (\\,VVFW.E^)M%L(5U+29XTEBLX]IGL6;;-"(UX)4-YB@#. MY,#K6!X=\8?$N.;4$FN=-G^QP&7[+KEI(GG@KE&BN;=V7!XR&#%<\@4^R_:4 ML-+T4)\0=-C\)7$[JMMJ.G7BZEI-YR"!'=1_ZM^"-DH0Y'!-.,XMM)ZK^M3. MW4[2W\8-XT\<:8^BZIIU]X6TZWFFU+$A:=+UBHMXBG_+/:OF,VX!L[1@5UMQ M9:-?,DU[96-U-&=R-/ DC*1T(+ X->0_".;P+\0)+GQ3I,-[H_B/Q9.VIM)# M/LO8EC41(IV$A5"*K>6P*@N)H_-< ML0T,J(I1&4 '>2@(;@9S65..CDU9R_K7<;-#5? GA/Q1J,%YJ.CV=S=P@"*9 M-THQ6[M:W6H0ZM)9Z6SJU(0VU[<0VE]K&ER+<2Z=9.?](N8U3)++&#@ M@'9NWXPIKLO">EZ1X?\ "^EV6@QP0:-!;1I9"TRK"6VDKW+,6Z= M>*G)V@AGS[ XQ6D?=5D(\&A^'WCCPCI\\NC:]I^KW,S+))8:A+*\8< 9$'+VPN)U+00QW5NZS,$W2%'9U4;1G.X@5[C\ MS,W?/IVKRSQ)HR_&3QA::%-!G=M1OM@)OKQ1A;.)NIB0G=,0<,P6/GY M\3&*7Q,31YPOB;6+VQD3X/0_V/XDOYM]QI]["MUH=ON)WSR,A,43]#^Y?+$\ MQLO2>%9KOR;UM.=;.99=H$RZ:\O8 !6? +$1L6 M&1Z/X5USPMX@T74?!W]CS0VEE%%%)H&N6[%DA9?E#!RV_H?FR3GG.:S<.9=T M^O577V;6^_?S+3LK&I\+_"O@_P "^%UM_"+02:?>2O=2WR3>>][,Q^>:27^- MB1CT&, #%:_C#QMI7@7PMJGB'4YLV&GP&>1(N7#]7MG\.VF)+GPOX@O#'',N0"MO.QI=7W_+-A8F,^1;0K@@N-TKD,W"C.ZC MV)N>A_#'Q&V@^'[FX-M-KWB;Q!?R:IJT&C,LL5D[X5+5*GFL"T\1+\-;J4^,-'TW2+:>3_ )&O38]EA(Q.1]I#$M:L M2>K%HR2/GR0*[\+B*=%2YXVQP8K#U*_+[.;C;>QQ=OX7MO@%X"EGO-"T/ MQ;H>EP)L@M(5MKB#HH2**0/&V6;E@R$YR1Q7/>/-+\,CP'K=Q=:IHNH^/M3\ ML6]KHLJ2"U_]6.JG'ECRI6L?0F@W:#1[!;J1 M4NEMXUE5FR5<* 03ZYI;[4K6.7<@MY;@<(RJ-X^I/05RL?Q4TR7S&L-)\3:H M0/E\G1YE5AG^$N%S0WQ,O+6\7[3X%\3V]@RMNO5MDE(;C $2,7(/KCC%<]F: MG8+)8N2\B6GFR@&5C&I+D=,G'./>G_:K623S-]NSA=GGX("ZK:2VF?8%P%/YUT$FN12.@M(&FB[R(ORMZ%3WH%4+4-#D1E(@/*SUV\<9]JYA%+2,$D3;ZDX_6NYO+I_+(*&-B>% S^)K M%FM)%9FDG54]#425R64=-LK1;J1FDC=A$FY@_NW%6I--MR=R.N?][]:BL\0Z MQ,HW-NC3YNG=NE=)M*XW-A3T&.3196&<]%9GS"8W#=QQS]:Y+XL>*/&'A3PS M!=>"/#5OXKU-IS'<0WET(%MX]AQ)R5W?-@8R*U?&WC'P[=:L/"-_I&J:[J3* MMTMG:0O$C@ D%96>-7P,Y56;'\0% MW+(H)_BQQUJX6A)2M?R_X9I_B.+49)M7.*TW6?%>O6IM-6T#PYJ_Q#CC?^V? M$'AN)'32+*9=L< !=?M5RR[CY)?:HPQSP&N>'9/".DWCVFF^(M$ 5+:1(EGG '#*ZR)DX!XX]#^$W@R7X?>$X[.Y^RIJ5W/+J.I"R MC6.%KN9MTNW 'RKPB]/E1:[K[5+(Z^66.!RI; Q7-)*MS:.#?R=D_GI^/H+F M2=T>#^'_ (A?$/5[.:T\*Z+;^+_"D^&YO"GBZ[T328$M&UVX@1O+[Y9=P_=J&'*DA0,#[M= MEKWAVSU^[^VVC?V)XBCPT.M:>H\X$=!*!Q-'V*29!&<8.",/5/B#=_8KFP\1 M^'!K]A-$T-S<>&G^VQRJ1A@ULV) ",_*ID^M6TH6YI??;4:=]CF?"4GP]\;: M]KFJHVF^"_%L]]+''>Z%JBVT^I0 @QW!12%G)!P697^8.,\5K:/I/Q,T&YNA M<^+O#7B[3P=UF;S2I+&[*Y.5E:*0QDCCYE09[@57\*:#:ZM)/!H_B.Q\2VEO M(L\%EXDL6FO=+QP(U5BLBH.,;QNR#\QSQIWWA'Q3;Z[8ZO;ZKYZVX)N[/2IY M+)[Q0057R96D@8CYLDA"PP-X/-1)3EI?INM_DG=?B*]QF@?'"]WW*Z_X'UC1 M&M"!-*&6:,#GYEY7>O'\&\CTKK4^+'@V6))G\2Z3#O4,%N;I(),'U1R&4_4" MJ]OJ&N>+9/\ B17&B:CI.[R+_3=3LIH;N _QHX#$ D'&UTP?4@US&H1:5\.[ MR33-!TX:(;E\F?3;NTNX+.8\?-9RS(RJ ,D1@#GL>:?M9)J\=_P[W>J_KJ4E M<]#_ +=TW5;73KNUO;>^LYI0T=Q;R+(DBX89##(;GT-9=]\1(X]7N-,\,Z?) MXCUJU8)/MD6WLK5\ A9[AAA3@@E$#O@CY>:\+A^)1^$>I:O=:IXP\(WS:QK) MO7BT:RG=;1=JPA4M1,/WA(RRIN=V+'GBNO\ "WC1/!(I5-8/R]?3O\ ()1DD>B?#OP; M:^"_ ^FZ'J+6.HRVYE0 M3$HQ^E8OA3XB>'/$[W$&GZQ%!?6V#L+>YMP>A:-SG![,N5/8FNR$.UMQ MW$D<;AVK5QCO822*],^)W[07PA\ M,Z/?1^)_%>@W\5JR[M/61+N620C*K'&N26/.".GJ,5\J_"WXI>&_%7Q0\6?% M"#3;Z7PIHMM"NH:3?(EUJ2V?G1&*Y,:Y)B@=&<$LSA2<#Y*\^6&J4%[:FYQI<>#=*@F,]K (7N[F] M203(^2VV$+$A\M3]_DM\N*[21H9D ,JAAT-8OQ.AB\)^.O#OC;3Y8[JS\1"W M\/WMK$.3)Q@GN*SY8S$Y7.:]:,E(\Z47$JR747EOB5?NG^5 M>8>+/$6F3_&SX$:/'?0OJD?B,W#V@)WK&=.N0&Z8QFO5I5_*-;NM% MUK[-;W,4-GJ4=CJ,Y\UHP9%C83;(8SN7Z_P#1<->7?'KQ-:>$OVF/@]?WWG&#^R/$$?[B M%Y6R4M<<(">W7&*]0^$?_'QX\_[&>Z_]%PU\S?M]3:O:?%KX-W.BZ)I'B&YA MM]::2QUR)GMGB\NW#$E5+(PR,.,;3WI-Q2O)V7F:4ZQ]*^'_$&F M^+K.._T:[74;5B=S1Y^5@/ND'D,/0BM"2V<1Y<$98L2S$#\_:OSYT'XJ2>(- M%C\#ZKI, M-:M9-6N;:&:-IX]DH:6".90KK*=K*"PSM&1U#U]>>&?AA\+O'O M@G3[NW\$V']A:A""ME/$R+M/\,D8?:3D"+/3Y[RW\5Z%>P MVT>6DM]3AGP ,X"HQ)8@< #)K1T?X8^#O#>FFTTOPAH.GVF-AAMM,A52N,$' MY>1CUK1L_#ND6N5M]*TZTBSPL%G&F2!R>%IV>MC/0\.\3?M0>&+/PA8U+#.U7?<#]Y1TK:TGQ9\.+KPWI6JZYXVT7 MQ'91QI?1:EKUW;GD@D2^40JQM@\ (".!UKL?C9\,[3XO_##6/"DL%I++/$)+ M#[9'NBAND.Z)R.V",9]":\SD&C>*O".O^(9_ ]GH-L8;B"[NK*ZB,/GQ,8Y+ M6[M678Q\T%=RK(#A2&!QC/EIQ]Z=W9WZ:>@][&3\+?'6M_$71Y]9\!V0U6Z\ M9:U=G5/$UUOBM-(M(5>.VA'&]W6-8\1J 9'RZL:]H^&'P?T3X9Z'9VD$$%W MJ,*,KZ@T6UF+,2VQ26\L$G[H//4DG)K@OV0=/L_#/PIM_#MU#IVC>)[6ZN7U M'1[*[\R2)C*0LA4L6 90I_N\@9KW*1G7[C!O4-50<:G[R&SV].FS:^X4K7:6 MPK0K&AV1*Y_N@ 5YS\3/#MG9^&;NTT&+2?#FO>(+B&T%TL"*9?G!E8Q@8F=8 M@Y 8$9P3P*[V;4WA6K>]4X+GXB>&]'N[O48)=,6U!S(FK$*B@??VS?:(I$]B M\1]A7JMU<2+,QWL<'UHM?$#0O\Q9AV*GD5>WPNWY!S'@6H?&SP)8:+>^(/$> MDZ3JMUHUO-(NH2V:Z;[:5;]VS/@#=#*YP>$YK8^!>K?"EOACI]QIWC7 M3F2=GO+BWL];EM(K*:=C*UM';^:#&B%BH7&>,]ZZ;]H(V'C#P7I'A_7;>WGT M?5_$6EV5]#?[65[=K@,PPWJ55?HQJ/P[X6^&7A/7+BR^',^B>&/$(9I+BRT6 MW$T$8MR?_#%*S1>M-2^&]C%(D/BB^=9)7F++JM_* M S')Y5B ,GBEO-6\(W5OY6G?$K4="G+*?-DU!F!&02-MTI'/3/7FLCQI\;?$ M>@ZKIVF7*0^%A+,T3:O=023V]PPP%$,;[&P21ECD#GDUG>'/ >HZYKVH7NM7 M.G^(]/FN6F:_?Q)*JP*5P4CMX\@ -G[SC'M4\\>G:_\ 3V [9OB4F@1RW$OB MCPCKMK;J97E&IQ6$Z*HR68%GC( &QU#P+J47Q,7PQX9U"'4%A@C MO+W3-1M?M=AI<+!E1I7E9G:>1@2D:X^569N,$X4_P1\$?"_2[N2\\4+IWC>6 M8W?]I:;$6F@D9]S,L"'()/&Y\#'' XIQ]]>\M/ZW7_#AZ'HEG\2/'&L16,VA M>"72S=VQ:WUK+;%(<$1@RR-&FX_*2%! Z9;K6%XV\%^+O%\3ZQX@T'PKI"6< M9;SHM3DBNE0<[1<;65/JFR?".[\11V:^,O%=_P"(4C97DL8XTM[.5@A^(_"_B;X@>"->U^UUO5-&L)!+I]IXD=9[B"Y&!'=F,+L5.?W94A MFRO&<8^D[J71/BSJDNGW=C>6=W8H+BTU2-O)O(SDC?#,G,94XRI.#G!4C(K$ M\=?#FVTP2II.E+]_X13Q'-YFKP0-<65\J[4U:V#D-*%Z+*A($D8X M&0P^5N.SDB:=",E5;C@UX]XZD\1V7@V.\\06VE+%IK:S:?< L% MD,%R0K!LE6C$IWJQ7'(K.\-_$[7?B=#9P>)OMGPBLIX5S;W"&WO-48]6AN6^ M2"$]E!\\@\^7QGR#U#O]:\8+I>N/X?\ #5@NO>(XD$ES"LHBMM/5ONO=38.P MGJ(P&D8#A<6_G>,M[,2Q[FJUMJAL; M\6MM'(\6>2RG=^)J;V%=HY[Q?XL\8_"_P=J.LZK8Z/XQCM44*;69["YNI68) M$GE,LD>]G95^5@,G@#I3_"&FCXL:4+[Q3>SWDNGWS6UWX>BB^RV=G>0L"T;A M69I]K;2&9RC##;>U,\87:>./B7X4\)VS&:VTBZ'B'7-GS+!Y2D6<#XX#O,PD MV'G;#G&,50^,'AVSO+[^P_"\^I:%X_\ %RR!-2T6]DMC;QQH!)?W"J=CK&"B M#R-(3EGDP?\ :-1R.9%!BE4KWVCK]*\P^&FA_$CX:^#K31-< MN(_B/!@>LC'_:-=*OQ!GM>+_P +>)-/[E_L NHO M^^K9Y./PI-:Z#]"SXCTJR\40S:3>0Q7MG<1E989@2I4]>,5X9_:7_"J/BO+& M+B]L=!CTS'_$RNYGMYI-Q.V(N2"548 !'O7IMQ\2O#L&J2MSN+&XM; M62Z%G?VS0R2A$+;4!^^W&,#UJ";Q#JMJR_:?!GB-%Q]Z&*WGQG_928G]*Q_$ MGA[Q#\2WTVRLM 73M%M;N.\OIM><6EQ?(GS"VA$8D:-6;;O=@,J"H!R2)OW) M,/PUJ-MI_AS3KWQ)XZUBV\2WUI%=W+6FHK*/M#Y=HXX&5UVKD($ Q\O3)K2A M^+SQVD;MXZD5M[1.NH^&?+G@ ."TRK(H4#CYB #UK3L]KT+55B1VXUYYXK\&^$O!_A^YO[FVN[ M6RC!D'V.\G1XF8_*(@&PN3C Q74?#^TUJQ\)K=^*+J1))!Y@CN&&^TC/W4D M<$!VQW]ZF=G&][!K?:YU+7E])D"SM82/^6;3LY/X(O'YU1D_M0ZI;V+)8-)- M$\S+$'40(I #,>2V2< #'?GBK,>J2R1XL+-A"O\ R\768(OKC&YOR'UHT^;3 MM'6:XN[Z.>ZE.Z:=F!>0CHJJ"2 .BJ/U))KDYOY9/U_KZ+9\.Q-'YFI7 MZW,*\F$ 0P?BN%P,#IG.:O7DFG:7L+DI)(=L<42G>Y]%1>3_GI6D79>T6GK MJQ.S?+N8&M6&@>)A&=3?3KJ6+F*Z,@2YA/JDB,)%_P" D5E&'7]';S=!\0SZ M]''REIJ^G^>K?[+72F-L?[1W$=\UU-GH\EQJD6J7Y-I)"KK;6ZN&90^,EV[L M0!P.![FM&=I&D A$S#'5I#C]:N+J25V[?(EJ,=OS.>U328/%,EE!##$GHQ4 NQZDGC MGCU.I')-#M!^^QYVIW]SBK='(LB266H M7%L693E6VQN%R/7&?>NQNK,QS6O&]FF'+G_9/:J_B37-'\(6/VS6M1@TJ C& M^=PAD/HB_><^R@D^E6XT]&TM"?>;.%^('P7M/$GARWM-)M]-.J6/SVM]JEBD MEQD*0 )QAU)[O\W4Y!KSS3?!?C7P3X'NI(/'>O\ A2\MB7N(_$>I6OV)!PI= M+@Q31K']T*K;>F,+7KT.M>(O%3'^S-.3PMI6,+J.N1;[V4>L5ID;!Z&9@?\ MIG4I^&&DZBT4FL/J7BMT<2JFO7)EM5<'AA;*%AX/(RAQ4>RVY':W>_\ F/F[ MGA/@#Q-JOC[P3!_PE'Q+\;OK:R&*>U\+1VK"[\MQ_I-D8K823VY #;X]V!D$ M<5ZEI'PN^&MQ;VVJ:I<:EXC:ZP(Y/&FHW4VXDXV_9[HJ@)/;RP:Z3Q-\+=/\ M0:'_ &7;M!HL22^?!';V$$T"29SN$,BE 22<[-K<_>%VK/%NQ<1V5Q*"&(;#!)&)PN <5-ZL79OKZZ?A;\0T9ZQ MI/@[0=!6,Z7X;TG2EC'R&UL880H]MJBO,_#O@F.Z^(GB^XT&Q7PCI5U#!=0W MVC(L*ZO*P=9))8S\KA'SU4;PW'!S2MX1UV\\-PZ%X?\ $VBZ+;!1_H-G:3Z; M,L1!W1>6TDH0'/($9QTJ/PK)X@L?'FKV:7%I>^-_[%M #>7;2:5<64,TB[E\ MB-?L\^^0J08_F"K@':<<\I3K2A)+W4^CO^J_7T-$DHM=SE)+6YT%+?X4^/\ MQ.LFL:KJKWO@CQ/:V(@"RQ_O8H&CW$"2,[UV@X>,E20378Z3XNN;*^M]%\6V M \-^()CLARVZRU!AU:UFZ,3U\IL2#/0XS3/B]8_\)@W@[2O$^BWS26ERVNW- MIX]GB, "12Q;45FV32(V=N>,8.2*T/!/B*_\ '%EJ'ASQQHUIJ5K-(6TZ M[EM'2WUBW'(:2WF4-!<(1AD8B2=OE;[B#1E@N6'3%,_X55<:=&K>%_$-YI$:_\ ,,U,'4+, M#^ZN]A+&/]V3 ]*J75OXVT<@7/AJSUF,'YI=#U#$FWU$,ZID^PD/MFOH:>+I MO6]F#R#QD$$$$@UQ/CJT,'Q.^ ;EL@^*6'3_ *AUS796 MJ1E2E8YZ,'&JKGT_XQ_Y$_7?^O&?_P!%M6?\*_\ DF/A#_L#V?\ Z)2K_C'_ M )$_7?\ KQG_ /1;50^%?_),?"'_ &![/_T2E?/'N&/\(_\ CX\>?]C/=?\ MHN&N%^*61^U9\'L$C_B2^(>G^Y:UW7PC_P"/CQY_V,]U_P"BX:X/XJ'_ (RL M^#G;_B2^(?\ T"UI/8#SL_LX^&/B5\6/BGJ5Y->:=KEIJ]N]M<6S*T2>98P. MKM$PPQSN]#@]>E8=JWB_]G7Q,CZHC2:5.6#313'^S[]N-F"W^IFZC#XS_>/% M==\2;'XRZ+\?[#5OAUH>C7/AK4[6W@U:2^FVPW)B+A=5.U'C5L@@-G M ]?\-^*-'^(ND7]C+:*MQ"/(U;0-2C!FM'(Y26,]5/.UQE7'*DUQU,-*GRU: M,DFUZKTDNC^YGN1QO-3A1QB]I3MIK[T?1]/\+NO)/4H^ ?BEX>^)=HHT^ZF@ MNPF^73KL%)D&<$X[C((R..*[$((W()VH>5;M[BO&]<_9]N-"_M&Z\!ZM&8[<27ETUI<7,RMOB3878Q.#A)"JL S!N3D#BN8\0V, MVG?#?P>?#NI#P+X-U?3'UV?P_P"(F:[33&788'29&W -<7$+LA+*S 'YGL&*7<,HEC8*2&(<'! (.<>E8.C!QMMTTT>GFC$XCPG\1I_$MK?7-Y;V)@ ML7V/=Z;>&>('NLL;HDL#CCY77OP37$R^.E^&?A73=%U;5+KQ'XJU*6:X:06[ M%F9YBX4J/N* 5C5<_P /U-<1\<-22[6,AG, ML:'?-9Q,L98[6VD@C R:]FT/X>Z/HOAR/5+6X77=6O8(I)_$+2&5KW=@[T8L MVU#G(53C&.MFW,TA:/39K M8R"%.< LK?>(QGK@\9-9&G7^I^ =4$OBZ?5=1M+MF4ZD+R2>T@/W@/(2,>6. MVX_2O7Y-+:.0;HU!)ZU:MM-.5W)N0]VB'R+^9E5HVC5>DC!@'BY*/D=,5@?M!:/H^D_#][YK-8;^.?-E>1/Y+6 MTH1Y#+O R J1OG')Z=ZS? OPKL$\-^')O$T][>33VZ7L6FVDSVUO9M*!((K:XT/1=;TWQ?;M#]FO;AG6:*-6W_+9 M)O=@>AW*@.>6%=!X@^'7BSXHM UYI=KI:&99I;G7+:S42 X!M8DDD90<-B2 M=<[1D"O7-"T[3O#VG^5I>GV^FVC?,8K:/9N/JQ_B/N+[;P## M,]M82:>=3UR>%R)&MC)Y<=HK#[AF8/N;KY:.!RV1=RCQ#XLVIAM8X[:WA2 MW@A18XXHE"HB@855 X &,>U4]>\,V7B*"(7#2)=P,7M+R!_+N+1\=8W XSW M!RK#@@BKYIWFBD?;!K]G!Y-J:67[1/A MKXO>.M7\%^$O'>DZ+#I;+%?:K]H5;N\8\,FGB0;&"D%6G^;!X5?XJ]C\/^&= M(\":.+'2K'[':EC,[$EY+B0_>EED8EI'/=V))]:2WNXTNK M>3[\,RAD?_>4\-^-96DZPDEG$%C9OO=N/O&MJ-BX&!D^U2(XB;X:'1YC=>$= M6E\-R@EO[.D0W6ER'WMF(\HG^]"R?0UQ'Q)^+&K^%X]-\-ZI8?\ ",:YJ]S' M&=?L9!=V-K9!A]HO-Q4/#A?D4S(%#NOS-@UV3>-=4\=W4]GX'%NNFPL8KCQ5 M>(9;4.#ADM(P1]I=3P7)$2GC+D%:WO"W@JQ\(17LMN]UJ6JWV#>ZIJ$@ENKM MAG =L !!D[8U"HH/"T_49@ZQJ6B?"7X4WVK>&;"VO;.!5^R16\XD6]NI9%CC M+S DR.[NNYR2QYYK8\(> SX;U:_UK5M1DUOQ3J$4=O=ZD\8CC6*,DK!!$.(H M59F.,EF)W,S'IYU\2/!'AQ_&'@73-(T6WL?$][KD&IS+8QF "RM7\R>>>-,( MR[O+0%PO-+(L; MR-EBV3DYJD;96D9Q&RM_"2V4>)/$^M>(-<.E>%)+J2V MM95CU66&)8B,@'$=PQ"@@%YM0T6:[622)(]22WTJU4#?[0MXKI6Y/5MH;\XK*3@9D!P/NXYIJ*'H:.EZ3JWQ 6,37%YXZM6VK)=K*VF:-@'/+;= MUT<_\\TV''45Z//05G> M!_'SR:$EQKT,GAJ6-_)8ZXRVT<@ $B%R!M/!'UKC/B=\4OBEJ>KZ1)\&M"T M[Q%H,?F+J-]J^(+:[DR JP.SJSQCG,D8VY'!85/L56DE*VG?;_(TA=NR=KF] MJTGB;2_&FE: +G2O%TU]%/=&\U2.2%].A0#:TD,7[LJ[G8' 4ENQP<=%;MXN MM]H30/#<;K_RVBOY44^X'V;(_.N3TU/&OA_QPGB+7-.TO6]0UO3H;6YLM#G: M(Z>("SF. S$+<[FE=SN:-N/E!QBNO;XD:+9-C4_M^@-_=U>PE@7_ +^;3'^3 MUE&,'>RU)DV.6S\;Z@Q\W5M&T&'I_P 2^T>]G_[[F*H#_P!LS3[/P;K5A--/ M#XSO)+B;[T]UIMI*^.RY"+A1_=&!_.MC2O$VE:TN=.U73]1']VVN8Y#^2L36 ME'Y3-D@I^-7RW>O0GFL*K&V7_IGHH_]FG-=P-5H. M[//M0\$WUQ]F_M+QQK%^&G&;>Q\NP0\'@&)?,_\ (E:FB_#;0]-CN6LM'M+> MYN8FCDN[C=/<-D$?-+(6?'MFMBZTN4S6C@*?WXQGCL>M:'V.5A^\F4@?W4&1 M4M9]T,1ZX) MK'N]'M[K8)PMP@_AF4,/PSTJ-_#M@K K;Q1_]9;<6[ MFT&VM@=>^*0\8SG/X5CKI+QG$-_>P'LOGEU_)PU3+:ZF@.V_CD7IMFM 3^:, MM7>7\OY!9=SD?B]\)K?XH0Z%>6>HS>'/%?AW4(]0T?Q!:PK++:.#B6,JQP\< MD99&0\<@]J\D^)?P)\63[3?7D@DF MD5-JC PJ*.RJ/4YY)[TN:;LHJQ6D=V?*WCCX8>.=3L/ 6GZA\1K7P#X@L(E$ M6H:OJMWHWP>!I7$IVQ*L@B*^2"X_>$@' \6_"GXP7GAOQ%8ZUXJ\0O> MW=^MY8:YX?"WTMM&LWFK&J!XFB8*3$)$A/R$9!Q7T;XZ\9>%/!NCR_\ "5:G MIZ6\Q4?8+K;/-!?!6X1+H2V6 M^*\0$GS+MI&5(R>/W<;-C #*W:'+E7+-J6C?G]W4EI2W1YUX!^(EY:^*K#3_ M !Q\=(/"^I6,]D7TJ\FF"7L=JLHE5G=PRM.LL;2JZJ=T657'3VGP%KEW8^&M M8M=!^+?ASQ7XNOY1?V]SK=M METZVMYAK3:3=_P O30\(^)'BKXB_!7QQ>7=G\5K3Q'+KER;J_;2(HY+,2$[ MKAPP$ORA?DP2J#<<\5!\$_BOXU\;?M,?"33/%7B"[UVW7Q%/=6FZ...*%193 MKY910 ",\$9)R<]J^A?C/\'H?#>I6\&A^*8))=7AB\+:5X=\569U&"&:42NC M6Q!!RH+N3)NV[,DU\Z? GX(^-_AS^T!\!=:U^VMI=&NM6O+9+ZSNFEVW"07* M-'*"H&X^6S C(QWK[;!9AEF)RVOA\1#]_'X)*ZOK;E:2Y=+.[WVOT/H*5;+J MF"JTL12M75G&2TOKLTE;:^OH?J5XQ_Y$_7?^O&?_ -%M6?\ "O\ Y)CX0_[ M]G_Z)2M#QC_R)^N_]>,__HMJS_A7_P DQ\(?]@>S_P#1*5\V?.F-\(_^/CQY M_P!C/=?^BX:\J_:$DU^']I+X/MX:ATZXU,:3K^(M4FDAA9-EKN^9$^]CU M7XG7$=W^T1\#IKR19?.\/ZXS,SJ!(QBM#U0[3DG^$D>E9U%>#_S:_%:@:>H3 M?%&UOOM=A>Z+J"*W[W2);^WMDB4C_GK]F9SSZX/\JXOQ<=8\<^(;/4](UB.3 MQ;I0&RV\/^)-,22T7H\;N]L3)$6^]$YP?13S7H>EW'A;P]K5[I/AGP8DVHP) M')>'2[&"&--XW(LLS%1N(^8 D\&NE5?$MU'Y5KHNC:2'SC[5^R*,*3 M_P #KA]C.+YE/;;_ (/^:L_,23T5W^'^1X=J'QI\6>';>VE\8&:PO+<8N5\- MZSI3V+E6Y$S2H6MG(ZAF"=E?/%<7>?M$6=G8WWCWPCK&OV>FW3O)K.@6DVGZ MA.)V**ERD#$_*P4*VW;G*MDG(/H'QS_X1?P_\+=8G^(7B30DFOK62PG@\.V$ M%M/=RL,,BS-YDB+G!=L?*N<^_C'[//[->DZ+X@T[QKX;O_'NL^3$Z6]Q:Z7' MIMKI)5%91MJG_ #)]O)OKI?H^NG"E M*$G.;4M+:*S[HG\;_M6_#WQ5H9UG0_#RQ>(U+Q+%J6FO8ZBT@7Y6\RUG!10> MI?\ *OG*W^-WB>?Q7<^+=3,ES=:BPT]YI+B7SXK3A8U4DDY!R Q^8!R>3BOI M+]H']F75_$MY_P )=/K.D^"#:C;>:AXFGMY(F5B<,XM(4S*6(&XMD@XY.*^4 MM62#0=2:P_M>WUV-9?)35K*"2&WN&QG*K( RC.0,]<<=:_4N$.'>'M:1JMCH^FVFR'[+6-KD$DESVZ\U[WX2^+'P);2[>5 M(?$>KQV\D-DFG:LT<,4DY"K&1:F95(Y51A=@Y]Z^3/ _A74?'7C31O#FE+G4 M-0E*JP*_NU499\,R[L#G .<9QFO5M+_8V^(-SXVFM]1TK0_$FER9-G?S:K]G MLG=>4P(G\S#G(.Z-L%1VR:YN)LAP&2UIX.&+E/EC>,7;FBWW3Y5)/>\=5UB] MSGXFRG),"I0P]64:L=>3>.O:]FO-7D^I]1^,/VE?!"Z7=Z4;3Q5I'B6&"5M/ MMM&T%KF\C9!P\)C5X@ 3G;(0I .1BJ'P5^*VA>'?ANUCXHUVVM=>N[N346L( M+.>"VMQ,1*8X%=N>)-;L799=#TC29IKE< M$_.Q52@C.#\X+#'Y5X7HGA76?$6J/J_Q$T;2OC'J-C<[8WUR"ZT"*UA/./L4 MMDL;R]R[2/VX&*[?PQ\2OAA#ILMC8> ;K3]+A.9X_!VNBX2W)SRT-M.K+DYY M"UKSI.5I)VMIM;UZZ^@^:%[7V\S8^&/P8\2_%3Q(?'GQ&\276L>#[V3^T-$\ M%76[RX QW1O<<@$*"0(BN>FX_P -?33Q;G5A&F>K.1\W3@"O!/ NH>&_&FEZ MG/\ "_XBZSXHO+>0EM(OO$TZS6QP,P_O5=D"\_ZR-\$X+>G73:OXE\*^'%U? M5_$%UX?A7 FA\3:5;WZ1'.!NFLRAP?[Q['G%5*M&_O::V6VI5FSM-0F::Y"1 M22-(.%&.!Z\] *X/Q5X,UG0=2U7Q?X3GW:V;4&ZTVZ&^UU=858QHV/FBD +* MLBH3:;I_B?2)!OCU3P?>K=*Z^OD/AO^^'<^U=-X?\ M%6C>*))(M,U"*:>,$2VA!CN(?]^%P'7\5J_,BPSPAK%GXH\)Z3KVGL7L-1M8 MKR$R??574-@^XR0?<&M.ZD+0_NP\CX.-QXKA?@>O]C^!;3P=?+Y.N>&(UL;Z MW;HP)9HIX_[T4B\JWJ&4X*D5Z&J#R\'!#=1[4QV.4O-:>.RO5O&L5ABA+7:R MRJ/+CP=QD5C\JXS][@UY%X=\.ZIXLM9+/0=0F@^&982M;ZY++NU?MY5O)GS8 M[,X&=RX?&U (RS^,S:7X5TV\\QV&J^*IIKMY+6*S9Q)!IXCZ$S2 M1A]K9*QQMGAP*^EY;=+K)>-7.>/E%5-1B_<;:\]/U8Y1BG[KN>;#3[#3]097 M^%.E&UNX2+W4-'M[6ZW*N J&(HDC]^ IP!WZ5>T?X?>&-2T^.^\(:I?:#;RL M2&T.]9("PX*M;2!H@0>"IC!'?%=-+I\EK J#GZ#%-QX$B%HB?JB#W%<]H^HWOQDO;_ $KQ-))X:CMBWVGP+%(8[R6( M' >ZGX\V%O[MO^[(.&D;E:ZOPAX\MKKR-,U: Z'K!5F%O<./*G 8Y>"7@2*, M].&'=16OXJ\'Z5XRM[9-2A8W%JQDL[ZVD:&ZLW(QOAF7#(?7'!Z$$<4QHU[6 MWCL;2"VMX([>W@C6.."% B1J!A551@ <8%5M>^R1Z!J9OKZ72K!;:5KB]@E M\I[>,*2\BO\ PD#)SVQ7''Q+X@^':E?%*2>(?#T8X\2V-OBXMU];VV3L.\T( M*]V1.M5?C-JUIXE^&-QH.DW,.I:AXP@;3M(^S2J\&-1Y2R$]6SGCZ5F7MN(FFNY#%%!"K2.S-MVJ!SFMN6-.'=^/8\5 MQOQ0\8:+X:\%ZDNHEV6ZB:UBBC&&ED<;550>I)(J;$'F?ANSUGXNZ2?$%[JT M^FZ#>2.MKIVGQ"-KB!20K/*R[@I')"XZ]37;Z?H^F>&]/CL[*QC2%1QY 3' M3'/\ZR_AWIVJ:/\ #W1-*U!,7%K;JDB;B0O<#MZUI3<2;"L6.NU4)S4RWT)' M6UU,Q*Q(J[AC[I./Q%6XXHAA9D4.?XMQ('X4_39GT^%BL&0X)+< _3Z59:9Y MD#-M0X['I4KN!7%[)'<26^GP,S*B,S, N[EJYWXL>"SXR^'>JIJ%W_9,5FC: MA,JKOMKE(D9S#U=1IJ[]4EPZN%B0GIQRWWWC;^U_%.HZ?H<.H"WT$ M:)#>>8);QF9HIC W[RV?K$0V0^4Y! !])\<:#;ZEL6[N+^VT29/)E>RN7M6A ME+<.[QD-L(^7J,=^#DQN+5MYDDQNC:+'WCR.!U!(/>NJLS#3:66E--9I;Q"WMUD"2)!'C 1 5^48]#D]R:W6_M5(RIEL)77/+"2,_ES MBHC*49N;3_,EI[7-G&SC_@6,_K5N:U@TJW66UO8 MM,A4?ZF[DS;^WWCE/3*G\#5!K&]NI#]KOBB< K9KL)X_OMD_D!63<>'-.U+4 MKO1]2M(I=.>%94CD D>X7/SLTC GY6V_*",9!IU*DI6]WTZ!"/GH=C8WS-+% M'-&UE-)Q&"0T4W_7-^C?3@^U2ZA.6!L$3Z1=OI]P,<@LB,L;,#WXZ=*["UOKMC';2:Q]FG(VJE]8> M7(Y^N0K'_=K2-1Q=I?I_7W%LVC'*0ZHG=(QY,P^@)VM]"5KC]6^-GA M6RN#9:=_:'BC6RQC.DZ+;M/.CC@K)T2,@\')XKHC)-V(Y6EH=#>:W>K);E]) MG6);H(65MQQL)W8QTSQ5BUUJ]N+J%'TF:"*2/>\KYPAQ]WIR:X:3Q=\0]12) MX?A9%II^T#RUU3Q%!O9-IP62-6 ;KD;^..3FF:IXB^*5O!,(O!WA*TG5-P%[ MX@9=ONRK$QQP>AJI2A%FWK^M>-:#\3 M/B!XO^T-I7@;2KJ"/A+HWES#!)G/W'FABWXQR5!'-2:1H/QU\47-Q)K5_P"$ M? =C]R.'2$DU>; /W]TJHH)],D<=*F\7D7\>GZQ^T!=SZQ<29BMIK33X9&ZD*D"XXQ M[$G'6JVH^%_$$GD^&+GXC^,]:MI=JW%SIF@"-S&QR=UX,(GH2,D#M6;DKN/, MD^G5V[V'J=U=?%JVT.4P^*([+P;=2?-:Z?J6HQW%_<1]W^SP%BOIU;KR:Q[S MXE^,O'D$_A?X0\-QP'3O"] MC9SPJ8Q=7,23W4H(Y:2=]SN3W+,:[*5HVC D;<%& I;(]A]*J'+*\KMI]_\ M+_,5SR+P-\#](\+^,'\8:XL?BKQLZ*CZU=P1YAP/NP@#"@K!_'UCJDVHZ7X7O=-USQ+9P[S:"Y)A@8DJOGR( M&\L;@>/O<<#O53_A7L6NZ+##XLFMM!?!-]X@U*QO-?U( M-';VFBZ86(>YE<)%"@!&XY8%G;@!2> *Y:U*G6NIKG2UMI9:=^_]:&TGR1]X M\=U/6U\(_%_7O$.K)!J^MV%O;Z+I.LY:>!$#D37$ZJH,5Q$LS*0C99>X .*> ML2+X9^+'[-7A#[7>:DXUFYU3SFF1T16MKD,\I7@R22.VU5R%"MR3S7KDGPQ\ M-_#7X.W6FM>1: UG%)J5[KLCEFBN&8O)-)+G'O MCQ\!M?UG39-)TYM;GLHI/-&W4$:SGEB K^\.)*)8 M)YCE?)W,OEQ$1D;ER^7(R/W?KZ-^T-\-[+XE?'_]G2QU6^OM/72[/5=662Q< M"9IH8;;8N]TX&6R3M!..@SQZ%X;^#7A3XB:QX_O]_B5\&]7CLGO(;;2M8TRUMS?&W.Y MH[5(]TI5B1\O/&351IU*K]G25Y/97M^+T1I3IRJS4([L]$OO&FDV'[0 TF]N METRXM]!)1H[E6>_#.9,2X&(Q"L;L!(029"5XS6=X9O/B5\9O#=S>7RZ=X4\( MZP'6S,3O=7LEF2523;A!OE3#\D*@(^5\FOFG0=*^,_C+XE0R>//#NLZCX2U" MXM[^YT?2(&DTM?+97#L49S.S*@4;GX)!P!7V9J6DP+<6NMV^A^+;V1?+$>G0 M:J]LB7+)IOR: M>_FFT3^!/@[X8^'-O(FA:2L4]PGE75[=1HTLZXY5FVX"?["A5]JS?!4^BB8G ;]V%PV.ZX8= >M8QJMVO'R>^_W:KST.=GP[\?/C)X_P#'>L2IXACU M3PYX;;SX+73989+6*Z@\S :8-P[C: >2,],5@6_[/_B[Q9\,[?Q98:8M_H]U MYLCB*58Y+6",$BX=G(4!BOR@$L3CCFONC0_!!O/'DO@S7M5G\6:9;Z*-1O[> MX+?9[&YDG*VP@$CR.N8EFRK.X(4' S7:W/PKT#3]/WQBXM(8(RV8V!4*.1\F MW! (!QCM7Z;E_%M7!8*G@\)2C1=_?:CS^T5MG=W7X^21]73XIQ67X18; 4(1 M7VG?XM-I73_!KRL?EKX"\;:CX;U#27L].U274?.VW.H:'>3QMJ5JV#]E98T; MR0WR[FYXS@KU'VQH/@CPO^TYXDM/&WBI4T"P_P"$?;PW=^$9KQ(YV9+E)UFC MFCD#"/*!1\JMC//K8^%/@NT^%^M37O@NVE\W4+R225=LDD,C ;3Y2\,$VDM@ M=.,UZGJ>@>(_%\L=U-I.AJ@17:UOK2*:29U).,LA*;AP06/L17#GTH8[$^W2 M46_M2E)R]'=O1=+)6ZGS&-SZGFE256%&2=]VY2;7FV[:=+=.YS=W\$_B*VH: MO<6GQB0K MX#UXN'A32;N22TW=0LUL3Y3H3D,H&<'Y6!YK6NO$/BN33Y4D\(VLDZ[0\D&M MQB#=N'36=AXJ3PQ\3[K0[G7M9N=8G MOH;63ST9[:*%!M1PK,'BWG@ [B !CGU#0KV[UK=%JWAK6;%HXT!OM3L[9A=, M!M9@$=W7)!;#@<&M1O%?B*%R+GP5=L!R?[/U6TF'_C[1FN-^*GQH\5>$?"%U M?>&/A5XI\3ZW@K;V7DPK K?WYG25FV#T0$G&..M82C.=TGN59/1F?9_#GX.> M.-W\11AO.GL]/.EZC$,X+"18XY!D_P 0//O7R7XJ^*5W^S3\>WT/ M1Y_$WC?PLL^V6^;6;F29FEP#"DL9>(/@_XB^#T-OJ'P MU\&>&?&6NW4GDW,]]";6:+Y<).%\T1@$_?\ +"<<@=JN,???-%2NK6;M][[% M0C#F]Z*?3^O^'.QM_"OA/XD7$\>D_$[4+H1QI>3Z;INL6KFURN5?S(5$J ') MR),9ZUB26^J>*+@V&B:A#\4[6U AMM2U6S^S16#@_,S:K&V^9@,_+ C-G&2* M\&\=?!?P+\.O$GP\\+S7&E^&/BGXHOK9K]=(L;K[/<1.[-<1NWF-')$S@+L* M\_*" *]$^)VG?''X6^)=)U+2_B3X;@\.S,+==+\3:A%;V[NJG,:$QQ;01C:J MY((.3BH^JI2_=QM==[7?Y/U#V?-)6./\4? _]J#P[\4=0\1^$?&MO?PWD"6B M^9>^9##;IETB(N \V [/@_-G=DXY%;'ACXT_'K1[R'PUXSTZRU&^LX"U])X+ MEMY]:;&27%K=A$E&"!F%6'U/%>P7'[1$W@C18-3\:>$=2L-!./-\1:;-'J%D MH8@*VY /DR<;N<5D_$[]L'X>P^"-9'AKQYX47Q=; )::=XH>2W42%@&5D90Q M^7/W>,TDZLHJ$=+=&EOZI;>6J*NVE!]_+_*YR>@_#OP/\3KA/&?A+Q1\0/#? MBF&]^UWLFK+6ZA2%. OR%<*-J\#%=O=_M=>#?"VD:K=>,9K_1)M M,;9/-9VD\]K(V0,1LT2,A)(^654QV9NM<]H\/PR\17!U>]UK2O%'Q!9$+0^ M]1N%-X\H/E"&(S,5;Y3EPRJH!+;17*_%+X1_%K3KK0];O8+?XG 7BBT\+_93 M*;$[@4%W?[DDGA0X)W'9O&=C 9!_M#J*$K9+:> M.48^H&*^(--^,&H_#[XK>)+?Q!X \5>'?!CSJ;J70=,AO=.MKA<)+*$GM01; MRX&2K#:59AD'->XZ+'\+_$VK2_\ "$:OX+T74A*;>^L+OP_%;S22 @[&P\)W M 'H-W7-*HZL)6Y=U=:K\7_DO6Q,XS5[6\CTS6/#.F>,M'CL]6T\7L2N9%%P1 MMC96.'&!PPSPP((/(-5=(-"@91=P3QJ;RVA) :83* '5 M =S>8,X!^?/7FK?X*W7AL1:CX3B@M[B8.;BWN=;U*&(C=D>6H>1%.1_+_'.L>.]'E\0>,]4\'1RQ:1?:'9W]A-YCO"DTX\VYC1]@WK&%1@<%L]>% M&-+P_\(5#%/I$60_B'5"RVLCCC;;1IAKC!SF0 M%8^.&;M\]:;^S3!^S?\ &[PWXYTV_O\ Q!;ZQT%9/ MDEP\8W-G?L^;YN?2=5NOB;\-8],O;+6I-<\)Q1;)M)U3PV9=2M5"_*HGM7*L M% P2R@N:Y\/[VQ(\.2V.L>3;:;#,MY8:BUX[ VYC+J\+,LB MJ^=X 5221@UI3KW]V-[/^K%*FW2:-<>- M+?4-ODGPVJ)?M&PR)#9RR?,.>?+D8YS\M',M//R8N9:'MU])>1Q[;>YF7=QP M!@?CBO(OBMIU[H.K:'XRN99-0TC1Y&%[;2,NV)6QBX7(Y=3P!WW<*T!.-T\D@ C0?Q-@X'/2LRS\6>%?%< \: M^+?%FD:GI=BWGZ;I%E*TEG;,O'G.&56N)PY5T[ MXFZEXT\3V6FZ#%!:V-_927EAJ.N3D_VELDV2)!'%DJR<,RN0^U@0N,D=(=(\ M=3QA0OAY2>-Q:Y8C_@.!_.O$?C!K7AW7O!^JZ]X#DN%M+J16NF2S)M8Y5&V& M> CF*Y$C)M*8+$X/4U]8,;BUL[<3PR27#1IO5CLRVT;L_CFJ:0'G.I:%X[TN M'SU\2:3-*A'_ !*9;$V]O*O<&8.\B-Z-@CU4U8\-^)+;Q0U[836]WHNOV:K) M_!"GBK>I>;>7Y,[K&%;;M!)P/7BN?UB6ST?XH M>']0U^1M*T#3[&5=/UC&();R<^7)#)-;MM0M[S M0-$EDM=0O)(P8DEB)WF-CD./F #+G)X%8FI?$FZFM;/5X? 8$$\8.GC5M2BA MO9U?H(K=5>3+>@Y]<5G*K"G:$M7Y)O\ *YW4,%6Q$'4@DHK2[E&*OVO)I-^2 M/,OB!\3M!^*?@OP)KECI6J3MJGC2PT_2=2U:W@$8G$LB2$_/N5!Y3CG&3L([ M$;%O^V-X6L_"OVCQ)'J#W2PWTMW_ &7;>9 T5K>K93/B0AN9'4[>25)()Q5G MXK>+/$L_A/3]+;X7:0;K5K^UAL+"ZUL9^UAO,7B$(R.FS=O5_DZD]CY:_P"T M)\;? 'A36;C5_AOX6CAT&>&2ZM]:U)Y]1CL;@;HY79556B5_D:8DD' ;)!:K MH\M1N45KMK=?G8*V&G1Y5)Q=^THR_P#26[?,],^-WQQLO@!9W<,UK>:[-%I, M^M:?:+)Y:+#$Z(T;S$=,R+MP&8#J,#-:E]^T;X9^S^(VCA\0WK^'_P!U?O9V M0D1)<1%D49#-Q,I!VX8*Q7.*^:?$/[:'QL\(VD4?BOPCX2MKC4':[TS^TK"0 M$P9 V0A7*S.XA 4 M#8PV, F\.1EBJY'(Z5V5\#6P=*G5G'W)WL[I[>EPK86K2IQJU%92V=UK]QT> MM?&.TTNS^'&J66_4],\8ZM;Z='.TXC\F*6*2038VD-@1XVY'7K7+M^U9X!OK MJ'4Q<:LUGI5S''GZ0-/ M\0&505N(=3L88(U)P"/-E5B1WV*>WK6?J>O1>'X&_LV'03J$$8EU2-K6:]O& MD&6$<<<2A!\OW09 !G@5Y%2K3;C%_:U7R.2,79LB^)7QENOA)XH\"Z=;:=-K M)\5W\UD%CD/F0^7 TP94"_O"VW:%R.2.:S_&G[7NA_#WQ)XB\,^-M*G6^L;3 M3)+:STUSO"7WQS\1^/KJXA\+:!KF@3+$PLK MG4+.UD^T2YQS%^\G0#!X537LW;\K_A<7+R.TCQO2_V@-/\ BU8: MPVN^+-;TGPE9Z/'X@NO#GA.(SFWL'W@"\N2ZS;B4P8(E7&5/(.1UWPG_ &IO M"UGK6C>$/"GA1M*TK4'^R6=TH^>>0' #^5YBDMR5S*6;#<9&*^EO#'PZ\)>$ M9)Y_#WA;1=&EN"6FFL;&*)Y23D[V"Y;GGDUO1P6UOY2+;01^4,1K'$H$8_V< M#C\*3IR::3MVMT_KY&G/UW/)/#7B#QGK/B2>&[%U=P).5C\RWAL+:+&[ +M M<,2/XG7''05I:'X-UWPMKDS:9X9\/Z?I;4)GY.6+H@.#ZNWMBN\ MU[3[/4&LS<0K*5F&V3I(O!Z,.1^!JG-IUY;INM-7F95Z17:+,/H3PWZUSNC) M-N3;NNENGKJOO'S1?0PVTW7IM::]O/$?B!;/H--@T^W6(<8^:0!Y&]<[A4$G MAOPPNN+K%\VKR:@IS&U]=W1ACXQ\L;?NUX_V>];L7B"73V":I#]D7.%NHW+P M-[$D90_[PQ[UKM,D\8D0LR'HR'(/T(K:,4]G?2VJ_/4C3>QD6*^'_.>XMWM$ MG? ::'R1(^.@+ 9/T-3R76EL!YFH;3GC="*;/>2-6_4BIX;.#; M\MM&N.,")1_(5LN9)**1'NLBC73[C_CWO&F8<8BD5C^E)))#;QEI;M+=%ZM/ M*@_I4LVFZ=,<3V$$C_[<*Y_E4UOI=FF6AT^U@(Z2")0?J.*?[SR"T69<.J/J M:LFCSMWSGS1@E9?]Y .3_=..PK;C2:7&XK'&HSGIP._ MT]S6<+SYE4UM]QI+W+G KSWS'\9?&)&T_Q"I\. M^#HY(+^PA"LS:I,JE?,?MY4))VCG,@)J'Q?\;O[,\+ZKJ?@[P_J7CB2UB*V\ MMGY=O9W-P3M2..>0@2_,1DQA@ #S3?!/PQ\36_A-=+O[W2?"D>H/)?:POAU6 MGN[JZGYG;[3*H"$DD;EC+8 PPZTY-3DJ?1:O;Y73U\_DWR_KR#P M3HY^+WA_2_%WB2\:XTZ?&HZ=X;B(^SVI#$Q2W/>>885L-A$/W5)&ZL#XN:'+ M'\7/@%JCZIJDHD\3>3]@EG4V@QIMT?,"!<[_ ')]>*]A@\(:'IFCV^GVND6D M-G9VZV\$:1CY(T7:J@]> !U->2_%338K/Q_^S^T)GC4^+"/*:=GC_P"0;=<@ M$G!^E:QKD[?KWX6_\DR\(_P#8(M/_ $2E<=\1O@3X.U:Q\1:[/I]PNK3!K^2Z MAOIXV>2.,;5;:X!CS&I\L_)D9QDFNQ^%IW?#'PB3_P! BS_]$I7208WPC_X^ M/'G_ &,]U_Z+AKQ;]ICPK_PEW[57[/5LSQI#9)KFIN)8]\9:&"%H]P[@2%&Q MD9VXKVGX1_\ 'QX\_P"QGNO_ $7#7CG[4.JC2OCA\.W&LP^'KB3POXI2WU2X MQLMI/L]N1(<]EQN^@-9U&XP;0SUKX>^'[KP[X-TC3[[5GUR>TA N-6FPINY3 MDM+CH 23@#H,"M*ZUM5!^RPF;:?O=C[YK,TR&X.@Z3;W+)<2Q6D*G9Q&S!!E MACL3DY]ZT+.1]I*QJN#MPQX_#%94TG%6T0F[$VG^;_Q\7<9.WW^M1PJ%F#"7#'JJJ-OUYYI;F[CARLLNYAR8XDSU]:H$>4:3XAL M?!_Q=^(8UG48]+34(]*O;>:\^595%N\3!&(^;:8QD#INYZUT?_"SK"^N"-$G MO/%,ZG_5Z1:M,J#U,C;8U/U>NT6\F('E"0+@8:0X ]0%%5%M;F[F;S;AU8G! M"D<#V_"I?D#,SP;XPT_QCX?BU+39IC;O)+%)')%Y#P2HQ62)XS]QE8$$?CSD M&M1]8;R0L;$*,\("1@>_>O-?V?H8+_P7?7QE EU+6]1O9K48,EJ[W#CR),\B M1 HW CJ?3!KU*2VMTAPB1Q*O>1QG-4]B=1UM="ZV;MP;'J1?\2^8HVU MLKD*\ADRP+(IPX.1P"H18U/5TCS-*L:C&2>G ' M3&<#.<4TD[C374YSX86,?Q"UBX^)NJQ12_:?,L_#4,JAOL.GI(1YRY'$MPZF M1F'.WRU[',/QT^)7AKP;)XO-<%\/?BQX=^)&KO;_!#5;B.[BG:36M'UBWN7V&O]8O,>?BQKA5]R23?\ #E[Z MU7R*UB]4<5I/C9-:\SP/X;\&6.@VZ0/;KI7BHKIZO;X(;RK%%9Y8B">FT<\X MKG]6^$MR]S_9/Q"O-.U7X:?9%2&+3[>/3H;"0-@V\Q;?*T+ C;(LJ[<$,.0: M]*^)DWAHZ);VFO:;_P )!+=2^7I^D0J'NKBX SB#)!C8#DR!E"#DL!5?P+X5 MUF'POJ6F^,+R#6+6^9EBTF\?[=]EM60*;:6=@#<]\LR]\98#)PG&_O1=GW)N M?'VD_"V3]DGQ4OC+P+X&NM9O-/U&?0?$>FQ:Z0AM[J5#93(LB9 (>/# E,AM MP!^8?=4$5S':Q2S(\%RT>Z6W9_,,;D#_%GP7#HL<'ARUGL M_#^C7FEBQM=4U#4/W;)$^Y+.7S&#H\;%7@N,ML;T_P] MI.N:#X(\:PM(U[?^(,)#?)$%/[IMKQPN=RLXDXPX,;,I##>,GB&N?1]V_P ] M^G;H:K]Y)*3M?JSWKQUX;T3XC^#[KP[XLMY+O2+P*);5)9(A(0<@ H03S@XZ M<\$I3'S-#R<+^-::L([@B,(^!NR), MA/SXJ.9IJG!^\"#[ MUYY\08_$_P )/A[=G0?$<4OA>WCCA+:DRKJ>F6VX*PM)3A;APF5CCEP^[;AV M("G&,%%)+2P7ZLU?$'[2/@'P?:P&?6TN[N9 T-C88GD8Y"@%U)CB&2 6E=5' M.3Q7*ZA\+?&_Q;FLM>\0&T\-ZQ"\DVGW.GZI]ICTQ9%V96.*-5N9/+)4M/(R M':?#.UM_&UU/X#U#XB7&B:1JUQ/>Z-X;#6UP+-ED=;C3)A.K3+.LG[T%7&06 M"$;,U[S\4;?6;[7O#^D:+K\=K#II_P"$AUB'4K%KV(6\'S0%RC+)EI5X522P M1C@XP?.(_.\;7VO:YX;\%Z?XA\.7\-S=S6.KM:3S6FI2*A29;=\36R/M9V0L M26;.U.354VTDFFO77\=1,V/B5=:E\/\ P3/X0U'Q'KVEIJ5JVF0-#+%J<<\+ M(59UDNCYT)"YW!V8>A:N!DU8Z?X6N?%FI:C/<:K;0I!8N(E.G11A$2.W2>:) MQO*8+ 8W,2N>#6SHNE>&])U#?XBU[Q/X;\1V&V:07&R?RU+/'GABXD5CXXMR57[V;;R=IYX\S<&^@CTVYLH;,R/&S1J T+&.5V9\$Z?X3T_0O#:6[7/V5/M'V?Q@D5[YFT"1Y(YY(F1\Y!7 P>.U=G MX9^#O@OPYIQTS1/"VE:5Y(;^SI+30[>2]M0WS8+W &]8\"Q?#^^\2>)EMA +SQ)+92)I@.?+>::#*P"/)985 <]EQDUYU#$4< M9&7+#3FL[KL]7I>]OZ=M12I0EHT9OBCXK>&?@[H<][?^(_%T+2.L=M:WVKPZ MEY\A) 2.3?*J_P# V XK@;'XQ>-?BSX2\1:/HGASQUX\T2^MY+6ZEU.UTVV@ M@C;H$EV()7(.=N#C:.O6O0O@;^PWX0^'+6^O^.M-M_$?B6W8F&UO/)%A#CI* MD,>59CUS(6(] :V/C-I.FZ%K/@VST/P%HP@\2ZE):W6N7L$HT_20(RR-.L1' M^L8; 3M7/4]!7K8A4:71YHSE*]]))=.UN=6];_ M "/@2\L_$'POT>\UZ&S_ +$A@E2Q6%V#6ZS%@?,900FY50G9SDJ/K7V?X%;Q M%\/M/T>^\=ZGJ^L7DD;FVUS^T8(KP(V7$<2^5+(B$,.%F!.?F' %9UCXW/B1 MM6\$Z]\.-.OWOM3N/">BZKX?L52WN(Q;L[W$3W)S"F[*;E)&X#!-7/AW^TWK MMOXYU[X;^)SJ>MWVEZNFCV=QI]A#IZ_9T&TW$O)4 8)+;L/\NQ[W;LMWY::+?=]K>> M)-4\+^-;7Q!!X:\;:NEY MN)M+TQ-:N1&"Q\MYI)-T,1W;BL4:EC]YS@"NT\ M=SZ=XBTNTN;?3[^PU_195O;&_P!>TYK.S(4@RV+O">O-X3MY;W5O"FI7.ECS4OM8TR M2WBMP!\[J\,RM",==K8P.SL M9995!NIEMKJ.7]U(0''F*KEG<@@$&NJG)*#35KO_ (%]+C]J[6U/6M?_ &>_ M /B1;!+G2EM9]/E-S9_9\26EO*PPS?9) UO@\Y4(!SQ@\UG1Z>WA'QQ%H&H> M!O!.KVM];I)I>J*AT[^T) 2'MMKK+$LRC#!-PW*Q*_=(&3HOC#XQ^&=!FOO% M7@.U\7PI(%BM_"NJB2^^OEM&D;@]?O*1T)-:%Y^TOH7]@RVWBWP#XKT+3F.) MK76_#QGB&.06$9D!'HV.M.G:"Y>BTZ_KN)5+L]2A\;V7@^$1ZOX1U'P99/\ M))=+9PR6:$=I'MF;8/1G4+[BM2/6O#FN1+MZ;=1N-RR0WD3KCU&&KRGX$ M_'[P?KEYXW32O$-P?"FF7%J;#[?;W2/:;[??/#F5 X17&55N@) XQ78Z#J'@ M3XT-.-.?PQJ5N/GN;>S%M<7K ]IL M$#W'WNV1S3E4A=QCJ^W^?8TBXR;U6A ML>"?B)X6\875Q8^&?%6E>(;NW&9H=-O8KAXQG&6"DG&>,^M=BT0;AI7W#KP! M7%>)OA#X7OM)U-0^T-@\'/%5/#OBZX\ M ^$]&T[Q7H^NVB6%I%;7&LS,FHQ%D0*99)(69P"03N9 !WQ6]^PVH]#LM0LV M9K79,VXS#&[!'0U7>WN%XP,^QZUBW'Q2\%WDULD?BG2&(E!RUVJ<8/(+8!'N M#6C-XPT'[-YX\1:48?[_ /:$./SW5+,VD2^8^"K1-G'(QD$51_LF"&3S;17T MV<E>:^$_B1;?"W4+KP-=Z=JBVT8-UX9N M-<8:?&VGG :!Y)CN'V=SLX5F*-'P<5HK6&E(]^3%U@J-HZ9VDDGT JAJFI:? MH[.+_6;/3MHW,+NZCB('K\Q&*\]C\6:+K1(U[XAV*6[==+\,2R)&?]EYU!FD M&/[OE@^E:NEZQ\)M+PME+X9LW!^]/;QQR9]2TJAB?C'GOZVW[L>THYKT2X^)7A&UM?M$OBO1O)4?PZA$WX M!0Q)^@%V-JICM9+Z: B"%R M.&\F)M_ECA2Z9'2O4VA=>5;:/3)KP_X%Z+\7_ OAFRT_7-(TK6VN8WN[RXO- M56&XM[ISGR]Z)(9XPN%WR 2?+DEL\>H6_BKQ!$K)?>!M16<<9T^_M;F%O<,T MD; ?[R TJ<7%7EN_Z[(RA'2[ZG2[6^SR[B#E3P![5X?\9/$&FK\6OV>]#^U+ M_:__ DAN_LH5BWD_P!G7*[R<8 SQRQR?%5W!IWQ%^!&C2^'M1T+4V\6 MMZ_P#1<->2?M":7JFI?M2_ B72 MKMH)K*UUVYE@!4+=Q>5;JT+EC@(=X8GD_)P,UG4UA)/M_6VH'L.FK"-*T_R% M98VMH]HD)#*NP8!]P.*MP;%MT:5L@C"H@R6K&\,V,?A;0-.T1FE9PYG!EG6+9O\ F-7K-;Z6ONCXWW'TB4K_ +8JS8_"N&]N$OO%MZWBJ\B8 M21PW<0CL+=AT,5H"5R.S2F1_<46$2+\5/#U]&'T^6\U.$G_C[L]*N[B$C_9= M(BK?4$BJMYX^N[ABNB^$-:U-O^>VH(NFP?4M,0^/]U#77S,]PIWN54<*HR / MPJG)&>&.W@],'\J5P//O^$#\5ZMXHMO$\5]H/A/4&_=WG]FVTUX;Z(C CN"S M1*^#@JX4,N, X)!Z633_ !?IV-]EX>UM :>PF;\&$JY_X$!736:^)-:73W#^!]3497.W4+-S]X=?WPKJ1?+(Y"I++)W6-"?UJMJGVIK&3*Q MQ+E<@ON;[P].!2&8,VI>-M7E*6&AZ7X:@S\UUK%U]LF_X#! 0N?]Z7\*O66F MZY;W&[5M7T^_M"K#R;73&MY&;L=YF?CVVUMR)-YP)DB5,\#!QG^M8OC7PQ-X MN\%^)-%@NS:WFK:=<6,5V 5\EGC9%(P<@9//-(9S$?C33]2F:;P_8ZEXG"L8 MFN-,A0VJ.IP4$TC)&2#P=K-C&*N'3_%/B9/*:\B\&:8W^N%A,MUJV%A<6$>%^Q7$'[J:# X&UT;'M@]ZZ M*SLY+=F\]6JCY5!Z\+FEH4>4?&"_B^& M.LV?Q0GN;-K#2M-FTJ^L+Z80O+#+(D@:T<\>?N0#RS_K!@9! KK_ !\2O#? MQ.\,6VN^$]6@UC2Y@/WT.04;&2CJ>5<="IZ$&N9^..GVGB31_#WA+4K2!]*\ M3:LNFW-U=0K)]FC\J24^6K A97V>6CX^4N2.0*[W0/#NG^$M"L-$T2R@TW2= M/@6WM;*!-J0QJ,*HQ_7D]35>[R^8[JWF8?Q#^&7A7XJ:1#IOB_P[8^(+&-F: M-+R,L8B5P61AAE)''!%>!?&[P';Z%J'P^TTS:BMM:PS:))K\T(:&XTVX0P?8 M[V6, A5($@Y"D@'ICJ.O446["CAF8Y"J<$CYZ\"^ ]=\+^,KWPCXR\7>)?B5XGT.WCU& M#;J[Q:A!;L#_ *3ILHP'; _>6TFV08!!D4@'K_ASI/BCP3\=%\27'CU->^'/ MBV"%8;Z6T>>6YEC'EQ07,KY-JZL6.=RJ6W*$5B15N]23-/!+^, M_!L-E;S1VNH6=W'J-BUPNZ 744A9/.3^.,GAA[Y'(%,\+^-9O%?GV,_G:/XB MTY0-2T>X(:>W)Z.AZ/"_.R1?E(XX8%1D0=%KEA8ZW:M;ZMI]MJEKN 6&\@69 M3GJ<,"/QKB?&G@SPUX/\)ZOKFF6M[HMSIUK)=*VAZA+;.2JY V!C&1G&=R$8 MSQ78:A<(L(P,B,[>3G/TP?UI<+JFFRV<\6^*[B:)T'#/&1AE''<''XU/4?0^ M:/A?X#^+/P\\>>*] N_'D7BW[?;VGB#5+M5%KJ,DDIEC6"UFF(FF4^H7->AV:Z]\ M1M/EO(+Z?PEX;NE$EHJ1@:G=QD9$\C,"+=6X*H%W@\6Z]>7EY#I>EVVUY9$.7C\^8K$A12I*F0\<@&NET?6/ MC#K/AG[7J?P]T3PM/(C 6M]XC,ETS[3C9Y,+K'DX^9FR/:H/%'P,NUU.TNO# M.I2V4MK>"_C6XD:6%;H*1YZXP22"RNK'Y@S#-0^%?BUXAL-%U27Q5I\^J:;8 MWTVF7-YI\:%H9XF"NQ52-\7S*<@9'((XK*<5--=_-K\B#5^%OA?0[GPQ'96N MJWB16LA.KZ#"6LI[>9^9#=-O:XE9B2?,,I5QR,BO2["WT_PMI\>FZ-:V]GIJ M9:.UM8@D:YZL?4GN3R?4UYW\24L8O#5OXDM=1L]+UO3WCGTW6)2R^9&&#/:R ML@RT,J@J5PP7.[&16MX2\:6GCK0XM1M1]G9@//T]Y5:2T?DF-]I(X['N"#WK M/6UR;G8W7V6Y5.%ED(^5>N3[^U5H[L6DAB=@JL,-AL8!ZX'IFJ[>([;P_82W MVH7,-C80KOEN9G2.-%]2Y(%>>KXXN?'_ (JGT+PP'T,QQ"\N]9U:T*3R6S=' ML;:0 RJ>GG, BD]&.!1N!M>,?&$/A!IM0CBFU&XD-O96EG:X$ES<2N4CA7.! MDDYR3@ $]JR_A#=7T>K?$B?5K:*WU]_$ MIA;3M.D4<=G;^6BN54D#- M5I+6'2_'6FQPKJWC/Q#8P->6%MJ$\5O:V"-NB:[G=(E"MRR+\KORVU>I">'M M"\9:/Y$*#8D<<:1F,'"I&HR3DG)XZ!B/0;JZO)X M@#).9&YX R?UJ6.SEM+>%I"[-)T#-\JCT(!Y.*P;72_&U\K*-7T.T;/S>3I\ MLC?FTX_E3%M?$&C7,JW>IV.OKC<8UM_LLJD=0"'92/0$ ^]9OW=1FKXNT#3O M&_AG5/"]V&6QOX3#(T&!(K9!5U/J"%89XXYXJEI%QJ>EL]GXHGL)KEVVQZK; M(4BN/EZR(Q_=2GG(#%3@X(Z5IZ7='7K..XLF'D@D$C*-G."IX[$$&M%9K2SM M99;F9#!"C/*5^8!0,GJ.:'=QO%V6XUO9HBLC.RY=\)U3:>"GH,?SJ&X=(U=5 M+?-U5N0<\%K=9M.F(CO+6:=MC9/^H=VSMC9L&)C MQ%)\O$'Y-:C9)(=:431WNEDVDMNP!4F-U.]) 00Q)SN7D< M5:O])BO=/EL;ZSBN;29"DUKNY3P0?0UP$OPUU;PA=2WO@?Q#-I]M, M,W.BW:K+;2L 'C+@E7P ,DY( !;@5;C&I;G5[?<+2SB]F>A06OC3PSK$:Q2 MV'B_PN8PICN,P:O;D#KYG,5R#WW"-AZM6KX1^)'AKQEJ5]INEZ@JZUI[;;S2 M;J)K:\M_=H7 8J>S@%3V)KRC2?C;J'A&[AM?&^CW&DB3[M[;Q%@/^ND0+D#U M:)I5&?FVU>A^)3_%#6M2CTKPY8^)]&L0B6FI6VI"UO=Q'S-$YZ(#_&I SZXJ M^6:OR_?SVUXYI_Q%USX;:-+>*:WMKS3;QUW/INI0&WO(_7,9/(_P!I2RD<@D57/T;MTUZ^ MG<;FKVV+:^!_#.)1@1H=H ]O2E!; M:&0AU]C@TUY59@"!_NMP:TL]BR"1X%;+LS'N68FO.OC(T7AVWT#QS#S_ ,(S M?"6\"9R=.GQ#=CZ*K)+_ -LJ])D:"12AX]L4DEC;3P/&\4)9M.GC7>]DS2NH:(H&:(YW (R<@*:ZA?B.(9 FI>&O$6 MGD=9%LENXQ_P*W>3^5,/4Z:&QL4G\Z*U@CG_ .>L<85_^^L9KS/QU!:?$;XJ M:+X,OM'N=1TK1HX?$]_?2L?LPN8Y<6=N?^>C[@TNWD (I(Y%;6N_&+P5X9T6 M_P!9U;4;G3=/L8FN+F6ZTZZA6-%&226B 'IFN1^$WB;2]'T&]O\ 6O$EYJ^O M:U?S:G-'_9UR'ACL*C3U/>H;J^M=/M+B\NY5M+.W1I9IYWVQQ(HR68GH *YX>.+^Z8 M+IOA#Q!=Q]3)>0Q6*'Z>=(K'_OFN&MM<\5_$#Q9J+ZAX-FNO"VBWGV:#2TOK M5#->QA&:2=C+B1$9AM4#&1N.2 !OKW--C&T:W\/VF MHRXBCMV +W,N &1Y<#@@,J*HZEJX/QI>:I-XV^ B:E<0W;'Q>622TM)(80/[ M-NOEW/\ >/TKUZ:RUKQ/HTJ:['%I239,FFV,PG< '*[IRH!;@$[5 'J>M>*_ M%/Q!'XH^/WP+@T[6)'M_#OBAK34[!8OD-W-I:,X.*E5IK MW6M&^UW_ ,!#Y5O?4^H_&7_(GZ[_ ->$_P#Z+:L_X5_\DQ\(?]@>S_\ 1*5H M>,O^1/UW_KPG_P#1;5G_ K_ .28^$/^P/9_^B4KH$>)-^T/HWP;\1>+--U3 M2=4O9+WQ#=31R6BQ;&^6)=B[W4M)_LCU'-/^,^L74?[2/P7NK#3);^XNM%UY M4LVGCMWPT=J2"SG ('4X8'G]X0@/(3/-:'@KXF6/CK3[E]/@^Q:A9.L6I M:/=MY=WI\Q7/ERQ-@C_9;&&'()K935IEE(-MDJ<;LKP/SK%3ZH&NYQLXBEK;QB../LBCH,DTYF=LC=M4]=O4U1,\LVXM 6SS\S =/QJQ&91$<6[ M =AO7G]:&W)W8+LBRJ$+M)+8YQCD^U5?+1F.!S_#W_*H[K46@C1(HV>3_9*D M $=S4EJLNX/);["OW5648_'VIVZL';8JZIKUCX=GTL:A*UN+^Z2PMBT9VM.X M.Q"0/ESM."<#.!U(K0B6)>-Q Z'8O'TS5#Q%IMEXJT6ZT;4K47-A=)Y4T:$= M^A#9^5E.&##D$ CD5P'PK^)5E?>"=+_X2?6;-/$EIYMA?K>W\$$S30RM$79& M8$%M@;..=V>]._9"/5_MD2KM6 JB]%(.6]\50U":6:RD"A8Q\O&,G[PZGH*D MCO)7A61(G:)AE61PRGWSG!JOJ%W<264I,,G&W@,./F%+Y#+[*T4A;R?M$N?] M8[\#].*033[MQB&,=%-9=YH,6I:M]KE6X#*BIY*S!!D,3G.>9(I MU*]0.'VA9$&SU'R'J<3J>L1?"_XO+<75Q!I'AOQE!(\SWDJQP1Z MM;JOS G@&:#.1W: 'KFO0M'UC2O%$,EUINLVFJQQ2>5(UG,LRQOUVMM)P<=C M7DOB+06_X7SX0V:A=ZY)%87*3Z8L@9],61?EOW/*A6"^2%?#'?E,_-76:E\, M[^+7+3Q!X>U632]>M;=;1A=(LEI?PJ#MBN45@6 )W*X.Y"3C()4O0+=SMKZ, M\A9/,*C)XQ^&:?#/)-;QLG _'3>-[&\6YTYM+UO39S9ZKI# MS*[VDXZ8/&Z-UPZ28 92.X('0S1,<*+0@9R )0 /PS2TZA9]#B_B=IUMKOA7 M4VN[6YN/[,B?4;0V<[07$5S"C.DD4G\#C'!P1R0002*3X=>)M5O/ OAJ[U*Z M&HW]UIEO=3W<< C69I(U?(4<#[PSCOZ=*[*X2.&,^9;><'&SRGD5E8-P5()Y M!!Q7 _!-KFQ\.ZUX>4-*/=W,:R"(\_\ +/%3;L([ MRQU83.#*"@)QG/ J+Q1K5YHOA76M4TS2Y-8[!41$7+.[,555 R2:YR'PYJ7CKQ M=HVHZOX.U61[;R57Y5164 #& /Z"HFOG8JPA< \YWJ._UJ9I2GSQ]W7I^6M]/Q+;U M>AY?\-?'C2:?''H)F\5>'($#O;L3'JVD*V2L4D$F'E3&"K$[@,C,G%=)JVG: M'\5&BN=-U"2PU_2LBWU*S4Q7]@6ZH\;J"8VQ\TP\9:]H5_IB;8]-L;B.&&10S!E\Q<,H<==V\9QQ3(QK7C6SNT,&I:M)H]Q M)9SSV"*)A%*ZJ!>( M?B)\-? /B/5+J\L]+N(=0DT.TNC]GMU4O+*\\V T[,@!;.$S.JA>Y^N;K5)+ MC<1&J1AR!(V#G%>"_"HZ38_&B751#))J?B;0=DLU\ LG]H0S>9%C_=/" MZ*H :-0PW#FO9]0N+V8;8[ S;'VJ@VA1^%8RNS)EG[?%M1RY(++]$E\MGM_$^K1GS,E=CS><">.NV85Z%<37LBK&+3,A&=Q==J]LFO M']8&I_#'Q+J.I6&F_P!M6GBO48+:.U%PL#PZFZ>7E205\J18U+L>5*$A6SBD MNR).'A\+Z!XO\::WIEAX>O;Q-#U%K)/#>G(PCDV*C++>7$K>5##)N!$4>&90 M,[LE:[W4/A+J7B'4)M4UJ?1=(OYXU5[&QTO[0BHOW1))(5,I'J%4#L*Z[X?: M+>>#])U2.[9K_6-7OI-2U">URD"RNJH(XE)R$1$10S'+8).,X'4^XP:;ES; >26OP1N=+N-&U&SUI=3N-.:65+?6K7SK2.1^AAB#?NR. M,'+$=L9JW:ZHGQ1GOM$\46,=IK>B3+)#J>FW;AXY&&/,MY>-[/P[HMK=W<>K-/,M_/Y4L0= M%(E$(8;XW&2C!@&VMG!J?F%CHOA3ILLGBWXEQZAJMWJ^K6^J06INKL1QN;-+ M=&MOE10N"'D.X*-QW'K7H1A>23RH9F8YV[4BW$^_M^)KE?@W;V5XVIZ^MS>: ME?:E)&M_?7<:0-(\6Y%C6,?*B("0 -Q.22Q)S1\9O$5K;:YX4\+7[7%MH>K& M[N=3M[.&2>>>UAC!"D1!G6%Y&"N<#^:RKSXG>%;%;6UT^6+4_P!W&+2RT\*P"%,HJ1Q]!MZ+QQ7):]\1-8,T M%M+::7X(>\)6%_$5S''(X!'*1;L$X/=A@]JSJ1YER-VO]XXZ.]COK+Q0]I]G MA:VDTZWC_=K^['EJO0 L"0![FM2321&)IKV7]TY*F)0"#GL2>,&N*L?"'BNW MM_MVE>(7FOVYFBOXTFL[B,=5$2G* @XR&/XUGVNF^-M7<:/_ &O::5)90I+# M]FB$R2)DC$C28PH(QA0#C'-0ERV5TT%KZK<[6&=M''[I9)-'SD!X]3' M^97GMTU;5D?$L(65)%WK(K A@>X-,;6/2HG&+:\TZ7S+(D M=0[D#RSWYXYQFM74->TG0[%]0>]_LG3Y&\T#SHF0L>28U()R>N%[G.*.65-V M2NOZV#XM]SK9)))$^N[NWTVR M;7T0;X]LT%O=HO1O,@D9"%!Z,.O<#J=A?',4TYL/^$3\33:INVMI_P!@50H_ MOF=G$&P]F$A/;%;13DK[$N.IE^)_$6@6=A-9ZW-:W!>+SCICQ&>>9!7LW@W6-"F MM#;>'9X;N&R 4QVLH)C&/O-W)/7-:Z16@:Q.MM_$6B>+)!H\\:P:BS?Z5H6H M!?.5-I!8QY(>,YXD7*G/7/%<1\0OV>O#/B+38[>S:[T@Q,K0M#*\T43K]UD4 ML&B8=FC9&]ZT_&&I:/#H\.J:\#HRV\J"WUB-A'F^+M(BBVFY%XT-X[ #E^#TYW;B<_>I]C\>KC4].0>Z3,1Z8IC_ !8\$^)K6&7Q7X5UK29+:Y>"UFU[098FAEY! M\J=0PC/!&0ZFLUS0C[NOJW^>IFHM*T3JI/B3>Z!;M+XD\):QHT49'FW5FJWU ML@)QG0(^QV6-D=&]'1@&4_45Y1;_%"]\# MRW>H1:Y?>+_#$A4PV-]9*MY;%F VQ7*8$J<])4W#NYKC='^/6@R>+-1\4^#O M[0U*]U66.'5O"^H:3/4=*G[17L#;X3_NL04;_9=JT_!/BBT\=^$=)\0V<7D1 M:A;K,86'S02=)(F]&1PRGW6N%\._&>;XB73VO@_1['SU)W-KFIBV<8)!*V\: MN[X*G/*XQSBL:UN-3^!/B:ZU7Q%>67_"%^)+MI+U;2,V]OH^H%"_G)OD8F*? M8P?)&)-I ^=JJQKT.G^)4-SXS\8>&? [:/!JOANY\S4O$,UT08XH8L&WB"?Q M-)-M.", 1D^E>EO)*Q_US@=U)R*\H^"=L=3T_5OB#"M_//XXEBU18]2;8]O: M+&$MH4C/W%$8W8/)+DFO2?M$_P#';2*>V67'\ZPI)N\^_KMTT?4QAK>3Z_TC M.\7>*/\ A&=-#K&U[J5U)]FTZQ@ ,MU<$$J@!X &"S,>%4$FJ'P_T.X\(>&+ M>QU&]COM6EEEN[ZZMXRB27$KF20A23\H9MHZ<*.*Q[YIO%'Q6TA].,T<7A=) MQJ4T;1^67GC 6V!(.7P%=\$;0%'5J[29I%E$AM68G@[67_&MC6[1<>4+#([\ MQ;"2R^F/2OG#5H-3DUCX :EKMA9Z7K6I^-Y[N>ULCE44Z?=K%N;^)_*6/*5G62:QE$:F*W"RRPM(#E#(OR^I&\9%*QC[U6_\OZ]O^&*NK'8_ M$;]H_1=+\3ZQX"DT?5GU22"2W$J)%M8O$2)%4ON,8!Y;'&#QQ7I?PL_Y)CX0 M_P"P/9_^B4KXD^+S6C_M,:S(KVSI]O7S%5X"%<0JH,BX\M6+8"M*/-)&$)(7 M'VW\+?\ DF7A'_L$6G_HE*[2#YE\7?!#Q=\4/%WC/4M!O;6&TL]3OH4MI[Z: M!IIV6/@,J,(N"/G 8MC:0.#79?$#[1I_[17P-COMHO(_#NN1S[7+KY@AM V& M/)&<\GDUZ?\ "/\ X^/'G_8SW7_HN&O._C,H?]J3X/!C@?V-X@/_ (Y:TI; M0_$CP3JUWKVG^-O!CV,/C>P5;=X[TF.WU:QW9:RN' )7!^:.3!\MQ_=9A6EX M;^(^G>)O$D6D2VNI:5K+K+)]CU"-,9B"F5!(C,I*AT;G&58$5UIB65]O(51N MR#BO/OB!\+],U"ZN_%>GZ E]XOM[=?+^RWCV4]T$/RA9E(V2A2RJYZYVM\IX MXY.2L_P_IDJQZ*]Q'9S,Y.48X*IDX/HKS;PYXNOK?Q- MX?TN^EN-0TSQ!:33Z9)J=NL&H6ES"%:6SN @"NVQBP. P,; [N#7HMC-#>22 MPQS17$]O_KXX959XB>F\ _*?8U46I:Q=T-JQIV[&.'$2@+CEF_C/U]*@D4LR MQ%MWR[FP<#'^%6K>V$=N%+NIZ'!Z#TIRLJLT5NN2,,S8Z#N236CM<-;&?JFG M:M)#!'H]]9Z8')\ZZGM6N) ,<"--RJ#[MD>QJIX>^'FC>'+6_1K4:K=ZE=27 ME_>ZC#')+=3. &9L*% PJJ% &*U[;5[*X=XK2\M[V>/@K',K%3Z$ YS^% M0:IJT>BPR7.IW<=E O+27$RP(OKDL0!0V4>06/PZU?X<_$&?7((=2O= -S)- M%8^$/)MX1&P($-S8D#S=N'6L1>%])N]==N4O)3]DLOKYKC+KKQ#9>+)O$FFQZK96LE@-,CTUC92V\LD;LC.9/,W!T5A(,'J"N# MBC?<1ZMYB7.]$!+'Y0#UR3T%ULXH;%HVW+)"%&QPP^]N'S9[ MDDT=+#,CX4^$M1\(Z#?2:NT+:UJVH7.IWAA;>=TDA,<9DP-_EQ[$'8;<#BNU MW+'"-[[6D_&LI;U;IT+N%5 &*]S[?F*7Q3XHTWPAH+ZIJKL+9)(XD2",RR2R MR.$CBC11EG9B /7\:0S-\6> XO$%Y;:O87LN@^*;2(Q6NLVRAV\O.?)GC/R MSPD]8VZ=5*GFO.O$W[4V@?"O7;7PQ\189-&\8W: Z=:6,;3VFKY<(AMIFP%+ M,<%)2I3!R2H#'NKC6_&FN(\.C^'8/#ROQ_:/B&X1WC!/)6U@+;B!T#R(,]:X M'QO\/=%F\=>!=*N/,\6^,KK5(]4O-0U94FDATV .93L"[((&=HT5$50S,,[B M":I6ZC]3L]0M_%_C26W@N;:?P7HOEE[FXL[^&6[N NW MEJZCPUH.C^%M+ATO1[*&TL[8-L@3) ))+,2GU#P?.QW?\ $CN3% 3ZFV<-"?\ OBLNYU[Q#X*OHCXA4^(M%!RNMZ18N+BW M..ES:Q[LJ>?WL7 _B1>M(1M?$#P;<^+M#MK:VN5TS4;&^M]5LKQXO,B%S!(' M021Y!:,\J0"#@Y!R*KQ>/M=TV3R=<\(ZA%,J\S:"\>H6[^K+RDJCV,>?K55? MB=H'B#>?#\ESXQNHVVM:Z+'O$+<';-(Y6.)L?PNRMSTH2R\9:W<,5M=+\*Q; M/^6\K:E<8)[JACC4_P# VH$5=6^-_A+184CU.^NM'O[I_*M+34=/N+>XNI&/ M$4$;1YE<_P!Q,FFV_B#Q1KEPHL?!TT$88*'US4(K60CWBC$K+_P+!]A5^T^% M^G7LD\OB2>;Q;>7,36\LFK0QF&*$D%HX8% 2,,0,L,N<#+' K!T_Q-#\'=1. ME:U>S7'A:8A--UZX9G:Q8G"VMX_89($0AC\H"V_ZYQ5K4F\>M;SS6>F>$HM6\DQ07-U?7112>0K@0@L,] M0".M7;!;R\L[;[&LX0AB"XP/O'IQ^M:1%] ZK):H\A^Z$=6(]ZAI/=!>QY=X MBTG4?&.FV$?Q,T_4[V,_,^@>$-*FFMX9%(SOO!F9@3T*&+(ZBI/&DGC#X9Z# M)>>!].UOQJC "#PKK$/G9&!E4NV;?" ,\2^8.V!7J4;W3)F=FMBI_P">@_+B MG3769!&S[^.2N0/I4J,M/>_X)2ETL?F!\5?VCM:OO$'AO4_ 6G:QX%O]!EF> MYL=3M8;@:?M#PEK]UINH:K M>6LKPW5ULM1)&%&^)X\+E_FP"I.1GC->@_M'?LZ^&_C1\4?#&G6*MINOW1%[ MX@-E$HCDTQ77=)\Y/9^5NGD_P!# MUJM3!+#QA1@^>VK;V?E;IZ_?H.;]G_XE^'?$WC;4O#FL:78W6M:[::E8(D;B M33K2)!#):(Y4B/S(LGAZEJ/ MV^PO"2"[6,>3(B[/G!5TSD*(\YK:\._&Z^-]+IOBCPT8YHPLT.H>%7DU&WF3 M!R_V=D2Y3&.?W;@<\UX5]6>/8\1T'6/V@IX[^\&NW-_X95'TV/6)[-TD2?[3 MY_VE[58O-5%A86I90PW(QX'SUZ9\+=%^(VI1Z5=:K\3]/\4:99)VZDQ MYQ-\NTX^4YZ5U/AWX0ZU)X%T$^(O$C7OQ%TM)$B\7V<>UW#2,R1R1L )8MI1 M71Q@E2PPV&K5C^(UAI]E)#XEL+WPK>KM)74(FDMF/EQZB_B#3[O>RPP6EI>12W$[G[J*NX*@S_ !,0 233Z SQ[2];U;1 M=+3Q%X>L[O2+N2[EA\4Z;:Q+<6UA/ T@NI$BDR5RR[A@X(=2W%=CX=\*ZSXM MM9Y=&M;S1['6DCFO_%>J7@FU2_BV@JL07(5=IX'RHN3M7O6)<3^&M>OO%>O> M(;Z^@T#48TGU/1?#4,\MG)&BE6DO;H1J&)4 /Y;(C*H!WXS79:5\7H?&U[;Z M!X2TQ]/N# KVZ>(UDTB-X-ORM#"RF690H_@7 XY%%P,'P;JNJ>#V3X=Z9I%B M/$.E>=<7NJS1%+/[*SDVMRVP9>69\T[0]5U"-?[9O80CIOE M6"'A_=?,+8'U&:JZ?\.M5D\7Z;XCU+Q':+?VR-;O::/II2*Y@()\J5Y)&9U5 MOG!P"K XP"0>GF\B29XW#W,AY*^G_P!:N:JE+<5[:G!^(/ >B^*9$CEM33&>I# JRG@?=857\0^&KZ:S@@L;O4-'N[:/;%>:1.D@<<9C<3 Y4X& M<@XQG)KK]0NIWC6-=MJJDC;D#(]@*KS73LG#I(,8PYQ]>!U%G)&:] TNUE>..X>2-8HN2R+V M^O>M9GBAC5S&UPT@XVC+'/J2:UA3<4K2?WBT);(<,F5<$XSR ,UZ%J/Q$T;5/#-K<6NK?8+>^"R/=W@:T% MM;[@'D;S NS/*J3U)&/6L?XB:/'K.EP:-JDID&HR[/EP7@107,B YPP(4 GH M6%<;8>,-7^#=Q=V>M7-EXG@N]T]NUW=[+PPH.$,:PD?*".2<8Z57O5E[.,M4 M]?3LK6U\_P RHOEM)H]%\0:IX;\.:*VN0W%I?^%KN(:=>0Z-E4@9 M)./QHU*^T?XL_#V[N]0AM_ %I!.ESISQW$,(O)E^8%@R+E=P Z2NSTVW\ W,/B2+Q'K&K0ZWJRNMO81V]KY$&FP[3N6!&=CO<\M(3N/"C M &*V.864$M&03E5'7]>MM+1]8\47>D33:WX=C2_C8^3"J_8I)EQP65II0I)_VN.])UN:[Y7H[: M)O\ !7?X&5NIT&GWQL9"Z-)L^\P8]1Z5T$C6WB72;FUD7?#=1-%)&W\2D8-< M1K$FLV\-XMGHXGD$/F1(]P7WOMSM.T$@=!D YK+\">/-;N[&[&KV4.@7D((0 M7.GWD2QC;D%A*J;\H"&!%!.?W)CB&S']TY'/:KE*5.\>7F2]/ZT\TGZE/EE MOH>:7GAFX^!>N746IZ>/%WA;7KI+>S%W? 7@E5"8R96 Q+QM\S*=%);.37FG M[5'QTU*U\"Q?#]$ENCJUQ'>1:Q?>5)>6]K$R2B"6'.'F$@1!,&*LH+OW#'5Y-0N;-R6:'4-5EO6))SA%?Y(A[JN<<9 KROQ)\'[CX>^'W/B+5_ M#>O>%+6[*6B>)].,MI:0R<+O(!:W8,0I=&\L@+G97;0K4O;0EB8-TKZI;R3[ M.SY=>K31M1]G&K%UES0ZI.S:]=?U+7@/]KBV^+$&EQ>'](>POY(#'<:=/937 M%['<1J/.6WACQ'+$I( =I4ZYVXKT2-?$&J0&34]"\87T4@*M&NK65EA3Z00S M+CZ%R1ZUY%H_PQ\._$[PG:S>&;B;PQJ-G.[R^"]'U*."RO7C.'EBC96,4I&" MLW7[H) Y'?VNH?$7P[I-O/X.U:P^(>G02[;W1?%(:TURU4$;XUF4[7D4=%F0 M%N/WAR#3J2BI-0BTM;=;+HGMK\K&,G'F?(M/T_S^1V&D^)M.\ Z78V%YX:U/ MPMHGFB%+^]>&:%99&X,\D@K*-2,FM=7T>C^YF?M(.WF=#XIM M]3N/'?A2"RO+2WL%CO;G4+5R#/=*(@L7EC'17;+'TQ7$?%ZW*_$#]GZ5HRC_ M /"6%?F4C_F&75SR1RVJ21E= MI#P0R/D_,%51C/.K\1O ^B^&?B1\ KJPTZ*VO)/%C(]P6=Y6']FW)P6=B3S1 M12O*5MWY=DOF6[=!_P 5O@3XXO/'GB'QI:7MG-8&=)8[-]1GC=+9(AN8G80? M^6F(1A<\[^2*^@/A;C_A67A''3^R+3_T2E7_ !E_R)^N_P#7A/\ ^BVK/^%? M_),?"'_8'L__ $2E=8C'^$?_ !\>//\ L9[K_P!%PUYU\93_ ,92?!T9QG1_ M$ ^OR6O%>B_"/_CX\>?]C/=?^BX:\E_:,U:]T;]I#X/W%AI%YK=Q_96OI]EL M)(4DP4M(N].S_Z55='Q,UQ>/^%8^)<=O]+T_'_I56+B[[$),MZY M\(]&\4>)/[7N'D>X,*I/93HLMI,RDF.4HW,,JQ5B&R,5Q/BS2=;^&_ MB+P]XFB\)Z);>'-#NW&H7?AEW2[?3I8V1O.MS'^\$;F.5L.V C$"M+5/B=XZ MMVABT;X6:N[29\VZU#4+ )%SU\M+C=(3Z;E'O5?_ (6K\4H] U:W;X;WMSK7 MVCRM,OQ-810B!@O[Z:'[4W[Q"7^16PVU>1DXF-.UVM/Z[;&B/2O#?Q2\,>)H M=0>TU6.,60W7 N_W.U#DK*&;"O$P&5D0E2._6N9@LS\9=>M-6NP9? .G;S9V M;J0FMW/3[2ZG&ZWC&1&&X=B7QM5<^0ZM\*=(N=/+:=\,O%^F>)AN8^(&N=-G MDFE8#=)+"]UY?) /R!"G\!6NX\ ?$/XBV/AFSLO%O@+7M3U:V+(^H6UUIH\] M0<(Q N ,E<9X!SZ]:-8V37]>?8>Z/2M4\"^$A;B)_"FB2,H&U?[.A7 /& 0N M?RJMI_PO\,:;<1W5OX?TN*ZW K,UJKM'Z%2^<8QQBLK_ (6IK2KE/ACXE1^A M/GZ:>/QNJ@7XG:UYFX_#+Q0WRXYN]-_E]IJK,1WGEQ0R/(WRMG!D<98XJ#5+ M@2V,BHQ;XF:])(,?#/Q,$'0?:=-_P#DJJMY\0-?N(65?AIX MF)XZW>G#."#U%SQ19@>K2WBV]];Q*VZ263:2O&/S->8?!.^'_"#WMTL0MK2] MUK4);/35/R:?$MP\8@7T :-FP. 9"!@8I8OB3KL1=U^%_B-9V;AQ=:<=J^@S MW=MI\UUKG[N&RMI)&WK/LWE65RSX4$[5'"JN20J@$FM75O$-AX;T^?4]:N8+.QA W7$@Q\S= MA@9)[8%*]]$,V)KR==SKB4XZ*<$'^55/MTZW& %)SN8\FN2F^*5K=1Q+HOA MWQ#J8J.>WK2V7Q3T%KA%U5YO#.H,=JPZ]926V6 S@.

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end GRAPHIC 14 fig2.jpg GRAPHIC begin 644 fig2.jpg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�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

J:#JEM+-=^)H,?9=.9,[8Y/=L#'U%?(WQH_X)D> M!O#/PE\;WG@>\\>7>N2VL]W;:+:ZP6@NKAN0K0J@#Y)QCN!0![C^S>X;]@GP M1@Y_XH6/..W^B&N,_P""5/\ R9OX:_["FI?^E4E:W[*OP//P._8W:RNQK=OK M>IZ U_JEAK5P9&LKDV>UX8T('E("O"=N:R?^"5/_ "9OX:_["FI?^E4E 'V! M2TE+0 4444 %%%% !1110 4444 (WY5\8_L:R1^-OVG/VH/$^KVT-QJ]OKEK MHT$SQY,-I'$ZB)/8:+(/MEAJ"1LK$IDDQM\S%L8RZCC&" =)^Q7H5E\/_CM^TUX&T2,V MOAO2?$5C?V=IP%ADO+4RS*H&%5-P 50!A0!SBO;_ (V? 7PC^T!HNFZ)XSM; MB^TFQU*'4Q:0SM%%/)'G"3 ??C(/*]_45X_^RUX$^(7PT\#_ !1^*/CO1&O/ MB-XTNWUQ_#MFXDFBABB(M++=P#(JG9C'&!GG-=)\1-0^,?Q.^ ^@>*OA_9S^ M ?B#!.FJ2>%]:";;M$9@UC.2/EW@9!!7G&2* / /$_B*U\6?MQ?"_5?$/A2^ M^#FC>%I;G0]&O-4TYX#XDD;"_#7B?X2W_ ,*/"?A_6K;5]:U+5[O,D[1AB(;5-N7!;/SXP,C/6N'^.OB? MXN?$;]I34+KQ5\"?'/C/X3^'I]FB^%X( EE>W41*_;9\ ^:IRS*I)&-F1G- M'M/[!_A;_A(/B%\8/C)H^G7'ASP/XVU&(:#I,UM]F$\,*;6O/+& !(V2O&?F M;-<7_P $M_\ D?/VF_\ L=&_]&W5?1/[-OQL\6?%*XU2P\0_!W7OA;9Z;!%] MD;5D"13C[OEQJ ,;0!P.,8KYV_X);_\ (^?M-_\ 8Z-_Z-NJ /OZBBB@ HHH MH **** "BBB@ HHHH 0C-?-?[9'[/\?Q;\*ZWK>M^)M8'AC0_#E_,/"=G+Y% MG>7:1/)'/.RD-(%(7$9^7* ^N?I6N.^,VFW6M?"'QSI]C;R7E]=Z%?6]O;PK MEY9'MW544=R20!]: /E73?&ES\/?^"3^GZ]8QQRWD'@**%!)G \U5A)R.<@2 M$CW KQ'P3)XTTW]DO3],M/V;--O?@C)I4=_K;7VKQV^KZDB /->[!A@Y*%T) M)RJKT!P/K;X0?!>7Q9^PWX5^&?C#2KC3[B\\)QZ5>V=ZC));3;, LO!!1PK? M@*\)OO%?[2?AWX13_ 1/@Y-KWB$Z6_AV'QS'.HTB:U:(H)W;C:WE$@@D?/\ MD0#['^ ?B3POXJ^#7@W4O!MU.SSB(* %D+XMIO MRC8M[)G+?V@)N5MV#,$WL,D$ 9S MQZYX:T?7_P!D/]EOP9H&@^%=1^(^M:/%;6%Q8Z/]]V?/FS+D?<5L]>Q%<%\; M/ GQ!^%/[1T?Q^\"^"Y?B##?>'ET;6O#D-QY5[ 0\926W7'[S@ %1R,,: .5 M_8KFN_$7[5?QJ\2^,])3X=_$>\CMHKCP+%&1$ULJC%\LO G+MNRP'4Y/WJO_ M ++/_)__ .U-_N:=_)ZZ7]GWPI\2_BO^T%??'3XB>%/^%?6MOHC>&M \-S,7 MO1;F?S'GN/[I+ X''!Z$8)YG]EG_ )/_ /VI?]S3O_9Z /N*EI*6@ HHHH * M*** "BBB@ HHHH 1J^,_C+(/%O\ P4@^"7AO588[S1M+T/4M6@M9DW)]J\M@ MLA!X)78I4XR#GFOLPU\H_M8?#'QUI/Q<^'GQP^&OAZ+Q5KGA**ZL]4T'S DU M]8RQG=Y1)YD7Y@J@9)?OC% %#QUX=L/!?_!2/X4ZQI$7V.]\8>&]6M=8\O"I M6^%I*ULJ%03*$.P G@H:AJT4>IW$KS$W,T5N#P-J M@KQSC/ -1?M!?%JW^,7[6OP8G\+>!X?BK8_\(O)K>@Z.9UCMFNYV^6>[9OD5 M(3'R><$&NZU;XD?M.>,OAM>_![6/@K--XRU#36TR\\:2WT8T=E9"&N=X^4MM M/W >6R/:M?Q1^R[XE_9UC^$_COX6Z,OC+5_ >BR:%K.C22%;G6+&0%G,)P!Y MB.79%QDA@.: &?"WQE=0?M<^'I_C9\,[/X?_ !7US2IK?0];TC6/M5IJD"L_\ID-"_P"Q+;_T3-70^ ?"?Q/_ &G/VE_!?Q4\<^ K MCX9^$/!-O<1Z;INHR_\ $QN[N0 ,SKVC'!Y S@X)KGM8_P"4R&A?]B6W_HF: M@#[_ **** "BBB@ HHHH **** "BBB@ I#2TA7- 'RE^V;\9O$GVS1?@E\,K MKR_B;XU!C^V+D+I&G8(FNG<XR2.=MW-C#+_8#^'?QB^*FH_$34M6\6:1XGO[>*VF MFT'5_L:LD<:HJC"$@$(N>>U>;?L-_LBGX/\ Q4^*/B2_'BZS>S\27EAHJZO> MLUOJ.GLD>VZ=2O[V0D,/,_2@#B?VV/@%IW@WXC?"OQ_J&MZQXF\4ZS\2M*@C MGU*X_<:?:F<,MM;0K\J*-J@GJVT$\U]F?&[X$^$_CMI^@V?BVTGU"UT74HM6 MMK6.7$4D\9^42I@K(F,@J1T)'/%^# \.:'?:V=+\?:9J-]]B MB,GV>VCDR\KXZ*!U-0?\%"O%/QN)(-4U;P]#YMQI M]HH7>%'9Y Q"MD8V-@@X- '"?M$?\(S\?OVGOA!X)\"VECJ'BCP5K$>LZ_XD MTU"?[#L8&WI9-(F%/G-\OEDG;@'&&-2_M58'[?O[+ P-^H8&.G[LUD?LU_% M#Q+\([/PWX%\._LI^,_#6DW-U!:W^NWB*TK[Y )+JZDVY[G)P!D# XK7_ M &K%V_M^_LL#T?4/_19H ^X(ONGZG^=/ID7W3]3_ #I] !1110 4444 %)2T ME 'E7Q._9_\ !'Q6\;>#_%?BS2TU*\\(R3SV$=P^;5?, #--&1M?:55AG&"H M[<5\XV*[*/]QJ5U,@2*S68#$K(I))R M0 6';%1_\%!O$GQAUKQ!X=\">!?!'C+5O!4Z"[\2ZCX9A >]@8LOV*.7^ D MECP?F3'>NH_9I^-'B:SUOP[X LOV8O$?PP\)X:/^T)(1':VH5.&DXRS-M5=Q M)8DC.: /-?\ @I5\![&'P'JWQ.U?7=8U[66UK2K72K&[G*V6CPM/&KK!"N 7 M8[\R-DD.1V%?H,JJK,0.6.37S/\ \%#O OB+XC?LZR:+X7T2\U_5&UO39Q:6 M,9DD\M+A6=L#L "37L_Q9\ZCTNU.);G;R57 MTXR<^U 'S9_P4BFM6\+_ UDTZ6WU7QQI_BFVU#P_P"$9[0W0UV9O>,/'O[>W@O6?BYX.M_A-X@T_P_=PZ':6K?:UUXN")4>[& M!F-6R(^HR?6O1_CQX'\7?$^/X-_'SX<:-%JWBSPW:KJ1\+WMSY7VNRNX4DEB M1\8$J\8)ZX/!.!7/Z'I7Q1_:U^-'P]\5>+OAO>_"SP/\/[UM5@M]6D_XF.HW MVT!%5,?+$.I)Z\X.: /9_P!KSXV7OP)^!^I:KHJ-+XDOYH](T5"N\?:YSL1R M,@E4R6..>*\(_:<^&(^ O[ [^"[6\DN[O5M3T^TU[4))6>:^N+NY07DK2'DL MQ) )Z!5XKU'X^?#WQ/\ $C]J/X"Q16%\G@SP[<7?B"]U*&'?!'=Q(!!%(3]T ML"0#GOT-=O\ M8?!6]^.WP/\1^$])N([;6YUCNM-GN"?+CNX7$D1)'3Y@.<' MW!H \/\ ^"A'@W1_AK^QG9)H-A#:-X*O]+?1I!&H>W:.5$R&4#!89W;<;LGU MK@?^"GVIS:U\/_V<]1N-OVB\\36=Q)L&%W/$C' ],FIO%TGQ^_:U\(^'OA'X MJ^$]YX,L[6]LY/%?BC59E-O>1V\@W&VQCS#(5W$+V)QQS5C_ (*NV<&F^'/@ M):6L8AMK?Q?!%%&O1$5%"C\ !0!^@U+24M !1110 4444 %%%% !1110 444 M4 ,906R1SZU\A:3>R?M2?MBZL)Y6N?A[\()5@AL\_NK[7G#;Y9$9<-Y"Y5?1 ML,IY-?6FK74]EIEY<6UN;NYAA>2*W7K(P4D+^) 'XU\W_P#!/GX?^(O!?P*N M;_QII%YH_C7Q%KFH:MK$6H1&*>25YV5'=>@S&D>, #&* .UNOA=\-?A3\1O% MWQMUI[72]9O[6"+4-:U:X406L<2[ T9&? ?C/[%I>@V<<#VPN[=)5MY[Y$( 5)C.Y"XZ[@>*ZG]HC7?BU\0? MVH;B;Q#\#_&OC3X3>%+KR]'\.6<.VQU2ZC8@7TYZ2H3\RJGS>( M?VQ_@M\0OAIXI^$FM?"&PETR&WTV35X]D#RY+1>6J@86)XHR5'&"* /G[Q=J M/C+1_P!F>QTK6?V9[-OV>-.MK:XDBFU:)==6U0KB]>- "ER5R[' SN8$X)KU M7_@HEJVD^(/^">$^JZ!=27NAWRZ1<6%S,Q9Y;=I(S&S$\DE2,D\UA^*O'O[3 M_C#X:O\ !"Y^#LG_ E.IZ;_ &%JGCR[NE?2&@D@VS70=0!O:/\ A_A3)&F[\=N: /LCX<_\B+X< M_P"P7:_^BEKI:YKX<_\ (B^'/^P7:_\ HI:Z6@#S_P#: _Y(3\2/^Q:U+_TE MDKX:_P""=/[7_P (/@_^RGX;\,^+_'&GZ)KMO=WLDME<;MZ*]P[H3@=U(/XU M]R_M ?\ )"?B1_V+6I?^DLE?(G_!,?X&_#SQQ^Q_X8U;Q!X)T'6M4EO+]9+R M^L(Y96"W+JH+,,G 'X4 >V_\/#OV>?^BG:3_P"/_P#Q-'_#P[]GG_HIVD_^ M/_\ Q-=[_P ,P?"'_HFGA?\ \%4/_P 31_PR_P#"'_HFGA?_ ,%4/_Q- '!? M\/#?V>?^BG:3_P"/_P#Q-'_#P[]GG_HIVD_^/_\ Q-=]_P ,O_"'_HFGA?\ M\%4/_P 31_PR]\(?^B:>%_\ P50__$T <#_P\-_9Y_Z*=I/_ (__ (4?\/#O MV>?^BG:3_P"/_P#Q-=]_PR]\(?\ HFGA?_P50_\ Q-'_ R]\(?^B:>%_P#P M50__ !- ' _\/#OV>?\ HIVD_P#C_P#A1_P\._9Y_P"BG:3_ ./_ /Q-=]_P MR]\(?^B:>%__ 50_P#Q-'_#+WPA_P"B:>%__!5#_P#$T <#_P /#OV>?^BG M:3_X_P#X4?\ #P[]GG_HIVD_^/\ _P 37??\,O?"'_HFGA?_ ,%4/_Q-'_#+ MWPA_Z)IX7_\ !5#_ /$T <#_ ,/#?V>?^BG:3_X__P#$T?\ #PW]GGK_ ,+. MTG/_ /_ .)KOO\ AE[X0_\ 1-/"_P#X*H?_ (FC_AE_X0_]$T\+_P#@JA_^ M)H X+_AX=^SS_P!%.TG_ ,?_ /B:/^'AW[//_13M)_\ '_\ XFN\_P"&7_A# M_P!$T\+_ /@JA_\ B:7_ (9>^$/_ $33PO\ ^"J'_P")H X+_AX=^SS_ -%. MTG_Q_P#^)H_X>'?L\_\ 13M)_P#'_P#XFN]_X9>^$/\ T33PM_X*H?\ XFC_ M (9?^$/_ $33PO\ ^"J'_P")H X+_AX=^SS_ -%.TG_Q_P#^)H_X>'?L\_\ M13M)_P#'_P#XFN]_X9?^$7_1-/"__@JA_P#B:/\ AE[X0_\ 1-/"_P#X*H?_ M (F@#@O^'AW[//\ T4[2?_'_ /XFC_AX=^SS_P!%.TG_ ,?_ /B:[W_AE[X0 M_P#1-/"__@JA_P#B:3_AE_X0_P#1-/"W_@JA_P#B: .#_P"'AW[//_13M)_\ M?_\ B:/^'AW[//\ T4[2?_'_ /XFN]_X9?\ A#_T33PO_P""J'_XFC_AE[X0 M_P#1-/"__@JA_P#B: ."_P"'AW[//_13M)_\?_\ B:/^'AW[//\ T4[2?_'_ M /XFN]_X9>^$/_1-/"__ (*H?_B:/^&7_A#_ -$T\+_^"J'_ .)H X+_ (>' M?L\_]%.TG_Q__P")H_X>'?L\_P#13M)_\?\ _B:[S_AE_P"$)_YIIX7_ /!5 M#_\ $TO_ R]\(?^B:>%_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\31_P M\._9Y_Z*=I/_ (__ /$UWO\ PR]\(?\ HFGA;_P50_\ Q-)_PR_\(?\ HFGA M?_P50_\ Q- ' G_@H9^SR64_\+.TG@_[?_Q-?*'_ 3M_:T^$WPC^'WCBR\7 M>-+#1+N_\47=];Q7!;,D+D;7&!T-?=C?LP_")60#X:^%QS_T"H?_ (FOCO\ MX)F_!/P#XX^'/C^X\0^#=$UFXMO%MY;PR7UC'*T<8QA%)'"CTH ^B?\ AX=^ MSS_T4[2?_'__ (FC_AX=^SS_ -%.TG_Q_P#^)KO?^&7OA#_T33PO_P""J'_X MFC_AE[X0_P#1-/"__@JA_P#B: ."_P"'AW[//_13M)_\?_\ B:/^'AW[//\ MT4[2?_'_ /XFN]_X9>^$/_1-/"__ (*H?_B:/^&7OA#_ -$T\+_^"J'_ .)H M X+_ (>'?L\_]%.TG_Q__P")H_X>'?L\_P#13M)_\?\ _B:[W_AE[X0_]$T\ M+_\ @JA_^)H_X9>^$/\ T33PO_X*H?\ XF@#@O\ AX=^SS_T4[2?_'__ (FC M_AX=^SS_ -%.TG_Q_P#^)KO?^&7OA#_T33PO_P""J'_XFC_AE[X0_P#1-/"_ M_@JA_P#B: ."_P"'AW[//_13M)_\?_\ B:/^'AW[//\ T4[2?_'_ /XFN]_X M9>^$/_1-/"__ (*H?_B:/^&7OA#_ -$T\+_^"J'_ .)H X+_ (>'?L\_]%.T MG_Q__P")I/\ AX;^SS_T4[2?_'__ (FN^_X9>^$/_1-/"_\ X*H?_B:3_AE_ MX1?]$T\+_P#@JA_^)H X+_AX;^SS_P!%.TG_ ,?_ /B:/^'AG[//_13M)_\ M'_\ XFN]_P"&7_A#_P!$T\+_ /@JA_\ B:7_ (9?^$/_ $33PO\ ^"J'_P") MH X'_AX=^SS_ -%.TG_Q_P#^)KY/_;(_:T^$WQ"^,W[.FL^'?&EAJNF^&_%D M=_JL\.[%K )(27;(Z84_E7W;_P ,O_"'_HFGA;/_ &"H?_B:^.OVW_@GX!\, M?'7]F.PTCP9H>FV>K>,8K:_M[6QC1+J(RP@I( /F7!/!]: /HA?^"AG[/*Y_ MXN?I/)S_ !__ !-+_P /#OV>?^BG:3_X_P#_ !-=XO[,/PB;=GX:^%SR?^85 M#_\ $TO_ R]\(?^B:>%_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\31_P M\._9Y_Z*=I/_ (__ /$UWO\ PR]\(?\ HFGA?_P50_\ Q-'_ R]\(?^B:>% M_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\31_P\._9Y_Z*=I/_ (__ /$U MWO\ PR]\(?\ HFGA?_P50_\ Q-'_ R]\(?^B:>%_P#P50__ !- '!?\/#OV M>?\ HIVD_P#C_P#\31_P\._9Y_Z*=I/_ (__ /$UWO\ PR]\(?\ HFGA?_P5 M0_\ Q-'_ R]\(?^B:>%_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\31_P M\._9Y_Z*=I/_ (__ /$UWO\ PR]\(?\ HFGA?_P50_\ Q-'_ R]\(?^B:>% M_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\31_P\._9Y_Z*=I/_ (__ /$U MWO\ PR]\(?\ HFGA?_P50_\ Q-'_ R]\(?^B:>%_P#P50__ !- '!?\/#OV M>?\ HIVD_P#C_P#\31_P\._9Y_Z*=I/_ (__ /$UWO\ PR]\(?\ HFGA?_P5 M0_\ Q-'_ R]\(?^B:>%_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\31_P M\._9Y_Z*=I/_ (__ /$UWO\ PR]\(?\ HFGA?_P50_\ Q-'_ R]\(?^B:>% M_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\31_P\._9Z_Z*=I/_ (__ /$U MWO\ PR_\(?\ HFGA?_P50_\ Q-)_PR_\(?\ HFGA?_P50_\ Q- '!?\ #PW] MGG_HIVD_^/\ _P 31_P\._9Y_P"BG:3_ ./_ .%=[_PR_P#"'_HFGA?_ ,%4 M/_Q-'_#+_P (?^B:>%__ 50_P#Q- '!?\/#?V>?^BG:3_X__P#$T?\ #PW] MGG_HIVD_^/\ _P 37>_\,O\ PA_Z)IX7_P#!5#_\31_PR_\ "+_HFGA?_P % M4/\ \30!Y1XV_P""@'P U3P;K]G;?$O29;FXT^XBBC&_+,T; #IW)%>!_P#! M/#]L#X/_ D_9AT7PWXM\<:?HFMVVH7\LEG<;MX1[AV0\#'((-?6OCW]F?X3 M6O@7Q%/#\-_#,,T6FW,D%_\ P50__$T?\,O?"'_HFGA?_P % M4/\ \30!P7_#P[]GG_HIVD_^/_\ Q-'_ \._9Y_Z*=I/_C_ /\ $UWO_#+W MPA_Z)IX7_P#!5#_\31_PR]\(?^B:>%__ 50_P#Q- '!?\/#OV>?^BG:3_X_ M_P#$T?\ #P[]GG_HIVD_^/\ _P 37>_\,O?"'_HFGA?_ ,%4/_Q-'_#+WPA_ MZ)IX7_\ !5#_ /$T <%_P\._9Y_Z*=I/_C__ ,31_P /#OV>?^BG:3_X_P#_ M !-=[_PR]\(?^B:>%_\ P50__$T?\,O?"'_HFGA?_P %4/\ \30!P7_#P[]G MG_HIVD_^/_\ Q-'_ \._9Y_Z*=I/_C_ /\ $UWO_#+WPA_Z)IX7_P#!5#_\ M31_PR]\(?^B:>%__ 50_P#Q- '!?\/#OV>?^BG:3_X__P#$TG_#P[]GG_HI MVD_^/_X5WQ_9?^$/_1-/"_\ X*H?_B:3_AE_X0_]$T\+_P#@JA_^)H X+_AX M;^SS_P!%.TG_ ,?_ /B:/^'AO[//_13M)_\ '_\ "N]'[+_PBS_R33PMC_L% M0_\ Q-+_ ,,O_"'_ *)IX7_\%4/_ ,30!P/_ \,_9Y_Z*=I/_C_ /A1_P / M#OV>?^BG:3_X_P#_ !-=[_PR_P#"+_HFGA?_ ,%4/_Q-'_#+_P (O^B:>%O_ M 50_P#Q- '"+_P4-_9Y) _X6?I [<[_ /XFOC?_ ()^_M3?"SX3^+OCU>>* M_&5AHUMK_BIKW3'GW?Z3!YEP?,4 =,.OYU^@B_LP_"($'_A6GA;.<_\ (*A_ M^)KX@_X)O?!WP-XT\:_M$P:_X0T768=-\7M;V4=[91RBVC\RY&Q,CY5PJ\#T M% 'U%_P\._9Y_P"BG:3_ ./_ /Q-'_#P[]GG_HIVD_\ C_\ \37>_P##+WPA M_P"B:>%__!5#_P#$T?\ #+WPA_Z)IX7_ /!5#_\ $T <%_P\._9Y_P"BG:3_ M ./_ /Q-'_#P[]GG_HIVD_\ C_\ \37>_P##+WPA_P"B:>%__!5#_P#$T?\ M#+WPA_Z)IX7_ /!5#_\ $T <%_P\._9Y_P"BG:3_ ./_ /Q-'_#P[]GG_HIV MD_\ C_\ \37>_P##+WPA_P"B:>%__!5#_P#$T?\ #+WPA_Z)IX7_ /!5#_\ M$T <%_P\._9Y_P"BG:3_ ./_ /Q-'_#P[]GG_HIVD_\ C_\ \37>_P##+WPA M_P"B:>%__!5#_P#$T?\ #+WPA_Z)IX7_ /!5#_\ $T <%_P\._9Y_P"BG:3_ M ./_ /Q-'_#P[]GG_HIVD_\ C_\ \37>_P##+WPA_P"B:>%__!5#_P#$T?\ M#+WPA_Z)IX7_ /!5#_\ $T <%_P\._9Y_P"BG:3_ ./_ /Q-'_#P[]GG_HIV MD_\ C_\ \37>_P##+WPA_P"B:>%__!5#_P#$T?\ #+_PA_Z)IX7_ /!5#_\ M$T <#_P\._9Y_P"BG:3_ ./_ .%'_#P[]GG.?^%G:3_X_P#X5WO_ S!\(>? M^+:>%_\ P50__$TO_#+_ ,(?^B:>%_\ P50__$T <#_P\-_9Y_Z*=I/_ (__ M /$T?\/#?V>?^BG:3_X__P#$UWP_9?\ A"?^::>%_P#P50__ !-'_#+_ ,(? M^B:>%O\ P50__$T <#_P\-_9Y_Z*=I'_ (__ (5\G?L^?M:?"7PG^V9^T%XL MU?QK8V7AWQ$MD-,U"3=Y=SLW;MO';(ZU]W?\,O\ PBY_XMIX7QC_ *!4/_Q- M?'/[-?P5\ :U^W'^TAHM_P"#-#O-'TI;#[%8S6,;0V^[=NV*1AE 'T5 M_P /#OV>?^BG:1_X_P#_ !-'_#P[]GG_ **=I/\ X_\ _$UWO_#+WPA_Z)IX M6_\ !5#_ /$T?\,O?"'_ *)IX7_\%4/_ ,30!P7_ \._9Y_Z*=I/_C_ /\ M$T?\/#OV>?\ HIVD_P#C_P#\37>_\,O?"'_HFGA?_P %4/\ \31_PR]\(?\ MHFGA?_P50_\ Q- '!?\ #P[]GG_HIVD_^/\ _P 31_P\._9Y_P"BG:3_ ./_ M /Q-=[_PR]\(?^B:>%__ 50_P#Q-'_#+WPA_P"B:>%__!5#_P#$T <%_P / M#OV>?^BG:3_X_P#_ !-'_#P[]GG_ **=I/\ X_\ _$UWO_#+WPA_Z)IX7_\ M!5#_ /$T?\,O?"'_ *)IX7_\%4/_ ,30!P7_ \._9Y_Z*=I/_C_ /\ $T?\ M/#OV>?\ HIVD_P#C_P#\37>_\,O?"'_HFGA?_P %4/\ \31_PR]\(?\ HFGA M?_P50_\ Q- '!?\ #P[]GG_HIVD_^/\ _P 31_P\._9Y_P"BG:3_ ./_ /Q- M=[_PR]\(?^B:>%__ 50_P#Q-'_#+_PA_P"B:>%__!5#_P#$T <#_P /#OV> MO^BG:3_X_P#X4?\ #P[]GG_HIVD_^/\ _P 37>_\,P?"'_HFGA?_ ,%4/_Q- M'_#+_P (?^B:>%__ 50_P#Q- '!?\/#OV><8_X6=I/_ (__ /$T?\/#?V>? M^BG:3_X__P#$UWW_ R_\(?^B:>%_P#P50__ !-)_P ,O_"'_HFGA;_P50__ M !- '!_\/#OV>>G_ L[2?\ Q_\ ^)KXXU/]J3X63_\ !3W2/B1'XRL&\$P^ M%6LI-8RWE"?RI1Y?3.5-\YCQMW9 YQGB@#ZB_X>'?L\_P#1 M3M(_\?\ _B:/^'AW[//_ $4[2?\ Q_\ ^)KO?^&7_A#_ -$T\+_^"J'_ .)H M_P"&7OA#_P!$T\+_ /@JA_\ B: ."_X>'?L\_P#13M)_\?\ _B:/^'AW[//_ M $4[2?\ Q_\ ^)KO?^&7OA#_ -$T\+_^"J'_ .)H_P"&7OA#_P!$T\+_ /@J MA_\ B: ."_X>'?L\_P#13M)_\?\ _B:/^'AW[//_ $4[2?\ Q_\ ^)KO?^&7 MOA#_ -$T\+_^"J'_ .)H_P"&7OA#_P!$T\+_ /@JA_\ B: ."_X>'?L\_P#1 M3M)_\?\ _B:/^'AW[//_ $4[2?\ Q_\ ^)KO?^&7OA#_ -$T\+_^"J'_ .)H M_P"&7OA#_P!$T\+_ /@JA_\ B: ."_X>'?L\_P#13M)_\?\ _B:/^'AW[//_ M $4[2?\ Q_\ ^)KO?^&7OA#_ -$T\+_^"J'_ .)H_P"&7OA#_P!$T\+_ /@J MA_\ B: ."_X>'?L\_P#13M)_\?\ _B:/^'AW[//_ $4[2?\ Q_\ ^)KO?^&7 MOA#_ -$T\+_^"J'_ .)H_P"&7OA#_P!$T\+_ /@JA_\ B: .!/\ P4._9Y/_ M #4[2/\ Q_\ ^)H_X>'?L\_]%.TG_P ?_P *[[_AE_X0_P#1-/"__@JA_P#B M:3_AE_X0_P#1-/"__@JA_P#B: ."_P"'AW[//_13M)_\?_\ B:/^'AO[//\ MT4[2/_'_ /"N]_X9?^$/_1-/"W_@JA_^)H_X9?\ A%_T33PM_P""J'_XF@#@ MO^'AW[//_13M)_\ '_\ XFOD_P#:+_:T^$OB[]LG]GSQ=I'C6QO_ ]X>>\. MJ7T>[9:AT(7=D=S7W;_PR_\ "+_HF?A?_P %4/\ \37QS^TU\$_ .A_MQ?LV MZ)I_@S0[+2-4>^^VV4%C&L-SM0E?,4##8]Z /HA?^"AG[/*C'_"SM)ZY_C_^ M)IW_ \._9Y_Z*=I/_C_ /\ $UW%_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\31_P\._9Y_Z*=I/_ M (__ /$UWO\ PR]\(?\ HFGA?_P50_\ Q-'_ R]\(?^B:>%_P#P50__ !- M'!?\/#OV>?\ HIVD_P#C_P#\31_P\._9Y_Z*=I/_ (__ /$UWO\ PR]\(?\ MHFGA?_P50_\ Q-'_ R]\(?^B:>%_P#P50__ !- '!?\/#OV>?\ HIVD_P#C M_P#\31_P\._9Y_Z*=I/_ (__ /$UWO\ PR]\(?\ HFGA?_P50_\ Q-'_ R_ M\(?^B:>%_P#P50__ !- '!?\/#OV>?\ HIVD_P#C_P#\32?\/#OV>?\ HIVD M_P#C_P#\37?']E_X0_\ 1-/"_P#X*H?_ (FD_P"&7_A#_P!$T\+_ /@JA_\ MB: ."_X>&_L\_P#13M)_\?\ _B:Q_%G[<7[,WC;0;W1-9^(NCWNE7L1BN+5F ME59%)Y!*X./H:]5_X9?^$/\ T33PO_X*H?\ XFC_ (9?^$/_ $33PO\ ^"J' M_P")H \]M_\ @H)^SM:QI'%\3-'CC0;51 X55'0 ;>!BI?\ AX=^SS_T4[2? M_'__ (FN]_X9?^$/_1-/"_\ X*H?_B:/^&7_ (0_]$T\+_\ @JA_^)H X+_A MX=^SS_T4[2?_ !__ H_X>&_L\_]%.TG_P ?_P *[W_AE_X1?]$S\+_^"J'_ M .)H_P"&7_A#_P!$T\+_ /@JA_\ B: ."_X>'?L\_P#13M)_\?\ \*^./^"C MW[4OPL^,6F_"2/P?XRL-B M^X@ &9&R.E?H)_PR_P#"'_HFGA?_ M ,%4/_Q-?$/_ 5"^#O@7P+I7P:/ASPAHNB->^+HX+EK&RCA,T9491]H^9?8 MT ?41_X*'?L\@D?\+.TCK_M__$T?\/#OV>?^BG:3_P"/_P#Q-=\?V8/A$Q)/ MPT\+9S_T"H?_ (FD_P"&7OA#_P!$T\+_ /@JA_\ B: ."_X>'?L\_P#13M)_ M\?\ _B:/^'AW[//_ $4[2?\ Q_\ ^)KO?^&7OA#_ -$T\+_^"J'_ .)H_P"& M7OA#_P!$T\+_ /@JA_\ B: ."_X>'?L\_P#13M)_\?\ _B:/^'AW[//_ $4[ M2?\ Q_\ ^)KO?^&7OA#_ -$T\+_^"J'_ .)H_P"&7OA#_P!$T\+_ /@JA_\ MB: ."_X>'?L\_P#13M)_\?\ _B:/^'AW[//_ $4[2?\ Q_\ ^)KO?^&7OA#_ M -$T\+_^"J'_ .)H_P"&7OA#_P!$T\+_ /@JA_\ B: ."_X>'?L\_P#13M)_ M\?\ _B:/^'AW[//_ $4[2?\ Q_\ ^)KO?^&7OA#_ -$T\+_^"J'_ .)H_P"& M7OA#_P!$T\+_ /@JA_\ B: ."_X>'?L\_P#13M)_\?\ _B:/^'AW[//_ $4[ M2?\ Q_\ ^)KO?^&7OA#_ -$T\+_^"J'_ .)H_P"&7OA#_P!$T\+_ /@JA_\ MB: .!_X>'?L\_P#13M)_\?\ _B:/^'AO[//_ $4[2?\ Q_\ PKO?^&7_ (0_ M]$T\+_\ @JA_^)H_X9?^$7_1-/"W_@JA_P#B: .#_P"'AW[//_13M)_\?_PI M/^'AO[//_13M)_\ '_\ XFN]_P"&7_A%_P!$T\+_ /@JA_\ B:/^&7_A%_T3 M3PO_ ."J'_XF@#@O^'AO[//_ $4[2?\ Q_\ PKYI_P""B/[8'P?^+W[+>O\ MAGPCXXT_6];N+NS>*SM]V]PDZLQ&1V K[3_X9?\ A#_T33PO_P""J'_XFOE? M_@IG\"_AYX'_ &2?$>K^'_!.@Z-JD5Y9+'>65A'%*@:=00&4 C(- 'VI\.?^ M1%\.?]@NU_\ 12UTML:;.;;4-/T_Q!=VTZXS'+&\[HP!X.& //I7 MUK^T!_R0GXD?]BUJ7_I+)7Q[^Q%_RBKU[_L#>)/_ &XH Z#_ ()G_M!>./BA MHOB?0/B?XAFUSQ9!'9:W9-+$BXTZZ@5HN44#.0201D;A7#?M1?M.?$JS_; T M+0? 'BI[#P-H6LZ!H?B*UA6(B6YOKAVV_,I8YC1E)4C;CUK!^'GB2R_9^U;] ME+XH:OJ%MI/A7Q%\/U\,ZQ/L(*M%"+B.:3'WN-J \D $=*YNSTJ^U;X ^"OB M9JZ0_P!J_$/XZ:7K9D2/:P@\^6.)<\G9A-RKD@;NW- 'Z"?&K]IGX?\ [/*Z M='XOU6>*_P!2=OLFF6%M)>7+[">Z;["8E\\6>P_(OG'Y_4L/>M7X2>%;[X._%C]H#Q7\2O'7 MA;Q'J,WAV.\\3^&/!EK-:R0K' S+,R<%7DC9CN#;BSDYH ]AUC_@H=\#="\7 M3Z%=>*9BMO /@5H%CJWB MW78[:/4?^0?:VL;7-S?I.!P#FO@?Q5>?$*\_8#UJ'PK\._!_P M^^#UUILE_9'5M6:_U"6UD)E#!-NT3.S#;D[E(Z=Z]!TKX1W7Q2^&_P"R_KO@ MWXA:5X:^,/A?P7!J&D:5K:"YCO8)+>*.61X\[\ ;AN .2?\ 9R #ZT^#/[27 MP_\ CU8WLWA'6_M-S88^VZ;>0O;7EH&+!3+"X#*&VD@XP1BN@T7XN>#?$7P\ MF\>:9XCT^]\'0P3W,FM0S VRQ0EA,Y?T0H^?3::^AZ!\35\,Q7[^*-!E66+5K2)_+RYQNCRS[E0DX (/ %>>&.Y0!U.1ZB@#['U+X[?#[1_!ND^++_Q?I-IX M:U;_ (\-4FN L%U^[:3$;'[QV([8'937'Z'^V1\)]>^%VK_$!?$O]G^'M)F^ MS7O]I6TEM<0S'[D1A=0Y=P054 DA@>]?'_B33;76/V-OV*;&^MX[JSNO&_AR M&>"8921&2<,I'<$5WO\ P4*TW7;OXS?L\6.ARZ/IUG?:_=RFX\06C3:4VK"& M);)KA4Y>7 D5,GMSP* /H[X,_M9?#7X\:A3Q-#&_B>Y\9:JGB7[T?M"_!7Q#\9=/T:W\/_ !)USX<2V,S227&BQ)(; M@$ !7W$< C- &C\#?C=I_P ;M-\5WNG:=>:='X>\1WWAN9;LJQEFMF4/(NTG MY#N&,\\&O29"=AQ^%?FA^R'^R9X^\16?CJ[A^-?C#PK!IGCO4[26SALD5=2: M*2,M=/N8?-+GG&1QU-?I?)_JQQW'% 'SO\"?B9K_ (@_: _:,T77=8>ZT#PK MJ>F+IL$P4+90R69EE ( )!89Y)J_XG_;N^"'A2XT-;GQQ:W=MJP5X]0T^.2Y MM+=&U>>? K_ ).&_;(_Z^]+_P#3:]>5?"[PQI&E_P#! M'769[33;6WFU#PMJ=[=NL0S/.)95$C>K (H![;1B@#[4^(WQ\\"?"GP';>,? M$>OV]KH-XJ&QFBS*U\SKOC2!%!,CLO(5>37S9IO[85C\7/VLO@_H'P_\57+^ M&-1TW5GUO0KBU-O.LT8!A,T-XO"^D^*6^VW,S6]E>7=G+!97T@.-D$[J$D8]@# MSCBOB_XQ2:ROAO\ ;3_LCS_*;QEI":GY*Y'V I_I&_T39G<1VK[1^*UA\&]% M_9VT34?&FFV,GPVT>.PO[06L+/%&PV>0\0C^8C+#H)_BQX M'\06-Z+&WD@LX[Y'0K?8^2WEB.&5R?X3C->;1>.]3\4?M6^.=3^"?PRTO7?$ MFFV-OI?B'Q1XBUM[2 AU6:)(H0K.3C&6 QQBO%O"%MJ:_ ?]N"'7Y-%O-8B MO"UPWA^'98";[+SY*GI@\$]2030!]I? ']H;2?'G[-VA?$WQ-XATR"&/3Q+K M6H1MY-K:SC_6JP/W=I('XU'\+?VVOA+\7_&*>&-!UZXBU:=&>S35+&6S2^53 MR;=Y% EXP?E['-?'OQVBUB/_ ()N_ RVT0K:6MW=:0FHO)'FU*,WRFY ZQ;\ M$@]<5VGQR^$7QFUC3? ]S\3_ (F_"G1=%TOQ!83:3>66E7%M.DX<;(;>3G D M4;=HX( ]* /J#XT?M;?#7X#ZO9:/XIU:Y_MF[C\Y=-TRREO;F.+_ )ZR1Q*2 MB$\ GKVKRO\ 8[^/FI_&[XQ?'/'BD>)O!VEZO"GA]X0ODQ6[IG"$*"1_O9.0 M:/V4UL+G]JC]IFYU#$GBR/7;>"%KDM]H33?)'EA0>D.\'&."17-?L0V^G6O[ M2G[4D6DQVT6GKXEB$26841+PVX*%XZYZ=Z /MI_]8E?$7_!*7_DE_P 2/^QS MOOZ5]NO_ *Q/J:^(O^"4O_)+_B1_V.=]_2@#[AHHHH **** "BBB@ HHHH * M*** &LVU2:^1/C[\3?B=\2/VB+;X)_"/Q#I_A$VFAC6O$/B=XA<3V>Z3;#;H MA!"NPVMR#E9,\8KZZE!:-@IP<<5\:^ ;&7PC_P %.OBA%J0CAE\4^$;'4=)7 M>#Y\,)2&7/HX>-OEZ[1GI0!O?LK_ !9^(UK\6/'OP5^+&H6.M^)?"]M;ZCI? MB"W3R)-6L91@R&/H=C;5+#^)B.P)]O\ CQXT\0_#SX3^(/$'A/PU=>+_ !': M0#[!H]HI9IY68*"0.=B[MS8_A4U\[>"+N'Q5_P %-/B-JVDNMS9^&/ UKHFJ M/N \N[EN%G1!_>^16R1T((/-?2WQ:^)WAWX.^ =4\8>*[YM-T'2U5[FX6)I& M&Y@B@(HRQ+,HQ[T ?%>K>/?VC?V8_%GPU\1?$WQOHWC;1O'?B"#1;_PM;VPA M.F27!++]E< %A'R.202%7/S;JZ7]O?(_:"_9,W'+?\)O#_Z.@K$_;4\-:'X! M\-_\-3^"_&$VH^)K*XL[G2[;5+A-0T6ZCE\NW(MX'XC;;MEWQG<&C)XR<6?V MTM4EUSXO?L<:E/!]EFO/%MK?3./PH ^\(_XO]XU)4<7\?^\: MDH **** "BBB@ HHHH **** "BBB@ HHHH **** $;I7Y\^+/%/QG^-W[3'Q M4T?P5\86^&'@CPE-;Z9'/>64)MY;P)F6)6D7)/.,$8K]!68+C-?&O@_\ M8Z_9L^,TGB_Q?:"Y\;VVJZE=?VA)J6JRO%8W:DK,Z)E?+D''+9X48XH ]!\> M:O\ %WX._LVV$&B;OBI\4O,AT]-2-MM@+RN*OVB? MV0SX;\8?$+XB:3\3O"VLZS::/J>C)8_9Y;5YR^UK60*N0".=V<@#CO6W^Q;\ M<&^'/[(OB'Q-\1]9O)_"?A75[O3],U6Y4RSW%C'+LB5".93N^5<>F.@K<\!^ M"O&O[8GC+P]\1_B-I4OA3X8:/<+J7A;P3-D75Y,&_=7M]D<87YDC']X?B ?7 MUG)YT0?^\ V">F17QKK=G^TW\?O%GBN?PWXJ3X+^&-%U6:ST:UU#1RUWJJ*! MB>4L& B)Z!<'K[5]GJRKE@,9Z\5\I?%G]H3QC\0_'FJ_"/X$V,=YXHM4-OKG MC&]5AIOAW<%(*D B:;#-A1T([X(H M?L\_&SQ;\8/@;\3K+Q[96=KXU\)7.I M:!JTVFL#:7$L&_^PIJ7_I5)7IGPW^ ^E?L MZ_LZ:QX2TRZN-2E73KZZOM4NAB:^NI(W:65_3)/ R<# S7F?_!*G_DS?PU_V M%-2_]*I* /L"EI*6@ HHHH **** "BBB@ HHHH 1NE?$WC+QQ\:/VEOCMX_\ M"?";QEI_PZ\*> S;V]YKPMUNKF]OI$9S$N<@1@9!&,AH^O.*^V:^-?V)[*3P MS^TC^U+H>H^5;:H_B*SU%+4."6MY8I'1U]1AESCH3@T =W^QA\9_&'Q'TGQE MX3^(T4">/O FJMHVHW%LAC6^C(W07/EGE=Z@GT(P1C.!V'[3'C?X@^#/ D"? M"_PR?$OC+5KV+3+1IE)M-/\ ,SFZN#VC3'?C.!7DO[&^M6GC7]H?]J'Q;I,W MVK0K_P 1:?IUO( MDTB^T?7YQJ!N;6XD+O\ 8W(WP; Q4!,KM<#TSS/CSQ'\3-2_:B\5?$#QG\#_ M !WX@TOPY;76D^$+?288VL;>,K(DEZ^\\NX(8$=./04 ?6?[$/Q"\0?%C]F+ MP5XN\47YU+7-6BGGN;@H$W$7$J@ #@ !0![ 5\[_ /!+?_D?/VFO^QT;_P!& MW5=C_P $M?B!J>O?LV>&/#=SX,UO1M/T>R&-4\5>/+K2)]3M+>WA*V=I;QJ_F7,\Y^550H?E^\3M' M>OH>N#^.T*#X)_$1]HWGPWJ"ELI%<=I?[)OP:U?]B&'XBW4EQJ'BI/"S:Q!XUN-3D2\BNTB9 MXXT;?M0+(!&(P.,8ZT ??W@G7+GQ-X/T75KW3;K1KR]LXIY]/O8_+FMY&4%H MW7L0>)=,FU6X\5ZHH9D6-V @ME; MY6E_=DD<_*WM7I_[&'B_Q!X\_9?^'.O>*+J:]UN]TJ.2:ZF7#SCHLC>I90#G MOUKP3X_:+IW[3W[:=G\%/&[36/@W0O#C>(+)=.E%O=WMX[(FX3%=VU5++L3J MC]FO2-*_9W_:\\2_!'P-J\>K^#KO0# MXBNX;G;/>:5?+*D;02W 9PZOY@#\KNXH_99_P"3_P#]J;_ ?@U\*KNPTGQAXP2ZN;K M7+Y1*-,LH4^>14S]_DEU2P MMYVH'KVH E^!/C_XN?"7]HZ+X+?%KQ##XZMM)II"HR0JJ2< =>!7R?\ M2-ZI'CB".YC"0\_WB5Y'4 J>XKZ0^)>I: M+I/@+Q!=^([J6P\/Q6$S7]U$6#1P[3O8;1G(7/(H ^ O@G<_'_\ :5TW4/&> MC?M##P9H6HZ[>1:)H]]I\'G3V*RXA= R[B",KZY4U[E^V)\;/'7POTOX:> O M"6K6FE>*O&]Y'I$GC#5(O]&T\A 'EVXP)&8Y&1@<\5YA\1/V*_@#X/\ V3_$ M'C/PB9EGL-+;6-"\9SZJ\MS;,A\R$12!@H7=P$ SEB.IK"\;>--=^.7A/]F; MX6_%S4HO#FF>/M,EU#Q#=W$"0W5W-!M^SP1NX(B>8,A+#YCNXQG% 'IGP)^* M?Q/^'/[3UG\%/B#XTTKXI6^K:3-K%KKEC&L=Y8LF28[A4X",%(7@9)ZFN6UC M_E,AH7_8EM_Z)FIWACP-H7[%G[8WPY\&?#QKN]TSXA65S%KMGJMS]LN83"08 M9DD*[T49;()VL!TR,ANL?\ID-"_[$MO_ $3-0!]_T444 %%%% !1110 4444 M %%%% !112&@#Y)_;Q^(_P 0O#]S\*_!7PUUZ3PSX@\9:]):R:I'"LC06\,8 M>1CO!4(H/CUX4T/QWJM]<>,]/TV6[L/#T&I26\-S9EV$C-&O MWMWS*VT@E00<@5\^ZK\*;#X4_M/_ ! ^&'PD!L_"_B?X8ZE&!F#$^6[#;R3D[SVQ@ NQ>,_VDOCMX9;XJ^&OB/H7PYTZ0377AOP)@VVA MZW&8EMKZ0[9)&C)R8U*\<]'4]*\5_9I_8]^"?Q:_8]TCQ/XQU&36]9?3#%=^ M*+N]9)= :!0GV>(;MD:0;,8(^;D_Q<<$VO>(/%W[+O[*'C/Q-JLVKP:5\0UL MKG5KN4&3[.+QX[=V/=1'",N?09ZT >Y:=XJ^/'[*_P 6OAW9?$[QW:_$WP5X MYU'^Q9KK[$+631[TC,.QP "KEL -G=L;H0,V?VJ\K^W]^RQDY._4/_19KH_V M\];M-4UWX ^#K243:_J7Q%TO5K>W3G=:VI9II#Z !UQGKAL=#7._M6?\G_?L ML_\ 734/_1;4 ?;T/W3]3_.I*9%]T_4_SI] !1110 4444 %(:6D- 'SS^U% MXC^,4UYX4\%_!^SCL+WQ%+5/%>9?#GXA?& M'X _M >"_A7\3_%=C\3=.\<07DVF:U;VOV>\LI(0A=90,*T>#Q@9&3SQ7NW[ M1G[0WAO]G7PG:ZEJUI>:QJ^J7!L=(T/3(C)=:C!O',UHUKH6@6+'[+X*7OQ4^ M-?[3/Q$^)O\ P@GQ.TCX1>'_ #J$FEPZ7J,$;W-\Z??FN"P.V,F-MI&/E;O MS7T?^Q3\?-2_:2^!.G>+];T^.PUM;F;3[UK<$6US)$0#-!DG]VP(Q[AAVKY3 M^$_P"\$_MT:I\4O'OQ4U2ZB\16'B*\T)K/1+U+".RL+?:L32J%R^?FR\A.=O MM@?0G_!//Q]>^,O@CJFGW=[;:G:^&/$5]X=TR^M84B%S96Y40N0@"EBK'Y@! MG@]>2 >K_';XV:?\$?#EA?7&C:QXCU+4[M=/TS1]#M6GN+RZ925CR!A <'YF MP!7C'[!?QT\9_'K2?B9J_C(/8WECXFDL;?1R !ID:(%-OG^(@@Y))YS7U:5C MDF4E5,D?*DCD9XXKXL_X)MI\GQ[0':/^%AZBO';]XU &%XH^(WQH^/WQX^)7 MA?P3\2='^$N@_#V:.!8;B));G5'="YED,@XBXQQTXYYKM?@W\0/BC^UQ^R=+ M>:/XHLO /CZ#6I=.D\1:9 )[6X6VE >6)&!&V13CN.#7E'PX^#?A#]O;XC?% M+Q-\3;VYMM<\/ZS+X>MM"T*Z^PO9643%5EF(7?*92"VY^!MP*]>_X)]?$*\U M[PCXZ\#(\-]H7@'79-"T;6+>-0MY:Y8H'*@*[H!M+C[V03SR0#Q+XI>&OVF/ MAMXL\%^$[7]I&3Q!XN\57PALM)BT:)-MNAS/&>U M\+_ &&ZG^U7,?BVW26?&/,<(H9L=LG)_&O0OV;Y4^.O[57Q:^*LTC76F^&)1 MX-\/QR0E?)5!FYD7/\1?*GU!KAO^"M6?[)^!F>O_ F<7_H(H ^_Z6DI: "B MBB@ HHHH **** "BBB@ HHHH \*_;$^-OB'X&_"^PO?".G6NI^+?$&M6?AW1 MXKYMMNEU*=:MM NHH M;;[-=Z9=7&[RY87VA7B4J=RL,XYST%>L?MT>%?#/BKX*1CQ)XK7P/+I^L6>H M:-X@D1GBL]2C9OL[2J!S&22I]-V>H%?('[36B?'K6K7X/Q?%/QGX;U)KOQQI M::-H'A6V(%_\Q9KR9R3PBCY=O&)')Q@4 >Z?%KX@?%KXT?&+Q?X(^'/C;2_A M5X/\%O:Q:EXLO8UDEOKV6,N;>$ME%"!EW*>1G%>D_LM^-_B5<>$_$VD_% MJW:ZU;PQ*;*VVV>O603Y+F)E.&<[3N QD<#-?.7P)_9A\#?%']I+]H MG2_B8G_"07NG^*9M2M/",UPRVD<-WMD2_P!B,"TCJ%3)X0#_ &JT/V=;7PM\ M+_&'[4GPT/B^_D^"?ANSM&BD6]+_ -DBY@E^V+%*N638?EXZ&//7- '-? F; M]HW]ISPBGCNW_:&M? T6M:E=BR\.M80.R1I.\8$>Y=Q7*E1U/RU[+_P50#+^ MQ/XF#OYC"]T]2WJ1<(#^M>:_%+]D/]GOP'^R'K/COP5=+IUU9Z2=8\.>.)]1 MDEN_/5O.@CC?W&:T/VV-:USQ)_P2[TC5?$QE/B*^T_0KG43. MFR0W#M$TFY>QW$\4 ?;GPY_Y$7PY_P!@NU_]%+72US7PY_Y$7PY_V"[7_P!% M+72T P MN?)?8_E2SRH^UNQPQP:^F/V@/^2$_$C_ +%K4O\ TEDK\T?V'W_:X7]G/0!\ M)$\&-X(^T7?V4ZR%^T^9Y[^;NYZ;]V/;% 'W[XX_8Y^'/Q"^"/AKX5ZO;W[^ M&O#J0)ITT-T$NXA$A0?O=O=6(;CFM?6/V8? NL?#GP)X'>VN[;P_X+U"QU/2 MH;:XV,)K3/E>8V/G'S'=GJ>:^9?._P""@?\ SR^&_P#X[_\ %4>=_P % _\ MGE\-_P#QW_XJ@#Z6^-'[+O@WXY:UI6MZQ/K6C>(--B:W@UGP[J3V-WY#-N,+ M.GWH]WS;3WJW\._V:? /PU\&ZYX=_P4#_ .>7PW_\=_\ BJ /5+7_ M ()T_".'0-0T"X;Q+J7AVX21+;1K[6YI;/3RX8;[:(\(RAVVDYQUZUU'BG]B MSX:>+/!_@O0KBVU.RNO!UC'IVB>(-.OVMM5M;=%"[!<( 2"."",OWO;VXC082-I'_ (0. .P]*\[N/\ @G1\'IG\20+!KT&A M:\9I+CP[!K$J:9'-( /.C@'RB12 RDY (!QP*\J\[_@H'_SR^&__ ([_ /%4 M>=_P4#_YY?#?_P =_P#BJ /I.X_97\#W/@/X:^$'_M+^R/A_JEGK&BXN_P!X M)[;=Y7FMCYU^TR7,4D$IBGMID.4EAD7 ME''/(]37R+YW_!0/_GE\-_\ QW_XJCSO^"@?_/+X;_\ CO\ \50!]%_";]DS MP1\(O$R^([2[U_Q)X@A@:UM=3\4:M)J,UG"V-Z0%^(PV!D@9/0G%9/CC]B+X M;>./'6H>*VD\0:#J.J%3JT.@ZS-9V^J;0!_I$:G#<#!Q@X)]:\*\[_@H'_SR M^&__ ([_ /%4>=_P4#_YY?#?_P =_P#BJ /JSX%_ 'P?^SGX8U/P]X)M9['1 M[[4YM5:VGG,HBED5%*1D\A (U !SC'4UZ/QZU\&>=_P4#_YY?#?_ ,=_^*H\ M[_@H'_SR^&__ ([_ /%4 ?>"QA6SDDXQR:7PW_P#'?_BJ /K/PS\$/#7A/Q9\0O$=A]L_M'QT\$FK^;/N M3,4)A3RUQ\GRL<]>:RM)_9J\&Z+^SV_P9MQ?_P#"&/I\^F$/=_P4#_ .>7PW_\=_\ BJ /I#Q5^R?X M \9?"7PW\/=1@U$:3X;$)T>^M[YXK^RDB&$ECG7!#X)&<=ZP? /[$/PZ^'?Q M,T7X@6=SXBU3Q?I<4T*ZIK&KR7]>&^=_P4#_YY?#? M_P =_P#BJ/._X*!_\\OAO_X[_P#%4 ?4^@_L[^"] U+XD7:VN:;>Q2^)-3TS3+A;JP\.ZKK?L3?#OQY\2KWQU]H\1>'/$&HQK%J4GAS6)+%-0"]/."?>.,#. M1TK7\)_LC?#7P;I'C_1].TJ9=#\;[?[7TN27PW_\ '?\ XJCSO^"@?_/+X;_^._\ Q5 'T=X%_9/\#^"/A+JGPSDE MUCQ+X)OU\LZ7X@OVNE@C_P"><385D7(!P#P1QBN?^'O[#/PX^'OBC2M=%UXD M\33:.I72[3Q-K,M_:V![-#$_RJP' )S@5XCYW_!0/_GE\-__ !W_ .*H\[_@ MH'_SR^&__CO_ ,50!]$?%K]D?P1\7O&4/BN\O?$/ASQ&MN+2;4O#.KR6$MU" M/NQS%/OA><9Z9-6O@/\ LI^ OV;[KQ'/X*@O[?\ MZ5)KN.\O&G77PW_ /'?_BJ /O!_ MOI]:^(O^"4I_XM?\2/\ L<[[^8K-5_\ @H [J'C^&V,CDA3CW^]7SE^Q&W[5 MB>"?%G_"IE\'OI9\0W/]H'6 OF?;,CS-G/W/2@#]?\T9KX,\[_@H'_SR^&__ M ([_ /%4>=_P4#_YY?#?_P =_P#BJ /O/-&:^#/._P""@?\ SR^&_P#X[_\ M%4>=_P % _\ GE\-_P#QW_XJ@#[SS1FO@SSO^"@?_/+X;_\ CO\ \51YW_!0 M/_GE\-__ !W_ .*H ^\\T9KX,\[_ (*!_P#/+X;_ /CO_P 51YW_ 4#_P"> M7PW_ /'?_BJ /O/-&:^#/._X*!_\\OAO_P"._P#Q5'G?\% _^>7PW_\ '?\ MXJ@#[SXKR/XY?LM^!?V@KS1]0\1Q:A8ZYI =;#6M$OGLKVW1^'195YVL,@CW M/J:^:/._X*!_\\OAO_X[_P#%4>=_P4#_ .>7PW_\=_\ BJ /J'X&_LV^!_V> M=!U/3?"-G7DIS\TLK"_AK>^! M)7U+Q1X?O6E-S'XFO7U"259/O(SOR5'8=J^5?._X*!_\\OAO_P"._P#Q5'G? M\% _^>7PW_\ '?\ XJ@#U/P;_P $X_@SX-U[3-0%EK.MV>ESM=:?H>M:I)=: M;:2E]X:.W/R@@GOD<\YKS[]OK"_M"?LFCI_Q6\)Y.?\ EM!6;YW_ 4#_P"> M7PW_ /'?_BJ^=/VGV_:L;XI_ T_$'_A#H_$7_"21_P#"+G30OE?;=\6WS^?N M9V>W6@#]>X^-W^\:?FO@SS/^"@*\+#\-P!V 4?\ LU'G?\% _P#GE\-__'?_ M (J@#[SS1FO@SSO^"@?_ #R^&_\ X[_\51YW_!0/_GE\-_\ QW_XJ@#[SS1F MO@SSO^"@?_/+X;_^._\ Q5'G?\% _P#GE\-__'?_ (J@#[SS1FO@SSO^"@?_ M #R^&_\ X[_\51YW_!0/_GE\-_\ QW_XJ@#[SS1FO@SSO^"@?_/+X;_^._\ MQ5'G?\% _P#GE\-__'?_ (J@#[SS1FO@SSO^"@?_ #R^&_\ X[_\51YW_!0/ M_GE\-_\ QW_XJ@#[SS1FO@SSO^"@?_/+X;_^._\ Q5'G?\% _P#GE\-__'?_ M (J@#[SS1FO@SSO^"@?_ #R^&_\ X[_\51YW_!0/_GE\-_\ QW_XJ@#[Q90^ M,U\X^/?V OA5X^\5ZMKTG_"0Z%+K#F75++0=9EL[2_D.=SS1+PS-D@XQFO'/ M._X*!_\ /+X;_P#CO_Q5'G?\% _^>7PW_P#'?_BJ />OBE^Q1\,OBQ\-O"W@ M&_MM2T?PGX:7PW_P#'?_BJ/._X*!_\\OAO M_P"._P#Q5 'USK?P?TG7OB5X<\;3:GK4.I:%;O;6]E;:B\=E*K;LM- /ED8; MC@GV]*\%LO\ @F?\+=)N-0ETSQ%X^TD7]R]W M=_P4#_YY?#?_ ,=_^*H\[_@H'_SR^&__ ([_ /%4 ?1?AGX&Z+\!_A#XVTK1 M=7\0:S!>6MU=R3>(=3>^F5OLY7:KOT7"CCU)->3_ /!*K_DS?PW_ -A74O\ MTJDKSCQ5)^WJWA?6!J5Y;;\?-UQFO'/V)6_:W7]G_2C\ M*%\%OX/^VWOD'6 /M(E\]O-!Y'&_./;% 'ZU49KX-\[_ (*!_P#/+X=_P4 M#_YY?#?_ ,=_^*H ^\\T9KX,\[_@H'_SR^&__CO_ ,51YW_!0/\ YY?#?_QW M_P"*H ^\\T9KX,\[_@H'_P \OAO_ ..__%4>=_P4#_YY?#?_ ,=_^*H ^\\T M9KX,\[_@H'_SR^&__CO_ ,51YW_!0/\ YY?#?_QW_P"*H ^\S]:\,^,W[&OP M[^-_BR+Q3JW]M:+XF6W^QR:OX=U22QN)[?M%(5X9<]L5\_\ G?\ !0/_ )Y? M#?\ \=_^*H\[_@H'_P \OAO_ ..__%4 ?4O@#]G/P5\+O@_/\-?"UK=:-X=G M@EBDDM;EDNF:08>7SASYA&/F[8&.E+-^SOX.U+X+CX7ZU#>>)/#'V=K9FUJZ M:ZNFRQ8.9F^;>">&ZC ]*^6?._X*!_\ /+X;_P#CO_Q5'G?\% _^>7PW_P#' M?_BJ /;?A3^PI\+_ (2^+=-\2V:ZWX@U?2H_*TJ7Q)JDE\NFKC'^CJW"<8'3 MC QC%>]7NEP:AIMS8REO(N(GA?#<[6!!Y]>:^&/._P""@?\ SR^&_P#X[_\ M%4>=_P % _\ GE\-_P#QW_XJ@#[!^#_PIT+X(?#K1O!/AK[5_8FDQM%;?;)O M-EVL[.=S8&>6/:OC/_@EO_R/G[37_8Z-_P"C;JK@E_X*!Y_U7PX_\=_^*KY@ M_8P?]J!?$WQD/PK7PBVH_P#"1M_PD@U8#9]MWS9\GG[F[S/TH _9*DS7P9YW M_!0/_GG\-_\ QW_XJCSO^"@?_/+X;_\ CO\ \50!]YYHS7P9YW_!0/\ YY?# M?_QW_P"*H\[_ (*!_P#/+X;_ /CO_P 50!]YYHS7P9YW_!0/_GE\-_\ QW_X MJCSO^"@?_/+X;_\ CO\ \50!]YYHS7P9YW_!0/\ YY?#?_QW_P"*H\[_ (*! M_P#/+X;_ /CO_P 50!]YYHS7P9YW_!0/_GE\-_\ QW_XJCSO^"@?_/+X;_\ MCO\ \50!]YYK,\4>';/Q?X9U?0M0W_8=4LYK&X\IMK^7*A1MI['#'!KX?\[_ M (*!_P#/+X;_ /CO_P 51YW_ 4#_P">7PW_ /'?_BJ /LCX?_#/0_AK\/=# M\%Z3'*^AZ/9)86\=V_FLT*C #G&&R.O%>$ZM_P $X_@WK.N374]MKT>B37GV MZ3PK!K$L>CM)NW$?9AP%+?,0".?2O+?._P""@?\ SR^&_P#X[_\ %4>=_P % M _\ GE\-_P#QW_XJ@#ZR^(?P/\._$3P#:>#I)]2\.:+:20O GAJ\;3Y(UB!" M1JT>,)@XVUB_&C]EOP%\>8=(?Q+:WD.K:.NW3M=_P4#_YY?#?_ ,=_^*H ^F?@3^R_X#_9 MUM=6'A2SNI=1U:?[3?ZOJMR;J]N6_P!N5N2,DG'J237SQ^RS_P G_P#[4O?Y M-._D]9OG?\% _P#GG\.![_+_ /%5\Y_!4_M5+^U)\:#X5'@UOB#MLSXD6]5? ML@^]Y7D<]N=_P % _\ GE\- M_P#QW_XJ@#[SS1FO@SSO^"@?_/+X;_\ CO\ \51YW_!0/_GE\-__ !W_ .*H M ^\\T9KX,\[_ (*!_P#/+X;_ /CO_P 51YW_ 4#_P">7PW_ /'?_BJ /O/- M&:^#/._X*!_\\OAO_P"._P#Q5'G?\% _^>7PW_\ '?\ XJ@#[SS1FO@SSO\ M@H'_ ,\OAO\ ^.__ !5'G?\ !0/_ )Y?#?\ \=_^*H ^\Z\W^.'[/G@O]H7P M[:Z1XPLIYULIQ=V-Y9W#6]S93#I)%(IRK?G7RIYW_!0/_GE\-_\ QW_XJCSO M^"@?_/+X;_\ CO\ \50!]'? G]DWP%^SUJFMZOX;34[_ %W6MJWNL:Y?->7D MJ+C$9D;G;\H./8>@KIO!/P5T/P/J'B^Z@OM8U0>*+DW%[;ZOJ#W4,>0P,<*- MQ&A#GY1[>@KY+\[_ (*!_P#/+X;_ /CO_P 51YW_ 4#_P">7PW_ /'?_BJ M/3[?_@F[\&+?4$*6WB Z!'E?+/G?\% _^>7PW_\ '?\ MXJCSO^"@?_/+X;_^._\ Q5 'T3\%?V1?A[\"_$%YXAT6'4M8\3W4?D/KOB&_ M>_O5AX_=)(_W5X[?G7S5K/\ RF0T+_L2V_\ 1,U7/._X*!_\\OAQ_P"._P#Q M5?,&H-^U!_P\ TPW"^$?^%S_ /".-Y"J!_9_V/9)G//W\;^_I0!^R6:,U\&> M=_P4"_YY?#?_ ,=_^*H\[_@H'_SR^&__ ([_ /%4 ?>>:,U\&>=_P4#_ .>7 MPW_\=_\ BJ/._P""@?\ SR^&_P#X[_\ %4 ?>>:,U\&>=_P4#_YY?#?_ ,=_ M^*H\[_@H'_SR^&__ ([_ /%4 ?>>:,U\&>=_P4#_ .>7PW_\=_\ BJ/._P"" M@?\ SR^&_P#X[_\ %4 ?>>:,U\&>=_P4#_YY?#?_ ,=_^*H\[_@H'_SR^&__ M ([_ /%4 ?>>:/QKX,\[_@H'_P \OAO_ ..__%4>=_P4#_YY?#?_ ,=_^*H M^GOC=^S/X%^/\>FR>)K2Z@U;3&9M/UO2;IK2_M-V-RQS+R%;'(.1R?6HO@;^ MR_X$_9[&L3>%;:^DU76'1]1U?5;U[N\NRF=N^1SR 23T[FOF;SO^"@?_ #R^ M&_\ X[_\51YW_!0/_GE\-_\ QW_XJ@#UGQS_ ,$[_A!XZU[5-1D@US1;35IQ M2[@2\ENORDM@9QCH,8Q7K6O? /P!XD^%+?#:]\-6?\ PA)@ M6W72(5\N-%4AE*[<$,& ;=G.>3FODSSO^"@?_/+X;_\ CO\ \51YW_!0/_GE M\-__ !W_ .*H ]P^$/[#7PT^#?CZV\9Z>(M5>^-E$<@K#N M^[PS#Z,?4UY#^U8H7]O[]ED#HKZA_P"BS6=YW_!0/_GE\./_ !W_ .*KYR^- MS?M5G]J+X*GQ?SZ9Q0!^OD/W3VY/\Z?FO@SS MO^"@/\,7PWQV^[_\51YW_!0/_GE\-_\ QW_XJ@#[SS1FO@SSO^"@?_/+X;_^ M._\ Q5'G?\% _P#GE\-__'?_ (J@#[SS1FO@SSO^"@?_ #R^&_\ X[_\51YW M_!0/_GE\-_\ QW_XJ@#[SS1Q7P9YW_!0/_GE\-__ !W_ .*H\[_@H'_SR^&_ M_CO_ ,50![K\:C>:>[/':ZMXEGN;5R5*_/$>&'. M<'N >U>(>=_P4#_YY?#?_P =_P#BJ/._X*!_\\OAO_X[_P#%4 >Q_%']@#X2 M_%3Q?JGB6XMM8\.ZEJ\9CU7_ (1O4WL8M1!ZF=%&')[],]3D\UU?C+X(Z+X5 M_9WUKX?>!= N;#3_ + \%G8Z#>"RN/,.,,LY.0Y/)8DDX(]J^=_P % _\ GE\-_P#QW_XJ@#[.^&^@WOA7P%X:T34KMM0U M'3=+MK.ZN\L1/+'$B/)EN3N92>>>>:YSX0_ 'PI\$?\ A*?^$:%\/^$DU:76 MK[[9<>;_ *1(26V<#:N3TKY4\[_@H'_SR^''_CO_ ,51YW_!0/\ YY?#?_QW M_P"*H ]R^+'[#_PU^+WCFZ\7WK:[X?U^]@%M?77AO57L#>H.@F"??^IZXKU3 MX8_"OPQ\'?!NG>%?"6F1Z1HEB"(;>/GDG+.QZLQ/4GFOCGSO^"@?_/+X;_\ MCO\ \51YW_!0/_GE\-__ !W_ .*H ^N_A'\'?#WP3\/ZCHWAL70LK_5+G5YA M=S>:WGSMNDP<#"YZ#M7QQ_P5K_Y!7P-_['2+_P!!%7/._P""@?\ SR^&_P#X M[_\ %5\P?MS-^U ^G_#;_A;R^$5A_P"$BC_L7^Q@,_;<#;YO/W,=: /V2#49 MKX-:3_@H$&($?PW(SZ+_ /%4GG?\% _^>7PW_P#'?_BJ /O/-&:^#/._X*!_ M\\OAO_X[_P#%4>=_P4#_ .>7PW_\=_\ BJ /O/-&:^#/._X*!_\ /+X;_P#C MO_Q5'G?\% _^>7PW_P#'?_BJ /O/-&:^#/._X*!_\\OAO_X[_P#%4>=_P4#_ M .>7PW_\=_\ BJ /O/-&:^#/._X*!_\ /+X;_P#CO_Q5'G?\% _^>7PW_P#' M?_BJ /O/-&:^#/._X*!_\\OAO_X[_P#%4>=_P4#_ .>7PW_\=_\ BJ /M'X@ M?#_0?BCX/U7PMXFL5U/0M4A\BZM'8@.N01R.000"#Z@5Y'\&?V(?AG\#_%-K MXBT9-9U?6+&V-GI]QK^IO>_8(3P4MU;B,$%>=_P % _\ GE\-_P#Q MW_XJCSO^"@?_ #R^&_\ X[_\50!]$_&;]D3X??&_Q%:^(M635=$\2P0_9CK? MAO4'T^[FA_YY2.GWU&!UYX'/%;7P?_9I^'GP.\"WGA/PQH,2:9J <:C)>'SY M]0W JWGR$9?()&#QR>.37RYYW_!0/_GE\-__ !W_ .*H\[_@H'_SR^&__CO_ M ,50!ZE#_P $W_@I%K$,[:;K$^B6]T+RW\+S:O,^D02AMVY+U&]D\JSM+C5+B>0]$C2YE9F/T )KZ._: _Y(3\2/\ L6M2_P#262OD M_P#X)^@?\.S[CC_EQU__ -#GH ^R/AS\2O#OQ:\)V7B;PIJ,>KZ%>;Q;WD60 MLFUBK8!&>""/PKIMU?FK\&_C)XS^"?\ P3K^"^J>!(-/O-?U7Q9!HBVVIK^Y MG2>YG!C+9&SM^)?B5\9/@#\>OA#I?C3QAIOC/0OB)HP ?1GQ7_:$\ ?!&;3(/&7B.WTF[U,L+*SV MM+<7&W[Q6- 6(&1SC'-=OHVL6VO:5::C9LSVEU$LT3LI4E&&02#R.#T-? GC MCPK\7K__ (*6:=]@\3^$TOE\)3WFESWFCM*+;21J&TP'G/VGEOWH(X+#OBF^ M%OVG/%'QVU#Q?XGMOCQX5^$.BVE_-9>&-"NX;>:2]6$E?M%[YK!E61P.%Y W M8[$@'Z$[J V:^"->_;Z\37'[%NF_%C0+;27\6V/B.#0M7L.9;.619")!&V00 MLB;&##[H?VK4^/OQ,^/G[+7POTSQ->^,] \=ZCKOB/2K*"QETC[-%"9HY3<0 M*P;(B++&$8_,H!)Y- 'W'N]J7-?%?QF^+WQ6_93\ H_B;QYHOBWQ)XRUFSTK M0;J[TT6=GHLDJ_Z1-.0?GA0YVCK@ GJ:YW2_VD/$OPB^+OP]TZ[^-7AOXT>% M_%^HV_A^]MK5;>#4-,OIB1%-$L3$-!NPISSSZD4 ?>VZN1\"_%CPK\2M0\16 M/AO5X=4NO#U\VFZI'$#FVN5)#1MD=1@]/2OFWP[XR^+O[37Q8^(J^"_&=O\ M#CP%X(U.7P[;.FG1WMUJ>IQ;3.TN\X6)20,#D@C'4US'_!,F/6H]>_:#7Q)- M;7'B$>-IQJ4UDA2&2XR_F,BG[JELD#L#0!]T4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110!&X_>1]^:^(O^"4O_ "2_XD?]CG??TK[=;[\= M?$7_ 2E_P"27_$C_L<[[^E 'W#1110 4444 %%%% !1110 4444 (>*\]^+ MG[0/P^^!%E:77COQ18^'4NVVVZ7+_O)B.NU!DD#N<8KT&3[I[5\2:;H^D_&+ M_@IAXY@\3Z)8ZK#X%\(VEGI=M>1">+=<%9GF96XW@3.@X(P?6@#ZG^%/QI\$ M_&_0YM8\#^(['Q'I\,ODS2VE?&_PA\/Z;\)?^"C/Q*\)^&["WT_2?%7@ZT\2W-O;Q MB*.WN(9Q!MC5> K;W<^A)QQ7TQ\:OA38?'#X7Z_X'U6^OM.T[68/L\UQI\WE MRJN0<9[J<89>C D=Z .-\!_MF_!?XG^+H?"_AGX@:3JFNW#%+>T20J;A@"2( MRP 8X!.!UKPC]OAP_P"T'^R:P_Z'B+_T=!7FO[2&F^!='^-GPF^&^E^"(OAA MH/@;Q)8WMQ\0[ZS$-I-$D(=;:.9%R[R,5&YR!O7KUKTG]O8Y_: _9,)X_P"* MWA.#U_UT% 'V_%_'_O&I*CB_C_WC4E !1110 4444 %%%% !1110 4444 %% M%% !1110 E87CGQUH7PU\*ZAXE\3:G!H^AZ?'YES>W+82-20!GW)( [D5MR M/MQP3GT%?EY^WCXWU3]JCPU\3D\-:A=V?PM^%UH7N[ZW4&+6=8\U%$*MGYHX MT,M&L/"3^)[O4;>TT!+3[>^H7#A(D@V[_,)/0;>:\U^&/[ M8'P?^,7B<>'?"'CG3=8UMD:2.R1BDDJCJ4W ;L#G YQ7A'[:]O)JO['/PV\/ MO//;V6OZQX;TF\\LE6:&7;O4COT''L*H?M\_#'PM\*_AW\+?$_AC0-.T/6_# M_C+2;:TO=/MEMY3$[$.C,@!(81KG.>_K0!]TYK&\8>,M&\ ^&=2\0>(-0ATK M1M.A:XNKRX;:D4:]23^(_$BM*VD,T2N1@D D?49K\Y/VW/&>N_M2Q?$SP?X8 MO9K/X7_#;3WOM?U>TPPU+547='9*<\HF26ZX9<_W: /NG5O%NE>//@MJ7B+0 MKM;_ $;5-#GN[.Z0$++$\#%6&>>0:^>/^"5/_)F_AO\ ["FI?^E4E=I^SC\O M[!/@=2,'_A!(CT_Z=#7%_P#!*G_DS?PU_P!A34O_ $JDH ^P*6DI: "BBB@ MHHHH **** "BBB@!"<5Y7\6/VHOA?\#;NTL_''C#3M!OKM?,AM)I-TQ3^_M4 M$A?<]:]4:OAS]EOPQH'QB_:F_:8\4^*O#^F:QJFG:S::):?;[=;A+>VCC92J M!P0-YB5CQU''?(!]?_#_ .(WASXI^%[/Q'X4UBTUW1+P,8;VSD#HQ4[6'J"# MP0>15KQ9XST;P)X?U#7O$.H6^CZ+I\9FNKZ[D"1Q(/XB?Z=37RU^P_X;MOAI M\9OVE?A]I7&@:-XDL]0LX\!1$;VV,SQJHX"J0JC'917MWQ\^ /A_]H7PSIWA M[Q-<7Z:-;ZG;ZC-:6DVR.\\I@?)F'\49].,'![4 5OA3^U=\*?C=KEUHW@GQ MGI^O:K;Q>>]G"Q64Q@@%U# ;@"1G'3-6/BW^T]\,?@5WM@ME_PD MUPV(XX+<(H#+PW+')5N.M?46H?L\_#3PW\3?&/Q<\5"VU&\U.T@CEF\3F.>T MTV*($$0^8,1AN#CU!Q]XT >H_#WXD^&?BOX9M?$7A'6K37]$N<^5>64@="0< M%3W# CD'D5\3_P#!+?\ Y'S]IO\ ['1O_1MU76_L'Z!#K'Q7^-GQ(\)V[:;\ M*O$FI0Q^'K983;PW#11JL]Q%#P%0N" V!NS[5R7_ 2W_P"1\_:;_P"QT;_T M;=4 ??U%%% !1110 4444 %%%% !1110 AJGJFKVNBV-Q>WTR6MI;QM---*P M5(T49+$GH,5<-?,W[:'P+U+XO>$==OM1\8ZEIW@?1O#U[=S^&--(B74KR.*5 MT:>7[VQ<1D(."0^^$?&ND>//#.F>(=!NTU'1M3@6YM+N+[LL9Z,/8UY3 MJ'[;WP/TGQL_A*\^(VC0:Y'=?8I(3*2B3YV[#(!M!#<'G ->-:/X_OOA;_P2 MITCQ1IB;[^R\#0)#^\,91I56'>&'(9?,W#W45\\>&;/R?V5]*LXOV:+CQ'\) MFTDR:YXIDFAM]?NV4L\M[;J061-RAP6/W0W&.2 ?JXL@D164@AAD$+4_'/B2Q\.V9\9VH@Y; ]!Q1\#?$6@>*/A#X/U'PQ MJ5YJ^@W&F0-97FH2;[F6,( /-; RXQAO<5\G_MDFQT']K3X6^)[7P[#\6M=@ MTFYT\_#N*W\^YAA+,[:C&#F-2,K'^\&"#QR,@ ^K/A3\>/ ?QRT>YU3P+XDL MO$=G:RB"Y:U?YH'(R ZD C(Y!Q@U\N_LL_\ )_\ ^U+D?P:=_)ZS_P!A^UL_ M$'[37QF\6R:=#\.];NDMK.?X:BU-O<6,,?\ J[J7@(^\8;,? 9V'N=#]EG_D M_P#_ &IO]S3OY/0!]PK2TE+0 4444 %%%% !1110 4444 )7(_$OXM>$?@[X MTF-Q']HO) H9ST51U8GT KKFKXI_: T_3_B1_P4,^!_@SQ%IM MOJF@:=H^I:REG: /H[X0_M%_#KX\0W\G@3Q38^ M(38E1=16[D20[L[2RD X.#@].*]'R?2OC/7? 6C_ I_X*-?"Z^\-V5OI$7C M+PSJEGJ-C8P)! ?LJ+*D@5 6)(SD?PBOK3Q9>7MAX=U2ZTZWEN]0AM)7M[> M+&Z64*=BJ#WSB@#Q/6O^"@'P$\.ZU?:3J/Q#T^UU&QN'M;B!EG^./C3X+^&O@B/Q?XH\06>B>')5C:.^NWVK)Y@!0*.K,0!D)$:*,X)ZACTYKJ/V MDOBWI/Q,_:P^#.G:9X.F^)GAF/P__;F@Z!8NJP7UU/D12SJ_R)'$$YSTY!'& M* /N'X1?M'?#CX\K>CP'XKL?$,MD%:YAMV(DA!. S*0#@D=:^2]9_P"4R&A? M]B6W_HF:M#X"ZY8Z9^U?I?\ PL3X6S?![XGZOI$]KIO]AWJG1-:M8\,R-&H M,R$YY_NK[5GZQ_RF0T+_ +$MO_1,U 'W]2T44 %%%% !1110 4444 %%%% ! M112$T ([%5R!N/I7*^"?BGX7^)$^NQ>&=7M]9;0[]]+U!K5MRP7* %HR>A(R M.G%>$?ME?&[7=$71OA'\.U:Z^)WCK?:VS1?,=*L3E9KUP.0JJ),'L5)[5Q?_ M 3/^'L/PITCXW^#K:[GU*#1/'MSIZ7EP 'F\NW@4NV.YZ_C0!]5^/OBEX8^ M&*Z*WB;5K?2AK.H1:58>*_%VC>!M O=<\0:E:Z/H M]E&TMS?7DHCBB4#)))K\_/VW/@9+X;^*7PJ^(6N>*=5\3ZUJGQ'TFTL[:Z81 MVFE6GG*?)@B7C)V+N<_,VT9K[*^/?P'T#X_:/H.E^([J]CT_2=6M]8%I;R 0 M74D+9$9 M P&['7 YQ7S_ /M6,&_;^_998=&?4.G_ %S-9O[2'AGP5XW_ &DO@[X*^%^@ MV,'Q#\.Z_!K>LZIH$200:5ID3$S0W+Q 8:7 55//4'[U:/[56W_AOW]E@KPN M_4,?]^VH ^WX1M0@>I_G4E,B^Z?J?YT^@ HHHH **** "DS2TAH Y+XD?%;P MI\(?#%QXB\8ZW:^']%@=8VO+Q]JL[?=11U9CZ =JP_A#^T=\./CR+\> _%=C MXBDL-INH;9R)(0V=K,A .TX(STR*S_BU^SGX4^,OC/P5XC\5)/?Q^%+B:X@T MF5P]C"-,O$\8ZI MH<2V]E(9546]MNCPLS@\E><=?X: /K_XD?%/PS\(_#IU[Q=JL.BZ2)H[<7,Y MX:21MJ(!U))]/<]*ZB.3>S#:1M]:_/3_ (*7? F3_A#M2^)NN>+-5UJ>+6=+ MM=%T-F$=CI2-<(LC(B_?D8;LNW0,0*_0SH3Q[T <[\0?B1X9^%/AFX\0^+M: MM-!T6WP)+R\D"("> !W)/8#FN.^$O[4GPN^.FH7%AX&\8Z=KVHVZ>;+9Q.4F M5/[VU@"1GTKPO_@I1:Z5>>"_AW>W,NG:KJ6D^*+>_L?!UY$\TGB23:R"TCC3 MGG?DL1M '->>?#"\M?'O[>'A#6+_ , K\#-2T?0;I;+P_J%B(KSQ"LB.)'1H M@(L1<PS?@ ?0VL_\ !0+X!>']6OM,O_B+I]O?V,\EM<0,DA*2(Q5E^[V( M(KN/AK^TM\-_B]H.N:WX3\56.J:3HF/[1O-YCBM@5+ NS 8&U2<^U>>_M7:U MX%^!?P;USQ4?!GANY\373"STE)=(A?[3J$QVQ;B4Y&X[BQ].:\2^/WPAC_9_ M_P""?4WA* +'K'B2_P!/M?$&H+&B2S7%Y<)]H<[ %.TN54=,** /I'P'^VE\ M%?B;XKA\->&OB#I.I:U.2L%J)"AG(ZA"P 8\=.M?-G_!6IMVD_ P_P#4YQ'_ M ,=%7/V]/@MX-^#_ .R7I6IZ!X=TVTUCP3?Z4^G:E!:I#<,R2HC%W0 DN!\V M<\G-8/\ P5%U1]<\"_L[ZE)&L4EYXHM;EHU.0I>)&(!]!F@#]$12TE+0 444 M4 %%%% !1110 4444 %%%% '$_%KXS^#O@;X;AU[QOK<.@:1-G67Q&TZXO+R9+>&)4D!>1B%5>5[D@5[KK MWAO2?%%F+36=*LM7M582""^MTFC# '#;7!&>3S[U\.*_UV0,!&Y"!B(%)X!P)%YZB@#Z+^+G[2OPV^!*Z?_PG M?BNQ\.RZ@K/:V]PY,LJKC+!%!.T$@9Z9KH/AW\5O"_Q;\)V_B7P;K%KXAT.= MVC6\LY 55U^\K \JP[@^Q[UYYJ7[//PXT;XK>+/BYXI2'4KK4;""VN/^$C\N M>SL$AR-T/F#$08%00.,C/5C7P]J6N'PY\&_VOOBU\-;*;P_\-O$0L--\/",M M;)/)O2VO;J",#Y48S':P SC'&V@#[@A_;<^"%QXZC\'Q?$31Y=>DO!IZ01R% MD:X+;!&' VD[OEZXS7EW_!5B3S/V+?%)Q@_;[#_TI2OG/Q+)!HGP)T33]4_9 MNOA\"+.VM(YO&4/EVOB<0QX*ZB8U7=&&=%W?\ !1O5]/\ $'_! M/>[U32+Z;5-*O/[)GM+ZX;=)<1-+&4D8X&688)..] 'UY\.?^1%\.?\ 8+M? M_12UTM-G/J'_!-HVEK$T]U<6NNQ10H,M([23A5 ]22!7U5^T ?^+%?$?GG_ (1K M4O\ TEDKX@_X)Q_M8_!_X4_LG^&?#GB_Q_H^@Z[;7=]))8WY=E) 4] M00?H: &^%?@WXYMOV'_@!X;E\*ZG'KVC_$/3;_4-/:'$UK;I=S,\KKV4!E.? M<5[=^V'X%\0>+/CO^S9JFBZ/=ZEIVA^(KNYU.ZMTW):1LD(#R'L"0?R-==_P MWM^SS_T5CP_TQ_K7Z?\ ?-!_;V_9YQ@?%CP^HSGB5_\ XF@"AJ?@W7)O^"A6 MA>*4TJZ;PY#\.KC3WU0)^X6Y;4-XBW?WMGS8]*\&^#OAN^_9>7Q?\._%_P ! M-1^(=C9:G=77A;Q#I.A6U[]OMI6\V.&65AD2!G8%FX4<=%&?H?\ X;T_9X'_ M #5CP_\ ]_G_ /B:>(K74IO#WA.RCC2SA\QBJ$)@.R1[ [_WL]L5Z-_P4(^'_B3Q]\&? M .G^&]$O-:O;3QAI5Y<6]G'O:*&-)=\C#LHR,GWKLO\ AOK]GK_HJ_A[_OZ_ M_P 31_PWS^SUC ^+'A\?25__ (F@#!_;@^".O?%CP)X1USPMIT.OZWX*UVU\ M0QZ#.%*:I#%S+;@-\I9@. >#T[USOA'Q1J?Q)^(7@RR\%_ &/X?6EK)%J6OZ M]XJT"WMA;Q+NW6MJ5&YIR^S;(. 3VKOC^WO^SR8RG_"V/#X&,<2N/\ V6E_ MX;X_9YX/_"V/#Y(YYF?_ .)H \O\!ZCXS_9'^+7Q6T2Z^'/B7QIX-\6Z[/XM MT;6?#-JMRPN+D 36LRY!0AD4 ] !G^+BS_P3K\*^-M'O?C5KGC?PC?\ @V]\ M2>*Y-5AL+Y #LDW,0I!^8*3MS[5Z.?V^/V>FZ_%CP_Z']Z__ ,32K^WU^STO M3XL>'O\ OZ__ ,30!]!T5\_?\-^?L]_]%8\/?]_7_P#B:/\ AOS]GO\ Z*QX M>_[^O_\ $T ?0-%?/W_#?G[/?_16/#W_ ']?_P")H_X;\_9[_P"BL>'O^_K_ M /Q- 'T#17S]_P -^?L]_P#16/#W_?U__B:/^&_/V>_^BL>'O^_K_P#Q- 'T M#17S]_PWY^SW_P!%8\/?]_7_ /B:/^&_/V>_^BL>'O\ OZ__ ,30!] T5\_? M\-^?L]_]%8\/?]_7_P#B:/\ AOS]GO\ Z*QX>_[^O_\ $T ?0-%?/W_#?G[/ M?_16/#W_ ']?_P")H_X;\_9[_P"BL>'O^_K_ /Q- 'T#17S]_P -^?L]_P#1 M6/#W_?U__B:/^&_/V>_^BL>'O^_K_P#Q- 'T#17S]_PWY^SW_P!%8\/?]_7_ M /B:/^&_/V>_^BL>'O\ OZ__ ,30!] T5\_?\-^?L]_]%8\/?]_7_P#B:/\ MAOS]GK_HK'A[_OZ__P 30![Z_P!^.OB+_@E+_P DO^)'_8YWW]*]>/[?/[/C MNF/BSX>&#_SU?_XFODS_ ()S_M3_ F^%'P]\=67BWQYI&A75]XIN[VWANG8 M-)"Q&UQA>A[4 ?IM17S]_P -^?L]_P#16/#W_?U__B:/^&_/V>_^BL>'O^_K M_P#Q- 'T#17S]_PWY^SW_P!%8\/?]_7_ /B:/^&_/V>_^BL>'O\ OZ__ ,30 M!] T5\_?\-^?L]_]%8\/?]_7_P#B:/\ AOS]GO\ Z*QX>_[^O_\ $T ?0-%? M/W_#?G[/?_16/#W_ ']?_P")H_X;\_9[_P"BL>'O^_K_ /Q- 'T#17S]_P - M^?L]_P#16/#W_?U__B:/^&_/V>_^BL>'O^_K_P#Q- 'T >17QG\;M'\(_#RZ-XAL-#D NQ=Q29AN2IZC8LF?\-^?L]_ M]%8\/?\ ?U__ (FHW_;V_9Z?'_%V= 7_ '9G'_LM ' ?LJ^&_'GC_P#:!^)G MQP\>^#+SP560@Y.#M7S%W*K<[20W.*@7]OC]GI2Z M^Q>+[:W\^;[\FV2W7\6Q7VJ7%O(Q6T@$L),C_ "\+A3Z]* /TRC_B_P!X MT^OGQ/V^OV>UW9^+/AXY)/\ K7_^)IW_ WY^SW_ -%8\/?]_7_^)H ^@:*^ M?O\ AOS]GO\ Z*QX>_[^O_\ $T?\-^?L]_\ 16/#W_?U_P#XF@#Z!HKY^_X; M\_9[_P"BL>'O^_K_ /Q-'_#?G[/?_16/#W_?U_\ XF@#Z!HKY^_X;\_9[_Z* MQX>_[^O_ /$T?\-^?L]_]%8\/?\ ?U__ (F@#Z!HKY^_X;\_9[_Z*QX>_P"_ MK_\ Q-'_ WY^SW_ -%8\/?]_7_^)H ^@:*^?O\ AOS]GO\ Z*QX>_[^O_\ M$T?\-^?L]_\ 16/#W_?U_P#XF@#Z!HKY^_X;\_9[_P"BL>'O^_K_ /Q-'_#? MG[/?_16/#W_?U_\ XF@#Z!HKY^_X;\_9[_Z*QX>_[^O_ /$T?\-^?L]_]%8\ M/?\ ?U__ (F@#V_Q!I::WHUYI\CRQ1W4$D#20,5D0.A4E3V(!X]Z_.OX\_\ M!,#0? 'P&\9W/P_UOQMJ^M+ )[704OR\-Y,9$!WQ# >>*^I#^WY^SV?^ M:L>'O^_K_P#Q-'_#??[/1_YJQX>_[^O_ /$T >.^//V-=>TO]C"'PQX)U36- M6\86-]8>*K6#7KLS2B[@56-O&S'"="%7IGCOFN>\::_\5?VT[SX<^!KWX0:[ MX T72-9M-<\0ZUXA=?)86Y!\N(#!8NQ<8///L:^@C^WS^STR[3\5_#V/^NK_ M /Q--_X;V_9ZW9/Q:T$]_P#7/_\ $T >A>(_B3J/AWXJ>&O"%OX,U?4-+U:W M>6;Q);;/L5@R9"QRYYR=HQC^\*^,_C)_P3$\,^$_A3XZU#P9XB\:W6L36\][ M!HEKJ!\F]N&Y"M&,!\].>PKZ,;]OG]GINOQ8\/X_ZZO_ /$T']OG]GDX_P"+ MK^'N.G[U^/\ QV@#D/V3?@C+/B#H^A:S;ZCJ$LEE=NP MD"O<.R,0%/52#^- 'Z-4M?/W_#?G[/7_ $5CP]_W]?\ ^)H_X;\_9[_Z*QX> M_P"_K_\ Q- 'T#17S]_PWY^SW_T5CP]_W]?_ .)H_P"&_/V>_P#HK'A[_OZ_ M_P 30!] T5\_?\-^?L]_]%8\/?\ ?U__ (FC_AOS]GO_ **QX>_[^O\ _$T M?0-%?/W_ WY^SW_ -%8\/?]_7_^)H_X;\_9[_Z*QX>_[^O_ /$T ?0-%?/W M_#?G[/?_ $5CP]_W]?\ ^)H_X;\_9[_Z*QX>_P"_K_\ Q- 'T W3CKVKX;OI MOB#^R%^T3\3O$&A_";5/B!X&^(4UMJ<3^')5,]E>11[)$D5NSEG?/TQWKV/_ M (;\_9Z/_-6/#W_?U_\ XFFM^WQ^STV/^+L^'QCTE?\ ^)H X;]DGPWX]\"^ M#?BY\6_'OAF^C\9>,M4EU=/#JE3??9;=&2TMCV#;?E4'M@GK76_%[QE\8O&7 M[.^D^,_AEH=WX:\8V\\.IW7A'6(8WNKNWCE/F6F[.%=E7/')!V\9JXW[?'[/ M+8S\5_#W'3]Z_'_CM'_#?'[/17!^+'AXCWE?_P")H \$^(U[\2_VX-7\ >%' M^%/B3X6:-H>NP:]JOB'7I(QY:1 XCM\\>^+/@OX>N%;3_ _HT*P0:U=QD@SW3-RT62=J@X(53W-?5'_#>O[/)SGX MLZ 1Z&9\?^@T[_AOC]GK_HK.@?\ ?Y__ (F@#0_9I^,.H_$*&ZT2;X.^(?A5 MI>C6L4=FNL)&D,J?=$<2ITV@#MWKYU_X);_\CY^TU_V.C?\ HVZKWM?V^?V> ME;_DK/A\_69__B:^-/\ @GO^TY\+/A;XP^/UUXJ\1AU_.@#]3J*^?O\ AOS]GO\ Z*QX>_[^O_\ $T?\-^?L]_\ 16/# MW_?U_P#XF@#Z!HKY^_X;\_9[_P"BL>'O^_K_ /Q-'_#?G[/?_16/#W_?U_\ MXF@#Z!HKY^_X;\_9[_Z*QX>_[^O_ /$T?\-^?L]_]%8\/?\ ?U__ (F@#Z!H MKY^_X;\_9[_Z*QX>_P"_K_\ Q-'_ WY^SW_ -%8\/?]_7_^)H ^@:*^?O\ MAOS]GO\ Z*QX>_[^O_\ $T?\-^?L]_\ 16/#W_?U_P#XF@#Z (S7'?&;3;K5 M_@_XYL+&WDN[VZT*^@@MXAEY)&MW55 [DD@#ZUYA_P -^?L]_P#16/#W_?U_ M_B:0_M^?L]G_ )JQX?\ ^_K_ /Q- &7\)_@K-XT_8/\ #'PR\5:<]A=7GA*/ M3;JUO8R&M9_+^1F4'.4D"-C_ &:\,D^+'QRTOX+7/P5G^ VN:IXQ72W\*+XB MMYT&C31LI@6Z#=0OE-O] >O'%?0J_M\?L\KT^+'A_/?]Z_\ \33?^&]OV>?^ MBL^'P/03.!_Z#0!#X)TW6OV/OV6?!>AV_A?4OB%J^CPV]C=67A_;O:1\F65= M^/D4_P Q7G'QB\+>-/@W^U1#\?/#/@K4?B-H^L^'AH>I:+I3(M]8R HR2*#] MY,( >X)^E>G_ /#?/[/6,?\ "V?#_P#W^?\ ^)IH_;T_9Y4Y'Q8\/CG/^M?_ M .)H \__ &>=#\?_ !@_:DU_XW>*_!5W\-M#M-!7PUI>CZD%%[?9D65YYMO4 M*1A3[X'W36'^RS_R?_\ M2_[FG?R>O7A^WQ^SU_T5CP__P!_7_\ B:^3?V>? MVI?A-X5_;._:$\5:MX]TBQ\.^($L?[-U&61O*NBF[?L.WG&1GZT ?IK2U\^_ M\-^?L]_]%8\/?]_7_P#B:7_AOS]GO_HK'A[_ +^O_P#$T ?0-%?/W_#?G[/? M_16/#W_?U_\ XFC_ (;\_9[_ .BL>'O^_K__ !- 'T#17S]_PWY^SW_T5CP] M_P!_7_\ B:/^&_/V>_\ HK'A[_OZ_P#\30!] T5\_?\ #?G[/?\ T5CP]_W] M?_XFC_AOS]GO_HK'A[_OZ_\ \30!] T5\_?\-^?L]_\ 16/#W_?U_P#XFC_A MOS]GO_HK'A[_ +^O_P#$T ?0#5\E_M7>"?&?A'XV?#;XY>!_!S^-I_#$-WIF ML:-9R[+NXM+@!1)$#P3'ESCWYX%=G_PWY^SW_P!%8\/?]_7_ /B:1OV^OV>F M&/\ A;'A_P#[^O\ _$T >7?!V#XB_M"?M;6?Q8\5>!=6^'WA#PCH4NG:-I^O M%//EN[C*SRJ%[; 3T^51W./>-'\?^*OB98_$/2=-\,ZGX'U72)'LM(UC6X( MYK:^=NT_%CP^P_VI7/_LM"_M\?L]+_ ,U8 M\/G_ +:O_P#$T >%^,?C]\>/'WPGUCX9:G^S_K\/C_5K*71[C78)8QHWFM^[ M-T&SD1[?GQGZ9JYK_P"SQXH_9=D^#?Q \!^%Y_'EYX.T%O#/B#1[20"\NK:7 MYC-"3P3'(SX7'W6YKV?_ (;V_9YVX_X6QX?QZ>:^/_0:B,?\ "V/# MW_?U_P#XF@#R#P?I/C_]J;]JKP1\1/$?PXU/X:>#? -K<&VCUN0"\U"ZF&/E M5>-BD D_X\86L?\ *9#0O^Q+;_T3-7O0_;X_9Z!!_P"%L>'SCUE<_P#LM?&^ MJ?M-_"R?_@J)H_Q#3QSI1\%P^%&LWUH.WD+-Y'O^_K_ /Q- 'T#17S]_P -^?L] M_P#16/#W_?U__B:/^&_/V>_^BL>'O^_K_P#Q- 'T#17S]_PWY^SW_P!%8\/? M]_7_ /B:/^&_/V>_^BL>'O\ OZ__ ,30!] T5\_?\-^?L]_]%8\/?]_7_P#B M:/\ AOS]GO\ Z*QX>_[^O_\ $T ?0-%?/W_#?G[/?_16/#W_ ']?_P")H_X; M\_9[_P"BL>'O^_K_ /Q- 'T#25\__P##?G[/?_16/#W_ ']?_P")H_X;\_9Z M_P"BL>'O^_K_ /Q- ',_&S]@/P9\:OBS??$;4O$WBK1=>N((K?=H]^8%B2- MF$QR 0N2!U))KSS]A;]DVX^$?Q:^)WB+4K[Q3";+Q%>Z?I,6IW3-!J=DR1E; MMP?]8Y.?G/I7L[?M]?L],,'XL>'_ /OZ_P#\32#]OC]GD'/_ MCP_\ ]_7_ M /B: .<_;N\"^(?'$?P6'A_1[O5SIOC_ $N_O/LL>_[/;H^7E?T4=S5C]OCX M@?%7PA\,],TOX1>'-9U7Q!K-T8Y]4T6$22Z9;Q[6=ESP'?.U'_P#OZ_\ \33F_;Z_9Z;_ )JSX?'TE$_LP_$>?X+V>E^$- M"_9J^(>FG6+^(:OXHU8PM/=3R.%>[NI.I R6P. ,XY))UOVJEV_M^_LL+G.' MU#I_US->O_\ #?'[/70_%G0#]9G_ /B:^3OVBOVI?A+XK_;,_9Z\5Z1X]TB^ M\/\ A][TZE?Q.QBM \9"ESMXR3@=: /TQA^Z?J?YU)7SXO[?7[/2 C_A;'A\ M\_\ /5__ (FG?\-^?L]_]%8\/?\ ?U__ (F@#Z!HKY^_X;\_9[_Z*QX>_P"_ MK_\ Q-'_ WY^SW_ -%8\/?]_7_^)H ^@:*^?O\ AOS]GO\ Z*QX>_[^O_\ M$T?\-^?L]_\ 16/#W_?U_P#XF@#Z!HKY^_X;\_9[_P"BL>'O^_K_ /Q-'_#? MG[/?_16/#W_?U_\ XF@#R;_@H'X[^*=[DW6MZG_;>FSBULX]\AC2X5G;'H M ,FO;OBEXYE^'?@'7?$UMH][XCDTNU>Z_LO3<>?2%SQP,G\*\KD_;V_9Z MD.?^%LZ I_V9G_\ B:Q?&/[9'[-/CKPOJ6@:G\6-&&GZA ;>?[-=RPR;3UVN MJY!X[4 /KSX&?M%> O#MQXHO/#L,>H3>%5,9GN+"[B21C&W0RI ME<8XZD=*QK>3XC?M;?M$?"_7M1^&FN_"WPAX!N)-7GO=<$?VN^N" %MX]O\ MRS; W#TY/05Z];_MV?LYV=O';VWQ3\.6]O$@CBBA=U2-0, * F ,8 ]*F7] MO?\ 9Y7'_%V/#[8&!NF<_P#LM '/?M%?#SQ+\3OVF/@/IT=E/)X*T6[NM?U2 MY,(DM?/A4>3%(.F6R<9[UVO[8WPDU;XT_L^^*/#>@1K)XB5([_2MS[/]+@<2 M1_,> _[ M^O\ _$T ?-7C[Q5\9OVNOA]X4^$6I_!C7_"[S7EB_B?Q)X@=8[7R[=E:4H!R M3(5/'O@>M:/_ 5>LX-.\._ 6TM8UAMK?Q?!%%&O145%"@>P %?0)_;V_9Y/ M7XL>'S_VU?\ ^)KXU_X*2_M-_"OXM:9\(T\(>.-*UY]*\51WE\+-V;[/ 9 M&RHX% 'ZG4M?/W_#?G[/2DC_ (6QX>_[^O\ _$T?\-^?L]_]%8\/?]_7_P#B M: /H&BOG[_AOS]GO_HK'A[_OZ_\ \31_PWY^SW_T5CP]_P!_7_\ B: /H&BO MG[_AOS]GO_HK'A[_ +^O_P#$T?\ #?G[/?\ T5CP]_W]?_XF@#Z!HKY^_P"& M_/V>_P#HK'A[_OZ__P 31_PWY^SW_P!%8\/?]_7_ /B: /H&BOG[_AOS]GO_ M **QX>_[^O\ _$T?\-^?L]_]%8\/?]_7_P#B: /H&BOG[_AOS]GO_HK'A[_O MZ_\ \31_PWY^SW_T5CP]_P!_7_\ B: /=]4NI+'3KNXB@:ZEAA>1($^](P4D M*/<]/QKYI_X)Z^!==\)_!"^U3QAI5UI?C?Q'KVH:IK OTV7,DC3LJ-(/]Q5Q MCC!K>_X;\_9Z_P"BL>'O^_K_ /Q--7]OC]GE)=Z#1CYJF&:Z1AR(V0EAV /MBKG[?'@=_AC_P $ MV(/!\DPN7T"VT73#.H(60Q/$A89]=M>VC]O?]GH#'_"V/#^,Y_UK_P#Q-?-7 M_!1;]K+X/_%G]E?Q#X<\)?$'1])-)O=+U* M!+O3KZ"2UNK:092:)U*NC>Q4D'ZUX?\ \,!_L\_]$G\/_P#?I_\ XJOH"B@# MP#_A@3]GG_HD_A__ +]/_P#%4?\ # G[//\ T2?P_P#]^G_^*KW^B@#P#_A@ M3]GG_HD_A_\ []/_ /%4?\,"?L\_]$G\/_\ ?I__ (JO?Z* / /^&!/V>?\ MHD_A_P#[]/\ _%4?\,"?L\_]$G\/_P#?I_\ XJO?Z* / /\ A@3]GG_HD_A_ M_OT__P 51_PP)^SS_P!$G\/_ /?I_P#XJO?Z* / /^&!/V>?^B3^'_\ OT__ M ,51_P ,"?L\_P#1)_#_ /WZ?_XJO?Z* / /^&!/V>?^B3^'_P#OT_\ \51_ MPP)^SS_T2?P__P!^G_\ BJ]_HH \ _X8$_9Y_P"B3^'_ /OT_P#\51_PP)^S MS_T2?P__ -^G_P#BJ]_HH \ _P"&!/V>?^B3^'_^_3__ !5'_# G[//_ $2? MP_\ ]^G_ /BJ]_HH \ _X8$_9Y_Z)/X?_P"_3_\ Q5'_ P)^SS_ -$G\/\ M_?I__BJ]_HH \ _X8$_9Y_Z)/X?_ ._3_P#Q5'_# G[//_1)_#__ 'Z?_P"* MKW^B@#P#_A@3]GG_ *)/X?\ ^_3_ /Q5'_# G[//_1)_#_\ WZ?_ .*KW^B@ M#P#_ (8$_9Y_Z)/X?_[]/_\ %4?\,"?L\_\ 1)_#_P#WZ?\ ^*KW^B@#P#_A M@3]GG_HD_A__ +]/_P#%4?\ # G[//\ T2?P_P#]^G_^*KW^B@#P#_A@3]GG M_HD_A_\ []/_ /%4?\,"?L\_]$G\/_\ ?I__ (JO?Z* / /^&!?V>?\ HD_A M_P#[]/\ _%4?\,"?L\_]$G\/_P#?I_\ XJO?Z* / /\ A@3]GG_HD_A__OT_ M_P 51_PP)^SS_P!$G\/_ /?I_P#XJO?Z* / /^&!/V>?^B3^'_\ OT__ ,51 M_P ,"?L\_P#1)_#_ /WZ?_XJO?Z* / /^&!/V>?^B3^'_P#OT_\ \51_PP)^ MSS_T2?P__P!^G_\ BJ]_HH \ _X8$_9Y_P"B3^'_ /OT_P#\51_PP)^SS_T2 M?P__ -^G_P#BJ]_HH \ _P"&!/V>?^B3^'_^_3__ !5'_# G[//_ $2?P_\ M]^G_ /BJ]_HH \ _X8$_9Y_Z)/X?_P"_3_\ Q5'_ P)^SS_ -$G\/\ _?I_ M_BJ]_HH \ _X8$_9Y_Z)/X?_ ._3_P#Q5'_# G[//_1)_#__ 'Z?_P"*KW^B M@#P#_A@3]GG_ *)/X?\ ^_3_ /Q5)_PP'^SS_P!$G\/_ /?I_P#XJOH"B@#Y M_P#^&!/V>?\ HD_A_P#[]/\ _%4O_# G[//_ $2?P_\ ]^G_ /BJ]_HH \ _ MX8$_9Y_Z)/X?_P"_3_\ Q5'_ P)^SS_ -$G\/\ _?I__BJ]_HH \ _X8$_9 MY_Z)/X?_ ._3_P#Q5'_# G[//_1)_#__ 'Z?_P"*KW^B@#P#_A@3]GG_ *)/ MX?\ ^_3_ /Q5'_# G[//_1)_#_\ WZ?_ .*KW^B@#P#_ (8$_9Y_Z)/X?_[] M/_\ %4?\,"?L\_\ 1)_#_P#WZ?\ ^*KW^B@#P#_A@3]GG_HD_A__ +]/_P#% M4?\ # G[//\ T2?P_P#]^G_^*KW^B@#P#_A@3]GG_HD_A_\ []/_ /%4?\," M?L\_]$G\/_\ ?I__ (JO?Z* / /^&!/V>?\ HD_A_P#[]/\ _%4?\,"?L\_] M$G\/_P#?I_\ XJO?Z* / /\ A@3]GG_HD_A__OT__P 51_PP)^SS_P!$G\/_ M /?I_P#XJO?Z* / /^&!/V>?^B3^'_\ OT__ ,51_P ,"?L\_P#1)_#_ /WZ M?_XJO?Z* / /^&!/V>?^B3^'_P#OT_\ \51_PP)^SS_T2?P__P!^G_\ BJ]_ MHH \ _X8$_9Y_P"B3^'_ /OT_P#\51_PP)^SS_T2?P__ -^G_P#BJ]_HH \ M_P"&!/V>?^B3^'_^_3__ !5'_# G[//_ $2?P_\ ]^G_ /BJ]_HH \ _X8$_ M9Y_Z)/X?_P"_3_\ Q5'_ P)^SS_ -$G\/\ _?I__BJ]_HH \ _X8$_9Y_Z) M/X?_ ._3_P#Q5'_# G[//_1)_#__ 'Z?_P"*KW^B@#P#_A@3]GG_ *)/X?\ M^_3_ /Q5'_# G[//_1)_#_\ WZ?_ .*KW^B@#P#_ (8$_9Y_Z)/X?_[]/_\ M%4?\,"?L\_\ 1)_#_P#WZ?\ ^*KW^B@#P#_A@3]GG_HD_A__ +]/_P#%4?\ M# G[//\ T2?P_P#]^G_^*KW^B@#P#_A@3]GG_HD_A_\ []/_ /%4?\,"?L\_ M]$G\/_\ ?I__ (JO?Z* / /^&!/V>?\ HD_A_P#[]/\ _%4?\,"?L\_]$G\/ M_P#?I_\ XJO?Z* / /\ A@3]GG_HD_A__OT__P 52?\ # ?[//\ T2?P_P#] M^G_^*KZ HH \ _X8$_9Y_P"B3^'_ /OT_P#\51_PP)^SS_T2?P__ -^G_P#B MJ]_HH \ _P"&!/V>?^B3^'_^_3__ !5'_# G[//_ $2?P_\ ]^G_ /BJ]_HH M \ _X8$_9Y_Z)/X?_P"_3_\ Q5'_ P)^SS_ -$G\/\ _?I__BJ]_HH \ _X M8$_9Y_Z)/X?_ ._3_P#Q5'_# G[//_1)_#__ 'Z?_P"*KW^B@#P#_A@3]GG_ M *)/X?\ ^_3_ /Q5'_# G[//_1)_#_\ WZ?_ .*KW^B@#P#_ (8$_9Y_Z)/X M?_[]/_\ %4?\,"?L\_\ 1)_#_P#WZ?\ ^*KW^B@#P#_A@3]GG_HD_A__ +]/ M_P#%4?\ # G[//\ T2?P_P#]^G_^*KW^B@#P#_A@3]GG_HD_A_\ []/_ /%4 M?\,"?L\_]$G\/_\ ?I__ (JO?Z* / /^&!/V>?\ HD_A_P#[]/\ _%4G_# ? M[//_ $2?P_\ ]^G_ /BJ^@** / /^&!/V>?^B3^'_P#OT_\ \51_PP)^SS_T M2?P__P!^G_\ BJ]_HH \ _X8$_9Y_P"B3^'_ /OT_P#\51_PP)^SS_T2?P__ M -^G_P#BJ]_HH \ _P"&!/V>?^B3^'_^_3__ !5'_# G[//_ $2?P_\ ]^G_ M /BJ]_HH \ _X8$_9Y_Z)/X?_P"_3_\ Q5'_ P)^SS_ -$G\/\ _?I__BJ] M_HH \ _X8$_9Y_Z)/X?_ ._3_P#Q5'_# G[//_1)_#__ 'Z?_P"*KW^B@#P# M_A@3]GG_ *)/X?\ ^_3_ /Q5'_# G[//_1)_#_\ WZ?_ .*KW^B@#P#_ (8$ M_9Y_Z)/X?_[]/_\ %4?\,"?L\_\ 1)_#_P#WZ?\ ^*KW^B@#P#_A@3]GG_HD M_A__ +]/_P#%4?\ # G[//\ T2?P_P#]^G_^*KW^B@#P#_A@3]GG_HD_A_\ M[]/_ /%4G_# G[//_1)_#_\ WZ?_ .*KZ HH \ _X8$_9Y_Z)/X?_P"_3_\ MQ5'_ P)^SS_ -$G\/\ _?I__BJ]_HH \ _X8$_9Y_Z)/X?_ ._3_P#Q5'_# M G[//_1)_#__ 'Z?_P"*KW^B@#P#_A@3]GG_ *)/X?\ ^_3_ /Q5'_# G[// M_1)_#_\ WZ?_ .*KW^B@#P#_ (8$_9Y_Z)/X?_[]/_\ %4?\,"?L\_\ 1)_# M_P#WZ?\ ^*KW^B@#P#_A@3]GG_HD_A__ +]/_P#%4?\ # G[//\ T2?P_P#] M^G_^*KW^B@#P#_A@3]GG_HD_A_\ []/_ /%4?\,"?L\_]$G\/_\ ?I__ (JO M?Z* / /^&!/V>?\ HD_A_P#[]/\ _%4?\,"?L\_]$G\/_P#?I_\ XJO?Z* / M /\ A@3]GG_HD_A__OT__P 51_PP)^SS_P!$G\/_ /?I_P#XJO?Z* /G_P#X M8#_9Y_Z)/X?_ ._3_P#Q5+_PP)^SS_T2?P__ -^G_P#BJ]_HH ^?_P#A@3]G MG_HD_A__ +]/_P#%4O\ PP)^SS_T2?P__P!^G_\ BJ]_HH \ _X8$_9Y_P"B M3^'_ /OT_P#\51_PP)^SS_T2?P__ -^G_P#BJ]_HH \ _P"&!/V>?^B3^'_^ M_3__ !5'_# G[//_ $2?P_\ ]^G_ /BJ]_HH \ _X8$_9Y_Z)/X?_P"_3_\ MQ5'_ P)^SS_ -$G\/\ _?I__BJ]_HH \ _X8$_9Y_Z)/X?_ ._3_P#Q5'_# M G[//_1)_#__ 'Z?_P"*KW^B@#P#_A@3]GG_ *)/X?\ ^_3_ /Q5'_# G[// M_1)_#_\ WZ?_ .*KW^B@#P#_ (8$_9Y_Z)/X?_[]/_\ %4?\,"?L\_\ 1)_# M_P#WZ?\ ^*KW^B@#P#_A@3]GG_HD_A__ +]/_P#%4?\ # G[//\ T2?P_P#] M^G_^*KW^B@#P#_A@3]GG_HD_A_\ []/_ /%4G_# ?[//_1)_#_\ WZ?_ .*K MZ HH \ _X8$_9Y_Z)/X?_P"_3_\ Q5'_ P)^SS_ -$G\/\ _?I__BJ]_HH M\ _X8$_9Y_Z)/X?_ ._3_P#Q5'_# G[//_1)_#__ 'Z?_P"*KW^B@#P#_A@3 M]GG_ *)/X?\ ^_3_ /Q5'_# G[//_1)_#_\ WZ?_ .*KW^B@#P#_ (8$_9Y_ MZ)/X?_[]/_\ %4?\,"?L\_\ 1)_#_P#WZ?\ ^*KW^B@#P#_A@3]GG_HD_A__ M +]/_P#%4?\ # G[//\ T2?P_P#]^G_^*KW^B@#P#_A@3]GG_HD_A_\ []/_ M /%4?\,"?L\_]$G\/_\ ?I__ (JO?Z* / /^&!/V>?\ HD_A_P#[]/\ _%4? M\,"?L\_]$G\/_P#?I_\ XJO?Z* / /\ A@3]GG_HD_A__OT__P 51_PP)^SS M_P!$G\/_ /?I_P#XJO?Z* / /^&!/V>?^B3^'_\ OT__ ,51_P ,"?L\_P#1 K)_#_ /WZ?_XJO?Z* *NFZ;;Z38P6=I&(;6"-8HHEZ(BC 4>P%6J** /_V0$! end GRAPHIC 15 dc_hdr.jpg GRAPHIC begin 644 dc_hdr.jpg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end GRAPHIC 16 dc_ftr.jpg GRAPHIC begin 644 dc_ftr.jpg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exh_1.jpg GRAPHIC begin 644 exh_1.jpg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ⅅ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
XML 21 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated statements of financial position
Dec. 31, 2023
CAD ($)
Dec. 31, 2022
CAD ($)
Current assets    
Cash and cash equivalents (Note 13) $ 4,245,983 $ 6,658,076
Gold in trust (Note 8) 1,082,801 974,397
Accounts receivable and prepaid expenses (Note 4) 453,640 259,471
Total current assets 5,782,424 7,891,944
Non-current assets    
Right-of-use assets (Note 5) 330,597 432,319
Property, plant and equipment (Note 6) 6,601,742 6,610,871
Exploration and evaluation assets (Note 7) 1 63,115,076
Total non current assets 6,932,340 70,158,266
TOTAL ASSETS 12,714,764 78,050,210
Current liabilities    
Trade and other payables (Note 11 (a)) 851,158 340,509
Current portion of lease liabilities (Note 5) 100,531 88,295
Total current liabilities 951,689 428,804
Non-current liabilities    
Long-term portion of lease liabilities (Note 5) 277,104 377,635
Gold loan payable (Note 8) 4,371,546 3,929,015
Warrant liability (Note 9) 102,787
Derivative financial liabilities (Note 8) 108,830 306,084
Deferred income tax liability (Note 14) 3,090,208
Total non current liabilities 4,757,480 7,805,729
Total liabilities 5,709,169 8,234,533
EQUITY    
Share capital (Note 10) 141,040,654 141,040,654
Reserves (Note 10) 23,356,523 22,546,373
Deficit (157,391,582) (93,771,350)
Total equity 7,005,595 69,815,677
TOTAL EQUITY AND LIABILITIES $ 12,714,764 $ 78,050,210
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated statements of comprehensive loss - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Expenses      
Professional fees (Note 11(a)) $ 1,113,336 $ 864,051 $ 772,887
Salaries and benefits (Note 11(a)) 1,811,073 1,923,952 1,876,911
Travel and promotion 50,120 107,869 200,995
Depreciation (Note 6) 11,166 14,424 16,638
Office and other (Note 11(b)) 182,457 156,686 218,879
Amortization of right-of-use assets (Note 5) 101,722 106,791 121,479
Occupancy expenses (Note 5) 39,858 42,655 40,542
Interest expense on lease liabilities (Note 5) 39,502 47,379 13,330
Interest, accretion and standby fees on gold loan payable (Note 8) 540,709 468,308 394,371
Listing and filing fees 193,490 154,505 187,169
Insurance 103,491 96,068 89,476
Directors’ fees (Note 11(a)) 140,000 145,000 102,500
Share-based payments (Note 10(d) and 11(a)) 810,150 1,478,100 1,870,800
Total Expenses 5,137,074 5,605,788 5,905,977
Other income (loss)      
Administrative services fees (Note 11(b)) 1,422,347 1,376,428 1,382,344
Interest and other income 370,741 253,869 490,245
Impairment of property, plant and equipment (Note 6) (7,441,293)
Impairment of exploration and evaluation assets (Note 7) (63,823,478)
Unrealized gain (loss) on derivative financial liabilities (Note 8) 191,732 110,177 (18,156)
Unrealized gain (loss) on gold in trust (Note 8) 132,895 (6,518) (35,775)
Unrealized foreign exchange gain (loss) on gold loan payable (Note 8) 103,700 (257,803) 11,535
Unrealized foreign exchange gain (loss) on gold in trust (Note 8) (24,491) 64,920 (4,011)
Unrealized gain on warrant liability (Note 9) 102,787 520,503 1,747,884
Gain on debt forgiveness (Note 11(a)) 177,200
Foreign exchange gain (loss) (49,599) 302,930 (22,202)
Total other income (loss)  (61,573,366) (4,899,587) 3,551,864
Loss before income taxes (66,710,440) (10,505,375) (2,354,113)
Deferred income tax recovery (expense) (Note 14) 3,090,208 (1,341,185) (314,141)
Net loss for the year (63,620,232) (11,846,560) (2,668,254)
Total comprehensive loss for the year $ (63,620,232) $ (11,846,560) $ (2,668,254)
Basic net loss per share $ (0.46) $ (0.09) $ (0.02)
Diluted net loss per share $ (0.46) $ (0.09) $ (0.02)
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated statements of cash flows
12 Months Ended
Dec. 31, 2023
CAD ($)
Dec. 31, 2022
CAD ($)
Dec. 31, 2021
CAD ($)
Operating activities      
Net loss for the year $ (63,620,232) $ (11,846,560) $ (2,668,254)
Items not affecting cash      
Deferred income tax (recovery) expense (3,090,208) 1,341,185 314,141
Depreciation 11,166 14,424 16,638
Amortization of right-of-use assets 101,722 106,791 121,479
Impairment of property, plant and equipment 7,441,293
Impairment of exploration and evaluation assets 63,823,478
Interest expenses on lease liability 39,502 47,379 13,330
Interest, accretion and standby fees on gold loan payable 540,709 468,308 394,371
Unrealized (gain) loss on derivative financial liabilities (191,732) (110,177) 18,156
Unrealized (gain) loss on gold in trust (132,895) 6,518 35,775
Unrealized foreign exchange (gain) loss on gold loan payable (103,700) 257,803 (11,535)
Unrealized foreign exchange (gain) loss on gold in trust 24,491 (64,920) 4,011
Unrealized gain on warrant liability (102,787) (520,503) (1,747,884)
Share-based payments 810,150 1,478,100 1,870,800
Changes in non-cash working capital components      
Accounts receivable and prepaid expenses (194,169) (103,833) 19,370
Trade and other payables 601,499 (169,206) 19,352
Net cash used in operating activities (1,483,006) (1,653,398) (1,600,250)
Investing activities      
Property, plant and equipment – purchase (2,037) (47,056) (10,505)
Exploration and evaluation assets – costs (799,253) (1,681,790) (2,784,645)
Net cash used in investing activities (801,290) (1,728,846) (2,795,150)
Financing activities      
Issuance of shares, net of share issue costs 11,610,581
Options exercised 564,750
Repayment of lease liabilities (127,797) (130,056) (144,253)
Net cash from (used in) financing activities (127,797) (130,056) 12,031,078
Change in cash and cash equivalents (2,412,093) (3,512,300) 7,635,678
Cash and cash equivalents, beginning of year 6,658,076 10,170,376 2,534,698
Cash and cash equivalents, end of year $ 4,245,983 $ 6,658,076 $ 10,170,376
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated statements of changes in equity - CAD ($)
Issued capital [member]
Reserve of share-based payments [member]
Warrants [member]
Total Reserves [Member]
Deficit [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 131,189,978 $ 18,528,024 $ 715,968 $ 19,243,992 $ (79,256,536) $ 71,177,434
Beginning balance, shares at Dec. 31, 2020 120,650,254          
IfrsStatementLineItems [Line Items]            
Share-based payments 1,870,800 1,870,800 1,870,800
Private placements, net of share issue costs $ 11,610,581 11,610,581
Private placements, net of share issue costs, shares 15,846,154          
Warrant liability $ (2,371,174) (2,371,174)
Finders’ warrants issued pursuant to private placement (130,731) 130,731 130,731
Shares issued for cash on exercise of stock options $ 564,750 564,750
Shares issued for cash on exercise of stock options, shares 725,000          
Fair value of cash stock options transferred to share capital $ 177,250 (177,250) (177,250)
Total comprehensive loss for the year (2,668,254) (2,668,254)
Ending balance, value at Dec. 31, 2021 $ 141,040,654 20,352,305 715,968 21,068,273 (81,924,790) 80,184,137
Ending balance, shares at Dec. 31, 2021 137,221,408          
IfrsStatementLineItems [Line Items]            
Share-based payments 1,478,100 1,478,100 1,478,100
Total comprehensive loss for the year (11,846,560) (11,846,560)
Ending balance, value at Dec. 31, 2022 $ 141,040,654 21,830,405 715,968 22,546,373 (93,771,350) 69,815,677
Ending balance, shares at Dec. 31, 2022 137,221,408          
IfrsStatementLineItems [Line Items]            
Share-based payments 810,150 810,150 810,150
Total comprehensive loss for the year (63,620,232) (63,620,232)
Ending balance, value at Dec. 31, 2023 $ 141,040,654 $ 22,640,555 $ 715,968 $ 23,356,523 $ (157,391,582) $ 7,005,595
Ending balance, shares at Dec. 31, 2023 137,221,408          
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Nature of operations
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Nature of operations

 

1.Nature of operations

 

Almaden Minerals Ltd. (the “Company” or “Almaden”) was formed by amalgamation under the laws of the Province of British Columbia, Canada on February 1, 2002. The Company is an advanced exploration stage public company that is engaged directly in the exploration and development of exploration and evaluation property in Mexico. The Company’s shares are trade on the TSX Exchange under the symbol “AMM”. The address of the Company’s registered office is Suite 1710 –1177 West Hastings Street, Vancouver, BC, Canada V6E 2L3.

 

The Company is in the business of exploring and developing mineral projects and its principal asset is the Ixtaca precious metals project located on its Tuligtic claim in Mexico. The Company has not yet determined whether this project has economically recoverable mineral reserves. The recoverability of amounts shown for mineral properties is dependent upon the establishment of a sufficient quantity of economically recoverable reserves, the ability of the Company to obtain the necessary financing or participation of joint venture partners to complete development of the properties, and upon future profitable production or proceeds from the disposition of exploration and evaluation assets.

 

These consolidated financial statements were prepared on a “going concern” basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. As of December 31, 2023, the Company had a working capital surplus of $4,830,735 (2022 – $7,463,140). The Company does not currently hold any revenue-generating properties and therefore continues to incur losses. The Company incurred a net loss for the year ended December 31, 2023, of $63,620,232 (2022 – $11,846,560) and negative cash flows from operations of $1,483,006 for the year ended December 31, 2023 (2022 – $1,653,398). As at December 31, 2023, the Company had an accumulated deficit of $157,391,582 (2022 – $93,771,350). The Company’s ability to continue as a going concern is dependent upon its ability in the future to achieve profitable operations and in the meantime, to obtain the necessary financing to repay its liabilities when they become due. Management estimates that there is sufficient working capital to sustain operations for the next twelve months. External financing will be sought to finance the operations of the Company and enable the Company to continue its efforts towards the exploration and development of its mineral properties. There can be no assurance that steps management is taking will be successful. These consolidated financial statements do not include adjustments to the amounts and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern and such adjustments could be material.

XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Basis of presentation
12 Months Ended
Dec. 31, 2023
Basis Of Presentation  
Basis of presentation

 

2.Basis of presentation

 

(a)       Statement of Compliance with International Financial Reporting Standards (“IFRS”)

 

These consolidated financial statements have been prepared in accordance and compliance with IFRS Accounting standards as issued by the International Accounting Standards Board (“IASB”).

 

(b)       Basis of preparation

 

These consolidated financial statements have been prepared on a historical cost basis except for the revaluation of certain financial assets and financial liabilities at fair value through profit or loss. In addition, these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.

These consolidated financial statements, including comparatives, have been prepared on the basis of IFRS standards that are effective as at December 31, 2023.

 

(c)       Functional currency

 

The functional and reporting currency of the Company and its subsidiaries is the Canadian dollar.

 

(d)       Significant accounting judgments and estimates

 

The preparation of these consolidated financial statements requires management to make judgements and estimates that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. Actual outcomes could differ from these judgements and estimates. The consolidated financial statements include judgements and estimates which, by their nature, are uncertain. The impacts of such judgements and estimates are pervasive throughout the consolidated financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and the revision affects both current and future periods.

 

Significant assumptions about the future and other sources of judgements and estimates that management has made at the statement of financial position dates, that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions made, relate to, but are not limited to, the following:

 

Critical Judgments

 

oThe analysis of the functional currency for each entity of the Company determined by conducting an analysis of the consideration factors identified in IAS 21, “The Effect of Changes in Foreign Exchange Rates”. In concluding that the Canadian dollar is the functional currency of the parent and its subsidiary companies, management considered the currency that mainly influences the cost of providing goods and services in each jurisdiction in which the Company operates. As no single currency was clearly dominant, the Company also considered secondary indicators including the currency in which funds from financing activities are denominated and the currency in which funds are retained.

 

Going Concern

 

oManagement makes an assessment about the Company’s ability to continue as a going concern by taking into the account the consideration of the various factors discussed in Note 1. Judgement is applied by management in determining whether or not the elements giving rise to factors that cause doubt about the ability of the Company to continue as a going concern are present.

 

Estimates

 

oThe estimated useful lives of property, plant and equipment which are included in the consolidated statements of financial position and the related depreciation included in profit or loss;
oThe recoverability of the value of the exploration and evaluation assets which is recorded in the consolidated statements of financial position (Note 3(f));
oThe Company uses the Black-Scholes option pricing model to determine the fair value of options, warrants, and derivative financial liabilities in order to calculate share-based payments expense, warrant liability and the fair value of finders’ warrants and stock options. Certain inputs into the model are estimates that involve considerable judgment or could be affected by significant factors that are out of the Company’s control;
oThe provision for income taxes which is included in profit or loss and the composition of deferred income tax liability included in the consolidated statement of financial position and the evaluation of the recoverability of deferred tax assets based on an assessment of the Company’s ability to utilize the underlying future tax deductions against future taxable income prior to expiry of those deductions;
oThe assessment of indications of impairment of each exploration and evaluation asset and property plant and equipment and related determination of the net realizable value and write-down of those assets where applicable (Note 3(f));
oThe estimated incremental borrowing rate used to calculate the lease liabilities; and
oThe estimated fair value of gold in trust.
XML 27 R8.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Material accounting policies
12 Months Ended
Dec. 31, 2023
Material Accounting Policies  
Material accounting policies

 

3.Material accounting policies

 

(a)       Basis of consolidation

 

These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries as follows:

 

       
    Jurisdiction   Nature of operations
         
  Puebla Holdings Inc. Canada   Holding company
  Minera Gorrion, S.A. de C.V. Mexico   Exploration company

 

Inter-company balances and transactions, including unrealized income and expenses arising from inter-company transactions, are eliminated in preparing these consolidated financial statements.

 

(b)       Foreign currencies

 

Transactions in currencies other than the functional currency are recorded at the rates of exchange prevailing on the transaction dates. At each financial position reporting date, monetary assets and liabilities that are denominated in foreign currencies are translated at the rates prevailing at the date of the statement of financial position. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

(c)       Financial instruments

 

A financial asset is classified as measured at: amortized cost, fair value through other comprehensive income (FVOCI), or fair value through profit or loss (FVTPL). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. Derivatives embedded in contracts where the host is a financial asset in the scope of the standard are never separated. Instead, the hybrid financial instrument as a whole is assessed for classification. The Company's financial assets consist primarily of cash and cash equivalents, and accounts receivable and are classified at amortized cost.

 

Financial liabilities comprise the Company’s trade and other payables. Financial liabilities are initially recognized on the date they are originated and are derecognized when the contractual obligations are discharged or cancelled or expire. Trade and other payables are recognized initially at fair value and subsequent are measured at amortized costs using the effective interest method, when materially different from the initial amount. Derivative financial liabilities are classified as FVTPL. Fair value is determined based on the present value of future cash flow, discounted at the market rate of interest.

 

(i)     Impairment of financial assets

 

An ‘expected credit loss’ (ECL) model applies to financial assets measured at amortized cost, contract assets and debt investments at FVOCI, but not to investments in equity instruments. The Company's financial assets measured at amortized cost and subject to the ECL model include cash and cash equivalents, and accounts receivable.

 

(ii)    Embedded derivatives

 

Derivatives may be embedded in other financial instruments (the “host instrument”). Embedded derivatives are treated as separate derivatives when their economic characteristics and risks are not clearly and closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the combined contract is not held for trading or designated at fair value. These embedded derivatives are measured at fair value with subsequent changes recognized in profit or loss.

 

The Company issues warrants exercisable in a currency other than the Company’s functional currency and as a result, the warrants are derivative financial instruments.

 

Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred.

 

(d)       Cash and cash equivalents

 

Cash equivalents include term deposits and money market instruments which are readily convertible into cash or have maturities at the date of purchase of less than ninety days.

 

(e)       Property, plant and equipment

 

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, and are depreciated annually on a declining-balance basis if available-for-use at the following rates:

 

   
  Furniture, fixtures and other 20%
  Computer hardware and software 30%
  Geological library 20%
  Field equipment 20%
  Mill equipment Straight line over mine life (11 years)

 

(f)       Exploration and evaluation assets

 

The Company is in the advanced exploration stage with respect to its investment in exploration and evaluation assets and, accordingly, follows the practice of capitalizing all costs relating to the acquisition of, exploration for and development of mineral claims to which the Company has rights and crediting all proceeds received from farm-out arrangements or recovery of costs against the cost of the related claims. Acquisition costs include, but are not exclusive to land surface rights acquired. Deferred exploration costs include, but are not exclusive to geological, geophysical studies, annual mining taxes, exploratory drilling and sampling. At such time as commercial production commences, these costs will be charged to profit or loss on a unit-of-production method based on proven and probable reserves. The aggregate costs related to abandoned mineral claims are charged to profit or loss at the time of any abandonment or when it has been determined that there is evidence of an impairment.

 

The Company considers the following facts and circumstances in determining if it should test exploration and evaluation assets for impairment:

 

(i)the period for which the Company has the right to explore in the specific area has expired during the period or will expire in the near future, and is not expected to be renewed;

 

(ii)substantive expenditure on further exploration for and evaluation of mineral resources in the specific area is neither budgeted nor planned;

 

(iii)exploration for and evaluation of mineral resources in the specific area have not led to the discovery of commercially viable quantities of mineral resources and the entity has decided to discontinue such activities in the specific area; and

 

(iv)sufficient data exists to indicate that, although a development in the specific area is likely to proceed, the carrying amount of the exploration and evaluation assets is unlikely to be recovered in full from successful development or by sale.

 

 

An impairment charge may be reversed but only to the extent that this does not exceed the original carrying value of the property that would have resulted if no impairment had been recognized. General exploration costs in areas of interest in which the Company has not secured rights are expensed as incurred.

 

The recoverability of amounts shown for exploration and evaluation assets is dependent upon the discovery of economically recoverable reserves, the ability of the Company to obtain financing to complete development of the properties, and on future production or proceeds of disposition.

 

The Company recognizes in profit or loss costs recovered on exploration and evaluation assets when amounts received or receivable are in excess of the carrying amount.

 

Once the technical feasibility and commercial viability of the extraction of mineral resources in an area of interest are demonstrable, exploration and evaluation assets attributable to that area of interest are first tested for impairment and then reclassified to development asset within property, plant and equipment.

 

All capitalized exploration and evaluation expenditures are monitored for indications of impairment.

 

Where a potential impairment is indicated, assessments are performed for each area of interest. To the extent that exploration expenditure is not expected to be recovered, it is charged to profit or loss. Exploration areas where reserves have been discovered, but require major capital expenditure before production can begin, are continually evaluated to ensure that commercial quantities of reserves exist or to ensure that additional exploration work is underway as planned.

 

(g)       Impairment of property, plant and equipment

 

Property, plant and equipment are reviewed for impairment at least annually, or if there is any indication that the carrying amount may not be recoverable. If any such indication is present, the recoverable amount of the asset is estimated in order to determine whether impairment exists. Where the asset does not generate cash flows that are independent from other assets, the Company estimates the recoverable amount of the cash generating unit to which the asset belongs.

 

An asset’s recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value, using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset or cash generating unit is estimated to be less than its carrying amount, the carrying amount is reduced to the recoverable amount by way of recording an impairment charge to profit or loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously been recognized.

 

(h)       Income taxes

 

Income tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to items recognized directly in equity or in other comprehensive income.

 

Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted at the reporting date, and any adjustment to tax payable in respect of previous years.

 

Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss, and differences relating to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date.

 

Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously.

 

A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.

 

(i)       Share-based payments

 

The Company’s stock option plan allows Company employees, directors, officers and consultants to acquire shares of the Company. The fair value of options granted is recognized as share-based payment expense with a corresponding increase in equity reserves. An individual is classified as an employee when the individual is an employee for legal or tax purposes (direct employee) or provides services similar to those performed by a direct employee.

 

Fair value is measured at grant date, and each tranche is recognized using the graded vesting method over the period during which the options vest. The fair value of the options granted is measured using the Black-Scholes option-pricing model, taking into account the terms and conditions upon which the options were granted. At each financial position reporting date, the amount recognized as an expense is adjusted to reflect the actual number of stock options that are expected to vest. In situations where equity instruments are issued to consultants and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received.

 

(j)       Share capital

 

Proceeds from the exercise of stock options and warrants are recorded as share capital in the amount for which the option or warrant enabled the holder to purchase a share in the Company, in addition to the proportionate amount of reserves originally created at the issuance of the stock options or warrants. Share capital issued for non-monetary consideration is valued at the closing market price at the date of issuance. The proceeds from the issuance of units are allocated between common shares and common share purchase warrants based on the residual value method. Under this method, the proceeds are allocated to common shares based on the fair value of a common share at the announcement date of the unit offering and any residual remaining is allocated to common share purchase warrants.

 

Certain of the Company’s warrants are exercisable in a currency other than the functional currency of the Company. As a result, the fair value allocated to the warrant is recorded as a derivative financial liability with residual value being attributed to the equity unit. The fair value of the warrant is determined using the Black-Scholes Option Pricing Model and is marked to market at the end of each period. Upon exercise of the warrant, the fair value of the warrant at the date of exercise is transferred to share capital.

 

(k)       Reclamation and closure cost obligations

 

Decommissioning and restoration provisions are recorded when a present legal or constructive obligation exists as a result of past events where it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made.

 

The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation and discount rates. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows discounted for the market discount rate.

 

Over time, the discounted liability is increased for the changes in the present value based on the current market discount rates and liability risks. When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount receivable can be measured reliably.

 

When the Company enters into an option agreement on its exploration and evaluations assets, as part of the option agreement, responsibility for any reclamation and remediation becomes the responsibility of the optionee.

 

(l)       Net loss per share

 

The Company presents the basic and diluted net loss per share data for its common shares, calculated by dividing the loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net loss per share is determined by adjusting the net loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all dilutive potential common shares (Note 12).

 

(m)       Leases

 

At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether the right to obtain substantially all of the economic benefits from use of the asset during the term of the arrangement exists, and if the Company has the right to direct the use of the asset. At inception or on reassessment of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of their relative standalone prices.

 

As a lessee, the Company recognizes a right-of-use asset and a lease liability at the commencement date of a lease. The right-of-use asset is initially measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received.

 

The right-of-use asset is subsequently depreciated using the straight line method from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. In addition, the right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

 

A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by the interest rate implicit in the lease, or if that rate cannot be readily determined, the incremental borrowing rate. Lease payments included in the measurement of the lease liability are comprised of:

 

·fixed payments, including in-substance fixed payments, less any lease incentives receivable;
·variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;
·amounts expected to be payable under a residual value guarantee;
·exercise prices of purchase options if the Company is reasonably certain to exercise that option; and
·payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease.

 

The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if there is a change in the estimate or assessment of the expected amount payable under a residual value guarantee, purchase, extension or termination option. Variable lease payments not included in the initial measurement of the lease liability are charged directly to profit or loss.

 

The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments associated with these leases are charged directly to profit or loss on a straight-line basis over the lease term.

 

(n)       Standards issued or amended but not yet effective

 

The Company has not applied the following revised IFRS that has been issued but was not yet effective at December 31, 2023. This accounting standard is not currently expected to have a significant effect on the Company’s accounting policies or financial statements.

 

IAS 1 –Presentation of Financial Statements (“IAS 1”) was amended in January 2020 to provide a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments clarify that the classification of liabilities as current or noncurrent is based solely on a company’s right to defer settlement at the reporting date. The right needs to be unconditional and must have substance. The amendments also clarify that the transfer of a company’s own equity instruments is regarded as settlement of a liability, unless it results from the exercise of a conversion option meeting the definition of an equity instrument. These amendments were further revised by the issuance of Non-current Liabilities with Covenants (Amendments to IAS 1) on October 31, 2022 which further narrowed the scope of the amendments. The amendments are effective for annual periods beginning on January 1, 2024.

XML 28 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounts receivable and prepaid expenses
12 Months Ended
Dec. 31, 2023
Accounts Receivable And Prepaid Expenses  
Accounts receivable and prepaid expenses

 

4.Accounts receivable and prepaid expenses

 

Accounts receivable and prepaid expenses consist of the following:

 

          
   December 31,   December 31, 
   2023   2022 
Accounts receivable (Note 11(b))  $389,895   $198,942 
Prepaid expenses   63,745    60,529 
 Total  $453,640   $259,471 

 

At December 31, 2023, the Company has recorded value added taxes of $164,189 (2022 - $251,775) included in exploration and evaluation assets, as the value added tax relates to the Tuligtic project and is expected to be recovered when the asset is sold (Note 7).

 

XML 29 R10.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Right-of-use assets and lease liabilities
12 Months Ended
Dec. 31, 2023
Right-of-use Assets And Lease Liabilities  
Right-of-use assets and lease liabilities

 

5.Right-of-use assets and lease liabilities

 

The Company has lease agreements for its headquarter office space in Vancouver, B.C.

 

One lease containing an extension option exercisable only by the Company was exercised on November 22, 2021. The lease was therefore extended from March 31, 2022 to March 31, 2027. The Company reassessed this significant event as a lease modification and has estimated that the potential future lease payments under the extended lease term would result in an increase in lease liability by $508,799.

 

The continuity of lease liabilities for the years ended December 31, 2023 and 2022 are as follows:

 

          
   December 31,
2023
   December 31,
2022
 
Opening balance  $465,930   $548,607 
Less: lease payments   (127,797)   (130,056)
Interest expense   39,502    47,379 
    377,635    465,930 
Less: current portion of lease liabilities   (100,531)   (88,295)
Long-term portion of lease liabilities  $277,104   $377,635 

 

The Company entered into a sublease arrangement with a third party to lease an office unit from May 1, 2021 to March 31, 2022 under the same terms of the Company’s lease. The Company remains beholden to the obligations set out in its lease dated October 31, 2018. The rental income during the year ended December 31, 2023 (2022 - $8,508; 2021 - $22,452) from this operating sublease was $Nil and is recorded in interest and other income.

 

The continuity of ROU assets for the years ended December 31, 2023 and 2022 are as follows:

 

          
   December 31,
2023
   December 31,
2022
 
Opening balance  $432,319   $539,110 
Less: amortization of ROU assets   (101,722)   (106,791)
   $330,597   $432,319 

 

During the year ended December 31, 2023, the Company recognized occupancy expenses of $39,858 (2022 - $42,655; 2021 - $40,542) related to short term leases.

 

As at December 31, 2023, the remaining payments for the operating lease are due as follows:

 

                        
   2024   2025   2026   2027   2028   Total 
Office lease  $170,672   $173,970   $177,268   $44,523    -   $566,433 

 

XML 30 R11.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, plant and equipment
12 Months Ended
Dec. 31, 2023
Property Plant And Equipment  
Property, plant and equipment

 

6.Property, plant and equipment

 

                                   
   Furniture
and fixtures
and other
   Computer
hardware
   Computer
software
   Geological
library
   Field
equipment
   Mill
equipment
   Total 
   $   $   $   $   $   $   $ 
Cost                            
December 31, 2022   159,171    271,540    198,981    51,760    245,647    6,568,841    7,495,940 
Additions   1,770    267    -    -    -    -    2,037 
Impairment of property, plant and equipment   -    -    -    -    -    -    - 
December 31, 2023   160,941    271,807    198,981    51,760    245,647    6,568,841    7,497,977 
                                    
Accumulated depreciation                                   
December 31, 2022   153,203    251,441    192,138    50,975    237,312    -    885,069 
Depreciation   1,223    6,066    2,053    157    1,667    -    11,166 
December 31, 2023   154,426    257,507    194,191    51,132    238,979    -    896,235 
                                    
Carrying amounts                                   
December 31, 2022   5,968    20,099    6,843    785    8,335    6,568,841    6,610,871 
December 31, 2023   6,515    14,300    4,790    628    6,668    6,568,841    6,601,742 

 

   Furniture
and fixtures
and other
   Computer
hardware
   Computer
software
   Geological
library
   Field
equipment
   Mill
equipment
   Total 
   $   $   $   $   $   $   $ 
Cost                            
December 31, 2021   158,219    267,004    198,981    51,760    245,647    13,968,566    14,890,177 
Additions   952    4,536    -    -    -    41,568    47,056 
Impairment of property, plant and equipment   -    -    -    -    -    (7,441,293)   (7,441,293)
December 31, 2022   159,171    271,540    198,981    51,760    245,647    6,568,841    7,495,940 
                                    
Accumulated depreciation                                   
December 31, 2021   151,390    244,043    189,206    50,779    235,227    -    870,645 
Depreciation   1,813    7,398    2,932    196    2,085    -    14,424 
December 31, 2022   153,203    251,441    192,138    50,975    237,312    -    885,069 
                                    
Carrying amounts                                   
December 31, 2021   6,829    22,961    9,775    981    10,420    13,968,566    14,019,532 
December 31, 2022   5,968    20,099    6,843    785    8,335    6,568,841    6,610,871 

 

As at December 31, 2022, the Company recorded an impairment of $7,441,293 on mill equipment to its recoverable amount due to the delay in receiving development permit and the lack of available for use in Mexico.

 

XML 31 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Exploration and evaluation assets
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Exploration and evaluation assets

 

7.Exploration and evaluation assets

 

               
   Tuligtic   Other Property   Total 
Exploration and evaluation assets  $   $   $ 
Acquisition costs:               
Opening balance - (December 31, 2022)   11,308,721    -    11,308,721 
Additions   -    -    - 
Deductions   -    -    - 
Impairment of acquisition costs   (11,308,720)   -    (11,308,720)
Closing balance - (December 31, 2023)   1    -    1 
Deferred exploration costs:               
Opening balance - (December 31, 2022)   51,806,355    -    51,806,355 
Costs incurred during the year               
Professional/technical fees   159,031    -    159,031 
Geochemical, metallurgy   1,022    -    1,022 
Travel and accommodation   70,324    -    70,324 
Geology, geophysics and exploration   172,455    -    172,455 
Supplies and miscellaneous   318,047    -    318,047 
Environmental and permit   384,421    -    384,421 
Value-added tax (Note 4)   164,189         164,189 
Refund - Value-added tax   (561,086)   -    (561,086)
Impairment of deferred exploration cost   (52,514,758)   -    (52,514,758)
Total deferred exploration costs during the year   (51,806,355)   -    (51,806,355)
Closing balance - (December 31, 2023)   -    -    - 
Total exploration and evaluation assets   1    -    1 

 

During the year ended December 31, 2023, the Company recorded an impairment of acquisition cost of $11,308,720 (2022 - $Nil) and deferred exploration costs of $52,514,758 (2022 - $Nil) with respect to Tuligtic property due to the Mexican government’s action to revoke the Company’s mineral concession title and to prevent any further exploration and development plans on the Tuligtic property.

 

Title to exploration and evaluation assets involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the potential for problems arising from the frequently ambiguous conveyancing history characteristic of many mineral claims.

 

   Tuligtic   Other Property   Total 
Exploration and evaluation assets  $   $   $ 
Acquisition costs:               
Opening balance - (December 31, 2021)   11,211,756    1    11,211,757 
Additions   96,965    -    96,965 
Deductions   -    (1)   (1)
Closing balance - (December 31, 2022)   11,308,721    -    11,308,721 
Deferred exploration costs:               
Opening balance - (December 31, 2021)   50,219,882    -    50,219,882 
Costs incurred during the year               
Professional/technical fees   143,075    -    143,075 
Claim maintenance/lease costs   169,651    -    169,651 
Geochemical, metallurgy   3,929    -    3,929 
Travel and accommodation   155,195    -    155,195 
Geology, geophysics and exploration   307,712    -    307,712 
Supplies and miscellaneous   310,804    -    310,804 
Environmental and permit   640,541    -    640,541 
Value-added tax (Note 4)   251,775         251,775 
Refund - Value-added tax   (396,209)   -    (396,209)
Total deferred exploration costs during the year   1,586,473    -    1,586,473 
Closing balance - (December 31, 2022)   51,806,355    -    51,806,355 
Total exploration and evaluation assets   63,115,076    -    63,115,076 

 

The following is a description of the Company’s most significant property interests:

 

(a)Tuligtic

 

The Tuligtic property consisted of two mineral concessions which the Company applied for in 2002 and 2008. The mineral concessions were granted in 2003 and 2009, respectively (“the “Concessions”). The Company held a 100% interest in the Concessions subject to a 2.0% NSR royalty held by Almadex Minerals Ltd (‘’Almadex”). The Concessions covered approximately 14,000 Ha, including certain endowed lands of the Ejido Tecoltemi, which comprise approximately 330 Ha. The Concessions are located in Puebla, Mexico and underpinned the discovery made by the Company in 2010, referred to as “Ixtaca”.

 

In 2015, the Ejido Tecoltemi initiated a lawsuit against the Mexican government (President, Congress, Ministry of Economy, Directorate of Mines, Mining Registry Office) asserting that the Mexican mining law is unconstitutional because it fails to include provisions requiring consultation of indigenous communities before granting mineral titles. This lawsuit ultimately came before Mexico’s Supreme Court (“SCJN”), and in early 2022, the SCJN ruled that the Mexican mineral title law is constitutional, but that the Ministry of Economy (“Economia”) should have provided for a consultation procedure with relevant indigenous communities prior to issuing the Concessions to the Company. The SCJN ordered Economia to declare the Concessions ineffective - to revert them to application status - and to conduct indigenous consultation prior to re-issuing them.

In July, 2022 the Company announced that Economia notified Almaden that the Concessions were “ineffective”. The Company understood that the mineral title had reverted to application status, and that these applications preserved the mineral rights for Almaden but did not allow the Company to engage in exploration, until such time as Economia completed its court-ordered process to properly issue the Concessions after conducting indigenous consultation in the area covered by the mineral title applications.

 

However, on February 22, 2023, Economia made a submission to Mexican courts seeking to deny the two mineral title applications which were first made by Almaden in 2002 and 2008 (the “Submission”). The Submission claimed that the applications contain technical faults, despite Economia’s previous statements to the contrary and its acceptance of the mineral title applications and grant of the Concessions in 2003 and 2009.

 

This Submission has been reviewed by the Mexican district and appeals courts, which have ruled that the Submission complies with the SCJN ruling. However, the appeals court’s ruling did not address the validity of the Submission and therefore safeguarded the Company’s right to challenge the substance and legality of the Submission through the Mexican Federal Administrative Court (“TFJA”), which the Company has done.

 

The TFJA has granted a definitive injunction to Almaden’s Mexican subsidiary, Minera Gorrión (“MG”), which prevents Economia from releasing the mineral rights covered by the Company’s mineral title applications to third parties while the TFJA trial regarding the substance and legality of the Submission continues.

 

In summary, the rights held by Almaden to the Ixtaca project are now based on two mineral title applications which have been denied by Economia, through its issuance of the Submission. The Company is in the process of disputing this denial through the Mexican Federal Administrative Court.

 

(b)Other Property

 

On May 26, 2022, the Company transferred the 40% carried interest in the Logan property located in the Yukon Territory, Canada to Almadex for a consideration of $1 equal to its carrying value. No gain or loss was recognized in the statement of comprehensive loss.

 

(c)Other

 

Expenditures incurred by the Company in Mexico are subject to Mexican Value added tax (“VAT”). The VAT is included in exploration and evaluation assets as incurred. Under Mexican law, VAT paid can be used in the future to offset amounts resulting from VAT charged on sales. Under certain circumstances and subject to approval from tax authorities, A Company can also apply for an early refund of VAT prior to generating sales. During 2023, the Company received a VAT recovery of $561,086 (2022 - 396,209; $2021 - $506,394) and other income of $173,876 (2022 - $139,313; 2021 - $446,184) related to a VAT refund from prior years which is recorded in interest and other income.

 

XML 32 R13.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gold loan payable and gold in trust
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Gold loan payable and gold in trust

 

8.Gold loan payable and gold in trust

 

The Company has entered into a secured gold loan agreement (“Gold Loan”) with Almadex or the “Lender” pursuant to which Almadex has agreed to loan up to 1,597 ounces of gold bullion to the Company. The approximate value of this gold as at May 14, 2019 was USD$2,072,060 or $2,790,858.

 

Under the terms of the Gold Loan, the Company will be entitled to draw-down the gold in minimum 400 ounce tranches. At any given time, the amount of gold ounces drawn multiplied by the London Bullion Market Association (“LBMA”) AM gold price in US dollars, plus any accrued interest or unpaid fees, shall constitute the Loan Value.

 

The maturity date for the Gold Loan is March 31, 2024, and can be extended by two years at the discretion of the Company (the “Term”). Repayment of the Loan Value shall be made either through delivery of that amount of gold drawn, or through the issuance of common shares of the Company (“Shares”), according to the Lender’s discretion. Mandatory prepayment shall be required in the event that the Company’s Ixtaca gold-silver project located in Puebla State, Mexico (the “Ixtaca Project”) enters into commercial production during the Term, requiring the Company to deliver 100 gold ounces per month to the Lender. In addition, the Company has the right to pre-pay the Loan Value at any time without penalty, in either gold bullion or Shares as chosen by the Lender, and the Lender has the right to convert the Loan Value into Shares at any time during the Term. The conversion rate is equal to 95% of the 5 trading day volume weighted average price of the Share on the Toronto Stock Exchange or an equivalent.

 

The interest rate of the Gold Loan is 10% of the Loan Value per annum, calculated monthly, paid in arrears. Interest payments can either be accrued to the Loan Value, or paid by the Company in cash or gold bullion. A standby fee of 1% per annum, accrued quarterly, will be applied to any undrawn amount on the Gold Loan.

 

In addition, the Company has issued Almadex 500,000 transferable share purchase warrants (“Warrants”), with an exercise price of $1.50 per Share and expiry date of May 14, 2024 as an arrangement fee to cover the administrative costs of setting up the credit facility. These warrants were valued at $50,000 using the Black-Scholes option-pricing model with the following assumptions: expected life of five years, risk-free interest rate of 1.54%, expected dividend yield of 0% and expected volatility of 44.25%.

 

Security for the loan is certain equipment related to the Rock Creek Mill, which is not required for the Ixtaca Project. The Gold Loan includes industry standard provisions in the event of default, material breach and change of control.

 

The Gold Loan was recorded at fair value at inception and is subsequently measured at amortized cost using the effective interest method, recognizing interest expense on an effective yield basis.

 

The Company has determined that the Gold Loan contains multiple derivatives which are embedded in the US dollar denominated debt instrument. As the convertible Gold Loan is denominated in US dollars and is convertible into common shares based upon a variable Canadian dollar conversion rate, the fixed for fixed criteria is not met. As such, the conversion option cannot be classified as an equity instrument and is deemed to have no value. The embedded derivative from indexation of the loan principal portion to the movement in the price of gold is classified as a derivate financial liability and is marked to market at each period end using the Black-Scholes option-pricing model.

 

At inception, the following assumptions were used: expected life of five years, risk-free interest rate of 1.57% and expected volatility of 11.06%. The fair value of the embedded derivative for the year ended December 31, 2023 decreased by $191,732 (December 31, 2022 decreased by $110,177) based on the following assumptions used in the Black-Scholes option-pricing model: expected life of 0.25 years, risk-free interest rate of 4.00% and expected volatility of 9.93% (December 31, 2022, expected life of 1.25 years, risk-free interest rate of 4.00% and expected volatility of 11.57%).

 

The continuity of gold loan payable and derivative financial liabilities are as follows:

 

          
   December 31,
2023
   December 31,
2022
 
Gold loan payable – opening balance  $3,929,015   $3,227,545 
Accrued interest expense   353,372    314,024 
Accrued standby fees   10,377    9,416 
Accretion expense   176,960    144,868 
Foreign exchange difference   (98,178)   233,162 
Gold loan payable  $4,371,546   $3,929,015 
           
Derivative financial liabilities – opening balance  $306,084   $391,620 
Change in fair value through profit & loss   (191,732)   (110,177)
Foreign exchange difference   (5,522)   24,641 
Derivative financial liabilities  $108,830   $306,084 

 

As at December 31, 2023, Almaden has 397 ounces (397 ounces at December 31, 2022) of gold bullion on its account at a fair value of $1,082,801 ($974,397 at December 31, 2022).

 

The continuity of gold in trust are as follows:

 

                    
   December 31, 2023   December 31, 2022 
   Ounces   $   Ounces   $ 
Gold in trust, opening balance   397    974,397    397    915,995 
Sale of gold in trust   -    -    -    - 
Gain on sale   -    -    -    - 
Change in fair value through profit & loss   -    132,895    -    (6,518)
Foreign exchange difference   0    (24,491)   0    64,920 
    397    1,082,801    397    974,397 

 

XML 33 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Warrant liability
12 Months Ended
Dec. 31, 2023
Warrant Liability  
Warrant liability

 

9.Warrant liability

 

In connection with the registered direct offering private placement completed during the year ended December 31, 2021, the Company issued a total of 7,923,077 warrants exercisable at US$0.80 per share. The fair value of these warrants on issuance was $2,371,174, valued using the Black-Scholes option-pricing model with the following assumptions:

 

     
  Risk-free interest rate 0.53%  
  Expected life of warrants 3.00 years  
  Expected annualized volatility 72.42%  
  Dividend Nil  
  Forfeiture rate 0%  

 

The fair value is recorded as a derivative financial liability as these warrants are exercisable in US dollars, differing from the Company’s functional currency. The change in fair value resulted in an unrealized gain of $102,787 (December 31, 2022 - $520,503) and is recognized in the consolidated statements of comprehensive loss for the year ended December 31, 2023. The fair value warrants were re-valued at period end using the Black-Scholes option-pricing model with the following assumptions:

 

          
   December 31, 2023   December 31, 2022 
Risk-free interest rate   3.91%   3.99%
Expected life of warrants   0.21 years    1.21 years 
Expected annualized volatility   36.25%   69.83%
Dividend   Nil    Nil 
Forfeiture rate   0%   0%

 

XML 34 R15.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share capital and reserves
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Share capital and reserves

 

10.Share capital and reserves

 

(a)Authorized share capital

 

At December 31, 2023, the authorized share capital comprised an unlimited number of common shares. The common shares do not have a par value. All issued shares are fully paid.

 

(b)Details of private placements and other issues of common shares in 2023, 2022 and 2021

 

On March 18, 2021, the Company closed a registered direct offering private placement for the purchase and sale of 15,846,154 common shares and common share warrants to purchase up to 7,923,077 common shares at a combined purchase price of US$0.65 per unit for aggregate gross proceeds of US$10.3 million (CAD$12,838,950). The common share warrants will be immediately exercisable, have an exercise price of US$0.80 per share and will expire three years from the date of issuance. Share issue costs included a finder’s fee of $834,532 in cash, and finders’ warrants to purchase up to 435,769 common shares at a price of US$0.80 per common share until March 18, 2024. The fair value of the finders’ warrants was $130,731. In connection with the registered direct offering, the Company also incurred $393,837 in share issue costs. These amounts were recorded as a reduction to share capital. The proceeds of the registered direct offering were allocated $10,467,776 to share capital and $2,371,174 to warrants.

 

Share issue costs of $40,990 was recorded for fees paid related to the Short Form Base Shelf Prospectus filed on February 25, 2021.

 

(c)Warrants

 

The continuity of warrants for the years ended December 31, 2023, 2022 and 2021 are as follows:

 

                              
   Exercise   December 31,               December 31, 
Expiry date  price   2022   Issued   Exercised   Expired   2023 
March 27, 2023   $0.50    5,489,658    -    -    (5,489,658)   - 
August 6, 2023   $0.90    3,100,000    -    -    (3,100,000)   - 
March 18, 2024   USD$0.80    7,923,077    -    -    -    7,923,077 
March 18, 2024   USD$0.80    435,769    -    -    -    435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        17,448,504    -    -    (8,589,658)   8,858,846 
Weighted average exercise price       $0.88    -    -   $0.64   $1.08 

 

The weighted average remaining life of warrants outstanding at December 31, 2023 was 0.22 years (2022 – 0.80 years).

 

   Exercise   December 31,               December 31, 
Expiry date  price   2021   Issued   Exercised   Expired   2022 
June 7, 2022   $1.35    4,720,000    -    -    (4,720,000)   - 
March 27, 2023   $0.50    5,489,658    -    -    -    5,489,658 
August 6, 2023   $0.90    3,100,000    -    -    -    3,100,000 
March 18, 2024   USD$0.80    7,923,077    -    -    -    7,923,077 
March 18, 2024   USD$0.80    435,769    -    -    -    435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        22,168,504    -    -    (4,720,000)   17,448,504 
Weighted average exercise price       $0.95    -    -   $1.35   $0.88 

 

The weighted average remaining life of warrants outstanding at December 31, 2022 was 0.80 years (2021 – 1.51 years).

 

   Exercise   December 31,               December 31, 
Expiry date  price   2020   Issued   Exercised   Expired   2021 
June 7, 2022   $1.35    4,720,000    -    -    -    4,720,000 
March 27, 2023   $0.50    5,489,658    -    -    -    5,489,658 
August 6, 2023   $0.90    3,100,000    -    -    -    3,100,000 
March 18, 2024   USD$0.80    -    7,923,077    -    -    7,923,077 
March 18, 2024   USD$0.80    -    435,769              435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        13,809,658    8,358,846    -    -    22,168,504 
Weighted average exercise price       $0.92   $1.00    -    -   $0.95 

 

The weighted average remaining life of warrants outstanding at December 31, 2021 was 1.51 years (2020 – 2.08 years).

 

The weighted average fair value of finders’ warrants granted during the years ended December 31, 2023, 2022 and 2021 calculated using the Black-Scholes option-pricing model at the issue dates, are as follows:

 

Weighted average assumptions used

 

           
Number of
warrants
Date of issue Fair value
per share
Risk free
interest
rate

Expected life

(in years)

Expected
volatility
Expected
dividends
435,769 March 18, 2021 $ 0.30 0.53% 3 72.42% $Nil

 

(d)Share purchase option compensation plan

 

The Company’s stock option plan permits the issuance of options up to a maximum of 10% of the Company’s issued share capital. Stock options issued to any consultant or person providing investor relations services cannot exceed 2% of the issued and outstanding common shares in any twelve month period. At December 31, 2023, the Company had reserved 1,217,141 stock options that may be granted. The exercise price of any option cannot be less than the volume weighted average trading price of the shares for the five trading days immediately preceding the date of the grant.

 

The maximum term of all options is five years. The Board of Directors determines the term of the option (to a maximum of five years) and the time during which any option may vest. Options granted to consultants or persons providing investor relations services shall vest in stages with no more than 25% of such option being exercisable in any three month period. All options granted during the years ended December 31, 2023, 2022 and 2021 vested on the grant date.

 

The Company’s stock option plan permits the option holder to exercise cashless by surrendering a portion of the underlying option shares to pay for the exercise price and the corresponding withholding taxes, if applicable.

 

 

The continuity of stock options for the years ended December 31, 2023, 2022 and 2021 are as follows:

 

                              
Expiry date  Exercise
price
   December 31,
2022
   Granted   Exercised   Expired   December 31,
2023
 
February 9, 2023  $0.97    350,000    -    -    (350,000)   - 
March 3, 2023  $0.96    250,000    -    -    (250,000)   - 
March 31, 2023  $0.68    1,975,000    -    -    (1,975,000)   - 
May 8, 2023  $0.69    100,000    -    -    (100,000)   - 
May 28, 2023  $0.65    100,000    -    -    (100,000)   - 
July 8, 2023  $0.62    2,420,000    -    -    (2,420,000)   - 
September 18, 2023  $0.51    960,000    -    -    (960,000)   - 
March 7, 2027  $0.38    1,125,000    -    -    -    1,125,000 
June 10, 2027  $0.33    3,640,000    -    -    -    3,640,000 
October 4, 2027  $0.30    755,000    -    -    -    755,000 
December 16, 2027  $0.33    855,000    -    -    -    855,000 
February 14, 2028  $0.30    -    600,000    -    -    600,000 
April 3, 2028  $0.26    -    1,975,000    -    -    1,975,000 
July 10, 2028  $0.16    -    2,520,000    -    -    2,520,000 
September 19, 2028  $0.18    -    1,035,000    -    -    1,035,000 
Options outstanding and exercisable        12,530,000    6,130,000    -    (6,155,000)   12,505,000 
Weighted average exercise price       $0.49   $0.21    -   $0.66   $0.27 

 

The weighted average remaining life of stock options outstanding at December 31, 2023 was 3.96 years (2022 – 2.53 years).

Expiry date  Exercise
price
   December 31,
2021
   Granted   Exercised   Expired   December 31,
2022
 
March 4, 2022  $0.47    1,125,000    -    -    (1,125,000)   - 
April 30, 2022  $0.41    100,000    -    -    (100,000)   - 
April 30, 2022  $0.58    220,000    -    -    (220,000)   - 
May 31, 2022  $0.62    600,000    -    -    (600,000)   - 
June 9, 2022  $0.64    1,980,000    -    -    (1,980,000)   - 
October 3, 2022  $1.13    860,000    -    -    (860,000)   - 
December 15, 2022  $0.89    900,000    -    -    (900,000)   - 
February 9, 2023  $0.97    350,000    -    -    -    350,000 
March 3, 2023  $0.96    250,000    -    -    -    250,000 
March 31, 2023  $0.68    1,975,000    -    -    -    1,975,000 
May 8, 2023  $0.69    100,000    -    -    -    100,000 
May 28, 2023  $0.65    100,000    -    -    -    100,000 
July 8, 2023  $0.62    2,470,000    -    -    (50,000)   2,420,000 
September 18, 2023  $0.51    960,000    -    -    -    960,000 
March 7, 2027  $0.38    -    1,125,000    -    -    1,125,000 
June 10, 2027  $0.33    -    3,640,000    -    -    3,640,000 
October 4, 2027  $0.30    -    755,000    -    -    755,000 
December 16, 2027  $0.33    -    855,000    -    -    855,000 
Options outstanding and exercisable        11,990,000    6,375,000    -    (5,835,000)   12,530,000 
Weighted average exercise price       $0.68   $0.34    -   $0.71   $0.49 

 

The weighted average remaining life of stock options outstanding at December 31, 2022 was 2.53 years (2021 – 0.98 years).

 

 

Expiry date  Exercise
price
   December 31,
2020
   Granted   Exercised   Expired   December 31,
2021
 
February 7, 2021  $1.11    300,000    -    -    (300,000)   - 
February 7, 2021  $0.84    425,000    -    (375,000)   (50,000)   - 
March 29, 2021  $1.08    400,000    -    -    (400,000)   - 
March 29, 2021  $0.90    100,000    -    -    (100,000)   - 
May 6, 2021  $0.69    557,000    -    (275,000)   (282,000)   - 
July 7, 2021  $0.80    1,612,000    -    (75,000)   (1,537,000)   - 
August 13, 2021  $1.01    150,000    -    -    (150,000)   - 
September 16, 2021  $0.90    1,155,000    -    -    (1,155,000)   - 
December 12, 2021  $1.00    200,000    -    -    (200,000)   - 
March 4, 2022  $0.47    1,125,000    -    -    -    1,125,000 
April 30, 2022  $0.41    100,000    -    -    -    100,000 
April 30, 2022  $0.58    220,000    -    -    -    220,000 
May 31, 2022  $0.62    700,000    -    -    (100,000)   600,000 
June 9, 2022  $0.64    2,180,000    -    -    (200,000)   1,980,000 
October 3, 2022  $1.13    1,346,000    -    -    (486,000)   860,000 
December 15, 2022  $0.89    972,000    -    -    (72,000)   900,000 
February 9, 2023  $0.97    -    450,000    -    (100,000)   350,000 
March 3, 2023  $0.96    -    325,000    -    (75,000)   250,000 
March 31, 2023  $0.68    -    1,975,000    -    -    1,975,000 
May 8, 2023  $0.69    -    100,000    -    -    100,000 
May 28, 2023  $0.65    -    100,000    -    -    100,000 
July 8, 2023  $0.62    -    2,470,000    -    -    2,470,000 
September 18, 2023  $0.51    -    960,000    -    -    960,000 
Options outstanding and exercisable        11,542,000    6,380,000    (725,000)   (5,207,000)   11,990,000 
Weighted average exercise price       $0.80   $0.67   $0.78   $0.90   $0.68 

 

The weighted average remaining life of stock options outstanding at December 31, 2021 was 0.98 years (2020 – 1.08 years).

 

The fair value of options granted during the years ended December 31, 2023, 2022 and 2021, calculated using the Black-Scholes option-pricing model at grant date, are as follows:

 

                            
Number
of options
   Date of grant  Fair value
per share
   Risk free
interest
rate
   Expected
life
(in years)
   Expected
volatility
   Expected
dividends
1,035,000   September 19, 2023  $0.10    3.96%   5    71.15%  $Nil
2,520,000   July 10, 2023  $0.12    3.81%   5    70.98%  $Nil
1,975,000   April 3, 2023  $0.15    2.87%   5    68.52%  $Nil
600,000   February 13, 2023  $0.18    3.43%   5    68.61%  $Nil
855,000   December 16, 2022  $0.19    3.07%   5    66.04%  $Nil
755,000   October 4, 2022  $0.22    3.42%   5    82.02%  $Nil
3,640,000   June 10, 2022  $0.22    3.38%   5    82.61%  $Nil
1,125,000   March 7, 2022  $0.31    1.65%   5    85.37%  $Nil
960,000   September 17, 2021  $0.23    0.45%   2    82.96%  $Nil
2,470,000   July 8, 2021  $0.25    0.45%   2    84.98%  $Nil
100,000   May 28, 2021  $0.30    0.32%   2    86.03%  $Nil
100,000   May 7, 2021  $0.30    0.33%   2    86.33%  $Nil
1,975,000   March 31, 2021  $0.31    0.22%   2    85.85%  $Nil
325,000   March 2, 2021  $0.43    0.26%   2    85.48%  $Nil
450,000   February 9, 2021  $0.49    0.19%   2    84.04%  $Nil

 

Total share-based payments expenses as a result of options granted and vested during the year ended December 31, 2023 was $810,150 (2022 - $1,478,100; 2021 - $1,870,800).

XML 35 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related party transactions and balances
12 Months Ended
Dec. 31, 2023
Related Party Transactions And Balances  
Related party transactions and balances

 

11.Related party transactions and balances

 

(a)Compensation of key management personnel

 

Key management includes members of the Board, the Chair, the President and Chief Executive Officer, the Chief Financial Officer, the Executive Vice President, and the Vice President, Project Development. The net aggregate compensation paid or payable to key management for services after recovery from Azucar Minerals Ltd. (Azucar) and Almadex (Note 11 (b)) is as follows:

 

               
   December 31,   December 31,   December 31, 
   2023   2022   2021 
             
Professional fees  $50,588   $60,000   $60,000 
Salaries and benefits   398,307 (3)   484,435 (2)   450,522 (1)
Share-based payments   702,000    1,212,300    1,551,850 
Directors’ fees   140,000    145,000    102,500 
 Total  $1,290,895   $1,901,735   $2,164,872 

 

 (1)As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.
 (2)As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.
 (3)As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.

 

(b)Administrative Services Agreements

 

The Company recovers a portion of rent, office and license expenses from Azucar pursuant to an Administrative Services Agreement dated May 15, 2015 and First Amending Agreement dated December 16, 2015 between the Company and Azucar.

 

The Company also recovers a portion of rent, office and license expenses from Almadex pursuant to an Administrative Services Agreement dated March 29, 2018 between the Company and Almadex.

 

During the year ended December 31, 2023, the Company received $75,853 (2022 - $185,068; 2021 - $412,812) from Azucar for administrative services fees included in other income and received $1,346,494 (2022 - $1,191,360; 2021 - $969,532) from Almadex for administrative services fees included in other income.

 

At December 31, 2023, included in accounts receivable is $7,005 (2022 - $64,006) due from Azucar and $369,045 (2022 - $117,044) due from Almadex in relation to expense recoveries.

 

Under the Administrative Services Agreements, the Company is the sole and exclusive manager of Azucar and Almadex that provides general management services, office space, executive personnel, human resources, geological technical support, accounting and financial services at cost with no mark-up or additional direct charge. The three companies are considered related parties though common officers.

 

(c)Other related party transactions

 

At December 31, 2023, the Company accrued $Nil (2022 - $80,727) payable to Almadex for exploration and drilling services in Mexico.

 

During the year ended December 31, 2023, the Company employed the Chair’s daughter for a salary of $45,300 less statutory deductions (2022 - $48,800; 2021 - $41,300) for marketing and administrative services provided to the Company.

 

XML 36 R17.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net loss per share
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Net loss per share

 

12.Net loss per share

 

Basic and diluted net loss per share

 

The calculation of basic net loss per share for the year ended December 31, 2023 was based on the loss attributable to common shareholders of $63,620,232 (2022 - $11,846,560; 2021 - $2,668,254) and a weighted average number of common shares outstanding of 137,221,408 (2022 - 137,221,408; 2021 – 133,842,894).

 

The calculation of diluted net loss per share for the year ended December 31, 2023, 2022 and 2021 did not include the effect of stock options and warrants, as they were considered to be anti-dilutive.

XML 37 R18.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplemental cash flow information
12 Months Ended
Dec. 31, 2023
Supplemental Cash Flow Information  
Supplemental cash flow information

 

13.Supplemental cash flow information

 

Supplemental information regarding non-cash transactions is as follows:

 

               
Investing and financing activities  December 31,
2023
   December 31,
2022
   December 31,
2021
 
             
Exploration and evaluation assets expenditures included in trade and other payables   -   $90,850   $89,203 
Right-of-use assets   -    -    (508,799)
Warrant liability   -    -    2,371,174 
Fair value of finders’ warrants   -    -    130,731 
Lease liabilities   -    -    508,799 
Fair value of cash stock options transferred to share capital on exercise of options   -    -    177,250 
                

 

Supplemental information regarding the split between cash and cash equivalents is as follows:

 

          
   December 31,
2023
   December 31,
2022
 
         
Cash  $1,658,863   $1,542,956 
Term Deposits   2,587,120    5,115,120 
 Total cash and cash equivalents  $4,245,983   $6,658,076 

 

XML 38 R19.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes
12 Months Ended
Dec. 31, 2023
Income Taxes  
Income Taxes

 

14.Income Taxes

 

(a)The provision for income taxes differs from the amounts computed by applying the Canadian statutory rates to the net loss before income taxes due to the following:

 

               
   December 31,
2023
   December 31,
2022
   December 31,
2021
 
Loss before income taxes  $(66,710,410)  $(10,505,375)  $(2,354,113)
Statutory rate   27.00%   27.00%   27.00%
                
Expected income tax   (18,011,811)   (2,836,451)   (635,611)
Effect of different tax rates in foreign jurisdictions   (2,005,959)   (83,891)   5,281 
Non-deductible share-based payments   218,741    399,087    505,116 
Other permanent items   2,484,720    1,838,169    (620,413)
Change in deferred tax assets not recognized   15,403,428    2,471,723    733,447 
Share issuance costs   -    -    (331,660)
True-ups and other   (1,179,327)   (447,452)   657,981 
Deferred income tax (recovery) expense  $(3,090,208)  $1,341,185   $314,141 

 

(b)The Company’s deferred income tax liability relates to the Mexican income tax and Special Mining Duty (“SMD”) associated with the Tuligtic project.

 

The significant components of deferred income tax assets (liabilities) are as follows:

 

          
   December 31,
2023
   December 31,
2022
 
         
Deferred tax assets          
Non-capital losses  $-   $2,477,570 
Exploration and evaluation assets   1,434,880    - 
    1,434,880    2,477,570 
Deferred tax liabilities          
Exploration and evaluation assets   (1,434,880)   (5,567,778)
           
Net deferred tax liabilities  $-   $(3,090,208)

 

(c)Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:

 

          
   December 31,
2023
   December 31,
2022
 
         
Non-capital loss carry forwards  $32,616,394   $25,487,951 
Capital loss carry forwards   23,360,422    24,538,993 
Exploration and evaluation assets   39,102,815    8,188,922 
Share issue costs   551,134    858,548 
Property, plant and equipment   7,748,032    7,782,024 
Donations   32,960    32,960 
Investment tax credit   223,873    223,873 
   $103,635,630   $67,113,271 

 

At December 31, 2023, the Company had operating loss carry forwards available for tax purposes in Canada of $27,592,166 (2022 - $25,487,951) which expire between 2032 and 2043 and in Mexico of $4,588,699 (2022 - $Nil) which expire between 2024 and 2026.

XML 39 R20.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial instruments
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Financial instruments

 

15.Financial instruments

 

The fair values of the Company’s cash and cash equivalents, accounts receivable and trade and other payables approximate their carrying values because of the short-term nature of these instruments.

 

Except for warrant liability and derivative financial liabilities, the Company does not carry any financial instruments at FVTPL.

 

The Company is exposed to certain financial risks, including currency risk, credit risk, liquidity risk, interest rate risk and commodity and equity price risk.

 

(a)Currency risk

 

The Company’s property interests in Mexico make it subject to foreign currency fluctuations and inflationary pressures which may adversely affect the Company’s financial position, results of operations and cash flows. The Company is affected by changes in exchange rates between the Canadian dollar, the US dollar and the Mexican peso. The Company does not invest in foreign currency contracts to mitigate the risks.

 

As at December 31, 2023, the Company is exposed to foreign exchange risk through the following monetary assets and liabilities denominated in currencies other than the functional currency of the applicable subsidiary:

 

          
All amounts in Canadian dollars  US dollar   Mexican peso 
Cash and cash equivalents  $2,343,681   $458,149 
Accounts receivable and prepaid expenses   4,703    113 
Gold in trust   1,082,801    - 
Total assets  $3,431,185   $458,262 
           
Trade and other payables  $53,348   $14,087 
Gold loan payable   4,371,546    - 
Derivative financial liabilities   108,830    - 
Total liabilities  $4,533,724   $14,087 
           
Net assets  $(1,102,539)  $444,175 

 

A 10% change in the US dollar exchange rate relative to the Canadian dollar would change the Company’s net loss by $110,000.

 

A 10% change in the Mexican peso relative to the Canadian dollar would change the Company’s net loss by $44,000.

 

(b)Credit risk

 

The Company’s cash and cash equivalents are held in large financial institutions, located in both Canada and Mexico. Cash equivalents mature at less than ninety days during the twelve months following the statement of financial position date. The Company’s accounts receivable consist of amounts due from related parties which are subsequently collected.

 

To mitigate exposure to credit risk on cash and cash equivalents, the Company has established policies to limit the concentration of credit risk with any given banking institution where the funds are held, to ensure counterparties demonstrate minimum acceptable credit risk worthiness and ensure liquidity of available funds.

 

As at December 31, 2023, the Company’s maximum exposure to credit risk is the carrying value of its cash and cash equivalents, and accounts receivable.

 

(c)Liquidity risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company manages liquidity risk through the management of its capital structure. Liquidity risk is considered low as the Company has sufficient cash and cash equivalent to meet its current liabilities.

 

Trade and other payables are due within twelve months of the statement of financial position date.

 

(d)Interest rate risk

 

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to varying interest rates on cash and cash equivalents. The Company has no debt bearing variable interest rate.

 

A 1% change in the interest rate would change the Company’s net loss by $42,000.

 

(e)Commodity and equity price risk

 

The ability of the Company to explore its exploration and evaluation assets and the future profitability of the Company are directly related to the market price of gold and other precious metals. The Company monitors gold prices to determine the appropriate course of action to be taken by the Company. Equity price risk is defined as the potential adverse impact on the Company’s performance due to movements in individual equity prices or general movements in the level of the stock market.

 

A 1% change in the commodity price would change the Company’s net loss by $11,000.

 

(f)Classification of financial instruments

 

IFRS 13 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value as follows:

 

Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities;

 

Level 2 – inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and

 

Level 3 – inputs for the asset or liability that are not based on observable market data (unobservable inputs).

 

The following table sets forth the Company’s financial assets and liabilities measured at fair value by level within the fair value hierarchy.

 

                    
   Level 1   Level 2   Level 3   Total 
    $    $    $    $ 
Derivative financial liabilities   -    108,830    -    108,830 

 

XML 40 R21.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Management of capital
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Management of capital

 

16.Management of capital

 

The Company considers its capital to consist of components of equity. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the exploration of its exploration and evaluation assets and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk.

 

The Company considers its capital to consist of components of equity. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to pursue the exploration of its exploration and evaluation assets and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk.

 

The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares and, acquire or dispose of assets.

 

In order to maximize ongoing exploration efforts, the Company does not pay out dividends. The Company’s investment policy is to invest its short-term excess cash in highly liquid short-term interest-bearing investments with short term maturities, selected with regards to the expected timing of expenditures from continuing operations.

 

The Company expects its current capital resources will be sufficient to carry its exploration plans and operations for the foreseeable future. There were no changes to the Company’s approach to the management of capital during the period. The Company has no externally imposed capital requirements.

 

XML 41 R22.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segmented information
12 Months Ended
Dec. 31, 2023
Segmented Information  
Segmented information

 

17.Segmented information

 

The Company operates in one reportable operating segment, being the acquisition and exploration of mineral resource properties.

 

The Company’s non-current assets are located in the following geographic locations:

 

          
   December 31,
2023
   December 31,
2022
 
Canada  $361,967   $472,435 
United States   6,568,840    6,568,840 
Mexico   1,533    63,116,991 
   $6,932,340   $70,158,266 

 

XML 42 R23.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Subsequent event
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Subsequent event

 

18.Subsequent event

 

On March 12, 2024, the Company provided notice to Almadex that it is extending the maturity date from March 31, 2024 to March 31, 2026 pursuant to the Gold Loan.

 

XML 43 R24.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Material accounting policies (Policies)
12 Months Ended
Dec. 31, 2023
Material Accounting Policies  
Basis of consolidation

(a)       Basis of consolidation

 

These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries as follows:

 

       
    Jurisdiction   Nature of operations
         
  Puebla Holdings Inc. Canada   Holding company
  Minera Gorrion, S.A. de C.V. Mexico   Exploration company

 

Inter-company balances and transactions, including unrealized income and expenses arising from inter-company transactions, are eliminated in preparing these consolidated financial statements.

 

Foreign currencies

(b)       Foreign currencies

 

Transactions in currencies other than the functional currency are recorded at the rates of exchange prevailing on the transaction dates. At each financial position reporting date, monetary assets and liabilities that are denominated in foreign currencies are translated at the rates prevailing at the date of the statement of financial position. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.

 

Financial instruments

(c)       Financial instruments

 

A financial asset is classified as measured at: amortized cost, fair value through other comprehensive income (FVOCI), or fair value through profit or loss (FVTPL). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. Derivatives embedded in contracts where the host is a financial asset in the scope of the standard are never separated. Instead, the hybrid financial instrument as a whole is assessed for classification. The Company's financial assets consist primarily of cash and cash equivalents, and accounts receivable and are classified at amortized cost.

 

Financial liabilities comprise the Company’s trade and other payables. Financial liabilities are initially recognized on the date they are originated and are derecognized when the contractual obligations are discharged or cancelled or expire. Trade and other payables are recognized initially at fair value and subsequent are measured at amortized costs using the effective interest method, when materially different from the initial amount. Derivative financial liabilities are classified as FVTPL. Fair value is determined based on the present value of future cash flow, discounted at the market rate of interest.

 

(i)     Impairment of financial assets

 

An ‘expected credit loss’ (ECL) model applies to financial assets measured at amortized cost, contract assets and debt investments at FVOCI, but not to investments in equity instruments. The Company's financial assets measured at amortized cost and subject to the ECL model include cash and cash equivalents, and accounts receivable.

 

(ii)    Embedded derivatives

 

Derivatives may be embedded in other financial instruments (the “host instrument”). Embedded derivatives are treated as separate derivatives when their economic characteristics and risks are not clearly and closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the combined contract is not held for trading or designated at fair value. These embedded derivatives are measured at fair value with subsequent changes recognized in profit or loss.

 

The Company issues warrants exercisable in a currency other than the Company’s functional currency and as a result, the warrants are derivative financial instruments.

 

Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred.

 

Cash and cash equivalents

(d)       Cash and cash equivalents

 

Cash equivalents include term deposits and money market instruments which are readily convertible into cash or have maturities at the date of purchase of less than ninety days.

 

Property, plant and equipment

(e)       Property, plant and equipment

 

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, and are depreciated annually on a declining-balance basis if available-for-use at the following rates:

 

   
  Furniture, fixtures and other 20%
  Computer hardware and software 30%
  Geological library 20%
  Field equipment 20%
  Mill equipment Straight line over mine life (11 years)

 

Exploration and evaluation assets

(f)       Exploration and evaluation assets

 

The Company is in the advanced exploration stage with respect to its investment in exploration and evaluation assets and, accordingly, follows the practice of capitalizing all costs relating to the acquisition of, exploration for and development of mineral claims to which the Company has rights and crediting all proceeds received from farm-out arrangements or recovery of costs against the cost of the related claims. Acquisition costs include, but are not exclusive to land surface rights acquired. Deferred exploration costs include, but are not exclusive to geological, geophysical studies, annual mining taxes, exploratory drilling and sampling. At such time as commercial production commences, these costs will be charged to profit or loss on a unit-of-production method based on proven and probable reserves. The aggregate costs related to abandoned mineral claims are charged to profit or loss at the time of any abandonment or when it has been determined that there is evidence of an impairment.

 

The Company considers the following facts and circumstances in determining if it should test exploration and evaluation assets for impairment:

 

(i)the period for which the Company has the right to explore in the specific area has expired during the period or will expire in the near future, and is not expected to be renewed;

 

(ii)substantive expenditure on further exploration for and evaluation of mineral resources in the specific area is neither budgeted nor planned;

 

(iii)exploration for and evaluation of mineral resources in the specific area have not led to the discovery of commercially viable quantities of mineral resources and the entity has decided to discontinue such activities in the specific area; and

 

(iv)sufficient data exists to indicate that, although a development in the specific area is likely to proceed, the carrying amount of the exploration and evaluation assets is unlikely to be recovered in full from successful development or by sale.

 

 

An impairment charge may be reversed but only to the extent that this does not exceed the original carrying value of the property that would have resulted if no impairment had been recognized. General exploration costs in areas of interest in which the Company has not secured rights are expensed as incurred.

 

The recoverability of amounts shown for exploration and evaluation assets is dependent upon the discovery of economically recoverable reserves, the ability of the Company to obtain financing to complete development of the properties, and on future production or proceeds of disposition.

 

The Company recognizes in profit or loss costs recovered on exploration and evaluation assets when amounts received or receivable are in excess of the carrying amount.

 

Once the technical feasibility and commercial viability of the extraction of mineral resources in an area of interest are demonstrable, exploration and evaluation assets attributable to that area of interest are first tested for impairment and then reclassified to development asset within property, plant and equipment.

 

All capitalized exploration and evaluation expenditures are monitored for indications of impairment.

 

Where a potential impairment is indicated, assessments are performed for each area of interest. To the extent that exploration expenditure is not expected to be recovered, it is charged to profit or loss. Exploration areas where reserves have been discovered, but require major capital expenditure before production can begin, are continually evaluated to ensure that commercial quantities of reserves exist or to ensure that additional exploration work is underway as planned.

 

Impairment of property, plant and equipment

(g)       Impairment of property, plant and equipment

 

Property, plant and equipment are reviewed for impairment at least annually, or if there is any indication that the carrying amount may not be recoverable. If any such indication is present, the recoverable amount of the asset is estimated in order to determine whether impairment exists. Where the asset does not generate cash flows that are independent from other assets, the Company estimates the recoverable amount of the cash generating unit to which the asset belongs.

 

An asset’s recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value, using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset or cash generating unit is estimated to be less than its carrying amount, the carrying amount is reduced to the recoverable amount by way of recording an impairment charge to profit or loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously been recognized.

 

Income taxes

(h)       Income taxes

 

Income tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to items recognized directly in equity or in other comprehensive income.

 

Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted at the reporting date, and any adjustment to tax payable in respect of previous years.

 

Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss, and differences relating to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date.

 

Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously.

 

A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.

 

Share-based payments

(i)       Share-based payments

 

The Company’s stock option plan allows Company employees, directors, officers and consultants to acquire shares of the Company. The fair value of options granted is recognized as share-based payment expense with a corresponding increase in equity reserves. An individual is classified as an employee when the individual is an employee for legal or tax purposes (direct employee) or provides services similar to those performed by a direct employee.

 

Fair value is measured at grant date, and each tranche is recognized using the graded vesting method over the period during which the options vest. The fair value of the options granted is measured using the Black-Scholes option-pricing model, taking into account the terms and conditions upon which the options were granted. At each financial position reporting date, the amount recognized as an expense is adjusted to reflect the actual number of stock options that are expected to vest. In situations where equity instruments are issued to consultants and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received.

 

Share capital

(j)       Share capital

 

Proceeds from the exercise of stock options and warrants are recorded as share capital in the amount for which the option or warrant enabled the holder to purchase a share in the Company, in addition to the proportionate amount of reserves originally created at the issuance of the stock options or warrants. Share capital issued for non-monetary consideration is valued at the closing market price at the date of issuance. The proceeds from the issuance of units are allocated between common shares and common share purchase warrants based on the residual value method. Under this method, the proceeds are allocated to common shares based on the fair value of a common share at the announcement date of the unit offering and any residual remaining is allocated to common share purchase warrants.

 

Certain of the Company’s warrants are exercisable in a currency other than the functional currency of the Company. As a result, the fair value allocated to the warrant is recorded as a derivative financial liability with residual value being attributed to the equity unit. The fair value of the warrant is determined using the Black-Scholes Option Pricing Model and is marked to market at the end of each period. Upon exercise of the warrant, the fair value of the warrant at the date of exercise is transferred to share capital.

 

Reclamation and closure cost obligations

(k)       Reclamation and closure cost obligations

 

Decommissioning and restoration provisions are recorded when a present legal or constructive obligation exists as a result of past events where it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made.

 

The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation and discount rates. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows discounted for the market discount rate.

 

Over time, the discounted liability is increased for the changes in the present value based on the current market discount rates and liability risks. When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount receivable can be measured reliably.

 

When the Company enters into an option agreement on its exploration and evaluations assets, as part of the option agreement, responsibility for any reclamation and remediation becomes the responsibility of the optionee.

 

Net loss per share

(l)       Net loss per share

 

The Company presents the basic and diluted net loss per share data for its common shares, calculated by dividing the loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net loss per share is determined by adjusting the net loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all dilutive potential common shares (Note 12).

 

Leases

(m)       Leases

 

At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether the right to obtain substantially all of the economic benefits from use of the asset during the term of the arrangement exists, and if the Company has the right to direct the use of the asset. At inception or on reassessment of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of their relative standalone prices.

 

As a lessee, the Company recognizes a right-of-use asset and a lease liability at the commencement date of a lease. The right-of-use asset is initially measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received.

 

The right-of-use asset is subsequently depreciated using the straight line method from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. In addition, the right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability.

 

A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by the interest rate implicit in the lease, or if that rate cannot be readily determined, the incremental borrowing rate. Lease payments included in the measurement of the lease liability are comprised of:

 

·fixed payments, including in-substance fixed payments, less any lease incentives receivable;
·variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;
·amounts expected to be payable under a residual value guarantee;
·exercise prices of purchase options if the Company is reasonably certain to exercise that option; and
·payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease.

 

The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if there is a change in the estimate or assessment of the expected amount payable under a residual value guarantee, purchase, extension or termination option. Variable lease payments not included in the initial measurement of the lease liability are charged directly to profit or loss.

 

The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments associated with these leases are charged directly to profit or loss on a straight-line basis over the lease term.

 

Standards issued or amended but not yet effective

(n)       Standards issued or amended but not yet effective

 

The Company has not applied the following revised IFRS that has been issued but was not yet effective at December 31, 2023. This accounting standard is not currently expected to have a significant effect on the Company’s accounting policies or financial statements.

 

IAS 1 –Presentation of Financial Statements (“IAS 1”) was amended in January 2020 to provide a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments clarify that the classification of liabilities as current or noncurrent is based solely on a company’s right to defer settlement at the reporting date. The right needs to be unconditional and must have substance. The amendments also clarify that the transfer of a company’s own equity instruments is regarded as settlement of a liability, unless it results from the exercise of a conversion option meeting the definition of an equity instrument. These amendments were further revised by the issuance of Non-current Liabilities with Covenants (Amendments to IAS 1) on October 31, 2022 which further narrowed the scope of the amendments. The amendments are effective for annual periods beginning on January 1, 2024.

XML 44 R25.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Material accounting policies (Tables)
12 Months Ended
Dec. 31, 2023
Material Accounting Policies  
Schedule of consolidated financial statements
       
    Jurisdiction   Nature of operations
         
  Puebla Holdings Inc. Canada   Holding company
  Minera Gorrion, S.A. de C.V. Mexico   Exploration company
Schedule of property, plant and equipment
   
  Furniture, fixtures and other 20%
  Computer hardware and software 30%
  Geological library 20%
  Field equipment 20%
  Mill equipment Straight line over mine life (11 years)
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounts receivable and prepaid expenses (Tables)
12 Months Ended
Dec. 31, 2023
Accounts Receivable And Prepaid Expenses  
Schedule of accounts receivable and prepaid expenses
          
   December 31,   December 31, 
   2023   2022 
Accounts receivable (Note 11(b))  $389,895   $198,942 
Prepaid expenses   63,745    60,529 
 Total  $453,640   $259,471 
XML 46 R27.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Right-of-use assets and lease liabilities (Tables)
12 Months Ended
Dec. 31, 2023
Right-of-use Assets And Lease Liabilities  
Schedule of continuity of lease liabilities
          
   December 31,
2023
   December 31,
2022
 
Opening balance  $465,930   $548,607 
Less: lease payments   (127,797)   (130,056)
Interest expense   39,502    47,379 
    377,635    465,930 
Less: current portion of lease liabilities   (100,531)   (88,295)
Long-term portion of lease liabilities  $277,104   $377,635 
Schedule of continuity of ROU assets
          
   December 31,
2023
   December 31,
2022
 
Opening balance  $432,319   $539,110 
Less: amortization of ROU assets   (101,722)   (106,791)
   $330,597   $432,319 
Schedule of remaining payments for the operating lease
                        
   2024   2025   2026   2027   2028   Total 
Office lease  $170,672   $173,970   $177,268   $44,523    -   $566,433 
XML 47 R28.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, plant and equipment (Tables)
12 Months Ended
Dec. 31, 2023
Property Plant And Equipment  
Schedule of property, plant and equipment
                                   
   Furniture
and fixtures
and other
   Computer
hardware
   Computer
software
   Geological
library
   Field
equipment
   Mill
equipment
   Total 
   $   $   $   $   $   $   $ 
Cost                            
December 31, 2022   159,171    271,540    198,981    51,760    245,647    6,568,841    7,495,940 
Additions   1,770    267    -    -    -    -    2,037 
Impairment of property, plant and equipment   -    -    -    -    -    -    - 
December 31, 2023   160,941    271,807    198,981    51,760    245,647    6,568,841    7,497,977 
                                    
Accumulated depreciation                                   
December 31, 2022   153,203    251,441    192,138    50,975    237,312    -    885,069 
Depreciation   1,223    6,066    2,053    157    1,667    -    11,166 
December 31, 2023   154,426    257,507    194,191    51,132    238,979    -    896,235 
                                    
Carrying amounts                                   
December 31, 2022   5,968    20,099    6,843    785    8,335    6,568,841    6,610,871 
December 31, 2023   6,515    14,300    4,790    628    6,668    6,568,841    6,601,742 

 

   Furniture
and fixtures
and other
   Computer
hardware
   Computer
software
   Geological
library
   Field
equipment
   Mill
equipment
   Total 
   $   $   $   $   $   $   $ 
Cost                            
December 31, 2021   158,219    267,004    198,981    51,760    245,647    13,968,566    14,890,177 
Additions   952    4,536    -    -    -    41,568    47,056 
Impairment of property, plant and equipment   -    -    -    -    -    (7,441,293)   (7,441,293)
December 31, 2022   159,171    271,540    198,981    51,760    245,647    6,568,841    7,495,940 
                                    
Accumulated depreciation                                   
December 31, 2021   151,390    244,043    189,206    50,779    235,227    -    870,645 
Depreciation   1,813    7,398    2,932    196    2,085    -    14,424 
December 31, 2022   153,203    251,441    192,138    50,975    237,312    -    885,069 
                                    
Carrying amounts                                   
December 31, 2021   6,829    22,961    9,775    981    10,420    13,968,566    14,019,532 
December 31, 2022   5,968    20,099    6,843    785    8,335    6,568,841    6,610,871 
XML 48 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Exploration and evaluation assets (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of exploration and evaluation assets
               
   Tuligtic   Other Property   Total 
Exploration and evaluation assets  $   $   $ 
Acquisition costs:               
Opening balance - (December 31, 2022)   11,308,721    -    11,308,721 
Additions   -    -    - 
Deductions   -    -    - 
Impairment of acquisition costs   (11,308,720)   -    (11,308,720)
Closing balance - (December 31, 2023)   1    -    1 
Deferred exploration costs:               
Opening balance - (December 31, 2022)   51,806,355    -    51,806,355 
Costs incurred during the year               
Professional/technical fees   159,031    -    159,031 
Geochemical, metallurgy   1,022    -    1,022 
Travel and accommodation   70,324    -    70,324 
Geology, geophysics and exploration   172,455    -    172,455 
Supplies and miscellaneous   318,047    -    318,047 
Environmental and permit   384,421    -    384,421 
Value-added tax (Note 4)   164,189         164,189 
Refund - Value-added tax   (561,086)   -    (561,086)
Impairment of deferred exploration cost   (52,514,758)   -    (52,514,758)
Total deferred exploration costs during the year   (51,806,355)   -    (51,806,355)
Closing balance - (December 31, 2023)   -    -    - 
Total exploration and evaluation assets   1    -    1 

 

During the year ended December 31, 2023, the Company recorded an impairment of acquisition cost of $11,308,720 (2022 - $Nil) and deferred exploration costs of $52,514,758 (2022 - $Nil) with respect to Tuligtic property due to the Mexican government’s action to revoke the Company’s mineral concession title and to prevent any further exploration and development plans on the Tuligtic property.

 

Title to exploration and evaluation assets involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the potential for problems arising from the frequently ambiguous conveyancing history characteristic of many mineral claims.

 

   Tuligtic   Other Property   Total 
Exploration and evaluation assets  $   $   $ 
Acquisition costs:               
Opening balance - (December 31, 2021)   11,211,756    1    11,211,757 
Additions   96,965    -    96,965 
Deductions   -    (1)   (1)
Closing balance - (December 31, 2022)   11,308,721    -    11,308,721 
Deferred exploration costs:               
Opening balance - (December 31, 2021)   50,219,882    -    50,219,882 
Costs incurred during the year               
Professional/technical fees   143,075    -    143,075 
Claim maintenance/lease costs   169,651    -    169,651 
Geochemical, metallurgy   3,929    -    3,929 
Travel and accommodation   155,195    -    155,195 
Geology, geophysics and exploration   307,712    -    307,712 
Supplies and miscellaneous   310,804    -    310,804 
Environmental and permit   640,541    -    640,541 
Value-added tax (Note 4)   251,775         251,775 
Refund - Value-added tax   (396,209)   -    (396,209)
Total deferred exploration costs during the year   1,586,473    -    1,586,473 
Closing balance - (December 31, 2022)   51,806,355    -    51,806,355 
Total exploration and evaluation assets   63,115,076    -    63,115,076 
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gold loan payable and gold in trust (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of gold loan payable
          
   December 31,
2023
   December 31,
2022
 
Gold loan payable – opening balance  $3,929,015   $3,227,545 
Accrued interest expense   353,372    314,024 
Accrued standby fees   10,377    9,416 
Accretion expense   176,960    144,868 
Foreign exchange difference   (98,178)   233,162 
Gold loan payable  $4,371,546   $3,929,015 
           
Derivative financial liabilities – opening balance  $306,084   $391,620 
Change in fair value through profit & loss   (191,732)   (110,177)
Foreign exchange difference   (5,522)   24,641 
Derivative financial liabilities  $108,830   $306,084 
Schedule of gold in trust
                    
   December 31, 2023   December 31, 2022 
   Ounces   $   Ounces   $ 
Gold in trust, opening balance   397    974,397    397    915,995 
Sale of gold in trust   -    -    -    - 
Gain on sale   -    -    -    - 
Change in fair value through profit & loss   -    132,895    -    (6,518)
Foreign exchange difference   0    (24,491)   0    64,920 
    397    1,082,801    397    974,397 
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Warrant liability (Tables)
12 Months Ended
Dec. 31, 2023
Warrant Liability  
Schedule of warrant assumptions
     
  Risk-free interest rate 0.53%  
  Expected life of warrants 3.00 years  
  Expected annualized volatility 72.42%  
  Dividend Nil  
  Forfeiture rate 0%  
Schedule of derivative financial liability
          
   December 31, 2023   December 31, 2022 
Risk-free interest rate   3.91%   3.99%
Expected life of warrants   0.21 years    1.21 years 
Expected annualized volatility   36.25%   69.83%
Dividend   Nil    Nil 
Forfeiture rate   0%   0%
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share capital and reserves (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of Continuity of Warrants
                              
   Exercise   December 31,               December 31, 
Expiry date  price   2022   Issued   Exercised   Expired   2023 
March 27, 2023   $0.50    5,489,658    -    -    (5,489,658)   - 
August 6, 2023   $0.90    3,100,000    -    -    (3,100,000)   - 
March 18, 2024   USD$0.80    7,923,077    -    -    -    7,923,077 
March 18, 2024   USD$0.80    435,769    -    -    -    435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        17,448,504    -    -    (8,589,658)   8,858,846 
Weighted average exercise price       $0.88    -    -   $0.64   $1.08 

 

The weighted average remaining life of warrants outstanding at December 31, 2023 was 0.22 years (2022 – 0.80 years).

 

   Exercise   December 31,               December 31, 
Expiry date  price   2021   Issued   Exercised   Expired   2022 
June 7, 2022   $1.35    4,720,000    -    -    (4,720,000)   - 
March 27, 2023   $0.50    5,489,658    -    -    -    5,489,658 
August 6, 2023   $0.90    3,100,000    -    -    -    3,100,000 
March 18, 2024   USD$0.80    7,923,077    -    -    -    7,923,077 
March 18, 2024   USD$0.80    435,769    -    -    -    435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        22,168,504    -    -    (4,720,000)   17,448,504 
Weighted average exercise price       $0.95    -    -   $1.35   $0.88 

 

The weighted average remaining life of warrants outstanding at December 31, 2022 was 0.80 years (2021 – 1.51 years).

 

   Exercise   December 31,               December 31, 
Expiry date  price   2020   Issued   Exercised   Expired   2021 
June 7, 2022   $1.35    4,720,000    -    -    -    4,720,000 
March 27, 2023   $0.50    5,489,658    -    -    -    5,489,658 
August 6, 2023   $0.90    3,100,000    -    -    -    3,100,000 
March 18, 2024   USD$0.80    -    7,923,077    -    -    7,923,077 
March 18, 2024   USD$0.80    -    435,769              435,769 
May 14, 2024   $1.50    500,000    -    -    -    500,000 
Warrants outstanding and exercisable        13,809,658    8,358,846    -    -    22,168,504 
Weighted average exercise price       $0.92   $1.00    -    -   $0.95 

 

The weighted average remaining life of warrants outstanding at December 31, 2021 was 1.51 years (2020 – 2.08 years).

Schedule of -Warrant Fair Value Assumptions
           
Number of
warrants
Date of issue Fair value
per share
Risk free
interest
rate

Expected life

(in years)

Expected
volatility
Expected
dividends
435,769 March 18, 2021 $ 0.30 0.53% 3 72.42% $Nil
Schedule of Share options
                              
Expiry date  Exercise
price
   December 31,
2022
   Granted   Exercised   Expired   December 31,
2023
 
February 9, 2023  $0.97    350,000    -    -    (350,000)   - 
March 3, 2023  $0.96    250,000    -    -    (250,000)   - 
March 31, 2023  $0.68    1,975,000    -    -    (1,975,000)   - 
May 8, 2023  $0.69    100,000    -    -    (100,000)   - 
May 28, 2023  $0.65    100,000    -    -    (100,000)   - 
July 8, 2023  $0.62    2,420,000    -    -    (2,420,000)   - 
September 18, 2023  $0.51    960,000    -    -    (960,000)   - 
March 7, 2027  $0.38    1,125,000    -    -    -    1,125,000 
June 10, 2027  $0.33    3,640,000    -    -    -    3,640,000 
October 4, 2027  $0.30    755,000    -    -    -    755,000 
December 16, 2027  $0.33    855,000    -    -    -    855,000 
February 14, 2028  $0.30    -    600,000    -    -    600,000 
April 3, 2028  $0.26    -    1,975,000    -    -    1,975,000 
July 10, 2028  $0.16    -    2,520,000    -    -    2,520,000 
September 19, 2028  $0.18    -    1,035,000    -    -    1,035,000 
Options outstanding and exercisable        12,530,000    6,130,000    -    (6,155,000)   12,505,000 
Weighted average exercise price       $0.49   $0.21    -   $0.66   $0.27 

 

The weighted average remaining life of stock options outstanding at December 31, 2023 was 3.96 years (2022 – 2.53 years).

Expiry date  Exercise
price
   December 31,
2021
   Granted   Exercised   Expired   December 31,
2022
 
March 4, 2022  $0.47    1,125,000    -    -    (1,125,000)   - 
April 30, 2022  $0.41    100,000    -    -    (100,000)   - 
April 30, 2022  $0.58    220,000    -    -    (220,000)   - 
May 31, 2022  $0.62    600,000    -    -    (600,000)   - 
June 9, 2022  $0.64    1,980,000    -    -    (1,980,000)   - 
October 3, 2022  $1.13    860,000    -    -    (860,000)   - 
December 15, 2022  $0.89    900,000    -    -    (900,000)   - 
February 9, 2023  $0.97    350,000    -    -    -    350,000 
March 3, 2023  $0.96    250,000    -    -    -    250,000 
March 31, 2023  $0.68    1,975,000    -    -    -    1,975,000 
May 8, 2023  $0.69    100,000    -    -    -    100,000 
May 28, 2023  $0.65    100,000    -    -    -    100,000 
July 8, 2023  $0.62    2,470,000    -    -    (50,000)   2,420,000 
September 18, 2023  $0.51    960,000    -    -    -    960,000 
March 7, 2027  $0.38    -    1,125,000    -    -    1,125,000 
June 10, 2027  $0.33    -    3,640,000    -    -    3,640,000 
October 4, 2027  $0.30    -    755,000    -    -    755,000 
December 16, 2027  $0.33    -    855,000    -    -    855,000 
Options outstanding and exercisable        11,990,000    6,375,000    -    (5,835,000)   12,530,000 
Weighted average exercise price       $0.68   $0.34    -   $0.71   $0.49 

 

The weighted average remaining life of stock options outstanding at December 31, 2022 was 2.53 years (2021 – 0.98 years).

 

 

Expiry date  Exercise
price
   December 31,
2020
   Granted   Exercised   Expired   December 31,
2021
 
February 7, 2021  $1.11    300,000    -    -    (300,000)   - 
February 7, 2021  $0.84    425,000    -    (375,000)   (50,000)   - 
March 29, 2021  $1.08    400,000    -    -    (400,000)   - 
March 29, 2021  $0.90    100,000    -    -    (100,000)   - 
May 6, 2021  $0.69    557,000    -    (275,000)   (282,000)   - 
July 7, 2021  $0.80    1,612,000    -    (75,000)   (1,537,000)   - 
August 13, 2021  $1.01    150,000    -    -    (150,000)   - 
September 16, 2021  $0.90    1,155,000    -    -    (1,155,000)   - 
December 12, 2021  $1.00    200,000    -    -    (200,000)   - 
March 4, 2022  $0.47    1,125,000    -    -    -    1,125,000 
April 30, 2022  $0.41    100,000    -    -    -    100,000 
April 30, 2022  $0.58    220,000    -    -    -    220,000 
May 31, 2022  $0.62    700,000    -    -    (100,000)   600,000 
June 9, 2022  $0.64    2,180,000    -    -    (200,000)   1,980,000 
October 3, 2022  $1.13    1,346,000    -    -    (486,000)   860,000 
December 15, 2022  $0.89    972,000    -    -    (72,000)   900,000 
February 9, 2023  $0.97    -    450,000    -    (100,000)   350,000 
March 3, 2023  $0.96    -    325,000    -    (75,000)   250,000 
March 31, 2023  $0.68    -    1,975,000    -    -    1,975,000 
May 8, 2023  $0.69    -    100,000    -    -    100,000 
May 28, 2023  $0.65    -    100,000    -    -    100,000 
July 8, 2023  $0.62    -    2,470,000    -    -    2,470,000 
September 18, 2023  $0.51    -    960,000    -    -    960,000 
Options outstanding and exercisable        11,542,000    6,380,000    (725,000)   (5,207,000)   11,990,000 
Weighted average exercise price       $0.80   $0.67   $0.78   $0.90   $0.68 

 

The weighted average remaining life of stock options outstanding at December 31, 2021 was 0.98 years (2020 – 1.08 years).

Schedule of share option fair value assumptions
                            
Number
of options
   Date of grant  Fair value
per share
   Risk free
interest
rate
   Expected
life
(in years)
   Expected
volatility
   Expected
dividends
1,035,000   September 19, 2023  $0.10    3.96%   5    71.15%  $Nil
2,520,000   July 10, 2023  $0.12    3.81%   5    70.98%  $Nil
1,975,000   April 3, 2023  $0.15    2.87%   5    68.52%  $Nil
600,000   February 13, 2023  $0.18    3.43%   5    68.61%  $Nil
855,000   December 16, 2022  $0.19    3.07%   5    66.04%  $Nil
755,000   October 4, 2022  $0.22    3.42%   5    82.02%  $Nil
3,640,000   June 10, 2022  $0.22    3.38%   5    82.61%  $Nil
1,125,000   March 7, 2022  $0.31    1.65%   5    85.37%  $Nil
960,000   September 17, 2021  $0.23    0.45%   2    82.96%  $Nil
2,470,000   July 8, 2021  $0.25    0.45%   2    84.98%  $Nil
100,000   May 28, 2021  $0.30    0.32%   2    86.03%  $Nil
100,000   May 7, 2021  $0.30    0.33%   2    86.33%  $Nil
1,975,000   March 31, 2021  $0.31    0.22%   2    85.85%  $Nil
325,000   March 2, 2021  $0.43    0.26%   2    85.48%  $Nil
450,000   February 9, 2021  $0.49    0.19%   2    84.04%  $Nil
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related party transactions and balances (Tables)
12 Months Ended
Dec. 31, 2023
Related Party Transactions And Balances  
Schedule of related party payments
               
   December 31,   December 31,   December 31, 
   2023   2022   2021 
             
Professional fees  $50,588   $60,000   $60,000 
Salaries and benefits   398,307 (3)   484,435 (2)   450,522 (1)
Share-based payments   702,000    1,212,300    1,551,850 
Directors’ fees   140,000    145,000    102,500 
 Total  $1,290,895   $1,901,735   $2,164,872 

 

 (1)As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.
 (2)As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.
 (3)As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplemental cash flow information (Tables)
12 Months Ended
Dec. 31, 2023
Supplemental Cash Flow Information  
Schedule of supplemental information
               
Investing and financing activities  December 31,
2023
   December 31,
2022
   December 31,
2021
 
             
Exploration and evaluation assets expenditures included in trade and other payables   -   $90,850   $89,203 
Right-of-use assets   -    -    (508,799)
Warrant liability   -    -    2,371,174 
Fair value of finders’ warrants   -    -    130,731 
Lease liabilities   -    -    508,799 
Fair value of cash stock options transferred to share capital on exercise of options   -    -    177,250 
                
Schedule of supplemental information of cash and cash equivalents
          
   December 31,
2023
   December 31,
2022
 
         
Cash  $1,658,863   $1,542,956 
Term Deposits   2,587,120    5,115,120 
 Total cash and cash equivalents  $4,245,983   $6,658,076 
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes  
Schedule of deferred income taxes
               
   December 31,
2023
   December 31,
2022
   December 31,
2021
 
Loss before income taxes  $(66,710,410)  $(10,505,375)  $(2,354,113)
Statutory rate   27.00%   27.00%   27.00%
                
Expected income tax   (18,011,811)   (2,836,451)   (635,611)
Effect of different tax rates in foreign jurisdictions   (2,005,959)   (83,891)   5,281 
Non-deductible share-based payments   218,741    399,087    505,116 
Other permanent items   2,484,720    1,838,169    (620,413)
Change in deferred tax assets not recognized   15,403,428    2,471,723    733,447 
Share issuance costs   -    -    (331,660)
True-ups and other   (1,179,327)   (447,452)   657,981 
Deferred income tax (recovery) expense  $(3,090,208)  $1,341,185   $314,141 
Schedule of deferred tax assets and liabilities
          
   December 31,
2023
   December 31,
2022
 
         
Deferred tax assets          
Non-capital losses  $-   $2,477,570 
Exploration and evaluation assets   1,434,880    - 
    1,434,880    2,477,570 
Deferred tax liabilities          
Exploration and evaluation assets   (1,434,880)   (5,567,778)
           
Net deferred tax liabilities  $-   $(3,090,208)
Schedule of deductible temporary differences
          
   December 31,
2023
   December 31,
2022
 
         
Non-capital loss carry forwards  $32,616,394   $25,487,951 
Capital loss carry forwards   23,360,422    24,538,993 
Exploration and evaluation assets   39,102,815    8,188,922 
Share issue costs   551,134    858,548 
Property, plant and equipment   7,748,032    7,782,024 
Donations   32,960    32,960 
Investment tax credit   223,873    223,873 
   $103,635,630   $67,113,271 
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial instruments (Tables)
12 Months Ended
Dec. 31, 2023
Notes and other explanatory information [abstract]  
Schedule of assets and liabilities
          
All amounts in Canadian dollars  US dollar   Mexican peso 
Cash and cash equivalents  $2,343,681   $458,149 
Accounts receivable and prepaid expenses   4,703    113 
Gold in trust   1,082,801    - 
Total assets  $3,431,185   $458,262 
           
Trade and other payables  $53,348   $14,087 
Gold loan payable   4,371,546    - 
Derivative financial liabilities   108,830    - 
Total liabilities  $4,533,724   $14,087 
           
Net assets  $(1,102,539)  $444,175 
Schedule of assets and liabilities at fair value
                    
   Level 1   Level 2   Level 3   Total 
    $    $    $    $ 
Derivative financial liabilities   -    108,830    -    108,830 
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segmented information (Tables)
12 Months Ended
Dec. 31, 2023
Segmented Information  
Schedule of non-current Assets
          
   December 31,
2023
   December 31,
2022
 
Canada  $361,967   $472,435 
United States   6,568,840    6,568,840 
Mexico   1,533    63,116,991 
   $6,932,340   $70,158,266 
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Nature of operations (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Working capital surplus $ 4,830,735 $ 7,463,140  
Net loss 63,620,232 11,846,560 $ 2,668,254
Negative cash flows from operations 1,483,006 1,653,398 $ 1,600,250
Accumulated deficit $ 157,391,582 $ 93,771,350  
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Material accounting policies (Details)
12 Months Ended
Dec. 31, 2023
Puebla Holdings Inc. [Member]  
IfrsStatementLineItems [Line Items]  
Entity name Puebla Holdings Inc.
Jurisdiction Canada
Nature of operations Holding company
Minera Gorrion, S.A. de C.V. [Member]  
IfrsStatementLineItems [Line Items]  
Entity name Minera Gorrion, S.A. de C.V.
Jurisdiction Mexico
Nature of operations Exploration company
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Material accounting policies (Details 1)
12 Months Ended
Dec. 31, 2023
Furniture, fixtures and fittings [member]  
IfrsStatementLineItems [Line Items]  
Property, plant and equipment 20.00%
Computer equipment [member]  
IfrsStatementLineItems [Line Items]  
Property, plant and equipment 30.00%
Geological library [member]  
IfrsStatementLineItems [Line Items]  
Property, plant and equipment 20.00%
Field equipment [member]  
IfrsStatementLineItems [Line Items]  
Property, plant and equipment 20.00%
Mill Equipment [Member]  
IfrsStatementLineItems [Line Items]  
Property, plant and equipment Straight line over mine life (11 years)
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounts receivable and prepaid expenses (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Accounts Receivable And Prepaid Expenses    
Accounts receivable (Note 11(b)) $ 389,895 $ 198,942
Prepaid expenses 63,745 60,529
 Total $ 453,640 $ 259,471
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accounts receivable and prepaid expenses (Details Narrative) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Tuligtic Project [Member]    
IfrsStatementLineItems [Line Items]    
Value added tax receivables $ 164,189 $ 251,775
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Right-of-use assets and lease liabilities (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Right-of-use Assets And Lease Liabilities      
Opening balance $ 465,930 $ 548,607  
Less: lease payments (127,797) (130,056)  
Interest expense 39,502 47,379 $ 13,330
Ending balance 377,635 465,930 $ 548,607
Less: current portion of lease liabilities (100,531) (88,295)  
Long-term portion of lease liabilities $ 277,104 $ 377,635  
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Right-of-use assets and lease liabilities (Details 1) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Right-of-use Assets And Lease Liabilities      
Opening balance $ 432,319 $ 539,110  
Less: amortization of ROU assets (101,722) (106,791) $ (121,479)
Ending balance $ 330,597 $ 432,319 $ 539,110
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Right-of-use assets and lease liabilities (Details 2)
Dec. 31, 2023
CAD ($)
IfrsStatementLineItems [Line Items]  
Remaining payments for office lease $ 566,433
Not later than one year [member]  
IfrsStatementLineItems [Line Items]  
Remaining payments for office lease 170,672
Later than one year and not later than two years [member]  
IfrsStatementLineItems [Line Items]  
Remaining payments for office lease 173,970
Later than two years and not later than three years [member]  
IfrsStatementLineItems [Line Items]  
Remaining payments for office lease 177,268
Later than three years and not later than four years [member]  
IfrsStatementLineItems [Line Items]  
Remaining payments for office lease 44,523
Later than four years and not later than five years [member]  
IfrsStatementLineItems [Line Items]  
Remaining payments for office lease
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Right-of-use assets and lease liabilities (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Right-of-use Assets And Lease Liabilities      
Increase in lease liability $ 508,799    
Operating sublease income 0 $ 8,508 $ 22,452
Occupancy expense $ 39,858 $ 42,655 $ 40,542
XML 66 R47.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, plant and equipment (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]      
Carrying amounts $ 6,601,742 $ 6,610,871 $ 14,019,532
Computer software [member]      
IfrsStatementLineItems [Line Items]      
Carrying amounts 4,790 6,843 9,775
Furniture, fixtures and fittings [member]      
IfrsStatementLineItems [Line Items]      
Carrying amounts 6,515 5,968 6,829
Computer equipment [member]      
IfrsStatementLineItems [Line Items]      
Carrying amounts 14,300 20,099 22,961
Geological library [member]      
IfrsStatementLineItems [Line Items]      
Carrying amounts 628 785 981
Field equipment [member]      
IfrsStatementLineItems [Line Items]      
Carrying amounts 6,668 8,335 10,420
Mill Equipment [Member]      
IfrsStatementLineItems [Line Items]      
Carrying amounts 6,568,841 6,568,841 $ 13,968,566
Gross carrying amount [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, cost 7,495,940 14,890,177  
Additions/reduction (1) 2,037 47,056  
Impairment of property, plant and equipment (7,441,293)  
Balance at ending, cost 7,497,977 7,495,940  
Gross carrying amount [member] | Computer software [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, cost 198,981 198,981  
Additions/reduction (1)  
Impairment of property, plant and equipment  
Balance at ending, cost 198,981 198,981  
Gross carrying amount [member] | Furniture, fixtures and fittings [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, cost 159,171 158,219  
Additions/reduction (1) 1,770 952  
Impairment of property, plant and equipment  
Balance at ending, cost 160,941 159,171  
Gross carrying amount [member] | Computer equipment [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, cost 271,540 267,004  
Additions/reduction (1) 267 4,536  
Impairment of property, plant and equipment  
Balance at ending, cost 271,807 271,540  
Gross carrying amount [member] | Geological library [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, cost 51,760 51,760  
Additions/reduction (1)  
Impairment of property, plant and equipment  
Balance at ending, cost 51,760 51,760  
Gross carrying amount [member] | Field equipment [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, cost 245,647 245,647  
Additions/reduction (1)  
Impairment of property, plant and equipment  
Balance at ending, cost 245,647 245,647  
Gross carrying amount [member] | Mill Equipment [Member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, cost 6,568,841 13,968,566  
Additions/reduction (1) 41,568  
Impairment of property, plant and equipment (7,441,293)  
Balance at ending, cost 6,568,841 6,568,841  
Accumulated depreciation, amortisation and impairment [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, accumulated depreciation 885,069 870,645  
Depreciation 11,166 14,424  
Balance at ending, accumulated depreciation 896,235 885,069  
Accumulated depreciation, amortisation and impairment [member] | Computer software [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, accumulated depreciation 192,138 189,206  
Depreciation 2,053 2,932  
Balance at ending, accumulated depreciation 194,191 192,138  
Accumulated depreciation, amortisation and impairment [member] | Furniture, fixtures and fittings [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, accumulated depreciation 153,203 151,390  
Depreciation 1,223 1,813  
Balance at ending, accumulated depreciation 154,426 153,203  
Accumulated depreciation, amortisation and impairment [member] | Computer equipment [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, accumulated depreciation 251,441 244,043  
Depreciation 6,066 7,398  
Balance at ending, accumulated depreciation 257,507 251,441  
Accumulated depreciation, amortisation and impairment [member] | Geological library [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, accumulated depreciation 50,975 50,779  
Depreciation 157 196  
Balance at ending, accumulated depreciation 51,132 50,975  
Accumulated depreciation, amortisation and impairment [member] | Field equipment [member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, accumulated depreciation 237,312 235,227  
Depreciation 1,667 2,085  
Balance at ending, accumulated depreciation 238,979 237,312  
Accumulated depreciation, amortisation and impairment [member] | Mill Equipment [Member]      
IfrsStatementLineItems [Line Items]      
Balance at beginning, accumulated depreciation  
Depreciation  
Balance at ending, accumulated depreciation  
XML 67 R48.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Property, plant and equipment (Details Narrative)
12 Months Ended
Dec. 31, 2022
CAD ($)
Property Plant And Equipment  
Impairment on mill equipment $ 7,441,293
XML 68 R49.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Exploration and evaluation assets (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Opening balance $ 11,308,721 $ 11,211,757
Additions 96,965
Deductions (1)
Impairment of acquisition costs (11,308,720)  
Closing balance 1 11,308,721
Opening balance 51,806,355 50,219,882
Professional/technical fees 159,031 143,075
Claim maintenance/lease costs   169,651
Geochemical, metallurgy 1,022 3,929
Travel and accommodation 70,324 155,195
Geology, geophysics and exploration 172,455 307,712
Supplies and miscellaneous 318,047 310,804
Environmental and permit 384,421 640,541
Value-added tax (Note 4) 164,189 251,775
Refund - Value-added tax (561,086) (396,209)
Impairment of deferred exploration cost (52,514,758)  
Total deferred exploration costs during the year (51,806,355) 1,586,473
Closing balance 51,806,355
Total exploration and evaluation assets 1 63,115,076
Tuligtic [Member]    
IfrsStatementLineItems [Line Items]    
Opening balance 11,308,721 11,211,756
Additions 96,965
Deductions
Impairment of acquisition costs (11,308,720) 0
Closing balance 1 11,308,721
Opening balance 51,806,355 50,219,882
Professional/technical fees 159,031 143,075
Claim maintenance/lease costs   169,651
Geochemical, metallurgy 1,022 3,929
Travel and accommodation 70,324 155,195
Geology, geophysics and exploration 172,455 307,712
Supplies and miscellaneous 318,047 310,804
Environmental and permit 384,421 640,541
Value-added tax (Note 4) 164,189 251,775
Refund - Value-added tax (561,086) (396,209)
Impairment of deferred exploration cost (52,514,758) 0
Total deferred exploration costs during the year (51,806,355) 1,586,473
Closing balance 51,806,355
Total exploration and evaluation assets 1 63,115,076
Other property, plant and equipment [member]    
IfrsStatementLineItems [Line Items]    
Opening balance 1
Additions
Deductions (1)
Impairment of acquisition costs  
Closing balance
Opening balance
Professional/technical fees
Claim maintenance/lease costs  
Geochemical, metallurgy
Travel and accommodation
Geology, geophysics and exploration
Supplies and miscellaneous
Environmental and permit
Refund - Value-added tax
Impairment of deferred exploration cost  
Total deferred exploration costs during the year
Closing balance
Total exploration and evaluation assets
XML 69 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Exploration and evaluation assets (Details Narrative) - CAD ($)
12 Months Ended
May 26, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
IfrsStatementLineItems [Line Items]        
Impairment of acquisition costs   $ 11,308,720    
Impairment of deferred exploration cost   52,514,758    
VAT recovery   561,086 $ 396,209 $ 506,394
VAT refund from prior years   173,876 139,313 $ 446,184
Tuligtic [Member]        
IfrsStatementLineItems [Line Items]        
Impairment of acquisition costs   11,308,720 0  
Impairment of deferred exploration cost   $ 52,514,758 $ 0  
Logan Property Located In The Yukon Territory Canada [Member]        
IfrsStatementLineItems [Line Items]        
Proportion of ownership interest in associate 40.00%      
Carrying value of property $ 1      
XML 70 R51.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gold loan payable and gold in trust (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Gold Loan Derivative Instruments [Member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities, beginning balance $ 306,084 $ 391,620
Change in fair value through profit & loss (191,732) (110,177)
Foreign exchange difference (5,522) 24,641
Derivative financial liabilities, ending balance 108,830 306,084
Gold Loan [Member]    
IfrsStatementLineItems [Line Items]    
Gold loan payable, beginning balance 3,929,015 3,227,545
Accrued interest expense 353,372 314,024
Accrued standby fees 10,377 9,416
Accretion expense 176,960 144,868
Foreign exchange difference (98,178) 233,162
Gold loan payable, ending balance $ 4,371,546 $ 3,929,015
XML 71 R52.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gold loan payable and gold in trust (Details 1)
12 Months Ended
Dec. 31, 2023
CAD ($)
oz
Dec. 31, 2022
CAD ($)
oz
Dec. 31, 2021
CAD ($)
oz
IfrsStatementLineItems [Line Items]      
Gold in trust, amount $ 974,397    
Change in fair value through profit & loss, amount 132,895 $ (6,518) $ (35,775)
Gold in trust, amount $ 1,082,801 $ 974,397  
Gold Loan [Member]      
IfrsStatementLineItems [Line Items]      
Gold in trust, beginning balance, ounces | oz 397 397  
Gold in trust, amount $ 974,397 $ 915,995  
Sale of gold in trust, ounces | oz  
Sale of gold in trust, amount  
Gain on sale, amount  
Change in fair value through profit & loss, amount 132,895 (6,518)  
Foreign exchange difference, amount $ (24,491) $ 64,920  
Gold in trust, ending balance, ounces | oz 397 397 397
Gold in trust, amount $ 1,082,801 $ 974,397 $ 915,995
XML 72 R53.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Gold loan payable and gold in trust (Details Narrative)
12 Months Ended
May 14, 2019
USD ($)
Integer
shares
Dec. 31, 2023
CAD ($)
oz
Dec. 31, 2022
CAD ($)
oz
Dec. 31, 2021
CAD ($)
oz
May 14, 2019
CAD ($)
$ / shares
IfrsStatementLineItems [Line Items]          
Borrowings, metals, noncurrent   $ 4,371,546 $ 3,929,015    
Net gains (losses) on change in fair value of derivatives   191,732 110,177 $ (18,156)  
Trust assets, metals   $ 1,082,801 $ 974,397    
Gold Loan Derivative Instruments [Member]          
IfrsStatementLineItems [Line Items]          
Deriviative liability, assumptions, expected life (Year) 5 years 3 months 1 year 3 months    
Derivative liability, assumptions, risk-free interest rate 1.57% 4.00% 4.00%    
Derivative liability, assumptions, expected volatility 11.06% 9.93% 11.57%    
Net gains (losses) on change in fair value of derivatives   $ 191,732 $ 110,177    
Warrants [member]          
IfrsStatementLineItems [Line Items]          
Number of warrants issued (in shares) | shares 500,000        
Warrants, exercise price (in CAD per share) | $ / shares         $ 1.50
Warrants, fair value         $ 50,000
Warrants, valuation assumptions, expected life (Year) 5 years        
Risk free interest rate, warrants granted 1.54%        
Expected dividend, warrants granted 0.00%        
Description of expected volatility warrants granted 44.25%        
Gold Loan [Member]          
IfrsStatementLineItems [Line Items]          
Loan payable, ounces, loaned to company 1,597       1,597
Borrowings, metals, noncurrent $ 2,072,060       $ 2,790,858
Loan payable, extension period (Year) 2 years        
Loan payable, gold delivery payments per month, ounces | Integer 100        
Borrowings, interest rate 10.00%       10.00%
Borrowings, standby fee 1.00%       1.00%
Loans payable, ounces of gold | oz   397 397 397  
Trust assets, metals   $ 1,082,801 $ 974,397 $ 915,995  
XML 73 R54.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Warrant liability (Details) - Warrants [member]
12 Months Ended
Dec. 31, 2023
IfrsStatementLineItems [Line Items]  
Risk free interest rate 0.53%
Expected life of warrants 3 years
Expected annualized volatility 72.42%
Forfeiture rate 0.00%
XML 74 R55.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Warrant liability (Details 1) - Derivative Financial Liability [Member]
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Risk free interest rate 3.91% 3.99%
Expected life of warrants (in years) 2 months 15 days 1 year 2 months 15 days
Expected annualized volatility 36.25% 69.83%
Forfeiture rate 0.00% 0.00%
XML 75 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Warrant liability (Details Narrative) - Derivative Financial Liability [Member] - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Warrants exercisable 7,923,077  
Warrants exercisable share price $ 0.80  
Fair value of warrants $ 2,371,174  
Change in fair value of derivative financial liability $ 102,787 $ 520,503
XML 76 R57.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share capital and reserves (Details)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
$ / shares
Dec. 31, 2022
shares
$ / shares
$ / shares
Dec. 31, 2021
shares
$ / shares
$ / shares
Dec. 31, 2023
$ / shares
Dec. 31, 2022
$ / shares
Dec. 31, 2021
$ / shares
IfrsStatementLineItems [Line Items]            
Balance, outstanding and exercisable 17,448,504 22,168,504 13,809,658      
Issued, outstanding and exercisable (in shares) 8,358,846      
Exercised, outstanding and exercisable (in shares)      
Expired, outstanding and exercisable (in shares) (8,589,658) (4,720,000)      
Balance, oustanding and exercisable 8,858,846 17,448,504 22,168,504      
Balance, weighted average exercise price | $ / shares $ 0.88 $ 0.95 $ 0.92      
Issued, weighted average exercise price | $ / shares 1.00      
Exercised, weighted average exercise price | $ / shares      
Expired, weighted average exercise price | $ / shares 0.64 1.35      
Balance, weighted average exercise price | $ / shares $ 1.08 $ 0.88 $ 0.95      
Warrants Expiry [Member]            
IfrsStatementLineItems [Line Items]            
Expiry date Mar. 27, 2023 Mar. 27, 2023 Mar. 27, 2023      
Exercise price | $ / shares       $ 0.50 $ 0.50 $ 0.50
Balance 5,489,658 5,489,658 5,489,658      
Issued      
Exercised      
Issued (5,489,658)      
Balance 5,489,658 5,489,658      
Warrants Expiry One [Member]            
IfrsStatementLineItems [Line Items]            
Expiry date Aug. 06, 2023 Aug. 06, 2023 Aug. 06, 2023      
Exercise price | $ / shares       0.90 0.90 0.90
Balance 3,100,000 3,100,000 3,100,000      
Issued      
Exercised      
Issued (3,100,000)      
Balance 3,100,000 3,100,000      
Warrants Expiry Two [Member]            
IfrsStatementLineItems [Line Items]            
Expiry date Mar. 18, 2024 Mar. 18, 2024 Mar. 18, 2024      
Exercise price | $ / shares $ 0.80 $ 0.80 $ 0.80      
Balance 7,923,077 7,923,077      
Issued 7,923,077      
Exercised      
Issued      
Balance 7,923,077 7,923,077 7,923,077      
Warrants Expiry Three [Member]            
IfrsStatementLineItems [Line Items]            
Expiry date Mar. 18, 2024 Mar. 18, 2024 Mar. 18, 2024      
Exercise price | $ / shares $ 0.80 $ 0.80 $ 0.80      
Balance 435,769 435,769      
Issued 435,769      
Exercised        
Issued        
Balance 435,769 435,769 435,769      
Warrants Expiry Four [Member]            
IfrsStatementLineItems [Line Items]            
Expiry date May 14, 2024 May 14, 2024 May 14, 2024      
Exercise price | $ / shares       $ 1.50 1.50 1.50
Balance 500,000 500,000 500,000      
Issued      
Exercised      
Issued      
Balance 500,000 500,000 500,000      
Warrants Expiry Five [Member]            
IfrsStatementLineItems [Line Items]            
Expiry date   Jun. 07, 2022 Jun. 07, 2022      
Exercise price | $ / shares         $ 1.35 $ 1.35
Balance 4,720,000 4,720,000      
Issued        
Exercised        
Issued   (4,720,000)      
Balance   4,720,000      
XML 77 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share capital and reserves (Details 1) - Warrants Issued On March 182021 [Member]
12 Months Ended
Dec. 31, 2022
shares
$ / shares
IfrsStatementLineItems [Line Items]  
Number of warrants | shares 435,769
Fair value per share | $ / shares $ 0.30
Risk free interest rate 0.53%
Expected life (Year) 3 years
Expected volatility 72.42%
XML 78 R59.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share capital and reserves (Details 2)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Dec. 31, 2022
shares
$ / shares
Dec. 31, 2021
shares
$ / shares
IfrsStatementLineItems [Line Items]      
Stock options, balance, outstanding and exercisable (in shares) 12,530,000 11,990,000 11,542,000
Stock options, granted, outstanding and exercisable (in shares) 6,130,000 6,375,000 6,380,000
Stock options, exercised, outstanding and exercisable (in shares) (725,000)
Options outstanding and exercisable, expired (in shares) (6,155,000) (5,835,000) (5,207,000)
Stock options, balance, outstanding and exercisable (in shares) 12,505,000 12,530,000 11,990,000
Stock options, balance, weighted average exercise price | $ / shares $ 0.49 $ 0.68 $ 0.80
Weighted average exercise price, granted | $ / shares 0.21 0.34 0.67
Stock options, exercised, weighted average exercise price | $ / shares 0.78
Weighted average exercise price, expired | $ / shares 0.66 0.71 0.90
Stock options, balance, weighted average exercise price | $ / shares $ 0.27 $ 0.49 $ 0.68
Stock Options Expiry Date February 09, 2023 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Feb. 09, 2023 Feb. 09, 2023 Feb. 09, 2023
Stock Options, exercise price | $ / shares $ 0.97 $ 0.97 $ 0.97
Stock options, balance 350,000 350,000
Stock options, granted 450,000
Stock options, exercised
Stock options, expired (350,000) (100,000)
Stock options, balance 350,000 350,000
Stock Options Expiry Date March 3, 2023 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Mar. 03, 2023 Mar. 03, 2023 Mar. 03, 2023
Stock Options, exercise price | $ / shares $ 0.96 $ 0.96 $ 0.96
Stock options, balance 250,000 250,000
Stock options, granted 325,000
Stock options, exercised
Stock options, expired (250,000) (75,000)
Stock options, balance 250,000 250,000
Stock Options Expiry Date March 31, 2023 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Mar. 31, 2023 Mar. 31, 2023 Mar. 31, 2023
Stock Options, exercise price | $ / shares $ 0.68 $ 0.68 $ 0.68
Stock options, balance 1,975,000 1,975,000
Stock options, granted 1,975,000
Stock options, exercised
Stock options, expired (1,975,000)
Stock options, balance 1,975,000 1,975,000
Stock Option Expiry Date May 8, 2023 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date May 08, 2023 May 08, 2023 May 08, 2023
Stock Options, exercise price | $ / shares $ 0.69 $ 0.69 $ 0.69
Stock options, balance 100,000 100,000
Stock options, granted 100,000
Stock options, exercised
Stock options, expired (100,000)
Stock options, balance 100,000 100,000
Stock Option Expiry Date May 28, 2023 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date May 28, 2023 May 28, 2023 May 28, 2023
Stock Options, exercise price | $ / shares $ 0.65 $ 0.65 $ 0.65
Stock options, balance 100,000 100,000
Stock options, granted 100,000
Stock options, exercised
Stock options, expired (100,000)
Stock options, balance 100,000 100,000
Stock Option Expiry Date July 8, 2023 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Jul. 08, 2023 Jul. 08, 2023 Jul. 08, 2023
Stock Options, exercise price | $ / shares $ 0.62 $ 0.62 $ 0.62
Stock options, balance 2,420,000 2,470,000
Stock options, granted 2,470,000
Stock options, exercised
Stock options, expired (2,420,000) (50,000)
Stock options, balance 2,420,000 2,470,000
Stock Options Expiry Date September 18, 2023 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Sep. 18, 2023 Sep. 18, 2023 Sep. 18, 2023
Stock Options, exercise price | $ / shares $ 0.51 $ 0.51 $ 0.51
Stock options, balance 960,000 960,000
Stock options, granted 960,000
Stock options, exercised
Stock options, expired (960,000)
Stock options, balance 960,000 960,000
Stock Options Expiry Date March 7, 2027 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Mar. 07, 2027 Mar. 07, 2027  
Stock Options, exercise price | $ / shares $ 0.38 $ 0.38  
Stock options, balance 1,125,000  
Stock options, granted 1,125,000  
Stock options, exercised  
Stock options, expired  
Stock options, balance 1,125,000 1,125,000
Stock Options Expiry Date June 10, 2027 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Jun. 10, 2027 Jun. 10, 2027  
Stock Options, exercise price | $ / shares $ 0.33 $ 0.33  
Stock options, balance 3,640,000  
Stock options, granted 3,640,000  
Stock options, exercised  
Stock options, expired  
Stock options, balance 3,640,000 3,640,000
Stock Options Expiry Date October 4, 2027 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Oct. 04, 2027 Oct. 04, 2027  
Stock Options, exercise price | $ / shares $ 0.30 $ 0.30  
Stock options, balance 755,000  
Stock options, granted 755,000  
Stock options, exercised  
Stock options, expired  
Stock options, balance 755,000 755,000
Stock Options Expiry Date December 16, 2027 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Dec. 16, 2027 Dec. 16, 2027  
Stock Options, exercise price | $ / shares $ 0.33 $ 0.33  
Stock options, balance 855,000  
Stock options, granted 855,000  
Stock options, exercised  
Stock options, expired  
Stock options, balance 855,000 855,000
Stock Options Expiry Date February 14, 2028 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Feb. 14, 2028    
Stock Options, exercise price | $ / shares $ 0.30    
Stock options, balance    
Stock options, granted 600,000    
Stock options, exercised    
Stock options, expired    
Stock options, balance 600,000  
Stock Options Expiry Date April 3, 2028 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Apr. 03, 2028    
Stock Options, exercise price | $ / shares $ 0.26    
Stock options, balance    
Stock options, granted 1,975,000    
Stock options, exercised    
Stock options, expired    
Stock options, balance 1,975,000  
Stock Options Expiry Date July 10, 2028 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Jul. 10, 2028    
Stock Options, exercise price | $ / shares $ 0.16    
Stock options, balance    
Stock options, granted 2,520,000    
Stock options, exercised    
Stock options, expired    
Stock options, balance 2,520,000  
Stock Options Expiry Date September 19, 2028 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date Sep. 19, 2028    
Stock Options, exercise price | $ / shares $ 0.18    
Stock options, balance    
Stock options, granted 1,035,000    
Stock options, exercised    
Stock options, expired    
Stock options, balance 1,035,000  
Stock Options Expiry Date March 4, 2022 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date   Mar. 04, 2022 Mar. 04, 2022
Stock Options, exercise price | $ / shares   $ 0.47 $ 0.47
Stock options, balance 1,125,000 1,125,000
Stock options, granted  
Stock options, exercised  
Stock options, expired   (1,125,000)
Stock options, balance   1,125,000
Stock Options Expiry Date April 30, 2022 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date   Apr. 30, 2022 Apr. 30, 2022
Stock Options, exercise price | $ / shares   $ 0.41 $ 0.41
Stock options, balance 100,000 100,000
Stock options, granted  
Stock options, exercised  
Stock options, expired   (100,000)
Stock options, balance   100,000
Stock Options Expiry Date April 30, 2022 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date   Apr. 30, 2022 Apr. 30, 2022
Stock Options, exercise price | $ / shares   $ 0.58 $ 0.58
Stock options, balance 220,000 220,000
Stock options, granted  
Stock options, exercised  
Stock options, expired   (220,000)
Stock options, balance   220,000
Stock Options Expiry Date May 31, 2022 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date   May 31, 2022 May 31, 2022
Stock Options, exercise price | $ / shares   $ 0.62 $ 0.62
Stock options, balance 600,000 700,000
Stock options, granted  
Stock options, exercised  
Stock options, expired   (600,000) (100,000)
Stock options, balance   600,000
Stock Options Expiry Date June 9, 2022 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date   Jun. 09, 2022 Jun. 09, 2022
Stock Options, exercise price | $ / shares   $ 0.64 $ 0.64
Stock options, balance 1,980,000 2,180,000
Stock options, granted  
Stock options, exercised  
Stock options, expired   (1,980,000) (200,000)
Stock options, balance   1,980,000
Stock Options Expiry Date October 3, 2022 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date   Oct. 03, 2022 Oct. 03, 2022
Stock Options, exercise price | $ / shares   $ 1.13 $ 1.13
Stock options, balance 860,000 1,346,000
Stock options, granted  
Stock options, exercised  
Stock options, expired   (860,000) (486,000)
Stock options, balance   860,000
Stock Options Expiry Date December 15, 2022 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date   Dec. 15, 2022 Dec. 15, 2022
Stock Options, exercise price | $ / shares   $ 0.89 $ 0.89
Stock options, balance 900,000 972,000
Stock options, granted  
Stock options, exercised  
Stock options, expired   (900,000) (72,000)
Stock options, balance   900,000
Stock Options Expiry Date February 7, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     Feb. 07, 2021
Stock Options, exercise price | $ / shares     $ 1.11
Stock options, balance   300,000
Stock options, granted    
Stock options, exercised    
Stock options, expired     (300,000)
Stock options, balance    
Stock Options Expiry Date February 7, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     Feb. 07, 2021
Stock Options, exercise price | $ / shares     $ 0.84
Stock options, balance   425,000
Stock options, granted    
Stock options, exercised     (375,000)
Stock options, expired     (50,000)
Stock options, balance    
Stock Options Expiry Date March 29, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     Mar. 29, 2021
Stock Options, exercise price | $ / shares     $ 1.08
Stock options, balance   400,000
Stock options, granted    
Stock options, exercised    
Stock options, expired     (400,000)
Stock options, balance    
Stock Options Expiry Date March 29, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     Mar. 29, 2021
Stock Options, exercise price | $ / shares     $ 0.90
Stock options, balance   100,000
Stock options, granted    
Stock options, exercised    
Stock options, expired     (100,000)
Stock options, balance    
Stock Options Expiry Date May 6, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     May 06, 2021
Stock Options, exercise price | $ / shares     $ 0.69
Stock options, balance   557,000
Stock options, granted    
Stock options, exercised     (275,000)
Stock options, expired     (282,000)
Stock options, balance    
Stock Options Expiry Date July 7, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     Jul. 07, 2021
Stock Options, exercise price | $ / shares     $ 0.80
Stock options, balance   1,612,000
Stock options, granted    
Stock options, exercised     (75,000)
Stock options, expired     (1,537,000)
Stock options, balance    
Stock Options Expiry Date August 13, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     Aug. 13, 2021
Stock Options, exercise price | $ / shares     $ 1.01
Stock options, balance   150,000
Stock options, granted    
Stock options, exercised    
Stock options, expired     (150,000)
Stock options, balance    
Stock Options Expiry Date September 16, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     Sep. 16, 2021
Stock Options, exercise price | $ / shares     $ 0.90
Stock options, balance   1,155,000
Stock options, granted    
Stock options, exercised    
Stock options, expired     (1,155,000)
Stock options, balance    
Stock Options Expiry Date December 12, 2021 [Member]      
IfrsStatementLineItems [Line Items]      
Expiry date     Dec. 12, 2021
Stock Options, exercise price | $ / shares     $ 1.00
Stock options, balance   200,000
Stock options, granted    
Stock options, exercised    
Stock options, expired     (200,000)
Stock options, balance    
XML 79 R60.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share capital and reserves (Details 3)
12 Months Ended
Dec. 31, 2023
shares
$ / shares
Grant One [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 1,035,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.10
Risk free interest rate, stock options 3.96%
Expected life, stock options 5 years
Expected volatility, stock options 71.15%
Grant Two [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 2,520,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.12
Risk free interest rate, stock options 3.81%
Expected life, stock options 5 years
Expected volatility, stock options 70.98%
Grant Three [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 1,975,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.15
Risk free interest rate, stock options 2.87%
Expected life, stock options 5 years
Expected volatility, stock options 68.52%
Grant Four [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 600,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.18
Risk free interest rate, stock options 3.43%
Expected life, stock options 5 years
Expected volatility, stock options 68.61%
Grant Five [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 855,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.19
Risk free interest rate, stock options 3.07%
Expected life, stock options 5 years
Expected volatility, stock options 66.04%
Grant Six [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 755,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.22
Risk free interest rate, stock options 3.42%
Expected life, stock options 5 years
Expected volatility, stock options 82.02%
Grant Seven [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 3,640,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.22
Risk free interest rate, stock options 3.38%
Expected life, stock options 5 years
Expected volatility, stock options 82.61%
Grant Eight [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 1,125,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.31
Risk free interest rate, stock options 1.65%
Expected life, stock options 5 years
Expected volatility, stock options 85.37%
Grant Nine [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 960,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.23
Risk free interest rate, stock options 0.45%
Expected life, stock options 2 years
Expected volatility, stock options 82.96%
Grant Ten [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 2,470,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.25
Risk free interest rate, stock options 0.45%
Expected life, stock options 2 years
Expected volatility, stock options 84.98%
Grant Eleven [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 100,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.30
Risk free interest rate, stock options 0.32%
Expected life, stock options 2 years
Expected volatility, stock options 86.03%
Grant Twelve [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 100,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.30
Risk free interest rate, stock options 0.33%
Expected life, stock options 2 years
Expected volatility, stock options 86.33%
Grant Thirteen [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 1,975,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.31
Risk free interest rate, stock options 0.22%
Expected life, stock options 2 years
Expected volatility, stock options 85.85%
Grant Fourteen [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 325,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.43
Risk free interest rate, stock options 0.26%
Expected life, stock options 2 years
Expected volatility, stock options 85.48%
Grant Fifteen [Member]  
IfrsStatementLineItems [Line Items]  
Stock options, granted | shares 450,000
Fair value per share, stock options (in CAD per share) | $ / shares $ 0.49
Risk free interest rate, stock options 0.19%
Expected life, stock options 2 years
Expected volatility, stock options 84.04%
XML 80 R61.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share capital and reserves (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Notes and other explanatory information [abstract]        
Weighted average remaining contractual life of outstanding warrants (Year) 2 months 19 days 9 months 18 days 1 year 6 months 3 days 2 years 29 days
Stock options issuance limitations, maximum percentage of allowed issuable options   10.00%    
Stock options issuance limitations, maximum percentage of allowed issuable options for services rendered   2.00%    
Number of shares authorised (in shares)   1,217,141    
Stock option limitations, maximum amount of stock options exercisable during a 3 month period   25.00%    
Weighted average remaining contractual life of outstanding share options (Year) 3 years 11 months 15 days 2 years 6 months 10 days 11 months 23 days 1 year 29 days
Expense from share-based payment transactions with employees $ 810,150 $ 1,478,100 $ 1,870,800  
XML 81 R62.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related party transactions and balances (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Related Party Transactions And Balances      
Professional fees $ 50,588 $ 60,000 $ 60,000
Salaries and benefits 398,307 [1] 484,435 [2] 450,522 [3]
Share-based payments 702,000 1,212,300 1,551,850
Directors’ fees 140,000 145,000 102,500
 Total $ 1,290,895 $ 1,901,735 $ 2,164,872
[1] As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.
[2] As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.
[3] As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.
XML 82 R63.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related party transactions and balances (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Azucar [Member]      
IfrsStatementLineItems [Line Items]      
Administrative services fees included in other income $ 75,853 $ 185,068 $ 412,812
Amounts receivable, related party transactions 7,005 64,006  
Almadex [Member]      
IfrsStatementLineItems [Line Items]      
Administrative services fees included in other income 1,346,494 1,191,360 969,532
Amounts receivable, related party transactions 369,045 117,044  
Almadex [Member] | Drill Equipment [Member]      
IfrsStatementLineItems [Line Items]      
Outstanding commitments made on behalf of entity, related party transactions 0 80,727  
Chairmans Daughter [Member]      
IfrsStatementLineItems [Line Items]      
Related party, salary contracted $ 45,300 $ 48,800 $ 41,300
XML 83 R64.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Net loss per share (Details Narrative) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Notes and other explanatory information [abstract]      
Profit loss $ 63,620,232 $ 11,846,560 $ 2,668,254
Weighted average number of ordinary shares outstanding (in shares) 137,221,408 137,221,408 133,842,894
XML 84 R65.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplemental cash flow information (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Supplemental Cash Flow Information      
Exploration and evaluation assets expenditures included in trade and other payables $ 90,850 $ 89,203
Right-of-use assets (508,799)
Warrant liability 2,371,174
Fair value of finders’ warrants 130,731
Lease liabilities 508,799
Fair value of cash stock options transferred to share capital on exercise of options $ 177,250
XML 85 R66.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Supplemental cash flow information (Details 1) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Supplemental Cash Flow Information    
Cash $ 1,658,863 $ 1,542,956
Term Deposits 2,587,120 5,115,120
 Total cash and cash equivalents $ 4,245,983 $ 6,658,076
XML 86 R67.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details) - CAD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Taxes      
Loss before income taxes $ (66,710,410) $ (10,505,375) $ (2,354,113)
Statutory rate 27.00% 27.00% 27.00%
Expected income tax $ (18,011,811) $ (2,836,451) $ (635,611)
Effect of different tax rates in foreign jurisdictions (2,005,959) (83,891) 5,281
Non-deductible share-based payments 218,741 399,087 505,116
Other permanent items 2,484,720 1,838,169 (620,413)
Change in deferred tax assets not recognized 15,403,428 2,471,723 733,447
Share issuance costs (331,660)
True-ups and other (1,179,327) (447,452) 657,981
Deferred income tax (recovery) expense $ (3,090,208) $ 1,341,185 $ 314,141
XML 87 R68.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details 1) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Taxes    
Non-capital losses $ 2,477,570
Exploration and evaluation assets, deferred tax assets 1,434,880
Deferred tax assets 1,434,880 2,477,570
Exploration and evaluation assets, deferred tax liabilities (1,434,880) (5,567,778)
Net deferred tax liabilities $ (3,090,208)
XML 88 R69.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details 2) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Deductible temporary differences $ 103,635,630 $ 67,113,271
Noncapital Loss Carry Forwards [Member]    
IfrsStatementLineItems [Line Items]    
Deductible temporary differences 32,616,394 25,487,951
Capital Loss Carry Forwards [Member]    
IfrsStatementLineItems [Line Items]    
Deductible temporary differences 23,360,422 24,538,993
Exploration and Evaluation Assets [Member]    
IfrsStatementLineItems [Line Items]    
Deductible temporary differences 39,102,815 8,188,922
Share Issue Costs [Member]    
IfrsStatementLineItems [Line Items]    
Deductible temporary differences 551,134 858,548
Property, Plant and Equipment [Member]    
IfrsStatementLineItems [Line Items]    
Deductible temporary differences 7,748,032 7,782,024
Donations [Member]    
IfrsStatementLineItems [Line Items]    
Deductible temporary differences 32,960 32,960
Investment Tax Credit [Member]    
IfrsStatementLineItems [Line Items]    
Deductible temporary differences $ 223,873 $ 223,873
XML 89 R70.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Income Taxes (Details Narrative) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
Country Of Canada [Member]    
IfrsStatementLineItems [Line Items]    
Operating loss carryforwards $ 27,592,166 $ 25,487,951
Country Of Mexico [Member]    
IfrsStatementLineItems [Line Items]    
Operating loss carryforwards $ 4,588,699 $ 0
XML 90 R71.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial instruments (Details)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
CAD ($)
Dec. 31, 2023
MXN ($)
Dec. 31, 2022
CAD ($)
Dec. 31, 2021
CAD ($)
Dec. 31, 2020
CAD ($)
Notes and other explanatory information [abstract]            
Cash and cash equivalents $ 2,343,681 $ 4,245,983 $ 458,149 $ 6,658,076 $ 10,170,376 $ 2,534,698
Accounts receivable and prepaid expenses 4,703   113      
Gold in trust 1,082,801        
Total assets 3,431,185   458,262      
Trade and other payables 53,348 851,158 14,087 340,509    
Gold loan payable 4,371,546        
Derivatives financial liabilities 108,830        
Total liabilities 4,533,724 14,087 $ 102,787    
Net assets $ (1,102,539)   $ 444,175      
XML 91 R72.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial instruments (Details 1) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities $ 108,830 $ 306,084
Level 1 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities  
Level 2 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities 108,830  
Level 3 of fair value hierarchy [member]    
IfrsStatementLineItems [Line Items]    
Derivative financial liabilities  
XML 92 R73.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Financial instruments (Details Narrative)
12 Months Ended
Dec. 31, 2023
CAD ($)
Notes and other explanatory information [abstract]  
Possible effect of 10% change in exchange rate regarding the USD to the net income (loss) $ 110,000
Possible effect of 10% change in exchange rate regarding the MXN to the net income (loss) 44,000
Possible effect of 1% change in the interest rate to the net income (loss) 42,000
Possible effect of 1% change in the commodity price to the net income (loss) $ 11,000
XML 93 R74.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Segmented information (Details) - CAD ($)
Dec. 31, 2023
Dec. 31, 2022
IfrsStatementLineItems [Line Items]    
Non-current assets $ 6,932,340 $ 70,158,266
Country Of Canada [Member]    
IfrsStatementLineItems [Line Items]    
Non-current assets 361,967 472,435
Country Of United States [Member]    
IfrsStatementLineItems [Line Items]    
Non-current assets 6,568,840 6,568,840
Country Of Mexico [Member]    
IfrsStatementLineItems [Line Items]    
Non-current assets $ 1,533 $ 63,116,991
EXCEL 94 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�(8>@EAV MG@JJI]5'C#"/P\G#IJ^Y$<7M*Z6@WZ:*WBVMKE0K- CO,6:+0=_?!5$)FL5* MV)()\ZK3:!$Z^%:I[("=14M,8&N,OY*+KVJ$^*#WDBG;)4(L@Z$[EI"H>?^^$"8.3)UGN MV241\(C64>U L&#+0!?[B/\:K"B1O/W6RE M<.:(=2N(*BQ:L63D$I%=?Y^S;VIH$ '9)H>=AB9( GJ:TOL M#\8-"=Z,"*%"MS\%N5-0)&57JZIF7UV#OC]RCB.\4UI#R0F@G%"$J*W2ZE^, M==L3[/>*HF9,N$T_H56?+XK5?IL9OK\TJ>B'OH2F\Z'NAA^5]1WE-(5-TMVE^L>?*54$(]-;?S5K IA^VZY]'FE&ND7=JL,WI36 M-3+@T6V6?NN4+/A04R]7IZ>_+ANIS>SZDM>^N.M+VX9:&_7%"=\VC72'&U7; M_=7L;-8MW.E-%6AA>7VYE1MUK\*_MU\2.>M5TL'Q M[T[Z1_8=OJRE5[>V_J\N0G4U>SL3A2IE6X<[N_^;2O[\0O)R6WO^*_9Q[VHU M$WGK@VW285C0:!/_R\<4A]&!MZ=/'%BE RNV.RIB*W^705Y?.KL7CG9#&OU@ M5_DTC-.&DG(?'-YJG O7-])K+VPID%*O3) 4J\ME@&C:L,R3F)LH9O6$F+.5 M^&Q-J+SX8 I53 4L85-OV*HS[&;UK,3?5;X0YV=SL3I=G3\C[[QW])SEG3_K MZ#]+\>4'CD8Q;XZ+H1IYY[79 M>%[,:B&.2A*OY(FXQV^%L@IXF]W:9EMK:7(%W(5*?#)!.<.;92T^:H-7&K_N MU-:ZH,V&CIM"NL*+5S__]':U.KWX]/'NGG^>79R(?U50)W)KO*UU 4V%*'LI MOE/M125W2JR5,F3@5CKLTR:3>6Y=P>9 "\1\8QTTB??8TQJVQ?>V2"^T]RVD MK \B5.H;1T9G!OMO+/X-7KR_O^F\6(A7ZY-)"&$AR\K^#_]P6HI*HZ2=SK$[ MMSX0HT")>LS5-@AP+!OOU$[6;4P9].?*!=#K2)'T7D$)Q6A81*36NM9!*[R! M,*F=(#D*,IUM-Q5,L:4.&;34UOL%@B1D46C2,R?%\.RESK2>@DG&(F>NQ?YU M%R[9!WL^=BR7OA(EF@ 2'9L)U"Y>"I@Y3N5U6Y!6@@7G8Z?\/#L::;:LMXAQ M,X E5 @/-@I5EHJ[ N$':^ $-W/JSU:#*M!;#)HQ\T.P>'I0 MK$X=TQ<#R4%,N*4(0(5LR-2(A@&JWP"43I!%793&1F9'<3A$>:I#/6)&\9!: MM*Z#Y9"-K7+:%@N00""<8C(!@+ 9X:P+46C8[T3I;)."-;B;3=QEK+Z@]"-0 MGPG;OM)Y-4],A2(%3;5.S1F2@%2L]JA- S@Y#(&3OLVKIV7263BZ ^1W?<'# MU>\B^T1UD;1&'D3"P:B(01%?,8?$@- Q/55MF2SL'G".H7G3NTT#6N>D#,2 M,+72J=P"U7\QX[-Y,4'TQ)'AM>X,E8K"V:0S0D1%*, MUD7!L&Q41P3(MMD&ME.NNQ"E$W08P@ (;UL'KRCRS^-_5#"5I/I!ZA.Z_:C5 MCN*^M9XYE]'OYU%,1",J$.,DA4(*TN&8[?L$9 @L)U0Z=^#<_*C0YEV0U8Y+ MFBLV%D+4Y2<5, X.>3+'KIK2$"P VT;:-#9DM6XTH8G6.7Y@+;N'2>_$K8-F M:G!_[V@JLPQF!*H^)$H.4_[L&9,ZA9( <[I\!V#%@HQP1@<&SUP7;1Y!*GI MQ65-!MB:"-P \!\ M;\2'QYP7Q1VE+LT+W$BAK>M/'&18D'W#Z1W5'_,[V4S]*V$8C4+TC>(0FY[A MC(X0U_FH8F7TXA(R,1H>,K1;# %4HBDL/L2IQNXTV[NQMHC H7E6Y]%ESL)7 M$*HO=+Q!30JTRPBNARZRXWL/9 B:"^J1)7O41%XKZ6!)81LJ@C"?=L7:V[$C M7E%>R6=MH%K&M(VB.Y+>FX28P@?&<"HT @4U]]1O@%MDG@V@_M)QR5.2(E,1 M$2NTCC\LB;NU1,X&:/X\9( ZI&?XH?Z\Y[6!5I*/!)2SWRZ(<*@N#T20/L@1S$R88U<&N0#UA!\E+))SX]@NP$G1W&"=OZ'NB%]K@_^HCS?UC4\-F" M2S+:#2S*+:;K6$DC2&%W5V5DTKY2Q(R MQ6IAV_4X'IW_WY3U#\+!S2W>8Q;B0T>_B54Z.J:95)4MS<&8"Q/" R^'TW:Y6A&.D[B0U>J^4"A8"JVI)(91,?I6Z3I^R*9 M3^UPAU1. Q/G]O2 \::V*=GLPW [2*0??>%621>HXZYDHQGEN"NO&";GK\J3 MD\Z\+D.M3_1Q4\O\X?5]7MF:HLR] JYI+KC&%JJF;/8\'0EON(I <3P#'MNC MBTF:/K@:@6>]XZ'^B3L-7"+?'*-%UGG+CL-!B2!KC4YFEPW "Z*/#6\YJBB_* MP3J:U8!#[5)16Z+#7D*7GZF)J>&Q"GJ$L=IU+^-8] ,NX,6.^"+O95/>BY>H MCJMBF4[B;"#%*8E@L$^Q1NC4'H.=>EW8O1D\Z@E(T?1,#27G4T>H9"!JA,DQ M!NBS@76.!T=!8P3Q3#$M<#()\P-TCVCA!TF)X7Q[[.+4?? M31OE-OQUF"^&)L1/J/UJ_P'Z??SN.FR/7Z\_2[2$'_6?[Z?U!+ P04 " #.@)I8 M[Y[*$%8< #:50 & 'AL+W=OP*77+,^.5;$7(DCVC"1\*R^-Y!JM $E:QP &JV.K]]9L7 MKF*QI8W8%ZE9!Y!(Y/'E@?KFWOF/86_,V'PZ]$/X]FH_CL<73Y^&=F\..JS= MT0QP9^O\08_PT^^>AJ,WNJ.7#OW3NV?/_OKTH.UP]>H;NO;>O_K&36-O!_/> M-V$Z'+1_^,[T[O[;J]NK>.%7N]N/>.'IJV^.>F<^F/%?Q_<>?CU-HW3V8(9@ MW=!XL_WVZO7MB^^^PN?I@=^MN0_%WPVN9./<1_SQKOOVZAD29'K3CCB"AO]. MYHWI>QP(R/B/C'F5IL07R[_CZ#_0VF$M&QW,&]?_VW;C_MNKKZ^:SFSUU(^_ MNOM_&%G/7W"\UO6!_FWN^=F[_[YJVBF,[B O P4'._#_^I/PH7CAZV<77KB3 M%^Z(;IZ(J'RK1_WJ&^_N&X]/PVCX!RV5W@;B[(";\F'T<-?">^.KG_1HO-4] ML*=UTS#:8=<<76];:\(W3T>8 9][VLIHW_%H=Q=&N[UK?G+#N _-]T-GNGJ MIT!:HN\NTO?=W:,COC7MNGE^NVKNGMT]?V2\YVF]SVF\YY];[^N\WO>/K)=' M^VIY--28%^&H6_/M%:A$,/YDKE[]^4^W?WWV\A%:OTJT?O78Z/_GO7E\M.?K MYK$!FR>-OFZ^T\&&QFV;U@T![G2:=.>W/2RNN&:Z9FL'/;0X6!CA NCI&!H[ MM/W4F6;NP\OU >P0MW4FYJF"_.K?T[>ALZRPO^LQ\G3BV#"/"TDJ/>3V?2Z^8?K M.UA]:-X-(%]O]*"[=!'F(4K53\!!KYN_.^_AW57S8?UZ#1K?O%G_#KPTGVSK MFN\_'7O'@\?W8$Q@\TW\M=$]$(K+@H6/7@]!$WUA)>S"*:PO0%?A67A8UOO#O!6.7P]HH8%F]Z"H2 FV:$!N3S"Z_#R^&6;N&Z> M;*X;,'E@T&!-D_=F( 'YK9@)1RYN.1C;PP1ZH*W>3@,]!N/*0P\**?.F=1[L M0J-'>@[X9DC:S*<6WMT9I/:D;8_D.AZK6%^#1 -]K\?&Z'9?4']TP8[L)H[. MDUSCLZOFX 8S@K,!F0H&! 2YVEN]@2E&)!Q('HEIG1EJ M)11DRW6-S^[X291:N'9@K"#T0'$F*B"?3\0O_86'(.W M+3+8A1'OZ3G-#_3ZX$9@2J8;=K>%W4V<@+L!%9SW]AWL)B"S%0_\L/&VT'&5]QJW4I,%-C0U3!>012!",^8R MP\5V_U!VVBID37(,_K#_&<";O0H8RN\JJ)K0(-@X-:F M9WN':RKE;9R)V+H0W%*+2;YL,*6?^?.?OKZ[_=O+@#K;T?"*A?&H'W#"<&DP M),(.\#>)#IJLW4 4B/R09L,?K%^@A3LQ&W$%G2E>@GWFUPK)46[3VQT[)'[# M!A0A%#3< '07?<\_P 58;]9H?'D53;V*)MI5F2]3#MPKU K?1"<+>T'[[XTJ M='G&Y]!,03Q&8[9;0\B9_8Z!K3Z8<>] R&AM!\$4,&-GX5F/PY.?PK>%'!P? M-KQ4C$(NY]RO30XI/FQ67@M(;&?0%EJ$#I5R$PH# OA!- P3@8"DJRMB-A*3 M;3C([4FA(TO[Z$IUUBZ.VP%.P7&BV M1 B;)]^_^?%:#(X^'GMR/4Z=C79Y2U9)@.*SN*.=V:"9 #,SL@F']\BLKL#, MC63\1U<] #8%U7%\*"W_6GU&R2_3%07K#U@[SH7\A,4FX\IX\'%[D*%BM@?( M?.#^]]%X=MFBEM85]@[,.TAI86190;:++NX)W%.X*W?/7K+A33?IZNU+<#&+ MD[+[-ZSI(1G=ZIFH[""IH)$(*-JY;Z#UPM\?@XKNN>V-]CT#XQ:DQI#9891! M'(5+T?S/:&9#GV !Z>LY\4P[.@^-P#+D(37[DQO= _I0^0W>%C9;APVI61(_ MT#ZD>F]Z]A=H7PFO>9@R ")\"A;G[4$$ NTA1KDZ+%$$?=VW)=6BT%BJ.W= M#"E4#@N(#1-NC/: @&#_S2?C6QO(XQ!H2F I0UBUY$46("V++CI2L!93+YN1 MIA)7<&;N*L5;-(B5Q%YT1S6K:OL.3Y8J.V=IY","W7SK,UPM<#C[B-KSJ+-W MD#=@ )!;"#N[:XBS+I@!OE->2)$DR#:PD; R*P\"Y0>QV26GE, XH@I$$G@ M,@L :;2\VZ!+-"^0M]9!6D+P5"/0G_",4L.7NF4+-FF!;81-\ M=X^TD^RZ[4@_GC]3?S>N=SN*;GJ[\1@4P7L_6+0XF8-PZ2?;]\65#V"*, G7 M8.JC<8B-$2+ SRV$&[>WS0,8VG#=/-E>5W$[8D.#.B _V>?59B2"<=V=D(<4 MFZ^"Q9$($W: "MIP, MT4<[8LJ @LZ> T'TH" [A-V<9&& /1(#'C-F\N01RA1(""M,5V$]QA7(![<:G^X<1/*OD?[P_8- M:$ C IO%D0.;EIU&S18/%,;HW*);9-+6S>MB=?RFV(V5VDQC"H#-)[A(L2CF.Y[U!+ 2#'$ $)GAIKLQ 1J>^.V-\6 #/0SPH9;)\.B"W]NR(M* MVE/\KM[MO-FA&2W$D>?4&WC/(928"1A!_HNTB46BE2-BP0PBC\3RZAEUP1LH MDQL#?Q?! :91T)][BAK,R7;((!ZH,*;U'59#& SQPC+.6E9"T@HP>L([G M,2EQ )8( WGDL*:G.9H$C9]B1E#)##@!65-Z(HXP@,&4$(I=C8"_%.O I!N4 M@<'R7XKL5]1,\+\G2RKR MGPFY04!C<::(M0T^Q=L*3MMV/ 4-C[EZ@&AD!*B0Q<,MT?@2DYRP[A/NQ':+ MR7W0$X V&MA@T2!02-AA@L>0@L#6]J#HF'73E3-89 &PO+E7HM=B5&BQWP9VC*TX&[@V9C$$9\6:X'Y!6>BI./ZZ"%)]?1YG2G+P,Z9 M81&G;N])^TE<.#K I6QAR)*ZO>[88F48O6[^SFE+M>2 : ="F:3(^U: XIS@K[T#FFOPGF8)!N5I==5H$\MBS\YL,CKA)D8&*7T M*!ME%,>08OV9PJV;7]"Y<4J@W0^$/;8@,%8X2:XK&2AULC,6@QIX"?$NF43- M,EB)(,1ZQ_G(6^L1"<)/25 7"B26DQ0H M)PW1:!9"P,ET1.>\7Y>#%[ >"*0CLIZAP)F\%ZY-DA@.$)3SD4JVL)3CQ245 M6./?A$=TQO2)O8["H56%<$,"- 3O,M4[QC&A)8@C'9(*-FSR[MQ(MUZXXT4B.$=U-WG96L3\E!;#1AIP4H\5YC=3$BCG7S9%6\I=DV"R&M:\M3H'U$.-J:TQ^OF'0-N@AW%.#;$1#M9:E7: M\-KWIT(:"*8]Q.HJ%H$]JZD@=10:0G'%\ABM1'7)HR7?S 6^L9G57F42)N@Z8N+H6ED4B[:V[$.CYG #9B>81<(B]"5E$5<&-OR MK'OPT$ >EAA21DY11HA=2O)(F)0'"9%*R-!, ?=I$$N140G?XH5FYL_+(;G^ M)"41!D36UY64E>*"D,;+-Q"WIEZV")$C'F*,K;9APDJ*YA)XX MHQ=1,"7',^:,>0SDH\IQ4-ZSA2)/R#B=#(_N_I@"%TBWC^RQENWB(MSY7JM* MCME4YO0@E8=KO5HM*IM%.0![EB.(!7( SZ)A(2,EV: Z9%4";<]-4B_B**Q <.Z M*8 ;. /43_;7V.:#/0>4<2E^1#2<*LA9>#DQ)LD@>'3=O.$["M^;WSTOP\Z1 M(2[X."XQQHZ2U^+(C-H_BJ$Z<)$M[EHNW1&\4)=[*Q*M1)I8F.SCX9J4CV<@ MD\$Z+E *),2GN (J]L! F$5=Q0HQC,4M,&;0;=D7,VO$H3PUYFY(%6G?D!4% M*19WC9.GY#-Y0Q7E;(N\G*RHYG7Q(K /9L:<<2Q' W(%H1CO3:S$U_).%J2H MJ9;5:%QR+LOD-1TG#Z:X"-WC4%/LHD >DJ^,C^8E*%D"M^:D943VYGS3XE)> M5'5U>3]"=ED&[EBQ"BITE7U4%.<*!3HWQ'"M+X-=]J54_\]IEJ)U<)!UXN[5 MTL[[75#=E'GIHAZ-5:.Z]P_>^\-9,E-4!$UK, M9;)W,9^!F#(80T^SZU@K]* "]E:U9E_8*5GWXAZE?CV)?B_LULZY#FD\%XVR M>$?^,JE9PCED_5=UYT2O[V5TM+IL1:-..U\F]6!GXHW- MPX*RSY3U@FI1\\QV2_ P(U:EP:/N*#%@!N!SR[N4,ISR1EN8MVI0JL@RPA/5 MC+5T%KS""_2(JM,2J#1.Y$[CWGFPLDH8$^\0(9RB(YR-_8BIX85\B<@H!SIA^TRY!(!B,Z< M543E,Z&>!K)?1)S4%^%OQ=6=V'%"D=A%T5]]J88*9JOM1UY**DW&6I!**/M! M@L!F&FW/+GY1X,K(24O+:"VIJ7HZPV/GM /B0$QOO#JS,[E7 ^;> &)$.SC? M$>XE^@"0S=RPVH';8TA^PGS*_TZ+4D_K TA&T]_F317((&@?SYW("3,B]H,70S&Z69 M-ZB5%IPX6. @DD3TQ^W>S-B:^^YVV/ '<1XB;K@DI3@J:A>%(2GDY @T[MJ) M,T%GNUH^4^QL(I<(H&S^=[UN/]Y\:+%)-,@[-P"2*>%*[5UH'3[RQI* <4"8 M.Y)$"MFK!DX&GU-ZCY9?2%GH[587>[LS[JK:8E@01 Y1+"3XPZV4$%4JX]3% M.TR'#0?>I=(M.%K,4C)7 2L 29,D]SC===Y4QUD([#_J.#^=U9$;'AA:8^E> M]@7Q (&W)(4I&2Q>BMV/TB'5*'7,BDGZ)L;-Y$*QVCF2"JW8<,YZK1@-G'OKP\L(Y_B'5,:<#W,1>?>DFE=\N<[Q7RL^R[ M4OF@@9BI-&QLXV"YJ>NJ8F_Q&@^&.&?32Y@*>B!9J]0>I&5P&52,Z8H MX!) M)2X%Z86C&C-0A$^6*0: MRA,&M>R BM 6I?FP!Y%TG-,WJ/)FWB$5:6(3-6Y;&@DAHO,RE< M.RJHJ*:H15C7Y E34/DF6.Q!"JUIIRA!Z! ;Q98.+B QU2"E>&J2#&BX3- Y M$R"\-YXJ8+473_"AZD&MSN6+8CE"L;<"AE=7%1( M7;1%%BW0?:I&$7B8[>W&\.$:KAH54(WM+G+ZDKLKR"C22-G35HY._<)&X+TX MNI^X9YM;'T@C:.J8VAS%+'=4UT3'Q8X9A/!(I99LL@I2SE@WHY1[5I(HI5%L MX# ^@EU7&SZB+P*V>@+$Z1Z0]%];)<6XT?<[6$L_%5TOS1-6'!,:B%C'3Y M>*$SB,R+B8I"1DRGB:96JP T0SC:'@1&%N]E,U3EP>-PTCJM[-)YD\ISS*H@ M-1NK$/Z!MX98.RP!PW,9CT*B,D/+'5E($.6>!'+2&OVC1WQ'I4>I0L1$<)T: M8$@M28.MZ.G)^I&[C$66E!2![&$S^<#.,*NBX-@Z7UI.&54J"I(HY8-PI:K7 M8:4[B( /$;;IG3=RRI*+,9<;+T).$@7B0!T9Y:%6#8>OJ8."F\<>N-^@,++@ MRDTGG=H;M*NIF%B^KJII#!YRZ:^;GPVWY 2BB(G]T '[L$@M>_*# MP]G;BGJ]J%8\AAK;K(#-?YPYB;')/'T# M/<:BT,ZH'%G5^ H,.ITZ(8N5&A&3XWQ[<6'S@U^QFA!'2&_,FTN6%A$E<4YV M\R5D1VM@)#F.T! DG?8$O5_N[*C&4$]^AAO-[=TU[/SANOD1;4O F!<,C3FF M+'XZ;%/7J>689DC%\OR@LF$E/AAU$26[P=X ;(@KC^XL/R09V/P@'9QXF'67 M2CJ>D6U(3;0IQBQJM#KF)U!4L-;+K4M\QGLK6"&YO+J_ZFR5%65V.+G^)-IU MF8J5*M_.Z6-N'$O);#XH^9BA)6,Y900G+0A9;.F 2KR9&]L%]:S(\MA:8<[Z M=B695"PI3;6>20?EG=$GQ9IZ+3"--+SP!J?]Q2(A&!PP:*H2*$'L(?*X# OK M8ZO4&8/X=C9@.E4=/QS!R6HN]YSB>64\7L:!9) 8 NOFQM3R7736:68.]J/3 ML13B.AT=%@*R[XQ1JS2_5T%84H+?(KOK$7E+I_.=[TJ&;9D5H D;!U%$.C*V9M^6Z9?#,UVWQN2^C [:\4'_^T^W7SU_BN;*B@%)^1L4.-V+;6W/VV.>4 M'"RSC'27N. M"9?V@3O+J%)'50OSB0 [K7RUM-$Y*J*GL:A'.Z'#Q6U,E,36@AF>CVT3U(/( MD769+]E-FE+J>9R416 [7)]SE&3BS%%1&*"#PRQHPOE\T$3&HDX"?OLEV6>9 M+/$+9S&#[E,[!4N03J!-A,_.S4!N)^/KZ"[BO&SY(EJGDCK)MWDM!*X\1RE+1<2HC(!Q>HQCD3H>IC/N7CI3"Q*!7MG&HV M-E&9$@F^J1$!Y\M%8,1)?:G$K))>ERQ?/DB(8L$MR,> JHFCD(8]R,4-B6'/&#UU M1B1,%8'?[1TV,.(WSZCF&"2VY]?P +&[OY$$*4U;"F9D%QZ><.)D*?LYTGEY M&>3+F,&- ]$QWY!C%E06BX:9<(@_ANOF@WQ,!C^70Z4"E*,#-LUVZ?L1#^! M\S= YORF#J+8>K*O#@Y+Q^"['W[]$+D7N*U$)L,9[F6,>A9X^"V89(K#XK?? MD&TVE.U'Z5,XTJ$C"1=L'2E,I>P9?IB ZF)#G"CV=\R3YTO?1JO:P,I/9;U[ M_:&YY2^ W+Y\SWX\G2G+WY?YD#^1]D2^/@%OJMOXS0GB0^0\:,L_]3#QL>>[ M9[+36)^&=1P0)^9XC)3ISO;IAP\8>^' M),&D+?XBL?S20+4J=J/3D"K4TEE] -C'/5 )2IRM5/?!G2\WYN93I:@B&(]0 M+52)R9?L=*I6YG5P_!)-XDI- UD7:A?%+/J%TJB6SQZPU3[*05Z3'"[PRQ8= M@PM$Q<]U% NF(KVX.EAJDL]>9V'AGT@ MF;S&??ZE'5VA]7<2@L5SHX-&D,FV1E7?QP&?WHS76WBATM?\_14ONS"9V;2EG$['5K.2PE$1M MJXK*IP4PL9\Z@?.\<%]N"FT6O-FDIAMX /VC7DKTO XE+RO@JA2<2%A/G7DP M7L0FW@;\+&&OCFQBE*R$>#3.UWSJ^(80,,BT0:#XMX,K8,P (8W?+:;3E32) MQ_8S^JW5CEI65,&58+_*7!=39^20'-9TR_2]V'^!5D]B\#+!E/TE^R8VQHK9 M5FE1MCA)'_1D+8)H26=U/(LKRFFLXF4NR)--&(9@PKU68C MN9*;2WG0$G=+S-.S>9:)+=<*#SB#$YY*\!/*39<0V?N2["LXC7D/5)%+@D],/H#%[4 M:8\L7O0O[?H?=EJOSFCO4&.3R.;ES16-#8 MAUOTG7 ]; VH5B!M>QP[/=,KIF'"WBEN%]^$!A($%ZO+2_*11*/4':4)6D$Z M)Y$[B'VTPB1UXV% YOH5#]NSKM5Z M):J:\B=24$M%2'P=9$?9%K7E:/OT5 MR(V=<>:$46PS"+K5;HS.F^GQ$M[,X#LJ-R57A,$:4_W^,'&(;.9:XVA1VUFR M$AHGDS4+_!2 - &XOQ9XGJUC"G0?E]D?4$L#!!0 ( ,Z FECA/[-;,@4 M %T, 9 >&PO=V]R:W-H965T6*-\R,U9I+_+)0NF$6MWHY,6O- M6>64FGH2!4$V:9B0H]FY>_=1S\Y5:VLA^4<-IFT:IK=7O%:;BU$X&EY\$LN5 MI1>3V?F:+?EG;K^N/VK<3796*M%P:822H/GB8G09GETE).\$O@F^,7MKH$CF M2GVGS?OJ8A00(%[STI(%AC]W_)K7-1E"&#]ZFZ.=2U+<7P_6?W.Q8RQS9OBU MJO\4E5U=C(H15'S!VMI^4IO?>1]/2O9*51OWA$TGFT0C*%MC5=,K(X)&R.Z7 MW?=YV%,H@B<4HEXA MG;DJG*K%:6LX,&.X-/#4P0YPYL-("]BHY:?,O+,<2A#U$0Q4?LQ;O@8VGDL&GJI3.S9B6_&&&S&*[O^&CV\D68!6^. $]VP)-CUO]? MU8Z:/@P\'<.S7<*7%8=KU:R9W,**F5Z"+37GV,VHAJ,$!/ZN<(C\:)FV7(-: M+$3)/><9A(1O3):JO>/:AZOQ]1AN)>\-E<@I'#9"+M$_\'O;3PBU=FW.[[DN MA6'SFH.2]1;F6\_N(=H@HEZ&5R@!?Z@[WLP10A0Y8H5C%T'GC*11&R>%TKQS MAE2&A58-?&"Z7 UTC,"JQV_R\:-,X,3$I.%?A7"$ 2.64F#,3%K@=Y@73"JP MWFVC*O>M&UR890. M>B>!*6^\C6KK"H$9G&"4T,;N_!< IDF8J%6C2>%.?,^XP%4M53&Q3^Y\@:S M+OG[&^\6CR_BRIS52"F.(219ZD_C@())"C\+C+X]E$KX)97^?O6Q&J7" M$?@3DZ[*LL5WY7;H*D>5$^JM(BT@B?PLQ9Y"MTF$YS3@]'O">,<; K/KXZ$2 M>(_5&*9<>@/WB0-/I_WYIJB6"8%(Z9&YX4^/ KXH))QWV[5.Y_8$PCSPLSQR MJ]B?YH%;Y7Z4%933Q$^1&<2W-,O\)([AT(5ALG?E:[A>NHNM0:ZTTG:WO]W; MW=WYLKLR/HAW%V_LW"7U6LT7J!J,\W0$NKO,=ANKUNX".5<6KZ-N24&ULM59M;]LV$/[N7W'0AF$#F)BD2$KJ M; -.VFS]$"!H]O*9D6A;J"2J%%4W_WY'R7&ZFG)* MU;3691,M9L.]&[>8V=Y796-N''1]76MW?V$JNYU'+'JX\:%<;WRX,5W,6KTV MM\;_V=XXW$WW*$59FZ8K;0/.K.;1DKVY$,%^,/BK--ON8 TADSMK/X;-^V(> MT4#(5";W 4'CWV=S::HJ "&-3SO,:!\R.!ZN']"OAMPQESO=F4M;_5T6?C./ MT@@*L])]Y3_8[>]FEX\,>+FMNN$7MJ-M3"/(^\[;>N>,#.JR&?_UEUT=#AS2 MYQSXSH$/O,= \NWVNO%S-DMN&"-:&$QI#IX([FR"4VY]0Z?ENCG%S<.^^O\ M/8&VTHT'W11@/O5EBX7WLZG'$,%PFN_@+D8X_@PX9GHC/MLHL5//S!%?SW!5>RYBE/H_[XY)^&.DU7G<#+,Y!;? T5? M&; K:$]:7O6N*7WO#%S:NNV]<8^+WXRM[+K,=057I:D*N"ZK"OZP7E>3'^'@ MFES:SD^PZZ:^0[]=YSDPF1&6,. )(U)08%E*LI2!9"11%+B01(D$%)$J):E@ MD!"129().ED611E> 1V@;8*V*H&SW<4)C9/)^[K5I0M)O)CEWG.XOB$: _8> MHXY$4YI\']&$9$DR6>9Y7_>5]J; -POV*"]U('ZT'#'A- :.L )!6,8)BU.0 M&#R1P..$Q'@8SR!-):$J0XA'/*P#1Z8*'ZA0 8FL)3(E:J@,8X0I=2PU*8C@ MZ"(3(H?4!&'9D!J+.0;%3),L!,T4X;&<7&KG[LMF#;JV?>.[(XE@BU2*2T*S M#!FE(H8DE9"2.)8'15)$,4K2A!VAA59, A,DIA0$23(*BJ?!1:5/(2CV0/#_ M4ZC8"9D2SK*@,D*I>*[_+ Z)(SD5F*<9174G!U+-),=<9*QV4A,L) ("0:7Z MCX+].0E:(3R+X9_%K&*4.Y( (JB&0H098-@D8!G86R"BY>X^R\*.,@KI0C7V2A&&1(7D*H M%FI6"@<%_2B" M8]^KZ<%@41NW'L:G#O)0A7'&V-_=3VC+<3!Y-!_'NVOMUB7JNC(K=*7GB8S MC2/3N/&V'<:4.^MQZ!F6&YPRC0L&^'QEK7_8A #[N77Q#U!+ P04 " #. M@)I8Z3&L@M$+ !2'P &0 'AL+W=OOP+C=CCW#V*3NSL4SCI.TZ6R:3.QV'W;V 2(A"0U)* !H6_]^ MOW- 4I0<.>[V8<>3"""!EM)O7JC!WKX[2H_;!9[U<>7IP=O%R+9?J6OG?UY\L9F<=E5R7JG+:5,*J MQ:NCR_3YZQ&MYP5_:'7G>F-!FLR-^4*3]_FKHX0$4H7*/%&0^+E55ZHHB!#$ M^-K0/.I8TL;^N*7^CG6'+G/IU)4I_J5SOWIU-#L2N5K(NO"?S=TOJM%G3/0R M4SC^7]R%M6-PS&KG3=ELQKS45?B5]XT=>AMFR8$-@V;#@.4.C%C*-]++BY?6 MW E+JT&-!JPJ[X9PNB*G7'N+MQK[_,7;^W5AK P6JG*A;F51-U/GE'!1BF]4=BJ&:2P& MR6#X"+UAI_20Z0T/T/O->.587>-7R@H%(\A*>F,W0E/:##J-!@]1OU_<]NC)+\M M\/14?)=5= VDR.M"";-@4SZ^^J8N]-+K3'QDVW^R !CK-^+&>%E$W^4F?J2_ MZ#+[6FNG^45FG'?/HX\ *ETMD:1P9J;$,W&,P%'E'%R:X!F>=)3[O,7QQVQ1)P0\_X\NBJ,^XYP M0PA',H'U0EFK\AUC_B4EQVD\2R;Q<#S&@NTDNF))=9753#^O+=&"'\1&21O! M%POE"&]E<>95MJIT)@NQ4,B6='P>)T,6,(RBGY6A$D%+8E$J>*^H[7(CTA@R MT#KZC6ZLO%4%^U)FF2E+DP>%IDD\'(RP+@R(7&&6FU@LE5FO-DYG(47[1DBG M@WC$2C6CZ+I>KPO=9'.I709\EY4RM8,Y9G$RFF)Q,XK>5K?:FHI\*(-("+U2 M>S&(11T0SBOY V*EG,@> "2_OQ3%AAAC!19-1G,[.V]_HLUK4(/1,/-@Q MGL "LTD(AFZR%T?Y(5]CRR >IZ-X.IXU)'KSB+/E\&ZW[UMLW\9$(->;/S$\ M0R($UM]-]!#,XLV>'(IJ@GA /.855P;&J3:H]IFQ6!?)2NA'\XZ>_2AZJ9:( MGIT2<:,]@,F;)\BKJUM3W"*4,N 1VIE(5P HXFNU^T(694(D9ZX7"YVA\%/D ML1<]!5+5:@K:&G"RH7<--9$54I>(4R?N$*/T2RO7"*O*:\HR8\7:FGFA:!58 M$K&%-65$ZQ96?:VQLM@(6<[ULJ8(STQUJS9P&"U=:<<%+%M)*ED*% AE(4%) M)H5TRH)-$./T_PK#*

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�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end XML 95 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 96 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 98 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.u1 html 413 337 1 true 99 0 false 9 false false R1.htm 00000001 - Document - Cover Sheet http://almadenminerals.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated statements of financial position Sheet http://almadenminerals.com/role/StatementsOfFinancialPosition Consolidated statements of financial position Statements 2 false false R3.htm 00000003 - Statement - Consolidated statements of comprehensive loss Sheet http://almadenminerals.com/role/StatementsOfComprehensiveLoss Consolidated statements of comprehensive loss Statements 3 false false R4.htm 00000004 - Statement - Consolidated statements of cash flows Sheet http://almadenminerals.com/role/StatementsOfCashFlows Consolidated statements of cash flows Statements 4 false false R5.htm 00000005 - Statement - Consolidated statements of changes in equity Sheet http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity Consolidated statements of changes in equity Statements 5 false false R6.htm 00000006 - Disclosure - Nature of operations Sheet http://almadenminerals.com/role/NatureOfOperations Nature of operations Notes 6 false false R7.htm 00000007 - Disclosure - Basis of presentation Sheet http://almadenminerals.com/role/BasisOfPresentation Basis of presentation Notes 7 false false R8.htm 00000008 - Disclosure - Material accounting policies Sheet http://almadenminerals.com/role/MaterialAccountingPolicies Material accounting policies Notes 8 false false R9.htm 00000009 - Disclosure - Accounts receivable and prepaid expenses Sheet http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpenses Accounts receivable and prepaid expenses Notes 9 false false R10.htm 00000010 - Disclosure - Right-of-use assets and lease liabilities Sheet http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilities Right-of-use assets and lease liabilities Notes 10 false false R11.htm 00000011 - Disclosure - Property, plant and equipment Sheet http://almadenminerals.com/role/PropertyPlantAndEquipment Property, plant and equipment Notes 11 false false R12.htm 00000012 - Disclosure - Exploration and evaluation assets Sheet http://almadenminerals.com/role/ExplorationAndEvaluationAssets Exploration and evaluation assets Notes 12 false false R13.htm 00000013 - Disclosure - Gold loan payable and gold in trust Sheet http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrust Gold loan payable and gold in trust Notes 13 false false R14.htm 00000014 - Disclosure - Warrant liability Sheet http://almadenminerals.com/role/WarrantLiability Warrant liability Notes 14 false false R15.htm 00000015 - Disclosure - Share capital and reserves Sheet http://almadenminerals.com/role/ShareCapitalAndReserves Share capital and reserves Notes 15 false false R16.htm 00000016 - Disclosure - Related party transactions and balances Sheet http://almadenminerals.com/role/RelatedPartyTransactionsAndBalances Related party transactions and balances Notes 16 false false R17.htm 00000017 - Disclosure - Net loss per share Sheet http://almadenminerals.com/role/NetLossPerShare Net loss per share Notes 17 false false R18.htm 00000018 - Disclosure - Supplemental cash flow information Sheet http://almadenminerals.com/role/SupplementalCashFlowInformation Supplemental cash flow information Notes 18 false false R19.htm 00000019 - Disclosure - Income Taxes Sheet http://almadenminerals.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 00000020 - Disclosure - Financial instruments Sheet http://almadenminerals.com/role/FinancialInstruments Financial instruments Notes 20 false false R21.htm 00000021 - Disclosure - Management of capital Sheet http://almadenminerals.com/role/ManagementOfCapital Management of capital Notes 21 false false R22.htm 00000022 - Disclosure - Segmented information Sheet http://almadenminerals.com/role/SegmentedInformation Segmented information Notes 22 false false R23.htm 00000023 - Disclosure - Subsequent event Sheet http://almadenminerals.com/role/SubsequentEvent Subsequent event Notes 23 false false R24.htm 00000024 - Disclosure - Material accounting policies (Policies) Sheet http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies Material accounting policies (Policies) Policies 24 false false R25.htm 00000025 - Disclosure - Material accounting policies (Tables) Sheet http://almadenminerals.com/role/MaterialAccountingPoliciesTables Material accounting policies (Tables) Tables http://almadenminerals.com/role/MaterialAccountingPolicies 25 false false R26.htm 00000026 - Disclosure - Accounts receivable and prepaid expenses (Tables) Sheet http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesTables Accounts receivable and prepaid expenses (Tables) Tables http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpenses 26 false false R27.htm 00000027 - Disclosure - Right-of-use assets and lease liabilities (Tables) Sheet http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables Right-of-use assets and lease liabilities (Tables) Tables http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilities 27 false false R28.htm 00000028 - Disclosure - Property, plant and equipment (Tables) Sheet http://almadenminerals.com/role/PropertyPlantAndEquipmentTables Property, plant and equipment (Tables) Tables http://almadenminerals.com/role/PropertyPlantAndEquipment 28 false false R29.htm 00000029 - Disclosure - Exploration and evaluation assets (Tables) Sheet http://almadenminerals.com/role/ExplorationAndEvaluationAssetsTables Exploration and evaluation assets (Tables) Tables http://almadenminerals.com/role/ExplorationAndEvaluationAssets 29 false false R30.htm 00000030 - Disclosure - Gold loan payable and gold in trust (Tables) Sheet http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustTables Gold loan payable and gold in trust (Tables) Tables http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrust 30 false false R31.htm 00000031 - Disclosure - Warrant liability (Tables) Sheet http://almadenminerals.com/role/WarrantLiabilityTables Warrant liability (Tables) Tables http://almadenminerals.com/role/WarrantLiability 31 false false R32.htm 00000032 - Disclosure - Share capital and reserves (Tables) Sheet http://almadenminerals.com/role/ShareCapitalAndReservesTables Share capital and reserves (Tables) Tables http://almadenminerals.com/role/ShareCapitalAndReserves 32 false false R33.htm 00000033 - Disclosure - Related party transactions and balances (Tables) Sheet http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesTables Related party transactions and balances (Tables) Tables http://almadenminerals.com/role/RelatedPartyTransactionsAndBalances 33 false false R34.htm 00000034 - Disclosure - Supplemental cash flow information (Tables) Sheet http://almadenminerals.com/role/SupplementalCashFlowInformationTables Supplemental cash flow information (Tables) Tables http://almadenminerals.com/role/SupplementalCashFlowInformation 34 false false R35.htm 00000035 - Disclosure - Income Taxes (Tables) Sheet http://almadenminerals.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://almadenminerals.com/role/IncomeTaxes 35 false false R36.htm 00000036 - Disclosure - Financial instruments (Tables) Sheet http://almadenminerals.com/role/FinancialInstrumentsTables Financial instruments (Tables) Tables http://almadenminerals.com/role/FinancialInstruments 36 false false R37.htm 00000037 - Disclosure - Segmented information (Tables) Sheet http://almadenminerals.com/role/SegmentedInformationTables Segmented information (Tables) Tables http://almadenminerals.com/role/SegmentedInformation 37 false false R38.htm 00000038 - Disclosure - Nature of operations (Details Narrative) Sheet http://almadenminerals.com/role/NatureOfOperationsDetailsNarrative Nature of operations (Details Narrative) Details http://almadenminerals.com/role/NatureOfOperations 38 false false R39.htm 00000039 - Disclosure - Material accounting policies (Details) Sheet http://almadenminerals.com/role/MaterialAccountingPoliciesDetails Material accounting policies (Details) Details http://almadenminerals.com/role/MaterialAccountingPoliciesTables 39 false false R40.htm 00000040 - Disclosure - Material accounting policies (Details 1) Sheet http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1 Material accounting policies (Details 1) Details http://almadenminerals.com/role/MaterialAccountingPoliciesTables 40 false false R41.htm 00000041 - Disclosure - Accounts receivable and prepaid expenses (Details) Sheet http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetails Accounts receivable and prepaid expenses (Details) Details http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesTables 41 false false R42.htm 00000042 - Disclosure - Accounts receivable and prepaid expenses (Details Narrative) Sheet http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetailsNarrative Accounts receivable and prepaid expenses (Details Narrative) Details http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesTables 42 false false R43.htm 00000043 - Disclosure - Right-of-use assets and lease liabilities (Details) Sheet http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails Right-of-use assets and lease liabilities (Details) Details http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables 43 false false R44.htm 00000044 - Disclosure - Right-of-use assets and lease liabilities (Details 1) Sheet http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails1 Right-of-use assets and lease liabilities (Details 1) Details http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables 44 false false R45.htm 00000045 - Disclosure - Right-of-use assets and lease liabilities (Details 2) Sheet http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2 Right-of-use assets and lease liabilities (Details 2) Details http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables 45 false false R46.htm 00000046 - Disclosure - Right-of-use assets and lease liabilities (Details Narrative) Sheet http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetailsNarrative Right-of-use assets and lease liabilities (Details Narrative) Details http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables 46 false false R47.htm 00000047 - Disclosure - Property, plant and equipment (Details) Sheet http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails Property, plant and equipment (Details) Details http://almadenminerals.com/role/PropertyPlantAndEquipmentTables 47 false false R48.htm 00000048 - Disclosure - Property, plant and equipment (Details Narrative) Sheet http://almadenminerals.com/role/PropertyPlantAndEquipmentDetailsNarrative Property, plant and equipment (Details Narrative) Details http://almadenminerals.com/role/PropertyPlantAndEquipmentTables 48 false false R49.htm 00000049 - Disclosure - Exploration and evaluation assets (Details) Sheet http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails Exploration and evaluation assets (Details) Details http://almadenminerals.com/role/ExplorationAndEvaluationAssetsTables 49 false false R50.htm 00000050 - Disclosure - Exploration and evaluation assets (Details Narrative) Sheet http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative Exploration and evaluation assets (Details Narrative) Details http://almadenminerals.com/role/ExplorationAndEvaluationAssetsTables 50 false false R51.htm 00000051 - Disclosure - Gold loan payable and gold in trust (Details) Sheet http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails Gold loan payable and gold in trust (Details) Details http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustTables 51 false false R52.htm 00000052 - Disclosure - Gold loan payable and gold in trust (Details 1) Sheet http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1 Gold loan payable and gold in trust (Details 1) Details http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustTables 52 false false R53.htm 00000053 - Disclosure - Gold loan payable and gold in trust (Details Narrative) Sheet http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative Gold loan payable and gold in trust (Details Narrative) Details http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustTables 53 false false R54.htm 00000054 - Disclosure - Warrant liability (Details) Sheet http://almadenminerals.com/role/WarrantLiabilityDetails Warrant liability (Details) Details http://almadenminerals.com/role/WarrantLiabilityTables 54 false false R55.htm 00000055 - Disclosure - Warrant liability (Details 1) Sheet http://almadenminerals.com/role/WarrantLiabilityDetails1 Warrant liability (Details 1) Details http://almadenminerals.com/role/WarrantLiabilityTables 55 false false R56.htm 00000056 - Disclosure - Warrant liability (Details Narrative) Sheet http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative Warrant liability (Details Narrative) Details http://almadenminerals.com/role/WarrantLiabilityTables 56 false false R57.htm 00000057 - Disclosure - Share capital and reserves (Details) Sheet http://almadenminerals.com/role/ShareCapitalAndReservesDetails Share capital and reserves (Details) Details http://almadenminerals.com/role/ShareCapitalAndReservesTables 57 false false R58.htm 00000058 - Disclosure - Share capital and reserves (Details 1) Sheet http://almadenminerals.com/role/ShareCapitalAndReservesDetails1 Share capital and reserves (Details 1) Details http://almadenminerals.com/role/ShareCapitalAndReservesTables 58 false false R59.htm 00000059 - Disclosure - Share capital and reserves (Details 2) Sheet http://almadenminerals.com/role/ShareCapitalAndReservesDetails2 Share capital and reserves (Details 2) Details http://almadenminerals.com/role/ShareCapitalAndReservesTables 59 false false R60.htm 00000060 - Disclosure - Share capital and reserves (Details 3) Sheet http://almadenminerals.com/role/ShareCapitalAndReservesDetails3 Share capital and reserves (Details 3) Details http://almadenminerals.com/role/ShareCapitalAndReservesTables 60 false false R61.htm 00000061 - Disclosure - Share capital and reserves (Details Narrative) Sheet http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative Share capital and reserves (Details Narrative) Details http://almadenminerals.com/role/ShareCapitalAndReservesTables 61 false false R62.htm 00000062 - Disclosure - Related party transactions and balances (Details) Sheet http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetails Related party transactions and balances (Details) Details http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesTables 62 false false R63.htm 00000063 - Disclosure - Related party transactions and balances (Details Narrative) Sheet http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative Related party transactions and balances (Details Narrative) Details http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesTables 63 false false R64.htm 00000064 - Disclosure - Net loss per share (Details Narrative) Sheet http://almadenminerals.com/role/NetLossPerShareDetailsNarrative Net loss per share (Details Narrative) Details http://almadenminerals.com/role/NetLossPerShare 64 false false R65.htm 00000065 - Disclosure - Supplemental cash flow information (Details) Sheet http://almadenminerals.com/role/SupplementalCashFlowInformationDetails Supplemental cash flow information (Details) Details http://almadenminerals.com/role/SupplementalCashFlowInformationTables 65 false false R66.htm 00000066 - Disclosure - Supplemental cash flow information (Details 1) Sheet http://almadenminerals.com/role/SupplementalCashFlowInformationDetails1 Supplemental cash flow information (Details 1) Details http://almadenminerals.com/role/SupplementalCashFlowInformationTables 66 false false R67.htm 00000067 - Disclosure - Income Taxes (Details) Sheet http://almadenminerals.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://almadenminerals.com/role/IncomeTaxesTables 67 false false R68.htm 00000068 - Disclosure - Income Taxes (Details 1) Sheet http://almadenminerals.com/role/IncomeTaxesDetails1 Income Taxes (Details 1) Details http://almadenminerals.com/role/IncomeTaxesTables 68 false false R69.htm 00000069 - Disclosure - Income Taxes (Details 2) Sheet http://almadenminerals.com/role/IncomeTaxesDetails2 Income Taxes (Details 2) Details http://almadenminerals.com/role/IncomeTaxesTables 69 false false R70.htm 00000070 - Disclosure - Income Taxes (Details Narrative) Sheet http://almadenminerals.com/role/IncomeTaxesDetailsNarrative Income Taxes (Details Narrative) Details http://almadenminerals.com/role/IncomeTaxesTables 70 false false R71.htm 00000071 - Disclosure - Financial instruments (Details) Sheet http://almadenminerals.com/role/FinancialInstrumentsDetails Financial instruments (Details) Details http://almadenminerals.com/role/FinancialInstrumentsTables 71 false false R72.htm 00000072 - Disclosure - Financial instruments (Details 1) Sheet http://almadenminerals.com/role/FinancialInstrumentsDetails1 Financial instruments (Details 1) Details http://almadenminerals.com/role/FinancialInstrumentsTables 72 false false R73.htm 00000073 - Disclosure - Financial instruments (Details Narrative) Sheet http://almadenminerals.com/role/FinancialInstrumentsDetailsNarrative Financial instruments (Details Narrative) Details http://almadenminerals.com/role/FinancialInstrumentsTables 73 false false R74.htm 00000074 - Disclosure - Segmented information (Details) Sheet http://almadenminerals.com/role/SegmentedInformationDetails Segmented information (Details) Details http://almadenminerals.com/role/SegmentedInformationTables 74 false false All Reports Book All Reports aau-20231231.xsd aau-20231231_cal.xml aau-20231231_def.xml aau-20231231_lab.xml aau-20231231_pre.xml f20f_042624.htm dc_ftr.jpg dc_hdr.jpg fig1.jpg fig2.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 100 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "f20f_042624.htm": { "nsprefix": "aau", "nsuri": "http://almadenminerals.com/20231231", "dts": { "schema": { "local": [ "aau-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "calculationLink": { "local": [ "aau-20231231_cal.xml" ] }, "definitionLink": { "local": [ "aau-20231231_def.xml" ] }, "labelLink": { "local": [ "aau-20231231_lab.xml" ] }, "presentationLink": { "local": [ "aau-20231231_pre.xml" ] }, "inline": { "local": [ "f20f_042624.htm" ] } }, "keyStandard": 177, "keyCustom": 160, "axisStandard": 14, "axisCustom": 0, "memberStandard": 17, "memberCustom": 81, "hidden": { "total": 373, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 269, "http://almadenminerals.com/20231231": 100, "http://xbrl.sec.gov/dei/2023": 4 }, "contextCount": 413, "entityCount": 1, "segmentCount": 99, "elementCount": 532, "unitCount": 9, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 990, "http://xbrl.sec.gov/dei/2023": 44, "http://fasb.org/us-gaap/2023": 4 }, "report": { "R1": { "role": "http://almadenminerals.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R2": { "role": "http://almadenminerals.com/role/StatementsOfFinancialPosition", "longName": "00000002 - Statement - Consolidated statements of financial position", "shortName": "Consolidated statements of financial position", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R3": { "role": "http://almadenminerals.com/role/StatementsOfComprehensiveLoss", "longName": "00000003 - Statement - Consolidated statements of comprehensive loss", "shortName": "Consolidated statements of comprehensive loss", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfessionalFeesExpense", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfessionalFeesExpense", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R4": { "role": "http://almadenminerals.com/role/StatementsOfCashFlows", "longName": "00000004 - Statement - Consolidated statements of cash flows", "shortName": "Consolidated statements of cash flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfitLossFromContinuingOperations", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AdjustmentsForDepreciationExpense", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R5": { "role": "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity", "longName": "00000005 - Statement - Consolidated statements of changes in equity", "shortName": "Consolidated statements of changes in equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R6": { "role": "http://almadenminerals.com/role/NatureOfOperations", "longName": "00000006 - Disclosure - Nature of operations", "shortName": "Nature of operations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R7": { "role": "http://almadenminerals.com/role/BasisOfPresentation", "longName": "00000007 - Disclosure - Basis of presentation", "shortName": "Basis of presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanator", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanator", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R8": { "role": "http://almadenminerals.com/role/MaterialAccountingPolicies", "longName": "00000008 - Disclosure - Material accounting policies", "shortName": "Material accounting policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R9": { "role": "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpenses", "longName": "00000009 - Disclosure - Accounts receivable and prepaid expenses", "shortName": "Accounts receivable and prepaid expenses", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R10": { "role": "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilities", "longName": "00000010 - Disclosure - Right-of-use assets and lease liabilities", "shortName": "Right-of-use assets and lease liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfLeaseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfLeaseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R11": { "role": "http://almadenminerals.com/role/PropertyPlantAndEquipment", "longName": "00000011 - Disclosure - Property, plant and equipment", "shortName": "Property, plant and equipment", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R12": { "role": "http://almadenminerals.com/role/ExplorationAndEvaluationAssets", "longName": "00000012 - Disclosure - Exploration and evaluation assets", "shortName": "Exploration and evaluation assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R13": { "role": "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrust", "longName": "00000013 - Disclosure - Gold loan payable and gold in trust", "shortName": "Gold loan payable and gold in trust", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R14": { "role": "http://almadenminerals.com/role/WarrantLiability", "longName": "00000014 - Disclosure - Warrant liability", "shortName": "Warrant liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:WarrantlibilityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:WarrantlibilityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R15": { "role": "http://almadenminerals.com/role/ShareCapitalAndReserves", "longName": "00000015 - Disclosure - Share capital and reserves", "shortName": "Share capital and reserves", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R16": { "role": "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalances", "longName": "00000016 - Disclosure - Related party transactions and balances", "shortName": "Related party transactions and balances", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R17": { "role": "http://almadenminerals.com/role/NetLossPerShare", "longName": "00000017 - Disclosure - Net loss per share", "shortName": "Net loss per share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R18": { "role": "http://almadenminerals.com/role/SupplementalCashFlowInformation", "longName": "00000018 - Disclosure - Supplemental cash flow information", "shortName": "Supplemental cash flow information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfSupplementalCashFlowInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfSupplementalCashFlowInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R19": { "role": "http://almadenminerals.com/role/IncomeTaxes", "longName": "00000019 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfIncomeTaxesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfIncomeTaxesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R20": { "role": "http://almadenminerals.com/role/FinancialInstruments", "longName": "00000020 - Disclosure - Financial instruments", "shortName": "Financial instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R21": { "role": "http://almadenminerals.com/role/ManagementOfCapital", "longName": "00000021 - Disclosure - Management of capital", "shortName": "Management of capital", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R22": { "role": "http://almadenminerals.com/role/SegmentedInformation", "longName": "00000022 - Disclosure - Segmented information", "shortName": "Segmented information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R23": { "role": "http://almadenminerals.com/role/SubsequentEvent", "longName": "00000023 - Disclosure - Subsequent event", "shortName": "Subsequent event", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R24": { "role": "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies", "longName": "00000024 - Disclosure - Material accounting policies (Policies)", "shortName": "Material accounting policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R25": { "role": "http://almadenminerals.com/role/MaterialAccountingPoliciesTables", "longName": "00000025 - Disclosure - Material accounting policies (Tables)", "shortName": "Material accounting policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfConsolidatedFinancialStatementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock", "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfConsolidatedFinancialStatementTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock", "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R26": { "role": "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesTables", "longName": "00000026 - Disclosure - Accounts receivable and prepaid expenses (Tables)", "shortName": "Accounts receivable and prepaid expenses (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R27": { "role": "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables", "longName": "00000027 - Disclosure - Right-of-use assets and lease liabilities (Tables)", "shortName": "Right-of-use assets and lease liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfLeaseLiabilitiesAndCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfLeaseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfLeaseLiabilitiesAndCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfLeaseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R28": { "role": "http://almadenminerals.com/role/PropertyPlantAndEquipmentTables", "longName": "00000028 - Disclosure - Property, plant and equipment (Tables)", "shortName": "Property, plant and equipment (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R29": { "role": "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsTables", "longName": "00000029 - Disclosure - Exploration and evaluation assets (Tables)", "shortName": "Exploration and evaluation assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfExplorationAndEvaluationAssetTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfExplorationAndEvaluationAssetTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R30": { "role": "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustTables", "longName": "00000030 - Disclosure - Gold loan payable and gold in trust (Tables)", "shortName": "Gold loan payable and gold in trust (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R31": { "role": "http://almadenminerals.com/role/WarrantLiabilityTables", "longName": "00000031 - Disclosure - Warrant liability (Tables)", "shortName": "Warrant liability (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:ScheduleOfWarrantAssumptions", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:WarrantlibilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:ScheduleOfWarrantAssumptions", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:WarrantlibilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R32": { "role": "http://almadenminerals.com/role/ShareCapitalAndReservesTables", "longName": "00000032 - Disclosure - Share capital and reserves (Tables)", "shortName": "Share capital and reserves (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R33": { "role": "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesTables", "longName": "00000033 - Disclosure - Related party transactions and balances (Tables)", "shortName": "Related party transactions and balances (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R34": { "role": "http://almadenminerals.com/role/SupplementalCashFlowInformationTables", "longName": "00000034 - Disclosure - Supplemental cash flow information (Tables)", "shortName": "Supplemental cash flow information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfSupplementalCashFlowTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfSupplementalCashFlowInformationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfSupplementalCashFlowTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfSupplementalCashFlowInformationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R35": { "role": "http://almadenminerals.com/role/IncomeTaxesTables", "longName": "00000035 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclsoureOfDeferredIncomeTaxesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclsoureOfDeferredIncomeTaxesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R36": { "role": "http://almadenminerals.com/role/FinancialInstrumentsTables", "longName": "00000036 - Disclosure - Financial instruments (Tables)", "shortName": "Financial instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfFinancialAssetsAndLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfFinancialAssetsAndLiabilitiesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R37": { "role": "http://almadenminerals.com/role/SegmentedInformationTables", "longName": "00000037 - Disclosure - Segmented information (Tables)", "shortName": "Segmented information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:DisclosureOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R38": { "role": "http://almadenminerals.com/role/NatureOfOperationsDetailsNarrative", "longName": "00000038 - Disclosure - Nature of operations (Details Narrative)", "shortName": "Nature of operations (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:IncreaseDecreaseInWorkingCapital", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:IncreaseDecreaseInWorkingCapital", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfBasisOfConsolidationExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R39": { "role": "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails", "longName": "00000039 - Disclosure - Material accounting policies (Details)", "shortName": "Material accounting policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_PueblaHoldingsIncMember", "name": "aau:EntityName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "aau:DisclosureOfConsolidatedFinancialStatementTextBlock", "aau:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock", "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_PueblaHoldingsIncMember", "name": "aau:EntityName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "aau:DisclosureOfConsolidatedFinancialStatementTextBlock", "aau:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock", "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R40": { "role": "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "longName": "00000040 - Disclosure - Material accounting policies (Details 1)", "shortName": "Material accounting policies (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_FurnitureFixturesAndFittingsMember", "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "aau:DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_FurnitureFixturesAndFittingsMember", "name": "ifrs-full:DepreciationRatePropertyPlantAndEquipment", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "aau:DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock", "ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R41": { "role": "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetails", "longName": "00000041 - Disclosure - Accounts receivable and prepaid expenses (Details)", "shortName": "Accounts receivable and prepaid expenses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock", "aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CurrentTradeReceivables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock", "aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R42": { "role": "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetailsNarrative", "longName": "00000042 - Disclosure - Accounts receivable and prepaid expenses (Details Narrative)", "shortName": "Accounts receivable and prepaid expenses (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_TuligticProjectMember", "name": "ifrs-full:ValueAddedTaxReceivables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_TuligticProjectMember", "name": "ifrs-full:ValueAddedTaxReceivables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R43": { "role": "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails", "longName": "00000043 - Disclosure - Right-of-use assets and lease liabilities (Details)", "shortName": "Right-of-use assets and lease liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:LeaseLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfLeaseLiabilitiesAndCostsTextBlock", "aau:DisclosureOfLeaseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:PaymentsOfLeaseLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfLeaseLiabilitiesAndCostsTextBlock", "aau:DisclosureOfLeaseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R44": { "role": "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails1", "longName": "00000044 - Disclosure - Right-of-use assets and lease liabilities (Details 1)", "shortName": "Right-of-use assets and lease liabilities (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:RightofuseAssets", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": null }, "R45": { "role": "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2", "longName": "00000045 - Disclosure - Right-of-use assets and lease liabilities (Details 2)", "shortName": "Right-of-use assets and lease liabilities (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "aau:DisclosureOfLeaseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "aau:DisclosureOfLeaseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R46": { "role": "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetailsNarrative", "longName": "00000046 - Disclosure - Right-of-use assets and lease liabilities (Details Narrative)", "shortName": "Right-of-use assets and lease liabilities (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:IncreaseInLeaseLiability", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "aau:DisclosureOfLeaseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:IncreaseInLeaseLiability", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "aau:DisclosureOfLeaseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R47": { "role": "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails", "longName": "00000047 - Disclosure - Property, plant and equipment (Details)", "shortName": "Property, plant and equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "ifrs-full:PropertyPlantAndEquipment", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R48": { "role": "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetailsNarrative", "longName": "00000048 - Disclosure - Property, plant and equipment (Details Narrative)", "shortName": "Property, plant and equipment (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "aau:ImpairmentOfPropertyPlantsAndEquipment", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "aau:ImpairmentOfPropertyPlantsAndEquipment", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R49": { "role": "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "longName": "00000049 - Disclosure - Exploration and evaluation assets (Details)", "shortName": "Exploration and evaluation assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "aau:ExplorationAndEvaluationAssetsTransactionCosts", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfExplorationAndEvaluationAssetTextBlock", "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31", "name": "aau:ExplorationAndEvaluationAssetsTransactionCosts", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfExplorationAndEvaluationAssetTextBlock", "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R50": { "role": "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative", "longName": "00000050 - Disclosure - Exploration and evaluation assets (Details Narrative)", "shortName": "Exploration and evaluation assets (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfExplorationAndEvaluationAssetTextBlock", "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:VatRecovery", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R51": { "role": "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "longName": "00000051 - Disclosure - Gold loan payable and gold in trust (Details)", "shortName": "Gold loan payable and gold in trust (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "AsOf2022-12-31_custom_GoldLoanDerivativeInstrumentsMember", "name": "ifrs-full:DerivativeFinancialLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_custom_GoldLoanDerivativeInstrumentsMember", "name": "ifrs-full:DerivativeFinancialLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R52": { "role": "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "longName": "00000052 - Disclosure - Gold loan payable and gold in trust (Details 1)", "shortName": "Gold loan payable and gold in trust (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "aau:TrustAssetsMetals", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_GoldLoanMember", "name": "aau:GainLossOnAssetsInTrust", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfAssetsInTrustTextBlock", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R53": { "role": "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative", "longName": "00000053 - Disclosure - Gold loan payable and gold in trust (Details Narrative)", "shortName": "Gold loan payable and gold in trust (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "aau:BorrowingsMetalsNoncurrent", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2019-05-012019-05-14_custom_GoldLoanDerivativeInstrumentsMember", "name": "aau:DeriviativeLiabilityAssumptionsExpectedLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ifrs-full:DisclosureOfBorrowingsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R54": { "role": "http://almadenminerals.com/role/WarrantLiabilityDetails", "longName": "00000054 - Disclosure - Warrant liability (Details)", "shortName": "Warrant liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_WarrantsMember144110500", "name": "aau:WarrantsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "aau:ScheduleOfWarrantAssumptions", "aau:WarrantlibilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_ifrs-full_WarrantsMember144110500", "name": "aau:WarrantsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "aau:ScheduleOfWarrantAssumptions", "aau:WarrantlibilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R55": { "role": "http://almadenminerals.com/role/WarrantLiabilityDetails1", "longName": "00000055 - Disclosure - Warrant liability (Details 1)", "shortName": "Warrant liability (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember", "name": "aau:WarrantsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "aau:ScheduleOfWarrantDerivativeFinancialLiability", "aau:WarrantlibilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember", "name": "aau:WarrantsRiskFreeInterestRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "aau:ScheduleOfWarrantDerivativeFinancialLiability", "aau:WarrantlibilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R56": { "role": "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative", "longName": "00000056 - Disclosure - Warrant liability (Details Narrative)", "shortName": "Warrant liability (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember", "name": "aau:WarrantsExercisable", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "aau:WarrantlibilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember", "name": "aau:WarrantsExercisable", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "aau:WarrantlibilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R57": { "role": "http://almadenminerals.com/role/ShareCapitalAndReservesDetails", "longName": "00000057 - Disclosure - Share capital and reserves (Details)", "shortName": "Share capital and reserves (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31", "name": "ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R58": { "role": "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1", "longName": "00000058 - Disclosure - Share capital and reserves (Details 1)", "shortName": "Share capital and reserves (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "From2022-01-012022-12-31_custom_WarrantsIssuedOnMarch182021Member", "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31_custom_WarrantsIssuedOnMarch182021Member", "name": "ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R59": { "role": "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2", "longName": "00000059 - Disclosure - Share capital and reserves (Details 2)", "shortName": "Share capital and reserves (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "aau:ScheduleOfShareOptions", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2020-12-31", "name": "aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "aau:ScheduleOfShareOptions", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R60": { "role": "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3", "longName": "00000060 - Disclosure - Share capital and reserves (Details 3)", "shortName": "Share capital and reserves (Details 3)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_GrantOneMember", "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_GrantOneMember", "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R61": { "role": "http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative", "longName": "00000061 - Disclosure - Share capital and reserves (Details Narrative)", "shortName": "Share capital and reserves (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R62": { "role": "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetails", "longName": "00000062 - Disclosure - Related party transactions and balances (Details)", "shortName": "Related party transactions and balances (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:PaymentsForProfessionalFees", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:PaymentsForProfessionalFees", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R63": { "role": "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative", "longName": "00000063 - Disclosure - Related party transactions and balances (Details Narrative)", "shortName": "Related party transactions and balances (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "From2023-01-012023-12-31_custom_AzucarMember", "name": "aau:AdministrativeServicesFeesIncludedInOtherIncome", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-12-31_custom_AzucarMember", "name": "aau:AdministrativeServicesFeesIncludedInOtherIncome", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R64": { "role": "http://almadenminerals.com/role/NetLossPerShareDetailsNarrative", "longName": "00000064 - Disclosure - Net loss per share (Details Narrative)", "shortName": "Net loss per share (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:ProfitLossFromContinuingOperations", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:WeightedAverageShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R65": { "role": "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails", "longName": "00000065 - Disclosure - Supplemental cash flow information (Details)", "shortName": "Supplemental cash flow information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "aau:ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfSupplementalCashFlowTextBlock", "aau:DisclosureOfSupplementalCashFlowInformationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2022-01-012022-12-31", "name": "aau:ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfSupplementalCashFlowTextBlock", "aau:DisclosureOfSupplementalCashFlowInformationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R66": { "role": "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails1", "longName": "00000066 - Disclosure - Supplemental cash flow information (Details 1)", "shortName": "Supplemental cash flow information (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:Cash", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "aau:DisclosureOfSupplementalCashFlowInformationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:Cash", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "aau:DisclosureOfSupplementalCashFlowInformationTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R67": { "role": "http://almadenminerals.com/role/IncomeTaxesDetails", "longName": "00000067 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AccountingProfit", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclsoureOfDeferredIncomeTaxesTextBlock", "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "ifrs-full:AccountingProfit", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclsoureOfDeferredIncomeTaxesTextBlock", "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R68": { "role": "http://almadenminerals.com/role/IncomeTaxesDetails1", "longName": "00000068 - Disclosure - Income Taxes (Details 1)", "shortName": "Income Taxes (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "aau:DeferredTaxAssetsNonCapitalLosses", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfDeferredTaxAssetsAndLiabilitiesTextBlock", "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "aau:DeferredTaxAssetsNonCapitalLosses", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfDeferredTaxAssetsAndLiabilitiesTextBlock", "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R69": { "role": "http://almadenminerals.com/role/IncomeTaxesDetails2", "longName": "00000069 - Disclosure - Income Taxes (Details 2)", "shortName": "Income Taxes (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTextBlock", "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTextBlock", "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R70": { "role": "http://almadenminerals.com/role/IncomeTaxesDetailsNarrative", "longName": "00000070 - Disclosure - Income Taxes (Details Narrative)", "shortName": "Income Taxes (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "AsOf2023-12-31_custom_CountryOfCanadaMember", "name": "aau:OperatingLossCarryforward", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_custom_CountryOfCanadaMember", "name": "aau:OperatingLossCarryforward", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "aau:DisclosureOfIncomeTaxesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R71": { "role": "http://almadenminerals.com/role/FinancialInstrumentsDetails", "longName": "00000071 - Disclosure - Financial instruments (Details)", "shortName": "Financial instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfFinancialAssetsAndLiabilitiesTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfFinancialAssetsAndLiabilitiesTextBlock", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R72": { "role": "http://almadenminerals.com/role/FinancialInstrumentsDetails1", "longName": "00000072 - Disclosure - Financial instruments (Details 1)", "shortName": "Financial instruments (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NoncurrentDerivativeFinancialLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember", "name": "ifrs-full:NoncurrentDerivativeFinancialLiabilities", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "unique": true } }, "R73": { "role": "http://almadenminerals.com/role/FinancialInstrumentsDetailsNarrative", "longName": "00000073 - Disclosure - Financial instruments (Details Narrative)", "shortName": "Financial instruments (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:PossibleEffectOf10ChangeInExchangeRateRegardingTheUSDToTheNetIncomeLoss", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "aau:PossibleEffectOf10ChangeInExchangeRateRegardingTheUSDToTheNetIncomeLoss", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } }, "R74": { "role": "http://almadenminerals.com/role/SegmentedInformationDetails", "longName": "00000074 - Disclosure - Segmented information (Details)", "shortName": "Segmented information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfSegmentReportingInformationBySegmentTextBlock", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-12-31", "name": "ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "unitRef": "CAD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "aau:DisclosureOfSegmentReportingInformationBySegmentTextBlock", "ifrs-full:DisclosureOfOperatingSegmentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "f20f_042624.htm", "first": true, "unique": true } } }, "tag": { "ifrs-full_AccountingProfit": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccountingProfit", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Loss before income taxes" } }, "en": { "role": { "documentation": "The amount of profit (loss) for a period before deducting tax expense. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r23", "r24" ] }, "aau_AccountsReceivableAndPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AccountsReceivableAndPrepaidExpenses", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable and prepaid expenses", "label": "AccountsReceivableAndPrepaidExpenses" } } }, "auth_ref": [] }, "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated depreciation, amortisation and impairment [member]" } }, "en": { "role": { "documentation": "This member stands for accumulated depreciation, amortisation and impairment. [Refer: Impairment loss; Depreciation and amortisation expense]" } } }, "auth_ref": [ "r30", "r36", "r47", "r51", "r54" ] }, "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Additions/reduction (1)" } }, "en": { "role": { "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]" } } }, "auth_ref": [ "r31" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "aau_AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndPrepaidExpenses", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Accounts receivable and prepaid expenses" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation" } }, "en": { "role": { "documentation": "Adjustments for depreciation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r240" ] }, "ifrs-full_AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment of property, plant and equipment", "label": "Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment" } }, "en": { "role": { "documentation": "Adjustments for impairment loss (reversal of impairment loss) on property, plant and equipment recognised in profit or loss to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss; Property, plant and equipment]" } } }, "auth_ref": [ "r240" ] }, "aau_AdjustmentsForIncreaseDecreaseInTradeAccountsPayableAndOtherOperatingPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountsPayableAndOtherOperatingPayable", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Trade and other payables" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForReconcileProfitLossAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Items not affecting cash" } } }, "auth_ref": [] }, "aau_AdministrativeServicesFees": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AdministrativeServicesFees", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Administrative services fees (Note 11(b))" } } }, "auth_ref": [] }, "aau_AdministrativeServicesFeesIncludedInOtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AdministrativeServicesFeesIncludedInOtherIncome", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Administrative services fees included in other income" } } }, "auth_ref": [] }, "ifrs-full_AggregatedTimeBandsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedTimeBandsMember", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used." } } }, "auth_ref": [ "r13", "r74", "r82", "r83", "r84", "r85", "r86", "r87", "r102", "r190", "r200", "r201" ] }, "ifrs-full_AllLevelsOfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AllLevelsOfFairValueHierarchyMember", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails1" ], "lang": { "en": { "role": { "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used." } } }, "auth_ref": [ "r37", "r71" ] }, "aau_AlmadexMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AlmadexMember", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Almadex [Member]" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "aau_AmortizationOfRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AmortizationOfRightofuseAssets", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Amortization of right-of-use assets" } } }, "auth_ref": [] }, "aau_AmountOfSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AmountOfSharebasedPayments", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based payments", "label": "AmountOfSharebasedPayments" } } }, "auth_ref": [] }, "ifrs-full_AmountsReceivableRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AmountsReceivableRelatedPartyTransactions", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amounts receivable, related party transactions" } }, "en": { "role": { "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r39", "r42" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r222" ] }, "ifrs-full_ApplicableTaxRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ApplicableTaxRate", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Statutory rate" } }, "en": { "role": { "documentation": "The applicable income tax rate." } } }, "auth_ref": [ "r24" ] }, "aau_April302022Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "April302022Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date April 30, 2022 [Member]" } } }, "auth_ref": [] }, "aau_April302022OneMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "April302022OneMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock Options Expiry Date April 30, 2022 [Member]", "label": "Stock Options Expiry Date April 30, 2022 [Member] [Default Label]" } } }, "auth_ref": [] }, "aau_April32028Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "April32028Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date April 3, 2028 [Member]" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r10", "r70", "r71", "r72", "r114", "r116" ] }, "ifrs-full_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AssetsAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r222" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorFirmId", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r219", "r221", "r222" ] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorLocation", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r219", "r221", "r222" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditorName", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r219", "r221", "r222" ] }, "aau_August132021Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "August132021Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date August 13, 2021 [Member]" } } }, "auth_ref": [] }, "aau_AzucarMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "AzucarMember", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Azucar [Member]" } } }, "auth_ref": [] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Basic net loss per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r43", "r44" ] }, "ifrs-full_BorrowingCostsRecognisedAsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingCostsRecognisedAsExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 8.0 }, "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Interest, accretion and standby fees on gold loan payable (Note 8)", "verboseLabel": "Interest, accretion and standby fees on gold loan payable" } }, "en": { "role": { "documentation": "The amount of interest and other costs that an entity incurs in connection with the borrowing of funds that are recognised as an expense." } } }, "auth_ref": [ "r230" ] }, "aau_BorrowingsAccretionExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "BorrowingsAccretionExpense", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails" ], "lang": { "en-us": { "role": { "label": "Accretion expense" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsByNameAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameAxis", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Borrowings by name [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r243" ] }, "ifrs-full_BorrowingsByNameMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsByNameMember", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]" } } }, "auth_ref": [ "r243" ] }, "aau_BorrowingsForeignExchangeDifferences": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "BorrowingsForeignExchangeDifferences", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails" ], "lang": { "en-us": { "role": { "label": "Foreign exchange difference" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Borrowings, interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r243" ] }, "aau_BorrowingsMetalNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "BorrowingsMetalNoncurrent", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Gold loan payable, beginning balance", "periodEndLabel": "Gold loan payable, ending balance", "label": "BorrowingsMetalNoncurrent" } } }, "auth_ref": [] }, "aau_BorrowingsMetalsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "BorrowingsMetalsNoncurrent", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Gold loan payable (Note 8)", "verboseLabel": "Borrowings, metals, noncurrent" } } }, "auth_ref": [] }, "aau_BorrowingsStandbyFee": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "BorrowingsStandbyFee", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Borrowings, standby fee" } } }, "auth_ref": [] }, "aau_BorrowingsStandbyFeesAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "BorrowingsStandbyFeesAccrued", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails" ], "lang": { "en-us": { "role": { "label": "Accrued standby fees" } } }, "auth_ref": [] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r221", "r222" ] }, "aau_CapitalLossCarryForwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "CapitalLossCarryForwardsMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Capital Loss Carry Forwards [Member]" } } }, "auth_ref": [] }, "ifrs-full_CapitalReserve": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CapitalReserve", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Reserves (Note 10)" } }, "en": { "role": { "documentation": "A component of equity representing the capital reserves." } } }, "auth_ref": [ "r232" ] }, "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r30", "r33", "r47", "r48", "r50", "r51", "r52", "r53", "r54", "r97", "r106", "r107" ] }, "ifrs-full_CarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CarryingAmountMember", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r33", "r48", "r50", "r52", "r53", "r97", "r106", "r107" ] }, "aau_CarryingValueOfPropertyConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "CarryingValueOfPropertyConsideration", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Carrying value of property" } } }, "auth_ref": [] }, "ifrs-full_Cash": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Cash", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails1": { "parentTag": "ifrs-full_CashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails1" ], "lang": { "en-us": { "role": { "label": "Cash" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]" } } }, "auth_ref": [ "r241" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails", "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents (Note 13)", "periodStartLabel": "Cash and cash equivalents, beginning of year", "periodEndLabel": "Cash and cash equivalents, end of year", "verboseLabel": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r7", "r56", "r69" ] }, "ifrs-full_CashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashEquivalents", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails1" ], "lang": { "en-us": { "role": { "totalLabel": "Total cash and cash equivalents", "label": "Cash equivalents" } }, "en": { "role": { "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value." } } }, "auth_ref": [ "r241" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash from (used in) financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r55", "r58" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Financing activities" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r55", "r58" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Investing activities" } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/NatureOfOperationsDetailsNarrative", "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "negatedLabel": "Negative cash flows from operations", "label": "Cash flows from (used in) operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r55", "r58" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Operating activities" } } }, "auth_ref": [] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetailsNarrative", "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r41" ] }, "aau_ChairmansDaughterMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ChairmansDaughterMember", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Chairmans Daughter [Member]" } } }, "auth_ref": [] }, "aau_ChangesInNoncashWorkingCapitalComponentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ChangesInNoncashWorkingCapitalComponentsAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Changes in non-cash working capital components" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "aau_ClaimMaintenanceAndLeaseCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ClaimMaintenanceAndLeaseCosts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Claim maintenance/lease costs" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfFinancialInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsAxis", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3", "http://almadenminerals.com/role/WarrantLiabilityDetails", "http://almadenminerals.com/role/WarrantLiabilityDetails1", "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of financial instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r106", "r108", "r109", "r110" ] }, "ifrs-full_ClassesOfFinancialInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialInstrumentsMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3", "http://almadenminerals.com/role/WarrantLiabilityDetails", "http://almadenminerals.com/role/WarrantLiabilityDetails1", "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes of financial instruments. Financial instruments are contracts that give rise to a financial asset of one entity and a financial liability or equity instrument of another entity. It also represents the standard value for the 'Classes of financial instruments' axis if no other member is used. [Refer: Financial assets; Financial liabilities]" } } }, "auth_ref": [ "r106", "r108", "r109", "r110" ] }, "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Classes of intangible assets other than goodwill [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r49" ] }, "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfPropertyPlantAndEquipmentAxis", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative", "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails", "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of property, plant and equipment [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r34" ] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r3" ] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive loss for the year", "label": "Total comprehensive loss for the year" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r1", "r20", "r60", "r62", "r67", "r197" ] }, "ifrs-full_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerEquipmentMember", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing computer equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r236" ] }, "ifrs-full_ComputerSoftwareMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComputerSoftwareMember", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Computer software [member]" } }, "en": { "role": { "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r192" ] }, "dei_ContactPersonnelEmailAddress": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelEmailAddress", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Email Address", "documentation": "Email address of contact personnel." } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "aau_CountryOfCanadaMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "CountryOfCanadaMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetailsNarrative", "http://almadenminerals.com/role/SegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Country Of Canada [Member]" } } }, "auth_ref": [] }, "aau_CountryOfMexicoMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "CountryOfMexicoMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetailsNarrative", "http://almadenminerals.com/role/SegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Country Of Mexico [Member]" } } }, "auth_ref": [] }, "aau_CountryOfUnitedStatesMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "CountryOfUnitedStatesMember", "presentation": [ "http://almadenminerals.com/role/SegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Country Of United States [Member]" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r14", "r63", "r197" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current portion of lease liabilities (Note 5)", "negatedLabel": "Less: current portion of lease liabilities" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r76" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r15", "r65", "r197" ] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetails": { "parentTag": "aau_CurrentTradeReceivablesAndPrepaidExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Prepaid expenses" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r230" ] }, "ifrs-full_CurrentTradeReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentTradeReceivables", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetails": { "parentTag": "aau_CurrentTradeReceivablesAndPrepaidExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Accounts receivable (Note 11(b))" } }, "en": { "role": { "documentation": "The amount of current trade receivables. [Refer: Trade receivables]" } } }, "auth_ref": [ "r186", "r187" ] }, "aau_CurrentTradeReceivablesAndPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "CurrentTradeReceivablesAndPrepaidExpenses", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 3.0 }, "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetails", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accounts receivable and prepaid expenses (Note 4)", "totalLabel": "Total" } } }, "auth_ref": [] }, "aau_December122021Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "December122021Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date December 12, 2021 [Member]" } } }, "auth_ref": [] }, "aau_December152022Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "December152022Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date December 15, 2022 [Member]" } } }, "auth_ref": [] }, "aau_December162027Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "December162027Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date December 16, 2027 [Member]" } } }, "auth_ref": [] }, "ifrs-full_DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Deductible temporary differences" } }, "en": { "role": { "documentation": "The amount of deductible temporary differences for which no deferred tax asset is recognised in the statement of financial position. [Refer: Temporary differences [member]]" } } }, "auth_ref": [ "r25" ] }, "aau_DeferredExplorationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DeferredExplorationCosts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Total deferred exploration costs during the year" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxAssets", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Deferred tax assets" } }, "en": { "role": { "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r9", "r11", "r26" ] }, "aau_DeferredTaxAssetsExplorationAndEvaluation": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DeferredTaxAssetsExplorationAndEvaluation", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Exploration and evaluation assets, deferred tax assets" } } }, "auth_ref": [] }, "aau_DeferredTaxAssetsNonCapitalLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DeferredTaxAssetsNonCapitalLosses", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Non-capital losses" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxExpenseIncome", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": -1.0, "order": 2.0 }, "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://almadenminerals.com/role/IncomeTaxesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails", "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred income tax recovery (expense) (Note 14)", "label": "Deferred income tax (recovery) expense", "totalLabel": "Deferred income tax (recovery) expense" } }, "en": { "role": { "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r27" ] }, "aau_DeferredTaxLiabilitiesExplorationAndEvaluation": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DeferredTaxLiabilitiesExplorationAndEvaluation", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Exploration and evaluation assets, deferred tax liabilities" } } }, "auth_ref": [] }, "ifrs-full_DeferredTaxLiabilityAsset": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DeferredTaxLiabilityAsset", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deferred income tax liability (Note 14)" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities or assets. [Refer: Deferred tax liabilities; Deferred tax assets]" } } }, "auth_ref": [ "r26" ] }, "aau_DeficitMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DeficitMember", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Deficit [Member]" } } }, "auth_ref": [] }, "ifrs-full_DepreciationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Depreciation (Note 6)" } }, "en": { "role": { "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives." } } }, "auth_ref": [ "r230" ] }, "ifrs-full_DepreciationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationPropertyPlantAndEquipment", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation", "label": "Depreciation, property, plant and equipment" } }, "en": { "role": { "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]" } } }, "auth_ref": [ "r32", "r35" ] }, "ifrs-full_DepreciationRatePropertyPlantAndEquipment": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRatePropertyPlantAndEquipment", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Property, plant and equipment", "label": "Depreciation rate, property, plant and equipment" } }, "en": { "role": { "documentation": "The depreciation rate used for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r29" ] }, "ifrs-full_DepreciationRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationRightofuseAssets", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails1", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Amortization of right-of-use assets (Note 5)", "negatedLabel": "Less: amortization of ROU assets" } }, "en": { "role": { "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]" } } }, "auth_ref": [ "r77" ] }, "ifrs-full_DerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DerivativeFinancialLiabilities", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Derivative financial liabilities, beginning balance", "periodEndLabel": "Derivative financial liabilities, ending balance", "label": "Derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r232" ] }, "aau_DerivativeFinancialLiabilityMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DerivativeFinancialLiabilityMember", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetails1", "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative Financial Liability [Member]" } } }, "auth_ref": [] }, "aau_DerivativeLiabilitiesForeignExchangeDifferences": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DerivativeLiabilitiesForeignExchangeDifferences", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Foreign exchange difference", "label": "DerivativeLiabilitiesForeignExchangeDifferences" } } }, "auth_ref": [] }, "aau_DerivativeLiabilityAssumptionsExpectedVolatility": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DerivativeLiabilityAssumptionsExpectedVolatility", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative liability, assumptions, expected volatility" } } }, "auth_ref": [] }, "aau_DerivativeLiabilityAssumptionsRiskfreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DerivativeLiabilityAssumptionsRiskfreeInterestRate", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Derivative liability, assumptions, risk-free interest rate" } } }, "auth_ref": [] }, "aau_DerivativesFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DerivativesFinancialLiabilities", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Derivatives financial liabilities" } } }, "auth_ref": [] }, "aau_DeriviativeLiabilityAssumptionsExpectedLife": { "xbrltype": "durationItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DeriviativeLiabilityAssumptionsExpectedLife", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Deriviative liability, assumptions, expected life (Year)" } } }, "auth_ref": [] }, "aau_DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of consolidation" } } }, "auth_ref": [] }, "aau_DescriptionOfAccountingPolicyForCapitalSharesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DescriptionOfAccountingPolicyForCapitalSharesTextBlock", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Share capital" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForEarningsPerShareExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss per share", "label": "Description of accounting policy for earnings per share [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for earnings per share." } } }, "auth_ref": [ "r231" ] }, "ifrs-full_DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Exploration and evaluation assets", "label": "Description of accounting policy for exploration and evaluation expenditures [text block]" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy for exploration and evaluation assets. [Refer: Exploration and evaluation assets [member]]" } } }, "auth_ref": [ "r99" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Financial instruments", "label": "Description of accounting policy for financial instruments [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r231" ] }, "ifrs-full_DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Foreign currencies" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for foreign currency translation." } } }, "auth_ref": [ "r231" ] }, "ifrs-full_DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Impairment of property, plant and equipment", "label": "Description of accounting policy for impairment of assets [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the impairment of assets." } } }, "auth_ref": [ "r231" ] }, "ifrs-full_DescriptionOfAccountingPolicyForIncomeTaxExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForIncomeTaxExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income taxes" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for income tax." } } }, "auth_ref": [ "r231" ] }, "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Leases" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time." } } }, "auth_ref": [ "r231" ] }, "aau_DescriptionOfAccountingPolicyForNewAndRevisedAccountingStandardsEffectiveAtTheBeggingOfTheYear": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DescriptionOfAccountingPolicyForNewAndRevisedAccountingStandardsEffectiveAtTheBeggingOfTheYear", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Standards issued or amended but not yet effective" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Property, plant and equipment", "label": "Description of accounting policy for property, plant and equipment [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r231" ] }, "aau_DescriptionOfAccountingPolicyForReclamationAndClosureCostObligationsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DescriptionOfAccountingPolicyForReclamationAndClosureCostObligationsTextBlock", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reclamation and closure cost obligations" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based payments", "label": "Description of accounting policy for share-based payment transactions [text block]" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for transactions in which the entity: (a) receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or (b) incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r231" ] }, "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents" } }, "en": { "role": { "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r57" ] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Expected volatility, stock options" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r94" ] }, "aau_DescriptionOfExpectedVolatilityWarrantsGranted": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DescriptionOfExpectedVolatilityWarrantsGranted", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1" ], "lang": { "en-us": { "role": { "label": "Description of expected volatility warrants granted", "verboseLabel": "Expected volatility" } } }, "auth_ref": [] }, "aau_DescriptionOfOptionLifeSharesOptionsGranted": { "xbrltype": "durationItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DescriptionOfOptionLifeSharesOptionsGranted", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Expected life, stock options" } } }, "auth_ref": [] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate, stock options" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r94" ] }, "ifrs-full_DescriptionOfUsefulLifePropertyPlantAndEquipment": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfUsefulLifePropertyPlantAndEquipment", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "Property, plant and equipment", "label": "Description of useful life, property, plant and equipment" } }, "en": { "role": { "documentation": "Description of useful life used for property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r29" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Diluted net loss per share" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r43", "r44" ] }, "ifrs-full_DirectorsRemunerationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DirectorsRemunerationExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Directors\u2019 fees (Note 11(a))" } }, "en": { "role": { "documentation": "The amount of remuneration paid or payable to the entity's directors." } } }, "auth_ref": [ "r230" ] }, "aau_DisclosureAccountsReceivableAndPrepaidExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureAccountsReceivableAndPrepaidExpensesAbstract", "lang": { "en-us": { "role": { "label": "Accounts Receivable And Prepaid Expenses" } } }, "auth_ref": [] }, "aau_DisclosureBasisOfPresentationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureBasisOfPresentationAbstract", "lang": { "en-us": { "role": { "label": "Basis Of Presentation" } } }, "auth_ref": [] }, "aau_DisclosureIncomeTaxesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureIncomeTaxesAbstract", "lang": { "en-us": { "role": { "label": "Income Taxes" } } }, "auth_ref": [] }, "aau_DisclosureMaterialAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureMaterialAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Material Accounting Policies" } } }, "auth_ref": [] }, "aau_DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock", "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of accounts receivable and prepaid expenses" } } }, "auth_ref": [] }, "aau_DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock", "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpenses" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts receivable and prepaid expenses", "label": "DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en-us": { "role": { "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date." } } }, "auth_ref": [ "r13" ] }, "aau_DisclosureOfAssetsInTrustTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfAssetsInTrustTextBlock", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustTables" ], "lang": { "en-us": { "role": { "label": "Schedule of gold in trust" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBasisOfConsolidationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBasisOfConsolidationExplanatory", "presentation": [ "http://almadenminerals.com/role/NatureOfOperations" ], "lang": { "en-us": { "role": { "label": "Nature of operations" } }, "en": { "role": { "documentation": "The disclosure of the basis used for consolidation." } } }, "auth_ref": [ "r229" ] }, "aau_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanator": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanator", "presentation": [ "http://almadenminerals.com/role/BasisOfPresentation" ], "lang": { "en-us": { "role": { "label": "Basis of presentation" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfBorrowingsExplanatory", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrust" ], "lang": { "en-us": { "role": { "label": "Gold loan payable and gold in trust" } }, "en": { "role": { "documentation": "The disclosure of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r229" ] }, "aau_DisclosureOfConsolidatedFinancialStatementTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfConsolidatedFinancialStatementTextBlock", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of consolidated financial statements" } } }, "auth_ref": [] }, "aau_DisclosureOfDeferredTaxAssetsAndLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfDeferredTaxAssetsAndLiabilitiesTextBlock", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred tax assets and liabilities" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsExplanatory", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustTables" ], "lang": { "en-us": { "role": { "label": "Schedule of gold loan payable" } }, "en": { "role": { "documentation": "The disclosure of detailed information about borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r243" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentTables" ], "lang": { "en-us": { "role": { "verboseLabel": "Schedule of property, plant and equipment", "label": "Disclosure of detailed information about property, plant and equipment [text block]" } }, "en": { "role": { "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r34" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://almadenminerals.com/role/NetLossPerShare" ], "lang": { "en-us": { "role": { "label": "Net loss per share" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r46" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "presentation": [ "http://almadenminerals.com/role/SubsequentEvent" ], "lang": { "en-us": { "role": { "label": "Subsequent event" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r22" ] }, "aau_DisclosureOfExplorationAndEvaluationAssetTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfExplorationAndEvaluationAssetTextBlock", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of exploration and evaluation assets" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfExplorationAndEvaluationAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfExplorationAndEvaluationAssetsExplanatory", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssets" ], "lang": { "en-us": { "role": { "label": "Exploration and evaluation assets" } }, "en": { "role": { "documentation": "The entire disclosure for exploration and evaluation assets." } } }, "auth_ref": [ "r101" ] }, "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueMeasurementOfAssetsTable", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails1" ], "lang": { "en-us": { "role": { "label": "Disclosure of fair value measurement of assets [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the fair value measurement of assets." } } }, "auth_ref": [ "r73" ] }, "ifrs-full_DisclosureOfFairValueOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFairValueOfFinancialInstrumentsExplanatory", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of assets and liabilities at fair value" } }, "en": { "role": { "documentation": "The disclosure of the fair value of financial instruments. [Refer: Financial instruments, class [member]; At fair value [member]]" } } }, "auth_ref": [ "r229" ] }, "aau_DisclosureOfFinancialAssetsAndLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfFinancialAssetsAndLiabilitiesTextBlock", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of assets and liabilities" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://almadenminerals.com/role/FinancialInstruments" ], "lang": { "en-us": { "role": { "label": "Financial instruments" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r113" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsTable", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3", "http://almadenminerals.com/role/WarrantLiabilityDetails", "http://almadenminerals.com/role/WarrantLiabilityDetails1", "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about financial instruments [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of financial instruments." } } }, "auth_ref": [ "r105", "r108", "r112" ] }, "aau_DisclosureOfIncomeTaxesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfIncomeTaxesExplanatory", "presentation": [ "http://almadenminerals.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "verboseLabel": "Income Taxes", "label": "DisclosureOfIncomeTaxesExplanatory" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of -Warrant Fair Value Assumptions" } }, "en": { "role": { "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's other equity instruments (ie other than share options)." } } }, "auth_ref": [ "r96" ] }, "ifrs-full_DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of share option fair value assumptions" } }, "en": { "role": { "documentation": "The disclosure of information about indirect, by reference to the fair value of the equity instruments granted, measurement of the fair value of goods or services received as consideration for the entity's share options." } } }, "auth_ref": [ "r95" ] }, "aau_DisclosureOfLeaseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfLeaseExplanatory", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilities" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets and lease liabilities" } } }, "auth_ref": [] }, "aau_DisclosureOfLeaseLiabilitiesAndCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfLeaseLiabilitiesAndCostsTextBlock", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of continuity of lease liabilities" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of remaining payments for the operating lease" } }, "en": { "role": { "documentation": "The disclosure of a maturity analysis of operating lease payments. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } } }, "auth_ref": [ "r83" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Continuity of Warrants" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options)." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory", "presentation": [ "http://almadenminerals.com/role/ManagementOfCapital" ], "lang": { "en-us": { "role": { "label": "Management of capital" } }, "en": { "role": { "documentation": "The disclosure of information that enables users of financial statements to evaluate the entity's objectives, policies and processes for managing capital." } } }, "auth_ref": [ "r4" ] }, "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfOperatingSegmentsExplanatory", "presentation": [ "http://almadenminerals.com/role/SegmentedInformation" ], "lang": { "en-us": { "role": { "label": "Segmented information" } }, "en": { "role": { "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]" } } }, "auth_ref": [ "r114" ] }, "aau_DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property, plant and equipment" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfPropertyPlantAndEquipmentTable", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative", "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about property, plant and equipment [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of property, plant and equipment." } } }, "auth_ref": [ "r34" ] }, "aau_DisclosureOfPropertyPlantAndEquipmentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfPropertyPlantAndEquipmentsExplanatory", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipment" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of continuity of ROU assets" } }, "en": { "role": { "documentation": "The disclosure of quantitative information about right-of-use assets. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r81" ] }, "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of reconciliation of changes in goodwill [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill." } } }, "auth_ref": [ "r97" ] }, "aau_DisclosureOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://almadenminerals.com/role/SegmentedInformationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of non-current Assets" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReserves" ], "lang": { "en-us": { "role": { "label": "Share capital and reserves" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r18" ] }, "aau_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Material accounting policies" } } }, "auth_ref": [] }, "aau_DisclosureOfSupplementalCashFlowInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfSupplementalCashFlowInformationTextBlock", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformation" ], "lang": { "en-us": { "role": { "label": "Supplemental cash flow information" } } }, "auth_ref": [] }, "aau_DisclosureOfSupplementalCashFlowTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfSupplementalCashFlowTextBlock", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of supplemental information" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits." } } }, "auth_ref": [ "r28" ] }, "aau_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTextBlock", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deductible temporary differences" } } }, "auth_ref": [] }, "aau_DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of related party payments" } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalances" ], "lang": { "en-us": { "role": { "label": "Related party transactions and balances" } }, "en": { "role": { "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r40" ] }, "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable", "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetailsNarrative", "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of transactions between related parties [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to transactions between related parties." } } }, "auth_ref": [ "r41" ] }, "aau_DisclosurePropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosurePropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property Plant And Equipment" } } }, "auth_ref": [] }, "aau_DisclosureRightofuseAssetsAndLeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureRightofuseAssetsAndLeaseLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Right-of-use Assets And Lease Liabilities" } } }, "auth_ref": [] }, "aau_DisclosureSupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureSupplementalCashFlowInformationAbstract", "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information" } } }, "auth_ref": [] }, "aau_DisclosureWarrantLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclosureWarrantLiabilityAbstract", "lang": { "en-us": { "role": { "label": "Warrant Liability" } } }, "auth_ref": [] }, "aau_DisclsoureOfDeferredIncomeTaxesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DisclsoureOfDeferredIncomeTaxesTextBlock", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of deferred income taxes" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r221" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r219", "r221", "r222" ] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r219", "r221", "r222", "r224" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r220" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r208" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r221" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r221" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r223" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r211" ] }, "aau_DonationsMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DonationsMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Donations [Member]" } } }, "auth_ref": [] }, "aau_DrillEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "DrillEquipmentMember", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Drill Equipment [Member]" } } }, "auth_ref": [] }, "ifrs-full_EmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EmployeeBenefitsExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Salaries and benefits (Note 11(a))" } }, "en": { "role": { "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment." } } }, "auth_ref": [ "r0", "r21", "r183" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesLineItems", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesTable", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r210" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r214" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r210" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r210" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r228" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r210" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r225" ] }, "aau_EntityName": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "EntityName", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Entity name" } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r222" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r210" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r210" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r210" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r210" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r226" ] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetailsNarrative", "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r41" ] }, "aau_EnvironmentalStudies": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "EnvironmentalStudies", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Environmental and permit" } } }, "auth_ref": [] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodStartLabel": "Beginning balance, value", "periodEndLabel": "Ending balance, value", "label": "Equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r10", "r16", "r59", "r61", "r70", "r71", "r72" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "EQUITY" } } }, "auth_ref": [] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL EQUITY AND LIABILITIES", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r10" ] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r3" ] }, "aau_EquitySharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "EquitySharesOutstanding", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance, shares", "periodEndLabel": "Ending balance, shares", "documentation": "The number of equity shares outstanding.", "label": "aau_EquitySharesOutstanding" } } }, "auth_ref": [] }, "aau_ExercisedWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExercisedWeightedAverageExercisePrice", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Exercised, weighted average exercise price" } } }, "auth_ref": [] }, "aau_ExpectedAnnualizedVolatility": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExpectedAnnualizedVolatility", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetails", "http://almadenminerals.com/role/WarrantLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Expected annualized volatility" } } }, "auth_ref": [] }, "aau_ExpectedDividendWarrantsGranted": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExpectedDividendWarrantsGranted", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected dividend, warrants granted" } } }, "auth_ref": [] }, "aau_ExpectedLifeOfWarrantsInYears": { "xbrltype": "durationItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExpectedLifeOfWarrantsInYears", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetails", "http://almadenminerals.com/role/WarrantLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Expected life of warrants", "verboseLabel": "Expected life of warrants (in years)" } } }, "auth_ref": [] }, "ifrs-full_ExpenseByNature": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseByNature", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total Expenses", "label": "Expenses, by nature" } }, "en": { "role": { "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity." } } }, "auth_ref": [ "r21" ] }, "ifrs-full_ExpenseByNatureAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseByNatureAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Expenses" } } }, "auth_ref": [] }, "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 13.0 }, "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative", "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share-based payments (Note 10(d) and 11(a))", "verboseLabel": "Share-based payments", "terseLabel": "Expense from share-based payment transactions with employees" } }, "en": { "role": { "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]" } } }, "auth_ref": [ "r230" ] }, "aau_ExplorationAndEvaluationAssetsDeductibleDifferencesMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExplorationAndEvaluationAssetsDeductibleDifferencesMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Exploration and Evaluation Assets [Member]" } } }, "auth_ref": [] }, "aau_ExplorationAndEvaluationAssetsDeferredExplorationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExplorationAndEvaluationAssetsDeferredExplorationCosts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Opening balance", "periodEndLabel": "Closing balance", "label": "ExplorationAndEvaluationAssetsDeferredExplorationCosts" } } }, "auth_ref": [] }, "aau_ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "label": "Exploration and evaluation assets expenditures included in trade and other payables" } } }, "auth_ref": [] }, "aau_ExplorationAndEvaluationAssetsTransactionCostAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExplorationAndEvaluationAssetsTransactionCostAdditions", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Additions" } } }, "auth_ref": [] }, "aau_ExplorationAndEvaluationAssetsTransactionCostDeductions": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExplorationAndEvaluationAssetsTransactionCostDeductions", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Deductions" } } }, "auth_ref": [] }, "aau_ExplorationAndEvaluationAssetsTransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExplorationAndEvaluationAssetsTransactionCosts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Opening balance", "periodEndLabel": "Closing balance", "label": "ExplorationAndEvaluationAssetsTransactionCosts" } } }, "auth_ref": [] }, "aau_ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment of acquisition costs", "label": "Impairment of acquisition costs" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "aau_FairValueOfCashStockOptionsTransferredToShareCapitalOnExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "FairValueOfCashStockOptionsTransferredToShareCapitalOnExerciseOfOptions", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of cash stock options transferred to share capital on exercise of options" } } }, "auth_ref": [] }, "aau_FairValueOfFindersWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "FairValueOfFindersWarrants", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "label": "Fair value of finders\u2019 warrants" } } }, "auth_ref": [] }, "aau_FairValueOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "FairValueOfWarrants", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of warrants" } } }, "auth_ref": [] }, "aau_February142028Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "February142028Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date February 14, 2028 [Member]" } } }, "auth_ref": [] }, "aau_February72021Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "February72021Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date February 7, 2021 [Member]" } } }, "auth_ref": [] }, "aau_February72021OneMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "February72021OneMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock Options Expiry Date February 7, 2021 [Member]", "label": "Stock Options Expiry Date February 7, 2021 [Member] [Default Label]" } } }, "auth_ref": [] }, "aau_February92023Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "February92023Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date February 09, 2023 [Member]" } } }, "auth_ref": [] }, "aau_FieldEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "FieldEquipmentMember", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Field equipment [member]", "documentation": "This member stands for a class of plant, property and equipment representing field equipment." } } }, "auth_ref": [] }, "ifrs-full_FinancialAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialAssets", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Total assets" } }, "en": { "role": { "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]" } } }, "auth_ref": [ "r104", "r106", "r107", "r109", "r199" ] }, "ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r103" ] }, "ifrs-full_FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for financial instruments measured at fair value through profit or loss, because a credit derivative is used to manage the credit risk of these instruments. It also represents the standard value for the 'Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk' axis if no other member is used. [Refer: Financial instruments, class [member]; Credit risk [member]]" } } }, "auth_ref": [ "r103" ] }, "ifrs-full_FinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Warrant liability (Note 9)", "verboseLabel": "Total liabilities" } }, "en": { "role": { "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]" } } }, "auth_ref": [ "r104" ] }, "aau_FindersWarrantsIssuedPursuantToPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "FindersWarrantsIssuedPursuantToPrivatePlacement", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Finders\u2019 warrants issued pursuant to private placement" } } }, "auth_ref": [] }, "aau_ForfeitureRate": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ForfeitureRate", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetails", "http://almadenminerals.com/role/WarrantLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Forfeiture rate" } } }, "auth_ref": [] }, "aau_FurnitureFixturesAndFittingsMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "FurnitureFixturesAndFittingsMember", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Furniture, fixtures and fittings [member]", "documentation": "This member stands for a class of property, plant and equipment representing furniture, fixtures and fittings that are not permanently attached to real property." } } }, "auth_ref": [] }, "aau_GainLossOnAssetsInTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GainLossOnAssetsInTrust", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 6.0 }, "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized gain (loss) on gold in trust (Note 8)", "negatedLabel": "Unrealized (gain) loss on gold in trust", "verboseLabel": "Change in fair value through profit & loss, amount" } } }, "auth_ref": [] }, "aau_GainOnDebtForgiveness": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GainOnDebtForgiveness", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Gain on debt forgiveness (Note 11(a))" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnChangeInFairValueOfDerivatives", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative", "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized (gain) loss on derivative financial liabilities", "label": "Net gains (losses) on change in fair value of derivatives" } }, "en": { "role": { "documentation": "The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r234" ] }, "aau_GainsLossesOnChangesInFairValueOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GainsLossesOnChangesInFairValueOfDerivatives", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value through profit & loss", "label": "GainsLossesOnChangesInFairValueOfDerivatives" } } }, "auth_ref": [] }, "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Foreign exchange gain (loss)" } }, "en": { "role": { "documentation": "The amount of exchange differences recognised in profit or loss that arise from foreign currency transactions, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: At fair value [member]; Financial instruments, class [member]]" } } }, "auth_ref": [ "r5", "r38" ] }, "ifrs-full_GainsOnChangeInFairValueOfDerivatives": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GainsOnChangeInFairValueOfDerivatives", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Change in fair value of derivative financial liability" } }, "en": { "role": { "documentation": "The gains resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r234" ] }, "aau_GeochemicalAndMetallurgyCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GeochemicalAndMetallurgyCosts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Geochemical, metallurgy" } } }, "auth_ref": [] }, "aau_GeologicalLibraryMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GeologicalLibraryMember", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Geological library [member]", "documentation": "This member stands for a class of plant, property and equipment representing a geological library." } } }, "auth_ref": [] }, "aau_GeologyGeophysicsAndExplorationCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GeologyGeophysicsAndExplorationCosts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Geology, geophysics and exploration" } } }, "auth_ref": [] }, "aau_GoldInTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GoldInTrust", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Gold in trust" } } }, "auth_ref": [] }, "aau_GoldLoanDerivativeInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GoldLoanDerivativeInstrumentsMember", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gold Loan Derivative Instruments [Member]" } } }, "auth_ref": [] }, "aau_GoldLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GoldLoanMember", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gold Loan [Member]" } } }, "auth_ref": [] }, "aau_GoldLoanPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GoldLoanPayable", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Gold loan payable" } } }, "auth_ref": [] }, "aau_GrantEightMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantEightMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Eight [Member]" } } }, "auth_ref": [] }, "aau_GrantElevenMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantElevenMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Eleven [Member]" } } }, "auth_ref": [] }, "aau_GrantFifteenMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantFifteenMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Fifteen [Member]" } } }, "auth_ref": [] }, "aau_GrantFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantFiveMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Five [Member]" } } }, "auth_ref": [] }, "aau_GrantFourMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantFourMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Four [Member]" } } }, "auth_ref": [] }, "aau_GrantFourteenMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantFourteenMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Fourteen [Member]" } } }, "auth_ref": [] }, "aau_GrantNineMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantNineMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Nine [Member]" } } }, "auth_ref": [] }, "aau_GrantOneMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantOneMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant One [Member]" } } }, "auth_ref": [] }, "aau_GrantSevenMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantSevenMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Seven [Member]" } } }, "auth_ref": [] }, "aau_GrantSixMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantSixMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Six [Member]" } } }, "auth_ref": [] }, "aau_GrantTenMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantTenMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Ten [Member]" } } }, "auth_ref": [] }, "aau_GrantThirteenMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantThirteenMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Thirteen [Member]" } } }, "auth_ref": [] }, "aau_GrantThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantThreeMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Three [Member]" } } }, "auth_ref": [] }, "aau_GrantTwelveMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantTwelveMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Twelve [Member]" } } }, "auth_ref": [] }, "aau_GrantTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "GrantTwoMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Grant Two [Member]" } } }, "auth_ref": [] }, "ifrs-full_GrossCarryingAmountMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GrossCarryingAmountMember", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Gross carrying amount [member]" } }, "en": { "role": { "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]" } } }, "auth_ref": [ "r30", "r47", "r51", "r54", "r97", "r107", "r109", "r199" ] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r219", "r221", "r222" ] }, "aau_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "IfrsStatementLineItems", "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetailsNarrative", "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity", "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative", "http://almadenminerals.com/role/FinancialInstrumentsDetails1", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative", "http://almadenminerals.com/role/IncomeTaxesDetails2", "http://almadenminerals.com/role/IncomeTaxesDetailsNarrative", "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails", "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails", "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative", "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2", "http://almadenminerals.com/role/SegmentedInformationDetails", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3", "http://almadenminerals.com/role/WarrantLiabilityDetails", "http://almadenminerals.com/role/WarrantLiabilityDetails1", "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "aau_ImpairmentOfDeferredExplorationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ImpairmentOfDeferredExplorationCost", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment of deferred exploration cost", "label": "Impairment of deferred exploration cost" } } }, "auth_ref": [] }, "aau_ImpairmentOfExplorationAndEvaluationAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ImpairmentOfExplorationAndEvaluationAssets", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": -1.0, "order": 4.0 }, "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment of exploration and evaluation assets (Note 7)", "label": "Impairment of exploration and evaluation assets" } } }, "auth_ref": [] }, "aau_ImpairmentOfPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ImpairmentOfPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Impairment of property, plant and equipment (Note 6)", "label": "Impairment of property, plant and equipment" } } }, "auth_ref": [] }, "aau_ImpairmentOfPropertyPlantsAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ImpairmentOfPropertyPlantsAndEquipment", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Impairment on mill equipment" } } }, "auth_ref": [] }, "ifrs-full_IncomeFromSubleasingRightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeFromSubleasingRightofuseAssets", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating sublease income" } }, "en": { "role": { "documentation": "The amount of income from subleasing right-of-use assets. Sublease is a transaction for which an underlying asset is re-leased by a lessee (\u2018intermediate lessor\u2019) to a third party, and the lease (\u2018head lease\u2019) between the head lessor and lessee remains in effect. [Refer: Right-of-use assets]" } } }, "auth_ref": [ "r79" ] }, "ifrs-full_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Profit or loss [abstract]" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Change in cash and cash equivalents", "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r56" ] }, "ifrs-full_IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Fair value of cash stock options transferred to share capital" } }, "en": { "role": { "documentation": "The increase (decrease) in the fair value measurement of the entity's own equity instruments. [Refer: At fair value [member]; Entity's own equity instruments [member]]" } } }, "auth_ref": [ "r72" ] }, "aau_IncreaseDecreaseInLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "IncreaseDecreaseInLeaseLiabilities", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "label": "Lease liabilities" } } }, "auth_ref": [] }, "aau_IncreaseDecreaseInRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "IncreaseDecreaseInRightOfUseAssets", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets" } } }, "auth_ref": [] }, "aau_IncreaseDecreaseInWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "IncreaseDecreaseInWarrantLiability", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrant liability", "label": "IncreaseDecreaseInWarrantLiability" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseInWorkingCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInWorkingCapital", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/NatureOfOperationsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Working capital surplus" } }, "en": { "role": { "documentation": "The increase (decrease) in working capital." } } }, "auth_ref": [ "r240" ] }, "aau_IncreaseDecreaseThroughForeignExchangeInTrustAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "IncreaseDecreaseThroughForeignExchangeInTrustAssets", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1" ], "lang": { "en-us": { "role": { "label": "Foreign exchange difference, amount" } } }, "auth_ref": [] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Share-based payments" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r2" ] }, "aau_IncreaseInLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "IncreaseInLeaseLiability", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Increase in lease liability" } } }, "auth_ref": [] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Insurance" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } } }, "auth_ref": [ "r230" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwillMember", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]" } } }, "auth_ref": [ "r49", "r191", "r198" ] }, "ifrs-full_InterestExpenseOnBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnBorrowings", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails" ], "lang": { "en-us": { "role": { "label": "Accrued interest expense" } }, "en": { "role": { "documentation": "The amount of interest expense on borrowings. [Refer: Interest expense; Borrowings]" } } }, "auth_ref": [ "r230" ] }, "ifrs-full_InterestExpenseOnLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InterestExpenseOnLeaseLiabilities", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 }, "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails", "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Interest expense on lease liabilities (Note 5)", "verboseLabel": "Interest expenses on lease liability", "terseLabel": "Interest expense" } }, "en": { "role": { "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r78" ] }, "us-gaap_InterestIncomeOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestIncomeOther", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Interest and other income", "documentation": "Amount of interest income earned from interest bearing assets classified as other." } } }, "auth_ref": [] }, "aau_InvestmentTaxCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "InvestmentTaxCreditMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Investment Tax Credit [Member]" } } }, "auth_ref": [] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Share capital (Note 10)" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r188" ] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r3" ] }, "aau_July102028Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "July102028Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date July 10, 2028 [Member]" } } }, "auth_ref": [] }, "aau_July72021Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "July72021Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date July 7, 2021 [Member]" } } }, "auth_ref": [] }, "aau_July82023Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "July82023Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Option Expiry Date July 8, 2023 [Member]" } } }, "auth_ref": [] }, "aau_June102027Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "June102027Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date June 10, 2027 [Member]" } } }, "auth_ref": [] }, "aau_June92022Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "June92022Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date June 9, 2022 [Member]" } } }, "auth_ref": [] }, "aau_Jurisdiction": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "Jurisdiction", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Jurisdiction" } } }, "auth_ref": [] }, "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en-us": { "role": { "label": "Later than four years and not later than five years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than four years and not later than five years." } } }, "auth_ref": [ "r82", "r83", "r87", "r200", "r202", "r230" ] }, "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en-us": { "role": { "label": "Later than one year and not later than two years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than one year and not later than two years." } } }, "auth_ref": [ "r82", "r83", "r87", "r200", "r202", "r230" ] }, "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en-us": { "role": { "label": "Later than three years and not later than four years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than three years and not later than four years." } } }, "auth_ref": [ "r82", "r83", "r87", "r200", "r202", "r230" ] }, "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en-us": { "role": { "label": "Later than two years and not later than three years [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of later than two years and not later than three years." } } }, "auth_ref": [ "r82", "r83", "r87", "r200", "r202", "r230" ] }, "ifrs-full_LeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LeaseLiabilities", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Opening balance", "periodEndLabel": "Ending balance", "label": "Lease liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration." } } }, "auth_ref": [ "r76" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "ifrs-full_Level1OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level1OfFairValueHierarchyMember", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails1" ], "lang": { "en-us": { "role": { "label": "Level 1 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date." } } }, "auth_ref": [ "r37", "r71" ] }, "ifrs-full_Level2OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level2OfFairValueHierarchyMember", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails1" ], "lang": { "en-us": { "role": { "label": "Level 2 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly." } } }, "auth_ref": [ "r71" ] }, "ifrs-full_Level3OfFairValueHierarchyMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Level3OfFairValueHierarchyMember", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails1" ], "lang": { "en-us": { "role": { "label": "Level 3 of fair value hierarchy [member]" } }, "en": { "role": { "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability." } } }, "auth_ref": [ "r71" ] }, "ifrs-full_LevelsOfFairValueHierarchyAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LevelsOfFairValueHierarchyAxis", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails1" ], "lang": { "en-us": { "role": { "label": "Levels of fair value hierarchy [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r37", "r71" ] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r10", "r70", "r71", "r72", "r114", "r117" ] }, "ifrs-full_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LiabilitiesAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "LIABILITIES" } } }, "auth_ref": [] }, "aau_ListingAndFilingFees": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ListingAndFilingFees", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Listing and filing fees" } } }, "auth_ref": [] }, "aau_LoanPayableExtensionPeriod": { "xbrltype": "durationItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "LoanPayableExtensionPeriod", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan payable, extension period (Year)" } } }, "auth_ref": [] }, "aau_LoanPayableGoldDeliveryPaymentsPerMonthOunces": { "xbrltype": "integerItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "LoanPayableGoldDeliveryPaymentsPerMonthOunces", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan payable, gold delivery payments per month, ounces" } } }, "auth_ref": [] }, "aau_LoanPayableOuncesLoanedToCompany": { "xbrltype": "pureItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "LoanPayableOuncesLoanedToCompany", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loan payable, ounces, loaned to company" } } }, "auth_ref": [] }, "aau_LoansPayableOuncesOfGold": { "xbrltype": "integerItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "LoansPayableOuncesOfGold", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "periodStartLabel": "Gold in trust, beginning balance, ounces", "periodEndLabel": "Gold in trust, ending balance, ounces", "label": "Loans payable, ounces of gold" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "aau_LoganPropertyLocatedInTheYukonTerritoryCanadaMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "LoganPropertyLocatedInTheYukonTerritoryCanadaMember", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Logan Property Located In The Yukon Territory Canada [Member]" } } }, "auth_ref": [] }, "aau_March292021Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "March292021Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date March 29, 2021 [Member]" } } }, "auth_ref": [] }, "aau_March292021OneMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "March292021OneMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock Options Expiry Date March 29, 2021 [Member]", "label": "Stock Options Expiry Date March 29, 2021 [Member] [Default Label]" } } }, "auth_ref": [] }, "aau_March312023Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "March312023Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date March 31, 2023 [Member]" } } }, "auth_ref": [] }, "aau_March32023Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "March32023Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date March 3, 2023 [Member]" } } }, "auth_ref": [] }, "aau_March42022Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "March42022Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date March 4, 2022 [Member]" } } }, "auth_ref": [] }, "aau_March72027Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "March72027Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date March 7, 2027 [Member]" } } }, "auth_ref": [] }, "ifrs-full_MaturityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MaturityAxis", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en-us": { "role": { "label": "Maturity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r13", "r74", "r82", "r83", "r84", "r85", "r86", "r87", "r102", "r111", "r190", "r200" ] }, "aau_May282023Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "May282023Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Option Expiry Date May 28, 2023 [Member]" } } }, "auth_ref": [] }, "aau_May312022Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "May312022Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date May 31, 2022 [Member]" } } }, "auth_ref": [] }, "aau_May62021Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "May62021Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date May 6, 2021 [Member]" } } }, "auth_ref": [] }, "aau_May82023Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "May82023Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Option Expiry Date May 8, 2023 [Member]" } } }, "auth_ref": [] }, "aau_MillEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "MillEquipmentMember", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "label": "Mill Equipment [Member]" } } }, "auth_ref": [] }, "aau_MineraGorrionSAdeCVMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "MineraGorrionSAdeCVMember", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Minera Gorrion, S.A. de C.V. [Member]" } } }, "auth_ref": [] }, "aau_NatureOfOperation": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NatureOfOperation", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Nature of operations", "label": "NatureOfOperation" } } }, "auth_ref": [] }, "ifrs-full_NetAssetsLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetAssetsLiabilities", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "label": "Net assets" } }, "en": { "role": { "documentation": "The amount of assets less the amount of liabilities." } } }, "auth_ref": [ "r196", "r230" ] }, "ifrs-full_NetDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NetDeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails1" ], "lang": { "en-us": { "role": { "label": "Net deferred tax liabilities" } }, "en": { "role": { "documentation": "The amount of deferred tax liabilities net of deferred tax assets, when the absolute amount of deferred tax liabilities is greater than the absolute amount of deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]" } } }, "auth_ref": [ "r235" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "aau_NoncapitalLossCarryForwardsMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NoncapitalLossCarryForwardsMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Noncapital Loss Carry Forwards [Member]" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non current assets", "label": "Non-current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r14", "r64", "r197" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/SegmentedInformationDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Non-current assets", "label": "Non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets, and rights arising under insurance contracts" } }, "en": { "role": { "documentation": "The amount of non-current assets other than financial instruments, deferred tax assets, post-employment benefit assets and rights arising under insurance contracts. [Refer: Deferred tax assets; Financial instruments, class [member]; Non-current assets]" } } }, "auth_ref": [ "r118" ] }, "ifrs-full_NoncurrentDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentDerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails1", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Derivative financial liabilities (Note 8)", "verboseLabel": "Derivative financial liabilities" } }, "en": { "role": { "documentation": "The amount of non-current derivative financial liabilities. [Refer: Derivative financial liabilities]" } } }, "auth_ref": [ "r232" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Long-term portion of lease liabilities (Note 5)", "verboseLabel": "Long-term portion of lease liabilities" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r76" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non current liabilities", "label": "Non-current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r15", "r66", "r197" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities" } } }, "auth_ref": [] }, "ifrs-full_NotLaterThanOneYearMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotLaterThanOneYearMember", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en-us": { "role": { "label": "Not later than one year [member]" } }, "en": { "role": { "documentation": "This member stands for a time band of not later than one year." } } }, "auth_ref": [ "r12", "r82", "r83", "r87", "r200", "r202" ] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "aau_NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Options outstanding and exercisable, expired (in shares)" } } }, "auth_ref": [] }, "aau_NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock options, granted, outstanding and exercisable (in shares)" } } }, "auth_ref": [] }, "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1" ], "lang": { "en-us": { "role": { "label": "Issued", "verboseLabel": "Number of warrants" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement." } } }, "auth_ref": [ "r96", "r242" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, outstanding and exercisable", "periodEndLabel": "Balance, oustanding and exercisable", "label": "Number of other equity instruments exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Exercised", "label": "Number of other equity instruments exercised or vested in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Issued", "label": "Number of other equity instruments expired in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) expired in a share-based payment arrangement." } } }, "auth_ref": [ "r242" ] }, "ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Number of other equity instruments outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r242" ] }, "aau_NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Exercised, outstanding and exercisable (in shares)" } } }, "auth_ref": [] }, "aau_NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Expired, outstanding and exercisable (in shares)" } } }, "auth_ref": [] }, "aau_NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Issued, outstanding and exercisable (in shares)" } } }, "auth_ref": [] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Stock options, balance", "periodEndLabel": "Stock options, balance", "label": "Number of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r88", "r92", "r93" ] }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock options, exercised", "label": "Number of share options exercised in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } } }, "auth_ref": [ "r90" ] }, "aau_NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock options, exercised, outstanding and exercisable (in shares)" } } }, "auth_ref": [] }, "aau_NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate": { "xbrltype": "dateItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Expiry date" } } }, "auth_ref": [] }, "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Stock options, expired", "label": "Number of share options expired in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options expired in a share-based payment arrangement." } } }, "auth_ref": [ "r91" ] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Stock options, granted" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r89" ] }, "aau_NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Stock options, balance, outstanding and exercisable (in shares)", "periodEndLabel": "Stock options, balance, outstanding and exercisable (in shares)", "label": "NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement" } } }, "auth_ref": [] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares authorised (in shares)" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r17" ] }, "aau_NumberOfWarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "NumberOfWarrantsIssued", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrants issued (in shares)" } } }, "auth_ref": [] }, "ifrs-full_OccupancyExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OccupancyExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetailsNarrative", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Occupancy expenses (Note 5)", "verboseLabel": "Occupancy expense" } }, "en": { "role": { "documentation": "The amount of expense arising from occupancy services received by the entity." } } }, "auth_ref": [ "r234" ] }, "aau_October32022Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "October32022Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date October 3, 2022 [Member]" } } }, "auth_ref": [] }, "aau_October42027Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "October42027Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date October 4, 2027 [Member]" } } }, "auth_ref": [] }, "aau_OperatingLossCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "OperatingLossCarryforward", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Operating loss carryforwards" } } }, "auth_ref": [] }, "aau_OtherIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "OtherIncomeLoss", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total other income (loss)", "label": "OtherIncomeLoss" } } }, "auth_ref": [] }, "aau_OtherIncomeLossAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "OtherIncomeLossAbstract", "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other income (loss)" } } }, "auth_ref": [] }, "ifrs-full_OtherPropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherPropertyPlantAndEquipmentMember", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Other property, plant and equipment [member]" } }, "en": { "role": { "documentation": "This member stands for a class of property, plant and equipment representing property, plant and equipment that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r236" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r221" ] }, "ifrs-full_OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Outstanding commitments made on behalf of entity, related party transactions" } }, "en": { "role": { "documentation": "The amount of outstanding commitments made on behalf of the entity in related party transactions. [Refer: Related parties [member]]" } } }, "auth_ref": [ "r39" ] }, "aau_PaymentsForProfessionalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PaymentsForProfessionalFees", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetails" ], "lang": { "en-us": { "role": { "label": "Professional fees" } } }, "auth_ref": [] }, "aau_PaymentsForSalariesFeesAndBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PaymentsForSalariesFeesAndBenefits", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetails" ], "lang": { "en-us": { "role": { "label": "Salaries and benefits" } } }, "auth_ref": [] }, "aau_PaymentsMadeForDirectorsFees": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PaymentsMadeForDirectorsFees", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetails" ], "lang": { "en-us": { "role": { "label": "Directors\u2019 fees" } } }, "auth_ref": [] }, "aau_PaymentsOfLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PaymentsOfLeaseLiabilities", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: lease payments", "documentation": "The total cash outflow for payments of lease liabilities.", "label": "Less: lease payments" } } }, "auth_ref": [] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of lease liabilities", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r195" ] }, "aau_PaymentsToRelatedPartyServices": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PaymentsToRelatedPartyServices", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetails" ], "lang": { "en-us": { "role": { "label": "Total" } } }, "auth_ref": [] }, "aau_PossibleEffectOf10ChangeInExchangeRateRegardingTheMxnToTheNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PossibleEffectOf10ChangeInExchangeRateRegardingTheMxnToTheNetIncomeLoss", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Possible effect of 10% change in exchange rate regarding the MXN to the net income (loss)" } } }, "auth_ref": [] }, "aau_PossibleEffectOf10ChangeInExchangeRateRegardingTheUSDToTheNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PossibleEffectOf10ChangeInExchangeRateRegardingTheUSDToTheNetIncomeLoss", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Possible effect of 10% change in exchange rate regarding the USD to the net income (loss)" } } }, "auth_ref": [] }, "aau_PossibleEffectOf1ChangeInTheCommodityPriceToTheNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PossibleEffectOf1ChangeInTheCommodityPriceToTheNetIncomeLoss", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Possible effect of 1% change in the commodity price to the net income (loss)" } } }, "auth_ref": [] }, "aau_PossibleEffectOf1ChangeInTheInterestRateToTheNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PossibleEffectOf1ChangeInTheInterestRateToTheNetIncomeLoss", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Possible effect of 1% change in the interest rate to the net income (loss)" } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r215" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r216" ] }, "aau_PrivatePlacementsNetOfShareIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PrivatePlacementsNetOfShareIssueCosts", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Private placements, net of share issue costs" } } }, "auth_ref": [] }, "aau_PrivatePlacementsNetOfShareIssueCostsShares": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PrivatePlacementsNetOfShareIssueCostsShares", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Private placements, net of share issue costs, shares" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromExerciseOfOptions", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Options exercised" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of options." } } }, "auth_ref": [ "r239" ] }, "ifrs-full_ProceedsFromIssuingShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssuingShares", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of shares, net of share issue costs" } }, "en": { "role": { "documentation": "The cash inflow from issuing shares." } } }, "auth_ref": [ "r194" ] }, "aau_ProceedsFromSaleOfTrustAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ProceedsFromSaleOfTrustAssets", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1" ], "lang": { "en-us": { "role": { "label": "Sale of gold in trust, amount" } } }, "auth_ref": [] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Professional fees (Note 11(a))" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r230" ] }, "aau_ProfessionaltechnicalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ProfessionaltechnicalFees", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Professional/technical fees" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before income taxes", "label": "Profit (loss) before tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r98", "r183", "r184", "r203", "r204" ] }, "ifrs-full_ProfitLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/NatureOfOperationsDetailsNarrative", "http://almadenminerals.com/role/NetLossPerShareDetailsNarrative", "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss for the year", "label": "Net loss for the year", "negatedLabel": "Net loss", "negatedTerseLabel": "Profit loss" } }, "en": { "role": { "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations [member]; Profit (loss)]" } } }, "auth_ref": [ "r19", "r68", "r114", "r115" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Property, plant and equipment (Note 6)", "verboseLabel": "Carrying amounts" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r6", "r33" ] }, "aau_PropertyPlantAndEquipmentAccumulatedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PropertyPlantAndEquipmentAccumulatedDepreciation", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning, accumulated depreciation", "periodEndLabel": "Balance at ending, accumulated depreciation", "label": "PropertyPlantAndEquipmentAccumulatedDepreciation" } } }, "auth_ref": [] }, "aau_PropertyPlantAndEquipmentCost": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PropertyPlantAndEquipmentCost", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance at beginning, cost", "periodEndLabel": "Balance at ending, cost", "label": "PropertyPlantAndEquipmentCost" } } }, "auth_ref": [] }, "aau_PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Member]" } } }, "auth_ref": [] }, "ifrs-full_PropertyPlantAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipmentMember", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative", "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails1", "http://almadenminerals.com/role/PropertyPlantAndEquipmentDetails", "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r34", "r191", "r198" ] }, "aau_ProportionOfOwnershipInterestInAssociates": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ProportionOfOwnershipInterestInAssociates", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proportion of ownership interest in associate" } } }, "auth_ref": [] }, "aau_PueblaHoldingsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "PueblaHoldingsIncMember", "presentation": [ "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Puebla Holdings Inc. [Member]" } } }, "auth_ref": [] }, "ifrs-full_PurchaseOfExplorationAndEvaluationAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfExplorationAndEvaluationAssets", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Exploration and evaluation assets \u2013 costs", "label": "Purchase of exploration and evaluation assets" } }, "en": { "role": { "documentation": "The cash outflow for the purchase of exploration and evaluation assets. [Refer: Exploration and evaluation assets [member]]" } } }, "auth_ref": [ "r238" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Property, plant and equipment \u2013 purchase", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r193" ] }, "aau_RealizedGainLossOnSaleOfTrustAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "RealizedGainLossOnSaleOfTrustAssets", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1" ], "lang": { "en-us": { "role": { "label": "Gain on sale, amount" } } }, "auth_ref": [] }, "aau_RelatedPartySalaryContracted": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "RelatedPartySalaryContracted", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/RelatedPartyTransactionsAndBalancesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related party, salary contracted" } } }, "auth_ref": [] }, "aau_RelatedPartyTransactionsAndBalancesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "RelatedPartyTransactionsAndBalancesAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions And Balances" } } }, "auth_ref": [] }, "ifrs-full_ReserveOfSharebasedPaymentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfSharebasedPaymentsMember", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Reserve of share-based payments [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity resulting from share-based payments." } } }, "auth_ref": [ "r185" ] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://almadenminerals.com/role/NatureOfOperationsDetailsNarrative", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Deficit", "negatedLabel": "Accumulated deficit" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r188", "r189" ] }, "ifrs-full_RightofuseAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RightofuseAssets", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails1", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Right-of-use assets (Note 5)", "periodStartLabel": "Opening balance", "periodEndLabel": "Ending balance" } }, "en": { "role": { "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee." } } }, "auth_ref": [ "r75", "r80" ] }, "aau_RiskFreeInterestRateWarrantsGranted": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "RiskFreeInterestRateWarrantsGranted", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative", "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate, warrants granted", "verboseLabel": "Risk free interest rate" } } }, "auth_ref": [] }, "aau_SaleOfTrustAssetsOuncesOfGold": { "xbrltype": "integerItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "SaleOfTrustAssetsOuncesOfGold", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1" ], "lang": { "en-us": { "role": { "label": "Sale of gold in trust, ounces" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of supplemental information of cash and cash equivalents", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "aau_ScheduleOfShareOptions": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ScheduleOfShareOptions", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share options" } } }, "auth_ref": [] }, "aau_ScheduleOfWarrantAssumptions": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ScheduleOfWarrantAssumptions", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of warrant assumptions" } } }, "auth_ref": [] }, "aau_ScheduleOfWarrantDerivativeFinancialLiability": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ScheduleOfWarrantDerivativeFinancialLiability", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of derivative financial liability" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r209" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r213" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r212" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r217" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetailsNarrative", "http://almadenminerals.com/role/SegmentedInformationDetails" ], "auth_ref": [ "r123", "r124", "r128", "r129", "r130", "r168", "r169", "r170", "r171", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r205", "r206", "r244", "r245" ] }, "aau_SegmentedInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "SegmentedInformationAbstract", "lang": { "en-us": { "role": { "label": "Segmented Information" } } }, "auth_ref": [] }, "ifrs-full_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Office and other (Note 11(b))" } }, "en": { "role": { "documentation": "The amount of expense relating to selling, general and administrative activities of the entity." } } }, "auth_ref": [ "r234" ] }, "aau_September162021Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "September162021Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date September 16, 2021 [Member]" } } }, "auth_ref": [] }, "aau_September182023Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "September182023Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date September 18, 2023 [Member]" } } }, "auth_ref": [] }, "aau_September192028Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "September192028Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options Expiry Date September 19, 2028 [Member]" } } }, "auth_ref": [] }, "aau_ShareIssueCostsMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ShareIssueCostsMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Share Issue Costs [Member]" } } }, "auth_ref": [] }, "aau_SharesIssuedForCashOnExerciseOfStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "SharesIssuedForCashOnExerciseOfStockOptions", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for cash on exercise of stock options" } } }, "auth_ref": [] }, "aau_SharesIssuedForCashOnExerciseOfStockOptionsInShares": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "SharesIssuedForCashOnExerciseOfStockOptionsInShares", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Shares issued for cash on exercise of stock options, shares" } } }, "auth_ref": [] }, "ifrs-full_ShorttermDepositsClassifiedAsCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermDepositsClassifiedAsCashEquivalents", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails1": { "parentTag": "ifrs-full_CashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/SupplementalCashFlowInformationDetails1" ], "lang": { "en-us": { "role": { "label": "Term Deposits" } }, "en": { "role": { "documentation": "A classification of cash equivalents representing short-term deposits. [Refer: Cash equivalents]" } } }, "auth_ref": [ "r241" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r218" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetailsNarrative", "http://almadenminerals.com/role/SegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r123", "r124", "r128", "r129", "r130", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r205", "r206", "r244", "r245" ] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r3" ] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetailsNarrative", "http://almadenminerals.com/role/MaterialAccountingPoliciesDetails", "http://almadenminerals.com/role/SegmentedInformationDetails" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r119", "r120", "r121", "r122", "r125", "r126", "r127", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r207" ] }, "aau_StockOptionLimitationsMaximumAmountOfStockOptionsExercisableDuringA3MonthPeriod": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "StockOptionLimitationsMaximumAmountOfStockOptionsExercisableDuringA3MonthPeriod", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock option limitations, maximum amount of stock options exercisable during a 3 month period" } } }, "auth_ref": [] }, "aau_StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptions": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptions", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock options issuance limitations, maximum percentage of allowed issuable options" } } }, "auth_ref": [] }, "aau_StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptionsForServicesRendered": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptionsForServicesRendered", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock options issuance limitations, maximum percentage of allowed issuable options for services rendered" } } }, "auth_ref": [] }, "aau_SuppliesAndMiscellaneousCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "SuppliesAndMiscellaneousCosts", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Supplies and miscellaneous" } } }, "auth_ref": [] }, "ifrs-full_TangibleExplorationAndEvaluationAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TangibleExplorationAndEvaluationAssets", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Exploration and evaluation assets (Note 7)", "verboseLabel": "Total exploration and evaluation assets" } }, "en": { "role": { "documentation": "The amount of exploration and evaluation assets recognised as tangible assets in accordance with the entity's accounting policy. [Refer: Exploration and evaluation assets [member]]" } } }, "auth_ref": [ "r100" ] }, "aau_TaxEffectFromShareIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TaxEffectFromShareIssuanceCosts", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/IncomeTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Share issuance costs" } } }, "auth_ref": [] }, "aau_TaxEffectOfChangesInTaxAssetsNotRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TaxEffectOfChangesInTaxAssetsNotRecognized", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/IncomeTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Change in deferred tax assets not recognized" } } }, "auth_ref": [] }, "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/IncomeTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Non-deductible share-based payments" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]" } } }, "auth_ref": [ "r23" ] }, "ifrs-full_TaxEffectOfForeignTaxRates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxEffectOfForeignTaxRates", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/IncomeTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Effect of different tax rates in foreign jurisdictions" } }, "en": { "role": { "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to foreign tax rates. [Refer: Accounting profit]" } } }, "auth_ref": [ "r23" ] }, "aau_TaxEffectOfOtherPermanentItems": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TaxEffectOfOtherPermanentItems", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/IncomeTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Other permanent items" } } }, "auth_ref": [] }, "aau_TaxEffectOfTrueupsAndOther": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TaxEffectOfTrueupsAndOther", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/IncomeTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "True-ups and other" } } }, "auth_ref": [] }, "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TaxExpenseIncomeAtApplicableTaxRate", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/IncomeTaxesDetails": { "parentTag": "ifrs-full_DeferredTaxExpenseIncome", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Expected income tax" } }, "en": { "role": { "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]" } } }, "auth_ref": [ "r23" ] }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en-us": { "role": { "label": "Temporary difference, unused tax losses and unused tax credits [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r28" ] }, "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember", "presentation": [ "http://almadenminerals.com/role/IncomeTaxesDetails2" ], "lang": { "en": { "role": { "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]" } } }, "auth_ref": [ "r28" ] }, "aau_TotalReservesMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TotalReservesMember", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Total Reserves [Member]" } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayables", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://almadenminerals.com/role/FinancialInstrumentsDetails", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade and other payables (Note 11 (a))", "verboseLabel": "Trade and other payables" } }, "en": { "role": { "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]" } } }, "auth_ref": [ "r8" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "aau_TravelAndAccommodationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TravelAndAccommodationExpense", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Travel and accommodation" } } }, "auth_ref": [] }, "ifrs-full_TravelExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TravelExpense", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ExpenseByNature", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Travel and promotion" } }, "en": { "role": { "documentation": "The amount of expense arising from travel." } } }, "auth_ref": [ "r230" ] }, "aau_TrustAssetsMetals": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TrustAssetsMetals", "crdr": "debit", "calculation": { "http://almadenminerals.com/role/StatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetails1", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative", "http://almadenminerals.com/role/StatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Gold in trust (Note 8)", "periodStartLabel": "Gold in trust, amount", "periodEndLabel": "Gold in trust, amount", "verboseLabel": "Trust assets, metals" } } }, "auth_ref": [] }, "aau_TuligticMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TuligticMember", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails", "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tuligtic [Member]" } } }, "auth_ref": [] }, "aau_TuligticProjectMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "TuligticProjectMember", "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Tuligtic Project [Member]" } } }, "auth_ref": [] }, "ifrs-full_UndiscountedOperatingLeasePaymentsToBeReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "UndiscountedOperatingLeasePaymentsToBeReceived", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/Right-of-useAssetsAndLeaseLiabilitiesDetails2" ], "lang": { "en-us": { "role": { "label": "Remaining payments for office lease" } }, "en": { "role": { "documentation": "The amount of undiscounted operating lease payments to be received. Operating lease is a lease that does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset." } } }, "auth_ref": [ "r83" ] }, "aau_UnrealizedForeignExchangeGainLossOnGoldInTrust": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "UnrealizedForeignExchangeGainLossOnGoldInTrust", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 8.0 }, "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized foreign exchange gain (loss) on gold in trust (Note 8)", "negatedLabel": "Unrealized foreign exchange (gain) loss on gold in trust" } } }, "auth_ref": [] }, "aau_UnrealizedForeignExchangeGainLossOnGoldLoanPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "UnrealizedForeignExchangeGainLossOnGoldLoanPayable", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 7.0 }, "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows", "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized foreign exchange gain (loss) on gold loan payable (Note 8)", "negatedLabel": "Unrealized foreign exchange (gain) loss on gold loan payable" } } }, "auth_ref": [] }, "aau_UnrealizedGainLossOnDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "UnrealizedGainLossOnDerivativeFinancialLiabilities", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized gain (loss) on derivative financial liabilities (Note 8)" } } }, "auth_ref": [] }, "aau_UnrealizedGainOnWarrantLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "UnrealizedGainOnWarrantLiability", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Unrealized gain on warrant liability", "label": "UnrealizedGainOnWarrantLiability" } } }, "auth_ref": [] }, "aau_UnrealizedGainOnWarrantLiabilityNote9": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "UnrealizedGainOnWarrantLiabilityNote9", "crdr": "credit", "calculation": { "http://almadenminerals.com/role/StatementsOfComprehensiveLoss": { "parentTag": "aau_OtherIncomeLoss", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://almadenminerals.com/role/StatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Unrealized gain on warrant liability (Note 9)" } } }, "auth_ref": [] }, "aau_ValueAddedTaxExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ValueAddedTaxExpense", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Value-added tax (Note 4)" } } }, "auth_ref": [] }, "ifrs-full_ValueAddedTaxReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ValueAddedTaxReceivables", "crdr": "debit", "presentation": [ "http://almadenminerals.com/role/AccountsReceivableAndPrepaidExpensesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Value added tax receivables" } }, "en": { "role": { "documentation": "The amount of receivables related to a value added tax." } } }, "auth_ref": [ "r233" ] }, "aau_ValueAddedTaxRefund": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "ValueAddedTaxRefund", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetails" ], "lang": { "en-us": { "role": { "label": "Refund - Value-added tax" } } }, "auth_ref": [] }, "aau_VatRecovery": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "VatRecovery", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "VAT recovery" } } }, "auth_ref": [] }, "aau_VatRefundFromPriorYears": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "VatRefundFromPriorYears", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ExplorationAndEvaluationAssetsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "VAT refund from prior years" } } }, "auth_ref": [] }, "aau_WarrantLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantLiabilities", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity" ], "lang": { "en-us": { "role": { "label": "Warrant liability" } } }, "auth_ref": [] }, "aau_WarrantLifeWarrantsGranted": { "xbrltype": "durationItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantLifeWarrantsGranted", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1" ], "lang": { "en-us": { "role": { "label": "Expected life (Year)" } } }, "auth_ref": [] }, "aau_WarrantlibilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantlibilityTextBlock", "presentation": [ "http://almadenminerals.com/role/WarrantLiability" ], "lang": { "en-us": { "role": { "verboseLabel": "Warrant liability", "label": "WarrantlibilityTextBlock" } } }, "auth_ref": [] }, "aau_WarrantsExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExercisable", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exercisable" } } }, "auth_ref": [] }, "aau_WarrantsExercisableSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExercisableSharePrice", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants exercisable share price" } } }, "auth_ref": [] }, "aau_WarrantsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExercisePrice", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants, exercise price (in CAD per share)" } } }, "auth_ref": [] }, "aau_WarrantsExpiryFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExpiryFiveMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Expiry Five [Member]" } } }, "auth_ref": [] }, "aau_WarrantsExpiryFourMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExpiryFourMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Expiry Four [Member]" } } }, "auth_ref": [] }, "aau_WarrantsExpiryMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExpiryMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Expiry [Member]" } } }, "auth_ref": [] }, "aau_WarrantsExpiryOneMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExpiryOneMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Expiry One [Member]" } } }, "auth_ref": [] }, "aau_WarrantsExpiryThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExpiryThreeMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Expiry Three [Member]" } } }, "auth_ref": [] }, "aau_WarrantsExpiryTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsExpiryTwoMember", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Warrants Expiry Two [Member]" } } }, "auth_ref": [] }, "aau_WarrantsFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsFairValue", "crdr": "credit", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants, fair value" } } }, "auth_ref": [] }, "aau_WarrantsIssuedOnMarch182021Member": { "xbrltype": "domainItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsIssuedOnMarch182021Member", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1" ], "lang": { "en-us": { "role": { "label": "Warrants Issued On March 182021 [Member]" } } }, "auth_ref": [] }, "ifrs-full_WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WarrantsMember", "presentation": [ "http://almadenminerals.com/role/ConsolidatedStatementsOfChangesInEquity", "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative", "http://almadenminerals.com/role/WarrantLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Warrants [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing warrants." } } }, "auth_ref": [ "r237" ] }, "aau_WarrantsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsRiskFreeInterestRate", "presentation": [ "http://almadenminerals.com/role/WarrantLiabilityDetails", "http://almadenminerals.com/role/WarrantLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Risk free interest rate" } } }, "auth_ref": [] }, "aau_WarrantsValuationAssumptionsExpectedLife": { "xbrltype": "durationItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WarrantsValuationAssumptionsExpectedLife", "presentation": [ "http://almadenminerals.com/role/GoldLoanPayableAndGoldInTrustDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants, valuation assumptions, expected life (Year)" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Expired, weighted average exercise price" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r242" ] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Issued, weighted average exercise price" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r242" ] }, "aau_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "perShareItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance, weighted average exercise price", "periodEndLabel": "Balance, weighted average exercise price", "label": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price" } }, "en": { "role": { "documentation": "The weighted average exercise price of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r242" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock options, exercised, weighted average exercise price" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r90" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, expired" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r91" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, granted" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r89" ] }, "aau_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement": { "xbrltype": "perShareItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Stock options, balance, weighted average exercise price", "periodEndLabel": "Stock options, balance, weighted average exercise price", "label": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails2" ], "lang": { "en-us": { "role": { "label": "Stock Options, exercise price" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r88", "r92" ] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding share options (Year)" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r93" ] }, "aau_WeightedAverageRemainingContractualLifeOfOutstandingWarrants": { "xbrltype": "durationItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingWarrants", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding warrants (Year)" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageSharePriceShareOptionsGranted2019", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails3" ], "lang": { "en-us": { "role": { "label": "Fair value per share, stock options (in CAD per share)" } }, "en": { "role": { "documentation": "The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]]" } } }, "auth_ref": [ "r94" ] }, "aau_WeightedAverageSharePriceWarrantGranted": { "xbrltype": "perShareItemType", "nsuri": "http://almadenminerals.com/20231231", "localname": "WeightedAverageSharePriceWarrantGranted", "presentation": [ "http://almadenminerals.com/role/ShareCapitalAndReservesDetails1" ], "lang": { "en-us": { "role": { "label": "Fair value per share" } } }, "auth_ref": [] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://almadenminerals.com/role/NetLossPerShareDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares outstanding (in shares)" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r45" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://almadenminerals.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r227" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r1": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r2": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r3": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "134", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_134&doctype=Standard", "URIDate": "2023-03-23" }, "r5": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_35&doctype=Standard", "URIDate": "2023-03-23" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "o", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_o&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "56", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_56&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61_a&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "61", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_61&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_e&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_c&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_d&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_i&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_a&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "75", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_75_b&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "142", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_142&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_a&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "18", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_18&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_c&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "76", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_76&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_c&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_79_d&doctype=Standard", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_54_f&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "46", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_46&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "120", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_120_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_a&doctype=Standard", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_b&doctype=Standard", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "f", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_f&doctype=Standard", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "Subparagraph": "j", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53_j&doctype=Standard", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "94", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_94&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "97", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_97&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "109A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_109A&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "132", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_132_b&doctype=Standard", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "6", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=6&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "6", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=6&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "6", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=6&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS06_g23-25_TI", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "23B", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_23B_a&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "24G", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_24G&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "31", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_31&doctype=Standard", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35H", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35H&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35I&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35K", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35K&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35M", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35M&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "36", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_36&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42E", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42E_e&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r182": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r183": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r184": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r185": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r186": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "68", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_68&doctype=Standard", "URIDate": "2023-03-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r188": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r189": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r190": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "147", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_147_c&doctype=Standard", "URIDate": "2023-03-23" }, "r191": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "36", "IssueDate": "2023-01-01", "Paragraph": "127", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2023-en-r&anchor=para_127&doctype=Standard", "URIDate": "2023-03-23" }, "r192": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "119", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_119_c&doctype=Standard", "URIDate": "2023-03-23" }, "r193": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG63&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "53", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_53&doctype=Standard", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "35N", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_35N&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B11", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B11&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "B35", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_B35&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "IG31A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r206": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r209": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r210": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r211": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r214": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r215": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r216": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r217": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r218": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r219": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r220": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r221": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r222": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r223": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r225": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r226": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r227": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r228": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r229": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r230": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r231": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r232": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r233": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r234": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r235": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "g", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_g_i&doctype=Standard", "URIDate": "2023-03-23" }, "r236": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "37", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_37&doctype=Standard", "URIDate": "2023-03-23" }, "r237": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r238": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16&doctype=Standard", "URIDate": "2023-03-23" }, "r239": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r240": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r241": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r242": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r243": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r244": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r245": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" } } } ZIP 101 0001171843-24-002288-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-24-002288-xbrl.zip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
  •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

    #0+&85K&(7S)(RBV"YU4:I=ITZUV\-4N\[+2+5; MBKJ_5P_A=3_B"6#!\G?L"" MBQ5"=A,A7RRRPK$UZ#DL@M$-/-GF!VN?+ S,T6V0QJ FV_U^BFKYC.)-S=H( M\4^HA@/729Q/83=76'B([>N?43*NHU.>4V[BBH MQ8DJ+$WUUS^H9?TI?&EN2&A)/JOWA;7_HD"$+#]&Z=P=5/:-Z*&NJW0 P43+ MG0LKKO@9I-4$2%A>POMHV+!+"-"18HNN][)$WJ6FK&Q 9.[[L\M?/_YYX7'S M6RXMPT+$6()9JNNQ*\ML\P@/%'2.Z0 +6HV9A>OX',0@7J]!,?DSF 09!MZN MV&2C3?KN1(?=C18./^BT5FH8%?J3.&5BTSNLI+\=5+MEOM;_I$RM!W5NI>Y* M6U-5C3O=N88QE7&&\<"\#8N-S-%*'C1?4"6<-3L=PTEH>;_\]@E7P!KNV006 M-?3M-Z/==EI-*M(C;N8WA$2Y\VG[+" J85K'+H8 WDU=5G]:J!^K"35NO$ M/<(,I.9APY$/PA$47N=5'!*%?OKSG(\4?I 1]*M?.<\$89"8[-."7PR' M_96O=>9S%P)+6_DF#WX]_Z5Q >M@)7X,NAWW8;U"_BBQD@=XV[C&.SIM>FUB M>!.AQN29YN*R=L0&!IZ% @=!ATD?.E_X@&IVXZHN#@4HVL"2):N M%J7I.[3>QNS]V+JUM.GEUF!EDAO97AHPPN(DNWF?AJC 3Z<2'$8Q!)E !!+A MO_Y'N]MZ __=.7[C2T^:>-?#?> $P9W#_D< MHZ;EA$?-/5+AIS'>B(:E,ZXAN!P%?LQ-W.\=R1!(HCV*):"W2+>7(V&-'SI+ MKH%V\HSO0]ZGZ@'$!5ER18Z%?"U!%511=4J&MAK!5W8[!E*)P!(SR$,66/2)P^^,H5G,2?.1JX<1:G3!O8HCF)Z4^?Q"@AK#UD M51(K0+$6M .-',9MS3(PD[AV)BU-W)U6##0[P 4QL:'(56?F&*'V*9$(!U36 MKCB75US#;]C_#V8UB"58#BPG5E$0\97GBG4+6V'$_ 5[!;DD @= M.(%1/I0O"XOG)T&(+159&[JG]7\!>?2-KYE!3Q!P"V&V#.R&=.E)DD6*^9=L M8FJ.C "ZF:%^\=.O[KL879.R ITR:0*XF'-0ATQ&'O";H;!V>(# 3:BOP2U] M*@]N1CWTJ+]A$.6L3'*JD^QEW\-4< Q!FIHT0Y4&]6FK PAK=X!8R^EJDI_72-?F5".82WX45OQE*P) MJ 144#3Y2,1X9'BHU0A^E4/+NPL/^'UDT#KUB# .<''X%UPF<7\RMG XC.L8 MT0&G\7_RKRBT9#XD&;?6]:--D6F$IN)EHCQ7 .W<(M&/OI(*/LQEB^A*7PES MNA1$QQT9R[>X8X:Q0O)I-9OFJE,-@F@ N5X=NP-\^C$#0TI7 M$$/U!)8BCQ MBH:6Y3S!&U&FNX,@6(2#-^NMH!FDX\.E-P^&("JP?GB?!LA\KN%-TP(E ;,C MH4C"#*BH]E0^9:U^3XPN4W@U:ADS!%\8E\&7X)!]^ T23)&8)?G(8RAV\2[)"?O()9]I"6OYPBFW4#:C$E8-?&0@)?TL+,4 M1B86L&X4>&%<5!\XPN3,"?E<@=;@9_"U.S^RR$I%K)0!]!MB0?X61W$NV!O&M%.;MLU"&!E- MQ_<:IM $?=Z=P:_AEUF>;0.CY?&.$"LY31DR^BC05V"\(!+?!N7 P?FG,V G M9Z0S.%6W>S5DLI;APSF7.Q,D5&W?V4%8"&D2\*16Z^5-(L"V+:@YP.1_T[Y* M3]I;B-4DQ4+$*HX.OWL6>IC\FGPNZ/J!EY8))1Z J'$C[6;SY A3W4IV0-$. MD83$5L\5/,DLTWXX]T_9;94=M%HOI$B>?T?K?&<1:TD= 6D 5S11O6S\F3VY MH1Q_J* J4)NB>U9Q/"MZI\7^P_%\^%JL5+^'@G5*V>:'0&Y2QQAF.G?Q$>;O MT_9SZ-9ANCT,TW5?=IAN4QEEI=QCR:J4CV*^C&BB6.D0%OZZ)"#CT8Y' NA_LH-JWDMN\7HF9>D8)ZY,>FL M4JWBLP1QG&:0JVVC@12)KV3*3,1S\,GH,RQR46DDPEXG05 MZ?$QV(>>V96E_AP 5+RC5)@1++$UNCQ): MWCI2RR22Z*R5><&*G9)@CW[JY21RI196AL08J$HS@JNA1Z_]:NBP@^73S04I M;D"L&T'>._E\X>](\7_ ET;QQ-"UY10:!=,0EJL0O"0.(VH< M2N,[D 5IL ,]0OB?]W$'KNO\#.^SL7(98^@CGI8\09_OTYA^N!__W# M_]O_>@._CPJED?_7IVI)YQ'1AB"U]TY)I>3P)X!^!-\G^A9CE1\$2FX1P6\6OV$UYV";7D32"F2785+Q85MLQ M,>Y?GU10E&'#S[(0D9^'QJ>>!M_DYY#C=GP9/X?W-X441(G^!H M)*HQ'D%5LZ#+&%WUGY'XR7F*M0IDTF*,;.=8 T.>P\ D M4-R('#I64K:5^ V7!V(#U"/\)SEDPH#*5!/.:DA=N\\DG[&&8S:%VXD56)-R MBY*D4PGRYY8*O2L^WRB#&SES\HY-E%PEM#-B,_*I,@R0G8U87=!6&+*&;-T4 MMN/>2',&)%JV>HO'HNKC65C5[&.7ODWDCCX+Z\%V#8E+>! M@IVU\J.)_U4"N ]5R8Y$'"V#JT=)LNHDGDT^Y7053-*<:O /!4FP73VI_(6T'9^9^,L;?SN+IAC-6,HXB M:6:HUP3RR[,6B]F%5J2PU6MZ38PGTI[]K#0\29D705W=%:BK0NK>F28=(#%D M@Q605?YUXD]O7 3EPL8]6H#XU$1#WKH]%K:M%%1Z!4>O+W%69R\[:; WY6+R M*Y/8S&4W'EFL_2165*G!IXL$3]8J]NK#!$),CDH".&SZ+9S*")OX)/07ZWF8 M1E?4GMQT&IAE"&0$J4X#.Z:A1/O%,K!;(>,1,]"N-CP0BF4H[.4:7&9 F^ W;1 MH%>6(+"H_^I=;'?_E9#TU&Y8P62UNRZ6"=RDWUN[>4K\@&/ +?%@K;S*H M][L?,6RI1"AHN%?Y(*7(!J5>FZ"V6;;#"=5PH(LV@M6":.1/>')JES.)98OD MPIKP-XD8W+M2,V>O+F\-F %2[UZ6;RB'1D_23X\OB:N)4H.88FZ#ZC*ST^\4[@>T@ ]$W0 MLI6JZ[1ZI.JV]^=)GUW0L/8OO%(/P[>6 M0@++T&1$U0%SEE)!:XZ- N=3;K2B%B:?G;N+?Y(DM$/PMT(%3E+WS&S'3I&Q MZW.E*N=4A1[LSW(2DDAMEZ9==#7[_8;ZG5'KTL*0O1^P-*+=)K[2 K.PU?GA M$)-&R:^&KKF1M"XC$1J:49DNLD4&M43%)&=JR)L*ZD^!75?E,N9.W^^7Y^^> M_G#H\OS.^O/+!HP8S?,TEH3)O,..6N2:/FZ5Y^^W>7[IDR6N!UJ+4P0J).YA M^LH3J_+8?Z)>X#R2?^*DA%Z=E+"'20F].BGAT?T&PQ"4Y^C(XI47A58\MJ7[ MJL-BC7G!D?KYD(P&$&[.%ZV02-Y00F$VNF2I7J "E'AF=C^R-<%7K=):6G(M M&*U\U2O^K<=_0G64;.6B2)Y9]4KXS1C2P/:P]E)I8@3943P^FL+R1*8E M#*KT*$\0@0@%122;5\D^\:@)YLI^5&DA>L1GQX$D;/B(K8I'*ONE*.A@ MQ8S2(T^*+.^,U6H2T_PE1ZL"\)V!N/'#\4P++..>,1_&C!).PM!-C>.Q%2 # M'=U\C9*U1X%NAV6@:COLP?822$L9T?(AYJH#$Z3 MU2A,'1JFOEQS%T[/B1-N&"974)P<#Q4KV3@M9><4RB\SKBZV3 ;WA=ODHPKO MU3G@Q:=?$4]V@%=\FP4W8P\=MMJ-<;@7XN #9W-@C8 M?)5/L!*TR&!IJN^$U+R<7Q*&03C __V/?EGAFP<77(W/N!B@^(Q[_A7CM+9W M\VF6\6<<71^1OZ-P2V?(S=,Y"^IL[RVHM?/-E'UJ=>5T[UF#TN/+/.9L;;P!B5'5R69' /'"W: M#L-O#Q!PB,5$9FTLL2V>JS7*'-L-FCOCK[?+79$?_\ M\O[3]HX S5PZ[,53=!\QA10IE6#PFW@QGS@I*,1T.XG\@CK:9F_A_X!UO&%* M(3?Y9L?\)8[R=+-#VGK)_]HB'4J-9Y-+_Y5-_;'S)IRV*&CS-P6[U"#8B25^UVCVO53R/#;_$BN(1*N#<^)ML M;_M-]GI>I]?E64ZV,L467NAQ9RZ][^8+E6&O^H4J2= ^(;+;FIZ[K)9KRKU^ M:9R;/N4;?L6M;;_BDS:1UWZ]8F ]W=X^O>)^+6>+K[AS7+[!#IYM_NT,ZZD:F]X^@?XPX9G.^D_R#R> M:'_?[V3GV]B;(ZE^QSOM'6_5NVWWH-D_C;_5:7O]ULF&1^UTO'YGTX-V3UI> M>Z]4!-##CFLEP;[#?O<8>'Q_BP^2L3F?B2;?:AU[)\>]3;].L/+[_4T/VNT" MJ]VGU]GR6@]+X1?U.KNG)U[KM+5!0[Q*DC^TC')7)WYD_:?7NDGK__X:VG.8 M[56_OXJ3;J_WVNT]Z-Y[-KK]JV[3^)HZAP?=1:_T*13^Y@R=;3KLIC6+CQ^V MIEBT=]Q=MWG_W\E*_&$'5MQY^)7OF.Y0?JN]%=_J6K&WQS_'C28NDM*^VT]A M"[[U3G_/8MA+B-#Z<;6.9Z[U.VCKLI>BU4I.&L7-6F'?X]E>G;1>C,+>>TD* M>Z? I[ZSMMZ:(;*M:>O;] .^/'6]-]]QMIL:17O_-(K'O-1U&/[,E=:J^M.K MZOWC/5/5EQ">N_:PVFTZXZ=Z6*W3F1/Z#GKZ3.?B6DO?_]EJ+?VY:NF]7=+2 MG\ZG?GYQ^=^>[-1;J^FUFKX'VD3W:=7TTUI-_^X#UFIZK:9O24TO]F:OE?1G M,-M+RGUYP4KZRB&_S>>^U-[T_50G:C7]";SIQ<>Z:J+:.IKZH_6)6E-_O*;> MJ37UK;^MUK&MJ3_%VVK-LLSOH*S_&UWI_L3]O>'^.TY 80_Y#$YK??T9SO;< M=/7=F.U9UY^6IMZP.OX.NZ0FI5JW6AW?:5E9;W^+6L$CGUN)"ZP)(K.U6M/] M))M'Z'CM?=/<]TUQWS;PVF/3TQ]*/0?YYWY) I$_M:+]/:%@'D84V/2,[?Y< MW(5M[?$%>EXS>Z&+?!7[9[7 M;V\:G:EUW,2VS7OT%)>0O"_L*9YX)\??VZ=^$>?7H9^ZE\,+[)>YL#W$/?$=K(G5X)KW6[=OURB/3Z#;MT]/MISX4NSV[6K0QUJWYQ3H$Z_5WC1* M7:O7]CI[!2C7?_BYORR% HBM5T0OK'5[2[=O>J_#/^2PRWH=!O5A3WG]!GM5^"_*3+2=!-[K+5 M7$=CV.XV-V(Q+W+(IR/W3M;N=N MD%(?U3'V5+WUPUQ@9]5XBG]+W6ON&>_"9H=YZ.,_\Q2.EUNO(M\XNAK>Q*%( MY5=H-?B?:1+@/;B3>"1"U\]X*'<$8S0JN41]N0>M!:Z9Q:.<_9T/_<2]\5/@ M]_)RX:[PEO"R_>C><]O'/[BC/,%+>1>DL$,7]2W/;74J?M_V7#\:N;W2G_3U MHDL'"05&=M,;/X')IB))XRB"VQX+H ?X^NLX<>_\:Y&B"TJX_B"^%2[?;B+& M(=A_0#91>$_K'-I$.89O"G]XXP;1*+@-1DBU4S\8N8-[]RR<^&!$NOX8!)-> M4"*&,'IRCXM*<_@F;)?W!D/!-L9)/''YF%X,_76P6_H*]+?(\?X _=&=?%M, M@)W3:@+L5OV^3?37[Z]#@!(<.WT:0M1+(H*<)438-N\1AL+],"7R@;T84ER5 M%2X"H%D\BBK/*A!!?.79E7^G0IVKHPI'- M'AALY_44O_#_'!T!&Q#AZ$?W$[SF-^Z5^$\NHB$LJ==_X_X+M1PW567&PB_*]' P&<&L:>$ETL M=Y6 M%@7F%X]2BO,'11T<;&_?3>"?>$FO*$\#566PS*/LQIWF29JC99[%[@U\\WTT M$O!5C-+!;499XM/]GETG0F!X0&N[(QK\]QRTYA;=[&G#?:NO_4(,Q60 L]#? MVAW/O4ST M%*\'% .+,\Q=EH:M+6\R@+P(+,$W)81#'<1NTPF$];OT;_@[WMZK-N?W MN]=)G*+51:ZFU _A\1NBL6VY5#H:T JD$>$?3;"?@"*(B,+[AOLQ F5BFMFT M!-\@5H/\WUHTR/^Q (V42\]X7?BY/&)[#1:"J@7_UBP(MXK&(R^4E@$;1ZV0 MOIV("7! 7+,UP"O,W,<9(HO.>[RXFE;GT.HBD)[%H\S"_L!Y^2E?^T 4Q%#$ M'*G=9;*J;V.>JW$1QNGB868[D-&K*3<\6%U5N/03=)>T#$?0S[0(TSIW:#/6 M[SDLJWW*0ZUFA])5H1(_:Y8-?OXIT 9" &,-E%Z_Y!A%R^FO/,V"\;T:^+.8 MP*H35G3A_[Z(9!)$_.-ZT]G6S"K?^F+=#XH&"A" [1K?D>_?6MO435%+9#XO_1,+42JK\WMDT 5U2?HN8U)4 0AQ5?0/=L6HBI="Z!TCX MR.C:S3<7G\RGZ5>M-X?.0&1W0D0%AH;SE-0K>QR]83D(*"@CT!_P$_84A^[= M30#L,!'3T"=.%\'+F@9X=N;,;-O8J3XUR05;G<(J?KO\/+L==]YV?O/OOKJ7 M,>CFH RYGT4:Y\D07OV?V:CA'L@A+_W(OV8;07Y7C0L7AO' 6[1!AG)8D *\ MP?6.JK#^0S1Y? X#W,0A?,;CP9T[9%Z273&Q3/(,]5)?7[RMQ+'L:?4X3&!? M!S X4#OT4.C+GX":"-J'-3P&"VAOD=(S#==T$E!9XBC]<2,OZCDR11SZP#]< MGA7>QB%2)+SQ>[Q9/&Y-,9Z;3^%FP?8-X=Q1EX>+= \ZAVSVIDB/&!1*T)D4 M23N3+LT2;N5!M3H"K,MZ(F^ &O9?P7SX;@8KW WJ VA#G:-ZL,G+4&Q)7H&^ MFS?Z^P8$&JD Q&),5J;;)T"O<48 '2F27P;H%W .S*[""83,0K@7[ W_<:- MOV D_>.VQ,%YHMA%=R0"3*4"'A6Y NK(<40]$#T,BXV;NF_.[U&MX<7L\Q- MR5\&Y([_T3V27UZ*VCUED])ZZ\ MBJ[,ONRIX(@0$/9(@.Z59@D;+GX0YHF8975PYU.1C!'XL?+&8<] $_@Z1O![ M"M^,K*2\\O5[,D<*)L#GT"W MI'/3'G4 T\$33TMCH_\+-%)[H3"^7*I9 MF_E"->6_%%5A%2,!SPC9YS@/71%=2^_![(G"=4V"%#TW^3"3-Q<8VL/KCO[* MP8;(TY)IYJ&%(5BD60:"&Z/,N M>C@J\BKE +@P*OZK+N0WB<(XR),4\R=V4 MA MF&9&VRV9FJCZ>DMJJE[%>C&(771>!1$Y)L-\ L>33]"A[$_0I^N*_Z!+%#GG M7>P>M _=+)B4Y:#>*.GDPSQ)<$^_^+#P*PJ=>VXH,.X/ M6:#:5*H=R,.13S2<,SQ6F$/K\I8B[VI%?D;8\_X&@F)*091S%# HFQOH^H4+ MA8^BYYQN1XAR\!&FG!&:/<2+AC$R"R[+3E16M^,C*AR'E<**5C0@U*JX;R7I42VZ$$#.1'TF[#)^P570O,V7%AR%%M?3_/D-IBQKIFB MT%2'7OS5N8P-=%$JY^-OI5U#T@=!Q "7.U!OWGXT+'H*3FX7*![ M38Q*=80-3/W$OT[\Z8U9&2P*129]A1;D9[A\?-L.D2 ^RR""HY9N2G187BM: M1\NA,"LIEQ64N@6]8Z,,^IW.1#J_\:-K.A?*?8C#[\"EZ;^/FXW3=1V5_%UJ M+X;9V-,8\ZDJC&C,HN -.V;#ACA&^"EZ+S<^UKWUJ6J$J_F MF_$TP4&PHK.$"T]=:=_)GU "$6/BGS4C\-,T'F(@@D2T/Q[#F\.?**M)2E*]IOB%G@+AYXF,E,:G@)- MQ)CGPFHG'!>5#JA*<#DJ+B$+LEP5R/\2^PFM]$(3(:FOL [T%6C2Q%9=5ITJ>9WG12<7I M%/:NUU,X ]S?%#@+!@]",&IBO5N/JPS*?CN@!G.!)2Y2O=.:.VR1.ZS"'O!Z M_.%_\B -%/T7Q7?Q%W,EN);9)%:T/"])<(,+,2/)468SP(J2)*O AVV[HT(Z8E::YZW![,VLQ?B.=9FLCA#CC:6]CP[)G$B M#]VD44;GA XO]Z#=_.&04F+1LI8K1*]@YD?*[)B[A15>QX+RZN=.Y[HQJ+NSCH-6C*K_LAFO\R#=E%W#- MB6;YQM^EO&(F-*ASMA<$!YUY_MB&^][XKCR7-VB\LA$J72$\1^3;RP3\RO[8 M@H[O2+V>58>7,BN/<2I?+DM/*V?/#S-5LBH%"KPOS"7$ MW#ZYO(=6I!8OPU:( (";)3Z,OY/AE9@],-*79"?T%NST&<$S%T5TD?%UVNBO M^_87!=E/ZB#['@;93YYED'T=0G^^K'LEIS_P*)G'5-82YZJ8A>AT:C$R56^D M=)1R=87E6Y>E^"G0)Y6?DBX]0+T'Y$/"F!C,+-$?@/R0S'5BVJ4<;RN76GUW MJ87KY>B8Y9A<%K.V!,ZJH8<8L0$CDS*4S-%+A!HFQ?FKN#? 3,N@B=FX,^1 MNE=531(P38:V]:4\M"47PAWF5)3SM95AQNA3VD&EOEH6T)JF['C5^?MS]T^Y M!%V@3LX#O; ))[.@R06VS[U[T&L>NI, T:A]C!KIM Q[+*WXE W]!-AZ@-9H MP7%=J(4 &V1 CVRMF=T#*^=3SX8.BEL1*C907I5RWMBUQP0%0)I@L2BA2D6< M?<_:-:0F'L#U^XSWO5B1.JP?XI,[\N:S;64-4Y$.,^.*'!4K$U7%:T"*C/W; M&'@QGB[)%%"M3[HR+8S%Q<"I/YG^5L1GR3E>*2/8XWL5Y.)KC][9* M._2R2.(*99N26:*WANDK A$FRB<@UZ&KE,;XXG1&V/RMSN5:5M#/;%QYR.=> MU8+K(8LI)_0)]&,HE\^M+WD&917!$!5N6BQ-,K?F)^A1DEP$N%1 4O0>?D__ MT*YOJ_O?Z6<][UNN^ZI(PA7N.!X2Q@O[K+$C'A+YX;\&5Z#PO> %PG2F_ M2#]-\PGC<-%'K<*]N<5X<.^>RD@TX8)-!PA0&4CC<&2[XA,[;D QW#P9 C%S M^HGZ%.=!\D-7RY,Y\G!ZM&N]U<7OB_1E4H()?8;YGO%IL(O%LSB-A<-5*#8> MEWTF+D6/I2*\O$=BG6C"8Q[<8[V1RG%? ?\&8[#]<1VVY]/'++ MR[ESN8GO(Q,3J5"#;1>^54&NW.O5I4*R\+V4[DDO86:(!\^;TJ_,>::"4/;0 M\XB:XY#>#V;$)#*&X5AOI'0/Q9D*/GA,H<&)0,$E*80U-(G1$ M?XWA,.QZ&-F8)HUA-"R4P==,$+%<-CRS"94Q7!2_2_CYFXU>$'T'TOE2[7U% M/Q7N1T5ZR%&,;B,\*: %,=+D8S,G/"_IT6=3 .-P1&,JHD9!3ZF%JT;Z0Z M"4DK46:!Q4FS:\@2%[7$D.33%KC3_NA*RR(>ME='/-2-8]W_\B?3-^[YVX_; MPS_P:5&_QNVLU.C6LWL[?SCK >L,:6&];U_%(:+WARX#64Z=5@^L]^@CW#5YO M48+#:9W@L(<)#J?/,L'A.Z,(%-TE-6ID4?M?$C5R:U"1VF_K["!4Y 9MU>^, M [D]P,?G:+ U&^U>$.T-MN/E,\=VK#X7^SAFCN'%F$N:5&O$QQV]F*?'?+Q\ M29B/^ISW!O61_INMSO4T 66Q[@LLY%.KQAN C+Q10Y&UQOTWY]9P>QN%VUO6C[4MG+W+&F=ODUG3;"8L"GRU>WN!M$6N Y-E(8[;VLC-@>2_AZ=3 >#4P7@V,M[G4!?A0G;JP=ZD+_>:S M3%U8A]"?M;"K<1XS59#Z['$>:[5OP4NHD2!K),CM($%>UDB0:96#KA()I)''0>E=[BF4WN4.0>G5]/U(9\0LF%X!%VY# MJ'8%O_)<=+O9+/ MHMJ9%[<8W>YI4.V*![09=+OZ;3S./5'CV\G_U/AVF\"W MVQB\7?VN"^]Z7P#N+FN NX.G?N^TN 2*V;.#%(K@B APZ,MSVQY?%2(F% M]_8'(BQ\20*1%T$295W2+$:B/?IA-2*B4T1$=&M$Q&5)?E.(B/+VR@A\Y0*E M5? 0Y9#&<*SA$&O\O8VB%5:!1RK]I+JP64E\BUDMKA%EHM4TK+[X6W*L;*9^<,>\&'.0V51=\/,!9E,[ M6AF7S=8X%N.RJ2EJ6+;=AV4K\>P:E6UMWMYN]%96&CGN_VA4MK+@?1B4S7[, M&P9E4Z]_"YAL:NBE(-G*AS*#R&:?P8M!9%M+@<;36H#(IOE]#\,AZ;I=0\"1S;PM-YR/.X [KYL\1LH\+G]&$UJA0W=*3# MS2[[,+KO/%PG[3TJ8P9Q F@ >@)\?D+5-3)7IYPZ!V0W1!QXJIUP%E5I/-ZJ MWQ.0L?7-Z?TA4TV*5]1;'T=.]KQOEZ\;IAC8!D2I:>/0*2I+996GOV9/XD\$9EYT*-;K0FNM&. M(QK9GHOOBF@TC//$H X5'2KHM23HG%F1^!XPCI[K;R6:\YM\9&.QA1]\:T$(SU%HC"^VR M#Y&TQ%E8(2NL_"A4H7+^D;'.BJ!"9:K9%J;0O/74D$([3M(;QA,JT]LJ<$*% M3$E-T$\#)[1XW0O1A J*T.IH0G+F&DSHNQOUNXUR*6-^O%"#^]J.=8[C9'UI=*%]4*!81;< MXUJX,%9,QW-V$A?FF6ET2X+%=%<'BS$ECO]"1?L37 A=]'- D+D2TTR0C=)N M$UQ,=RZ.C&-CP%QSF\B",?M,;ET&3L.2K09!R5W5.CR=1H M,L^Q&K!&DZG19/;W/G8238;^FY>X7BA>;:\&>7E"D!=;$:A!7FJ0EQKDIS#'7&"^KJL(U M/$L-SU+#L]3P+/L(SU)U;8NB]]TZ>K^'T?ONRX[>(V6ORI36_-J+@2XJVRE *V18%X:$LQ,GF6ST>R] $K? M(8"80I:EIO.=!X@IZ$?[ Q#S8@F^QHVI<6/JUU+#R=1P,C6^"-5-T3F8UUDR--5-CS>RA];8D MUDQO=:R9(L*,!_^,_\(+N1!@FL?3R59A9S9?8X#/_CVH\U-!.CUS2**_&22: MWW-XRPPUQ9JYO>311160W,H%Z X.=>#I2Q"/3I/MX!+03 E!YD44 M&@Y6._!"O_VH$KS] M(8UVG<2@94?B&DZ.3-38E+Y:I<=SUT 9THDH\"MTRV",(H_@VI'+D$HOMV/, M@-C>"MDQDN:)6N,IYL3 $!F[^7(YB3H5G(2"-4I-]RI01"JQ*T8JOP(NPT?Z MS^[M2[,6!?]'W[)^A*!(% MCT' %EAU"OV[E$.@\?"KR7)G1SD1BF6UXTB]&BQ"%TVV/.L&,)P?0Z\ M#C^8\3\_BB'PZ[$?B*'LPALJ:;5KOY>9F..+J5 ?/4)P;$14&\I;,:[T'>Q: MI"]&OHON9[+8/"O#7-OW&%D)!G!E]VSY3N);X5B<4[NQ9(J]RA.V/A(4]5X% M@S@FVQ0MM@"8>1+(+&&8!:BHTF;"-NPRI\?&EB\/,5;2>>LM#_Z76PP<)#>."1&B$40,G) MD7SS/[I'S4:+C,'W$;K6T<.1%I:"'CKIX7,LP6>"Q8J+P<%?)WXD&9Q58B(T M-BF3"_U.YS3@]6,,. \Q)CSCPT1!S^5G_+D1.?Y2QQ]B5)IXFF2GACP*F4;H M\_(C?^1[^'SA"\P.?GJ-I_+SEZO_7NYX/.G> &4+=($1N1N0>3@\M1'W:@.6 M\D#S!SB).3\4"$%*4D7Z6(JCL%>$=H2?:!E[RN#8<[H_N*E\BN33:OXP+UT;/RQ& M7&@ O&D:9#)CSK%3B6QW*I*K&@U70E?5X9O*4+.\U?CDH M/E1'#0.TB5'P1$6)S:-"MBJK-W@H7&H0W8HT(XDG:+F#M(\&6A:C2E"R5:TD9<)T'(X[E M(/=RI%0"44GU.+I$Y=)/OHK,_<1KGTT:IO4VBA\+6!5 @%=@Z'=APM2%K^+OP1R[AD\3942QE9P*;_+DY(U.'U!4QSXZ6S1+I81JQ8]( MICE*+SE#C:"T,RG)WP4I@F.UF^V.9_W0)@%I?F[10K'TT"(H.53#_:D>ET=P-6BEV17901I@!#/3^:M9 ? M6JSA3O/!7S*LCW>KS1J?9NG>5:WJ!TCVC9Z_AD);#DVK)1D0+8:Q=JA[7>GVG_T/IWJIP MQ% =YCW+2ZOP7R\Y7VN.*O_@&OY'U46X_^5/IF_>&L&JPPJ;66[K=-WEOE5J M*>MLYQ1^Q%L/B8D@VC1 MME??2Z_9])K-YF8';38ZG0V/V'_=:KX&GG^\W:,^O_$#[43A: @]"PVYL]EM MM;=T^AL>$8Z^V=W(Z5M>ADTL:R]HM]5^W>KOWNEU>ELYO59_LR,>RX=_\LC# M6^@3;"G1\(]%9[SXJ^M(DG:_]] =;'Y2N*.3IYWQ]'7K=!-W^, TEW%R#7_> MCJ#L'#]X56LQFX57L<:(G=?-XR<0E%;2DA*-+"DWS#N];8G(O550 C%V39O/ MCVRBUFK)#@G6_:#8'55+VMM12S9->TTXO>Y&9-I&3Z^_'=JKE;I5WG^K5NHV M)_#.PG$B1K'[Z28(PV":;EC2;8G;[*EVL1TOQY9\3.T-,R70)4![?JY^^R[( M_KX6B1^.:I[T%,_E\:QK"Z^J?E:;?%9O0S^(A/LVQ.*B&W^R:3_6=A[6GKJ6 MMQ1J?6'<:[-^I6ZM*M6JTO/BZ7_$R<3]D@0BWP]&LZ?3HAV9UG\ R>OL2JN!';)]I/[_=!;7DJ8CA*TM/?67$27<4GQ_ M9[6YO4@[W'2,=6-ZU$[JPJV7$61M/E&4]2+.KT,_=2^'%UB/OB>>PSU5B4WV M5A%"<]-)7/N@7^RHOZ-6;1_WWO?"$-M1W79+B<8O1+7=CJBI5=M:M7TRU?;A M2ZA5V^6UK2+,]H8ER$M+5EX\SU*(\'MP_HN?PGW4PS[! M?6X%[WD1]N%QC7THO[%/V(?'+QO[WC$&U,HT3A)V9QHE;& M%*=?,.H@,OZPS,:K@)_L.Y-L\FDF_15.(O'#S(X)++@'9'?IW)5ANA?['P,PVZ=FM)#[09X$"WT=IEN1$ M:+V3HU:SY1[\%/Q\ >09QBDWE'1,\L:O,;#$B. S/R&H/B(S'R(PO +33\04 MF+LPS4(('%I-P9AXNGM*ZOIA&E=T-IFS4Z>X4\^ ZI<:9>C=(?S"\!YWUI8[ MJ]S+KQK4\[!!./<+C@BAPSCPJE\8PX.:]C #Q Y*J:M" MD"##XC8^W&9!C,?8U@?6C "FA+4WRHN-X^G[[D0@9!U_A,&NY;(*MVJ02#.8 MFGOSI?I^ H.\2G"A!3!5;A&(H(@(%4I?43NX-G>%[?@TRMX 3/F[=;'N]HKA M5=+M]V9_E5SNBT:KPCN=P%.^EG2 :/788B"S&L[)\S@H*"*RZ MVP,3.?VB_!HLYO?/QE6C,,#.=0>INHAI0BCTA)>):@CL438,0^A710@$\@]' MHOKO.A*7U0^2E/"/8U=$-W0L%O@KG#48%\5KN@W$76J85_4U$![F1/CBU!-CJC^(I\@OYWIQA/)+B8HK"E_J^2-1JW4X)2"&TG3ON"<62;/_XY3_,Z(M(!?5*?KM]E-,*SZP[GLP8?? MY@_1@5Z8\SO7C<((IY.5'@\S>95R]D5"A"&R&0D^>0-^72:;.S%(@XSZ1-W=W37\$!LU10C\ M#G9"V@"&R[CD9DCY*-2X/H*0ASS!VXM?SSX3^P *_W8#1ZQY0+O9[+EG493# M._@LL"D:?N$=)O"WFT?OY!A:S)SKGCKXL4L_&=XXG29"!C?[#1@'E@'/;L22 M0K,97")V2J1NQ!KJ6#=]4^U4^(/4:V1 '\O=HUZ!C78OB.8W#)1___GHP8B>/HD_A3]*+5)A!0385^9_ M16$!HC(:I4=H_<>A*#6Z,Y+5OX=-'\'_6 *_,<]W_*(/_#<13F4/^[J08?02W0QA*J/1J0BYJ2ZM M"O]#VD?HT[?KNZE4;(GF\4+P,A*;!=V7=<&25JF:3ETG\5UVX\'QBZ]T2[%[ M31Y%$) IS!: 3 &U4%_*6)>,7?M!9#3.D@%07];,97WD=Y.:EFXWP30U^I%L M0JMUWA0YFNKYH7QFV "UHA$TOT'4=JGKH;HL[@B221>D-E"JJ,(W+6)\\G7: M%A]0U]P[75*P+>G<86&JQ)V2H$_J7R*5I!+.T^@E;S\6M9(U%KAI'80U<-2< M?]Q%+HGU2S2<6W0U!IX(T#-Z!W+PT; M=!MQ@A8UL2=/&5C*2:8YAB,;"Q'[S?#]7P=#B[V7VL+(#JEF4.Z'20Y"YCC: M#D*IB[WJA_"#G]RSTWZ(O*?*&[7Y6UL483^I(^Q[&&$_J2/LCQWDD@P55L45 MZ] OEMS%%*4TG*#B28Q*"-Q(GL#I60 M?#'A"F-^&960 F*6.:"=X#R@GV4(V#/:13?*F6E*[4G7(6VGPJY_X3;]?*6X M?=+H]*06=^ ?\DDMJQ[#=V0J@ZMDKCKL511/^F^YD!6N7UV&OMO]N9!VJP'B M;<&MM,!6H4R^QO*WH944$\.PU!3) NR(I@QAF+!"A?8A4CS5(+T1[$Y60VM[ M10>H0-7)DCB4L8DC"D2QTY^:+5/_2,EF9$=#;;X\ ^-SZ1MMKW"C[] GCDD+ M5C!J"+P^5PDRTR2>Q-@24F#H YZA#AY[)OS%AXT.]H"(XBY.OKK#,)C@<"+" MZXVN"_:GU940^#\.23E=?L#^!Y@RN*5P$FBN9"%SVSZD@O_D/GDR-%&]I+OM MK'"W?P@QM9VBXSQ$X1YA0'@0IEN"4UO0G^9J:%F5-#>FG*I\F.LZ$_I?.T&&F:#]'JPJ0N_8S@ M95XG^,M;PV"Q)W$0J9CJR)3R\*?]26II;6E1:6-Z2(5.6WI!M]U;X;;?DD8M MLP3L8'XA"$P<$7.UI@FVU"VY]TB1EH1B1T,+'7WC<27+-/EEMB_P)=U6?YVW M":\JP)H*\0V3 -Z=^;-Z5[#=G?FEW2FQRN1\<8LNSS/A,[L+)5A:)43CZE?"D> MA2.73*@R(5'GN\*($[.)%R=X5['H"JHG17[AT+-9KPJ:%"-XDW#>^-[\L;C. MX5C%J&"AB/GGO("?]_J-XY?B1%M6O@Y7EZ]OOX'%QN8VY[+:L MK"=IFHQ=$ MC[F714*\+V061I0PZEN5;X3#T)6L!8XD3.Y/2 M?#2-P#P5SS@UF%M1BGMAY/0^S<1$OBF,9F8ER>F(TE799G4\14M:)FC(G-RW M'PMI\KQ,RM7F)-5@@M'38E[.CWOW-I9F<*MD+L52/&G=1*64%7Q3AFQ*U&'R MQZP[\^P+\]P)^4<*Z612<")-Z>*OER2"5KNA (F=$L'B,&=GA]0+0'LPH<4A MDKV(KF=NJ3[9>2<[]7$)P10/%Y2\-,Z3H5*Z(W$=X['CSY9C-DE0">?L>,7Z MQGE"! UOP*=RZ3+7TL0_]_G\%8.*X-["9U'?@$3/8@KGJ4)CH%3[7\L9F:P*VXY SYW&F:PL N-* MI*2]6V6FLO!4WF80C6"Z9/X[6R#G6\>-DW6]*:UNH_T"?"FC65V/,L+TF^24 M.]C:N@X3IJL-)CRL,ZS.2T624B$WBN<&$RX+)8(SK"A1VVXXGZO""_.LUO-W M'U4H"H-,NLJ:#9CAO2+KBIEF+-B8S-&=KCI4U2W5C39T*ND[G4KJ[G"%RS:R M2Y4*O84J[%U8 MB=H^&*[W?RMEGCVD155^Y&?^,U";MW".GXV\CZP#LZ )ZG.K3 WF3%WI#E%! M;U7:GV;/P<>QA6,[2],@S71%%*@BH+J"V0;6.?YRD(^NT>L&JTA6^=2 MZZ47GTI#SVBDGJ[H,I$6^H@!"Y (3@0M4-1\+9)_?DZ5+5SENSPFT@N6R__8@/T"-BV[_7UB)C8GT>G.Q)=U^E@YR=F937*6=#HWQ[FR MM(O#QO=6M5B%"?[VHZ<=N+-A7^>!L&])I;&'+52AE0._I?BP58A:%=UTUHEN M[I;%+$GC@8M@PN'X%8%;YG#AMT$JK+B60P G(U.IX^E]\\L221"/\/W#"0DL MR%-AK2*<':(^H;&&815)>.2V47B;6-P71\3(X#+R!"6/"3\[1C)I-+O*8#0Z M=F ATO?) !ES#&N+\?UPE\$80H5AI?H9[0[()-A #M/)0PDP35I1$:]$8EN M1HB+#^V*-X4)ZPG[64G02L#(L"#9*^6Q4Q6H1#Q3,4:@I&BH:J@1=L?]&L5W MD1JO!)&T<7@?PJ$!U PTQ4] >X$8E7/&=3D.DG640Q M'X[TD'XT\*.O^#MM, 0&VM2."7F%HDLR/U)=@S41H\"?"X3^DN_OD[;M^%I( M2#$,X@1^ND',Z5NAT]J8L^/ITG.X]BG1@X%@K<);F8=7K(8S"?U6:*2^E(I+ M.8^5YDON"V)(K .CDFJ27F4V E43*_A?2R6V97=!7U4 0SID;176B 0EL2(( MY+#7])#KBYJ7DTAG9269FF+"D8V4C1C>(':&-Q&5$LI"(T^"PH^3>**AG.]N M KC,NS@/1_ MT+% ,]0W-$8-F5&Q*:4J3_!I:F'\[F-]4Q4W]>\X^3ICH!5\ M6R7^1P ?6K:0]: U@TSX$RU;:C8VGXT1>"B=IJ;[,CR"E"68%2DR9#X1VVI@ MW0$K0[*6&?N%;$/TABN0Y8G(DF"8%CR*6 B@? V,TZF8J*K5B808K9P$O%W( MHH7J)UO&5%Q)+=_AIZ*TT2*DX> M::2;A$.G4!A8M-JU7\?P2\M90BMG: UY=V4U@RYRQA&\B];C4MWF:KMPM^W" M)2ZQ-A&K30P)6%DT$#EV%'$=N.7A??\M\X>^.MY:KCYL<\M4<76HLPR6D3!E ME9JB6R,151& M R&8D214IT0JP6K^JKR,7KT\3S1)07T!Y#:"*8>P1$*D; I M::[9,_ETVON($ZO?RK'K>U]D;> UJ\LP@%*>FP[CJ0%4((\K26;TPT8R1$"6 M VBUL:Y.5B-IK=96#^J+>.@BRMTZ;H0?$GRL/Q;9/;Z$VR")(WJ1"KY'!L&M M?D4J,\&H0M+IOVS[/GE\LX>W3.K?<;-._=N_U+_CYO-*_7N8A%\RTRE)?5T2 M'S!B^$BJ4<:&\F"!UX*J)-C_+D% .(FG6'6H?FGGAMC^VGB:!1,X/3!#L:D% MN0;CZ/J(*G#LZ0F_1_4IN;L)$,HGB/"[,A6+W6%HUH&HCR<2E+'()#$N7@N> M^84)1 /88HAZFFB'K\>_2#%B3AAE1<5KFHBCH>XXHNBH\)OZT%?/B=N.WW!G M7!C+VK[+I/PX#X4(R\XI+BI>87INSL8]BQ[R.3J/]SFNZFO\?LZ=)9'F+U'K MS'2")5=GMAR^LC]<108*HBT-)3:X3XV<5.1Q@$T% M*?='I#-).PWW?81P@2IY$K.]Y&H]LU;/]2^!^B1CL1U>T_N M#^->5(.H4A67.@;"V9W?EWW]\Z5V;\3RW2+P4"1UL*&NWYO*;H(>,@T_0Z18 M2H>&_\/F8%JU&OC B+R9 3WLW4/$1YAAPV&<1\Q54362JEN!-15(6+>P4$_E MC7T@>RW>-T-?1=3OFN0$R(<>TK&P) HLW2ZY;T[AG^B5/!,L;KJH*FN6-$&HJCH M$O?9]NWN04 ]_@XK^AA4-U$5_E;+X8ZMV.9)PG=+RZ"FL5D:$UNBL4)G9]W,6=^X;'$G M_T[-+3TWDMUQ97H 7&F VK=Q2"'UJ-YXA6Q"Z?*@]%!)3Y16GA;M#&9J;/GA MYW2[XZ'53/<-?JRFE!E*&6^)4D1TS92"]IMIM*3Y$-S&:[SW;^KG$=B(,=6@ M+;RC[V1X/<&T[[D"\UV0(G.[%WZ"?;,%XND-"1;'Z;2PF7"[@Y^C8"!VPPF^ MN0?]0WWD4PEQ0G4R\_1?Q1MD:6F(81'\;,G.252-%J5(%@"<, =VP)',&/9!3_,# M_*N'J$ H5("#T,)S/)OBUN" Z>0&]Z[P86#%$1I/?JD;HR45COII\+-U%H_- MB;%&O52G=Z9.;X.#+P#.M%EKF?56L=H%<<09/]GZ#+9U7 P8EC\F5T'\G<.G MK09P7022"T8ZHMGIFP47@ZTM\]FJ(U/] Q\Q=[NUYMSJ_A\Q]^F:4RL:K)QZ MSLUH&;'D15?=ZL\7N1\):E3_GSR('A2%:KW]-3^Y\?5?4C>./=[ VQ#K7-VW MY*2]\2?[MX.S$.3L*'8_W:"G>5I-PSN]@S_$+8AJA=;U![R(O=O#P@07BU/] MX^?/@0^J5O;W-5;J+N1U

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�H>^;YLU:<1ZZ<=YB6/]?$<%19F<"I,D,\#NOZ&QW;)AWL\&T7A M9)@*3/RN24#M3:,\L"K#(5#8Y6%*,X (JRO*F'O&9%"R)QELVNQ.V:?K4=7H6YJ%K0MJQ*Q66O$AVN/S2V#=D4Y,%OBJY[%=L?/]([+

    =-!#JVYY*F_A(V:_:AW'_U>5C;K?/.JNS^=S,N-[#[72=[GP6B M[IZ3BX%8AR;>-<[YY#F,#SGA"P:*NAM2'6?9,,+0[Z+X?@[S.AMV0X+B<%0) M1#NY$WLJ""N&;8OT=RCGSWL&9.)5H/2SECC=-U 98=Z08Q@V''P EHF_,V^) M(7V]QI ,%_E=K!/LW#A_7'=:G1OB_,-PAV"(,'T%:,]WMSMWGMTE>W(#L.$A M !X#Y!"EWF=>TB<\IC.SG^\XITNFXO', H7!"LP[J[H>S*2A1\U%7.+5D6AF M82#HC\0&-K<F#K21"MXD[)F.:BVQ-$5<8]1[1C_?']OX:X1)LTV?%$RE\=YR M 7FLD+%9\#<U(Q>.\3Z30M\=WZ-DF$#P,($Q/S;E^0=YP;[0-P#[O?$,:!1X M!L]36-_UR"Z8&OKN% *- [$CWB?$/)5;>V-FX*:]V699T[1Y=2#&-=/:#TL< MH\7.NIF%Q0S>(RSYXU]O/2%YM2!P1N9OF2&[<EP?3?P,-[R!6N2W&VYXC:=] M7,SOTG^/7UKC.!JFJ.>-+SSG:B>/NMJ<88NV;D95P0M(]M1?FITP#I[#*GTQ M.-<Z )!CN.9?8-$>WHT&EWU=N>:3VR^^%#CX=4'J 7?<Z;$_'J*B891FPSAV MV85X1T#P-S>NWP8+/#CFN10E/'[M#OS.,$%B'X;]_7VY)# FN6"7F;LS A1) MA]DK[OP_#!=^OV-CC71T6)37D[D-/OS6>J,=2V]PHX2H*T\)7@)I?TF\Q1@* M_0D39V"ESE\AT=_F;]-?^7X@\A?KHTXQTWTVGKDA-["%"3_E)8<1%@ECR.4\ MW;OV/%ZIR;\CO/Q-S'3!YC,!3"E PS@!?$;F,NS SPSK+\$SEUR *84X"@1 M1J^H<_J, [CC/==NU[0,G6DT<UMLZ;>HA1CS-TYN--ZIY00 N_]T//?3T.T7 MD#\A<F=_A=AY UQ[7)OJO.K\SW\Q&$K_8QY#1PPI,M^7%=ER0H:H[,*O%\4E M6+ZZ^UF8NZCKHH="7/2JAUX2-OCFG_ -&/)/O9CP?D+_^0M>*FK@@[ C;"%; MDO=(S@:+!$2!./)CX$K_O>6;_WL57CM)_4W?R0EGGHIAUS]U]<LU##R*>KSI MDQNZ!O(0$LWR4.\UU9NWO@-+^;)+3/_6]<_U <BB":AFB+<-9P]B[8<(]H%" MK3(GQWCL*%/_M@<$5(4M,3@Q.-C5&]_8<V?4)-NI3?)H>G([!.O'SVA?CQZ$ M.GK/7SROS _Q5Z,]-Q-7TXEXM,TUMEC/U^"O[G XU!H[3/Z)T5@?NR+Z+?%5 M;[C9^($%_8$%_8$%/4>QKS2?_2%U\S.*_8;5OBN,RMF$YM9H?T,C\ZTV^P2, MPF,^Y\J3I8\&U,=[[T <(</YJW#RUQ=!P=V@53'43MQQ&&N S<7]O16\K6V' ME0^V@(#) LF@-9R,M[>P:F^I\B9C\0#P[K6E.@QS8ZG.PP0^P?WOBX^Z/=OX MW6>[@LS+Y9)$-CLFQQ/FX;.]Z>KRXG*O'ZW*!C(IG:#I,$D_ 3_Y>4KOWKO% MK2]W9TP.IY1J!N\=*8RDQ3FOV*M_'C75OT,=T5;JV#-2MT.:J"HD-X0YJEFQ M5H.7>=.RN^.-]%VD;?A80N/JZ"'P/H6K*7#]?&WVKDO0PYLK B?"#/->P^K? MKS+MG0M9MFP?>YCM5T9';<W+Q>BPOIS+'\;V#W@=[)ERZG>N<'E2G];]2<CG MYT.W_)@Z5=3CL^1;=5O+I,?=?#9?F D;OCL29]X]U.KV"]OHZH57:\9;2J<? MUHQ?/$V\Y13B:DY9::A$F]<G%F/@MGP?ISR-+8Y[P+=4!C_' _Y4;N^M^:6] MFZ!OEW?Y5IM]MT$8/T'68]8=.^IM[MR,WQ1IT4;<U>MM8UP5[W8Y=[3$L\.M M,XT!MQ'C6M<"1Y"[LB@G^TP^8?3UQ3H(MJ* W"T*;QP;ICYAL:J54\?LQ\K! MNS/]$<<),'V0Y=9DF*3H,$W?6VX=6(_,Q^84KXPE/[?P!<C6]SWY/:JE?XC] MN;,R@52EET3KI/K^#?N!]N[&=H)^0(;C1N2MKQ@C#%6:9Q;X:'LE=H:(%VQ@ M8./=+B4F@36[.3'YI Z?+]BRL>4;YF:^6=^EHJ*!3L:M":X\G7'NZ50[N94; M_*6[\H^?ICWMHL=T79=(JN?6!VVT'QUAI3AUIJSZ@=: WZ1)Y,_!7U=WAVS! M8 %]ICKP[ UG,V!A(((PQ%9M<RU'7I& %Z_L_'8 >%NV8*^" 5EB( %>.'9O M]"+Q<S'4%T5U!UW.;W2P+$/NVS[Y5UTG?N<#H/G_WMH;0F!_DU>W"1VT0OQ: M]1@]M1<"B#1SJA>"6Q]"8G,&#8_4*T1>$;8J;'X3]TG_A Z)Q];1<VT=3W*- M5GF1$N[HF\#>MV\B6'#%(\T3U:'2+.4SDUG_NMZ)\S+YTSCQE6[$/D\&_H,: M)WYZ)'YZ)'YZ)#YMU\'76NUSTZP/EJF'!KP!3#5PA!>\(7RUFG7LH&!C[80< M<07-E&:TH*M?T@XK*++F"J@5>(9OTCR]W2%!]WB8T:5L]GIKAQ70?[ M7XY# MXJ=6M"]Z&@6BH++)Q12;\05LIZCDO'\5:%7]Q0*4Q\E\[KYQ1:O>15+M!RAH M .7=.!:F4"J,LT3P]=U?L6^ >J9\81\D7S'=Z#=9HC%EQ(#EZS,)$_:8, 50 M6HV188*AP^R]DUX_IEGB@0D%UYO5SQ#W;J4\^N6L:/R"B%=PTUA4-5ELWB[A M7]QJGB?-@90' ..$X6&<0L($=AGR\XMG1;8"0W\YLWA)8) I/XZZI#DJC0*0 MF,\D'M@#XA% %3U&A$D0N['L^XS/^/!ZZ9NK43^7*3SL%0E LH^4F08LW*?J MV_SV@.TF=M:^EOMJ*<%1@[CE9/O?SE+>3;8#+1% 4P7.AE$$"S/H90#-W\:( M/M7K?(H1?4#.L 7"5MOY#M/F?V_[&I!080$D<Y@PR@#+&YAC^M$QY^ZXHD\\ MJ^B=W.2G6-+-X!I_:LU:>M.(A<_[-:*;D;Z=E3Q*D@-A#2!91))H&,7O3+M^ M1?,7^W+F[X1P1#5F4DVTVW(I".'X3)* W2X) 214&)()DT10,S,_>;A8,30= MO-$)AW0%0@][(>/,EO6IJ%J?V[J17S%47-.[ JD-';0UK<^O?Q,N(BK&#&F3 MJ5#?SA ^1+H#-1% 8HD.TP031O!OE'9EGV RA6=:S >E;4FZ0IR47"3VFP>- M08I6 -D8(%H,%@;&_-/;X&L#QX2F>E'X)P\8XU\N8-P0=BVS9'_!%$N3:;U] M1_'.%[>0!\38%TP\F/(<-K!IKE_ X#VUO.TI%N^-/#1J-H=@+-5F?O/H\#SS M!Y A"93Y/S/8Z!6+S:IST;2@A[#3SO5[X]P\-5_T%-NX/:3-)S8EKN/4O.\N MM:*DW*X5WA6Z]/VMZ$FR':B4(&IW,#S,T)<K$WZ@3S\P0GVNP3XCI/J251LY MMM"XIP[]>0.-W]^T7RN1090+O:M$?GZDDL P(CXS LE3J^Q78"5(?3:-HD8C M1\A!"7,0B"4?;',/!#B W!&*X&$*)\'_[L6T^\%:^9!:(=?0B](BCXBN0+Z+ MA'PF<3@*XD($D+&AZ#"*XF&,_IIS?A,]EZ5I6K'Z?'N\!4+8 WBX"[8%O%-< M#A1;$'=?B.'1GJNZ\TZ7:LQ%1 CJA=X>U^\[\_9XSQ4F=)LBLC%9YA][^Z7W M_I]?OT(I652$_PU5^)'X3Z@NSFS(Q^"I.!;Z]6NE701YOK/"5,\M(0M+<?.U MAMH_+W[$EG-VH6VH(] VE ]M<PN6SF4LCZ,P.Y<0=(ZB<[QIZ</Q_USH%<2) M_^P_:@#<5^"Q_IOZM4OZ-='_"7&.#I88-?B^//@G5 *:QS^8D@;/ L=VOQ59 M?PW^Z=0"\/\<U7&'PKB6Q/\; 2=]],S9GCN;D8PLLVESNJ6_(?*37WT1:"BP M4MUCH5N/>?=8#X_]*LBDDTQP&2CI2)_F\7<HO*/9UJ^1(0N_IIH ?J_($'YE M#^UM]UN$M\O^OQXL02BJ3'E!5.',:]$ ZCI4L(2_?:RE'4@6[R2N7_&5BSRE M&DZM'-.]#O6=0=[ 5GDB[,WB'LHJKWH#O$T+_ (&9.8GW 4*=P&,L;<!1^0- M,R2J EC_'F@$=$*]_\>\HA?P _K(7NYP0(+9K:_39-CX88BFZ0UH#\5YE1=D M\ 4!RH-A^M/?#W=W1/)WE0S4/KZ"N<YZQ7IN,C>3QNVYPL8&5UJO:\WD;1A5 MGM(J\16JF9;&@L&?OM&X G1MSZ#<9C\VQW<,ENV8>CZ/TH82?U^-T@8^O@>4 MY7U1_O?/.*" K-JB\)?/%#",.&"'ZXX;![[9(F$:G#LU%\J#SDI_PP;]HY[+ M&>RV%;;7=2^*6L>T %04<6T*Q,,)2;P0@M40/*#2:*>7^&7=2QSBY[RL>.P( MX>O@_8=N&[H&8>[6HL=#3*[_WD?U8A%TBYM67K]ATPBW>OS1&C33L'[]JJ]U M;EK41L#UEB#G'709:K9J&4YYZ"]BD^UO1H7^B"K5U.T=8/G(%M<[/#=&[.3" MK^J-/;:^@Z"'#B")1X=)%@NC%'4DZ/&48.A/3_'_>GM&S,UGA 5R1GVAF<^, MAURY2;WS&1TV:%YQ1NR3P0F\,_IKA0PI+G79@""0U@+B0&((OK;8!.[] (2N M*"[E@0:$[N7-@=)7'N@CXN:_?GV4S6PLQDJ9OI/&/XFX[:YO_RA)]/JCW#] M(DPR3)ABV<LR5I*5PU.)OIN8[9^-W6S69HETI9.X4A6N[<X!]N*SA>_,B>&/ M"]^QU.AYF<.(M9=,_;U*H1SF;8(&/"7)/]XFX';@1E/K:"2KFN#;7C0"N]^ MVK(T SH5.YDDY*!:_/KG]%RCV[ 3Z50*;P\O0XR><6]O10O^XKXJ>9.O>H" MBD5[+D$3,Q<M+5$) _'<)O:4M\>T"6GZQQS9 -W&O4,,ZJ$<A"SF92,$FS2! M\PA<QAU']'_^B\%0^A^HCTS)$S[O!]B< 3X/=Q]^X0<#J#!,"(XL@E]#YH*? MM Q>\'_2P!.-D,X[\&_ ==5U0UL"!6&)\%W@W9ZV@[IOM8B^..!M4UPOQI0T MH' MT9@"6;0@_J[_!_")G7/X.V#*/(7<R>5 !-_Q(*?!IF&WRQKDW?%H!>)W M0$-+GHL[F8X='/CPRVZ<(&B 6JIFK9"&X*^&QW@TQ%NA5).K%+X$D;B='<HF MM .:A]FM 25E6#QPM;:;-&1S8H;!7F&4!ECH96 ;\";$\?X27E6%K?ZAR(!Q M!4AJ_]\RS(:*)O@SY$7X.Y_'M>E4$]8G ID=_*@#@^)_YJDT_%Q0[C<H9W_' MMRKH/_GK(=_!Q^.[AWN7QD6#Y^T;'LD=4:WZJN]APXWF3C QY2= R5DAT^Z/ MQ8'U F0 YKK!4T,;1A\J]L#R&^S-52PR5+Q_PHM*+R$'=*:Y\JJF/&!K 9RU M*2K@I^$0//:HRM_*&! _&3XN#%2\:2N6^0+T[RH]L7ZG9Q>&BK8P_PX=R*__ M#B# ?2<TD'AUY.<HQ*7_#T_XS(V;YRUE/W/HYT8:]=4_?>LBB2\>C<"G=-'4 M]M^ZT8NR5[4#7_>&;- YA)ZGEV:>@@V.5@;)URD?I2EOX*:HI]<OI)+V%>B: M"FOBOWA*SY(,S1Y)^_,+0E,09%B0A7S,'H_L.Y8(F"I5FP(FL?QT[XJP\"^^ MP;? &_Q'VJKGX -6VE!_9=J!+Z" ,P1R^P)8W 3*&;SP?Y])^L C!/K42(2- MM^C#7D1586>,RB.C#[#CHP^N>Q]P:=4\.\D.C#A+G!UQ<-3;W<PZ.#?I /VD M<PX.+C*VHP[0GHNF>5U@+"E6'5\SZ^"X3%PWX>!W!.K_5IO]R*D$IVR!HH3X MJ1^(';U[^P8S#(ZIB86O)C;.0_"$.//6;S0_X@P5=MVT#R/_)\'?W\AK_%1" MY=/ ?N_WX<+U H\"_B>Y7>PV.VXWZHG=4F.1&%"Q]F!*U3<I[I-;?AJN]O%% M7U\+3#YVQP1(\L>_6!@G\##%O#O^]2=@H>1M+%1LEW99*&^:QKQ+I(39%V8A MZH:[K2,L!$CRQ[\$R811XM@=UV\%H+[U94YDE'5#U'E9@/&LJ)IO)]*^5T?V MSO7\>JFUS4H!LU3\=297RSRM)*EZM5A/5_ERFMZP^+6;#Z _&@:LUVS@!FY_ M[%[04YA$F$;>!R?Y_3DG=3?G'.A&1,>D?K%83-7[OPGGD(_K213]'?"U'VJ: MW.C0-'"-82!H&> W7[63=D?1POUD50[NYK0^C:?RYGBRL,3&MJ-\CQ#OT)D* M16-GL3=(P&-%9Y[N1,,(@X49Y-Y&FV#;;+X>PT4O,=R!&AYC WE>*I5MFWT/ MAKMRM#O%WCK:_8OV#-^J%#D-CN8Y/H+@D['HY6'S!^G^TUJQF$/,.CM&^K"7 M;,6DNY1XUW;]@U5?KQ[IQP(I3SWB80)'PRAS&6#_6ZO'8[P7NY+W#A1DE:&& M#)L;TPOQ*_/>8V'-)HC'J,M G9]=03^(^/OF4O;;71Y]J\U^6 Z).U%]^.0S MN&RVO86!2+D,E^77,UF5U>).V_!*2E42,:(5=7;TZ(DM!HJ<=VZY-RC0QZ)[ MSWB3>!A_)T3T=V6/^#WL<6!F9:N4(_!\8^$P7Y(]'@M]_>0/ 6)?^C?(_]R0 MWU$T>*WJD_NC4IK)_9"Y ):T8H#3VFR4F;A(E1R-Y,%^V+R[H8#2E >+NH$I M [C\(\(XC89)XE@/X!=26^>PFB\?_H&NPI26K.%-4RR@01W^E7D1!CV=%_EH MO?#4O$?B0E/!)X]'KTG7;;=H;L*\G?+'T[HH-1M--,-M\C5\!_%I\[#C!'NG M//*%35VORY@ [N50A DS=P.:?9/4R3D4[]M9]4!S3L=$.\5$YVV;_RA6O5;3 MDE\W _U>-W1^&NSK:.'+D'RW*5X)HXUD7!9F_.0@-?B^BO9(?O ^'1O _1V< M$XV'Z2N&CGQK+7N,%5.WL.)AI5F_0!;2JM4H*K\'*SX6NMP23W]V;?Y4O_I+ M"$M 1>A7IXV_M6;Z'8G]$<[4([#2&_$LB=9-E_V?'/$8;,>_N+S*O=)QPDKQ M%;3<W%8(;@D2,&;QGY?LV;&U7V_/V+ON_DVP0A"EO*V10A$,^%F7ZZF?!T;\ MUQ=E2/86ACQPLHR4."\G&@4FB3V?(9_,CT'4 Q!$&*7OK43Y6$3L:,_-ICML MV\&FM(C>C$?T7AWR9UK#HN!;_UFA$7C%>GL ]ON> \71%3\W.D*CO:@MS*T MT&Q%6#_K&)*""KC<0_7J.V^Q_G;N3RK@,Q#7/>D!)I2'*!+W'II5DZL%U<!Z M:N*(-V"7.">)0*%Q&O@O8&<?9Q/B?>U"-R(H@O9Z.T%W=*R*0M3 F.T$B/5K M0Z(/!J$-#XBSA]0 R+%Z_XIHB35=X#9E'^WS3[C=O\ZE-@/:ZQ]7=_#OR>]C MU]'^C <4"2/(21"S*^ C@N#CJ_#DJ9Y+S6-2/XG-XAWQC+@&L:*'(-_Q4Y#O M3,]E6VVUSCF9:1T];RQ^(-]W'_4@Y#O^<9#OL9[;IK $P\2K_0S]@_G^@_G^ M@_G^@_E^' 1<G4P8LSE'97SR9/OV'*1X8-]TM#B-3IW9=(Y_3_3-XWA#@4/& M$SU7T,Q%O<WF-/W$?)O;@Y>+X/&/< >L\)MDV8I=;&%3Z0?^SX=J?,,9X!.K MQSW$((#:@MCLS%K<D&J-@U GY[1&0%!P1^+97=R52T'LRV-!;.R1(+:X5(\$ ML4?#UQ*61)&T.\N4T6#"UV*[]$[AZ]%=WA6^HL@-Z:<#O'3BP9CU,9WX#?%- M^[<IN"U:[6^";GH2.#K$&V)($OU>6:"!1N++/G2Q;-D>O&@8J)W!&F02G*VT MGFX"G^K#I/X=BA\^?>H#1?- :0'GU,>B5(&7:SDA@7?,D& ;:QU@+40%*,8I MV*-D;O$O/:#E3;P!U<I;1-00C$_VH$<W&S\&BPV#&MGTGK7&:A-L,30$<N\K M:+!)G3<\=$T?K140R0/&].)N2W&\.--#4PTRP?0<;MA!5?402.%Y0 SG+8^' M 7/((OO3\0!P90)94 V)4@F$-MX6*/@B8H,7K2.&F&^PP>FA63>?=E"MB0/ M(GL$["!@)5Z=0!;8X35 =-$0UYBE@L>C+Y!'P_ UHNIMP3M6T5B?DR "QC$M MS[9,956>VE-X]J*^TG2["] ,2P(\:/JXD:OG;4&I(5MLQ_K !7SZ0[X&@G8C M$E-^Z9%GS0TO!]P@F_XA[J'!0ZK(UCD$>N^W1\3MB<3[;E9L<),5*^S!K']! M0[:_@35?KJ"2^3VX;*!5%,6#FNX#:P-QC"&:M A]26NW(E<#BFNTQLOVGN>$ MACSX*C ^]C54V#=($3V/EC]'D:S_Y&U6?*E0Y<M+S]F0#!P0_S[Y>TF//,C M T'>RT6JV7L:5C3'@ZA6E6MD_(6VMV?#^=L[9;)?7J5=:HOSG-(H#F&=@*& M4'MN@8]7_7*5/_"C=X+2.\)->B?[9IS#%]0];S=Q7/]LA[:$- -X"U#H7[8H M_)XS<708B*^QUD,#Q-UA*SOH_& /$R\@WEG-6VC_'63Y.>\;[?4W7GQ8_W,> MWO[CH/Y1->!/]:$NY0W? S!DC^7WUO'I54PTA!XF8_9'C5S*MKR<S;8DSF1; MUFD(0-DU)\%,Q&U5 CJ;:J5B0T+)\6?3+.<W&4A>Y>K]W)E*": 2@,#>JQ#@ MFUL#\;9<RODI/E_0-$!MN9X5M3^GRPM/E[JB&:+GE_D_^U&PMWMH*+Q_ONP, M+O#C7"]/HAO:$#B0QQ_N.48R"*Q@ F*=IUA)]\I.^'0%WQO!3MX=YPI\2]9L M$/N)P#W=U_@OP+62+<TP_2]YC_#B>4&$L[Y H+P>$6)HX(]0I8 8S_!-U4IS M@$\#O]OB)S"@=W97_7<H>7CDT&()(K")8/DKYU?7+&")@(%\6<W$"<G@VU"] MJ4=#6%TT/'4!:R"@KPB=86WNWTA#+2BK@CR7!1M8W%V.,Z&-'HG>1?S^%^!+ M%'$N*EL/4QM,5F1]HNZXNB2'.%62D^JY'"F/BV)<3TTF/R4Y[U:20WQ<20[3 M<W.#I#R(+YK2K/]3DO-3DO-3DO-3DG/D#IWLN<D"GZQI4R+7)H*Y0[]457%0 MY%$O-]$*72'U&GG\_6=Z*H(MWXCWW((B%H?C6EK'QS_%/4\L[HE#OHL7"B3& MVXT3M1N?HJ0GT7-G3K-11_GXI,G_1&DGHK3@.03KN4YUED3CG),A1^]6_O6T MQ-)V6*U/M<=22]AUJ:7-J57@.V]++K41OH'9RQB!GF]!N;31H--+E_9T7X() M?:Q5;-5J\E.U\[XZ;'B;#E-XP%9#L,IUV<'1(=Q?,..43=7J(13?J;PPX:W" M]NI!DD$@8PPDQ[^8 )*I&;(%'FN^^ EAW?8'[&X24.!% TF59W#.N[VZ.YB* MO%<*L?-@?EV)8UXQ#?:#;XN]] T:\C0L^D]H9FM>(8^?^/G3!NXW_"PP75"5 M0>&=K_-FY@N<!"\+, <UV(!BPV31SHUJL*M]&@&P#0%6I[XS!7B?)/ZP=B\Z M>5D3SV,?F&C4^J9H^.52PU7<YE%EERA.."3*WM,W:<D_Y;_%OR'7^._X"WX< M)N/V_BQ L"P8O,*"J]4'_X&.Q]>@,'Y(X=,$VM)3U:R7/@\%#:JF+7%7B5L0 MS?.01W?^XC_\KX\:@'W30[F]B=6^F?)$: AKK<[/-7\Y,==ZI8T$6-FTHY& MN^0G:M?U ?N7L!M-^%2Z!3R]&D7)/][TQN_-E 8;;,+][8R7SFY-6G*I*[S* M6YKAW#''>A]-X+[7]MQLEW94T\BIV/B!<=8A]-Q Z]6!!3C2^B+N[]LAU2!R MR9:;A=%D7"HDY/N'5._S]<_(ZI_-_FSV"V_V(X>1/Q65ZVGSK(\<S\H-#7(? M7Y\<V \Y=LF!_Y##)X<'C1DH,:Z%F+O":_KD=N#\W=U_/Q&=_H<8/\3X(<:G M1[M<!9($<]W ]F!&.QQ9P)&!\0]B#MX_B=XZ/2^II*FK)I0M)8Z"/^O"^D+* MNX;J[3S#,^_F3M8AL\[E1)>R^?:CZ+&/%KURDI[;<A<-+",CTV,8_7=!]!^C MX=&KE4MR=!JP'T7I6P'[+R(0/G3<OPVW(G=RZ_;^]&%VQ<ZQ*X)',;,V;@GD M^%/PZR7<SBL)> [+<TN@WB7Z'"1+'X-5]^]R'YJB\B-T7\1$X.=DSLEDB61E MSE'Q3R%R5YH([,STK!]N?8!;L6!,A-N51J*;SV3CO/@I^.H=5/F^?L:"J+7Y MK/KY-H1FO.?RPU8^,XT;R<0AR-FJ^.9MZ<W!9>/A"X*^?,0N7#Z6^V/1JY8P M*RNTCZ@J5 QM &N;S91F%&$?O*R.XG[W^_YMY XY$/SD3>,#[^BYS7HYAI0% M(MVYML0X\+:^+UY$3-U41'QP(XI%>VYF.3?2&:8VH_D__BWNX2*L,!$V)NN> MZBOJ;Y*$!/O@$H=U)]X:P<'< WV ,"I;9*$!^*RFPLOM%_ OOZ+V.$21MN%] M"'RC^K 2L(YB_6#>1^PQ^:$XLGE#.%I/L:DX\5;A%>G".AP^--*\9T%('D-] MD=60IS+AYW3;,&V_.G6W4W&%97&Z>7'W0AN6C?&R:O&PIBHT5,2E5T#Z!@AC M!:2DZ98\W=2E#333,G=X!%Z)\^HN;@\L/CY?R?'#%#],\9G+H@[Q9'QHI4-" M0*I-^0FL"O&J%+VJ&(AA(UL>,!M4X@?0$"(X/6WJ>P""O(*T6;43>S7[X+/0 M;0)> EC.8(V= APM<-**!Q+A'QE@P)WSTHS5$G97^K)9Z1ZD%/B6 X['$J>Z M!T@CFY!U5'$1,L&[16\]87!R@,\-#Q\#%LEHYDY1S)<XQNR.>'C@6> +(4WU M96A7(L0AK'<S]VCT(FBBZ2$3Z8!8FFV%O-9D$<**'95\605"[S& CZ[F(7Q MXGJ_]Z30E,!K?L'N;(BJ"8',/$P/<'H28!3%68$6[7SN98T)\6N-Z;%]C>E# MLGD?#GD/]5#[/*\_'#)%'^C._Y /V[GI102;]_\(!1@\%"HU\"O(CS8\?Z_" M<Z5Y():?IHL^J9Y[\%=W59.GNJJ3/;?.(5K",9FE(?UT5;];5S7Y<5W5(%@3 MF\U^.Q,?IH;RNW55[_5$5?0TK<9S([2L_/1;__1;__1;?ZU^:Z;G9A>-X21& MC!3Z1%?CW?W.!^V30D..E2OUXB1-!]8^&7!W+05665[0G:F8'_'T]TR6'$V& M/*7C>JS7'(3@Z$HQ^%%P-_31WATA^<ZDN8=HN:87D&O--F#7D@>;UQ=W,#(] M_%H(5OLF0H4Y0C\HVCJ>FVX=:,]-45RA_'I@G= ?AU&IZ#7L;(*M-5;_87 - M$9%X$+_Z?W^9'CWI'81KL 99$X["[0':@$"<5X#O+D]],+_MUKWPR3,U3_6: MGYUGAG\]FV?VST@=U<71D;:6W41R['0B^<Q#>FZ-BHL3JNT@I0=!";YMIIA^ M*%/,]MQ9<X3)$X>*SO_X=W5&GL'V;XR A#Z2*#[._.^0W?'UBY^8T50XWD(' MT;3'%]J:(T$H[6TW#-37&MC>RXVL0&N]?-I^RFWJ>\P;]0<!XG31N!+@]QTS M)\>G#@#U\6NMR=?I00BUOATD8.TU#HY$;63PN@34C?<9J*^OZ#N^ZM0#UV;X M'SN(!KLJ:,75-8\%P+:R6]Z..:L_<N#E,;#'R1W]>CM37NY^+73,*FDT56,[ MS.1LO]Y1&=WTZWVR;KVSD<.VA2_9<W%Y)G8KE8HV1:]IX=OEY.AJEODU#7LK MKMR=DGY;->^;KS]0X'OA60&T2 6WVI\6L6!;Q"YH_8>:2*YF\J=UQUS'V7O) M#R\U!57]DS?_E3N,WA+L!6:+/J3GZ+Y"_Y6%H2]62VTDPI]J="+9?+1@Z#8- M?].3CFF4_[ZATM(W566(T<&!8/98$W]"'(K@LP+'+_U/5S037N@IF@/_'A-5 M<2BO'A15A1I<G!DU@-.JCAKP*C$+Y^= )%Z8RX 7CF9/SKZMG#8-Z]>O^CII MFMYX>KSBEVZN79HXG!]C..6A?Q";>G[1FN3JLUHZRFZJZDIOW,LW.7/L#C+? M7#CW,50^6UOM4[-WE)@'?FP T.LXA899BKY8K7=S+=X#_L2=Y::W509^-5G$ M I%%QIUFNM,JY^;Z#\OB[R)XV.V"1P<P\X#&P@1.!B]XSVO.:_GSF^\+Y!I@ M]R 2]5CW34_=9PB]MFH@]8G5P+TFV2>_3_VU,I +"Y2V1VA]-+Y&&?P8XV-D M/- , 30X46&28L(,<;F$_HM']EN)PS^QQ-UK>(])7-_0"T:_T\[2S%T2][N( MURF3>TF\"/3SB=?G:X8_D_ X:IK]$<#OE4D*[/$W:9CD)]8P]]IT_]PV?<@3 M)*'/FRI9$*[1+4'3_RNKHU/6?I? !XHHB$:Y,(GC=[;)!9QEO;T]],;49Q#Z MZLZ6Y<\@X??Z$/L2+B;E8J923#L$^10)_UW$^91W<4:< \BD47@81:DPRZ+O M)-/O'NC?427Z\,W5V:<'X7'<]H)K,XGLYU)&;SK=.[&:1,J\:[?X^U7)(Z3[ MROKE:.L\$4!.$&@/' OC5X0F=S;//]\O.,,300OG=9*(?E9)]'T"EQ@2TT5! M88I#]$F2^+N('794[ )(N-%(&"5!B$U1[R9W02)5P$EM<ZR=49?EA7:(5/$U MZHO)"_7%R3EDM.C0$HU-D5S%*\D^76B<.EEH?-73>FXT;^C-/F]U$X.G$/4[ MU1XS#]4>(SU7R&8EOFXZ\=H?_];MONEU%UHA$1YE\&7'[]FB7%9#10AN%4(Q MKZ.+V._3U@T-]AP+L ]Y-;3+;\I;>A-*7F"7N>DU(:C"NEMAU03LP-DDHM_) MZ[]BU3I&P*?L_8;RP0-XU5JW3*3A1.F"QJO/K%8^K]E0K.?R=LY9"(5\87*D M)VOO84<6>/'$/O #;QMO#V3Z&+C0^3ZZU"^<VLC"R>6L_K33*U>S%?'7IE\. M=M8>? L'9\S;EG:H4'8^NC*,WM+?]%;OKG37#X2=>ZO_WVW=VUO/U;NHB]:Z M*1EPSS^A;,+[H8<PL9XG'J;70P0?Z7U-S#ELFK7J!-+'XI%LI<TMN66BZW98 MJIBH+[N+'+<LYJQ\OX4 \F:$-*_V,3(;)8D(5HB( W2&LA.A6N=2>1U+C6<# M^G7H6ID:(Z2;ME25^ H_9R*34@N)(PEU$N]'B1B?BXI$S.8HG'WM#D>D1+6R M2095.G/"3$R(ACI*,DPD-2F5"\2BX%*%=&$QIPLQ"7W-:"B;R;#2@LTT%MV* MB-?H2)4AIO71,!;+:?G,.&D/\9:-HJ-LW1@/NE*T&6DV<ZDT49DEVU53J;AY M2183="43P=*C1::0I-G!<JA4B)I)VGU'2,Z7K_RP35"VE33:KZ5^BE_DZYR1 M+R3CN60*$]49SI1*38+/.0;X4((H=\AQO9SKZ_'Z1"&&":(U(M(91ZMPM5QI MH.FMUMA>+!=,LAAA\IT:4:B@=*)EVI'LO%T2LE'.3)05H3^K#22%,^,">$A: M1:A*:T(/M4Q_4<CGTDLQWJXS\G*L&Q6WFVU2Z;D^JTIV,^945&2<4R=),IU# MRC&F7+$:P\Q0KD^*'3U9*1835'HH59N+4<9HC")R!V52"28V))HI,K=P7ZN- M4G96U5)(WN%;F9B:';_&BHX2'>&S6,OD<L,V(LM8&DFWZUJIXVA6N\^TE:0\ MZS0= ^DOZVT67R9DE<S,"KB6BT7=URYJ#$PKWLB9M#*(=^-4PH@GT<8$&Q:C M:BZ&%-5I95*K\LEJ.X+@J;*IFWTV-JVZG9%5D:J31D.KM^*BV)6FPZ6$VBEI MLK0:#57*-[!8SJHV"J9>L99ZIBI'Q@6M:Z8&A928BUO9#IY*X[+ Y^)SMA)) M%^2$D(W$JFQLJ45%17WE.XD,5LFUY33:KLZRDZ[:C3;K\=FDQ4C.#&D6E[:B MSC*Q<G%0=LAQEXD3K1I?)9:O8WTTS<[$:EJL1;774HQN9W0IFN4<SHZ]DJ5, M-([49*: M\6H-6\M"&EF$ZZ<DCL:ER/G'42,2_E</K*8Y H.;8V*,9><9OM. M$RLE1OCKD!J/4Y6E,%/01=L9+=QRG6O@'2XS6T[2,38JYB9 B)H9<<Q.^7YI MFFNT"YUNKAA3^69.3<?DFH#PG>Z\46VG&+.:G3;0;+RQ2"8&!)<B1TL.Y9/< M,-=VV40$+6;F>GY1:LQ4MJJB$\HI=WE;*PNR-2HTN\N9E,F4.\L4AR?+0P17 ML_E<I5PE"L5T@M#43":71%M=FJ^*BT$M*<SJN<%X4(_4,".YY#I2GDF]CO!F M?:+5T3C9%60A9K-RW!6%1'K2[#1?DVTW@<3Q;D(6EYVJ4VDVY2R12P$62+F4 MFLQ8O)$HZW0CT=>*.8=HY:74:ZDRES+SJ$)QS#+:9)=$=J I4[#^M@.V7ET2 MS=>679>[F:(0Z33D69N,M)$:;B8+65,W2-L@H^ZDC^(DDZQRHT9C@G!6C'6Q M-+G,BVZT$(DD+#>7GZ+N+%6/JT93I76D8R-1RA2,4;);FZ<P?A"A1^U<,T?$ MYY.(67*DO"18]F21'5%8<E+ ,[(TZ,Y5-1XQ)3$R'\3LPJO2,NNO3'*<%FG. MK)06K,@,N"PY8M)+(CHHRZ5V7<:K=B&1I]P1,U036':8ZRS0.=8US6&DU:ET MG2)'CBK]3,'!BO+8&'!\9XKD^06F-8 &&H\-2R]&"LVD%3-25+X9F66Y^FLM MEU(RC6G;1DBGNVP8R4(B6YDF)Z5BU6YT=4>*,HUEKBNAG#U8:J]R?9HB*G%E MULU-<^-BJ5\>C0IDL6HY;+D/.$F,YNIV.9K@I@6RL9!B^E*><9(T3TX(@<B# M%6LUJ]F7NRT'2S?Z6.)5;FG*<%0UFLE1<<K*L4IZ6M(X)UFEF('2;*!Q(KWL M$F;-6<:C2F%&8\,I)K^BN6@KIR8Y9T!E,UP3, =*=U]YN8 T.VVYBNI\')EG MTPHZHUH,D#MCP=')5KY5K]8RAK%0E^,6SDWMM#;JO\ZD>;VCM:?=J%E*O?)Q MQ>ZC#AY=S.7(3#"I8F=<DN+3 6NFK 8R4_AD08CE2W&9-RK95'6^'-'M<G7D M+--(.1DUNN@"P:14Q*TQ[8*$R'J<+&MHHI;G!4[!EAG72:>R#=9TEZY5&F"F MT6W8KV9+M16]VL<PUHQA[2)7U\PR-<+&8RN6J=BO^93=*HT49#1>I"J1MIB) M5$TST:!8)9XP!;GEDE:5:TT;,S.-XVJ^52GI[5&.+]=PN3,JB'4EFAJ0^*Q3 M=*-&3:TF'2X+K'>BZ1"(VW;D29>*NZEH?EQ/-YO#&.UFXFK4*+1CXTASEES, M*V)Q)!7[5=2Q%2K3ZDM4K,O&)CFDA,9T.D](KW4'F<QJ\DQM<FU:SC&Q5#/> M&M>(>(3@%\.TQ="E;$-6YDM1:2&YPEB8$J/T%+%SO#LAXP4JURE,JW'P-,[@ M8C4\-HE*DTYW0:9D-T4M$8($Q^H4"2,FUOE(-E<;9%J\-:RXK[9.-/6Y6:PN MF)D;+_0;BX4ASEBN$Q'M:DZ?1M!$2==':4',44V!E]I"AVS9,R'E\(9C8<.H M61NJ*39:YD=\H:4RP.MV^XVAFH\U6L2"'F5R3-+N)D1+Z>K8U!QF&]5)BDFA MDVY40&93?N%0DUETY+RBT;QM264EJ[J=SBBI86F]AG>9;M'$8G0WU96,)"LM M.XJ,:\49$W<:$Y9/**]2>CGERYE*9[KD4YD\1JD-KMO/ZA&@DF0BV<DT";;O M5F+#Y1@Q2XW8B+%:T50D/J<,IQ6-6<DFGQ_*4Z$[&8Z8:@LI9Z(6-5[HA4PJ MFV>S:6VR?%U.'<MP$WQ^5AIC&2V7'(V6:*PL5;KU:5&)+<6.M%R,EKJC#?"2 M'2?4ILAIR4RWI EM71URU6:U3TV$FIFC)Y/TY#71KZ;RFMP79;SNC*:I8LH> MSC33:LI8QZ8XLVU'D6%QU&^1>+T\SO4EJ3Y/1B.YD1RI$8M4I%UD4;X38]*( M/J>$Y0"5]6:+:I>!3[ 4:V5V/' ;Y9K=R*J82":)5BZ&)E* 4Y.NGL?BK_D1 M*>>&,1O1A,)L\8I$1UJ"MSC%8O'.4*C&RTS=9(2ZKBLY(6LZPASR9L>L$Z_8 M*#O#DEJT*_2G]7E<="0;I5D*C5HZ(0GS MO@^0+><3DEGC?3A51G)+20I2A6 MY]%$MMP=B1&=-.0ISRZEJE8RYJ6!@3&=&)J17@6^6QF(9HIXC2VFL4&BP@\: M=5=O+RNL5GNE6;:-+)9J>DJ1";JFIR3-JJ>! 5B.4Z^=ED,61KJA)@FDR=+1 M:C71TB4YBE<M8]AJQIF1U9C(3K-,]=M-95I*XPI>Z<_B2ROCE+37EIP2)7NF ML$YBD2S$C'1]) @":Y<Z3)'+M$=I5,3(G&0Q\TISV"51\;75XC'%KIE.O!_I ME^0R67VUG)*9+=#NA&<S"RQ3TY967K#ET;"FT62N)!?!PHF&P^GJ/"WBBDFW M.-HMR ZZ'"V:KW0!-7/UV:*HY/.D1<70M!MQ4<P9RID%,-Q:*R\,<K4T.=:J M>MP6\33NY@JV4IXB*)FO:W%!RTWR1F%D5_/%#.LJS5HMWJJ1<9M@P.=F,RV9 MIG,)#8GD[<K,KK2%4;NE=M-DL1D7*;PZ'D31;+N<T.(F*<U&UDA!K8+0:+3Z M,WZ6>XWWN7*RI*:3_0599S@]64+:0/Y0$C!8;%+J#&,L(>AXQR)DJ[ZT<>!( MD:@U* B<U8[&3!2KU72FA:(.UZ^9IE9%DIQN+=U)$6.6=9E/\)I,TK'D*P]< MB*%+L>.8D*\XS(CB^MUNE6U&&]-8NMO&1*8R;!72J"[S7*522T3(5KP:*SAS MUBW&2V6[S]4CD<ETR(YS(-01<CB*+P7LU5$IDV-DC!+[U5BNW'19M*V([5@? MS8VP5M=6\#I12(W$.=%L$_S$5A9=@U7Q%%596C.*9*)$.VXM.DJI/V *26DJ MH'2L(TT7^LP4$\* CH^TLE0RJ89-%^K+,4[66T49TU :[X^7L1H_%&<M2S*- M=L>6U,;<P44ZBY#5J6L4:ERNWY311K6E9YK+1LE&8WFAA VMFJHV[.XXR^!S M:H1J<:/:7J)",R);:7+6$::DN*Q/"T8EDI%LMJ./\[-X6Q\7EP4,FPH@"IRG MI50'FRGS>*325Y=B_=75$67!DC5@NB,HDLZ(.;.5)*QL:SG+CR-M?9F6U?IR MU#**11#U8 4FP39G6:8V+2A.TS2X:GZJ=G)FFN;+4J)J2D5=%Y;)^D#)(7A. M>8TL!EFU.K4MF[=>!SI:CR* '%F+M&EKJE82\^6,SXT26--J6F4J)N<<JM88 M)++M;J*5J(Y+3B'N6#@C%*UAK5M+8PF)+$6M#C**THE2H_ J\RQ7*"WX5Z-C MRC4@+PM$,F=J 2^/YI+!C.TQ;G;[B7S'2CNN.)WQ_0@NCAM&K&Q%6M6^HQ8T M/CG %4:*Y.,Z;TT[=@KGEG@^U<>+(XNDL45YPAM1(C/K4]U1.:).JF)5):98 M64FTBW,7>6V;>8XSTN6R9)9JLP&:ZG++:*X[[J+3>K=;4UKM-)\84.5T(Z7- M9H)M#[LMG<87TWS%1&/MC'<#%6+B:%:2R4Y)808-<3G""M$Y\*\R<S%=R<2B MS"*A+1.$:/.%CM+LDFIU(9ASJBE5\$RMR@FD)F9?"=0>BJ\&8S*9I=V=Y.+B M.#%L)ZH-KC.PRN6.V%'CM25+=0:3BKF(6&*^/^H*1@3H:6[0790J='N<EPO MDQY3R#@2323*K_,Q)Z5GKV@\R=(@D,F A7!RMF0BEA03EFY:S11IOEBKV:+0 M+2#UEDA2:,>QDER40.C\Z\C-BFE7EZ9)E9@5[4I7HTLBEV[6.FVN%6^80\G0 M1ICJSIR!G1ZV9AF.Z7?=1;[8XDRMFUO8S&"^L(!W0B>B?=7HCV?@S%0F:M)X MNMI:*H4:C56;_11"IB4SE10RE2IBR51ZS$HCBLHV)@DJG^"4,65G$3IKU%X; M"QR;"/)T%FWTB\T85GFU4PNAFNJ^(AW&7 )39N4:-7Y@V46=&RKC N(T\VW6 M7*)-8>)DH\IKGBQJA03!9")16G_ML,7_Y^=R(GU-<.!_)6NJ_/O_ 5!+ P04 M " #.@)I8$),0*!1[ 0#2@0$ " &9I9S$N:G!GG+H%4!Q?\#^X! BN MP=U)@@6WA0TA>(#@#DEP-D#PQ26X2_ P1V"+N[N3G!8W'?1#2QP^?[JI/Y5 M5U=WU_-JJJ9>SU1_7K_^='>]>?KSM D@5I97D@>@H:$!/OV[ $\K %D ^K-G M_XU_@O%O8&)C8F)@8.)B83W'QL?%Q\?#Q<,C("0E)B D(<3#(Z8@)GE!1DY. MCD]$245!1D5*1D[VWT?0T/^]@X&)@XF)0T: 1T#V_UF>N@ DV&BA:/?H:"R M9R1HZ"1H3WT 1@ #1/M?P3POPO:LW\V/L?"QL'%^Z?00 QXAH:._@P#_3^K M_\WZ_IL'8)!@DC+SRSQ_H?$9B\6)3" P(1>;]5U--[GF-)Q-\(MS$ XN!245 M-0T[!^?+5Z^%A$5$Q<0E9-_+R2LH*BEK:>OHZND;&)I;6%I9V]C:N;BZN7M M/+V^!X>$AH5'1"8F_4A.24U+S\C++R@L*BXI+:NMJV]HA#8UM_3T]O4/# X- MC\S,SLTO+/Y96MZ";>_L[NT?'!XA+BZOKF]ND7_O_L.%!D!'^S_D_Q87R3]< MSS PT#&P_L.%]LSC/P42#$QF_N>D,AI8GYU>L @$8I.]2\BMZ<9A%=2$DW]Q MGL:E8!/:8D?\!^U_D/V_ Q;T_PO9_PGL_\*U#,!'1_OG/'02 AP?[GU! BI M[WQAYR?6/&_OMP'T8VD.8;"ECQRHZ6]0 *(E=5V7MH&=X.5;8XW\D.QCI:F] MCHT;_7->7.#]&^-?$VIKHS]=ARJ)@OT1B.W)>^JSSBMCX5Z?CTQ^\QM8:@+^ M-3ZR3X!?AE.8@0C63177Q2O!)X#]>KH3 K3)_M//<C ""')D>'>><9C@[(6? MM-":0PQN<0R^:KXV47XTD1ZF)B]X-V:P%L3RNH0]/3TH!)"H2'[Y!!CDRB%# M;O=M$/8B54P;X%D=I:QK;8LI<'6OVGQ9^N:8M/"EB%4*U<+ 5\TXPJ(=75ZB M*!Z^ -GAR8@V:>#YM4&+X[I33FI.9BSD=!ST2&'=]7FQ3X(8= W?V-9/96"K M1P8B6A5G'>W="#@F>R6 +6GU<_;CN=#6Y#X<UD3W6D_YM]E&;X9]_S#;W?;' M@+7A7[VXE[FG5L?]G1MW"S>XRAC0%6@2VG9BD?2>A1Y_WN_#)D_N*EERR"%? MA?Q]?.MW)2\G&6/X_=[X31) ':-0;U8ZSO@N6P\O78RAT7%A?N@V1><F;2T+ MPFM^+HW8>1L>I9,!;VKV;7!Q2ZV8M<TY&SQOTF$$H'[*5!%=0XX<6]]FGQB0 MZDQ>:_872B=':7G]*;YW V\$9]UXK?\0?84B&^ZE35*((76]+C_$'%]?=<P> M?(.49L*LNSZ!=KY,*3RT09&+J89KR+#NBIK5#:7-+5[%UDRUVNS^H8-:H :S M[HX;Z[%)51+BA=9T05W#8I)Z<V-GPA<H@CQ)K,' *"36U=DGQ7'STU@T9(CM MF<M?G%8&?X26-MPC'.549(I4V>8,1?$7X.%\LA?1\^"39KS=DF&P1<O?_,D[ MMKG7_(KG:I3*?B=G>S_TZB!%G%A):K6VLA641J*4Q&C#UJ9O^V9("Y<0O/[( M ;'6G*_'UGJ7:1UYM>2W6&@VU*])?2?1_+@3;BABS$ K-D0^*@O;AE7R#;0H M1-1C\_)=@9&?[05F/I>P;K$TQ3EL_AJABNUZKC'I-:&3C^F1A[&TQ[C4"-XU MW^X(M&VD3I95!SX!K*PN&TLWXNI]D9V>'-3 ZA]TBV4^(HC%'B(<B,.B*L*C M#T1PU#)V^X**1E5F:>SK3L'K"^)+<@R"/HL[W:H$!(F;O=V^ZD(7O'\A![N] MTVBT9,?(U>&+$L>0NG JKX8H!H9EK9S/$P"QHNX8NT%5S\,HZVNHTPQ^>>5/ M*N/X>OF0?Z!NU(/+@IGM=Q2F^OB/7J?(B6P.P:3HI,CVJKN_5<=W<C89FMXY M'Y7^1=0'H%+U@>WCU=FK3GB=-+K_5/^O)\"FK'^,)M)CDTL]I(-\%B4)]O4O M57"HF#4SG;A0 8Z/*O8E!:F_%2.OOBF-&0YAV'Q=1?R2/=;K^G#0:WYN8=A8 M-0^*XJX.> )<O;'Q1Q(_ ;9U'*3Y_"9U/6S!H*@V0<R5JFMHROW7Z(Y<I6$& M9!D#/S*PBHCD8/W%=#0%34HQQB)>F1TC\$T%NT>!;3Q[#D$3,_.[<OXA*DEI M0GAVSF86D*=%U<U;DIK7S>@W1VMK_,]T]E1JML1OSP%4 "_SF11S]Z[)T#/ M$/+%$T#F@>CQ"=#.^<^B0-J:)P#.\[ <=:GCW,?%]KE<LQK)49)#\7A[QUM? M+[T$,(7A?HB/&7UC)XS'[[AW^6%;%G?)+.UQE)4HF3%H"P=K+R940$!R5O,K M;_HJM)\H .RTPTB*]%&'^O]PR/3;,&F>D#I\ L!K.S#\I[ISMZM1/B#D[)4_ MEDT']4)LOKW%J-_G"\,S< 1'/!_C2]Y!P/9E5=<PW0:7B3(6?/]L?T6HO7#0 MI?>1#U*^%1;3QBJ2OFD6X<<(GV@FGU,5GO,@'-^--235XZ'^)+,6O>F]US:H MWS!38:;=UH(\WVJ5!/^ _H%27JZ\IR;&(H&B?FO*F,?QI\&5@^1\<38W0EIN M0ZX69O,0NRL&PT"HGH=(BH:<BZ=03/-NBK4 _<Y/G\@F %H OXE47( /R-R) MOGMV:Y[O<ORL@&!ME-%,P&0,A(_;&OV7WHV(T.[25.;SO0($I)']*53LM(%# MH:EK-VA *8!7WJ>]&W%I+GR0@W\]B0:Q'LA(0#CV;Q!"$M=A*Q0W#-X%T5N! ME\'B?3)Z.ST6(AYT--?EYT1(O.Y'DMH<@VD?4+%M8_]6HT$],F)U1M#S6\F[ MD[&^K(A$I4-U.,JKL$W>$0_Y0@T^1XD.LIVGY]YW.H+WQ&[ZUYX5S^%Z/(L& MD3T")IW8Z_TXX5>I_.9C(;Q_AM*I:5/%Z;SF-N UCQA/@"GO]T^ SG/CVP&^ M,-5J&Z>C#FY$UPQ;389DIG<6Q?A7:]+\Y_K] _OI\9NE<EQ-HM+)PCE]1K2C M8KSU9G3(&4D1/*;4>R:SE8$":P*NE11+ZB/CA&.#UZE),6'V!*'(+#BYE;YZ M^!6)X"NW\-7&BU\!^KS.;]GP[Z>=$**;/!5$P$?6J4^!STT-' Q(%$K9-G$O MVSEA]0PO$(/1;J-1Q^?4QG9OWF?HA5-@;\HUAM+/K##91P4G9+RK"3+R %8S M-&^:H#G4XZD:;NO- Q5X"TF-,[.<-3A$"2-PRP:IG@"6VMY)[XO9"_3^HB4P M]DT&7+ZO58#1XVQ_;C9QH"ME^+5?2(#@V@3:&;3)Y):5#)M+!F!5>AG6O$3_ MT ^X;^TP&TF#$@E/_UW-"U!<_=9W[\NE]IG!GJAO(P#Z<5"(@77*.E2.,+'? M>2RV.!>#CN3LU38,U)4R(7Q*_,#IY1_L1P_)[S'\<&?2&76R6>N]DMD/]J7S MC-K_,$,U!RP2DEL+*&O:ECKV A$A,X!1C@QVP>9[MO7W'&9C[YL>;%V,K<6> M "0=&/5?05M,TV^!%L9BH&ROQ>_2F5MI3X"Z157D5N&@:VJ2L=F@4XFQ<65+ MV] 4"Q>IB2Z&Q<4NDZ#R9#:@NJS^S[4OK6I;QK%V9C]-$)>279T"?1X%^FXT M&14 BB!VRK[N\^&<KZI *93;9IR&/.3$-J3)MY<,\T>=7+Q.AN+@Q"J@L: 1 M/^]]\S=62<QG+=CGWMRR&*]<Q06QWYOG[4FAM$6I]0'QZJ*.B\OE9=)H#HDT M"7#C1U90E8VA7Y:Y;_ZH+Z+\71,4VAIK%$[0W[LG;//A9SQP0XBM=]2'V\]C M1*W;S,#H4+<QFZ-C;H8L3JNY/@@O:F@*Q_*]]<OH->52JZ[3IKL%:-I^1=7^ M0Q$GF0L3<,0Q(@?-'F9KA:#XCJ]R6Y"XFZPPEQ2HSDC2@2FJZOT>=+-V]*^L M48FBZB '+[1$&X:L>F5P9!%498BN#@N=U?3O!CG%[_!S!I E]3OU#FZ0=U#: M2B3?]N&!U8F7^KG!!+>A]O,\E=M=FI?G\8K/3^JD9\J(?HU;2HQ(<HS43/OW M#"#)_W'IZ8O_N!0+)MI5?4=DDW/[]UAV*ZR/QV,P@^LH^HY]O R:6J?6G&X= MJG8H(,:,3<44RAR(08K-::V,"(66&*O:^V_YZLEK'[HN4MQJ@,2Z+@JX"<7_ M_M!T2VQ?6%>_NP]V!O\+$D'/- 1%T+H94>-N[.1M\S:BY&L'C]]D2W+9ZA*R MNM>C<4PYHK+Z0[CBD>@K5M:9K%)#)+@O6SK,<-:-0*M76G1V"^*W*)PU7Z$7 MC_Y8MF5"(1G>+6ZJ\FI7L3I'FL4(&:6"D)J_[27"7D>:;>LMDQY=]GJYG5CW M/K+5;ER:B(M%IWY\^U7NS3>954JA+=/,'+:LCK/.B$QG$Z+<)\"6E<_S)T!N MF,P3H"OT"4 #VK)"/:?WD?L5=^_IB*BRWC(;L!>%I:3@*WGD'D^=QSX!>N_2 M^->65:FY7G_:'M/YI.=E"3DU*1Q,%X)<4F5O\%>;BMF,ZO 0*GUAIZ=39H37 M=3S[1U*#_^5A%?\83_6^YT@G&(]YG^@=47\F_3/)+ %)$^F%#;TL\\C-(?S9 M9.9DVE&=]Z^+,;/".:FNW6USQ:P_(S-D!;-]!E#'_B5\>V_NCA^U]FT_SU2. M@4&#U?BL2A@?7_O60CJFCEC6<'<2H]>-!R<U+:1M_[[5T(R1[J*XE):$^&UZ M\G,1U4]29L5QNIKQW54WB]Z]VY/=N\BW]_:K*5ZQTS/4AKHCUE2LW:$BDP*A M;Y1)?B@&/RSTOADZ4;7UG'&ZA.XKS%%>8BV:7:0]8B$6N\<I>R3D0CNW?=&- M%BI/$R7;WWX8WA_"XHE^ MS=+6R@N)\ 3E7 C:,2-*-[0_W[[\C5R[+%IT% M7WTZP=ZO!/T#@D(_GORKD@.OET;[MT*C_SH/%*XCHB@G,@= 61V!DI"&6J/ M!$7.$/?!A>8U9[TX_XG!Z.OBA^S.3#CE8L[%(Z?W$P#/Z,;_G_^*>SN15/X# M<4C#C;J_A[ <PG_+_?F?.Q']G?'[^XX3U4N3W&5J>ZAQO1OG1\<N,U/_461V MB1^7W^3Q8K\T/:-1[Z-0#KP19'U^1],F_@0(#$.!1QI<1,]27<RKO297MP&M MF ??[!;T*_W\N\R6B?[ZOUCRW_KJ-]EY)0QQ? *@JR,7,U%@A$*O/Y5M"]#T M.;)Z*P?'>&4=IVH7//B DE'$N<A.[V:Z'M0PU2O(H1YT*Y8K:5DS4 +&\0R] M(IL:$+6/?;\C!N*@?^/?)KFHUZ*6F7DIE)]2RG7I!T"<^N;TC;8]#H# ;LA_ M6Q:2+VIER7&C@YO3QF*\OXM+#9H>/)M,'76VNPV[DE2G KMGZ(8AMGL-4_)+ M35-J&Z#M[MYQR2MCT>@3E%@GHVE#[SRTBH.-5]0Q>L=#]9?%6?UT?@1ALS:Q M1@Y-G\)JD,-PAIEUX: %(F(A)UFJ'OE\]28T;7> KD[MOWR$)0W^LY BN*RD MD.IR8(:%PIM#46YUTDS"VDWY2("_E7BB6)7Q,37?30CXJ2ZIKU6/9(H!,ZZK M0P657. K/8GCK./<&:KYP$1^*ZLWN6Q)PYP+59#!Q_</'H]MUD^ :7MMZ7_, M-,P/#WL(//E7<BKKQ7I9@7I 2"1B_R'ZUNR.E^;2/T:/)J;Z5 [N=M5*)8Q7 M?>)/3,0!VUFI6DMIMN^F0QQ&7L7]+PWH;@XCRN3S9MRRWN9-9=G?TJ+!@N-C M)R<:1R.W5^#[)< .T]E;L<D/'[',73;7P .IRQ;K+]MK&F:N5H8:L(7LJ4U2 M5-(R71V!%X Q\M_=),2D:&Q71:@/-4&71DA_-D0$Q49?O"646,;&:F7J"0!Y MA>("]6]0^0B;;_T!:A5!<J\).%YIX$*<9^]UJJG#\8@5NYG;Q:DFU)4W.S@A M^7V,5$#!3SY$6_<F?'UW<FL=)3.0#8K?MM-OW!AM_IA9!-/#6%.Z, /(AT\/ M#D>YUE946J4G5CPW'/)O&W0EXI;-U69.A7+PD-6:S4;,^4<U"L# GF'VY%[L M8AVL\Q,.\<;-N+47!HRTUQMX=A2=]HUS? YNJA1+A37M,Q?<YA[1>5RKK[#) M(Z@_>N!_[]IQ<?>B64/R$C!^0,C==&Y[\M^<*G3%_QWT0/0_Y+H:? F^ HF) M39#Y+D_#U4^Z\P^R\4P8^^ZR=C<F:KL+_ZBVC*I]<@DG_3AB?&V+>^&LHU7( M'E[^DGUD1MW:OK5<] [$?"$G;:6%X.PR(Z@.6NS+4(_D:2A?H3767P731'^9 MGJM-MT<A0M__*%5=:6)[T4J^BN3K6W:,,E<UZSW-6[%)B*L=Q]>(:UP>*1,U M4I19IM:_82,)$B"T>_5(C!*?\N'WQH3/5=;/AQ2VM"89MT!IOZD(4F61??( M.)GZP_<W.S(Y2ITJ("+TLETM[&V1W+R<I"9F8*X@4Y4?S5\P.XRP*_)D@W93 MF;3OE<L$ECI2ES?V/N13NTF>:O5UT"PX5K5)$46Z[BQ6,2=9MI@40+'Y1ST- M...<C'G#8.6,81)^Y9L;I/J%CUD$P1>J3G2D:56?]4>;+7^@1?N[UEK$RE0= M&R-5'BHV'.8;YKQ;Q<;BE3,PHVI;LKI^\]<I"J+04JN-+\WXD#,JYR\@Z_MR MB,+$AZB3W^-2\U%6M,D97W8U\0M:B9(C2$R&T 'Q8#NAUQ,_BS9:.D&F&ZRB M+P>4*>>S\S?-7OB\0^K!+U4Z$-G5X J(Z?J :+(2JV[C.G$>L#KDYX4V2\#? MUZ+27/TGG39Q:#8Y>(],_5L/GR#F@W=[Q9Y.['TW,YGPGH^LBLGSF9"0MR;[ M>,SB@\+'TTBK#5AQ;'V60M_LJNS6J;1*E"JCRHQ#45W#PEJ^)N/H*H,FN5GT M*=[/ZZK]_FS,*2#1K^5_>IR/)-=*\8V96[X,:^=G5)LLW&-$2UTK8^GT6&/M MJ.N7EPT:%Z.J.:OM!RMF;.E.=>O[](ZY*."<T H/IEN:CT;E,3BU_MX"7*KT M ]_0JG=";3HTGORM2WTU^0;$S' &R+656<Y?=+A,)^(5;4@/71J^L&B)#Z1C M>8=CGM@IHC@\:#S?R>C#5X=,!Q?3VZG$4 U&1+NKXII$O,$]:^L5PW5)C@YQ MV(G^WF>G-P[?NU>I6ZCG\C573^T3.66,2%G% ZLP51Q=8GQDSGA%QGL:2"4F MCB5VE.QO'^;\T],B)65FXO[8$@I!57W^QU>0#"^WQP;4I-;,&5"&[:MP)8TD MSE1 Z(KV_=O/$TH,AIBGQPLE-G>AC8N&O^9<FX1XI,S566R%V;(*=Z-CN[4Q M/CZ[Z+N6XA\YZB3C9NZ<O5IC5H@2'I?UJ5GYL_HK%)N2MCA#HXGM4WQ^D$$X M+I&8,".V7?;KOFS>["D;*SFW*:%& 06)T@E>:S<")K9GYCIR3)_.J$N2I6U- MVD%5&Y7C:AX]7WT\RU8@17+F>4NJ A _45H*R\^[PWY+U'W?G>5!^]E&B=L, MI7;E;@Y#XXW:3,\=1.*]<<?"A]EB7/,$^D+D+F[MZ0'HOP#:LZMRQ:VBR^^A M7Y>^C"8] G3:SYZ;Q 411GAX/ &P!YK=MDXE;G2;$GLD%:T#V=E2$]&8I-4N MG$?0-)W?E;+E2"-'MQB)-XQL+M?6P30GQ*N>M::&R^],QY,#M>C;7A9& ?2< M'-"$CW7O\HQ%UJJ]7]Z7_-H6O_OR6_@\8MDO+37EV\@C*P)#,MB4<3HLDU4- M:R2QB?8+]< VZTN-1#O8=1/GG\MQ#QC[9&"]T+QK>8SGL]6WA&$P;_EL:O(E MV0H]!0%63.XN:KIG3?U>VT<IWCDTR:U%2J/&++'BFR^RL\H39E$8Z\PUM:D# MFJ+A;D4QIENFSBDX(@*C9"2GF@$[S[^-O:4&+OP X:'$2]Z-W#&D"U?$YFDG M3JOP8[B*339H[<8;6\4AHGHEYA>7F.;8U,5JC<9=7LAB5+2)IK("BB]+.[?$ MYH$:/E]]7N +/A\3E69NB^FL.]5G3'LO)JH9)\?RQN_R"8"S]R@&\5M1G':U MUUQ_^7FZ#02)\S"G0?O*O2N+GYA,OT7(KO4]ICC63CW0C_5W#;RR.M2-0'-A MP_"W)\_,A/J:V@CC[I?F7E)IQZ18!;*KW2EKR\TGP+,E&V>YRC5C]2I( !?? M36-!CU(\J7,-0.1MV'U-V?U>JPKX.ZL@:=_+,TB5IC^%C2G]S.>4>XU(IEI/ MMM35=7/^'DQJ<>FT:A"BKZ5SH)P6CQ%WV8Y8O]=I7ZG,9&BA412W^+E(W/F( MU._G"H:DYKRH#XL50 ]8W/,EB&\G])I 4C]V3Z<A9K<Q4AA#4AGYAW]"0&G2 M[LHLC%.O858X2U(;VM!H M)N"NWGALC7<M,\TP*QVG_!/KS8^6;WF%K8_^O0 M/25E(>5F^GU9)4$9]O:$>$_LTEXS>/*DFM#'8O;,5'++?YL'N(3#^L4>/T6F M\&V7[Q*-."-6TSM)W(&RVUSA6?4D5/+)72IE"W^'J&T-9*4O&Q/.WE!9<:MG M^-/K)N\2D]%ZUIZ*FMH[)5&)-1QM:0.HU6:P.>2#MR6EK@%O+*RV)2A>&19N MCZE<F71 4J_L*K4&'HB1QVU**:\,F#50]ADM_FZV14GF+]LLNQ>!MA>'$Z)3 M7]'&4J-V>^^^HB^T9\#F^2HL0Q7;^E($7Y2[+LMC3TXMU"2?X5_XHZ/4$![A M,%7I@5&510>A>SR#!@)#F#LTUJ!0<RRA+)<:G3'+<1DEN^!ZJ@8C\._VJG=D M$%D]&+TY=@ZV$#GAL@::VW97F@%0$M./= =UMBU2K=UV%I<F!F.QIP'/]2^^ M =#_Z'W&S]0#_' X_LDX4-]RP#J9BYS>@B8G:87I3]D/_>6<KU^RAR6A<^ZS M1GMO"WOH(CLW[ZD^I2$C>R['-:=EO^SMQ$LDUH1R,J050:(&#;,&HPK@82$5 MW.<-8+#BV37MJ;(\A:&SHF($'=,:6Q7Z&QGH+C6W@& JPW>8+\,%S'6VC0^& M[L28ZG2C:*;4+'Y$?OGZ]S_R++W-5[%CS8=WQEPY4LM?VM+4TZ0L+,_(;WYE MI=8L3@9>L31OA H:V6V0^''8D4[29=1+%'A]^-;V?3QH IOU]3,W;5O+Y,MH M?O%A6)LUC#$4)0@_>QRY.%?RQUEGK5B('_=E*$8/^>0.Y&)RPVS&%^.)SKCB MXB- GL.8'U?F,I7@-\7F0J*&]%<I=M!?I:,*H)3]6U)F"XM5-5JQ(;+3H@!O M-L7.9:WLSI8/C_:ZHE3(R#=*4C%.-(QQ3.K$XT7(R'$?_HKAW7Y\TLF]%5-2 MH^?+/H"_AS5!34#R<Q.1NM*E0W=GX;YQ.VN698$*4OF$1QW]2Y1?CO*(IC9L M7RI!GB.NV@29,R Q9J[2!)UQ%55DFN.PKUE?%7C!'^Y/*H];]1@2A7:KZKH MG5Y_5[>L""5I?#>,%RH;2TA%"GJ]N84,R4-J4OGPY\J60#+V5:(-1Z9&JG[7 M!N!.NK"^IE;7_%6W\[.DBK'W1AJTV.;&6[CEB&?D(SC="<GXL5P0:N,FS]7 M(/FRQSX!&VMB)!3==OV-@A2OLL\X2EW/WJ?=BVRA-8NS;S(T):IL";DPVE>^ M*=DN++*Z(5]30-J/XF(6&YX$\%LR)?R&*X#@@S?9=8B;&A@/Z8KRW'6[BUSS MQ?L6^9^(%3MBD@LU&ME:YM;7'J"OL=CD,S8@]'R))+M'($(^'T&IK<OC(*QH M#OU=,^%RXZW8)<=&Y_#E/ Y6#D=F*_K(E2#YNCMHZ_2F?T$3#ZMX-0=&,+-4 MY,E)J#>8G'4 D]3C8%R?RHN#5M>S*^CQ!7O\@<03( :HX5)EQ-%<<&C8D?1: MQB5_L%AXOJ%UF'24INWD8"8KMJ#>FU*<2EBJN)O^^647U! K'*/E=#UOU*G, M[D(9L6:\%L O,53L^J& B)L9#0!P6C3JDB;*Z76&1&ETSC'/-<2X(QP=&19> MD-=+LBB:1[*SU>B\9Q0DU4^$;!*66KVM4+DBKVL<,BV>D!9':A'&5.@O'?&# M26T]/N A%]43V#/6#P"DX -%3., K!7FY;Y-I>YRP]#B;?\@PU>=B.#R[2< MUGO1SHAZ20ZC^Y?>*FY?"X.G Q?TU;;FB@3 !YC.(Y8)WR*Q=5C/G;[GV%UV M(M\Z2E,.5AP]HM=G?C0J%G5&2AMM\,[O EL-!7>,AI;8JGP:'483;4*4TSS. MCEH=SOU%H3 799QR83?DXY=#FH$<F#W-J/8L'\\U#^\=>_;RV5)?@BHM?J@N MO4S9I=$H71I/\*3A91'<JB&O8%T(*?Q%KF&6-L9[RZI>NF_=V_D<_#-*)6GX MU9A -H33Z4B:UL<0?MLO*3EY4LI9/U]_>]&@BJ4=OG)$\[5=1!UGU_.@]_5: M1+4W052():1NHEQ^N5*CVC70\ ]ZSGK<CIVA>R56ZHV'3.!>=,D=3:PXSM>O M'.TOAU7,(\H)!\Y>U1KER\OR Q 7<Q7]>NQ.&BEK<SJ)FBGCK''82M+7426V M_LMI<LP*7H?ZZ,OEF8X\Z?'F/V&E_(+/9KL;#]^PIS*>:GM=4:PSRL52RB=W M!N/^:3(0_=8/QM.?]3E/R]HGUV,;>@($!TD.H4HU#+S,R1.J3 P/;D0E8OJ. M'8M7Y&?5N</"$V2X^^X !&^/>/8LSS/^KMR,+ )-8/Y$RRA^.&&<?R588B:B M0:0V.AE:C[6KX$<.'* ?^JNW7E2HH,RKXGS8NZST_M(LT+]1:%W@(?^Z':3; M9./#!WNENZ(8J152#[E@OO/\SMRY_-G,KAX$ B7[61XS_G;LG\0[=+\K;*B, MN<FE)A4.S?$BF&.C"Q)X5O,$<(M3OJ^[\4=&E:#>([W!')V6+H7(<M7^E&IK M3SQ9IO2W?9GZZ&%47Z\F?+ERL#2+ZH\J/1347O\4RN(LUIJA?S> O*K@$GX" M1*W A3N/+)*> *JWPBU_7V[(ZKM7/@$HZS9MG@"E*>H/HJN+\H+(%U</']YT M#L25WC)&^^^H+_H?#_@_4,S+;IFADABQ_?\P3#X!WA>:(>)0$7?G#Y!_3WG+ M)3Y<3X!$\RVB>_2E)\#!C^IXZ;1!I,(3@)$!^ 2HR3Y^ LCUFHK?J]N*>.V? MXL"#!IX *CD&C:FJBSAUT);8I;1 .YE+-E> ]=3^3'O<%B/*!W+Y..!=_4!) M -DXE=HR E'Y38.PA.Z/341NV&?=EH(E&N);@VL+JPA[>K&RJ>@B(WRX"6-\ ML)P(,OQ[A.%GCGAVQ$5_W%3HW?$\]3HGAM@O0[V5J[A@G41(ZW\A&(WRA%6J M*[1. PV\[;$7'7B8109FQ^(%PFF6Y@-;GE.H5N7;1G\J$;[FC)-^M@IIKJC^ M/*>65&I@3RP25VHGX6KD$32"Z!?7&PD2D/<]RHGIM'IP[%M4+3M@?.$(1/.Z M5YT]2+GP+^:V>Y?^9PR/3-,=KC@\X:4+ >HHOXA*%COV/F7K4.7J3,F)J*29 M*6;G2)TTZ\Y?E":"1)[W/P$(@%(>O*7V)>O&*WA1W\&X[QO[6WIKWBY_W%5D MHON>$09CC .*PH_F'87;'6:&T_Y^6ZG9 (XOF8<X7_!?X1EC;! *@4V>@X@W MCBA:'I.\23\LCQHO]\W&M DH.8>=NW7%XV?//0%"[\*Z#=@R+K@83WRM)OQY M%5$J7TF/.*F8\X^I&>(8%-J=?>W">(ZDU1&V?P\>]<3;"]R3ZBY?'Z7JY;RH MH!GMT_60QH*'G,W%VRTX\ZRAO+]_%2#96>'Z9,V>@X54]0K9B 8*4_Q,G49F MRL?.6%^DF#4.-NP.TQ([_,UDBB94=<GF1B97(3.5H2"B:TE)>HDC=1Z40KE1 M'>^Z<^/O9KG$=_)H\2'TWQZXXN"+@>OWIFV=.3T4=X[AS%#BY>.2;,LA>8PL M:.U[,I'MIBA(8Y7?I2X?N3+XEB]CK>.TY>\-0RW2_?S!P?D)0 JR+:EO:L@T M(XHZT%T7TD5@1)8$CA(R1]1>6"?COZN"D9&J>NGU;@2)4KP8A3G2J8+"@0JN MIVRZBS,X6A]".DY8ZX:PUOW2V5YV#5\.M7%YYB&/5:<:<+ZZ*5V'[SS.05M# M5<J5/D='8R6ZV[+')\W_)KK5 ^A5(KV5%]L8RX: $J"&-D&@C%I8Z1$!]>\T MQDY[P?*<5X'=$4V::)H"NJT\9Q>CCXP[VNYU0L*3.(?+_[9 #D]%XVV4S0WQ MFN'0YPP\#Z:6]\??B;^4)S8!">T*LJEG?1BWD/7CI /T$DLF2K%,ZK2!W&-J M^DG#W$J<E39V# +S5Y[$=C2,85=+^I:@>J!:0@I].(,"2UTU2@.FJJ+:E+@H M.^66]I8@AK./BRM;076J[-ZY)U=+8YZ@/\]](-<U;D]%?&*V'E-NO[G?"B73 M,N6Z@6L74:W<:/AA6DAKE+9%F3QT_F+)[S.SV ITCY/J>1-79Z1$:&4)/2G, M"NY>27N6V=NBEL-^4UOS$S7*K(4=\]O?IVRT&Q!:GN$?ZD9O;EK;6C=S_:JH MCH#;$!JSXTFZ--1U+U7[FX<9 [7S4F-J!Q9K="8S#O%UXS$:I''(P0H+"[P^ MIA7C\V\\S]-WO*X4DUXBU=_$P_D"<8U/?;?54RI\UGCS!+ ?'>70LV&EQ@5) M-_0B<V00OI5[8:[9;+\SASIBSERGBZA@38V' NF&"I_^,)524:,#:0ZNSXD, MD+]D;Z8]<#[ZC;6XH1IK2P\[72U<NXZP*PZUU32+_<,FG@#^.8?5'U-E#9A% MJM2S*>2-R32)&).MC^X&XG(_7Y]^F?P0S)R6.1H<\PYM>"?(Z=0X:S>N+X:# M+$YEKC[+=%RP!7QLJ:J(_XT<RDU*<C02?)^1_^O7C%5G9PN\L:X*&72SJ>[F M7UH8S6U ]IH%E*8K-H768*ZU>J$DW%2AW] TU\%FNRAJ6'";30MO'XMNS! . M5K7W]OA*2&$4$3=)F?;\G$<DOL#A:R*6>?ZA2 M# GEH3M'*@:%P$RU3R+,@ MJ8 S[Z3A"J2;(ZE$^AY\+?/[)08-G%ORZ@U O4/5Q>L)T&>B81'!6^U#FR^O M]LSDR-E8<?PPH&:?(:BP:#!/BE*UZ9)ZA^3E^B!^7Q)T=3[M3'-]QL;<@-W= M\8<\D=^2\%X&;Z$C#)R$A>+.@9J,;" .\]<,#2X?YE5C7C'"67R/?ZD_JZ>4 MG4 P1BXO2F:LJWX((<2R)?>9$IR8NG=9+N/_;3R'$ WD\;'=NH_AU&QIJC=@ MB_W,7DJ;"UE5C/9X5O&KA%V?G)4)8:JRE8-M]P2@%<K"&G !$_=*[1"/\]0G M#-W4J-!% _]\%!MX*.LC55";7T3.=G4P(]3#'%!\E)&/BP5V1-3)#;3/P4/; M!N3KK*\EN$NZW5''B51!ANTL&TJQ$R".<=VYEW]UY#' 2]JN ,*L$)._[N3W M=(Q!?A2V+3S=<PZZ4MZF*3"CPP:E7R0"=:3/?F$54V'L!*ZW$X+J!\K&5D-Z M$%W2R5JR>C4ULE#WTS_FPR#^ ?5*DY9T:ZVTR_KM/6?*XT"#=H^7L>!<NK'$ M3@QG#VN@KFALE; GD/36D&"5QJ'A,YM>XRVE2@MI^.983'=/O>F7,_3H_0:; M5F#"R<<F<4QSD[SR8>8U\K9(*_R*:MPJV'81]N/9:TY;F1ZC-VH3^T2;3P T M3(1'5#60>5OIB@?=K>RPQ33I6ZI[8^PT=:& #)-K7^7K)FSM3SOFXE)N3X#( M-K,M$Q9?68-IH4J[GA&1C M[BB/%XHL?I!<%I%4S;S$C<5RZ 4D!3AUX2-!; MI&?AQB$#74V<>@,XV7KYY-%J3G\*U;>)^?$7>@!EY+DPE]N<T,J*J+O(Y0!< MJ2Z(?*[<?&HS8Q#+0"^7IER'JR-K YRO9'-B&*;W7;.FH:TNR[*^)88CR%+K MDK7$\G/.1YD*$!VD:J7+CWR^3<8GT43&G"@M9>C;[(BB/HSA[*3\"?"L6JI^ M'F@$S^FF,)2;#-E!>!U2U!@8VAER'^7ISV$H9#]G^$+^%N_O.^/-9#I8?7W6 M<_6(\L*CY?-PUP<CQ9I6HQ+7+%S*V+FU]WY:WRY>L(6*[,B___0&\\>FGD.! M\8$?!<0$1;_5(RR^<-R7$3VHN7#.GR2UD[:.=8_]K"]JBANLSR"!K/8G6'L" MA+51YZU#POHTMG@M0MSEONA;JC1CJIC'__1*T@5:([14IWBL&J;-X\P6E(%Y M"^MN.+A,H\/ ]!527D+].[U,".O@1YN.E]_[/3+8KQ^AV\QLAFI)6ZU?8&#( M#\'U(9,?;/87!!<,TJ;/3[1'"FR/I5L][WC^S"\=;1#XD2TA/52A<T 9,+@, MTF*^;W*DA<:=;?VI8NV-V-]O$IMZ%LL+Z?2PI?;KQ#5B9:/TI/%!9TIQU@WR MW0R3G'X0!23H:%^C8QHEG-?\9N70)@><P<;F<R$07\V)(OHTN28%-IS<!(54 MK*JPZ>E=RA?Z#*:>'$?_#-''L"L?_OO-:]Y%._F.-P>^\*"0._$X#2+^/(,2 MK8(X,Q*80D)]M=1U@BPS\+Q?6N$/B"3J98AH1I?]_1#_MGO<IVY+/9J1_E%T MS0!B@WQU_6#>?:E0JE3]!!@,A@^-:. 5A'P<,1<X32#ON-G]^&W^5B',AWYK MDL!.SC4&3[T^\\N7]XWJ;^AJV)HQ.^D6<D+KVW4'CG6;YBWKVMK:.U+T=VHC MDNRABJS.2[Q'^4FSG &O,^T8)C1:[<'N&0TW9SE6MM2%6 PFWMF"<!53^$8O M'\&D?941,E6^=4X8K_SPS$>F4)V&O2\F-82J/O:Y)^;D.8[5,"?Z8ILX KVW MY::0(LFZ%+U4R6'QX]*J##?I*.YO C8P"U]:F?ZST9\65B4;/HJ-;8E&9KC+ MT&BWES][V;Q\HFY4/+%TL@\>SX >'PV> $OCWU3NQ98/,Y*A45<K3:>/'(7G M*SOS^9ZL]<D_R5/FWN%H0U^._0I9):0[$R^)$_),2=E0!55K\1 Y-KT/?7-! M7S9(M_.8/(!,ZG;W>]T4M&\_D%J^4G/_O-DR_*RR^8 (P?SX<I7L\YQ'E141 M)61#IJ-9G7QI73H^-X,VRH1M8OKG;?;2JD @2A7#>J'Q,[)_2^Q+8XJO ]7I MOB.WR9E [PO7OHJ OU)>P_7><V6EZDEFS2OG?^QM712V/*+.4"Z;M+[*9U3V M;B563;_GF(.)$]:ZN>1> K+1N)J(Y,FG'F)8-5AX;QT,%8!^SYJ(0E0<*R&] M WXOI](_P1]VAV=W:E9!,PUX5OR37J-/ &XE-/.5A;>1I]%5OL_->>8'4VFP M%_AO]4D[D)55+=BNB1$T[_6X2]ZH?/)R)1=4)-N,]F\?9&@P!*5GLT67KO)? M;',>'NKRX6N8T-4D!.T$/KSTUO=5XX-1]K2+#G9:-(-'UR@-:BV]?;54T_-^ M )Q9?Q"RA=]J3>8^;TOMZ\#\UQ%>#A@Z9,+:01_ABW$GO;*YJ'=P)(Z@'(JY MD'6T27YPW/XEFW6Q9/F!0LN[-XJ>U- ?:G[?02$Z"*R0$Y_/N<:V-+M!9K8> MX=/C=DLF77<"\2,*5AC$GN0:/[<H\B_:KRY-_6>;)S43?S1OGOQK_X\ZM;JO M_",DH&$H)?\M$&.WX_/\_/65Y9P7AT=:*AVV>1O8WP9%Z@02TE:3)W'WF?0* M&])-^OWTSIJJ@=-7E0J;!"D-A1"H8A,B+(#/#:?:P4='T-_&Y"]OK@[?)M,P MRT <X(L("%4"I'[;:&32"%,&$1P=%R!>K-0;.26M7__04+)C0,K=(=4M;7C M3T_'.T%>*J*4=CI>_N&+82'G^5\%F9$2<FML.?S"K*^KR1TN5G^+&8L![^;Y M+]V&A,\&C(<N"AET.1E^C"^54KO/?)HG56!O&>M\LU]31IEA)&3IM5_%I>YD M*JAJ.2G>+QE^V:XEJV)0-["EH_=1[F$#;Y*U>-^D\"9Q=I@U>5U=&>9XI?0X M,_$B^@+3)EC)TR&U)M08Y^WFW3W-\.OWP8IOMK]G=RJO1:0(HT=O)^@(J_C7 M\R('SREGFRK-N6QDY;"6:T2E8EP:FT"TTL\3%A])E4!7&RZ&%1\BNW8V:09J M:/U$?0@8KP64G@!%]QF]U"B<.[^B/V;;"G/W.0.@"\[CSNMMT&.472Z\^E$I M+AAT0F3]KZ'5K$;^/YYC#S&J^9Q7^LULP M]]+8)7D)\A>,D#5O;/:77:Z@6 MOZI<\@[\:?.O\"U=S"9P8R3EB#-X*.S -6DYC35!-_T9G& ,,*\'0;XI2"D\ M[W!]R(NN1'#J:T<JC=A!$P>PTGP:&71-GJ]RN?[-X^-43RKR%;W)6RB G_>= M!RTC&Z;/GP"U5SQ6-^I(16'*ND8Y$L/G+J_>>03X?3P2??']NP8HY ^1]CS0 MNRA+\Z9G;E7I!GO9:.4)P#?ZNPX7C<6HN._3]L]77SWZ/3G[U",8V.#^H2= M8Q\5^L&P\UV<HH,.QIFXF]"JDTU9\E:U[DP_/T_E$O0SYOOYU#R4/#)Y6R5] MJ8W/%KP5U94HYPV3U&F$AO(JAU=XU"\*O(BE*\-'K]=FX(;_=._X=SLDZV!! M6(<#E>S9]\HKG@ %9JL5N)=_=1%!K U063)/Q:Z_"F/.+L8_?NL@HC(D9%5= M=\'5&7]%H<,([0&-HCGM!G]0RZ 4/+7+RS059F\NA\S<:MUX1N7X:<ZU&?-* M;V'9V>39="^78FP"3$L(S"NR\Y6[F/IN4/4?J#9&UU1^HZAQK;.&G05X9G-= M-^\A38H82JQ*<ON9\<$=?5CLM8D 7M$T#,Q';)NR.0:],QG6;OINRR@N_^KU M]X<%QG[CZM .+E"(4!J*KW"U.K+BZD^!BKV52G'#O7"IY*=01#H>6\WW.G=Q M;,$@5='@8DHP>,-_\$[!0FH>D@6*19ELY>"B/LS.^]""PMLTA,2#SGTT1QV: M#X #',Q),2. TXR&_$$$7Y]$2F[IJJG!@5+K2./,&7<BC#TNB&ZHB@YJ' UK MSGEF@.3L%:7Q*X:ID]GZ<2%^?@[O"+TS*M+>!^0Y -%C^@#@^?KS"!K"4H<D M@^,[LNDK9C?LN;@O!4$@8BY+JG[#EY43\HZA$NN=OK8>,!-#VE$CZOXQ"B^W MDF#J,$1]<"I()O"Z\L'(I!X^'K)77K+*DYQ<2UV<[9_R,MZ-[<X5=9Q7AR"O MRA<<M/8M,E.A<7QE[UK[FUXP9)(!646Y[1AV!I2#SQH3N(&_W+S,J%7W2,(& M&U!LO<^G&_@ <4"*E]CM_'C$.I@YHF@YCVI88YD9_(C@@<]IJ335KPG'8]<D M"PR))C#)Q3/COG"BE5>D5X_JH$6"^V@\O6.P5 U(OE?.?<3FI/Y\:QE'V!E8 M!B)L\\#J(WBVJ%-??R]U.9!H>N@ADW+48_5QX)46-09ZO#H^-NMW$^EB]AUW MP2]B_\JS'6X%!)&=]YFAWVF<\ P*J]I'?$YX8(8IKJ_1,'EQ66Z@L&0H%1&0 MJTN9/(T:FF7D9 I09+H67^=')L-R@M?Q%H"6,'I!A4S9&99[G;U,<YX^:!%= MP("X<ADE]<1,H!K1F,1B":2XGQ@"4LK17JABJ6W0TU]TV/>DCZ40BW]ERV;> MI8.19*P0Z9I#[*,R_4)U[@JQE?7\K_^L:SY?9HEI]Q, :.E&RR2_#='\EP%W MA_-3)G8.F[))%H&L""Y5?P:(GZK&WCS/S!^.4C)X/?^ $O9OT$@Z3U/MOE/W M<+\KE!0/PLRA TT*&.\%J:6=:A?,L]JKW[/@K4FK?I#';ZQ9)4"\O,^W_OC+ M/."U9_U-@[6"QFNTA/IX@[A/_'<+SKL'4$$/AQT")P=SV_<\WU;@AIY8P@G; M<92=P6V2F".VQVX>+A++MADFI3B\N6Z<)'TX!V+L.50ZNN8S+8I%&<M4]IL- M4/"PO%-35J=6Y%:;-<8R8Q\(@$S<_=4LU]8\S69+E9;G71*6_'([=(,R-6'Y M@T<AU5ITL]OFJ^M9>U",L-M\/-]XKNW6KUG9N'/4@$HT0^:0J6 ME*?>A+/7 M4CZST';Y\TH]'MY[>?J6LLAF-_=+^E VC\GU&'W\6_3(T"T'WIV 43I^CK<D MGC%-]_&8*DE_<)<7XL"P>]V&SNGMN8J<'2/OJ&_'T9\:3RP8O\DP-%<LP,,B M@:]PFJ;<5K(L<]%'9]H4R]_$H]V2[J"QT'VC1DTX_;P [YXS2#T!(J2E(;.J M)IJ'_C 7S)"607\)60<:;/EYG4\ _+YX+$V[A5QX4K\[=+F/6&HOU[Y@==3> MS9NP^F4D1[1%W=D/,@Q7GNB;X<IY4?!J.:,94F'0T"]O8=D7Y7*0<14^X1IC M".+8^7U$">+N\O<2^1P+=@;_?1^P\G96;3RZC)&':+%SRPP/^7USKY(5XC[S M=WL^1Q-JHCG!,;\N@TW-?#'S6=^<*>Z7^+@ZJ)>1RL!DS6BU*M>&QSS2MKAI MH2"6S,!_/N?-".7>B6#VZX>T"M\$>_KK_H)7W+5\/!<%%OXD)7P\/N&]]MF> M!FE$@N)WV^2(@2CX9+\?"SAX=N;NS,B3@3-6RG*40B.1S+-3!,NI^\06B+;) MHP![7ND+MBU;-QRUMF4_B6,_78T>"7Y65M*?WKRI>>/8U.R=HP59OF D-#+H M2MI0*!LQR*^K:3383=?QD/SQ120OMLK@+1M^XEN@$*LQLC1/7\%MLY.D,&>9 M8LO^&MQTM=,9[9QCJY^A1 K\^5?2@U^C%?W[CA>TR]>90&UU>9BCTL/WTZ+: MP*.WYS8T8L#G.GT^09:^UX.^7Q.*M(6-AD3\HJP5@LDWQDK9CZ7:I:]/56>E M:W^Z:,:BLTHJ?L5.+6Q9M8S:T-GA?9\U?;Y!X*/Z&=1W7.-\ZZ40WF"3HY[3 M,_N"6\2#@J[U_:;Y?J3-JCG:+!@M_L_-#P.8UGWC*$.F.CF\!,E7J51B=$3A M#GVQMJHO6ZI20CO\V2;?I\![UQ9+2MME*F$FN8,:V2A^SMH2]?$W6"6D/KWZ M.IU)0Y!W-UIP!)W?%,(9:RL?QSO6RFA[O,[4 *_*]"P[FGF(4ZV+GN3IBU3\ M*!$/&)8*H$M\B\[1X3O79E &B5)'[)X'&]V+OINK(KUP<7/:7<>K>#U>:^RI MM*= $_=R:(:9+F1B>B?[-=*IY-"4>MK-Q/1@S< N=ARSU:YV;&0:A)GJ28TO M@#V!3?<]\LIQR:/[YI$);I%15%\+/K6O,%NV7<C(&AUWM"7]X+=C'T^HM).= M_4.LJ7R5L'=+O3>+%:;0FPE"*@'?^>CD'M$FFO"IQM2/\\=#^97(+$V_.N,D MA)O_K 0_CC\23+=)_CJ^=9>P\++*Y:CQ+%:Q9/C@]95B5NCC4F^B^P")SA 6 M_LR+R),VQ85ESL#KO+M@:?+ZT(G/#\5VN9AQ(PH94= 431ET+$ZJG7E0L#O4 MT+]WC8(VBX*/8())0-WJI+N7@FWDOG9E!R;;E(()[TO0\G[3$>:$'S;&PO[E M>(+,]6[A1Q1[WYO=&WXQ"W0FQHG?7\\<"E))%!B6U&#H/W_ZD;<7C7,G,J8( M@=9X_7O*8.])R4,OM'X"OPU\-*_F66Y2CZSUK3.$\Z;[NS@Q!@M+Z:JHFGQ* MR#/8L:$]^:U\_'U7Z253P-LO).I86%Q]RZGA.\@:MU^-=4\ [%51BBCIV)O& MFC6"M_*"3GO R!4:@2[/3[S:H:NK@7SA/A3+"Q&>6-% G3*5HI@Z8P%C64N' M<MJ*R'Y=( >U]OG$IH*&CE_@7#/\"2 S+TU>55,(#2OPE;C5;YOG.;NRD 73 M.?]^]>(M;IN<ALZWLA%%3B"L'4TXRGO4B&M2B@V:H).0Q/GM'WO=S>^W./81 MR,((YM?&6@:2?T%T5<*^JX>J#GN7=Q$[-"NX8[):<5-:6*:]DOPMY\9OLN9W M*G0J0M88_+I_7_$S?GX B4@B5BN:?G/3I%XQS'X4DEE=643OW$WV4^![R@W# M==\:DL*,Y@BJ7E64N)!HR12F7FO1%@%9835-(:PE4NP)S"YJ"5[@R+B3Q.'N MKUR2?=W/C&E,B"-O'#H@KX!A72A]WB>KYE^W-$CP6"!]]:9FQ+O5'%NZ[0[= M8+B4J]FVH?$)\-W9GB<N$6A> 3G?/#\E@=%+;DWDBD9BM+R=%XYHTW+],GO: M5O"U<"RAAZRC*],20UE)Q\IRTUNA]Q#(L[W&.^%(:=?2"\D^PVAIGFI3<>)( M65@)?:=@%UN3-@"Q%+!N?:%7D'([P$C\K^U'ID",>A]I[C'*"[K&F%M:DPT_ M728*OF8B.94-6<<C%Z,Z;QB7[NU+0?#F6]IZT>[I5[.2EK(Y?QMQ0NKI;)/E M8X()5?D7'NF^]]S >[?VC+A\"U-&Y&UY5CC%C1-'<W38O+4X.C+>3GH7KQNQ M/)RS8_:0;"2+HQ;A568R\*S;0+?2(OAN@0#$ZM#@[$HG.;PVISKK*W9/N4L' M2>!/@0!GHL^.548FW%_Y*M+G+ND2T_XPOHM&>U[C'H6L?/ W(C"IC!)Q(7@W ML'I831>O["'<]Q4;_?=V9TWQQH9GL%'/2N.60=VP=%")78;A6.?7@$%K3XZW M;0V^!??$E(12F5=E- 0[=REAMI[L#6V:(R%&HU\HOWTIB!4<QHBURQ?9'14P MG$&(X"=XIM@V9\C]1,\..!7>WB#NM&ZGL.$[ U)OJ1.JW2;6'=T1_/%6,=$5 M?0(8DNJ'O_FP-/0%MX;*<O_;^77X67Y;PQJ0_[T%;5#SVM2]=K%AY@F,%O(V M1"H32VJXG_-\^0$_0]UE+TMVD.$UT@@F^<>5$8H<[?'R[K=WV[)_'^%6R>F\ MBZ'U<DT@^;YFA#J<FK WX3@;"W$;YO?2QMP OE!*?UT+305:?,U8EED0SP<) M.4@1;66HTSZT]K3L=O;1O^A5J;"K"1<:-[&W6''B3=\CM0#$_>P:LP!LGJZC MG1J Z*4!<C"P/U*]C=[-?/,)0+_4YJ$)OJD3(C$SJ!8H'-)98?EK$3^!@X&/ MR#C/3WO]>EYHU_"XY2RE:J-JF4ZZ=WF=YWXC?6%5L(=VA[M;"9MH?3M NJ%[ M&;)BRK,WF3?YVI/!XK>"+9O?^Y ?V*,UHR2)2CA!9 G:E7[<=AVX8!-16%'$ M/PJY4T;TFV_3JJ\?>(6EQW$)<LBUQ21<#)$K 4E^ZA6.X]^<R+)9H"\Z/0%P M[WY*<_S(=ZWRU/E]S7);TZ\"RR&VHTDT.FP173K-^$S<TAG[5N3\ZVA@-$&X MVNS:; :T'%*G4=/2'KHHT]SV!@M;?FN/A&'7OS4F^H\:K;O+(/D,-?MA+>C^ MX D00IUY7_,$V%! <17.??=_AE+SM^;;MQ8LA4293G-,P7SYW4@/S+03!SB9 M!4-T@E\,KWI.PH,@59X^.C#J&SG?K>9/B3!=#L4('#JC)7DE+&YR#]$/.Y]< M3*/+^1^IG@#G^8_D=/!1EF0N!J)[!=3K?$.*NJ).$@GG]KDEF ORNXZE0%68 M>Z"%Y;>NG5\#C,6 ,PPW,8(!^=?].>'5AC=4A,DO==VT.,?0M'XVC<12TIUU M[P>:1CD5#C.<#GV?W0-M&>^5@GG*A,K*7LQRHKC4[96JMQZYXZRE_G:RI.1: MU2JPU0#8NX<>;\D'_RBU;H=U;=Q3LST!9GW[W8C75*4WR;V\<N!5AI)2:D3+ ME)O!<01YA^HPK!66H3U_T1-*:DSW4[S8OY,-GG]*_6 J0V>]?!OO;T$19@W8 M,SZ.E4BB1Q+D;AQ/<6/A0T&@K!+AIOIH@]'>$T![@@X1.%1MBS08[&7$CKL+ M-OB?4_.H1[[Z_9N\^0*2$<-7T])3^"L)!$U_/;ZNEWAND>>)BSM=FI\2A71> M?&AC?0)\BE)_($V^:"<JD/:=DP:L^^@B1/MX-!>U9DX*[GWWLDC-;"<E<7 ' MNE%SR?3/:>.X\]V&+27M.@?.0T08>)%;]R"DBU[0Z$=[5H7Y*J9[;0X5QWH9 M\E]*-"Q^WXC&R&L%T,3[O>/^E[_U+\R6F7UD0:>OX%:+O3A?6[(6,JNZ%E-S MA'0_)C=<<O(_ 49U/[ZIN>+N!:++G99D-'/&UL<HJ"Q<J4H,&C6T(2C#'5%) MSC>ALIAM3JE-35Q-%BQE9=5XS7.,RN<^]/#J]_"J@I9>X8$:&#JM[$-EZ?#> M)-U7&1N8#AJS;&!\I&"L4B4C 9)2#DZ=?6CH?>IP_6[U:/EGA_WN$%T(3Y<V M??[;$DG</]#_C92OBFJ#B;I-"RU0K+B[M;B[M%"LE$)QIQ0GN 9W=RA0H+B[ M6W!W]Z )5CQ!4PCT?O]]_!_NRWV<M6:M>3AGG[WWK)EM"^'J]^SX&R#[^L/E MM*TFB4[CP>_FQUZF]'3"<"RQ ?'[K:<SJXZB-62H<M>BXX(9T(M(CD/V4(1= M 8]<-VP#A/;MO[X/K?PC38,@62Y"FGZ(.H84)\O2K@ C_5L72;Y,4C&;C8F- M8E#0KX+M1-(?I+/=RG>,!RV!MM@J;EYN] 3]E'%-?&< ]%03I]UX'@V$=2Q7 M +W!ADB$8/QGKJ:U33+?&KLMK9KFIM&!#WUFJ=79F#HCSF)I,P.]00'O><*@ M[0LH#VJ(:0Q,,5V?JWEE7:I2&'U7MMC^XJOH&!O)'S=<_&'2MR=\'TM.=5:5 M:#DN63G"/)ZO>O "Q0_\ J$"=4 =\>'P?8A"9VD$:=O\?AA&)?@?@#"7GV,4 M)6\.NWPM5XF,5.N8;W[ZZ.(EZ:.6Z42RAGL=[3#^[B!H!$;2(</;5P%.'^@X MH\P;[!;YIE?6I"3(Y3B-VL#556U-$*O9/QX#8#$Q1<3WZ&!04Q.\+H&J$:$4 M(W:4$.[B\GD19$=+!0NUEIXK%'K$<1'JWT.9W&J/> :L'96GYP-8[6S+0=HM M4H2K7^91\LX.].TB)4<A3BR'<O1K;SDPUS_@*(E6/3,BGW83\4ZM%3,T,S2Z MXO5+GT?;1%SZ)D-;%4W3ON)YB^[NQZ@ XZD"WL._!M?:8;GYYAML;56&JP2] M46MV_\:8A*2)<.:(0ECE^>YZ:_"\/M%4JQZ;H!H0R7#=@DR41$Y-#>=.X?4X M>MZ]&XHY96AH1P:_V=ZT$_B3A3Y?G)YDZQ5[U_D;-:#/S<1)@#G"%)_P<5+$ M3&T(O"1-K=S%LIO#/=PR2+BY-<FMLZJF8-9HF%+FURC"8CYS!TB9Z)KO[/S> MO'8@305*',H51-!VPTS?(O%L)56*_CO@KO7M26NCH2U[3$G<EZGB\7?.T]QS MGFG?@O!\C,V?"<\=MQ',N;/]\"GAKKL4JHU]TT^N5<36%/U#OV: ;OT/7Z2Q M%V^IW#O;E^IN.<:%L,\_[[,+#0^&ZSC$7A6&:VM_FWNW_SN5>*[D8(&]L7X& MG_GVPHZ%>ZC-;2R !40D-]_%46AWMTT=<B\+KSE>NN60F[HV),\5<Y3L^Y3( M^1%UEC[IX.@6<RR4]_($3-MB70WZ?'KNF6I(7NL>+_NPO[']FATQ31UGP2=* M00&1PS@B)^E&A(Q(_.=0?0+KNP]C;6L@6\"DPLN='\'W32-B*4)N5/S7 ZDA M+VJS@-<5&_V^UH)N_>P8"3;DY#E4:1;?G3^2BU&K7YI1UX7XZ>-'<Y<N:BS[ M2=4.#J\DE[_E8:3;-ED8\8DF8E=T!E7ND'.Y_WDF.?7,$"_VU-54/+1=3;7 M;_MTRM+^X865.?N[@9"O:B1 F$)>_A925V-)4HD)R,6^8#C<FR2A8C%1_#>Y MD8"QGMY_ .O81,[;"<KS L4%7XWNX3#=.<YE)QB6U+W>:7Y8-'TE^DB/#NWY MX=="]<&A5GS!1%:B,S 18E+9>LX=76/K4YQ<-6E6(T^:BU#2/?K S:*Z)@:( MBT$X1>>U8$1Y8%=(2NP:BU,9ZYPHM(DO?FZ[&AD-X3(+Y1 L6I]@.$@D+QK\ MAE)YJN*\Y< -U'#"1-*I=0J+.!L91%VV<+YR9HF]0&M(=89)#:$2YWPQ(I_1 M0<#^=#-)#MH"Z+G6@$,@E#YD;ZJC_=N\A>*$4M!_ U>J0/$#:5XGS3W%U668 M) ;L\M761!X\$IDB]96J&2Q29\]#>Z%>/N!I$ZRZ#B YTSKL)I0A]-/"]=$< M?*;?J%!E&88%?L_)2-C#L:3BW:-Y ?7]T;TX .F-H=R6P#7O]YJNWAB;FW:Q M,C.4F"[#%G15H8<D\'I^_RF&(3I^*BD&BT+90C=HK&9&'*2W6+.VSLO83<08 MDPN378LKJ)*@P?0)0!,OX!JW7[0_0F#$!*=KX<>2X);NYUQLX44'B^ZYS+<; M;7H&.JKM-SA]"<OM#_?#-&KNC4@WPR6NVO."Z,)4V6N'PQC&+XJ.TV6.7\E] M5I<[C7_\)"%49,.GPJEZ? N2?%C]"<JZ&QV4YF^#MX6Y^]OZF7FCF<XZ03M_ MU9S_B**E!.WK1#)?$;.>N>4J:)0?E$1XXT=*>B"XMP^O1I7G6XK<2C>I*@IB M/QZN**>*C6:$X^3?[ 'V2*9 =+H(KB%()KPUN=98Q<MB?HM*E5UWNKE:5XRC M[T<DNH^%R[17U>YEO.ZS:*_XP3] !%=UEXK5O'S^L.N/GB6&9D5,UG>Z!!%Y M[C'A<CCO^YAU&TW]^%9NN_$'$7;2C.WPFP?!:/%IZ(%>K>7W;-.I[!>\@TAT M7V* &)K0[\K9G'?ZM9W/-!/SCG[G!7]DWKHK]/C+#$BSQE_6F,Q >QM9W)AY MXB<G<MNI;RL,ATS?2I*4K/U]H&TIZ_].NSUS<JH@[5'9ZE6LT>CX91\N;K%' M<KFZ_5XDJ^4WI;TT*S*^8++#L;;96&4R87WTPSYF8;($';=&WZVL6/5C/,]0 MJAT6<!<?"ZD[*$)H_ ]0>B)>%6ACM,X!L$Q+)G_GRDLJ=:9,W[H\8WWZ[2M? M7B?;?(N+'8@G1L8F]IS4QICK0A";RI]_]6O*C(I7!SYF4I3!=UV)S(W0X-G/ M8Z%[GK4U,*T4B=/RFW5H[W)!]QRMGKVE6>M[?1.NAA3>%]0$"84]G?5(K++* MK4P/B:J5]DYC#4M?0YO"CIZ/CYD7I*)+TP?U.GKKK2^+$MCSPIK_2K*Y_V<! MI,*+3BB7"+=5JA0YU,BBK !<HUD6ZI/""S4'-(.34#PB- \1X!I^FL<L*3)2 M'=X;"5MR[S8X4LPIR5;*HJ'8%W!BV92=+^#$.K(Y3OBM"WX>@ZN*#%#0F*=# M;&[/E8M#8 +$\(ML=N;X()NU!.<^:FI8#BSPY7$N ;(!*L71!Q&.+E:C)K1[ M7_;9!%N?FR1"Q.& )MA//'1\\G6=-G@>Q0&;)3<F!J=^1?PD37YJE))^5E%9 M?"'#D]D0F4-.'S3$2_."8MA:/+H%HQ.;NFVXV+ 5Z0\4^/M@L?V^.>%B@T(? M05U'V'8?E,9D[_Y7P<U8)@&E5HPT&>'HUO$24&/+ )K;X[2)- :ZD@=/YLUY M,.,!AR6!Q:@/+4\E*!JHK^%?!\G7B.FJ-3N?RAS5X1OABS<1GK+%6"J8:^"0 MRNTJD]E\)),J_!+"4R1"F=#BFFV]XH%!N#71N[GY06]Q0?!-Z$)J3(PN<5IU M@HO[EB;L=8$36W2U0AKTT<.):7#%R_Z2,_+98$N%0GU8<2L>ZX,RRZ\]*G&O MT%LIG'&'(F3GMY;%GR]H:FX(=OZ:C'/F=6&?3:V=ZZ9_'&C^)?;8T H+Y+2^ MKM&[D)ZE+*HPWG,-"G :)7GS2<1\L@1^DXN&[)>)O5VL <6,J++8FRT5_=J4 MBKC;XDN'\/)1$:O6$+X-HAED\U!'SL-.57SK(@-82---.."29"(IG^MW1K@L MP%?8AIGD$9KQC:]P\"\I%'%C;LL]T)RJO@:EC#!#*L9/-G5?[#FP:</]LG82 M!/&;;%<:]%MFFHIGP]MZ$S@[?O'^ V@[D]$KAU =X(BB2P,;:_60;"4G/CRA MY[=;3K+A*.LJC"4/BMHC39GL]]Q)WMDJC(7$<>\ [XS,:WVZV88>8.-NK#4% M^GI;'$34PI#038RQ9[8K7=N[_HJ;IX^U[IT<OQ+&+F#*\ZRRM6CE9KT)^$S2 M-PX)VU;7S(2;U"F;R;D#]0>IX$.?!]N#MD/J80Z)2T)DYB_@@U6J);4]<YNX M VJ:L0=3AB\:<P]\.S[-G2K<763D'_,PJ-"\.$E$=^>/FF7Z?>,,3U Z^2BY MDM7D_7TD7C#[Y878L#SCI#>3LJLR;]G6QS:,Q<TLO]SKM'L4QM2Y^0R*R 7& MP1-%*S;G9'\SV5'<:?IVO%+.GPWBR'7$F8[X!:$'A)L1I% !7HUR FO!RY*: M+K6&&RP1B7AIY-?22ZN-+0.EXG\#=.;<GN=A&:.YE'DF\[K?%B[RY_WDBA7N MQ:WJQ(.X\N@$71OZ>)6D=35'\'R"Y!-?(*^_(OX!PFZV/+%5RDO 85B[ALKD M_8P(9M]6:-#W#V9)"IBB0AJZ71TYK<]=_:P/-*097BXDG1S*AV)66_UOW,9$ M*R?+L2NF^)N="'-JP+P[D4*?_P&^@1<W9EH6ZC!_[HE(O,63>+G^Q X>+>\> M4B;)^V6( U,)TSY:M7%:*>17-M2]"MS7Y8R;C4XQ^,.+E%!O\Q9TX#\:$IX[ MI8ROCB!6L=)_O2Z<1$*K]A[;<VN<!CA7&$'E2RX?P^EI\W*0&LT;4R*.^H51 M8M3S3KF1@>&VGD+K"^/BH+$ZJH8^605IR\>=]^3[M"XQ1X?(0*BWI'*)H6)! M_X].VL/=X_*5X;0/VK(_./JMCE;)"[1B.K^UJ6G<^@C[D-:88\M9,U_4_U?8 M%=7IN2N@U!GJC/.U,HG"Q0=M=7P-@97Z6Y[( *H44<;&MB5W_:X^G;M%S0YE M@B!FWJFXXD0%'8P"=*UYI*%>C[9*'LUIIOR0PLCVS*;3Z+:['OXO_P0R2*>8 M)K]/CE#,:&F5(K6L'WQBBXXIR;]JIHN,*S*XY7T X8F7+CB\M@3H76Y+!\DN MN>8T'LL=4TG\/7CX_3U+5ZM)OLZCK31O+@$:,E6YE5TX>](?3\[Y^=GPBSE. M0)BO9VW@Z XZ,P(CS.EU7J"+%VSRTW7SZ7_NQ$C%@\K( YN9(>R'F/0I>^$N M=?"P);NKR=4?ZW<MUC3S!=#@HO_VO;F=?76JHPH]IQWF]N.&GPCP7'(E2[:7 MQN]#ET8F)KYZDTO&7-.%20OVPLM-PY^%4[00GL' QHF'H[#5FWT)ANYPL(3] M^N$[YHJCXV60B@H\IS>Q6D@X]F-;HG']\XPT#5#/XI&V MAQ@6ZO*UED]C/( M.6H+H4=')V.])6,,;\FMV.VH%>SV[;]WJ#TF;3296J'X!H9!1-M(HCX'_R0A MUW")(^2P?\W(JSR\Y;!ZN[.D30P<_ HNFB]*XG?$$+LI>5V.%!FAY(F39"@" MMJ(KFE5 Y+U?=K[WT%7O-T2/B]M]C.FX*VYWVCK'?IX5NE.NX"@ZVC3R8L;> M7+#P+' %%3EN-X\SY;X0M*"-Z/#75+;2J)EX>%C55Y^U8XVKPL,5'')^7Y2M M?A:;UO^L/6,'X!F^#&9:')K]O\\?;L8+WHZ<Z.8+'1FLR< [ E[19"NBF&=G MGP8O@-1J<,OCAVSH/T LT8(TY_-TV\-A$2R1Z&.5+=]3(4*("2<+&*WSKDAU M\HBY(#,Z#KY1M$_'29!ZGH=MZ#4H@YEGS#CW#[!/7-7#]P^0+/.?:*BC^ >X M,=3&#P^\^N+'\ _PW5?FB3#M&F.>_!\ \Q]@;V\T[TY@*_!/.W"BU\:4R @D M<Q>/5*DR_.-3%A7?$PM[>2?.:<NRP3UIU.S26>XJ \93^^ZC6XEB^@=(3*0- M7)OU^ <HA-;BPYI[=,\-X?;G5FP*", +!;7-EGQ,/P9$Y0;LQZ@+U%A\Y%RO M$7P"V21=?4\O:K.]]2FEB$>V.C_46/4@,4%H'!IQ")3!/&;'^GGL]?KP;O]. M.T4IS>S;4E+U:/[&2A%B=$ *?P02<L*O2%-;_8N+?4.1WRCY7G[HBXQ/T0F^ M)&^=-,*SI!#%WRJ<X6R*=#+Y+CT")FUCUA'1%\5M5; ,LXBK*GLLJ:*3C4N, MIB6C5!M2PS\6KSGL#<RWZS%R_NR(>ZKLW2MAH;PVVH8FR<#D"*J]'MHF0O@W M<ZX$$K:$I8B]E<FS=OSD<C&^_V[R.NXW M(!K,-%5BDC<W;U'/V4VJ3?+=4X M67>T@^L3+CA 9O%\U&\\27Y<L1J1C&V=&Z/2>P3"@_*>"6J\M?X!*L,O./5$ M:I4RE9_>]9KI7:MJZB,L3-[5P[<K8*+V].VMUK$&"?VZYQJ73),2"7/(_EVW M-9VGQ('_D%=/I ;$:Q'U7S QE8%8)8\?B>WB2?_9U56I_0(9CEE#1D)7BCSL M$AHQ[8]:NN-X_^Q&:U_G!OP1&MD&D0VD5U$;Z [^AW/#Y$X+9:L)IDW783>1 MR3Q[K6;6V%Z"\_,NX[)UE'3(2G]"?3S'N#^09+B[NXLSUXK)/N(7!A6Q^PSL M _6?X[9<#*0NM"'_6 3\-1QHBY\^SWE"EQQ_Y6H\SI:R+G1(RPA/2(-V&PX* M/SA%2!J6J'#G__#U5=+K6AE6[DB2=.VL8D\:CF2[R-73M:P$;4#S!NG>;!D9 M8$NQV#/9&JQ<;2MQER7EI0M=+PDH77PX\;9?<KTA;96\[OL'(*F[F0T+H)AO M-E1H[&@(L^6WTR6HWG88L@A)5T=[3AK"[?]=_)T@98W#P$<F5-)Z-UM5T2C! M,--A!;ZYJ6^ZQ;&Y,]1'EAP3(KD[V(L.R'\'T V$[^V>"8,M(Z-:ZGCT$%H' MEQ?,;2Y2+=57I [)K_X&>M8<1-#('G6;_D>%,=5^;(4SD'A8R5F0HFT9_9;4 M4#$\ZG>Z^9\7PU*Y03=S<_#9Z$*$5:93N?ZU&?^E;NJ^>1[4;"WA-K,<=$7E M[WJIN-B\)6?26__&22&;\*].R1*_(G.*..M5L? R<]!'>@O=#)#"XW //OS, M0,"V$>E*Y?EC-<6VT8Y0S)/S<Z%X99 :@O2>Y,\.CM_'W2<\P3F'%HZ,91[' M_<[VCN4"F[(>L%M&4KJVQE? FZY7VFC!*AG?B"9A,N1V.@NL&=#T11[C+RZF M=JO.?X6+X[ H1=<AJMV>.(Y,Z,'3%DA3E08D!6P6'_1#ZGM;A-"D&*/E4FTJ MG]V8WR O^O.94<7/,R-Z=ZH/L]*A;/$UQ5V=37,WI[-O9ZT%/KI#W%U&G7"J M[HML#]P5/&;92Z(DJ2FO9" J W>]),]4)^ED=%@6*UU?YGXU9Y]_)F=5P3), ME)D.4?B%CMZZ3,<',,^JHE3@^T]748N,."6DY[W-'LTE@'." ^]Z@P\C]3J7 M6V++5U73''I!Q]3>6Q[7%7%E$\%!+&"T/_\ .-*8($<:63H:U7(CY.GP0QC! MU#/S"@5K>[2QG+=Z(2J]4B"1FY=O,[?EBGJGX02I:P17;U\1W*$8)\+N_ ? M E+B%91F/X+&B#@)HW:8CDQ[B!TW<O$X+F0B PF[R*QI(D(M"Z?A5Z)JR<#B MG>/>]97S<T<DP>? +8EN>7D6#?6G?7M4SJP:?T%P@;;B"_VE^+2-1.YN[=KG MYQ'3T*+G460%@GUDBSGCRS5GRWLJ\BLGR\C[!K=55V9^1-^VO(?LE4Y21^($ M)R^YM6L(D.K.^TIQH)O[PJ;K\?Q;&1C<[3<N=$J10^JM][NID=T? /B.H^MB M75J<P:]()*A>9?G+QT?3_58RFR)+1?D57&_/RCPQ38$X0$JY&C^,M!5N@&P: M9+D;A#ZY'F)+4)@^,5)Y<3!V=:\;[_\LRJT*3OE8>_CPH"IL])&RCLZ/]=#) M,>=T+."]G=RW57>DI,2KX:,A*6[8PLFV"H<7CY/C]0O&S8G7A%AO5:XZ^C?2 MT.,655DFF%:XF>+=: ?(:J< 18M"UW3#-A[Q&+#(J&>6-;L4/7V0A-;"7N^B M6>-U6&NJ0;4#2-K#*AD]C'B38%[Z8A?7_[TW:)&YIN%71M]F,8YU73=(,9Y; M$)\*N0J;#:J[_7-CM<+5C*QU6F%)=K]M:^&1O"+]:PZ%Q>M',:>0)6M.%7D+ M:GE)S$9Z;G,CM!9!,Z>*\(ZL;]QY)3M3CO2Y#D*6G"F[WL&D5D^'<S[VS'<T MI!50GK>@_J)Z!,E(MA.T#WKA_L0V[=G3/Y9@:\3-,,L9PX]ZZ;E/JPF5KN_% M=^_FWS!X7PP2,&B.,68X3$M?56U7G^0JMQ6+H2#1L=&>I7#?W:7[E/AH/41Y M>T:T;K@.DOJ^3AW_'M@MJS#R=7Y(/3@Y--W5[2IX2KC"M\+$H-/KLO-BLN76 MTK?J_//]4#H8+[F$>($Q*'O:9JQ^T"F!<'L+P+)_VZ<M/\J\JSV+ \+_ J<- MR;)*Q&QJ5O2F<#4^2$XP4::)MJ6)'O=DSC/8:&D+5:R/69E8YN)R@!$,XF"^ MS$<# ,1??#O)95ALEF)U4-'NC%5K;%-=F':%:OMW3VN];ZG.V9G9\=A!$;J3 M<S/,"W9F/RE<2*B(,MF6=K0[1Q.;ITR-!F%4U(DCY#;]+.:L&MH6(]*@6"^G M>:*$JOQ3P0ERZQ_6+.S]-Z*%]\2T'5LFD66PN^ ]-3(]R0:C':2ITD=.<9DD M@SV=)?)0(BI'T_'P%]\M +U]&8O:DME\$Y[B?;!V<,U+L4@SP\Z//@?15\? MJ^ET>.R'_@-(]H_6. =,1*!SG)0-4);GQO*@[I8Q@7J22MP1"&W:N7O4.(+ MO3%\-OO]>LV@R03%N0!*\%S/.]L[\3.=$\?J=6A\613+128?VE14;D/;ER#/ M^O[]MW8/2/S!5&\.X= 2\% VTY8U!8-+G+6#.?)1*6] .C"^2\1NP4[<O_UY M?N%\]6"YNHB"[YSN"B(T^>D)],ZU9FB&KX)6WQXC!SFIM]3%A&"#-N=*+S5' MG9FW+W]O7?G.Y40R*$E0+6MA'V7ZZB<TAB@T;89CY?8_"(N1HCM^@+X&S;@< M&T5&ERU*>B DH#_6!"E'TGQ+3R#)?S\ES5JS-'\+T=KG-6>/H_-)')867WPF ML6N%XQI^_,]\&8B2;O[Y]C?/H379+9'^$S4OD]U?3C+R,<?EN-3XNLK5@^? M3(U$ ;"P6<99H6(,[Z+_PH4K1JOO$T;)=U#V<*C\LF - ]?AJM#69['BEE;] MYUETYR'B<::QC[MD'\-QANKW*)C2(O=TJF"7U.-0!Z;^%*3L%6S^PKVJE^;O M'59ET NGIL)/F^7TC4U5P3-3;E^0H;O_$:$)_SQ]O33-HB"-'40[94.O?FF9 M=CG@+()"Y.+O7&/._/V^,Z;+YSL^%VN-56D193:OQ$'Q-][*4X<PKV^I$7^[ MZD?7=G7?5U+)O+7S"<BF+>PE%.KGS3J4F&P$2_^.33U4H4:;X.I\P<CP.]<5 MP%HE#V_3FBLUC-<<I&19SAHI5#OC4+JE*@>P'5IV4AVR4?R(,Y0B7KD)$)7& M35 Z$'8HKGB:A;C[UI#9/8XA?J$1G1XD!MQZTB2$S([JOC5ES8,Y<*N^,8P6 MWC@AK76TY\97+_Q04.@V.\E>+@K- K.FS-A\2;^D1OPGHDWB.]GF\HZUW .I M;,F<O\R*KTF2_@/8YF)O-30.QOWM&-=GZI/I4K#<JW$E0'WYC_Z%VO?KB=;_ M7&^S9OY'+LP.=S8677R9Z%S4,=C.+R_IXZ?(>H BTX$>Q-7WXA*]Y/+0;CFU M>A7@M(K6$FJG84V?_6\*YW<*9LZS\N1RRTF^DSZ<U!ACH![B+,D;K!9Q0\61 M?/^ZK5H"O^*M[$[ZY4B]GT6;"14R%+ZAGPFY$%[B;I9[CF^XV]P0X+!P7K,A MRZ=Q,XEIPI#W#&_Z?1'P#Y!C2U8(9H.>>-=&ENZ !H=ULZP3_+I-C1<6.'K/ MQ!(SBG\9Y7&?;&D1B$Q51\[B3$R.\&/=9-YRR5N_AO6CRE>_"[MZK^V!=T7V M\4DTU>%GNI!]\#Z1JF75^'?!?X#FC?K_>A0<'T8-.&(CG_4IG]]>QY9?XG9: MT,_A&H(;,15U.O.VXQ2)2>))_,99(6%Y)UT1@*'EP#*WF:C7T-T.M.B,OGQY MX,#"PG+T%#$8(#A[MM027PH,=7@3UTG(9%H;6*,7.2C,@9ZDXH ^*IG)A#?E MKT+=P':JOPHQ22QMYG&?W_B2V"&][*QG_I0TY>.S%].[+>^[(G!OLDHC8'2R M\+JAS?M[W_#P?H3H!FWH)2\*<%^M^K%.<,M-I2,+9)$@G](WBL/9B0W]N9_Z M^^?&1GEMI0R1GC*%B]N1S!.?8FKBQQ95BU/G<1C7?ZP(&0'%A?$;J3'V:2\= M&*&E[P9YHY68"Y;0>>H"C26[<1FK[QJY^4?Y#81'^M)<B7UI<6U4O3A3T:A5 M"/?]IL_G'G5P>_)/!4G%?\JN?C/O*&*[=TTJXZ$*)'QT5G3F*&XP)P'__>U M8803:OPM)04L=K;8Q!1Y_LV1 >;%7'_[LM26N]@K0I J]8B-B4U*X%C-84-_ MX_)^*S[__F&>.IY1N#\]R=S9*("U64[:#[E5, WOU4T<[:&%TZ%8R2A+ZYRX M*TBRPWU]@^E2,O)I7UQ-*ISQ+7M9N$H]2^B1",LQ1EO*DOST0\6]E!IQ4_45 MO>0J;NZ*4[7EM!*)[M#1[*\3A3^59E<@B8;IL,]:.CM:ME[W-]LZU;+(V)J* MOS1+&GOM2K":9S9^:J1R[W&_$-!9IVM1TZAS\LE_Y.+F2>W54Y;@8OX::!8Z MI4I;@!_F$<UEOE+]T1?8_XZPE1G-Z5?M&8U;VAA-D^E'&Q]&/7W4%2E3'870 M'AU>T5( U@EEEWA/"N?Y"I7W;:>$S'9-);/*2SO/8<5+!RJK=5TJF.6FP@)P MFZG#L,KF($0^'4M=7)GJM8X&/R93.5.W?PEEP[?]KW>2=DL[(@(Z'<IK'"X+ MOW;XIJG>Y"K@2M@Z=NF:#8F44"_4;RA_(+F ZC,X?YA9G(6: &%Z=WYZ2-P1 M?!0+_G]N_C3KYF_OTOCS\;/V42[OMW\ ;)5=)J__QG9!Y+-F+3"/ $5!0QX( M&WKX__CF,)WWP?Q_V>TZRJ=R]ZHG\[L@I/SKS ((,N'RD<?8K,QX6ZAPK-/! MBX#]=P5:F<&-TTO4!_ALF </U0;0YSF[>%,%IE)!R#%9'!UC'^78+^,E]:#+ MAL@S>)Y\*GW&W3%<-[$;@PCW1MT,*5NP:ZP> >K1_?&\R8M?NP>0/^)%<JU4 MP4V>1P[%T!3Q(V[+Z[@?<8?CDB_L]_>8S6F016H(QV#X_0!XIMMM-Y!8O[^A MM*=]]>;:Q9WI8P0WI2*+MJLS'E_6N06RQ,P!M&B7=$II#+ZR6A*,_?4CSJ?I MC#W?)S7F#TJ^I&P(_\4II4-Z 6;SRLUX3?X2 Z,>@M/R4U#%((_8[K71]E-S MADEW[XN'/$F0Q(BXP_(C2G'>LBOTR^+Y!>?-#IZ=SG6U+7HX3F/F1+(34Y@L MDUB,T%Z(,FW#;F_B-A;"KW!F1[^^?CF=@'/%B^Q-!/]7O!51?3(I"BP,2+.[ M*?ED:6DR])+29K+81)G84]T42^=4M3M-BR<])>F-@#D'=65)4Y#>2FO%+AW> M"43H(,16!^SG5:FAW/SHT9H)&CFP!$30]DZI;^YYIOBWF1YJK,H%JBUQ<D,] M&WM:P9C"S>E7G 7*%/WL:J)'615N%09K&]->+HRC3F\R4FQ[U &7)A\+_2B; MD%+6@721-8[V]&"/%&,O17R6=4OF4&]@2E,=L\ 20.*(VYY!S/GQQ5514WM M;)2@8AR'G<@V2\SI5_X(B661@87WY!2ZCQTCH&F)SLZJ.K:JQSNVTNQ$Q&Q4 M<QZQ'2T!@9'I<9LP>,CMJ?,HF*EM[?#'E'AU#+JO7H(1M3.'X:A.!:PN>OLE M?'J.T);OJ6K(ZZV2"/.T/:$H$SNH+R50(!=1XST;*ICX=ANYH[%\*R6AN8*B M<L-6_,'%N9<^'974-%,>3QT7EE3Q6-3.(?+%6FTHD"!O4(:B2P9&HW&M^#S< MT98ZF#Q0Y>+@[<!<VZ1P-<QH&2K(*I/166>P0R".]7S(WP+>N-!9^0?@D:.D MW=[I!1ZX+5_VD"*%KZS337&/*_<MIYM-%"X]KR:.$,6T;^"]H6='>5_G;I[$ M3^3?6(5L^1U215+]M?=7=5-'V9NV$05"-^(E%).Q!\LGKO %\3*CH3J:JPDN M"2W9+HC[ <A*!7=FJ?ZIP5E?.3"'2$WD[GA,1J)O^L"=B?"5V.N.GXN>3Q1S M7F24REU@VSS^UVS8?>H2.DY1?EAEH"85!P$-H_X.2_VP["\XD:[@/"B[@ML& M27R%G]OB]U4RY<3!'@;5'S^8VB*UFIYGVY+')NIR&" R@-&-%G$IF2\(JI[L MO5YR6R]-XW=L V"'*P@$W1'='ANKUFVSX\W.)EK,9W7'\:K+JPO5!,W=[HQ8 M<WAN@3_T6/!)36Z9IU8(6U7-.%VIEGN0UU1PE'R@*FP3GZJ1O'S:@S(P1E(? M"JP8C48)/TR$T%+-XI?]"C9$?N%^O.KI?GQSL^:PP$&^6]\23Q^&KA7^(4$( M#< >G "@UGV_5T>L!R(;O*RVJSNH$A\F9M_IRE(0U<;('[\ D=0\,E"KA4B: MD<7U, )I!5(..>@:UW#Q!K\D_P,L[,5]L<CRUJ3KY.?/QQI_*?WU*X9UM4D_ MC$/?P4-"M(Z3FVPR9?OD!;-C3[C>6^",-"624,]/#H9/83+I1+%B=6V^6,-* MQ-)IS8E=A[-^LQO@\:?I<]<D$[$?JC.2TY_OF>1GG3^6Z#2M<@#^*80UUF8- MZ5^I)/B(69OX"R($'8\A">BU_FGYS5#:,%S=LQUM84,/C2\*(D!%+"KIK];M M)KY<D]M6O&GSD%8&<7\L_^)%\"7,TO>M(GO?;@0Y?9"\6R \$RB#X_Z8V:5Z M"(H=;)UK3D:FK!!QSC-6,#B9Q5GD J[W7JGI:DEF3+.5]"7LZ:2.]!)UJ12> MW&<P*<R=GX6)RU?7O#$11#3'"TZ%";SKDY?MPXU3$B-9 3FIM,%7D(+&K!N? M$SQQ>5O:WE@Z3NWC-(Q2,,,ZZ$*VJ3S@I)G5V\J]1JM%QM;:/3]J%V?Y(_J8 MXMC/X[6<"P D&\!G<?C]8#<>C=R0SW1N-'IC31>_"?6X9+5S@SSYW^*D.VWT M+',%GO-7>]F)F'YBX.;%EG:4#"S>C'95=>GW:.-0943ZE>IN7=H;RVSZ(_:B M0\M:TT\+-[YT>""T@47#S?&BDSG5&M-Q7T?5HRC''QSOE+\%V4]<6%DFO0C' MZH,UU#;_ U :GDHS(*-K0%9[PY"+TJ3C'DIDH!V#XJ)]&JJ?:W^!IJ&IG7!, M[(TV\6M+\IM>#!3[UIX+ G\X7 B?HKN\N3F>Q9O+'>A) :H9-+]/"%Q1:2;M M(P?\Z/A;(M:"EZ$[7W4,GM^9?[@1_*-(-XCLX0+1;L_"7H>_:BGZLFA@X]G& MN6,Y2/=^WY*!TGT&VDRL *A5PC7HQ;A]4C&"QV\:3.\N7=X8?[V4S]9Z0W;> M:YWZ_7=PGR?Y)@;5H/E"0_Q(!8)JF#(O@M.IMED&SR::VJ?E-ONOEU<&82CC MANS3CWAS]EE&U%"[-D>(76)\,Y5,L E%+T(F;(5&XG.]?-;]P!7:G<1EIJ:[ M8NJK04(9[XF.T5_%J,%2OF^JW/D^^^WJP@EJ)L#10!L)B?0&^/10MD+DZQJJ MD_=CS(&3PF/[T(817N]IG[\ZD#A$&AO%98BO]4K'9;0)7C-B->Q2$&O;QI%; MUZ-YOLH*:_57L>A938BB,Z[&ID)\:Z)51L2=A![AX2?U>VSR:PJ7/JZX) '= M,#/01M^Q"?ZC%,JV'4'2LEP6W:)4,%SM1=I&ECIZ3<)%?'SH3%X=-8KNV(^^ MZK"'#\'N"\":OQ"BBG>44C4SGL;+>$[9RRGRW"9C2U"ZFR;][H.[M5R;8<UU ML F'& QT'K3G###R5)CWD4R<Y)&Z^W.9Y5+Y?[Y;;B,JE[>:-Y +3K+(=4@N MEX2VF2=TQ2$@CAE[LU$&5Z?BN7GXD<U1F\IEM@87&\'V??@WH4ZTB\P=,SM" M Z4@#>]:Q='<=UWPO)%8NC<?H1*)L;G<V1]2ATB;[!YBADA2#AAXA['4FC;@ MPT._QK!#U Q>^_VG?5!:(?\ =V$K?G1EQS[;:44F+\SR(?P-$>MLOS:_GC@D MYK%T),N--)"H8^'2RP_[]^_FA8-%@JT,Z_=T5OT:J.PR^ H;WSUC,GT@1+_[ MF+H<2PL,79&QY8E,'JQ&%EY^6.(^@N<<W=E#,N[L).>,,E>6H=%KD1A^^6Y! M8RHX,9V^CPH@WZ^(2!233T)RK2T8/)&^L"'5V,E\"6194+SJ0"<O=-K&&:F6 M34=?GDTK&:LI!6]?7NB@_!59<SJT._\!="1DHDW09 B:#?4*.HQEM!8O4M47 MG;+XWH6XCTTR,/F(-S'5*F@GBO77$H[*+_D1^7L$!A::'O_8RZSM$O.5+B@3 ML&95;'3I83KY9KBY1(OU5-DEL0>% AU$/B_#ECR>^#?T$I8+E*6GG23 (POB MK7@4F/X=Z\F=%'6R70@YP:G\6K*XNH]&BW$&S7&USMLT"-JZJNVM::&9Q)JU MG[BX.Y$75-,R GZ-'_;3S';P K=(RJ!UM'J@JEEC:9A3LX%,JI>UEQ,SD:R2 MI#)UD(CD7?]Y5JS^G!\/+/:T0LB8<.(."M.\RW3X.?%53:)OZV$%S4]J\; ) MR.%@.J1SQUDB7VFW(&F'3VXJX/;N#C>QQ/+=N'$_*G?GD.LUJ&FW-_A6\N1* M:C5\NMXSXY%5/7VJ>F(!H\T#-- @OTF@*_7P^^8A([@6I6W-TE,!>U+47%"[ M9(E046$QVV%U8F-0$.A#-Z]Q,Z ;$,C7&[0L W4.$^@/I]1OV4V+H3T6K'D' M^>!N:F68D(3,JD=^7KWI)3HUD$QHY/P'@*CYETK@_^(:DNB:>OEB*'CNMS_[ M4TFVQCQWMTR=(8G;@1H$3;T>:0:;Q6E-1/ [T9;E<*VBF*[LL(DVQ"TX!WSE MU3^_MGS18\DF><4!D48+6*6E0*R&<)HA6"O=\0G7(8-WH97*E"77PHJ96!B' M8B/0YN^YOU>SG]=V,-VWY+0#J4$_'+!JS(.YN&^H5,R(8\4QTFI9+*E^[%&/ MD2$5O$G8!NG6]+L4@= =(A.4[ (4W/IVVS]4J<GPT0('S=O5.^Z%*+W__ SP MC$F1-5WM_$"_ZVMK?$Y>VCG0T'#G2CI&D+\MPU=YV:[[KNGRV &\>2^#_;Q* M2[S4I>(/?9)=N!^$Y(1VSN(5U%=!RO\Z0BV95:GH?J)/HMV'+'.9WM7#N6OJ M0'K'/D7*AZ<519?"0Y-.@BMUC)+SA)WF?%>8F^OTW]VT_<R@-"I0R^Z>IAJ0 M;K^T.-PD[0KK^T+*J,8BZ0]"Y9\-%GPIZTG[9EZT(:T,V=#[, ]L7RF5W9XJ MZ-K>N@?-#2UUR,7P%]N#ZEBA)J47>N. 79KBO9B_KY>*+O_TUO;N@["W?*A( M>YLCPSW>HY-NL]6+<)7W%X<ZF;MQ3GM(JG(25+,$7!<V4# [?SR*:2A$.2/- MW;<I0V:'G$V,02E*>XL7^S&:7)NU"^P5KGD<I#':$)>0L+>B91 4 U(>@:8T MWT)#I;80V'CF@>VOL+(W>,7Y36H8W/B)F>_I/.:BQ]!]AI<C7RW\&:>EJ[$C M=%"<+>\'(VDC=]Y;7Q<B@4],]'Z=V!WD?_0>LA;3);KEI^[$.] +9#/;381W M8^PUO!?>3I S]-'FWAQK'S+QA(^:Q05HM;86"EGHLAL>8F!D=1JE$NE<LR*L MDFG^\.D[7G,BXJ3Z<,@%/&8&^W;ILFLYW$>2)O)?L3_-JIE^GD(H9 M7E"@Z M4(=P)$I91-@'5B6[CJW1AN$/"E[78%;_WH%LZO]T.'\GQTF/IS:5V7>Z]&9$ MIC/U</WV"3?@795C?%7-/1G!R+#L^S]=>)FS4&V'4I8MK>88?AFO<<= ]II2 M4.KGU6J'"_=I@X6+;0N\IHV9!$MT"][O/I1=LR2-3<.2?)]BKY4LR(^6[FI^ M%OF/-7$8"XR[)U=>Z'58:H;3KE\ 1WJ8;40HG89K,$8@>&D>5 9K1K,5)L>* M]VV3;UX]$L__ TRJSPL(VO-/( !\X&[7;?C7\SL._1:^.&7!+X0R^5;T?/\ M7M*WR; =?+:$+@GA1 <OWT*@SJ)<N:&DZL'F*"<_9XR6_ZH"1"M!*X)^E<2] M4FXKO<H)2;/5NF,2XNR@GTOW^)%K-@'% 4VD0\KH)J-DJOZDVO(;?^2+Y-OL MTMCP'JT<N1K=5_[MP(\:PEFM +'I+0K-XNAM_D%PU<24)7&&!6CJ-P<R&38& MHBE\E.UN,#';NZ3AZAVL(]K2W[*]0HDAIK/T;:Q TUU@8]2B-]FW+WC2GYBG M7OS].7(:YV;2!IN-$-BP2T'&]K?!(<@0I2*R]#;]1[R6A@\ZO[B_N!$LN&/$ MO<8#C%:%#DL8J#@-UEENPBKP[7J[P*3<1;9,?8#[^\H7LU ME,@>E;$/#$@5 MQ2UH'+ L9V*3%87E@=%.PQQWEXRE>0IIYO[)/(@6<=B3\O-G>F2:!I>CPN8U M)"7#BWR8#N3,X?92K'=9YK&TZW[$]$HKX&7@VL+.@V-'[;/-^GR$,Z^;$7X\ MD][S.S^T05(9^,\VTT<,HU5I)J2&N/,_P%!BQ2W/_R.#T!JT!Z,+/V_><OJ4 M,61@X=/?G,53WP+!\OHUCJDKAN/*V_U5W@;UOY()LZ6N=R\A8GZST2;TV/PC MFNI=ML3$;%;F!^VO=)_*^,N>!$X[MP,X0$5*\+K1V:!52 M*F%0M_Y2W>.&M M5J>\#<E';;0\2[0UW5S49_C<:@ #LE7_QD'SVZ*#4]V%8RV7?=W%7G"(0@-8 M'KVRYMWF$(G&'T^^/72?WE@6$;KFP#[;U-D/V]2K=/?0L'QR^]DI\O2MTY2O M/K\7?%^<?MN1+8I.PY<\0M<E]2,K/181$9$F6[KH>N_B?JA?U*2=,J'+EB%< M^^:UU+HPT6;6N078,I:)Z7=J0DY0<8)A1K2^N27%))$>#NP6E\UTI;DS1T1] M!250>7R/^2-78IK0N)&GZ%W':(\"[P<F$E-YI*]P=O$HL +Y..33J: 4G7Y_ M-DEHS?#BXZ$H#9K2Q1IUB^<B9ZX^5\O(Q6OQY;IT[5<;=-Q\IVKYB]:9?P)X M4_O$#YZC8=T&5O/;+MRQ,)7KQ[;HU<.6CE^ "DY'*N!X(A^%-R>N/;((VA;1 M96CWIU'1JHG8NV>B<J5MHJL\%\?;K32P2Z#OL)/8QDJ?(8W4PYT=,=:9-NK\ M\40JWD7D'P ?Q0?-!L9_7K@ZZKLK+U6N%>S^M 8I\VO^\D64]E1%-I87"/X' M"$\+?VK)K2OZ5$7M9J,.-OJ0;^ZVT21\<!<?#7 N:^-"A)JV((.AHEWOH9TC M2Q[GCIBWN"+J+3\QFY<BW#D"KMYZ1NVKDP XI]Z<C\!X6Q)C39@7499 *-)# M8LM:Y7G"V.PV'G^PQW]1X>JO"V=P]EB\$MZS#8#7A-CK[^-@'GX T@ ME*R MAST;HSO_%QS[![ZN]Y1[8EB2I<FA@*#7*["DGV0<\?*K5D:'E6B50F>GCSM[ M2U)OWRO<KZQ(CRY*TR*_CC#*-)[=<I1)E"VU1(5O;0WF5E]-4'3<D*/E UR, M_@$2)04<2C>/ UCG[1F,591S!=,Y1.\RS_1;IS'C02QRWC& F?V^4SU:&D3D M4/OA$B$P1SBPH<_RD;O#EM%[M_9;84>;IQ$M/SF?T=4KZ<F[G_4+-^IY;]W7 M4"PN$I4;=N(>L!,#U2/Z8)JEP).=$.'/;_>=545GN)ISJQZ69K:^+NR,X.ZI M4=LF%IYD>=R'-Y]ZERXU,-@NW,;$@F(")Z6J#@4<7S0U?]<U=+$L,N57];4T M]Q"T=A6$,\<5N]/7BPKMRV >PGF&L+C]-(L'?8N0B<.IK:4+<M*3:^E"!(PY M8>'J,34']>S8O^-2C;.0@[KPV>A:P5Y"A=XU[)<J#C#=Z*)KHP9<G/*8;Q0? M,+S?83J^=M/73$A0U9]\6'5IDM.&LX6AOI7W>Y?_N?,2<0YBS!119/R^#QC[ M> II-R51+?7[W %>E!0$YQ:1=+;4K!3@U;#DIL^4X5/(R$#>$(0V8&(P.8N1 M="-BAU,#![J3D+X:;S=,-N5L_:MM7;F&P!ZI>3>QOY;Y53B_[P9Y.N[$O:^= M'/ Q28;^ V ?>QK@.'\L^NA J8^MB$^6A#'>,N)EX=8IF:+F4_(5J[2P>6,, MGR3VSF%^5;4E#IERLJ@9OY_K6R-$HJ-HQ?F2":V>U;D:[YE?>;Q&9?8%2G:I M2YHK,<&]4]\\U8[3D^=Q[4/?SKOOT(T*RQ$)W<9JEM:4[DD^QQQ0Q3@$TWJV M7G38ELY#'Q-N$T 'VAL0][OZ [G+J]J<FF1.IPQK[#+KHR"89.!^,2JW>215 M\= VHM(;>:_L5 %RO1N >7"A\VT9@J?Z192^K2\KS/^^H-=M1TU-[TCG5$U* M*A?QC*B1&]B.)2M#55][.2@\?F=]0"B0SK">_)#U^O)QD%?O[U\$7XPI$9'B M;Y[HEM@-"J+=&YFU9^;>;/^1/-\W6S:>C]$[DG%APT0W,AU^#9(CHT*'_W/% M')8@$PMQ><IWL%R6U'7@3(?(1._Y]] NYMOT>01]*/)8;*<6IJ)10K.]/8T7 M&=)I"WB_T$5@7:<,U:]%9:\LYM@?ZGL&\Q_7\7P'Z/@!L FH2"EH$Z'&;@/; M]/,>=!B!YM.X)3^_R;,&UQHV6(1G'.!0MSY''HZ+'8E5;XIEN#_<ZII:K3S> M7W-)<%#F8:,X_B=&'VGL@&*<4R[;_GROL<.\[;L]-7J4I1P8'TU^0]X'P-'I MC9-T* &1#4#*HCS$FLS*^JR3&0\VC][$2#3QO9%:TXWV^]"V] ]@]82AC<@( MO?6UAI^7,G? >Z-X<%RF.@ U74=L4Z-;"J_& :\EN=QZ:%8D11"^, N?Q&@A M7(-'Y3F+1PN(]EV&+Z6QZ7]FG9158-]0MIV^?8LC:7H@[J)H+3LW$CXZY)"/ M##C<W5"M V4/D5W99353"G VZ$M -38W"9DV"!D5E'Z,XGCNKD0FMM1826%" MLAUX=^P.JL^:]0X>M>ZO2,04TS]=P<(5#)0EVR!%"4HS3Y'#N+CNO\Z;LU7E M],'R9GAY9;9-D5;C P=%>GL/30 .Q8$ DL[6G@X$3S2M1!VQR2>&JW-E&\%' MOPO2.:(EZU?[NV.#DH!\*<!U8$@ ";P :4F2@_(B,[C()$ZR:\WJ]ZWJ%C9O M_\64(+MA;O1\9,.0]!Y]E:K*)IWV'7R]4;PU_WN2,M#VSG>=,=F+)CLFW1)' MHESCM3CA*]^=Z"XJ((Q+@\9@XF%/%L%5'/!%?.2WUICYC%]F<L1ZX:P$M;.W M1EE67S."$"4$_HD<5%QTC[7=_P=(KE--M R+^ZH(D2-<J58^&2YB3LQC?G,Y M 'L_KW$4*>!K[_RC_I;CZE&L?<.7VK@W_+SG!>B-_J4@%_XPF#;CI7W( DEK M>VAA6,Q[M)%UJX-0!K%Q:EVIO6F>0:8^GZWAE8K"$VGI)52#$[!P(@5;EXU@ M S+2_E=;^;7<9,K0[[<8AC 'RNL]G?*\];:'^+HPU'YGJL92AD-+OUHG33-N M1(JPE'%(!07$5&@:U&8$AI,E=DD*Q7))2H?[9.BT0?Q3('*!UOSDW$P0//1Y M#'UBZYQ(&F!N<4?)U-;ED]Y)&:W>50F03M9&Q$;0]Q4X6>/884]?.YO%Z!TZ MT6F6X?GG%3$O^K;T7>>X2I'$"JE7K@THK466:\I!981P^8>_?CFTECH4SX10 M-SF_+UTM7:;-2+*ANSN<&O"M0XH&5=P+0CY7_%K18;?UK)R0\1_[7=&VAQ,O MTN+L5)(7V:CWMO/NJO29KT4VFL+7CYS)WS^_]=G;$!K;0)G"X[)BUHU.-&S; MVNFYJVRY2OV#G8F?/>:4:^69\IN#2V.[HGHY?$BD_I!,U3CK<]H>8*O/[2MH MT$M6WVZ,4MS5FA$WQQ%^VCCY*F-PX<2=-TE?$!\-_3 + Y("E4DRBW.TI7 _ MI8U;T@A/S#L66Z6(F!$Z?G\^'S9(56UC<Q4_>KI<*6P:$A^:$!'^LWAXO 76 M56ZN%1$FOB'?G[<T^WVC8SW%*H*[Z3*[TL$32_L.$1DN*?!J-412R G6K5K& MMRGG[4YO"+JC5AXWWA%^S<^A.[+-!S]?J99D"BRVR[HHGFA3L;;%'DH ,).D MY0KYX1QH9],-O7+UHN2.*)Z1ID#&:F2]-=@>01;?01_QMS<;W[$A&T8-V@T( M-5I0O="LP"C8DD6VKFB-B#["I-O.0<@!;3"K=TAT+_ \[RW(D=E]@;/4N*'O MA<>C]B3WWGX&I C'K0^82Y,Z(*ZZ!['M85SEJFXF9VR(V%&?S^)2!'T@X2I6 M2O?NH^8'CV6*8B1(X4-%0EF0_E#1LXN B:RTS:L3\:3&>//PVD.'A?,^.G9X M[.*!?.WIN<;8Z4&Z*'6%/8ZN8$K-=%%H()O%LT^ =,BA\A8M_G^4%F7Z]M97 MK$:2HW #V3O@9OB4TY)']"79Q$!Y8BQU/;Z.EQZ>>% OAIL$+(?W#K7W$/SQ M48LXA)?%UMZHLJ(W.WC"T)UX>O2]\+?*S292B''P.XW3NZ$;4@&7YZWQ3]&P M=_"Y4P.?1%&"N<\81(IKQ9GHUN2B3/A:R%"O.XYL? *D,_".Z-/<YB;(]GF# MNE*!7*CIQP?,V8E2M1K#SZ2'&3L."CEW8GE8RO#[$<A=1V61;0\VPOY^893F M(KR2J_GA)R"4IE^>P9J9FM0R\)?H+$E-T;$,D2!5=H$;[!(7U*F&X9'9M5#< MT,F1FI96F#2BM'>H17'Q2A=>&@JL4I:DE(DZ\U.Q=6*<?941S6D W.*AQES6 MJXX)C7.B:L2?<AO)N0_STW2J73NY>ZC+;=W-[I1B]^;,17Q\I3N>5AP<];=1 M2780#22YI/S5P+3T-##%RS2JSB4+8Q1[ZYZC#DFG-T\Y%RQ8D&[3=W1HHNN# M0%&-W=2V2'."A/52K!'<J7BW.*2'Q_2I&,O4$9JW+ZLV3BB/8BW^ :))1J++ MCR6Z8I]$-!NSJ-KQ$45!0R\_CJQ^H=/ =:,,,] =[!P7G,;X2LG0X9=YL]&I MTLYY*.FWXCH55PD8)P@2._,N.[?(ZO)"26R=]-:6L+C-_0.TN6_IK'[M;.EN MZVG*4I_?-!QK9(Z-H,#AI\J3T_?:(6!*U&U?E!0H&X=)V2V'J+7*MS6V^+TD M]8T@UPS!^H2'9#HX[.*FBU:$TI94;=GE\L+CKX&4X]V@9N#[+0<RNP$2KD^# M]V%QC:5'GIS>L/_4.C9H7I*,M<:7NZ($63LX9)!]$L\2%_JE.\+VDTM4SZ3[ MGFLP97 D?O_$?5595(FFG@R/Z==_ /J?%LE_\O!05,#=7K1C,&WABGA<ZZ$N M/S/:I!QS'5L&N7W]IYT6MQEB*[#HS3F6GE+KBD1&TI?/? \Z/.'2C""WH4N7 MUWG5\J]N6W%G<GP&M@\W:<.+W'[33G5HKF6=A4D8NFPJ4SO25.F27YJQ,19N M?CKBX!_I;MJ!2U7B*E"I:KP@OGJI=9$ RK:H;[.66TO\!S"1M^/SW+6@-"XQ MMS5U'0KE8OK][B'W9TYQ]=QJ9Z6T2V^6$[DIJ.T_/"4*<DB8XJNR=-]%2^8K MG#O7SBSF)SK+=&G[O:10$:_O1]_[TTLD \5<]MABGQP65XMLCE45W#(Q^$6G M$?NY*\8]&A;"P-A8#8.]5AJ=H&+03>%8E&8+F#/%]!,HVE&$!9+\$4$8-%XL MKGSJ3%?&G*AVJ54VG\$\/N$S94=Q(4N@O21^Z@CK84S!C6._]X4;LN"(5+]H MCPJNO!R"F/V1#M9W-!3]G#/$O_%3NOZ:5:J;0+(SV!L;-W2+UL^K5@^U8)"[ M"IMFZSEPR4@!+#'VP:.GSI?2""3R.<1<JOHE66='MS+ZV%^NUK<-#%=+3\\J M?NVU"PH1%H")@D@YO5ZB@MB! ''X97SS7W-P$^)M&_SIO%J11UIE'.B&)_U7 M=0&#[GJZ+?"5^V360Q=-D?*[[D2ZMWG2I2*0'SKT$\7X/J:M<O\ 4F37-;IM M"5]^?\^%-1W$#1VX9=T6L3#-_#3ZW&@L?]##8@H.3/..C)64+U5#-.TJ)-+< M\%0JP@2<[X)R3BD6:S\X_AH!+I>8;O:*2JA=U4DB4NF0^CN 538Z^,^&4:>_ M&$8K>HG0SR-K@;!/UY=Q](&#7T_YO?\P&OY9SG#WE?//<:9H=<!=?#/?F<O' MCF@[#_Q?(0Q'PPZOS) -L'C'4_F5GFDG-V)AGY^>XG%'TS;]R>9FPF/F$AEN MX02-$9IC]$^*\+;$B ""?X!Z^;+GZ,]_FW;X>OY;C8XFRIQ9_P>1>>?5C/]# MV%N'->&^\;]3%*0%I%-:.J1+1(&!A"(Y0D!BC,X! Q2E&P24_- -DJ.[0[I& M;G1OY(0!Q^]_OW/.=9WS_Q-_//=SWZ_W==T!\\-(%'WO ,=]F[]:=?MVP]%+ M<8>B3:[Y,,_$Q@,WM6I3^;_-2("-W01HE2%@)E@IC]S=-+5P9TOX7)HFLSNW MOUW4")P$J"\0+2:RP:CCI]7'/[3HFZ97)#O]<:\,7GU>%893+L0V_Y&[93CR M8C3@\5#+3OYRD\^B0OZ:_[6F'<56%[U5;^U3)24'W-^)0#X@BI1&"6^_^=W# M:9/Z)(.FAE![!/12@\&(X]?KYF'OFN >.54UW8N+G=! .I@0YB38\Z8EZ-%" MD*7#T^ &O=[!%AWT$%U _J9'QDZ;!T++S&1%8L7GKOUT7R^9WEU?2W%<I7ZV M52]O][*6\=9%<YJ=@.OX)">:EWG(%E6;C^U;CU)0]!_Y9_*&OY?44A+7]$)A M /$OQ;TI;*Z H0IF5F3<MU:IPG0MX6X&LFQP3"BCDQCUA\8N@JU-Z[DZ1YQ< MOLF6TWF%[)0 ^K=Q_R\V=ZB)M]_"N$I/J]:-+M1JO)M6MJ[YL)VH-L6F(<YH MYOQ7Y12-]6EMN6^,)LF184#G[18S/P2(L>N)JB+=,ZELVG"B[?5^WY\ZZ6!R ML=*T&?RF_3U1=0,Y@(WCZUP+:TPVR9&B,$YD3OZ% $WBB/QK3?(&M69>Y_CC MB,&C8-'LUY#130:IR%:.*FQH$-[BKF0_8[C0<7EEKL@_716K"6HQ,(N&31BZ MEW]!JG]RB_X+'EC-7,F\!N\J''[&"6+FX!A:M6QC-'/\K'.K3859IE[O/ A5 M-R7XW# 60=%_Y15CW>L P%<;*6.XC ME)3C7"?5CSLQ_JNQ3W!U=5?P29!PE M*E@-=!&@#-R5O^#,2%OO^,RL.-ZC1.2$D_,BR\R#9LWM;UTPLPR?C"9RB\77 M4 L8X>L6W;1^3;MZ03]_+.*B.ZOK5G(SZ'AYOE<+.7Y6X9W27<?/P)S GWW\ MY;'O>.\XV>(BUO9X6CD*B-YN0Q&'.SV>ZHRT^=N5'/W)RL[H6SP=10959^6E MDQ;2/52 U>2,\> 'QJ<WZB"J@M+FGT[4?A:E,ULT& L\_D$_1[WKS9Y;>S9" M3;?=A*'YH9!NV)&'&_J@"@H<31-*]O4I 7OT2SBU"%:FK/(#-:(3F HE3I>I M<.8F\#:]X!T43^BY?TN;*J%G7SV!&'?YZ]RO5Y=CE^'Y.E885DOS,B\W]M$! M?R96$T'8JXF.4>,PJZ($0WCWT5\"T763L/[QAT;V\'8V#$M2_C[<1*)U2BA' M,&T/3LZ3V@(VN%T27R>=&-XA^+[=H/AX?XT(A(S-=BN"SFM_SLPZ1:V.@U*F M^%\46?.#U%RVOS$\M\IQRQ)?;79!/%F ]G3YJ85=+/G[G@=8])J8)9]+W1B; MKU3BB?3X)>M?BQ;CY) NH>94\T("[4SCN5#KWN=IFE&"-,M:3(TWW2CJ\T,5 MCBIK1,/.=ZOE;)RHQAAMA81PZ*6H>CPV]^\<T-QJI'1M&$]T:,OHBQBTH'6V ME</+90N\1EG/3.0^#%N4P/^DJLSA-)4P_NYBNT8>C('W^I&5%8%37Y"'?*]] MJ56VHLQY>44B\DR%\="14M5HD\Q7(A,Y_F!?=KNMV/S 4#8H_/QOI8EM1Q"E M1MG#Y"[UHXU!@&3@6;3_Q[.!(L@]0.>3G"WV1]HC]V5-5-R3@X:&?1M?U2+J M[[NE8L9?[:*_X'O\J*+ >F"DM.8*,8_+#<VYT?,] ?Q&F@>:7O44X][.'&>( MR<\&PI<NHJVSA*%>/U]TH_W_-^_SAP45;0\+_<SS&1HZCM:V:0E&B_H%L.MO M&]7D+5OO+-5'^9"X9./T:*H0I2[61S#AJ>/-5LSKO56I%&N?VX+"7A-[3KOE MT=_/!SDQ36C1 ;Q(MZOYUKH[N 4:N>O'E=T;QP2A,!K+@7)-C:U40P(@@M7J MKF\^C7"HIL<-J^N^VDLY,#*71%M$M5I0';"P3<#X\[DR;%IWZV78FS\R'=$R M&NOMN_,3:T[C+%":Z_*$!!'G?4F.J5F\&,6<:J&_?W;7$<A8=^EU,E'S=)YN MN0X*-=MV,8S9/_C^(&F8V"\]M?K'@$":]P'G9T\>@@F#"*Y<BK.L,)02,38= M11 L<10X#YI]"2%\U!Q0%,%LUQB\^4G-VYJX6B][)?EY.G^_6US^<<&DHL!^ MXMZ5MU2*CS>OD*"$^M)0:_1F#'HTH__C!I\VF>O'Z,A>S'Q/NI.(1IKV#[@L M\\V#H+SN;[8;(91\#\Z$%-%'7]X:HH6[VM2 H0,?)UMU2K%&I4J+Y\"G*XNO M"/OG0JWCR<V*!_&A5:"%B5!&Q+!ATM+(UBW'R.6L3<3''T[4'=E_[@$AL2V= M[7PS3B=!R&<8IE7;JD>D;C:PLGH)R*?-ESE^ L7JE*K2]"2*!ANUB=R93X;T MG:4E-E9EDWJ]S4ECSWII$!_Z"D8N1Y2HP%)E$,EL5^+'\5WNKW\[)MOW%OE5 MF[KSR_4$4=6O14PL=J%<&F#L-5G48VW=C/YC[^,,0K?:U9\K_&"5_S:>V@_[ M-B-W"^DG+CB(^T=EI$9";2CI>* 'T3![P_1L^\&*UK??6;DB#*IX(0,2424X M#A<6T-]5L7FA>BU5>AI_WG/XC6!*-E_#5J*T]HE$U]T+7*<:XT<F0T.[]0#A MGF93 ]DWA/E[PYI_)>\!O-[RJ;8R0CLMH@+^:15.I8R,&(@34QR-KT"1#\K! MQ=(L+PL3%"5OC>[H0L36EB[LWHG&SCY[4?_K4,BYP):0TO==C5I;9G*@ 1[/ M%UD]W//"N"@&W7:,UN'5OP<=<_)![N;>"&9F;@H0JR*-TP(JZD+M>'M(X?7B M_;3@C;B(P&?HS%KZBKJH'!2SA]WH;U^-MQGDL7BMHYP+ODMD;M'ZY-$LS+6M M[7<]Z-;KE)"->P"MP%<)09I+36L7)OM'J5=$1=;EGW))AXT7$QXP&_3[<ZAK M&V]VW0/L9]QE$I0C]?G7[ _.JT2PX!R<.A:R?J!%9=H8AU(8*Q.1G78@=O$0 ML]O28ZI>_^0W.'";9\:'4\Z:C_H?^R?I'%L</MP7OME?W-Q Y\\UDT_4HA3^ M4>_3L?Q5%>JCS%X;F]!/&LD*T#ZHW64JCB\N\K1?2-C1D^Y\-*AW^-@.GJ;5 M>Q3>Q);\_@O@D?]\X3), WW(D%_A4<8L[D^><MV_O4QQ=Y[P14DV] 9E&':! M=ZD@I].,B1EUBD\S^]H8*7G8;[=$F1VP/A7W"]\IKF^OGM^S+:P[K>]/-ONQ M\<^WQ,T;<M\=E\(5PBP*WA;C7">MJML:_>6B&*- QD(AF;>U*IPY3QMF"$[@ M=)T7Q=P8LC*'D<ML?&@,+:L?7<5.?] B,.*6G[4WBP5#W@N?=BRO>SQ=!P(U MG@@7SF>8F%JPP[H1%'0)>09.+2M?AH/_8TKDOAT2P4D4+X'OF*:K8,"-"JNE M7OA<@MER?6%N35R=HEE>++ZA65G\5\# R#1W70ZV%8-0/=HHH8;7:3?'A<*: MU@'K=<,UO+K2?\,!%Q5R"AY =& 3_T$@!1P=DE\ &].8'\D:E%2WD#2:?<>V M\XV=#W-5-E&O'T'+R5_0'>P12OEB+\.+;N_M%-[HRQ@>PRF8EP?*/TH/0S:O M%ZY9Y)#RFG=S:G.ANNYI>=*SI^IYWN?/X;2D\:H*M)JS$NGYB9I5Y.D 1L)G M:='N<D**&(1DK+^SQ$X6/]KE>RLK\B;])AW2 N+MB@^(/?6$_HH;9G_PNTFZ M$X]Z!J94-U<.XX8'\C8G<,;[!LN%,AYQ*'EQNK[R'@CR^[78?_4;$E#I)>@; MP/VJMOY[W%_;Z=HD+#OF[RR]4CU9B8O5T*<I+:K1D:=>3]GC\40W&X"=>,Q_ M4>4#I9J<T-^UED3W@)&^N4]1!]'.+H,!]M/;TW5>::CC:YGC KG"S)^T\;&1 MI81L9)%Y%YQIF]MWQDH6!Q[.YKL-,#DJM6T'PP,/HE-+@ H!JFDDJ#.BN-*E M;LLE2;_>[-N6>J$N[?07!U)6#<T#=:$+H]:5UZ\^>V:3/!_B9,]!NHK(VLF4 MS2>"$>;=F_F)S-5]E)G' =2T27=^!@G>YI/@@S*J6EC+3X;9T*\H2_J9->WF M%"&K9K%'3=^O\\.[W]X#OB08JS('J;E(*6-(KL_=3E/2VK-WRH)JYC6L'8/J M?"C6)&86=T]-'1(<4C<10*+F)5!9J UY=*KSX2LF,H*F"GJ$:OR3-Z.BL_G2 MMPZH?:!9"RS"073I3.9(#_BM3\S8]""0,1:$35#1*MKGYIC^8:?'*(LW"8IS MF)YJE2-?7.6P9,ZG[_66A3[MH?03U26NW@=N9"EHY[MKD4T$WK!X%P5Y1,(Y M/3:M/GC,)K]2^E4A(]/.$W0P 1O/K4ZPRUW8$^F!0,!V14MM:]D"[]FSQ5Z3 MF35NM0V->;0K8H61K.%3O8BC@H%,IBAVH$VQ*8C&1L9@B3%D\*(_X*"ZN59T M#-)_"0X3"EI4*.V(D!AC[:91<IRKIWM9_*3_[_+S^&OVVQW%84+%9.>7YTZ" MA%?ITA;AK(^/Y('($7\M[C4MV8*X<4A J5%^*CW1JX=N81_\.\9F-AG.QJ2Z M B70.E^/\[\-^/T+2\*"$?[A.+42D]L( B(S(1(]U>K;B=(E/VMB\S:R>I0P MM>C=Z'12-\) I#FVB>9F4:W<X!<C0<ZOK_> 0J\76,O\?<%G:3W[YOR>;GR% M;>XV]88$H33#-"SD'+QN[P\;-KWA_O> GW];LJC6R:D<VA71[_Z)39@FIN4 M\CS2WX)8S:'[9,3M+NFS50.ECO,KTG:%!?I';N8%^3 A+,3-Q:G4(94A-1QQ M\%!&'ER\HM68%--AU\SWY5^(Q6_6H8()3N.4<^X!-DMU# ) X>Q'WI=/M1X" M,XZ?#A8\X,PX1"S?(DT5V] #']%M;;.SF9$0 ZE)99J2?.,]UU5$;5\++<6B MJ<83*T822E4>XB]N>G[5WBY5E=DA'4\GLZKSL7+*$P;B!5@7X%2*Z"DCB,Z2 M2*&AN$H<?1)LW8R-0-W$X/?!. K,5![/2"'$!/C+AKOF@%S1N$J*LUE5]+*K MA\8JQ;R+O!19R+]02V7?+/C[_=TW.[!BNEBO\@IMRI3&4Z;31W;,?$I$0RAB M5A:'2[ ;V'\CZ!#TBG1K"5A@:JSR,JH)%CY_>'827X*O])-OG;F(Z?3'@0:E MYHI.7L=^AX7*F\0HLS\?-$&9CP7OGF'O ;T'W-6E^U7^ZW%4B(7PAR.L)U9? M\Y9?)8JW>7\+BT[FI#*+34(=I/,?!-#V->#U!++]/ P3;![1M9RML-WMO3A- MIR0YEQX31UW$X;A)UX_X>Z\%SX!@=\316%$8E_\B2@20H$DS8^"4I!Z3V;1! M)\->)T^%XK\',!D[L#!A^F/ )29CSYUDCT%JF@%6R^X,FKX_7M(^4:6G<U?= ME-Z;5:%GXLI=R5U)/I_/!2YM.?VAG]+B'=F\!W"ZB"6O1U,LM1FVA+^T"=X* M>Z>GA-0W!4^602UZI=+>_*-HD;%WS*]'R8\K+RG[E5:2\*9*S4#8)34V4ZS# MN'$T:YH9N6YO>L ;\=+/-X3D#9!=,&JOS<7679-4HG"#ZWF>QQJX2@[S:[R/ M_$OVY4OX77HEI&W2:XF<!GQ5:YQ_>0;2X2J8K5]6?7%4I-/&%)%%SH:)5WY$ M2>JF*%LG M/&XF_5D$<:>=X#BKW&O U*Z#\DQ_J)N)56!BAML/ZENEB[QF3? M ][6V_T_4BW*[OY_.D$,-/X_JTLJ:5$I:D?&:/]'<=A$;%C134K]"NS_U>_A MG]E'EV-EENXXV_\=-B$(5OAR5GLCC;5&&?;%1?HE;\ZG>3>!RY;:ZOMJ^=]D MV42354Z*]# =GTLK^!DPET$[+KTP8HK%,=S),I^FWXK>C7<X2WZ"7_]JCE84 MO]WH\UJC= P4V^U@/91P"3-AB?% 5FC/K9*::.XU]+A;"8[U!.R:?3Q2BP&Q M?5GLQ)O'2:%B6%%""4'6@KD5O1R#LW6D&B*V=>XR0&N%CV?U_?H#?%IN,ST: MV8(F8L#Z_3;.9J6FK$VWUAFD&EU;@1RXJHU5;1HG=#"DH*'X %N /(GPCGQY M4_)?"V&[F>SALU_XKMIRT<%BTJB6I\%2;)G%O@9'Q_S]%^.+EQNO[R:;T2P5 M'H42J$?9ZBGK^6)L783/_J.).E[WZM<63=N$2:$(ZB<%+YHJ6YV0H":IJLO8 M_'O $D/@QQ\B?ZKCDJQ?/!++>T@&S-7/T0'N72V=R+Q8+T4)H>^NDN>E[O#\ M.Y)'.AKF^^,H<!18:T@)U%;.C6MKVL34=+2BG7/!+%J;C/)U::<X_N8F&?]/ M#&DTPJ<GB"";;%^ELYUT]GQ@W@[]3]'\JIQ^9[/PR?,7HRNIFQMQ#>7PZ(._ M[IW7]2T.'90ORRR%LM=96?<PP[6L0GL(A9$KBQ&O@&B9DWY(_[G"ZSLZKRHR MB(&L0D55J.=(F8*4)D9P()DI2A E+_(K0FZ.@N@H(.,;7;^'&347_?O;X=;Z M68DJB(7.Q%9&0/;Q_ML2[I.@4X6;MVB=F+H5 HWZCCEYJ=)]&IH$1.W*GAY- MJL.7T>F_-SVBCV-IZ17XLK)YPG'$;CY"!44.J<V>&:6+#ASZP2NUB1]D*(3T M@Q;Q7\D1';3*;;11]<LZIL4FE77Y6#+^S&^^!WQL^0%;;E>2MZH<J #[F#CL MO[=87-D[I"M8%HNP_I0?^KRK"_ MP\^ +)K)":[UTL\WCRH<G=T+QFE" CQ\ M7:P^50?$^12NTJ,(FD<8<S7Q8A4-S7%4IN_:92U" ZFG/<U 'YLQK)'U+VP; MP8];:&Q]HT+X%%%?#"1,[P'D,_,4F![3Z79>;&2GD;$O@WS*:;_7@M,J4&A. MC'ZT.F=-(N-==8H<",P639)VZ42./([+Q;HK?)A#>JV87#[)S^X5?)Y<Y?/I M1%5@27?G^<<-N@/3J?PM_?8 2@2B:$7SS(#8WCW% _9J]OE-8(YOP1Y<7-U$ M01)BS18BTRE0<17>[[>.23)F\+HK6F?6U43M79BI3AW]TLX7YLR:PKOZ<DHI MNA6[%#?5%J@EF!?O'*/,4V'2,*UMZ.ZL,B]1GD._HF4F)B'?/])]#R#!?99@ MENT6Y-UG"";D:JIF,R]9YC2F&!\MKRQ=)WOPOI^_ KW6%Q4@_'9V'6-V3F&Q MF[I7:&:.>'XJO&UC$).GO\>!_P"UF;?IV?<I<,)$,2X?I^2_76ODLI$M:9B@ ME#@W]=V7I*5SD"BAW6UH;[461HRN[)*70@ZU:BD<;4XO%1R:..6/.[G83GU] MWOE.;E"3^<\HD'-N,MJZ!$2W1E4_(LP$C41LJ$QZM4GU71Z1+U8YT\_9YQFL MG2YR7WWR8Q[^LI-"/0']AIR/4N2M(_4M0.S9VQH7-,T+EL^H Z3QYS@3575= M%Q*]_DS&\\^_%)331E]F;X'] MK3[==$(Q$*Z7%EK"C%'>XF83J+H&XGU(T+ MH$=\R0A8E*ECFD7+KMH@YNN&X"=OM/UTDUZ5$DL@F.##BR$/8P7@WJ+(0U/A M'V!O,"P%EJ7[LM_GKP,R)O?R/K[G5V.:6.X/U==C F_EU18N\[)]FB_&X6%! MZ\(/=\$%8 :NE=A:Q_[M[?G>6*X9ZH5[0*7-D+:K".:S]Q\/\UH'R_I8.0CT MP^J3]]:QO#_XV+^&Z.-] = -U.O-MXK;H'C9:4G9S3K[CH39@H10DY@Y*;SH M*P*^GN G9=NIPH+GK.)P816;G_!5SFR/]\"8X<;E@82$Z=4F4KE>$_CW2Q/H ME+]O;L)E5]5BUR8B8_W)]KMLKC/<FT-']$=</>*HQ_-H+5;!@:HAER-6H9'S MV')YGA_E$BZZ)PN_)(O[?,>!T6-S*UAJ?-.@-P4J">=_%&1:&T14[UN0>D2% MK(I:E9W%T2*%F?=D!61! H:(*@2U\PD=>J@H K^?2-D@>[L+:8@M6\ I(3,Y M.M.DJZ?* P<<C$8/@;Y"G$I^QI^M3-045B)XYC)R44=<EG4;>3)QA#@E*5J: M?Q 96;F!P>\@M*NW$*B(_>G#%&6DH_H/#\=_D9?&I;3XCQC5\_L*'F]HEODJ MXL1Y/P==_4"OQ=B 9;N!=D^-%MNOG!4Q%<4+C73TBK/LTA'M#,PLUEY(9A,+ MTF%"E\.]IRM@=U9_6XYAGIN)F@!2-U;*0 &'.]HX+?1JB>4]X$E_4]GR /W\ MX6=:;\D&Y3"$L!0U.1GMII[88[*#,TE2;ZT-,[T!'[U%+!.H,IV8KE)>'QH* MTEU')DZ)J"',=!X/4;S8$%(V647#@\MASZD/&TZ\2AS@"U+-A3EL*?M'H:[, MOP'*20T21)'DQ#HSMF35)?;9A('/UAQ6Z7\WM-5^-3Q, /WA!"V5?#;:$!;A M'#P^;LE(',B"6'>SX"DRSE9=5(#>)X$PVCG/O*_\DOHY8JRB$W\K/T7QZO^* M%3..6!X=*,J$J:/5PEC[61Y/OXRA61WHO6K>9,@8L:;_0LQO>,:3!9U^,M(R M\LJ4J34J]JW_QRGRER\$Z)N8SO][_;>Z0:.#(S8YTZVLK6V\<#KD8$P@BG%P MT6I11J94==%$U8V1/XA0,",H1*7CM;IS/>2';P$)\@'C;X_Y!H?$@QBGEM$? MOD=#]"N_O9FNKO6U#&R3!')2%AKTE6\&,/*W;N;O43I4!^9L\V3)2*!0?D-] MLO6L32A7>/07-^:>I_]]'0)0Q?Z4D&OK]7\C9>$8_<B%PW>_IWB@X!V:GG;( M:)&->1 @>B&Q=1E(,N=("'%A<9B/Q07>/;&A..\G-&]O\\B8RX/J]))+0SH8 M';0<RKZ2-JLY+(5OIA!Y'.T9%KWGCHVI6W3RTHRKK:FIXZL1^$:D+!BOYJI6 MX>L358Y"*Y84V:_2INM.VK88<T9PS"2N:=3K2HGV#K%7!24 6+J;BV%R5:#] M=W/F0C-$ TR^=Q/PR#U0TFQ#*,[#'()Y.& P6^%5@/FV.N">D#SE1:RK^N.+ MI(^86F-Y_KKM*U?%8YG"W+"<O()_?ZSW<;26F^]&F0&BQJR\HM!^@4"^865> M3>EL3)+)BWKWBI4T"X7Z@])RO^N'O((5G]\#!#KSH_%J;)+<\')XXI2-5PDP M9T,Y7/UM)%D,*5*G1@?1#9.# (!ZR""CSJ, 2#0V$Z.)2BDJVZ.$,4S4G5#8 MB_Z-*EYSP 8CCM]]*<.K+9.WSABB6TKHLM0[U =S\8/77$Y?ABS5>#>UE0%1 M3L+]:09?A#RK:+4"GEVIGGV,5;?0#@$@IE1HCX=;,K]V?@!5=PV\=5X5@B.H M7J&7G3M.$?Q_W^LTLMH.X@Z2IO7ZVUDQW= HT^FZ-A?=N?-=)V?'.AD$1U$X ML4PLGBBQ1U.!CUR:Y,86 5UE6SNG?8-6C,[1-5Z0C^'OE,?W@([T=T%)<^^C MF0_KN;5B04J,^R2P%9#JA.7>/8#R1JTM^^[F9RG>/<!Q3'&\JWGV^[0.>?0) M9V/ZB8Y7(4(#>]CTI/'][>17W(&U!D8RN4+(\\A09T;MRJG2.OY.HW?N1Z"> MI/H+[.SIRL%$%H1I>4Y18FDK^^FN0RFA\3V@.O^,[O)QX&0=N9O>DMK&&YU4 M/?1@$E/'@A!==N=XG^?=A]_T0^<R10,DH- MY\:= ETF>.:&;9+E+$PI^]JF MP)3J'E! 5T(6M:'YW[LLONH&BVN[W+C;- \S]W('D?2W'#F.ESR_)4S(#L^. M5+JDYEEM[Z8P_=6!#&[I_JQ"7>0$7ZPLQ.\![ :%4>@EE6GK)H@@R]3J]C9W MK&9+S/2RI#+KRQH:F+]M@U!=T[NYV(?9:]%VL0,5]@&Q!JRMO]195Y03/LR+ MU=(4^H1Z2:=J-=2T\9,5.48]0X]V*E[0"8A??>U7(=F1F!#(LELA4:LD+/=O M8UD]^)0AV$V._*5"WJ/ )X4^"O[-[_(LZ&)H.&B7T\!-+[(A=FW^EU-?2[IR M0P.!.39?WEIF'&ETD-]J]W1MM=-?.,LLB(=43["R\,M11^S;O0;(*YWMZ'J? MU-,[99OES4!A&#<<FT,6XFM7/(8<I\;ZZ,;I3N*4(40C@GG?(JSY!LB9$E)4 M50;8+JLXL:EHG@%9PUY!Z]XU$GE;P?H8-6U-??319")Q$*<:IQ-GS4#_/4#2 M()/3K1'8Z%Z$MYLM;ASCJMC%?@_P[,5LG-H6V5^[U4!*MI*.I.83";D3]!RB M2?AX#TL5M'UYVH3 +;QEU/D^=L.KTEC+C4SMGDZ3P!P,PWRG(MOOB#<FH56E M*\LK^U)=ZV!3#>_>,K;PJD3BN%7*!_VDV32X%]@N7V0'A=&!.1^&>'5EK6(K MM F)AD\MJ=;ZEC'\!TWC)GKW^LUWW/?/3(:3[;*8U!!YQKR1>P"A05%106N? MVH)0P[C$"*5DOC>NKEQ;I#1_AWJ]1GE#)WI5F/]2B19*VP7ZKIDCF(*M>DH) M&VE(2.;@B5OI'XL&#*_DC"2[CY78KV6OS*3\@*ME0@E07%M5D>4O_ZEEF.>W M[NODZ,NWYV5#A83^S*7#7 8^KL/3Y=5UI?M%GL;Z SI@-$V3CS6RPFI>&0O_ MWQLTW[T/<O&H&)*I"UYS?<P1/FC,0?11B%# ?10D;X+AZ5P+N[RCSUKJ6WUD MIJ)F<+;9"#>NVHX99PQ6)6:CYSSZ@*_C<'8"P+%B-:V]<J$&IRA>9R](D]"Y MEL[;YL:Z,/U(CB3'F-:?7/K]V.0?#7-\@$$*-0KZ AM!"Z/Z':=4[0;X3XA6 M_LH]0%B+_ DV 545WO$8YN;K8X<QF>YU/TCEWK^M"\]+'%77[JQD$J'$Y02^ MHRR68L+HPJBP51L6C('3K(0OQZFAP2=F< L*'2]PL_1&)#6-7E7*^U> :+0J M<&C<X9IV0ZEK%R95 NK*P182<LTBH[H1AF$P?5LONN=I[_GS0$^5AX./WZ4W M' Y)G!5U9@<K2F$];E[!'L_5WT# GI *D]-%X?+C-#,XX>/AE^[!_SDK@D0X M.)@/CGX;AQI'C$"0F*>WN$!"_K(#9X/$K:D_)P%5$]=$^C7[/_GJJI]5F!GW M:VH>U )!D(/=P +H_]D8XI^K(;H';/[$JMQU7@9=<_&K_)\])<:QAO< SH%N MUDN"VG^K7UA(PO9BT'%WBO*^]P!KA?F[J-#6LLOO219AEXE8Q56&,.W&F?ZD M*I3@!_#SD"2;RI-?%(/./_^J5_%CFS#^?=GD,%\41)C\H!:<,N4P[R/VENAU M%^C*>E3&P+)SX,3[[<#JS<*%1<0\Q<K=)"M>86N"S5FK4J6XN.Q7#KH*\H]R MVL [2K4"N_?FY#@$SN _\#X5['U]^XU9R'%4,3O\Q#/"Y>@HD8OCSN_V5\;9 MP3=<613&;4[> \6HH*,^QY'4UZS+*-BJA-(2Y:PSCV-L6:+B?-M^KNT:\.S, M/*Q@&0KJ0<P>)R&S\3D1T81,J6&:U<%TT]#E*('1C\X<VX"DKLIDPU[X^[\& MS4(Q^6%_%&?=YTD(3VIXNY/N 7B5K-;2[38*_YMJ=.<P/@I4H%Y#WJF%.; R MP(R12_Y@V"?;WZUPNB8+T@-9O84F@\UW4SD0.XYB6\)%"WE#6M^;-\:+"VO0 MJV[9_@Z[PA6YH?)=FB3P]7>4-V^)>[RH$O]CHB7O';Y%'K9K@@$E[%N<$AIN ME(VBC7C)F78]ITFXCC[Z3C.],MQ#$B7NF\B^\WB)E6]'\4[T1OYNS$\["D4J MU]_.V($YKMWLW7-Q@Q0,%"*6"91_/4_<+3J&,^40)M+R5'CVQ]"_3]X'?C1X MWU!R#Q +:$T_*+A6;'8MX 7^<=+4M"^_R0UBO)OM((?IYV3:J:!/^U 2PI1] M)> JZ^*ZKX$&9X)VCY^Q%-P#^/X.KVWX1.Q@S,:CO,2YQN9R>W1\\QM3QR.G M0V(^)FHK#Y($?F+*TN;?$T807-K,XC3_612AY_6?I/5O#I*K#BS<6:OJOXPR MQ*/4]<12V)P%$\EDI*M^U'_^ICR3UG-COF868W.J9U 3K.YTS$@_7/Y%+'J3 MY&* &7(A]!2YROR']T^RMI>AF5>=E\'5%/!:,XB?M02]0M(A5L!']VOX@QEW M4QYU0?EA15#2F5KQ 8L(VB*VO<NN LQ0$1M7B' ,.X0+%H]ED&+R2;=B*I4Y M4Q6:S\ROD,)1K ]!FO#DYQB6*N;6^$7NS+*7KGV<FWS];TM^?8S55Z7]M+/: M_@ZM%.+%R@R=5D5O_VB:D2#4*'O8T:)/;]<C=MRY ]BA[X?,UG4L+*%(QV,* MX3.>%>2]:::_)'W.'#KL:GS,]1[RG(GLL!W'_/[H/53IS#WH2B\(7D=&_?AK M#>U;2A.\TDD&*IPP&QJU_0GD'G9_1_1#Y,*&H7H^"7J N(2,F>N47+!&*X$M M'@FE^A0PZE"#6;A""4$Z#9-U-$VM,?&NZ)^S* !59LW3?+R$R!RT(:HA!+D6 M>F2-BO%&S)NWM"2]ASP1V E&++][4RA-/?^<8+37DV24=JO/QEZ)^(YMEX'7 M"WW1GNGA(K=\^ZWGNA-:Y%2@_>!T6HCPT>_Q-CM(%C6FOPV91_%-%VTV%C/J MDU(SEB\Q-DHY *?L%2SJV805N7Y:#B8--$:7E1BOF)WNW@.J>.[4MF#HN9,S MQ:_H@;X@4NB4W*^Z$J&"X&5\WTI!DV> JY$-I>EV_G'Y]S>?80KHV_8<YFB_ MG0B)%EJ;5)6IE[\*FTRISJKU>3FDE:0%1/\:ANQF4<_!WI8J5F&H5*?:1?<E MI>2L ]R)*Q[R&^E(WSQKT&0<66Y1OVVDJUSK8:5LIU,I'+&V7&>L4-+\O@W% M,5=&?8?SR-=)3I<):?L2FYSE;X%Y(.#Z-K^#745[\_FET06L-=JZMX-:7AWF MBV'L3349^';R^6YB4I[:JV7DB^@*X[+[ R+"A^Q->XWW -* EQAG+TL&NS(9 M5BEM0-4CM% .LH,![)=Q#R"^8S]0Y&V%QZ=,";=JR8XYNHJ3G^@O/CR[JY'J MDA;<F]<JPZ9VMS.961AB'L^'(4T)<_[AI$M@ M.Z<]IH3M<=YM"W[V.9ZMUE MVJ)3B8'CD01A&B0^ <BA+OT^EJ!* 5!)WF=.,N?)K*F/"?J^LU*1KNM<MY33 M/F]HI!]MO_ W-_[A< T/J\AR.;^U"B:T)<"2)4<RO0B;K1[O$O<1';"_PE]5 M%8]UN4$NWQAJ(>\!U/:KO(GJ=6.O7Q1%4PCFX,N%!ZV%='KA#*I&HTC0H=5V MJ#C"/=G+K+Y#"4:CJN=B 1>&N@N*&YRLKA#M_=<3=X?R<=]B!B*1@015ETI? MG>298>W:3<CPN?[KE681KK07&W?G'X3Y5G-^K)=0[SI\&^GJ(IWQUV.._7!F M CVL,L"4&]#E"'K7#.>-Q!&X)1CARJ)OCTE]:<-@<J70FCE-!0+=-/)0F^\5 M+I6:0D<6\&07;MC"X1]\'R%61MTG0W\<@VI=OA[>B4NF(LTDST:]&:HB"].. M-NLCQS* ^%D<N^^F5%DAG\O=&J"N_'N^3E,'7!N&,AM;U'KOHZX8(>,ZL['O M(P,/FK9[='Y/7^ ;8O4*&$&-ZFTS+_W]017#C42A[!$<5^LO.IFO]8]8D5>A M$H**<B=/'%(1I*WEZDYD%XD/>X(KG-CLOQ($%XJHP0RUA+*Y*H9^F2:;/_QO M9U?4]$_U^LV"U[=R>T3.Q,4' \V0V'_.Z5-,B6M[)T6;R(:".JKPZ/CMTG*Z MRC3.*6=)=7)UCX6W'G"WC<(K6MEP6U</R>79#U?H\T HYOEC$B_O 1J8EXE0 M!SFK-3!:X /="5<X$T%S=IPDS=U1Q_&@-)@QN;*JFT6^H?GTY9@)7L[!8^.0 MMIXX/E>ZK?74K^S1Y\@P+^HJ5!7!GKD8O$%+@T:*IOQS;7M#0DYSK;MH.WTJ M2=@\$\MWBC[1//.Y53E&=<&*]=C5U2=STNLA#SD=\*GU50$ MZ_Z]2<U:O\Y MV%Y?F_%U.15 HA:X3K-61?);(^\!W:^&QAT-F6":*/(P!\.^%SSA, 6ZC=X& M26PCW *T]/E0;NP)_TJ"[*Q%-**^*"*0;ME>5FM4-B5GXPFC]I3B&%^K1XK9 MN!!F("4AU-M%.3:?Z"W3SF$F.G0 N19\?#%KIJJEUGM6?PHL7Z8_8:L6T*IH M$=U]S2KZ!6\GH391W+S+P]+-S:/I\^WD(53"C=E A#KMU7\/ZJR5UOG4-_Y^ M$][6?OPQ?WLY_W@!V"37-KQF [5^OR7P_<)Q)Z[ UGPI/ W21/)>F:@N=G3) MNYAINV$K1MHG4"&.NA^GBPF-0E8]WM<L3K5ICJBPBA0-35%CU/_(DI_(YZB\ M'<A8.Q<HM,?32]M<=^W\S9>CHC*SJ)<#$OXLOORTYIA(C5-(]D)B:>]:\1>R M35%.CI]NBIK)%_!HX)T'[D 8N9I9:G\/(/?4XM=]9VJR5*J>'D&\3+9:7R!% MZ<A/(WOTD4=";.VU&LCL76^Y>EFC]7%27*]^(RK<TO8M65"4&UO@LUM)NVFD MU>_/TIQPP*UBLDVA;[RXDTKL0('&\6,W?TX?2M >6EPL5UP<T-+DL!,H !7 MCB!72]-"UB[?&=@CO@^7M2.VV%4]2(=M?+H7_J:Z[^!ES<Z RSH^II)5TG#R M%#'!/4S)CT@E[LK6HS3-J%3:,$P3#B)F8TY6'#^D8Z*<T@AL;M[(]._.A$H_ MLJ,K,R\ -PWCY&9 'T*G4#WKT9)B@C'U??TE\BGM)D !AVW>=]GB3QGE71\ M,C!FA54;9A_&TG9TT8'_2(K!&;(D5UP5S4<@AWHG#2!?-^QSSR8+Y#=?@R[= M6/3)QF;G]!03!SRRCU_U#0;UV]H7BDB="&:7OY%4V9)Y! C@&6 @;2^H=CX6 M/JH#)@TE'U::S^;\@).=T)/^CDLM'@@D4Q.6$GZYTW8T-W)RZE>KQF+WV79E M?RX-'O+AE/_G=JP^\-!9$.2;^,XY)G=@53Z60%==X:"T5DJXJ/.LM,=SM]!H M@XE@8#0OXZ+2 HAV@G_3*DCY,6U<T/IZ=>4S(;LRBPC% XL?UA.;5]QPT(T^ M!Y_-[^1Y^=^)XG\](L.'WZ>GZYQQ%8Q\'AT#*4](O! MV4VS^7L\+^E6&X>E M$;^>;:KX-%4Q!P(MU U^#"II29*\6X-N*8@5H264RUV<\Y4@[;P9#QL@O[.4 MVA>5XJF3W)!C<A]F*L\#-*9>>.Z$V*AO/E1K-,4=3HGP;#EU\'+0XV=J)":W MK6E_??)WUUM2:G2JCVFR_L>4&QWG2[V@>:G=-6WR>LUBTWWO*[<NYF^F E\< M?P7N,^&6;J7W#DQ_!#TYUZFF6Y_<2,'OHMJC=2E:)G$G9A?K'R4/E/6L[)Z[ M/HKVGH*PVF;$E*;.L9C&!C81#=PBIB28S JN@RS<3",U,/R(_>8?T?_9GQ5^ M?B+?C4^@)"J_3A)8SWZ R'VW=QOBVLGD^Q_2;T-!_*]MW:C?6!Y3OFRNC_I MDLCU0V_X1'*ED@%V$0GB_V93%&0/S0,)6,MJ1SE/_XF5YN=Y$_VM:PC5S,&Y M$KX%MO>42EO9'W*V &9:@?X+288S.?)XBT[+ZT>9.5RB]I\%<-NS)RJ<\.\\ M<;OR<X>$)O6M/;UX%H'$&M.D!4[(U\_*O\6_U"IZG"CQB;%2]4YZ<_M7*30* ME=Q*]:25&<D/G)5ZX(_"-VL_+*-B<O5C*-&@,)V:I"I3X/D3J<JQZ;R<EN T M[<H7WN+G=' ]'V.O1*7(!NTX(BV ,FHT!RM2[JZ:]CSZ-;[LFQ,5*#JDJR;! MG? ?S@OS=JPW;?8>\!U&8'W%$:8.E/#]3;ZVPI<;'""FQLSG0NMV,U#S9)M$ MXQZ@Z, 8D5\?Q_VB2)KS+1&MM_0?P(4B]M]5_SPO5<D>+6;O>N#H@8]BM1NW M54/:M$ZHZO[K?.)8T4/@@$E%,=:BE])7D:X)&[>AX( P*W/S*+1_*"5:/;0" M%8G851_"J[?=K-P83=J;76H+*UDQ@YDT3&R)8'/EA/%7@&<F>]<I><Q]M[T! M:X=H&OZ]V>93",L9RB*ZU9=IKH,,IN ")GQ,'H[3I1?46WD>?1Q_3;JF^]@% MJH,,^BXOQ42@C6Z+R4"71)N9]B:M:#S9RL^\DDM:KF4X++!'B' Z=:D^3!F\ M9-4H=A\^;0%?_9/Q9]3C[&BISEN.[CN1(#I(%&MDJ^-N\?7L,L4V$WG+$SPB M NES9D"5B6RZ>F3- 'L2[IWW=MEM)O=#A:JMB^= @O/R6P+D>"A,W,O-MW#7 M8 YNB'<U3T(\N"'39<>YH5!B I1XO'<+>NVUWX4+L"[5*MX+I&V;]AJG7.QI M11 G6GZ-X&N'A3..,'[=.''K/-%70IKW5>[^[D$-5=2/.8JD:6D0N]2&%](C MY@X2K1<;0QQ3CK6!%6")"MF5SZ'=CQK3W5QJC+X8+\T<,1JN_(S<O'L.#8?2 M=DFMLLV4NTC<JK_TODP3^FD4UI3<_98(H+J1\CBS\0%PG6BK0B,34E+I6=^0 M8N)S<FOOQ#/$"L6LZ( LGN LYEM5RC@9VN&6+BZY>[)_3* 4> D2O?NE)(84 M J/Y'#:IC0!45C4[U@XU<#B+)*]?=="62,_4^P-.F*2NJ%21+X"* 3D:9DU# MB):3QOPVLTE@4NCY]:.YM/D$>U*[9VG)QRT<*?:5]%%#+Q-W/&Q^QC9Q #PB M_^;U!)&VZB-/XE@?U-_::24!I]-!6<,OY"?ANJJU64897=7F#SM:I5.%8#V) M;FDC>*H5Q/U5/?Z55?JU+2XZYD4*2NZ204%[+4M-UX\WA/\_\A&J4MKY89\Q M 7$#I'8]NMA@^W/6.F(51YJ%_F+TP\F4_E7-(*8H*24^UE0E/9C@OZTV2-:; M1R9!_W8Z3F"S-\+"O(2?PM[-Y?P.J>2ZFVZ'YAKQ_-R"98ZVF[Y15=T:V1H< MO%VKR@N<6",];.>"!=UF"GB!#HX4/%L4# V,!4P)T^PM&Q9:5J3I'9/JJ&*_ MR?O1AMZ10O50W-4;-[?NW> 3$*BE&O13F#M8/>\%Q>V2ZO[[=BLI(4*"1PE] MOJQ'.1BQ\4M_;#+:Q3!VZ.1YPU1]C-C<\AJC1U->O?J5AGX$J[#\YUG53(VJ MQ2G#I$7SM:A)!KTBOEK=V,-SS1,&L"1K'6#*Q3GU72-\ J@:NV5\TB.31+EN M)4K4?_CH.^5G+NB8'=3V#&78[T*ZO&HAE(G4>7+P8&ZT]\3+G^L7UP>M1N7V MCSVGK__CV(*E_2U2GFH7QXZ@/HI!SWJ:_^0A!5^C5N]VU*;8P"_K3Q=-Y9[9 MB=?R/6;,#E;NI+ZT+<COA-,TK[2'H986:4<H]B8<JAPC!C"OKPA9"%Z30:(H M5 M>J%*;. "5O#7>MU]NQVWX[,?L3T)]W8<*<6G^?PLGE;XJDF&MD6.M$3E@ M_F=7A%MFYBNJ,0('L?KIS@^#?N<8(FIAU$S99,>@+I.8E1[P9#Z<A;'%EBYM M,M#:%G@/2)G "WF$FSSB.&[@Q-!\A52H04I'UF]-S@PB#&W3N=LOD0"9!PT: M5IQ>=P+GI2R\6!=K#(?RV_E60B362_K4,LRHR7\WU\J5\<K2=>&XT7*"I3[: M 0X9&#KI6"D]F]BQZ^E@512#W@,&_'I+4'07.F10IU:LH.>B9>(<?['\*/Y/ M*;(->X)$\6GJKRXW2MB6OFR2(YRQ9:'@79S7]B#JA8&,X*=H2B'FC) 'D;C_ M*'LW8B'',>1=^&<#B5AQ\UF[_PUWR(U1O5M=AR\>.G_.J/C]1?U4=ILKG>_/ M>@@!G@1B&<<_\?)6"6:%FJ+C$/RY0$TDP\J]_/0) =V11>$6#F3X.+CH6_>' M&-J@@.*SF[=.F2OS&YL)%Y[8(NI4) WC@]<4%N UU#383*FKBI\UI?TAIB$/ MV:8"]%>0^YCZ_JQA>9^!>1/34."PH&1C$\,X1'IZ[ S]0W3!ZFBO^ 3=<22# MTM1AA);HO?K]+^($M$KY(.FK*&46$[=XC//29/">G'Y5&ZZ(/CNP1NH$'RG2 M'NB98X40%E*ZK8E 0\=$%8X'=7\U>QXA-#]Y;DCL^V5]12G1CC#/(+1#BRG, M*EPJV-. F4#ID><O&EV5K0_?NNY,A<I1'4V]=SG2^.!^[N/R=FH(5')&MWR= M!?Z@;ZD*7//>XIY/=T9XPK5WI'S0.BA^!X:VOJ*^,4V=Z<IY/3-%X9I?I#^; M*&Y_XL;K^ZK5E@;850;9:UIM;F2P2::I;^9R,1<7L6WY8-IKJ_U7(YQ#@C/Q M"?+"C<S5=!%&:VS'7=),UX^42-*8^8_\./G7%:"-4#U@2Z*FULKK,4>='[O: M*KST77^-6" F![V*_$DZR9SHF/*DRHE3Y8I^MI5&S^7T3IYJTUO(A@TM[:XE MO9GI::;'I0=F*S,L,JF'E>JX3B[3W[AICJ<]=$Y'@?XH-P1_QK6\"[4*!1RS M/8@-4'G=UC('?UL&A1A7VV^\<JF7D[.E?8<_]XEB99Z3IN=K5X4JQB(\QUT( M1NW=Z1Y4>P$"AMTI3J9M!/+![#&&WV'/O0*0<2'F+S"*\."&2_-W_ _A5]N> MR>F?SE\!^Z4/C#3$,Z?\DS^?VP9D]V1_RY*>%_XPH#YYA'M+YR+KKR"_YQ>M M(BW :;01__D>\%3^9GXHD ];X'/S$N<?0*Z6W;LJA:X9;P!MSSE__I5FBD>D MR51!)29Z\^=K_Y-/!&,6#KN*SUPBS.FGO2QH]]/F2BY'1.X!BU+Q]P [9<=# M1:>YDN!1LE>4M>L!'N8V*/)O=^Q8!=+V'/1\5Q8])J7%BR?)0^&<>\Z^W903 M"9ND>W1[#Q#@8?J*J!2]6GOYL;+"]NBJO>^UR/95;K;.P1W3H1..'ZD404LU MD(_3GA'Z[E:P>>V<7F[25#^\93$:\J;XP=!@$OV!42)H/XNW49*!.X>\3PZD M^[QAIAZD5/OVTSIN%%'NU&Z+IR3P9"SC<R3:A1E&BQ;NJ:*$R:-;YQDL0A5? M8'.O%ZOFU:N;;Q1ZM0_G*5I\8Y@2Q+^T$)V=!@.JWF SBV!N6!#*C.?#U!TG MUIF<;+1[Q;.#RH$"M-12FM'_?8!F0E6R=#.83)M/L?1'AP^CF4_]VN:MRN(9 MT&@#]QZM=/D?^J2/6:4WD )3T8:3BN?*_9O:_EEDJ=",G7U=?H%L_-N9G;>V M#'4U,BY&B:7.?Q FL:$@._*^O?9+_7D6<<IJ +@ZT=1DY3M0]0E]B%& #O4A M+6O=F]4GDY]F<& DLT:/LO09[&WA&$O.YYQPHJ5X\B0>QJ:^SSCMV]^!+#WK M,9^AD(&L9Q:T($!*FD\DBZ87)<V#Y(0?HG\]KJ!CG/O#?!13*PR@ZP)X2G%9 MPP_6(.'3IJ%=)3(<.486*6^'%'X&>X5>B[1LNS$[3*M9SFG*9JLQ!Q5_>+8N M/&A()%F%1[VT<C=O3HIN2"A=@?9#;BF=1!MT)#+SSQ"#BW@4M6^BOR<J&NN+ M+J97>"#DE4A:W[IZ^:] -#!JO31O!,F_7#"&2,7Q*NJ&<HA3N_S8ZN$K?M0P M:5K5)_P]B*;NH((<U!:\AG*EC124%[[4>U$M]U79)ZB),^N9-(_;8JN=]8/X MH#K92$HXWUV%_YU\ _=4!W] $-YN%1[.$JW36T6.V+]CPIAE;A7T D4,VD)L MXWS>)I#SKD E)I;V*5;YAL "/IU9GQNR9%05_[-J9YL.%'%0(F_GAR:N];( M,(9A,+JSDN94Y>GG;=,5E;2$ CD\]8] (U\3RR63;>D))(YE!8*(<5IEFO> M)ZI5ZVVT'RC3_0^(.\C[7%XF/B3K[^GV ?B1KGAHY)41@E*]O$IQ%G^%0532 M8^9SIPKB1N@_OS8$6>040#JTU?R_GIE2-$@:2+M][2%!=P:3L\V:>1C/!C+: M0\I-'?YAXL1_-K2N.@SI(_; !X54O ]F'RRO?OKSX._9?!H<R^^%K*;)0TK_ M!V_\*=,(;YJ[X+7B\%9+R=E\*\.Z7$E@BI:*PGF40T_44GM9Q&?EF9FJP;0( MYLS;[ZO6K2]>;HPUQ;!^6JT.425X7#L?0C_49NUR<+W_>KN]^+),F-EA]66K M$CI$Y=GU&V-R%+-N#6)P(Z9ALI!A@T FGCHNEKX%=E%X-R82.'8/8&R5VLB4 MO+L']-)<]XUM13?4F'&%9(8<S8^Q3!CH))K*6WO8!8ZG;^],>8&J(CI(K:>% M'>M+),8)^VB&ZC+U>FS--&9?XTIYZMW+GY%0#A.PPG8D1F!FV*)*2#;YB:,Z M>K-!=B#)J;!';-7(01!Z2-H4W=PJ,,)>M@-]\#%1E12LW7:[L#I^7:WA;F)< MEG6+%*9=PL)UFM/$ ZP#;'RY,P.*EK^?.552T:LN);,%EY>3T1NQ7+1M;N*N MQ*EN5WIP_-O947=B&(.OD$+L^)MI@</ZI[^! >6[+.RU*<RVO/T\88>UO&>+ MJB<"Q4)/]!\]?.N\IU2'D,A*]TR3&(@1O"!M!Z(1N19UCF*<DNY#9V2^IYO6 M&;@Z#T%YW,^FE#"X!="7R=_IV-9LV16?8"/R5#@2X77\K<P^4*PI14M%?7+3 MTM^)0V@AN3HJ9'!K!DT0L.QAB+.\T; WQY]0K2Z&^O3-S=G,?DX\4&Z$1TY0 MQ4P/L3U\R=J[(,UT7CZB1 ,U[',E9\#"^])4BPH6X-F%>S0?ZE*\1UM]_]#K M5_(02'.]+D(+N<_,; 3@VBW'6+;,Y%#.!1LZ5(O@9A)=DX6U1:"O9?%!4M)M M08U6(B=%7V)YACA__(W1T\8AYN=3\E[REJ^QOL --T@*QQW>5]Q!;Z (Q)QY MOI6U]& 5+Q'I))1OT/RYEGM.YJ-3*/3)-G\"!_?43P%M<CT+(]'&^EHX50]G M*BF#BX&<V)+JX9U,*?C!CFQ*R$:;$*L"#)@_QD=Q#Z#\Y:C5UEJV3/^M-7PU M)ECAXVP<*39QJ8_4WU*B;36J:K%TR*/(0KURA-&U5G584I."@W&^X]$+5,6^ MN=/67_'F?NJ&HT<9Y.;\V7-<M9-WO- @W?E-)_Y7TX<V9DI&_6PIIQY;0Z2C MV:=]K_E^D'_W=CP>?F#,,_9?-'F4!8V0(N4>@ON_9FN'-<3U2FS85D1K;JBW M*Z?NL^.EN)9^CYF/<%9FSRJR_3D&[FI(,3AM=L,8_S073$/A*][GR,@F>3JH M\IV$8W^ :1Z<@SWK]JN 1TBT.+U>/7LUR94X_P^=1*R 5CR^,;$J<3\!(QE9 MCZT<+"B="^MK9Y%HNJ<Z=++0V7K>G+9,B_\B5_0W1_S( MR,A\M?("AG_W+? M _@S9T3TJY]ZL25&3AV_C^R #.6O)<J/H AZCPA0V<$XPDJC/9/\HU+H5(_. ME)>@R>H#N@Q-=G6=\29=7VV9?NUN.8IJEQMKJ,EX=X<]AM/OVXJ U-3*_ZH2 M?.-?&L#+;,11KQE_,6NO C^H\U#;H>!1\II*W\]O!=MIP?@'!AWUH=W=!R#Z M&R,74>AW#H["L:79.^W\2T63>T =3_\: *IGW#A[QX@UD?:D1R;NKYG,9 6H MRC%^;98Q2]8WX0I**.2,=V7DI"G+&WG?]!;2 +?(#&Y@\/3]F&%VHR%V#Y@" MP4?/QV/6F!S; <8K/1(5VRTO3=Y=SV7;U_C:_^[=C6$<57LWV.)*_V5?1-PD M=:W.)31P'"49R_ITM2/L'N 5>.G]^@W0C>+S^_BQWF'EI5"BOG^*M:A7J2&L M?_P)XBUK)(X#R0^)44:<O+N;^AU/A?]J\8DAOQ2K$&:<0Z$,T<IQ8PZCQ>!' M4(_-1SAZ@B\@X2CXY 6Q82SJZ3/2:$D1PE89>JNRA,$]LV2TQ&_/DMF,@*'5 M/WM'>ZX5(64:&0XS!A\65R!7S"SUF-AIS5JL6ZFQR\SY.-W^W+6G1QU*B?N% M5:*RI&3\ L6&LYIY_0C\R'B=\:#82]2M3"(KV8/)AW6W6(-KE&12)[[7U\C MP#E2?;S"3SL),])U'5MA5[2'IX-YD*P,"O>2H_L4 ^SD&$LV2EBSREJMSRXY MF(0&XM^-A2G+?J>(\%)'S$&6^N-MOKL-4'YG%5[!?X4/I=[\6*;5V'=;83BX M&6V6SHY-QJ0<('DBY8F+0.!I"$^?SYGQXUB5;96MSFG\C\0WW4O>(8.;_Q=; M;Q74AA>U_::%MA2'XJZEQ1V*EM*B!8H4"^X67(*[%2M0'$)Q)U@($H*[NSN4 MX@D42(M]_W?.G)GS?G-N]NVZV7O-\YOU[&<E.LH.Y,/.HE$W?1 6U&1"4\7" MOX'9SRDKDVH>[HN7)MSQ++T#5:1EZ8)G[_]V^*$R-NGN%'>/JV(">'XZ9F./ MOL+CROLPL:#1I)KK07G.\9X?_'74DMH$=LCX7(8"5FER_"#]#:3:UY98XN%) M<T+E\2KB(^EJ50-7Q.<W[-_>KD+T]51_S+CM+39ZWT$Q1D:(Q!DI%]7[G\*/ M@#A=FEY')/?"G_R7!K_1F+#C7LBKF G0"2/XZ<5>VWC+C^XP=B-K#:8]K\V7 MCP '%SR#8T.Q"*FWVPHS335R#\.VGD4'D/>N6']-+%+6TL9*<@@&%+@.7? # M)% 9$5:08"(P\--T20M[:?; P!N(EKKZ-5[Z 43-1?$9K/-'' @[Z$N?(YT* MMN5]+J$LKGINMKVD-USC>,]^<M%C6$IDAXCZ6(8-0EOOY?-475=6<(,6SZZ^ M'?#TU+4O:<=KD/Z9O5T0P6( 3^WG%=NH -FR0P_KTE88PA?V,C\UG3>&D*@* MWLR%6&RZE9:K'N_C>FL0M2RAA&"(?\<86NEAOYA^V#:KEY7F]\D[CO_?J]X@ MV,3O8=&]U;9#9T@;%!$P'8@O.NMU""OM0* 98R@F?\Z:S9XN, _(V -\:1<E M(^4XHN[XVW:.*<>KALO?CH$"?3S-D^(#ZN%GBTG7_@LG)DP9&F;9Q;)61MO. M1>XHL7HV:Z+;7H:KVEDV="QQ(_/O(7>BJ6\K AJV@3R5=U>L:B=6^M#HNX,6 MN/_'/!2-74 RZ^Y/[N<:4W,7QO9.+[+*0>]VO49FQO$I"3+"WC9N*,UW:G&" MG;96+U856G:?LC,.Z8YFL14F,QRS)'C>)F%N$/:9;C'%NK(E;"GR+M3VSC/K ME%4:G$2'6N.EA[-T&N;820]K7/G[VL!#;_OT: U82&(*S@_&\IW\<ZFP:1LC MB:(CA^&BB45FT]&4K;NZCPJ"+[MXEV2] A64*DQ[Z];X*>%ZV7%\').N]?FW M-D6,$ =D4_Y2VW[D'BFCY)<TD"U\(F Z3-?TYCNAQHVZ).YJPNL,VF^#-/$' M95B=LVL+KHB_:6J@&QK5-3C?EZAYBU@6 [8HYAGQ]U@,N;B7FP)WUNA86@TT M;CXA1N(=4V==!)>00RIGVB4C/.TEA]V!X%,'1LH[YX<Q%+*J B/9^R\CD0T6 M4X-H#C+NR!OOEM02/_@>RC>F\-D\!'"IAM+X#S"!&#7/]MMUCI[D(R+VZSHD MO2[D[.@HR-:E:>0G,UMRJR5/"']OS3N1=YR!%%"7M-G%R3T/E=F4N"O_@$XH M$TH],8@/'*R*]HGEH]E5SZ=)S-MNB;F5KL#_K+5V S&/=!(E(5K74CCJPK06 MC#+V3X88%AUE%Q=JO/*5-4OW$@VG 4U?/GTV\0AP#P1#S<-[:!BRBE8/K]L^ M%8MZ>Q^[8-M3_67]M%))9 *@5_/EZU<3Y9)E?)@\?0D1D>%F';%?WGT$? <M M,I&Z!J55&T$K)>B31#$5VQU:E]>)B^>GVRGZI]:)RE9*M=2%L368L4+Z\C*" M"_/0[ONCO=-_-]LN=ZE\.(^ )9;9_TF2==LD06)C)'7KT13M,OFN;4W=T+VV MJ'_@Y;U$ 1C0,<1RS"&@\<+*EOIU.V-DF4\O(T[J(^!]W/_\8IJ1^[^]3L#K M3!3TCGT3IG=RY31)(V^5_:MT1_]FP)"*V>Z&<$M)LSXYKP5JCU%\!# R2#T" MZB''CX!/O2;O;K\<%:E@ME&G XU$T;5LJ,YO6ILZ+0.C]C*3SA^CI3-HD2$+ M7K3QM/+2CMOGT6<(R:UU5@WD?+X19(:85\2^KO1,.V5F]R=V:H@$/NY,V\*\ MW"WW:U#9N;?,W^IQ0=KPGX>B-]P9I/WVN'FY"F/$UE&2KU+S_:8:DZ]3ZBNW M3GL99/%U=6;<=*=?MK^R?W"Y"S >(T??J-I2%Z(C<@)2BBL.J"4#'V!TG!1F M/48"1Y5%+HL0>V?GW6@N[O9,=\M8H<6%<I)]&HT8IP!&M,\.U8(7U9^F.=89 M*.@7XJ_N5XKS5]@6,J!2@>\2S@<UGL&HQFJ^6IQI#@3Z\U'P_"%%C>#/*T'1 MI;E[D_9/B,S0_9=/M\R+Q;'FGI%K@IR=?[F(;L_'=N,J8JVB*H+>CTT^Q_1J MH).B=^::EDM%S]GJE>F2?8FPR_NM8G=EW=)"L8.D]FCF LT1W^OK<85ZGBJ\ MZ/2[-%W^1\5W1QD88/W46!4XYV(#HQ(T;%\3OV";9/F(*_94(O\SS=5;GIH9 M.A9%4J@OG:V(AH47/<B3M]EYC99^0D#S*#FX#VF1 &MHI?L>9+Z0V7S2U>3Q M9,(U\_BJW'FOM7EVCX]6L,*TS3T(59SSB88=0DVW]EPJKT2/%5URF:PIM\7' MR"=;HWA?P2(DG'Z2)0Y(= !#F5,YV+SQDCH> 0N5;99Z==S?7+?V7%].^(JH M#_;1B%RW>A0#CYI?.5)4UGA8TO=0;VM/YSU9*Z(?*AMF+Q+BMR85TRH^^%/- M0]D=1#-UIUR%J1U4:FQ",Q10B$@;LX[-5#L(I/BYOOALB_6N7SBU9=98W6,[ M,CZ8&!:7%-M6K:EZG2\XV?MEI #96U8<X3N:W <G+%4PG]CD\:?K1<_NZ$4A M:#FBA1-\NO4V9#,,6SS#U6:;EL[W8G4(9C)S..AVF?PNC2A[-^,8Z#')51V= MW02Z.Y(M9?8B-8SZ<(_20[00_6RF,F&*I%7AAVW]J#4R#Y/M;3[<98R.T=JP MR$)9K:DY]"INS/=&_+8J<IO5)(YF6V\M1>T10&CR;S[@VP*?CINA1D*JX:44 MT7;G<_W?HH=8J[5I.X5M?AU('!?.?G*(?@Q'Z?2D>&VP+D;5_49V6988*GRJ MMUVV3,X<IP%/4H_J>;\D>DFQR?6A*Z&!NPJ.S;]'\P<:FPJV^YU^G7V=\PAX MB0W7^NL7E(P;W=;2@B4>SD:U1/@Y] ?37AVY:1>2?,$<A2PIQ?1<$%@L_,VR MF'%A/-VTAEGA@DKR0L2D+\8ZT.E8'"\''OX8Y[L[!P06W_&D7BNCM3"C7<CG M;0LNPO<*@2_Z_)P,#W% 9R7RUH+<L=]QP*BN'T.@+L;,P'EL/8&5?NXAE%&3 M?PG<]A+?69&KQ=4[-SZ14,B$"&W;[?J[OGM[U.#D3K;(Q-YB8%%G3H1HO>'C M;<J$J4!XT4"_"5Y\\\!:M4!W+QH^<,YXA&28O9,N/LXF"I-RQ%-:A#\P]<@' M)#^3;0-!Z7A]N,13X\4%&M_BB\5#F&L#&;T? =+_O'\[=/JR%9\&5=] Z<$N M'S%)6[=00DS#AFH'"^I-^CQ["C/S"Z:G$:\F""7<)AR'3H*M-G$Q?'+1"JB# MZ!,IC6W/'Y.\H5 D+X4%_RS0I!P_4>%)PH/Z<VJN101IA@0\PE-RW%)_UNOT MZZEFV5Q3K.S402JCD/QPSX-(:35K"PM_4F@[R^>(.TSY+WOW37G)]O^.86%C MT5F-%F/)'@:N.1FZXV&\D0#)'3PW+W.)"EF)3ZQW(T]S8=5%K>9&![VR,1M< MJ,W0R1B8*6##P=OD]5SM52N,Y_7A9WNR"6QUDH%];1KFWM.NP3''51@?@=V& M! KA)]I9M'I,8SS3?.O?<O/:O=<=4ND:A&*Z780$R"7U_7<K9!C6\U[TN:EN M^X-W(YJ+1]H@6: 6+CQE=8KM'FO+1".9TQ9OIK<#_)K*/-R41^.FQ$$S,D]0 M@=7/ T&\9[_>3RTM6?A2[;UY-I>Y0\U$D3:O^$Y*CZL\@ ?=V=]:#3LGIM4@ M."9&I-K?2 157&?^Z4_VMK;\)@+,DFK0:;H0I!^/Z/=C['T$D(")5.O@TU*R M/*6Q2';991]T#M?"T+!@/[\!FT>*00Y;BKMO#2-%@.QTP,?FRTT#(SF?)^L@ M'TL/GA_H5_%I=EGJA.^&954B2EM=;)T[]Z0E&(30+[:Y[L2FSOB:Z DG=>;. M(D2+^B&N\/F37RF?8G'9S(D_BKUYB?=:X(:VQK>L5Q(83&NLL24MO\,^$%OL ML/AJX_<&+0'(E7O9RJME]O6KJL^-U?D=SXRL*' 4QA81=YKP!1?8.=$A#6\G M?;6$_2,@(EH_6JO><2D2P2C\;$1P.#T-_)6M3D%<O/LRYNZ<UM1QY2#JCK(, M$]V;@5I;'[>L@A5?&CIH<9)E@39? 5E/;:VXE6TFYO;FM4%LV8Z+IH.:0I8[ M7Q=*4(^ ;B&,O"::H:.DM,1AQ8H O][!;1*/6=<KY???J>^M:_29?A2US]7T M#Q\H6M$V)>63;I6K'[[KM\2JYY&9D[#"E7_%#EQD<C\7$^""$#C];M.+^I,G M'QP#.W^%<>GSIK7Y;N24/ZKWQ'OPXC.V+1.(0_9-53")#,WO!Z:66"G-6G#C M((2J)5D?XWZLX1_G_C7H&H3(*X-(C?>NQ.IH.@CZ/\CDX/Y;&QSON:- OR[S M8.PU]NU&ADF+_AJA%6(=&*<)F:I/U+,QBE<0RP4X1/<8^W=+!/]'R'B]]LZ+ MLM8:38'Y R_)S[.:7C(H':2\5IR0,\)GD-2SW<X/1^*A?N5ZCK_J6=%-VXMZ MF$B9E8>G7,^)C8?=/!G^3JH +'U_FMV'IHSP/(\QH5V0PJ/LO3TG!6>!(IY> M]J4L*V6;O;O8L/\YTL4Z;!WYWF/9+=7$"_\3G97U*,&[ZK-V:9.,CLXRT"?. M+^D)U,@WF)K_2K;1W< ?6-&>/*S5W@OP%81$1CXS&W:BVD7E(Z!KB9 KM![3 MOVL:)T.*ID@J!'L,FDA-\]7LP=HRM&&SH)]AHK])C6/8W0F]MW;MCA<Z\+9< M3L2VB:)Y7*"88S4XFC$6M)0)<I%*-B>44/D^F&8C[<%L(?VD)BE^13VGP%&& MH''J[ED1CI1JA;*C5ZU)]YO9/]]9N1,D^A3_#= ^D=23UI S:6;6+..@$_8] M>WB]YGV2&ISU^P/$F,%N0JOC3XJQ)# /N/ (8-U2'94E#N";/A?Y[?2?_F(. MTZG7-PX'5O>'7E++O6S]^G)Y0B6I)C!_2Q=-V7LJJXA$;Y15'5.F*/Q:-7J8 M#N/J2L@@Z4/J-+ 0]T9FOLK/='UFJX]9PR3#7+"/-PF%CV^0<V=2'(5'2,9Z M'7A+/+"QHT_#W0/7><192V&+7\T(XW.K=MS\\&X128O)/?);O\ZH*DVR=2M; MDB^#+D^!Q$@O=)Z$J3KWWK53<I!'<9'$#7R%O&XPNK!'?J5WJO[ATF#LTMXN MV?AY^A=IO#F#OL*UH<FY]PD\R- .OGX-A[#-2_'M DV)Y;:AM Z'OD]78YLZ M!$2JDJFX ^#9RF+R).LMU9H5EC>Y6[BG4CXR>3L\O#._-C4ZZQ;_&.A>#SP" M3&:S)\8BF49M>?HR33FMUR)(%5R7)!V'2N\+2U ;&;M<G43ZF"KCN3^>S>EO MKO["#=<_WOR:D6-,B=',P!\$H)M2%WYB*M 9&CF*'YK]=I0)R[QPONV^;YA/ M^R@TB*>!I]2)B,B2(\01USU(]&6F^TAG<7^6")2]>[X@XW?7?'P?$'\,?=Z9 M$&!0<SP-#M9 :Z\=^E#Z/<311R@'DUT,C3K]\Y2L?],<9WYIR<V!_P@0 %5* M<VR9]JXZYF-M8&9[:7@SMO!<*):!RA09!-],V)R*_V8(L39W2^5"TSLYGQEW M9])Y07A1$,3&*WCZC2ZJM,2C)$F$#Y8@J JNZ6*4K.H5;&*E]V[F?S<.?@2$ M(?!V]4^N[C5Z;A*VCX%Q:1W3)]4B]B<GUNE?GQ]9-[<EFJXKO7?[Q=EJZXZ# M37-4QO9S5K?]$1 :R"OK< K2,%Q\!-AV C#)3J0'*D"#/W_5QO.7T>PEB&K^ M\6ME+.#691K."RFS2X/IP]-M1KI//QT8GJ/4H8Z!SBGV?H4%LYU-;-C1S2O' MW*J"\?QJO>[U7#=*U!)\\3("&%NY[-M^$RP8.N MDW[-'5=E+!\2"51(;I$. MNDB>2C6DS&]"1MZ'\\#C K!V.O#4+6-KO#J)J'>H]BA(LIXP)"0V':[@913. M0H];TE0;YPK0'1GAVR1'#R1S =16CP"V#%5;_'0[17N&Y1RS/[9?D#LPU@7$ MN]J/<%&_C1POVH11-K%DB=TY\ZJ1(.R[(%10J^^NYPQ"WC7@;:F180X1?'6= M=<4%OBGU+@TK0H_ZJW/(=_%^;PG"@BV-! +QV?Q>FK26OV>@DWY8_S'6BM/3 M::RUP+-ENMDT)>,!">3FP=(,KZ#+UX+ZK?P8" 4Z<KX_*2K@:PDXZFS-QLYS M=:F602#7.BS%#2)T;!SWD38J[880\<1(+Q9)C#&Y59Z?R-AF) ZZE&D*((\ M_SFY61A'?#3>_7(K;X;RZ-=!G<?52F%M2].JHTV2:E?8(XMU%VG&QK+C/R4_ MS;)*H; %?%?_]?Y%@.[-B6C1U D,3]0&MBSD+(3OW$U/H.?O'[F+)3-88[$6 MH(4RWEL89OSF&<7RQ7W1(=?L L^,Y(S ;GR7X,7)!AA-\</\X7_VAHG?W>@T MBB;S96(XIT7=A@;DR!5O7^-878+(_RP/OE:5JQ-K?(U;]^];G91FR:B-K;&> M1LJL<\ Y3'$_]$A?E LB2X%@&!NEZ+!]I]TT[(($7SY<O-7&T$QHQK>]-'8: MR;Y)A$&C/>@5^RQFOZ!B QN/FKTG\?^9<3\==J.VT8MF>Y[,KUUAW,HZI?<E M08?N+78\^3MLOR3#/:+XZJLX XI>Q7G$)W,602-5^])4K+=45O=HN==R3!$$ MAR:.V[*Q%)MX7GA0+./#E<)5!8+%*&>1 9H 4%GN\]"]S#-&6X_&2)LWTR@W M0RY]>Z6;O?X%W(2B4N\4Y3]/RQVRT_.+&N/N;2;55\3XV]L265Y QQ2X)BW1 M-G$UI"+G,=YOG=<]._%5612"EWWGJ(NI'L[3B4H<#OT&>T!\>-9\44YKC!W2 M"+?A?*V9<HO X7%IU2EH,>81\'E.9%SK4J5I#@'TK&U>D%W63>!FD:[4CUUU MXL0[X#;%*/ZL+LL^'C!YDRJ'R63LU=73<II%2+J(.GEY'6'#BQC\_ZT&G?BK MO(-^;,&D;=,"39M4=SIHAS7O)"+4,,_PE?\],4I*0G* _U/(W1+U^;T29;%_ M%*,)>9T22G+'U%D9O(;CK5J-!)]V;4'%JW?2A%<#UWO<==NGR6H+9X-8[TP; M9T[X>%,U,!Z<:OZ6#J62!GRE(3',[N(NKU]O[B>2M5EY0K7MC'UU5Z0%'7L? MGOWNI+S#V\[AD36:$:X!U5KZMX_&C7\U;X&W>>3S^;%%@7NV?8:P\WF5G=!' M% ^<:&R5X< MT"=;.EN-3EAK9$>O<'(=XSF3<$5_OPFP\[A!,,*S_<BS'7AR M<<:TKP'PUXN^LT(_S^ZDZ+3M(#I5O8?^IW"9VV_?Z/+L_=>AC&HOW$*$!CDX M8#J86#1PER)OQ]&8[R/&WK[L=W9NKWKS/-]5)EN[O;$/=0K5Z!N2PJ%^(&N( M\HE[P%>?YWEHRBV%!+YH&#V>M@L%;&QV/1_VNN 10+KZW>;6<-_*67%D5=\3 METSO0T*VB,/@W(;@_QL-\_)_HF%T@WLZ_[Z6(7X$U$GG/\2J3*$S[F+_G=^# M-1X!A2N-#_][+[%N1.8C .<1L+L[F'\MM![\N\6Q.]@ID,R1D5J&NG5FTQ0H M2X@IW&ZRNZ#]HNWXE.H)/=X+V72NC?\[93<E:"K;I*(B:*[S*?M,[<K+ZAJO MU2RS9Q_6^_>!51_V$Y_2;\?NW>7B+WB)1*2>WH/*&7K_8Q65V;M(ZX2:HA4V M-L':[I# KIV:[GK0=(E3&']Y.'L5;:^H ;X?K;)HWS3,158Q=S6)KG_/9TC MHXN*>D6:[(FAV]J@[;.Y13YZA&N4+W7NLP3 ,'N2W!HD+?==+J7HKG_DSJ3$ MPRG-LN30JD>20W&GS6S-+X@]*:TXV3![WQFY#F'U&!AK+7N_<UNJ YURBC)) M]XJS>01DSA^+(-.1OS&;;G]B51X!S9SC23TM+LZDM_WPFIVJH4QE.C$WG!.> M)4\!PZ=ZK(TJ5L%NGR*4.LFEI .I F6 X^JDP;MGDRKM+1%)U\8LG)M?E"KA M$)GV%HLVO@B1&K7.@^:?<:7=5SP"1$DW7Q9-A:1[\LZ^*N(6,1'U5 Q3;R=N M$'UF'$GKNCS'O+_3JP(7KO:A3>UD7LW1WOCD+S?/FM#^CNE*W&K\" T/JR43 MW 5L??<S$'X$4!XN;5IOGX*># %]R^JR.I^3U@9OO==3LT%Z8*_#:&NE)1>B M5W["+8@IG+SWLF=5N4*'NVL=%BIU#[HEYK1V0VT];"7@TV.CH5>:RA7@5$-C MZ5X,H[9FVL3ZA_')#?K@ *X*RE'6[Q7<#3[Z4_D+50[Y#H[4@O5]K49AMSGG M1.K/F#.%'$Q$Y_??FA<<!M&$RXHLU'M=#W=N\;__<'!_&(S;85UZG'Y#"P.9 M:G0V<?8.PV9I-A2<!WVS,->K0'>V#=?72FE"7=T#P346F,7>5^#V[B"V:;-V M47AV<YZ;)?G2LX!T\#)9/%UHZJ1PE <)9E9CKM0>(6M9 <[EHLK>_1Q)4"F1 M2_9*:9B:">7=:$E5%:V!UHA-'7$<0E"7BOW;-A=<=W#W?ZET\9/AB,WE0X?# M8J^TUNH (V&39"9(MI$-WDQ!24&R'=3O]N*L-!PK%#9=?QJ^T<8E^8YG&7$U M\O:OFF1-M1KL+=BTQX\CK*GSY/Z%.KPAHMY[=71DS'U&F7E4Z429/3-%>6^A M-5Z96=:GV3_;M24VQ_X%]>"8>-GP?F52FMQQSZ_T2 9-=-@#7Y3$>'[_RS.G ME5Z569L9:#5?*3&B;I1%B69ZDB%H#VM4]OCY<[FG_[TP0( *:K/O'!_HB'PU M_W-!N#7D_L^[9[34;XY\]>AQ(1$TOX+$#Z\A;--WTML\*C,O9A!J5;PY'EY> MN,/7=G<5[#*&=<S6@1!#&1FMO<3WM3?O46?YVSRXO1^GN7_.>N;)/(/#&D)% MBP7*>\H'K_:N1$S.^3+/:GZ9W\ECK+=-OV5_E'")NY.TW,&C6LX61L37QZ1U M6YE':2G2D9@\0[=W>?^C*$#=J@DY<($<\5?8LN^FHJ)VU5KD7RR=6\<_)3?J MGAR]2.GUX,*Z$G(Q\6[(__KNGBL! ]]2#N*X$T$S1C(O. M3B\0I-$E$\$># M0YGVWC(Q9!Y)7)$9#/>;?N2U<37%D<$*>(,)MI2)M-P:56,U M"V2]M'SO=Z M=']3_&L5 TF@8CP%@&OC^E88PYL2O ??STH1%1PS,+6%UB[TGM1__+Y:]4QH MDEE[?[ =5]S&\GNEJ]+?XRXDUF( WR[7)@YFM'^#'9.V$TBX(:U T-;>7R[G MW/4(*#YLB'_A1+0!5&Z6"Y%+5GH!Q7@48XJZ9>DI^S(8I-7\MR?CS"+-D>G3 M!^F_] <SR"@%D6I5513OUBJ![A&Z;%_;YU+=TY&!J@MJK;(8#ENB7MI3F<U; M"T8*^WRB\8K+XD"*Z<C"<H\?N6IB&2S)@VO:4PFE-6!6M8S_R(%R;_',RVVG MD]#.T$+1TN?Z6=BP%S4[]PP0__LYG0K9:/I@YM/DJ$G0K@9V9_P=+4$:8GKE MB,+'[4B4Q[7])Z6FDH'4WH/X\'8T4I%)^S^*,4#H'2Q-'M@]L,S^(%!5;&$N M@W,4%?Q&=4JRF?Y(%#?3L9*;=DRGD%BO AZM!#97.+8\B[IXEJ7NE\O/BJ[E M&(#@HQ;#[SBJCK.M:\[B/,H,ASUK"HY(5]]QMF*965)3#_@P4TV2+SE0XM3% MX\=,;*A[_.F^MW=M*\WAR46[?#M['3OE.DE-94WG\X(Q04/SCXP=QG1+-DZ6 M2,IWI^/I^6 R&'YZ?0UAFN>=_U1;Q):29:G/8^.*QN[SY8&!N[1RLZ]X9/O: MB,)K17#.I(1V> BO=U\9#5<")P-YBSAYB:770/RN$IR4 (\0KF2,?R!1:(#Y M]NCJJ5IBJE?1T3^IFW\1)9UNI49-Z9?M#)FQI=I'E"*_O1VA 0JS^XBP?\$O MP<Z'']._)8=6K \H?+P0>LHSW\(9ZA,ZS*G^O#$UM?WYZCSDTQ9C+",J'ART M;3;C1>#?WW:UO[\G89(!@NTG$YK(REC4,W_B5,DBH@MQ+)F^2HJ7F(P*6JRX MDYZ6XI&*Z3+<!,</>TXV[=JFXE7[BO_-:I"N)"(+P&\W5I\Y[I7XT:RULH&' M6=A12"=OPU6$M'2SA8T<#?["[Q4AB@SB 4?U?IIG1^OFRU24+FVJE1IMV*,+ M[&QCP]K)M<3Z+]\.4=.%B5>7D0LO!HMVLA"81B(II\X"!.C3:JO R89#ZM"? M/88C_K[Y602S+HZQ!K$<8X)I;D-#4-4Z^.P=3]E@Z>^%YFL_!^LB&"R&S1%2 M':A\IL$QMYAWIZQ*A1!QV5$U5IA47?ASDQ@HIO^CX6]R%/YU0P-^DV YIQX^ MI61]LN$&*;JD++%)'$:K>>UM)G4OO:^;,OWWM=B*TF[]&8[TL33(W=E;S-2Z M56?;^GM2FM_>[>U7N[/^XB@.L\I>@JB!)\>AA]FU&ZS-J/L(^$KDF*@H<>U? M9QO/1&%3K;U0$S^D>"OZ$?"M; K!SR@OT,?'>Y5G.%5\ 113K&_^CL4)@7@ MOFDHB),Y/U^,#S GBJ !?1 OG7-F$[W63?=N(35:4]EGC?0(35%W5P=@7U=W M1HCI31]MDG+,UQ3"%S?[GJZ8@R35DQ7I\SK3O^WK?!<3,[])T$U9H.<;-'1R MK:W9E25>ZEI,IUB)0 -7EEB=8VL//&,_P+GC+MHO5O4J7FZ?X@T82D^T>@]O MCR:8 N> 7UI;E,\^OA%E<QM(SNSN*7805%<>WOUI(?W\Z.@"'"*H;N4,QN*X MJK!L3)_9H/C>+IR')392-!7B*UY-:\PWL#@R(A)(.-UXZ2L1T"#V:S9I_S/0 ME-AN4;!FH\P26BM&M;!YTE!!_YYY6>D/-M:Y0:>/9C:2=TKXG!9CJX/J6+*N M[XSH994+96F6T],^PM&EWDT$5QI^&B@K:5S&%/J_K#5N'JQ<95:JE3%I8&5< M5_$=PM?9VDI,*RM9I_>;D(Q[S:#$1BJ8D+M5L5N/33-M4,-]:IW^RXK_0_Q% MVM^0+X)^B78^;@CC]%W@<B$7JR2O,2I/VWZK[.?@9;DS/:O>5YY++]T].O2$ MOW: I W(DRW;[BY9JL$(1^>^WYO]RY-9+#I"H6RKF:BL$%VZ>*+#;YG#PQQF M*?O>BAE'_XPWNSO< KYN.WKEJ&?&G//8Y#6+:OR+]IY86JZSL.S3"D HOET] MI"&,W9Z,,6%,-4Q(4?(J>:7H7Y)JS],.T,E<5__SG5B>U*/5E^YKU?UKKG49 M(.VQ>"WH]8=4P[7"8=J*XU8-;$9Y(^Q. B\7'&-5_ZU@XO&RU<]"'H7KE:,@ M+@ /!KV%048?L<$ (;J[M*D'^C!UWBX=ZYM"^0<=S7PCTFJM9; G3V_^$LE MX[NK5K]+_,WM=R<*[!%EJ#%$DF"2MZ'4#GHKSAGEG,>&_B#$C'.AH^-HL'=D MET598XC.]6M$D3)FM1RL<$9K2OO[AD8I]6QCM4^?Z-\A,>_[*[OLK]1_F^=_ M!['+]A,X:B6IH/:38O\X$L?:5P =/BS<N#$*?3PHQ+IS>#]9R_G7!CIZ(_;O M:+@QJ?<FN'OMVEB+K46TBI.[Z@"_*D11W@#T\S>>IY4:D;K]/VJ9?H9@:=AN M=G"?L<=V<^["O[7L@48V,=J?]6A:>?*>Q/>Q(N1XV'\GY'Y4>6)#8$?(5^B\ MZ 2>G>R-E4LUA-?:/^>2)W!$TJ) ZM CP%[U+5W8)SU9A=-9$V3>P"\H*,YQ M*YA@W-69#;7PW68BH-><Q*76>^&B71$GUAJ\HQE*0_^3R$7E"]#.BGEQ:6O6 MY*L-(/3AV-5153J.*7E+=[11X,P@%BJ!&9H&>V^^1X])/0)ZA +8$2]S\R0" MY+UEOE6G/ )6.?]DT;PD*]A=)4O17]7 &D KLFF]54SX(=B0'%:B@4W239;7 MC:6&S<;9LKI<Y&3E%^]5YALS&K7.Z8.O?-?O&^9(N?DR0*T8;$'/>VZ*^E7' MKD8Y F'/48>(;%Q_GFF+BOEI$W/@BC,\A.M8;AJS0_W4P80&30%1-* 8=MYE M1''YI/[5)M(NC1KHY[@LA(6]>P0<5+M%!M\>4T.%T',4^21(3CLD/G+ZS(N> M2R&1\=7FILK@2<^O=VZVSL$'16<$O!OO<8H3/X$<.ZD0Y-MY%(\ @WD8;9Z8 M1GUL+:]UVVQM@?ZT@C)[(<#/II4Q8N/US)_ Y]>/ $,T^R\HU%'OTL%#\3[/ MG8%J[1>>9[R"DO[.2M'<F?0Q;L*("M[\^>RX[Q]DY2^/^7+H\;^[)/.LJ+L? M&QK:&P5M2-CL*2\?[SY05=+3W@;BLTJG5,2>"0G!/8A.Y#O+Y,W9)B(V'IP; M]L77?1,$\?PV^/"WEF;5"&W:1T3AP%<.%G6$XMG!\VW"556/=81,!DBRE9=& M8TFHH^:QJ&D3E0 N4 ^UA'$2F :I<@5F57.6>6:#5@&.NB\MXF5)7 _A\^ % M6/FZBC,)%I8?&;;(TI@XI()7MU@<](C7Z]&^5BDS,TKF6+>BQ_MKCP#P/==B M:<,"0J-()?O$S5Y9]',V*+['!T!7>S@2 @Q1GP?X06 [G61W<HS?9&0#\,+5 M%]C\@PDQ!34BDL_B]L0\[#V4J6QE^Y+C3ZD'LX7"OZ49.JX[*MS^A\E=\OO M3>TC6>K@H?S:1\!BQ"/@'T^5[/_>AVL''OU_0ELX_G]#6WXJQHJ=$A4%T*(I MXX37M97G^:PZT 1ST\-V]4XNZ>Q+[>NJR@]#5W2S#T+'E)H/,[+/SJJ%AUW. M>)N,?;7&RQ+74=,K*7CONIB\Z++_[E['WPKGDR*4\#Y8&W_XK4P%CJB.X'(/ M/[!Z8I0OYLGYA(W0XY 1IINTHV:ZX]-E@"!R<I'2*+7W2R\K[248X^]G_9@> M;^GQ/8I#:^@#.GHD\:UTR(VY_ZYDQ]3*[VSVQ'E 7(*#@<IM0#IF<E<'N!V' MR9,'7VJ'&S1(E4::)5!D%WO:R[&?43$$@S]@#7V^-&3 Q619[M;([/_!R/27 M&TCT5]C=@/;7#R_))S.XU<)DEYW,HYFRE]4,K7^$@U+*:!L01!/UVD>AM?NC M(O#ID],3IYVWCBY4B>*W+(GA;+-9>0UB(.U%%VV=SQ?C+4W/&B?'NCSO'/IL M-$GZVY\LN9@$&]*Z^YBULXP4X#6E+!U0[=U^->6A3GPAV[MY47X&HP@35BJR M3;U/*08H>F@95K>'#[O40=>__K!$7Y<Y5],W<QYE7R5%V\X,%' !XVZ+ZYIY MJ%=F6R2)O\L8G8IS8(G3*]7@I+/ONF$5+"$"A72D/I4N@ZL^M4W#N#0]S#TA M.M,%]/^(E_\:J%/Q[Q'C[.D]04%WOJ;=A'EV8I2O<H31[&4YYD%P.$I.2 V_ MAL1;P4P.%-J8Z&/;(7G]0=KT-)GS5!^W\(\6(7"37/Y+MD%U,2Z%P 4Z/A\A M 0DK3KS0B[12RBLT3[-R'0F\S*6!EANO*5N_Y1\>V, BE#%7W1.\Y?K$[,)Q M2GIP;]F)]6?GNYK,Z0!SO*>V@4\VOF%ZS76K[I9@85E*(S8UOKI'[L&AIEK! MAF_*VSGH%_' BNY1H_GQQ"W*7_-"X:R5Q7') %\& 2<4H_8GH$6_8-4:M*7 M<Q#;#]8&'7NY1?US0M$[A*$5^F'Z*H&KGWC8J_18-+O:37E?:<&#>Y3V:F55 MN7O0TD1UA^=9YW8 1MZFP*=6F3QR1*.4.S3_LP'E?J?'2*094DFOE_[OY[OY M!0=3_/.=11XIN>U3734^$Q@<J$"IU&!HVO/S]-L^>:C9R[5:PCVV7:8TOO=P MCV9D_ 6%!G_Y\"YCE#UJDFT!7=_UA?\50][PN=%!R)WGAE@] ICWKJG#12UW M^:A-?JSV.C4Q4\HY89$PQ>RYEF38"WGASZZ%4Z&Y(>P HE[AIB.*0$*^'>\\ M4"U&3]NQ'9B3=#*4K]DDZM%$26+4$W_(IA6,%>_JJLA&+,>2NKT8"P-./L4X MG&NUT23<+V2Y>$FON>(LV*2(!$32$2&$$A_RN!I:E+;C_Z9ON+HUCOB2IX6[ MZH3Y8M/I8:'4:IT")&O OO)&*V 7@_;I&G;"3O0IM=XWZ?4Q1Z:8RT< -UK; MN4=RE%[_\]8([E.W7!0G'YFC7C9?I%>-]N>9O46^ZM.]% *9M^0$?2$!Y<8Q M7ZF/^E!"^DC>^:9S/'L?B8V&F=7E#YI"E!,;EG4Z'S^-2C:2?_TBJ%SKSDCH M8"*!]DXH/WJ@:VM$U>;;NI8I+I0E9!\=;@C1G3^5Y!BJW+V)N'\@(\EV.':K MF?"_]E'SWU$,10!W$GR498@6$'(U:\8&1O*<1@BE[X/8[@-*O4QVF\Y@:YFH M$K1-_@YCI-_7@QAGX7UT;59 ?X!:H9V?/^<&\Q.U$^])5HLOSZUP589>O'_O M</T5 3[556R^^!KT]9,U -\,(/NS//OO4A6.$=:$3_GY546V5KY4X+I?D.&F M1E_SE1^#*6IQ,.%U/IW?RYQ^$[I0K([V5PPUQ5Q6U5IRKQET!G#K)4.&QG+U ME*OL5QC[%;X=J,VQU2W^J8X+5!G_K'?]K*UHX.AE0OVE(LL/)[^M1+R!S<;] MS40DDYV)6!TZO:/ ]#"V65IT8$?</%F>W_J2$K]@T'AUP*U?4* &O#!QBD^3 M7O,ZR8T]]W)Y*%LVMFF![H2-D=/33/YI_+>M\*B]+R4-D <]^-6] Y>WI+30 MH.Q2VYP,!1J13B,6PTM>4M<>B:CBL1 9.(AV&W/'3YBJ9[/E-'+G1WQ"-TQJ M+4(#!+8<#1#6.WAVBIG_/(*+##/8>&VPGS-53% ]&^0F(O^E%2" IDQ$<G2% M]R'I$=,_O[!-W6D7MSL*[1%,,KLW^&9A.?9MDST)<7=@3,B6'0B.;&N.VSDG M,+4C/93@5ABQ@> 4FI/55CX;-0]V;<'.3:E^LIL*O!49)Q^#W4FK[G>DC>7Y M;$L?Q 2Q!(B@B&*N5*M&I7EWZ#^H$<[\OH>LZR :$)=FPB=#3YRVA23*30Z. M<VJT5!/Z%"JHW+$3PG/UPNXX)=22!F*]-/%3'()>3WFKBJ#P.*XCA'PS^$'; MEO>S/;\K 79S_&OOH+9SO'PVM)9U0DZ!E>%VFAA=P79!ZWQX/XRNE0G.GI'4 MNX(XWN;6%;(SX9MFOU@^O=.H4@@82UNZ].V"2)QFZA48J?FS5%O,"I+D]2\Z M7 ]#&1>>EZ$&_\=;;%[Z" 9@J&:82N2FJYU4A(Y91EI;.07Q?IS[0PZ!<Q M\>)V%G4&1KS?#'SH4GBI/MCO&BTL_:DZM=?/G3]1[5M\PX:1RH8._W +"1G8 MYHM0.[MCQYP,Z9$)\]SK>9&*/\8L#^!YDX%!U=L/G'SKI,K,VF\9"G0(>]K. MHU=X#L+_Y&E)-CO>6^HA4[7F.& C[QO:*G%VM-Q)2$CD!4;-4N.WO&0\'"1U M_16V JHG!"&[SW,R1+M\V:'=M'F\NPIS3E<E<V?"O])UX LU <=*>T%15.%! M)XG\[GW> P[KM>7Y9+;(:2E-2_I2>.'G!OF*0[@SPSLJRS%XQI.IW3!"N=\^ MA%QS? :G//I 159G\?O=MY-0UI* VP)C<%6O#T2L$746Y^CCPU ].P:__*O5 M1T\6^Y$Y"K-F5?3\27.SJT.0N64A1KMTE",NB'VPW 'NAZQQJ91S<*[M<VMM M5/5T=$DCX\7Q)=PJ<EOS6RR@,E&6*K>Q>;<*8UG3Z(3O.*9AQ%RLP2L0)%PL M.^VZA,TQ.-"'YOV,%##94G]P)";D.V!-79E;>9R1&O')$50+UNY9/'4#%1P- MG!UHPQNCE \@"U3=N!_E\LQ]J;AR";I 0]AS+<U=G40)U6<U5JF]_W3+=L W M3:8.=7+7%EO;(2W)*:+=V*35"HK:>B*?D(BIZY7#!"LV7'8B+YP4D<G)L'@Y M)RM"_U\-4!D.L&X_".3YUV+N$>!#U=0PVU.'H_VF@B[P^4;<(/FPXR:)2+@P MQ<R*?1".?X\N)9I\S&UHBV3D4SOVUHUY^$IC!8/UT#KT)E%"<NF\&O'E.M\V MLJ9XMF;W?N7AQ->A \#]$N"?/9>J3!);VI%QHZZ2^>,IH3\IN+N6<["'@0L. MO_5.VZ',OF_-YL+,.$K&#'XE>3ORE%"0ZD$DW[$4LZKG5O0(<%RQUS+XD-)[ M;1<QS&(5KS1CB8LS0(85[_$E@R=M5L[Q""ZI;PNB"SJT2E6<>&_4;@C9G1O\ MFW8 5P/J*O;51::Q&1^SU#&'GA&X7F!NOJ &"ESL=VGU_Y3G6JQ<JF>,-;!Y M$>X1<=\<)+IES\^)G'+(UP?*G0<W>/ZE'<>:B/U>OY<Y%^;NM^V?NY-HH.VM M<OQO28;G1F*9+>7CWY%&,58.-EVOQ>RZ6'TO:8$)R5=&CX#((&8"O[.S3;4& M4""Q2Y+3%'"]\(^+X$MJG"]^_,=KA&7F 1YDLSE$F(]W:J(5[8[VCP"SK[BR M2%M;8B?I3"4-)]UI=95;TMV*C)U@$CL*[U<&QQZ&:Y1Q$Q*6?;80ZZ$O6KQW MR4,'+5 F#-<6O?MY_Q1X\3V-DX24QR37X8V>AZ+P>%YE94##T^_OUOS*AZ0= MI U)RC&[_1(W,0'2E;S1+D%.SL^JPZT1WXB?SG"Y?B%>72R7$MC2:P2+Z4^5 M-HENT$-H6YQ"M.FK?V8.R%SZL%V-.Q;KAE:K-V_V&7+$L=%(H:MIXL3^Z4:6 M/[M,$_VN/YC"( 1A,ZJ8-$(;*?;Q+1_WRK#,6L(;'3N8^D:FF@01TQ^/;PS( MZNPRO>V6:3>:[LPK[%"_44?9* G!U9&P3?V$"!^!X7"8N1E>.ZDKZY-P6UHE M\>J75Y-Q;;!,Y"RE?'U#XD?KQ@7N%1Z5:W[WVS1K@54APF_+4KE_ _,+]-IX M[=HR_L<#-TY0TP_)V3EE>=.<DPR>VI $ /8QTN_66W+OCP*3!JL2-(PR>J\A MK[)-7RGBCJQPKR0@?/#2!W:JY<D&U*_PQ0=??+/.'WAY,C)8 U;45=X#<-,X MYPD9U4^B2AG>O6C[W.=GD?D(H)!ZM>.H;XTV_4]YO%9US A; /G+I;^.,I&[ M*/O2(]1-35C::#25U ZM"H:4.O!P?3PJQJ3Z_P0V(=E0Z?5%GZ@90//9-5<- M3]WRAB]W%_=VVDSQP;V*:*^<#7L]MXWW2?7+EE:>+HH*3W[<?_+]U-F/MXDU MZE/^J=84W-E+2LZ_M&G N0&D,!/M=\\D+9-F5^MMS][U#$XRQ(=PSP5H;YV? M$JC<?$T7]W+!.Z)1&T*&?M]J4Z81?(:5CQA]F*I*^+BJI?O0GI3E-.F%J=BF M3:+"\)ZMJGJ% V'@*WK.H&F3KM5MV;/Z9[3W&0ZS*(UO/%(^V_0<?:)NOB0. M%,<"D='CV'ELL1W4=(+Y7K64O9W4OS"QGM=(HNF3@"L.#\?LS&:W,#DN%YIV M)&[N1<N@>+4C,$%C2R.V%F9*8F(0W$.YH]J<<@5B%;W^)_/S2V=NSIZ%1;[E MBV&J5'NL X<JFC\2P;%?UC"3 PS4*$D[E .2MO52A(]XW%,N\8U%-SR& RV< M"A)G!2AHE/@!A[D8KR9>>'&P((JV\NKG_MP#=_"Y@J4>Q--Y-"WG<BQ75[C- M>0J4)M<TJ=;#AWF5H<JW'Q\!@R 6R++UX&7UV]?G,@_MGM-7 E'PU.-[5LG^ MC3>/@ A;-<)ZV%F)%\=RTS$50'#=B%CEYXN0YWA"#.1RK\L#9*?.I)BWX_SI M%:XE3PT-K-N1;?#X0F4WKBPV9F79-S8K$JY%WP:1]@A--% I4'R<SH12>:!$ M&,28;@+N IHIO0MXYM--^UYSOJHIJ]C@8]1\)H1PP11=D^ \[;:/AY]XUU^7 M,GJ8I/*W5S=<.U4?\Z3"L9G"SP16@=GP;SUU2OQ*=GCC2/'K@>,B77K\2,V/ MKU_YO^XK?/[$5+X2*+>3EF>5/:!)DUG3,\K-P_1.GN4.6>Q"33YT9]@Y1]0/ M#1'E4 ![MMRI,$@KG@J0\]SG>$H5$$L.O$ S<%'=SKO<=4)=,!:UU=ZR))UV M]Y2J:)GZK;?"@097RDPI:RJQ% M\)"R?M&[CS1B =&;H?C_3GLG_[T <D[IS M:2A[*E ]!'4ZO+ZZ)#=Y2M['^7.HY6(^SHQ+16I&@3B%DA%T][]B2VIGB+(" MC%'R_9MD4L:[TJIR';"HF4EM9"1/&3+[>;:W/@:_O(<7YV^7Q=+*^ZU%:S36 M*4WP*3E*5/*T\$*6\#AY$C8*S61N(HB22LZ]\!4Y_+^G[A,/0F^"5U*W4):A M]PD[6(^ 1,.9]"YY-&NW!&RCHPRSVIUD291P0@[:D)RQA,]7^UA7U](]U7OQ M*_$S(\_@C4&D/=AE1R9OQX7T4[&J8X6]X6AU0V#2EP2!S+"L+TKQ(RK1"@?4 MNMAZAA8&IB[,.LY#XE 93"BJ\_,<;^V=7MGOEX$[M_Y>%P^CX&OM=6S9-P8_ M$E(BN2L/:KWA(^#=U)3&.]E2E?K?4#?ZW+&]?:JM2JNM&[;9_K$9A?,;,E3E M8#E4%'40!ZVY4]N^Y_T'3)#_C'Y6/'N8XN!]_+S W@-'-WUBBPGWM#X.*Z1K MH.ML:[%P:9Q@+Z67;MI(P^4!*6ZM"XX]1&!=Y%M^I2BI-IY:J2]S'A!W(PUI MV<_!3"[._$Q6%>P#^HRVUKD*/) [;"PI.I.U5_QV]2-2<6^H$M8]3N$?6_HM MF:)F=^JZ,!!44>8P(X_M)WT%R:3+ESCRUVWYCN_*JC;R\[99L;X2PH#Q+0*[ M+]S3S/VGEM+F,C)NVN(%AGGF)@ V3F^^\%<6O < GG.9K.HUM/A\F[G8N 9C MN.A&^C4* >RD7*5#M._ZX8]*M8'K9]>S!A]KF/YMU</^+*L^%W_3F+^@>Y. M+M\HC%[EYKV8H!IY4H14#OBC$P[QVM)WJ?76H937:TK8Y;4W#Q2BJ=7&,AFT MQH9':I0K%*.:]=D+-@E6GVPT61*Z*+YXI\;'7U5NHB#TCB1@4^7V1>-6U6&- M96XDTC%A0O8X6VRA#I84O<';AB;(B'N-?IW#4&7MR!XRRSJKOZSJPIW<SOHN M=6R-GCPB_$4Y5_@WL37%*M]8CPYBTL%]P-6P]#/W+W?JC0N667_H:8'H9P@M M!".H 9; 8Y4B^F;;.FV*'Q\WG=HH?+C6=L<G)L#E)YA/[R) %E]/:W OST,) M>?O9+\#IP[#GE 1;\<?(?!RZ?46JX=ICN9D_4$*,AO*L)T?T+</"Q!LG0]&U MA@]D3JZ]Y\Z,HOXI:O3<0JS;&A$P1IS?8C,.IWB.ALT%'A4;5$#?=;:(0>I4 MK. ,AC[ZJ#5"+MA:?8\8<B$575W2 2S[<$;^Y3G7VFV014:_S)O9 .:?R(K* M=CRK%/%DIOA1MH:A;=9OPIKIWA8 K$5TL9!8/P0KKH\R?:4C\J2-Z!N(1<#P M6'2$'H$X&(8(74R^E+9TSM.I^(4X[MN$B8:BH,:P_U!$WVH:8>D=<KB0+M!T MG8TT8J&USWFB*M"MK/*C>Y@3B^%H%X@N;4DB3-I>DI*"#EXGQ3B3;/!KL(/, M>%I"IZ1BA!9:&&GOI*=MT(NAGE5)0OU(P;9YUGD^$0(#+7OF63-":\FG)V'/ MO1/(272$^"=V7E;J'LEJ-\[QW)GN*H.V6IOSN_WXTDU^[4P\4#N?>234R[/8 M#G^V:@HG!./!TVN+>@W_*PWBI>=3;(B:F5@2'7K%]E29NR\WW:(OI2]%F2W% MD1I)^GL!_P+C%RC??5F__@@@E4PEP_Z78TOP\A& Y.(],$$3A4$+99BU=WC( MZ&KAQ?HM+7#Q0P]'AI.*@YMZ5]E8RAIF6E-B*5J/G5/"E965?<]QA8%_FU\; M$&#$4.08Z0LY-M]G15(5@/#P[^Z<"!.91<]EJ3R/'HD(;<Y+T3#T$<7YT>B( M2M'28'[-5]/8E1<Q8OE$PQZ[M.6KCH:_Z\^)X2^<9M[I[S@%XS7 I=^H\E$[ M^N#K+JJBJH&R^XB:"B,SR%&4^']JOVLEE-S+)>&!=-I<Z4KRN(;AX?"N2E5- M4:,%WM*6G$0B1ZN8]9^4=1.T;WY@0BNTNA8.=L_*49D57(U_X#+ N?DFP,5W MA_=BZ>NM1N0_KY/4T1WE7VC0_IB:"W=VDT"F1<1W0W&S+Z3\??AUH[GX]5W5 M]+)]4W?T<^II-2;C;MOV,6IB)BTVWO46KLWPI"6K4+K!,/Y:>8 ^EK9J&SKL M$(TC#"5:5K"RMF>;LTW>8TX:>;KZT-IO.)<S6.,BM>!G&U$XCT@EHQ336_Q$ M!OG00AS6*_V>M<:X#C@Z*NE27[V-8X$73X3P<_NWD$PY)5&=7G[!V$8R'W-3 M;B\]93*8 8Y3G@NP+%U21 MIS)U;R@K]9B">*<W>H":+/T=09X5*XU(U2'Q+ M'4@!]VY#PMD/0O^<N@R4=^%(<57+'UB966N=Y@0PX:/Y,B7-]"H4;CYGY64O M53P"(.$7.WDB"U8DC>>[*:U8AUI%/-+G&/:WGO5_0]%ZUXD+4(3<=H=&EZ%W M_1;P_KD!Y->@-BQJR_[F;6M FM,O?1WA@J]33J3\+^P!_I0GT%L+<-(N0Y,4 M.W3=OBVJRM>1J]?+JV%.F4H3R9&$E_&W#C<U&2)D$GZK&#2!I,5,HQ5[:;R^ M->= UTG\=["L26/V9LD7/3,X*E(^(#\'KGJD]M#8)G7:IF/DB6*DU% G=FTN MT1PZJ0;3SL*?V@4,!L@H8HV_P=.?>'19E+X7]+;\?:PWBJS U;&7M5M$[%T' MZ1[N/0+D%ZJTL>O0D50R_@ZKRW^!9=#-G[_N\Q_8,3Y]&Z)SB'?5]MYBA@OM M]A7Z+ H[:A(S;,3#=HDZ,7=##3XLN0P_4[,'T-%=LG'!J(Q'0(]UV?%"&VP] M:]KY]:PS+Q7L3SJ/T$@^9[6-\L=0>4 1*P?YYB/ G/<_<]@_NZ)N:\+")]$ MU:?@R#!I]83O)5.[_F J"^]D+KGGQ(>8R^P5U/G \6X@;\Y.$@'5KWCNJ2,& M<E\16M_4%WS7WA];/UOFK[?079J07]DF6?9YTEM>AT$D;[MKUS8QUII_EJYB M3];9E!]F#^Y+3G7Y1#3-S1T,Y F&!D,O%TL#>*:#6!TT#_4,H7WWLOTTUBE& MJQ.>.PL7RJX<]BR^&ND^C.SI')$]R4W\[]Y!S6>DM+>A9/9PB8V\'2[)8SRI MFK&>/9:54VKS-Q;X'PD+NE@0HQK35X\ <O"J$?H@HM9\QG-TR*P1WC3'DRD' MC8&_\GW+*&7\T4WI9TI<NIY6BQY)7MF="&9$6.QA!E-D+YSJ( 'JD4:H9=98 M8)NL5@@<O IH5Y?1AJ3-87RV"6$<H9ZO=OA(1<[[C'G8E!"FM@R+KC-";.X* M72\M5C2-Z<S2N/F7'.:3=D2B\JW99-CK.E U1Z?L7CC9JC;28SX"X;3,5^P: M4N6EX+C=_+ [L9+!\LX8X=N.D[IN>WM?,OBKUMORJA9._$? *V( =JK&3Z'! MI@X7W6G/)C1E=/79G[A6WOWH?@E0M:H;R%R*@*DMF265W7VTQ6PK6FM-SW)[ M$_=8A@<&,:99N%2L7TAY![W3JS1Y"5/%-(=5$1M%&I>%7A3NG9I<Q;K)1L&. MS\F/-YB1R/#W<Y;*5]*4O5\F>7*3"]/L^9PC'*C2 ++I0_&53S;C%ZU+ DRB M!Q:;_[V(:!J</</'O3[<$4E52MA:O6CB;\BR^5*$H<1*_$2)]:*[K;9BZUHC MVL\FV4)*OL1WD;*M>IJL\9;KG2B<I\YZ/\N]Y,DSP[<OQ0?\QR7EY[UP%F]M MKHD3<_;UF;?O%\=X0J^H*]N">VMT-2@/D:QS"$4[^/70PKE]T6$)2VM(6$"% MB3)UWE>DJRMNG7@7&P/$A449(D;DP;P'+7L$&+96EO#T^SNX!C&A&.)VLDC? M@=1&@.D"4B5[ W[?NZK>;@4ND)OVR= @LR=PN)VO"!C.5J3K3>Q?%8<.4B?T M=>VK/W<G%,C-/K["J]@02?!>J4P1W<-/,N-$+*H/]Q:'4_7F_A^^WBHH#C:( M%IP$]T!P=Q(TN T00K 0)+@37 8)/L#@P1T")! @! @Z$&08'(*[,[@.[H,. MOO^]NU5;=_?6??@>^^6KTUWGG.[J#@0S*'H 9:39TZ%H?Y\;*MJDP.$?AT#% M$H=ZX\!"1/7HNF)WUC3IDB(KDA W8HK]CC! GSV8P.#?+*5QO!2O+,M,?KHK MV9*3MHD)^US7@&LBC?65^<^4K LB?H1!HG14JF@LOQKKU>TUU Z<GV#:.TO$ MC'08HK]-!1GJN'^8# ;_K!I'M9.",H/P4.GP;CXUE9;8T0"WORL+-*0KXQG] M7P;2OV@(]P,(9_.=Y$A%7'2ZQ."43? YOI.P_FO?4"@6K&V-4>G\^>$8=^$E MNS6B^I'5 74@94HK5OHZV4GH\.:+.::6:7_(#B&N%MZNH0&=)9+(8FVY9SD7 MYFF[ >:_UG2=]0T0('PEH4#;J3R(N_G3NLB@U2A 8DCW\N(0Z@)Y @C]OG'A M3%)$89>NMQ,[0"L5W!V#UT$-D3E^Q#\/OM2\QM+Z]<[WS9)NZ #1/L]7M.+: MLJ=BZ^Q)W1, G>H('Z'73P:GSAR[:N,FL_+K(6VUL=^R(U$%VFT3C[SW,LW- MTRSP4ZS"ET6C/U%+"K@M/X(^&PKQ&WS!*)88!8G_,Q><J)-NO'A6I>I9H&XU MJ[_0F^AJTRAT/#?!Z[:=D4SZ\]6"%)+BT\,R4IWOJEWS_ S'CZ=VRN4>PY,D MAA7%6%VN -T?/'"S9&BM2L'.)IYJ_*SD([UT-OFRX;0 8%4O&?&-;")90T_9 M8A;J(06\S7(H]W8I18<;>:?G+HO*L.B?L*@0;&&&M /O%U49#M24$<!/OH7J M8O#UN<E',=F/W.U6J;9]6.E_OKWF>JB4GO1NK+PQ3US@? )@^:)I3$K'':][ M>]_M3CK?#5-?,J:/JR!6."9=76S,3I??3ZC2!9.EA)LJ57/6NA%MS.]N^&'* MVJA<8UVW+1U)RS-[T0"V:^[QD".NQ[V'3E=:NU3)82],]ZY3>*U=Y2VY_]Q[ MIA93'_,(5"AQ:SC..QQGK2)ZE*Z;I'@"Y90F<6E7(@IO2A9?:C^.1=F@=X<7 M@PS82IP]?[J;^%]'75C0.$1]F.&E1&JD?"E_6<?')(DM'E^N%(B?8CKV];(4 MJ&KIZ^V&3,#IX9Y;R9*I<$@.(R%N\_JZ\U#A52(B1^041)$F"([3FF%-3D7X MAT1B:FD$>UA'._==:RC+E&V]UFGQ\TN]>*P[5[W]=F/;%I5E#K9#KIDW>E,6 M%R=1@4W,F]0"!'TA6&OI6M\'TD.Z6US.A7+(,T;5_8J//J&FM&&GO!8D$QQ- M4K!NWQ00U8IN9L95M= 'Y@SZ]6TR3/DW5A6_X%Q54_;K@;GM7_H,TK0::SV, M\J=%C=P,4SV_&MRP,NXW]M$\;ZGJSL,YEF5$!XY%PX*)#E;(8<VO'7*YIN+K M,Y('.D^8*>&?NU][N?&&-,Z;U?%H7XUG<!)-MI6ZL=])RYKYUTW F.QIJ[TS M1:0*#Q<N9R_YP"17#?7H:NQ,JJB+J+_MJ1@,O3DRWV:IJI>4"D9-P-;='MV% M(0Q%&HV+L1<JL]VTA=CJFN]0$1?:SZ&T^PA]0YT]3&%^V8@!1MBFL5P7$_&] MQFE.Q0I-0W87;<+/XS.T@/)T0=C@)5+"SRHA/5X[):S6^^Y7LB3#0V4^BJJK M2;WED7BF0I9E;URM_EH1I0)2]YB1IT,:?3OR(_<R2J9$7D<Q3Y6^*A7%K8/! M3?ACCJH&>X7<MR%QFE/WC\J6A>ALC5/B3&M+OW6H9N<"5Q:+VMULI(.^$5TX M,&7PL&CN"0!-"^NVK0&UIM)D2M*]!1Y3;(NM4N6CV(462+"=%I;C\W:SONEK M]7Q!."]1NQ[9V/P0$@J>J4GY2<;=VM/>I8Y]U?4QT ?9F956.?3*;K:R@F/Q MIW.,;?)KFK57F/[X@Z)LG+"9"W^YQA]W*M)^.?_IH4OI) :T-@'/D%H 5N+5 MCA;,@_#Z RL!58;@A%E-WQ1%-\0<SH/"N I*+WCU!#C-H+CYEG03:6; A=)Y M&[:*%(\P- .7;03H6#O=?EVH*"<:*3H\4^8K4Z4Q*P2^Z+^1>Z/W*?Z\'$77 M<2L0&<0.>=[T=^IW?4M:3WS2%Z,5?:9Y.!=63@QP0I%G4'_YQD=MVP0N_Q_7 M:,-$;YSWY;*@BHJ.?B*PO3*DQ:?M$R;G6>F^YWQENG&,5J("GFS&WF*LN\JM M&X&5&>1J^.0N/N@] ?Z/PQS>T7W_OPT1WJAO3X!>;0@#3:]7\ N2J@%0C[] MIQP:C=IYB+^VN.6G/;-8$-9OG6AW) F_IJ15W(:[/Z17%<\[LT>P_U,SK;?U M,B6I='RVMU8@W/MR&.*-(7'U!#B8/EUL[35\3_%&UF[3?99B!]$F.[MV<#K; M/:BYPGJB,?:8KC>!$C8UEULW1&<RM$]>W ?OZ5EMG%3C":TTGB8IH91CY&#' MC,H-;\HT;:5XZ].$4JV_%7C2EQ"\ @]6Z[/4")IJQHGDN*VW1[?(;#BT</TV M 7LJ-+N7F*%ME_E7-3+$E,ZAP\$MI(V)^EWUSP6?U\$T8U:DX Y6$VV43L>3 M]B--TZ($@!3/V2&UA,F7>XW*K09/@(ARU <9#'VX6^0U7&IV 0@5NE>W)&?% M)KC;R[_3"4+A!:>8$,'\:"2^3\$6IFZ/JG_+\'0%D[<(;CAXX]3-6,<;$<T^ M/[F6UMJLR,_&1[VA,7J1SM9NO/VY5H[&^T#=^) &@E'L)N;C6L@)]YPZXB^F M@R)I2"/7YS)[9TQOB*&GQ2J-4T..JX0M%G_ WUVM-[ ;I^Q3'0V))M4(EOT@ MR23]+XI/*2J1'4PO'EGGT':C0SUMSV=A,L9S-;+Y+MY_DF3D.P6?KQ&F]X)Q M9%L=$&+JP>:!44TR/+JG E\C&F+N7_]6&<2>>1R-^$)"C<D?S TMOA<X[<UV M9YAIC[IHJ(0_KQ4M:U;>U6USCW>/'?SO0TJAW%NRU.ATIGS9H"SPO6L9%CH' MZI>=U"5 +CZ4Z'JQNG6552[(L)-)+@1,.*O_8N.>(5$BJA;*%Q\;;UJMH=*K MM-Y1R>@6DW612@@11KV1'P\L5G\";):5^Z$P+!HBTH-HP=]SI9;WNB28+ZF MG^QPRM7 ]=<(%(]KJI%8:HOUN>@V$^9)U#WS-5SM17U=*P*&YWPQ(\>91[8$ MM,*Z>%9@U[%&@TM-712WH=%,ZFL1\<AF--_@[EW,4+XK[&DJWKFLT+-">"H3 M&54*$9]E;ZCU2ZF$5HE<W6G756[H+WO@-T<.$7^9_R=RV!T0T3I0FS"7)C)) MMJAESSA?2;+!7Y> HEJ/I\T.S%9,O-U''?-3V6!?\@T:=X^-"PHU\[NG_O2, MS1*(R5JN>=%."/R8;U"U<'&89W'C7ZF\8=#]NHT7@G':,QO)1SFEA#I:KL\3 M133>-3A#"U/@%7?BZ?:OMU[3NR9#.I(=/BS&Z31-M^AL,%&#I!)#UP6X/D1I M9A\V%4=7XGQ'G!WIOS%YOZ3Z1E_;[/']DH1GQ\II5<3%*A9[S)\>IH7*(!#T MG9WC<>62_7:6/D=.$Q)(> K8J&UYN9Z)#ORM5AP(=:LL;LZZW=\M2;#)->!% M:VG,T'-7JN+_(@,9Z*.(HB(O;BYEG+8)I*G?+KLS]PTO1V*K'H5^N)X@G,LZ M\UXZB-&0>OT/YT9/$ZX!IP9@<4E_/P.E9F^D0Z?=^>/65U_L>THL%7DAX$I( MMIWO)3MP*%]FCPQ6):FW07:75#A#.7&K+4>](>&:Y"#I,6T>SQ*AS)N#V^+N ML9?@O']_%U1M;5XJSGC=[1ES(-Q8NT2J&S 5V5]M,!\6#P_H=R@Z'57(LLV) M0=T*0?KBCQ0SQXF+#MZVBHE[S14O"T0\Q.^>A?LNFON!4/A3G>9\36[XIB;@ M<HW9*N/])\"'R?E*^[JFS^)+W8-OK ,+O%R52(:+4V'%3-UX0=Q@]_LDC)6# M!8ZS-Z3+:@[U9T=6A4+-@H34I.>?2QFB_\Q<OKIP^>0QX(;I"LW[7A>5Y*P; M/%_OXL8KI'A5;J=O-*G2]7X0S!)*S7P7;S"6)1?7$L 4RP]YO6[VCOJ(SUS- M$U2Y%)?]_:,)I-^Y,O;[<HJA_1'=U05F(DX1F$?AU#XQ:\O;"R'J]F)O6':Q M"%R_5YPUGM?T^ Z>;.U:ROI:Z= #%[_#RL04'- I?F8*5NB]98SAZ;1L.GUX M6'D0TS?@,,6"+/8_X_[P1>F90H@CW((6*L*C6><TL><KIA(\R7$ZVDIQV'[" M2UC=O^;/;'>A8P[-_QUL!_WV0A%D]P./T!V33H$Q]@W@GB<+COKVR#Y]S <D M*EY8,5KHMVI"44S'9_"\ZG?(GS\WE<JE<]0USSY/4<&L1N>MJ[NN2%8 %0J_ MT\BK'/,C)-V3-A(&:_+L '?Z0:4H6II*N1J@"!]$<^,U?A\])73;Q!A;[L"U MZ&.%0T%.X\I<9Z*'N!W:VF4C3#/N\O7]AV)H9D8] GPAR#6,G%^.@CD9SSG* M$M? I[P>9!%]&M%!QW0F7I&O'M+)G^5]?C4N)M3"M_[]GA6^53E:7K:J4K,O M!1LG$%T*^>P^0:H\F))($:BA.C7#51O(?['O2XG:2\ H&EI2J>YEM>6^F_N/ MLVN*NAX<9MS9:OT6>RN.Y'+?X3JMY.E;88TSG6$]Q<[[[=C&W#PC<L-_4H"@ M?HA<&7Z3Y/5/WIY_Q^DW4MHP]9===ET$P['':FU>+Q%;CU14- 3O]Y!?Y5X0 M":F1(3K?Q<A%(%_7]+U=;Q?P<UDJR>B;-<*L7=&\<./B:%EA>60CQ+M\T<AD M[\3>Y;>)]1 L/2R<UV9+8ZW]#;?GE,1&31#UXU ;$=K@?W2NJ,T=LR;H3D27 MN:] CL=_V%./Q=/9?F)][@!@>2TTH9\ G4W.Q8J9FJCRLC=J@8;0A$GQ4_@/ M:M)A'&\>.J83?6BEHU2 W['#9@'74#4JJ=L%IR.8,$@&W=RSPANIC%(L-U;D MC[,6.0)5#HEX ,^[R1^WOT3B:(U\#1*L*R>IAA!M\.18=/EB=&45S4:+JKVM MXH]#*ERI*TU]P;+*F909ZEOV429ZN#HP?:C,7,^6PY>)N%]AKD.)9(4B\DRF MZ^@B&Q\GG@"YZY]H\+$>YA(,JS+$=EIU9ENLB]#YT$N3_#\W31]!>2_ ;@9G MES*266^C'A@-$9I<VT.*S+:]8&?=$25'AY.#ZV#CN!\FPT>78_2<F99$JS$N MV9WXP]4C5P?1N12>R>2C7_^06"WZGR>F3QO-S8\50T_3U%\<GA-U?@5?78[] M&$^";#26],5?&+&KH2^8R-^J*DB;BF6[UZ'N^N?9HV_)BN0?=_?,'7^AQ=70 M<]="J_OZ"YS0WTLBK]<>B-:R&/CE4YJV:9[%'GBD+_0\QY+C8L_JG-08LSBX M/51LRA&]CON#6OE198(V4&A V2:,U,XKEIKA'M65+H>7?AY=+(I^&=8?3X?Y M6A1&%>)LB?;-!VN:U=?.'-4-J3"G@D(,,Q(H(./+GV+H*:2CZ*=OBW9B@9+L MW%[A57-=A.[+8M^LX T1V.]2,-*5F0X+XJU#_'5]'P6KI[W?3P:M,L!0"KP^ M!AJLC2G*-*2Y*HSS%<N*O^?;<MZ/TMXIHUU &XY .;_?^UF]?S,<@[GFH*Y5 M'"I&/_2^-@\EZCZ,_K2GH9F>LE!LJ-8\!(MNPWI[K&:5-(JWTD8WF>RVX3!- MDCU9MD0*!*_5C.P0BV!='DM$]&9%.&'C2=VY@=<3@. )8(]KH:Q$>4I()VGC M3AAR_6XS&7G75Z6P+UQ^HFA$S"7(F09!9=:&:\7:=20=G><G2?:-REX)[HUX MU]]^U/]2,<E:6]*+QVZ_*,HK-=(RC&*E%K#^3 3K7!]GC ^4__>/!@=1<SGR M:1;?9I6:AEC*]0D@4XY[IA.7G9$71EYYX3!CE3PG3[X9ID086)N+90LNZ)E M^[Y/TVXF9H%;9)#C0*K&"0$:LN$PSZ%2</@G%.WB0RQB2"E29JS4;/DXPYXM M(I:"Z15.N21CQV65S SD)6C#@N*_@JN0JK;8'-.R'&#0EJ46F?A&7"E/\M\_ M.790!(.*S$F6'IN3N?'%_3$':)^OO9OG"4#O^ 0 G3[D/"!@ 4*E/B%^,2XM MK[TQ/-YC&Y9)+OEL1:K[*_U8DR/>%9\EK,<K6QT-67(R_OY2[?5BW8D==:]$ M!R# 0!>Q/?0Q<8)CE=VIQ*:SM_#9+$;H!44.^X)K8I6[MWAVK\G6C<$42K10 MNX!.<9=8X^,(#.V]+DWGFSC[MAI_L>;LW[9E]&8I!+DK44'T<CTI"DC"F>/X M9X_,?$69/?-LV8T/;&VQKKQ6:L_L'A_!5DPQK^Q7<3#YWH6WK<<)&WA0_=>Z M&N\Z"5FGURJ&X./?=B=/XAW._].2>?*A:W;<_UD'U%IGD4,5*OV8)^2\=W<] M'==ESEZ'>F^'=\PI3ALX'C?\W<^CQ595R?)@1D.ZM)SVLFG9:*DCVE56(<*/ MA%>222A9F=F7(F6CBF01E. F85\]@^&L_FZF_H-0\;/HNZZY6.1E !Y06"PW MB2MEFW/'AJDE(2P1\R?. &9HLE]54<?ZPZ-:.W\[3ZZL .FKKMR!Z[WS:N*H M#9[&Y7@#JE@U9P>^XQ_=[%_Z=MA3+CB;CG#Z4LP5K@+?]I?2'08J##@,^ONE M_*7WNLE,LC3]4^0;4.I88]1'+AZ=ZFKR_;2*[@6N98AX)$ZRDG^X0<89:$!D M&CY%.^DGO.WG\:(&^9OW8Y"!S-\ ]]ST$ZLW%^7*&86ROHMC!;+^N:Q0[D3= M,K,G $];FYFW].KAG8/-^22!2:C0\=U[]W(\92L3^MB"]9-G:#>UU UU.@TI MF6[T>>J*'Z9+>.Z+:KV#F;>50=+-JT1+?LRJQ32RUB _IN,\F8XQG%E'G&G] MGKQHZ!^>JXS'T2;]&_+VXT69&?1](A'$AXLG760'LYAJ\5(VC>2'3ME#CJ9' MX(^B]7:"?6..GJ'B6%'U#YQ<+AFEFQ]2/'^65S@]2'2]U!<I3R*'/DS3%NSZ MYV:RUG K@_A:YKCH3(6;I)#,I\)[!B*+2/_?EO7O@;P3;VR=Z>E35D5'P5T; MWQ9DBQ[2UMN)U)$Y_HS\=8MTA2'S&30*(HG .IP&.V(<%I,BOY6Q #-Q-*3> MPOV@U'0[B <B.U5WA&^FHS+.-7FI@F* ;8<ZV:;.='16OPG9$ S!Y1Y*DN_O MG@KB0UOMSZI/9\FH?41_9?!J7H3*]JNQU[#["2Z5OVQC2\3P*#Y.&:BL"8YZ M%$1Y[)V!VE]XF]'2Q[C5Y1'S^I0*KMT02& KQGL08/,_ 5;,O^51 85/K]^? MTHENY[@5ROP5G%,'T1A][28K;WANXG[0++DC \I-H%%*2^"\/9G:^JVV:2'4 M.+P$ <ZVB8#+)N],4!AH<;VI-;)"XX\3/64##B,=J2(<0:/=7NG;-*//:2=1 M(OJ/N%./(QLG!*(/S1_8X"C*. _$E9^<=Y6V*FZ=Y/X.Q.:".0<V?"]ZFEC. MU!6(83;90DVGDU"8N_#XFDU<;+C+,9? UT8YIF\EPIS^<D'=7SGB/KAB5[^I MF^G%)1'^\3;#N0E7%/+G$JRQ?Y&C()SS\/Y7R6?/\'U;*P8FC[:X]N#4Q9W\ MHL9Z8%OP_)@>.JX*'*Z*$H/[%>V^6%A<V8/3RHQG']G9VZ>P?XM82?F.Q'!B MEA[ 2(H8?8ENT\ )EELA]2#K.Z4O386-VGUZ4KV)GA#PL5!$NL^PBASA)I5 M99DP_EF?.=Y%L\#76T2NJ!PE1!I1? JKA!%5IW7.5N?7)["MC*8(D@7&VI\3 M^_"PYI;F*M-MQ(@0*2-Q.B1I73R8*.?062I%4T!%\*2I2?>M]S^[!-4YE*!B M=\J6!J ?2'1:1A_SC[UR)7:QK=>T3(H]T.W_N;=S^K^]MP,E^3\:'+[_6X.C M ..J""VATD^K'"TDMT8)6X7PM,%KFU =N>!\(?#O/2V5=5\F?D9L_ZPU61'K M1]K,M3GKB,=^%';P29PQ %E7A7MO,@$AW5C&']*?C(0%ECI1+6C&"+@5-HE- MJ,G](.3#4.PP/ LG?/?S!2YUI7@?K>\113XZ6!,^<:F)5O%6AK5:"&O>L5NM M;!5JUOS8S!#<[BUM>5'2R$ZF(8F8A 2B1F>[M<=*P4(K=PJ.WI9NCBZXB8Z8 MA!N#0HOM'G;/-+/NDL.3OJ48P%;C5\F]EHD#XDB^9AKW[*L TZ.'R#VKDMEM MYYX +0GA:2_LL SC$U\]6X@*#P(.E8%S07(,#BDF2\8?FX#J3LU\6S;RQ)>" M9/@2R;7'G^^BAO;$8&MR\9.+^Y09LA*PK)Z3+0=:)14!HO+Y,E::C.7T#Z8G M$,PA%@PPZX_*>VUT.4DL6Y0:VJ-/+5)M'#5:(VRJE)%_E#?VJ1HX$*->1I/I MB.EI'G,*[Z%] L3=O\J*BFD1%X_P=I-5R>W42=;3'&+=W &1F#)*:6&-138Q M0M?SHH)H)BX/3HYD7+LTPA9NT2J3@;^]WS*J#XN+:6AHBDY,* +(/_V_3\CM MTN7Q()C[)O,JN"'U?$T@5.0)0 ?K_7%Z:K@XY.;G\ />Z/6S;7'^!N1MI/L9 M2_<SMLUFR:V3\\W_#%N3L^&(/;\R0WL[LH.DU(JH5UYCZTT/,;.$[N,B&2^* M0$XXY0/V=,,F3M'9=#[TX;N>*RV^&[VM?T KS*<];0F\69>/">7=UUEF%21 M*Z$O1B%T&/G,9QZ"QGF$EZUR71;XE\%'?"K_U@.%==LGO89*"Z4W:Q*MZ56B M3LB*(6J)*@F.JUA'$+TBM*OZ\W--,W'-5.6&VM:4=%?VT.Q'XUXA/532][2? M5R6J?&\OYN;,-*[Y^-'3WZ+%_"[=^HKX>F+:-/G78OCN3))I!(])C#,42;M# MOAM]\BDK2_V",UGZRB0D D_1_(>K].0%J=6KHXIMW3LA95KD5A)N,_A0R@#K M5-\]?PY=WC5[F+QO+-OHYQX@+<:6*EU*NTWS#XCIL$3L3VYI=MLY42VK(TPF M19]V,_L-K-G5)-Y]$L?(AS+-<I:*C,/47^!(6Q'X0;3<4Y=:=\YNOV5CD#FH MS[S9B^[8)T_$JDR1Y3(DDMVG^1]S8W@N(S.)[?@QA&>FBYF-<(TQVD%<(7YE MB4/U@. $$2+B@Z[J@Z;EX2S"6XZ"I>)H%Y/!YK]:S3]C!,-^>M)A*^WJHLS= M4%:=#Q!5\ES!6C5-',=KP0%;[T+JA$YDJ<MPU8LG0&5@N4YWD-!4T!M0+MEI M;[C4_H*4>5_Y 5WZ-P)0<.ZK')M_UNPK^CC,7ZW ^4M.O7)A]VS(/ :PFQH" M8@\";1@*Y%.]<$A=;DLA?&7XC8IR@.ZFAC229:F$/2&<8K^=!.AHO5%%5(?P M#[YZ;QPXO6 ]5]E%J-VQQ6#E=6,.3*1YNZOT#%/_. D8V3N_F4F2^KSV65K+ M]645,UH/R<?3&8Q9MQQLT&3"4F9NOAQGB.0_ <YZ5(<M SBUJ=.U0HX/QJ<) MKZC?IRF*V"EL"S^?<]M2#;2_^C%_K*<T<5>'X\YX[UO)N/($Z)5]E;K\NS:N M8\%'?$!F-3.@5#6E,_K;]_QKWM'E^D38,#A5@'01(G^:&"4>#V.?%+5I"_A1 M4 .#9RA%B@AVT8<2(ZRVDFAXZ*Q;G]N7+!E75 .=AG^Y-RDLW?G/?M]S6#UM M;5$3&9X,MMKUT?<IQ[WYY,J>:J2P4YY&;H_S>PVY7=DF%[4M8:338\X9+W7L M^?#GUX.O7T 4TS)K\;B7&5.7&$_1'J*ZS\ETC ?'T2Y7:6LS58DC)Z97C0Q, M'B-@!"*@EN,-U5 5\MJ&L4P#>X98CPZ)W&694?HYOTU/FEO"->";V+EZ;S6D M78%9PU-M7";+,<75D[!6IVF&WX&R'2TN4QQFT822^T(R^]Z[N)>"['T<%)_< MXTLJ@LG / HH&^>LJZ3B_>H:ZLY5XS[^9_3Q?_^3%!3]\&XB3^VOE1%KK1H; ME@DU3F<<\6QL[#G=< 8)<YB"[FP;:Y] A@@1+;JYK-=RFLE9LG<G62BLBZ;# MW%\_%FGW<07O=.S?GGE .0.5Z>F=Q!- OJ4NM*INUS,,14:P]#N, 'LH@D;; M/?;B;NP9VEH7%DE01;P[M=A+\+[=*FZ3:&SPW?VO4W"/WVCX:2Q/W!C%OKE8 M;)]1FC%S=S7.\YEWR*%$A7/EGS[_QOSCC*<A)J<Z"G<NT)&J&" ;>8J:2%;= M(=Q'Z^7YXWDH)QZ DHUA/[?""5'ML6ZROMH=B-.%2%/S_ 4.'R6=,QT]J\]A M%Q1IWK!G_VY(5(376<N_@D<Q-;9.Q-1]C;^0FP(J520X46I.,"T,+V !EF., MRF.WP'70I85F$(N)%@U$YK6Q,RUY/39FO;5H^A*<]"]17O(/BG?/F<I"A)M: MN37CLMY,?408"T3SD[U:4"5PU,3O!7"$MWS74B+V$X'^^0V;#T<FO!OZ]\@R M]0EB[9A/,*GK8)S*CC+#8A)6YB)[OQ1?;6>>QP^B7=S(*"WKA=-Z^7-$Q"X] M9"T@#1O3@Y;F1G=3#-Q--XEWZ#%,QR(>J?<MJ"N\Y2C!Q7JMB0>Z,$.O1F<? MUAZ'CI:/+T&ON\0>*G#97SLCHR\LGC\!.NE0!BJ3&(ZRK--YRHTM\.E*Y@SI M<HR7K)D^CAQ,K?9L'B&#\AALH7TBN^7:9K)J6\7;HJ!]+U]&3I0,(M^[3'.M M_.Z[=?@ E91U5+_%]SKWH>KZ6GK;D X&$M&\M=6(%:FIQZG2_87I#VY7PT%+ M5=XB[/;7;]T,D5J%UDZ)Q<R7_U$2=11G@>WOI?9HD4_%IGB4$KF#3X"C52?K M*8>Y1)GGZ2=&66YQV3VSVK!NXZHH*%3UG,^;P(AO>^_?T)_E%OIO?)<4P_O: MQ2,CY9,/5:MF5"L6O$65O;97$67S0CW_E5+] M] \2&*5ABT9LW^Q*/8@6G% M.JFWB80 [;.XCD@/\*8;*G4R+MP];UOKW=X,R=?Y@XWS!X YDT,<R*4SM=TP M=<P\S;>T=<QW0N8FVNSZ12,PRNU#=7$?&SIT(^LUWM1G>3=BJ9N0XV\!P8"+ M+G]$ZK<CT/Z%Q>SE7#KYPPO$U,GQ'^7F)A,OYVTZT0'&/&F,VV>:20HPJ@%N MX-00T[)?X?)6RG@(F,G4KKXR/\TA\( 4K_/OCFB*" L+H<T\'5.6J+-M:S]% M56V2F<JV;<P?AW5#O0[/@9M$PR> 7QD>(X^AGN^1-]V*]I=?OL"K$DB#9:1: MC'(F?FE*4=IQ66AJX!, /W9E *:=*?[)CY+WMUK BU^I4E'?+\9^_PQ=Y2H< M=+TOU^>@@_KP@#+CRHRZ*',%]#:_"9G]_LYFBA'>$J;"-4X_2^<-$JTLPOJZ MH=:<OLAJ^L;'PL!VB*%8DOZRQY_OT/)QN#"33TS52A7(&%8^4C!OOJPN;*@L M4HAE9QD?VH&#:/W9S@3DS:MW5:O>0GX!D1+H3%S/7DC4U8>-#ENTGM9GO#&< M:VWN+/0Q6_>I#7B![4^;NU8)=1H >97I=?C@,V%ZUB7V%3= R\<(6S)L#)6Q M8$/P$?8TU4:#7[@>;W>J,0W$RPU5BV&=:L6PY/1W_0,TRP+L]0@F'@"V9HGU M9%LS05Q!C$$\[/ HN.$&:$<,?<V)/#> ;[@I;D 5"YKJVFO5-598AFM)M[^C MKA.%<(]2VW6,:OW$:1-B'2=%([Y&^SXT*;Y)FU>P_2LC.!MZH!GU+E?-1@#$ MDDA-=5@.'&+*/?0OMR>*V'PV*_%;VF11;4B=T\11=L8]N=WI&?:*>V=X^EK\ M59^,DR4]T)[K@ZJ<P.@L? VD;_AC,JR<V.8.&G3G&*QO\<,[B=#(PLA)T-QH MCVJ'CS-3/%-$4HN@1VC'4>*8J@J3%G%ZU;J>0Z)9.UEG43/O&.M)[U[Z?FDI MPX=MVR/H7) ]MS#K7^2!_L3)QA3?U_KSD3KEY\-5&&3=Q-0,!>%[DU6*;G\. M#)0(YA!$YOP"?$=FJ32;YK\ 7^8P;4BF#3)C\_&"SNK;W.\7@G/&+/",?R?5 M%A7E0.4&1-N+DC[ !57*E):[O1F([%0=26)$[^+H(A)-B*2'_/CFGMNG1VXM MD9R^ZIM)@GE*N>8%KZ/U5Q#"WM;$']VCG@ J,<(YOUY&8?ST();8KD^O&S&F M=K/U2F46RI1\'9H;%(1_/FWS.19]HZY^5M57)OM;]AA*[YK]!HVS0>2\GZ$D MAW,@GN=0UU;#+&_)8OK=G#7H[1>-+63EVP,S^XB+ :")Z%BTZ%T.G3X1RV-_ MTH?NN.)%9-)%4LM9.V&W"T:$UMN!-8CBNIG5%8*$L;X*BHYT(5SA2XC(22^L M571A<_'+5V5C]<-T$$QFR/0HARPUKP='P9X +]'B76VBIPAH,=I'\^5>M699 MCXN3\8M->G5"KBU5]X3^I=?]1\8!#=]70,M3RB#_\!:SA ?KM<"%_:SZUGPT M7+=FAC_=)M8D@YT]FKCC, *X^]?G^Q91GQ(UQ496937R"4 &L7O(W4;5AP&% M.;,W7A\E5)#Y_35568 \ =H2WQ:9X9K&"Z4/Z+]3VM^7905SJ@73\F=N,)$> M9/AC&,=%MZB52 ]_W/?8Q8=G,GZ1L*'&1(J6H\1[;[%K4=)7_I,71U:SVJT6 M9#^&?2;Q<.,=X3R-T>M^;.$CNF_V*237CK:@;6HV] N&MVJ]%F=<!^V72+G' M.*<QM,$3@+VOD^D*I_8),/%:O\4QP+6-!G$4CR*(G-JQC0*O*&<LA<Y2&/RO M$M(G&<)PIZ+0O*'?]EX>OB_NL&._8MIW5D^WS73X-R9XK\JL71ZBHM5>1]51 M1! "E(:& D2PL^A!U!A$'%4##5$2G!&(JG>SA5F=P'#D];4F?Y1/]I&RB2 M4(>I$X_!H_(5M;5S$C#63?"U!7UY2@LV@6BCW8R];'MQW\PG@_684D,/I3Z- M2V5[F-^_(Y,=8>K"$O+)F.874@*/'3=-!<VC7CZ&K% ] ?Y%]#T!:,L/(2Z- M]0*1/O9;2]=&?<XHU3RZ)X!OYQ/@>GD6;2#P-_C\S"+JAK%J-O\)(,MRK?:? MG&:9K@3:/P%PS0LX8!EI3+$A/3\%!\^-\WZ\Y3=DV6M(EI&HM'.C@JC7M/@Q M_=-/VSM;XIQ)1$&&3+[$LO,J, E>NWX&[$4<C'@W=8';'TF)E \5/CP!OF:[ M\MZG;L\Q=&6<2XZ*!WA52&ZB?Q2[)K".7T*C/#3$W]KT9^+Z42]&>_Q3.CJ* MMVIB;=2K\APMY?>39$^_Y?MZ^@2(!0:7\>4MW',Y6I*/D/P0F66G+G UB\5( M[?"$8SA*2![H@,-UT1$@S\"'M-^.\(Q2B/;B<",/;\;*6Y9HN5>RK@;2M4GK M)WH"L*I8_2"M\"XIAAO';\+*X FLI !L"7LNCN=_+WB5B(5-I+"A&P<)?KR7 M@9RC! *UL.Y,GU&TTLI@,F$JPV"$1U<('O4H=_RHO0)JMMLLR#Y+ ,=DWMAD MT#I#>CN5*C/Z"3"3(7FCIB)N350;(JSO!K%%"=%)#S"C@VWYNCVX_U%=E>5) M:GC,(UW%G@#(O=VY-,U9V5>F[ F>ZX%DXT5=+O&KE$)==ZT%+(F(;7,-Y7Z) M[8K%%8A"X^EQ*T=/9)YM!9XEK8T@>0IF@,$(WX\W?=)7&3PIX75>O[#A\4!/ MGG=7N41A#DH%5ZKP%3^W34+7AK=S-QY?GAW4Y<K37)!LL)4<NIL[%A_(4;#9 M)1YT^8M4%^7;-HAWJ/+>K%&8<J/NV9*N(DRB#-%I(I-*$+F"Q;YO>$ X1XCV M($ULQ=>TNL;YE+!?V)#39[LB!AG[QM<]#=<#]NLNE/HF07Q9%R["#-]E+;^H M,+5@NE C,Z#+TL:H I /Y>PM1[R8KP!+EB&'SQV[0YF\W2A#3MPK#.K%M)2W M#-]6]Q<?$(]ZYWD=3/'Z3<H=)%%!.*>7W4(0A6F1)/Y!NMIZQ%Q+JI6C[5V! M4]C&"TA?!WZ#=-2$A_CQ_QT'/QS[TW.:=F5Y:A 3QEF\+B-/N6,TQ<^JG+'B M6/DQ& 2'N#H+FDU4RPF\4A+[N6^^LCNQET?61C^4?\]P>AUY80<ZDI8/\&FZ MT5T:HK?W' ZY;[-T;L3T%=T-HD)4B([0.R%\5UWJ&SH2;3$XGH<(23,YV59% MB,J0F+0WUB(XIKT&&M5I'ZF7Y#G]SNP[;!4>^I:$QT-[P+E_;PVB@69BF>MY M..9@WUXX[C59ZW359T0\+N$D;AQO5_+@0*/F=0W/JZ%L)9B%[^JT\RUSMI\U M-Q(_P :_N,))V^'67RRG6+.<,K!-_>=X><D_Z:2LW4+[Q-:#4+<7%F Z]4D( MSU4&*C/^I,":/C.%]U6L[,7D"YSC:>0?P^WB:: 4H:@*W5?RC[6"G'Y?</. M1>QLDJG:5$7C'>>;">2OFR3G&4-EG74+1D=S]H#^-3]G;R))!)^"^K3UBR4C M0:S0%%4VT+,&"0YJF[ OH-%[@K5%.3+S)?7?J_M-%ET.D/ZZ(TXB)96U:1O[ MI6N\?C T=(F4- 22<=<L_P_5'<2 RB@J,@?IIZ U>ZX^*W#F;8@&! KK1YUD M&VTJ+8I8/GI+NL1+ZF.67JQBW\M/0M2]%LQZ:G;;F.&?6";9!1NS9,/4'*FV M<AD7TXJ5](!:O7&WOB$M @6UL+PHD<(?PH_)X^QI@6IMAGF]U??RIU=/ 'T4 MIBSG9,O;+*5FAK]UBJGLC:$;F,F10DI"_NG,=[,F'%N-=^^^!_N=%=_^?9[W M%D='+[\Y\G5,"MMRZ+4U)DEG%*L&4Y>L7-M?%$-F1(L:5IW_5T25NV.@K2#8 M=8*.C/#-X)NQY8%^*)2J(XCX-&?3-TLLQA'DWYSZFE3MNUX,AQ5F"EFJGR[ M<[*1)'I!O;?(97W930EVY_V8Y'$6&/,F%^+\H5\7U:^3+/52#80BT&E)-!)9 MQ7-Z.:?T!&C)W(2G=TBX\5,]R\:9JI08X5G5Q2FQ,&OJT!DQ_%9%XTUS=2D: M4PYV^XC*S>-/KU!F>/@V7 GXUCLA]3"O+1].5[HI]#-VV^LDQIRT^:OTOIA8 M[=^-R=-HSB29'%-LHMRY2N=E4XC3;$'-A$W;%)#.9LN;R&GI1L[E,^[99XDA M0-"YU]&[\Q<0&?0_L?)?<WMV/.TTH.362;IREQ38S#<#$GJ#1!."'Z3/D"?T MR6] 0<@-T>,"]OH%@:_>#I>I[[B=WA1J*:1T-4<R5]TU C]O%* IUK-E<#IO M,Z(X6O2#N*9.C%=U$QIY0_)JA\AR]6E8\0=Q!HG79]3]=3/D]GRJ%<E2\(;J M_\4'<F>;17JL4* #K*U+G@ .Z,2K_SC!".Z[ZU=AN%*IK-&$A+>7$E!U8_0_ M3G/P$,9=.?A15Y%!@@%DKJ9"Z5>D]_6#]8(OU[,:=T/AN84EC8V ]/0:PE"M M9WU./?67UNE7#'_VXX32E>BJSRF#'UOM#AC%PU5G\\=Y*UQ%JU[(-#1+!68S MOWAK6)+A:/HU1NTY@+WV\[H&$<<5] _:CL:MJI+7*X%?'/_<3*JW/#<D;2:I M6,>P'7_Q3D<+E1F]/>5J&=Y-6[9DQ)Y\F'V8(D\O2*DMU!S;7,;XUCTE[?TG M+E6BL431Y\!R-Q('P;R6:RJRU:$+_-_L.*ON95*(HDIH6WX^NEA9EG7\!+H) M?YPZ/92VT?-B234QHJ_Y^3*&S9Z>,*(R\<40&U/MT0\)NMC[7T\ [@G2B [; MT!!D-=<Y X_#8LD8"]H3>:!)"68\_S@-82H'QQM79/&>]CCB19Z^.Z*VXS2K MIM0JW PIE@#B)\YV7=]23WE5Q4J%[P=1-SI,_K-L> (HP#SF8L>TTI[ML&WI M_>A/? >PQ<%JXI'1T4!;(!^L$+<K6W6!_II'/*#^BA4'/JZ%58=$ T4.#!?B M1@!D9*S88$-=7!,=NLY@H)G 5W7H#:*!6H,'F\0N6 R%4-=_E:1(/WPLR8)_ M^06SRW6885N39Z04^=0KT;=EJAE[SU,$3M.:.C[,0JHAO-8VIO3_OJ)E1J_2 M\82E=L]I?PJE 83ACIBA3:#*&V,10=0SE1.5,,[J1.FB=%E+;^JS/_K4U):L M$I*[\N6WG7[U'J4JT[E0,F*<ZI,D\_2?E?7L9R[6YBB]S 6OQHMR!O]/K,A/ MXW:D:B\(<5-^?5N3Z'UKI*$) ( :QR&6?]!#(V9BIQEUWHEGHV=L6#VE&!%9 M7,]"9)3I3"0Q9TQDQ&2HU. FS>SU<<?*OEL;DF.E7,>-QR0ZXUG-)6#Q]ZAP M0\T )XU2!T$7/[OMA>TEW^[22.8G@'>,Q2?3"RC/P+&DH\.%(,2L#&RQ_A@C M6UDO5G/@&ZE2(;)H2,$Y79F.ERA3'3(V*J2)7YCZMMA1EBK06)JN-<!@1N!> MX[_$G5L5_28VW$&EDHIM\8U1:&M@,=7I..<4J3;9HBOJ6%DERJ<S '(X$:49 MWJ8VW$J1P ])QN,6^B*D@>6D[%H*_IQDLTE&\3O>/Y#[X:=.D_$UUX\"*N-Z M5/#7BX#F$1X]3;(%$PS>*ZD&Q4;P-[)']4X7K%,)(RH<:G[AK.:B;J!JOJ/Q M,&VX6+H?IJ_6C0.+3Z(B8>. E01;HO3,$X#4H9[QU>EHP?J#]N)H=1L<9%)2 M8!=]:'EN.8O)] 64-],BS >-8R Q1ZQEK= KN'ESF[U#6Z3[J$0Q")ZM34C\ MJ;REH.&R20R],)&NRKBZ"ICS>0*49\G7NN43P.42G:8S,4]^"G&3?B5&]S-( M5'+V=36U7OX4]S$7:]$1 0F"6H4F5;*!1W.D*GT:3'#)PB@SE&PF74_%KK6^ MPX#^=!U9*F],+M/AZ/MH]QG=-I)W3M84H+Z2HJ"* ZX?-G?2)7I$KY;F^R2 MA#-'$^\!*VV6)PVD26-Y17YU"["=:!B!F5R7_\?4)?4WYZ+JQKV@ !ZL'8[T MSKJJ/5KOON%!GL)ZM!OMN\[@EP?P6>:U(<P)HU*9?I44GR27O@/CLV:S5(<# MVD+]E++6[C?*N1P_$"*:W3_UU!5Z&/'%!.5+T$D?&KT@90K^-</TJ B5&$CN M]^>_J]$FZU >+9/%<M'I*I6QO+(/LQZANX01U6BKYE9^:;J/-V+U5]WTI)C< M>3^>EV5_24U-S^+H%3*MF1'.GKHWLI3]P0!+BA!]>-=#91-05TWXL6#JB(2F MKXV;Y&C*J@<*%-YPX5=OT*.L-GO7-5[VL2?X>7N"]R.$2OJ/KN&$YSD%!@6/ MB(=R'O]_[-6!&3M&291)>!5U-T+>J)<Z?K;LUKT@<Z?@N1$H9W8*JW/;S-'8 MF"[Z_5S>["S^^S]GRSE ,3K"ZU'J]*$(D<EPSV0?$/TVI=#H^<W$L[&QGV12 MD6.N+=-9%[3=!F2:1=1<L-<U)JJ_E):GR?!ZE8CQ4WFBHM1K)U)O#D6.%#H7 MLX7AD<=L8HXL2,]%";#\)37-R8%Y+Z-$W#NOG9&AR2= 1,N84&U7F[]GG.EB M<U";TI^TC3YX=9(';*N9?_>8C:FE[\Y)9:#/?0SNOR=R7F#VIOD,RI^ALXTG MV&B4I/]ZRK=-V%Q/#%IN/.13XT!+V0KL@QAGK0X5BX1'$&UR?R"-V2_SXSJ. MWRB8$JVB0NLK-S773,("13[V:4T<3OQJ"26YA\6J4O-(/+Z:UY*@P60DT1<0 MB W?=L[@T'K:B\DWLP-K!>6SI04UK?!S:K&K[^[Z4MB*/(ZM!K@W'B:NY6B M,51.,ZJKP/ />1:T@1L/?YX \N,"?Z*H,$Z63!3I2OB1)[TXPTKKYR\S'"U> M'HFR"\^CK;MU%C\S"7H5I9APT5-X]A]+ZW?3[L1X1\[_!K^?BW1U \KS?E$J M7[KYE)F2].M&]G>;ZZA:NC23PLA2ZY^]*N@N95;?U_O@TB%'/U>ND'T7QGP7 M(=*45G:]E$!B!D,/D@^G%B\AVFG:#P6/!& ZK5/[*\XJ^PW.ED"[:>[YU5]3 MQ^34\&<L=QUGN-02UN;E4#2HS]^UF///(\>4R B6RZ94>FY"X0]^)AI+=]QO M_6Q?A"H @4/]6EVBR#;N).7ZAV(Y>YH+4 ,,AOB3IIW9;4 ,IQ(OJY_J(1<< M!."16_Z(=P L(=E8ZXNX?&E.'DQ,J+SG"E!AI$\ (KGRJM0_8JVJU'Z@NK]P MB^])PHYN5_'12\%ESD2KSI#_95=!5<RCL$IRT,3"<;[(1)<E<0$Y$7L$A;E= M*"#!L.]O^W"QI7(:#JLB?=6B' $8;;].?_G87_<_O *35$L(1PQ[ VK72Q^G M>];)EW"3>KW_UB 'XO"V'8;S;T:+G(BN&_!L')(!VV/Z_^PO"!)Y8[&0MK;N M:G#'UDW#=$I@#-@'MNJD[1B%GKQ\ J!T_?SS[N^-@E<SGP ;![V5=<$)9^^< M76 \)J XDQPG;P1'0YA*%6LZ^^-PU,!\X\>/$\=+ #H2OJQB]\)[_RQ1\$F% MMLH:A,VTN\VK6 V_N3.,/+"9[XST['PJ=FR^\N1$X/LU05S WL5B2<3"XG+- MF\@ 70QKZ_"H):G;Q/3.(:8>=7'UNL11=1+]9AU7SD#Y^I=W?UV)M5[=W:6_ M_10!^#G+SQLDO3 $MFJ>J"JDFE)S$+!1.>IIG.J(%#][].E9\;7/:6"^%;5[ M^#79]]Z3)&*GD<KE(1\/C\9!7!F^0_Q/ [C:4"PGH*!?I\]^*-*.-CH%45I= M>DGGO#XQ7;;LS^!Q*:.R!-C6MJR%_TQ\6Z5$OIKYTZMH2<8QVOC51B(6@%S; ME;&N#O"ISE[DB\,O;/5':/NRVY:Y]9TXV'BV-Z]Z-:0N\+W*%96_EOZ9A77O M@7232L+\S(SARU[=+Z"IHKN$_]DASKNR1*?X%C^./>).BA)9,>'.]5FS1&[. M:?+U+-R,"KX<H(EF5%XV(OI8C[%;18PNUQ^_''(C '>"[:>/Q1F$32/EN/ET MN;<FT@H-\']ER)_]'>("E-WD]9+@+H-]S5'F4*+$(J#4QH*J2^#ZQ?/CWGT\ MTG'2^)I&4S*/0C+<[?)]E/'0Q@D1.OO=>(O:1L!_T%VE&SJRT"/K-U[^#<ZE MSM+ZSC9,3,F.[W.^T$KV'X B628+IKV&^KT=5];Y=#2JOP66J<ZMZU@#Y&6+ M$Z40$/A$_L_Z=#K(Q[BN8#)O-RJ'6_5"]^PXL<G:9XF4SJKD:1]\Z=.[^'O^ M:;^&"'M70#ZB[&-.G$6733Z<=@OQ^G@:&RF3+0<'6*M$2;"=A%]<EK7C0/ H M5J ;# :]0=2)L[H-WTU-%$JC5Q1<>Z)U2'@8.Z5"SRD'MEMK*.I2?!1@+-&V M>M*!@B'<;*(<!:UU-^' =D.T)WLT,PS%7TOH(#;8]+,TD#SDRF&;:.R/H/YA M$!/:7AX=3!E1QI&PDE+,,[!]\*G[/5W-Q^9%.MS^38J+$>\I(U[>3KGE=QJ^ MKF,;ZGXGL7SKJ,R$>X%?CA,,QJM*,U.?9DWL#EZQ&=J<(=.3!B=O$NAX%7C? M4(< 1&862?-/Q?9O#]83HRBF-+U%HS/ZG<05E_;QZ-*I5!NP!?L!W"8_W?O_ MR53$IKW@2@(?G/TU9?I%8;6ON+1BLZ_G04U(,H:HKF0G[G,@EMKTP$%^4,<M MMR:4LT\:6HK'P]CIO^O;^V0^XN[N52V<BDHE4Y3.DVW7W-.8/);;L" #<I/Z M<BUOWO<!;*:&A;D'MI+8<%*+W=:G1)-CA[9J\ANJ(_XH<0];KEY(_MNH]\)) MK[MA3MJ*,4ME3;&)O\;(W[Q&QA:Y6=.)$?USX^M]AQH QB-@X>H@>O>.(;KD MY0#"7$U_QU"2\'LJZ_5751^)1(\>IG@S;V'WN;8]BR%OA60!G6<4Y%B?.IXW M2:M0D _LBKM/+?SZFA_N>KJH^4?RDM[=R)P3]2=S;9&Z4I0GQG=9,G9R<)D6 ME#T0O/-3D"1+Z?:+5#5&UO0$3FR+7B'ZW0HBT$*O?FIA\UN8I,?DL'\*O1-! MXQ/ B]Z P!V9\^YVP?!>;MWEPY5C#($?-+1XH1@HJ0W983A]8?]'V7CNE"2* MW^L*\1_.3>RB>HQGNN32Z'AK#(TJ,2G#Y).?ERS=R6H?[^3"VCWI35(4*_KB MZY7DGGU O,O8R7)\Q(H=Z]9?&(6[<T5[]X?BN;M3&[K01+$N$.L++KKS[C1? M57UT-)_5-.MR,!4S2?34]9K8L6CYPT*H>O\,3G]5-$UUM$4Q'U:UHB7D_YA. M?$?CW9!I\-QO\W,75C@AH;W<8UD#FZ63+=% &N]BI&;Q9(U*W/"+2M9X8I,3 M^H -Z.(23;0NH:5YPM_DE0=N);6K4M89(U*/CZ\SEI.R^4R/=B(OY8A6QX+7 M<XRGU-.TFA,#1F3WQ\><AP%$K%BV@LTA&)_7D#[" XBEN)*AZS=6FBVX?7RF M)]$0%[?B?8NY)K/X7':4I#SS%-3"ZFW4\8#G:[K/FIX9;NOZY2:[V +_Y,C5 M?H/AW<'$HG-L4U7(MH:9BZ0\#[/%T5ZC]\YO!>J5DN/O%S6(/[PT_R>6RJF^ M1,' UD?]"$/F,J.Y5U_0J4^WZ&V8H+T?)+\VN8Q%]==%?<R4'/Z@(%+(>%:- MP^3M:7C-^ K5'B;+B0[N8A1',<!C[Z4W8LSII'>=-7+WWE!3CJ;4=PK6;>9E M>WKU<A>N3"Q-B%S+J)DC-/*M$!EBJB4FQW-G'Y']$H_T%VY??B%\(R\6XTQ$ MZE/W5.-?W'FF9'!AS-EC</VB0*SNEHUW3K(Y*W;H?BZEOL#X2Y'G*/I5"/BE M)A\'^'/GP/#,8RA+X^24O,A[,(8%KBX[J(];<[3''FO")E.VW)K0I5G'JL3V M3]:"GM&OTF!CM9L@*:H=#VBVD2 V2/3N7&G*KBU6&F8;J:38K\\<ICQU7DFL M&9W+-R504-^&:O_*!R,H<?G8[T6'2)Q;(EFJJ"%(2,GD(FA)6$UP^E94+29C MMQ>9[Q'4]R(EGRN@=HW)E;L"#A?NUW_]^2VN:3KP\T.P\?E(0$^N -J-Z!<" M:+1.8#!M"PJPE<+:3!W>+_K.730 ?,6."OVT;WP=*T(W@B]]0@'F[MTQRN&[ M.#!)P#]5\Q1^F,%W]<6X!!!?!$AB)78BA/.=J%ZJBV?_SA#*X_.H/V,T/=JW MEO' P9%)<!G9@#+W*B],LG9YQ+"];@R4_RPDF[[YZ2"7"^53Y/[;"'W2Z>;G M3G^UM[4K7E9S8^^\04.[QAZ!U^7,17]KH.GM@APCV3M;,46'_\M B'WYP9Y2 M)PTMB14R? (4D7W!LCQT4E:1\VKWWD<4ZRY 8<A%589)C5PG%$T_#DXBMZ,H MC^&-D>[+(4',V7@+<.?M[6G+RNO3O*NFX5!H\#K5-.(^(Z;0]"T7F8M@V+\P M) ;4ZY%A"N)7ME??E)N'%,#=7_">Q(.ZRE6[FID+CT=2L?DBQZ#:Q=JW^2)- M#(?.KGE'>-OT@0AG8FG4G@%[PHP'ARV'GZTY:-@[B0H-5T#P762O4H.5!J]\ M$T5PNN KYC>JI"S)IL[Z5KB OYSE:+>>1SZ4WGSMQ+WW.EU,/.?Z"[#/E: [ M;F"DX8]C0#J&>R,>35\)5.9;3*V,DP1" OD9@('6E)#;:35,TTZ4]F152:@[ MLCL8*Z;8$:<EZ<[C-DCK87R9R&^NY$*Y]:Z$/E5]%H-!W;UO0ZS L\#$?!%] M_F]6["5=TNO#%IF2CQ\6Z^<W%](R2//O)DGA*6.B[G\0%1I7TLV+,CJZL_9M M\.IFV%M@=78M35KQ2,(3X-5!". 2B#(RAD>Q5M>*>:ZH7QTL'P_0.Z-4FN,P M>?$S),<\_+@8#I16IC:(\^U=O'&B6^@\W7A![$(]!6;D7LP4GQ5GF<.(0=]G M@'I5*^"PNRY?<YY3&_B54\V*R1.@4\9_8I&$MY]657:B7KAV>X -<#42H'N. MG^QN6A][U([T'"C-?.VI+CUP/0])3ZSI4H2AL*- I49Q.5P&D9K+,=EC\'.J M\%&AH47)_NT"5,*T.7_NPJR^SB^G>E<XJ0:*X#O' LFS6<Q\&7E (L^(* DC MZ)$&'8 4($7[FI_F%M[R9RQL9@7L+D0T:[Y(R!*W$$/*FH;BDKUB7INMWI-5 MCJDSD]V^FJ9LJHO<+7.'K8BZ_5_M?6=44UVX9BB"@H+T7H0@"-)[#8@TD:KT M+E)#$1 (-7207@0$!)0J76KH+70$E$ZH"1T$$FJ4 ,-W9V;-G7OONG?-FG^S MYL?YD;WV6?O=9S_/?M[G9*_SIM<G*\E[90]4BV87;K=%:^_= (*NH:&5[ZIS M!8R!^983Q](6=/WZ3C)A+W[,UFQ];(TE$GS0/2"IJ@Y/20Z0U+.X 9RG:;AE MDKYCI<,KA RSAZ]B*EE>]9**?S-V:^]S \:>?J#)G.+%(Y;_4WE Q-1U']$@ M\_GI>\AA.J?7XVWEQT(:U\#E04750Z\Q584JQN_GO](1?T#95T9+-B'%IA&Y M#(-JY;/[MP9RR]<*;!;@T_JQ^7C=24%7\UT16C;?^8_,N.PJ8Z ;E@#U[;<U M^CJN&!(;0#29P6YQ1IHKXW1H+!)2SDG*[/+%ZY&GG^F9>]R*:+YI4QM:,MI[ M'B=<:4E8EV-HTPEV2/?EZJC#)UV2\WNSZ@/\DP0DL6)Q\LECP\!^'Q4[G>\Z MV;BC@I(7!P & SG>^7W;P M@-J:01F9X&$RS/8<.\,^;O# J.\U/>)30SE9] MF&!V160[1)S"]*8L\/_H:*P_@?#UOZE5EH-SN0&D%6!E;P#6T(?0'=I_;V84 MQ!VN&>/6#D$[Y"CR*_S9$$GQ'/[@/:F!],H%)S?Z3*?3*4]Z'X!?15*-F#.M M GN.3BR?O/W Y!^?/YGZ3B6O@Z7[@CW7N:\*8R=F<:*H#J6'3BO2:6J//MA; M,"+6W_U6"/YT5M2)'HP3$,-^:<1,9QAIPH+F?U45"X9.#*WR#&\GIH_1[[+Y MF%W@K@Z,5G=T1*=TANIKG"PY.]$6RY%YL <U,1LQ0-,&B0)@ NQ^<WPFP>8$ ML?BP5@G.I*D=_*DQB&CKGANEB0OB<9]N.6^#;NJ7S1C[I<$CR0L5;\;,J$"5 M@+6 L4>!!I+GOX<HQ'<."F&IHLV4(Q^.PT,4_\X)2T8$\RRNR$^SBDR5F+CI M^U5N-,@2.L>6T'N2=<]S [>]'*10K;3]=.T@.\QC)7MO5QT-6$S#@W>U2IT& MVG6\&)B/T#VN*$]58IKB,D=6;H7'>1=:& +EDB'7[OJ6O@_T=W!7%?45Y#P" M&@/TL[[1.%G, ]J)2ZM^VF#+'5,44X"=DT3B6Q7/9D)T6Z?+L>I*ND#IFA75 MTKYI=:G3.E^;E<2:AEVIZUB#GFL\_1)K>V6$*T$F _#M*_R2-!O,RV1$7BUR M9E'8AJ6Q0@@RRCW2%Z)*-];#G/I*?K>)T:%?@Q]%AS@/)1Q-'G.W-]>X0&LC MC_// LD6VZ;]W:,Z>=41@9G7@I/(.,(5T\$WU1OI@,B/O)C</@"1B()]_U,% M,FR6:_$?/<A>?XVA4!S70![7LW>76762M%MR7J&-S=+] " "VI]^8OC %AXA M7CO_%N:I#Q7E9/9LD]HN[="Z$]W/]0PXTR[?49B,(:WC2W<-3R<,690G(GC+ M'.\,\5+!C"6V.4C4HN1!KR8S1D=:FF)_J' N>5WV6Q.SB.9KA[4IY:%"I*4. M<!9@<#&#0&4C7T[ '\:#UU>?S!'I'O27\30]/-H 8E=K"Z=\FHP19:<:1S8G M;E*6_@J1<K2O&X#R2@TD(-SO[X!40RHRNT>[XES)6CP19X<IWH7BL3&S([2) M=BTDDGE>'[D]-C I)J"ZE_U0>YTH^,@)R6[DQX,--@GM])VZJX$;@'=7.D3P M]^C:@69_?GT-?.@LP6(BFG.J+ELBDVDQJ,COEH-LHD<":[:'C_M!_6W%S\\) M=HV/V#/LC"A5.$YUU;>KWDE:D;R"^\(8M\.X:FNGL]6:&>TK7.I-1@[[E]0> MKTHL!E!ZQNM2Y49_GFU%6ZQ&UE0=MK.(T>I1Q"60ZV;KV0K]WE'=BE+:^U)! MWM[2PZ13C4W=8SG&BKU\[6K?-,?.$S2PJ?S7\(5V=R)!OZ4"NJ,F7HX?Y?YP M%]&4@HKS(XM"O/TE99>X6V@HFWGA2\%9+O7VC>*HM77H 081\X9'D3-=%C+. MU]<I#H&BZ!(#*>[ (MIEW0O ?^UP,E41B+PRPHR#IS:AJJ1I0_8]OSWR1,VC MX2!JW-LIE]/GV"34&.W*R+Y^$%G >\(4UP5[]D[CL0]Q>?2GSZ[S?L(Q[-U M]>IZN&EK6F;.;;29+ON*Z[7[50<X). <5]A:IAI8:$>TK/K](SR;<JV->>T MRW(_H#,]#'9+VZGJ!G=B:$K11[U/UMCN.5FRG$ ;! [>B%JNVA*AME1%=(0G M+C;LV?UM)[^BM\,;;@"D^ZU195NK8,:94R>:E8HR*;]L(+!(L]' -E[8MI;Z M?JJVCGC#*'6LY@^_/TE2#*<$B/(^"F>11;/O!K$K?EXG@5_NK)?)S8IUNXK( M/4]6.">Y5ISM_-+D_]YQ@*4.+W=$"112*0V$.22LB/0GKF5==DWG5]GQ#[UQ M:G*_2K,3GSA,__PQP<HK3T</D27FY"'\_&-23J$@P?2,)FE)<R/92$^BK0%Q M!&'^YJ[%X[22P?M\8BFAP,^;;?Z>:MJR^J8Q4:-:.AG&ZV3?R&93PA)6FH], M?6H;:W+$^V)K"S)3#9GT;J=@G!<^/4OWH=W6;FVZ,=2U6MS"[2K+10RLU>78 M[E84FI]"5Z$^_YI%1]'+38&6G&471HQZO5LU*+*!]1]7B].$33Q29+)$#N+. MDM<Y><M,@:;/?V%'#3"SV'925WRGK[&@V$:>X0;0BL1W]!P0&I@>!^K#]KM M?+O]K:+.&+R5N09*J\VY,Q7JOX%RO'EO !XZ^%+_% 98)^E<WB<;U,-D1E1Q MUF;W!]J4/L,W757Q9>DLW$AJK5<3F-_PIF>:F?,1><T\F]O5Y\J!"G 4)VY% MG^'&*9DL/ F<)X5WOFT+M\B'M3R.K@5[E8DH?9#X2D#ONN3 TK$O<WRGM>VD M5+%VF[?2#U<?:K1E8N_'J=QPBLCM&#XKOEINQ_<S&UM#OGXGOS>7=;_*MKA_ M0V-S,.0@55411^X_YBKH>II2,40G_<>/X?H6*Y20$7CWWY>^,DDY3R_T_6AE M@@K\8))I%.FQ]#> #VW;A]\V8P#9&U#DPQDY5^Z<=7!7O?'W48B9QN=*@JN< MG!#E)38#BY0S9+2XB'I>!"(S44R#.X"??1D2>RRY(.9/_7A#54WW&)]37Y[4 M0;Z"8WW '=P*PJH$OKQXV@UT??OE_M^69.XM<$%6U?N*AH;:,#ZPIC<%W,FE M0*K _+V!+H#M!0SXS''*[]C6Z_.WLS4J$\HS*;,JV_XY*O.K.'AV<()TJ(& M=P!2.H[K^Q;]QVC.ZE6A^XG:?.#NO'ON1%@W/B8[@?$#KX"RE28WP4/S+8V- M02/;Q2_T>B%WW,V<A%0J7Y9H'3]55_+NWEM"-547&EM3"K^*/UCR%/&GTC&D M_>W1*8[114M&G 7YF)FXS^DT!:2Y4T7:DRYR2YUQ?P;XSZ7O,:I,#+C30.TL MG-&(_8S0SO$2FJC5EPE-F2V-'Q;'V[)"2-*28T(RZ"?&#D3,%BM#VD>]VGPP MR:I!$GGSZ]DG-N@)8UCJU#7%:(19@%,30LFCKU5CW%#S2<S3GVO)YW4LQ1HD MKT-X7T_;?YF] ?C^Z(RNTV"96, M?C':2QB>M.6+LHG%X#";>8O%F,NO_4\ M#+: ,O:AC_J <^)/&O@M$:Y4IHT-='1"F8:-'XEYME9<DM>$&)A%#@$A7J93 M8$8AF&/_6.?997D\\V704BVN0D-*S8>Y+H#5X5+K65KP6!<5JX9Q"O*RD@^D MDQ9JZ8LY&L@G[;R[(R,9$\SN+'.0F(_RL,Z4D'G]S-%]J_X#,&*D>:GM70MB MM,V16*IZZCRCTP_D /U@:9DNALDEVF'*XCQ.5UTI]/T!Y=WWSH_JI,1F(5V) MYOI7&";;M5S![M3?E<L1E?M4GS[2ZL+#U&B*GSSA^U*?&/_'88 -K>>^L#H MM0-7!?2='YMED;3+4'OBL_A\Y^/QWET"J%4966%YN']/D4>WBQ; RR$E?.1D MRZ;+\TF_YQQ6W33B944IX< -W_.:0BCRXS7I;8K(C89>DW#< $A _[KAT6W# M_/V:Z+]N"1[$T8&OOD+<!^;^2L4&*2O#\OB@]8O\VQ.< YW6T$_"W9X^4>QO MVL9>64XWLBCL(03O8[NT4QVSQ=OJ84TF7X&V@7;%[$)[]XCS9@8#M=&K$0K4 M./E\DUJT1>Z&CS["3*74[$^,A*8'LZR>06O('Q(A$<":$87?NB"I\2[=12;K MW;KOTX\ZFVL9[TRG7G7^*FC,1FK-+]'(]9"]'NSP@=T?_$(LBU%&9<(%%[+= MR9(85R G</\?1QZ^)7N3QHM:OL(\',TBZFWMD]TE+[\D/SL8X..$LZ'U=19& M>V[M[JF6H"Z&VC0H_AF]H1;7<FVJAKW@,#!5ITQ\VMETL&>5VAAA@4U"6N94 M/.4P5FR+9:J(*=&T]7B\Z$<_E)Q<=$^=)%C_W5WQ.S61P<3#4&HZ*$!,ECYA M+*$A#>I@,E9;P__C'/M\V*4\N3MH*O1$EY@8=0-8W#]WQ_1?M?^MB6FWX6\0 MZ9>9+\D@Y .ZID.&1_MT\-IA%MW6<[^N[Z$/2J.V)L]D!>]#$']EM:3F=S7\ M6.JY<C_'U]&OXZL 6<I&,UQX&&K(FD#XW@D"LAV":W31GX;%$Q66;<#X0$E) M/J(_]$G+K1F$A=!5<\;?="@8_ YL!J@3_3>D:0J9]URWS:)/].F=%PS$Z1DV M,%]"_W<\! MR6D^#A7XY3(HGX6&S+[0_EV60\_+ #ZR[*3,!Z^P>GUG/3GS[ M!>.L[MP [*^<6>CZ3K"7/:VSA:X![RIK2;/L&]H_9A4N3;#?M500CM)OF9"N MT:^=E7O W?<)1P5=<__=H55T3%AG45G;T&F44^LC/;28ITVFM,X\9UL9/'XK MWNU:[S(9)^!'Y& ZBNJ^'-TZLVB#<9^HP&01'=93O#5&'1SUU+GOSX8 %H'; MI,PJ;&#@[D$5BE$V-Z4@4B\5MX9G/E!ZZ1C\XW9O;]=BID/4Q K< !IJ.![W M[9(RZPA;<7GQ)HD),*63-_SUJ2F^ ?Q;(J0NGEM@I1T\:/J[>B?NPN4$@(G& MIY_".0F2N]?#[GXA@ZY+P@/8B' DV&+_S-M$ WH#N.LZ\#&3,;[\@*9(6-TV MTJ<\'K\O@[U67H=F)^]>_@]T?G0B>>;C'.?*;DP*B:'@ 5?&55XPMR\W///6 MQG%5Y*-+^T?O_#I](*H^Z9U$O:)2BOBPJ#SU-GME[L*YJ&';Y7G87=[XL0/S ML^*W$?[I?3F<Z>.*\<C/%U9ZNY:^ZSH?LE4&X5 JY]:7:&RB+-NI'K/ _IW^ M!785_)?EOFW2!OCR@QZ#S"A-=W*<$H:HT3O@F[/5O#_SZE-#F.ZSR7XV-I\[ M3^]'$_JE#BD2QT2;[IZZ$^[X^Q3:"L,RC=L:X4I>WU[82_R0\0/W>;!J2_"B MFO_8O5KVYW:W$ILR)4JY:,U:)0FF,\>ZP_DJL 6RFETL>Z1<*Q5!E.&;$[S? M(&_D#<5?/U\_\O,3C\8\(<$]O\J'02M9^5SRNDX>M-08.T .["G5F)U'U-\M M/&[W10$35ZD5\,)$Z/I=[DU ?^]_#D[O$"OD4S'.@RE\^L\+?$?'=VWHS$'W M>Z%7M#/YZ)IKC:0(T&]RA]O.^FV:_Y$YMNYJ).]!:0-^M2MJR!,/@RU3T$G7 M"G)^-P!;^;GKN*CVM/.4F88KMO,HK)Y$Z;>%7<-)QV#.$'.K)2"%NV-56-@/ MQ6$QP)5R/X)E6H<91"=V*2EP%W(H=OR:B+"&;PD?Q)C5[O2%.1]KBG!D.\.4 MW@ PXNC^KM^7Y7"WE!M [ROT#6"3?@+')='(C>-A>74=E02 (E^!K8JGD(=L M'ZF+LXM6M=6N'5;AG,-<U)M9P-M[;@ _+G^%8;=[_*NB(M>ECMSLKX9FG[[] M@%BH*TI:6B. *=P Q&U@\"16$_6,O[Y)"V)GV<@%=_[[]3(:N1]2@RVRZ!<3 MLXY"-ZSJ5SZ4!LIBW5$'!,;8<*0KE=Y,C6$ N$K0$O9IH$!,7X.L>5B?[*X4 M-R'C04VU&+CE3>K<^N/P(C7&H3NY&=]*'IJ8.UQDWA]+Z [1%NG@6Q/^6*;; MIYU^[Z1'XF-3ZY$MJO;U[J\:F?<.$]3+>7,6$U;HIO2@@IWOILXR<<XPQV/1 MY6;V9@=[O3"=94)!I!D##3(CNW=1V1&(O2PT'WV ;4G9:*['=Y3ZP?4\/#Q\ ME4#<_36&)JH0Y?KL7#"143XJX9W1\!2_>]7K;B(ID_L1&R=IB5[F#D\.6/R] M7G37$#X,VA_$2:(L"'1F#]W%)^*RV6+X[>LON1?87H51#]MQH>L.B#<Y>?'@ MGF!.S=9?IU*$C-"!959Z0K+R.N>'+P-1QA6Y)RQP+D_1SP)X@)_$;6_U+)\X M5)F851*MKW=F>C]]OMFY:!^[#KD<82/\?<=KSS? 2&4M*8:5Y795HU%U<PI/ M(- ^WYW?VE\?%[I2B:0=E^$KI\I#_NH2%_TRK\'QUQ! ?^XC)W!,B[>X> _M M1: EK\@ZF6\ /1U=-P Z11:Y_W&>=HNM+O)8[5(T4#)IB.V8%"3[%CIJPE>< MB1H,C97$&78R7U;= (0#H#H7^R-==C5LV,<3Y]YHEL:CV%.P9O/[XSJX5T4/ MD^H*^#.U_= ZK,-!/F+"'R;H^T@V9ZIT1"'=_ACMV'2\K"7V;J$[2H.>\H<B MVW8LBA/;LB8%//Z*&8PV?.G.B^AOD;I@VM=FB[<DY?D%[?5"UC9OW #Z9N=O M"<96N0[>TUIH6UNE4E[7]*M&)1H_:LH<67Q"*#R@1/C.;^@61(:"?3H10MB* MWDZAJ?>R.^W202@-CI:.5K">!W.F\.]%SD=V&S$IVI-2#/MCQM$H6"C-F]7U MK@=%SD(/G<^7DBX/;^D3V;9&&\B=*"?U1][,J(G@!J!<Q><Y;A1;MUMSYC&U M%:^?UB8J4(JM+=Z9--<"(]EHG6U([[H^;IG4*V*A9I##A(D.<Q(C:A?7)2I* M(3Y'KS'D(8$:!5JN3,/RQ545J]]4&)YR&;QV$_%?)ZCR3@VT09.,E%Y36=T? M%B2^5I;8("^=F*W0PD3WG-A D=+H)<6\<-,F^K^Y?\0_%C[A9^FJ$3D5;0>M M5^C00#S.8DZO7CR0'3T)O(S377%V76ZY_Q29R1I5<(N.A'9YE)+87Y]2EA^Z MGU\J.?IXY%96TT0S?YZU_.J--CUMF$ )DO3[F]<M[YH6=^3V@BQ&GVI7D@5L MGWQC,D535US> .*.^"H#@MVI3/) ;;GMU_+@)ZH%'?EK6@6^"O2MT7J3!QL- MS3!(SM=&[S3VVD%.^?*Y#W(6WN! .= 7,^4*;+7QK!+A;Y7&"+50C_>C(Z46 MWQ3\[O:NV44/6#)<E07>9H#W6"8B3S5S9$'$>\55&]BXJS1FR:83NYXFB@&Z M'S;A=9O)O'GE.*K?77=O (Y)X5#R=HX59O</K5I;%8ZKNXC&E;/6Z2*;XZ7Q M'_?\2-9HAS??"4G15;XMY.I<O)9QNOA8.%I[J$".YH=%;+5UM71D&F)HCI,. M'GAB\#6EK-H8>5 \1M@WEL2O,K@2^_L^,#;$QJ\U_6H.30XXF6S?5KDJ5*"& MI-IKR:($H[;R!,]2.HN9W8BD@-+$-"U>&"LDKFE+.M ;F:'*C%>QB#G*/;.5 MG$:(\N5$)LC8_B09QJ97JMC>+H1%[GMR[(N"Q%^Q.[VKXV8P.=XZZTTE]K2P M9V%J'"T]&-%NIB:E=9T'ZW*T,P=_SN0ZG!9OL]AG!R!T/L3.#_!MEK_Y5E1V M^<YH%C+1)X-YM&@0?)E.8[8=#/;V+ETH,C)-.![%ES;XD_,^5JCPRU.O2(:M M1GZ<$XJ<5A5F28O>4RL99OLK4(9ZDHUX0AT?G3A#/3*D>E=P<X-59JMH6N$I MA-B\,7M@?S"8-7L<Q1WF.%[O0EWXQ' /A];9-D_JM8I?H9X*%+BFF@ET1R++ ML7:9+RYM9JR-CUS3\9I:]*T(&\R4\7*KJ^5Y+Z9=CN0XU^Z>FFW/G5D\TX+V M4PUN-!5[5C#V4$@+F?4I&-MRIQ*9?)<4M38LZ> >:V4)_1BXD33>XOH*-1=F M"S#%;L/?.I3-''1A.\%<G>P05I36%/82;O:)O*-R,17*C2HP<DG,D+F+?+?# M87#GSQ*QU4!3PS)#2:JT@/E(7,*7$*+@7(SY05*?>[0NK\.@ H,MV\M]0RPS MM,O8DNN6L0G.? GD*)T(_M-YU-V?YONT_:2!"T""YFV^G^<'RSP7I"R1^RJL M+>QJHZIES=LUW)\-6&PMDF^UG0?O4Y0(P0G>[H&E#AA3K]8YURC/( =>@Y>; MF:IXR$_/#25'>/'$\^'3JHTD]*@CB#E33.G8'HH=T,Z:814>08BD7%?'4\%C MJMP<2_AF=ZMRKT2D)]"H?+[FQAW?[,;9?*0%D:N#93-M4ZUU8%^&/<B;1G&T MC16_AOND6J?W6C:M+UG#F[\8V3CJ)Q,<S3PG$$0;$*G'>IAEO/1MG)39B,X/ MM7HW4+>IHPN3%'^ZZ"?H:LHB0B_^B3U(@7AB;-/]D?V[U\+ U*XGW4,5G:S8 M%J*JKZ%V&"IXTZZ=S,(PUVR52X+HLTT[2!H Z*)P-!6^$DU]:MVQK,N?NPJ' MTFM@GITH13]#7^T+Y%;N* +';-V,7:<7/M9ER4W*+7<=_PCS'-$*.$(4:H8\ MNAIYCPPA],=<\?4*7G.8[$GZSAYAZ'IU2LT7Q4 .;=-5Q<JM#R.$)H"=*(WU M!ZO%^NC\O@,^M0XH@=)Z!]'LJDZMJ%-J9XM[[9>GE%R2A)*?;!8;DR.!(M^' MUL3ITWUFM[_C7J-=N_JLHOUO %%<+:D#4R9U&>,!0^],@1YA(W?9\]W 81W? M,0[1556N1BBQD_)R)<J:J"KJ=^UN]BYXH=,W@+,*ASXKR@;N*;%:)PQ3K\^% MQ"1JVZ?,%6A$PFF3D'-</M& ]@7(_%USRJ?D2.3S*[ZU9_?</)-X$]R6'_'2 MD3,]EA3F_RQET\,F2,_[PM"9K#NOM8!G U/Y-,X;(['P^%,^[\HJO.E8@O@- M-.;JCJM3JV""N*S>NWS*<WA^9Z"TLQ(+6M0\%O<\$42!T/3"@'JF+)28--S? M7=3Z><:'H;\_B#E)E4STB3QDDA?HP'##?27.\^?SY-!-.9L-6YI.C9KVL3Z< M&X;PM_A]M78]$S4<]25[X#'!$^:6]]_W$Y@&3L:3X9@[Q<K#3CA)1R)BV=JV M$)F-&7E)-<S*=UBFP^#WAA?J80[HF2\BSQ5V@7DW GBKZR-*9)]/-49$&[, M#2 L]M.ZN4#I/2<Z)Q.#<46XG?J@'&LZ9Z!V(ZP^51*S&K9%T9531XHE0]-% M]G@,> SXVLI#OK9FMF:$M3:VY@PCNQBZTCT[%1),S9]-YM]?V"@A'_U\NE[Z MHF&%!@-;6'&\9B?R[C&X 40X3TF/X^TO-GI,!K[_^?Y*1R7-&',4>?AH^@@Q M._) !,/FMA.GMI67$LGSQQ;VC7 CMH4[L: Q@CZ8$\)]\$A7U@+\<.@>X=%; M ]Z'K%+ 4WG_V<P<HQ:!+5PP.28Y:O\'YJHURF4,!J<-L&@[W-X"F7IW1>#L M/("IY&Q]P$]V.=<4.?*3>%,>$U(7U5:F6)AS4WU0YD >1;M=CI R:[%;;/ Y M_:''\;:]TO#EO#SOYEP_%RRWN XS%UK"3[CRUKVLMV@XZC@E.!APM>+I]Z>C MK$RG@K9)4D!.<)W)+#+//<9CD+-Z50SK//&#;S?9*W9\M@KG8><.G.VB6$_A ML/CM@#XKCSK357X7)+]7M=H71YOG='@[-R%<J&V(\T.*>$G9]#IMG[?O9% % M5G$K#)'_K%:_ EOJ#<")ME[Y6_?L^38Q^(_U!G-^NY(4P']6G%MJ4/7U*_=7 M;^8TL*%!U#ITB9OQ(L1\DM'\!IF<4IR^1%6E47+^M>UI@6JO#9@/T =EUXW# M3OGT5=!?>1.#UY09XVI)!_@GKZ.<- #W&(RI <+#)*JJ,N>5.3H(IN>SC:1: M"HL#K$P:A<VI3P2.&NEQ;9OQ24*](F0/ XL39_A#*N?%M8L*R< [D56#^XQ6 M<<&\D+2!U0>'<KZB$#?^!^PS1V]^\NM;2?P6,N9T[</GN+^QSNEI5+?3&E0: MCI,MVIDUW%J!ZS0E3L[R%-[]2H&?]/&=C$.2Z7'-O7T$>6C5&5$M-@&IFGU] M<,;TQZV1'IB!\GV]G+EZH7B'FKPU]HM7]OS/3CY(L*;7%6S=BF39HJ$JJGZZ M( '?VI58,*]E]Z?_I&]Z(W&!/(?F?ENSL3+M?$R/@%_IKC"IE)<P^8G#Z'UH MKE])/L;$MAY_'44<LI[+,)0HB\UB$<EYC5M#RZU\SD];J=# R/1NPP^H<(KH M/LD#2!V=EO["0[,UM_B'P1CV]<3H*@5+??ZEL[;+F50Z_0I8*AU!DO,Q-(8) MA'P;2-#[4">./BW_;]32C%E2+"-73%MKVB K99)FV+*]@\4S:0%%E1_S)*NR M#YG8= 'BD;[K1P\@BX-6]54#'VKFG>N7P/OO;9K:$C9($'8]3]\0^WOZ"Q$Z M$%4+.Y48O=K_+[[=_%\4XBZJ9T.RX0(A)]<# 357= \\0%15[)U7E0ID_5Z$ MOA106_#VVV_T#K2!:W.N_[N+;3Z*R3_V624&_29%D6\Z*+)6?#/&@C5>@_># M'@^;(TV1'/'"IPS[KYGTT2)!^S7D@K/JQ&<UF:"U$C 31+![0,60M&P\V";_ MC[73#0#O^L%N/O$U _99T*T#P&2TH):?28L37X^:U1:9UN'B_Q@BJ&F 'JEC M5PAEA:^7T##A_ 8LE.VHYUHL[AN$9<!P'[X1(,>V;I4';9#L#M")!#5TAC2U MNG#VKK#/\!]6/3I6^YB51?C3EKZ;FQWJW5VC<O55X0[$8="J<3 <1P5V<D?F MBNK],M5@4J^/%6&X_X-LN4U#5G&8Y4GHN<YB^ZW'![&RW0 ZUPH/5FXST_PD M\AO ZCNC7E:JJY1@1@@<=0M[EGEL11]GWU_&AI(]5YEE5XFP0G?]<27OX3]* MVS2Y:U8+.LB+O@ER[*P@.:303.$1NN2T-?M2.XI/>D/W!K W37EY+R%*D^#G M>N,C-NA56P_;"09Y [@\)%'M0!N2+>:3AR_RXUTW_DE'.ZRQQF$(>B2#.:== M<5J^&^JZ)CO9+GK*H:$9'<UV$0&)JY9\!=A?EX]W@XFQ <@D>HB[?DMKN%E' M6+=3=L%B>_*PP+/KO_BVU@SJ4D.'Y,Y$P;%!;3T +Z]_&8\<\]6;G.#[R!(V M,,F)O2;\[ :P4(,<[+X!Q*R2!X)0\E[&,X%ZY<MF2Q2NI=T(SR0I@6&*(<_X M!<M[4AN),S!,V[E[([;J\I_S)X^0BT&B<)GWID"Z.4\S!$>17A2OB:TYD>>+ MQ)4K'H(#=QB$\SI8#G0#".I1^]?/N2;<_BHID"+HFS-"'O9!,%#>[PV+]4SC M?I5P90WP55BGN?Z?VEN?"'$ ;#C$;G327?]08+UU4+=DP$Y8SE6_SPH4#Y!O M'RY=5/.B*E+2%#D5T#:C9P^:FA+#^PLZ/R*$3@Q&WP".FOFLL5[J7LV[/B]U MH/6E6*,MJT20 SG1(HY@ZIH7*VD\4_V4<8^'Z_L<OXV&=,X(D!Y+*.FFQ+)_ M1C1W+6]S _" I@M3=R&9)F6@=B;0-1EH)!LZP8GME*3N!M#]_I9MDP4AHE D MPZ\;P Z-[0T@9/B:.A\=OW,#.+U7>]OE[6V7J7_?!=HK6@3]R3MXRXPT'-^+ M6,#8K7*"U6\ 7PPRKPE*L8;N,7.]G13HZ\*J?8F_;KE%NVCYF9GIG^SJA8J: MPNO?:2:-F#"OD-J1F,S>0G@PUZ4Y@FE9V<O+P?7=SZKY#_!*_?2- >,GO'?' MB<7PQG:[&!1H]H.I)N6T7/UL'Z>5[]7N&$X.E\IHG&][QKEA&FS6@^#T[X1[ M=E0L,9)]$U$K][&A7["<9FU3[X\H]Y,UO4I-M!P5LZ5Z!'P/YIL1D#>BB7P9 M[5>)N#O<YU^^YUC\RM2=?=JNN&]7UD+A+ &G6"K-:8^V:5#P9'JSX:$'.3J7 M01OU$_*CKG3Z+-D[+@F<AK^9.^/+QB E[X%&?A4<6/\*;;Y_8,^R@[]<<\" MMGV-M>7N(W4U[-WOU0A\W]^1]#(]6S/YW9O$1W2?#E8W7W5S?WG<()X?#R)] M;Y9$UA/C_02G7-I943Q8Y#BY*CY30,@O$O/&A8>2VSQH;S3\7!KK^F#V\YC# MMV&[4F>C[/[J;/%[G$VQAYL&EKJUZ=*O]<O&J47]IQFM?@>LK=Z7C,Z!MPY^ M:)<*!#TXJ\YX?Z5N/XLX-,@P\SZYQ:\/ ]%/S]?O'@"T0+>16MA-VL*ZZJ8W M9MZ?E",$<HI&O;;,[MU75:X3A5'R/3*$X]]E-ZA27I_KJ>+4PTCD!I7M^OAG M1IW.GP49#H")3 X.@"K>F39) D*CR5_2ET2(P,.;6#XT+=PXP4A_6NZ)!S(] MOW?([6WB\U;/?3\!A5_,!2:YAP1N]#Y<(?341ZR!PE=Y.&@Q]E>[05!9EINX M5,/E@;:-')W0L@FBR,7Z?;SKJWOX6H6V#BF3(?*#@UT4G8R!0LWH/@6>'*U) MJSY87.FNJAEE+\H'4+ZI&[$G[4+F/RN0B=E?6X%56.QFR.1E>OLZU PB/]@F MZ7A6?&OV_$YTC/;:[/I!MII991OX\M8,]QPEECZ;\AY[H_5"7@3A7M>9_S1/ MGW\LB\%/[T7TL;%ZEG7W@;6,(5LO-&25T%LM$71GCP[FZ2B3F%[1SK&GN"M? MU=;O"HS=8P@O2_F4W[D@_85L$)[?0-QC1;OK[U98N,^H<E7]%>I1HOC+N.FH MH8=J[*EVL>0CBH&#$[QD$=&4[%:K Q8TV!B=]Q45X+2NP%([-5ZA4/HX6N89 M?ZC>%I%CU*&Q-9E.,20I-)#O4E;38XW?>634[)?1BZDSNKJ9DO8D2K.8TA/3 M/V]2YETT[.=/.-*7&UCC+"0BT49KEDEK.4<$2JA<LVN*JU>:22IYL^_57[X; M&;$Q<: =V?EMX.-7D[%$1J;TA=P*?3%@%<D*S#$)6T&-3 :Q:3'VG\ID9)R[ M/T@9%[B;(?X#RN<I.IE5'.B"5:O$/E[L;\IL#7!\M9?B6"&7_39E"):J7CM( MVO<K6O7I[L7'^T+R9. 1006FZ_'6(DG$>],A]$K6.E.0_)D6\<L.VB;?D;I@ M9"E%6&V6SV^IMR=TX7D-RP'(B6Y56-<E;0V*E-2=<M]4>5LCX]!X53?*Q=3B M^21GF.=74Q4NDH+PG[K$C8$OL+GH523_5HH-2@_L"JWPJ[*Q(_H\-2850_#$ MX+D<#R?(4M1(O(LI4!X]%_8TT*:,/S<_^HAU@;TM3=ONS53KX-TG]?X9#GHC M\0Z?#>GBH/:YG(/9!L6)7:@DRKU]E\GDBZE%;9:W !K'/ (J6S>#)G?SST)C MYC-=#N3WG&\ =TXG(G__+>Z*:EBMRS'AZ+3U27#G':7RFVA.95':3IP?I ;\ MHTA4"JPX[M;OX7VSE":YSQRKJM["?CJTQ)ILO*GM9>7)"AQ@1WIE]Z:=1V%! M#PYP=/JDCTJ6X:6KRQ8[DA1FQDOJ#P>I3\0><;P!:C/'NP%0K2QF:PKI*%<V MC:EVY1KP]2,+0?/&N0.'SC8=<0'^<5OS(N?[?L.\:M+[YM>P2RZ(9)],:2QW M5]?<UF2[7ME@!5CF;M>B38#,W=XCW:_GP7MRW]Z1K7@ILC;(2191Y/^N$,01 MZZ +KRDZ.-U =96U<VP.MS]5?RVJ7;JY'PE&CHV:WVGSM@%8$Z>S4ML021%S MIXTYZ1*YXSAE0%?XE5 T Z@W":OZ/NGO'>,;P#]RXZ2GR-"%3MC]5Y(#0C+] MHR5T_VC)[C4-<>SIF++!K\VX%]-,+Z>I/SSZ?+\:B1,0'LF+/JG)P6FNL\6V MRD^_P]; J32=W#RNZHL*U7\>0X,8E$/FI7H S)X\!+M0K.KI[9@+_Y'"80TG MSN,Q_?$PWK\I[90M2_;/ZKS-K<N8M!]Z'/K/34/)@N6<6(%3I_/>FOL0[YR^ MD\@&MWL)F@\)3A&J,MX#]_8565-N '>W4D5O )1M A#0SNXU]>KM@-X,,A8Q M;&>'^4@KH=7;C40YD-L)"6)PAL,1A:N.<ZYDF45EABVS!U&_+7M!8>2IS]ZZ M1-X;'L9OVT]"C';32M19K7867R4Y>3U(+*SF+]0H=;KPY*4@3$U"L;[!-U"_ M$Z5^RTHK<L?)^]59;^"(9?+34FBO9.$-X*? /\([A>,;W+BJ:L?;0*S(=[9F M!W]U\O(K<B8M?F$[LQ[J.WRNV^(K&VQ-D@!/R1YJN8(IT,+!3CSYQM,.&7W. MKQ"F\UF;=4U/#2SMGBD"PR/UQQ7E=(G;;G,BR5ME%QC]EP'^*47L_K]4W2@U MT/ZJ5 Z$MISKR=1Q\*LTQ<;:^8#?4!L;(U]F3A$S&*?]2)(>7#FO9*$[7T'; MUZRS4>R,VI8Q\2N8:5H(ZD9Q"I[C+AYPE"_T$5GXJJZI:\_V2'>/ 0*&T2O) M_KL^:M?+4[@G4"3+9*+2U-,A>>BOVSF.-K AVKIE+CZ\1:\U=WW'/*BSU @J ML3(5\YSG;P #2]Q>?$/L*1&&9V__[G(]BC8M_M9>']Y'Y31R+JSU32#U6J4] M\].EC/2XKX11R#VF4"EJO,-_ Y!;/$Z"=FCL_CL<UUB)KV"!XJ@Q4KUI>_1% MC&M>CX"@VP'_[\Z?YZV!GC+%&Y5%O$5ADH]4M_[H$#,4WT+938=XG_5QYV15 M0ZX]EK]NV21!86PSS[&_;NGEI.JSF+"G'X9M4^?7,(JL5[= FKU%D^*_(MIU MJ*$5EBP?:2#W8%U+$,4=?@JEVDD=EDBI,!WT P-K/RT4>J1SZ;!?,BY_N?\/ M[A*[%@QOC5+-/[%CK)(0!NE)?36AE&8FBXM#*\+6ECSIM]SK:SUIICE*1W8U MJ.$^NH>LGDM+7N?4\!#,!M[.DR/X=J$MJ6Y)V%1Y XB$'K_\Y]VW=0#HBC+] MZW_ZH=HO]Z$14 QF?>*2X;#KU%Q\,/#Y#2"M"2M]>[O50RB?S._@?_.'(PN& MZEI[<6W[*C10"5>Y0Y!VU2 FBG*G#*2;-/BJVH8!93"BV&2$ BO#?FVX,[#Y M<HIO!LNA)1.N@9 X(PQ1*4;[</!EV@MP$GE3''/&+^<GA.1/X<,F7>]U$^+[ M:I=Z.WNQD>A\>#XU62+BK.-'ZBX=T>$ 6'/8M2A,O\VW0G7$*Q;U]2HUF,7L M*=^#ZEK*'NJ?S^DLVO&EMJ2SZ"[:^5(U\>8Z"!3T,5'%&.Z!:PIT<=[7"D=) M1FATPS)5'[@"+"1BKLP%=XEP?[:E:'S'#<]E8QH&7W?KP'BRL:YJ(,U E)#@ M/>@#!,.GXL:^42;9;PP@^"-XK5ZJ/-]>U%6J G-'FUECR?>?8@\7Q=3,VQ%O M8@ZC1.166Z/36?!V7PU>\F')&&HV$[RG,ZY^P-Q:KW:<EN+IO+:.Y]?E/?K9 M%430/C4833B(BK_=MV0%X@@I'6P266'2X,RPXIW1WDXO5)&EIO?('<P?K\$R M3J $>TEU/DPN[LD C?R+(Z.JU[KMPXYE1Z,^W/4<L@&,;&RPAG7"ZO\):_=" MPHBV*;N__5QB:W)6_6RTWY%=^H=ZX,K##5R'M-AETH(R\FPN9UNY:G2KGYF\ MR[)#MC !-A!]T>5MMD50NZ%+W)?'@XGNLPI9O>\22( B9;L/J>G)U.)%J/@Y M7^CRJ5XN/ _YXB*\)"T/_H;9AXP.K(BA8=T!![XO&GY.+U@N.+]SW)KN/<!+ MYU1)B,5]C0T=\(E/!N]U>)V#L XH=[Y+*YT9<26RP%K?*HLA*GEU(NU[AP&S M57._9];VYUW?-#=CJ#&(H=3%RCR.3@XZG>;1RQ62<\YB(06+GS@-#--@'<3_ MQ&JZG<Y;_-.TE3(&B)!NF2Z])#E,3Q8B":F+Y&IJTF!WR#XF!24Q7L0&<Y#' M(.;BH$ARC&M'N^'LODVQ:+^'>YCZ6WOV^+SH,&EZ=J/5BDLA+(=8BXIK$.7F MBD9ZH)(_8?Q^XWR29.IHSQD+F$G_*JZ3>E]41>)KH=6J)O43=^9,QHZINN?A M=T.RI R8\1 A"F;UV$\KP%F!0YPP=Q3[C#LJ[=*HSU0M J\S(><. =$;4G5? MNX_,-#AP[B_O*J^>:XI9!<8=_P;87ZL8X*5AR1PC<Q22O^2U";=5CIR=1P\Q M.R;[DD[G*DZ!VDF4H?*]V;XT1'9MYO G9BJ%V[FIJXX.;I<_06O:G.^0N97@ M>>(S<;@]-B[?JD^ N@'0KT!*>T$ *)(XX)=DU($;AV^B*Z4C%YD;0=*J\("( MTFZ>QY%5B4\79I_\,@Y7,5 #NI7LJ.P(?IKEJ"I?*B&?Q"!/S$R,-&&X(-"H M@2-FQ@!"(O0D9(^G(/0.M9[B_[SH%60PU>GH_5Z9T@_B9=<3)4X_LXK=*@,( M]9:S8G1E4^_X743< )R2R" Y2O6?$2MJ-3I0@8P5U@92W_>9P@/VWD0B>IDC M5UOH175YKW[_Q(J">7#*8LE7NSM[9N.9NE5]-GV>7T?4\79&_(AK*W/!R(E( MG(:'AT<Y!*K=U=),\<$A>\%4[?C"S\_%@9<EY/2^FC]@R^P\#/W18W5I"!%A M:I_=A1&9SNM5@7WWN/MI4-26%R52%,],"_C\V5#F>B8//TTCXX_=]%"BNJW0 M P4=4<H*,?<IQV<4+4#K>&9*O(,YI%%X84?802!_854?1<P;[[IX%\5B $] M4D-OATSFU2ND8#CG5-%WG?M.3D[ .-'G32-$9W=>GPYU \D5U7<<"4:L]+&B MZ^Z,9CN3NVF6SC+]O7L83=X?&0>^8G?U(?/?]802N?#6-^^RTP"WR&-^XN@F M<2YB5E1.<UIEEI9?,U0RUGIADC&U-DU=1 ;/'X0F1JR=6 ZZHKMZ:4T3TJ^Z MHMY7!+1Q&31F\$E-=]/X5/^X_\0 B"\-6-,K#Q1&9[14LICIHE<R \KJ50]\ MY<O%XF\UK>*-^F8F@9-<O(<B*T,Q>)405._ZI7Y2/$"6;Y]/Y_MN.2QYL$*% MG=;G=PHQ*=_:TX#/;H GW #&.;1 VYI[U V K),=>PE?H>B:[*I="7CP#+'E M(VG$9]NB&XP9,B=V"6 %SY5@W9%F<6(-F?!6\XQ:1!SP0Y5NN2*]S$ A,X\U M/=[/$#5Q_M*00$E;Y&45T:KRU-HO@;B<!'G^:25A:*>%<!3_JGS 3^)4K76K MR!4VM&7A&J0=%'2KL+^%EQV/31871FRRC0^RM\S$,]GK/\&2O<+#)!UBM[]B M!N'N3(XP2XX9.>F*G8M)E=+A +=>H^@#<F9/X\KA9F6Y4::^=<_OND0Z(WRK M&VA0])9^3<&\3$YTVZ.JZ2V'^('C]Y?]]_3]D]7+YZSNXYX$E6K:@*+%6EPV M('80TQF)S \T'&Z?17C+R_8 %WB\4Z:Z6 \A E$WK:^<[H$4OA=Z]GARNL3 MQEDO_+@"B8'?J8?T[)A%-SXU#4QFS\G7@>,=!8XI?A>5@4*6AH/W1EJPJ2-& MD()077J4>%:PP4M*,HDUZP!_'!OZF9HK(U93S?B@R.E-O(DJC45^@(1PF"9N MZ09 )^]7T;1*%LAO/U=%'-TP-':L13/._XH*6-5I8)-HL+AE\S-/"V"]S\8L M)UH$"3VE"5A6LZ1\JEEBC&A(&S(E!_%*$=[]WK<='SH=:H"3QNS#KSDQ+Q$D M".<,NF=78HM.@J[WG;Q%3:XJ(^128NJTUZ1IOG<1!Y*U!LS71)Q&-J:J9!72 M?A@M_VTX+IK<)>!U =GMU_1 %_; 7NP+1IYF& K5XH\1"S]1C^E>*Z?\DACK M,14+V'A\]:V=@"S3J^RJ"7,Z"M8,&*XQ'-%Y0HM235R^-RC(66:@E^>_YF61 M";\!?& 4[*L2V;M037W3!'O@Y$73QT^=//)%6)^<..I5.M!KMACV#[ZT)-:U MP^'9YC)!?12+FF"6@KMY/,/"7\VMRS-DU5P^&V:$(SOX>F=!;R;%+H-DYOR2 M^]WI=7_XUP[J!^F(X16K4.OBW5[XC,>"B148_LK'2;T2?RU6DL\/SF,V(C2\ MNC?N0--#681$^_W/J/'^1()+G/W3Y/N+$V;@_+V]$X0O?7X,;KY,C-=1FNVL MP#J@O5!N2629WD$H62>QQ8C^Z\@RU<GKS2A&CCZV',)33DQ-0<'4@?7RYJ(R MZ_8)DXOU;;;6#MD_,N0A^-",U4%J4%""[NV4QQ7G4A-/K;L8IZ4YDZER3*#? M5[\:R*_OC*XQ-]GSET@JW E^%'7,%S7SJ%;%Y[E^FSK#*$6C+ZM/XMT:FX(0 M!1?TQ>_ABMUO)=?P;E]!CW8K4OE[_!=/>!55$?//E"ECJ3>2/J/*G6X =8FP MTD$'-P$Y-@]PJ6+9FTFL_R.1VG>'U7M$NL*>A=7JP+3LO_ZQ #3?1'C7P\8@ M-K>:<L@KX]F-VB#>P^N+%R9WQG*('K-4QAN0_K97%6QSVO1*B:R\'EWAFFZ7 M+UB4^(K,&=-?D4C\"QY[$CPLYZBS\,CX(3YG"-MRPKJ;67CV7^=8P)\FT +4 ML/W7T_<'VH($6@\JNP<IL<Z/GR? &>;?/U:5E08](?%](BZ>U$W.9(95/7J9 M=](#R_XX5VLEO]3*2U^<(1J1/%C_@0*_O,6AVY(&,OCKHRYQ#,3]_/WWYL0 M*!,VH.?Z42,,ECCZ0M."44JEH]EJY?E^/+5@!FDJD9:/OWO/;9[MY.M+1WM- M]7,M8^L>OQLP7.>YGTTR'M"N_L*8-TPVDF;EUN;Z6R:Y?]F=;6*T*# V1@Q\ M[W$B*>^GY.DM_W;Y!2^>Y&=DD=T5R@5D/OU1%\^2Z?(Y=%@5^^ &8)L&W6T] M[AAIESR/N<VU$]!,UX./;P!3WIL _XG_Y'!?@]Q_GLE_Q(M&&A\%,GV#E$@C M8<T6RB;9UX\3[0DYBZR)[DBY?SP=NJ@&#6;X=QP-N.-!$(C9X<KW3"S:XZ@5 M,YB&1?5S)I(W'$)R)>/J>\+9/%_(NJYIBR^N\/AO &CY+NP,&[I1L&OGGOL- M(/3@!C#PK2"$'&N:N7I*"+MU5><W@'4Q:.]TYZUUY.JZ)KYM8RR(!8"0SE;0 MGY2W7IE@\0:0H'<#(-6_O [)N %@65=QSK$\@'\J,][NX(J:4!RY^[6X&HY? M\^@OOMD-8"T BBGG^4+P?QC$Z_\?Q/\/XO\V"/M_%X3H_QM/P@ >J'B]@$U9 M%XR:.Y^5D'@'<;"4:1S*^#.JP;;@$.V,1\[?:B>7+/2 6I>X>/_OV7C9ESU# MO86^.O-%#9)Z<V;\(47NC=TQ%PB31HX26B?Z=#0JX?#IZ66 $R/'"UKU&0W" M$(^4)1*>+^0W"_\-4$L#!!0 ( ,Z FEBFX;'I> H! &MS 0 ( 9FEG M,BYJ<&?LNWD\U'O[/_X6TF))MJQ#9,F6G2Q#A20)E4)&24((86C,A*Q90BA[ M64M,LF4=^Y+*3AF,&2);9BQCF#'SF\ZY[W.?TSF?S^G<W^\?OS^^P_OQ\.#U M>K]?U_-Z7L_G=3%HGVA3P($S1B9& ,# S!._P!H:. DP+AKU_=/^HN)_LF\ MAYF9B8EY'PO+[CVL^UA9]^_;OY^-_> !-G9.]OW[#_ >X.3BYN'A8>7@.\3+ M?>@@-P_W]YLP,-+W,#'O96;>R\VVGXW['[]H30#G'N ;<S$CPV%@%R<#(R<# MK0T 0 #,\,O+^!?+X9=]#/N9MFS=]]^^H+* \ N!D;&74R,WT]-_VD0_>< M$R?S03$E@]U<%M=8#GMQ*P<G/-LC?J*LF<>R'R^A<MT[9.\^7KY#_ )')*6D M98ZJJJEK:&H=/WG*T,CXM,D9JPL7+UE?OF+C>,/IIO,M%U>?N[Y^_M" P- ' M8>$1D5'1B4F/DU-2GSQ->YZ;EU]06/3BY9ORBLJJZK<UM2VM;>T=G5W=[P8& MAX9'1C]]'L/BIF>^S,Y]G5\@K*ZM;Q W25O;W^-B !@9_OWZR[@XZ7'M8F)B M9&+Y'A?#+O_O"SB9F,64=A\TL&"YYL5U6#EX#_>)A&=ES7O%52SQ/->]^_?Q M2JABCQ"^A_9+9#\76,A_%=EO@?TGKC& E9&!GCQ&3@ ,[%@]CY8&_LN+X179 MJUE+$QF]84Z236TJ$;>L+\O4,9\;>X\W^3+OVE-SZ$7SVO$;UF/FF[G;LXUL M-"#DJ@$W9C]5@E\L[H2.$U3E\&[J]?MJ*"P>P@"NPV53N..I6L84O?U34ILP M*_KR!!K0*;N(*$,C>DM0.UL0?.Z2'V9MT9,&P*TITHPS\2087Y/Y-U(A#6 6 MIP%Q%C2 (X2T=P?#30.F\A"$=]N8WV\@\U13MFUI ":9!NP#ML2I(&8\%[E1 MA@8TGZ8!TX\1K5.-NQ#^[6"2#(CBW?B65_W]'7GYM1@:\.(<^(R!L^L=>/<_ M>S9J;?Y?&]130DLJ7V^W96/U01)_?-"/=[(>H0'7JVA MJT7#;AM19'1ZW;+ MV&][/4CG\2_GEOJ;<U>3A9&4;30]SN_K(64V-. 7^,SQ.1QT1/\OH[U_IY>; M@QS&0=6"V.[$H:E!\C1@Y1T-"(-=)0?:MJ"$:8!3V.KU/9,J#Y1?.>P6N:O# M&7>+T?-[#'R_BR$;3U*\GSU!,*?N,Z8!0LC2&Q65$Q\JJX)PYOB"=-EK-$ A MA09L?D&TW->C;XAHAC%15Z(1>$LPZ0OHA[TEC=UN@TLI.RK4?*T=&7B[.PW0 M^_G-U,[?UH-;XK^CD?\O\!+!/X-=_G^P^R7Y5O^ +?\E4_^8<;U.-WH 5;\& M\%,!N_T'H/BRL=5_Q/*)5R6/&8FF,*[X#5DJ=U <.F/,-OX5_4N&U1\!DO[A M)$&>1&W(UD8U#4#]LG4T?MW6"[US!A$&P!)^?- ?L?\7U]S_Q370K_6"(*_^ M9'TY5OYK/0IK0K0UB!E#%TD)M60CA<ZS=(._ X0:_PY0!!V@_%]//<:.X3X0 MI)J#(.8'*4WWW(.0].M-JR8Q4J:U'9]2*\R6(>J(9@7WJ22B7K_P,M;?W=JB M1\?5A :8P&?.,_URS^SQ?X.>^T-"DS=0GY91<R,8*@5)LB!J>_Z&RL^AZ/D[ M%'\'RS^&T;'J-UA^#L;_K#?^3P!T#'\@V?^+EQXO8F[@E^66@K:&3.EN#KL9 MWLL,K2_3'TP#_O<G#]::1U.DD*Y6\]LWBY\M:(Q\>3 R\J95(B%94_NQM];T MHBWB6A53_!M;0N?VKXH!^GO%^)W"0,IL_Z-R/V41/M2''IJ]V]_E)K=P04 2 MZ1/@Z2B9&:";D64V=&?/1,E,A]]IEJ.?YEC2@"W;OS/:/\B=>=G8OPP+\G.: M:_MOS7T9F#P;^WQ^#>.J[#(6E(Q2L;L:B8M3RG!Z^AKH%@ZZQ?C%_&_E+-=P M:%WQX.62;TEZ3U]>*>?FXX5?*$MDWS->(R1RE 9\3_K /TFZ3_P;=/PKF?@O M^N45'BDCG?,'0?,_3S737Q3-E"@+V5K_K4# ?U<@9LA%$1"^)'K2S=_F4L*M MWB^O-CNDSU=?2^G4$8@FM]D?&I@=?-Z &I#[,G3Y2**=JD5ZBF93/!B:V=.T M0;__YM\7H*PG_3R].U[_QQW9=Q:B_XG/_6Z]WB]&7?4/C;WJWS[W6YOSL\;^ M?Z4%_?])P(CO 2-J_A7P:?#4:PB#[7-2KFXGT7*.!AC]TH-6_HN!*"R$U96( M_ZY2JJJKCJMT@=CG6.Z SB[_@.9F^/3+F6F S__SB?_K\4+^2;Q6KUP%0!&W M[<F7TL\.+.5V+#[L/2K= >6_V50X[V]C5.G(_"WCMN*K;WQWK7E[A!+>;K#N MEF;\ OX) E_"_#;'_";5C_\!@?\M[=\'F: 4M/\F+*_7PRO>ZY\*X<5*F8H2 MD7=N/5@G9Y=]WU("^CDY@TS$@7M]+._ ?X=L;"K1(]^9;3C/S__2H&BBUK-8 M?F%SL<?!(1PE9K\*VC]A%N0OF/4S?>N%A;&XB)S\N@4?EUKO\3.B#R8"O*)N M:(GQ@0,B68)[>>[]'NR?D1?X:%LC'VJDH'_9ETUD[M(#I906OJBY>&%_T1G' MR1(W@;@H[")?P[#3X-T>:;S(+-Z8VS018$X'#IYF7-0'R?X-_L-I9K/QR/F^ M!0%'E^W8!TU/2DLN:8G?V<O"JJD3 MY70Q3T_"?.=%M>7E"SJE+"5\3R1A T M_P_D^'LRO1Q2K+AZV.VT9][@J_SZU*Y*TV !_IF.$Z+@@-=Z7[N+48Z536"G MZAGGGQXA1O\UKB+"=G\<0O3\K!\L+&JM9YHXJ2,<ZCA/7WO45-;8S3)IU(0- M#V!)N* 6SP6U;JU.(:95O7@V[V\-7A!M2#N49>^5S&H@KN,U>5_/X6_GUQZ7 MC^[NX;K7S/&O,L%M6;S#E6ZQ"IV6_1X;VK"MD6,]^WM%CH<;K+$&T0N8!OPM M1XHO-?;?%=9%;FBI+JMW!XY/!G@9J0S.>LB,79V-+;W2'E#0F%WT^9V*<'M. MW.5/SORL-;OOZUG]W-SX__STSP&;_G9HCM+'+-0A>D9_O[7Q+!V(/ -6<%EO M5)JF6&S8<@J_^'G$-%8[6!_D?*NV38"8[%QDZT'6'9+1N=?!/@+$4'<CK=7P MT_$,I#M^U!ZZ,?>;7I4'N"T,_^O+" ,_3CI)W4L_ET0=SGPGSC]Y\UX0:1'+ M03I234E<B0(3M2;/LXS]NMXX9R.'(QMQF^/@PF@6'WZT%<)^]>HG:!)N=QEO M//.W;#_Y4GEYQ\-NW<.U7ZZ?T)Q:H;!BR@JC-SZ88K/RIV@ =V^ /P[)L+ & M=:5^VV3^%G(MYXFZ]T)?A;,7OT16@UNKFB<K:8U8NE-,<<*A -+":%,MHE4' M"C$;ENI_/D1!%PB6?F;,?/E9E$5H67.ZOI$)WQL'=@*C&8V&J&*D;[T=1!!O M"?ILS8A>L\C3+YBQHEN,SS-#I?U"AY^6#=VX'V2 QTQ7A1)4<.#X>OX"6]<# M"UE[W\:A+5/FSY\4UW(O.)B7 GD\)V8&=5Y6(FQWXLR7H@C?UEH\BUTTJ.R- MQ]D^#*$=DI8MQO6O8F]X^UW#[VV>(5Q&E6='5YA'T( JOF43OBC?=$6.'K7A MTF="-AD]'JOHHW6J74*Q73R/4X1@39L\N)3C._'1J&LHM*#-H!3Y7&81%(>; MG0P*!RMK)'Y(KJK:TZ6[)X<-PTAA( F60F4-ABKCQY#MO (E7QY83=C$"]M( M)<E**Z1?\3[F?2R 9[TS5&TE O0&LK18!$T$1=H4QNN(5"NJ-9;Y%AF_F+ _ MMR3.BZ\%)+0[=L5%^)UC$.]L%""Q$.4;2)Y8$]^Z^/"35X*4)Y!F(V6[/LQQ M"V[&JX1_]$FK))\UQB^>W<F$@Q9 ^[^I7K7"=@8WBLX'%A3SA7L<_"9HZIL\ M=GOINK+-#4TPIO<,L.++@2Z#[1=Y !>GR!#B0]!M?+RO7;2GP['.:YO,"MB6 MEL4*C]B/>,%O&YU#7286"4.,BZ-I)&/J/B6":?.D'-Z\&2W/!QG8<)LP[DCS MRW<3R;Z;-#N^FTVT&:QPPR!K8]-[9Y@&^"+6.?7W&W*?9X#PPB=1J_8H)PA9 M"$LOA+[1,5^"\_(B#3BR2+Q( \H&0#O";$"0+B$=ZX[J\&3 0,^MV(SHZ'H& M]FN['N=IJJZ+[_'UJNS2[+83T6**IM 0N'24[XP&N#6&P'95T(]2C%),B#P M)@4A_'T5ZJA)0H_:O@7O,7MF8F_ 1([>44]:L>Y"\$2"\5:*(5=I .[I,&H] MRP987I]0::8!KYV;S0^XIJ&BZZUP5\44+GFI5VHV-J0$'$M -^U"3MZ^ V5* M/,VC2'^<:_$*Z:R.TC.8/LD-2=&B 0^J#'8'!Q3UL+7QJ21WA5R*B@J_R71- M:->=0'>U]XAF T(N21&;&N/I<"^;C63<*0 O*<ESJW]H[_AQL!7X6,,28RU+ MAKJ-0=IC05B64!WATBMN(F($ENA7*W=7RNSV[D)W[*_\:*5]7L;>N"B'PYJ. MFDOA+1K 6XD)&V,)A9G@>D7F4Y0F\Y,?6!QYU5S6G#F^9VB7<F^\0:+^"QT6 MLLW7R6,DQ^EL'@C4YQ)^]MG4I13P 9+?%O<D6EF24+&[-0)(!BO<"60W?THY MXH"APQ-K+)I-,I3; FV,"*V7ZI'WTX41 '8^+3>@9H6/ ($7-Y>7"Q$MC+FP M4X-P 5(+&5LR*.??*)$H?9WW1M7^@".;QQ6U\PZ=V\-Z6FT1<D@/#$5@.4+7 MY3U.*\),O'"RD:\JA#5.1O1F7\BZ.'&PO<N.1[N:*R9P]'W@0#SIKITQ->^+ M'F91,-\'7''S?I4/O"M+:9ABBJ +$LN8"V_MQ<F&_(\)YH6]:GGR0E\RKW > MR^,3CZ-;00[I'OF,G5LVMQC):QK!N AAKW>Y=W-TS#V3DG 5[<HI"6OE:9-X MYM1\Y)Q2IS>S=V#U<O(+.]<L%4\F>A%(M7&P0<\$R%>:(<S?AFCJ=&TEN_=5 MS4>S/X/?CG&P%D!QP !,!5]+W16J/'0-AW@H5^CN>:;BH<6;NLHW48YR'@I^ M1J_*CF.-!FNZIZR%7:9ZF>PZIU%1$$8];5?(/L5E7^WB;,ZO GU1KWAG13]S MN"A9\?LQ;47<$8MD? V0?;"8N+LT( K.TJ]CE7^D+="OY';U>?FEW?PA60-B M7RX[9DT^%1I-H=CM/-.QP'MV&LD;8^-02(INUJ'W<!G\P/Z:DOPQFVMJ+RDX M-48]YW.Y23:@-Z!VSP.4VSO9,*5I$(_+HWF;#]LF#>[-EYUC[1YD<J^^G+I+ ME&IP@MT@)1/2J5R%>$1+=D2*1HOV90\I0FJ41YJN DA%*_:Z>=9-P*>"4LC/ MS? 5L5]/'2HX[1=76Q@",RU<K&KG-0Z?M#,'='4^I7/P2]QU8(.0,@F,9TE6 M^)4V>Z41_M2S_;?SZI\H++VV6"T:VROXY.4,NX9S)72S.?ZS6CT/008N21IL MMX16XU2N]%S?O'0<=MS]P9W3X.%72D7.3MV"$U'B0OO65^*RV:UP<\W9_"3Y ML8O4L4')JO@N7R-EQ[L.*KMV7[W@\RF[!(#EXGN)$$+VLN$4F2,*PMTH1YH^ M64O@V/;(QF)8,0]E@]2'HU9SG90>?;S 6M7_*=$$>6,G0T>6X(-ES3J&1[7) M.U(/TH#=MP@/41S0ERZ,"WSG'[5/91PTN7M>SQ'S3+Q0G"P'_P3A$,2R1V'C M!4G%)GB-6(J21^VYLKS%:ID;EI=-SG;.J@N?!KY<WNP2LC;!CQ*3AL"W.*) MG!7QN^>KCE>WZK*<4T\@I<@(=?L7J3HKG7A[^-2ZCI_.['UM5#BXPCI"3P$F M.*0G>:O*)K,JU)$X*-\P[E72399VE!RVEOTX&(<XNC5-?+F#7 %CSU"4"2PA M%9Z'/G^&UED-JG&^O/RYE#E[C)W,EV"WG&5V_ZCB)+_@:S/O[#>I[>9[2/NI M>^G]E>U5?TCYZ_K*VM%7-U\GK-TM[YV54PHP31G__%&ICZN/RP+:<C&"NK>' MK'%ZZ:#J*$7]_?L[W'MGNJ5>YW#44\1P$-+9>L4"-]1GF[BPG6=[:JCOAY?; M^%*:H]I\C)/*.KV2[!&$>.+]2M)5G#!'2YIU1*6B &GQ:NS<($4W_[;1ZB-L M8=J5/:>?LXA[Z4)7[#;;4>$0 9V :;</SMBY3EE/%M)-:"[OF"L)/K)C<;\5 ME3$GQQ^L^56V9X,9$8["6S3PV1!N%O(4I.,@3#3@YGQM6.N>Z91OAY]?WMIR MO'GT,D.'DKX($H\B%E02/LS%KLM;-X_-1>@$3)$:^XN@9^Z:E)9>DZT1&7J! M/N;Q,'PFX5,(7((D0S9T32,F$\ X\TB8$N%DVZ3.P-Q08;]ONF9>D*SQQ> 4 M::?J@Z_$<N4;AG-O,SNB>=8WPR@&C@05NB>JYV.?B@U5K+"0Y-=CW<Y7^M[5 ML!KWC--MRGS_\I@!6&$/4FDG#D)5$B<^9G@K4!A91P,&\RH8D.2#):G1C8!; MHR)JD!(@%5. WQET%1$E7!SZX/RBHNN;V?.GK$Y\P"[.T\(FI3V_M'V2_L\0 MGZSI#?9 :FDJ\:HGJ0G,$D,#WC^39-DI"YQ%3:5@5IT#^7;"?$$[,H' ]L=H MZ9Q=_]O5J$=:RW<%5[(L:X&:7FP$F;;2Y7Y==Z_O"F>FY)?KZ58N0G+'$B\D M&VJ.,VA7.X<P(%^[S8#B(?A$^$=PQ6.$R*N[NB?;[7</K1OVP<P+OQ)QMCVJ ML=7MWO>KWZ=7I9!S'(57 07H-'5O'=YCKE7#L3GPU"0SX8'%5MJE:L?B<;F1 MT3W*,?ZG/_-WG-O[3:MT%"?5X8X@VNUDZL@C20,M8/Y%XHICGBOD4_ECKAZQ MS[,= S?JA#@:8A+-A66_]([MG[9>"B.@K8+@:Z<(H/A&T8G/.R$CK2850SDU M1A<\CYR]EQN3[-?<+)&QP:,1!^/'<>Q"-*M2^6_I20R65GSPQK0%.IH[>N>9 M\2Z.. @'AH9HZJKH@TY <XGAI!=X!!82I6-.8,%69GXLY![I_YK2*%"?>&M6 M@V5/*G/2L2V)EUUS(>;OCF8E$1:GI>C0/139C4>UH_9!;3 FA(H/A2ZU$>$* ML_YO&O?7&QX_P^"9&H/LH?;/7T),Y8 Y=:SQ*TTB(ND&PRLP%>S.2?NXSK9& ML4%YP_:1S.N8SH-)]TUO>#2+%[7#/@>YX6D 54"0&-2 =X[5<2-HMN*^1$^W MVTL,2=57!+.>O32B<:=XEFNM:GBZ1EB:<3X=-<:(,V_G )&*#4@R6"3KHH!& MZ+=+O1='*89%)D(:U9=[T#:1R8W7NB8QTKJ!UBGP3L2A$ABXD#J$.@B[EG\5 M:CG6TX;Q'%*M"W%*&2JIV:W \M[TF@%C1NA .AZ$XPL#.T(B,7PZ# 1%R[=] M-*!B8[[^Y/.%45[EAT'G)O6O/G R.+]P;B)O)BN#8 =IGE"TW<EMW$O]U.=B M(]\1_PJ::K/VJ@+]=4("!U+B?G$>_?2\@_M"RWU=OT5B'FD8"V9"4ZP)UJV> M'&B8?+K[^S'?K%QQMS3?QP\"_+ED1&SO[[E>'.+/GNDV!#\*3<5MCY-\VK/W MW*X "4"OXUHTZO"S+\"?/4K]JY\DV9IM7JPZ9EEZY_BT&L$CV9VLX(9A67\B MK\-5 LW&E0Q7V 20$#MEQ88^"CEUEJ=O]+C'&K"BN\8 (K*L4=0%(2 ^"!/& M*CX8$1'!7TH223TT5)EYW:_172F<Q[WD.6CQAL7'36;SHD5]7CT!ZJ@(+R&N M(9]DU59K7X;'=-9&>;&$4RR<C]2=LX@NM_UHW9.YEVE7H5?SEEMKO3P>8[Y3 MC;H%B;9!M@4HJ"G2APA+>DOI8XBOX#MHB]9YYJ_V'BVH0.J]HT61'=,3HG;5 M\H8B;U$5"-61E<@H&G#@[JB*[>+V\N"39:&Y.Y65+#UA>V<4]K(T0,?!!P[O MA*-N@2)I /[I_/%7"%:=H"*%!B=<L:G&VZK7M3(1U4_/JQ";=,V9%+1RV.<, M=Z*6&]E@SGA4#'R?JWAS[8GB,5)JZR97CVY5ON?PKF*NRE7S#PDQNXZG;62S M4FYY'J3VB>B2;JHBRCGVS]?"G_N"*SS)YF./,\-U40H8NPRR]8-NLA.$VH?A MJA>CMV_WV;R""M$+G!AH85M:2L+1RYW7^6:K6:>.)7R<TCMO<K%YT<(5Q*NC MC6<AXDE)1=#564\.%Q%Y_&2*:NREV<,C:Y5ODI/]%<XM93#$G=8;8JB<SAX+ M;6M4QV<OLSR#FC;U>!61>-T:!&SCEY]Y='"4?ZC=,(G_<HLXU\,OD1"B=!6R MQ/>*%&^SDPK;H[;"41K+5I7LSIMYI[IEOE(0(0>J.+9/Y[D)6*Q[6@O)L).Q M$3JMA7*7M^PY-R07CM3+E>#U)Y8(?Q09N2UK'%-\T%B$5+I&#,2G1)#/P+LP M^]>%Q7'@:)B,/_:J^N2@%6*WJV3'K';"@?=<B86BK$*!?2PH>!](4'7E/HC= MH]X<X:1>[+?6[E@PS]O)Y<KG7?4IYV1HR+D T2G&9DV6+BMB%*D<'V^+S\L6 MK#^"+9%J:92NBS"+N(!?7D)*Q@=(2TJ7)AJL>71,=-W)4Y(2UD*.64_I5>(Q M1/>*XY+5N-ZH0:A5>QKBX1R=32GDY>K5UMLSW:P>W%[AX[LU&6)],!6%':"] M\$_JF'T4!GRK95+;\<J5J*7*Q6ZQRD>2J2Z[RA+FCACUHBH88Y([O?3Y,7S/ M"!IM\21IQ8AZ79QYV"41^3YZO\IN+IF=OV SY.DFGVO_P/U"Q_E2?%Z\1,@Y ME@]-K[(_?Q3VQ_$M]Q(N07@I"H.^#/EFUSC==LYIEV,-#1^WN#/$STY:[.;R M>,\XUH Y'_6<!H0\AKJMJ+KA:^=/+AT%SX@-+MKU+KU\A:H:7;9L/WTIR:2Y M&2!HG '(+$BM[HV_>[\3,LP7L756A%XFUTT1\ZK#FQ=ALL4TX)W#NCGYH"T- M,"G(X:@M>AX-2/]X[7O?='1E.2:8M&9XM/O+F]=,C[QW$4A<\_J@/10VDF(> M==P_2Y9428"/+-KUSP[/#>JH8 D(N4M^ZGT@^9G5!%+"!/NW.UY9&XL0^OAT MPW@G&ZX&.@!3&1D]17)_@5X:J1>$KMI)9UYXD#7Q*?$!X9&Y#QH( +70@)A' M\!:](P3G5O/HE-KPIU-7U![&FK; CU:]3L1]P&;&Q'O,JLG/[FK+2!%-U 0$ MOE'XR9;0A\1$T@:VQ_/!@:N%+9G\4DEMDQ+#%7/18SMXG;?RFSG7#N,-WN$_ M)+3,,'K:D>BSLS'.N"V>%^HX%1]>K_7B,E3OYIOA#0R7W0>VAG;\>9L!9L./ M,U(I8)EI)G93$/%3==7.4XH[X3ABGXZ]./[J'/%F Y8?R>KI!E40#\M=JSK0 M$\48?AXZM99Q![.'*D-R)EJ1&@BH%A27+R/V;64O9S=N6?!2&K\-VXF1&^<M MU??W% P<\NT6O:LV(R+;KV9* SX9$]-(P?Z%'PHN4PP(BD1BDJ.7H!RN'[D\ M+#QTWVCIAE>7Z&8.!Y3>W <09+&SR5.]D5GB))]K>11) O-P0UZ":5&YF]_A MFRUVYH?,@L]D3MI\\]"2':C9<<1QM!G1F97HPCLRN<>VF!L/2R&^5J]Z(>CR M!H)\^F+I\VKW?9:DS4B+-2O45(Y%?7:98FA+L0K"Y5;]T43X2KX;?3RI-6Y% MD:2M0RI1W/:E#W,7P.S@LJ65PDL'>OQ&FR)/3C-4/;H3N$O7$/"WUR5])IC; MD3X74U1(%E,[\BNJ@M*^;,80PL->Y@?%"J>\T)&/R^?8UFZPYL9X)?6,P?N+ M"<Y$"U+Y*Q*Y*>'(7.A,0Q_%!%ND=E"T/HO)ZFBG<LQS]6]*=2*%)0%\#_4D MD9&H6ZBH0%#'2O2D'.F:\S/[PR1/(_RK%2>VC6!6Q\?=!^L^B!>+NW>)EAVB M\C21P,[.!=0V<&5I=N%E5QNG/#W1X<:>PH7F1C0WV#E2],E!$QA[@$[H!^#> M$*)2=9*QCPI C9L1K&A+A C47>%NB8+N9:.TZ\:WXQ)4E)7N7A15P9]X(7:9 M<#6B&15'!0_IJ;O1@+UZTB2WDP-TG\M5C'SE"V:?Z)9/GD@Z709*,9Q\]8:7 M*<.997\,UY0(AS6('^RP5O:Z<4\=JU^&(N7,*#+_'E_* *+9K*!C*AO_DL?T M@1QX1J9KNX]1@1YI-(J78HC[2F6!6K5L9X=3I (4GOH40U.HIS\6WQ,(E5 O M"HW-6YZ<<[MQP,O*E.SM8D;6*XP7P[<3"#?&NO$5]JS.-.#,\4]!!7V:AYKX MK[<YWYK/DOT2#U"T2#SX^(YL[GH5LG[["Q>X6.C5NN'U#Z>N+JB/;*>D2[,) MZHLZE$[-'%!NRV!=5ALCI3?[C6DL]=*=+%*$F72U"&K=:L]+BF6)$SSUMB%K ME6PU.+AIM/$@/4O][MBL2N;+IW.J#">)C02ICO1B2$@*B!LFBYW0&_,4<MFL MVBX,]YSQ8DT7"DJY/,./B9#C-P&)"2^N/T"40!PA&=E5\<MJ4Z#8 1A7/X7M M974D/\S=Z:6Y*N_ *[\NG@1'[W?'/LPZ>]K)?(#'(K>;T0GZH$0;>[I-(-"] M'2C>@MK3%?**G0>@/A=-&(_%36Y/7ERK0LJ_[M"<2V371#Y#3.6#"3X*]2SX M\!$<[A-F_PK7PL%6A7ZBJ;:_#_^2J8B!Z%3AN>2F*S#5;%PR:KG]N<V86D=1 M;4G<LP*I"7G?769RER6",]\=SP@<P@#U5Q!DXUY"^O1N9,"1F3'(_9)Z>=<! MFZ6U O5&W_'<L#%8W^+]^I6IJ?,LMF0]"JR!9$CFI>RA-[1A%6*XWDA[.=-T M73Y#%YVB<(4Y9;N/XPFL#K%M@7'ZLPW9S:@*CG@=*8+M*9(;X5YKELB;$<I) M%]V/P250S_,NJCLG+H?;#(^<1PHU1N1Z (RA$-[/) YC\\_%Q/.DT&E=R4UK M$N*Y\0L7>]'P#]_$$C\*%M><F.!]L)5N\1B6NW)PM]N$'C=4<6IW V&E^0U, MF*YM#PL&'J3%KCR4'*D$E=^ZIZ]T7U+N38_D'?'E^'1NAF*R)&D-MQM)MH3! MS0^0I,CJ(^Y&70N)I6^J$9]FM36.&7!?8\@PZ=Y27Y9Z5NR/JO3LZ.4D:;31 M *YZ?ORT/HBM8G\-U@UTX*J=[2)?OVWCY\+8,V$Q@;(S(:^T=/90#T$7.!CA M0Y *XB/G<$Q'[<1R)@V(4*VK<% #'6W>BL^Y(QA7GQ"]5;K6E@4B-9"U20^M M"*-MGE$BXJ2R(PW-C:1[3JI]-F/G$K4NNNE'ZSQFOI(9U<&A<YYE@ :(Z!UV MP?#)TPU)46!>5B(07C/M9MN5FZ2==)>MAN/LLD.KWN0&46TT74CE$(_(G0<= M;VI.R<<QJK/O#LP0"A2@K/8GHZ= 2T=6ZW@(%VL\'\_ RGV%B]>EK(;D[Q8+ MIJ/1D25RRS@5,R\5(.%Y3(I4WSY@J]Q@IX:BS1$"/[R@I]D_@S>/JM^O%&^! M7T\UE:L^TWE M\PW-O_*.4#;V&)4#?7"#2*D)P^3Q>=-\@VJ(L+31B/SY8O& M(?:"6^NQNOTV6M=;CE9VLX2))7LK^PS.Q$=-\A%2EPVG%S%CD.9&WC)/#BCO M+:L3 [ZR#J-Z4M$C=KW:P13 N8<IZXGPX@K=!4!\JAQQ]DQ]%"?LJ.=K5T % MW67\U$U:$WJ#\5MMUN0#(1]]$3X:P/1Y<+:2Q%EB,X$9=[56(@U>#G=;#)>T M#;^2;%I&77.46K2_2-:%]\ /[)0\)Z42!''Y>8U2([X0+HC+\=L?[JF:%]JB MRZ(N\EP6;6[E>!P<X]],Y"!)W0O*GNJ-,A7?U:@U\G'R 0W(DUFQU\:;$S/P MF"7'%Q0SD@OA+,2%[Y*>6-U(!;]\Q>?2W2^8>[;NRQ8U7[_#(&8]>5\+PDKQ M&ZV7H9]QFO MR]?LS(K-@-I\/7_!P@>]S\^BYCC;VIM8OI@U;6H70Z;GEGRF MXC^CB7[]C9(DWLDU8\)<:&/SR_%%KP6NO2OA5KV7YCP@"":&#@/N1M!.^@8- M.(AHUH7=.3+@J^W)M1C8WAFSI!H@_ED+?2QE3Y:R\GY)G+66CL-@HSI\=))W MIP#.3+J'!06[^[I;=V8=36P],[SN-W SVDSYB+3'E<SPI@O/FIF;Z#(X M/' MCSPD.U _V8 >4"YZ^H-#*/)3)%]T[(&)>B_[J_;2=V^+";U\;1E(R6&7M9K2 M"+N+_%Q-'",8M_2R=OISA%*LL)\V%MGD2R=/WUV,C),4LP7#A!@SIGS2B@DG M[?II@"-F;+"U\?CHX6&N)OAA_$OH/<M1YMP)8V<O5QY1;4?!D#=%\JT'S0$? M&U Y)DJU=\R*V$) M.\<Q%C06^23K=M"]J"^#9.2M$EA(Q-V#T&WV/<LS/!Y M_AD!@'SX+W]Q8D*G4P&B.QV:347=1JP_DUUTW9*B[GM* R3=<8CMG3(:,/ @ MAZ-$3X@&=#W$]I*9QVC U_S2E!ID!'CU,,F'VNR'VI9QR__??T'S-]<>]$HG M9 ^B61XUDPH[30/*/JXVKGBBA.'&\$[P7JHF::U53Z>!SBMO3--Q.;A,?9R[ MWE4M!0$3?RZ4CTQ3QV[=(L:-,]$D))6_FEA% W(?E]. 9CD(Q5"*HN*Y[$D# MC&7H#AIR&46*!LC6:496;X\=N7+.8!T930.PZ33 S7-;RQ1,.=A. ]KH4+*B MR;:(_G=7:,!4BB+U\'V]<KQY*Y*5HE%>7XZO"KV68V-_SJ-4;'!YA"?E^K$; M[CD>MP'EH*/F7"2.UDFU=+,D2-_ZCM-Z3UA]F1O:Z?'8QSV'3TE]J]+7$@EI MI(<7[KY3@OKZ18X^TYK2ZY33F*+BO^S^AT-N1[1#F&',TR5PM"U!*F1=^-[E M:@;Z5&TQ.)UVAT74\UH&8]^%7GQ$L_>MX\3H23ZZ,+Y16TP*>/EY_P5.R-DS MB:NEQSIG[,TWC?-A]!RR3I#IH\)_(GH,_X"JI'\__3>@@'LHBC)',VA;@LI) M_]8I,,7,KY&-9(M5C @\,AF+A;"YP$4&%/)4S!T+;2243,7.YS^]X)"9PYIM M )%!M*I31S#KWBD(TI&'],XB]WL>JG^?!^ 6?#B[K"JSF-Z6)5 D2%ZY-HM^ M</G70XI?!DN6EYW(W"?,CSW=>U[_"%S?&ZJ):VRSFV)[=>REUJ%>QFJ/(#=< M.5D=/M*)7/X-(@CIYLH8FAIGV4M7D7X$@9N!F,]#L/Z>[S] 25^'&4-GD[K_ MG=_S+&,9H^W9U8645.1G:R0E[A&=T5]=P-ATA)N'"OG,E6EJ4QF"P+.&7#;& M1TSWAL.E8:QE!$2'K">7FT!JY'1U'W)ZT%)QJ2Y)PN&LOD7]K@M3<_D '-E5 MLXB)'Z@AQP/0P+5V ?\H!=5[)O4G"]HE> /36PJ@XG=./J]2Y@[Q9BF!I6LL M8<@VY8FHBLRT.#W(TN778,*[>"I_W1_I"P0E%[OPVA#3?0M=U>^X"O@.N;.U M9\Z8RED9M3(+7S[0%-=1 V:BL)."\!C+H),MDWO[8."BXX<^C&06=K+6<>## M&47O6;\'XS]@*JMWA/*SJ7NOTP"<-)V#'G_DH#[HZF<2J'4;$>U),7-__AE- MBJ/R5-<.'WX@WT:08;889WW-Q-B;?PG,1I'#X!,]\,2,UK:WU+'=G[V*L.H< MVO'9^Q-Z'2&2-*!5 _X#%_X4U$T,.TQY<B]=LW2^JG-@/:666HT3)\R0R1E; M<'NE:MV70<Y-5!"!+PR!Y1]6-14^V4H]0^?O33OTJQ2<*G!X230& $2>(!-0 MWY.&^%/M_I[J]_7R\.#F%2:82LHL9"_4V! _4WV&%V>FWJ%I?YZ#(?K^:>+\ M%7O)G0PJ'W30KF[$=R6B47!XPZT*XQ7@7W!J]6R3X]T'\1E3#$GS$,U?B$X# M_E>F!Z4[.WH6HD]ZNC'Y$?$=9<:LTIR<W-<N7K@#" %'.]4(YM_+_0^:!/XA M##I%WSY+]4Z("5'JZOI5HQ!_(5%_#/,Q(7N)C!_%2;[V]?PN1&/$EQ:.&J/; MMRW?7S3:M2(NP=#$DN]+%<9/)F/91- F?>L]NB#32D&'-Z^#KX6+?7V9PP 1 M^5. >;_*%;U$?L^5LS2@)91T9U*BEL (%31P]_A:DWW^^%U[6-A0<2+9V\32 M0"IQ;XDI,JR1LQ%OA@HMK=<HL"-93AX)%Q9P<W*[W'_N I,XP#@XT&CU%_<W M^0L%;L%CPM:S=W_UJU4/*[2=/V[V<CGDXX"2D!?KW+[<X-Y\"T)U*XH-=GH@ M/!V7R7*.P!;=)6D:=&Y8ZM0C5A8@CJ,!EOJK#/[NKO&_EY"R[Q*RD1H,%R19 M8\.S=2,>P+0*H*X?<9X59NRIKH_DWC@*?I+^\AKHSNNG"M#'IEK)XCP7>Y'! M]0F5BP'VU(\C$X[1,UWY-Q1RKCUD##&W2]O2_A/U03\6(N,"Y #4V11?V-+@ M>*;_E>B@:ITP[^Q^6^W++8:LUWFW+AH;0/3HF^6MJ<?63M" UZ6Y-"!?T0X2 MA7)&C%7UM@J\W\RN<,J<R/!3J2?2@$]E<**2(*_=TK2XN-[&-*I,L3E[;'\' MHOSCTQ<DQFFSZE =S<U1%]YDR2=)AV:N/#F-CDY:4[<EY' ,Q0C(XI _(H+X MH9IS."IO(:/I98?Z6SX./V\\^F>O,_V+W []NM+COUUI_!<F?RF:5/RG;N#/ M\"_;_!(TYK\,>N*'\PTWYR7J$MXHAU\Z=+3USN%&^7BBVT[)3((U5<"R=U84 MT<5+7U9O2_1IV'F!NE5BBN/-OD:8O^N']RB]&Y4U?2:XO<?CL:>=<=-._]1V M-+"C:7LY-ZA'X!N+6%5,_$"F!-R9+?SD9G*X 0W81RK_3J_OVI/\O\3'[SYP MZ[U']-? *&YUQ''OMI>Y>UX:]+[+8=V>+@A:Q/7^.>%_M/(<CHK\8.?K'U]^ MZ#S"30.43+_L3%<:>*+"R'-E>I4$EQVZ,GG1 (W?H#?_4U$10\8Z!7E/]PM5 M+2_<UT!IOJA9QWU_H]Q?I/''-HALS9VH^*3N-%/@L0^P*W\B1/R/F6,@QOC- M[_41./J-_.F\ROS@0)3\=&IJ[-6(";F<Y6WK=M0/ ,D@_JR\Z<#UB[OFDH*' MR(/BU:>M]PJ(?CPWM#]IL1UV]<\T3_H+=WMY8?JM:EN8V-:U.$VK@D]][.!] MI.J?D()E,]0QAV/&@G73?2)#[EM/7VO1AUS&K='VAV0Z'\D1E!OY3^>H][_W M)C,(MNL[+Z@2,"]2+'X,,SWNY]_(<8 ?^67 X=8WG?&=YB^4M^T _(G#M@6$ MYS]TCGOX6[FX_ZE<_K)Y_E-"?JVKOX_%YE]B@OG;NOJ3NUG^C_7W)Q.<^!]$ MQ^,'1_DK:OT[Y.J_"]EV=R//" O%@^L4?3(Y@EI/<QT&E?^ X%;:)E:Q4Q,U ME1/H'WZ$5.<IU5:CHSK8B>M=^D0\4ITDMJI3\O9C7ZN?R@< 7H7['=K)_QAM MQ;^0.\O_(9C_0UW\8R73JP=5B?K#LC,VI,*?H8-DL 3Y*W)\-S__1J'<=;6Q M:$Y$;0[#EG4[XL=[_MDR]$$NII[T^7/Q>IQ!#%O77L9!O<=?8D\LR]2 :P/O MP2\2(']"#OR#5M/+.O:04_/YU@F#@NY][_V/&RU_Z@JNFBNE2YC_O\M!]M^[ M5Q6C+*A#&#:X!D6#Y.M#^*:-[N7G']G_M>()K[:GO(GV4&<*/8W)#1G>2C>C MU>'LQ!A>RORDOCLZV=:?98:?!FR01SO8OD\L[]H0K6>N;-" G._ :/R%6CRO M^OKR)2>?\WA+?-(\R:HE8^;^N6/L6IT%;CC4W[MQ15Z89%>*ZE-PW6'&C<5S MZ-5D<3\C=NPCQ+Z_J&?0O[%^0@/>_OKT9\*OO!PD+)['W$DHZMB]6Q.7_W-& M-[A*R 8?9OXP1";VW[])SY''YH6/E86'-PI%,0,@_Q9*'^1:LP?I#I=U$FV M @B,885?2&AY_>+"Q5,?_5[B&N5^:D F&W<)MBZ;;=& R^?YFKZJ+)O.A"5D M6AZ;"T'O-A_:1#Y$_$04 [<N3-V^6KQII#??H:PK8\/C%2&8.C@4*/"KM_X= MJ<_7&?&<0#HQ!I,NN'D49[X\X,L '/J543\<EX 8N[Y&+-AYZJ[#[U,$"S"[ M#4VR%CAKZIZOGV5Z@'WMR9;0>@['8$5,YZ-C97-'HX^Q((<&3#RY(WS:7M$ MC!-3\%=EV>F]B)N]8Q,WG, 5)4_'Z*8K^OW6SG^!C07?]3#@:!Q@$7S6U-?( M>E_Z:.Z>)K!]IAMNY<<T_$5-RXA?>2VBEA D[ ^_,F\6S;GO9<X%^X7B^W1. MU?V,=-C_)NJ(GQ'UOV^JGC?*_L64\%<V9OGS[H3Z$8GL[TC\L&Q+EKKO"7B: MC6*.WE'OI %G#M;0@!^JD@<+KAJE=]D<S8CRCLJ74!HP;8:,A:D(#[_LS3,N M,-Y_NN/BOI-A3 Y3&\OZH!=@=L2,(7YN)V09L6XY:FHWVIJ]Q0FC6[U#'62' MNW*@C^'[>XW_RXO)?7,:^0 \E4(#5DVI$O1Y8"X XE^-B6L\0,?(%M&M2$JB M 8Z97X @%4+HM,:#1B:2,GU:[+Q ?3_(V::T')6?$G#ZR/58;J<GTR(39M"K MA11NV69BN<M!:'E3]@$]T*WC^2T&;CC/@[<FC9Z0&['*NR5D-CKYNYOF63J6 M&<T)<\OS>',#@MQ#R;""KQICL]E.>KV2TQ8F?D5'%_P?/;-ES'YT (K,JP_" M<G# ]/'AQ<^A5>_0%_$;XVS$+L7X;_6OE2]G8SM4ZD*4FG/8%@,25YFR6*Y, M)9S,Z\_L6C RL-04#1U[_.AX%@D9CW U/V!'.38"OGEU?U/:EV]/L3W9!]ET MI\M1B8:UE9>GT4*)O)(7@>QZL[N0BNRHRA[0V"81CI]-+UD0\(@O-7MA4&3S M>;S":YSA-ME46O-(8(@QTSZ B&2 7<>/MB&YH3T&?<YOWS;@DVD \6;1ZHG^ MY^,,:X>=5]R_VCY;3ENF 4*!9.NY[*6'CE@:$(RB]\<N8 %2>D?6X8<G\,A( M#]7%%VJRJ K#XSHOF3^\.WSSRN:UDW'OH<CGV)U*/4%23U.6]@B% 6F(*SG9 M4GMJ[%45Q#D-.%%\:/6*L6 J2Z,TX]<CEYQ8.:OF5AQP]>1I1 >2 \:,/TG* M;D.XI0V77B^K*A_$K7EX*DB )904C;P9'9QSU%8OQK=D\T+CB2<]8SIQJ3%< M.*?).)@S=[_;P=+,0Q?<XM^D']-!2HNBJSWV=MZ.;MZI+$#$8LH]FT"1U0)9 M9<_'%],:HY/FJ_@,Y"U*+8U<JI9GG427X,WQN^_KQ0XC;I> #6K[UHMI0(2( M9FC'<6R:F78+PJDJR,CV5K@]]O'92YJK0FSO#RUI'FI&0OM]]_J:L;=LS[Z; M-LW",:68"K[)NLO:*JGQZ7U=\-3R=96^T3EP//@FM *%+L9&/&!I6XFD,]0% MZHU;([M.V[&]L.5Q >+XZU&)*G%&[-YNZZZKV+NQ(FXA H85U8H5&>5A]MY! MIUG2@!EWZK%;8Q'MQ=D1([R;:>'%S@[5V\DSG/%OYA?F.(WE'L1/GM;@,63" MFFCR3"S?YDAN>*NS/K\UVHPI1[7-PP6IK>"#<#U39T^IJ'J3%ZYI,QCG<VP] M=I7U)FL'3]UZ5^@B!63EX9[B>D/ME?L1CO=ZH[:-VST/(5K>T8 '012#>T$* M2+%R7RCE,];4YW$\9_E1Y:.OG2SWY'#4*:Y<&[Q-SY+MN^KJJ((4HZ\O<Q)- MB,!H$D5AI[!>AF!U%?\Q[)KS2Y=:8D-.==3R.OGKA<>#E)6C6OS#3PV\E0&) M^WH.A=&KH,A)N2'?[$^RV)&447=_'")RV_XA]LFWE9N>D[WWN*^[.%U; R5] MN-DDL:-B[Y]+_5CK&4I7T5Q[$3PQ"8?B_NR29AQ<LF&J>7BHF[.=;2ZE"DB> M(.IS/8F22EH[S_(I>S]<81[%E=[&>V<,XB*P&5&Y5W7"^O30<TYSC^G'L%TG MC0_S^-XY+1:A6SP;CQZDFF*6Z)+LF ?>/BZP4 \5Q/92N%6P5877F/,.4$[@ MB;FY"ZX'OOF5[\)*3@77'>'SZD8GS,=9$=<D*($[R5&"YA3)1WC$8H4J [$\ M:.',)3(F[,BO_R;471@WJ9YXA5?U_)7,N%U%"R9+,AMK_G0IZN#+.KB30C%E MNQ__<;2@JB\O41_AS_.^6"CFF/&'B@R1^T15AKY/U%$1[J'4YDW>,:,:R:?T MR#7"[L::+GU-N'J:.[NBR)G58?Q5'2'QPI1C6B^IC'R#Y(/UC%?0X7/&(O@H M^@2U6"1:31:TQP7LJL[)^6@UQ6D?1XX4AK]TD<H-"I_I@PM\'40'R$RY%=M^ M4))K>=FIHT2?]8R/!D@=NG[.QYZ'O'>1+VVSG6,,<F%(4@4"CA6/+7"ZJ.T8 M-7!,?_H^0)%F'-,3H [8[R,5XF\BHM)NYA"SA"NCG5'''\ O5)D=>/_B< PV M@@5XY'W,K;O"DR1=&+PA;-7ZH0@*[A01P#>BO*O2/!_Z9DH;Y-O52,A*I#]T M2)C?:(<-$UZN(B+ ^VG ;0@'R?=C9FZV@,LEU$W&]R)7I]CNUMS.SDCTR8C[ MA"Q"N.TPG@._OEE##IO(NV43M),B-,N?<SE&<32SL*Q+=TU?)(RP1LS ]R[M M^.>XI,6EOR*EMM6NU;HT"N.7J\<\2_TV9/E%W5DP\R9X+OJZT<X=4TC_DFJ) M3PM5NN^LHR5^,TK>L'*Y%C7A=S8AY-[<6^0^TD4DA(0ASN&7MF?H)WP[H,?[ MR?[*Z0OB)]6&7#T.N3-J1^D(!:-YP.WN'N3F[.IRD]Q>HI8:*GS[05K4&*C7 M[5;FE,0QS4]-(DI96SGL2?0F,R02"C(9T3%FSYS""$'36QN%Z^Z96;<'*CQ6 M4*TSLN?/,FNZ7XB>3]N(CX14I ;#A6#<\;ADXO/1++Z:<!FYV,25%,(74%VT M&G5K+C3&88YG%E)V+L(A^_5DZ-'6B-&*S),6P^PX>+^71MH1GU[!D+C=0"=@ M_2Z;Q2.?%(JW)9KA1QII@&<?"GL-\TG0BEPV@^:%<GE/40HSYJ1JZ+26:H&@ MP:W97/5>A=#C-* %KH#GB-R0]?$OM"'5F9(5B3$.-YZ<*6<,[M7L=1TE#9,O M0WVF-F->Z0CR1<#,I^,/3:"#*F[!.0?;)][[?>]UIQ[MVEC)OFW]A(H1J!R) MF/;\W'EQ,']5<;135.[=LS@!T9+FKADN2_C'VLS.2+!'_-C-("-(A>Z#0+_T MV^^?^=GFO),Z]''O0L!F#L<)O/%R$-8\$KQ'QYC 8M2O8Q# $E'*UHC,D7]- M'2IS,")"3>]>['F4ER'KU2'[64<;)Z_=GL:;^6I>PR2HP)5WWL?=A]>O6Y#U MA4CVN<HU_^8&]4'#G5H]\*T4XD*M7FZNBTW#EW3*O-K[5BYMCUY6Y7T[XWZY M1$X-N& 9J1*_<(WQ,E2\P]_O^+V6O.O\J*!RB76F1P CP* /LN@WY 8L#+D9 M0@F,U%,@+GH?H[!( TY5PH;I/1>]N4O2[D,MR;Q S)N.#J .@&<,"!H[(=]0 MZZ;6'R!X4\\ME8;]U);:>.KC!B#(^7MO=/H]CW>@Y8AQC(Y% 134DM89Z5N< MX)+GXI<X>?7C.]L;I\.>3'F?8P&\S<\ :T8[+W6X414/(,R"R[GMWC9!>79+ MYF]X5RG]NY?1]:V@WAA'QI)[!WH.LDAI;N_HNJT"%"C)5JI9,!L$CERO))$F MC^EI7+;LF%)? >]J,J^^$XG>.(_V5EJ!>%#'$#Q.]&86- H+FC(+_-:-E*_H M^:!M_28AYXFQ_##JJ!&_]RL#(5_1/I:AJUW4K]W/&YUV*NJOEI+ AB2);1'D MO?RJ?,)^X[(&-Y//;.WU#Q6?<DU1NMI80T=YUF>52<(^^D*@>+UC+B+,!.LP MV+&137JH.N;>?9_FMP-?)%R/N>D6(:=_.5>H3$I+%#!I]S^ZE_5$G;2N7]J6 M!C%P>%E/ CX*J>"(\SB,T&@-&6U)<^W.)!@(U">5*AN)7!CG*!P:521KDLS; MP)5\P?2Q-B8-$T^YDHM9#$P>;^0O&]C0$JL<<']V,XYMY!WL!<@;A@W=W;2A M!9!]/#7!BN1QN!KN.,>R[Y3[O;8Q]I"'+YI?N&V//'ON(G.D\7J=F_I^W9;: M1":#]%MR)X6<#\TV!NP\H>J0LEO KU?::( @M!>2WC8I.N";>:9#ML'R:X+$ ME^O1TLTZ+Y^"&(R1N^K1]!;]S1*( ZX.[YYDI?LRLDW]X+C+Z)UQO=2B-_*O M"%O>9T?"4N_";R2:H,!0AJ9Y?5"./3^I(9?T$ >.@K'2X8)$KJM&^[@'WM_? M<X6EQX=QUZF$;^_F0O:(1G\+9F5@.=QX?N=-Z7.2#R&="",EN+ASIT42E/#C MRR$"IJ9O+Y]^RW3C?HVE.=.ZZ.@P"8V1>M'4J4L#;'YY1V8BFJIWF ; $,=) M8.I>^A D'K$L3S?00NI0';)>'C6-4]SL7$.&HJ:>H%8UX0,8XG'$LFDM0*[Z MY>_D,JE\!SZC>WQ\CMJB3Q28.#U:OJ"O_-[< 9#(:CK/D@33W\G74<'WXCK# M*(S%-JY)KH&;J=1TEUV5!1E''G5RC-F]EIG5'*L72MNHYYDJON'+Y -Y'#C: MB7@ X:W7)ANXP>4)[ED)TR@NR"M[@5B]X3MR.8,?%]6O<*HG!_!!.S=KFI!% M.D[DJ_83U.9 "#T?'-VL<.F1J<I^1^A-KI*X7-D N8&#*LE'+X<H:[ WW&)< MQ,6 @U& R[/0NUK+6<-XC>6+>,]V# /"R;27#VJ.0\4,MJN/$'M?3=J[^9@) MK]:(.*>49!\)%6&]!STDV3B!%VY+S6+$OU_K&OB@GN0B]T:I^^:M\^4@;Q/) M^TJ-1V$V_8T'O_K9A.<*CSSS*8(8%LR/W4P_E#*[/7LR+$Y-@CWX2?F!G%TF MI2/" T:%CHS!-=Z"UZCSXC%QR:LX]#CE#-U HDR$<395J?BU%@LSYHJNRSLO MM]Y(Z7LS2A\:/Z:OR5_JUK1M.+<<0$C'+1-1N!7NKUG\^+@B'96\6XTBPTZO M!4.^W7O*"E76%M&_/15_3IIQ*?SC@$K\M9%Z6YN=8A@(NV/;1JPFN'+:?@W< M2 T7V9)?X][.[&)VGP92MAB8\QR*.Q@DZ\N)1@1D9#U?'K7?"G:*8+CY,+U9 M1.)M_'+JFQ!X+W/I<B0[IS+W'8 YO@&V2%"9NET-*0>U9 LNV!\EF,55XVB MP"<(Q.;(?+3RZ*CWZ:3ZVQS;9TTJ+W8"[.'WP:=*X7(NE\!\N23?(#?_@H5- MFX"A]<6:D'1;4M]RYO4[/HW*1E^""IEXF'RN(OMF_-16G9>[L?QP86IO(S_! M,#P_(. %17GDMJ_FAMO\0\RXOI#A\:>[-72>/=;0_Z2%+%8E#P^MDTV'(/(* M.7%38M0#"X*@$L"<KKJ[XIXWRNVD(.AVCW#)WI0#)UF/N6V&P:Z0Z4-\-PV M#X*_749(YG!4%.62Z&K?"KM):LB'<>%U.Z,JW4QW+%739$V#-$PC3?S]O61? M&G-+GV:=>3VMJV*#8:_W+X"9X14B< V'NNY^L.]7%+T2+F%X+;-4^4X3W@@J M.MJ)J8SH1$:,("I1K1 6Z(IMQ6"]./90>MM8NDJ/1GK1FZ6*X-Q()Q$U3TVN M(0V/;13>W//AY(%AM94H&L!*$7_UV55$L-_7?T1'8Z;[:/DGN[($W.E\06*K MV-B'Q<-D7H ,WEV#BLK2?D.Z@J<!;7J*0U,UV>9]2TY#"H<K]0?JO5[<W'/H M_CF&CM,\:[U+5Z;=$>T(3O"M>V9N5^J'Y2N0_.-C\_B)LP/R%:*-XC&@VEQA MY@!0*T)P<5)G)YP&N&HC#R[ZU[:-'$=%RKD7-#S-A[H/?-[7EI?%[7&;/2,- MV)B0(I(>V@TL;<AK$Q&DX2*7S4=YQ%&_1J%87)HDO[71P:D73 >,[4:K*,*D M?' '!YN=F^(4BILD87AWI-6,</5^19W818ZT TKOG>$,O1?UDE<UFFC 0T0E M/!UOV\2;)4(2?+Z0QMP8ZLB;'205N8QS2_?:M6?FAO*N_%2FT$&U48H?J9EP MC\J-NJ\J[',V'IO=!@)!WW#L-U5/AZ6RF%4EQ]V,,Y33J%4X_L4G(809"(IK M?CQ5S*[AK=59<@2F2#Y%T25P+"WBD"'E4##..,:IK[*7?W[[$K)PT6:\.AS; M=!UT#_;N5:/#7;:*S(A;:(@O\SC6F"GC;@X[7R>(K\*3$5K7 N=-F5R[0."+ M<KY;/KB^<2E!C.YQ41K']A]DO3&G<Y]!Q]I3H*K)+RDKS$"4;EC[MJ2(_J-R M5#'X,*+"N$V[2&B<Y%52K^)0BM&Y]#JW6SDX47F@8X^X4."-42WR<9)*&[AB MLQ5S@.(P0A6#(HV'*\F+-?7:;@4+B08N^>B6]RD+=*>K$91-93\DQ&&E#_(X M2FDZU@EN;]H>C;N%JE0,57/7.%5WK0C=60JM,M\]?],4ME.ZJBX](&.I'W&4 M!J@X9!8RYL,^DU4H4 +X <*!!D1250CA-1I1.B:%;C8%V6P?7]PU?WJG1?IY MI+8(=]?<OL9Z]N&/E+L[R5-XHV2R+#0 YHB+5;<>7:=+\CAZ/O!I].38S;@K M-^NK+EDZ9G2+4_%)'7H6^J [\V">NSTKT0+5]Q7D5U1IP($K5R3S/3S.[_%< MOE)5\?IX&8OCM2NVK'M9#FF5CI; 4LFW7:Q!K!0-_#V<86QS30,)@3,5='M8 M%ZX8$.!RS-8_YBVCWUIEQD$&T:QZZY%!A>Y,GPPE?LHMADI\51D-D'G01P.6 M3#QW)-,:YW_X/X8AALV+W!;ZS/1+)(B GC8*(X/_/_;>.ZJI[>T:W4A5A-"K M$!04E29(;T&1XD% 44%I45&J$) 6("0(2B\" @H"*B(J4J0J+?0B(E60&A)0 MNB0(84-"N,'3C^?WOM\=WQCWOM\=]]]-6&NO]<QG/G,^.WN%JCQ =2'POTMM M[,J)DEO\9.T695><V,H.7/K>H%,UN-R$$7?)YM/F> *6&B2=5LZ\]@DA5_.) M_4".4SCPZ)A$J!8W_ !Z""=:)V9-&X"S4P5)K+;E_=3]^+?3)-4"CI9G:8IC M=BG#;DR1_"EI'O G#?QY%(!ZA1C^\C7*#$3@Y3RZ+Q#)B?D=K\'@R7#GL<_C MJNLG]^U],#T%>$*\NH#@U*Y8I[?M>4HI-[G#YB;J4%NI*--\9 QA:(G#Z=5\ MFC\Y'1[/G!E7^^'#G#OD'B1%)/FN[??;K6[LM-VD*0[_5AP;RB28(&:_;E,; MTZ(95V(+_]BOV5R2^8*=QR^^J1P(EGOA:EEEF.V+"?(2R\U\IN"EO?)(UNO% MP4<4 /+%%MN(B4J%"Z($W0EQ1YO.EO<AI+QN'%P](?Z-JUEJ]G&2I*=2=;'Q MDCUD&V#F)NV/F-P&(FJ$WTQ 1< <\Y["ATK5[A,775@FC:2_,+Z8)%E#RRN> M%+FLH Z .I-+]E.-GLA1*UK[VT^K&]KY&2:BE\)JO-2%K7PW].,-=>BK/R[] M+5[T:(#Z@4=O2N6_6%Z=9V6ITR0=S,JE'*;UPG>[*\-YP0PX,2'A1K;^@#*" MR[7/E67"^:*]UH-G]Y/ROF[<YX)HS,JD;95H\PHV9OC7]=(.4B\,4(,)H^0* MXOJ=,BSOZV,!W\R$'5964DF/KCOU. E?85A+2ZA3<,;MK3F!=U=K%EBO&)S8 M7ZO*Y;H@I)JZSKIUX7S%K7#]MT=:^RZLR+PK2M6V(TI>Z,=<P? BI=M&UH9B M:O01C\?G_4=R%Y>.RXW(V(;$-_D-7-^3UQ]_9^@5NE-7]QV83=&D$Y'*HAO_ M&CF1X=VE(5=A_I-OSB6'&*\]AOPXI[@H&NL:CT$H#$?0JNBV<[84[CK4 B\W MHF:G+39M W8*V\#JY<>0BH-TAX:SOJ&+6(L[\^.+C9Q!!,$X>EJ&US$/42^^ M>LB2G7/Y=)!F\Y-'KXYH7313,CO&>LOK$I89K>2,$T,Q(@@% B,4L[O?#I5F MFW^2Y!X?L3W58G_D @]_@]CQL1UO<[8H5IR[7Z%.%'6<Y)CG=!6_A;@<8T&" MC(A8PH8'/TA]ME#(X&GGOUBBH1]_)Q8Q;#2UWD3!CGPGP,*H#(4V\^+<I-PR M],'B2X/&#A$6!L.^3%[&+-8&XEY7$][ABEG'?\F]?90=\/0\WB5M]CCA3'PY M*:UI-&AY9'2JLB4_SJ8%?;BG1FRR&J1J/7=.%\\]E&5_O3O3>W]4^%0M^FPS M->]Q ?QS%J5- "NT#3C#]B"'6C4C8I\1O^4^'[TT9M]98\!H<%QB#W#102@! MW:-4GV6NS+#6/L,8'^CX%A&.%5#NCH&.IHE#*VHTZ8J]\[G\2R\N8T1N),&! MM>OM4UC'VQ=,8942O+:"2VU3,5B 'C_-@;(-<5%*-7(U(RBR@X-QW+AXMQ*G MX?A&^\SGH0Q:3WKK2XHLW0T 1,&[,PDF)/D\N8@[!;Y:RO!#$_ZV8]VA6@3+ M\Z'^NL8+>E#[1WBSP?T)3$>4\T6+VPTE*:-F,$TP9ZHM= WQ>1LP)<*:L1#D M5$O5I^<9^=9S69)]Y4NN;NUK)I<?&'Z(VG\XB45#U!C@C0^M@-U48 *#\'4) M!&@4W?>WP*,V9=-*V7R6.4 W^TM/TZ=?&.,KPCJEF0J_-DS)(A]#Z$()=:%? M%X+TZ[<?<D? 3R6MB-I4+Q@W%82VCUH&6&G%!D4R/;YV/$FQR\^U(30QX8&' MD(:0CL9JT4/,#>SM+.72K8RU.%Y"6Z0*C'>!=JS$OZI\\)L(7O9 T@')RJ;8 M?(YASZ!"K8NXSZS-FQ&1&,=Q&=-/A3=J!VID7MB#KH25T\(MG3:GR]0=IY\/ M711N8^\YR]H[<,X X">F4?F]:7IP1CJ5>YMO,<M\&]DY0^7=-B !#862-?)H MH?<9UC.'J"@3&HGFRV_BNPU E;:!&DRF@1ZK0VMP?CN5E6**M"((MD+X4.K] M!>4R[O"3\NA17YZ"7#".;$YV&C/9N*EW3:_%!=T'%5BJ8T'QD#!QTNE\V>9O MO)SVKFR<#'HN>BW.AM(2*<%IUK\&S12!M>VT-O=HRQ %F^UY27:I+TF,32/) M4-XFP9''@D1<$D*M\\"5HQJ<)Z:^$$)@EU),@GLNH7UB4H49<6*T\A7,TC") MT8;X!!16NUM.Z=(=LB+=K1'DF?M>YA;@.G]'AA^F=$RCS<SMR59NS;G7SO"R MML69W+FJW"_Q#_,7AHI=!5+[E0S\11I23E_@$F+\".%C0!"<EM)R45K@RWP4 MK!1T([&V67]-<4,$^$WP]$U51Q_^>K;=9OUVA.TMQ40+*FRKH%!7 CETFH@' MI4DVC0LO3+YDVC2+[&FXX;Y2ZI%";2I'MGH-1!.7A9#5A"'Z6A'0F 1B=KV? MO59-1E/5 5Q+\,NVZW+WC.Y?L0M??!3+^:#H&GB:)$E.(ADE*(\?)T :QJ6; MQ/DR']C-IXZLJBGIKV2^-;AE9L9JMLJP>HOZN4U#?6HN751F**$ =9DH6E\G MN?6*3L'4\T.Z=)VC-Z B=NOK4).UQ]W\#N:L!/Y'S]773R3(6SJ99R"OO#?6 M_FYG3N7%M-H?)&'K@RTH+8%+RY'ESC4G@FX.#?65Q5^$,Q@&*M@RU-/K!NRU MJU^5>$K "YQMFX.#"Z^YSH>VW?M<=SM*%P-6:L0\@D%""Y9Y&)ESIG]-#F92 MYT\1'KAZZ=F[.SP\U\^>9@/'JHM'C=OY)Z'$<PK<52AI8ENHM8 J38UDF?W4 M7M6+%MTO8\P7=N_T[K!NDE=?&=;-5-\NPA(\071J&*D=NB-'=7^EF^F=[U*R M<=SZ\W!C20>?+,NY<6.&-DG&-P="=!]=<<"GI&'-!^]+'L-?+IV;6X#O Z-U M3,@7MY[K\KM4J45K&Q2!)@3><1?!$5BDKX:*0+ASBCB]JJ7)OIM@/"S!_2CL M=OQY\GOB!3@[/BB3G>#?8F=#D(XI9ZT@+M]9Q?(\\XP:2Z[N7%F7*S,JU@V3 M3 6@UD@*@99,[&ZNX^];&PWJ#()SCXGIXBS91#ZREW[P?#\\]OS$O1J'HX:& M;M7PZB$_]0Y&&-W]O2&Q3Z+S\FCUNM)$JX3RT00A-[*X>-4GCS63X70KRG77 M(?7+D \7Q?Q>JF\8:@T5H#_ N.311]#=& CU?&!TVF9\ N/87;M7-_;POX_- MVLTJ+-7#FF?5 2=>Z-XXCN'=!H:6$FCW#P:[P:6V@8;SL.FN&O-M %X!VSQ[ MGV$M[Q^/*H=4B#.T4W!.S&?YH6W 0,ZG##AWV5Z*=##[SJJ<N?7 HZ;G+A5) M$^-G7EUZ=NZ)OY9>1^-+]7U#G=G$-<QP/BTBHXC*C<.0TH%-0O0&E"9>0%'! M]'RG\T>HUC+MN!%5QX;LN@T\^;JP#3#YXZB.(;IOG]89T45-/KH+OJH]CIF, MIVP#L;UTV6NYE8Z=#:BBW[38^C8@_!A2>+AHYSSA>5RIU19$#0Y*UFT#4\J8 MID]8QZ)-<0\LT2AX&VAU9ER(EIG&@(&5BY^V ?VN(1K;,A;L@A+7$/__#?Y/ MO\$"T=_>&L%,IU%/_WAKI+H(#,Q>'/B()=F.>VT#9TUP-!7X$70#KF*H 7>; MQD@JS)B"\=JZI*5G1WGXBCI/]<L[X1BW!@]RW<[6IU-5*<6$RC!0IW@91%@3 ML]X@\!@H:+%.,3\U6"CQW2%V249*"?#^@A6>3 R[W86L*'J*_DSWH1G=S&#T M:#T-Z%E3OQYQCG0HW?KK9*.AV+6$#QKRSV*/S0:&1<_#\+/84L061! +'JBE M[Z0/IJD7YHC;%$? B 8!])V<9<")P:['C!;=S68OP]V-<V I)WZDR8P?:K+P M%JN=O+#KA.3>"O)1SM.MISM>%^CC%5JQ4?"R[@9$5)U,O[(.[RGB8AK+@EY_ MD6[OH2RIVP/5'_!G"K_5NQN,O&*5FA[,INKPDMWI>TWX3M]K*RS5(P$,E%X< MW0G:#(VM" :.TQ5.]F1W;-T^% 8L$BC QRDT8SAU)=P@K^N*#A(\RF759'FL M-3.G_(6[KWC9C[Y&"1,]RO%0+F2@ N3SG(#UE]@1WZDYU3>C[WNK4MIOV$X[ M26H(BW$@X7],3=P&QO;0HQ?7MPW\MGP%#-$@:&?YC*F5H!/%R 7.,C1I$/X0 M#P>->#[,GD-NFGP=%T\]^\2RY,C;CY('U1ACL\W3JW C$#+\DV]12#:[KAC( MAG%NHKL=KCE!V:'^H[#/2TD&3F-(QXW;]5]SZ&!ZBNZJP;1XTZ<)E<'1U(Q^ MOY^OOV]%B*:Y*$J )/^.XH92!=-<F.3P=I"F[W-#R<H--RX_:K_ -&_T04-, M9I;]K61=6>K(11Q'HU#F+<.+X1!SUPTWFG@4174;Z"$%_#;#SCF,I[8R,+,! M]% W\"]O Z*/(3"0%V_':+*51E-%,8-WO8*<'"8?^D+*[+H=+>&+'=8F#Q0( M<;<N>5AZOKMYO]68\ X1-2$'5K(NFA<@4:XT!@3C' WJIDB2-!D\-76YS&"E MKT_4_>'I+QM7'1UBE^N%;?TW\Y86*)(+XJJ5)/>AR.=I\/#WIFI+3B?K6&PN MZZXJO4BX&95XKY"-5;W5-*"2*@\'I0D+B?,++ES5\9BR9W(Y\^Z.)4XORB4[ MUJ8<-1Y#?$ '8EYSUN&2K0??5$R/C8)&#?:\X;0E^4-[KG\2_ZA^(.JQ]K>H M,[%"4\QOM??-4PU!%Q*KT58Q"D9R:@SDS*:[5',.R-YY >_Y WTVBN0BY3'Y M"U%F@^HGQFX9&C@44?E9R3?-LM1K6H%MX!['5\SJ11E,PUFLX^ V\'!^([A? MOX;U^\H+AB%R,NK*%G;5)L;Q+:T>O/C45J6YB^6J9LK\857\BNY5=JF(@W7? MCFD46I%7H20T]H:]]S; _VCGL30F!(OH'I;!QZ=YYX%NS<DN?D/^WO#Q@$ Q MBDY+<Z'UZ>M^)S].9[TV9V1DC"9VCW22AT MTGE"=[T.HLE>^FU=/^H(P7E- MS-ZJ7_[ ,3VIN!AF'^:/?,1WR@R;T;@@XK.B%!O:'GKTO\%(MA/<]-*X$_[3 MOX<?6?-G^%_-%J7022#[!PED_X,$%&"_9\%\%1$QBL''/R$YD-U)E@^?27UW MT_2,N%Q<61[S(8G@%L#TE-\V-FTT]GN"OBWBC\Q:_S.I%1;'-)%?5S&_9EH/ M:PU*%(QR(CG@$7>I=@XR'>(O'?;U!425#WJMO'^MV"0;/>\U!]= ]N-A;;"P M;!&4VQ0\U OT;Q91B,N-7CA+I%5IA[GXB[A_S[E:QB_!/UHM]6[J[4>BU=(6 MY1!*2[.>N!SUS>=MN=O@@/SCB%-U*^GX$,B!)Z8O;(#,Q[L"M(=,_V4WV-"B MM+:J!.KQ[&;S/<@9F]#OK1CN0V\'5((6@KQE5=.4KK1*XKY#99Y/]3^>2YZI MRJO/'HD@=-^I@1'#VOS1@B5$SFR=$APRS=PO:?E<9:7DM8W+^XK//E-ZH=ZQ MOOH'L[7L,!L&'(<25\V'*^GEJ)O*;8\A50&UE%-4"'@7THQAHEJ 2CZ1U//X M<5V[0U.&GW@[8\Z5(:IRAX0.LP W&0:XD'FT;A@S6M(6=8'DU(*(+7'&$A,7 M FT#Y;(BGK5];<D;.=)YS:C[PSB;\$<S<]>/OQ(.=E7;?AN8C-Z)0>_?=V#F M!QXT^]$LM'XL*Q5&@-Z%<7ZCRKU ,EI65;E!>."E;?ZYHV,\=MJO$U="]?:\ M9D$NW)Z%<F$=1+]N/4 Q3V)8W;B&D4WUMYI>S5D_ZMWPLK-K/9W\8?C[X63U M,<Y )YW</V\"\\][J.W>"MG9%. ZT@0/;<N.PPG6<$]!XQ)![Z9 2*B'"*WM M9,\V@!ZJC'W JW$PY-RZ5[4D8_Q: 2EL<KV%CC-4P !-'L6O*9ZK%JD\ZS.. M:++NY7K6*B^9N<]!RE?C2H"."^9WH/]>[;)_CP".'H%M@!Z"T:V': %D\N1: M97-"%%; 5VLW"DYPB<_/?YY50'97'622E;#RN,20'.(7'Z;C6K0HBM^R1S"" M0X1#%6F6Z]E<5!/OPB;W /?I]E3<+99US@<>846!4S5T"F9FV;J//@1>FVF: MD"+9?<W-L:U!Z&0X#\TF+5YY7U#.\J5=^/P]KW:5:@3]LSI;Z>[NA%"HB&W3 M7F/)>/55]I8+9X_MNBT ,,;N 3;KHC?._T3O1C_5TA#=_*=U%_Z+3?\+$>2@ M)3#M800$A7D<,YM:E/Z/\\YR",O@D;S%N7RDB>V;"E+YU-CX)7.F7WQ,ZH5' M5"\**Y(Z^ F88LQ2+Q$^B5F<>@::M^H>>=NO\EF%?7BZ,L'DW2.F)#\?K42V M+\8ZSHRK%?_+"RABVRK6%06[IQ2:"M3JLP03WO>5=UE/0+GA<GU-LB*NZ@%W MKFQ]O;F7\P&KM@B!+@W_"R[[(6@8QZ^",L1UBIQL6Z@R:\7**77-ZUK#?E.% M8]/1&\EGMI)H$JZX$FBSPFV1@O':W)K #.CN!<$T7<\@_BJ32 OWQ_<E7EHH MUE^]W>*#^PT^,=V_P>=W)E6C ZQF9W:&#JH1Z$;11_F'X<],'.JI4<'GPW:# M>68#"F6C8J=L3_OLA];6\!QCX-IULI%=<>(6^EQVA3]J>#9PM065^_=Z34]0 MD9R?-DV/"Z78[T[CH(W@>*D'?9E21<R;.XUK3CQM_\PU9GLR-BUUMBNI+^FK M!</&!7&@Q1.[R]<\$KIW%2((:DV.9;&#89.B[M:;<@H7/I6K]G\EEI86ITY\ M&[]?TR%*[0Q+M??^#E339.F3A:([)M233Z?9D P^+6Z:]N%<OA?&O3"0>[U0 M[^.CI]<@4>A9?^_$/JM'R/RIH47NJ01>.S#,!EXV/U0B7'2HLL]7ZV+5K=-R MLE[,1E+)F?4STAI=P+FM!%U>L)H@O;@\N75PL: <RFY..CK5K#GQ). V2\Z- MFPXW5IZV'KHL?<:!V;#ID8/D;/=(QN1R'-64Y(:'-!?MFDNUEZPAGED/G3I9 M4RMP$CES<:.YF>OM81;%CP;>UJQ4O@RR#;$PP>79+.UH\IE^.=[.T(]#34-> M+3R;1U_K,5A#_QK!'0K.IYS2EV[=!D:@DTY-R2Z^?%4'1Y"CS>?J0R\M"DC= MB#YBRYV@N-XJ)#X,D.#6,H)GS>W72!'AL,G'T!)$V%H7YG(?]9PO2T&1F;RO MS& O8CH57S]2_?#>O5<L_(9\WK>[?+#_! VP6?B_F@U%%=M 0B06!_U8QTG_ MV+5MH!U/,<%\GML&RN47>J_2K^6@NUXJ*9*Z9M[7T_^Z9WV(]LZJ8QLHQBT] M)"9,9D?IJHZ#V.8TD9OBATB* SX5":9OLS^&H:8UV"(0/ H<85T ^O4Y^%', M7X3PC[3YB45Z6#_Y?MD&R@:CIK+Y4-PD^3#BO+I-BV:-25Z+2G.C5&6X);MR M=<+ZV:QCISOJNP*D_[/4_[T@ H%#3=AA;+T](U$AO$9G&V +#_,ZE'B#H_0# MF?O#C<0+ ;%V Z4L[FU9GD:_;.2W0DL#B I-10D3PB33KH1P72Y[> O!G'WA MF+ TK;5:Z8C6$UO53[=V2\N$>MU3M,/])$M>NL&)%D7#0<WI.E]37H&%IB:F M-;%-7B[^^-%WUU(@%Z\[1UY==&9LP;HA!%$W27F+R;K)1=:@?),!NQ,C,DS_ M$VU<.OJZ+ ]?:8C"M_5'BAT:K<SH4%"@SQU6/R%2_C;NR;O*OH+]2<)\^88+ M>W8]\Y,(Y0R*!@6;H&*8*W!6,+3?I@]_:D!.ZKL[K3]GWO]8_?#'6?Q]96?O M]J,Y8ODCW51^0;*'0_)41E\PIGAY9X=,""\0NMRT\2PQDL^RMBX/>/>I0L2R MO 7\5 >JVIBA_1!_\/7%$/,]PU)XVT2>%!*X S)7B&T#PEOJTBO>.U!-[D< M"R)/^HO*Q(PA<L^O=%!&'9?*>#ZKZ\PCQ.@L<P)[?3D*+99VDB0=E?=)N4/L MX$INSW)*TJDK'0<T6X7%C/'W0[5$"&@I6C^N&-?*8<UQOF7]EFOZLV/!]^%& MN:Y^0SPM<4]N)$D4R+-"-909$HA6#;K:8#FQC1Q++*C+O5JXD+4?#./(JBQT M2<X(\BMK%.V0>["^Y_7C*S-^;"JKZTLN1.]F*#>-"\08$4UK"P;S\)G>)H-R M-Q6^JA+F94YZ"3XLN^O(=$MO'_2J_=5).'A8;?$AL;])P%Z<B(W,.-5[<^BF MJE^6>/4%N 7&-_5:@.PM<V\[UI^3Z2CM<V!$E*X,DA=?V5CZK" A%A7PTF;, M+9V_H''\8%8&8T2-PF'&::96IC"/7R:Y3(,=$&[\<:\%>O:>0(@T"<U\>W57 M+/@NRHT^*O.NK61W;7?O*3;J.9^)0V_+;00'GM-S/_&*A7'\L7;+@U))#<!8 M@(9*[Y\&\R_26N:+^7^2AG\AB3=H8E$,[$;V!FQYQ&FK$S+]J9_N5>BK&H,1 MWOZAX(H>UC'21J&L-1P46Y07:;"(X+)$/4ZX429R<60NC;/__GCU8:X2!\EE M!CWHB^S&P[+\)ORXVYEUY2MY/[:(3AK1_Y*@R[]Y<1=:US90FKD5GT=B;,T6 MH&KDS-<IDSPJ#WZ^G!-/O#Q\X$YER V_N/PLJQ<2/,:$[F9(B"8V N.,#8?R MU DY:QIFNSN6SDX<*:V\6$8QRSZR-Q8X&]%YY8-7N+3S-.>Q/\JWVM_Z$1-_ M7>'C/?;"((SD/XEI38BJU&7HIZH5@D9M(V'SN!'-KH46U63_ YFMQBGFF>(K M7B)7$BOE-5[#PN E1<TP%EH[1I3N5I].++>@9094;#*$4R]<J.(=;1,Q;A9[ MD^I[S4K;L2K[;QV(O^KT/U0B <400'&B:A.AX509!^+W^N/#SH&^=1E,E2)I MRV('XLZ97#MS_:YP888M>)I428XD'BS;!KCDJ%J3\$A=WJ$"7]P>T^?O/6Y. MIVI/VTHX'C0SGA):Z#]0]E<G5O,W]?([#3.V85VZW*;,(\N[0]2PW"@-/)TE M78XA*::5(NA,%$*ZJN9HVY)HQ=UXN:=Z+Y/0'C56L][[3M_S/$&H.T(:6EJB M2%+/T!JV@3L9S6G6+WK*U=?BU'7C7D@G^@OM/RC*Y2&AB"_1R7^Y0_>T+MRJ M]L3O=J&'";Y;5A;-01O&\==P!UPC;\*;8Y U1D\_3$?F):D/*[CWQIO /ER7 M".[1Y)0) ?>_I)X$ R:W 0&DVB1U8B^I+>3*)X6G?6L%-A9N1ZARJ1BEB97A ME*R+<;=E0MD5-#:*-6$"F(83L.O+^VR=AS2'HN6_?2MS:\'V?^,UQ$;;N-2W M?O'1&XMG^\C6+A$OTU5C2AHELY#2(HM4EJZ>VBQ8S'(?2-TTS',7ZW0ZF!LM M\7*_5)+)D8]FSKNPB_[$-+I%X(8Y9>^:4[H\ZBK.FT;0&8I<*] _:_?&5=63 M[_"U!*&4Z^G'/[\8\8XO7X,L725VMHJK)^"S*B>#-;NM![4%"2^T3_I44W E M[ .GKBN^?G;,LM,IL6??=9(M9QB= @YMI5(5<B[/:<*BG_6M=JHW6Y+]LL2J MXP_?][O(?260M&#U)[A_UZ8,-N27[FY31I%H#M2!^,^C]FZ:<=A(E$W>2,F8 M@4O>Z+VNNG.AK-EW+?:D21*+"NQBCBM.ONG@)Z&3?W#.?66X@)OXX7*2Z7MD MQ*5X]2)?P5Z%":-XV)J7_+2NK4-A2^/TC/#7*M@.H,=Q;6IWMH'/>[[_6KM3 MB(5%V\"1L%[8K]^%J-X&_DE"J)<OT</9N^5ADSG63BV15",MI !DKVKZ9@+9 MM][+:[H] U60L5D\([3^&/+)]2\L]L_$^:O4R9#<\"I=5%H27FFS;$.TUEG^ M5Y[P#WO"@1U>)OO65M2!85.0F$"6E)=@=TO@=)J)V'N#(+'<)%0%J?72L7.5 M2:SF'BG2S8C;FD41:!UZ]8LAMAF\*:5]/.Z"ENPO8%)-M'7I6X$SZ+GPO]MD MB*[_[[S1#\+9K;P< 1-&<Z'\P$3_2;OC38$S=W7WNYKDQUE9U"8)]GJ<7'1, M.I;WT7;OG3.\K9>L#"@0E @)T0"]LUD7-75XZ;S5NZ$B%8[!I->)'?N*4KS* M,M\M5&KP?_@CN15_Z]#\UJ##S@;\:<PXBD;[ZP6S9$$9%P*'M.G;3RI%S*YD M]*'*LO*3*^;[>,)D77/>P3/4U7?W%YB3<AH"$Y:@DYCP;%ZTT#RY&)FGEXDR MP,\I<%),GLA>2M\=*2P:,B)T91<G4F,?736&/D%WQ3Z#[K/GU^;RD1GCGJ,5 MOML&&'>$ .;Z-A"^J5UE%:%]WO>Y2Y]MAY_[M=ZB#VY2<>_(,OO9GGTO]\PI M?LR9;P3"26I3>:T)3& _H2+L&5+T)%$[:=REBC/E57!=4/4PEXRIU.C)R'K& M+U!%R9?\7VD"1-8EAJ>T'GLY\$TAZF ?ZBK!I%4U73E-5RYZ0DZD[6D3W[5# MG=R?NF%GDH+^@LO?JM#/L,J>ZJ;GM\@LK@0;?XA4&2I!;(M>\YP0Z_71D;YH M9[JVVR-'\87%BV=J7?M'0SU3%K&E]$)\'S0BFC3H0BZ?67[FXCG:=>3DW2\C M[!5]9K@'6<?AZF[9Q+/0X>/-6;(]-:=?(=/G*58]U-9^QPQ#[(T*?R&G2^2; M$T:BT=.<#,(JO0H_*O'%-JJTX -RSX]2&7S9 /7R9Z?]+PX.>O'G[VT4YO_T M.;@2*FBKO Z"G"&_ 86G@GF;UP71HL3J\8I\G\T;S>XLJ_L]8V]G2U,>][#. MG\$MB#R$'ZVD\HN2/1RE:;PQ=,[W_,]MP+D21;O'MRY-%2W 97YJ__V1)7\6 M Y:9$-JN!?%#6SGH@]1?P(R<N<#,N(&SSG7\;ZH4QV/L=)4NC]][>4%)=TBX M,^Z#.C]T29BB,0X?0PJVPMBH*D_FT+K$^'<<JXY<J0?FNU;2N!3/\H4S.6E/ M>@8TM/W'7E40DD"$4AA^.+6OJPI+N#O0,JN62%W.41#>.F59$TJQ)=H7O<I4 MV@:,L(HYHL_\+7E&VTM"O:BFM^.>6:#K_=!2B%AH67PNP=VRJ5GD[F#U5;[- MUGCL+,^8$=_$3:Y'M_9/)-X+F'0JN 7GP;J:?T80OA6F%T477A]0N7A.U)5K M3C.EH#E:?63EY*N/FI[-MZ,7ZJ!H'+9$K3&;0W^G%B_DZ?4^N;;@XH1?:+%H M ZJA,K+- +NBU*1W"Q"4O>1$K%N>HMO=*7-VE^+@O$M9 [9SQ4[B-\9D#]YQ MD@0'?*<&:SY2&N4H-]'M=7QO1:+ZJ;YY.K5CUJE/N,_?*+162U-//]@Z_K%$ M1GZ"<9HS19@.#OI>C=X6UZAAU=@&[OUH$Q0&-6*)9\V'80V:X=7^3\"LF3/! MMY:7UDD-3W&1N6\E6<Z)=T5^4'S[0K28_7H/2W=,G0CUQE9>N?ENT)O@%('2 MFLS>Y;QYQSJU?"OMI<IB%?7>L2/[3,I-:PQNWU2491 S;IBA'4+I@*,$Z$@B M^H ]2K.7ZO48>346#2E-;CZ==_"ANH+W 3HK&GK<+F9A%:_]V<RF_8[O[S\> M@'33\T!L#"N*<L$KW*G3($4T+S,-@^P4@5&_K"IT<56R7?M\PTF""@.U*UJ0 MU<LU@GP$='N-DMW*]A&%\EK78J/7 IR&RN\_N-KRJ1/A7N]94"9Q%&AH;PDP MBJ6#Z#&V)*)9-%@)PH5\OG"^LK](<D!NZ6NOP@?=P. V9*-[LLLT*],NAE8# M']@.N50SZFK6.L1?FK5ZISNS[L.PYK3P?R.9&V'$B]T; )5K&WC3!5OE*]+_ MJ<P,O8=7+B^E$).G6M.(51!F9%+PN5483R$]F_H]Y*@O5%_(:S>+5OD(*S-L M5O_ENRMP&5-ZZ3?:RKC^<'0GIU.E:7I6==BUCQG_DM6<E>0T4)^ B1=7!F_@ M!THKTO %\<]5LGF5OP,>9Z375?& ;,!&:2/Y4#4D"EK:?5L[8!+!A0RH$7[2 MM/7RADI)%_,=3V6S=C_5U;-6'&6D;OYI^._4B_M'Q^N/?AM#)S*9[ (6D7C) M=J!+SGR)2S'J AB4?W \\MVCVN=/^#@J%!3O>]KQ*SYRV$>H4.F^BQ6E'46A M0442I"70(^*)<YW@P,'T[TU5=I_?NAWK5:I9UF)6TM+8P\UP\:R&M$K.GTVQ MWSK&/Y>#%O#A)&8$T@ MEX[7QA#S&VFB0ZL)W'.:[F%UE2C)H^Y3,Z[AK,M. MR0/7RFMDIK"C'-1SN8>JB91ZOZKC=@;DX:6U7=?C.:8^W-C"=S)_5'_YWS\A MV5495B=,]=AZI,+AW0#G4!YG;15G_N3+'F=D/.#;65&1?"(UP$3IS*MG8Q(. MV#T,ZTN7=]X85\F"#0]9"9HEW-(VP7RMN7)7 ?M5LNYX^@@</*JV.!8KC/(. M9-. DGZ8 =\.E.I6#>PZ+&QSWZ9:6(V^]U,7;[O3 0?+ G6?2"B]ZU2=XT^0 MQHDWANA R)M$CO4HW;W#8(9Q_S<5,:?ZS:ZT*'QY:6R'5&^#Q/>SAV'C&Z5A MMX6G:FU _&2P%3F4Z-]D'HUA+\\X17**<*0;A# ]M7B.W,7SC0)N 6Q0^351 M_54FOX]&:M(_GI EJ9Z?BBD1_N7>" >>B3N4;67C-83QAWS'A5?IN^B*D%0& M4W*%G[T3\'+>O!VO(76MNUA)+/JT]#6\T97#C"][T0)4$_ +*;^>I@7F/781 M9^^M@<R8/@,QIP?0.+FNZ1>O^CL/7SPG!+B?^/AE(;[.;1+!0$7WH+60I82Z M6F*"$2D[JFAXL2RBBG3=LGAV!"GM7J/X^A1OK*-^!_E@U*K"/Q\D_XP3S!(S MR:VU"K&8,Z4_A6!JPQ<)@"&5X67NK$:?!,^GTDP>4,M'&EALOMY; AX9+=N/ M$Z7QC:C]X/');A:9AW##OLGR5(O<,TEW1#\7FNV^^<@I>J/(FDX$M]$==0=( MEA$$4Y/F(:N1P:BO&"=;\QS7O14M(%TWN$_HM:XHL7@:FOKH_WA,E["1A3 ? MTJ^5W@8,=J3YBCF5_SCMS&CSSID=#MM [F[+GQK;OM]Q2WB*-TH G*&H+J"Y MB4[1'BHZZ&_SG_ 5:;^\NWW9XH:CUOBN>(9E/6@N]K][O9\UF]:S!X8W0!E) MW=)6>4F?D^%Z41*=.!]@F&GB8#]9AUB73X P@$YV ],UV,L*OG+B$P0G=E^) MLW8];P" 59L!;HWN@:Z<1$MA/I>_Q,S)IJS %]D+X$@WVNZ8X/RY- Z7ERZ; MF$CY)0^^70ZI:IF)(1*A^D# *EU\[)S+@.;&],H0K6B\@YB=XB!<B1?<XL$R M0REIK^D*<!S5L7-T[-9C;6\23V=SG0B821!-X (?RJ[2?=TE.W,^K["K_L#U M4WM>7<K?=6E)\JO0H;?8$3=R*I@&67+)VWGS+,Q%G(4X@<7C( NIB@:B,:,Q M&YEC+(=QOMR)K5\DIAAK@>#L;6#O,#&&%@4/Q1*S2G<R'4OLPK!A9U- F6U@ M]RB,IG89*K@-N&!94*(DPRA\G*6=R06265F!7&K8DTL=04C2(7]CAUB>_ 8@ MJ]I,4V04U"?AZ-)+M(P]T[Q))/G,S:]N;A31=NN);XTW/L[.1-4[=XNULDT[ MAAR@R^V;H,$V<*JT 0Z:7]Y!*!QTQ-Z!KYIH\]/S<2U[I[]S>! S^21[MP]R M3?1K=K.@O<@;K.9-FG1IK_RAOCN3DZ_&CBY=@7@US,OTH970?6@V4#)WEA<, MIP4@M/4U1UU$_%)NKOM;K7!Q'HACD.+H_.ZS$3)O -C]Y\E_H>Y,OK0S^2O8 M[FW .9N-:C^HDBGZ2YI%/^K$TSO)9WO*JX5EB]Q[APY_/0(<9)/<JZ21/R&X M];@&,J40N@[C+RNPL$E@LAD9G^A #R;E1!:D&SRL>7YVQB4*;#53_V@ 0/^Y MR3N'[0W]'HC,G4#X9A2@/\'W4C6(W8U8+A4X-P>LT?Y0XH%^%=$8EW,WG.*F M]>H+S\N(!D]JU,\;> ]E5T0TQ0G6:[;%E(_&.32EBMA1 VT'TUL3=6JGTVX= MJ-+GDZW.O19;L#(#3)/TQ+*IQYT:%38/9M%7V!C8_:ODW#OZ-RSXQA"[R4^) M3LT)PE#69I4$"%BTB'6/,"#)/U3-]O9"="]?N\P7$'W,._[!ZP01VC"<LT:0 M,.ZM'^!;Z^'.<+%\-!-BG$4>-=Z73(Z2M. *V2V9!&@\YFS[ ^P8O(X3O9C, M8?#IM-_3H8*>#C6=9$&P^C75F0AO=D=<'*+GBV19!>E;@<,S>_FN,'/SPZ.O M^ E9E3H+;/ ]$V+$.TIFG#1[V-J.?VJX</=?@2XB!Y@L^&= *\&'F;\"/O' M7 D_1;W(Z.G_X0.6_FW +BP^@\8C<QC*CA)0\_3"+YC3O=4^NFI20D- 2&LV M1YV$*0'"!/K;I>-:*E.)'2]=CMDJGSLB>L[DR4A.\;X]6^P(K!B*/C!3[C:0 M!"=)TMJTEN?TH*:8)A4J/8V?6DT64:5O[M#63\"V3S MJHQ^$[8$/OH8/- M[W>P_0/OLZMG61_]OS<B]E]''/['B!\:+B1YRDQ#XVCJ8#+)C?RT%%0C=A*8 M[(%^GV!&BG>SYI>"4/NQ-IEV2U&[HI7PHQ9G>-Y92DL_ =9WSE[Z(XP_N.TQ MK2O[CQM9V+D128HLU1A,>(QR!].(#H2$* +)+^_Q"??7SNF+%2]=O%Y\?G]L MZ4LAWRM% RF?:TW2T>N(^(E#I(@P&C>8=HDH&$'/E,,DWX(<U>Q<#\:N>_>. MQ\:-GE HOC7JJ:', -])/ '8])\3PO?1QJ!LVJQX;#RVE#D^<3*!T\52,R_V M:26VHJ3O<;C6VYK/&/^CKX"%#GR)AG+5-A )<S8?CFB!LI0CA%'V"6U+!!S7 MZ&QZ6]ATOQQA19MXVME>\5WH%2KN,$=E*(<OIO(C!O]X&[B^N$9?-4%A2XP9 M"%:B%_9&U?'LNUE[%A(V! OH6D7KGV!>Z"'08.MQI_7$O7X*K,_/,0W4X6.8 M^2FP1C_%="BG]_]C(WZEZ^J_P.BW(1%_#MG_8\AT$$-^M56@N]\9?>@-<1L( MH6J\<DYG3HA>'1>T)L7G>$A&^Z7ZGD=<WX?^'M* 8V7,.^O,./<'9GE_QVPN MM-3I'V/KDZ"MQ?0ZI5I*.+VHPG%1>?;,TS:3D"YOS^$];UK#\H]SZ90F]]4Y M;]VG::+,P%S*+RB+/E1 WFF\NVJ;<;]"&9;=I+CCZKZOABS76)8UTCR^2 .D MVWKB2S^+$TR3*NJ?6X#R)QV?S&Z%,,W6'2*%YU*L%@(5(E;!O('K=Y#7.EIJ M9-)6!M)$(X7.S7N-]; 6@>MD7_"<TR2<NXNU"<+2H!SHWODL<58@^GWC(8E0 MR<E09M0,G>FZ0$4BI153 H]8,^="\C9I?LN3SWTAE5:5FH#P.GYTK)U/T$<J MA(55>\]J]G"20M00M&0FRC<[&GU@H'S<X5)%;<V;B(NET2.$C^WUC7R)#D)[ MY[4;M1!MKFUTO7QA&^C( -UHC>EIM!0ZQ+__'FRG/X+]DPRSCS/Y/P.Y'AC' M[COZ-)>_#JCZYX#N]&P//.Y3%+UFSHVRW7H!<T9$T@3!()(E++QN#W%W14E0 MK99I-"W8D.R\7F%"?2(Y,J\G$?9Y)@22@_V'; ZCJ%(E?PR<397^(9L#X(LZ M)(<V\>.]5/]);)2_VPMPJCYP:L[*JHLMU*33OW/T8V^(8NV)HWI 8?^\^0V* MI1N.KPQ^=^4$,=E8,R%&Q:1=>78Y*L$Q95]<^;>'MM0&[]F36X1C'( /G-B% M_1M;_YYF67^NOY/&3U)K183 RIV:L@&PE!"&LNO5=KGJXW$E^4ST8+"\\07% M!P&8AF[+>49/-I8RJCD!$KL-E/DOR4QE,R-Y"1#JT6QFJNXEV65?=ALA1&$Y M>\<4SW-+LVA!R5#%L$?35QAG<3LY&5PG@#P,I0C^ZA6TZ( = 4]/PH600^3H M"'LB/*+\K<^R8'GM_<#X%.;&D;:O8W&)$?IOT.<:)SUU9.;@PVI3TE'E18*H M4Z#)5)<%C MLJ[<ZVSPA$8YK%\DL:Q>3<AYP-[)K,!9#ZCZOL:'M1FP#DC-+ M:MN 0PYF=O05L(G[/UD@_3<#)M.$2_^F4!=Z%V8P(]7D2))1H\WN,A@#J&9! M,HKYIIP19ZJ@G5GEF,;DVI+W[L$D)W=%WBU@2E)"/.QW.>T4BOF3O?Z16)Y0 M-GIFN^#>(,+K#B.Q%C8+($JV:O")]ZT.MK=IG;)\Q0P72J\:LEJH%Z65;0," MZ)X)6>+'AU/J=3JS=5 P@B"7WA9!X[&S&380:\G7G;[]+"4LME548R;6@_4Q MZQCTKY =-?\-LI+]>'AHPE;G3@950W;CY@.+[J[FU[J9ND.MT@<U%)3)*5(4 M[1;#U;$[^5>FK_/H++36*5+9P?PIG$A'/ATO$R^)ZX;.#G$^-J9[1DC\ U>S M/R2&H=K* ;^=<PS9VB3Q3J&WZ>S-MY:W$XNX;8 >'W'&09@'?.2\T8 V-[YS M2_*,":1X;MWZ#(_-R#=(]?NX>Z^<ZGJ.VX=1Q+$MP8@IH_A"%5QT55LS)$*3 M]>'3D7%738/:1];Q3TNN!>Q?63GC>?](M92BP]SE[))N*CWD2R:TKYG4K!#= M]!]!-OK=V5EC_LW8%1GF/H:H_PL<_HF$6O%HX/O/^,KY2:[TSOX_-* ^G?,. M0+__]K\_-MCH4)WEUBN:-'+= JPFXB8KFQ1X1T!]>Y+%.-S5^KM-P8=! ;_Y M?8MQ)6KJ8RS?.-G:YP&=F!\N#',7O0>ZKO##_YK_)%"+ %"!L!R]#;!B7)?! M"U">&G>U9CM(<Z",:Q5G;4">P8W#Z3RH6<!,E+U#6/W]HWB#8'Y2$^%N40/F MKNYA4NVB8Y [Q#SU^^)DB*,G]L NX^D*9N#BSBF2/P)4](?UANT0^S;P)[/7 M'>A#&5#TY[/$>E"GW4CT#[\%<UZ_UOR4UZB1;!ZJ(?O%?4$P?5$(O2"=F*58 MK3U$%^MEJ3FD_N8*'(2J0'P_1.-:*.+Z18K$&BW4XJ/,9]Q4<\),G\?_,.I* M2KU$L3+#'&X'J]O 7P@=SNF*VXWB@%+Y,PR(C:!"4R>^DAACMGFL[[& NW2* MXL35X>)*QD=.M^V;**K(!0+F#L8U09BZCU04W]TB)S]D4#FXY+M<W(*0RSF^ M>.R]Y(9AP&12X)45 R_K;NIS_9/;P!LY[.J9 8:U'_8%]EOI"/R?:8C^=T:4 M_NO__EC?T#,+D1_ Q_V]O_-7X/]*M=+D$+"6 O7-,MPF5QFGK?7(-E7'A^9 M(Z=Z);K?K-_;[:M@3+#H?+02T*8?;T)F Q\2BJ*QI9;)!+BHJ_0%$M](? Y' M5^LG(,#_UM.G2X#[V<>0JQ,A.I"_M!W^* ?N?V37KT#<<*/MT:<X@C&3M#!8 M&%K 5 ;Y7HCWW)"*R27MY44MW@.OCO/LD7F_^$K-"5C=N#]42/N,$Z9>)F+( M@?UKV#W=[DX%\T,5FN?=TN\$+?G<?RL4-!S"RO9@_@10+"5^GV'N#T8^C!FK M_;'<J801[YU?-"U#C":377M]Z*4<>:O-:""+LC027)&,$*L=_/P1IZJB5Q0_ M>KO%99:F"983H>04T!P??'Y*&2.J#!>5ZL&YQ.2=V#NXAT_);G^$=&?[344) MKJ(5(MOGK5<9_DL;%-E]TX(#&JVP+QEG6?O/T>@W,7P:QJ[-9V9.[1S,PJY] MS/Z7V"8&]Z_!/F;_#Y.=QA@ZAG[3E[^VJ>;X.086$'N3JIGB^$J/^P"W3(& MY=_Z6W_ZE-Z?[(0OZ296J.X0-<#.ORULZFLR$=K0#Q]ST87T?:FLN.=V0."H M_)E2KDO&8QZVMV,!S],4&-G_4TUP/E6R!T?PR!!X.'7)846!UNVUEV1;0I0V MC'JHYQ5J).0^QA -!&S1&0VRD8O>\U_TUUK0 X%IK>PQF-U(.-ZTK.K&Q]H7 M[,'F+;0+Y]N>CH:8:$3%FXBW,0?Q)LE\H+$@^PEI38B1JO7)Y5C4+9R@3] X M+\51Q_F2D;M73LD;NTIVZ/L7T_S"4JEM9@9 ,.-/\_U=@.S8;E0;Q84V+*Y! M-$LCB$'QE>$JHEK!@A;E_;X)^^R;)<LKDBX?$#=X@5GK(QB,>9X,RPH*/D'2 M:D0?!:.(7WRP[,B1J7K-,=JISB+KX3;_ X>;-#<\3F8VQ9(?L_W:X_8#?\SU MJTS5V :8Z7IS$LXTAV6!-]6Q$\FA0UGR\1-?RFJ/LCMH!QF>(TN,U;5%CX,M M>&A"-@?*9=*<919;5E=+R!9$%FX#G1'F<,[+)RL&O2;'[-[['V?K]>[U-!<6 M<T6 1S_5#**%05;FEDY[6P/"@D\2_OZ1E-##\GJ3/ %MM4!PV%\AE_6?(*<B M]S^-2_\W1\S8!OX:]=>_#?EW*W,95BX8B3Z(#,+;=8#F.4;Y8!UYGIUM.IG9 M!\P-3O [NPV\7EGAG!B6/;'GQ$9VZ\A06_;G94LB)!IUGF1#$^B.\.UR'6I* M?QX1G*OO>#5I2LLQU'BE^:5^;'P TRTV8+/ZGSW??R-?$C9ZQ*AM1V^(E"M M0.^66R@QT/?IY1/>K%%RBU>Q:=:IMN&V&NQ"<??C'K(R*7Z<9%4APLBO28X9 M%#GJ>1(BKO U]<9KJM; \NK;-?=CLI:;D[>M.A\:UX]\^"R;\_317I(>]!3F MI^U %="!J;IC^!LP)= H%7,(2#?\ GEB2]&YWQ[FC(Y^N%W(=8PS4NBZ9\#K M)?%U<GH_C664UE.*LGPSR.Z")=XW)ZZ5O<CIQY:F'S]^LA*ZP/C:-KXFUL.# MDDT\BQ,=19VAFWZ?RIC%Q*<E0SE]*NH.R<M'3:5N >C;+Q@7%?[^&VZ%;OAN M:F3=OFV@V*Z(%FT]Y\Q(#Z\S9&,_C >V:#V 74W]!5PG2\)(KVI]_#75HA2W M@61^LN 2PS8@)4TPVHJQ3J,E=<!5, V*VEHW",N?!0U[U@Y_J/)[MEF>\L'5 MT_J(QT$C@/S^S6.("#$[>A'C= ES'1NK68L;KCG^$KD7A-O<J'39R_WZ .&( MWIG2-S?E%>NMFRM[EXNV 2<8@#+X=)DEG\0[E9I&N&PAM>=-Z_?V1.9IXCG& M*ZMC;LMP(?1[#&=- -'A%'BY8.Z\':AE($!H';"MZA!,BDW,G)R^][HIZUV! MC@/9EVA8/HE@1>H&:QI3M?"BHS);!SX*CP7PC#BU'XPZ&-+1+IT.;)B6805< M<<1SRS&J:#%2<,0=W^$:C=R*!YN%\0A:KS/WJ87=2A)Z!QLDG.A%Q6=P_7:- MS#/4$? )10\<:LG2J2"1*[2U]D[($6D1.3&'IZ*U_!5GUN\$) BAV9UD3[<$ M[R9AR#>(T#:.\X:?J.8.MU261#W[UPKDOYG(C/K>_&:0>HBC;)HT*BW4\3&O M"1.2Q0*>FQSM9@>#],/%9,XJZ3ZNE!H[C5[9)14P?<O:\(JQ5H)^_'V&C?6I M GU"YM#BB==NF@9TWKZ+W:7"P==]%=^<%-1EW'1LXD4ICZ12I\SU4+4CUS1D MNI^ _GCQ#-)Y?/=B\X0HF P-01]'NC6H5J5&L1NF[0JRJKB4BV/W/?_^F["$ MQX;YN65+6#&T(49,@)Y"M/K:*N)6>W)'+T+%[>'KF]:FHUDC+/>>(;Z_@80V M2;,F9^4U8THBFA+XD-*-:*':OF^2E<1'W*/.@7<SIU/7-P,/W-FE%=GNM1*7 M]PA:I,PP#0?0\BC#RJVG5!-B*:$[0OLH[;@Y).X:5 !IYU<P'FW\1NJ\S(U/ ME=7%>XV8\'H-NFX4[?D*52C1&,,MFO%6KAD-)<E5;Y0PC\IT^_$<G_UPV5,S MLVFPK@:TH6B"T,FMP9?!^"U=_T%?"^R(R,?< +DO:SWG[EAE6<I>U ,.J]?S M-XVC&[8!EB*%&GT9,'!FT7JA6^=KDHHPK8$<E>PV5E"W#<B:A'J"6F9LK2R MKLV0W-6:K03,-3>W%Y)O*]/:Q/?%7W(\^_Z]I>>%L :AM2+]K;HE7W6:%KH+ MP9F'P(^+F'.-&VWE!CB0JXW+5>,5K_>=$O97U0\QX:A)KB]Z=FCK(949%DIE MQ%OU/]=4NUTN:F=U*F*)HXH]QK-1P'&^WD-;O+R':@WJX"'Q]I#L1IIJ[Y4A M91>[&UQ=]WK;WXT>4&^2W)MU(7ZWV&X^AN^L<;J\X*NIJ?6&I?.MVX#0:G4V MWV>XK<F3N4VC<%1,QBPU:4BQ+-1*ACO.6-:P-]F,SA?NMKE8^A9$G@7#G:=( M4O9*GT:;V?WFI2\SF"ZIFGG%?N\OE!E#"Z#?9T/07&Y);NEB=\<'J]P-8JT+ MWP2K;'75OIAC,I=12Q.2(KZ==U-K@[]!-"(B[55K2(YYCTW=7\]S9;A;F"IM MNBE_VG_0Q.!6XEL>27?1VY3Q[WKB=(_&5)]LF(&7;LXCSB1O VS?40:#HJ84 MW5.8&P<8.<>V <ZNM^2B-PMW00.B52.<45G'W(CHD;F5\GQ>\]%FV>#[Z:?= MA\^.LA(+N?7.U>^J?M2SJ_=T^G$]=H-#SEV '-_#'&6@S,(Q]I^7GX8(X=": M8 QMMPF=SK!T.HOWQ_75C6/JLJUWKI[^R]407?S39&7'$('H,[WI@/61XX;. M#,[/NH0?,_^X+*QZY@P@1;%JF>!-[\</4?FF"/L"U]8*HDC9=UX7K=Y6?G*J MD:>X:E_B]Z_2[CFO7JJ0\Z;LS4G]9&O0C6(T.BP=3]5@R=>)/#!(5E6T/?5L M^D6BV2_9WQ[%UY4QX.&<OD$*4$R#"5IJ(?#@@%H5YBZ5U^WQ1)=H;/ KF[N/ MCB;>JS]Z3/H-DU4?3 MO_/;IDUV#FTB ]]-G\RQ2;US5Y7TEI;E P35OX2? MGMR;I,<TZ-\ 'V[";P.+Z_C16M'Z]+V:<N4+B.H'BDE!X:T, 4*IZL+U'UG, M@(Z7-&%T-VTW:$3\NE"?!>V[C[2>FPE8I;2JL2MDTLIM_&Z]YCP6=):U#5NA M%EZS?S(;@D,/P" H*V4LM[VIINDQT0<(.>EHJW#>?7[?8L_[H)+N')-X%/UY MJT*AT!<6F_UF?/Q+SB6[,63=X.4"N,;=SM%4_:S)1VC^A0FZJ Q%4ME ]RFD MMM534$7P8OF]+N=*-25SCM*9_8E"B2E+U>H+0^G?H:-?3M)Z,"7.K)(TWDCL MJ@\? WD1WD8CO3RJ#H[3UF#_'OY_0P631U$*;/*I5R2-%Q0*-4-+.$L+S]'N MN<W7#$%)^GBC"-UCSE5^*00W%_G7BRHRP=;,T>>%;2)%?=P3!QA':P'?$FIO M!:=NR@JVT1XV^00F;H:DNT]OO8V$+>_ S6<O;DCJN,7WTKA!Q$DPA0 3M[;1 M!!.:!2H&_;]KWTV<"N'FVMW#!;%?91@\'8S8.\>4W+;OF]*;TI /.GKS;M/= MHT]7$)&:,_14#3NV1%&(HYXJ=:W_8*4J$/8Q29@[X,@AQ4>Q?&)!0>N1=;N1 MYUM@_-H:) ':Q]/:%_$4%W=E2N*1W?MN.2&/]&29ZZXNG9_$WEU+B-$T;X[) M<(&W!-H_VK0K[WEPQ\;_UF*N)N^[!&4&3"OYW@A5A<3DV?;%0#SQ5F);%O\I M68 *\'^WHO+DT<[@FN!D/KI.>/7+IC_A,#MQO7ELM>_'N<P?X,1?"F$.&(YM MX+.5Q3;0]_(PX^(>ZU_^8P08BJ)A#OE;6O78<M8E?7R<T_F2DD$/E5%3:]$ MZ0M*HQV\%:MC)Z[4N;)(AES:0[&=C'6LT9^*6'0@II$C/Q7X(D1 1ZWQ:^/: MN0/NN4AI'^%&C?/AC-K7>;2X]<3A%&%D4ELK3ASK"A%UZ6<A;M'I;M$'E)>2 M8 G2<@RW[#;-+3[1+1%FOT!*F*J\B]X-^IL,:9OZRXJHYKQHR#,*=M^=+I1E M6!]@BWHIU-#)NZBA(GT7XX3;A13%ZW0W82"SB2[VW.\JTT>"#@M]N_^+HF1U M\KO,VY3FF<>SP-[2K4PJHQO1$8>_,,)G'7'[:KEJ3.Y$J;&J@$+F\)B0HM0Q MB;!0MA8 %4SJK ^47BPE635@>>H$YT=2:Z?,19!5,AQ&1F]KHBD4PT$__R2A M!T^2^)FHU9P P.7V!(S#R]F<V2K2-H$UP*,%Q#G B)>7] ,("9S(JO<.SW$V M=U>>5M\.O3IMS\)'UE!OUQTB^I/YZ1I4H86Q.8N/^%2_T%"U(2A :TSGK0ZJ MN&V/^?J;[,!^<(&RCWIT*Z=<AL.D35?,3O_"&_A1F86 ]-VQP:C*HVC?;DD= M+8=#(;HH>J)B0#6+\JVG,&<X5S<A0-OKBJ]HL#KXI.? O.#1C*]L?"F[CJ^X M,TTROX(233 ;4)@+EB(FN@T8CEN-P/?J"H#P25S8(E5A<DE\5+]GZ9;%X+BY M;&"U8H>?SG"4-&//S@^Y_?W_SK+B!BS._0L5_\K0,G= DM V<%>2Q%&"F;8= MH*=AY669ZBXG,.8$?7,CUG0$S^G+9[^T[G3R$JGHZVV_N\^IDJF'M56@CGV@ M3@+3<&AUB=4XTO2E+<C#&J[4C%AI_.5"8-(+3ZU'G&LS(PKUL.'&!3)O=FMR M0^Z\-98JJ82#<L]KA@6_\^7F=;<,;@A[33E[2(=%9AG'@&0U!ETF,P4;TYEN MV3AOZKRZ/&+XS2Y)60AX,Q^\T+B& *6EZSG<VOJ0%3/U/5M5-D45)BYBS5%. M4N\Z#G'Y358>-!0<W7>6]31%!"RU'H+=@(=786.^95 L9HSO=/@C*=876R7] M9 ,<;:&!I92KJ$MO01V**I+2(A+D9!%AYA8DEK1A/O/!4@HYRBJ;NQ["8M;= M6H6+@3)I2Y**ZHF@28MFP+N>)V_#OVJY^1^[@\1^FD+HZ6A:H,Z#^_'PV FQ M/A]SOI'.@+RYP+MU>6[[S@M%F[,=4&V?9YFBF]UKZ$[LG@(:)XJ1B+C3IWQY M<5$R:<4X:E1G(.Q#NOUIC?^+O3>/IW+K^\<O$1EW,H];(950QD*V!B2AD2)V MI3)/(=.VMS)FVJ&(,A2E$C)'V&9*ALSSGBK"9N_*=K&G[W;N<]_W.77N<Y_? M[WF^K]?S/-_GC^L5J^5]K;6NSWI_WI_/M:ZUG*_!$A%+OVX S!S$+KIBW\Z3 M1HGG+F\J^'0"H#:V(4Q^\[]?L&]G.1>E[8S_-4D+CC>H@6,Z!;=8 "X?Q4D_ M7 2W^S+N6/#(S<ZAOJWUI@1)9M.9W4$;,TW.RKTMJ2CL96HA>,@P$@<>M0"1 M<_%QS[S^]G/+9W'SBZF26)GG @7RX(&F7$A.72 ARZ =3CZE$6EGE:H_U8M' M"<RMC,>W-R5O^<3E^TPAY\'.S@.QR\7?J M]ZG7!-&7Z\?[O8M)IC^0?]C]P MOS8]T[5U[%"QU0)GFS^6'2&M?^0!+[\\IX$[P.'_IONP2VU]FDUFL+#5D=!1 M<L:,2Z-*ZD,!;SH,E,!#H_4[$@(.<+_%O:%XSF*&WI=EB ?[M$09<D1['9CE MQ#/L<= %XA-F,S]16#YU>W&#=!(5*FK^+*<ZRZ)+YD:GC,&P]YWML$CU?24W M0%O:87L7MJ!E\H&AA")2^SVBAMSL]"&']XFRRJW.[N;[.\T=^(134[H?GJ6P MQ=<4(T>B'4M.17,TJM=]\Z-J5%A087L>SKR="M?JP;Z9D"34.Q-&&F$;Z#YD M.'U;MF:?9X"E\/DKT6+PG453IF*/KS8=XI'U31(R$^7X:G:K#OJ4^195V=&" MYD3L'=189O!TB%=7RV\K:W@=1W495VAP&+ J70U7MW[774$[\[ML]=#WD4;, M&!3OO8#7^=1[LTY//NN9HV JMEO1VN?MPTB!5A+\:GOHYX:KPZA/FM(2C-N> M[-CZ6BX$,_OC]/\M*^3GL8L57=)34[0&(^!L'04+$+0XRHB:.+&> 24Y7.XG M.KXN?=5C-*#O,*GMZ\QXRH&2I@G?W=.DTT%7 :WQO;<:^*O))5&>^>4?<K/= M(^/.'T^0/R]M9H"F'7?A_ KM.$F_1.99Z*5$(<+(\+-H>TK19."T H6T_&YG M(G) Q 1Z5R)28 -NL^;'-;ZU<NI=L(2X)(;LP?!J8S>#-XCXG@PB6O@@OE?4 MKK/95>UEIG$L5RL']&&<O9(/I!KF3+<![=E:+5%^PQ!"CO @\$U?@(E);?1. M 8\FI?,2 ONAFL_IN[PE$5KDWE8(CT.0;6NM94-EKL.A5Y97_35?O@!DET_M MV7.02_B."R<>$YO#AX0R.Z%2#8+N<*X9!Q4[BG@-.TJQ;=&M3@P6+RGHM'YP M'9^18:=QKUI *!3P&T(.'2ME8C%ES<^:"^< ".V:^YB1 +.9;6$-&\!JYA;4 M)O"<_?R[1%F)D72(#W5N4B_]]9W\B,31'DVM6W[$G,K+) 8&<S7Y(7TM1H59 MDPG0D!JUR(+5@;E]UN_6__WV!Y)@&%GOMK*FQJ@(^K:].D5G:F!W/F1PB#YP M_O &+6/H Q;P:F6A@ZS1BN%8EK&.31/77TGP=Y^OASHX7*>TN*(%T+&Y7,^3 MU(KJQ'#E>WME0VWI(LZ.%NAPHZUQ!VPLEOB_R.\>TF9P+RY>GM,>G3(,+],[ M SR$AI"0>Y%-F(U,@Z"VNK,$#'_&\I>S-H3%_D\X/0,?T4Y1?"P@0-R'2[V9 ME$K --7O(E+]1I@RH%.+>+GK=5=(P9<U 2U&TI:]7W-3L^JRVI+,%5*'P]7I MIT \'A53.Q-9=X @$_]&BR@3,^"AL^GR)8^RN_L$?5=.QO;T65EIZMN^77-N MJ8=0#S->-(A_0?$'%%FT>A.[XN.]M[CJ1[T/'(%X2 1.V.%4[C_62E-X*'LE M6W6NWH(:2$8G-0C,Y@C2?9],@"5'![3G[34T\7Q[@[:=:^T\^-[CQLRG Y3. ME]ZW8*4QS=9C2^=JA@VE\+$DG0SBUZ2\ %5K?96 0QT?>1H )1^K?;D07;9+ MST)@R[(H75O&%Y._9F._N,+/SLYGR;]'#7"Q@#Z3ZUAQI!#H3G2.A+88J5:G MK)B%WO<:W_%I;W6&2,SAUR'"X(BS]P;[P[+F*\*'2OH$^ !PAGHNE2EA1CI( M>4"H;$H+/2#]!0%]-#%UZ*5G7DS&QT1,C-^GH[)W@@\4QK%O7XGJ5,0Y,Y)\ M4;/;&KI!>W)Z2PZ/OP%#L46\WVX,[J8G_;)+*>KMZZSJHP</<(?>*%G_%J4H MYRL?R-8'3@_A:YO8Q/#<]0_5P6_H ;(?7*:4M\#*9UJZ#[<WJ-:X:'=I)K_T MP77[JLHJG=P)T\JV.B"&=EOMQ>N%USG1#B$.D5?:2A+UUKS03UTU*V<B&^0G M>F7X=:\?#Y2H43K0:"HI=R;<)__R^D)R[,(0#CU^VJ+_>Z^<O2/<=<VCVW=C M926Q,=I4)G#?Z6@%_][C.:<=31ZS@"8-%N#, B#S=LA"9_R;T24/+\7:J)Z\ MG1N.7'QWM >BX&LL9]W:NQFAPW@4L"1%YQNIS#I]'#-PL:)^T$8J*;NG>()X M[LDE6N.&0ET.Z)Z9_1TQR-Y:TRA>1KX19_>S"^ #W$B4QR-[WB*UY,5+%K'R M%L^$\=98<QGU@TW7I_SNJ'Z!HZ%E,/:L'C]FJ8^2 X,#5$D'CM\8(1_KLTI. M396Z"M/\.,.S;W^[IM\ 8CLH@\/<9/)9\P5IF<8<_<"I]19@X+--)9WO/5 > M36#3!C>P(1RFCW J -]8,Q*6,[:"+. )F(X[^S3VXH?VU*M4!R1(VFP_:@41 M;B\7LSUA<>]0P7.Q+_ JE9AE""][/';2#1Z[59%<G[N.V]QT]_-JC)"-O61S M.AN78(N9A9.M>V_*RX%)".^K./NSP^*H2A/^+D6[P[I^GY64JR*RC?=S&G*T M[T.!N^HN0T>KVP _9M:E]=7^QE#K]9<#R1(M.53^2A;PP<)!S0_^^S7\QK(\ M'2S@MTE0^GM&K)$P<Q"ISLCR5[/&H]H%(<V.0BF$+VH5#^8=OK82 K=L0?:L M3H[!@I9)\*?P"A[ZG9S;4*J:&WS-0AF!9?O9VF$UA &-QT7ZR;QH>=F#LS59 M0X%BB>K*U_;)/@2"1#FZ4"U&R$GL=Y\&"1;0*,P".OU_*@F@FC6CXZ9EP2&< M)ZR-*5J3MG((@Z4&?[[YZ-IXF_T.W)Z/\H]KEYK#C=A#&(U@U&!F\0BV984K MLH [LS\7S2]Y'5#M)C(>&8KHW3;:ZG(2>^'M<Y"OQX 4(E9V]_ZVH,RS.Z,8 M^%V)S5<H214<7]%TK1E2-PLPX\>CZ!Q0>HS9CP5P%_I^,"H/<8;LE4'(@=1] M<UE+0'K6I>LN<27D)K_WXM106!;K3Y &0!6FU#?J9Q:0%T7&, $T\W#>CP4E M]>#WXM!VZ&9# ]S&?OM6_:*JE-JJ1T+WG*CI?%Y>G_?%B4);21$=N2J5 .(T M"Q!8I?FA/C2#<!8 F+& K1]^+AJ9QD9IR-_E(/_4\)][$GS!*NV5N59$F<[N M"5,KX"VAQCN2!:S'U.5X9BK1FG?*/!3/.''4TVL[>_C'5(^,F7'$O$_8+U=N M#)7Y*P]SI?V#Z0=C*"<+^-_*_[XRYE]59D[&==I3H\@=T[.[0UC QR>(&=H6 M^D[&4X0#KE>\E]Q"&+Z-5].%;+[0AO(,=:_K]H?T[F*;60/']\XUVP7.'=,/ MA2HI4/J6NZBV$C!Y_;C,E6^B'.B_9E!8&1,9$P !^9]=>YIF$HQJQX[;XV<6 MOGD7Z"56]B[0$H^\*B^MKD[Y_-GG]>2I'8.EG(HJDNP@H./?SRT[N@RX@O-& M-\BFVY--RS(K\T5D0N^/Z\:%NG)KIK3B-.7-3CHT%+T8<]&_VI/W;.KP52=W M&8L#;2V12=J<RO>SP]EZPGJ=+S[]RA<<$#9?9,%<>Z/@%;W1S%T(H0K*2%N6 M2&O(,@N()<:T!-X8GCAM5:<A>3X?ZGRA^(9O-*U>]3L_/H<T1;8G8!.+Z#OQ MO6(9E?'5*09; Z[JU-F^C(S>?&Q._' 3+?]S'8JZMA7C8CVF?7.DG<P"9F=W M<,JAG+$3B>F?&(_J]IC5I\/6S"W^:.22GZV^9BJ>\A3E(,/^_< @/$7_M^:_ MK1E*$NNDGP"+\*@().]@W7D"R>J RJ&! ?\1H2>WE7#;GDE=.W!7(!, )_Z] MDZG48&X%0\W)!RG1CYX?+@CR]!AF+/.7?S*3%7@4H1OB8\:#$?N(XL-X]49 MI1 .[O@<0?"QZ; WA^Z-%:J675BY5&=D9_A1'][FF9N9 !D%.O=./& F2;"E M%+@!MBJ$_K&@88787],;B]I<=X!<T%1;$E=W^EE;_JS=E>WN#YZ'[.@$@/W7 ME,*!CRD; 80& 1..JAHJB5J^O0Q!,Z5>OTKJ<7X=M?M5K^2A\Z9J/$K.]4$S M"V?):&H^Q;M1;3L+P*>W"_(W.XJZ=[5&'*^KQ&[K+']U[S;-8,;O8U*(-$.] MAE*%IJCB'&;B*GBG9TR&M7E+/#ZG;$_,5KD9E_*20U8^NHZ3R7OV&[*=*:/" MO%7[R[)Q6?8S62)U_9MG(G_WS7\-MOJ_RH0?.1SW4O*H#: M&6)3U6_H0.". M.9^M8>B:&99?G;Z3MT<YB&"S*V>G#%KV! ][A,B].=5Z#%F-*/:/7*BO<M ? M"\+ND=\0"J(:M$#UCC:DT-"E87^#1D1A[.NM-UL4=WXZ)__"U,214I#T'1+C M*#58=Y!@>4Q0T73@D=;DU.2>37'Z#&L/(2L73L)?L+S;H ;M*ET%9!#XL_B; MIA529LY'<US?[>WQI"+%!3.3?_FLPSQ6L?0Y4ALYBN)# O,V(1H)AF8?W=./ M*EON:AZVZ'J2<.MPA:^JV.G*&J.['-_2?S*#/<QV%#_*97UOHE2B $K0:)?+ MM%C]*XK(00)OB2>]Z9FC]P,ME44HW]$[W^'U_1A;YA;Z-3*\0T.@&(-+#!EQ M'+@N;AJ.QUWG^/KQ<+09\/4EAQ@%0]\R"0&M8:X-L,_^W@R9 &,15,L!YC]4 MPM9_*2F^_'>0-O^!RC6 S8UZ@J!!\YH.L^C%9(?3T]'&%3V]T^S8]=GN]]:Y M0!]/"^S?FV !#AYK!VU%;729WMU7+$T\/$2R^=I/.)=@\OC2G;9S&^I"1N+F ML.03)>%K&HGJ"*T HHG] _N2TMYGR@^["UHT MQS&\YU' KT6=_2#Y\#\_)> MVP?G9T?DF]B"3!_V4PFM9YJ@^B:H(&KXW)43L[/7I8YV*JQPV68AW!B/$1RT M U]N!$[O&QZQD"AV*J^,D\C^_.6FP_29H_Q&4UTI/.RH_2[JMY";UR%7!W"8 MYIQQ)QO&LP;-+_)28.7C+T;ZI>+.K=*351./,3U+N[>M\GCM\?M:<A)> .5B M 2XE +-O7&WQ"<[3Q2UYM)<:^B;X49"Z6LY#WFT^4GX1"4F^<&UF%^PK"ENI M1\L,_!H"=/XMAD*Q8ZB]?Q96^>3UI[OD0FZR^?@O# ;1)>^_7>7)< /;C90( M8OHM)&?0%?<&O6'\AY=74CMOGK<S][JJD"S+MC]2N!5 ,H9N^TNF_)W] PL8 MC\=WD$08S[(W#8^O+5D$V'?)O'%5\[HDN'*N;5NAITKB:+O[\%XV*-=?B;#F MUJKIHC$X+W2Q6\CQ\?9*M>FL8+6HCK$Z6+ F;][UI$=IFD*;#JB.()412+)& M,S2F-&BD+7,PQ/2FMN];@133=M?X\+.G%/3*+S+Z-'=P?NP%G3&_9]1+#: ] MS:R$M%(0Y.4=%Z)%O^ M5-$'YBRP->);U[)#E\8^ABUP,X48[M]G<#FDD^0! M:F1M0P7Y6IW7LJK8-W7MB2Y7-?44(YZ,3T=?3&@V>G%*E:3K)*!:/FJKPSY; M>#-$= #KOZS1U?\K4-)_D<KEET*=R<4B>.\."#?"!=VJ&:1GX^"&/30(/U;W M.EI7..S1V?/W)!/VM4 RKK,?K?6_]YYU8 :EO(D%;#*+0>%W##*;F0I#"A^^ MCZ9LOS?S^BX>.,L5U6MC*)"0[0XG0%I1 HB=Y/K>V#J'HO.STFHU_,J?%FYN MWCN;-X2^N%^;@^+\6]>Y8=UUZB,\P-.TXVQ"J5AI2E1M@XK[6\([]$C^A@=> MMGA6J1E&&ET*^"JQ7ZKCW=":(/D!]3.H1\EKZP/A+=G;DW5HD=_4/ (LI%[F MUTHZT4IT;(.;]S8NJ+9CW-K/P[R7QJY&\Y7/0=?4GG$J(=G\K^$]+M$BN5+& M A:/_<'\'E:608G0O]#^:Z@N=NVMG/WA1IO^6EIK/B<!+F<((4.:"UJ-]$>* MOJOMSWD7\[ZKRW<[[YBH&[_!11$V?1F03U/+00?:03>)3.\(Q!'URE!C1X== M:],6%J_"U:\('WO19G3I&T>2"^?GGXSAEX+T7PNXUJVC$:RAI#>C.!&[#$V( M<L9?:ITNM+@DE&J7*)7M.W+69..#U!X>3J41MP3H/CDA00 A]DLWK[. 7_L9 M\VO7:;\I^Z7O8W#1!M6@T[CJB,6ZDT0U1T$)D^I=B;YZRED-<[N2SJ,O<KO' M@:HT>\0>1JZ..TFE:6TA=5[<]_:3@4K^_1Z+ L&<[\]].KN[1C$Y$U@M_/<! MD=T(#)<'YZ(?*)J3MOS\I(1_0N:VVK5S]/TAN*,)9\,OB6_J-$RJQ-(5&85& M,G0/,O:V#@L0=!OA/$J>7QA<K#38Z9&&_:CN]_G%#(>5[T#"<BXDXV=-L!I/ M)8!PFAEHU(M_@S@%%N0%-:CV;N[@3JJR8<)'E_;HOF<!KX\_HR/OK4')2U0J MJ$*Q:!?/ENJCGV&[B< R28]$4N1PW[3Y&Y>C5Y(W=+9^![XY"K* C>X=5.O& MZ7TL(+)'@\%U8F,$C<T--?L8CQ :(TP$>YBWG?HC;AG7C0- Z+\?G@;=N/]A M-8N1V@@O<D&C!E\+04.B.]C[2?>-M&/#NII3F/OOWG,<'8J5-/V8X"_7%C2< MPQY?%5#BN5N:-,*NO2I=8F3O6--,4,A7'=<K%Y^]R53@-L^%J/ZU2?H%G@BO MK&[&CK& $V4#""?"5L^7CCM2Y':UCUN\*9>:NBUP4E6SX!WR,D"HU8C$R"-X M*%W-/*W3_!3!XM+\/-&LP=7K]GM.M%TS;3$]=,>GT=<8JO3S@\7#JCJ:H>.I MS:AR9ODSNC78] BL;J),VO-GJ;^;Z$HQU=IQ"#(VD'>1L3A$)6'HHEHXG9%$ M3[H63Z*X>WQ\96G\28O]20^_"=]Y/.]\-TSKC13A-7O*[VKA9L333]@R42]A MWQ_MX/R"_<W2ZAVV_]@'"+VV<9PM!9X4IX4;L@!J. M($:$H,MN*+%B ^962 M5/9TR$%]3:!%3)YWQZ[)+B_'_/#J8=6>R3M1,,D6WY;+9>51B^J+196=6Z/W MIB6/FS<_6U&Z"?;Q9"&V@D5$:!2*O+Z:4X+)6U=9.1+@+64W6U-OV=<ENW(Z MV@QWC^O%IW E 4+]Z0Y'=;"&MI_9!^59"(#?MB9V*Q*X\WR?SDD?6,P0K-/U MBDV0'^OS.B$0?JF\F4:9F98#%8D3T-$8G$3T57+TJTQF/(7'<K!23GM"Q-?= M+=VOO&M; )_8W=1%U0F8!R0F>P<%W:$QACG75Z$Z96O5AS +\'T^.=[JL)MP M)5:U,W3G^"3M!/>%:6TPAF:)[(-O-E3$86)M44)U4CBHBO6;NOZ%K9E?::<\ M,FQ7Y@ZUWE=4\&OBKLO!"3TA]G+0+S+*EB&B;C;53-T^?_[]EX<NWCRISJ5; M;>EI8)H?_OZVC.9:RKXOCNEAN4%+U*/@*H6GC2D%!A0B+,DJK?SW*V7R^ZZ8 MZZCILP#WU?A/NGI'.N[X??THD'HAL!D3@Y70\99 CM2N)!D*&D4]!S$MKUKR MQ\<ONQ3O=?5/;A)]<:-K6V%K@ADEM3]<[0O;41>T]LHC>!G9%7(R=F@K,)7B M2'#Y3(&..5TIK:BR29D[DY#UU.'!#<ZF)OE[;$THA%"A5.,#V_D%M6PI8;UM M&C'23R(3 UZX]8V/3W^1>';0F"OT2+(^)9Q_@U\CCY$,#C7VC> 53Y:@.E.N M1>&'45"$=LJ78D.50OWQ!P_<G[@4."R8OCUKO L"W=MK%69QF&+;CD6S &'M M,&NK/AWLK6SN?H7Z^!.5(_W0*K>54T<*-YUKO%S:CMV3JB"[YW.X80$!GMB@ MZFHD0^E(0/A15BQ!&$%&MR[G$%DY9U3]\IXCY^P[#*H^NUZ]5+%PH*D]2!;> MWBO.'MB;H IM-_W0:XH/>;F]DB@HWE9!<]BOG"1G\?[UR6?/K_$HJ"-2=+\E M#L'QL$:(%,A6&(E&<H[,'N&@",+G1]Z!U)Q8NT_O15RKD>XU20$U=\N#WY7G MI.WAO;(1S97TI&$+_? [#)T;,$$Y^G& AS)D 0/'9)]R\EFQ4$[_M#;+;%Y M3M_V?A-%4ZT6;X4;+(W'4Z.&&Z!T8]"3[$,_4T86(TW?#[ 6 5=.5$>+;U;8 MV_'1;+O3M^WWE-XE+ #R]]!D./5-1!-&NA+*R<:77$!J!AV;/_1ZV)^$?#=F MM];O?O6;2G5.)WQWA'3G7!#M9DBE!R((#"1,!1)L6U#C6BTY0DN&9CK%<6OP MVT;R<Q_:J)\KPI8DD_1LX+H[KUQNLK+G3=)R"&Q!\8-HH@WF)7P.PT]"BB#T M:_H6M?,'O'>K$4:\U;>ORE]VXND\8OPN]V%UQD.G7!Y.\O02D060.,EL&4#4 M3:3L] _M-M?PJC/ G?L^?V,@ORHQ:VOT9[.6U:0SBQ=Q L^7Q;Y R<?+( LP M<D<"<H[& BP65=\SQ>>@<ACG'#8GY%641 ;*;QW1GG!_;;B?N*/8B=F>)I[B M;%[\]N)E']BGV+?>=WUKZ].9O"NX^D#\S$(,F=8RO;U?_;O:]7<&I;X%6%.G MS&TCJ;6+IP=VO3,K%>7X;OGK2<[_ZA*NQB8UL,.^6Z=8P%N-7]^I?"^IME_J M@ NCFG:N'^!V=/T -]K:"9Y)[9,F@.@/E^;Q5<^DUR4)".@^"I8N.D\0S7QY M\H(Y#K-I_)S+4C7WQAR/,MA^!EZS=DERU4IU8554\TZ(;4>.'$*&PH\K(.V% MMB_%('E1\B[C[9':WB(N(7X$IODIXTLUB?9+F]^(\'\X6;:_&SA,GK&N E%L MK[8+3,^;?67F6@ 6-E5-*PX^2C2U^ZIZ<U, )\=AGAL>M\[?KPK6^5[0;AVE M+]&^%+W6<0MQK%KPL5MG\B2_><(IO,,%SXM"^T^.QJVR:=X.#*7PMT&EZH(I M$P1XC%E4I6#(.T&5%J9<QLK4EV%AN?=E1$!*5M5S_\7#_I*]?KXE""MPE:;O M_LTET_$)V9T@T$/Y\KQP6\8EEWP;&X_G,E> 8A\?2;9^*Z&^<A"Q!F^2"YHT M@[:CHK "#7)@TCNFAOR%+SW^,P3-JK3^(P77J#>FOXIQ'S4UWZ<S@ISV*J,C M&2D?3<\+UWGR;MGZ[F$71Z?1O7=TDV&8B_?X +YMI,G3&]<"RB\NNH@X4L(^ M#7?O/\7_>NQ))7'ER;M%OGRRE2:WNQ]UY .!O-)N/3I_++PTNJ-MN*HTG=9V MDC3HC 5.\$Q]0$%I[?G/?MU,YT_-HUOSH%2PY*ZDER%\]%)&M>&E9\P1>4FP MX,5L;60:.\!"2HR3HEV45!FE15+"O.-FW;(''SKO^R@\@AX\$&I231&/1SV9 M6J*I+=>EE:TZ"Y8.%EZD[MN.,4*Y:(#;-2+K(+0#8 5B7QV%6E0T,1&<B8HA M#KT?7MF2<=I'=RX<)N41>BW<(&?B%)0$'UW!9\=^.YHF/5V)KU=?]ORX-T,A M5:8O>13G<U#6_SD,]VA:9@ !(9?@O4IRQYJ>S,G+4-*279_TNDO>+L)?N_@A M,7=SI,*[6QR?T1+,UMJ;##2I3@X79G\.W;YG:C0HK8NYQ0);(;F\2<R^<[)Q MTX!RN*2"\(686'3[TL3A4V2)B#I;<B8+P%=':PM>'CE'V5[T8M^E0*6-5<IE M64^&[NL>G96%'@\/8WNKK6G3>DXI[R#'KYL@/9ECR.U#[,(@H^U?[-2?#F-Y MC23.OS7*\_.ZSQP=OG<N]M2A33LW*>Z;LPKN[)B<W@9&E;A Q>LT\#(0+K>0 MIQ$O["UTL+=S.\;\/Q\G)5G?:.P8M.W$2L-P&?+<Y-YFN,QTD/RWCO20CU7E M4Q,N5;5-+NK%,G>*^'(A*;Y)N!,\KYG=BS)47K*I$(H0A=Y'8L:Z)_RTW8P= MMJRD\1O9@*KGKEI:-#$?DAT^LO8DNM+GBKMJJG,E/G&3_*D-=2I>[BI,WM,L M8+LWOH3&YP9?.ZL,A-VT,+?XR7 V8>\AG&C2;Z&)&-?>\8C6M?H*/>GZAAKW MO(-:':F"^;[ZL>G[=\E<3N.\9>H+=]9!P B"4$+. IKRC6"6@! F]Q )UN'T M,.5*XJA+&:3JG!NOC.J6#*5VK)9XN^;<OO9-/.8TL5D;.(1I@!QPY/Z@J-L@ MTX\P<4(YNS:>NU)7J?G^!;?8:1^.,QQ1@%\<E04DYG @%&G&+K5>MXD&]O&D M[1VG8DZ+W^GY8&*8/,.[!XK4A*AB!VW1S"Y'+C"*/-#( D21.\"E(^Z]L=/: M;\)\Z0;7".:/HW?$5I1--6KNRKK?(2DUH]./.#)HM)=N!4)R@PKQC(=,#C"" MZ\L+<WR8R_:)"M.+PUHI1@ZX*YMM'UZ) \@0$3!NI"VG6J*98=MJ)-H [L\+ MLK//@IC6#6G/A(,III-LZ5):<O?5CK.CQ9,O"S@KP_0"V!8=N/[1C^,>$%\D MXZEQ?C W >Z>V=:X=]ST=KG'UIC%ZF).X'HK8!#Q+3U.FP7$8ZK%'^$P@D$Y M>#46T(SF!5%V54/+11:V;]ZG5ER*C1[2_=3D00<;.WOM\$Q],(<PT^H]?OI$ M+<6V,4<6[,7#8@K&'H..FS:<=YPZ<HQ1A>#\_+Q+\[F2TS53/V/Y 1H/:,_< M HF%2QIINJP%=,080HB>IEMSOVC9A]VW%MA966)8&LZ5F%+G_-ECA*WON:I9 M0/(WZ@.V'_F ^>XY%"9"TZ5[4)S;5!-/M;3"> *6HJI"/(3#DBNO\(H2%U=] MGW'*&,L*[8U;G?AYDQG:6MR.7TYP_^W%I:CS#4Y*IL$Z*-[-M=/51>"#<_*2 M??3]J#WDK(<-)EF?QH]\-3-<R->^>?2"*?)"KE'-FLWKI81QS^%*<DR'?EAB M77KZ2(C8<GU]G6IZFEEUP)F3DRG&4#M@U=:2\J2W!0LJ,7-*SG7(5M\)XMMQ MPOPA1,=FR_7]G5NV'&@L$28?S]8>0%VIAQVO8#S0GL#>TG0]B9WW#"OL\"Z< M.QIN./*&6W+_#@=>E5V%?;*0HH;-"(GTMIQ7V"BD%-AR[/7 HH:ABOR]4.>0 MA!1[RW*@C'S0C \;7L+;0(&35/#8R--T+NN(5/?IK?KVX VH;(=^XC9WF]C< MK(G$HD];-BDAV,,+T* XZ&U##4))A*/@8)U,@%\ /J.BTR1BVL"0H)"[\4ZU M\HCD_D753YAQK,TPPH &1VA2)%KJ]4<(&JUR,+/750\:JW>,5I<YJS%RMW_R M'-7BFFY1VLSMUU$<Y&XVP@*NP,:\FS*Y(_ .9@2CRKPVSTN^3GF,%>?>!YH? MP]H\EA=,?. RAKP4'KPU20[:L;0!5(?'[L$&!?M[NK?<F0RV?;69<C=MRI?6 M VPT4Q1PX;S'B/O\AB)!LJ44MC9H]9_&8UM#.TF/7Y-WGTP6L=^5 -]=Q]M5 MM?!*SLIZNI %_+JEB^4O6[K4PL=6FG.V,%69?;98.:-M0:>98LM%#;'3TGV& M>EH2]>*?47MG7C._[!;BD96/O)CM3#W/ M@A'.,Y:G( 0PT!:'%I*6GA?#L> M_^X2+B3"$LH@XBR@Z:@1;Y#WV6B#;AF+OF4U._[SJ=?#"KLNEFT.4KZQ\W1" M1+;[0@M\!W,8*H (R*=? (,I+?B2F,<4FQK\CN*7RY8\[WEUEA-*LZ9/JF1( M?.;+O9*^E'!B(T0NZ$9+$XI\"A:EWYXL,;J$N(2OMQLY]Y7\_'K5AY?)6@ W M7"7-X^,N(=VXM0>M _##C^;,+!,_-8BG5)8].G'\D5 C+\XOR5KLJW.3'(2 MZB@9OSY"5%E?34S7)V.CM6N^YT! U)F+(]Z&D]8^ML"+NUN#.PVX#3*I8; V MIC;X_"G]>%],C$Y.C.VX^]N"V=KO<S&DA,X)KUP!OGM<&B?,NHVA,G1!2@E) MA*9*%WEP>LA(2'DDILC;6V=);$XZND@T)*NU9*^>EHD7A-/M5IU? EG0A'80 M85<-MM'LZ)(YS=,\,80B-'W;5_<0H23G<Z3,Q1NKSF^NK8IMW?LUN(G[39$] MP8RTGZ@1/8+AJ43?*K<DJAVV]-3\UIZ"-=6^87-(>B9HU<(3YB-OKSA>23]) M4P?3J0%H/"R)*3[;152#-X;LSA0OSS/?:I]UN=WX_'L5(#CVTYB$U-;PS^%2 MY.IVVQ/($2/Y'*)SBP$LA@6(+7?O<@^#V/?KH"OMW.ZH0+C>Y3]+/B@3YM=[ M\%S([Q:U]X$\S>LG;;,=%KP))6;HAU-%1R,WDRWK6T.\'CSK8@$B,F]J (&> M^CQ9>>,>(=[BT',LX&ZG"YRJ7,V\G1ENQ (>Q^WXZ<K7KHCR,X;N1(YAI.K, MJ=T2N/06U1(-@G?B030I_DZM:=:M[;6!LGE.6T,34O9/7.BEBW@WWH#S+R#W M@X>M,MT++24ZJG7W=/DI!%_A]>9;W+TW)<S78:9M:12"Q[9KQ&6B6RTM;"C7 MD@FAM*"BIP\.#C';7R:W/WNQ)S+\D'HPR=&3)LCL+,"Q@#;K.",EC+QZ>2AL MB^,YE\+"Z7+[.?U0I5"OK&-,ZJ'#$*WON4(JU%%P8T&0'D&O&0.=DYXN)7B+ MSL.V5#Q3S#GUFM&>X^8L4#7<5_(N3O>92J$GUS?X-807*,)^0./("&?"A/DR MOX/$J7B;JLJD"R9*E)R[Q^ZK;G-2>"['*]<=K$(:PT&W!%&0 A AE\#QL7YZ MV%,W/>SEV+?44)>/7>_ V=P '1ZZJ&H;3$(;&UUK%L,4#@IU'"Q9GK^M,*3C M#3G\>=*5&B<1='+LH\"A*E-=W4W[M#F:D1^@Y 2V<BYHV!RDTEB5IA\39RCV MTNSE/%-IX$3.@H&D3,AY[=M11GZ(AO,J7ASMDH.82AL>$HVV&]BC-R<I^856 M?AY:#F^#;*$KEI.Q-]GTN!/L;;&S[!X4KUXC$52/T3YNL"A\KONI<WKQN@^W M<2.AD@6XM4W0D,PNS@_+$(:X"^?BIH8O:SDSUD]-5JP'68!^V#_#I+L5=SD^ MP44PSNM'=-I0JB/HMH1N-1W5WDUO#:G"DT:>MN\!+4LI&;CKV4L/+SXCM2&( MSMNC:$>1TTQ)2F#+(\'V1/*292VZ55ZU#+TB?6^P<XNJSGV!8YWY*=>--\9X MG$&13WAO05P:KCN(QVX(DFB2UQRJ$]/GQVR9,Y**Y*F_&:\QFI<.\@)IAM", MO=.UZ+$"HMGME\L8(7!#%_4R!=H"X<7G,?M2A.6*GIW!YQ-W=U?:^BK?5MR? M"]%AB\5[")[2F,:0ZE82W&%8AW2ULFC7R+'2-P^+TM#\UM*U37PX"2>,IJZY MD-DE>.Z[%R];A<Y]''G/ L@GV&X@GJ"W,+\]'A^VY1M\2,9^P%D\;6^&TM=^ M_/D)SE= JF,OQ;F#[=Z%D')@1&LM,@86NUC195N+MJC<ES;CK6P[D/"0=H*G M.X=\:F>1?3,+$+PR\*1Z".%; #Z=.$%F 9'.%7J''3*N%_&;ZBO8*I7B-FL- MOX9RS$_OH2R12+AZ9\),1!%3)"C"FLR8U)=[4AA6%$# W3ZYV,[M9-.)?O9V MN<0,I.!0$@AK- [;T1LCK6U7'6^HYU:;3*XG]=ZCOE%]?<K\LED[5V$[[WQ$ MTSZQWMD0VS;H^ C1K 4K%O0&7[_4W,M)A]5[VO"'V5F#]^?T)HQ-SG1T;9XS MG^\1<N$<8\O_WL1TS 8DSYQ=<5RBQFV-S^BC'TX44Z@U/:W7-7G/O'5*"BK9 MQ"@PDD2'8UX9@.K#7RW>U-N?'B#ID Z9G__<\/I-S<%@U:/!NUOO\,Z*!96< M!%?)*ZTL8 O,#19>:G()D2U )K5A8S4"=ES"<@7Z*FPVV0KS?Z7$F<T0O,$" M*F.:[+%)6$ZZ&?[ =H*!IU= TKQE-BY'W>#U!7-A)?_5\!F>26F /9K@#K,( M?U0TIC0KQ45W\[C>K9+OU1_RA9^%WD@Z<SSZQ)YSSC<FO=XN%_,P^<*>=Q<A M8(R'RS*)&)<ZBDY6ZP-N";_6!)\#FF[>$N84&K62C(YI$ 8+\0=F(G:3O#T^ M4N!Q.N?O3DR;>2M,>I:B]W3:^O*//O3M9O/HK>*QIJ>@'T[YR<O+,NXHB2;1 MDR5'3$SX8,!& !EQJO]4'X>)Z(D?+TZI@Q[)O46(J/SIM[13R-':5]DV-6 H M^=;96S*&S#F:H\_$IV0IG^E#GVP_O'H7K+/\M"C@0%I&L*^GE]?BI:B/<5,A MG4WF_. ='B*<;81-1D@H&-^$VE#L37?-=W1AZE#$:YZYC;?:19KN_'AOYJI9 MP*R6M%D"L#<.('DU2"!TP-,4F3:L3$!!9?_R ]JY;8,Z17;X(^*EK6\X32\@ M%\KNY$=TGI6<SXG4Z1#' FQ#0"<Z;OE@%HW@(<)*74,$'_H<>/6FVMQF.O3C M(>#,_9Z/ZOJ+/'%S*)?$0,)(*W0\FN"]F0ZAE"0:B02=FN_Z0-_O+#0A=VI. M5P%N%7(LDOZN0)'#CVY,R\[1BT5YH&YA-S=(!Q7@MU>2HYL=-&7"="T=#]PQ MK%&32'O!+:X2IWG&]]8.SIDE"3<CS0\LX%JHG.IY1L;"!#5HH*BH6"G.TTYY MQ&:(C[!,-.:[<*^KM+'G,Q<N<QD.[D@KR@<CF+QXH\)<!_/01UCU9-]+?EKB MP9[C1]][M'XU/Z5IK1-#*)%G#C#W@&YLHE-'"KUE ;Q6!4]9P"6W;,,WM;;] MTKP*$SI] 8"W"PN( 2_<X5#@9$N[C0!Y%V(/VP2\.G!@@=[)V3TN:Y=[4)\* M4I5<WU F,@&:X@_;G[AG@GXL8)M&#&Q!PIWM==-J[8!O+&"<DWG4NA5-$Z_4 M8"BG-$BO[[#"9&O73480YCND#+DWGNY;,)M)JI]:2!F[X#4=MR(T:\43H,#4 M6='X<:N4;:BFO4QNNB&E8P&%3[1OE>?M"R@Z9=^UG/)UK7G_U8O5ZB_X][QM M!)"B'"0,F;PT-L.,N\&6F&@60-%&M;1@G'/6=HY;,V$LH'4DE 4(-)%CF+<+ MUA?RG(6PI80979,=FT'7MF>S(Z2F,S"Z)> #)Y.Q?XH3QL;!_(2S\@,,[/<P M4= ?FJ>#1;5H(+:RQ\T5CZ*+'68CK[_/K/\]L+$LA&YH0 UF5\O*9P%$%H W M^Z& ;AF()7=A-Z%F,X/@[.=XXF]M_@&[CX>3!4"$&-FHV0)7&,CFF).__YU] M,X>5'[L!_0F8@QV2M[2@?C,>ZR<B"3*R0]@#V=/O]\N9703W!A80[0BR;WQD M8/V5[RZV"+R=QY1"X2$,$>OUMYHOH,SMX?LTP*# !;;-F!B8LX .=L5,&!Z/ M+>]EB))46 !T':EN_;O0'Y">_ %ZKA _4UZ.9L@"/ECUHR@L@+D=_1/Z$@J? MWK"9746;7,WD>\3&=_D#^+\,M;Z!I#89\T^D_VBC?H5RA;&Q?]],S@CV9(U! M]L*^GZ[(H:-^&<X?D-]@P:ML3PS[;FFHP9YTSU#KH_D#L@OGK;^$L_0C#//_ M.TSO+\U18;K^TYPM_LC")7XRZ)_FRC3;Z/YNT-Y_,^A^MHG3?S#Q#>LG4I2_ MO0HCEU=D0V@HNB6"W5HN$J/(2 2A"(81XS4D@OI;CKS!4$RFENML-Y8KJ9N. M2,H)AHUBRR'-RE<X\251';#O?.O/KB2);:89&"XZ)Q$=8P1[38%$^%M>(TS\ MLA-_F)-LD:R3I(F23UY_N-'M_W]C^I_T:/[?A&';2DPT\S<%Q32F5.CO^"5U MG7 D?B0<[Y\()^=WA%/_+PCG9Y;@^;$G#=:,,IB[=23;_VLA>S)[8Q"NEUY\ M:9"A7 E<>TE>;'NYX:CYC<XO4;![81/_="+E+.#B>J_!>2H65,&M)S,8]Q>T MT=PN(9[9143)HA(2R</I2&ULUZ:="IR?+X@T+>="'DLP^:1HAL4HPLP7PX>_ M-'U]=OW(Z 3F>]BF!S>0TN"%KZC/8O]9<_#/'-;_0OT/A9K_$>KW]/M'A+SQ M;]K@-Q;YHWK!.RS]I,'8JH,M%W\O.YI0?Z@Z?FOK_PH(\SN@3_+KGVN'(X A M0YF2L0F$1?_5FM<#B]OB]F)V=\L ^H%*MC?9?VX(\X"P72XO[)J<1 M2C=*> M\]C]QG@4O>S\I->T\*+<'?+>3H61X88#C RFB!THT7JZA8QMV=,M_L!/Z;IZ M^J9=S=L5T.G/=+Z5T$7,<-XMO3+(M^-"A26@RJ'A *E*-1/Y.;:"O<)6L*+B ME[(!X 1/U3]TIMD_>BCT%WKXHT!K^D&O_C'.O]5Y_T_ ]/_V=Z88%CJ&^MF# M_"19?_8@F-]X$+XELP4,.1[VU=)0#4W;^,O4^'FV_$V/"_RY'O_;\];X0XNV M_T>GFC7HHGK48"4(>'[-F-3SBR-BA]&WD,Q!++^1"/B&.#031[]Z*<_>G;G+ M?6KOS!0SE2?#!]$&^+>4S,!SXVE[Z-NXH*!-MG@/6[\K_.*+V%%F/3FP<5I[ M/0O-C<$+2IR/L:2$VH^9A5Z5?3P.T_SH<1Q]SZ>P\;LHQ_)_*QK[7ZB?PM=_ M&67VH/#.?[-.VU^CYQRPZA_&J/$'T3/L#Z+GW_+V" +V4U3PSRA<_&><Y+^% MSX@LFA%R.(<7H4*[ANQSW#U$=W>ZBL<*J]T9T.'5"PXTT/.:Z/!(JEP)_ 5, M'448#X)+LH#<=3B$'TV'+D;FKJ3Y,ONEU5A A+9!-_28/:3T7+>3S&'O-S=( M<:82^Z0ZG@!A8O^<AM _=EGL@!OS=VJQ_Y. >^-/$_K/D/XL=/]?I#]&^B-* M92-A_I12M7C^DMC .#]T8HK_2S/^@R20^3^+,'^?5]!?>O*%!?#_PUV Q-., MYT;BUNR['>@W4C(CJG*3CQN)N>_42:B^J_+UB3S\^,QNF#Z#\P]BCI+8 .\( M)@^:R=>6%W3>4/%Q2?1'<H35VM$R]$*WRCV]'J?VJ3'.A\YQP%K\/X,3V)^E M,'X?9_WGY3#^%^H_"L7%MM##&&>V!>H8'/WC]!C?$N;'1^CZ%Y,U,K\Q#G+Q MRC^$#NH7G8/^)7<#9\?D:K_&Y .\V-J[B,+&->@5H 6A*4)%2J"<B.9:"_# MGG)!P4M"S\/D26F/^J*FDB='IC"_JI8,\.]S3(?22](A6S?J0TEM--W93!2; MD=44SX0N58T==))N\:ODA>\U;G&:#C>*A8,[G!>^YD'7<SHU;)6V/>OG63V) M*N=I%K_ )OX*,N8"JG,7])=J_T6][_]-1_XSE,K/9-I!_9%8\O]5&E3F=\9< M2C]/\T6^G];M\_:W=":HHT.?.+9>?EUY[9Z-B<J=8SCBK/O0'Y+*3]B0 ]5L MP[J%[!DNS?=%'/] 3.0>.B(D=L8?\,1=?O*CO?[&/G\5XNB?<IT_&2C?3\+\ MUY2MUI^V[,<I3"Y)@N'RL)4:S;T)=M[-1^E0HJJ@[_<<T8[0$ 4U6BP@E5RF M;SNK\I,80K"!-QX"#7#P#5_@W.@8PZV/9Q-#";.X&G>9'7@MTS-7H2ZKZ:-] M/(-F3#[V'6^9T7>3%$O6TY8_ORR CD7@1;98MUCS._^:G\S_;T1E_^.A?DH% MHG\($YO_.#O_MS<(_R+)3]_Y@P7_/3EI\O-[E3]/<S8WN++O&<L<A?(P-9!= M(>O?%RD2$V'VPXOJ"].J!F$3DTIS[TW-+JJ28#\U<Q7.Y',F:^!G;K* *SG" M<TPHV2HBSRW9\?SNP#0;X;9=W%D'.>YNT!0$PIZ39YA'X$*H4?41]LW5_"N[ M?]H^#&!3T8^O^921C;5#2]'K^7:]D/8'^ZL&M1FP5HD; \5:LJ5UBPD<.'RX MX9KM,.:'C<)":<*H=[N6EVB<0>R)XK6#,Y?=9&=FG^,^\-%C,,<8S"%(5?:* M'Y1+J[[2WQJ?J#^WT:7&A',_UQU34_P%/9()S0IQK)SQ2EN-IU%^5RB$T\6N MY^8C,&Y8+/:VEW>Q7!7]W;G/VE>5CTZ@[9K 8(*%QAC-AG&W88?;6E15*AXN MC(#!!>9%%A0*33:]3G+=N_)Z//RK,9=_L5?OL8:A!@!4)5PKOL,"W.B'P2]/ MYJ\=0;MO,EQUNNWW=BQRLC"%>W&RCV=6I;UDW'E]=_&OM?Y(C2'G.!9PZ@9M M>\8E3^5/D\\T[0Z*7JQ.VWMKM%%)Z&DM))(%R!C*4-ZT.%T@>U4*E5Y[N2U; M^UVONWI?^\Z\?2X?I:1LQ"@QM[4Q<=(S=%$G0BQ9Z T^# JO)"^F,W)4XA=4 M:KU?W4_O%0^%=#;XKC(L("%#H#G>?BD"(PYS@8C1CU%&HNK,GG7C1Y<,K?%H M;KMN=R5568$N+96-CD?'DG 3\?OWYT(N#<-PC["<_AH2UH\<@IY>KEI1==4M M%<K1^I+<Z7O'Z]9J$!=)91^7\'B]#!%"DL-!;MIM3"HB3-TP<%F&KO*,C[>/ MZ.E-YAH=.<IOGCAGQ0-\;N"AG)UI5>T=A=C%-&.$Z% R#;<\_$"9D3Q4>0TS MJ%QY)^,PUT3%\846+ZM/B@4AW^54\7(C;1ILJRECOL%A8^ULHQOV@/ F'S=I MTWM%N35)5%XU0M)Y><.E1IEHG!![(C@K<,Y;1\ JTEO8K&JC5QYD9D^S[(XV MFG@Z?8@ZDG8S?J-F,TXS>OSHOB;)X@@3L :'%488/NC(=([]3L/R'.9:T70_ M\5ZPK(WWDE;Z]T/H',NG#==!?DI@:SJ\ A[; *6?! ,?S4)%;%OVPC%QVE(V MYRK=C^9T=3WT0N^FW>/=!T0TBLU R[,^U<')1W.$,]2W6C;(4K2]NA5D')[6 M\15D2RZ>X#F=/+>#<R',@EC=0H(VU5K':]#A^>-![C;L1@N><@]_Y8 DY;=Z M("FC2:-R=T>@CYAC4-[EI:AQ3.M&B@85%5.1T= =RGCBJ5S9J@6M$8X:W!_( M)7:"=^O-)3@43+6L'(8Y>8\^;5^;-B@T*)$!KTOA[E]5,C5OV2G7),:6&4V' M*J9N+!'U%BA.C[KRO@P'CC,FGQ);Q1-U[XZ_BE8N<X^R<KS *Z89ZM>8"\EK M$& .PP61AFX2^LY1R\]M[:I/*[I*%^6GV29N'C<<BCLAE;J;&Y]\)VQ73*OW MA %>HQDK8X97"VQ]/6QS)&EY=]'5&K3E5$6A0^W.<Z(Q4^F*X1VY)5F(2^0. M AU6 6O"BM MP#SR8@N\=% YQKSZ@W\-:5GPE/CQ"W:*>PSNYLE#^"YD:SEX MTT604^I,"-TLM;6OG:E20TE[D:U,NZXQ;G<P_-3'D(V[-^3<W> ['6Z &74F M+)92\II0P@%%M@YLKHL>GN@(*8I.O?'H1N(!PSRO%V<$GMDJB;SMU?D>:C3I M8V6U[Y=7@?=W/FHCYQ"N("7W0 4U6CVO^F/*2EV0;ZL@*I<,[XU5<U';0LU( M_&3;5IB4/T,:RS:R+0&],5M&W_>;^SYN39$)-^: ^\INT#*6AG$B]=B$+%.! M%9O^,A[P.0L:4V<6AJ])6RB4NE9U%;*-I/+1(%JKE[M^^Z$;LDBQU4>TK<RW MV484L9RD8CPX0H3P-3T-6CI=D=8CHW1V,'.GHIH_[3ZB?^;A%=_!D2^(G+D. MN0Y1CF^8QIS;F;\<#0T9US(9"8BI[3-4??XE_FG3GA-5)]Y>NWIW Z D+O4Q M$T- 3;S!Q42I:^O44-J*IJI>BA$'M<&/-175IM?COKV/.R6V>]-JYVRH;3:" MCP6D1C/*8/-+%BQ@P'WD'D*=W)[,EFQ-<@$9).T)^^!*"+];8+57J4#OOK2S M6_0*@3@.4L7E<*-!,)'RK3&'#\'C280*SU.IM8*$1Z69N]^-O)]OT+XI*J)8 M]E4L6.?;M0>T2^?H%Q@O&R"S4 C]['6FY*#_U/GE>C["X$1/N2E'9+=LG)S^ MW@L7A7N/?2N):><OB8>77M ?^^9O#1Y>_%251+I=K7^KT?!Q+OWI2?H!ANH M4GUBENV7FXXU<%NZRKV8UW*1?E[OTO@M@RLH\BU6$INP)@U0O:,:E'21^\$: MW2**>D=KK5?6<U/B\7=L_[EI\- 6.]X'G,7\5[*!E]:<S&GH1N;6H&D-_B]& M.[VK)M\/4VW3;UQONAJFL&^,:_&1DM,H9\^^DGCF7O.7)6R&\H0MH&'OO*5< M>9^OJB93-^1\D6&(7 L4'F_X !9=(GN;,+(J+,W:,ST3<@0K@A8T2!M?[J:8 MMCC?H6QB7M9L>?26YV$?SV%*.;48]"/SG!CXCA6;2U>Q;3B\V\XQW5F9U!?K M^[G"]]:[#*(O4:<=<8A17B>)+5NYS=P=!&T5UWO</GUT-['![%#UZ*K:IUC\ MO;=,D821!R;$>NLV:*5W4@#L%DJ@HCZP-=,SL2&= !4-BK<//;HIX/SCHX_X M>JSVI@$"OG$4[TWV;NYD*!47 T\UJ1O>5J?F,PV-N1K^8*%N=5?(1;+UJ8/: M'-3T1NBXC#EE9F'J$<*2HA?KW[D5;;UEWB[2\^/X> ]LN)!SY48*#_$D78U1 MU;"%#J?$!3D='"G>-E1@&JH]M/MJN<6GTV^K@T5Y@YI60V5'.C!RCX<5UY<E MT06J/O"-VTU-N?(^JTO^/)BG]\[+>%Z<O@5RP=:5TH67:/=TLB0?Z&UE2R(, MG[^#A 5E8^2XY:>T>[Z>^E:R'M'35CY*)ZM=<.$'=G#.01*AE=4M\/"U^C0T M(<MNAG9M$;;??TKSG?W$?0(+R"XSVY(2:PUDUQ>^8P%.&'1F3OM2 ER60D@F M>/.XAM3MQ*]$:J2*O7GJ$[E#"56?>L>%<7>X>8;ZC/'4*T# G-"Y/!&TU3T% MZV*I]U;^W(F0PW6R3K=,_."E@@U9[K1CR,%DU[T3)@4EMR\+*]\_N84\<2N* M6!P2F NIRF%<MFV%DX_!5Y77EQ8N^#4P[U'G66RS>UX2B\'=Q7RU8"JA1F?" M&#LX%Z5_6#R_?DEW5YJ7)!L9T2W!+(HB-;8*5"&C6_51D99/HW5*-H-9! F1 ML<54#]W9R,W%+>[7A6R.4^+6YD[8Z?+Y^+8AW'$R4@CVB&_4!Q^)YRM&PT5! MTXZ3_;9!1H@]=Z,OK.T+FO@T7^'\!/!&OEL_^5;1CGZ.LM0$CY>.2JHFP/DG M[.?TX;%J YVI-J5W+W8ZS=[0'=H-NQV[P$ME>S!Y;0JDI3>2J4#AB:3K!+"' M6GC<V*@I;WSGM6R;B[EW]H^^J=:%15DB2+CXUXBS[&9H@XF%KNK5NDA)LD[Q M[1=&.,,W-5[B_@<92\GV2OX*$=UA:A1W0F ,4@CD.4.)B5MZ8-GG7VE;\_I< MIJG,_6WA<9JMY3LZZ@&$;6'0"C61<9]^GCS2"A=!>.<%39A2L+$*'[SI:MX> M6_6OI'.5,>XU;HQ$))ES15V@3Q0^8=1_A;EHC&GY=J&:O2',I%NE,$]K01<D M!QE+UX'=HE_2S2.XJ\8;9*E/G'EM>=BD-@FN/AD?!(V=\!H+; _D3LC6]'6F M]@\ICQAI(#ND[Y+#TMQ[Q<<G#]3T.*E32=4YQXGD7$B=(E-C)='\9!L=M22= M\M,#_=W7$;6V,[WQAJ<I.<1 TE[*:3.R;;LX> F'YK7T?FIVX-/=[=/VC1EI MRJX2RAW3AD2NRYB#YV\1=2@E[-#"J62LG*B=K4$)RZVAU%<5/G= N9@_=RNK ML]%S._9^-@.N?K!#+5O4*0[X#I5W8P$22"%F=]5FEP<-NQ"GOFT=&#BE.W%1 M0_7AE*4T47@;4<GI68D 12\.XY(S)@!ZMT,W-VQSA8G4J;V<U\TT*LA31H]] MJ@SN(KF?WU!LK)@UULF9M%Q-$Z?[>,? RC1BV>P /5^7TXP4&UK\SM Z6W-Z M]XKXWJXRY4/[[RZNVLK?GU7U:T3R44I(MXD:$(09F/C$ F\=+7V@><Y1G'Q\ M3,(VE9LQ1**:2<(S%*'3T%B>D>'KP1]XF&3!6R%7;-MKIW)(>A1:6[9J3@MR ME_4MIN2'@/,OO[L['#93"WSQ^.;M3[LE-]V>E> IJ0S+?EF8QBDUWX9X0G&F M1E+0K3!Y-\PF)M=H1S A_HSNVDR"]]GH!_BIIJ.[C+>YONJ.DMNT=&O'AI&% M;Y3R-HRD$3?=JHQ"NI=5DHA0]GON(ETQ[L[IZKO;1QPBSMLXW@CU<9?XVS=[ MGGC,K]_LA3BWH,+7;!?F:?KN\EL&U(MU=MI:-=0V#*E';V^H3=%SO8HZGMKX MMK&Q.SCGA\-C -J&/_QPIM:V=5J3TM&.'K<G5J/IO.0'[7:HEA*^((&)B6GW MYBFO8F_O?%._+3,*IMP')3M=UK[%T:XUZ#!N+^23>TF*M%.S(>A[GB]@L2^7 M12N%>-V#+R=_&!F\E+YOUDH0"$25QK2C)!%F_8BK>%CL!^-L(_+V%^.Z>;X> MT3H-"8E]%U:=[TWGYAS:8ZIU<Q0Y(*\'1N!Z-QCG\-,U$19$-3NJFN:'IZ<\ MM5F UO[:UP?RC@<2]XE]Q)0V5+H2X>-0ZB.*5ZK>>(4JFQ%<UP+J>_9^MG1U M^V %,&>]$C_<Y+*MHU\$QW"8F[6F&2_ 5M+H:Y3@UL'+M:DZ%[YEM^C=\?H M++#E'!G(A:3508C81'@YAK23S +P(ZU+,J.($_UTE&"+R6[=YND9BVPQKGN M^F5E3*P\AZ'8S#3,W7M<>H!Z';0-+LIW.D%1P].V1^6U!UH$WVC=.)YU_K3! M VBS(&*(=@@\U$L] E;B4/',S2/+@J$.%.?8U*,-'Y97VW.]/+V4U-FS[+I> MTZN])T14*QN_]VH1>X7IQP<Q;AIB"&-*3B,+D ,C+,B?*H=3\?QAVR7'VZ<U MRY322^J^+FZZ:&9U8",0YDS;3#]$X6E#C\4W.:I33%8'*[OM=L[4O-XAXBNQ MY1D@!' 8RS?:]K" 7P]Y*?G[X3!.+("K$KSY?!Y;[AQMJ.>'Z_8V'?@>JJ([ MK5!_1MPNFY9A_G630=(D[N,-G0Y4DQH+^(A@/&5'GG_;)!"*[/_P\Z?ER@@* M[2QR(!#%[>GE#^$/<CI#L46K5]Q>-K (#3HV-F[?7O+YPO]I[\W#H7[7/_"1 MD*217991E$I2UH09I9(DK10QE629D)!MS* LV28JBAA%*#')5I89NZ0:NY!E M9D26:68LX\ULO]'G<\[WG#[G>_7Y7=?Y_<XYW^O\X;K*-9[G?N[G7EZO9Y[G MOHE&2V=//%E",8PM@I=5WL 2V[, #<8&9L)$0W!$2HMZ:-IQF#UHE.\G]C6P MXKY(O!I0SEDP7J"_Z5T0N[.VN:NRL7/WC("Z$"02V84@@P<JFC-E;I&'[U%H MZR<K$Y]X5>8FT-/?)^ [W&J7?-XBC8^^"[AHN!,TRG \QI7N-O'DKSRIN&/^ M33*BOUK,4\="36CUH=>N8XO]BANF#OD,P&?2Z0@[3LPE(,Y_2_,3<@Z]!"$1 MV$LYG:2]N>K((TJ"(JI;3'5#3"U%?MH,@@[4N/"687AKWM%^T;JR Z=]C9P9 M"F7"=B&"%/:[#85(W-A#A6NC>N'R>%5+1D,=;#4> F"L '00V5''TY;2%/PT MZLJYH;"(?H>O[NB;EDKL0JH3EB4?2&A4,>&D<I6FA[=5IBTZU'1F)R.>IX+W M?GMM^-P%-$&PI]M@!G9EL&Q0 S?10B9>7>< PP-T2F!$J]_DH9HA*N7U5M(> MQ\&S5KL:IVX<]PD3Z$&UHN6AJNCZKT DW94,CMF)#,@/M!4+&?26<^^(:>SX M(/APZ]FE@")&5WMB;9_1WS>6^<9)FT_09 :L-$.B6]0.5 <3;A7-"Y(UWWC= M) 8]@^]\KKA?JU;@\3["0\'9JC?9?WV_1_C21;C7+O)E\S\*0Y)X>TX!GXDO M0^YD"@#Z]!??&RP9T?&24^/3%_ GMW7M?&*3>>@8AVMY84SYMG/:\H,"BDV< M+.XINNX8="U";MBQ/",?"#GSJB+C,7+NY;&CD ,!^2HU^:O@X5 8\):>RDR, M&ZUHPDDT4 H\?:WNG6\W.95"'C@<B*$5/@0)>IZL"D]*:B5"G#SDZ.XIAH8! M0BEB@6GN:^/OOLAY+- 7#M=@'^G;R;;D(XM-@''VY%S0XK "O;<XY(5%HFKB M^.Z[<QRR75+WJKPWN!SHEBG[7?=&M24<@<0I!S"XZ9(N?.C@.;WK5.//G@KO M+LQN$QS5C@B 07@@=T?#$XS,!)8Y6-C-/K$J2/9.]H@[/:CK\\LWD>TZWU7C M<45G^MZB/F,53?SI!"O ?51;U*,WS2ZVVCM()4DC7O\(H:-T5D(DU6NW^E4C M!7DEAM,EAA13$Q <Y8'Z88TJNO0[CUQ?=0Z>:Z]VA;Z8_3*H ]'9(!T>$3E4 M:Z:;HO;\I;9B8)<C\)4$ZT\G>3=]/*J]WCT3VK6EV\0\P&>5N7^ GB**N-IK M-";SXCLK\,/O%(4F4+!K+386+<55XG;UHH6@JD#74>"9=X&[+D*V\FL\0OEK MW%;+1-+IL'CIR-$KF;EO/9VYIS<]07].&5G>ZA$092+^!-6$+3=LP HC31!5 M0[IDF0<?[*F9!;[,MH?'U.6O6JZE'5*X%G'SE;*.CN)+]/LK>MHLR4$>Z.!' MOI-U')(&G?S#SZ8L<#+:&Q+# TE4PWSIN#JXN/^DB2X9K(#HM&]]8;'V7;M# M@WR0/$WHP+8;U!%11^^9"1(D!@OV1)XL8!\"/GHS+"QWJSG4U%2?U+H3;WRT MZ2[(\E2U2CH"1FFIP]R"J4!- T^;,X8+0GTHIC#KE.\-#>T>IQP:?*\ZWH[O MP T/S6EZJCY8K10.ATX1UEZ#2G.[^+) Y9'JPL1ZK@;@_/S"%$JN+".GI*(; M61$E?+%QR:O!6WV,9EH<)E8<2&0F U12"E! PL4LRS5D[-NOWQ?%%O5=I3?P M<L.19FU3;(JN0-B9,'/MXV73$'E^8E *E&-ZTPTJ7$GA.4A'1@(G\Y;GDVF? MARD#R^;EEAMU;CB?JO;MZ)['R7#2T,XC$6A9@O.06B-W3_>5WH74KG5VJ&U5 M-5=2S=RD-?K)BN6'[UYK7K/T%M;4LGI@,<;$D;6+^UY%EV%08( 3?L 0OU;D MCWB[_]X,F4&IN&G:;;&F#;L_LU3@NWU +-[D!Z#'*_<CCS.&<(TC0H$3)[E- M:=,S!WJM5>;C&XIK004IM>(9@XI/! W0'M4X*H>U\\H8K1LV?[X(PYSKI>I; M!XR";Q5ND4(LIS8Z:MM65!P/L!](<<^!AHE<<"U25!;W)92YLK&+,R4\D*,^ MF"/;+<"<A_EQ;.:>;_]+5_._EC#8]"Q'3V".2#U$AL6?=@H\78<6F:&\JF%( M5VCF \U<L$'7H8B]<_<FU:1FKZB<83BYT"?(<LV0,%BI2 17AFW#<,0T#AFW M2#A9YR)LF037ZM?)$I&])W87JH#E%11,&$Y4UF%4^[ B)P.I@7CNT9N:UHQ[ M<4%16<V\:[..HX?A%JN='ME9E)1F88M\$2)W%5N2D4M@K+5)@"FH"#,^]"8@ MGKC)[D2UD=J,0%KR[]H^#2E475RF"Y!3"3)0?6X7; -T*P]4+\HP/@(<(O% MH"E)]^N3P?$;:C[.Y8VDC;XR=MYJ,' 8:DO[& IA2;.1W01W[?!] 7$+-5!C M<4^OJUTT^R\;/'W5#PKJ*6@L7EO3\N;2 /XT8$,7JX-5''[.L&HAR.A;Y5<? MND36_"CZ<MZJ^U7B^_H1C\;._ MXU+7JVQ/>Y2+M6+H-#.($M(TF/L\;&A[T MN(F79\@L1ONU39\[M<G7Q>O,@3'5M><*( \%,L%.1T0*V#>!_CSV!OK7R(7F MA)>!F%/=W_MLNO1"U_?DO:FN=-GB_$[>[#KJ:JT,!?(*WF*CP [N1&WUX.J MG8.<R>X[/>=O@#9><0NWQJ-C(M9;:CSNZWGFG.RRY4PK9,>1,==$33(1V#J MQ*JT*V=S956>5M_D4$X(R\5"U9!N (=!(=M%LJ48&A: 51;;-&VOK&),LD/& MR2&Q1U=TUF^F*/E1,A%E@"%#D(RA^K TK(*R@:=MM5#H+?O4X_<:[:^L"G&( M++\ODJ)^\7"_-.7-:-]]Y%[ D 0>'"0;-FE+(:UKWI;WF<!>MI&F/<4.5++$ M^L\?;+(]'^,X^^B(UEM \;IF'V$4"Y? Z=/6 -.U[^@C;DX"?5?:2STO#^N+ M!2%2MBGEK_T>YKD+RMQO,FMF8D5.C2*X8Z*&=]+AMZEH=P63_62:#'S-M=*' MI6[W/"N5B+YJ06AU']RIX'OA#@3ZV4#7,CJA5MXKCW7V TJKPM*UV:1ES9-T MY=<WT!OGM?OQ9X!IUEFD/5"@E^"?"UP^.3H";E'?@GRP/_V1'*P1OB-T?Y$B M=VT/=@8;_FB:!Q+]O7G/I/MVMW_T\EFPGG#-)@&_"5"DX^L7Z_?Y%^611R00 MMBCE#C+>LWS2_\:'#6-CR&SO_"DCG+2-+-N/<W>!GYNPLB;^S]C'Z:FQ_@6> MJZ:V>>(_!N0Z7O":_1K)C R\__S+2]U$WW:[EZ@A%1DZ,1:_]K"));F,;E*) M*G;-=QM635(@EW1G7V49'\WR55!_/C^4F67W#E+:>X<Q;5\&P.2:8 J ]RD$ M0<G=/=M-1:9<%<YN2IMU5:?'0AVK+UNLM$;XCI7%J_(UT<&(:^*N 7PIGMHD MNUML66:QA]/.FH0K*<O,<VWI@58NTJHN7_(>1XZYRDS"7H\D<+=<"+1I'+!I M*KA9V5.]YP;#/C#W_:!G9LT5J;&W=^Z3'E.-PP05E-;U?8*O0E^%"")/<G(( M;AG:Y,OH^OTA>4"NY]&N>MT+.@,6XL/]DCS0Y=U::OEG6DD@'LBC%.;J !=# M:C.BJ9;T=@#/M8E *9:4NN4X=/+S].9Q4=3GXJ-OKWQ&.>V3G^O3$_B(%$UG M)G#R3#9G&E=PGA0BQ67+GCO&::\ON[V^=>-Q1KC*UR]V.\[XP[1"M-DR9CK< M1N[6]5QGL2%3J^"DZV'<LG&"-.$*K)]6BWZM4D(A"#GNRO!WS<EP;LC<BSV9 M[$ P=?@4L7?D1K[.WEEFY+OA+U=+89X)B L,#;8D[4@/\I@+=#.^:UXSX^"G M='7#]1UZZ:G%7VRD!9@3OU7<XX$N5L$YTF6=??H_?7=7*E"+1/]4@.\18?01 M:N-K1AY;:M&*SLT>1[M.M=B]>CL+=UXZ1=P![9VYWB*,?\C)@HW=_E&R"K'2 MR_2\YIP%$X(>(*%=34%(=1MAPPAH1P#S],M(ELVC"4)Z56;ZHO.@M, B+1'F MC(V&2>#7 B2$\X;Q=U(GS)+\VL?6ET5<S!2A'9ST7;3F_&R!4Q_=&UE2P-V M5: RM8A:#1NM.=!RNO-)^9O/]8AC2T[.SA.0/4.9>6E+J7R:%!'. Q%7OB<" M:#R0C$4&'_D)\D"9<'$>B#'"W1$&30$Z6+L 0TI*V3-$<.-R;P)9W&!KQ:WS M].\Y3$.4N0%%;%_HMT7DH$UP!9W&=*>#&^#"TYE*7?.M_HJA*(,X^YJ>[T[? MY\[8FBNP#GX*,'QW-&P-R&\5WFF.,)J%GFLC$;C&/%#3R0ETG1D/-)':@&8' M\$"Q6> S92N/(]EJT6;=>F)1C%W/2(.WD[1*$50O]VOSLZ0HEAMFS7OE\GN/ M_:<=+6+1EXE1F3OIZ(AYS3C/X^^GZWKW3 YHQ.A-,\M[/#T[#LS(K1%035RC MIE2^YQY6\%=SYZ+6H3XXB0**^8B-N;'ZIG9.O3)JA-Z%Z<6:FC<)PI(&23S0 M[?4@P5?S..,W*V(B51ZQ+5?5X?8_032[[S(Q%B[>X9[T457P4Z+ [!WIL/?' MS525KFN^KZ8!VR#L6<";!TKD*_A,T C]!&SI*WV$3WUY('*^X*0QIA]>NP@5 MY.^Q"+>3^PY OS@_O7$7GSH':I0/?0TJQ&2@?).:$7D @0ZOQRI50[2CJL]? M60P..9:ZQW)U[G9JKOG]% 6Y^SY$M>Z^=_@ MC28&X0TY(%:T, +DY_F%YB' MUWOWZ]9!UE0?PZN55O6Q+<EK+B(<'&V:-I:FQ?=>+S?,$0+B#82/*)B*-ET! M*,S-@"<%H^RAHNENLC]K:M^3TP7F6=.ZYP>GTLT@DQN>-US?[7,K(A11_\N5 M3A'#T2 DA&4$.)^F+T9XNA9WT,J,RFS+,WVWQ9Z7D<ZY,BNQIAOD&^^O_XT= MW%>7^8N5+$8TRY0D']_3FJ<3)6^J.3IBS%TKP@.9X/GTGT)@GU7Y^[\'+1,; M8*M-]$DP6>0!AG+T(*P4Z4>W+%@J^7ZL2332I*RE=;:8Z(30M.2D52L^Y1*] MZ5>_P/F 17X9N7P)[)N.W6KGBAYV+KHP2NG$7_J50>68G&5I (+-<%&D(7WQ MY*V3&VVB&C4L\!7X0-Q,3LRE+8G^=>"(PS[#KY""+ GV/B" H7L("'?U)6N= M;EJ^</I 96YQ06N ^N3F!XW/N/031T[L%@[IBUKZ2:M_+\8)D>YE\ QMM$;P M%)!TL]P7CFL4;5RF%K+QUW22%# >1="S.UH2$42D)DN0O8N>^39WN$G[CKZI M[K$W#@7@]5.57_KLS[Y\L?^PU55CU"D=@7?"U8@_$3),!UNPQ88-!!7DT1I& MWX#)(1)1PF//2_O[F4J]ZL769MHV>S6&]]9^LCC:1\?.)-#[ZBHM,/.AQD<? M^<$4J=R^SK''Z;XQ;,)0F,"%1,M6]3FXT<_6\_,Z.X:%./?8X%',[<J\!J,M MO296H^D+LY]2R6+,RG-J?.%\#&22;@C4FFQHUL0"(:QU[+U "#E!TU'.29VA M-[#O02?5Q/IE&QIQ,41O#^S]2Q'0XU&[F%]IMP,B2[B"7HUT8MR':E;7,,#1 M)H?+R9V>5@W[JE,DAPY 9WRE6:2@YN K/;@P'N@U-HQPE87;0!S-UZ;R0!7/ M+(LHU=7N?3<FA +6Q8_=2_9-6ZKX,R&9_I>V\D?1Y+[?BQ\NQ7ZT6WFZ8YP? MR%5T5DN6IHS0[#[!BQ51/7=&L;+H^ERX"#X%:>[+R?(/P[L.ZIA\?,PA'@5Q MT!\5<+=^]J8_>"O-I",-T/TSPLW]:\:#:K[C&J':4$*<+)Q>J'FCCX?LOO&[ MRM?T"R679G">'8#?>;N,ESIK%J&Y>+=?>6L^2IC[$2_"R?13MK&F)V2\;WUQ M0;\W.W_D2UG3U[$\F-[K"JWXQR'%IA_/TV&U$+% ;5(A+7Q+J%63"J3&W?H# M:FM-Z %+6YOJ>%KKR<\W<0^0OY*_F\T/4ZLI@.[H4,BQ;J&4DL+^2=^R7NR3 M:?N<5'O/G&>+48E?V%D1(6.^GQ!$@O=+;:HH:VLBEN%0'\2'*2GMMMX_JP[O MQ\D;9+[TCD4+VC1" /-LAAQ;/6GE^K]?.]YN,*"I@CCQW=6UPA[$"<$DC- V MHA"C1%WNVE75.V'BM<IA)WF@DC^JIGKN,/]COXBM+*+>5?RZ7VGY/WFHIOM0 M7?A>8)&Y"CA+H<E,#<QCZ7>_G9I>[]*SLU3YJH.QU=+Z ),.[74?D]?O26/\ M:KQ%7"R\V*)!.PXB7JTUJLCRM+*@8Z,>M^9-5FK-.61YOA&:50Q2NFNC6KQ0 MY&#-]YI@0,J*4%89USPBF5$X9BEI9.)P_015->RPD9*SRH.OP[](E@N?*NAH MRS[\ED#?YBZ/X.Y]*9%>S%ZF[4!<B\N.\IG2=G#*8<5$4>8\3NCURJTQME:G ME[ZH'W%#(,M2;E$[P%<%2SY_T7*+<W+CCGBL[\?K*K_$&5$HX6\$ :X$,'BT MPQ\M@=CM9#_DV&H8XV^(?^0P\_5F >%0?:*II?X8#T0_BEO21?/-^+/="D)^ MKOG)Y*P&=6I8KE<X#])0G)MNA._Z&LD'0YX$B.&%J]6^S"W> T-H5\XV]C:X M$.$6=S!D3/DBN/0.DCFW?\R'L)?9!$*5G4P##/\:<*(A/^*-Y;_>DO[<4,3> M:EV*X0R"3J.@XS8SCA=RRIX"CSRY+5MQI*%35HIWJ*Q#FYP4? =EYGB@GR,! MYB<90*%6H^!^8AU<# \FTOOJ>ROL#:-=(\[E)/=^39Y,VQ^=^DEIZ;;S.#4\ M\7X)ZA-W?3=>#!.YW&V8J4YOZ1_H3[>O1!3DMLFNO^J='J@1-;7;5/,K]A?K M9(Y$PE[EU?-A,UZK"VEUM7(D1C]T!TSS:&IC6DYJ6V[1'FYB8;U/>%?\.F<9 MFEWEA8U1Z;[.V[TWDS4BZ5^H%_=/]*4!SG\F8=0!,'K> 6 3??HPW28*W\.Y MD]/<X1#ZVMO \>7,A.]%UQ33 @H,V$)@8["E?9S$!!XHV^O%:"I??NP"?#WL M1^R\R(F',+/@4L@KL+5]]5KY_+!Y>(2>+'Y.'.LY8H#,1(W3=.>SP/T[COT5 MF;+_5V2:Z?81J?#3GF;_82EFD*#Q^#^!<__)HR%TFU242QCH*/]0L1,C3.53 MGQ"*F.WEA-0=TIYYQ0U*&P'TG]$ZGZC0B>8 @KYH3G>ZIX1[\HUI><E;>7#I M97M^[7J?J'?338''"W_D.,.7T_<<;3QQ%D^M@YB3)IK"Q3N#C2VK?"!7E82T MYB363'16_RD8]!J(IL,:"!M,!-U')S6ZJXV>#EB*U69NK/:$'NE5/7"X4&7W MP[V#YP@;82X$ 610]!&TY,"P>8';=,7Q/KVJ\K)NK?W-!XY5CU+NWC RU4&, MHW_%&%Q';68(H[#^WCY;%>F2RM23/7DL:R[NQ9?T@L$4'LC+=BP^V6?*4G^N M9>4$5X,'8IU:7-*CC2VD_[Y=V(9PVBQ?_+-SV+K3K+/:5$M&%G F4!^O2BV! MJCOTP%^#:[X&*3$G] 26V856_]Z(Z\^/AS,$2"QHH#8SDDXM2J*(;9]PV-XT ME/ UH\'A2_^Q?9;2L3<*E_K>_\I6YP-JL?V&M?"2WN>%4UQ%Z^,\D&-O>>'W MXB*X_M>Q_#>-5P]/>+]?;QJ=591>!Q/R@PE.J6A71K#.]8C$[K)NHN)Q^:;= M>\9V[ZE/:'0SQ]X/"5Z[I/UG^ QTA"M:1;\\<N) RK#JOM4!$'>XF$&%L;O MHA?DVQA%X&US<%\!^QKG,5)TY1K=*P#1-&"7X7)M6NM94_:2H6QBS<;MH/?T M/9/PG;^D%# A]!5X-&$5>W\065E6V>H<P[0;93Z-WT0(8?5$8X;4,8MVB2,9 MR)Z7/-#??&5D]Q=M^?RFK;-SPEDC92)L$\%CAF(D"'"!GU43#>^^$&&B/S,M M'\\M,@B$9R!4Z]7?8X38_X\1YY\\&OO7278YA!(P0QR%8QB3KP/3.J?$'8Y= M]80Y='JE=7*[;AKN]-7>Y*!T*ZEU(1\OS&WCKN9D-A<;1GKB<GK\HRVZ_4-M M%[[3=KUW]5I2FA50G_^.&/?^Q80+6"6^(1AS)0*GG7KT%53[]!RL[7U\\[]5 M;BW<DIL1M&O4JM6+L%TK_+%S5O,>IS(<4I N<@<J7=& &!$_ST\VDA<=_#LW MP7?IG=UTO^B+1%V89_^G("/<O5^ZY1>H!+<!+@X5!Y8'FX-]$0.+,2^I"1D) M$S%E=GB#DTH1K[ZSJG7!V9#33N8LVVWP01;SO.!3_!,>Z.E'U[^,1OEMM(() M[82/K+/8@;C1YXSK]!L #Q0ZPE:[W*[=K_MJ*1,-?<3'57CS11LOF[F\\=]0 M#*Q!K@%YD_7_.6CR@0O_ZE"@DGV#$XL48>T/Y(&.,3!W_&%2 XA]+J\'SQM@ M"LI>.(0UQ66!J#=L=J[YU#.?CU+D-@Z# 6>*HV[C<D"<25#^L/MWHG)1(?G\ M=\\+#S3G&@,O?;H>$A9B%_.KB8O9)SEA4$GV&0;J.=DASM.YH3(%IX YRP<_ MWJ=#Y,LD@A]U'%;*Y.AVC\TYPN/Q:[[A93@9"[CH8:'V7=?T>*!7)K(W]XF/ MOGXSMWYWFY'1>ILM=]1',1Y++7\FW'X"O+.& ;M:IXT=^IKEW?K*AE;E)955 M;1M,BAMC9EW>&C^RG,@,*O(E@6LA:Y$;^$+E<3<\0<)(ZCW/>G'X?I]Q'BCG MB*7G8_&">YWX,W]97,O_LF$W@&(6F*T/U%#2<7+#Y54D#HHIX!GJ3ZHY.R,^ MM3[B(A8]%4RN.4W"U!/6(97I7ADDN*A[TN3&+3&;%0.7QAZ7%$]]L#D5A$O\ M)4F>)MQ&BR!-Z38-RXD)I&*_G;@%JPRG2P&&:<-(:N4QI76[@M?W,%K8,CCN M?K@@>L8OC@?:+^/[!Z7!=Z.^?&2=@&+I@US96>#0);X.8F$S\)F+NLPOXGAO MF*^RFR#SB#X_#=K; -LD+J]&B[\C/EV1*?-?S@3^>4.5HE21L';4-@!VEEYQ MYZ7=Z?:R(\BX HO+@D7[E1+WKUX%SI<90PNC+T.BT(+LTPBREH)^!OQ<<;E! M<&@SX7D-[?,F$^D*6_)N"\BVR:9 NU_3#BE&.O,@$,H@--KB-_?<.]MA8K4: M=G7?2-2"2-?W\6ANT)')Q>Z+_A/A1)DR.IKI#@31C6LK,J7HS;<DW=/"?/); M Y%+"^*U!4&S&U+?J5]DM%+NP7?]RAV?F_-AYPBP7;9X'35W6NI;RN*!V9'Z M.8\Y:-+J)Q5>5C>N&VF- (.];VG CD8$>.8\^;:3M-/DZ/K:T">:B7\_FAV? M7&)8%RIF%OE8MK[?1@@7@>] ,'$S%PGN(Q.[/E;S0"$*S"QP-SK:!/C;EUV^ M\/7HL4/T"4X$%3U_JL_*3.7'4[B_+0;)3]T1#AZ] W(S6TC4PTR;'9\Z*6?> M9)IWJ%D].O^0 ]J*3_S#=T=\M@QH?(/09UB)L*\M<!ZH?2(+_!JJQ#Y*IS7A M1/L#T^O3XH/QD4'5#L.'[K[VO%P8=CA0%5-?Z=FS5$#WIFC$<T7YF6H?5VPJ M<_4MF^J^!;CL_J=:Y;F$MQD:;Q_+MUVY]N5]-OK2/:<*,OP.7 $*8@<#YL^ MKN:-WO'SVC&I.I.+ XY%#[4./_+?*/RQ-.SK4^&#$-B' \G!\:!0!0:<>9LN M4J=0^L[$A6P<NI5V>N?.E\S2"CE%%.-<NZSJ%=]X7T=\PDL'Q,#9W.RK'YBI M)W=V&&\_=3)JO^KL7E-QI"@%LY;M1.!K)L5]Y"(#=KMS";G%=#S5=#RQ,\Y3 MW4/QF,AC3EX*YYM:1 -^.UZ6DV=RDC%X@H&^0\6;!-J1UL>YH_53H_0TWWB. M)R]<VH+J"!E_Y7)>:;W<74/G8E7($^-\\31 S8F#K[;V8<E.$F3UQ#RWL!V< MR7OUM)P:'EW[FG1E\W[%*Q*OMS:O@WY#>W0#+(8N96*FC$XXQM"GQ<^#E:?V MT6+F"[;M=.F$?I3>ZO;54$)3^%W,Z^8-F ]9DD%Z HLJ-(\+?4UH!;PVTI9S MG[T*0_96<<-K,33BR])--?=75G4=RLB,4R_@)NF-03*EC0;VC:X*3IOP(PR8 M-Q+6X'>Q3;N*N/J!WA2+2#8\?Q! ,0=Z/$>[]=HF[VRPEFQLU%-\E6<R-W4( M%$JM? M9Q3Y'QS46FC?:0A5[2#V[JDV1 U[/E<S&![Y:BBM>\9<W-=4<'UD/ MM)%I5'V&,WD'H-U\DP=:;R(TFG <OGYPGWO'\)!'\&.'8]1=<Y%W+ 4%D]>T MG+[0PI;::NIA&L*\!9>T]O0A;Z"X-S_33Y:.LHHG/'R7]_WYM;O&@F80OS_> M6OK#CX B9MAB)&WE!-N*!U(GD"TXB0$CG?@A;X(R\A#?69_Q0,EPAAJWQ9@V M:0:Y_H\N0T7'SHW$84O!#;1P6=M4)V/&(4ST*6KYX+,V[NSE?=3]R6;??6+G M%:"35+BD>R7T'B..N_82Y:&)S=-S4Z\ N7J#E&#'LK$#@1479!Z-NW@9ANMF MC<9#[$'+6))-,W8UV[M]O-<$3#:&;)BDMXU]U'K\:(]E/-7?Y'F=2-)'_XJ! MVQL]J[XX6BG75'L0U3O?G#D$2OY@ P+I6$["%=F;Z-QT>BIWK2Y#LQZE^*JB M:QXK$[BOJ['"@,F(R:YX$^4C_+DG<.W@$/&)AI)=%V0C7OHS\CH QP&0LWA\ M5RGU*KCDHT_>QZ_O"^[Z9$[Y1#G%BRI_$TR@0ZCI=#@9'?>$3HA"J;KORZVZ MWJ1%E3R02PI3CVD#R8]*A?=6JS&!ZSQ0*60FK8$;'4.8]Y,9)Y1&I8\Z0BBN M]=Y1R_"(S<"E+$"Q,<6P B)!>]EH<._@W6@'M_%#;=7Q9[QN""],]]9H,)E& M_&ASI9X/GF*'I6[U<?RD!9AL> N7\7S'7@*&0SGUAU+'?_NSRE8N$>G_!*E/ M+WI"ADMY7'=;5L%"'OF&W/A\I/NN<&BK*L@XR>'&RA.R4"&4$VH8:M@#\\"( M(X_;B'O(W42+H>3LY:KP%2<N]_IC]*4/%&+3]G:T0F\+?CDA,NG2%U^* (O" M[GQ?4 RQ%M""#B]'-MR^HSI(^* ^KQB$TP><61>1$*")[$,:61,X8=VK7WXX MV5C]<O+1[.?6M5ZU$X*/[6ZC!IBS'H1B8H,W/ZL.]B.66Z+FTXD['UR-<JSJ M3N2(J-3GHT9@ZY!:=!QII'Y$"G VZRHU]6[@ZG1Z%FK[L5PJ[C?.F&?K@(Y< MVCAA1)OF&_]X<?4EBI9B+?1'<W7Q \J:A[N>(.(*VJ(&D@[76,)BV$<*-=W7 M=6@F19BIAQY&S-UC?F%D5K%.-3%TZ[CR-6E$$KK!TY16QG'J6J>O=5;.[^91 MW_=;+;W>N! 7W02_9S@T5=IAH&(>3IO;BWIYH,,]>D;?9[[?E7C=2-]CJS!Q M%S&! ;;8L!\1^%AG9OMS].29!P.H3S#M&:E1?S41KL01C,VRGWX3/^3O0(]] M9.OS0)>L^3YX-"<+_&K[/[@D(R#:% 1OP@S$D="U@U56,*7 AN/MWD5]'Z(Z MW0V/G6:QSDC*?5G G?$ ?)D.].9P1APSEY-K<IJ, T^F-3_/0QBD;<D;I/:2 MM*C9"?=?B*P6']_BW'*R!1D6BJ;SD[5A-'0[X$1L1$GW:ND/2=+W1#$_F7UK M.MZKDG6+[VFVU><IIHJUF9!N?9K$E.PR-"ZO^6HEONJNNH\J=S,Z[S1<"]7 M52P'W/G(X@$0^LPGRVU8O:1[)Z7VY(::<ET3C^RP%P?R6UQDJ",0* A ,R/I MGS)(-*D+\-P$[^>#4[KV]M:OC8G;PV>O0IH4YBDB(F4@6^ TRPZY'1@J<G0; M%F5D8G$>Y8P@FJN8S/WF-4+=NQ7#U%V5=6VA6MRND74HH0N?!P.GFWI5(-4U MYEMJ"AMD'[4KR7W.NOOV>W!?B\XT2IKA3:72R580T8IZ,9CHQWSW#J?ASUJI M;/4^\1A*Q)?-86T--UJV."26+<@^89FP]>@CC2/R[ N,$^7=WOK&1]12O*4> M3I1V78Z1. B]V'CIS=X%$4A@NT@^VQ2X1\+&<A7*&'*W_0NLT0??$A\$N:CZ MJ2O)F#:L,A))@DOQ-_JGF^R.WC.0+/.72#N@GZ%6?Y.:R][!V/IL'4JE_)QU MM:&XM$?)ET-@@1-O5 V$9UAV6_[8&P<4ROE'_KXQ[X4'LU(KH8DZWXIP]U:T MUNM\=29!^DJQ1E;3!?TY0^H3NO8IH(:D?)-UDI'X+"\0<IB^0/W"E>\Z<L=? M\QWY04=>*NW:A<,'UHN*Z G0\!L814D4XKK)S$WM7ETG.\KVRHYW?M>NVNF: M#79V.IV/&AP1G,<JPF[CH&IN[8BDH=#8(\=RGMID5*T+\UQM*/)8T$D_&^"R M2-YLR;PCC,,/TVDSU>*KS%D-"H<?V"J3HC>E?OABVFU'5%$HF46[A.[XI-W_ ME-*(%DVWU$%D;D]V\UQ@E9\B:E$K[YZ7NA$MA!D2;S92A13$J2;)W(^0O[+A M$R(**&9TU1($2P/+8$I <DM#N:_EUP-]-RZ-(UT]5+^^,A611HHS9,/)F-M0 M<#=RSW,GCV7QYD>"YYT\)+W?INP. ^N_TJ'(>_O -;C]6UOV<PJALD!F7\,K MMGW?Q4XOOSGZ=TTT=%S>2K<\6]XHX<C[%E9=!%@I/@Q< )5F!](A+5HJ$V?H MVG=V5ENX(K9%?"V$CX>_>[<^9Y6.D8B\_BSMKZ>0?!2?P<[D_^\2RP$F@>J" M*U0[;,T -]1X36J]G \M*QKFN+W\$ %E:EAF.I+)1"!C.BW[9P4]-A*!1D/ M[T4]VMB\P.+:SG]0XWZ5G1I#F]QW&[4>N.$8TAR\@(TN??C%@AG7NBK*M^., M_^504-'; C)V0-"FBZN.KC.'B@"ZC?:>^.=9[@/09R^?9;Q?2K*Z(7'?U7PV M(TKUL&]?&FC9F 2FRM&G*8V&LX%230;0309;#G7;?C]X]_NGSO=F>_?N-=V+ MLVB=Q\4OC BX\4!KT:/9<#%<M:&+=\XABO:ZJ93@A(1XT=4B,_FO<\)/@,XE MZR:Q-^-+&2Y?J='1_E:%^X8=:@XH6CH-#^_T2CF1=SG?="X6Q#!%<-<*T*4: M*GN8]_+9YEU4?T7%Z+(WX0]:$\]<+LJ);%F]P0E+P21 Q0#$: P;3L9(G/^6 MJ?3 V8U6-.+1.@XZL6WJP_Y/(-PG[8A]BXTVX001FYAJ!Y9!$VY2],70U+!6 MGW]C>)ERIS5KR7/TBOKA6-V(X"A3HZ)L9C)0D<,^QGD)73<YX'HK%WA$>LB& M<=YF?9/=52"TT+VTP6H?X5U2H]3C^;$-S=L$OT-NPTL#&C 8S6 3$7(51*+M MBDS1I8K+ZK>EPC[D"$98V"]IG__;SB^ET%73*?M<J7 ^M*IO!!P,ZVAWEO%) MID7IG.C@O(.]A<X-.GH>(-U-1A.L NKYY9:_:3O3+;"XH/4/L_SM]E7&,A?" MWRS;:8YB8U%R0!*T2B[*/R34I=1XL7-!N,RS3>@]R%XG6%)GGX_3!I8+TJO/ M[U '?@/;V+82R* 4,LL_RGWP*Y!ZD+90.[8C_YY(\:D0NY5^7$0@!%R?H49! MWRHLFNC.ZC )\<U[]K568'R6.GJ*FCB!HYA!S@(L<FH45+XH=GAK3^'\DY=3 M&]QM57Q]3;NC13<FYMP;R:+99VHR;B:,>JY:O, 0?H;(_L8\65IAV)<<0[YC MUJJ>QF9S*J#"5B1"+'PM?A/?[7N0-H4>V WSZ5;&B-P- ^ZVF3>P6]>DQF?$ MO25^&#R,F,%AT +S8,P ]-8S('&*:0JS["E<"'?W5I5PM!2[8K%OPQTU-=5; MTVF@3P"<Y83<#'20Y=JK%2FAAO:]MEL?GFO^D/PN;O&1H$"5\G6C)B3?.6UW M>Z^<P5WJP)Z8Y($N?+S*[511H-LE\$#NVK?P:P%XUN<Z!KBADKUQN.2%VP9U M"7?[*\>.M7^I-KOTK/;L:>()U((;M\<!32*@72*J=W',(8O4?$$J<+A;-1@[ M<>KT9E;>%#H#^C^O4(YU=FX$C>'5D;;TO'K(N@N!<<W[AG#1\^>4G1%M+0,O MJ8LG+6R=OXEX- #F+ OD7F!6NR6,;>=,WK[3(#W?\_&=3>(9+]^9&1]?0SP6 M2P3*6$; :8IV/%N&#)-17V0 I\B(&+U'%TP3VHY$!EAOD+^<MTZQ?,TW:^20 M=S;@3-:F+HW&$6_?O"F['!"AU];(2'S^I+&<>4KA[*&:\F_TDKTF#R:4T5%A M4 *0Q+!I@*UA[_.GR7F\^E9Y),W8Q]>(E)-4_E2@.SG4E'AT2NU>R.Z!PR/V M['D^0TQ%BM[C2E"MR%YOR1_M[#.U7*W*.OP,+BDGWD^X'J>V67LD*6JFRF^= M&:[]TVT&S4R)U@BYHZ( G":E8R2 *OO2=C\'I*BVMOJ:L$R0<JMIV/@;VFU" MF48]+3$MLBDZO-HY#S&04!GTNK_QZ]8S7&8O* E[E$X MA\J>A T2H@.J-"9 M'"AZE@,\'>:VU/4EF70&)EN_C.C<VY49,%:L:*;4EXG<75W&H%%))/'+/%"M M)EWW5,>\XK/7=.Z3RYNK&6O?):K[N87%;?!I&6XP'!68-^"';*%5@!")8\\Z M1@#B\@9'/A.WE#6N2Y9,5I-Q8=7$;*["1!%**QK0<0/KWQ8"-DVV^W+O/75F M'9X+2M2\>.;5K@_"PCT:T)X)0MG-LE%X.%IX@2@#$0[TFFCL.[9S_G[JD4AN M5_ZQFTUO[H]Y&<=!CB,:\3#D)@P3S5=HJ#5IVZJ6EX')/)!-&4,XJ_BIE7[3 MU_K0)Y]JI:F[SEH<VY8%SD&*L-R1,D Z^0U2GX2+V7?\6>'QHW4>ZMM<U?(/ MU J;^$W##=!U]NDW[]%W\T#=$QMXH)9#%S@U4+% PU$^*$E]YA$L$NTW:.U< M9[A\>G+@ONQS\0:=HS%-0R#U-Q #W]:/%_D@YJ2_19^)&,MXZM3A8LL@<IQ# M2L+Q ZEWY,-"A=T$YP_^;\U71*08" KL%EX8\%(.:5[^LD\X2?_]^1;_ZZ*V MCQX\5*V=ONT,V*5,HNDGX&$;>Y^[YIU''NXJTM;>:A5X^<Q=N:28LTYV;U7M M*J>'%3N1)Z]JZ6?L:+,KLY5<HUW8Z=8 NCYX84.F#72!\2F5! .S;W)>N[RB M<R.S^P$YTFX[/$(9.KP7M] O**!X-SPFW')4250N\VD8- YXRSK*-@ D*]%L M#91F,7VF,J)D8/"+D<[[@OA7AU935X=G/BJZ11II\A9C.] S"'>0BB_M@6CS MC ']ZI*[,G;PZI?@'0UOH"TU0>//^)!Q;P=>,["$/!%[2OGH],E7$0,4KB1L M5XCQZF@U/SYDW!]^PHRB9GJNKV$@Y0W2B.[-Q -E]-[WWF"V 4/B51?21$WK MVKW6&BV<5U8\^('\AYNO!/>V**XTC$)[$B/D5/9AZAC(@QU?^W*J-P;O5XI, M*A*[MB%:T-T8[_3F8U 6^:RC2Y3BV'9#!Z<@<T_TYR 2;8*WZ%K'.Q:L.FO M!)!K2LI+$[T5S+\. (_-5=9.;=5W[(CRLS,R^MRREZ@RQ#=RQ1Z^!TN@ZTR_ M+UAO7O8\?;2:VYK9N4RJL/21LE*PE!]U>7CQ7N*\P,*?N)D]\:,<U-^?DWV% M QH)CY>CV5)N _:-74,7[*>+#ZU=5YK8>5S&;$$]''X6U2["W6G7B KB@6[_ M_D=D,* !H3K3T22;&2P)NSZ0T+(,O54TZ#ABN27A2[SZH9!4%W4AT_TBW]P$ M\#* (27=^S-Z5"3J*[TH3Z4FFX\@O!?$39\T]I9/!NB:%-7<%SZ-]7$:8ET" MY!I5=@(TEH%'VBY,P'/W 4A,T7=_XP*_+RE)KP\(O@M9M9^=X#]"'UZIV":# M <^W+/?QDP.R'>WMW3\A#Y$U@68;D>U6JF*MBLH;';KA#6RSC23?[RQ*;[C+ MWO>F:^2,*"ORK:=Y8%S 8CGR\SQ.&# F5='Z@Y!P.HW/_@3T(3$W#>PS>OHB MJ\USOMGV$;S+'U1_)J78*D@*WQ1*CU3R.XE]P@.1:F"NX3R0OG,##[2XM%+S MRQ<U BGI<N;N(D:W=+K^J,M5#W,GW"9(LL^S)/O=[53$B^$*PX&Q?:?2&X:E M7B?JE41_N)Q_X**Q>H@@8;%D4.;;"/T$)IJKSEBLPX(FN8H=VOH%@S;R[G:I MLDP?FMN3A"TC:NO?Z^B$3K_F@:*65RJ6%@ A7"[A1^U30^+,0CPX3@4"L82O M%!=;!QF\-9I8PW"NS=S09Z*59XZ;1JWM\T2:J]S:>RHM9X^OUAOQV92+>T5N M==7X\DG%X3R&!EGNULYJ.;HP++HWY?6AYXCEQ=A2L9!+WI+?AQ >9[S<VV8& M54=!-AXT#)7&,GGX'EW_F0[(MTB^X8'ZW=$D/,PU$\S6PH"3C<9_TT ;6R0? M(#(M@#*&P\%*P)<,WQAHV%0YP]7J*,.N&RAL$XN[N[JW9-?^ PK2@NT"6#*9 MR);"U>,-.F@H?42F(9V?[6]Y(RW);_7/7=.^*_C:^L.!NZB+.51B6; 1AS]? M[C3#N8$;O8A;J9>-HRZP3+5MXE14>" "[D=MUW8_.^((?01;,K)B+NB1OM]K ML;$YF3S0MY>!OZO/#&+6 8>A&U H(GK>UL24!T+#?]1(4YQCAO! 3XM)--;R M2A%$4*C@(22'!Q)?8O$_U'&.OLCAH%?JMGD3^VG<V)9H FWZ1S'8>7&9N46V MX<3,(M_YG!M&%A=^*\1)@+D2EC7_5D*]_V )"7\CH I_>M2^G\\N:P*Y([ 2 M2J4SF1@=!68O\$7!'^.G4%]N-P\DBI=&FC)Z4N.003EN=G;#VZMJ*J(F/^O= M+5:\<"E8I5M@V?/_C+8%QNR:T8JE:"6D .?E/8I&!%<9#K :,M7HL]^&-[UJ M'ULUX]BT]=+;'<$)<4JHAT2D7>X?YL\?83(YF5@(XZ:?$ ]TTQ7"T@)=A[S& M1;&#*#S0@ C9M06L NC,U;7E]SNX.2EUEED(SPY\@F6>,/N&4SW<RMU<>UVS M@U:-8&A3X#-4LA5-V"U@1 R_Z4AR76X_\$@MZ.S=6_=NE2&;OKSX0E4WW)LO MQP0XF:D:7-F6Z+<\4.[O;C;'=S,8O8QMBEV>^J$%Y"3#H06]$78-<CM[E$JL M4PZH2QLOV_+4 Z_>JRQE77)NJV5.DME2XC'TCN6[0EZH@8%M=%HS[#/MZ/FQ M2I9<'+60O81GIU^I<&SY0M&G\G<(4M)+1I.N!2(Y5U=,YCB''_,\T+>Y4*"/ MM=>#J\(8Q[R8'%9A7+,;>-94'6_;*;!3_1T/I"T6":W9)CC_'D;F@0*[IB<: M.7B":]D0-@ZJ8J3. Q6B?Y1X_6F[PJ#A3_&H/YJ!Q1],"K0L'+O$^H,90'XV M*<%O&S4G:#];P1\V- N<Y8;#$GZVTXY_)PF]&<(I:<,)07GO9IN4NR7-.LV: MKIA]._/ -$8$$\R>!N;XK+2V'2E 5VP.@($7"(H>RYVU&F7MI]C5AO<4))09 MZT3VMDYD:DZ9L_ACNW(]_F:R4"[1XF]^(4#!FW 2_*G:S-W1#2JB/?H)#LVR MAKTJ.\IN.57I'MTU>M;96W%/O=\FN]Q 6MI$M3N.?9932H,J 1L72<)5H^)R M1WH]]8D2TTZ;_&?/.=Q%O@FKNSQSX>(<L1B7A5DQ6QTJ3(9MBOG-; VYBH/, MX*%[#,1^_G+[8#^B6"09=F<?)AJU(Q!1+\M=U[,@KFU;$725L:6<6'Q.Y\K. M&Q./,[+EN71</%<'7;?'1)<$BX3NZS91(&MO'$)(.1!#A.\@\B%;F:2W:SOB M18C'0]8N[R%X8_LG*]GGZ%S8=,'*2B&#$\R@O3Q0'([T?1]J >!C?S?!NYQ[ MJ#5?D&!.HLMK0OKYC?B"K/(G^>>F)5,-=---"U=[H,C;X54#^>C?SJ@->:!+ MCC_.J(ON-8]4!-0J6]0%<S)P3=:K'.(2H.1MV9+X\VD&H-#AL;ZPE5LW,(3V M;<A:M,N06,/P3N!6]C?[C_CL?*LM#P9?W=7\8JPF(;UP"DPQ@V2?*?LMFB[\ MVT;3/QWOQ;L2:PI(59-X5>X[>*E-(TW"#2U:9A.C(@Q$ZI?G20$WSNKV.QU2 M:94\Y/7I_ CL6 #.^;<58-@]?UF3>R$+B2):8X J*$1^_L$/-R,1KF#%@<5: MO#CPEN'=@E? 8YJ=='JV]'0UO#@S$IHRI*"EA;DXB#HK4BXZ[>C=1%- 7F:D MSM!R "(I)3J A),?)*[/\R<I7Y8?GOH^;&3SR+UJKYW+!4:KB+="0<+*A%KQ M;#OZHC(LF(VFE*(;^+\Y=!VU,S 0$_2;9ZX&$D(8VLS1'K8 R0(X3;:)3#.( M+JK#>> W]>7$![E+[$T<47HDZHSQ*GN'ZE11!\(9:&;$VV*&71U-!2CA,_,B MF5(>"/RM_:4$PLXG>=WBL2^EYS4\;D7(V/C"SZ ;@KE$#2.@)&O#MZM(]#<] M?K3 K/3S^<1'OFCLB@CBX/X\ROILQEK%0DGO6_A-P-EGWWJ++:Y6UA^^^Q[K M9R&99YVU?FAZ O[3K>*"X3[F$B?S 6'L)?![A-?C@X(0;A=6#"H+-% 6^F*K M?9^YI2Q/Q XL6H?D7=R5-;<+_/"ATV%E]#X0Y_C_H7 -BN]39J1;5_9PP<!X M??.P5=5@X=KE-5IDA2!U1,#9$\;)1P2GG2[]88Z[7/XB^GF@M&(2#_2[_[BP M-0!-PP3811YH'5*'8?N8*6>7*8FQKBRKB8\JP[8M*=Q7^JJ^YC,/=+5:QR8. MHE1*B.B#";D"XD4>F7L<M=C;\)LK,H03]*[E"E6*=VO?'^0(3+?(S._@\A/R M^WF@F,1>Y/S0S0BPPKBXL<3HVGFIO9!E<9#Y:(:A/0=#<,$*?;O)E>O&;_)8 M-C%@&MHZ009K<I"/7!R!)6D>:(^3#R.N?E@/,&2=,6?,-4#7=J/4W);YZ##Z MN5OEZ<TCY]ZMU3F2Q1FK!X5$H![PV1V=#R![]_! 8JY_)5MN'#[_>F"TPO>, MB,N_;2&1!W+- +?P0/(P#VLT)2"6+1- 'S0O;;=KL'?"/!>2J^A/<@D:'^S> M+G^:%KYH?8G;!IM%\T!EVJRT@-G@!=**R\'YNPW[?;=Q]]"NV(%4DF$D^AIM M0*K)O@+C%P=9#X3O1)?X*USQWO$ME\I:/^R3A"T$H=(Z^XB$G\R*3XG^(T,F M? NW9UB4@;V-,D : %]'T2*PA#QZHV'PU>+L\VVOOY,[1X4D#X)7MZ3N79P( M=\3^8=3#*Z K5YX'BOP;VPP*J/L,W<QMQY:589LP,H%RMD H";SFVZG) 0,L M3GKN:]6;]\0=D=17(!N;!Q:^F, .-IJ,NY,"DYC/,&S8APU?<-QL\;I3/\%K MS7@Y_@;N-5EOM5>\C(((J_XM>B4R37AU\<G@#&S@ 9';=F#%8CMYH(_GZ'R+ M*?]M:9% "V6Q!0-!:O1"%3S0)5P"&+. V.X7DG!3U'FC8=I(E>'^DB25$:S" M\M4B! ]4TA(+<^F'BK/-Z)#("<;7B5NELG1BC%Z():BZLCQU7/> S>H6-:@< MQ/\MCD]XH_C@_"9E!2LS)L?QL/F-/BMZ>+IBNO_C[[-@D4DHC/.<X(%;C3S( M@#0DV)#R;B$%$=<]LWO'5LV=J'SH_/4LY?)=41BE6;:8!]I^MYTP8^7-D=(/ M:5^AO%G[?^AU#G/^ @\T4\; /V=9LW=BN6OO9+/-;90F+>JN R=?CMBO'S[P M\>M[D]<^C[]&>\T++*<?0K+^8">I_YD,UQ+.=])_^,G@O_ND+TP1=A$FC/0 M2D(9BJ<8AK&ECL'D-86+;HOC0G?4S!X>NR$@EBQRRA)GPHDD7!G$W$;+XC4" MXT[A&<>VMC7:5:+NR>;Y?13.N]*JX% APG&^AWV\;%=2L7+0L+L.^!_K5EW9 MF;N^/W::'Z1^V^H)F!=M%1#=LH$MJP+I^+[@F\O'>5:$:M;.$"[1"Y/Z@",= MH._,!/AYV:X>LF[^HS9)+EH_PZYQX\>.Q-#3AVY;[GKDK=)[\P)=>:[LQIZP MA=*1BHJ9V18-<DLT#_3;-HS_<#5^%B@A,>8?M'#;S%2D6+O9%MC1FLQ4DK@8 MTP.(SLVXS-U4 &3;[BY=//V.Y/1]ZGC.NI3:T7649,M>SHM4;RJ+M7.7;W3W M/G2?[LJ=,G$&R]0/)NLGN/!H92%+QLQ8SG.4)(!C?N!D5MOE!"X>P=-YH.CA M^2D[AK%\H6#S@53CP-:]RFZ"\\V02E3>4O>#.3)W!%[2N0JV0N+X',%T98OR M_JT84"MA- ME#.2%^#Y!F@)H$ES."4"Q@[@:O=5[0*S]I9ZMS'/JWO>-Q9LP M9^MYH& ^5G+1OH.E1Q-)M*AA)4ZZB3-]HB'Q:&N!QRKM[0K.ZA^-)WQ+9$"9 M.17/@B%LPY:9A4_0G4"H+U'RKV=T*Y*ZFO%725SQ#6$-MK1-7? BAN"JX(<5 MGS2T'\[C5.1^TKI&&=F4L$LFH_@;J!7G!3RC/$(I R*.#/UR3 C92*_*KI+; MUN4S\45H+)*HM Y;7UUD,\CG,G<GN+*?PO(XCU;0V4NX/+<?4F*36*W]W&TC MMBE!WGWYMO PNL2Q;5VZC6-1P=U JID2FBI'0DL%+L^-NE)E1K77?PE\.M?P MJB7?FG1VSZ/O.W>1+>6;A]8]?]"\=\KB:'/%/;(AU9-U$*G=5P:)2J/5CZP) M%"9;.X4,7;=@5DU'@!P"F3Q0FT'M%U,C4Z'@!0*UGV74/]CB[<FP:4AA,E03 MMST).)-@5KMVU470GC#3'2Z<&G[>?M#"=L2 RX6%)Q_S8UJI !'5 0>;6#&, MF0\!<)Z%BTGFV@ZO[V6<4V/UZF5SI)-C3:J3*:W-(7T(EC-2O0>OQR7BM]&' MPS>VDK<<H<T7$DLXNT0D+>94!-XS,G5CW_\6FP.D?O@GFS]'(8JP^!'&5:3] M%%J0/12:#/(JIP@/"3Q-DLVC.\/I51^#+G,U&!HQRLYEL]1^^U-A-XY%VJ@ M*F79/)"04\FMXW1:K8/5N5Y%!%JN3OHD[M"A0VM%7H'LVC56CFMLX'$J$!BS MYT<7IS[N6BM^N-8$RG*1:C9K BE'^[!'&6<"4NL_]N.)()""XHZ]T@++&5:_ M1\*C1WX$^W]'W/I/1M8!/;MRBKN*OF\.+WH6)9>D:E.C)J2^;=$4MG$ICRLZ M/>H84(]>K5VV<AYN#T]@6^ \-N:^TNYR^9"L-Y/?"5Z4\4G<C0CY0PK01_.1 MP=<;*T=): U"VF^;7,8ZC1B1P&NA.N0V:M^!2@:RFF!")H8Z,7Y:HK;R_H/O M'F*A)(S6^G-A+U 78P(U,(CSVH1KX'"8!%36D;V]#RKQ.6''-CTB]5VVE>U] MH\"#[BJ[\QF;KMW<7(7[P9$>(\^WBW#*^1I-&ZG S<PV2C$09GOY@.C"#P$" M88W@1#BDVI...0E8:-1F7 FDV19[BX\$I@:+RR^]N)0V*7]#[<J6Z(O@\AT3 M5,9H +!2I?/SK;K98[O@9N4=?@W[(F3-I1HCHT)O]I5C!D>8P8(0>KD)+'Z" M@UCI_#)GQY9V8+X&8 Q7IMU*_84M#!&+/OVJN"K#V.:.H9SK)04& B?;5Z'7 M@EA])"([!J_$ [URQ'%C[2<1:0 _D6U>>14P(\<?[6E*Y5'0DR*WFT[JG=Y^ M-4=75W7ALI)[IP;VWT_3.%64,'/F+JJ,GPGIM>@2(D<2#>:!1O)67LE\6[M- ML!9&"H>Y8I?5N1"^U=FLW+?G<Q/1'UU/-/@YA+.,YNZHX<:"Z&#@H@V?4=R! MK>2VKI4W!>B&52M=32S9_&2/XD>T6!SZ:9B)(%=>ZD=G(IN5[#O/5^A9"+T6 M^_=3CWS+ H/X=KQZI>/3/0#-Y<!6'H6P=VNL-#@YB%U)TGQJ ;Q87/ZOC/_6 M,LK]!\CXGZ#'GV748.^&_#3W\JI8$)\L_?&SVO_5Y7]E_*^,_Z]D7.GK*?+W M4^/#_N\O^]\PI/U?7_:_4$;L'Z;^+^;[Y\DXP?_'1=C?STWXAT/RA?AY.:=X MH/^J\I]EY/\E-O]Z&0MR)\N7K>-E;R;%>%Y,N!R[Y5M,MH#%*QF/V&V"O/[_ M!U!+ 0(4 Q0 ( ,Z FEB4UB:%:!L .IG 0 0 " 0 M !A874M,C R,S$R,S$N>'-D4$L! A0#% @ SH":6&+/![5B$P ;@X! M !0 ( !EAL &%A=2TR,#(S,3(S,5]C86PN>&UL4$L! A0# M% @ SH":6"&PI.C3,0 (&,# !0 ( !*B\ &%A=2TR M,#(S,3(S,5]D968N>&UL4$L! A0#% @ SH":6 GXMC9"9@ )?0% !0 M ( !+V$ &%A=2TR,#(S,3(S,5]L86(N>&UL4$L! A0#% M @ SH":6+TL(>XA20 94<% !0 ( !H\< &%A=2TR,#(S M,3(S,5]P<F4N>&UL4$L! A0#% @ SH":6&"*IC[&(0 !20 H M ( !]A ! &1C7V9T<BYJ<&=02P$"% ,4 " #.@)I8XQ<7ME4A M N)@ "@ @ 'D,@$ 9&-?:&1R+FIP9U!+ 0(4 Q0 ( M ,Z FEB=>,0"] *@! ) " 6%4 0!E>&A?,2YH=&U0 M2P$"% ,4 " #.@)I8<!'YU/X& "4' "P @ %\50$ M97AH7S$R,2YH=&U02P$"% ,4 " #.@)I8;58F%.H& N' "P M @ &C7 $ 97AH7S$R,BYH=&U02P$"% ,4 " #.@)I8^:X)C78# M #T"@ "P @ &V8P$ 97AH7S$S,2YH=&U02P$"% ,4 M" #.@)I82Z@K!FP# #0"@ "P @ %59P$ 97AH7S$S,BYH M=&U02P$"% ,4 " #.@)I8 JNNKQD! !O @ "0 @ 'J M:@$ 97AH7S@N:'1M4$L! A0#% @ SH":6"92(BR,'@0 P=0G \ M ( !*FP! &8R,&9?,#0R-C(T+FAT;5!+ 0(4 Q0 ( ,Z FE@0 MDQ H%'L! -*! 0 ( " >.*!0!F:6<Q+FIP9U!+ 0(4 Q0 M ( ,Z FEBFX;'I> H! &MS 0 ( " 1T&!P!F:6<R+FIP 79U!+!08 $ 0 +$# "[$ @ ! end </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>XML <SEQUENCE>103 <FILENAME>f20f_042624_htm.xml <DESCRIPTION>IDEA: XBRL DOCUMENT <TEXT> <XML> <?xml version="1.0" encoding="utf-8"?> <xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:aau="http://almadenminerals.com/20231231" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"> <link:schemaRef xlink:href="aau-20231231.xsd" xlink:type="simple"/> <context id="From2023-01-01to2023-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_dei_BusinessContactMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2021-01-012021-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="AsOf2020-12-31_ifrs-full_IssuedCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="AsOf2020-12-31_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_TotalReservesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:TotalReservesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_DeficitMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:DeficitMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_IssuedCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_TotalReservesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:TotalReservesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_DeficitMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:DeficitMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_IssuedCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_TotalReservesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:TotalReservesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_DeficitMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:DeficitMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="From2021-01-012021-12-31_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="From2021-01-012021-12-31_custom_TotalReservesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:TotalReservesMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="From2021-01-012021-12-31_custom_DeficitMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:DeficitMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_TotalReservesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:TotalReservesMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_DeficitMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:DeficitMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_TotalReservesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:TotalReservesMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_DeficitMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:DeficitMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_ifrs-full_IssuedCapitalMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_TotalReservesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:TotalReservesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_DeficitMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">aau:DeficitMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_PueblaHoldingsIncMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aau:PueblaHoldingsIncMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_MineraGorrionSAdeCVMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">aau:MineraGorrionSAdeCVMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_TuligticProjectMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:TuligticProjectMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_TuligticProjectMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:TuligticProjectMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_NotLaterThanOneYearMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_FurnitureFixturesAndFittingsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FurnitureFixturesAndFittingsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_ComputerEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ComputerEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_GeologicalLibraryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:GeologicalLibraryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_FieldEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:FieldEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_MillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:MillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_TuligticMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:TuligticMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_TuligticMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:TuligticMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_TuligticMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:TuligticMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_TuligticMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:TuligticMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2021-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_TuligticMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:TuligticMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:OtherPropertyPlantAndEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2022-05-252022-05-26_custom_LoganPropertyLocatedInTheYukonTerritoryCanadaMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:LoganPropertyLocatedInTheYukonTerritoryCanadaMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-05-25</startDate> <endDate>2022-05-26</endDate> </period> </context> <context id="AsOf2022-05-26_custom_LoganPropertyLocatedInTheYukonTerritoryCanadaMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:LoganPropertyLocatedInTheYukonTerritoryCanadaMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-05-26</instant> </period> </context> <context id="AsOf2019-05-14_custom_GoldLoanMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aau:GoldLoanMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2019-05-14</instant> </period> </context> <context id="From2019-05-012019-05-14_custom_GoldLoanMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aau:GoldLoanMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2019-05-01</startDate> <endDate>2019-05-14</endDate> </period> </context> <context id="From2019-05-012019-05-14_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2019-05-01</startDate> <endDate>2019-05-14</endDate> </period> </context> <context id="AsOf2019-05-14_ifrs-full_WarrantsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2019-05-14</instant> </period> </context> <context id="From2019-05-012019-05-14_custom_GoldLoanDerivativeInstrumentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">aau:GoldLoanDerivativeInstrumentsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2019-05-01</startDate> <endDate>2019-05-14</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GoldLoanDerivativeInstrumentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">aau:GoldLoanDerivativeInstrumentsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_GoldLoanDerivativeInstrumentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">aau:GoldLoanDerivativeInstrumentsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_GoldLoanMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aau:GoldLoanMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_GoldLoanMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aau:GoldLoanMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_GoldLoanMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aau:GoldLoanMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_GoldLoanMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aau:GoldLoanMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_GoldLoanMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">aau:GoldLoanMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_GoldLoanDerivativeInstrumentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">aau:GoldLoanDerivativeInstrumentsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_GoldLoanDerivativeInstrumentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">aau:GoldLoanDerivativeInstrumentsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_GoldLoanDerivativeInstrumentsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis">aau:GoldLoanDerivativeInstrumentsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:DerivativeFinancialLiabilityMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_DerivativeFinancialLiabilityMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:DerivativeFinancialLiabilityMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_ifrs-full_WarrantsMember144110500"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">ifrs-full:WarrantsMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_WarrantsExpiryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_WarrantsExpiryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_WarrantsExpiryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_WarrantsExpiryOneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryOneMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_WarrantsExpiryOneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryOneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_WarrantsExpiryOneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryOneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_WarrantsExpiryTwoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryTwoMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_WarrantsExpiryTwoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryTwoMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_WarrantsExpiryTwoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryTwoMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_WarrantsExpiryThreeMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryThreeMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_WarrantsExpiryThreeMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryThreeMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_WarrantsExpiryThreeMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryThreeMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_WarrantsExpiryFourMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFourMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_WarrantsExpiryFourMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFourMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_WarrantsExpiryFourMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFourMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_WarrantsExpiryFiveMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFiveMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_WarrantsExpiryFiveMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFiveMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_WarrantsExpiryFiveMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFiveMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_WarrantsExpiryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_WarrantsExpiryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_WarrantsExpiryOneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryOneMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_WarrantsExpiryOneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryOneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_WarrantsExpiryTwoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryTwoMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_WarrantsExpiryTwoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryTwoMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_WarrantsExpiryThreeMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryThreeMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_WarrantsExpiryThreeMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryThreeMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_WarrantsExpiryFourMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFourMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_WarrantsExpiryFourMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFourMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_WarrantsExpiryFiveMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFiveMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_WarrantsExpiryFiveMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFiveMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_WarrantsExpiryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_WarrantsExpiryMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_WarrantsExpiryOneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryOneMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_WarrantsExpiryOneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryOneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_WarrantsExpiryTwoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryTwoMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_WarrantsExpiryTwoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryTwoMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_WarrantsExpiryThreeMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryThreeMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_WarrantsExpiryThreeMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryThreeMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_WarrantsExpiryFourMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFourMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_WarrantsExpiryFourMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsExpiryFourMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2020-01-012020-12-31"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> </entity> <period> <startDate>2020-01-01</startDate> <endDate>2020-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_WarrantsIssuedOnMarch182021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:WarrantsIssuedOnMarch182021Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_February92023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February92023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_February92023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February92023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_February92023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February92023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_March32023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March32023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_March32023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March32023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_March32023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March32023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_March312023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March312023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_March312023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March312023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_March312023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March312023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_May82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May82023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_May82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May82023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_May82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May82023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_May282023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May282023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_May282023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May282023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_May282023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May282023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_July82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July82023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_July82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July82023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_July82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July82023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_September182023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September182023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_September182023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September182023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_September182023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September182023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_March72027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March72027Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_March72027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March72027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_March72027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March72027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_June102027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June102027Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_June102027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June102027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_June102027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June102027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_October42027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October42027Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_October42027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October42027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_October42027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October42027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_December162027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December162027Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_December162027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December162027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_December162027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December162027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_February142028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February142028Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_February142028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February142028Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_February142028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February142028Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_April32028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April32028Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_April32028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April32028Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_April32028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April32028Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_July102028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July102028Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_July102028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July102028Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_July102028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July102028Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_September192028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September192028Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_September192028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September192028Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_September192028Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September192028Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_March42022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March42022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_March42022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March42022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_March42022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March42022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_April302022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_April302022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_April302022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_April302022OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022OneMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_April302022OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022OneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_April302022OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022OneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_May312022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May312022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_May312022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May312022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_May312022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May312022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_June92022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June92022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_June92022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June92022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_June92022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June92022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_October32022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October32022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_October32022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October32022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_October32022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October32022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_December152022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December152022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2022-12-31_custom_December152022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December152022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_December152022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December152022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_February92023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February92023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_February92023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February92023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_March32023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March32023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_March32023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March32023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_March312023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March312023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_March312023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March312023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_May82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May82023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_May82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May82023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_May282023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May282023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_May282023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May282023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_July82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July82023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_July82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July82023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_September182023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September182023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_September182023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September182023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_March72027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March72027Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_March72027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March72027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_June102027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June102027Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_June102027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June102027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_October42027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October42027Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_October42027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October42027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2022-01-012022-12-31_custom_December162027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December162027Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_December162027Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December162027Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_February72021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February72021Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_February72021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February72021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_February72021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February72021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_February72021OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February72021OneMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_February72021OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February72021OneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_February72021OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February72021OneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_March292021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March292021Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_March292021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March292021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_March292021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March292021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_March292021OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March292021OneMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_March292021OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March292021OneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_March292021OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March292021OneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_May62021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May62021Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_May62021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May62021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_May62021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May62021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_July72021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July72021Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_July72021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July72021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_July72021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July72021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_August132021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:August132021Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_August132021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:August132021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_August132021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:August132021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_September162021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September162021Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_September162021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September162021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_September162021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September162021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_December122021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December122021Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2021-12-31_custom_December122021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December122021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2020-12-31_custom_December122021Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December122021Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_March42022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March42022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_March42022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March42022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_April302022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_April302022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_April302022OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022OneMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_April302022OneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:April302022OneMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_May312022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May312022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_May312022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May312022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_June92022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June92022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_June92022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:June92022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_October32022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October32022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_October32022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:October32022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_December152022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December152022Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_December152022Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:December152022Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_February92023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February92023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_February92023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:February92023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_March32023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March32023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_March32023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March32023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_March312023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March312023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_March312023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:March312023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_May82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May82023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_May82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May82023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_May282023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May282023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_May282023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:May282023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_July82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July82023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_July82023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:July82023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2021-01-012021-12-31_custom_September182023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September182023Member</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2020-12-31_custom_September182023Member"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:September182023Member</xbrldi:explicitMember> </segment> </entity> <period> <instant>2020-12-31</instant> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantOneMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantOneMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantTwoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantTwoMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantThreeMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantThreeMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantFourMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantFourMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantFiveMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantFiveMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantSixMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantSixMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantSevenMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantSevenMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantEightMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantEightMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantNineMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantNineMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantTenMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantTenMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantElevenMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantElevenMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantTwelveMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantTwelveMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantThirteenMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantThirteenMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantFourteenMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantFourteenMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_GrantFifteenMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialInstrumentsAxis">aau:GrantFifteenMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_AzucarMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AzucarMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_AzucarMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AzucarMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2021-01-012021-12-31_custom_AzucarMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AzucarMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="From2023-01-012023-12-31_custom_AlmadexMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AlmadexMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2023-01-01</startDate> <endDate>2023-12-31</endDate> </period> </context> <context id="From2022-01-012022-12-31_custom_AlmadexMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AlmadexMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2022-01-01</startDate> <endDate>2022-12-31</endDate> </period> </context> <context id="From2021-01-012021-12-31_custom_AlmadexMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AlmadexMember</xbrldi:explicitMember> </segment> </entity> <period> <startDate>2021-01-01</startDate> <endDate>2021-12-31</endDate> </period> </context> <context id="AsOf2023-12-31_custom_AzucarMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AzucarMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_AzucarMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AzucarMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_AlmadexMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AlmadexMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_AlmadexMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AlmadexMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_AlmadexMember_custom_DrillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AlmadexMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:DrillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_AlmadexMember_custom_DrillEquipmentMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:AlmadexMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">aau:DrillEquipmentMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_ChairmansDaughterMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:ChairmansDaughterMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_ChairmansDaughterMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:ChairmansDaughterMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2021-12-31_custom_ChairmansDaughterMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">aau:ChairmansDaughterMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2021-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_NoncapitalLossCarryForwardsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:NoncapitalLossCarryForwardsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_NoncapitalLossCarryForwardsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:NoncapitalLossCarryForwardsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_CapitalLossCarryForwardsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:CapitalLossCarryForwardsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_CapitalLossCarryForwardsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:CapitalLossCarryForwardsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_ExplorationAndEvaluationAssetsDeductibleDifferencesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:ExplorationAndEvaluationAssetsDeductibleDifferencesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_ExplorationAndEvaluationAssetsDeductibleDifferencesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:ExplorationAndEvaluationAssetsDeductibleDifferencesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_ShareIssueCostsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:ShareIssueCostsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_ShareIssueCostsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:ShareIssueCostsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_DonationsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:DonationsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_DonationsMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:DonationsMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_InvestmentTaxCreditMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:InvestmentTaxCreditMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_InvestmentTaxCreditMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis">aau:InvestmentTaxCreditMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_CountryOfCanadaMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aau:CountryOfCanadaMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_CountryOfCanadaMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aau:CountryOfCanadaMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_CountryOfMexicoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aau:CountryOfMexicoMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_CountryOfMexicoMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aau:CountryOfMexicoMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_Level1OfFairValueHierarchyMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level1OfFairValueHierarchyMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2023-12-31_custom_CountryOfUnitedStatesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aau:CountryOfUnitedStatesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2023-12-31</instant> </period> </context> <context id="AsOf2022-12-31_custom_CountryOfUnitedStatesMember"> <entity> <identifier scheme="http://www.sec.gov/CIK">0001015647</identifier> <segment> <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">aau:CountryOfUnitedStatesMember</xbrldi:explicitMember> </segment> </entity> <period> <instant>2022-12-31</instant> </period> </context> <unit id="USD"> <measure>iso4217:USD</measure> </unit> <unit id="Shares"> <measure>shares</measure> </unit> <unit id="USDPShares"> <divide> <unitNumerator> <measure>iso4217:USD</measure> </unitNumerator> <unitDenominator> <measure>shares</measure> </unitDenominator> </divide> </unit> <unit id="Pure"> <measure>pure</measure> </unit> <unit id="CAD"> <measure>iso4217:CAD</measure> </unit> <unit id="CADPShares"> <divide> <unitNumerator> <measure>iso4217:CAD</measure> </unitNumerator> <unitDenominator> <measure>shares</measure> </unitDenominator> </divide> </unit> <unit id="MXN"> <measure>iso4217:MXN</measure> </unit> <unit id="Integer"> <measure>aau:Integer</measure> </unit> <unit id="Ounce"> <measure>utr:oz</measure> </unit> <dei:AmendmentFlag contextRef="From2023-01-01to2023-12-31" id="Fact000003">false</dei:AmendmentFlag> <dei:DocumentFiscalYearFocus contextRef="From2023-01-01to2023-12-31" id="Fact000004">2023</dei:DocumentFiscalYearFocus> <dei:DocumentFiscalPeriodFocus contextRef="From2023-01-01to2023-12-31" id="Fact000005">FY</dei:DocumentFiscalPeriodFocus> <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-12-31" id="Fact000006">0001015647</dei:EntityCentralIndexKey> <ifrs-full:FinancialLiabilities contextRef="AsOf2023-12-31" id="xdx2ixbrl0129" unitRef="CAD" xsi:nil="true"/> <ifrs-full:DeferredTaxLiabilityAsset contextRef="AsOf2023-12-31" id="xdx2ixbrl0135" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfPropertyPlantAndEquipment contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0234" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfPropertyPlantAndEquipment contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0236" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfExplorationAndEvaluationAssets contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0239" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfExplorationAndEvaluationAssets contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0240" unitRef="CAD" xsi:nil="true"/> <aau:GainOnDebtForgiveness contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0262" unitRef="CAD" xsi:nil="true"/> <aau:GainOnDebtForgiveness contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0264" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfPropertyPlantAndEquipment contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0326" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfPropertyPlantAndEquipment contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0328" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfExplorationAndEvaluationAssets contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0331" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfExplorationAndEvaluationAssets contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0332" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ProceedsFromIssuingShares contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0402" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ProceedsFromIssuingShares contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0403" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ProceedsFromExerciseOfOptions contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0406" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ProceedsFromExerciseOfOptions contextRef="From2022-01-012022-12-31" id="xdx2ixbrl0407" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0439" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2021-01-012021-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0441" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2021-01-012021-12-31_custom_DeficitMember" id="xdx2ixbrl0443" unitRef="CAD" xsi:nil="true"/> <aau:PrivatePlacementsNetOfShareIssueCosts contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0447" unitRef="CAD" xsi:nil="true"/> <aau:PrivatePlacementsNetOfShareIssueCosts contextRef="From2021-01-012021-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0448" unitRef="CAD" xsi:nil="true"/> <aau:PrivatePlacementsNetOfShareIssueCosts contextRef="From2021-01-012021-12-31_custom_TotalReservesMember" id="xdx2ixbrl0449" unitRef="CAD" xsi:nil="true"/> <aau:PrivatePlacementsNetOfShareIssueCosts contextRef="From2021-01-012021-12-31_custom_DeficitMember" id="xdx2ixbrl0450" unitRef="CAD" xsi:nil="true"/> <aau:WarrantLiabilities contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0456" unitRef="CAD" xsi:nil="true"/> <aau:WarrantLiabilities contextRef="From2021-01-012021-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0457" unitRef="CAD" xsi:nil="true"/> <aau:WarrantLiabilities contextRef="From2021-01-012021-12-31_custom_TotalReservesMember" id="xdx2ixbrl0458" unitRef="CAD" xsi:nil="true"/> <aau:WarrantLiabilities contextRef="From2021-01-012021-12-31_custom_DeficitMember" id="xdx2ixbrl0459" unitRef="CAD" xsi:nil="true"/> <aau:FindersWarrantsIssuedPursuantToPrivatePlacement contextRef="From2021-01-012021-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0464" unitRef="CAD" xsi:nil="true"/> <aau:FindersWarrantsIssuedPursuantToPrivatePlacement contextRef="From2021-01-012021-12-31_custom_DeficitMember" id="xdx2ixbrl0466" unitRef="CAD" xsi:nil="true"/> <aau:FindersWarrantsIssuedPursuantToPrivatePlacement contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0467" unitRef="CAD" xsi:nil="true"/> <aau:SharesIssuedForCashOnExerciseOfStockOptions contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0470" unitRef="CAD" xsi:nil="true"/> <aau:SharesIssuedForCashOnExerciseOfStockOptions contextRef="From2021-01-012021-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0471" unitRef="CAD" xsi:nil="true"/> <aau:SharesIssuedForCashOnExerciseOfStockOptions contextRef="From2021-01-012021-12-31_custom_TotalReservesMember" id="xdx2ixbrl0472" unitRef="CAD" xsi:nil="true"/> <aau:SharesIssuedForCashOnExerciseOfStockOptions contextRef="From2021-01-012021-12-31_custom_DeficitMember" id="xdx2ixbrl0473" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments contextRef="From2021-01-012021-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0480" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments contextRef="From2021-01-012021-12-31_custom_DeficitMember" id="xdx2ixbrl0482" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments contextRef="From2021-01-012021-12-31" id="xdx2ixbrl0483" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0485" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0486" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2021-01-012021-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0487" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2021-01-012021-12-31_custom_TotalReservesMember" id="xdx2ixbrl0488" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0501" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2022-01-012022-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0503" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2022-01-012022-12-31_custom_DeficitMember" id="xdx2ixbrl0505" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2022-01-012022-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0508" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0509" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2022-01-012022-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0510" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2022-01-012022-12-31_custom_TotalReservesMember" id="xdx2ixbrl0511" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0524" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0526" unitRef="CAD" xsi:nil="true"/> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2023-01-012023-12-31_custom_DeficitMember" id="xdx2ixbrl0528" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2023-01-012023-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0531" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0532" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember" id="xdx2ixbrl0533" unitRef="CAD" xsi:nil="true"/> <ifrs-full:ComprehensiveIncome contextRef="From2023-01-012023-12-31_custom_TotalReservesMember" id="xdx2ixbrl0534" unitRef="CAD" xsi:nil="true"/> <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived contextRef="AsOf2023-12-31_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" id="xdx2ixbrl0741" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember" id="xdx2ixbrl0769" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember" id="xdx2ixbrl0771" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember" id="xdx2ixbrl0773" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember" id="xdx2ixbrl0775" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember" id="xdx2ixbrl0779" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember" id="xdx2ixbrl0781" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember" id="xdx2ixbrl0783" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember" id="xdx2ixbrl0785" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember" id="xdx2ixbrl0787" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember" id="xdx2ixbrl0789" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl0791" unitRef="CAD" xsi:nil="true"/> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember" id="xdx2ixbrl0817" unitRef="CAD" xsi:nil="true"/> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember" id="xdx2ixbrl0831" unitRef="CAD" xsi:nil="true"/> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember" id="xdx2ixbrl0845" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember" id="xdx2ixbrl0895" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember" id="xdx2ixbrl0897" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember" id="xdx2ixbrl0899" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember" id="xdx2ixbrl0905" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember" id="xdx2ixbrl0907" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember" id="xdx2ixbrl0909" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember" id="xdx2ixbrl0911" unitRef="CAD" xsi:nil="true"/> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember" id="xdx2ixbrl0913" unitRef="CAD" xsi:nil="true"/> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember" id="xdx2ixbrl0943" unitRef="CAD" xsi:nil="true"/> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember" id="xdx2ixbrl0957" unitRef="CAD" xsi:nil="true"/> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_MillEquipmentMember" id="xdx2ixbrl0971" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1015" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCostAdditions contextRef="From2023-01-012023-12-31_custom_TuligticMember" id="xdx2ixbrl1019" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCostAdditions contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1021" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCostAdditions contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1023" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCostDeductions contextRef="From2023-01-012023-12-31_custom_TuligticMember" id="xdx2ixbrl1025" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCostDeductions contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1027" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCostDeductions contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1029" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1033" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1039" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1045" unitRef="CAD" xsi:nil="true"/> <aau:ProfessionaltechnicalFees contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1051" unitRef="CAD" xsi:nil="true"/> <aau:GeochemicalAndMetallurgyCosts contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1057" unitRef="CAD" xsi:nil="true"/> <aau:TravelAndAccommodationExpense contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1063" unitRef="CAD" xsi:nil="true"/> <aau:GeologyGeophysicsAndExplorationCosts contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1069" unitRef="CAD" xsi:nil="true"/> <aau:SuppliesAndMiscellaneousCosts contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1075" unitRef="CAD" xsi:nil="true"/> <aau:EnvironmentalStudies contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1081" unitRef="CAD" xsi:nil="true"/> <aau:ValueAddedTaxRefund contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1091" unitRef="CAD" xsi:nil="true"/> <aau:ImpairmentOfDeferredExplorationCost contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1097" unitRef="CAD" xsi:nil="true"/> <aau:DeferredExplorationCosts contextRef="From2023-01-012023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1103" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2023-12-31_custom_TuligticMember" id="xdx2ixbrl1107" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1109" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2023-12-31" id="xdx2ixbrl1111" unitRef="CAD" xsi:nil="true"/> <ifrs-full:TangibleExplorationAndEvaluationAssets contextRef="AsOf2023-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1115" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCostAdditions contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1139" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCostDeductions contextRef="From2022-01-012022-12-31_custom_TuligticMember" id="xdx2ixbrl1143" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1151" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2021-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1157" unitRef="CAD" xsi:nil="true"/> <aau:ProfessionaltechnicalFees contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1163" unitRef="CAD" xsi:nil="true"/> <aau:ClaimMaintenanceAndLeaseCosts contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1169" unitRef="CAD" xsi:nil="true"/> <aau:GeochemicalAndMetallurgyCosts contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1175" unitRef="CAD" xsi:nil="true"/> <aau:TravelAndAccommodationExpense contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1181" unitRef="CAD" xsi:nil="true"/> <aau:GeologyGeophysicsAndExplorationCosts contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1187" unitRef="CAD" xsi:nil="true"/> <aau:SuppliesAndMiscellaneousCosts contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1193" unitRef="CAD" xsi:nil="true"/> <aau:EnvironmentalStudies contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1199" unitRef="CAD" xsi:nil="true"/> <aau:ValueAddedTaxRefund contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1209" unitRef="CAD" xsi:nil="true"/> <aau:DeferredExplorationCosts contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1215" unitRef="CAD" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1221" unitRef="CAD" xsi:nil="true"/> <ifrs-full:TangibleExplorationAndEvaluationAssets contextRef="AsOf2022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" id="xdx2ixbrl1227" unitRef="CAD" xsi:nil="true"/> <aau:SaleOfTrustAssetsOuncesOfGold contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" id="xdx2ixbrl1371" unitRef="Ounce" xsi:nil="true"/> <aau:ProceedsFromSaleOfTrustAssets contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" id="xdx2ixbrl1373" unitRef="CAD" xsi:nil="true"/> <aau:SaleOfTrustAssetsOuncesOfGold contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" id="xdx2ixbrl1375" unitRef="Ounce" xsi:nil="true"/> <aau:ProceedsFromSaleOfTrustAssets contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" id="xdx2ixbrl1377" unitRef="CAD" xsi:nil="true"/> <aau:RealizedGainLossOnSaleOfTrustAssets contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" id="xdx2ixbrl1379" unitRef="CAD" xsi:nil="true"/> <aau:RealizedGainLossOnSaleOfTrustAssets contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" id="xdx2ixbrl1381" unitRef="CAD" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1456" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1458" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2023-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1462" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1470" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1472" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2023-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1476" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1484" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1486" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1488" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryThreeMember" id="xdx2ixbrl1498" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryThreeMember" id="xdx2ixbrl1500" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryThreeMember" id="xdx2ixbrl1502" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1512" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1514" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1516" unitRef="Shares" xsi:nil="true"/> <aau:NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1522" unitRef="Shares" xsi:nil="true"/> <aau:NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1524" unitRef="Shares" xsi:nil="true"/> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1532" unitRef="CADPShares" xsi:nil="true"/> <aau:ExercisedWeightedAverageExercisePrice contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl1534" unitRef="CADPShares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryFiveMember" id="xdx2ixbrl1550" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryFiveMember" id="xdx2ixbrl1552" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryFiveMember" id="xdx2ixbrl1556" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1564" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1566" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1568" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1578" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1580" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1582" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1592" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1594" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1596" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryThreeMember" id="xdx2ixbrl1606" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryThreeMember" id="xdx2ixbrl1608" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryThreeMember" id="xdx2ixbrl1610" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1620" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1622" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1624" unitRef="Shares" xsi:nil="true"/> <aau:NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1630" unitRef="Shares" xsi:nil="true"/> <aau:NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1632" unitRef="Shares" xsi:nil="true"/> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1640" unitRef="CADPShares" xsi:nil="true"/> <aau:ExercisedWeightedAverageExercisePrice contextRef="From2022-01-012022-12-31" id="xdx2ixbrl1642" unitRef="CADPShares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryFiveMember" id="xdx2ixbrl1658" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryFiveMember" id="xdx2ixbrl1660" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryFiveMember" id="xdx2ixbrl1662" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1672" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1674" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryMember" id="xdx2ixbrl1676" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1686" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1688" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryOneMember" id="xdx2ixbrl1690" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1698" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1702" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryTwoMember" id="xdx2ixbrl1704" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_WarrantsExpiryThreeMember" id="xdx2ixbrl1712" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1724" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1726" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryFourMember" id="xdx2ixbrl1728" unitRef="Shares" xsi:nil="true"/> <aau:NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1736" unitRef="Shares" xsi:nil="true"/> <aau:NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1738" unitRef="Shares" xsi:nil="true"/> <aau:ExercisedWeightedAverageExercisePrice contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1746" unitRef="CADPShares" xsi:nil="true"/> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019 contextRef="From2021-01-012021-12-31" id="xdx2ixbrl1748" unitRef="CADPShares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_February92023Member" id="xdx2ixbrl1793" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_February92023Member" id="xdx2ixbrl1795" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_February92023Member" id="xdx2ixbrl1799" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March32023Member" id="xdx2ixbrl1807" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March32023Member" id="xdx2ixbrl1809" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_March32023Member" id="xdx2ixbrl1813" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March312023Member" id="xdx2ixbrl1821" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March312023Member" id="xdx2ixbrl1823" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_March312023Member" id="xdx2ixbrl1827" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_May82023Member" id="xdx2ixbrl1835" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_May82023Member" id="xdx2ixbrl1837" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_May82023Member" id="xdx2ixbrl1841" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_May282023Member" id="xdx2ixbrl1849" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_May282023Member" id="xdx2ixbrl1851" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_May282023Member" id="xdx2ixbrl1855" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_July82023Member" id="xdx2ixbrl1863" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_July82023Member" id="xdx2ixbrl1865" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_July82023Member" id="xdx2ixbrl1869" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_September182023Member" id="xdx2ixbrl1877" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_September182023Member" id="xdx2ixbrl1879" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_September182023Member" id="xdx2ixbrl1883" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March72027Member" id="xdx2ixbrl1891" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March72027Member" id="xdx2ixbrl1893" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March72027Member" id="xdx2ixbrl1895" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_June102027Member" id="xdx2ixbrl1905" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_June102027Member" id="xdx2ixbrl1907" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_June102027Member" id="xdx2ixbrl1909" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_October42027Member" id="xdx2ixbrl1919" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_October42027Member" id="xdx2ixbrl1921" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_October42027Member" id="xdx2ixbrl1923" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_December162027Member" id="xdx2ixbrl1933" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_December162027Member" id="xdx2ixbrl1935" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_December162027Member" id="xdx2ixbrl1937" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_February142028Member" id="xdx2ixbrl1945" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_February142028Member" id="xdx2ixbrl1949" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_February142028Member" id="xdx2ixbrl1951" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_April32028Member" id="xdx2ixbrl1959" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_April32028Member" id="xdx2ixbrl1963" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_April32028Member" id="xdx2ixbrl1965" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_July102028Member" id="xdx2ixbrl1973" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_July102028Member" id="xdx2ixbrl1977" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_July102028Member" id="xdx2ixbrl1979" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_September192028Member" id="xdx2ixbrl1987" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_September192028Member" id="xdx2ixbrl1991" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_September192028Member" id="xdx2ixbrl1993" unitRef="Shares" xsi:nil="true"/> <aau:NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2001" unitRef="Shares" xsi:nil="true"/> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2011" unitRef="CADPShares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March42022Member" id="xdx2ixbrl2032" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March42022Member" id="xdx2ixbrl2034" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_March42022Member" id="xdx2ixbrl2038" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_April302022Member" id="xdx2ixbrl2046" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_April302022Member" id="xdx2ixbrl2048" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_April302022Member" id="xdx2ixbrl2052" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_April302022OneMember" id="xdx2ixbrl2060" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_April302022OneMember" id="xdx2ixbrl2062" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_April302022OneMember" id="xdx2ixbrl2066" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May312022Member" id="xdx2ixbrl2074" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May312022Member" id="xdx2ixbrl2076" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_May312022Member" id="xdx2ixbrl2080" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_June92022Member" id="xdx2ixbrl2088" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_June92022Member" id="xdx2ixbrl2090" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_June92022Member" id="xdx2ixbrl2094" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_October32022Member" id="xdx2ixbrl2102" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_October32022Member" id="xdx2ixbrl2104" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_October32022Member" id="xdx2ixbrl2108" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_December152022Member" id="xdx2ixbrl2116" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_December152022Member" id="xdx2ixbrl2118" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_December152022Member" id="xdx2ixbrl2122" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_February92023Member" id="xdx2ixbrl2130" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_February92023Member" id="xdx2ixbrl2132" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_February92023Member" id="xdx2ixbrl2134" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March32023Member" id="xdx2ixbrl2144" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March32023Member" id="xdx2ixbrl2146" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March32023Member" id="xdx2ixbrl2148" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March312023Member" id="xdx2ixbrl2158" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March312023Member" id="xdx2ixbrl2160" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March312023Member" id="xdx2ixbrl2162" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May82023Member" id="xdx2ixbrl2172" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May82023Member" id="xdx2ixbrl2174" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May82023Member" id="xdx2ixbrl2176" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May282023Member" id="xdx2ixbrl2186" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May282023Member" id="xdx2ixbrl2188" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May282023Member" id="xdx2ixbrl2190" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_July82023Member" id="xdx2ixbrl2200" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_July82023Member" id="xdx2ixbrl2202" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_September182023Member" id="xdx2ixbrl2214" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_September182023Member" id="xdx2ixbrl2216" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_September182023Member" id="xdx2ixbrl2218" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March72027Member" id="xdx2ixbrl2226" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March72027Member" id="xdx2ixbrl2230" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March72027Member" id="xdx2ixbrl2232" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_June102027Member" id="xdx2ixbrl2240" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_June102027Member" id="xdx2ixbrl2244" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_June102027Member" id="xdx2ixbrl2246" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_October42027Member" id="xdx2ixbrl2254" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_October42027Member" id="xdx2ixbrl2258" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_October42027Member" id="xdx2ixbrl2260" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_December162027Member" id="xdx2ixbrl2268" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_December162027Member" id="xdx2ixbrl2272" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_December162027Member" id="xdx2ixbrl2274" unitRef="Shares" xsi:nil="true"/> <aau:NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2282" unitRef="Shares" xsi:nil="true"/> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2292" unitRef="CADPShares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February72021Member" id="xdx2ixbrl2313" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February72021Member" id="xdx2ixbrl2315" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_February72021Member" id="xdx2ixbrl2319" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February72021OneMember" id="xdx2ixbrl2327" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_February72021OneMember" id="xdx2ixbrl2333" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March292021Member" id="xdx2ixbrl2341" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March292021Member" id="xdx2ixbrl2343" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March292021Member" id="xdx2ixbrl2347" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March292021OneMember" id="xdx2ixbrl2355" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March292021OneMember" id="xdx2ixbrl2357" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March292021OneMember" id="xdx2ixbrl2361" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May62021Member" id="xdx2ixbrl2369" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_May62021Member" id="xdx2ixbrl2375" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_July72021Member" id="xdx2ixbrl2383" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_July72021Member" id="xdx2ixbrl2389" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_August132021Member" id="xdx2ixbrl2397" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_August132021Member" id="xdx2ixbrl2399" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_August132021Member" id="xdx2ixbrl2403" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_September162021Member" id="xdx2ixbrl2411" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_September162021Member" id="xdx2ixbrl2413" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_September162021Member" id="xdx2ixbrl2417" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_December122021Member" id="xdx2ixbrl2425" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_December122021Member" id="xdx2ixbrl2427" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_December122021Member" id="xdx2ixbrl2431" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March42022Member" id="xdx2ixbrl2439" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March42022Member" id="xdx2ixbrl2441" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March42022Member" id="xdx2ixbrl2443" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_April302022Member" id="xdx2ixbrl2453" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_April302022Member" id="xdx2ixbrl2455" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_April302022Member" id="xdx2ixbrl2457" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_April302022OneMember" id="xdx2ixbrl2467" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_April302022OneMember" id="xdx2ixbrl2469" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_April302022OneMember" id="xdx2ixbrl2471" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May312022Member" id="xdx2ixbrl2481" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May312022Member" id="xdx2ixbrl2483" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_June92022Member" id="xdx2ixbrl2495" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_June92022Member" id="xdx2ixbrl2497" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_October32022Member" id="xdx2ixbrl2509" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_October32022Member" id="xdx2ixbrl2511" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_December152022Member" id="xdx2ixbrl2523" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_December152022Member" id="xdx2ixbrl2525" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_February92023Member" id="xdx2ixbrl2535" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February92023Member" id="xdx2ixbrl2539" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_March32023Member" id="xdx2ixbrl2549" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March32023Member" id="xdx2ixbrl2553" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_March312023Member" id="xdx2ixbrl2563" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March312023Member" id="xdx2ixbrl2567" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March312023Member" id="xdx2ixbrl2569" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_May82023Member" id="xdx2ixbrl2577" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May82023Member" id="xdx2ixbrl2581" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May82023Member" id="xdx2ixbrl2583" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_May282023Member" id="xdx2ixbrl2591" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May282023Member" id="xdx2ixbrl2595" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May282023Member" id="xdx2ixbrl2597" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_July82023Member" id="xdx2ixbrl2605" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_July82023Member" id="xdx2ixbrl2609" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_July82023Member" id="xdx2ixbrl2611" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_September182023Member" id="xdx2ixbrl2619" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_September182023Member" id="xdx2ixbrl2623" unitRef="Shares" xsi:nil="true"/> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_September182023Member" id="xdx2ixbrl2625" unitRef="Shares" xsi:nil="true"/> <aau:ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2901" unitRef="CAD" xsi:nil="true"/> <aau:IncreaseDecreaseInRightOfUseAssets contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2905" unitRef="CAD" xsi:nil="true"/> <aau:IncreaseDecreaseInRightOfUseAssets contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2906" unitRef="CAD" xsi:nil="true"/> <aau:IncreaseDecreaseInWarrantLiability contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2909" unitRef="CAD" xsi:nil="true"/> <aau:IncreaseDecreaseInWarrantLiability contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2910" unitRef="CAD" xsi:nil="true"/> <aau:FairValueOfFindersWarrants contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2913" unitRef="CAD" xsi:nil="true"/> <aau:FairValueOfFindersWarrants contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2914" unitRef="CAD" xsi:nil="true"/> <aau:IncreaseDecreaseInLeaseLiabilities contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2917" unitRef="CAD" xsi:nil="true"/> <aau:IncreaseDecreaseInLeaseLiabilities contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2918" unitRef="CAD" xsi:nil="true"/> <aau:FairValueOfCashStockOptionsTransferredToShareCapitalOnExerciseOfOptions contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2921" unitRef="CAD" xsi:nil="true"/> <aau:FairValueOfCashStockOptionsTransferredToShareCapitalOnExerciseOfOptions contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2922" unitRef="CAD" xsi:nil="true"/> <aau:TaxEffectFromShareIssuanceCosts contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl2974" unitRef="CAD" xsi:nil="true"/> <aau:TaxEffectFromShareIssuanceCosts contextRef="From2022-01-012022-12-31" id="xdx2ixbrl2975" unitRef="CAD" xsi:nil="true"/> <aau:DeferredTaxAssetsNonCapitalLosses contextRef="AsOf2023-12-31" id="xdx2ixbrl2988" unitRef="CAD" xsi:nil="true"/> <aau:DeferredTaxAssetsExplorationAndEvaluation contextRef="AsOf2022-12-31" id="xdx2ixbrl2994" unitRef="CAD" xsi:nil="true"/> <ifrs-full:NetDeferredTaxLiabilities contextRef="AsOf2023-12-31" id="xdx2ixbrl3004" unitRef="CAD" xsi:nil="true"/> <aau:GoldInTrust contextRef="AsOf2023-12-31" id="xdx2ixbrl3069" unitRef="MXN" xsi:nil="true"/> <aau:GoldLoanPayable contextRef="AsOf2023-12-31" id="xdx2ixbrl3081" unitRef="MXN" xsi:nil="true"/> <aau:DerivativesFinancialLiabilities contextRef="AsOf2023-12-31" id="xdx2ixbrl3085" unitRef="MXN" xsi:nil="true"/> <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="AsOf2023-12-31_ifrs-full_Level1OfFairValueHierarchyMember" id="xdx2ixbrl3117" unitRef="CAD" xsi:nil="true"/> <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="AsOf2023-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl3121" unitRef="CAD" xsi:nil="true"/> <dei:DocumentType contextRef="From2023-01-01to2023-12-31" id="Fact000018">20-F</dei:DocumentType> <dei:DocumentRegistrationStatement contextRef="From2023-01-01to2023-12-31" id="Fact000019">false</dei:DocumentRegistrationStatement> <dei:DocumentAnnualReport contextRef="From2023-01-01to2023-12-31" id="Fact000020">true</dei:DocumentAnnualReport> <dei:DocumentPeriodEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000021">2023-12-31</dei:DocumentPeriodEndDate> <dei:CurrentFiscalYearEndDate contextRef="From2023-01-01to2023-12-31" id="Fact000022">--12-31</dei:CurrentFiscalYearEndDate> <dei:DocumentTransitionReport contextRef="From2023-01-01to2023-12-31" id="Fact000023">false</dei:DocumentTransitionReport> <dei:DocumentShellCompanyReport contextRef="From2023-01-01to2023-12-31" id="Fact000024">false</dei:DocumentShellCompanyReport> <dei:EntityFileNumber contextRef="From2023-01-01to2023-12-31" id="Fact000025">001-32702</dei:EntityFileNumber> <dei:EntityRegistrantName contextRef="From2023-01-01to2023-12-31" id="Fact000026">ALMADEN MINERALS LTD.</dei:EntityRegistrantName> <dei:EntityIncorporationStateCountryCode contextRef="From2023-01-01to2023-12-31" id="Fact000027">A1</dei:EntityIncorporationStateCountryCode> <dei:EntityAddressCountry contextRef="From2023-01-01to2023-12-31" id="Fact000028">CA</dei:EntityAddressCountry> <dei:EntityAddressAddressLine1 contextRef="From2023-01-01to2023-12-31" id="Fact000029">1333 Johnston Street</dei:EntityAddressAddressLine1> <dei:EntityAddressAddressLine2 contextRef="From2023-01-01to2023-12-31" id="Fact000030">#210</dei:EntityAddressAddressLine2> <dei:EntityAddressCityOrTown contextRef="From2023-01-01to2023-12-31" id="Fact000031">Vancouver</dei:EntityAddressCityOrTown> <dei:EntityAddressStateOrProvince contextRef="From2023-01-01to2023-12-31" id="Fact000032">BC</dei:EntityAddressStateOrProvince> <dei:EntityAddressPostalZipCode contextRef="From2023-01-01to2023-12-31" id="Fact000033">V6H 3R9</dei:EntityAddressPostalZipCode> <dei:ContactPersonnelName contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000034">Korm Trieu</dei:ContactPersonnelName> <dei:ContactPersonnelEmailAddress contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000035">ktrieu@almadenminerals.com</dei:ContactPersonnelEmailAddress> <dei:EntityAddressAddressLine1 contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000037">1333 Johnston Street</dei:EntityAddressAddressLine1> <dei:EntityAddressAddressLine2 contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000039">#210</dei:EntityAddressAddressLine2> <dei:EntityAddressCityOrTown contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000041">Vancouver</dei:EntityAddressCityOrTown> <dei:EntityAddressStateOrProvince contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000043">BC</dei:EntityAddressStateOrProvince> <dei:EntityAddressPostalZipCode contextRef="From2023-01-012023-12-31_dei_BusinessContactMember" id="Fact000045">V6H 3R9</dei:EntityAddressPostalZipCode> <dei:Security12bTitle contextRef="From2023-01-01to2023-12-31" id="Fact000046">Common shares without Par Value</dei:Security12bTitle> <dei:TradingSymbol contextRef="From2023-01-01to2023-12-31" id="Fact000047">AAUAF</dei:TradingSymbol> <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2023-12-31" decimals="INF" id="Fact000048" unitRef="Shares">137221408</dei:EntityCommonStockSharesOutstanding> <dei:EntityWellKnownSeasonedIssuer contextRef="From2023-01-01to2023-12-31" id="Fact000049">No</dei:EntityWellKnownSeasonedIssuer> <dei:EntityVoluntaryFilers contextRef="From2023-01-01to2023-12-31" id="Fact000051">No</dei:EntityVoluntaryFilers> <dei:EntityCurrentReportingStatus contextRef="From2023-01-01to2023-12-31" id="Fact000052">Yes</dei:EntityCurrentReportingStatus> <dei:EntityInteractiveDataCurrent contextRef="From2023-01-01to2023-12-31" id="Fact000053">Yes</dei:EntityInteractiveDataCurrent> <dei:EntityFilerCategory contextRef="From2023-01-01to2023-12-31" id="Fact000054">Non-accelerated Filer</dei:EntityFilerCategory> <dei:EntityEmergingGrowthCompany contextRef="From2023-01-01to2023-12-31" id="Fact000055">true</dei:EntityEmergingGrowthCompany> <dei:EntityExTransitionPeriod contextRef="From2023-01-01to2023-12-31" id="Fact000056">false</dei:EntityExTransitionPeriod> <dei:IcfrAuditorAttestationFlag contextRef="From2023-01-01to2023-12-31" id="Fact000057">false</dei:IcfrAuditorAttestationFlag> <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2023-01-01to2023-12-31" id="Fact000058">false</dei:DocumentFinStmtErrorCorrectionFlag> <dei:DocumentAccountingStandard contextRef="From2023-01-01to2023-12-31" id="Fact000059">International Financial Reporting Standards</dei:DocumentAccountingStandard> <dei:EntityShellCompany contextRef="From2023-01-01to2023-12-31" id="Fact000061">false</dei:EntityShellCompany> <dei:AuditorName contextRef="From2023-01-01to2023-12-31" id="Fact000063">DAVIDSON &amp; COMPANY LLP</dei:AuditorName> <dei:AuditorLocation contextRef="From2023-01-01to2023-12-31" id="Fact000065">Vancouver, Canada</dei:AuditorLocation> <dei:AuditorFirmId contextRef="From2023-01-01to2023-12-31" id="Fact000067">731</dei:AuditorFirmId> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2023-12-31" decimals="0" id="Fact000075" unitRef="CAD">4245983</ifrs-full:CashAndCashEquivalents> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2022-12-31" decimals="0" id="Fact000076" unitRef="CAD">6658076</ifrs-full:CashAndCashEquivalents> <aau:TrustAssetsMetals contextRef="AsOf2023-12-31" decimals="0" id="Fact000078" unitRef="CAD">1082801</aau:TrustAssetsMetals> <aau:TrustAssetsMetals contextRef="AsOf2022-12-31" decimals="0" id="Fact000079" unitRef="CAD">974397</aau:TrustAssetsMetals> <aau:CurrentTradeReceivablesAndPrepaidExpenses contextRef="AsOf2023-12-31" decimals="0" id="Fact000081" unitRef="CAD">453640</aau:CurrentTradeReceivablesAndPrepaidExpenses> <aau:CurrentTradeReceivablesAndPrepaidExpenses contextRef="AsOf2022-12-31" decimals="0" id="Fact000082" unitRef="CAD">259471</aau:CurrentTradeReceivablesAndPrepaidExpenses> <ifrs-full:CurrentAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact000084" unitRef="CAD">5782424</ifrs-full:CurrentAssets> <ifrs-full:CurrentAssets contextRef="AsOf2022-12-31" decimals="0" id="Fact000085" unitRef="CAD">7891944</ifrs-full:CurrentAssets> <ifrs-full:RightofuseAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact000090" unitRef="CAD">330597</ifrs-full:RightofuseAssets> <ifrs-full:RightofuseAssets contextRef="AsOf2022-12-31" decimals="0" id="Fact000091" unitRef="CAD">432319</ifrs-full:RightofuseAssets> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2023-12-31" decimals="0" id="Fact000093" unitRef="CAD">6601742</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31" decimals="0" id="Fact000094" unitRef="CAD">6610871</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:TangibleExplorationAndEvaluationAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact000096" unitRef="CAD">1</ifrs-full:TangibleExplorationAndEvaluationAssets> <ifrs-full:TangibleExplorationAndEvaluationAssets contextRef="AsOf2022-12-31" decimals="0" id="Fact000097" unitRef="CAD">63115076</ifrs-full:TangibleExplorationAndEvaluationAssets> <ifrs-full:NoncurrentAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact000099" unitRef="CAD">6932340</ifrs-full:NoncurrentAssets> <ifrs-full:NoncurrentAssets contextRef="AsOf2022-12-31" decimals="0" id="Fact000100" unitRef="CAD">70158266</ifrs-full:NoncurrentAssets> <ifrs-full:Assets contextRef="AsOf2023-12-31" decimals="0" id="Fact000102" unitRef="CAD">12714764</ifrs-full:Assets> <ifrs-full:Assets contextRef="AsOf2022-12-31" decimals="0" id="Fact000103" unitRef="CAD">78050210</ifrs-full:Assets> <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2023-12-31" decimals="0" id="Fact000111" unitRef="CAD">851158</ifrs-full:TradeAndOtherCurrentPayables> <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2022-12-31" decimals="0" id="Fact000112" unitRef="CAD">340509</ifrs-full:TradeAndOtherCurrentPayables> <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000114" unitRef="CAD">100531</ifrs-full:CurrentLeaseLiabilities> <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000115" unitRef="CAD">88295</ifrs-full:CurrentLeaseLiabilities> <ifrs-full:CurrentLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000117" unitRef="CAD">951689</ifrs-full:CurrentLiabilities> <ifrs-full:CurrentLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000118" unitRef="CAD">428804</ifrs-full:CurrentLiabilities> <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000123" unitRef="CAD">277104</ifrs-full:NoncurrentLeaseLiabilities> <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000124" unitRef="CAD">377635</ifrs-full:NoncurrentLeaseLiabilities> <aau:BorrowingsMetalsNoncurrent contextRef="AsOf2023-12-31" decimals="0" id="Fact000126" unitRef="CAD">4371546</aau:BorrowingsMetalsNoncurrent> <aau:BorrowingsMetalsNoncurrent contextRef="AsOf2022-12-31" decimals="0" id="Fact000127" unitRef="CAD">3929015</aau:BorrowingsMetalsNoncurrent> <ifrs-full:FinancialLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000130" unitRef="CAD">102787</ifrs-full:FinancialLiabilities> <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000132" unitRef="CAD">108830</ifrs-full:NoncurrentDerivativeFinancialLiabilities> <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000133" unitRef="CAD">306084</ifrs-full:NoncurrentDerivativeFinancialLiabilities> <ifrs-full:DeferredTaxLiabilityAsset contextRef="AsOf2022-12-31" decimals="0" id="Fact000136" unitRef="CAD">3090208</ifrs-full:DeferredTaxLiabilityAsset> <ifrs-full:NoncurrentLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000138" unitRef="CAD">4757480</ifrs-full:NoncurrentLiabilities> <ifrs-full:NoncurrentLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000139" unitRef="CAD">7805729</ifrs-full:NoncurrentLiabilities> <ifrs-full:Liabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000141" unitRef="CAD">5709169</ifrs-full:Liabilities> <ifrs-full:Liabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000142" unitRef="CAD">8234533</ifrs-full:Liabilities> <ifrs-full:IssuedCapital contextRef="AsOf2023-12-31" decimals="0" id="Fact000147" unitRef="CAD">141040654</ifrs-full:IssuedCapital> <ifrs-full:IssuedCapital contextRef="AsOf2022-12-31" decimals="0" id="Fact000148" unitRef="CAD">141040654</ifrs-full:IssuedCapital> <ifrs-full:CapitalReserve contextRef="AsOf2023-12-31" decimals="0" id="Fact000150" unitRef="CAD">23356523</ifrs-full:CapitalReserve> <ifrs-full:CapitalReserve contextRef="AsOf2022-12-31" decimals="0" id="Fact000151" unitRef="CAD">22546373</ifrs-full:CapitalReserve> <ifrs-full:RetainedEarnings contextRef="AsOf2023-12-31" decimals="0" id="Fact000153" unitRef="CAD">-157391582</ifrs-full:RetainedEarnings> <ifrs-full:RetainedEarnings contextRef="AsOf2022-12-31" decimals="0" id="Fact000154" unitRef="CAD">-93771350</ifrs-full:RetainedEarnings> <ifrs-full:Equity contextRef="AsOf2023-12-31" decimals="0" id="Fact000156" unitRef="CAD">7005595</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2022-12-31" decimals="0" id="Fact000157" unitRef="CAD">69815677</ifrs-full:Equity> <ifrs-full:EquityAndLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000159" unitRef="CAD">12714764</ifrs-full:EquityAndLiabilities> <ifrs-full:EquityAndLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000160" unitRef="CAD">78050210</ifrs-full:EquityAndLiabilities> <ifrs-full:ProfessionalFeesExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000166" unitRef="CAD">1113336</ifrs-full:ProfessionalFeesExpense> <ifrs-full:ProfessionalFeesExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000167" unitRef="CAD">864051</ifrs-full:ProfessionalFeesExpense> <ifrs-full:ProfessionalFeesExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000168" unitRef="CAD">772887</ifrs-full:ProfessionalFeesExpense> <ifrs-full:EmployeeBenefitsExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000170" unitRef="CAD">1811073</ifrs-full:EmployeeBenefitsExpense> <ifrs-full:EmployeeBenefitsExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000171" unitRef="CAD">1923952</ifrs-full:EmployeeBenefitsExpense> <ifrs-full:EmployeeBenefitsExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000172" unitRef="CAD">1876911</ifrs-full:EmployeeBenefitsExpense> <ifrs-full:TravelExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000174" unitRef="CAD">50120</ifrs-full:TravelExpense> <ifrs-full:TravelExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000175" unitRef="CAD">107869</ifrs-full:TravelExpense> <ifrs-full:TravelExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000176" unitRef="CAD">200995</ifrs-full:TravelExpense> <ifrs-full:DepreciationExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000178" unitRef="CAD">11166</ifrs-full:DepreciationExpense> <ifrs-full:DepreciationExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000179" unitRef="CAD">14424</ifrs-full:DepreciationExpense> <ifrs-full:DepreciationExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000180" unitRef="CAD">16638</ifrs-full:DepreciationExpense> <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000182" unitRef="CAD">182457</ifrs-full:SellingGeneralAndAdministrativeExpense> <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000183" unitRef="CAD">156686</ifrs-full:SellingGeneralAndAdministrativeExpense> <ifrs-full:SellingGeneralAndAdministrativeExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000184" unitRef="CAD">218879</ifrs-full:SellingGeneralAndAdministrativeExpense> <ifrs-full:DepreciationRightofuseAssets contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000186" unitRef="CAD">101722</ifrs-full:DepreciationRightofuseAssets> <ifrs-full:DepreciationRightofuseAssets contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000187" unitRef="CAD">106791</ifrs-full:DepreciationRightofuseAssets> <ifrs-full:DepreciationRightofuseAssets contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000188" unitRef="CAD">121479</ifrs-full:DepreciationRightofuseAssets> <ifrs-full:OccupancyExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000190" unitRef="CAD">39858</ifrs-full:OccupancyExpense> <ifrs-full:OccupancyExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000191" unitRef="CAD">42655</ifrs-full:OccupancyExpense> <ifrs-full:OccupancyExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000192" unitRef="CAD">40542</ifrs-full:OccupancyExpense> <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000194" unitRef="CAD">39502</ifrs-full:InterestExpenseOnLeaseLiabilities> <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000195" unitRef="CAD">47379</ifrs-full:InterestExpenseOnLeaseLiabilities> <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000196" unitRef="CAD">13330</ifrs-full:InterestExpenseOnLeaseLiabilities> <ifrs-full:BorrowingCostsRecognisedAsExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000198" unitRef="CAD">540709</ifrs-full:BorrowingCostsRecognisedAsExpense> <ifrs-full:BorrowingCostsRecognisedAsExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000199" unitRef="CAD">468308</ifrs-full:BorrowingCostsRecognisedAsExpense> <ifrs-full:BorrowingCostsRecognisedAsExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000200" unitRef="CAD">394371</ifrs-full:BorrowingCostsRecognisedAsExpense> <aau:ListingAndFilingFees contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000202" unitRef="CAD">193490</aau:ListingAndFilingFees> <aau:ListingAndFilingFees contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000203" unitRef="CAD">154505</aau:ListingAndFilingFees> <aau:ListingAndFilingFees contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000204" unitRef="CAD">187169</aau:ListingAndFilingFees> <ifrs-full:InsuranceExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000206" unitRef="CAD">103491</ifrs-full:InsuranceExpense> <ifrs-full:InsuranceExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000207" unitRef="CAD">96068</ifrs-full:InsuranceExpense> <ifrs-full:InsuranceExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000208" unitRef="CAD">89476</ifrs-full:InsuranceExpense> <ifrs-full:DirectorsRemunerationExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000210" unitRef="CAD">140000</ifrs-full:DirectorsRemunerationExpense> <ifrs-full:DirectorsRemunerationExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000211" unitRef="CAD">145000</ifrs-full:DirectorsRemunerationExpense> <ifrs-full:DirectorsRemunerationExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000212" unitRef="CAD">102500</ifrs-full:DirectorsRemunerationExpense> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000214" unitRef="CAD">810150</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000215" unitRef="CAD">1478100</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000216" unitRef="CAD">1870800</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <ifrs-full:ExpenseByNature contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000218" unitRef="CAD">5137074</ifrs-full:ExpenseByNature> <ifrs-full:ExpenseByNature contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000219" unitRef="CAD">5605788</ifrs-full:ExpenseByNature> <ifrs-full:ExpenseByNature contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000220" unitRef="CAD">5905977</ifrs-full:ExpenseByNature> <aau:AdministrativeServicesFees contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000226" unitRef="CAD">1422347</aau:AdministrativeServicesFees> <aau:AdministrativeServicesFees contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000227" unitRef="CAD">1376428</aau:AdministrativeServicesFees> <aau:AdministrativeServicesFees contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000228" unitRef="CAD">1382344</aau:AdministrativeServicesFees> <us-gaap:InterestIncomeOther contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000230" unitRef="CAD">370741</us-gaap:InterestIncomeOther> <us-gaap:InterestIncomeOther contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000231" unitRef="CAD">253869</us-gaap:InterestIncomeOther> <us-gaap:InterestIncomeOther contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000232" unitRef="CAD">490245</us-gaap:InterestIncomeOther> <aau:ImpairmentOfPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000235" unitRef="CAD">7441293</aau:ImpairmentOfPropertyPlantAndEquipment> <aau:ImpairmentOfExplorationAndEvaluationAssets contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000238" unitRef="CAD">63823478</aau:ImpairmentOfExplorationAndEvaluationAssets> <aau:UnrealizedGainLossOnDerivativeFinancialLiabilities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000242" unitRef="CAD">191732</aau:UnrealizedGainLossOnDerivativeFinancialLiabilities> <aau:UnrealizedGainLossOnDerivativeFinancialLiabilities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000243" unitRef="CAD">110177</aau:UnrealizedGainLossOnDerivativeFinancialLiabilities> <aau:UnrealizedGainLossOnDerivativeFinancialLiabilities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000244" unitRef="CAD">-18156</aau:UnrealizedGainLossOnDerivativeFinancialLiabilities> <aau:GainLossOnAssetsInTrust contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000246" unitRef="CAD">132895</aau:GainLossOnAssetsInTrust> <aau:GainLossOnAssetsInTrust contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000247" unitRef="CAD">-6518</aau:GainLossOnAssetsInTrust> <aau:GainLossOnAssetsInTrust contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000248" unitRef="CAD">-35775</aau:GainLossOnAssetsInTrust> <aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000250" unitRef="CAD">103700</aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable> <aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000251" unitRef="CAD">-257803</aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable> <aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000252" unitRef="CAD">11535</aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable> <aau:UnrealizedForeignExchangeGainLossOnGoldInTrust contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000254" unitRef="CAD">-24491</aau:UnrealizedForeignExchangeGainLossOnGoldInTrust> <aau:UnrealizedForeignExchangeGainLossOnGoldInTrust contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000255" unitRef="CAD">64920</aau:UnrealizedForeignExchangeGainLossOnGoldInTrust> <aau:UnrealizedForeignExchangeGainLossOnGoldInTrust contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000256" unitRef="CAD">-4011</aau:UnrealizedForeignExchangeGainLossOnGoldInTrust> <aau:UnrealizedGainOnWarrantLiabilityNote9 contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000258" unitRef="CAD">102787</aau:UnrealizedGainOnWarrantLiabilityNote9> <aau:UnrealizedGainOnWarrantLiabilityNote9 contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000259" unitRef="CAD">520503</aau:UnrealizedGainOnWarrantLiabilityNote9> <aau:UnrealizedGainOnWarrantLiabilityNote9 contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000260" unitRef="CAD">1747884</aau:UnrealizedGainOnWarrantLiabilityNote9> <aau:GainOnDebtForgiveness contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000263" unitRef="CAD">177200</aau:GainOnDebtForgiveness> <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000266" unitRef="CAD">-49599</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss> <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000267" unitRef="CAD">302930</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss> <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000268" unitRef="CAD">-22202</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss> <aau:OtherIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000270" unitRef="CAD">-61573366</aau:OtherIncomeLoss> <aau:OtherIncomeLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000271" unitRef="CAD">-4899587</aau:OtherIncomeLoss> <aau:OtherIncomeLoss contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000272" unitRef="CAD">3551864</aau:OtherIncomeLoss> <ifrs-full:ProfitLossBeforeTax contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000274" unitRef="CAD">-66710440</ifrs-full:ProfitLossBeforeTax> <ifrs-full:ProfitLossBeforeTax contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000275" unitRef="CAD">-10505375</ifrs-full:ProfitLossBeforeTax> <ifrs-full:ProfitLossBeforeTax contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000276" unitRef="CAD">-2354113</ifrs-full:ProfitLossBeforeTax> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000278" unitRef="CAD">-3090208</ifrs-full:DeferredTaxExpenseIncome> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000279" unitRef="CAD">1341185</ifrs-full:DeferredTaxExpenseIncome> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000280" unitRef="CAD">314141</ifrs-full:DeferredTaxExpenseIncome> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000282" unitRef="CAD">-63620232</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000283" unitRef="CAD">-11846560</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000284" unitRef="CAD">-2668254</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:ComprehensiveIncome contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000286" unitRef="CAD">-63620232</ifrs-full:ComprehensiveIncome> <ifrs-full:ComprehensiveIncome contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000287" unitRef="CAD">-11846560</ifrs-full:ComprehensiveIncome> <ifrs-full:ComprehensiveIncome contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000288" unitRef="CAD">-2668254</ifrs-full:ComprehensiveIncome> <ifrs-full:BasicEarningsLossPerShare contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000290" unitRef="CADPShares">-0.46</ifrs-full:BasicEarningsLossPerShare> <ifrs-full:DilutedEarningsLossPerShare contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact000292" unitRef="CADPShares">-0.46</ifrs-full:DilutedEarningsLossPerShare> <ifrs-full:BasicEarningsLossPerShare contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000294" unitRef="CADPShares">-0.09</ifrs-full:BasicEarningsLossPerShare> <ifrs-full:DilutedEarningsLossPerShare contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact000296" unitRef="CADPShares">-0.09</ifrs-full:DilutedEarningsLossPerShare> <ifrs-full:BasicEarningsLossPerShare contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact000298" unitRef="CADPShares">-0.02</ifrs-full:BasicEarningsLossPerShare> <ifrs-full:DilutedEarningsLossPerShare contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact000300" unitRef="CADPShares">-0.02</ifrs-full:DilutedEarningsLossPerShare> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000306" unitRef="CAD">-63620232</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000307" unitRef="CAD">-11846560</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000308" unitRef="CAD">-2668254</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000314" unitRef="CAD">-3090208</ifrs-full:DeferredTaxExpenseIncome> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000315" unitRef="CAD">1341185</ifrs-full:DeferredTaxExpenseIncome> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000316" unitRef="CAD">314141</ifrs-full:DeferredTaxExpenseIncome> <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000318" unitRef="CAD">11166</ifrs-full:AdjustmentsForDepreciationExpense> <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000319" unitRef="CAD">14424</ifrs-full:AdjustmentsForDepreciationExpense> <ifrs-full:AdjustmentsForDepreciationExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000320" unitRef="CAD">16638</ifrs-full:AdjustmentsForDepreciationExpense> <aau:AmortizationOfRightofuseAssets contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000322" unitRef="CAD">101722</aau:AmortizationOfRightofuseAssets> <aau:AmortizationOfRightofuseAssets contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000323" unitRef="CAD">106791</aau:AmortizationOfRightofuseAssets> <aau:AmortizationOfRightofuseAssets contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000324" unitRef="CAD">121479</aau:AmortizationOfRightofuseAssets> <aau:ImpairmentOfPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000327" unitRef="CAD">7441293</aau:ImpairmentOfPropertyPlantAndEquipment> <aau:ImpairmentOfExplorationAndEvaluationAssets contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000330" unitRef="CAD">63823478</aau:ImpairmentOfExplorationAndEvaluationAssets> <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000334" unitRef="CAD">39502</ifrs-full:InterestExpenseOnLeaseLiabilities> <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000335" unitRef="CAD">47379</ifrs-full:InterestExpenseOnLeaseLiabilities> <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000336" unitRef="CAD">13330</ifrs-full:InterestExpenseOnLeaseLiabilities> <ifrs-full:BorrowingCostsRecognisedAsExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000338" unitRef="CAD">540709</ifrs-full:BorrowingCostsRecognisedAsExpense> <ifrs-full:BorrowingCostsRecognisedAsExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000339" unitRef="CAD">468308</ifrs-full:BorrowingCostsRecognisedAsExpense> <ifrs-full:BorrowingCostsRecognisedAsExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000340" unitRef="CAD">394371</ifrs-full:BorrowingCostsRecognisedAsExpense> <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000342" unitRef="CAD">191732</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives> <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000343" unitRef="CAD">110177</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives> <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000344" unitRef="CAD">-18156</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives> <aau:GainLossOnAssetsInTrust contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000346" unitRef="CAD">132895</aau:GainLossOnAssetsInTrust> <aau:GainLossOnAssetsInTrust contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000347" unitRef="CAD">-6518</aau:GainLossOnAssetsInTrust> <aau:GainLossOnAssetsInTrust contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000348" unitRef="CAD">-35775</aau:GainLossOnAssetsInTrust> <aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000350" unitRef="CAD">103700</aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable> <aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000351" unitRef="CAD">-257803</aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable> <aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000352" unitRef="CAD">11535</aau:UnrealizedForeignExchangeGainLossOnGoldLoanPayable> <aau:UnrealizedForeignExchangeGainLossOnGoldInTrust contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000354" unitRef="CAD">-24491</aau:UnrealizedForeignExchangeGainLossOnGoldInTrust> <aau:UnrealizedForeignExchangeGainLossOnGoldInTrust contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000355" unitRef="CAD">64920</aau:UnrealizedForeignExchangeGainLossOnGoldInTrust> <aau:UnrealizedForeignExchangeGainLossOnGoldInTrust contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000356" unitRef="CAD">-4011</aau:UnrealizedForeignExchangeGainLossOnGoldInTrust> <aau:UnrealizedGainOnWarrantLiability contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000358" unitRef="CAD">102787</aau:UnrealizedGainOnWarrantLiability> <aau:UnrealizedGainOnWarrantLiability contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000359" unitRef="CAD">520503</aau:UnrealizedGainOnWarrantLiability> <aau:UnrealizedGainOnWarrantLiability contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000360" unitRef="CAD">1747884</aau:UnrealizedGainOnWarrantLiability> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000362" unitRef="CAD">810150</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000363" unitRef="CAD">1478100</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000364" unitRef="CAD">1870800</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <aau:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndPrepaidExpenses contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000370" unitRef="CAD">-194169</aau:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndPrepaidExpenses> <aau:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndPrepaidExpenses contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000371" unitRef="CAD">-103833</aau:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndPrepaidExpenses> <aau:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndPrepaidExpenses contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000372" unitRef="CAD">19370</aau:AdjustmentsForDecreaseIncreaseInTradeAccountsReceivableAndPrepaidExpenses> <aau:AdjustmentsForIncreaseDecreaseInTradeAccountsPayableAndOtherOperatingPayable contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000374" unitRef="CAD">601499</aau:AdjustmentsForIncreaseDecreaseInTradeAccountsPayableAndOtherOperatingPayable> <aau:AdjustmentsForIncreaseDecreaseInTradeAccountsPayableAndOtherOperatingPayable contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000375" unitRef="CAD">-169206</aau:AdjustmentsForIncreaseDecreaseInTradeAccountsPayableAndOtherOperatingPayable> <aau:AdjustmentsForIncreaseDecreaseInTradeAccountsPayableAndOtherOperatingPayable contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000376" unitRef="CAD">19352</aau:AdjustmentsForIncreaseDecreaseInTradeAccountsPayableAndOtherOperatingPayable> <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000378" unitRef="CAD">-1483006</ifrs-full:CashFlowsFromUsedInOperatingActivities> <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000379" unitRef="CAD">-1653398</ifrs-full:CashFlowsFromUsedInOperatingActivities> <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000380" unitRef="CAD">-1600250</ifrs-full:CashFlowsFromUsedInOperatingActivities> <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000386" unitRef="CAD">2037</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities> <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000387" unitRef="CAD">47056</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities> <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000388" unitRef="CAD">10505</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities> <ifrs-full:PurchaseOfExplorationAndEvaluationAssets contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000390" unitRef="CAD">799253</ifrs-full:PurchaseOfExplorationAndEvaluationAssets> <ifrs-full:PurchaseOfExplorationAndEvaluationAssets contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000391" unitRef="CAD">1681790</ifrs-full:PurchaseOfExplorationAndEvaluationAssets> <ifrs-full:PurchaseOfExplorationAndEvaluationAssets contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000392" unitRef="CAD">2784645</ifrs-full:PurchaseOfExplorationAndEvaluationAssets> <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000394" unitRef="CAD">-801290</ifrs-full:CashFlowsFromUsedInInvestingActivities> <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000395" unitRef="CAD">-1728846</ifrs-full:CashFlowsFromUsedInInvestingActivities> <ifrs-full:CashFlowsFromUsedInInvestingActivities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000396" unitRef="CAD">-2795150</ifrs-full:CashFlowsFromUsedInInvestingActivities> <ifrs-full:ProceedsFromIssuingShares contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000404" unitRef="CAD">11610581</ifrs-full:ProceedsFromIssuingShares> <ifrs-full:ProceedsFromExerciseOfOptions contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000408" unitRef="CAD">564750</ifrs-full:ProceedsFromExerciseOfOptions> <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000410" unitRef="CAD">127797</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities> <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000411" unitRef="CAD">130056</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities> <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000412" unitRef="CAD">144253</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities> <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000414" unitRef="CAD">-127797</ifrs-full:CashFlowsFromUsedInFinancingActivities> <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000415" unitRef="CAD">-130056</ifrs-full:CashFlowsFromUsedInFinancingActivities> <ifrs-full:CashFlowsFromUsedInFinancingActivities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000416" unitRef="CAD">12031078</ifrs-full:CashFlowsFromUsedInFinancingActivities> <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000418" unitRef="CAD">-2412093</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents> <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000419" unitRef="CAD">-3512300</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents> <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000420" unitRef="CAD">7635678</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2022-12-31" decimals="0" id="Fact000422" unitRef="CAD">6658076</ifrs-full:CashAndCashEquivalents> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2021-12-31" decimals="0" id="Fact000423" unitRef="CAD">10170376</ifrs-full:CashAndCashEquivalents> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="0" id="Fact000424" unitRef="CAD">2534698</ifrs-full:CashAndCashEquivalents> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2023-12-31" decimals="0" id="Fact000426" unitRef="CAD">4245983</ifrs-full:CashAndCashEquivalents> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2022-12-31" decimals="0" id="Fact000427" unitRef="CAD">6658076</ifrs-full:CashAndCashEquivalents> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2021-12-31" decimals="0" id="Fact000428" unitRef="CAD">10170376</ifrs-full:CashAndCashEquivalents> <aau:EquitySharesOutstanding contextRef="AsOf2020-12-31_ifrs-full_IssuedCapitalMember" decimals="INF" id="Fact000437" unitRef="Shares">120650254</aau:EquitySharesOutstanding> <ifrs-full:Equity contextRef="AsOf2020-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000430" unitRef="CAD">131189978</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000431" unitRef="CAD">18528024</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2020-12-31_ifrs-full_WarrantsMember" decimals="0" id="Fact000432" unitRef="CAD">715968</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2020-12-31_custom_TotalReservesMember" decimals="0" id="Fact000433" unitRef="CAD">19243992</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2020-12-31_custom_DeficitMember" decimals="0" id="Fact000434" unitRef="CAD">-79256536</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2020-12-31" decimals="0" id="Fact000435" unitRef="CAD">71177434</ifrs-full:Equity> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000440" unitRef="CAD">1870800</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2021-01-012021-12-31_custom_TotalReservesMember" decimals="0" id="Fact000442" unitRef="CAD">1870800</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000444" unitRef="CAD">1870800</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <aau:PrivatePlacementsNetOfShareIssueCostsShares contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" decimals="INF" id="Fact000453" unitRef="Shares">15846154</aau:PrivatePlacementsNetOfShareIssueCostsShares> <aau:PrivatePlacementsNetOfShareIssueCosts contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000446" unitRef="CAD">11610581</aau:PrivatePlacementsNetOfShareIssueCosts> <aau:PrivatePlacementsNetOfShareIssueCosts contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000451" unitRef="CAD">11610581</aau:PrivatePlacementsNetOfShareIssueCosts> <aau:WarrantLiabilities contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000455" unitRef="CAD">-2371174</aau:WarrantLiabilities> <aau:WarrantLiabilities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000460" unitRef="CAD">-2371174</aau:WarrantLiabilities> <aau:FindersWarrantsIssuedPursuantToPrivatePlacement contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000462" unitRef="CAD">-130731</aau:FindersWarrantsIssuedPursuantToPrivatePlacement> <aau:FindersWarrantsIssuedPursuantToPrivatePlacement contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000463" unitRef="CAD">130731</aau:FindersWarrantsIssuedPursuantToPrivatePlacement> <aau:FindersWarrantsIssuedPursuantToPrivatePlacement contextRef="From2021-01-012021-12-31_custom_TotalReservesMember" decimals="0" id="Fact000465" unitRef="CAD">130731</aau:FindersWarrantsIssuedPursuantToPrivatePlacement> <aau:SharesIssuedForCashOnExerciseOfStockOptionsInShares contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" decimals="INF" id="Fact000476" unitRef="Shares">725000</aau:SharesIssuedForCashOnExerciseOfStockOptionsInShares> <aau:SharesIssuedForCashOnExerciseOfStockOptions contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000469" unitRef="CAD">564750</aau:SharesIssuedForCashOnExerciseOfStockOptions> <aau:SharesIssuedForCashOnExerciseOfStockOptions contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000474" unitRef="CAD">564750</aau:SharesIssuedForCashOnExerciseOfStockOptions> <ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000478" unitRef="CAD">177250</ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments> <ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000479" unitRef="CAD">-177250</ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments> <ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments contextRef="From2021-01-012021-12-31_custom_TotalReservesMember" decimals="0" id="Fact000481" unitRef="CAD">-177250</ifrs-full:IncreaseDecreaseInFairValueMeasurementEntitysOwnEquityInstruments> <ifrs-full:ComprehensiveIncome contextRef="From2021-01-012021-12-31_custom_DeficitMember" decimals="0" id="Fact000489" unitRef="CAD">-2668254</ifrs-full:ComprehensiveIncome> <ifrs-full:ComprehensiveIncome contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000490" unitRef="CAD">-2668254</ifrs-full:ComprehensiveIncome> <aau:EquitySharesOutstanding contextRef="AsOf2021-12-31_ifrs-full_IssuedCapitalMember" decimals="INF" id="Fact000499" unitRef="Shares">137221408</aau:EquitySharesOutstanding> <ifrs-full:Equity contextRef="AsOf2021-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000492" unitRef="CAD">141040654</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000493" unitRef="CAD">20352305</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2021-12-31_ifrs-full_WarrantsMember" decimals="0" id="Fact000494" unitRef="CAD">715968</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2021-12-31_custom_TotalReservesMember" decimals="0" id="Fact000495" unitRef="CAD">21068273</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2021-12-31_custom_DeficitMember" decimals="0" id="Fact000496" unitRef="CAD">-81924790</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2021-12-31" decimals="0" id="Fact000497" unitRef="CAD">80184137</ifrs-full:Equity> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2022-01-012022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000502" unitRef="CAD">1478100</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2022-01-012022-12-31_custom_TotalReservesMember" decimals="0" id="Fact000504" unitRef="CAD">1478100</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000506" unitRef="CAD">1478100</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <ifrs-full:ComprehensiveIncome contextRef="From2022-01-012022-12-31_custom_DeficitMember" decimals="0" id="Fact000512" unitRef="CAD">-11846560</ifrs-full:ComprehensiveIncome> <ifrs-full:ComprehensiveIncome contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000513" unitRef="CAD">-11846560</ifrs-full:ComprehensiveIncome> <aau:EquitySharesOutstanding contextRef="AsOf2022-12-31_ifrs-full_IssuedCapitalMember" decimals="INF" id="Fact000522" unitRef="Shares">137221408</aau:EquitySharesOutstanding> <ifrs-full:Equity contextRef="AsOf2022-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000515" unitRef="CAD">141040654</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2022-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000516" unitRef="CAD">21830405</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2022-12-31_ifrs-full_WarrantsMember" decimals="0" id="Fact000517" unitRef="CAD">715968</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2022-12-31_custom_TotalReservesMember" decimals="0" id="Fact000518" unitRef="CAD">22546373</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2022-12-31_custom_DeficitMember" decimals="0" id="Fact000519" unitRef="CAD">-93771350</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2022-12-31" decimals="0" id="Fact000520" unitRef="CAD">69815677</ifrs-full:Equity> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2023-01-012023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000525" unitRef="CAD">810150</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2023-01-012023-12-31_custom_TotalReservesMember" decimals="0" id="Fact000527" unitRef="CAD">810150</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000529" unitRef="CAD">810150</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions> <ifrs-full:ComprehensiveIncome contextRef="From2023-01-012023-12-31_custom_DeficitMember" decimals="0" id="Fact000535" unitRef="CAD">-63620232</ifrs-full:ComprehensiveIncome> <ifrs-full:ComprehensiveIncome contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000536" unitRef="CAD">-63620232</ifrs-full:ComprehensiveIncome> <aau:EquitySharesOutstanding contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember" decimals="INF" id="Fact000545" unitRef="Shares">137221408</aau:EquitySharesOutstanding> <ifrs-full:Equity contextRef="AsOf2023-12-31_ifrs-full_IssuedCapitalMember" decimals="0" id="Fact000538" unitRef="CAD">141040654</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2023-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" decimals="0" id="Fact000539" unitRef="CAD">22640555</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2023-12-31_ifrs-full_WarrantsMember" decimals="0" id="Fact000540" unitRef="CAD">715968</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2023-12-31_custom_TotalReservesMember" decimals="0" id="Fact000541" unitRef="CAD">23356523</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2023-12-31_custom_DeficitMember" decimals="0" id="Fact000542" unitRef="CAD">-157391582</ifrs-full:Equity> <ifrs-full:Equity contextRef="AsOf2023-12-31" decimals="0" id="Fact000543" unitRef="CAD">7005595</ifrs-full:Equity> <ifrs-full:DisclosureOfBasisOfConsolidationExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000547">&lt;p id="xdx_805_eifrs-full--DisclosureOfBasisOfConsolidationExplanatory_zcEPMwFG0vFl" style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;1.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="a_006"&gt;&lt;/span&gt;&lt;span id="xdx_825_zJaxyP5ix0g9"&gt;Nature of operations&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Almaden Minerals Ltd. (the &#x201c;Company&#x201d; or &#x201c;Almaden&#x201d;) was formed by amalgamation under the laws of the Province of British Columbia, Canada on February 1, 2002. The Company is an advanced exploration stage public company that is engaged directly in the exploration and development of exploration and evaluation property in Mexico. The Company&#x2019;s shares are trade on the TSX Exchange under the symbol &#x201c;AMM&#x201d;. The address of the Company&#x2019;s registered office is Suite 1710 &#x2013;1177 West Hastings Street, Vancouver, BC, Canada V6E 2L3.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company is in the business of exploring and developing mineral projects and its principal asset is the Ixtaca precious metals project located on its Tuligtic claim in Mexico. The Company has not yet determined whether this project has economically recoverable mineral reserves. The recoverability of amounts shown for mineral properties is dependent upon the establishment of a sufficient quantity of economically recoverable reserves, the ability of the Company to obtain the necessary financing or participation of joint venture partners to complete development of the properties, and upon future profitable production or proceeds from the disposition of exploration and evaluation assets.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;These consolidated financial statements were prepared on a &#x201c;going concern&#x201d; basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. As of December 31, 2023, the Company had a working capital surplus of $&lt;span id="xdx_90A_eifrs-full--IncreaseDecreaseInWorkingCapital_c20230101__20231231_z9pCuyCEPDlj" title="Working capital surplus"&gt;4,830,735&lt;/span&gt; (2022 &#x2013; $&lt;span id="xdx_904_eifrs-full--IncreaseDecreaseInWorkingCapital_c20220101__20221231_zUQGBt500IXa" title="Working capital surplus"&gt;7,463,140&lt;/span&gt;). The Company does not currently hold any revenue-generating properties and therefore continues to incur losses. The Company incurred a net loss for the year ended December 31, 2023, of $&lt;span id="xdx_90B_eifrs-full--ProfitLossFromContinuingOperations_iN_di_c20230101__20231231_zFMjUU2S9VLl" title="Net loss"&gt;63,620,232&lt;/span&gt; (2022 &#x2013; $&lt;span id="xdx_90F_eifrs-full--ProfitLossFromContinuingOperations_iN_di_c20220101__20221231_zjURgeb0sZBk" title="Net loss"&gt;11,846,560&lt;/span&gt;) and negative cash flows from operations of $&lt;span id="xdx_903_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_di_c20230101__20231231_z7tYW6JORCbg" title="Negative cash flows from operations"&gt;1,483,006&lt;/span&gt; for the year ended December 31, 2023 (2022 &#x2013; $&lt;span id="xdx_90A_eifrs-full--CashFlowsFromUsedInOperatingActivities_iN_di_c20220101__20221231_zjy0RFGjbsCb" title="Negative cash flows from operations"&gt;1,653,398&lt;/span&gt;). As at December 31, 2023, the Company had an accumulated deficit of $&lt;span id="xdx_905_eifrs-full--RetainedEarnings_iNI_di_c20231231_z7LGDpvyuXb1" title="Accumulated deficit"&gt;157,391,582&lt;/span&gt; (2022 &#x2013; $&lt;span id="xdx_902_eifrs-full--RetainedEarnings_iNI_di_c20221231_zOTPFHTmP4U2" title="Accumulated deficit"&gt;93,771,350&lt;/span&gt;). The Company&#x2019;s ability to continue as a going concern is dependent upon its ability in the future to achieve profitable operations and in the meantime, to obtain the necessary financing to repay its liabilities when they become due. Management estimates that there is sufficient working capital to sustain operations for the next twelve months. External financing will be sought to finance the operations of the Company and enable the Company to continue its efforts towards the exploration and development of its mineral properties. There can be no assurance that steps management is taking will be successful. These consolidated financial statements do not include adjustments to the amounts and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern and such adjustments could be material.&lt;/p&gt; </ifrs-full:DisclosureOfBasisOfConsolidationExplanatory> <ifrs-full:IncreaseDecreaseInWorkingCapital contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000549" unitRef="CAD">4830735</ifrs-full:IncreaseDecreaseInWorkingCapital> <ifrs-full:IncreaseDecreaseInWorkingCapital contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000551" unitRef="CAD">7463140</ifrs-full:IncreaseDecreaseInWorkingCapital> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000553" unitRef="CAD">-63620232</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000555" unitRef="CAD">-11846560</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000557" unitRef="CAD">-1483006</ifrs-full:CashFlowsFromUsedInOperatingActivities> <ifrs-full:CashFlowsFromUsedInOperatingActivities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000559" unitRef="CAD">-1653398</ifrs-full:CashFlowsFromUsedInOperatingActivities> <ifrs-full:RetainedEarnings contextRef="AsOf2023-12-31" decimals="0" id="Fact000561" unitRef="CAD">-157391582</ifrs-full:RetainedEarnings> <ifrs-full:RetainedEarnings contextRef="AsOf2022-12-31" decimals="0" id="Fact000563" unitRef="CAD">-93771350</ifrs-full:RetainedEarnings> <aau:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanator contextRef="From2023-01-01to2023-12-31" id="Fact000565">&lt;p id="xdx_809_ecustom--DisclosureOfBasisOfPreparationOfFinancialStatementsExplanator_zY2OZf73doP8" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;2.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_828_zs2jhooDLic5"&gt;Basis of presentation&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Statement of Compliance with International Financial Reporting Standards (&#x201c;IFRS&#x201d;)&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;These consolidated financial statements have been prepared in accordance and compliance with IFRS Accounting standards as issued by the International Accounting Standards Board (&#x201c;IASB&#x201d;).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Basis of preparation &lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;These consolidated financial statements have been prepared on a historical cost basis except for the revaluation of certain financial assets and financial liabilities at fair value through profit or loss. In addition, these financial statements have been prepared using the accrual basis of accounting, except for cash flow information.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;These consolidated financial statements, including comparatives, have been prepared on the basis of IFRS standards that are effective as at December 31, 2023.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 22.7pt; font-size: 10pt; text-align: justify; text-indent: 11.35pt"&gt;&lt;i&gt;(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Functional currency&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The functional and reporting currency of the Company and its subsidiaries is the Canadian dollar.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 22.7pt; font-size: 10pt; text-align: justify; text-indent: 11.35pt"&gt;&lt;i&gt;(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Significant accounting judgments and estimates&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The preparation of these consolidated financial statements requires management to make judgements and estimates that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. Actual outcomes could differ from these judgements and estimates. The consolidated financial statements include judgements and estimates which, by their nature, are uncertain. The impacts of such judgements and estimates are pervasive throughout the consolidated financial statements, and may require accounting adjustments based on future occurrences. Revisions to accounting estimates are recognized in the period in which the estimate is revised and the revision affects both current and future periods.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Significant assumptions about the future and other sources of judgements and estimates that management has made at the statement of financial position dates, that could result in a material adjustment to the carrying amounts of assets and liabilities, in the event that actual results differ from assumptions made, relate to, but are not limited to, the following:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 10.9pt"&gt;&lt;span style="text-decoration: underline"&gt;Critical Judgments&lt;/span&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 22.7pt; font-size: 10pt; text-align: justify; text-indent: 11.35pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;The analysis of the functional currency for each entity of the Company determined by conducting an analysis of the consideration factors identified in IAS 21, &#x201c;The Effect of Changes in Foreign Exchange Rates&#x201d;. In concluding that the Canadian dollar is the functional currency of the parent and its subsidiary companies, management considered the currency that mainly influences the cost of providing goods and services in each jurisdiction in which the Company operates. As no single currency was clearly dominant, the Company also considered secondary indicators including the currency in which funds from financing activities are denominated and the currency in which funds are retained.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1.25in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 10.9pt"&gt;&lt;span style="text-decoration: underline"&gt;Going Concern&lt;/span&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 10.9pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;Management makes an assessment about the Company&#x2019;s ability to continue as a going concern by taking into the account the consideration of the various factors discussed in Note 1. Judgement is applied by management in determining whether or not the elements giving rise to factors that cause doubt about the ability of the Company to continue as a going concern are present.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 10.9pt"&gt;&lt;span style="text-decoration: underline"&gt;Estimates&lt;/span&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;The estimated useful lives of property, plant and equipment which are included in the consolidated statements of financial position and the related depreciation included in profit or loss;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;The recoverability of the value of the exploration and evaluation assets which is recorded in the consolidated statements of financial position (Note 3(f));&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company uses the Black-Scholes option pricing model to determine the fair value of options, warrants, and derivative financial liabilities in order to calculate share-based payments expense, warrant liability and the fair value of finders&#x2019; warrants and stock options. Certain inputs into the model are estimates that involve considerable judgment or could be affected by significant factors that are out of the Company&#x2019;s control;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;The provision for income taxes which is included in profit or loss and the composition of deferred income tax liability included in the consolidated statement of financial position and the evaluation of the recoverability of deferred tax assets based on an assessment of the Company&#x2019;s ability to utilize the underlying future tax deductions against future taxable income prior to expiry of those deductions;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;The assessment of indications of impairment of each exploration and evaluation asset and property plant and equipment and related determination of the net realizable value and write-down of those assets where applicable (Note 3(f));&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;The estimated incremental borrowing rate used to calculate the lease liabilities; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 1in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;o&lt;/td&gt;&lt;td style="text-align: justify"&gt;The estimated fair value of gold in trust.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </aau:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanator> <aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000577">&lt;p id="xdx_802_ecustom--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_zXzgxDByLHHi" style="margin: 0pt 0 0pt 89.85pt; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;3.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82B_zDhD580GkIo"&gt;Material accounting policies&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_841_ecustom--DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock_zfWXF4ZibZV8" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;(&lt;i&gt;a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_zN8l1k0PWxud"&gt;Basis of consolidation&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureOfConsolidatedFinancialStatementTextBlock_zB4FL5SjSyW7" style="width: 100%; border-collapse: collapse; font-size: 10pt" summary="xdx: Disclosure - Material accounting policies (Details)"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span id="xdx_8B4_zjxPLT7J6Uck" style="display: none"&gt;Schedule of consolidated financial statements&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 5%; padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 52%; padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 14%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 2%; padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 32%; padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Nature of operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--EntityName_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zel40f15nvYi" title="Entity name"&gt;Puebla Holdings Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--Jurisdiction_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zRRRBp8ZDsRf" title="Jurisdiction"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NatureOfOperation_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zU4ObOiXtohf" title="Nature of operations"&gt;Holding company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--EntityName_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zyL5Y5VPLdK9" title="Entity name"&gt;Minera Gorrion, S.A. de C.V.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Jurisdiction_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zehdfUxOEh4e" title="Jurisdiction"&gt;Mexico&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NatureOfOperation_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zmY8sw34YaW4" title="Nature of operations"&gt;Exploration company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Inter-company balances and transactions, including unrealized income and expenses arising from inter-company transactions, are eliminated in preparing these consolidated financial statements.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zoTR6AJWvrC3" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_861_zLwvV5eApXNh"&gt;Foreign currencies&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Transactions in currencies other than the functional currency are recorded at the rates of exchange prevailing on the transaction dates. At each financial position reporting date, monetary assets and liabilities that are denominated in foreign currencies are translated at the rates prevailing at the date of the statement of financial position. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zSvbin4aFbCe" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_862_zDAdsgpAmwyf"&gt;Financial instruments&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;A financial asset is classified as measured at: amortized cost, fair value through other comprehensive income (FVOCI), or fair value through profit or loss (FVTPL). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. Derivatives embedded in contracts where the host is a financial asset in the scope of the standard are never separated. Instead, the hybrid financial instrument as a whole is assessed for classification. The Company's financial assets consist primarily of cash and cash equivalents, and accounts receivable and are classified at amortized cost.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 56.7pt; font-size: 10pt; text-indent: -21.25pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Financial liabilities comprise the Company&#x2019;s trade and other payables. Financial liabilities are initially recognized on the date they are originated and are derecognized when the contractual obligations are discharged or cancelled or expire. Trade and other payables are recognized initially at fair value and subsequent are measured at amortized costs using the effective interest method, when materially different from the initial amount. Derivative financial liabilities are classified as FVTPL. Fair value is determined based on the present value of future cash flow, discounted at the market rate of interest.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 55.95pt; font-size: 10pt; text-align: justify; text-indent: -0.25in"&gt;&lt;i&gt;(i)&#160;&#160;&#160;&#160; Impairment of financial assets&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;An &#x2018;expected credit loss&#x2019; (ECL) model applies to financial assets measured at amortized cost, contract assets and debt investments at FVOCI, but not to investments in equity instruments. The Company's financial assets measured at amortized cost and subject to the ECL model include cash and cash equivalents, and accounts receivable.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 55.95pt; font-size: 10pt; text-align: justify; text-indent: -0.25in"&gt;&lt;i&gt;(ii)&#160;&#160;&#160; Embedded derivatives&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Derivatives may be embedded in other financial instruments (the &#x201c;host instrument&#x201d;). Embedded derivatives are treated as separate derivatives when their economic characteristics and risks are not clearly and closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the combined contract is not held for trading or designated at fair value. These embedded derivatives are measured at fair value with subsequent changes recognized in profit or loss.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company issues warrants exercisable in a currency other than the Company&#x2019;s functional currency and as a result, the warrants are derivative financial instruments.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zPDMx3aevBY1" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt; &lt;i&gt;(d)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_862_zPgoRrxZPmr9"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Cash equivalents include term deposits and money market instruments which are readily convertible into cash or have maturities at the date of purchase of less than ninety days.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zivnVh4Cyj4l" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt; &lt;i&gt;(e)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_868_z0ua9Q4T1s3l"&gt;Property, plant and equipment&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, and are depreciated annually on a declining-balance basis if available-for-use at the following rates:&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock_z0fC8DOUBqof" style="width: 100%; border-collapse: collapse; font-size: 10pt" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span id="xdx_8B3_zm4UcBBJyfJc" style="display: none"&gt;Schedule of property, plant and equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 9%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 47%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Furniture, fixtures and other&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 53%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_znxoDKCmIRw5" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zeDyBbxEX663" title="Property, plant and equipment"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Geological library&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z0Nz0kyqyrx7" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Field equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zPnqkseeNcQd" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Mill equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z0mkJsrDPBS7" title="Property, plant and equipment"&gt;Straight line over mine life (11 years)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures_zqAFbeLaETC5" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86F_zk992ffWZ3y7"&gt;Exploration and evaluation assets&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company is in the advanced exploration stage with respect to its investment in exploration and evaluation assets and, accordingly, follows the practice of capitalizing all costs relating to the acquisition of, exploration for and development of mineral claims to which the Company has rights and crediting all proceeds received from farm-out arrangements or recovery of costs against the cost of the related claims. Acquisition costs include, but are not exclusive to land surface rights acquired. Deferred exploration costs include, but are not exclusive to geological, geophysical studies, annual mining taxes, exploratory drilling and sampling. At such time as commercial production commences, these costs will be charged to profit or loss on a unit-of-production method based on proven and probable reserves. The aggregate costs related to abandoned mineral claims are charged to profit or loss at the time of any abandonment or when it has been determined that there is evidence of an impairment.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company considers the following facts and circumstances in determining if it should test exploration and evaluation assets for impairment:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;the period for which the Company has the right to explore in the specific area has expired during the period or will expire in the near future, and is not expected to be renewed;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 68.6pt; font-size: 10pt; text-align: justify; text-indent: -19.6pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;substantive expenditure on further exploration for and evaluation of mineral resources in the specific area is neither budgeted nor planned;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 78pt; font-size: 10pt; text-indent: -22.6pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;exploration for and evaluation of mineral resources in the specific area have not led to the discovery of commercially viable quantities of mineral resources and the entity has decided to discontinue such activities in the specific area; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 68.6pt; font-size: 10pt; text-indent: -22.6pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(iv)&lt;/td&gt;&lt;td style="text-align: justify"&gt;sufficient data exists to indicate that, although a development in the specific area is likely to proceed, the carrying amount of the exploration and evaluation assets is unlikely to be recovered in full from successful development or by sale.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;An impairment charge may be reversed but only to the extent that this does not exceed the original carrying value of the property that would have resulted if no impairment had been recognized. General exploration costs in areas of interest in which the Company has not secured rights are expensed as incurred.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The recoverability of amounts shown for exploration and evaluation assets is dependent upon the discovery of economically recoverable reserves, the ability of the Company to obtain financing to complete development of the properties, and on future production or proceeds of disposition.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company recognizes in profit or loss costs recovered on exploration and evaluation assets when amounts received or receivable are in excess of the carrying amount.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;Once the technical feasibility and commercial viability of the extraction of mineral resources in an area of interest are demonstrable, exploration and evaluation assets attributable to that area of interest are first tested for impairment and then reclassified to development asset within property, plant and equipment.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;All capitalized exploration and evaluation expenditures are monitored for indications of impairment.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Where a potential impairment is indicated, assessments are performed for each area of interest. To the extent that exploration expenditure is not expected to be recovered, it is charged to profit or loss. Exploration areas where reserves have been discovered, but require major capital expenditure before production can begin, are continually evaluated to ensure that commercial quantities of reserves exist or to ensure that additional exploration work is underway as planned.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_zzi8n7pnheu" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt; &lt;i&gt;(g)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_867_zGS25akS9gA2"&gt;Impairment of property, plant and equipment&lt;/span&gt; &lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-indent: -36.55pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Property, plant and equipment are reviewed for impairment at least annually, or if there is any indication that the carrying amount may not be recoverable. If any such indication is present, the recoverable amount of the asset is estimated in order to determine whether impairment exists. Where the asset does not generate cash flows that are independent from other assets, the Company estimates the recoverable amount of the cash generating unit to which the asset belongs.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;An asset&#x2019;s recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value, using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which estimates of future cash flows have not been adjusted.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;If the recoverable amount of an asset or cash generating unit is estimated to be less than its carrying amount, the carrying amount is reduced to the recoverable amount by way of recording an impairment charge to profit or loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously been recognized.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zeKsFWc0oCyh" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_zkf8xvoQaJbj"&gt;Income taxes&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Income tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to items recognized directly in equity or in other comprehensive income.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted at the reporting date, and any adjustment to tax payable in respect of previous years.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss, and differences relating to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zCvnS8Kdlq3l" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86C_zpYHDCQOi1Bi"&gt;Share-based payments&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.4pt"&gt;The Company&#x2019;s stock option plan allows Company employees, directors, officers and consultants to acquire shares of the Company. The fair value of options granted is recognized as share-based payment expense with a corresponding increase in equity reserves. An individual is classified as an employee when the individual is an employee for legal or tax purposes (direct employee) or provides services similar to those performed by a direct employee&lt;span style="color: black"&gt;.&lt;/span&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.4pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Fair value is measured at grant date, and each tranche is recognized using the graded vesting method over the period during which the options vest. The fair value of the options granted is measured using the Black-Scholes option-pricing model, taking into account the terms and conditions upon which the options were granted. At each financial position reporting date, the amount recognized as an expense is adjusted to reflect the actual number of stock options that are expected to vest. In situations where equity instruments are issued to consultants and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForCapitalSharesTextBlock_ztGzff0bOXMh" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_861_zOpg4igS5BEf"&gt;Share capital&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Proceeds from the exercise of stock options and warrants are recorded as share capital in the amount for which the option or warrant enabled the holder to purchase a share in the Company, in addition to the proportionate amount of reserves originally created at the issuance of the stock options or warrants. Share capital issued for non-monetary consideration is valued at the closing market price at the date of issuance. The proceeds from the issuance of units are allocated between common shares and common share purchase warrants based on the residual value method. Under this method, the proceeds are allocated to common shares based on the fair value of a common share at the announcement date of the unit offering and any residual remaining is allocated to common share purchase warrants.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Certain of the Company&#x2019;s warrants are exercisable in a currency other than the functional currency of the Company. As a result, the fair value allocated to the warrant is recorded as a derivative financial liability with residual value being attributed to the equity unit. The fair value of the warrant is determined using the Black-Scholes Option Pricing Model and is marked to market at the end of each period. Upon exercise of the warrant, the fair value of the warrant at the date of exercise is transferred to share capital.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p id="xdx_84E_ecustom--DescriptionOfAccountingPolicyForReclamationAndClosureCostObligationsTextBlock_zykRx7qLLMg" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt; &lt;i&gt;(k)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_868_zjnxrWdmmYY3"&gt;Reclamation and closure cost obligations&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Decommissioning and restoration provisions are recorded when a present legal or constructive obligation exists as a result of past events where it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation and discount rates. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows discounted for the market discount rate.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Over time, the discounted liability is increased for the changes in the present value based on the current market discount rates and liability risks. When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount receivable can be measured reliably.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;When the Company enters into an option agreement on its exploration and evaluations assets, as part of the option agreement, responsibility for any reclamation and remediation becomes the responsibility of the optionee.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_z2o7vGsrJfCk" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_zpaOkNqhaFJi"&gt;Net loss per share&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company presents the basic and diluted net loss per share data for its common shares, calculated by dividing the loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net loss per share is determined by adjusting the net loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all dilutive potential common shares (Note 12).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zC4khRDXeYa" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86E_zObEIzAEQfEe"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether the right to obtain substantially all of the economic benefits from use of the asset during the term of the arrangement exists, and if the Company has the right to direct the use of the asset. At inception or on reassessment of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of their relative standalone prices.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;As a lessee, the Company recognizes a right-of-use asset and a lease liability at the commencement date of a lease. The right-of-use asset is initially measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The right-of-use asset is subsequently depreciated using the straight line method from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. In addition, the right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by the interest rate implicit in the lease, or if that rate cannot be readily determined, the incremental borrowing rate. Lease payments included in the measurement of the lease liability are comprised of:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;fixed payments, including in-substance fixed payments, less any lease incentives receivable;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;amounts expected to be payable under a residual value guarantee;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;exercise prices of purchase options if the Company is reasonably certain to exercise that option; and&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease.&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if there is a change in the estimate or assessment of the expected amount payable under a residual value guarantee, purchase, extension or termination option. Variable lease payments not included in the initial measurement of the lease liability are charged directly to profit or loss.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments associated with these leases are charged directly to profit or loss on a straight-line basis over the lease term.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForNewAndRevisedAccountingStandardsEffectiveAtTheBeggingOfTheYear_zMcxCW51yPTj" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(n)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_861_zq36k72fJK59"&gt;Standards issued or amended but not yet effective&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company has not applied the following revised IFRS that has been issued but was not yet effective at December 31, 2023. This accounting standard is not currently expected to have a significant effect on the Company&#x2019;s accounting policies or financial statements.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;IAS 1 &#x2013;Presentation of Financial Statements (&#x201c;IAS 1&#x201d;) was amended in January 2020 to provide a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments clarify that the classification of liabilities as current or noncurrent is based solely on a company&#x2019;s right to defer settlement at the reporting date. The right needs to be unconditional and must have substance. The amendments also clarify that the transfer of a company&#x2019;s own equity instruments is regarded as settlement of a liability, unless it results from the exercise of a conversion option meeting the definition of an equity instrument. These amendments were further revised by the issuance of Non-current Liabilities with Covenants (Amendments to IAS 1) on October 31, 2022 which further narrowed the scope of the amendments. The amendments are effective for annual periods beginning on January 1, 2024.&lt;/p&gt; </aau:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory> <aau:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000579">&lt;p id="xdx_841_ecustom--DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock_zfWXF4ZibZV8" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;(&lt;i&gt;a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_zN8l1k0PWxud"&gt;Basis of consolidation&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;These consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureOfConsolidatedFinancialStatementTextBlock_zB4FL5SjSyW7" style="width: 100%; border-collapse: collapse; font-size: 10pt" summary="xdx: Disclosure - Material accounting policies (Details)"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span id="xdx_8B4_zjxPLT7J6Uck" style="display: none"&gt;Schedule of consolidated financial statements&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 5%; padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 52%; padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 14%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 2%; padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 32%; padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Nature of operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--EntityName_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zel40f15nvYi" title="Entity name"&gt;Puebla Holdings Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--Jurisdiction_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zRRRBp8ZDsRf" title="Jurisdiction"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NatureOfOperation_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zU4ObOiXtohf" title="Nature of operations"&gt;Holding company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--EntityName_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zyL5Y5VPLdK9" title="Entity name"&gt;Minera Gorrion, S.A. de C.V.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Jurisdiction_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zehdfUxOEh4e" title="Jurisdiction"&gt;Mexico&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NatureOfOperation_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zmY8sw34YaW4" title="Nature of operations"&gt;Exploration company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Inter-company balances and transactions, including unrealized income and expenses arising from inter-company transactions, are eliminated in preparing these consolidated financial statements.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; </aau:DescriptionOfAccountingPolicyForBasisOfConsolidationTextBlock> <aau:DisclosureOfConsolidatedFinancialStatementTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000581">&lt;table cellpadding="0" cellspacing="0" id="xdx_88C_ecustom--DisclosureOfConsolidatedFinancialStatementTextBlock_zB4FL5SjSyW7" style="width: 100%; border-collapse: collapse; font-size: 10pt" summary="xdx: Disclosure - Material accounting policies (Details)"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span id="xdx_8B4_zjxPLT7J6Uck" style="display: none"&gt;Schedule of consolidated financial statements&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 5%; padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 52%; padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 14%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 2%; padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 32%; padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Nature of operations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--EntityName_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zel40f15nvYi" title="Entity name"&gt;Puebla Holdings Inc.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--Jurisdiction_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zRRRBp8ZDsRf" title="Jurisdiction"&gt;Canada&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NatureOfOperation_c20230101__20231231__dei--LegalEntityAxis__custom--PueblaHoldingsIncMember_zU4ObOiXtohf" title="Nature of operations"&gt;Holding company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 6.6pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--EntityName_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zyL5Y5VPLdK9" title="Entity name"&gt;Minera Gorrion, S.A. de C.V.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--Jurisdiction_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zehdfUxOEh4e" title="Jurisdiction"&gt;Mexico&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-left: 0.5in; layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="padding-left: 5.95pt; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NatureOfOperation_c20230101__20231231__dei--LegalEntityAxis__custom--MineraGorrionSAdeCVMember_zmY8sw34YaW4" title="Nature of operations"&gt;Exploration company&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aau:DisclosureOfConsolidatedFinancialStatementTextBlock> <aau:EntityName contextRef="From2023-01-012023-12-31_custom_PueblaHoldingsIncMember" id="Fact000583">Puebla Holdings Inc.</aau:EntityName> <aau:Jurisdiction contextRef="From2023-01-012023-12-31_custom_PueblaHoldingsIncMember" id="Fact000585">Canada</aau:Jurisdiction> <aau:NatureOfOperation contextRef="From2023-01-012023-12-31_custom_PueblaHoldingsIncMember" id="Fact000587">Holding company</aau:NatureOfOperation> <aau:EntityName contextRef="From2023-01-012023-12-31_custom_MineraGorrionSAdeCVMember" id="Fact000589">Minera Gorrion, S.A. de C.V.</aau:EntityName> <aau:Jurisdiction contextRef="From2023-01-012023-12-31_custom_MineraGorrionSAdeCVMember" id="Fact000591">Mexico</aau:Jurisdiction> <aau:NatureOfOperation contextRef="From2023-01-012023-12-31_custom_MineraGorrionSAdeCVMember" id="Fact000593">Exploration company</aau:NatureOfOperation> <ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000598">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory_zoTR6AJWvrC3" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_861_zLwvV5eApXNh"&gt;Foreign currencies&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Transactions in currencies other than the functional currency are recorded at the rates of exchange prevailing on the transaction dates. At each financial position reporting date, monetary assets and liabilities that are denominated in foreign currencies are translated at the rates prevailing at the date of the statement of financial position. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory> <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000600">&lt;p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zSvbin4aFbCe" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_862_zDAdsgpAmwyf"&gt;Financial instruments&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;A financial asset is classified as measured at: amortized cost, fair value through other comprehensive income (FVOCI), or fair value through profit or loss (FVTPL). The classification of financial assets is generally based on the business model in which a financial asset is managed and its contractual cash flow characteristics. Derivatives embedded in contracts where the host is a financial asset in the scope of the standard are never separated. Instead, the hybrid financial instrument as a whole is assessed for classification. The Company's financial assets consist primarily of cash and cash equivalents, and accounts receivable and are classified at amortized cost.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 56.7pt; font-size: 10pt; text-indent: -21.25pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Financial liabilities comprise the Company&#x2019;s trade and other payables. Financial liabilities are initially recognized on the date they are originated and are derecognized when the contractual obligations are discharged or cancelled or expire. Trade and other payables are recognized initially at fair value and subsequent are measured at amortized costs using the effective interest method, when materially different from the initial amount. Derivative financial liabilities are classified as FVTPL. Fair value is determined based on the present value of future cash flow, discounted at the market rate of interest.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 55.95pt; font-size: 10pt; text-align: justify; text-indent: -0.25in"&gt;&lt;i&gt;(i)&#160;&#160;&#160;&#160; Impairment of financial assets&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;An &#x2018;expected credit loss&#x2019; (ECL) model applies to financial assets measured at amortized cost, contract assets and debt investments at FVOCI, but not to investments in equity instruments. The Company's financial assets measured at amortized cost and subject to the ECL model include cash and cash equivalents, and accounts receivable.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 55.95pt; font-size: 10pt; text-align: justify; text-indent: -0.25in"&gt;&lt;i&gt;(ii)&#160;&#160;&#160; Embedded derivatives&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Derivatives may be embedded in other financial instruments (the &#x201c;host instrument&#x201d;). Embedded derivatives are treated as separate derivatives when their economic characteristics and risks are not clearly and closely related to those of the host instrument, the terms of the embedded derivative are the same as those of a stand-alone derivative, and the combined contract is not held for trading or designated at fair value. These embedded derivatives are measured at fair value with subsequent changes recognized in profit or loss.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company issues warrants exercisable in a currency other than the Company&#x2019;s functional currency and as a result, the warrants are derivative financial instruments.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Derivative financial instruments are initially recognized at fair value and subsequently measured at fair value with changes in fair value recognized in profit or loss. Transaction costs are recognized in profit or loss as incurred.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory> <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="From2023-01-01to2023-12-31" id="Fact000605">&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zPDMx3aevBY1" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt; &lt;i&gt;(d)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_862_zPgoRrxZPmr9"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Cash equivalents include term deposits and money market instruments which are readily convertible into cash or have maturities at the date of purchase of less than ninety days.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents> <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000607">&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zivnVh4Cyj4l" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt; &lt;i&gt;(e)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_868_z0ua9Q4T1s3l"&gt;Property, plant and equipment&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, and are depreciated annually on a declining-balance basis if available-for-use at the following rates:&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock_z0fC8DOUBqof" style="width: 100%; border-collapse: collapse; font-size: 10pt" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span id="xdx_8B3_zm4UcBBJyfJc" style="display: none"&gt;Schedule of property, plant and equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 9%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 47%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Furniture, fixtures and other&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 53%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_znxoDKCmIRw5" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zeDyBbxEX663" title="Property, plant and equipment"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Geological library&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z0Nz0kyqyrx7" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Field equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zPnqkseeNcQd" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Mill equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z0mkJsrDPBS7" title="Property, plant and equipment"&gt;Straight line over mine life (11 years)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory> <aau:DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000609">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock_z0fC8DOUBqof" style="width: 100%; border-collapse: collapse; font-size: 10pt" summary="xdx: Disclosure - Material accounting policies (Details 1)"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span id="xdx_8B3_zm4UcBBJyfJc" style="display: none"&gt;Schedule of property, plant and equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 9%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 47%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Furniture, fixtures and other&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 53%; layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_znxoDKCmIRw5" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Computer hardware and software&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zeDyBbxEX663" title="Property, plant and equipment"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Geological library&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z0Nz0kyqyrx7" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Field equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eifrs-full--DepreciationRatePropertyPlantAndEquipment_dp_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zPnqkseeNcQd" title="Property, plant and equipment"&gt;20&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;Mill equipment&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_909_eifrs-full--DescriptionOfUsefulLifePropertyPlantAndEquipment_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z0mkJsrDPBS7" title="Property, plant and equipment"&gt;Straight line over mine life (11 years)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aau:DisclosureOfPropertyPlantAndEquipmentDepreciationRateTextBlock> <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_custom_FurnitureFixturesAndFittingsMember" decimals="INF" id="Fact000611" unitRef="Pure">0.20</ifrs-full:DepreciationRatePropertyPlantAndEquipment> <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_ComputerEquipmentMember" decimals="INF" id="Fact000613" unitRef="Pure">0.30</ifrs-full:DepreciationRatePropertyPlantAndEquipment> <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_custom_GeologicalLibraryMember" decimals="INF" id="Fact000615" unitRef="Pure">0.20</ifrs-full:DepreciationRatePropertyPlantAndEquipment> <ifrs-full:DepreciationRatePropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_custom_FieldEquipmentMember" decimals="INF" id="Fact000617" unitRef="Pure">0.20</ifrs-full:DepreciationRatePropertyPlantAndEquipment> <ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_custom_MillEquipmentMember" id="Fact000619">Straight line over mine life (11 years)</ifrs-full:DescriptionOfUsefulLifePropertyPlantAndEquipment> <ifrs-full:DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures contextRef="From2023-01-01to2023-12-31" id="Fact000621">&lt;p id="xdx_841_eifrs-full--DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures_zqAFbeLaETC5" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86F_zk992ffWZ3y7"&gt;Exploration and evaluation assets&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company is in the advanced exploration stage with respect to its investment in exploration and evaluation assets and, accordingly, follows the practice of capitalizing all costs relating to the acquisition of, exploration for and development of mineral claims to which the Company has rights and crediting all proceeds received from farm-out arrangements or recovery of costs against the cost of the related claims. Acquisition costs include, but are not exclusive to land surface rights acquired. Deferred exploration costs include, but are not exclusive to geological, geophysical studies, annual mining taxes, exploratory drilling and sampling. At such time as commercial production commences, these costs will be charged to profit or loss on a unit-of-production method based on proven and probable reserves. The aggregate costs related to abandoned mineral claims are charged to profit or loss at the time of any abandonment or when it has been determined that there is evidence of an impairment.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company considers the following facts and circumstances in determining if it should test exploration and evaluation assets for impairment:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(i)&lt;/td&gt;&lt;td style="text-align: justify"&gt;the period for which the Company has the right to explore in the specific area has expired during the period or will expire in the near future, and is not expected to be renewed;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 68.6pt; font-size: 10pt; text-align: justify; text-indent: -19.6pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(ii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;substantive expenditure on further exploration for and evaluation of mineral resources in the specific area is neither budgeted nor planned;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 78pt; font-size: 10pt; text-indent: -22.6pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(iii)&lt;/td&gt;&lt;td style="text-align: justify"&gt;exploration for and evaluation of mineral resources in the specific area have not led to the discovery of commercially viable quantities of mineral resources and the entity has decided to discontinue such activities in the specific area; and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 68.6pt; font-size: 10pt; text-indent: -22.6pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.75in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(iv)&lt;/td&gt;&lt;td style="text-align: justify"&gt;sufficient data exists to indicate that, although a development in the specific area is likely to proceed, the carrying amount of the exploration and evaluation assets is unlikely to be recovered in full from successful development or by sale.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;An impairment charge may be reversed but only to the extent that this does not exceed the original carrying value of the property that would have resulted if no impairment had been recognized. General exploration costs in areas of interest in which the Company has not secured rights are expensed as incurred.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The recoverability of amounts shown for exploration and evaluation assets is dependent upon the discovery of economically recoverable reserves, the ability of the Company to obtain financing to complete development of the properties, and on future production or proceeds of disposition.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company recognizes in profit or loss costs recovered on exploration and evaluation assets when amounts received or receivable are in excess of the carrying amount.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;Once the technical feasibility and commercial viability of the extraction of mineral resources in an area of interest are demonstrable, exploration and evaluation assets attributable to that area of interest are first tested for impairment and then reclassified to development asset within property, plant and equipment.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;All capitalized exploration and evaluation expenditures are monitored for indications of impairment.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Where a potential impairment is indicated, assessments are performed for each area of interest. To the extent that exploration expenditure is not expected to be recovered, it is charged to profit or loss. Exploration areas where reserves have been discovered, but require major capital expenditure before production can begin, are continually evaluated to ensure that commercial quantities of reserves exist or to ensure that additional exploration work is underway as planned.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForExplorationAndEvaluationExpenditures> <ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000627">&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory_zzi8n7pnheu" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt; &lt;i&gt;(g)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_867_zGS25akS9gA2"&gt;Impairment of property, plant and equipment&lt;/span&gt; &lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-indent: -36.55pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Property, plant and equipment are reviewed for impairment at least annually, or if there is any indication that the carrying amount may not be recoverable. If any such indication is present, the recoverable amount of the asset is estimated in order to determine whether impairment exists. Where the asset does not generate cash flows that are independent from other assets, the Company estimates the recoverable amount of the cash generating unit to which the asset belongs.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;An asset&#x2019;s recoverable amount is the higher of fair value less costs of disposal and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value, using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which estimates of future cash flows have not been adjusted.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;If the recoverable amount of an asset or cash generating unit is estimated to be less than its carrying amount, the carrying amount is reduced to the recoverable amount by way of recording an impairment charge to profit or loss. Where an impairment subsequently reverses, the carrying amount is increased to the revised estimate of recoverable amount but only to the extent that this does not exceed the carrying value that would have been determined if no impairment had previously been recognized.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory> <ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000632">&lt;p id="xdx_84B_eifrs-full--DescriptionOfAccountingPolicyForIncomeTaxExplanatory_zeKsFWc0oCyh" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_zkf8xvoQaJbj"&gt;Income taxes&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Income tax expense comprises current and deferred tax. Current tax and deferred tax are recognized in profit or loss except to the extent that it relates to items recognized directly in equity or in other comprehensive income.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Current tax is the expected tax payable or receivable on the taxable income or loss for the year, using tax rates enacted at the reporting date, and any adjustment to tax payable in respect of previous years.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Deferred tax is recognized in respect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for taxation purposes. Deferred tax is not recognized for the following temporary differences: the initial recognition of assets or liabilities in a transaction that is not a business combination and that affects neither accounting nor taxable profit or loss, and differences relating to investments in subsidiaries and jointly controlled entities to the extent that it is probable that they will not reverse in the foreseeable future. In addition, deferred tax is not recognized for taxable temporary differences arising on the initial recognition of goodwill. Deferred tax is measured at the tax rates that are expected to be applied to temporary differences when they reverse, based on the laws that have been enacted or substantively enacted by the reporting date.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Deferred tax assets and liabilities are offset if there is a legally enforceable right to offset current tax liabilities and assets, and they relate to income taxes levied by the same tax authority on the same taxable entity, or on different tax entities, but they intend to settle current tax liabilities and assets on a net basis or their tax assets and liabilities will be realized simultaneously.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;A deferred tax asset is recognized for unused tax losses, tax credits and deductible temporary differences, to the extent that it is probable that future taxable profits will be available against which they can be utilized. Deferred tax assets are reviewed at each reporting date and are reduced to the extent that it is no longer probable that the related tax benefit will be realized.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory> <ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000634">&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory_zCvnS8Kdlq3l" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86C_zpYHDCQOi1Bi"&gt;Share-based payments&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.4pt"&gt;The Company&#x2019;s stock option plan allows Company employees, directors, officers and consultants to acquire shares of the Company. The fair value of options granted is recognized as share-based payment expense with a corresponding increase in equity reserves. An individual is classified as an employee when the individual is an employee for legal or tax purposes (direct employee) or provides services similar to those performed by a direct employee&lt;span style="color: black"&gt;.&lt;/span&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.4pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Fair value is measured at grant date, and each tranche is recognized using the graded vesting method over the period during which the options vest. The fair value of the options granted is measured using the Black-Scholes option-pricing model, taking into account the terms and conditions upon which the options were granted. At each financial position reporting date, the amount recognized as an expense is adjusted to reflect the actual number of stock options that are expected to vest. In situations where equity instruments are issued to consultants and some or all of the goods or services received by the entity as consideration cannot be specifically identified, they are measured at the fair value of the share-based payment. Otherwise, share-based payments are measured at the fair value of goods or services received.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory> <aau:DescriptionOfAccountingPolicyForCapitalSharesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000639">&lt;p id="xdx_845_ecustom--DescriptionOfAccountingPolicyForCapitalSharesTextBlock_ztGzff0bOXMh" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_861_zOpg4igS5BEf"&gt;Share capital&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Proceeds from the exercise of stock options and warrants are recorded as share capital in the amount for which the option or warrant enabled the holder to purchase a share in the Company, in addition to the proportionate amount of reserves originally created at the issuance of the stock options or warrants. Share capital issued for non-monetary consideration is valued at the closing market price at the date of issuance. The proceeds from the issuance of units are allocated between common shares and common share purchase warrants based on the residual value method. Under this method, the proceeds are allocated to common shares based on the fair value of a common share at the announcement date of the unit offering and any residual remaining is allocated to common share purchase warrants.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Certain of the Company&#x2019;s warrants are exercisable in a currency other than the functional currency of the Company. As a result, the fair value allocated to the warrant is recorded as a derivative financial liability with residual value being attributed to the equity unit. The fair value of the warrant is determined using the Black-Scholes Option Pricing Model and is marked to market at the end of each period. Upon exercise of the warrant, the fair value of the warrant at the date of exercise is transferred to share capital.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </aau:DescriptionOfAccountingPolicyForCapitalSharesTextBlock> <aau:DescriptionOfAccountingPolicyForReclamationAndClosureCostObligationsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000641">&lt;p id="xdx_84E_ecustom--DescriptionOfAccountingPolicyForReclamationAndClosureCostObligationsTextBlock_zykRx7qLLMg" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt; &lt;i&gt;(k)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_868_zjnxrWdmmYY3"&gt;Reclamation and closure cost obligations&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Decommissioning and restoration provisions are recorded when a present legal or constructive obligation exists as a result of past events where it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate of the amount of the obligation can be made.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation and discount rates. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows discounted for the market discount rate.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Over time, the discounted liability is increased for the changes in the present value based on the current market discount rates and liability risks. When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount receivable can be measured reliably.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;When the Company enters into an option agreement on its exploration and evaluations assets, as part of the option agreement, responsibility for any reclamation and remediation becomes the responsibility of the optionee.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; </aau:DescriptionOfAccountingPolicyForReclamationAndClosureCostObligationsTextBlock> <ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000646">&lt;p id="xdx_84E_eifrs-full--DescriptionOfAccountingPolicyForEarningsPerShareExplanatory_z2o7vGsrJfCk" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86B_zpaOkNqhaFJi"&gt;Net loss per share&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company presents the basic and diluted net loss per share data for its common shares, calculated by dividing the loss attributable to common shareholders of the Company by the weighted average number of common shares outstanding during the period. Diluted net loss per share is determined by adjusting the net loss attributable to common shareholders and the weighted average number of common shares outstanding for the effects of all dilutive potential common shares (Note 12).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory> <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000648">&lt;p id="xdx_844_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_zC4khRDXeYa" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span id="xdx_86E_zObEIzAEQfEe"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;At inception of a contract, the Company assesses whether a contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. The Company assesses whether the contract involves the use of an identified asset, whether the right to obtain substantially all of the economic benefits from use of the asset during the term of the arrangement exists, and if the Company has the right to direct the use of the asset. At inception or on reassessment of a contract that contains a lease component, the Company allocates the consideration in the contract to each lease component on the basis of their relative standalone prices.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;As a lessee, the Company recognizes a right-of-use asset and a lease liability at the commencement date of a lease. The right-of-use asset is initially measured at cost, which is comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, plus any decommissioning and restoration costs, less any lease incentives received.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The right-of-use asset is subsequently depreciated using the straight line method from the commencement date to the earlier of the end of the lease term, or the end of the useful life of the asset. In addition, the right-of-use asset may be reduced due to impairment losses, if any, and adjusted for certain remeasurements of the lease liability.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;A lease liability is initially measured at the present value of the lease payments that are not paid at the commencement date, discounted by the interest rate implicit in the lease, or if that rate cannot be readily determined, the incremental borrowing rate. Lease payments included in the measurement of the lease liability are comprised of:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;fixed payments, including in-substance fixed payments, less any lease incentives receivable;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;amounts expected to be payable under a residual value guarantee;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;exercise prices of purchase options if the Company is reasonably certain to exercise that option; and&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 1in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease.&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The lease liability is measured at amortized cost using the effective interest method. It is remeasured when there is a change in future lease payments arising from a change in an index or rate, or if there is a change in the estimate or assessment of the expected amount payable under a residual value guarantee, purchase, extension or termination option. Variable lease payments not included in the initial measurement of the lease liability are charged directly to profit or loss.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company has elected not to recognize right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and leases of low-value assets. The lease payments associated with these leases are charged directly to profit or loss on a straight-line basis over the lease term.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; </ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory> <aau:DescriptionOfAccountingPolicyForNewAndRevisedAccountingStandardsEffectiveAtTheBeggingOfTheYear contextRef="From2023-01-01to2023-12-31" id="Fact000655">&lt;p id="xdx_84A_ecustom--DescriptionOfAccountingPolicyForNewAndRevisedAccountingStandardsEffectiveAtTheBeggingOfTheYear_zMcxCW51yPTj" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;(n)&lt;/i&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;i&gt;&lt;span id="xdx_861_zq36k72fJK59"&gt;Standards issued or amended but not yet effective&lt;/span&gt;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company has not applied the following revised IFRS that has been issued but was not yet effective at December 31, 2023. This accounting standard is not currently expected to have a significant effect on the Company&#x2019;s accounting policies or financial statements.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;IAS 1 &#x2013;Presentation of Financial Statements (&#x201c;IAS 1&#x201d;) was amended in January 2020 to provide a more general approach to the classification of liabilities under IAS 1 based on the contractual arrangements in place at the reporting date. The amendments clarify that the classification of liabilities as current or noncurrent is based solely on a company&#x2019;s right to defer settlement at the reporting date. The right needs to be unconditional and must have substance. The amendments also clarify that the transfer of a company&#x2019;s own equity instruments is regarded as settlement of a liability, unless it results from the exercise of a conversion option meeting the definition of an equity instrument. These amendments were further revised by the issuance of Non-current Liabilities with Covenants (Amendments to IAS 1) on October 31, 2022 which further narrowed the scope of the amendments. The amendments are effective for annual periods beginning on January 1, 2024.&lt;/p&gt; </aau:DescriptionOfAccountingPolicyForNewAndRevisedAccountingStandardsEffectiveAtTheBeggingOfTheYear> <aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000657">&lt;p id="xdx_804_ecustom--DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock_zgfdvGpqzUfk" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;4.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_828_z5Eli1KS6Wp3"&gt;Accounts receivable and prepaid expenses&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Accounts receivable and prepaid expenses consist of the following:&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock_zgH1ag1Gosu4" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Accounts receivable and prepaid expenses (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;b&gt;&lt;span id="xdx_8B2_ztJ4qCpnP4Pe" style="display: none"&gt;Schedule of accounts receivable and prepaid expenses&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td id="xdx_49E_20231231_zrFXWrzaxBD2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td id="xdx_492_20221231_zXWUHSRdg2G2" style="font-size: 10pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_405_eifrs-full--CurrentTradeReceivables_iI_pp0p0_maCTRAPzpEW_zdNVw3hoYY8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: left"&gt;Accounts receivable (Note 11(b))&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;389,895&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;198,942&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_402_eifrs-full--CurrentPrepaidExpenses_iI_pp0p0_maCTRAPzpEW_zgyMPkwqAid6" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;63,745&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;60,529&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_400_ecustom--CurrentTradeReceivablesAndPrepaidExpenses_iTI_mtCTRAPzpEW_zeVeRNz4aFTd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;453,640&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;259,471&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;At December 31, 2023, the Company has recorded value added taxes of $&lt;span id="xdx_900_eifrs-full--ValueAddedTaxReceivables_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TuligticProjectMember_zFy9HB4YoDgi" title="Value added tax receivables"&gt;164,189&lt;/span&gt; (2022 - $&lt;span id="xdx_900_eifrs-full--ValueAddedTaxReceivables_iI_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--TuligticProjectMember_zw90lGSg7BTh" title="Value added tax receivables"&gt;251,775&lt;/span&gt;) included in exploration and evaluation assets, as the value added tax relates to the Tuligtic project and is expected to be recovered when the asset is sold (Note 7).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </aau:DisclosureOfAccountsReceivableAndPrepaidExpensesTextBlock> <aau:DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000659">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock_zgH1ag1Gosu4" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 90%" summary="xdx: Disclosure - Accounts receivable and prepaid expenses (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;&lt;b&gt;&lt;span id="xdx_8B2_ztJ4qCpnP4Pe" style="display: none"&gt;Schedule of accounts receivable and prepaid expenses&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td id="xdx_49E_20231231_zrFXWrzaxBD2" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td id="xdx_492_20221231_zXWUHSRdg2G2" style="font-size: 10pt; text-align: center"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_405_eifrs-full--CurrentTradeReceivables_iI_pp0p0_maCTRAPzpEW_zdNVw3hoYY8h" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: left"&gt;Accounts receivable (Note 11(b))&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;389,895&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;198,942&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_402_eifrs-full--CurrentPrepaidExpenses_iI_pp0p0_maCTRAPzpEW_zgyMPkwqAid6" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Prepaid expenses&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;63,745&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;60,529&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_400_ecustom--CurrentTradeReceivablesAndPrepaidExpenses_iTI_mtCTRAPzpEW_zeVeRNz4aFTd" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;453,640&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;259,471&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aau:DisclosureOfAccountsReceivableAndPrepaidExpenseTextBlock> <ifrs-full:CurrentTradeReceivables contextRef="AsOf2023-12-31" decimals="0" id="Fact000661" unitRef="CAD">389895</ifrs-full:CurrentTradeReceivables> <ifrs-full:CurrentTradeReceivables contextRef="AsOf2022-12-31" decimals="0" id="Fact000662" unitRef="CAD">198942</ifrs-full:CurrentTradeReceivables> <ifrs-full:CurrentPrepaidExpenses contextRef="AsOf2023-12-31" decimals="0" id="Fact000664" unitRef="CAD">63745</ifrs-full:CurrentPrepaidExpenses> <ifrs-full:CurrentPrepaidExpenses contextRef="AsOf2022-12-31" decimals="0" id="Fact000665" unitRef="CAD">60529</ifrs-full:CurrentPrepaidExpenses> <aau:CurrentTradeReceivablesAndPrepaidExpenses contextRef="AsOf2023-12-31" decimals="0" id="Fact000667" unitRef="CAD">453640</aau:CurrentTradeReceivablesAndPrepaidExpenses> <aau:CurrentTradeReceivablesAndPrepaidExpenses contextRef="AsOf2022-12-31" decimals="0" id="Fact000668" unitRef="CAD">259471</aau:CurrentTradeReceivablesAndPrepaidExpenses> <ifrs-full:ValueAddedTaxReceivables contextRef="AsOf2023-12-31_custom_TuligticProjectMember" decimals="0" id="Fact000670" unitRef="CAD">164189</ifrs-full:ValueAddedTaxReceivables> <ifrs-full:ValueAddedTaxReceivables contextRef="AsOf2022-12-31_custom_TuligticProjectMember" decimals="0" id="Fact000672" unitRef="CAD">251775</ifrs-full:ValueAddedTaxReceivables> <aau:DisclosureOfLeaseExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000675">&lt;p id="xdx_803_ecustom--DisclosureOfLeaseExplanatory_zQSceD7COoVj" style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;5.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_820_zb6nURKaHaK8"&gt;Right-of-use assets and lease liabilities&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company has lease agreements for its headquarter office space in Vancouver, B.C.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;One lease containing an extension option exercisable only by the Company was exercised on November 22, 2021. The lease was therefore extended from March 31, 2022 to March 31, 2027. The Company reassessed this significant event as a lease modification and has estimated that the potential future lease payments under the extended lease term would result in an increase in lease liability by $&lt;span id="xdx_900_ecustom--IncreaseInLeaseLiability_c20230101__20231231_zfOo6XTbIoAc" title="Increase in lease liability"&gt;508,799&lt;/span&gt;.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The continuity of lease liabilities for the years ended December 31, 2023 and 2022 are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureOfLeaseLiabilitiesAndCostsTextBlock_zrh8p9etmep5" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Right-of-use assets and lease liabilities (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BE_zycnee5DoQm1" style="display: none"&gt;Schedule of continuity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: justify"&gt;Opening balance&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--LeaseLiabilities_iS_c20230101__20231231_zoXtuizBHKqa" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;465,930&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iS_c20220101__20221231_zjLHxhIs4ami" style="width: 12%; font-size: 10pt; text-align: right" title="Opening balance"&gt;548,607&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Less: lease payments&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PaymentsOfLeaseLiabilities_iN_di_c20230101__20231231_z99wFmY9yNJ6" style="font-size: 10pt; font-weight: bold; text-align: right" title="Less: lease payments"&gt;(127,797&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PaymentsOfLeaseLiabilities_iN_di_c20220101__20221231_zQct55Au8N5c" style="font-size: 10pt; text-align: right" title="Less: lease payments"&gt;(130,056&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20230101__20231231_z9fuOqEfP9xi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Interest expense"&gt;39,502&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20220101__20221231_zt1RHtU833qi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Interest expense"&gt;47,379&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--LeaseLiabilities_iE_c20230101__20231231_zZSjLhVSZCtb" style="font-size: 10pt; font-weight: bold; text-align: right" title="Ending balance"&gt;377,635&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iE_c20220101__20221231_zYC9OjfkG4al" style="font-size: 10pt; text-align: right" title="Ending balance"&gt;465,930&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Less: current portion of lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--CurrentLeaseLiabilities_iNI_di_c20231231_zgf0wuSaeqeh" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Less: current portion of lease liabilities"&gt;(100,531&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--CurrentLeaseLiabilities_iNI_di_c20221231_zt25x2k6fnD9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less: current portion of lease liabilities"&gt;(88,295&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Long-term portion of lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NoncurrentLeaseLiabilities_iI_c20231231_zqdN5XEpvt8d" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Long-term portion of lease liabilities"&gt;277,104&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NoncurrentLeaseLiabilities_iI_c20221231_zLiqifD7Avl1" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Long-term portion of lease liabilities"&gt;377,635&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company entered into a sublease arrangement with a third party to lease an office unit from May 1, 2021 to March 31, 2022 under the same terms of the Company&#x2019;s lease. The Company remains beholden to the obligations set out in its lease dated October 31, 2018. The rental income during the year ended December 31, 2023 (2022 - $&lt;span id="xdx_90C_eifrs-full--IncomeFromSubleasingRightofuseAssets_c20220101__20221231_zCEMCHgseO2j" title="Operating sublease income"&gt;8,508&lt;/span&gt;; 2021 - $&lt;span id="xdx_903_eifrs-full--IncomeFromSubleasingRightofuseAssets_c20210101__20211231_zOHlE5Brzg0j" title="Operating sublease income"&gt;22,452&lt;/span&gt;) from this operating sublease was $Nil &lt;span id="xdx_900_eifrs-full--IncomeFromSubleasingRightofuseAssets_c20230101__20231231_zoZfpkbHKp46" style="display: none" title="Operating sublease income"&gt;0&lt;/span&gt; and is recorded in interest and other income.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The continuity of ROU assets for the years ended December 31, 2023 and 2022 are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_z2fAa21ggcsl" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Right-of-use assets and lease liabilities (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zDFVXsKaQpDi" style="display: none"&gt;Schedule of continuity of ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: left"&gt;Opening balance&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--RightofuseAssets_iS_c20230101__20231231_z7V3MpJo6wZ2" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;432,319&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--RightofuseAssets_iS_c20220101__20221231_zApsu57zSkUd" style="width: 12%; font-size: 10pt; text-align: right" title="Opening balance"&gt;539,110&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Less: amortization of ROU assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_iN_di_c20230101__20231231_zfqjqq0Aemq5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Less: amortization of ROU assets"&gt;(101,722&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_iN_di_c20220101__20221231_zo3gGG2JjjY3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less: amortization of ROU assets"&gt;(106,791&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20230101__20231231_zO1BoBFWKHga" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Ending balance"&gt;330,597&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20220101__20221231_zYfdXf985Th7" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Ending balance"&gt;432,319&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;During the year ended December 31, 2023, the Company recognized occupancy expenses of $&lt;span id="xdx_90C_eifrs-full--OccupancyExpense_c20230101__20231231_zSEsD0Ghz4Mj" title="Occupancy expense"&gt;39,858&lt;/span&gt; (2022 - $&lt;span id="xdx_905_eifrs-full--OccupancyExpense_c20220101__20221231_zISCaqBBYgxc" title="Occupancy expense"&gt;42,655&lt;/span&gt;; 2021 - $&lt;span id="xdx_90A_eifrs-full--OccupancyExpense_c20210101__20211231_zv9dEkN59vb5" title="Occupancy expense"&gt;40,542&lt;/span&gt;) related to short term leases.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;As at December 31, 2023, the remaining payments for the operating lease are due as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_zEZ9Pw07dKJa" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Right-of-use assets and lease liabilities (Details 2)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zsf4emcrWK5g" style="display: none"&gt;Schedule of remaining payments for the operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2026&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2027&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2028&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 34%; font-size: 10pt; text-align: left"&gt;Office lease&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zUQVisRx5fee" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2024"&gt;170,672&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zue5gkAB6kkb" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2025"&gt;173,970&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zeeoOa9KOm6c" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2026"&gt;177,268&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zrPwCUAL5CBg" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2027"&gt;44,523&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zYTUeg4Jqbe2" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2028"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0741"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231_zpWpV2Lnln79" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="Remaining payments for office lease"&gt;566,433&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </aau:DisclosureOfLeaseExplanatory> <aau:IncreaseInLeaseLiability contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000677" unitRef="CAD">508799</aau:IncreaseInLeaseLiability> <aau:DisclosureOfLeaseLiabilitiesAndCostsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000679">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_ecustom--DisclosureOfLeaseLiabilitiesAndCostsTextBlock_zrh8p9etmep5" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Right-of-use assets and lease liabilities (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BE_zycnee5DoQm1" style="display: none"&gt;Schedule of continuity of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: justify"&gt;Opening balance&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--LeaseLiabilities_iS_c20230101__20231231_zoXtuizBHKqa" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;465,930&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iS_c20220101__20221231_zjLHxhIs4ami" style="width: 12%; font-size: 10pt; text-align: right" title="Opening balance"&gt;548,607&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Less: lease payments&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PaymentsOfLeaseLiabilities_iN_di_c20230101__20231231_z99wFmY9yNJ6" style="font-size: 10pt; font-weight: bold; text-align: right" title="Less: lease payments"&gt;(127,797&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PaymentsOfLeaseLiabilities_iN_di_c20220101__20221231_zQct55Au8N5c" style="font-size: 10pt; text-align: right" title="Less: lease payments"&gt;(130,056&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Interest expense&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20230101__20231231_z9fuOqEfP9xi" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Interest expense"&gt;39,502&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--InterestExpenseOnLeaseLiabilities_pp0p0_c20220101__20221231_zt1RHtU833qi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Interest expense"&gt;47,379&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--LeaseLiabilities_iE_c20230101__20231231_zZSjLhVSZCtb" style="font-size: 10pt; font-weight: bold; text-align: right" title="Ending balance"&gt;377,635&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iE_c20220101__20221231_zYC9OjfkG4al" style="font-size: 10pt; text-align: right" title="Ending balance"&gt;465,930&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Less: current portion of lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--CurrentLeaseLiabilities_iNI_di_c20231231_zgf0wuSaeqeh" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Less: current portion of lease liabilities"&gt;(100,531&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--CurrentLeaseLiabilities_iNI_di_c20221231_zt25x2k6fnD9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less: current portion of lease liabilities"&gt;(88,295&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Long-term portion of lease liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NoncurrentLeaseLiabilities_iI_c20231231_zqdN5XEpvt8d" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Long-term portion of lease liabilities"&gt;277,104&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NoncurrentLeaseLiabilities_iI_c20221231_zLiqifD7Avl1" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Long-term portion of lease liabilities"&gt;377,635&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</aau:DisclosureOfLeaseLiabilitiesAndCostsTextBlock> <ifrs-full:LeaseLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000681" unitRef="CAD">465930</ifrs-full:LeaseLiabilities> <ifrs-full:LeaseLiabilities contextRef="AsOf2021-12-31" decimals="0" id="Fact000683" unitRef="CAD">548607</ifrs-full:LeaseLiabilities> <aau:PaymentsOfLeaseLiabilities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000685" unitRef="CAD">127797</aau:PaymentsOfLeaseLiabilities> <aau:PaymentsOfLeaseLiabilities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000687" unitRef="CAD">130056</aau:PaymentsOfLeaseLiabilities> <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000689" unitRef="CAD">39502</ifrs-full:InterestExpenseOnLeaseLiabilities> <ifrs-full:InterestExpenseOnLeaseLiabilities contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000691" unitRef="CAD">47379</ifrs-full:InterestExpenseOnLeaseLiabilities> <ifrs-full:LeaseLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000693" unitRef="CAD">377635</ifrs-full:LeaseLiabilities> <ifrs-full:LeaseLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000695" unitRef="CAD">465930</ifrs-full:LeaseLiabilities> <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000697" unitRef="CAD">100531</ifrs-full:CurrentLeaseLiabilities> <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000699" unitRef="CAD">88295</ifrs-full:CurrentLeaseLiabilities> <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact000701" unitRef="CAD">277104</ifrs-full:NoncurrentLeaseLiabilities> <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact000703" unitRef="CAD">377635</ifrs-full:NoncurrentLeaseLiabilities> <ifrs-full:IncomeFromSubleasingRightofuseAssets contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000705" unitRef="CAD">8508</ifrs-full:IncomeFromSubleasingRightofuseAssets> <ifrs-full:IncomeFromSubleasingRightofuseAssets contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000707" unitRef="CAD">22452</ifrs-full:IncomeFromSubleasingRightofuseAssets> <ifrs-full:IncomeFromSubleasingRightofuseAssets contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000709" unitRef="CAD">0</ifrs-full:IncomeFromSubleasingRightofuseAssets> <ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000711">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory_z2fAa21ggcsl" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Right-of-use assets and lease liabilities (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zDFVXsKaQpDi" style="display: none"&gt;Schedule of continuity of ROU assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: left"&gt;Opening balance&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--RightofuseAssets_iS_c20230101__20231231_z7V3MpJo6wZ2" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;432,319&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--RightofuseAssets_iS_c20220101__20221231_zApsu57zSkUd" style="width: 12%; font-size: 10pt; text-align: right" title="Opening balance"&gt;539,110&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Less: amortization of ROU assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_iN_di_c20230101__20231231_zfqjqq0Aemq5" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Less: amortization of ROU assets"&gt;(101,722&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_iN_di_c20220101__20221231_zo3gGG2JjjY3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Less: amortization of ROU assets"&gt;(106,791&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20230101__20231231_zO1BoBFWKHga" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Ending balance"&gt;330,597&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20220101__20221231_zYfdXf985Th7" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Ending balance"&gt;432,319&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</ifrs-full:DisclosureOfQuantitativeInformationAboutRightofuseAssetsExplanatory> <ifrs-full:RightofuseAssets contextRef="AsOf2022-12-31" decimals="0" id="Fact000713" unitRef="CAD">432319</ifrs-full:RightofuseAssets> <ifrs-full:RightofuseAssets contextRef="AsOf2021-12-31" decimals="0" id="Fact000715" unitRef="CAD">539110</ifrs-full:RightofuseAssets> <ifrs-full:DepreciationRightofuseAssets contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000717" unitRef="CAD">101722</ifrs-full:DepreciationRightofuseAssets> <ifrs-full:DepreciationRightofuseAssets contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000719" unitRef="CAD">106791</ifrs-full:DepreciationRightofuseAssets> <ifrs-full:RightofuseAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact000721" unitRef="CAD">330597</ifrs-full:RightofuseAssets> <ifrs-full:RightofuseAssets contextRef="AsOf2022-12-31" decimals="0" id="Fact000723" unitRef="CAD">432319</ifrs-full:RightofuseAssets> <ifrs-full:OccupancyExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact000725" unitRef="CAD">39858</ifrs-full:OccupancyExpense> <ifrs-full:OccupancyExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact000727" unitRef="CAD">42655</ifrs-full:OccupancyExpense> <ifrs-full:OccupancyExpense contextRef="From2021-01-012021-12-31" decimals="0" id="Fact000729" unitRef="CAD">40542</ifrs-full:OccupancyExpense> <ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000731">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eifrs-full--DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory_zEZ9Pw07dKJa" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Right-of-use assets and lease liabilities (Details 2)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&lt;span id="xdx_8B6_zsf4emcrWK5g" style="display: none"&gt;Schedule of remaining payments for the operating lease&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2024&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2026&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2027&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2028&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 34%; font-size: 10pt; text-align: left"&gt;Office lease&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--NotLaterThanOneYearMember_zUQVisRx5fee" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2024"&gt;170,672&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanTwoYearsMember_zue5gkAB6kkb" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2025"&gt;173,970&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanTwoYearsAndNotLaterThanThreeYearsMember_zeeoOa9KOm6c" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2026"&gt;177,268&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFourYearsMember_zrPwCUAL5CBg" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2027"&gt;44,523&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231__ifrs-full--MaturityAxis__ifrs-full--LaterThanFourYearsAndNotLaterThanFiveYearsMember_zYTUeg4Jqbe2" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="2028"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0741"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--UndiscountedOperatingLeasePaymentsToBeReceived_iI_c20231231_zpWpV2Lnln79" style="border-bottom: Black 1.5pt solid; width: 8%; font-size: 10pt; text-align: right" title="Remaining payments for office lease"&gt;566,433&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</ifrs-full:DisclosureOfMaturityAnalysisOfOperatingLeasePaymentsExplanatory> <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived contextRef="AsOf2023-12-31_ifrs-full_NotLaterThanOneYearMember" decimals="0" id="Fact000733" unitRef="CAD">170672</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived> <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived contextRef="AsOf2023-12-31_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" decimals="0" id="Fact000735" unitRef="CAD">173970</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived> <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived contextRef="AsOf2023-12-31_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" decimals="0" id="Fact000737" unitRef="CAD">177268</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived> <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived contextRef="AsOf2023-12-31_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" decimals="0" id="Fact000739" unitRef="CAD">44523</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived> <ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived contextRef="AsOf2023-12-31" decimals="0" id="Fact000743" unitRef="CAD">566433</ifrs-full:UndiscountedOperatingLeasePaymentsToBeReceived> <aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000747">&lt;p id="xdx_80E_ecustom--DisclosureOfPropertyPlantAndEquipmentsExplanatory_zFfpI4DKgtQe" style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;6.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span&gt;&lt;span id="xdx_82A_zCbAXSO3024g"&gt;Property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zsYU4RvqR289" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Property, plant and equipment (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;b&gt;&lt;span id="xdx_8B7_zuCCVksEoKRb" style="display: none"&gt;Schedule of property, plant and equipment&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Furniture &lt;br/&gt; and fixtures &lt;br/&gt; and other&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Computer &lt;br/&gt; hardware&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Computer &lt;br/&gt; software&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Geological &lt;br/&gt; library&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Field &lt;br/&gt; equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Mill &lt;br/&gt; equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 30%; font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zTlOacWV5X3k" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;159,171&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zu3Zr2ylv3ck" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;271,540&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zkOChTkIgeyi" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;198,981&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zD2YGxaJ9DHc" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;51,760&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zL6Hl19BFOue" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;245,647&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zlfrSvzLoSTb" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;6,568,841&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zojYjI0gaKc" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;7,495,940&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Additions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zJp5cKpmPTJg" style="font-size: 10pt; text-align: right" title="Additions"&gt;1,770&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_znUcMcoegyq1" style="font-size: 10pt; text-align: right" title="Additions"&gt;267&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_z5xhQ6d2GXrb" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zYToYcSAuuXa" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0771"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zH99strmvAg6" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0773"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_ziFPawOlLKd5" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0775"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVt54DVa7Zsi" style="font-size: 10pt; text-align: right" title="Additions"&gt;2,037&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Impairment of property, plant and equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zORzI1ft8YQ4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0779"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zj48qxULAO4e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0781"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zeuYgxeVHYwd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0783"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z8xb9CJtw7mf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0785"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zAt5xW94pAA2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zKF0GWiXTAd8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0789"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQoRUQl0UMl5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0791"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCost_iE_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zQxBsq7JsXU8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;160,941&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zVwH0w6mqzy3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;271,807&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zit0JfG8OQB7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;198,981&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zdHmWsTzWyGg" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;51,760&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zWvUM2CXmoH" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;245,647&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zyLHjQLyDBD3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNmAJ66H9hZ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;7,497,977&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zLO4T0a6qAxd" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;153,203&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4rxxzii5iYe" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;251,441&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_ze3OChDIRYma" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;192,138&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zZN4lj6XQyff" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;50,975&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zhp8ANGkzP45" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;237,312&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pdp0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zeYFHNGjD4Uf" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0817"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zQOkOMtzPROa" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;885,069&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zJLPZtveVVbk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;1,223&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z6wOXZOMBRVh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;6,066&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zG3zHM7ViWG1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;2,053&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zRtB05IQ1sy2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;157&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zzd3J44kxlYa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;1,667&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pdp0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z4MO7o5UTE2k" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_ztYjuvtd5Fm4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;11,166&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zf4Uyxz91a9b" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;154,426&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zORC3bAyOyU" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;257,507&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zxde7jDA9iIg" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;194,191&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zoVVKgZ1Lgb2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;51,132&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zkjG0R6aVOw9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;238,979&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pdp0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z5jvJ0MgX5ma" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0845"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zcsiy3PXtXBd" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;896,235&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Carrying amounts&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zCSzQylrGbeg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;5,968&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zGJmYIBXlGJ4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;20,099&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zZiT7UhV5HSl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;6,843&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zTHp4x1Fqj97" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;785&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zVBbzlM1zQDk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;8,335&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zYVfBA0lMqsc" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231_zrstafk6K1Rj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;6,610,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zromMDgvUB1c" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,515&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zsi73sw1fHXf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;14,300&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zRooobqEOgG1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;4,790&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zj1SN89WD0T9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;628&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zbRdd9Ht1EW2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,668&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zrIzQbFwvyM7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231_zxKw38BI3oB3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,601,742&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Furniture &lt;br/&gt; and fixtures &lt;br/&gt; and other&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Computer &lt;br/&gt; hardware&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Computer &lt;br/&gt; software&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Geological &lt;br/&gt; library&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Field &lt;br/&gt; equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Mill &lt;br/&gt; equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 30%; font-size: 10pt; font-weight: bold"&gt;December 31, 2021&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zwDnPw4yGlMd" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;158,219&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z2u2Fji7LNm4" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;267,004&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zegnSjSPn5bc" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;198,981&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z0zpopXBc139" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;51,760&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zkkd2viV1r7a" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;245,647&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zGclPpK2DHo4" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;13,968,566&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjflbfK36Eug" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;14,890,177&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Additions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zCEHzTA4sNze" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;952&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zDqpB5RNQZ97" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;4,536&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zLs2koVg3Pbl" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0895"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z4UDXvygoId2" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zJC4uLyJt6Aa" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0899"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zZjYGzTww2l" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;41,568&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHZ7S5vAXotj" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;47,056&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Impairment of property, plant and equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zS246QqGJo5a" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zFCfIXabO8Jl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0907"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_znlJVfB3frr3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z3iFrnEumNM2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zpPh99PUG63" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0913"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zfr7UMODmS7l" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;(7,441,293&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTp58OrEJFQa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;(7,441,293&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zzeHdo8pMzM4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;159,171&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zqW4KKhDPW6i" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;271,540&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zeSi8fZ8anx6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;198,981&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zNONtTXPuJF9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;51,760&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zgcGPgUHROqj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;245,647&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z8JlqQWubRFl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9xHE9bn4rj6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;7,495,940&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;December 31, 2021&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zcxqG1UfSDgl" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;151,390&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_znlfFbv70xi8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;244,043&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zC33XdWPtLwj" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;189,206&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zH21eGIHuPOj" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;50,779&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_z6RMFlsb0Jdh" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;235,227&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zWfmddzJG97c" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0943"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zZIZXoqMdEDc" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;870,645&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_z0rTGaDdpy08" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;1,813&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zu8RvCWhCKWa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;7,398&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zpd0BWaFDE8j" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;2,932&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zMoFr9irY9M7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;196&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_z2gPTQ12gKv7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;2,085&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zycT4sp5Hgok" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zarVipnZYOM2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;14,424&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zBBtnRXt6YJ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;153,203&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zWYWlj5fb7yg" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;251,441&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zfyyIUSOg1j1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;192,138&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zBxNQRPGuD15" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;50,975&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zfqU9FVpVvll" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;237,312&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z9m79oSqaYgc" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0971"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zXKnXf6tJsv2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;885,069&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Carrying amounts&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;December 31, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zcCB6AljtV2a" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;6,829&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z6FIkyGNGsa4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;22,961&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zeV5A96di7Zd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;9,775&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z8i8Gn4UMoSi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;981&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_z9N9VqpKebG3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;10,420&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zA6Y0j1v55Of" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;13,968,566&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231_znQKu5WWyLlj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;14,019,532&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_z6am2oBklPvb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;5,968&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zGkbsJa5EPRl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;20,099&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_z893quSK3arl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,843&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zCLCX0WFoocc" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;785&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_z0uTMAfQkIW8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;8,335&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zgbZH2I47eG9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231_z4TAWxN5tY9d" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,610,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8AA_z2L9L0xIhMBc" style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;As at December 31, 2022, the Company recorded an impairment of $&lt;span id="xdx_906_ecustom--ImpairmentOfPropertyPlantsAndEquipment_c20220101__20221231_zgk3OIMM9XG2" title="Impairment on mill equipment"&gt;7,441,293&lt;/span&gt; on mill equipment to its recoverable amount due to the delay in receiving development permit and the lack of available for use in Mexico.&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; </aau:DisclosureOfPropertyPlantAndEquipmentsExplanatory> <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact000749">&lt;table cellpadding="0" cellspacing="0" id="xdx_891_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zsYU4RvqR289" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Property, plant and equipment (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;&lt;b&gt;&lt;span id="xdx_8B7_zuCCVksEoKRb" style="display: none"&gt;Schedule of property, plant and equipment&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Furniture &lt;br/&gt; and fixtures &lt;br/&gt; and other&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Computer &lt;br/&gt; hardware&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Computer &lt;br/&gt; software&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Geological &lt;br/&gt; library&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Field &lt;br/&gt; equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Mill &lt;br/&gt; equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 30%; font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zTlOacWV5X3k" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;159,171&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zu3Zr2ylv3ck" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;271,540&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zkOChTkIgeyi" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;198,981&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zD2YGxaJ9DHc" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;51,760&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zL6Hl19BFOue" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;245,647&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zlfrSvzLoSTb" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;6,568,841&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentCost_iS_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zojYjI0gaKc" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;7,495,940&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Additions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zJp5cKpmPTJg" style="font-size: 10pt; text-align: right" title="Additions"&gt;1,770&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_znUcMcoegyq1" style="font-size: 10pt; text-align: right" title="Additions"&gt;267&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_z5xhQ6d2GXrb" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0769"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zYToYcSAuuXa" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0771"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zH99strmvAg6" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0773"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_ziFPawOlLKd5" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0775"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVt54DVa7Zsi" style="font-size: 10pt; text-align: right" title="Additions"&gt;2,037&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Impairment of property, plant and equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zORzI1ft8YQ4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0779"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zj48qxULAO4e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0781"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zeuYgxeVHYwd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0783"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z8xb9CJtw7mf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0785"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zAt5xW94pAA2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0787"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zKF0GWiXTAd8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0789"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQoRUQl0UMl5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0791"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCost_iE_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zQxBsq7JsXU8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;160,941&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zVwH0w6mqzy3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;271,807&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zit0JfG8OQB7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;198,981&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zdHmWsTzWyGg" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;51,760&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zWvUM2CXmoH" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;245,647&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zyLHjQLyDBD3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNmAJ66H9hZ7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;7,497,977&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zLO4T0a6qAxd" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;153,203&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z4rxxzii5iYe" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;251,441&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_ze3OChDIRYma" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;192,138&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zZN4lj6XQyff" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;50,975&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zhp8ANGkzP45" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;237,312&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pdp0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zeYFHNGjD4Uf" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0817"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zQOkOMtzPROa" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;885,069&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zJLPZtveVVbk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;1,223&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z6wOXZOMBRVh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;6,066&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zG3zHM7ViWG1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;2,053&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zRtB05IQ1sy2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;157&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zzd3J44kxlYa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;1,667&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pdp0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z4MO7o5UTE2k" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0831"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_ztYjuvtd5Fm4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;11,166&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zf4Uyxz91a9b" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;154,426&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zORC3bAyOyU" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;257,507&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zxde7jDA9iIg" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;194,191&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zoVVKgZ1Lgb2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;51,132&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zkjG0R6aVOw9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;238,979&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pdp0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z5jvJ0MgX5ma" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0845"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20230101__20231231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zcsiy3PXtXBd" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;896,235&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Carrying amounts&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zCSzQylrGbeg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;5,968&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zGJmYIBXlGJ4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;20,099&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zZiT7UhV5HSl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;6,843&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zTHp4x1Fqj97" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;785&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zVBbzlM1zQDk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;8,335&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zYVfBA0lMqsc" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231_zrstafk6K1Rj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;6,610,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zromMDgvUB1c" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,515&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zsi73sw1fHXf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;14,300&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zRooobqEOgG1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;4,790&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zj1SN89WD0T9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;628&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zbRdd9Ht1EW2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,668&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zrIzQbFwvyM7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_pp0p0_c20231231_zxKw38BI3oB3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,601,742&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Furniture &lt;br/&gt; and fixtures &lt;br/&gt; and other&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Computer &lt;br/&gt; hardware&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Computer &lt;br/&gt; software&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Geological &lt;br/&gt; library&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Field &lt;br/&gt; equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Mill &lt;br/&gt; equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;Cost&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 30%; font-size: 10pt; font-weight: bold"&gt;December 31, 2021&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zwDnPw4yGlMd" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;158,219&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z2u2Fji7LNm4" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;267,004&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zegnSjSPn5bc" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;198,981&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z0zpopXBc139" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;51,760&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zkkd2viV1r7a" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;245,647&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zGclPpK2DHo4" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;13,968,566&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCost_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjflbfK36Eug" style="width: 7%; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, cost"&gt;14,890,177&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Additions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zCEHzTA4sNze" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;952&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zDqpB5RNQZ97" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;4,536&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zLs2koVg3Pbl" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0895"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z4UDXvygoId2" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0897"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zJC4uLyJt6Aa" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0899"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zZjYGzTww2l" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;41,568&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHZ7S5vAXotj" style="font-size: 10pt; text-align: right" title="Additions/reduction (1)"&gt;47,056&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Impairment of property, plant and equipment&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zS246QqGJo5a" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zFCfIXabO8Jl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0907"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_znlJVfB3frr3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z3iFrnEumNM2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0911"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zpPh99PUG63" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0913"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zfr7UMODmS7l" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;(7,441,293&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTp58OrEJFQa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of property, plant and equipment"&gt;(7,441,293&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zzeHdo8pMzM4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;159,171&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zqW4KKhDPW6i" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;271,540&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zeSi8fZ8anx6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;198,981&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zNONtTXPuJF9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;51,760&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zgcGPgUHROqj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;245,647&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z8JlqQWubRFl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentCost_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z9xHE9bn4rj6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, cost"&gt;7,495,940&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Accumulated depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold"&gt;December 31, 2021&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zcxqG1UfSDgl" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;151,390&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_znlfFbv70xi8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;244,043&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zC33XdWPtLwj" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;189,206&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zH21eGIHuPOj" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;50,779&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_z6RMFlsb0Jdh" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;235,227&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zWfmddzJG97c" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0943"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iS_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zZIZXoqMdEDc" style="font-size: 10pt; font-weight: bold; text-align: right" title="Balance at beginning, accumulated depreciation"&gt;870,645&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;Depreciation&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_z0rTGaDdpy08" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;1,813&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zu8RvCWhCKWa" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;7,398&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zpd0BWaFDE8j" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;2,932&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zMoFr9irY9M7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;196&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_z2gPTQ12gKv7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;2,085&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--DepreciationPropertyPlantAndEquipment_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zycT4sp5Hgok" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0957"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--DepreciationPropertyPlantAndEquipment_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zarVipnZYOM2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Depreciation"&gt;14,424&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zBBtnRXt6YJ8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;153,203&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zWYWlj5fb7yg" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;251,441&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zfyyIUSOg1j1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;192,138&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zBxNQRPGuD15" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;50,975&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_zfqU9FVpVvll" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;237,312&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pdp0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_z9m79oSqaYgc" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0971"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--PropertyPlantAndEquipmentAccumulatedDepreciation_iE_pp0p0_c20220101__20221231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAmortisationAndImpairmentMember_zXKnXf6tJsv2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance at ending, accumulated depreciation"&gt;885,069&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Carrying amounts&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;December 31, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_zcCB6AljtV2a" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;6,829&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_z6FIkyGNGsa4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;22,961&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_zeV5A96di7Zd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;9,775&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_z8i8Gn4UMoSi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;981&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_z9N9VqpKebG3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;10,420&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zA6Y0j1v55Of" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;13,968,566&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20211231_znQKu5WWyLlj" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Carrying amounts"&gt;14,019,532&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FurnitureFixturesAndFittingsMember_z6am2oBklPvb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;5,968&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--ComputerEquipmentMember_zGkbsJa5EPRl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;20,099&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--ComputerSoftwareMember_z893quSK3arl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,843&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--GeologicalLibraryMember_zCLCX0WFoocc" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;785&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--FieldEquipmentMember_z0uTMAfQkIW8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;8,335&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MillEquipmentMember_zgbZH2I47eG9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,568,841&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--PropertyPlantAndEquipment_iI_pp0p0_c20221231_z4TAWxN5tY9d" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Carrying amounts"&gt;6,610,871&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000751" unitRef="CAD">159171</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000753" unitRef="CAD">271540</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000755" unitRef="CAD">198981</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000757" unitRef="CAD">51760</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember" decimals="0" id="Fact000759" unitRef="CAD">245647</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember" decimals="0" id="Fact000761" unitRef="CAD">6568841</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember" decimals="0" id="Fact000763" unitRef="CAD">7495940</aau:PropertyPlantAndEquipmentCost> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000765" unitRef="CAD">1770</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000767" unitRef="CAD">267</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_GrossCarryingAmountMember" decimals="0" id="Fact000777" unitRef="CAD">2037</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000793" unitRef="CAD">160941</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000795" unitRef="CAD">271807</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000797" unitRef="CAD">198981</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000799" unitRef="CAD">51760</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember" decimals="0" id="Fact000801" unitRef="CAD">245647</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember" decimals="0" id="Fact000803" unitRef="CAD">6568841</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2023-12-31_ifrs-full_GrossCarryingAmountMember" decimals="0" id="Fact000805" unitRef="CAD">7497977</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000807" unitRef="CAD">153203</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000809" unitRef="CAD">251441</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000811" unitRef="CAD">192138</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000813" unitRef="CAD">50975</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember" decimals="0" id="Fact000815" unitRef="CAD">237312</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" decimals="0" id="Fact000819" unitRef="CAD">885069</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000821" unitRef="CAD">1223</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000823" unitRef="CAD">6066</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000825" unitRef="CAD">2053</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000827" unitRef="CAD">157</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember" decimals="0" id="Fact000829" unitRef="CAD">1667</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2023-01-012023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" decimals="0" id="Fact000833" unitRef="CAD">11166</ifrs-full:DepreciationPropertyPlantAndEquipment> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000835" unitRef="CAD">154426</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000837" unitRef="CAD">257507</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000839" unitRef="CAD">194191</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000841" unitRef="CAD">51132</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember" decimals="0" id="Fact000843" unitRef="CAD">238979</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2023-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" decimals="0" id="Fact000847" unitRef="CAD">896235</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000849" unitRef="CAD">5968</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000851" unitRef="CAD">20099</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000853" unitRef="CAD">6843</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_custom_GeologicalLibraryMember" decimals="0" id="Fact000855" unitRef="CAD">785</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_custom_FieldEquipmentMember" decimals="0" id="Fact000857" unitRef="CAD">8335</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_custom_MillEquipmentMember" decimals="0" id="Fact000859" unitRef="CAD">6568841</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31" decimals="0" id="Fact000861" unitRef="CAD">6610871</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2023-12-31_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000863" unitRef="CAD">6515</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2023-12-31_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000865" unitRef="CAD">14300</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2023-12-31_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000867" unitRef="CAD">4790</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2023-12-31_custom_GeologicalLibraryMember" decimals="0" id="Fact000869" unitRef="CAD">628</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2023-12-31_custom_FieldEquipmentMember" decimals="0" id="Fact000871" unitRef="CAD">6668</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2023-12-31_custom_MillEquipmentMember" decimals="0" id="Fact000873" unitRef="CAD">6568841</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2023-12-31" decimals="0" id="Fact000875" unitRef="CAD">6601742</ifrs-full:PropertyPlantAndEquipment> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000877" unitRef="CAD">158219</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000879" unitRef="CAD">267004</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000881" unitRef="CAD">198981</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000883" unitRef="CAD">51760</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember" decimals="0" id="Fact000885" unitRef="CAD">245647</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember" decimals="0" id="Fact000887" unitRef="CAD">13968566</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember" decimals="0" id="Fact000889" unitRef="CAD">14890177</aau:PropertyPlantAndEquipmentCost> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000891" unitRef="CAD">952</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000893" unitRef="CAD">4536</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember" decimals="0" id="Fact000901" unitRef="CAD">41568</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment> <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" decimals="0" id="Fact000903" unitRef="CAD">47056</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember" decimals="0" id="Fact000915" unitRef="CAD">-7441293</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment> <ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_GrossCarryingAmountMember" decimals="0" id="Fact000917" unitRef="CAD">-7441293</ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000919" unitRef="CAD">159171</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000921" unitRef="CAD">271540</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000923" unitRef="CAD">198981</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000925" unitRef="CAD">51760</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_FieldEquipmentMember" decimals="0" id="Fact000927" unitRef="CAD">245647</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember_custom_MillEquipmentMember" decimals="0" id="Fact000929" unitRef="CAD">6568841</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentCost contextRef="AsOf2022-12-31_ifrs-full_GrossCarryingAmountMember" decimals="0" id="Fact000931" unitRef="CAD">7495940</aau:PropertyPlantAndEquipmentCost> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000933" unitRef="CAD">151390</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000935" unitRef="CAD">244043</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000937" unitRef="CAD">189206</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000939" unitRef="CAD">50779</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember" decimals="0" id="Fact000941" unitRef="CAD">235227</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" decimals="0" id="Fact000945" unitRef="CAD">870645</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000947" unitRef="CAD">1813</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000949" unitRef="CAD">7398</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000951" unitRef="CAD">2932</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000953" unitRef="CAD">196</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember" decimals="0" id="Fact000955" unitRef="CAD">2085</ifrs-full:DepreciationPropertyPlantAndEquipment> <ifrs-full:DepreciationPropertyPlantAndEquipment contextRef="From2022-01-012022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" decimals="0" id="Fact000959" unitRef="CAD">14424</ifrs-full:DepreciationPropertyPlantAndEquipment> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000961" unitRef="CAD">153203</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000963" unitRef="CAD">251441</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000965" unitRef="CAD">192138</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_GeologicalLibraryMember" decimals="0" id="Fact000967" unitRef="CAD">50975</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_custom_FieldEquipmentMember" decimals="0" id="Fact000969" unitRef="CAD">237312</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <aau:PropertyPlantAndEquipmentAccumulatedDepreciation contextRef="AsOf2022-12-31_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" decimals="0" id="Fact000973" unitRef="CAD">885069</aau:PropertyPlantAndEquipmentAccumulatedDepreciation> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000975" unitRef="CAD">6829</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000977" unitRef="CAD">22961</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000979" unitRef="CAD">9775</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31_custom_GeologicalLibraryMember" decimals="0" id="Fact000981" unitRef="CAD">981</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31_custom_FieldEquipmentMember" decimals="0" id="Fact000983" unitRef="CAD">10420</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31_custom_MillEquipmentMember" decimals="0" id="Fact000985" unitRef="CAD">13968566</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="0" id="Fact000987" unitRef="CAD">14019532</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_custom_FurnitureFixturesAndFittingsMember" decimals="0" id="Fact000989" unitRef="CAD">5968</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_ifrs-full_ComputerEquipmentMember" decimals="0" id="Fact000991" unitRef="CAD">20099</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_ifrs-full_ComputerSoftwareMember" decimals="0" id="Fact000993" unitRef="CAD">6843</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_custom_GeologicalLibraryMember" decimals="0" id="Fact000995" unitRef="CAD">785</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_custom_FieldEquipmentMember" decimals="0" id="Fact000997" unitRef="CAD">8335</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31_custom_MillEquipmentMember" decimals="0" id="Fact000999" unitRef="CAD">6568841</ifrs-full:PropertyPlantAndEquipment> <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2022-12-31" decimals="0" id="Fact001001" unitRef="CAD">6610871</ifrs-full:PropertyPlantAndEquipment> <aau:ImpairmentOfPropertyPlantsAndEquipment contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001007" unitRef="CAD">7441293</aau:ImpairmentOfPropertyPlantsAndEquipment> <ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001009">&lt;p id="xdx_809_eifrs-full--DisclosureOfExplorationAndEvaluationAssetsExplanatory_z7ysOjOFdW2d" style="margin: 0pt 0; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;7.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82E_zbTckd1MdRO9"&gt;Exploration and evaluation assets&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfExplorationAndEvaluationAssetTextBlock_zfopRWpCzTUk" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Exploration and evaluation assets (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;&lt;span id="xdx_8BB_zD2ppMvUk6Rc" style="display: none"&gt;Schedule of exploration and evaluation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Tuligtic&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Other Property&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Acquisition costs:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 55%; font-size: 10pt; font-weight: bold; text-align: left"&gt;Opening balance - (December 31, 2022)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zCX3o0pf5jek" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;11,308,721&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zxn3AuwwJU9j" style="font-size: 10pt; text-align: right; width: 12%" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1015"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20230101__20231231_z3DyLMuaMgWi" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;11,308,721&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;Additions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zES7vgCQgtT1" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1019"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zAHfchAQMyY9" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1021"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pp0p0_c20230101__20231231_zqvYKw2NJB0l" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1023"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;Deductions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z5oMppuYSl58" style="font-size: 10pt; text-align: right" title="Deductions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zFb0Rq55hXmd" style="font-size: 10pt; text-align: right" title="Deductions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1027"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pp0p0_c20230101__20231231_zrrNMFRTS5g4" style="font-size: 10pt; text-align: right" title="Deductions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1029"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Impairment of acquisition costs&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_iN_pp0p0_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zPmsNhU21jg9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of acquisition costs"&gt;(11,308,720&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_iN_pp0p0_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z7tcjkZgLjY2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of acquisition costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1033"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_iN_pp0p0_di_c20230101__20231231_zIIyWova2Q11" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of acquisition costs"&gt;(11,308,720&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Closing balance - (December 31, 2023)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zjKynoHimXKj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zHbqlfvcltN3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1039"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20230101__20231231_zA65H6LSyRlj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Deferred exploration costs:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Opening balance - (December 31, 2022)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zGcTuDW6Gpt8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;51,806,355&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zJ7xMEEg28mk" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1045"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pp0p0_c20230101__20231231_z9VOuoOEzo52" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;51,806,355&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Costs incurred during the year&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Professional/technical fees&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ProfessionaltechnicalFees_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zCxzBBAHOPZj" style="font-size: 10pt; text-align: right" title="Professional/technical fees"&gt;159,031&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ProfessionaltechnicalFees_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zyF5YAoJi8J2" style="font-size: 10pt; text-align: right" title="Professional/technical fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1051"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ProfessionaltechnicalFees_pp0p0_c20230101__20231231_zj1VA455sCK8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Professional/technical fees"&gt;159,031&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Geochemical, metallurgy&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--GeochemicalAndMetallurgyCosts_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zatDq15eRp8e" style="font-size: 10pt; text-align: right" title="Geochemical, metallurgy"&gt;1,022&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--GeochemicalAndMetallurgyCosts_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z6dGTYw2DnPg" style="font-size: 10pt; text-align: right" title="Geochemical, metallurgy"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1057"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--GeochemicalAndMetallurgyCosts_pp0p0_c20230101__20231231_zglaMovEuX3h" style="font-size: 10pt; font-weight: bold; text-align: right" title="Geochemical, metallurgy"&gt;1,022&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Travel and accommodation&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TravelAndAccommodationExpense_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z7UIV4iL97Dc" style="font-size: 10pt; text-align: right" title="Travel and accommodation"&gt;70,324&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--TravelAndAccommodationExpense_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zi4voPbtzzt2" style="font-size: 10pt; text-align: right" title="Travel and accommodation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1063"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--TravelAndAccommodationExpense_pp0p0_c20230101__20231231_ztYoM4a7F7Sl" style="font-size: 10pt; font-weight: bold; text-align: right" title="Travel and accommodation"&gt;70,324&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Geology, geophysics and exploration&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--GeologyGeophysicsAndExplorationCosts_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zQFnHGY6l79e" style="font-size: 10pt; text-align: right" title="Geology, geophysics and exploration"&gt;172,455&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--GeologyGeophysicsAndExplorationCosts_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zNsWDOfbWBb7" style="font-size: 10pt; text-align: right" title="Geology, geophysics and exploration"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1069"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--GeologyGeophysicsAndExplorationCosts_pp0p0_c20230101__20231231_zaxAudABa1k4" style="font-size: 10pt; font-weight: bold; text-align: right" title="Geology, geophysics and exploration"&gt;172,455&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Supplies and miscellaneous&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SuppliesAndMiscellaneousCosts_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z3oe77dA1k78" style="font-size: 10pt; text-align: right" title="Supplies and miscellaneous"&gt;318,047&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SuppliesAndMiscellaneousCosts_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zUmBfMNvViDe" style="font-size: 10pt; text-align: right" title="Supplies and miscellaneous"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1075"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SuppliesAndMiscellaneousCosts_pp0p0_c20230101__20231231_zwpenurc7FHi" style="font-size: 10pt; font-weight: bold; text-align: right" title="Supplies and miscellaneous"&gt;318,047&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Environmental and permit&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EnvironmentalStudies_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zP8ab28Kj1d8" style="font-size: 10pt; text-align: right" title="Environmental and permit"&gt;384,421&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EnvironmentalStudies_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zeGj3RtChDd" style="font-size: 10pt; text-align: right" title="Environmental and permit"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1081"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EnvironmentalStudies_pp0p0_c20230101__20231231_zNUKyyS9mBz6" style="font-size: 10pt; font-weight: bold; text-align: right" title="Environmental and permit"&gt;384,421&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Value-added tax (Note 4)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ValueAddedTaxExpense_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zQCv0NPV27fg" style="font-size: 10pt; text-align: right" title="Value-added tax (Note 4)"&gt;164,189&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ValueAddedTaxExpense_pp0p0_c20230101__20231231_zCUjYKeM6Gzl" style="font-size: 10pt; font-weight: bold; text-align: right" title="Value-added tax (Note 4)"&gt;164,189&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Refund - Value-added tax&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ValueAddedTaxRefund_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zYK2ZH5DXnc2" style="font-size: 10pt; text-align: right" title="Refund - Value-added tax"&gt;(561,086&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ValueAddedTaxRefund_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zLzlYYjo3j2h" style="font-size: 10pt; text-align: right" title="Refund - Value-added tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1091"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ValueAddedTaxRefund_pp0p0_c20230101__20231231_zeTQUvtQmcub" style="font-size: 10pt; font-weight: bold; text-align: right" title="Refund - Value-added tax"&gt;(561,086&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Impairment of deferred exploration cost&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ImpairmentOfDeferredExplorationCost_iN_pp0p0_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zgrd1dvZcfCd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of deferred exploration cost"&gt;(52,514,758&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ImpairmentOfDeferredExplorationCost_iN_pp0p0_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zQhUxKf5Zrui" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of deferred exploration cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1097"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ImpairmentOfDeferredExplorationCost_iN_pp0p0_di_c20230101__20231231_z6qzl0zKDoCj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Impairment of deferred exploration cost"&gt;(52,514,758&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Total deferred exploration costs during the year&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DeferredExplorationCosts_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zB8DxeP1r1El" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;(51,806,355&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DeferredExplorationCosts_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z0gPgYgidqHl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1103"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DeferredExplorationCosts_pp0p0_c20230101__20231231_zIi6dzRudOje" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;(51,806,355&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Closing balance - (December 31, 2023)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zUm1sw4KwbRd" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1107"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z2hYSNwbMVVj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1109"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pp0p0_c20230101__20231231_zkSchUACcV21" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1111"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Total exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zJAqe0fzxP3k" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zDA9wxssYoMf" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20231231_zV3VsXcWmaz3" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;During the year ended December 31, 2023, the Company recorded an impairment of acquisition cost of $&lt;span id="xdx_905_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zyJvcILqNBt9" title="Impairment of acquisition costs"&gt;11,308,720&lt;/span&gt; (2022 - $Nil&lt;span id="xdx_90A_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zP6pMxvnj0k7" style="display: none" title="Impairment of acquisition costs"&gt;0&lt;/span&gt;) and deferred exploration costs of $&lt;span id="xdx_90C_ecustom--ImpairmentOfDeferredExplorationCost_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zyEg5a4h50Tl" title="Impairment of deferred exploration cost"&gt;52,514,758&lt;/span&gt; (2022 - $Nil&lt;span id="xdx_906_ecustom--ImpairmentOfDeferredExplorationCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zASTz2zUUtf1" style="display: none" title="Impairment of deferred exploration cost"&gt;0&lt;/span&gt;) with respect to Tuligtic property due to the Mexican government&#x2019;s action to revoke the Company&#x2019;s mineral concession title and to prevent any further exploration and development plans on the Tuligtic property.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.95pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Title to exploration and evaluation assets involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the potential for problems arising from the frequently ambiguous conveyancing history characteristic of many mineral claims.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.95pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Tuligtic&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Other Property&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Acquisition costs:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 55%; font-size: 10pt; font-weight: bold; text-align: left"&gt;Opening balance - (December 31, 2021)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zM7hoIryreR2" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;11,211,756&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zsD45vtkGeIj" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20220101__20221231_zmicojprRPbk" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;11,211,757&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;Additions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zM81Kjyrhpgb" style="font-size: 10pt; text-align: right" title="Additions"&gt;96,965&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zivR1UEXy6ac" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1139"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pp0p0_c20220101__20221231_ziuDOCLVyO2k" style="font-size: 10pt; text-align: right" title="Additions"&gt;96,965&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;Deductions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zA0Cg3CL0SU9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Deductions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1143"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zqTR1TwH7S4g" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Deductions"&gt;(1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pp0p0_c20220101__20221231_zFj02TYGJoL1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Deductions"&gt;(1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Closing balance - (December 31, 2022)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zViwptJGKsOl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;11,308,721&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zCfaK5GtqHkb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1151"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20220101__20221231_z4zrlqmzFvjk" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;11,308,721&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Deferred exploration costs:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Opening balance - (December 31, 2021)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zhGfvm7rtpsa" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;50,219,882&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z0HVFPcXwJYc" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1157"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pp0p0_c20220101__20221231_z4g3vNPXCFV1" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;50,219,882&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Costs incurred during the year&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Professional/technical fees&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ProfessionaltechnicalFees_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zHZnWEKCDft7" style="font-size: 10pt; text-align: right" title="Professional/technical fees"&gt;143,075&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ProfessionaltechnicalFees_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zSwzWzZdatyj" style="font-size: 10pt; text-align: right" title="Professional/technical fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1163"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ProfessionaltechnicalFees_pp0p0_c20220101__20221231_z70DuUYgg0Z5" style="font-size: 10pt; font-weight: bold; text-align: right" title="Professional/technical fees"&gt;143,075&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Claim maintenance/lease costs&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClaimMaintenanceAndLeaseCosts_iP3custom--ProfessionaltechnicalFees_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z5f7KiGWacP4" style="font-size: 10pt; text-align: right" title="Claim maintenance/lease costs"&gt;169,651&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClaimMaintenanceAndLeaseCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zYMuZ2OkEtw9" style="font-size: 10pt; text-align: right" title="Claim maintenance/lease costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClaimMaintenanceAndLeaseCosts_pp0p0_c20220101__20221231_zZVBrcw0r3Sb" style="font-size: 10pt; font-weight: bold; text-align: right" title="Claim maintenance/lease costs"&gt;169,651&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Geochemical, metallurgy&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--GeochemicalAndMetallurgyCosts_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zJAatel4fKC2" style="font-size: 10pt; text-align: right" title="Geochemical, metallurgy"&gt;3,929&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--GeochemicalAndMetallurgyCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zSnKKCXOk8ri" style="font-size: 10pt; text-align: right" title="Geochemical, metallurgy"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--GeochemicalAndMetallurgyCosts_pp0p0_c20220101__20221231_zYMwa8dDJZec" style="font-size: 10pt; font-weight: bold; text-align: right" title="Geochemical, metallurgy"&gt;3,929&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Travel and accommodation&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--TravelAndAccommodationExpense_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zJOHH7eBSkM9" style="font-size: 10pt; text-align: right" title="Travel and accommodation"&gt;155,195&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--TravelAndAccommodationExpense_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zGnmDjTYAEPd" style="font-size: 10pt; text-align: right" title="Travel and accommodation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1181"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--TravelAndAccommodationExpense_pp0p0_c20220101__20221231_z4GHTVVkv2r3" style="font-size: 10pt; font-weight: bold; text-align: right" title="Travel and accommodation"&gt;155,195&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Geology, geophysics and exploration&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--GeologyGeophysicsAndExplorationCosts_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zRqXKvyF6Qaj" style="font-size: 10pt; text-align: right" title="Geology, geophysics and exploration"&gt;307,712&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--GeologyGeophysicsAndExplorationCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zkVIi3lXeD1b" style="font-size: 10pt; text-align: right" title="Geology, geophysics and exploration"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--GeologyGeophysicsAndExplorationCosts_pp0p0_c20220101__20221231_zo0njGa3JRej" style="font-size: 10pt; font-weight: bold; text-align: right" title="Geology, geophysics and exploration"&gt;307,712&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Supplies and miscellaneous&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SuppliesAndMiscellaneousCosts_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zvg0NoZELSVh" style="font-size: 10pt; text-align: right" title="Supplies and miscellaneous"&gt;310,804&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SuppliesAndMiscellaneousCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zldzdyPRqBp4" style="font-size: 10pt; text-align: right" title="Supplies and miscellaneous"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SuppliesAndMiscellaneousCosts_pp0p0_c20220101__20221231_zUdD5sTRCyc5" style="font-size: 10pt; font-weight: bold; text-align: right" title="Supplies and miscellaneous"&gt;310,804&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Environmental and permit&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--EnvironmentalStudies_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z2w5nbaoETH6" style="font-size: 10pt; text-align: right" title="Environmental and permit"&gt;640,541&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--EnvironmentalStudies_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zHUsoEr7GmW4" style="font-size: 10pt; text-align: right" title="Environmental and permit"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--EnvironmentalStudies_pp0p0_c20220101__20221231_z3K201LfquFh" style="font-size: 10pt; font-weight: bold; text-align: right" title="Environmental and permit"&gt;640,541&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Value-added tax (Note 4)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ValueAddedTaxExpense_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zPLJCcqtvlW9" style="font-size: 10pt; text-align: right" title="Value-added tax (Note 4)"&gt;251,775&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ValueAddedTaxExpense_pp0p0_c20220101__20221231_zOTS6b9CTj9i" style="font-size: 10pt; font-weight: bold; text-align: right" title="Value-added tax (Note 4)"&gt;251,775&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Refund - Value-added tax&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ValueAddedTaxRefund_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zmmvy4L6P1B6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Refund - Value-added tax"&gt;(396,209&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ValueAddedTaxRefund_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zhpTQwkemNL" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Refund - Value-added tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1209"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ValueAddedTaxRefund_pp0p0_c20220101__20221231_z85TBZUbF6C8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Refund - Value-added tax"&gt;(396,209&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Total deferred exploration costs during the year&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DeferredExplorationCosts_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zdYwjVhMUfG3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;1,586,473&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--DeferredExplorationCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zz814z2uIVG3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DeferredExplorationCosts_pp0p0_c20220101__20221231_zkojG9Kp36E9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;1,586,473&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Closing balance - (December 31, 2022)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zJSto0WxEjb7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;51,806,355&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zb0IBxsa2tta" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1221"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pp0p0_c20220101__20221231_zpDXWrZcLLc7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;51,806,355&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Total exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zj9uAJKrTnGi" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;63,115,076&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zc9xlFfzbh7b" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1227"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20221231_z6CyBAxaZLfa" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;63,115,076&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8AC_zEN5Ig7Q0V0g" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.95pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.95pt"&gt;The following is a description of the Company&#x2019;s most significant property interests:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(a)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Tuligtic&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Tuligtic property consisted of two mineral concessions which the Company applied for in 2002 and 2008. The mineral concessions were granted in 2003 and 2009, respectively (&#x201c;the &#x201c;Concessions&#x201d;). The Company held a 100% interest in the Concessions subject to a 2.0% NSR royalty held by Almadex Minerals Ltd (&#x2018;&#x2019;Almadex&#x201d;). The Concessions covered approximately 14,000 Ha, including certain endowed lands of the Ejido Tecoltemi, which comprise approximately 330 Ha. The Concessions are located in Puebla, Mexico and underpinned the discovery made by the Company in 2010, referred to as &#x201c;Ixtaca&#x201d;.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;In 2015, the Ejido Tecoltemi initiated a lawsuit against the Mexican government (President, Congress, Ministry of Economy, Directorate of Mines, Mining Registry Office) asserting that the Mexican mining law is unconstitutional because it fails to include provisions requiring consultation of indigenous communities before granting mineral titles. This lawsuit ultimately came before Mexico&#x2019;s Supreme Court (&#x201c;SCJN&#x201d;), and in early 2022, the SCJN ruled that the Mexican mineral title law is constitutional, but that the Ministry of Economy (&#x201c;Economia&#x201d;) should have provided for a consultation procedure with relevant indigenous communities prior to issuing the Concessions to the Company. The SCJN ordered Economia to declare the Concessions ineffective - to revert them to application status - and to conduct indigenous consultation prior to re-issuing them.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;In July, 2022 the Company announced that Economia notified Almaden that the Concessions were &#x201c;ineffective&#x201d;. The Company understood that the mineral title had reverted to application status, and that these applications preserved the mineral rights for Almaden but did not allow the Company to engage in exploration, until such time as Economia completed its court-ordered process to properly issue the Concessions after conducting indigenous consultation in the area covered by the mineral title applications.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;However, on February 22, 2023, Economia made a submission to Mexican courts seeking to deny the two mineral title applications which were first made by Almaden in 2002 and 2008 (the &#x201c;Submission&#x201d;). The Submission claimed that the applications contain technical faults, despite Economia&#x2019;s previous statements to the contrary and its acceptance of the mineral title applications and grant of the Concessions in 2003 and 2009.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;This Submission has been reviewed by the Mexican district and appeals courts, which have ruled that the Submission complies with the SCJN ruling. However, the appeals court&#x2019;s ruling did not address the validity of the Submission and therefore safeguarded the Company&#x2019;s right to challenge the substance and legality of the Submission through the Mexican Federal Administrative Court (&#x201c;TFJA&#x201d;), which the Company has done.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The TFJA has granted a definitive injunction to Almaden&#x2019;s Mexican subsidiary, Minera Gorri&#xf3;n (&#x201c;MG&#x201d;), which prevents Economia from releasing the mineral rights covered by the Company&#x2019;s mineral title applications to third parties while the TFJA trial regarding the substance and legality of the Submission continues.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;In summary, the rights held by Almaden to the Ixtaca project are now based on two mineral title applications which have been denied by Economia, through its issuance of the Submission. The Company is in the process of disputing this denial through the Mexican Federal Administrative Court.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(b)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Other Property&lt;/i&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;On May 26, 2022, the Company transferred the &lt;span id="xdx_907_ecustom--ProportionOfOwnershipInterestInAssociates_dp_c20220525__20220526__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LoganPropertyLocatedInTheYukonTerritoryCanadaMember_zbfna1WyyxXi" title="Proportion of ownership interest in associate"&gt;40&lt;/span&gt;% carried interest in the Logan property located in the Yukon Territory, Canada to Almadex for a consideration of $&lt;span id="xdx_90A_ecustom--CarryingValueOfPropertyConsideration_iI_pp0p0_c20220526__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LoganPropertyLocatedInTheYukonTerritoryCanadaMember_zLi2mQtxpqv7" title="Carrying value of property"&gt;1&lt;/span&gt; equal to its carrying value. No gain or loss was recognized in the statement of comprehensive loss.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(c)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Other&lt;/i&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Expenditures incurred by the Company in Mexico are subject to Mexican Value added tax (&#x201c;VAT&#x201d;). The VAT is included in exploration and evaluation assets as incurred. Under Mexican law, VAT paid can be used in the future to offset amounts resulting from VAT charged on sales. Under certain circumstances and subject to approval from tax authorities, A Company can also apply for an early refund of VAT prior to generating sales. During 2023, the Company received a VAT recovery of $&lt;span id="xdx_900_ecustom--VatRecovery_pp0p0_c20230101__20231231_z6c5uNfOVv37" title="VAT recovery"&gt;561,086&lt;/span&gt; (2022 - &lt;span id="xdx_906_ecustom--VatRecovery_pp0p0_c20220101__20221231_zX8ra3m5TsNc" title="VAT recovery"&gt;396,209&lt;/span&gt;; $2021 - $&lt;span id="xdx_906_ecustom--VatRecovery_pp0p0_c20210101__20211231_z3PLvPywFFm7" title="VAT recovery"&gt;506,394&lt;/span&gt;) and other income of $&lt;span id="xdx_906_ecustom--VatRefundFromPriorYears_pp0p0_c20230101__20231231_zngsqSmPPwE2" title="VAT refund from prior years"&gt;173,876&lt;/span&gt; (2022 - $&lt;span id="xdx_905_ecustom--VatRefundFromPriorYears_pp0p0_c20220101__20221231_z7dzEe87TT8d" title="VAT refund from prior years"&gt;139,313&lt;/span&gt;; 2021 - $&lt;span id="xdx_907_ecustom--VatRefundFromPriorYears_pp0p0_c20210101__20211231_zV6VRZx0koUk" title="VAT refund from prior years"&gt;446,184&lt;/span&gt;) related to a VAT refund from prior years which is recorded in interest and other income.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DisclosureOfExplorationAndEvaluationAssetsExplanatory> <aau:DisclosureOfExplorationAndEvaluationAssetTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001011">&lt;table cellpadding="0" cellspacing="0" id="xdx_893_ecustom--DisclosureOfExplorationAndEvaluationAssetTextBlock_zfopRWpCzTUk" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Exploration and evaluation assets (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;&lt;span id="xdx_8BB_zD2ppMvUk6Rc" style="display: none"&gt;Schedule of exploration and evaluation assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Tuligtic&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Other Property&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Acquisition costs:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 55%; font-size: 10pt; font-weight: bold; text-align: left"&gt;Opening balance - (December 31, 2022)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zCX3o0pf5jek" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;11,308,721&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zxn3AuwwJU9j" style="font-size: 10pt; text-align: right; width: 12%" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1015"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20230101__20231231_z3DyLMuaMgWi" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;11,308,721&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;Additions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zES7vgCQgtT1" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1019"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zAHfchAQMyY9" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1021"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pp0p0_c20230101__20231231_zqvYKw2NJB0l" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1023"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;Deductions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z5oMppuYSl58" style="font-size: 10pt; text-align: right" title="Deductions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1025"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zFb0Rq55hXmd" style="font-size: 10pt; text-align: right" title="Deductions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1027"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pp0p0_c20230101__20231231_zrrNMFRTS5g4" style="font-size: 10pt; text-align: right" title="Deductions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1029"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Impairment of acquisition costs&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_iN_pp0p0_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zPmsNhU21jg9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of acquisition costs"&gt;(11,308,720&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_iN_pp0p0_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z7tcjkZgLjY2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of acquisition costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1033"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_iN_pp0p0_di_c20230101__20231231_zIIyWova2Q11" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of acquisition costs"&gt;(11,308,720&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Closing balance - (December 31, 2023)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zjKynoHimXKj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zHbqlfvcltN3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1039"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20230101__20231231_zA65H6LSyRlj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Deferred exploration costs:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Opening balance - (December 31, 2022)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zGcTuDW6Gpt8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;51,806,355&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zJ7xMEEg28mk" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1045"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pp0p0_c20230101__20231231_z9VOuoOEzo52" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;51,806,355&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Costs incurred during the year&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Professional/technical fees&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ProfessionaltechnicalFees_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zCxzBBAHOPZj" style="font-size: 10pt; text-align: right" title="Professional/technical fees"&gt;159,031&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ProfessionaltechnicalFees_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zyF5YAoJi8J2" style="font-size: 10pt; text-align: right" title="Professional/technical fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1051"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ProfessionaltechnicalFees_pp0p0_c20230101__20231231_zj1VA455sCK8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Professional/technical fees"&gt;159,031&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Geochemical, metallurgy&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--GeochemicalAndMetallurgyCosts_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zatDq15eRp8e" style="font-size: 10pt; text-align: right" title="Geochemical, metallurgy"&gt;1,022&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--GeochemicalAndMetallurgyCosts_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z6dGTYw2DnPg" style="font-size: 10pt; text-align: right" title="Geochemical, metallurgy"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1057"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--GeochemicalAndMetallurgyCosts_pp0p0_c20230101__20231231_zglaMovEuX3h" style="font-size: 10pt; font-weight: bold; text-align: right" title="Geochemical, metallurgy"&gt;1,022&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Travel and accommodation&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--TravelAndAccommodationExpense_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z7UIV4iL97Dc" style="font-size: 10pt; text-align: right" title="Travel and accommodation"&gt;70,324&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--TravelAndAccommodationExpense_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zi4voPbtzzt2" style="font-size: 10pt; text-align: right" title="Travel and accommodation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1063"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--TravelAndAccommodationExpense_pp0p0_c20230101__20231231_ztYoM4a7F7Sl" style="font-size: 10pt; font-weight: bold; text-align: right" title="Travel and accommodation"&gt;70,324&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Geology, geophysics and exploration&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--GeologyGeophysicsAndExplorationCosts_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zQFnHGY6l79e" style="font-size: 10pt; text-align: right" title="Geology, geophysics and exploration"&gt;172,455&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--GeologyGeophysicsAndExplorationCosts_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zNsWDOfbWBb7" style="font-size: 10pt; text-align: right" title="Geology, geophysics and exploration"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1069"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--GeologyGeophysicsAndExplorationCosts_pp0p0_c20230101__20231231_zaxAudABa1k4" style="font-size: 10pt; font-weight: bold; text-align: right" title="Geology, geophysics and exploration"&gt;172,455&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Supplies and miscellaneous&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--SuppliesAndMiscellaneousCosts_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z3oe77dA1k78" style="font-size: 10pt; text-align: right" title="Supplies and miscellaneous"&gt;318,047&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--SuppliesAndMiscellaneousCosts_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zUmBfMNvViDe" style="font-size: 10pt; text-align: right" title="Supplies and miscellaneous"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1075"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--SuppliesAndMiscellaneousCosts_pp0p0_c20230101__20231231_zwpenurc7FHi" style="font-size: 10pt; font-weight: bold; text-align: right" title="Supplies and miscellaneous"&gt;318,047&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Environmental and permit&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EnvironmentalStudies_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zP8ab28Kj1d8" style="font-size: 10pt; text-align: right" title="Environmental and permit"&gt;384,421&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EnvironmentalStudies_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zeGj3RtChDd" style="font-size: 10pt; text-align: right" title="Environmental and permit"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1081"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--EnvironmentalStudies_pp0p0_c20230101__20231231_zNUKyyS9mBz6" style="font-size: 10pt; font-weight: bold; text-align: right" title="Environmental and permit"&gt;384,421&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Value-added tax (Note 4)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ValueAddedTaxExpense_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zQCv0NPV27fg" style="font-size: 10pt; text-align: right" title="Value-added tax (Note 4)"&gt;164,189&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ValueAddedTaxExpense_pp0p0_c20230101__20231231_zCUjYKeM6Gzl" style="font-size: 10pt; font-weight: bold; text-align: right" title="Value-added tax (Note 4)"&gt;164,189&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Refund - Value-added tax&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ValueAddedTaxRefund_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zYK2ZH5DXnc2" style="font-size: 10pt; text-align: right" title="Refund - Value-added tax"&gt;(561,086&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ValueAddedTaxRefund_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zLzlYYjo3j2h" style="font-size: 10pt; text-align: right" title="Refund - Value-added tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1091"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ValueAddedTaxRefund_pp0p0_c20230101__20231231_zeTQUvtQmcub" style="font-size: 10pt; font-weight: bold; text-align: right" title="Refund - Value-added tax"&gt;(561,086&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Impairment of deferred exploration cost&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ImpairmentOfDeferredExplorationCost_iN_pp0p0_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zgrd1dvZcfCd" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of deferred exploration cost"&gt;(52,514,758&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ImpairmentOfDeferredExplorationCost_iN_pp0p0_di_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zQhUxKf5Zrui" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Impairment of deferred exploration cost"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1097"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ImpairmentOfDeferredExplorationCost_iN_pp0p0_di_c20230101__20231231_z6qzl0zKDoCj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Impairment of deferred exploration cost"&gt;(52,514,758&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Total deferred exploration costs during the year&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DeferredExplorationCosts_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zB8DxeP1r1El" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;(51,806,355&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--DeferredExplorationCosts_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z0gPgYgidqHl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1103"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DeferredExplorationCosts_pp0p0_c20230101__20231231_zIi6dzRudOje" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;(51,806,355&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Closing balance - (December 31, 2023)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pp0p0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zUm1sw4KwbRd" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1107"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pdp0_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z2hYSNwbMVVj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1109"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pp0p0_c20230101__20231231_zkSchUACcV21" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1111"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Total exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zJAqe0fzxP3k" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zDA9wxssYoMf" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1115"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20231231_zV3VsXcWmaz3" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;1&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;During the year ended December 31, 2023, the Company recorded an impairment of acquisition cost of $&lt;span id="xdx_905_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zyJvcILqNBt9" title="Impairment of acquisition costs"&gt;11,308,720&lt;/span&gt; (2022 - $Nil&lt;span id="xdx_90A_ecustom--ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zP6pMxvnj0k7" style="display: none" title="Impairment of acquisition costs"&gt;0&lt;/span&gt;) and deferred exploration costs of $&lt;span id="xdx_90C_ecustom--ImpairmentOfDeferredExplorationCost_c20230101__20231231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zyEg5a4h50Tl" title="Impairment of deferred exploration cost"&gt;52,514,758&lt;/span&gt; (2022 - $Nil&lt;span id="xdx_906_ecustom--ImpairmentOfDeferredExplorationCost_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zASTz2zUUtf1" style="display: none" title="Impairment of deferred exploration cost"&gt;0&lt;/span&gt;) with respect to Tuligtic property due to the Mexican government&#x2019;s action to revoke the Company&#x2019;s mineral concession title and to prevent any further exploration and development plans on the Tuligtic property.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.95pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Title to exploration and evaluation assets involves certain inherent risks due to the difficulties of determining the validity of certain claims as well as the potential for problems arising from the frequently ambiguous conveyancing history characteristic of many mineral claims.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -1.95pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Tuligtic&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Other Property&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Acquisition costs:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="width: 55%; font-size: 10pt; font-weight: bold; text-align: left"&gt;Opening balance - (December 31, 2021)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zM7hoIryreR2" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;11,211,756&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zsD45vtkGeIj" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;1&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iS_pp0p0_c20220101__20221231_zmicojprRPbk" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;11,211,757&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;Additions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zM81Kjyrhpgb" style="font-size: 10pt; text-align: right" title="Additions"&gt;96,965&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zivR1UEXy6ac" style="font-size: 10pt; text-align: right" title="Additions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1139"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExplorationAndEvaluationAssetsTransactionCostAdditions_pp0p0_c20220101__20221231_ziuDOCLVyO2k" style="font-size: 10pt; text-align: right" title="Additions"&gt;96,965&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-indent: 14.2pt"&gt;Deductions&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zA0Cg3CL0SU9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Deductions"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1143"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zqTR1TwH7S4g" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Deductions"&gt;(1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExplorationAndEvaluationAssetsTransactionCostDeductions_pp0p0_c20220101__20221231_zFj02TYGJoL1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Deductions"&gt;(1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Closing balance - (December 31, 2022)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zViwptJGKsOl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;11,308,721&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zCfaK5GtqHkb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1151"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ExplorationAndEvaluationAssetsTransactionCosts_iE_pp0p0_c20220101__20221231_z4zrlqmzFvjk" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;11,308,721&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Deferred exploration costs:&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Opening balance - (December 31, 2021)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zhGfvm7rtpsa" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;50,219,882&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_z0HVFPcXwJYc" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1157"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iS_pp0p0_c20220101__20221231_z4g3vNPXCFV1" style="font-size: 10pt; font-weight: bold; text-align: right" title="Opening balance"&gt;50,219,882&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Costs incurred during the year&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Professional/technical fees&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--ProfessionaltechnicalFees_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zHZnWEKCDft7" style="font-size: 10pt; text-align: right" title="Professional/technical fees"&gt;143,075&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ProfessionaltechnicalFees_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zSwzWzZdatyj" style="font-size: 10pt; text-align: right" title="Professional/technical fees"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1163"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ProfessionaltechnicalFees_pp0p0_c20220101__20221231_z70DuUYgg0Z5" style="font-size: 10pt; font-weight: bold; text-align: right" title="Professional/technical fees"&gt;143,075&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Claim maintenance/lease costs&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ClaimMaintenanceAndLeaseCosts_iP3custom--ProfessionaltechnicalFees_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z5f7KiGWacP4" style="font-size: 10pt; text-align: right" title="Claim maintenance/lease costs"&gt;169,651&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ClaimMaintenanceAndLeaseCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zYMuZ2OkEtw9" style="font-size: 10pt; text-align: right" title="Claim maintenance/lease costs"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1169"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ClaimMaintenanceAndLeaseCosts_pp0p0_c20220101__20221231_zZVBrcw0r3Sb" style="font-size: 10pt; font-weight: bold; text-align: right" title="Claim maintenance/lease costs"&gt;169,651&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Geochemical, metallurgy&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--GeochemicalAndMetallurgyCosts_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zJAatel4fKC2" style="font-size: 10pt; text-align: right" title="Geochemical, metallurgy"&gt;3,929&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--GeochemicalAndMetallurgyCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zSnKKCXOk8ri" style="font-size: 10pt; text-align: right" title="Geochemical, metallurgy"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1175"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--GeochemicalAndMetallurgyCosts_pp0p0_c20220101__20221231_zYMwa8dDJZec" style="font-size: 10pt; font-weight: bold; text-align: right" title="Geochemical, metallurgy"&gt;3,929&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Travel and accommodation&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--TravelAndAccommodationExpense_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zJOHH7eBSkM9" style="font-size: 10pt; text-align: right" title="Travel and accommodation"&gt;155,195&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--TravelAndAccommodationExpense_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zGnmDjTYAEPd" style="font-size: 10pt; text-align: right" title="Travel and accommodation"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1181"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--TravelAndAccommodationExpense_pp0p0_c20220101__20221231_z4GHTVVkv2r3" style="font-size: 10pt; font-weight: bold; text-align: right" title="Travel and accommodation"&gt;155,195&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Geology, geophysics and exploration&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--GeologyGeophysicsAndExplorationCosts_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zRqXKvyF6Qaj" style="font-size: 10pt; text-align: right" title="Geology, geophysics and exploration"&gt;307,712&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--GeologyGeophysicsAndExplorationCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zkVIi3lXeD1b" style="font-size: 10pt; text-align: right" title="Geology, geophysics and exploration"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1187"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--GeologyGeophysicsAndExplorationCosts_pp0p0_c20220101__20221231_zo0njGa3JRej" style="font-size: 10pt; font-weight: bold; text-align: right" title="Geology, geophysics and exploration"&gt;307,712&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Supplies and miscellaneous&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--SuppliesAndMiscellaneousCosts_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zvg0NoZELSVh" style="font-size: 10pt; text-align: right" title="Supplies and miscellaneous"&gt;310,804&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SuppliesAndMiscellaneousCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zldzdyPRqBp4" style="font-size: 10pt; text-align: right" title="Supplies and miscellaneous"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1193"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SuppliesAndMiscellaneousCosts_pp0p0_c20220101__20221231_zUdD5sTRCyc5" style="font-size: 10pt; font-weight: bold; text-align: right" title="Supplies and miscellaneous"&gt;310,804&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Environmental and permit&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--EnvironmentalStudies_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_z2w5nbaoETH6" style="font-size: 10pt; text-align: right" title="Environmental and permit"&gt;640,541&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--EnvironmentalStudies_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zHUsoEr7GmW4" style="font-size: 10pt; text-align: right" title="Environmental and permit"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1199"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--EnvironmentalStudies_pp0p0_c20220101__20221231_z3K201LfquFh" style="font-size: 10pt; font-weight: bold; text-align: right" title="Environmental and permit"&gt;640,541&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Value-added tax (Note 4)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ValueAddedTaxExpense_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zPLJCcqtvlW9" style="font-size: 10pt; text-align: right" title="Value-added tax (Note 4)"&gt;251,775&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ValueAddedTaxExpense_pp0p0_c20220101__20221231_zOTS6b9CTj9i" style="font-size: 10pt; font-weight: bold; text-align: right" title="Value-added tax (Note 4)"&gt;251,775&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; text-indent: 14.2pt"&gt;Refund - Value-added tax&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ValueAddedTaxRefund_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zmmvy4L6P1B6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Refund - Value-added tax"&gt;(396,209&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ValueAddedTaxRefund_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zhpTQwkemNL" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Refund - Value-added tax"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1209"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ValueAddedTaxRefund_pp0p0_c20220101__20221231_z85TBZUbF6C8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Refund - Value-added tax"&gt;(396,209&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Total deferred exploration costs during the year&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--DeferredExplorationCosts_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zdYwjVhMUfG3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;1,586,473&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--DeferredExplorationCosts_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zz814z2uIVG3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DeferredExplorationCosts_pp0p0_c20220101__20221231_zkojG9Kp36E9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total deferred exploration costs during the year"&gt;1,586,473&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;Closing balance - (December 31, 2022)&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pp0p0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zJSto0WxEjb7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;51,806,355&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pdp0_c20220101__20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zb0IBxsa2tta" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1221"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--ExplorationAndEvaluationAssetsDeferredExplorationCosts_iE_pp0p0_c20220101__20221231_zpDXWrZcLLc7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Closing balance"&gt;51,806,355&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;Total exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--TuligticMember_zj9uAJKrTnGi" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;63,115,076&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20221231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--OtherPropertyPlantAndEquipmentMember_zc9xlFfzbh7b" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1227"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--TangibleExplorationAndEvaluationAssets_pp0p0_c20221231_z6CyBAxaZLfa" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Total exploration and evaluation assets"&gt;63,115,076&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:DisclosureOfExplorationAndEvaluationAssetTextBlock> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2022-12-31_custom_TuligticMember" decimals="0" id="Fact001013" unitRef="CAD">11308721</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2022-12-31" decimals="0" id="Fact001017" unitRef="CAD">11308721</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001031" unitRef="CAD">11308720</aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts> <aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001035" unitRef="CAD">11308720</aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2023-12-31_custom_TuligticMember" decimals="0" id="Fact001037" unitRef="CAD">1</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2023-12-31" decimals="0" id="Fact001041" unitRef="CAD">1</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2022-12-31_custom_TuligticMember" decimals="0" id="Fact001043" unitRef="CAD">51806355</aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2022-12-31" decimals="0" id="Fact001047" unitRef="CAD">51806355</aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts> <aau:ProfessionaltechnicalFees contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001049" unitRef="CAD">159031</aau:ProfessionaltechnicalFees> <aau:ProfessionaltechnicalFees contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001053" unitRef="CAD">159031</aau:ProfessionaltechnicalFees> <aau:GeochemicalAndMetallurgyCosts contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001055" unitRef="CAD">1022</aau:GeochemicalAndMetallurgyCosts> <aau:GeochemicalAndMetallurgyCosts contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001059" unitRef="CAD">1022</aau:GeochemicalAndMetallurgyCosts> <aau:TravelAndAccommodationExpense contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001061" unitRef="CAD">70324</aau:TravelAndAccommodationExpense> <aau:TravelAndAccommodationExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001065" unitRef="CAD">70324</aau:TravelAndAccommodationExpense> <aau:GeologyGeophysicsAndExplorationCosts contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001067" unitRef="CAD">172455</aau:GeologyGeophysicsAndExplorationCosts> <aau:GeologyGeophysicsAndExplorationCosts contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001071" unitRef="CAD">172455</aau:GeologyGeophysicsAndExplorationCosts> <aau:SuppliesAndMiscellaneousCosts contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001073" unitRef="CAD">318047</aau:SuppliesAndMiscellaneousCosts> <aau:SuppliesAndMiscellaneousCosts contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001077" unitRef="CAD">318047</aau:SuppliesAndMiscellaneousCosts> <aau:EnvironmentalStudies contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001079" unitRef="CAD">384421</aau:EnvironmentalStudies> <aau:EnvironmentalStudies contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001083" unitRef="CAD">384421</aau:EnvironmentalStudies> <aau:ValueAddedTaxExpense contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001085" unitRef="CAD">164189</aau:ValueAddedTaxExpense> <aau:ValueAddedTaxExpense contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001087" unitRef="CAD">164189</aau:ValueAddedTaxExpense> <aau:ValueAddedTaxRefund contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001089" unitRef="CAD">-561086</aau:ValueAddedTaxRefund> <aau:ValueAddedTaxRefund contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001093" unitRef="CAD">-561086</aau:ValueAddedTaxRefund> <aau:ImpairmentOfDeferredExplorationCost contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001095" unitRef="CAD">52514758</aau:ImpairmentOfDeferredExplorationCost> <aau:ImpairmentOfDeferredExplorationCost contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001099" unitRef="CAD">52514758</aau:ImpairmentOfDeferredExplorationCost> <aau:DeferredExplorationCosts contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001101" unitRef="CAD">-51806355</aau:DeferredExplorationCosts> <aau:DeferredExplorationCosts contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001105" unitRef="CAD">-51806355</aau:DeferredExplorationCosts> <ifrs-full:TangibleExplorationAndEvaluationAssets contextRef="AsOf2023-12-31_custom_TuligticMember" decimals="0" id="Fact001113" unitRef="CAD">1</ifrs-full:TangibleExplorationAndEvaluationAssets> <ifrs-full:TangibleExplorationAndEvaluationAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact001117" unitRef="CAD">1</ifrs-full:TangibleExplorationAndEvaluationAssets> <aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001119" unitRef="CAD">11308720</aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts> <aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001121" unitRef="CAD">0</aau:ExplorationAndEvaluationAssetsTransactionOfImpairmentOfAcquisitionCosts> <aau:ImpairmentOfDeferredExplorationCost contextRef="From2023-01-012023-12-31_custom_TuligticMember" decimals="0" id="Fact001123" unitRef="CAD">52514758</aau:ImpairmentOfDeferredExplorationCost> <aau:ImpairmentOfDeferredExplorationCost contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001125" unitRef="CAD">0</aau:ImpairmentOfDeferredExplorationCost> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2021-12-31_custom_TuligticMember" decimals="0" id="Fact001131" unitRef="CAD">11211756</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2021-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" decimals="0" id="Fact001133" unitRef="CAD">1</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2021-12-31" decimals="0" id="Fact001135" unitRef="CAD">11211757</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsTransactionCostAdditions contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001137" unitRef="CAD">96965</aau:ExplorationAndEvaluationAssetsTransactionCostAdditions> <aau:ExplorationAndEvaluationAssetsTransactionCostAdditions contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001141" unitRef="CAD">96965</aau:ExplorationAndEvaluationAssetsTransactionCostAdditions> <aau:ExplorationAndEvaluationAssetsTransactionCostDeductions contextRef="From2022-01-012022-12-31_ifrs-full_OtherPropertyPlantAndEquipmentMember" decimals="0" id="Fact001145" unitRef="CAD">-1</aau:ExplorationAndEvaluationAssetsTransactionCostDeductions> <aau:ExplorationAndEvaluationAssetsTransactionCostDeductions contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001147" unitRef="CAD">-1</aau:ExplorationAndEvaluationAssetsTransactionCostDeductions> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2022-12-31_custom_TuligticMember" decimals="0" id="Fact001149" unitRef="CAD">11308721</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsTransactionCosts contextRef="AsOf2022-12-31" decimals="0" id="Fact001153" unitRef="CAD">11308721</aau:ExplorationAndEvaluationAssetsTransactionCosts> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2021-12-31_custom_TuligticMember" decimals="0" id="Fact001155" unitRef="CAD">50219882</aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2021-12-31" decimals="0" id="Fact001159" unitRef="CAD">50219882</aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts> <aau:ProfessionaltechnicalFees contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001161" unitRef="CAD">143075</aau:ProfessionaltechnicalFees> <aau:ProfessionaltechnicalFees contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001165" unitRef="CAD">143075</aau:ProfessionaltechnicalFees> <aau:ClaimMaintenanceAndLeaseCosts contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001167" unitRef="CAD">169651</aau:ClaimMaintenanceAndLeaseCosts> <aau:ClaimMaintenanceAndLeaseCosts contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001171" unitRef="CAD">169651</aau:ClaimMaintenanceAndLeaseCosts> <aau:GeochemicalAndMetallurgyCosts contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001173" unitRef="CAD">3929</aau:GeochemicalAndMetallurgyCosts> <aau:GeochemicalAndMetallurgyCosts contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001177" unitRef="CAD">3929</aau:GeochemicalAndMetallurgyCosts> <aau:TravelAndAccommodationExpense contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001179" unitRef="CAD">155195</aau:TravelAndAccommodationExpense> <aau:TravelAndAccommodationExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001183" unitRef="CAD">155195</aau:TravelAndAccommodationExpense> <aau:GeologyGeophysicsAndExplorationCosts contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001185" unitRef="CAD">307712</aau:GeologyGeophysicsAndExplorationCosts> <aau:GeologyGeophysicsAndExplorationCosts contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001189" unitRef="CAD">307712</aau:GeologyGeophysicsAndExplorationCosts> <aau:SuppliesAndMiscellaneousCosts contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001191" unitRef="CAD">310804</aau:SuppliesAndMiscellaneousCosts> <aau:SuppliesAndMiscellaneousCosts contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001195" unitRef="CAD">310804</aau:SuppliesAndMiscellaneousCosts> <aau:EnvironmentalStudies contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001197" unitRef="CAD">640541</aau:EnvironmentalStudies> <aau:EnvironmentalStudies contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001201" unitRef="CAD">640541</aau:EnvironmentalStudies> <aau:ValueAddedTaxExpense contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001203" unitRef="CAD">251775</aau:ValueAddedTaxExpense> <aau:ValueAddedTaxExpense contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001205" unitRef="CAD">251775</aau:ValueAddedTaxExpense> <aau:ValueAddedTaxRefund contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001207" unitRef="CAD">-396209</aau:ValueAddedTaxRefund> <aau:ValueAddedTaxRefund contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001211" unitRef="CAD">-396209</aau:ValueAddedTaxRefund> <aau:DeferredExplorationCosts contextRef="From2022-01-012022-12-31_custom_TuligticMember" decimals="0" id="Fact001213" unitRef="CAD">1586473</aau:DeferredExplorationCosts> <aau:DeferredExplorationCosts contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001217" unitRef="CAD">1586473</aau:DeferredExplorationCosts> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2022-12-31_custom_TuligticMember" decimals="0" id="Fact001219" unitRef="CAD">51806355</aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts> <aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts contextRef="AsOf2022-12-31" decimals="0" id="Fact001223" unitRef="CAD">51806355</aau:ExplorationAndEvaluationAssetsDeferredExplorationCosts> <ifrs-full:TangibleExplorationAndEvaluationAssets contextRef="AsOf2022-12-31_custom_TuligticMember" decimals="0" id="Fact001225" unitRef="CAD">63115076</ifrs-full:TangibleExplorationAndEvaluationAssets> <ifrs-full:TangibleExplorationAndEvaluationAssets contextRef="AsOf2022-12-31" decimals="0" id="Fact001229" unitRef="CAD">63115076</ifrs-full:TangibleExplorationAndEvaluationAssets> <aau:ProportionOfOwnershipInterestInAssociates contextRef="From2022-05-252022-05-26_custom_LoganPropertyLocatedInTheYukonTerritoryCanadaMember" decimals="INF" id="Fact001237" unitRef="Pure">0.40</aau:ProportionOfOwnershipInterestInAssociates> <aau:CarryingValueOfPropertyConsideration contextRef="AsOf2022-05-26_custom_LoganPropertyLocatedInTheYukonTerritoryCanadaMember" decimals="0" id="Fact001239" unitRef="CAD">1</aau:CarryingValueOfPropertyConsideration> <aau:VatRecovery contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001241" unitRef="CAD">561086</aau:VatRecovery> <aau:VatRecovery contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001243" unitRef="CAD">396209</aau:VatRecovery> <aau:VatRecovery contextRef="From2021-01-012021-12-31" decimals="0" id="Fact001245" unitRef="CAD">506394</aau:VatRecovery> <aau:VatRefundFromPriorYears contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact001247" unitRef="CAD">173876</aau:VatRefundFromPriorYears> <aau:VatRefundFromPriorYears contextRef="From2022-01-012022-12-31" decimals="0" id="Fact001249" unitRef="CAD">139313</aau:VatRefundFromPriorYears> <aau:VatRefundFromPriorYears contextRef="From2021-01-012021-12-31" decimals="0" id="Fact001251" unitRef="CAD">446184</aau:VatRefundFromPriorYears> <ifrs-full:DisclosureOfBorrowingsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001255">&lt;p id="xdx_80C_eifrs-full--DisclosureOfBorrowingsExplanatory_z0AIlyoc4UCl" style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;8.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82D_zIM00Eb9R1ik"&gt;Gold loan payable and gold in trust&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company has entered into a secured gold loan agreement (&#x201c;Gold Loan&#x201d;) with Almadex or the &#x201c;Lender&#x201d; pursuant to which Almadex has agreed to loan up to &lt;span id="xdx_90F_ecustom--LoanPayableOuncesLoanedToCompany_iI_c20190514__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zwSTUFnCkLae" title="Loan payable, ounces, loaned to company"&gt;1,597&lt;/span&gt; ounces of gold bullion to the Company. The approximate value of this gold as at May 14, 2019 was USD$&lt;span id="xdx_906_ecustom--BorrowingsMetalsNoncurrent_iI_pdp0_uUSD_c20190514__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zgM7KIwM3Ci" title="Borrowings, metals, noncurrent"&gt;2,072,060&lt;/span&gt; or $&lt;span id="xdx_907_ecustom--BorrowingsMetalsNoncurrent_iI_pdp0_uCAD_c20190514__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z2imewv6gg0e" title="Borrowings, metals, noncurrent"&gt;2,790,858&lt;/span&gt;.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Under the terms of the Gold Loan, the Company will be entitled to draw-down the gold in minimum 400 ounce tranches. At any given time, the amount of gold ounces drawn multiplied by the London Bullion Market Association (&#x201c;LBMA&#x201d;) AM gold price in US dollars, plus any accrued interest or unpaid fees, shall constitute the Loan Value.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The maturity date for the Gold Loan is March 31, 2024, and can be extended by two years &lt;span id="xdx_900_ecustom--LoanPayableExtensionPeriod_dtY_c20190501__20190514__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zYLpHssHLFv4" style="display: none" title="Loan payable, extension period (Year)"&gt;2&lt;/span&gt; at the discretion of the Company (the &#x201c;Term&#x201d;). Repayment of the Loan Value shall be made either through delivery of that amount of gold drawn, or through the issuance of common shares of the Company (&#x201c;Shares&#x201d;), according to the Lender&#x2019;s discretion. Mandatory prepayment shall be required in the event that the Company&#x2019;s Ixtaca gold-silver project located in Puebla State, Mexico (the &#x201c;Ixtaca Project&#x201d;) enters into commercial production during the Term, requiring the Company to deliver &lt;span id="xdx_905_ecustom--LoanPayableGoldDeliveryPaymentsPerMonthOunces_pip0_uInteger_c20190501__20190514__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zdmCagGQaO2a" title="Loan payable, gold delivery payments per month, ounces"&gt;100&lt;/span&gt; gold ounces per month to the Lender. In addition, the Company has the right to pre-pay the Loan Value at any time without penalty, in either gold bullion or Shares as chosen by the Lender, and the Lender has the right to convert the Loan Value into Shares at any time during the Term. The conversion rate is equal to 95% of the 5 trading day volume weighted average price of the Share on the Toronto Stock Exchange or an equivalent.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The interest rate of the Gold Loan is &lt;span id="xdx_90F_eifrs-full--BorrowingsInterestRate_iI_dp_c20190514__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zfPIThiXAs1b" title="Borrowings, interest rate"&gt;10&lt;/span&gt;% of the Loan Value per annum, calculated monthly, paid in arrears. Interest payments can either be accrued to the Loan Value, or paid by the Company in cash or gold bullion. A standby fee of &lt;span id="xdx_900_ecustom--BorrowingsStandbyFee_iI_dp_c20190514__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zbesAwk87Bm3" title="Borrowings, standby fee"&gt;1&lt;/span&gt;% per annum, accrued quarterly, will be applied to any undrawn amount on the Gold Loan.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;In addition, the Company has issued Almadex &lt;span id="xdx_90C_ecustom--NumberOfWarrantsIssued_c20190501__20190514__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zvy4KoZRaGFg" title="Number of warrants issued (in shares)"&gt;500,000&lt;/span&gt; transferable share purchase warrants (&#x201c;Warrants&#x201d;), with an exercise price of $&lt;span id="xdx_909_ecustom--WarrantsExercisePrice_iI_c20190514__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zi7DWUWb2TKh" title="Warrants, exercise price (in CAD per share)"&gt;1.50&lt;/span&gt; per Share and expiry date of May 14, 2024 as an arrangement fee to cover the administrative costs of setting up the credit facility. These warrants were valued at $&lt;span id="xdx_906_ecustom--WarrantsFairValue_iI_pp0p0_c20190514__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_ziMmifqWFexe" title="Warrants, fair value"&gt;50,000&lt;/span&gt; using the Black-Scholes option-pricing model with the following assumptions: expected life of five &lt;span id="xdx_90C_ecustom--WarrantsValuationAssumptionsExpectedLife_dtY_c20190501__20190514__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zLgRWWsykwPl" style="display: none" title="Warrants, valuation assumptions, expected life (Year)"&gt;5&lt;/span&gt; years, risk-free interest rate of &lt;span id="xdx_909_ecustom--RiskFreeInterestRateWarrantsGranted_dp_c20190501__20190514__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zMSYGsFLJWR3" title="Risk free interest rate, warrants granted"&gt;1.54&lt;/span&gt;%, expected dividend yield of &lt;span id="xdx_903_ecustom--ExpectedDividendWarrantsGranted_dp_c20190501__20190514__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_z7ntuH9BIvld" title="Expected dividend, warrants granted"&gt;0&lt;/span&gt;% and expected volatility of &lt;span id="xdx_90A_ecustom--DescriptionOfExpectedVolatilityWarrantsGranted_dp_c20190501__20190514__ifrs-full--ComponentsOfEquityAxis__custom--WarrantsMember_zXqMjjIgrMob" title="Description of expected volatility warrants granted"&gt;44.25&lt;/span&gt;%.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Security for the loan is certain equipment related to the Rock Creek Mill, which is not required for the Ixtaca Project. The Gold Loan includes industry standard provisions in the event of default, material breach and change of control.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Gold Loan was recorded at fair value at inception and is subsequently measured at amortized cost using the effective interest method, recognizing interest expense on an effective yield basis.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company has determined that the Gold Loan contains multiple derivatives which are embedded in the US dollar denominated debt instrument. As the convertible Gold Loan is denominated in US dollars and is convertible into common shares based upon a variable Canadian dollar conversion rate, the fixed for fixed criteria is not met. As such, the conversion option cannot be classified as an equity instrument and is deemed to have no value. The embedded derivative from indexation of the loan principal portion to the movement in the price of gold is classified as a derivate financial liability and is marked to market at each period end using the Black-Scholes option-pricing model.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;At inception, the following assumptions were used: expected life of five &lt;span id="xdx_90A_ecustom--DeriviativeLiabilityAssumptionsExpectedLife_dtY_c20190501__20190514__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_ztYov0W2zQ93" style="display: none" title="Deriviative liability, assumptions, expected life (Year)"&gt;5&lt;/span&gt; years, risk-free interest rate of &lt;span id="xdx_901_ecustom--DerivativeLiabilityAssumptionsRiskfreeInterestRate_dp_c20190501__20190514__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zwJd8t4perl4" title="Derivative liability, assumptions, risk-free interest rate"&gt;1.57&lt;/span&gt;% and expected volatility of &lt;span id="xdx_904_ecustom--DerivativeLiabilityAssumptionsExpectedVolatility_dp_c20190501__20190514__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zVHCFUNPIMp2" title="Derivative liability, assumptions, expected volatility"&gt;11.06&lt;/span&gt;%. The fair value of the embedded derivative for the year ended December 31, 2023 decreased by $&lt;span id="xdx_90B_eifrs-full--GainsLossesOnChangeInFairValueOfDerivatives_pp0p0_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_z3kB0lTPdNyi" title="Net gains (losses) on change in fair value of derivatives"&gt;191,732&lt;/span&gt; (December 31, 2022 decreased by $&lt;span id="xdx_90E_eifrs-full--GainsLossesOnChangeInFairValueOfDerivatives_pp0p0_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zPYH7g7syLLl" title="Net gains (losses) on change in fair value of derivatives"&gt;110,177&lt;/span&gt;) based on the following assumptions used in the Black-Scholes option-pricing model: expected life of &lt;span id="xdx_909_ecustom--DeriviativeLiabilityAssumptionsExpectedLife_dtY_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zaxM8952zjf5" title="Deriviative liability, assumptions, expected life (Year)"&gt;0.25&lt;/span&gt; years, risk-free interest rate of &lt;span id="xdx_909_ecustom--DerivativeLiabilityAssumptionsRiskfreeInterestRate_dp_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zmC6ASuVNBJj" title="Derivative liability, assumptions, risk-free interest rate"&gt;4.00&lt;/span&gt;% and expected volatility of &lt;span id="xdx_90F_ecustom--DerivativeLiabilityAssumptionsExpectedVolatility_dp_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_z4pZ4vAybkK4" title="Derivative liability, assumptions, expected volatility"&gt;9.93&lt;/span&gt;% (December 31, 2022, expected life of &lt;span id="xdx_90E_ecustom--DeriviativeLiabilityAssumptionsExpectedLife_dtY_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zLEuFTUNGE91" title="Deriviative liability, assumptions, expected life (Year)"&gt;1.25&lt;/span&gt; years, risk-free interest rate of &lt;span id="xdx_903_ecustom--DerivativeLiabilityAssumptionsRiskfreeInterestRate_dp_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_z3sLY64bw234" title="Derivative liability, assumptions, risk-free interest rate"&gt;4.00&lt;/span&gt;% and expected volatility of &lt;span id="xdx_904_ecustom--DerivativeLiabilityAssumptionsExpectedVolatility_dp_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zuZ4Z3iOd128" title="Derivative liability, assumptions, expected volatility"&gt;11.57&lt;/span&gt;%).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The continuity of gold loan payable and derivative financial liabilities are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_898_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zklvWUU56ei2" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Gold loan payable and gold in trust (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;&lt;span id="xdx_8B9_zgycvBrfi236" style="display: none"&gt;Schedule of gold loan payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: left"&gt;Gold loan payable &#x2013; opening balance&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BorrowingsMetalNoncurrent_iS_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z4taCovlzPx2" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Gold loan payable, beginning balance"&gt;3,929,015&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--BorrowingsMetalNoncurrent_iS_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zaiUsG5qryql" style="width: 12%; font-size: 10pt; text-align: right" title="Gold loan payable, beginning balance"&gt;3,227,545&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Accrued interest expense&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--InterestExpenseOnBorrowings_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zP7thfTrmcdl" style="font-size: 10pt; font-weight: bold; text-align: right" title="Accrued interest expense"&gt;353,372&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--InterestExpenseOnBorrowings_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zUFGzxhqhTNk" style="font-size: 10pt; text-align: right" title="Accrued interest expense"&gt;314,024&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Accrued standby fees&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BorrowingsStandbyFeesAccrued_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zajlkGa3wSc5" style="font-size: 10pt; font-weight: bold; text-align: right" title="Accrued standby fees"&gt;10,377&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BorrowingsStandbyFeesAccrued_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zXJHaAUYWD5i" style="font-size: 10pt; text-align: right" title="Accrued standby fees"&gt;9,416&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Accretion expense&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BorrowingsAccretionExpense_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zsZt2GYaDBXb" style="font-size: 10pt; font-weight: bold; text-align: right" title="Accretion expense"&gt;176,960&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BorrowingsAccretionExpense_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zCNLHh0uH4e8" style="font-size: 10pt; text-align: right" title="Accretion expense"&gt;144,868&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Foreign exchange difference&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--BorrowingsForeignExchangeDifferences_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z7BxzotCygBd" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Foreign exchange difference"&gt;(98,178&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BorrowingsForeignExchangeDifferences_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z3V4Tm8jOGv8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Foreign exchange difference"&gt;233,162&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Gold loan payable&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BorrowingsMetalNoncurrent_iE_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zbnwO2MzHqhb" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Gold loan payable, ending balance"&gt;4,371,546&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BorrowingsMetalNoncurrent_iE_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zhBvcRD4mbMh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Gold loan payable, ending balance"&gt;3,929,015&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Derivative financial liabilities &#x2013; opening balance&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iS_pp0p0_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zutfhj9xSn22" style="font-size: 10pt; font-weight: bold; text-align: right" title="Derivative financial liabilities, beginning balance"&gt;306,084&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DerivativeFinancialLiabilities_iS_pp0p0_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_z0v2ziFwZJ6" style="font-size: 10pt; text-align: right" title="Derivative financial liabilities, beginning balance"&gt;391,620&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Change in fair value through profit &amp;amp; loss&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--GainsLossesOnChangesInFairValueOfDerivatives_iN_pp0p0_di_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zG9TOaRKuu2c" style="font-size: 10pt; font-weight: bold; text-align: right" title="Change in fair value through profit &amp;amp; loss"&gt;(191,732&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--GainsLossesOnChangesInFairValueOfDerivatives_iN_pp0p0_di_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zVFv71fGEhh8" style="font-size: 10pt; text-align: right" title="Change in fair value through profit &amp;amp; loss"&gt;(110,177&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Foreign exchange difference&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DerivativeLiabilitiesForeignExchangeDifferences_pp0p0_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zW6w5PCR5Ic6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Foreign exchange difference"&gt;(5,522&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DerivativeLiabilitiesForeignExchangeDifferences_pp0p0_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zd6P6zAb3zg3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Foreign exchange difference"&gt;24,641&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DerivativeFinancialLiabilities_iE_pp0p0_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_z9I42T0A8in5" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Derivative financial liabilities, ending balance"&gt;108,830&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DerivativeFinancialLiabilities_iE_pp0p0_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zpGshEcPHMf4" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Derivative financial liabilities, ending balance"&gt;306,084&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8A9_z5d964uQEFE2" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;As at December 31, 2023, Almaden has &lt;span id="xdx_904_ecustom--LoansPayableOuncesOfGold_iI_uOunce_c20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zrPhUTtmH4Fi" title="Loans payable, ounces of gold"&gt;397 &lt;/span&gt;ounces (&lt;span id="xdx_90B_ecustom--LoansPayableOuncesOfGold_iI_uOunce_c20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zUXSqqaq7hze" title="Loans payable, ounces of gold"&gt;397&lt;/span&gt; ounces at December 31, 2022) of gold bullion on its account at a fair value of $&lt;span id="xdx_90F_ecustom--TrustAssetsMetals_iI_c20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zUO1Pf67sAu1" title="Trust assets, metals"&gt;1,082,801&lt;/span&gt; ($&lt;span id="xdx_903_ecustom--TrustAssetsMetals_iI_c20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z9bQkq9dVhB5" title="Trust assets, metals"&gt;974,397 &lt;/span&gt;at December 31, 2022).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 7.1pt; font-size: 10pt; text-align: justify; text-indent: 28.35pt"&gt;The continuity of gold in trust are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfAssetsInTrustTextBlock_zyk9G4IVP3ok" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Gold loan payable and gold in trust (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zyZs6kYZZyg" style="display: none"&gt;Schedule of gold in trust&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Ounces&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Ounces&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Gold in trust, opening balance&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LoansPayableOuncesOfGold_iS_uOunce_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zDPAx4cOPQFd" style="width: 10%; font-size: 10pt; font-weight: bold; text-align: right" title="Gold in trust, beginning balance, ounces"&gt;397&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--TrustAssetsMetals_iS_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zkuUIO7aLBM5" style="width: 10%; font-size: 10pt; font-weight: bold; text-align: right" title="Gold in trust, amount"&gt;974,397&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--LoansPayableOuncesOfGold_iS_uOunce_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zfI9JFtuLed3" style="width: 10%; font-size: 10pt; text-align: right" title="Gold in trust, beginning balance, ounces"&gt;397&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--TrustAssetsMetals_iS_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zGIH9BFiK2v9" style="width: 10%; font-size: 10pt; text-align: right" title="Gold in trust, amount"&gt;915,995&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Sale of gold in trust&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SaleOfTrustAssetsOuncesOfGold_uOunce_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zWLNv9oTVUL2" style="font-size: 10pt; font-weight: bold; text-align: right" title="Sale of gold in trust, ounces"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ProceedsFromSaleOfTrustAssets_pdp0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zeZcn1pjvlK7" style="font-size: 10pt; font-weight: bold; text-align: right" title="Sale of gold in trust, amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1373"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SaleOfTrustAssetsOuncesOfGold_uOunce_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zNNIxaiOR3k1" style="font-size: 10pt; text-align: right" title="Sale of gold in trust, ounces"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ProceedsFromSaleOfTrustAssets_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z69CWD419J7" style="font-size: 10pt; text-align: right" title="Sale of gold in trust, amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1377"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Gain on sale&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--RealizedGainLossOnSaleOfTrustAssets_pdp0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zColDqiPguF8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Gain on sale, amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--RealizedGainLossOnSaleOfTrustAssets_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zTq3ISByRzqk" style="font-size: 10pt; text-align: right" title="Gain on sale, amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1381"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value through profit &amp;amp; loss&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--GainLossOnAssetsInTrust_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zWeUOO3GF218" style="font-size: 10pt; font-weight: bold; text-align: right" title="Change in fair value through profit &amp;amp; loss, amount"&gt;132,895&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--GainLossOnAssetsInTrust_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zNVBOARBlpWd" style="font-size: 10pt; text-align: right" title="Change in fair value through profit &amp;amp; loss, amount"&gt;(6,518&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Foreign exchange difference&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;0&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseThroughForeignExchangeInTrustAssets_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zoM05yV2cL6g" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Foreign exchange difference, amount"&gt;(24,491&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;0&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncreaseDecreaseThroughForeignExchangeInTrustAssets_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zL7X4w9IWfq1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Foreign exchange difference, amount"&gt;64,920&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--LoansPayableOuncesOfGold_iE_uOunce_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zJqjI9ltSiOl" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Gold in trust, ending balance, ounces"&gt;397&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--TrustAssetsMetals_iE_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zZwocgpdfMCh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Gold in trust, amount"&gt;1,082,801&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LoansPayableOuncesOfGold_iE_uOunce_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zYkDwNqJNa35" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Gold in trust, ending balance, ounces"&gt;397&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--TrustAssetsMetals_iE_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zPWGaMDBGnIi" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Gold in trust, amount"&gt;974,397&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8A3_zGDx3GbwFCpe" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DisclosureOfBorrowingsExplanatory> <aau:LoanPayableOuncesLoanedToCompany contextRef="AsOf2019-05-14_custom_GoldLoanMember" decimals="INF" id="Fact001257" unitRef="Pure">1597</aau:LoanPayableOuncesLoanedToCompany> <aau:BorrowingsMetalsNoncurrent contextRef="AsOf2019-05-14_custom_GoldLoanMember" decimals="0" id="Fact001259" unitRef="USD">2072060</aau:BorrowingsMetalsNoncurrent> <aau:BorrowingsMetalsNoncurrent contextRef="AsOf2019-05-14_custom_GoldLoanMember" decimals="0" id="Fact001261" unitRef="CAD">2790858</aau:BorrowingsMetalsNoncurrent> <aau:LoanPayableExtensionPeriod contextRef="From2019-05-012019-05-14_custom_GoldLoanMember" id="Fact001263">P2Y</aau:LoanPayableExtensionPeriod> <aau:LoanPayableGoldDeliveryPaymentsPerMonthOunces contextRef="From2019-05-012019-05-14_custom_GoldLoanMember" decimals="INF" id="Fact001265" unitRef="Integer">100</aau:LoanPayableGoldDeliveryPaymentsPerMonthOunces> <ifrs-full:BorrowingsInterestRate contextRef="AsOf2019-05-14_custom_GoldLoanMember" decimals="INF" id="Fact001267" unitRef="Pure">0.10</ifrs-full:BorrowingsInterestRate> <aau:BorrowingsStandbyFee contextRef="AsOf2019-05-14_custom_GoldLoanMember" decimals="INF" id="Fact001269" unitRef="Pure">0.01</aau:BorrowingsStandbyFee> <aau:NumberOfWarrantsIssued contextRef="From2019-05-012019-05-14_ifrs-full_WarrantsMember" decimals="INF" id="Fact001271" unitRef="Shares">500000</aau:NumberOfWarrantsIssued> <aau:WarrantsExercisePrice contextRef="AsOf2019-05-14_ifrs-full_WarrantsMember" decimals="INF" id="Fact001273" unitRef="CADPShares">1.50</aau:WarrantsExercisePrice> <aau:WarrantsFairValue contextRef="AsOf2019-05-14_ifrs-full_WarrantsMember" decimals="0" id="Fact001275" unitRef="CAD">50000</aau:WarrantsFairValue> <aau:WarrantsValuationAssumptionsExpectedLife contextRef="From2019-05-012019-05-14_ifrs-full_WarrantsMember" id="Fact001277">P5Y</aau:WarrantsValuationAssumptionsExpectedLife> <aau:RiskFreeInterestRateWarrantsGranted contextRef="From2019-05-012019-05-14_ifrs-full_WarrantsMember" decimals="INF" id="Fact001279" unitRef="Pure">0.0154</aau:RiskFreeInterestRateWarrantsGranted> <aau:ExpectedDividendWarrantsGranted contextRef="From2019-05-012019-05-14_ifrs-full_WarrantsMember" decimals="INF" id="Fact001281" unitRef="Pure">0</aau:ExpectedDividendWarrantsGranted> <aau:DescriptionOfExpectedVolatilityWarrantsGranted contextRef="From2019-05-012019-05-14_ifrs-full_WarrantsMember" decimals="INF" id="Fact001283" unitRef="Pure">0.4425</aau:DescriptionOfExpectedVolatilityWarrantsGranted> <aau:DeriviativeLiabilityAssumptionsExpectedLife contextRef="From2019-05-012019-05-14_custom_GoldLoanDerivativeInstrumentsMember" id="Fact001289">P5Y</aau:DeriviativeLiabilityAssumptionsExpectedLife> <aau:DerivativeLiabilityAssumptionsRiskfreeInterestRate contextRef="From2019-05-012019-05-14_custom_GoldLoanDerivativeInstrumentsMember" decimals="INF" id="Fact001291" unitRef="Pure">0.0157</aau:DerivativeLiabilityAssumptionsRiskfreeInterestRate> <aau:DerivativeLiabilityAssumptionsExpectedVolatility contextRef="From2019-05-012019-05-14_custom_GoldLoanDerivativeInstrumentsMember" decimals="INF" id="Fact001293" unitRef="Pure">0.1106</aau:DerivativeLiabilityAssumptionsExpectedVolatility> <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="From2023-01-012023-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001295" unitRef="CAD">191732</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives> <ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives contextRef="From2022-01-012022-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001297" unitRef="CAD">110177</ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives> <aau:DeriviativeLiabilityAssumptionsExpectedLife contextRef="From2023-01-012023-12-31_custom_GoldLoanDerivativeInstrumentsMember" id="Fact001299">P0Y3M</aau:DeriviativeLiabilityAssumptionsExpectedLife> <aau:DerivativeLiabilityAssumptionsRiskfreeInterestRate contextRef="From2023-01-012023-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="INF" id="Fact001301" unitRef="Pure">0.0400</aau:DerivativeLiabilityAssumptionsRiskfreeInterestRate> <aau:DerivativeLiabilityAssumptionsExpectedVolatility contextRef="From2023-01-012023-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="INF" id="Fact001303" unitRef="Pure">0.0993</aau:DerivativeLiabilityAssumptionsExpectedVolatility> <aau:DeriviativeLiabilityAssumptionsExpectedLife contextRef="From2022-01-012022-12-31_custom_GoldLoanDerivativeInstrumentsMember" id="Fact001305">P1Y3M</aau:DeriviativeLiabilityAssumptionsExpectedLife> <aau:DerivativeLiabilityAssumptionsRiskfreeInterestRate contextRef="From2022-01-012022-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="INF" id="Fact001307" unitRef="Pure">0.0400</aau:DerivativeLiabilityAssumptionsRiskfreeInterestRate> <aau:DerivativeLiabilityAssumptionsExpectedVolatility contextRef="From2022-01-012022-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="INF" id="Fact001309" unitRef="Pure">0.1157</aau:DerivativeLiabilityAssumptionsExpectedVolatility> <ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001311">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_eifrs-full--DisclosureOfDetailedInformationAboutBorrowingsExplanatory_zklvWUU56ei2" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Gold loan payable and gold in trust (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;&lt;span id="xdx_8B9_zgycvBrfi236" style="display: none"&gt;Schedule of gold loan payable&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: left"&gt;Gold loan payable &#x2013; opening balance&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--BorrowingsMetalNoncurrent_iS_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z4taCovlzPx2" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Gold loan payable, beginning balance"&gt;3,929,015&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--BorrowingsMetalNoncurrent_iS_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zaiUsG5qryql" style="width: 12%; font-size: 10pt; text-align: right" title="Gold loan payable, beginning balance"&gt;3,227,545&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Accrued interest expense&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--InterestExpenseOnBorrowings_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zP7thfTrmcdl" style="font-size: 10pt; font-weight: bold; text-align: right" title="Accrued interest expense"&gt;353,372&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--InterestExpenseOnBorrowings_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zUFGzxhqhTNk" style="font-size: 10pt; text-align: right" title="Accrued interest expense"&gt;314,024&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Accrued standby fees&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BorrowingsStandbyFeesAccrued_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zajlkGa3wSc5" style="font-size: 10pt; font-weight: bold; text-align: right" title="Accrued standby fees"&gt;10,377&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--BorrowingsStandbyFeesAccrued_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zXJHaAUYWD5i" style="font-size: 10pt; text-align: right" title="Accrued standby fees"&gt;9,416&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Accretion expense&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--BorrowingsAccretionExpense_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zsZt2GYaDBXb" style="font-size: 10pt; font-weight: bold; text-align: right" title="Accretion expense"&gt;176,960&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--BorrowingsAccretionExpense_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zCNLHh0uH4e8" style="font-size: 10pt; text-align: right" title="Accretion expense"&gt;144,868&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Foreign exchange difference&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--BorrowingsForeignExchangeDifferences_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z7BxzotCygBd" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Foreign exchange difference"&gt;(98,178&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--BorrowingsForeignExchangeDifferences_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z3V4Tm8jOGv8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Foreign exchange difference"&gt;233,162&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Gold loan payable&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BorrowingsMetalNoncurrent_iE_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zbnwO2MzHqhb" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Gold loan payable, ending balance"&gt;4,371,546&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_ecustom--BorrowingsMetalNoncurrent_iE_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zhBvcRD4mbMh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Gold loan payable, ending balance"&gt;3,929,015&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Derivative financial liabilities &#x2013; opening balance&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DerivativeFinancialLiabilities_iS_pp0p0_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zutfhj9xSn22" style="font-size: 10pt; font-weight: bold; text-align: right" title="Derivative financial liabilities, beginning balance"&gt;306,084&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DerivativeFinancialLiabilities_iS_pp0p0_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_z0v2ziFwZJ6" style="font-size: 10pt; text-align: right" title="Derivative financial liabilities, beginning balance"&gt;391,620&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Change in fair value through profit &amp;amp; loss&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--GainsLossesOnChangesInFairValueOfDerivatives_iN_pp0p0_di_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zG9TOaRKuu2c" style="font-size: 10pt; font-weight: bold; text-align: right" title="Change in fair value through profit &amp;amp; loss"&gt;(191,732&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--GainsLossesOnChangesInFairValueOfDerivatives_iN_pp0p0_di_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zVFv71fGEhh8" style="font-size: 10pt; text-align: right" title="Change in fair value through profit &amp;amp; loss"&gt;(110,177&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left; padding-left: 10pt"&gt;Foreign exchange difference&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DerivativeLiabilitiesForeignExchangeDifferences_pp0p0_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zW6w5PCR5Ic6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Foreign exchange difference"&gt;(5,522&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--DerivativeLiabilitiesForeignExchangeDifferences_pp0p0_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zd6P6zAb3zg3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Foreign exchange difference"&gt;24,641&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DerivativeFinancialLiabilities_iE_pp0p0_c20230101__20231231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_z9I42T0A8in5" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Derivative financial liabilities, ending balance"&gt;108,830&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DerivativeFinancialLiabilities_iE_pp0p0_c20220101__20221231__ifrs-full--FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis__custom--GoldLoanDerivativeInstrumentsMember_zpGshEcPHMf4" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Derivative financial liabilities, ending balance"&gt;306,084&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory> <aau:BorrowingsMetalNoncurrent contextRef="AsOf2022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001313" unitRef="CAD">3929015</aau:BorrowingsMetalNoncurrent> <aau:BorrowingsMetalNoncurrent contextRef="AsOf2021-12-31_custom_GoldLoanMember" decimals="0" id="Fact001315" unitRef="CAD">3227545</aau:BorrowingsMetalNoncurrent> <ifrs-full:InterestExpenseOnBorrowings contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001317" unitRef="CAD">353372</ifrs-full:InterestExpenseOnBorrowings> <ifrs-full:InterestExpenseOnBorrowings contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001319" unitRef="CAD">314024</ifrs-full:InterestExpenseOnBorrowings> <aau:BorrowingsStandbyFeesAccrued contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001321" unitRef="CAD">10377</aau:BorrowingsStandbyFeesAccrued> <aau:BorrowingsStandbyFeesAccrued contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001323" unitRef="CAD">9416</aau:BorrowingsStandbyFeesAccrued> <aau:BorrowingsAccretionExpense contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001325" unitRef="CAD">176960</aau:BorrowingsAccretionExpense> <aau:BorrowingsAccretionExpense contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001327" unitRef="CAD">144868</aau:BorrowingsAccretionExpense> <aau:BorrowingsForeignExchangeDifferences contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001329" unitRef="CAD">-98178</aau:BorrowingsForeignExchangeDifferences> <aau:BorrowingsForeignExchangeDifferences contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001331" unitRef="CAD">233162</aau:BorrowingsForeignExchangeDifferences> <aau:BorrowingsMetalNoncurrent contextRef="AsOf2023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001333" unitRef="CAD">4371546</aau:BorrowingsMetalNoncurrent> <aau:BorrowingsMetalNoncurrent contextRef="AsOf2022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001335" unitRef="CAD">3929015</aau:BorrowingsMetalNoncurrent> <ifrs-full:DerivativeFinancialLiabilities contextRef="AsOf2022-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001337" unitRef="CAD">306084</ifrs-full:DerivativeFinancialLiabilities> <ifrs-full:DerivativeFinancialLiabilities contextRef="AsOf2021-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001339" unitRef="CAD">391620</ifrs-full:DerivativeFinancialLiabilities> <aau:GainsLossesOnChangesInFairValueOfDerivatives contextRef="From2023-01-012023-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001341" unitRef="CAD">191732</aau:GainsLossesOnChangesInFairValueOfDerivatives> <aau:GainsLossesOnChangesInFairValueOfDerivatives contextRef="From2022-01-012022-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001343" unitRef="CAD">110177</aau:GainsLossesOnChangesInFairValueOfDerivatives> <aau:DerivativeLiabilitiesForeignExchangeDifferences contextRef="From2023-01-012023-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001345" unitRef="CAD">-5522</aau:DerivativeLiabilitiesForeignExchangeDifferences> <aau:DerivativeLiabilitiesForeignExchangeDifferences contextRef="From2022-01-012022-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001347" unitRef="CAD">24641</aau:DerivativeLiabilitiesForeignExchangeDifferences> <ifrs-full:DerivativeFinancialLiabilities contextRef="AsOf2023-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001349" unitRef="CAD">108830</ifrs-full:DerivativeFinancialLiabilities> <ifrs-full:DerivativeFinancialLiabilities contextRef="AsOf2022-12-31_custom_GoldLoanDerivativeInstrumentsMember" decimals="0" id="Fact001351" unitRef="CAD">306084</ifrs-full:DerivativeFinancialLiabilities> <aau:LoansPayableOuncesOfGold contextRef="AsOf2023-12-31_custom_GoldLoanMember" decimals="INF" id="Fact001353" unitRef="Ounce">397</aau:LoansPayableOuncesOfGold> <aau:LoansPayableOuncesOfGold contextRef="AsOf2022-12-31_custom_GoldLoanMember" decimals="INF" id="Fact001355" unitRef="Ounce">397</aau:LoansPayableOuncesOfGold> <aau:TrustAssetsMetals contextRef="AsOf2023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001357" unitRef="CAD">1082801</aau:TrustAssetsMetals> <aau:TrustAssetsMetals contextRef="AsOf2022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001359" unitRef="CAD">974397</aau:TrustAssetsMetals> <aau:DisclosureOfAssetsInTrustTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001361">&lt;table cellpadding="0" cellspacing="0" id="xdx_898_ecustom--DisclosureOfAssetsInTrustTextBlock_zyk9G4IVP3ok" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Gold loan payable and gold in trust (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zyZs6kYZZyg" style="display: none"&gt;Schedule of gold in trust&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Ounces&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Ounces&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 48%; font-size: 10pt; text-align: left"&gt;Gold in trust, opening balance&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LoansPayableOuncesOfGold_iS_uOunce_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zDPAx4cOPQFd" style="width: 10%; font-size: 10pt; font-weight: bold; text-align: right" title="Gold in trust, beginning balance, ounces"&gt;397&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--TrustAssetsMetals_iS_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zkuUIO7aLBM5" style="width: 10%; font-size: 10pt; font-weight: bold; text-align: right" title="Gold in trust, amount"&gt;974,397&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--LoansPayableOuncesOfGold_iS_uOunce_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zfI9JFtuLed3" style="width: 10%; font-size: 10pt; text-align: right" title="Gold in trust, beginning balance, ounces"&gt;397&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--TrustAssetsMetals_iS_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zGIH9BFiK2v9" style="width: 10%; font-size: 10pt; text-align: right" title="Gold in trust, amount"&gt;915,995&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Sale of gold in trust&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--SaleOfTrustAssetsOuncesOfGold_uOunce_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zWLNv9oTVUL2" style="font-size: 10pt; font-weight: bold; text-align: right" title="Sale of gold in trust, ounces"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1371"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--ProceedsFromSaleOfTrustAssets_pdp0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zeZcn1pjvlK7" style="font-size: 10pt; font-weight: bold; text-align: right" title="Sale of gold in trust, amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1373"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--SaleOfTrustAssetsOuncesOfGold_uOunce_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zNNIxaiOR3k1" style="font-size: 10pt; text-align: right" title="Sale of gold in trust, ounces"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ProceedsFromSaleOfTrustAssets_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_z69CWD419J7" style="font-size: 10pt; text-align: right" title="Sale of gold in trust, amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1377"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Gain on sale&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--RealizedGainLossOnSaleOfTrustAssets_pdp0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zColDqiPguF8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Gain on sale, amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1379"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--RealizedGainLossOnSaleOfTrustAssets_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zTq3ISByRzqk" style="font-size: 10pt; text-align: right" title="Gain on sale, amount"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1381"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Change in fair value through profit &amp;amp; loss&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--GainLossOnAssetsInTrust_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zWeUOO3GF218" style="font-size: 10pt; font-weight: bold; text-align: right" title="Change in fair value through profit &amp;amp; loss, amount"&gt;132,895&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;-&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--GainLossOnAssetsInTrust_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zNVBOARBlpWd" style="font-size: 10pt; text-align: right" title="Change in fair value through profit &amp;amp; loss, amount"&gt;(6,518&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Foreign exchange difference&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;0&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--IncreaseDecreaseThroughForeignExchangeInTrustAssets_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zoM05yV2cL6g" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Foreign exchange difference, amount"&gt;(24,491&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;0&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--IncreaseDecreaseThroughForeignExchangeInTrustAssets_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zL7X4w9IWfq1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Foreign exchange difference, amount"&gt;64,920&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--LoansPayableOuncesOfGold_iE_uOunce_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zJqjI9ltSiOl" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Gold in trust, ending balance, ounces"&gt;397&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--TrustAssetsMetals_iE_pp0p0_c20230101__20231231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zZwocgpdfMCh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Gold in trust, amount"&gt;1,082,801&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--LoansPayableOuncesOfGold_iE_uOunce_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zYkDwNqJNa35" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Gold in trust, ending balance, ounces"&gt;397&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--TrustAssetsMetals_iE_pp0p0_c20220101__20221231__ifrs-full--BorrowingsByNameAxis__custom--GoldLoanMember_zPWGaMDBGnIi" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Gold in trust, amount"&gt;974,397&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:DisclosureOfAssetsInTrustTextBlock> <aau:LoansPayableOuncesOfGold contextRef="AsOf2022-12-31_custom_GoldLoanMember" decimals="INF" id="Fact001363" unitRef="Ounce">397</aau:LoansPayableOuncesOfGold> <aau:TrustAssetsMetals contextRef="AsOf2022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001365" unitRef="CAD">974397</aau:TrustAssetsMetals> <aau:LoansPayableOuncesOfGold contextRef="AsOf2021-12-31_custom_GoldLoanMember" decimals="INF" id="Fact001367" unitRef="Ounce">397</aau:LoansPayableOuncesOfGold> <aau:TrustAssetsMetals contextRef="AsOf2021-12-31_custom_GoldLoanMember" decimals="0" id="Fact001369" unitRef="CAD">915995</aau:TrustAssetsMetals> <aau:GainLossOnAssetsInTrust contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001383" unitRef="CAD">132895</aau:GainLossOnAssetsInTrust> <aau:GainLossOnAssetsInTrust contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001385" unitRef="CAD">-6518</aau:GainLossOnAssetsInTrust> <aau:IncreaseDecreaseThroughForeignExchangeInTrustAssets contextRef="From2023-01-012023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001387" unitRef="CAD">-24491</aau:IncreaseDecreaseThroughForeignExchangeInTrustAssets> <aau:IncreaseDecreaseThroughForeignExchangeInTrustAssets contextRef="From2022-01-012022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001389" unitRef="CAD">64920</aau:IncreaseDecreaseThroughForeignExchangeInTrustAssets> <aau:LoansPayableOuncesOfGold contextRef="AsOf2023-12-31_custom_GoldLoanMember" decimals="INF" id="Fact001391" unitRef="Ounce">397</aau:LoansPayableOuncesOfGold> <aau:TrustAssetsMetals contextRef="AsOf2023-12-31_custom_GoldLoanMember" decimals="0" id="Fact001393" unitRef="CAD">1082801</aau:TrustAssetsMetals> <aau:LoansPayableOuncesOfGold contextRef="AsOf2022-12-31_custom_GoldLoanMember" decimals="INF" id="Fact001395" unitRef="Ounce">397</aau:LoansPayableOuncesOfGold> <aau:TrustAssetsMetals contextRef="AsOf2022-12-31_custom_GoldLoanMember" decimals="0" id="Fact001397" unitRef="CAD">974397</aau:TrustAssetsMetals> <aau:WarrantlibilityTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact001399">&lt;p id="xdx_803_ecustom--WarrantlibilityTextBlock_zCVHFUxujIY" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;9.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_825_zeD4l9Vz3B3a"&gt;Warrant liability&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;In connection with the registered direct offering private placement completed during the year ended December 31, 2021, the Company issued a total of &lt;span id="xdx_90A_ecustom--WarrantsExercisable_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zbl9TKNQ0tW9" title="Warrants exercisable"&gt;7,923,077&lt;/span&gt; warrants exercisable at US$&lt;span id="xdx_901_ecustom--WarrantsExercisableSharePrice_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zMBlz3oXtFWg" title="Warrants exercisable share price"&gt;0.80&lt;/span&gt; per share. The fair value of these warrants on issuance was $&lt;span id="xdx_90E_ecustom--FairValueOfWarrants_pp0p0_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zbPBJk7JeZ75" title="Fair value of warrants"&gt;2,371,174&lt;/span&gt;, valued using the Black-Scholes option-pricing model with the following assumptions:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfWarrantAssumptions_zV59PS4bXWo6" style="width: 100%; border-collapse: collapse; font-size: 10pt" summary="xdx: Disclosure - Warrant liability (Details)"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&lt;span id="xdx_8BA_zlIlo6SCQRJb" style="display: none"&gt;Schedule of warrant assumptions&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 25%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 25%; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Risk-free interest rate &lt;/span&gt;&lt;/td&gt; &lt;td style="width: 25%; layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--WarrantsRiskFreeInterestRate_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsMember_z8hKQKD6JVLl" title="Risk free interest rate"&gt;0.53&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 25%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Expected life of warrants &lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--ExpectedLifeOfWarrantsInYears_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsMember_zxYGqRRlH0vf" title="Expected life of warrants"&gt;3.00&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Expected annualized volatility &lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--ExpectedAnnualizedVolatility_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsMember_zE2wH4Ae3dl2" title="Expected annualized volatility"&gt;72.42&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Dividend &lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Nil&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Forfeiture rate &lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--ForfeitureRate_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsMember_zpHzxsLvkuT2" title="Forfeiture rate"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8A5_zLfxhfTBPRk9" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The fair value is recorded as a derivative financial liability as these warrants are exercisable in US dollars, differing from the Company&#x2019;s functional currency. The change in fair value resulted in an unrealized gain of $&lt;span id="xdx_90E_eifrs-full--GainsOnChangeInFairValueOfDerivatives_pp0p0_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zrdTxEdm2cG6" title="Change in fair value of derivative financial liability"&gt;102,787&lt;/span&gt; (December 31, 2022 - $&lt;span id="xdx_90E_eifrs-full--GainsOnChangeInFairValueOfDerivatives_pp0p0_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zBhITelfbCA" title="Change in fair value of derivative financial liability"&gt;520,503&lt;/span&gt;) and is recognized in the consolidated statements of comprehensive loss for the year ended December 31, 2023. The fair value warrants were re-valued at period end using the Black-Scholes option-pricing model with the following assumptions:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfWarrantDerivativeFinancialLiability_z5gLt0lJ7OGk" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Warrant liability (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span id="xdx_8BE_zqS1AlE6j6kl" style="display: none"&gt;Schedule of derivative financial liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: justify"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WarrantsRiskFreeInterestRate_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_z2YOCkCdYPA" title="Risk free interest rate"&gt;3.91&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WarrantsRiskFreeInterestRate_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zgjtU1Cxgyo2" title="Risk free interest rate"&gt;3.99&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Expected life of warrants&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_907_ecustom--ExpectedLifeOfWarrantsInYears_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zn2LOLL1LfNg" title="Expected life of warrants (in years)"&gt;0.21&lt;/span&gt; years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeOfWarrantsInYears_dtY_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_ziKikJPPOFpf" title="Expected life of warrants (in years)"&gt;1.21&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Expected annualized volatility&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExpectedAnnualizedVolatility_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_z6VRSgeVOzQj" title="Expected annualized volatility"&gt;36.25&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ExpectedAnnualizedVolatility_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_ze31Fl65eVN5" title="Expected annualized volatility"&gt;69.83&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Dividend&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Nil&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;Nil&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Forfeiture rate&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForfeitureRate_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_ztIHDa9odCwk" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForfeitureRate_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zaS2hwcJLBQ1" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8A7_zCaNPjETW0xl" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; </aau:WarrantlibilityTextBlock> <aau:WarrantsExercisable contextRef="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember" decimals="INF" id="Fact001401" unitRef="Shares">7923077</aau:WarrantsExercisable> <aau:WarrantsExercisableSharePrice contextRef="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember" decimals="INF" id="Fact001403" unitRef="CADPShares">0.80</aau:WarrantsExercisableSharePrice> <aau:FairValueOfWarrants contextRef="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember" decimals="0" id="Fact001405" unitRef="CAD">2371174</aau:FairValueOfWarrants> <aau:ScheduleOfWarrantAssumptions contextRef="From2023-01-01to2023-12-31" id="Fact001411">&lt;table cellpadding="0" cellspacing="0" id="xdx_896_ecustom--ScheduleOfWarrantAssumptions_zV59PS4bXWo6" style="width: 100%; border-collapse: collapse; font-size: 10pt" summary="xdx: Disclosure - Warrant liability (Details)"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&lt;span id="xdx_8BA_zlIlo6SCQRJb" style="display: none"&gt;Schedule of warrant assumptions&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 25%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 25%; layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Risk-free interest rate &lt;/span&gt;&lt;/td&gt; &lt;td style="width: 25%; layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--WarrantsRiskFreeInterestRate_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsMember_z8hKQKD6JVLl" title="Risk free interest rate"&gt;0.53&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 25%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Expected life of warrants &lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--ExpectedLifeOfWarrantsInYears_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsMember_zxYGqRRlH0vf" title="Expected life of warrants"&gt;3.00&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Expected annualized volatility &lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--ExpectedAnnualizedVolatility_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsMember_zE2wH4Ae3dl2" title="Expected annualized volatility"&gt;72.42&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Dividend &lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Nil&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: top"&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Forfeiture rate &lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--ForfeitureRate_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsMember_zpHzxsLvkuT2" title="Forfeiture rate"&gt;0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:ScheduleOfWarrantAssumptions> <aau:WarrantsRiskFreeInterestRate contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember144110500" decimals="INF" id="Fact001413" unitRef="Pure">0.0053</aau:WarrantsRiskFreeInterestRate> <aau:ExpectedLifeOfWarrantsInYears contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember144110500" id="Fact001415">P3Y</aau:ExpectedLifeOfWarrantsInYears> <aau:ExpectedAnnualizedVolatility contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember144110500" decimals="INF" id="Fact001417" unitRef="Pure">0.7242</aau:ExpectedAnnualizedVolatility> <aau:ForfeitureRate contextRef="From2023-01-012023-12-31_ifrs-full_WarrantsMember144110500" decimals="INF" id="Fact001419" unitRef="Pure">0</aau:ForfeitureRate> <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember" decimals="0" id="Fact001421" unitRef="CAD">102787</ifrs-full:GainsOnChangeInFairValueOfDerivatives> <ifrs-full:GainsOnChangeInFairValueOfDerivatives contextRef="From2022-01-012022-12-31_custom_DerivativeFinancialLiabilityMember" decimals="0" id="Fact001423" unitRef="CAD">520503</ifrs-full:GainsOnChangeInFairValueOfDerivatives> <aau:ScheduleOfWarrantDerivativeFinancialLiability contextRef="From2023-01-01to2023-12-31" id="Fact001425">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--ScheduleOfWarrantDerivativeFinancialLiability_z5gLt0lJ7OGk" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Warrant liability (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span id="xdx_8BE_zqS1AlE6j6kl" style="display: none"&gt;Schedule of derivative financial liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: justify"&gt;Risk-free interest rate&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--WarrantsRiskFreeInterestRate_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_z2YOCkCdYPA" title="Risk free interest rate"&gt;3.91&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--WarrantsRiskFreeInterestRate_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zgjtU1Cxgyo2" title="Risk free interest rate"&gt;3.99&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Expected life of warrants&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;&lt;span id="xdx_907_ecustom--ExpectedLifeOfWarrantsInYears_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zn2LOLL1LfNg" title="Expected life of warrants (in years)"&gt;0.21&lt;/span&gt; years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--ExpectedLifeOfWarrantsInYears_dtY_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_ziKikJPPOFpf" title="Expected life of warrants (in years)"&gt;1.21&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Expected annualized volatility&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_905_ecustom--ExpectedAnnualizedVolatility_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_z6VRSgeVOzQj" title="Expected annualized volatility"&gt;36.25&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_909_ecustom--ExpectedAnnualizedVolatility_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_ze31Fl65eVN5" title="Expected annualized volatility"&gt;69.83&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Dividend&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Nil&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;Nil&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Forfeiture rate&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--ForfeitureRate_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_ztIHDa9odCwk" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_902_ecustom--ForfeitureRate_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--DerivativeFinancialLiabilityMember_zaS2hwcJLBQ1" title="Forfeiture rate"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:ScheduleOfWarrantDerivativeFinancialLiability> <aau:WarrantsRiskFreeInterestRate contextRef="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember" decimals="INF" id="Fact001427" unitRef="Pure">0.0391</aau:WarrantsRiskFreeInterestRate> <aau:WarrantsRiskFreeInterestRate contextRef="From2022-01-012022-12-31_custom_DerivativeFinancialLiabilityMember" decimals="INF" id="Fact001429" unitRef="Pure">0.0399</aau:WarrantsRiskFreeInterestRate> <aau:ExpectedLifeOfWarrantsInYears contextRef="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember" id="Fact001431">P0Y2M15D</aau:ExpectedLifeOfWarrantsInYears> <aau:ExpectedLifeOfWarrantsInYears contextRef="From2022-01-012022-12-31_custom_DerivativeFinancialLiabilityMember" id="Fact001433">P1Y2M15D</aau:ExpectedLifeOfWarrantsInYears> <aau:ExpectedAnnualizedVolatility contextRef="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember" decimals="INF" id="Fact001435" unitRef="Pure">0.3625</aau:ExpectedAnnualizedVolatility> <aau:ExpectedAnnualizedVolatility contextRef="From2022-01-012022-12-31_custom_DerivativeFinancialLiabilityMember" decimals="INF" id="Fact001437" unitRef="Pure">0.6983</aau:ExpectedAnnualizedVolatility> <aau:ForfeitureRate contextRef="From2023-01-012023-12-31_custom_DerivativeFinancialLiabilityMember" decimals="INF" id="Fact001439" unitRef="Pure">0</aau:ForfeitureRate> <aau:ForfeitureRate contextRef="From2022-01-012022-12-31_custom_DerivativeFinancialLiabilityMember" decimals="INF" id="Fact001441" unitRef="Pure">0</aau:ForfeitureRate> <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001443">&lt;p id="xdx_804_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_ztrJYfzX12Y4" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;10.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82A_zo0zfqxmhAa2"&gt;Share capital and reserves&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(a)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Authorized share capital&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;At December 31, 2023, the authorized share capital comprised an unlimited number of common shares. The common shares do not have a par value. All issued shares are fully paid.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(b)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Details of private placements and other issues of common shares in 2023, 2022 and 2021&lt;/i&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;On March 18, 2021, the Company closed a registered direct offering private placement for the purchase and sale of 15,846,154 common shares and common share warrants to purchase up to 7,923,077 common shares at a combined purchase price of US$0.65 per unit for aggregate gross proceeds of US$10.3 million (CAD$12,838,950). The common share warrants will be immediately exercisable, have an exercise price of US$0.80 per share and will expire three years from the date of issuance. Share issue costs included a finder&#x2019;s fee of $834,532 in cash, and finders&#x2019; warrants to purchase up to 435,769 common shares at a price of US$0.80 per common share until March 18, 2024. The fair value of the finders&#x2019; warrants was $130,731. In connection with the registered direct offering, the Company also incurred $393,837 in share issue costs. These amounts were recorded as a reduction to share capital. The proceeds of the registered direct offering were allocated $10,467,776 to share capital and $2,371,174 to warrants.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Share issue costs of $40,990 was recorded for fees paid related to the Short Form Base Shelf Prospectus filed on February 25, 2021.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(c)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td&gt;&lt;b&gt;&lt;i&gt;Warrants&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The continuity of warrants for the years ended December 31, 2023, 2022 and 2021 are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_zt17ghDKFVv" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Share capital and reserves (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_8B7_zoZdz0CCb17f" style="display: none"&gt;Schedule of Continuity of Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zF16S9xTlMaj" title="Expiry date"&gt;March 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zKy1eW63L1Of" title="Exercise price"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zOKtua1hSZHk" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zAYAJdtyUoD6" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1456"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zI3RdLJgFRY" style="width: 8%; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1458"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zOfNKSUT6lO9" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;(5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zVCmsDU4lJT2" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1462"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zDGragCFvIg7" title="Expiry date"&gt;August 6, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zDsnKtOLEAPk" title="Exercise price"&gt;0.90&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zw5ZkxPiF9Ol" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zFhoKBG8q847" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1470"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zzzusmUkUqI1" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1472"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zkpRYH1IqlB8" style="font-size: 10pt; text-align: right" title="Issued"&gt;(3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_z2qKzoUhbG8d" style="font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1476"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z0XQMb6FVMwj" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zAKVWLJXKme" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zuClzw9TpWSf" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zyZGYsJsUK3k" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1484"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zEnCz6uJ2LFi" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1486"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zVboCTGkbYNd" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1488"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zfkFf9YmBrB3" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z2lSPLHnEGv4" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zpsajRWvvRhd" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zwrNcwit30ia" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zcIoGfHmLvf3" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1498"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zqLr7T8ZbAvh" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1500"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z3VqEJYL2207" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1502"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zob19PlVG8Lf" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zwYJhTP3y7Hf" title="Expiry date"&gt;May 14, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z9Bbz39YgtB9" title="Exercise price"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zuXHEDdVi5qb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zqWXKDZsPOL9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zlhDTLx7AOh1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1514"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zoBgAzlmTmcl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1516"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zl4gjlQe54R8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Warrants outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231_z6d3ZJCP5Y5f" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, outstanding and exercisable"&gt;17,448,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zbI9FXOonsg3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zbmCHuuPOo4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1524"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zqYwDGApmBk7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, outstanding and exercisable (in shares)"&gt;(8,589,658&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iE_uShares_c20230101__20231231_z3ozagDWZTp9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, oustanding and exercisable"&gt;8,858,846&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20230101__20231231_zkN8QT1ONLti" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.88&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20230101__20231231_zKtc9v2W7w6h" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1532"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisedWeightedAverageExercisePrice_uCADPShares_c20230101__20231231_zND9ZwZbS57b" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1534"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_uCADPShares_c20230101__20231231_zSRr6XQ5mXte" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, weighted average exercise price"&gt;0.64&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uCADPShares_c20230101__20231231_z5aSNHAiIjqe" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;1.08&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of warrants outstanding at December 31, 2023 was &lt;span id="xdx_901_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20230101__20231231_zflWr9s6yCG8" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;0.22&lt;/span&gt; years (2022 &#x2013; &lt;span id="xdx_902_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20220101__20221231_z8mjtdzxRR5a" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;0.80&lt;/span&gt; years).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zC8zZYDyhkx5" title="Expiry date"&gt;June 7, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zPXnp3bUxFl7" title="Exercise price"&gt;1.35&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zBdfY2HG1CCk" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;4,720,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_z0ZupdJTW1S1" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1550"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zoBdvkNeG5t4" style="width: 8%; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1552"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zELRJ9O9EHLl" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;(4,720,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_z3VC2PUuwZN1" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1556"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z7z3SvhFfpFd" title="Expiry date"&gt;March 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_909_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zcLEg1aEDVa" title="Exercise price"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zSjukoqKs05h" style="font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zfAPp0sYf6ji" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1564"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z9EQ9DRAFbuh" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1566"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zsETH64Nw4hb" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1568"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zE1Gh2amlhr" style="font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zeuLqQM4mao8" title="Expiry date"&gt;August 6, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zQ08fa1cMxV3" title="Exercise price"&gt;0.90&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zGOLvcUaZab4" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zQ6iC3gvF7Rl" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1578"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zYFIA1OCJiP9" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1580"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_z9biVRWYwp6j" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1582"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_z3ZIZA0NHZ7a" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zTviwnQnsXL5" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zSPVMrp1Eu4g" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zbYY3SM6MITb" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zZFXcOAc8kCj" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1592"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z9AmUYA9pA7b" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1594"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z8UItO5iJcX5" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1596"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zFnlzGRaKjV9" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z5GTVbck9wlj" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zVfbRfgNkOih" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_ztyyNBI6gfu4" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zzEspT0bXrBk" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1606"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zMayns4SLFC7" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1608"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zU1wTGu4BjXl" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1610"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z3SXzdZaCEB7" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zXJrlv4MUgkc" title="Expiry date"&gt;May 14, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z2RqVo9XFyL7" title="Exercise price"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zMcAVmZXjOo9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zj7TFd8bh3L2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1620"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z5M2QLtg6nV4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1622"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_ztyM7Hf4yE4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1624"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z93wpKw2k822" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Warrants outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231_zXmrJ3KwwUt2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, outstanding and exercisable"&gt;22,168,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zOycXnwwYhY3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1630"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zEJxy3eo2ROf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1632"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zh2YbMUNBnZc" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, outstanding and exercisable (in shares)"&gt;(4,720,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iE_uShares_c20220101__20221231_z90pvPXrHau8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, oustanding and exercisable"&gt;17,448,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20220101__20221231_zp6zhiHyErKj" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.95&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20220101__20221231_z4YGHkanxtk7" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1640"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExercisedWeightedAverageExercisePrice_uCADPShares_c20220101__20221231_z0yH4fUIVhFa" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_uCADPShares_c20220101__20221231_zi5j3X6iJ6ub" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, weighted average exercise price"&gt;1.35&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uCADPShares_c20220101__20221231_zbXunOHW29T1" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.88&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of warrants outstanding at December 31, 2022 was &lt;span id="xdx_902_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20220101__20221231_zebc8pttZNV1" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;0.80&lt;/span&gt; years (2021 &#x2013; &lt;span id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20210101__20211231_z1iBXDVvSDy3" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;1.51&lt;/span&gt; years).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2020&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zpkq0nVUoVmb" title="Expiry date"&gt;June 7, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zjfwvhDFYRXh" title="Exercise price"&gt;1.35&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zKieOUYFWtjf" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;4,720,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zIxxIP9u0pU8" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1658"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_z2URiOGmm3ve" style="width: 8%; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zbLvkPGuOPLc" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1662"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zscbBsRI8Ic2" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;4,720,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zSvepFa1CYwi" title="Expiry date"&gt;March 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z5mpvHmt1s82" title="Exercise price"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z0SGvyPt5ABh" style="font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zQ6kmOQerX7b" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1672"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z7p7y2VzwSg6" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1674"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zxNicSwPtJb" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1676"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zInLd5GLQdXd" style="font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zyg80vlMDURk" title="Expiry date"&gt;August 6, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zooh5MaPiZXl" title="Exercise price"&gt;0.90&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_z8p053abZZb" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zyi4OZzdgNs2" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1686"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zUI3uB0vkx13" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1688"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zi4GSjkin71k" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zOevAkGHYxH9" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z7GTR0zgwfB5" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zM5zuChRvmH5" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zuandZSfBTXb" style="font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zEQMNCJGqNke" style="font-size: 10pt; text-align: right" title="Issued"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zqchelbC0Bm7" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1702"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zTxK0BIHbKS4" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1704"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z3FhJI6EAdA7" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zp7T3vpfFzQ" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_908_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zAQ6TAUUJxv7" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zK8Ap5r8Gp62" style="font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1712"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zSCWr7tyZyfj" style="font-size: 10pt; text-align: right" title="Issued"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z5k0S3Dhcd3f" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z09y6cge6Md5" title="Expiry date"&gt;May 14, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zz5aPepHlNy3" title="Exercise price"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zTglfmlWUqM5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zFk1JBjvaPs5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zGiXfhxm5zh9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1726"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zFm7Besu0Jg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zKsb6vddAzce" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Warrants outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231_zHA4noV8uxZf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, outstanding and exercisable"&gt;13,809,658&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_zWcgM5Yyzl32" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, outstanding and exercisable (in shares)"&gt;8,358,846&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_zUuQAE2ROYl1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_z4FA3n3F2N1j" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1738"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iE_uShares_c20210101__20211231_zOX6fKSfnBL3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, oustanding and exercisable"&gt;22,168,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20210101__20211231_zgwDYoNVBaE4" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.92&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20210101__20211231_zF7QdeLMpQd8" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, weighted average exercise price"&gt;1.00&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExercisedWeightedAverageExercisePrice_uCADPShares_c20210101__20211231_zpbG8D0XgDJ4" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_uCADPShares_c20210101__20211231_zBXO71ywYQ6j" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1748"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uCADPShares_c20210101__20211231_zLwCWsb3uOkk" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.95&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of warrants outstanding at December 31, 2021 was &lt;span id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20210101__20211231_z6Qy1SYVSmie" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;1.51&lt;/span&gt; years (2020 &#x2013; &lt;span id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20200101__20201231_zI1TsdtExVVl" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;2.08&lt;/span&gt; years).&lt;/p&gt; &lt;p id="xdx_8A1_zfiwtrkTm8Kl" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average fair value of finders&#x2019; warrants granted during the years ended December 31, 2023, 2022 and 2021 calculated using the Black-Scholes option-pricing model at the issue dates, are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -9.55pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;Weighted average assumptions used&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_zdRlBYMT61de" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Share capital and reserves (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="layout-grid-mode: line; text-align: left"&gt;&lt;span id="xdx_8B1_zxz4oKFrZVmf" style="display: none"&gt;Schedule of -Warrant Fair Value Assumptions&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 16%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Number of &lt;br/&gt; warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Date of issue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Fair value &lt;br/&gt; per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Risk free &lt;br/&gt; interest &lt;br/&gt; rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%"&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: right"&gt;&lt;b&gt;Expected life &lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: right"&gt;&lt;b&gt;(in years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Expected &lt;br/&gt; volatility&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Expected &lt;br/&gt; dividends&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98C_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_z4u09MoiBApd" style="layout-grid-mode: line; text-align: right" title="Number of warrants"&gt;&lt;span style="font-size: 10pt"&gt;435,769&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;March 18, 2021&lt;/span&gt;&lt;/td&gt; &lt;td id="xdx_988_ecustom--WeightedAverageSharePriceWarrantGranted_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_zJjBtAoT63v8" style="layout-grid-mode: line; text-align: right" title="Fair value per share"&gt;&lt;span style="font-size: 10pt"&gt;$ 0.30&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--RiskFreeInterestRateWarrantsGranted_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_z774Uo4W9u8f" title="Risk free interest rate"&gt;0.53&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--WarrantLifeWarrantsGranted_dtY_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_zcuiC7Kc04Lj" title="Expected life (Year)"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfExpectedVolatilityWarrantsGranted_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_zLaJyCjRQcsk" title="Expected volatility"&gt;72.42&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$Nil&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(d)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Share purchase option compensation plan&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company&#x2019;s stock option plan permits the issuance of options up to a maximum of &lt;span id="xdx_907_ecustom--StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptions_iI_dp_c20221231_zR37lx99cHmc" title="Stock options issuance limitations, maximum percentage of allowed issuable options"&gt;10&lt;/span&gt;% of the Company&#x2019;s issued share capital. Stock options issued to any consultant or person providing investor relations services cannot exceed &lt;span id="xdx_902_ecustom--StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptionsForServicesRendered_iI_dp_c20221231_zMk9Kd6QIvod" title="Stock options issuance limitations, maximum percentage of allowed issuable options for services rendered"&gt;2&lt;/span&gt;% of the issued and outstanding common shares in any twelve month period. At December 31, 2023, the Company had reserved &lt;span id="xdx_909_eifrs-full--NumberOfSharesAuthorised_iI_c20221231_zMGYOOO2WDce" title="Number of shares authorised (in shares)"&gt;1,217,141&lt;/span&gt; stock options that may be granted. The exercise price of any option cannot be less than the volume weighted average trading price of the shares for the five trading days immediately preceding the date of the grant.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The maximum term of all options is five years. The Board of Directors determines the term of the option (to a maximum of five years) and the time during which any option may vest. Options granted to consultants or persons providing investor relations services shall vest in stages with no more than &lt;span id="xdx_902_ecustom--StockOptionLimitationsMaximumAmountOfStockOptionsExercisableDuringA3MonthPeriod_iI_dp_c20221231_z4AO01H7zjf" title="Stock option limitations, maximum amount of stock options exercisable during a 3 month period"&gt;25&lt;/span&gt;% of such option being exercisable in any three month period. All options granted during the years ended December 31, 2023, 2022 and 2021 vested on the grant date.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company&#x2019;s stock option plan permits the option holder to exercise cashless by surrendering a portion of the underlying option shares to pay for the exercise price and the corresponding withholding taxes, if applicable.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The continuity of stock options for the years ended December 31, 2023, 2022 and 2021 are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfShareOptions_zXlBuvxDn9Qc" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Share capital and reserves (Details 2)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zdeoI116tw6k" style="display: none"&gt;Schedule of Share options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; price&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zuQD8idGrGM" title="Expiry date"&gt;February 9, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z9UMfNgAdxaa" style="width: 8%; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.97&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zCegD5DxAIoa" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;350,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zWLoYqwC0mF" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1793"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zkni8ACAT3tb" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1795"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z5BNMRAozeR5" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(350,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zDdVdKd7l4H6" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1799"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zEk5RhqBr7q8" title="Expiry date"&gt;March 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zxdhPKIGZPxh" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.96&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zIhXY2lMeuRk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_z0KaEVcaQ3C8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1807"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zO0gJBpqOVS4" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1809"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zbCY251bJCb" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zZZAe42YiOZ7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1813"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zfFNgo1hiRh9" title="Expiry date"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zcxBan9cO9Wf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.68&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zvcnbWM4Vgrk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zeMv4qsLqk6" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zJ6F5Ovrtbzd" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1823"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zBl2gsf9kGNc" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zv2MhLJyTaOe" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zIx5rU8LAMu8" title="Expiry date"&gt;May 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zLf3LosfFyFi" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.69&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_z9JhftJHprdl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zLkvjGhl9God" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zeb6gIapBa8a" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zfkMl5lanOK2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zLlPTdKeVhN5" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zKqwMMgzUXfl" title="Expiry date"&gt;May 28, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_z9KPwGnIWpeg" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.65&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zR9u4Ja8T4df" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zpleoGTu5Dy5" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1849"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zmUw3YBEVhkl" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1851"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_z2pB3QrU1sug" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zBwy0JQ3m9Z7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zI4yODg5Rxv4" title="Expiry date"&gt;July 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zNk6Q9qrEyBk" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zAGsoih8qsK4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,420,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zbsm4LKyfX28" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1863"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zw09ytxwSBWe" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1865"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zChtVID24CJ2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(2,420,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zgKTkPQLXNWl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1869"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zO9VHl9VdSmk" title="Expiry date"&gt;September 18, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zcqYzpvf2Ne6" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.51&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zyCrOFqZq2Vb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;960,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zyjpkm1ZNPN5" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1877"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zSWRAgG1vvfd" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1879"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zhXalBEFd4E5" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(960,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zuTm1Rwyy2Cd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1883"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zYSIY13KL0J6" title="Expiry date"&gt;March 7, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zaVwQXsyHXa1" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.38&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zu2VUBCyIiOa" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zQMHDXrUMSLi" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1891"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zlybp5JeRQ7g" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1893"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zHYxhOLnLzag" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1895"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zHIwRxv70dja" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zYlzVYooQ0J1" title="Expiry date"&gt;June 10, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zYdfUyUl3CKf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.33&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zwQCaWOSSMQ3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;3,640,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zG4dOz1GL1H" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zKE4QUJUDFaf" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1907"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_z6TRlH2osWgk" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zFF76EtQd8Rl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;3,640,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zHL76pag14tg" title="Expiry date"&gt;October 4, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zACbTk3FOVp8" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.30&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zwpTaR3EHU8c" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;755,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zwEfLSwuI5Fl" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1919"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zpB5MduS77rk" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1921"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_ztb4LxJF7jV1" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1923"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zZuy2sMJ3nDd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;755,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zGYpr66LKa4c" title="Expiry date"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zjqfne3wRh24" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.33&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zUgwNrFSVxrj" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;855,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zOqz4kgTZuY9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zAScAfVvi9Lb" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1935"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_z4SQRGi8qf0j" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1937"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zlwwJxqIp4y6" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;855,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zVEjdUh2qH61" title="Expiry date"&gt;February 14, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zbkrJqgjfRHd" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.30&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_z5tmGMLFRAV6" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1945"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_z2qF3EEzUpB3" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zFkwDUjjL569" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zB4yz3CY5t3f" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1951"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zUoWJR09oQab" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zZAtfsI1zJhj" title="Expiry date"&gt;April 3, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zWtIMMrBRSBl" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.26&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zupwo9R6BMTe" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1959"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zSaqJ41vrSna" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zbcBznzVrQ0g" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1963"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zOnB5uU7x4ac" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1965"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zowou58otNUk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zJt1UIl3Zto" title="Expiry date"&gt;July 10, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zGVacftxE31f" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.16&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zWtegadkRjk6" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1973"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zhOF17WTJvze" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;2,520,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zlKXjAJ1YKSl" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1977"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zAH94UBRh8Ak" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1979"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zXsEZL1gzTGf" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,520,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zUxXfRs2HNcb" title="Expiry date"&gt;September 19, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zvR23DCvhjL8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.18&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zSG2a8TnFGv3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1987"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zmO0otkAAEZh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,035,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zO0r07h8BVZ8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1991"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zIDIG79cBftf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1993"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_z7BUrBGt8KX1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,035,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Options outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iS_uShares_c20230101__20231231_zkxbNtRbAnNa" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;12,530,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zCuE792dGTbf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, granted, outstanding and exercisable (in shares)"&gt;6,130,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zwRD45OKjCI4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2001"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_z1k474TmKsZb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Options outstanding and exercisable, expired (in shares)"&gt;(6,155,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iE_uShares_c20230101__20231231_zYgB2S7xPjW" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;12,505,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iS_c20230101__20231231_z6FjIDtxKusc" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.49&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20230101__20231231_zZWlfDimVAjb" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, granted"&gt;0.21&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20230101__20231231_zcxCqft9yw6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2011"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_c20230101__20231231_zuyrYXQVo0f3" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, expired"&gt;0.66&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iE_c20230101__20231231_zHWjLSawg0Pe" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.27&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of stock options outstanding at December 31, 2023 was &lt;span id="xdx_90E_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231_z7i6cGWZUDQg" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;3.96&lt;/span&gt; years (2022 &#x2013; &lt;span id="xdx_908_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231_zIsSwKhFzUEj" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;2.53&lt;/span&gt; years).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; price&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_z8xephuwu9E6" title="Expiry date"&gt;March 4, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zYikgJAMJNFl" style="width: 8%; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.47&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zWRIeyvvyOf1" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zgBGwvzzq8Ma" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2032"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zwqxRB5pS8dg" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zbffrGfyYffb" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zzfD65cO3ag5" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zOl23WzhH7W2" title="Expiry date"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zpLg8baNn3X2" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.41&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zEGscAsrdFS8" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zztuqBvSQSz9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zXQPcMhyEnih" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2048"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zAxNEsKmDaye" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zDILVf8NCnh9" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2052"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zKYKT4q5lBnh" title="Expiry date"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zkgstVFDvRa7" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.58&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zph6kHWGFnh8" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;220,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zx2WFhoDjlrg" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zx2lMCzTEZBc" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2062"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_z7H4dr5Josme" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(220,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zc8CoR3GjGHk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2066"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_ztJRO2w33GZ" title="Expiry date"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_z63mOAusXLgh" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zNWQ8DcLY8rd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zwCF1rYTgWc3" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2074"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zcDX93ziGMt5" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2076"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_z4TGfxTsCsBd" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zFLklrf2nRT1" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2080"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_z4vStgvVC8q7" title="Expiry date"&gt;June 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zeOG8vkY8KKc" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.64&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zTnY3veiFxPb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,980,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zljAEm14KPja" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2088"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zZcuLkFg3h3d" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2090"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_z2AkW4QSSDi6" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,980,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_ziK4XYCQuIph" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zNeIDc0ZbnZ9" title="Expiry date"&gt;October 3, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zJAGMaoXYwhf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.13&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zitBfsn5572j" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;860,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zf69aIK875l6" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2102"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zWv3PZxYoKka" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2104"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zb3TuHXmXqbb" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(860,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zanA0b23sMLg" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2108"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zcTVDoi9wRVi" title="Expiry date"&gt;December 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zR5NUnzjSm1l" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.89&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zqz5KRRpdRA4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;900,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zZ9UxBvcn2qa" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2116"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zjKsoBAqxulf" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2118"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zAQq2pfSk0wh" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(900,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zeK7uWM8K5qe" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z95FZJwSvigc" title="Expiry date"&gt;February 9, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zP4y8HlbRad9" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.97&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zhgtrtOiSzse" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;350,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zSGoM3rYzls9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2130"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zJ1bNuMw1UDh" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2132"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zLpHudmdFaV6" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2134"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z1Ux3tUvKNCa" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;350,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zNVY5KgjKCY5" title="Expiry date"&gt;March 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zdpi7DL0SWz6" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.96&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zuUeYnLOasMa" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zWy71YJhJqI8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zpQhupvxHPUe" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2146"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zqKwG5b38EK3" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_z6QjutN2DzC3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zc5Fh84va99b" title="Expiry date"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_z2b5HKZgBise" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.68&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zpyi2j3sSX2l" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_z86Y8T9PHqM2" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2158"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zkQddb8ELYf8" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_z2gjOQWZ0RY2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2162"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zTz8StHkz9x3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zTJgN85g5Z72" title="Expiry date"&gt;May 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zh57P9E7bhq8" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.69&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zS8FWHyU6z06" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zSK70ddgn09f" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2172"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zcrtlREEtxVl" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2174"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zsOflVAHy3b" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2176"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zJiNDo0ipr84" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zuN2dqBjg3ca" title="Expiry date"&gt;May 28, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zA2bzHH6geh8" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.65&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zclzls1DV5b" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zMVlhZuNjyh7" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zzcVP3kZxnWe" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2188"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zpSRgBpwfee5" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zT2HRpwwlpHg" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zCbI3SN4SMYg" title="Expiry date"&gt;July 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zB4vrzHVR3Sf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zU7uGMFU2p96" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,470,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zi4QzQdlZx4" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2200"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zoxjcAHe69zj" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2202"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zBqZYLiceHfg" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(50,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zLjNj0Mx5APb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,420,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zZ0yxf8xQYQa" title="Expiry date"&gt;September 18, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zWT1grPaX1ia" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.51&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zfKUSx6TeXwd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;960,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zVZVrFKT9JA9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2214"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zldqOQHl5LMh" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2216"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zTzX8epecvCj" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zb0WxDYsQXj" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;960,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zzhgZquGabi5" title="Expiry date"&gt;March 7, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zrdcOh786roc" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.38&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_z9i3nfZ3x2v7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2226"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zlVj5S50gOSa" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_znRfYTL0qwj9" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2230"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zBhyWmzR6mD" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zRz4FvSSVPkh" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zgK1xZijAbEa" title="Expiry date"&gt;June 10, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zYOo2XHcRFu9" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.33&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_z2oxCTT9RfY8" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2240"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zkX2LqbUkMPb" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;3,640,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zMd6QU77GKI8" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2244"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zydMG9AAtkVi" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2246"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zzXY4wzd7Jsb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;3,640,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_z9wOd9cUN9xc" title="Expiry date"&gt;October 4, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zyLy1O3R9Iug" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.30&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zm0cboyj87O" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2254"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zc9btSMTM293" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;755,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zps6Gd1lXKRd" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2258"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zxv8Rpx0fIda" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2260"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zSAXTSMpYjxg" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;755,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zS5qhjyrUcq5" title="Expiry date"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_z0cQdGVnUkP3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.33&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zi35s0zAcn34" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2268"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zuVMnEfPoL39" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;855,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zUbPQ6P9Ipre" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2272"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zGisWzyHHqyf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2274"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zqCrpcySGXD5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;855,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Options outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iS_uShares_c20220101__20221231_zB4zuhYwHbhf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;11,990,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zimbMMjI0K3d" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, granted, outstanding and exercisable (in shares)"&gt;6,375,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zQjBzdkvRyD2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zWWHryFaBfY3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Options outstanding and exercisable, expired (in shares)"&gt;(5,835,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iE_uShares_c20220101__20221231_zNGWwWze2bZb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;12,530,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iS_c20220101__20221231_z2zak6CEGaVh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.68&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20220101__20221231_z2EYV2rHA9Bg" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, granted"&gt;0.34&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20220101__20221231_zWL89tq1fbQc" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2292"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_c20220101__20221231_zK6DumkvNUQh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, expired"&gt;0.71&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iE_c20220101__20221231_zlwv6Lj8MDD8" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.49&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of stock options outstanding at December 31, 2022 was &lt;span id="xdx_908_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231_zHTBQqx0lHN7" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;2.53&lt;/span&gt; years (2021 &#x2013; &lt;span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231_zAMk5WkEoyLc" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;0.98&lt;/span&gt; years).&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; price&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2020&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zzNgcWVgSSN3" title="Expiry date"&gt;February 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zQom6DswKQjb" style="width: 8%; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.11&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zmOQwazqC4Li" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;300,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zk7HR990Jaxk" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2313"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zrU4RP3u1cI6" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2315"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_z149VrBtCiX4" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(300,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zfwcCxgk3rZ6" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2319"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zyZTvYuRElI2" title="Expiry date"&gt;February 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zYS9jqZqtT5k" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.84&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zzHHfNTZHrM3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;425,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zSjlRGNrgGd8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2327"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_z8DkzOlIXg0e" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;(375,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zUWIrtZevGmh" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(50,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zrIlMCDej016" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2333"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zaPogUgPS7Bc" title="Expiry date"&gt;March 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zYHv6DRmFkW9" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.08&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_z9JZpK8Sn0cb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;400,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zcFwXa1254p3" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2341"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_ziovW29hpLBb" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2343"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zzxa7vQdJMZ8" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(400,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zcb5MKjwAYP7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2347"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zma1bJ1tWjF3" title="Expiry date"&gt;March 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zrKq5gh3zOb1" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.90&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zA6ESlT8ooZb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zqKhx7ANnlMk" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2355"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zNmr1vUTuVz8" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2357"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zx46PjT2PdS5" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zOzWkrWwtKI3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2361"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zsGT2mcfhjY7" title="Expiry date"&gt;May 6, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zwmxNDKBqBCa" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.69&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zsxbPM5lF9fg" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;557,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_znImYmRv0bLb" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2369"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zJDR5MWVUmF5" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;(275,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zFsUYbhEeU04" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(282,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zk96ngLIFUk4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zhJGB7bI6bI3" title="Expiry date"&gt;July 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zF2E4JFucRBd" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.80&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zjPW3hK6ywk3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,612,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zObcswrJKtJ9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2383"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zNeFs44tiloj" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;(75,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_z7NfwMvZ6ohi" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,537,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zSCZHiBKVEK6" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2389"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zxTgno0uT2H3" title="Expiry date"&gt;August 13, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zxf1DUCVwntd" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.01&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zBbW8LeYuGg9" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;150,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_z4QgFFqUvrak" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2397"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zMElHrXFvrCf" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zHN8IPaJnd66" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(150,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zA4nrh0QDqp5" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zcVaBshsY4tg" title="Expiry date"&gt;September 16, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zCE8I2YsqGA8" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.90&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zO7KqI2ELFp4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,155,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zr8Cz3n3Ypwf" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2411"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zrU56chbML2" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2413"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zutvupsKIked" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,155,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zn6QbbsXw08g" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2417"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zLP3S5NSdKdi" title="Expiry date"&gt;December 12, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zRTGU6ePS9Bc" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.00&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zQaY7IdYWNDa" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;200,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zFCpBfckvUY5" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2425"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zfiAnvE7TVHa" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2427"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_z2wekS4NiLg7" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(200,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_z2P65JIGGueh" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2431"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zt9Cm10awQSd" title="Expiry date"&gt;March 4, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_z0bCGfTBNbLk" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.47&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zOoGUmhGSiJ4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zYnDHFna5028" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zNzDXfLqpuK2" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2441"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zyz2Afy8v0O1" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2443"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zSJrPsNe2bkj" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zO32LxsNAmki" title="Expiry date"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zmAQqdswFoh1" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.41&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zZf5Zi2BzbSk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zi0PW4Mmkbj8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2453"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zhm7XOAtti37" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zf2AQ1rkflw2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2457"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zbQbETrS0n0l" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zIZulkiEzp12" title="Expiry date"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zlRPCb4bv1q6" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.58&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_z1FILmU3rtve" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;220,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zFaluctYUFkk" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2467"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_ziN3fey8wlb2" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2469"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zlFZniXYVNh2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2471"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zKoYJIkwFDq5" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;220,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zIZ3vz1qb9of" title="Expiry date"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zP4pVmLItsB7" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_znm2xTG5n2T1" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;700,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zYUQVuAuH8va" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2481"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zVT7NxC9EHE1" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2483"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_znBFr2ZEnGT9" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zFz1WoEZuN86" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_z6BptB7RxiG8" title="Expiry date"&gt;June 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zuucILhBpBKk" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.64&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zfwyJtYq7jd1" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,180,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zjESpevBuMX" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2495"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zmcntlOeswt6" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2497"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_ziOQELL8X1rd" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(200,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_ztnEFHFx3lQd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,980,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zM0dVhUzCDbk" title="Expiry date"&gt;October 3, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zXzffyjNtta6" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.13&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zqXdxRPxqmsc" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,346,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zGyk50HZkjzg" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zUT8Fnr00q86" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2511"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zynGigWEan7h" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(486,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zbAMx0RXD342" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;860,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zBSIX22qKvM8" title="Expiry date"&gt;December 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zNeRMThmY0vk" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.89&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zTaHvnU40rV" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;972,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_z3FxexLHbDf9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2523"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zKgMkNJyb927" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_ziY0OgyD1h97" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(72,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_z8Exical2tHc" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;900,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zVK4gICeLFUk" title="Expiry date"&gt;February 9, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zuSu2MOlm4Of" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.97&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z83euE9wz3Dk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zmDM5xiABTLi" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;450,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_znuMhv796rsd" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2539"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z7iM90QEmUQa" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zVD9epkR0nxl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;350,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zNEJf0dQw739" title="Expiry date"&gt;March 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_z9etNtdSkhx4" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.96&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zfpo7tF2Cw9b" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zUCjuk8s63g7" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;325,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_ze383KENbfq8" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2553"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zlhPaik0ex1a" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(75,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zupvHSARO4Qf" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_z0SEWdiU83ge" title="Expiry date"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zJJYbRXvH9Fe" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.68&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zWRmfO1bqs91" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2563"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zSggGaJNWAZh" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zZj4uhGe33W2" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zIvvVgjk5HH5" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2569"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zsTLAf8haey1" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zdXcESO8x1og" title="Expiry date"&gt;May 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zfUj2HzIPN8f" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.69&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_z4QzTJtfh2Na" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2577"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zW1ALMMCDPda" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_z7MUaGbR2DFj" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2581"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zv20ilU3yrrg" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2583"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zNKtlyfNIgJe" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zOlY26Bcpqll" title="Expiry date"&gt;May 28, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zGZH66ekGLwf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.65&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zoaHLZzvcl4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2591"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zkkv8gI2Whr8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zEeenIS4G5z3" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2595"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zH8WWWd20wc9" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2597"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zxGOydLLFmnh" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_z3JYAN2SuUs4" title="Expiry date"&gt;July 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zw07cwQ60nB3" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zARCnRMrl0vl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2605"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zdYYx8QOGmq8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;2,470,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zFiwfgESBfZ" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2609"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zY41AfqKFw16" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2611"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zBOpQqADjoO7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,470,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zGKbuGN4JL8f" title="Expiry date"&gt;September 18, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_z7k5SH4xZCc4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.51&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zSZbqq96paKl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2619"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zjnB5P5MpK03" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;960,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zo1W4iQLJSh2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2623"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zFJz2ctSQPGf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2625"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zIZmrAq3FPp3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;960,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Options outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iS_uShares_c20210101__20211231_zJ5eHqqf7KM1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;11,542,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_zWZdzsHblmR7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, granted, outstanding and exercisable (in shares)"&gt;6,380,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_zkVNQnPuBzv6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, outstanding and exercisable (in shares)"&gt;(725,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_z7GfxS81gp7j" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Options outstanding and exercisable, expired (in shares)"&gt;(5,207,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iE_uShares_c20210101__20211231_zaqihFgJcsH9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;11,990,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iS_c20210101__20211231_zzIxd4DHjhYk" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.80&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20210101__20211231_zsOe0IIrQDP4" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, granted"&gt;0.67&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20210101__20211231_zYP6fwU0Nr2d" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, weighted average exercise price"&gt;0.78&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_c20210101__20211231_z5qdcYVL6kn3" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, expired"&gt;0.90&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iE_c20210101__20211231_zMcK0dVeBCth" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.68&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of stock options outstanding at December 31, 2021 was &lt;span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231_zADbaLa8EdNb" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;0.98&lt;/span&gt; years (2020 &#x2013; &lt;span id="xdx_90A_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20200101__20201231_zpNY4xDtRNLi" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;1.08&lt;/span&gt; years).&lt;/p&gt; &lt;p id="xdx_8AC_zdQKw1md1Wpj" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The fair value of options granted during the years ended December 31, 2023, 2022 and 2021, calculated using the Black-Scholes option-pricing model at grant date, are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_z9cv7Azgpj23" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Share capital and reserves (Details 3)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B3_zlNUGh0R7BCk" style="display: none"&gt;Schedule of share option fair value assumptions&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Number &lt;br/&gt; of options&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Fair value &lt;br/&gt; per share&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Risk free &lt;br/&gt; interest &lt;br/&gt; rate&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expected &lt;br/&gt; life &lt;br/&gt;(in years)&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expected &lt;br/&gt; volatility&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expected &lt;br/&gt; dividends&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_zpJCgeBLQDW6" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,035,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 15%; font-size: 10pt"&gt;September 19, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_zsZeFYf7wRhf" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.10&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_zMX6fItUfOKj" title="Risk free interest rate, stock options"&gt;3.96&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_zfSTVJxK2d1f" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_z5nlXQhXe7ej" title="Expected volatility, stock options"&gt;71.15&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 13%; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_zuOA1otk9Bui" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;2,520,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;July 10, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_zn4EOJIFFMKc" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.12&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_znRHZteolXS9" title="Risk free interest rate, stock options"&gt;3.81&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_zYhS9TsIdFL" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_zybQqMfVS3Dj" title="Expected volatility, stock options"&gt;70.98&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_zvXRfhTVU2w6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,975,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;April 3, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_zVMGj4s04n78" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.15&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_z920VC6IWKDj" title="Risk free interest rate, stock options"&gt;2.87&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_z23dpNM38aUj" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_zTanrAkfRiY6" title="Expected volatility, stock options"&gt;68.52&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_zgs6b5006GP9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;600,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;February 13, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_zHVuntY5xm1b" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.18&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_z1LVNIQsEsy7" title="Risk free interest rate, stock options"&gt;3.43&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_zqaflZQ71dhe" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_z4vYLcG6hia2" title="Expected volatility, stock options"&gt;68.61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_zASXIAQq9oC6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;855,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;December 16, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_zNC4iyQmOxH6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.19&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_z2nOrqw5mcf4" title="Risk free interest rate, stock options"&gt;3.07&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_zWeZzGuU13t4" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_zmWYlZagefHa" title="Expected volatility, stock options"&gt;66.04&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zFBTFalcIKI1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;755,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;October 4, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zbFHMGYDfthe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.22&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zE8CiW91Fw43" title="Risk free interest rate, stock options"&gt;3.42&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zSnzqI055qP4" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zzfY5Isjxb02" title="Expected volatility, stock options"&gt;82.02&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_znJ1V34SzIQ1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;3,640,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;June 10, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_zwEay1pGXWFf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.22&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_zx019DrZhoqi" title="Risk free interest rate, stock options"&gt;3.38&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_z5mj702L8iS8" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_zxV8o7I3qJN9" title="Expected volatility, stock options"&gt;82.61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zR3kor4E2Drk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,125,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;March 7, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zxNSE17ML82l" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.31&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zetKkvFRtri5" title="Risk free interest rate, stock options"&gt;1.65&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zpK96Y0VaUJi" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zloTNX4Ajil1" title="Expected volatility, stock options"&gt;85.37&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_zcBJqjROLRe5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;960,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;September 17, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_zv4rrNezN3o" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.23&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_znGEOwsh71Ba" title="Risk free interest rate, stock options"&gt;0.45&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_zf6riN8PZUik" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_zaxpibWBRzW4" title="Expected volatility, stock options"&gt;82.96&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_zKXqwNs2Qelb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;2,470,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;July 8, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_z7IsRm06BD3e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.25&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_zppd7XQLoc9e" title="Risk free interest rate, stock options"&gt;0.45&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_zRfSDUEmCiT8" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_zki3aR475Ntj" title="Expected volatility, stock options"&gt;84.98&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_znkeUYyBekl6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;100,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;May 28, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_zzH9cYwliEsc" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.30&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_zABlXAywrA57" title="Risk free interest rate, stock options"&gt;0.32&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_zVuHYW7rPl54" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_zFguun6YCNAk" title="Expected volatility, stock options"&gt;86.03&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_z6FsEK2658Mf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;100,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;May 7, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_zUQ5kFzICTH7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.30&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_zAdLyZnO7WUd" title="Risk free interest rate, stock options"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_zXrytEJOOCHe" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_zUjfYnjBeoC6" title="Expected volatility, stock options"&gt;86.33&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_zrZlBgyiSIya" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,975,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;March 31, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_zvFIAkSQ8pRh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.31&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_z60B9FXz5Lz2" title="Risk free interest rate, stock options"&gt;0.22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_z0MdFJu92vIj" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_zBPjF1AVAw07" title="Expected volatility, stock options"&gt;85.85&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zhB9sRDyU7i6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;325,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;March 2, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zyNY05qJLD89" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.43&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zSGLcYzrLrLh" title="Risk free interest rate, stock options"&gt;0.26&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zjfJh6p86wei" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zErUXQNcsU73" title="Expected volatility, stock options"&gt;85.48&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zPNC8J426Xza" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;450,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;February 9, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zS0ZJaM8XRn6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.49&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zUt7RxLgrku4" title="Risk free interest rate, stock options"&gt;0.19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zIWz3AjMf8Nj" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zIAqGGWDytW8" title="Expected volatility, stock options"&gt;84.04&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8A6_zVUn9JXkQnX9" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;Total share-based payments expenses as a result of options granted and vested during the year ended December 31, 2023 was $&lt;span id="xdx_909_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20230101__20231231_zeYueACCcC9k" title="Expense from share-based payment transactions with employees"&gt;810,150&lt;/span&gt; (2022 - $&lt;span id="xdx_905_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20220101__20221231_zaDLKspuyrb3" title="Expense from share-based payment transactions with employees"&gt;1,478,100&lt;/span&gt;; 2021 - $&lt;span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20210101__20211231_zn3lQrBEhJl3" title="Expense from share-based payment transactions with employees"&gt;1,870,800&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt; </ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory> <ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001448">&lt;table cellpadding="0" cellspacing="0" id="xdx_89F_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory_zt17ghDKFVv" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Share capital and reserves (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_8B7_zoZdz0CCb17f" style="display: none"&gt;Schedule of Continuity of Warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zF16S9xTlMaj" title="Expiry date"&gt;March 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zKy1eW63L1Of" title="Exercise price"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zOKtua1hSZHk" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zAYAJdtyUoD6" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1456"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zI3RdLJgFRY" style="width: 8%; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1458"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zOfNKSUT6lO9" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;(5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zVCmsDU4lJT2" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1462"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zDGragCFvIg7" title="Expiry date"&gt;August 6, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90F_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zDsnKtOLEAPk" title="Exercise price"&gt;0.90&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zw5ZkxPiF9Ol" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zFhoKBG8q847" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1470"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zzzusmUkUqI1" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1472"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zkpRYH1IqlB8" style="font-size: 10pt; text-align: right" title="Issued"&gt;(3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_z2qKzoUhbG8d" style="font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1476"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z0XQMb6FVMwj" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zAKVWLJXKme" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zuClzw9TpWSf" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zyZGYsJsUK3k" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1484"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zEnCz6uJ2LFi" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1486"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zVboCTGkbYNd" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1488"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zfkFf9YmBrB3" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z2lSPLHnEGv4" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_902_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zpsajRWvvRhd" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zwrNcwit30ia" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zcIoGfHmLvf3" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1498"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zqLr7T8ZbAvh" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1500"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z3VqEJYL2207" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1502"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zob19PlVG8Lf" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zwYJhTP3y7Hf" title="Expiry date"&gt;May 14, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_907_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z9Bbz39YgtB9" title="Exercise price"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zuXHEDdVi5qb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zqWXKDZsPOL9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1512"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zlhDTLx7AOh1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1514"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zoBgAzlmTmcl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1516"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zl4gjlQe54R8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Warrants outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iS_pp0d_uShares_c20230101__20231231_z6d3ZJCP5Y5f" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, outstanding and exercisable"&gt;17,448,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zbI9FXOonsg3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1522"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zbmCHuuPOo4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1524"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zqYwDGApmBk7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, outstanding and exercisable (in shares)"&gt;(8,589,658&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iE_uShares_c20230101__20231231_z3ozagDWZTp9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, oustanding and exercisable"&gt;8,858,846&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20230101__20231231_zkN8QT1ONLti" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.88&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20230101__20231231_zKtc9v2W7w6h" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1532"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--ExercisedWeightedAverageExercisePrice_uCADPShares_c20230101__20231231_zND9ZwZbS57b" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1534"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_uCADPShares_c20230101__20231231_zSRr6XQ5mXte" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, weighted average exercise price"&gt;0.64&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uCADPShares_c20230101__20231231_z5aSNHAiIjqe" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;1.08&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of warrants outstanding at December 31, 2023 was &lt;span id="xdx_901_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20230101__20231231_zflWr9s6yCG8" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;0.22&lt;/span&gt; years (2022 &#x2013; &lt;span id="xdx_902_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20220101__20221231_z8mjtdzxRR5a" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;0.80&lt;/span&gt; years).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zC8zZYDyhkx5" title="Expiry date"&gt;June 7, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zPXnp3bUxFl7" title="Exercise price"&gt;1.35&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zBdfY2HG1CCk" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;4,720,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_z0ZupdJTW1S1" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1550"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zoBdvkNeG5t4" style="width: 8%; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1552"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zELRJ9O9EHLl" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;(4,720,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_z3VC2PUuwZN1" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1556"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z7z3SvhFfpFd" title="Expiry date"&gt;March 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_909_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zcLEg1aEDVa" title="Exercise price"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zSjukoqKs05h" style="font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zfAPp0sYf6ji" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1564"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z9EQ9DRAFbuh" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1566"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zsETH64Nw4hb" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1568"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zE1Gh2amlhr" style="font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zeuLqQM4mao8" title="Expiry date"&gt;August 6, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_905_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zQ08fa1cMxV3" title="Exercise price"&gt;0.90&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zGOLvcUaZab4" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zQ6iC3gvF7Rl" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1578"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zYFIA1OCJiP9" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1580"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_z9biVRWYwp6j" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1582"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_z3ZIZA0NHZ7a" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zTviwnQnsXL5" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_90D_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zSPVMrp1Eu4g" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zbYY3SM6MITb" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zZFXcOAc8kCj" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1592"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z9AmUYA9pA7b" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1594"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z8UItO5iJcX5" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1596"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zFnlzGRaKjV9" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z5GTVbck9wlj" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zVfbRfgNkOih" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_ztyyNBI6gfu4" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zzEspT0bXrBk" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1606"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zMayns4SLFC7" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1608"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zU1wTGu4BjXl" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1610"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z3SXzdZaCEB7" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zXJrlv4MUgkc" title="Expiry date"&gt;May 14, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z2RqVo9XFyL7" title="Exercise price"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zMcAVmZXjOo9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zj7TFd8bh3L2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1620"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z5M2QLtg6nV4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1622"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_ztyM7Hf4yE4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1624"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z93wpKw2k822" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Warrants outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iS_pp0d_uShares_c20220101__20221231_zXmrJ3KwwUt2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, outstanding and exercisable"&gt;22,168,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zOycXnwwYhY3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1630"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zEJxy3eo2ROf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1632"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zh2YbMUNBnZc" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, outstanding and exercisable (in shares)"&gt;(4,720,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iE_uShares_c20220101__20221231_z90pvPXrHau8" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, oustanding and exercisable"&gt;17,448,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20220101__20221231_zp6zhiHyErKj" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.95&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20220101__20221231_z4YGHkanxtk7" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1640"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ExercisedWeightedAverageExercisePrice_uCADPShares_c20220101__20221231_z0yH4fUIVhFa" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1642"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_uCADPShares_c20220101__20221231_zi5j3X6iJ6ub" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, weighted average exercise price"&gt;1.35&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uCADPShares_c20220101__20221231_zbXunOHW29T1" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.88&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of warrants outstanding at December 31, 2022 was &lt;span id="xdx_902_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20220101__20221231_zebc8pttZNV1" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;0.80&lt;/span&gt; years (2021 &#x2013; &lt;span id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20210101__20211231_z1iBXDVvSDy3" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;1.51&lt;/span&gt; years).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;price&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2020&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Issued&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zpkq0nVUoVmb" title="Expiry date"&gt;June 7, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 8%; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_90A_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zjfwvhDFYRXh" title="Exercise price"&gt;1.35&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zKieOUYFWtjf" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;4,720,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zIxxIP9u0pU8" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1658"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_z2URiOGmm3ve" style="width: 8%; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1660"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zbLvkPGuOPLc" style="width: 8%; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1662"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFiveMember_zscbBsRI8Ic2" style="width: 8%; font-size: 10pt; text-align: right" title="Balance"&gt;4,720,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zSvepFa1CYwi" title="Expiry date"&gt;March 27, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_903_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z5mpvHmt1s82" title="Exercise price"&gt;0.50&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z0SGvyPt5ABh" style="font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zQ6kmOQerX7b" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1672"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_z7p7y2VzwSg6" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1674"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zxNicSwPtJb" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1676"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryMember_zInLd5GLQdXd" style="font-size: 10pt; text-align: right" title="Balance"&gt;5,489,658&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zyg80vlMDURk" title="Expiry date"&gt;August 6, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_900_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zooh5MaPiZXl" title="Exercise price"&gt;0.90&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_z8p053abZZb" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zyi4OZzdgNs2" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1686"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zUI3uB0vkx13" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1688"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zi4GSjkin71k" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1690"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryOneMember_zOevAkGHYxH9" style="font-size: 10pt; text-align: right" title="Balance"&gt;3,100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z7GTR0zgwfB5" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_90E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zM5zuChRvmH5" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zuandZSfBTXb" style="font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1698"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zEQMNCJGqNke" style="font-size: 10pt; text-align: right" title="Issued"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zqchelbC0Bm7" style="font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1702"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_zTxK0BIHbKS4" style="font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1704"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryTwoMember_z3FhJI6EAdA7" style="font-size: 10pt; text-align: right" title="Balance"&gt;7,923,077&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zp7T3vpfFzQ" title="Expiry date"&gt;March 18, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;USD$&lt;span id="xdx_908_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uUSDPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zAQ6TAUUJxv7" title="Exercise price"&gt;0.80&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zK8Ap5r8Gp62" style="font-size: 10pt; text-align: right" title="Balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1712"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_zSCWr7tyZyfj" style="font-size: 10pt; text-align: right" title="Issued"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryThreeMember_z5k0S3Dhcd3f" style="font-size: 10pt; text-align: right" title="Balance"&gt;435,769&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_z09y6cge6Md5" title="Expiry date"&gt;May 14, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$&lt;span id="xdx_901_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019_iI_uCADPShares_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zz5aPepHlNy3" title="Exercise price"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zTglfmlWUqM5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zFk1JBjvaPs5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1724"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zGiXfhxm5zh9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1726"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zFm7Besu0Jg" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Issued"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1728"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsExpiryFourMember_zKsb6vddAzce" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Balance"&gt;500,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Warrants outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iS_pp0d_uShares_c20210101__20211231_zHA4noV8uxZf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, outstanding and exercisable"&gt;13,809,658&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_zWcgM5Yyzl32" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, outstanding and exercisable (in shares)"&gt;8,358,846&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfOtherExercisedEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_zUuQAE2ROYl1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1736"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_z4FA3n3F2N1j" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1738"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement_iE_uShares_c20210101__20211231_zOX6fKSfnBL3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, oustanding and exercisable"&gt;22,168,504&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iS_uCADPShares_c20210101__20211231_zgwDYoNVBaE4" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.92&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019_uCADPShares_c20210101__20211231_zF7QdeLMpQd8" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Issued, weighted average exercise price"&gt;1.00&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ExercisedWeightedAverageExercisePrice_uCADPShares_c20210101__20211231_zpbG8D0XgDJ4" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1746"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019_uCADPShares_c20210101__20211231_zBXO71ywYQ6j" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Expired, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1748"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_ecustom--WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement_iE_uCADPShares_c20210101__20211231_zLwCWsb3uOkk" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Balance, weighted average exercise price"&gt;0.95&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of warrants outstanding at December 31, 2021 was &lt;span id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20210101__20211231_z6Qy1SYVSmie" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;1.51&lt;/span&gt; years (2020 &#x2013; &lt;span id="xdx_906_ecustom--WeightedAverageRemainingContractualLifeOfOutstandingWarrants_dtY_c20200101__20201231_zI1TsdtExVVl" title="Weighted average remaining contractual life of outstanding warrants (Year)"&gt;2.08&lt;/span&gt; years).&lt;/p&gt; </ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryMember" id="Fact001450">2023-03-27</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_WarrantsExpiryMember" decimals="INF" id="Fact001452" unitRef="CADPShares">0.50</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryMember" decimals="0" id="Fact001454" unitRef="Shares">5489658</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryMember" decimals="0" id="Fact001460" unitRef="Shares">5489658</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryOneMember" id="Fact001464">2023-08-06</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_WarrantsExpiryOneMember" decimals="INF" id="Fact001466" unitRef="CADPShares">0.90</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryOneMember" decimals="0" id="Fact001468" unitRef="Shares">3100000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryOneMember" decimals="0" id="Fact001474" unitRef="Shares">3100000</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryTwoMember" id="Fact001478">2024-03-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_WarrantsExpiryTwoMember" decimals="INF" id="Fact001480" unitRef="USDPShares">0.80</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryTwoMember" decimals="0" id="Fact001482" unitRef="Shares">7923077</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2023-12-31_custom_WarrantsExpiryTwoMember" decimals="0" id="Fact001490" unitRef="Shares">7923077</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryThreeMember" id="Fact001492">2024-03-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_WarrantsExpiryThreeMember" decimals="INF" id="Fact001494" unitRef="USDPShares">0.80</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryThreeMember" decimals="0" id="Fact001496" unitRef="Shares">435769</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2023-12-31_custom_WarrantsExpiryThreeMember" decimals="0" id="Fact001504" unitRef="Shares">435769</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_WarrantsExpiryFourMember" id="Fact001506">2024-05-14</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_WarrantsExpiryFourMember" decimals="INF" id="Fact001508" unitRef="CADPShares">1.50</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryFourMember" decimals="0" id="Fact001510" unitRef="Shares">500000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2023-12-31_custom_WarrantsExpiryFourMember" decimals="0" id="Fact001518" unitRef="Shares">500000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2022-12-31" decimals="0" id="Fact001520" unitRef="Shares">17448504</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement> <aau:NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact001526" unitRef="Shares">-8589658</aau:NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2023-12-31" decimals="INF" id="Fact001528" unitRef="Shares">8858846</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement> <aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31" decimals="INF" id="Fact001530" unitRef="CADPShares">0.88</aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019 contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact001536" unitRef="CADPShares">0.64</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019> <aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2023-12-31" decimals="INF" id="Fact001538" unitRef="CADPShares">1.08</aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants contextRef="From2023-01-01to2023-12-31" id="Fact001540">P0Y2M19D</aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants> <aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants contextRef="From2022-01-012022-12-31" id="Fact001542">P0Y9M18D</aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryFiveMember" id="Fact001544">2022-06-07</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_WarrantsExpiryFiveMember" decimals="INF" id="Fact001546" unitRef="CADPShares">1.35</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryFiveMember" decimals="0" id="Fact001548" unitRef="Shares">4720000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryFiveMember" decimals="0" id="Fact001554" unitRef="Shares">4720000</ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryMember" id="Fact001558">2023-03-27</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_WarrantsExpiryMember" decimals="INF" id="Fact001560" unitRef="CADPShares">0.50</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryMember" decimals="0" id="Fact001562" unitRef="Shares">5489658</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryMember" decimals="0" id="Fact001570" unitRef="Shares">5489658</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryOneMember" id="Fact001572">2023-08-06</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_WarrantsExpiryOneMember" decimals="INF" id="Fact001574" unitRef="CADPShares">0.90</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryOneMember" decimals="0" id="Fact001576" unitRef="Shares">3100000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryOneMember" decimals="0" id="Fact001584" unitRef="Shares">3100000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryTwoMember" id="Fact001586">2024-03-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_WarrantsExpiryTwoMember" decimals="INF" id="Fact001588" unitRef="USDPShares">0.80</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryTwoMember" decimals="0" id="Fact001590" unitRef="Shares">7923077</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryTwoMember" decimals="0" id="Fact001598" unitRef="Shares">7923077</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryThreeMember" id="Fact001600">2024-03-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_WarrantsExpiryThreeMember" decimals="INF" id="Fact001602" unitRef="USDPShares">0.80</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryThreeMember" decimals="0" id="Fact001604" unitRef="Shares">435769</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryThreeMember" decimals="0" id="Fact001612" unitRef="Shares">435769</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_WarrantsExpiryFourMember" id="Fact001614">2024-05-14</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_WarrantsExpiryFourMember" decimals="INF" id="Fact001616" unitRef="CADPShares">1.50</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryFourMember" decimals="0" id="Fact001618" unitRef="Shares">500000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31_custom_WarrantsExpiryFourMember" decimals="0" id="Fact001626" unitRef="Shares">500000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2021-12-31" decimals="0" id="Fact001628" unitRef="Shares">22168504</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement> <aau:NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact001634" unitRef="Shares">-4720000</aau:NumberOfOtherExpiredAndCancelledEquityInstrumentsExercisableInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2022-12-31" decimals="INF" id="Fact001636" unitRef="Shares">17448504</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement> <aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31" decimals="INF" id="Fact001638" unitRef="CADPShares">0.95</aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019 contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact001644" unitRef="CADPShares">1.35</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019> <aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31" decimals="INF" id="Fact001646" unitRef="CADPShares">0.88</aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants contextRef="From2022-01-012022-12-31" id="Fact001648">P0Y9M18D</aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants> <aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants contextRef="From2021-01-012021-12-31" id="Fact001650">P1Y6M3D</aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryFiveMember" id="Fact001652">2022-06-07</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_WarrantsExpiryFiveMember" decimals="INF" id="Fact001654" unitRef="CADPShares">1.35</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_WarrantsExpiryFiveMember" decimals="0" id="Fact001656" unitRef="Shares">4720000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryFiveMember" decimals="0" id="Fact001664" unitRef="Shares">4720000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryMember" id="Fact001666">2023-03-27</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_WarrantsExpiryMember" decimals="INF" id="Fact001668" unitRef="CADPShares">0.50</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_WarrantsExpiryMember" decimals="0" id="Fact001670" unitRef="Shares">5489658</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryMember" decimals="0" id="Fact001678" unitRef="Shares">5489658</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryOneMember" id="Fact001680">2023-08-06</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_WarrantsExpiryOneMember" decimals="INF" id="Fact001682" unitRef="CADPShares">0.90</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_WarrantsExpiryOneMember" decimals="0" id="Fact001684" unitRef="Shares">3100000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryOneMember" decimals="0" id="Fact001692" unitRef="Shares">3100000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryTwoMember" id="Fact001694">2024-03-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_WarrantsExpiryTwoMember" decimals="INF" id="Fact001696" unitRef="USDPShares">0.80</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryTwoMember" decimals="0" id="Fact001700" unitRef="Shares">7923077</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryTwoMember" decimals="0" id="Fact001706" unitRef="Shares">7923077</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryThreeMember" id="Fact001708">2024-03-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_WarrantsExpiryThreeMember" decimals="INF" id="Fact001710" unitRef="USDPShares">0.80</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryThreeMember" decimals="0" id="Fact001714" unitRef="Shares">435769</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryThreeMember" decimals="0" id="Fact001716" unitRef="Shares">435769</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_WarrantsExpiryFourMember" id="Fact001718">2024-05-14</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_WarrantsExpiryFourMember" decimals="INF" id="Fact001720" unitRef="CADPShares">1.50</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2020-12-31_custom_WarrantsExpiryFourMember" decimals="0" id="Fact001722" unitRef="Shares">500000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31_custom_WarrantsExpiryFourMember" decimals="0" id="Fact001730" unitRef="Shares">500000</ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2020-12-31" decimals="0" id="Fact001732" unitRef="Shares">13809658</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement> <aau:NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact001734" unitRef="Shares">8358846</aau:NumberOfOtherGrantedEquityInstrumentsExercisableInSharebasedPaymentArrangement> <ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement contextRef="AsOf2021-12-31" decimals="INF" id="Fact001740" unitRef="Shares">22168504</ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement> <aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2020-12-31" decimals="INF" id="Fact001742" unitRef="CADPShares">0.92</aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019 contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact001744" unitRef="CADPShares">1.00</ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019> <aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31" decimals="INF" id="Fact001750" unitRef="CADPShares">0.95</aau:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement> <aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants contextRef="From2021-01-012021-12-31" id="Fact001752">P1Y6M3D</aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants> <aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants contextRef="From2020-01-012020-12-31" id="Fact001754">P2Y29D</aau:WeightedAverageRemainingContractualLifeOfOutstandingWarrants> <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact001761">&lt;table cellpadding="0" cellspacing="0" id="xdx_88E_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory_zdRlBYMT61de" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Share capital and reserves (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="layout-grid-mode: line; text-align: left"&gt;&lt;span id="xdx_8B1_zxz4oKFrZVmf" style="display: none"&gt;Schedule of -Warrant Fair Value Assumptions&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 16%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Number of &lt;br/&gt; warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Date of issue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Fair value &lt;br/&gt; per share&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Risk free &lt;br/&gt; interest &lt;br/&gt; rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%"&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: right"&gt;&lt;b&gt;Expected life &lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: right"&gt;&lt;b&gt;(in years)&lt;/b&gt;&lt;/p&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Expected &lt;br/&gt; volatility&lt;/b&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 14%; layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Expected &lt;br/&gt; dividends&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98C_eifrs-full--NumberOfInstrumentsOtherEquityInstrumentsGranted_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_z4u09MoiBApd" style="layout-grid-mode: line; text-align: right" title="Number of warrants"&gt;&lt;span style="font-size: 10pt"&gt;435,769&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;March 18, 2021&lt;/span&gt;&lt;/td&gt; &lt;td id="xdx_988_ecustom--WeightedAverageSharePriceWarrantGranted_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_zJjBtAoT63v8" style="layout-grid-mode: line; text-align: right" title="Fair value per share"&gt;&lt;span style="font-size: 10pt"&gt;$ 0.30&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--RiskFreeInterestRateWarrantsGranted_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_z774Uo4W9u8f" title="Risk free interest rate"&gt;0.53&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--WarrantLifeWarrantsGranted_dtY_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_zcuiC7Kc04Lj" title="Expected life (Year)"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--DescriptionOfExpectedVolatilityWarrantsGranted_dp_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--WarrantsIssuedOnMarch182021Member_zLaJyCjRQcsk" title="Expected volatility"&gt;72.42&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt; &lt;td style="layout-grid-mode: line; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$Nil&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedOtherEquityInstrumentsGrantedDuringPeriodExplanatory> <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsIssuedOnMarch182021Member" decimals="INF" id="Fact001763" unitRef="Shares">435769</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted> <aau:WeightedAverageSharePriceWarrantGranted contextRef="From2022-01-012022-12-31_custom_WarrantsIssuedOnMarch182021Member" decimals="INF" id="Fact001765" unitRef="CADPShares">0.30</aau:WeightedAverageSharePriceWarrantGranted> <aau:RiskFreeInterestRateWarrantsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsIssuedOnMarch182021Member" decimals="INF" id="Fact001767" unitRef="Pure">0.0053</aau:RiskFreeInterestRateWarrantsGranted> <aau:WarrantLifeWarrantsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsIssuedOnMarch182021Member" id="Fact001769">P3Y</aau:WarrantLifeWarrantsGranted> <aau:DescriptionOfExpectedVolatilityWarrantsGranted contextRef="From2022-01-012022-12-31_custom_WarrantsIssuedOnMarch182021Member" decimals="INF" id="Fact001771" unitRef="Pure">0.7242</aau:DescriptionOfExpectedVolatilityWarrantsGranted> <aau:StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptions contextRef="AsOf2022-12-31" decimals="INF" id="Fact001773" unitRef="Pure">0.10</aau:StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptions> <aau:StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptionsForServicesRendered contextRef="AsOf2022-12-31" decimals="INF" id="Fact001775" unitRef="Pure">0.02</aau:StockOptionsIssuanceLimitationsMaximumPercentageOfAllowedIssuableOptionsForServicesRendered> <ifrs-full:NumberOfSharesAuthorised contextRef="AsOf2022-12-31" decimals="INF" id="Fact001777" unitRef="Shares">1217141</ifrs-full:NumberOfSharesAuthorised> <aau:StockOptionLimitationsMaximumAmountOfStockOptionsExercisableDuringA3MonthPeriod contextRef="AsOf2022-12-31" decimals="INF" id="Fact001779" unitRef="Pure">0.25</aau:StockOptionLimitationsMaximumAmountOfStockOptionsExercisableDuringA3MonthPeriod> <aau:ScheduleOfShareOptions contextRef="From2023-01-01to2023-12-31" id="Fact001785">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--ScheduleOfShareOptions_zXlBuvxDn9Qc" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Share capital and reserves (Details 2)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_8BC_zdeoI116tw6k" style="display: none"&gt;Schedule of Share options&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; price&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zuQD8idGrGM" title="Expiry date"&gt;February 9, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z9UMfNgAdxaa" style="width: 8%; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.97&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zCegD5DxAIoa" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;350,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zWLoYqwC0mF" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1793"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zkni8ACAT3tb" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1795"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z5BNMRAozeR5" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(350,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zDdVdKd7l4H6" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1799"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zEk5RhqBr7q8" title="Expiry date"&gt;March 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zxdhPKIGZPxh" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.96&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zIhXY2lMeuRk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_z0KaEVcaQ3C8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1807"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zO0gJBpqOVS4" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1809"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zbCY251bJCb" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zZZAe42YiOZ7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1813"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_909_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zfFNgo1hiRh9" title="Expiry date"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zcxBan9cO9Wf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.68&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zvcnbWM4Vgrk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zeMv4qsLqk6" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1821"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zJ6F5Ovrtbzd" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1823"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zBl2gsf9kGNc" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zv2MhLJyTaOe" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1827"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zIx5rU8LAMu8" title="Expiry date"&gt;May 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zLf3LosfFyFi" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.69&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_z9JhftJHprdl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zLkvjGhl9God" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1835"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zeb6gIapBa8a" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1837"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zfkMl5lanOK2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zLlPTdKeVhN5" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1841"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zKqwMMgzUXfl" title="Expiry date"&gt;May 28, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_z9KPwGnIWpeg" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.65&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zR9u4Ja8T4df" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zpleoGTu5Dy5" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1849"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zmUw3YBEVhkl" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1851"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_z2pB3QrU1sug" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zBwy0JQ3m9Z7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1855"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zI4yODg5Rxv4" title="Expiry date"&gt;July 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zNk6Q9qrEyBk" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zAGsoih8qsK4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,420,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zbsm4LKyfX28" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1863"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zw09ytxwSBWe" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1865"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zChtVID24CJ2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(2,420,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zgKTkPQLXNWl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1869"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zO9VHl9VdSmk" title="Expiry date"&gt;September 18, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zcqYzpvf2Ne6" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.51&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zyCrOFqZq2Vb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;960,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zyjpkm1ZNPN5" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1877"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zSWRAgG1vvfd" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1879"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zhXalBEFd4E5" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(960,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zuTm1Rwyy2Cd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1883"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zYSIY13KL0J6" title="Expiry date"&gt;March 7, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zaVwQXsyHXa1" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.38&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zu2VUBCyIiOa" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zQMHDXrUMSLi" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1891"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zlybp5JeRQ7g" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1893"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zHYxhOLnLzag" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1895"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zHIwRxv70dja" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zYlzVYooQ0J1" title="Expiry date"&gt;June 10, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zYdfUyUl3CKf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.33&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zwQCaWOSSMQ3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;3,640,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zG4dOz1GL1H" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zKE4QUJUDFaf" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1907"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_z6TRlH2osWgk" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zFF76EtQd8Rl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;3,640,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zHL76pag14tg" title="Expiry date"&gt;October 4, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zACbTk3FOVp8" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.30&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zwpTaR3EHU8c" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;755,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zwEfLSwuI5Fl" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1919"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zpB5MduS77rk" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1921"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_ztb4LxJF7jV1" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1923"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zZuy2sMJ3nDd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;755,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zGYpr66LKa4c" title="Expiry date"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zjqfne3wRh24" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.33&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zUgwNrFSVxrj" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;855,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zOqz4kgTZuY9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zAScAfVvi9Lb" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1935"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_z4SQRGi8qf0j" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1937"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zlwwJxqIp4y6" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;855,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zVEjdUh2qH61" title="Expiry date"&gt;February 14, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zbkrJqgjfRHd" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.30&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_z5tmGMLFRAV6" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1945"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_z2qF3EEzUpB3" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zFkwDUjjL569" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1949"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zB4yz3CY5t3f" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1951"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February142028Member_zUoWJR09oQab" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zZAtfsI1zJhj" title="Expiry date"&gt;April 3, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zWtIMMrBRSBl" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.26&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zupwo9R6BMTe" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1959"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zSaqJ41vrSna" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zbcBznzVrQ0g" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1963"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zOnB5uU7x4ac" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1965"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April32028Member_zowou58otNUk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zJt1UIl3Zto" title="Expiry date"&gt;July 10, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zGVacftxE31f" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.16&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zWtegadkRjk6" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1973"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zhOF17WTJvze" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;2,520,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zlKXjAJ1YKSl" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1977"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zAH94UBRh8Ak" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1979"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July102028Member_zXsEZL1gzTGf" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,520,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zUxXfRs2HNcb" title="Expiry date"&gt;September 19, 2028&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zvR23DCvhjL8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.18&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zSG2a8TnFGv3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1987"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zmO0otkAAEZh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,035,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zO0r07h8BVZ8" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1991"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_zIDIG79cBftf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1993"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September192028Member_z7BUrBGt8KX1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,035,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Options outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iS_uShares_c20230101__20231231_zkxbNtRbAnNa" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;12,530,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_ecustom--NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zCuE792dGTbf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, granted, outstanding and exercisable (in shares)"&gt;6,130,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_zwRD45OKjCI4" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2001"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_ecustom--NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20230101__20231231_z1k474TmKsZb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Options outstanding and exercisable, expired (in shares)"&gt;(6,155,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iE_uShares_c20230101__20231231_zYgB2S7xPjW" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;12,505,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iS_c20230101__20231231_z6FjIDtxKusc" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.49&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20230101__20231231_zZWlfDimVAjb" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, granted"&gt;0.21&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20230101__20231231_zcxCqft9yw6" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2011"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_c20230101__20231231_zuyrYXQVo0f3" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, expired"&gt;0.66&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iE_c20230101__20231231_zHWjLSawg0Pe" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.27&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of stock options outstanding at December 31, 2023 was &lt;span id="xdx_90E_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20231231_z7i6cGWZUDQg" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;3.96&lt;/span&gt; years (2022 &#x2013; &lt;span id="xdx_908_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231_zIsSwKhFzUEj" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;2.53&lt;/span&gt; years).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; price&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_z8xephuwu9E6" title="Expiry date"&gt;March 4, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zYikgJAMJNFl" style="width: 8%; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.47&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zWRIeyvvyOf1" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zgBGwvzzq8Ma" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2032"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zwqxRB5pS8dg" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2034"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zbffrGfyYffb" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zzfD65cO3ag5" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2038"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zOl23WzhH7W2" title="Expiry date"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zpLg8baNn3X2" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.41&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zEGscAsrdFS8" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zztuqBvSQSz9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2046"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zXQPcMhyEnih" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2048"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zAxNEsKmDaye" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zDILVf8NCnh9" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2052"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zKYKT4q5lBnh" title="Expiry date"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zkgstVFDvRa7" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.58&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zph6kHWGFnh8" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;220,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zx2WFhoDjlrg" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2060"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zx2lMCzTEZBc" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2062"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_z7H4dr5Josme" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(220,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zc8CoR3GjGHk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2066"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_ztJRO2w33GZ" title="Expiry date"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_z63mOAusXLgh" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zNWQ8DcLY8rd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zwCF1rYTgWc3" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2074"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zcDX93ziGMt5" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2076"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_z4TGfxTsCsBd" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zFLklrf2nRT1" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2080"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_z4vStgvVC8q7" title="Expiry date"&gt;June 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zeOG8vkY8KKc" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.64&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zTnY3veiFxPb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,980,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zljAEm14KPja" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2088"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zZcuLkFg3h3d" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2090"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_z2AkW4QSSDi6" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,980,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_ziK4XYCQuIph" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2094"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zNeIDc0ZbnZ9" title="Expiry date"&gt;October 3, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zJAGMaoXYwhf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.13&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zitBfsn5572j" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;860,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zf69aIK875l6" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2102"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zWv3PZxYoKka" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2104"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zb3TuHXmXqbb" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(860,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zanA0b23sMLg" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2108"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zcTVDoi9wRVi" title="Expiry date"&gt;December 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zR5NUnzjSm1l" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.89&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zqz5KRRpdRA4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;900,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zZ9UxBvcn2qa" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2116"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zjKsoBAqxulf" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2118"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zAQq2pfSk0wh" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(900,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zeK7uWM8K5qe" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z95FZJwSvigc" title="Expiry date"&gt;February 9, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zP4y8HlbRad9" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.97&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zhgtrtOiSzse" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;350,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zSGoM3rYzls9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2130"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zJ1bNuMw1UDh" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2132"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zLpHudmdFaV6" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2134"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z1Ux3tUvKNCa" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;350,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zNVY5KgjKCY5" title="Expiry date"&gt;March 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zdpi7DL0SWz6" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.96&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zuUeYnLOasMa" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zWy71YJhJqI8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2144"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zpQhupvxHPUe" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2146"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zqKwG5b38EK3" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2148"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_z6QjutN2DzC3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zc5Fh84va99b" title="Expiry date"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_z2b5HKZgBise" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.68&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zpyi2j3sSX2l" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_z86Y8T9PHqM2" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2158"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zkQddb8ELYf8" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_z2gjOQWZ0RY2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2162"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zTz8StHkz9x3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zTJgN85g5Z72" title="Expiry date"&gt;May 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zh57P9E7bhq8" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.69&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zS8FWHyU6z06" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zSK70ddgn09f" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2172"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zcrtlREEtxVl" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2174"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zsOflVAHy3b" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2176"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zJiNDo0ipr84" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zuN2dqBjg3ca" title="Expiry date"&gt;May 28, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zA2bzHH6geh8" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.65&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zclzls1DV5b" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zMVlhZuNjyh7" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2186"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zzcVP3kZxnWe" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2188"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zpSRgBpwfee5" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2190"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zT2HRpwwlpHg" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zCbI3SN4SMYg" title="Expiry date"&gt;July 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zB4vrzHVR3Sf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zU7uGMFU2p96" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,470,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zi4QzQdlZx4" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2200"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zoxjcAHe69zj" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2202"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zBqZYLiceHfg" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(50,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zLjNj0Mx5APb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,420,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zZ0yxf8xQYQa" title="Expiry date"&gt;September 18, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zWT1grPaX1ia" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.51&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zfKUSx6TeXwd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;960,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zVZVrFKT9JA9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2214"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zldqOQHl5LMh" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2216"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zTzX8epecvCj" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2218"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zb0WxDYsQXj" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;960,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zzhgZquGabi5" title="Expiry date"&gt;March 7, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zrdcOh786roc" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.38&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_z9i3nfZ3x2v7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2226"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zlVj5S50gOSa" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_znRfYTL0qwj9" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2230"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zBhyWmzR6mD" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2232"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March72027Member_zRz4FvSSVPkh" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90C_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zgK1xZijAbEa" title="Expiry date"&gt;June 10, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zYOo2XHcRFu9" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.33&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_z2oxCTT9RfY8" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2240"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zkX2LqbUkMPb" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;3,640,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zMd6QU77GKI8" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2244"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zydMG9AAtkVi" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2246"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June102027Member_zzXY4wzd7Jsb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;3,640,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_z9wOd9cUN9xc" title="Expiry date"&gt;October 4, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zyLy1O3R9Iug" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.30&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zm0cboyj87O" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2254"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zc9btSMTM293" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;755,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zps6Gd1lXKRd" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2258"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zxv8Rpx0fIda" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2260"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October42027Member_zSAXTSMpYjxg" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;755,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zS5qhjyrUcq5" title="Expiry date"&gt;December 16, 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_z0cQdGVnUkP3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.33&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zi35s0zAcn34" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2268"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zuVMnEfPoL39" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;855,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zUbPQ6P9Ipre" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2272"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zGisWzyHHqyf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2274"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20220101__20221231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December162027Member_zqCrpcySGXD5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;855,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Options outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iS_uShares_c20220101__20221231_zB4zuhYwHbhf" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;11,990,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zimbMMjI0K3d" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, granted, outstanding and exercisable (in shares)"&gt;6,375,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zQjBzdkvRyD2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, outstanding and exercisable (in shares)"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20220101__20221231_zWWHryFaBfY3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Options outstanding and exercisable, expired (in shares)"&gt;(5,835,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iE_uShares_c20220101__20221231_zNGWwWze2bZb" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;12,530,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iS_c20220101__20221231_z2zak6CEGaVh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.68&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20220101__20221231_z2EYV2rHA9Bg" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, granted"&gt;0.34&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20220101__20221231_zWL89tq1fbQc" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, weighted average exercise price"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2292"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_c20220101__20221231_zK6DumkvNUQh" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, expired"&gt;0.71&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iE_c20220101__20221231_zlwv6Lj8MDD8" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.49&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of stock options outstanding at December 31, 2022 was &lt;span id="xdx_908_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20220101__20221231_zHTBQqx0lHN7" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;2.53&lt;/span&gt; years (2021 &#x2013; &lt;span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231_zAMk5WkEoyLc" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;0.98&lt;/span&gt; years).&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Expiry date&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercise &lt;br/&gt; price&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2020&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Granted&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Exercised&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expired&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; width: 34%; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zzNgcWVgSSN3" title="Expiry date"&gt;February 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zQom6DswKQjb" style="width: 8%; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.11&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zmOQwazqC4Li" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;300,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zk7HR990Jaxk" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2313"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zrU4RP3u1cI6" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2315"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_z149VrBtCiX4" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(300,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021Member_zfwcCxgk3rZ6" style="width: 8%; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2319"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zyZTvYuRElI2" title="Expiry date"&gt;February 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zYS9jqZqtT5k" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.84&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zzHHfNTZHrM3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;425,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zSjlRGNrgGd8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2327"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_z8DkzOlIXg0e" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;(375,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zUWIrtZevGmh" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(50,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February72021OneMember_zrIlMCDej016" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2333"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zaPogUgPS7Bc" title="Expiry date"&gt;March 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zYHv6DRmFkW9" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.08&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_z9JZpK8Sn0cb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;400,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zcFwXa1254p3" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2341"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_ziovW29hpLBb" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2343"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zzxa7vQdJMZ8" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(400,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021Member_zcb5MKjwAYP7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2347"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zma1bJ1tWjF3" title="Expiry date"&gt;March 29, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zrKq5gh3zOb1" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.90&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zA6ESlT8ooZb" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zqKhx7ANnlMk" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2355"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zNmr1vUTuVz8" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2357"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zx46PjT2PdS5" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March292021OneMember_zOzWkrWwtKI3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2361"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_901_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zsGT2mcfhjY7" title="Expiry date"&gt;May 6, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zwmxNDKBqBCa" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.69&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zsxbPM5lF9fg" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;557,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_znImYmRv0bLb" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2369"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zJDR5MWVUmF5" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;(275,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zFsUYbhEeU04" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(282,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May62021Member_zk96ngLIFUk4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2375"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90B_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zhJGB7bI6bI3" title="Expiry date"&gt;July 7, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zF2E4JFucRBd" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.80&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zjPW3hK6ywk3" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,612,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zObcswrJKtJ9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2383"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zNeFs44tiloj" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;(75,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_z7NfwMvZ6ohi" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,537,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July72021Member_zSCZHiBKVEK6" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2389"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zxTgno0uT2H3" title="Expiry date"&gt;August 13, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zxf1DUCVwntd" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.01&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zBbW8LeYuGg9" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;150,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_z4QgFFqUvrak" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2397"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zMElHrXFvrCf" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2399"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zHN8IPaJnd66" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(150,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--August132021Member_zA4nrh0QDqp5" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2403"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zcVaBshsY4tg" title="Expiry date"&gt;September 16, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zCE8I2YsqGA8" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.90&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zO7KqI2ELFp4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,155,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zr8Cz3n3Ypwf" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2411"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zrU56chbML2" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2413"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zutvupsKIked" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(1,155,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September162021Member_zn6QbbsXw08g" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2417"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_906_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zLP3S5NSdKdi" title="Expiry date"&gt;December 12, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zRTGU6ePS9Bc" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.00&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zQaY7IdYWNDa" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;200,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zFCpBfckvUY5" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2425"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_zfiAnvE7TVHa" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2427"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_z2wekS4NiLg7" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(200,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December122021Member_z2P65JIGGueh" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2431"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zt9Cm10awQSd" title="Expiry date"&gt;March 4, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_z0bCGfTBNbLk" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.47&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zOoGUmhGSiJ4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zYnDHFna5028" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2439"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zNzDXfLqpuK2" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2441"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zyz2Afy8v0O1" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2443"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March42022Member_zSJrPsNe2bkj" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,125,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90E_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zO32LxsNAmki" title="Expiry date"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zmAQqdswFoh1" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.41&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zZf5Zi2BzbSk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zi0PW4Mmkbj8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2453"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zhm7XOAtti37" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2455"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zf2AQ1rkflw2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2457"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022Member_zbQbETrS0n0l" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zIZulkiEzp12" title="Expiry date"&gt;April 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zlRPCb4bv1q6" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.58&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_z1FILmU3rtve" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;220,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zFaluctYUFkk" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2467"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_ziN3fey8wlb2" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2469"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zlFZniXYVNh2" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2471"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--April302022OneMember_zKoYJIkwFDq5" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;220,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zIZ3vz1qb9of" title="Expiry date"&gt;May 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zP4pVmLItsB7" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_znm2xTG5n2T1" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;700,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zYUQVuAuH8va" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2481"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zVT7NxC9EHE1" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2483"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_znBFr2ZEnGT9" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May312022Member_zFz1WoEZuN86" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;600,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_z6BptB7RxiG8" title="Expiry date"&gt;June 9, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zuucILhBpBKk" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.64&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zfwyJtYq7jd1" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,180,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zjESpevBuMX" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2495"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_zmcntlOeswt6" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2497"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_ziOQELL8X1rd" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(200,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--June92022Member_ztnEFHFx3lQd" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,980,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zM0dVhUzCDbk" title="Expiry date"&gt;October 3, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zXzffyjNtta6" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;1.13&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zqXdxRPxqmsc" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,346,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zGyk50HZkjzg" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zUT8Fnr00q86" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2511"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zynGigWEan7h" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(486,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--October32022Member_zbAMx0RXD342" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;860,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_903_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zBSIX22qKvM8" title="Expiry date"&gt;December 15, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zNeRMThmY0vk" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.89&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zTaHvnU40rV" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;972,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_z3FxexLHbDf9" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2523"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_zKgMkNJyb927" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_ziY0OgyD1h97" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(72,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--December152022Member_z8Exical2tHc" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;900,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90A_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zVK4gICeLFUk" title="Expiry date"&gt;February 9, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zuSu2MOlm4Of" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.97&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z83euE9wz3Dk" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2535"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zmDM5xiABTLi" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;450,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_znuMhv796rsd" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2539"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_z7iM90QEmUQa" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--February92023Member_zVD9epkR0nxl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;350,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zNEJf0dQw739" title="Expiry date"&gt;March 3, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_z9etNtdSkhx4" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.96&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zfpo7tF2Cw9b" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2549"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zUCjuk8s63g7" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;325,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_ze383KENbfq8" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2553"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zlhPaik0ex1a" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;(75,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March32023Member_zupvHSARO4Qf" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;250,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_z0SEWdiU83ge" title="Expiry date"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zJJYbRXvH9Fe" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.68&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zWRmfO1bqs91" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2563"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zSggGaJNWAZh" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zZj4uhGe33W2" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zIvvVgjk5HH5" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2569"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--March312023Member_zsTLAf8haey1" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;1,975,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_907_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zdXcESO8x1og" title="Expiry date"&gt;May 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zfUj2HzIPN8f" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.69&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_z4QzTJtfh2Na" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2577"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zW1ALMMCDPda" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_z7MUaGbR2DFj" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2581"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zv20ilU3yrrg" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2583"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May82023Member_zNKtlyfNIgJe" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_90D_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zOlY26Bcpqll" title="Expiry date"&gt;May 28, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zGZH66ekGLwf" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.65&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zoaHLZzvcl4" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2591"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zkkv8gI2Whr8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zEeenIS4G5z3" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2595"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zH8WWWd20wc9" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2597"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--May282023Member_zxGOydLLFmnh" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;100,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_905_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_z3JYAN2SuUs4" title="Expiry date"&gt;July 8, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zw07cwQ60nB3" style="font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.62&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zARCnRMrl0vl" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2605"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zdYYx8QOGmq8" style="font-size: 10pt; text-align: right" title="Stock options, granted"&gt;2,470,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zFiwfgESBfZ" style="font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2609"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zY41AfqKFw16" style="font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2611"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--July82023Member_zBOpQqADjoO7" style="font-size: 10pt; text-align: right" title="Stock options, balance"&gt;2,470,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;&lt;span id="xdx_904_ecustom--NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate_dd_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zGKbuGN4JL8f" title="Expiry date"&gt;September 18, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iI_c20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_z7k5SH4xZCc4" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock Options, exercise price"&gt;0.51&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zSZbqq96paKl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2619"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zjnB5P5MpK03" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;960,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zo1W4iQLJSh2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, exercised"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2623"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pp0d_di_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zFJz2ctSQPGf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, expired"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2625"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iE_pp0d_uShares_c20210101__20211231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--September182023Member_zIZmrAq3FPp3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, balance"&gt;960,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Options outstanding and exercisable&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iS_uShares_c20210101__20211231_zJ5eHqqf7KM1" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;11,542,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_zWZdzsHblmR7" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, granted, outstanding and exercisable (in shares)"&gt;6,380,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_ecustom--NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_zkVNQnPuBzv6" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, outstanding and exercisable (in shares)"&gt;(725,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_uShares_c20210101__20211231_z7GfxS81gp7j" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Options outstanding and exercisable, expired (in shares)"&gt;(5,207,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement_iE_uShares_c20210101__20211231_zaqihFgJcsH9" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, outstanding and exercisable (in shares)"&gt;11,990,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-indent: -10pt; padding-left: 10pt; font-size: 10pt"&gt;Weighted average exercise price&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iS_c20210101__20211231_zzIxd4DHjhYk" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.80&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_c20210101__20211231_zsOe0IIrQDP4" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, granted"&gt;0.67&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_c20210101__20211231_zYP6fwU0Nr2d" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, exercised, weighted average exercise price"&gt;0.78&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_c20210101__20211231_z5qdcYVL6kn3" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Weighted average exercise price, expired"&gt;0.90&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement_iE_c20210101__20211231_zMcK0dVeBCth" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Stock options, balance, weighted average exercise price"&gt;0.68&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The weighted average remaining life of stock options outstanding at December 31, 2021 was &lt;span id="xdx_90C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20210101__20211231_zADbaLa8EdNb" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;0.98&lt;/span&gt; years (2020 &#x2013; &lt;span id="xdx_90A_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20200101__20201231_zpNY4xDtRNLi" title="Weighted average remaining contractual life of outstanding share options (Year)"&gt;1.08&lt;/span&gt; years).&lt;/p&gt; </aau:ScheduleOfShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_February92023Member" id="Fact001787">2023-02-09</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_February92023Member" decimals="INF" id="Fact001789" unitRef="CADPShares">0.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_February92023Member" decimals="0" id="Fact001791" unitRef="Shares">350000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_February92023Member" decimals="0" id="Fact001797" unitRef="Shares">350000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_March32023Member" id="Fact001801">2023-03-03</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_March32023Member" decimals="INF" id="Fact001803" unitRef="CADPShares">0.96</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_March32023Member" decimals="0" id="Fact001805" unitRef="Shares">250000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March32023Member" decimals="0" id="Fact001811" unitRef="Shares">250000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_March312023Member" id="Fact001815">2023-03-31</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_March312023Member" decimals="INF" id="Fact001817" unitRef="CADPShares">0.68</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_March312023Member" decimals="0" id="Fact001819" unitRef="Shares">1975000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_March312023Member" decimals="0" id="Fact001825" unitRef="Shares">1975000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_May82023Member" id="Fact001829">2023-05-08</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_May82023Member" decimals="INF" id="Fact001831" unitRef="CADPShares">0.69</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_May82023Member" decimals="0" id="Fact001833" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_May82023Member" decimals="0" id="Fact001839" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_May282023Member" id="Fact001843">2023-05-28</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_May282023Member" decimals="INF" id="Fact001845" unitRef="CADPShares">0.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_May282023Member" decimals="0" id="Fact001847" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_May282023Member" decimals="0" id="Fact001853" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_July82023Member" id="Fact001857">2023-07-08</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_July82023Member" decimals="INF" id="Fact001859" unitRef="CADPShares">0.62</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_July82023Member" decimals="0" id="Fact001861" unitRef="Shares">2420000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_July82023Member" decimals="0" id="Fact001867" unitRef="Shares">2420000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_September182023Member" id="Fact001871">2023-09-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_September182023Member" decimals="INF" id="Fact001873" unitRef="CADPShares">0.51</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_September182023Member" decimals="0" id="Fact001875" unitRef="Shares">960000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_September182023Member" decimals="0" id="Fact001881" unitRef="Shares">960000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_March72027Member" id="Fact001885">2027-03-07</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_March72027Member" decimals="INF" id="Fact001887" unitRef="CADPShares">0.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_March72027Member" decimals="0" id="Fact001889" unitRef="Shares">1125000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_March72027Member" decimals="0" id="Fact001897" unitRef="Shares">1125000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_June102027Member" id="Fact001899">2027-06-10</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_June102027Member" decimals="INF" id="Fact001901" unitRef="CADPShares">0.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_June102027Member" decimals="0" id="Fact001903" unitRef="Shares">3640000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_June102027Member" decimals="0" id="Fact001911" unitRef="Shares">3640000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_October42027Member" id="Fact001913">2027-10-04</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_October42027Member" decimals="INF" id="Fact001915" unitRef="CADPShares">0.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_October42027Member" decimals="0" id="Fact001917" unitRef="Shares">755000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_October42027Member" decimals="0" id="Fact001925" unitRef="Shares">755000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_December162027Member" id="Fact001927">2027-12-16</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_December162027Member" decimals="INF" id="Fact001929" unitRef="CADPShares">0.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_December162027Member" decimals="0" id="Fact001931" unitRef="Shares">855000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_December162027Member" decimals="0" id="Fact001939" unitRef="Shares">855000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_February142028Member" id="Fact001941">2028-02-14</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_February142028Member" decimals="INF" id="Fact001943" unitRef="CADPShares">0.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_February142028Member" decimals="0" id="Fact001947" unitRef="Shares">600000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_February142028Member" decimals="0" id="Fact001953" unitRef="Shares">600000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_April32028Member" id="Fact001955">2028-04-03</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_April32028Member" decimals="INF" id="Fact001957" unitRef="CADPShares">0.26</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_April32028Member" decimals="0" id="Fact001961" unitRef="Shares">1975000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_April32028Member" decimals="0" id="Fact001967" unitRef="Shares">1975000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_July102028Member" id="Fact001969">2028-07-10</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_July102028Member" decimals="INF" id="Fact001971" unitRef="CADPShares">0.16</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_July102028Member" decimals="0" id="Fact001975" unitRef="Shares">2520000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_July102028Member" decimals="0" id="Fact001981" unitRef="Shares">2520000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2023-01-012023-12-31_custom_September192028Member" id="Fact001983">2028-09-19</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2023-12-31_custom_September192028Member" decimals="INF" id="Fact001985" unitRef="CADPShares">0.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_September192028Member" decimals="0" id="Fact001989" unitRef="Shares">1035000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2023-12-31_custom_September192028Member" decimals="0" id="Fact001995" unitRef="Shares">1035000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="AsOf2022-12-31" decimals="INF" id="Fact001997" unitRef="Shares">12530000</aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact001999" unitRef="Shares">6130000</aau:NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact002003" unitRef="Shares">-6155000</aau:NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="AsOf2023-12-31" decimals="INF" id="Fact002005" unitRef="Shares">12505000</aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31" decimals="INF" id="Fact002007" unitRef="CADPShares">0.49</aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact002009" unitRef="CADPShares">0.21</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact002013" unitRef="CADPShares">0.66</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019> <aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2023-12-31" decimals="INF" id="Fact002015" unitRef="CADPShares">0.27</aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="From2023-01-01to2023-12-31" id="Fact002017">P3Y11M15D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019> <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="From2022-01-012022-12-31" id="Fact002019">P2Y6M10D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_March42022Member" id="Fact002026">2022-03-04</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_March42022Member" decimals="INF" id="Fact002028" unitRef="CADPShares">0.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March42022Member" decimals="0" id="Fact002030" unitRef="Shares">1125000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March42022Member" decimals="0" id="Fact002036" unitRef="Shares">1125000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_April302022Member" id="Fact002040">2022-04-30</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_April302022Member" decimals="INF" id="Fact002042" unitRef="CADPShares">0.41</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_April302022Member" decimals="0" id="Fact002044" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_April302022Member" decimals="0" id="Fact002050" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_April302022OneMember" id="Fact002054">2022-04-30</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_April302022OneMember" decimals="INF" id="Fact002056" unitRef="CADPShares">0.58</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_April302022OneMember" decimals="0" id="Fact002058" unitRef="Shares">220000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_April302022OneMember" decimals="0" id="Fact002064" unitRef="Shares">220000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_May312022Member" id="Fact002068">2022-05-31</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_May312022Member" decimals="INF" id="Fact002070" unitRef="CADPShares">0.62</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_May312022Member" decimals="0" id="Fact002072" unitRef="Shares">600000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_May312022Member" decimals="0" id="Fact002078" unitRef="Shares">600000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_June92022Member" id="Fact002082">2022-06-09</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_June92022Member" decimals="INF" id="Fact002084" unitRef="CADPShares">0.64</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_June92022Member" decimals="0" id="Fact002086" unitRef="Shares">1980000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_June92022Member" decimals="0" id="Fact002092" unitRef="Shares">1980000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_October32022Member" id="Fact002096">2022-10-03</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_October32022Member" decimals="INF" id="Fact002098" unitRef="CADPShares">1.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_October32022Member" decimals="0" id="Fact002100" unitRef="Shares">860000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_October32022Member" decimals="0" id="Fact002106" unitRef="Shares">860000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_December152022Member" id="Fact002110">2022-12-15</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_December152022Member" decimals="INF" id="Fact002112" unitRef="CADPShares">0.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_December152022Member" decimals="0" id="Fact002114" unitRef="Shares">900000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_December152022Member" decimals="0" id="Fact002120" unitRef="Shares">900000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_February92023Member" id="Fact002124">2023-02-09</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_February92023Member" decimals="INF" id="Fact002126" unitRef="CADPShares">0.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_February92023Member" decimals="0" id="Fact002128" unitRef="Shares">350000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_February92023Member" decimals="0" id="Fact002136" unitRef="Shares">350000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_March32023Member" id="Fact002138">2023-03-03</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_March32023Member" decimals="INF" id="Fact002140" unitRef="CADPShares">0.96</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March32023Member" decimals="0" id="Fact002142" unitRef="Shares">250000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_March32023Member" decimals="0" id="Fact002150" unitRef="Shares">250000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_March312023Member" id="Fact002152">2023-03-31</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_March312023Member" decimals="INF" id="Fact002154" unitRef="CADPShares">0.68</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March312023Member" decimals="0" id="Fact002156" unitRef="Shares">1975000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_March312023Member" decimals="0" id="Fact002164" unitRef="Shares">1975000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_May82023Member" id="Fact002166">2023-05-08</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_May82023Member" decimals="INF" id="Fact002168" unitRef="CADPShares">0.69</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_May82023Member" decimals="0" id="Fact002170" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_May82023Member" decimals="0" id="Fact002178" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_May282023Member" id="Fact002180">2023-05-28</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_May282023Member" decimals="INF" id="Fact002182" unitRef="CADPShares">0.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_May282023Member" decimals="0" id="Fact002184" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_May282023Member" decimals="0" id="Fact002192" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_July82023Member" id="Fact002194">2023-07-08</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_July82023Member" decimals="INF" id="Fact002196" unitRef="CADPShares">0.62</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_July82023Member" decimals="0" id="Fact002198" unitRef="Shares">2470000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_July82023Member" decimals="0" id="Fact002204" unitRef="Shares">50000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_July82023Member" decimals="0" id="Fact002206" unitRef="Shares">2420000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_September182023Member" id="Fact002208">2023-09-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_September182023Member" decimals="INF" id="Fact002210" unitRef="CADPShares">0.51</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_September182023Member" decimals="0" id="Fact002212" unitRef="Shares">960000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_September182023Member" decimals="0" id="Fact002220" unitRef="Shares">960000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_March72027Member" id="Fact002222">2027-03-07</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_March72027Member" decimals="INF" id="Fact002224" unitRef="CADPShares">0.38</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_March72027Member" decimals="0" id="Fact002228" unitRef="Shares">1125000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_March72027Member" decimals="0" id="Fact002234" unitRef="Shares">1125000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_June102027Member" id="Fact002236">2027-06-10</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_June102027Member" decimals="INF" id="Fact002238" unitRef="CADPShares">0.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_June102027Member" decimals="0" id="Fact002242" unitRef="Shares">3640000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_June102027Member" decimals="0" id="Fact002248" unitRef="Shares">3640000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_October42027Member" id="Fact002250">2027-10-04</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_October42027Member" decimals="INF" id="Fact002252" unitRef="CADPShares">0.30</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_October42027Member" decimals="0" id="Fact002256" unitRef="Shares">755000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_October42027Member" decimals="0" id="Fact002262" unitRef="Shares">755000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2022-01-012022-12-31_custom_December162027Member" id="Fact002264">2027-12-16</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2022-12-31_custom_December162027Member" decimals="INF" id="Fact002266" unitRef="CADPShares">0.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31_custom_December162027Member" decimals="0" id="Fact002270" unitRef="Shares">855000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2022-12-31_custom_December162027Member" decimals="0" id="Fact002276" unitRef="Shares">855000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="AsOf2021-12-31" decimals="INF" id="Fact002278" unitRef="Shares">11990000</aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact002280" unitRef="Shares">6375000</aau:NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact002284" unitRef="Shares">-5835000</aau:NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="AsOf2022-12-31" decimals="INF" id="Fact002286" unitRef="Shares">12530000</aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31" decimals="INF" id="Fact002288" unitRef="CADPShares">0.68</aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact002290" unitRef="CADPShares">0.34</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact002294" unitRef="CADPShares">0.71</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019> <aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2022-12-31" decimals="INF" id="Fact002296" unitRef="CADPShares">0.49</aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="From2022-01-012022-12-31" id="Fact002298">P2Y6M10D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019> <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="From2021-01-012021-12-31" id="Fact002300">P0Y11M23D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_February72021Member" id="Fact002307">2021-02-07</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_February72021Member" decimals="INF" id="Fact002309" unitRef="CADPShares">1.11</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_February72021Member" decimals="0" id="Fact002311" unitRef="Shares">300000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February72021Member" decimals="0" id="Fact002317" unitRef="Shares">300000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_February72021OneMember" id="Fact002321">2021-02-07</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_February72021OneMember" decimals="INF" id="Fact002323" unitRef="CADPShares">0.84</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_February72021OneMember" decimals="0" id="Fact002325" unitRef="Shares">425000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February72021OneMember" decimals="0" id="Fact002329" unitRef="Shares">375000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February72021OneMember" decimals="0" id="Fact002331" unitRef="Shares">50000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_March292021Member" id="Fact002335">2021-03-29</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_March292021Member" decimals="INF" id="Fact002337" unitRef="CADPShares">1.08</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_March292021Member" decimals="0" id="Fact002339" unitRef="Shares">400000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March292021Member" decimals="0" id="Fact002345" unitRef="Shares">400000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_March292021OneMember" id="Fact002349">2021-03-29</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_March292021OneMember" decimals="INF" id="Fact002351" unitRef="CADPShares">0.90</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_March292021OneMember" decimals="0" id="Fact002353" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March292021OneMember" decimals="0" id="Fact002359" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_May62021Member" id="Fact002363">2021-05-06</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_May62021Member" decimals="INF" id="Fact002365" unitRef="CADPShares">0.69</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_May62021Member" decimals="0" id="Fact002367" unitRef="Shares">557000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May62021Member" decimals="0" id="Fact002371" unitRef="Shares">275000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May62021Member" decimals="0" id="Fact002373" unitRef="Shares">282000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_July72021Member" id="Fact002377">2021-07-07</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_July72021Member" decimals="INF" id="Fact002379" unitRef="CADPShares">0.80</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_July72021Member" decimals="0" id="Fact002381" unitRef="Shares">1612000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_July72021Member" decimals="0" id="Fact002385" unitRef="Shares">75000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_July72021Member" decimals="0" id="Fact002387" unitRef="Shares">1537000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_August132021Member" id="Fact002391">2021-08-13</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_August132021Member" decimals="INF" id="Fact002393" unitRef="CADPShares">1.01</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_August132021Member" decimals="0" id="Fact002395" unitRef="Shares">150000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_August132021Member" decimals="0" id="Fact002401" unitRef="Shares">150000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_September162021Member" id="Fact002405">2021-09-16</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_September162021Member" decimals="INF" id="Fact002407" unitRef="CADPShares">0.90</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_September162021Member" decimals="0" id="Fact002409" unitRef="Shares">1155000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_September162021Member" decimals="0" id="Fact002415" unitRef="Shares">1155000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_December122021Member" id="Fact002419">2021-12-12</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_December122021Member" decimals="INF" id="Fact002421" unitRef="CADPShares">1.00</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_December122021Member" decimals="0" id="Fact002423" unitRef="Shares">200000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_December122021Member" decimals="0" id="Fact002429" unitRef="Shares">200000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_March42022Member" id="Fact002433">2022-03-04</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_March42022Member" decimals="INF" id="Fact002435" unitRef="CADPShares">0.47</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_March42022Member" decimals="0" id="Fact002437" unitRef="Shares">1125000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March42022Member" decimals="0" id="Fact002445" unitRef="Shares">1125000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_April302022Member" id="Fact002447">2022-04-30</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_April302022Member" decimals="INF" id="Fact002449" unitRef="CADPShares">0.41</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_April302022Member" decimals="0" id="Fact002451" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_April302022Member" decimals="0" id="Fact002459" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_April302022OneMember" id="Fact002461">2022-04-30</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_April302022OneMember" decimals="INF" id="Fact002463" unitRef="CADPShares">0.58</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_April302022OneMember" decimals="0" id="Fact002465" unitRef="Shares">220000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_April302022OneMember" decimals="0" id="Fact002473" unitRef="Shares">220000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_May312022Member" id="Fact002475">2022-05-31</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_May312022Member" decimals="INF" id="Fact002477" unitRef="CADPShares">0.62</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_May312022Member" decimals="0" id="Fact002479" unitRef="Shares">700000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May312022Member" decimals="0" id="Fact002485" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_May312022Member" decimals="0" id="Fact002487" unitRef="Shares">600000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_June92022Member" id="Fact002489">2022-06-09</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_June92022Member" decimals="INF" id="Fact002491" unitRef="CADPShares">0.64</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_June92022Member" decimals="0" id="Fact002493" unitRef="Shares">2180000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_June92022Member" decimals="0" id="Fact002499" unitRef="Shares">200000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_June92022Member" decimals="0" id="Fact002501" unitRef="Shares">1980000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_October32022Member" id="Fact002503">2022-10-03</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_October32022Member" decimals="INF" id="Fact002505" unitRef="CADPShares">1.13</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_October32022Member" decimals="0" id="Fact002507" unitRef="Shares">1346000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_October32022Member" decimals="0" id="Fact002513" unitRef="Shares">486000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_October32022Member" decimals="0" id="Fact002515" unitRef="Shares">860000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_December152022Member" id="Fact002517">2022-12-15</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_December152022Member" decimals="INF" id="Fact002519" unitRef="CADPShares">0.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31_custom_December152022Member" decimals="0" id="Fact002521" unitRef="Shares">972000</ifrs-full:NumberOfOutstandingShareOptions> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_December152022Member" decimals="0" id="Fact002527" unitRef="Shares">72000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_December152022Member" decimals="0" id="Fact002529" unitRef="Shares">900000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_February92023Member" id="Fact002531">2023-02-09</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_February92023Member" decimals="INF" id="Fact002533" unitRef="CADPShares">0.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February92023Member" decimals="0" id="Fact002537" unitRef="Shares">450000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_February92023Member" decimals="0" id="Fact002541" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_February92023Member" decimals="0" id="Fact002543" unitRef="Shares">350000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_March32023Member" id="Fact002545">2023-03-03</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_March32023Member" decimals="INF" id="Fact002547" unitRef="CADPShares">0.96</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March32023Member" decimals="0" id="Fact002551" unitRef="Shares">325000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March32023Member" decimals="0" id="Fact002555" unitRef="Shares">75000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March32023Member" decimals="0" id="Fact002557" unitRef="Shares">250000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_March312023Member" id="Fact002559">2023-03-31</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_March312023Member" decimals="INF" id="Fact002561" unitRef="CADPShares">0.68</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_March312023Member" decimals="0" id="Fact002565" unitRef="Shares">1975000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_March312023Member" decimals="0" id="Fact002571" unitRef="Shares">1975000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_May82023Member" id="Fact002573">2023-05-08</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_May82023Member" decimals="INF" id="Fact002575" unitRef="CADPShares">0.69</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May82023Member" decimals="0" id="Fact002579" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_May82023Member" decimals="0" id="Fact002585" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_May282023Member" id="Fact002587">2023-05-28</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_May282023Member" decimals="INF" id="Fact002589" unitRef="CADPShares">0.65</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_May282023Member" decimals="0" id="Fact002593" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_May282023Member" decimals="0" id="Fact002599" unitRef="Shares">100000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_July82023Member" id="Fact002601">2023-07-08</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_July82023Member" decimals="INF" id="Fact002603" unitRef="CADPShares">0.62</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_July82023Member" decimals="0" id="Fact002607" unitRef="Shares">2470000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_July82023Member" decimals="0" id="Fact002613" unitRef="Shares">2470000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate contextRef="From2021-01-012021-12-31_custom_September182023Member" id="Fact002615">2023-09-18</aau:NumberOfShareOptionsExpiredInShareBasedPaymentArrangementExpiryDate> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 contextRef="AsOf2021-12-31_custom_September182023Member" decimals="INF" id="Fact002617" unitRef="CADPShares">0.51</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31_custom_September182023Member" decimals="0" id="Fact002621" unitRef="Shares">960000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31_custom_September182023Member" decimals="0" id="Fact002627" unitRef="Shares">960000</ifrs-full:NumberOfOutstandingShareOptions> <aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="AsOf2020-12-31" decimals="INF" id="Fact002629" unitRef="Shares">11542000</aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact002631" unitRef="Shares">6380000</aau:NumberOfGrantedShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact002633" unitRef="Shares">-725000</aau:NumberOfShareOptionsExercisedOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact002635" unitRef="Shares">-5207000</aau:NumberOfExpiredAndCancelledShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement contextRef="AsOf2021-12-31" decimals="INF" id="Fact002637" unitRef="Shares">11990000</aau:NumberOfShareOptionsOutstandingAndExercisableInSharebasedPaymentArrangement> <aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2020-12-31" decimals="INF" id="Fact002639" unitRef="CADPShares">0.80</aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact002641" unitRef="CADPShares">0.67</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019 contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact002643" unitRef="CADPShares">0.78</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019> <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact002645" unitRef="CADPShares">0.90</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019> <aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement contextRef="AsOf2021-12-31" decimals="INF" id="Fact002647" unitRef="CADPShares">0.68</aau:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="From2021-01-012021-12-31" id="Fact002649">P0Y11M23D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019> <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019 contextRef="From2020-01-012020-12-31" id="Fact002651">P1Y29D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019> <ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002658">&lt;table cellpadding="0" cellspacing="0" id="xdx_89A_eifrs-full--DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory_z9cv7Azgpj23" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Share capital and reserves (Details 3)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B3_zlNUGh0R7BCk" style="display: none"&gt;Schedule of share option fair value assumptions&lt;/span&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Number &lt;br/&gt; of options&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Date of grant&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Fair value &lt;br/&gt; per share&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Risk free &lt;br/&gt; interest &lt;br/&gt; rate&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expected &lt;br/&gt; life &lt;br/&gt;(in years)&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expected &lt;br/&gt; volatility&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;Expected &lt;br/&gt; dividends&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_zpJCgeBLQDW6" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,035,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 15%; font-size: 10pt"&gt;September 19, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_zsZeFYf7wRhf" style="border-bottom: Black 1pt solid; width: 12%; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.10&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_zMX6fItUfOKj" title="Risk free interest rate, stock options"&gt;3.96&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_zfSTVJxK2d1f" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 11%; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantOneMember_z5nlXQhXe7ej" title="Expected volatility, stock options"&gt;71.15&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; width: 13%; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_zuOA1otk9Bui" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;2,520,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;July 10, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_zn4EOJIFFMKc" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.12&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_znRHZteolXS9" title="Risk free interest rate, stock options"&gt;3.81&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_909_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_zYhS9TsIdFL" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwoMember_zybQqMfVS3Dj" title="Expected volatility, stock options"&gt;70.98&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_zvXRfhTVU2w6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,975,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;April 3, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_zVMGj4s04n78" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.15&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_z920VC6IWKDj" title="Risk free interest rate, stock options"&gt;2.87&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90F_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_z23dpNM38aUj" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThreeMember_zTanrAkfRiY6" title="Expected volatility, stock options"&gt;68.52&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_zgs6b5006GP9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;600,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;February 13, 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_zHVuntY5xm1b" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.18&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_z1LVNIQsEsy7" title="Risk free interest rate, stock options"&gt;3.43&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_zqaflZQ71dhe" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourMember_z4vYLcG6hia2" title="Expected volatility, stock options"&gt;68.61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_zASXIAQq9oC6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;855,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;December 16, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_zNC4iyQmOxH6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.19&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_z2nOrqw5mcf4" title="Risk free interest rate, stock options"&gt;3.07&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_zWeZzGuU13t4" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFiveMember_zmWYlZagefHa" title="Expected volatility, stock options"&gt;66.04&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zFBTFalcIKI1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;755,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;October 4, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zbFHMGYDfthe" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.22&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zE8CiW91Fw43" title="Risk free interest rate, stock options"&gt;3.42&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zSnzqI055qP4" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSixMember_zzfY5Isjxb02" title="Expected volatility, stock options"&gt;82.02&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_znJ1V34SzIQ1" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;3,640,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;June 10, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_zwEay1pGXWFf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.22&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_zx019DrZhoqi" title="Risk free interest rate, stock options"&gt;3.38&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_z5mj702L8iS8" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantSevenMember_zxV8o7I3qJN9" title="Expected volatility, stock options"&gt;82.61&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zR3kor4E2Drk" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,125,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;March 7, 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zxNSE17ML82l" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.31&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zetKkvFRtri5" title="Risk free interest rate, stock options"&gt;1.65&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90A_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zpK96Y0VaUJi" title="Expected life, stock options"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantEightMember_zloTNX4Ajil1" title="Expected volatility, stock options"&gt;85.37&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98B_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_zcBJqjROLRe5" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;960,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;September 17, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_zv4rrNezN3o" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.23&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_znGEOwsh71Ba" title="Risk free interest rate, stock options"&gt;0.45&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_zf6riN8PZUik" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantNineMember_zaxpibWBRzW4" title="Expected volatility, stock options"&gt;82.96&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_98F_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_zKXqwNs2Qelb" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;2,470,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;July 8, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_z7IsRm06BD3e" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.25&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_zppd7XQLoc9e" title="Risk free interest rate, stock options"&gt;0.45&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_907_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_zRfSDUEmCiT8" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTenMember_zki3aR475Ntj" title="Expected volatility, stock options"&gt;84.98&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_znkeUYyBekl6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;100,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;May 28, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_zzH9cYwliEsc" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.30&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_zABlXAywrA57" title="Risk free interest rate, stock options"&gt;0.32&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_zVuHYW7rPl54" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantElevenMember_zFguun6YCNAk" title="Expected volatility, stock options"&gt;86.03&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_z6FsEK2658Mf" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;100,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;May 7, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_zUQ5kFzICTH7" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.30&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_zAdLyZnO7WUd" title="Risk free interest rate, stock options"&gt;0.33&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_900_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_zXrytEJOOCHe" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantTwelveMember_zUjfYnjBeoC6" title="Expected volatility, stock options"&gt;86.33&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_98C_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_zrZlBgyiSIya" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;1,975,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;March 31, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_zvFIAkSQ8pRh" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.31&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_z60B9FXz5Lz2" title="Risk free interest rate, stock options"&gt;0.22&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_z0MdFJu92vIj" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantThirteenMember_zBPjF1AVAw07" title="Expected volatility, stock options"&gt;85.85&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td id="xdx_984_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zhB9sRDyU7i6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;325,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;March 2, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zyNY05qJLD89" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.43&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zSGLcYzrLrLh" title="Risk free interest rate, stock options"&gt;0.26&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90C_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zjfJh6p86wei" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFourteenMember_zErUXQNcsU73" title="Expected volatility, stock options"&gt;85.48&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_uShares_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zPNC8J426Xza" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Stock options, granted"&gt;450,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;February 9, 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--WeightedAverageSharePriceShareOptionsGranted2019_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zS0ZJaM8XRn6" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Fair value per share, stock options (in CAD per share)"&gt;0.49&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_dp_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zUt7RxLgrku4" title="Risk free interest rate, stock options"&gt;0.19&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_906_ecustom--DescriptionOfOptionLifeSharesOptionsGranted_dtY_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zIWz3AjMf8Nj" title="Expected life, stock options"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_dp_uPure_c20230101__20231231__ifrs-full--ClassesOfFinancialInstrumentsAxis__custom--GrantFifteenMember_zIAqGGWDytW8" title="Expected volatility, stock options"&gt;84.04&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;$Nil&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantOneMember" decimals="INF" id="Fact002660" unitRef="Shares">1035000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantOneMember" decimals="INF" id="Fact002662" unitRef="CADPShares">0.10</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantOneMember" decimals="INF" id="Fact002664" unitRef="Pure">0.0396</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantOneMember" id="Fact002666">P5Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantOneMember" decimals="INF" id="Fact002668" unitRef="Pure">0.7115</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantTwoMember" decimals="INF" id="Fact002670" unitRef="Shares">2520000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantTwoMember" decimals="INF" id="Fact002672" unitRef="CADPShares">0.12</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTwoMember" decimals="INF" id="Fact002674" unitRef="Pure">0.0381</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTwoMember" id="Fact002676">P5Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTwoMember" decimals="INF" id="Fact002678" unitRef="Pure">0.7098</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantThreeMember" decimals="INF" id="Fact002680" unitRef="Shares">1975000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantThreeMember" decimals="INF" id="Fact002682" unitRef="CADPShares">0.15</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantThreeMember" decimals="INF" id="Fact002684" unitRef="Pure">0.0287</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantThreeMember" id="Fact002686">P5Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantThreeMember" decimals="INF" id="Fact002688" unitRef="Pure">0.6852</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantFourMember" decimals="INF" id="Fact002690" unitRef="Shares">600000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantFourMember" decimals="INF" id="Fact002692" unitRef="CADPShares">0.18</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFourMember" decimals="INF" id="Fact002694" unitRef="Pure">0.0343</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFourMember" id="Fact002696">P5Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFourMember" decimals="INF" id="Fact002698" unitRef="Pure">0.6861</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantFiveMember" decimals="INF" id="Fact002700" unitRef="Shares">855000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantFiveMember" decimals="INF" id="Fact002702" unitRef="CADPShares">0.19</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFiveMember" decimals="INF" id="Fact002704" unitRef="Pure">0.0307</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFiveMember" id="Fact002706">P5Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFiveMember" decimals="INF" id="Fact002708" unitRef="Pure">0.6604</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantSixMember" decimals="INF" id="Fact002710" unitRef="Shares">755000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantSixMember" decimals="INF" id="Fact002712" unitRef="CADPShares">0.22</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantSixMember" decimals="INF" id="Fact002714" unitRef="Pure">0.0342</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantSixMember" id="Fact002716">P5Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantSixMember" decimals="INF" id="Fact002718" unitRef="Pure">0.8202</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantSevenMember" decimals="INF" id="Fact002720" unitRef="Shares">3640000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantSevenMember" decimals="INF" id="Fact002722" unitRef="CADPShares">0.22</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantSevenMember" decimals="INF" id="Fact002724" unitRef="Pure">0.0338</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantSevenMember" id="Fact002726">P5Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantSevenMember" decimals="INF" id="Fact002728" unitRef="Pure">0.8261</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantEightMember" decimals="INF" id="Fact002730" unitRef="Shares">1125000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantEightMember" decimals="INF" id="Fact002732" unitRef="CADPShares">0.31</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantEightMember" decimals="INF" id="Fact002734" unitRef="Pure">0.0165</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantEightMember" id="Fact002736">P5Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantEightMember" decimals="INF" id="Fact002738" unitRef="Pure">0.8537</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantNineMember" decimals="INF" id="Fact002740" unitRef="Shares">960000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantNineMember" decimals="INF" id="Fact002742" unitRef="CADPShares">0.23</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantNineMember" decimals="INF" id="Fact002744" unitRef="Pure">0.0045</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantNineMember" id="Fact002746">P2Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantNineMember" decimals="INF" id="Fact002748" unitRef="Pure">0.8296</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantTenMember" decimals="INF" id="Fact002750" unitRef="Shares">2470000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantTenMember" decimals="INF" id="Fact002752" unitRef="CADPShares">0.25</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTenMember" decimals="INF" id="Fact002754" unitRef="Pure">0.0045</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTenMember" id="Fact002756">P2Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTenMember" decimals="INF" id="Fact002758" unitRef="Pure">0.8498</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantElevenMember" decimals="INF" id="Fact002760" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantElevenMember" decimals="INF" id="Fact002762" unitRef="CADPShares">0.30</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantElevenMember" decimals="INF" id="Fact002764" unitRef="Pure">0.0032</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantElevenMember" id="Fact002766">P2Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantElevenMember" decimals="INF" id="Fact002768" unitRef="Pure">0.8603</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantTwelveMember" decimals="INF" id="Fact002770" unitRef="Shares">100000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantTwelveMember" decimals="INF" id="Fact002772" unitRef="CADPShares">0.30</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTwelveMember" decimals="INF" id="Fact002774" unitRef="Pure">0.0033</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTwelveMember" id="Fact002776">P2Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantTwelveMember" decimals="INF" id="Fact002778" unitRef="Pure">0.8633</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantThirteenMember" decimals="INF" id="Fact002780" unitRef="Shares">1975000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantThirteenMember" decimals="INF" id="Fact002782" unitRef="CADPShares">0.31</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantThirteenMember" decimals="INF" id="Fact002784" unitRef="Pure">0.0022</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantThirteenMember" id="Fact002786">P2Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantThirteenMember" decimals="INF" id="Fact002788" unitRef="Pure">0.8585</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantFourteenMember" decimals="INF" id="Fact002790" unitRef="Shares">325000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantFourteenMember" decimals="INF" id="Fact002792" unitRef="CADPShares">0.43</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFourteenMember" decimals="INF" id="Fact002794" unitRef="Pure">0.0026</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFourteenMember" id="Fact002796">P2Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFourteenMember" decimals="INF" id="Fact002798" unitRef="Pure">0.8548</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement contextRef="From2023-01-012023-12-31_custom_GrantFifteenMember" decimals="INF" id="Fact002800" unitRef="Shares">450000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement> <ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019 contextRef="From2023-01-012023-12-31_custom_GrantFifteenMember" decimals="INF" id="Fact002802" unitRef="CADPShares">0.49</ifrs-full:WeightedAverageSharePriceShareOptionsGranted2019> <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFifteenMember" decimals="INF" id="Fact002804" unitRef="Pure">0.0019</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted> <aau:DescriptionOfOptionLifeSharesOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFifteenMember" id="Fact002806">P2Y</aau:DescriptionOfOptionLifeSharesOptionsGranted> <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted contextRef="From2023-01-012023-12-31_custom_GrantFifteenMember" decimals="INF" id="Fact002808" unitRef="Pure">0.8404</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002810" unitRef="CAD">810150</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002812" unitRef="CAD">1478100</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002814" unitRef="CAD">1870800</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees> <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002816">&lt;p id="xdx_800_eifrs-full--DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_zFZrYueeddN4" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;span style="letter-spacing: -0.1pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;11.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_822_z1YEx9mYCQea"&gt;Related party transactions and balances&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(a)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Compensation of key management personnel&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0in"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0in"&gt;Key management includes members of the Board, the Chair, the President and Chief Executive Officer, the Chief Financial Officer, the Executive Vice President, and the Vice President, Project Development. The net aggregate compensation paid or payable to key management for services after recovery from Azucar Minerals Ltd. (Azucar) and Almadex (Note 11 (b)) is as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock_zTIygpai5QUl" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Related party transactions and balances (Details)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B0_zaqQZFNICoD3" style="display: none"&gt;Schedule of related party payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230101__20231231_z3TEe5iRpFJh" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220101__20221231_zf3mrgqDMjj8" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20210101__20211231_z9UIfvoxeDWa" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40C_ecustom--PaymentsForProfessionalFees_zBUOQJ76Joyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Professional fees&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;50,588&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Salaries and benefits&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PaymentsForSalariesFeesAndBenefits_pp0p0_c20230101__20231231_fKDMp_z9PPTNaOI2R8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Salaries and benefits"&gt;398,307&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PaymentsForSalariesFeesAndBenefits_pp0p0_c20220101__20221231_fKDIp_zGGCl5a45Pu2" style="font-size: 10pt; text-align: right" title="Salaries and benefits"&gt;484,435&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PaymentsForSalariesFeesAndBenefits_pp0p0_c20210101__20211231_fKDEp_zNh8CB9OkzPa" style="font-size: 10pt; text-align: right" title="Salaries and benefits"&gt;450,522&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_405_ecustom--AmountOfSharebasedPayments_zbBdpa9SGilb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Share-based payments&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;702,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,212,300&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,551,850&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_401_ecustom--PaymentsMadeForDirectorsFees_zeuw0mFf8Su5" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Directors&#x2019; fees&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;140,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;145,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;102,500&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_408_ecustom--PaymentsToRelatedPartyServices_zewJaprYpfUg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;1,290,895&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;1,901,735&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;2,164,872&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&#160;&lt;sup id="xdx_F05_zKhaHnVk9w3i"&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F18_zEWXVYJgfSqj" style="text-align: justify"&gt;As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&#160;&lt;sup id="xdx_F03_ziTqVRuBDu7e"&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F19_zFDUAjAExih4" style="text-align: justify"&gt;As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&#160;&lt;sup id="xdx_F0B_zIcisz8uuFv5"&gt;(3)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F1A_z8FoJbZ2INH2" style="text-align: justify"&gt;As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p id="xdx_8A5_zuv9On8gF6k6" style="margin: 0pt 0 0pt 57.25pt; font-size: 10pt; text-align: justify; text-indent: -21.25pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(b)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Administrative Services Agreements &lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company recovers a portion of rent, office and license expenses from Azucar pursuant to an Administrative Services Agreement dated May 15, 2015 and First Amending Agreement dated December 16, 2015 between the Company and Azucar.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;span style="color: windowtext"&gt;The Company also recovers a portion of &lt;/span&gt;rent, office and license &lt;span style="color: windowtext"&gt;expenses from Almadex pursuant to an Administrative Services Agreement dated March 29, 2018 between the Company and Almadex.&lt;/span&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;During the year ended December 31, 2023, the Company received $&lt;span id="xdx_90D_ecustom--AdministrativeServicesFeesIncludedInOtherIncome_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AzucarMember_zUVD61MOCSOa" title="Administrative services fees included in other income"&gt;75,853 &lt;/span&gt;(2022 - $&lt;span id="xdx_903_ecustom--AdministrativeServicesFeesIncludedInOtherIncome_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AzucarMember_zryOHC3v3f44" title="Administrative services fees included in other income"&gt;185,068&lt;/span&gt;; 2021 - $&lt;span id="xdx_90B_ecustom--AdministrativeServicesFeesIncludedInOtherIncome_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AzucarMember_zkUmx5qbylyb" title="Administrative services fees included in other income"&gt;412,812&lt;/span&gt;) from Azucar for administrative services fees included in other income and received $&lt;span id="xdx_901_ecustom--AdministrativeServicesFeesIncludedInOtherIncome_c20230101__20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlmadexMember_zPDHL7uXlVp8" title="Administrative services fees included in other income"&gt;1,346,494&lt;/span&gt; (2022 - $&lt;span id="xdx_901_ecustom--AdministrativeServicesFeesIncludedInOtherIncome_c20220101__20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlmadexMember_zZzwNizzOIxh" title="Administrative services fees included in other income"&gt;1,191,360&lt;/span&gt;; 2021 - $&lt;span id="xdx_90E_ecustom--AdministrativeServicesFeesIncludedInOtherIncome_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlmadexMember_zeheNbOGljPk" title="Administrative services fees included in other income"&gt;969,532&lt;/span&gt;) from Almadex for administrative services fees included in other income.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;At December 31, 2023, included in accounts receivable is $&lt;span id="xdx_901_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AzucarMember_zwdlOWghTK43" title="Amounts receivable, related party transactions"&gt;7,005&lt;/span&gt; (2022 - $&lt;span id="xdx_907_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AzucarMember_zC4qtjsmYgZ7" title="Amounts receivable, related party transactions"&gt;64,006&lt;/span&gt;) due from Azucar and $&lt;span id="xdx_90F_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlmadexMember_zCuQXJUcA6x4" title="Amounts receivable, related party transactions"&gt;369,045&lt;/span&gt; (2022 - $&lt;span id="xdx_909_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlmadexMember_zBvcMa4PS9pi" title="Amounts receivable, related party transactions"&gt;117,044&lt;/span&gt;) due from Almadex in relation to expense recoveries.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Under the Administrative Services Agreements, the Company is the sole and exclusive manager of Azucar and Almadex that provides general management services, office space, executive personnel, human resources, geological technical support, accounting and financial services at cost with no mark-up or additional direct charge. The three companies are considered related parties though common officers.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(c)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;i&gt;Other related party transactions&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;At December 31, 2023, the Company accrued $Nil&lt;span id="xdx_90F_eifrs-full--OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlmadexMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--DrillEquipmentMember_zhosLhrEcAq5" style="display: none" title="Outstanding commitments made on behalf of entity, related party transactions"&gt;0&lt;/span&gt; (2022 - $&lt;span id="xdx_90D_eifrs-full--OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions_iI_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--AlmadexMember__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--DrillEquipmentMember_zh3bvIDPeeV5" title="Outstanding commitments made on behalf of entity, related party transactions"&gt;80,727&lt;/span&gt;) payable to Almadex for exploration and drilling services in Mexico.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;During the year ended December 31, 2023, the Company employed the Chair&#x2019;s daughter for a salary of $&lt;span id="xdx_90E_ecustom--RelatedPartySalaryContracted_iI_c20231231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ChairmansDaughterMember_zBcCmOAph424" title="Related party, salary contracted"&gt;45,300&lt;/span&gt; less statutory deductions (2022 - $&lt;span id="xdx_903_ecustom--RelatedPartySalaryContracted_iI_c20221231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ChairmansDaughterMember_zQ7uONIJJhrl" title="Related party, salary contracted"&gt;48,800&lt;/span&gt;; 2021 - $&lt;span id="xdx_907_ecustom--RelatedPartySalaryContracted_iI_c20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ChairmansDaughterMember_z2ceOIs51src" title="Related party, salary contracted"&gt;41,300&lt;/span&gt;) for marketing and administrative services provided to the Company.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory> <aau:DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002818">&lt;table cellpadding="0" cellspacing="0" id="xdx_890_ecustom--DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock_zTIygpai5QUl" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Related party transactions and balances (Details)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B0_zaqQZFNICoD3" style="display: none"&gt;Schedule of related party payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20230101__20231231_z3TEe5iRpFJh" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_497_20220101__20221231_zf3mrgqDMjj8" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20210101__20211231_z9UIfvoxeDWa" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31,&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40C_ecustom--PaymentsForProfessionalFees_zBUOQJ76Joyk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Professional fees&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;50,588&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Salaries and benefits&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PaymentsForSalariesFeesAndBenefits_pp0p0_c20230101__20231231_fKDMp_z9PPTNaOI2R8" style="font-size: 10pt; font-weight: bold; text-align: right" title="Salaries and benefits"&gt;398,307&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--PaymentsForSalariesFeesAndBenefits_pp0p0_c20220101__20221231_fKDIp_zGGCl5a45Pu2" style="font-size: 10pt; text-align: right" title="Salaries and benefits"&gt;484,435&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--PaymentsForSalariesFeesAndBenefits_pp0p0_c20210101__20211231_fKDEp_zNh8CB9OkzPa" style="font-size: 10pt; text-align: right" title="Salaries and benefits"&gt;450,522&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_405_ecustom--AmountOfSharebasedPayments_zbBdpa9SGilb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Share-based payments&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;702,000&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,212,300&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,551,850&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_401_ecustom--PaymentsMadeForDirectorsFees_zeuw0mFf8Su5" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Directors&#x2019; fees&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;140,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;145,000&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;102,500&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_408_ecustom--PaymentsToRelatedPartyServices_zewJaprYpfUg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;b style="display: none"&gt;Total&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;1,290,895&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;1,901,735&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;2,164,872&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: 0in"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&#160;&lt;sup id="xdx_F05_zKhaHnVk9w3i"&gt;(1)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F18_zEWXVYJgfSqj" style="text-align: justify"&gt;As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&#160;&lt;sup id="xdx_F03_ziTqVRuBDu7e"&gt;(2)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F19_zFDUAjAExih4" style="text-align: justify"&gt;As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&#160;&lt;sup id="xdx_F0B_zIcisz8uuFv5"&gt;(3)&lt;/sup&gt;&lt;/td&gt;&lt;td id="xdx_F1A_z8FoJbZ2INH2" style="text-align: justify"&gt;As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </aau:DisclosureOfTheTransactionsBetweenRelatedPartiesTextBlock> <aau:PaymentsForProfessionalFees contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002820" unitRef="CAD">50588</aau:PaymentsForProfessionalFees> <aau:PaymentsForProfessionalFees contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002821" unitRef="CAD">60000</aau:PaymentsForProfessionalFees> <aau:PaymentsForProfessionalFees contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002822" unitRef="CAD">60000</aau:PaymentsForProfessionalFees> <aau:PaymentsForSalariesFeesAndBenefits contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002824" unitRef="CAD">398307</aau:PaymentsForSalariesFeesAndBenefits> <aau:PaymentsForSalariesFeesAndBenefits contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002826" unitRef="CAD">484435</aau:PaymentsForSalariesFeesAndBenefits> <aau:PaymentsForSalariesFeesAndBenefits contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002828" unitRef="CAD">450522</aau:PaymentsForSalariesFeesAndBenefits> <aau:AmountOfSharebasedPayments contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002830" unitRef="CAD">702000</aau:AmountOfSharebasedPayments> <aau:AmountOfSharebasedPayments contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002831" unitRef="CAD">1212300</aau:AmountOfSharebasedPayments> <aau:AmountOfSharebasedPayments contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002832" unitRef="CAD">1551850</aau:AmountOfSharebasedPayments> <aau:PaymentsMadeForDirectorsFees contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002834" unitRef="CAD">140000</aau:PaymentsMadeForDirectorsFees> <aau:PaymentsMadeForDirectorsFees contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002835" unitRef="CAD">145000</aau:PaymentsMadeForDirectorsFees> <aau:PaymentsMadeForDirectorsFees contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002836" unitRef="CAD">102500</aau:PaymentsMadeForDirectorsFees> <aau:PaymentsToRelatedPartyServices contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002838" unitRef="CAD">1290895</aau:PaymentsToRelatedPartyServices> <aau:PaymentsToRelatedPartyServices contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002839" unitRef="CAD">1901735</aau:PaymentsToRelatedPartyServices> <aau:PaymentsToRelatedPartyServices contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002840" unitRef="CAD">2164872</aau:PaymentsToRelatedPartyServices> <aau:AdministrativeServicesFeesIncludedInOtherIncome contextRef="From2023-01-012023-12-31_custom_AzucarMember" decimals="0" id="Fact002851" unitRef="CAD">75853</aau:AdministrativeServicesFeesIncludedInOtherIncome> <aau:AdministrativeServicesFeesIncludedInOtherIncome contextRef="From2022-01-012022-12-31_custom_AzucarMember" decimals="0" id="Fact002853" unitRef="CAD">185068</aau:AdministrativeServicesFeesIncludedInOtherIncome> <aau:AdministrativeServicesFeesIncludedInOtherIncome contextRef="From2021-01-012021-12-31_custom_AzucarMember" decimals="0" id="Fact002855" unitRef="CAD">412812</aau:AdministrativeServicesFeesIncludedInOtherIncome> <aau:AdministrativeServicesFeesIncludedInOtherIncome contextRef="From2023-01-012023-12-31_custom_AlmadexMember" decimals="0" id="Fact002857" unitRef="CAD">1346494</aau:AdministrativeServicesFeesIncludedInOtherIncome> <aau:AdministrativeServicesFeesIncludedInOtherIncome contextRef="From2022-01-012022-12-31_custom_AlmadexMember" decimals="0" id="Fact002859" unitRef="CAD">1191360</aau:AdministrativeServicesFeesIncludedInOtherIncome> <aau:AdministrativeServicesFeesIncludedInOtherIncome contextRef="From2021-01-012021-12-31_custom_AlmadexMember" decimals="0" id="Fact002861" unitRef="CAD">969532</aau:AdministrativeServicesFeesIncludedInOtherIncome> <ifrs-full:AmountsReceivableRelatedPartyTransactions contextRef="AsOf2023-12-31_custom_AzucarMember" decimals="0" id="Fact002863" unitRef="CAD">7005</ifrs-full:AmountsReceivableRelatedPartyTransactions> <ifrs-full:AmountsReceivableRelatedPartyTransactions contextRef="AsOf2022-12-31_custom_AzucarMember" decimals="0" id="Fact002865" unitRef="CAD">64006</ifrs-full:AmountsReceivableRelatedPartyTransactions> <ifrs-full:AmountsReceivableRelatedPartyTransactions contextRef="AsOf2023-12-31_custom_AlmadexMember" decimals="0" id="Fact002867" unitRef="CAD">369045</ifrs-full:AmountsReceivableRelatedPartyTransactions> <ifrs-full:AmountsReceivableRelatedPartyTransactions contextRef="AsOf2022-12-31_custom_AlmadexMember" decimals="0" id="Fact002869" unitRef="CAD">117044</ifrs-full:AmountsReceivableRelatedPartyTransactions> <ifrs-full:OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions contextRef="AsOf2023-12-31_custom_AlmadexMember_custom_DrillEquipmentMember" decimals="0" id="Fact002871" unitRef="CAD">0</ifrs-full:OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions> <ifrs-full:OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions contextRef="AsOf2022-12-31_custom_AlmadexMember_custom_DrillEquipmentMember" decimals="0" id="Fact002873" unitRef="CAD">80727</ifrs-full:OutstandingCommitmentsMadeOnBehalfOfEntityRelatedPartyTransactions> <aau:RelatedPartySalaryContracted contextRef="AsOf2023-12-31_custom_ChairmansDaughterMember" decimals="0" id="Fact002875" unitRef="CAD">45300</aau:RelatedPartySalaryContracted> <aau:RelatedPartySalaryContracted contextRef="AsOf2022-12-31_custom_ChairmansDaughterMember" decimals="0" id="Fact002877" unitRef="CAD">48800</aau:RelatedPartySalaryContracted> <aau:RelatedPartySalaryContracted contextRef="AsOf2021-12-31_custom_ChairmansDaughterMember" decimals="0" id="Fact002879" unitRef="CAD">41300</aau:RelatedPartySalaryContracted> <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002883">&lt;p id="xdx_80B_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zahWtaGMnUrb" style="margin: 0pt 0; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;12.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_827_zA0mxEFPpnZg"&gt;Net loss per share&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1.75in; font-size: 10pt; text-align: justify; text-indent: -90.55pt"&gt;&lt;i&gt;Basic and diluted net loss per share&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1.75in; font-size: 10pt; text-align: justify; text-indent: -1.25in"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The calculation of basic net loss per share for the year ended December 31, 2023 was based on the loss attributable to common shareholders of $&lt;span id="xdx_905_eifrs-full--ProfitLossFromContinuingOperations_iN_di_c20230101__20231231_zSsjzr9DI0fj" title="Profit loss"&gt;63,620,232&lt;/span&gt; (2022 - $&lt;span id="xdx_907_eifrs-full--ProfitLossFromContinuingOperations_iN_di_c20220101__20221231_ziKHmQ3eZYDl" title="Profit loss"&gt;11,846,560&lt;/span&gt;; 2021 - $&lt;span id="xdx_908_eifrs-full--ProfitLossFromContinuingOperations_iN_di_c20210101__20211231_zHV59RSL3u69" title="Profit loss"&gt;2,668,254&lt;/span&gt;) and a weighted average number of common shares outstanding of &lt;span id="xdx_90E_eifrs-full--WeightedAverageShares_c20230101__20231231_z1himnmaOi0l" title="Weighted average number of ordinary shares outstanding (in shares)"&gt;137,221,408&lt;/span&gt; (2022 - &lt;span id="xdx_90E_eifrs-full--WeightedAverageShares_c20220101__20221231_zXeUFY1mlE4" title="Weighted average number of ordinary shares outstanding (in shares)"&gt;137,221,408&lt;/span&gt;; 2021 &#x2013; &lt;span id="xdx_905_eifrs-full--WeightedAverageShares_c20210101__20211231_zOhBw8zgcvie" title="Weighted average number of ordinary shares outstanding (in shares)"&gt;133,842,894&lt;/span&gt;).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The calculation of diluted net loss per share for the year ended December 31, 2023, 2022 and 2021 did not include the effect of stock options and warrants, as they were considered to be anti-dilutive.&lt;/p&gt; </ifrs-full:DisclosureOfEarningsPerShareExplanatory> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002885" unitRef="CAD">-63620232</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002887" unitRef="CAD">-11846560</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:ProfitLossFromContinuingOperations contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002889" unitRef="CAD">-2668254</ifrs-full:ProfitLossFromContinuingOperations> <ifrs-full:WeightedAverageShares contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact002891" unitRef="Shares">137221408</ifrs-full:WeightedAverageShares> <ifrs-full:WeightedAverageShares contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact002893" unitRef="Shares">137221408</ifrs-full:WeightedAverageShares> <ifrs-full:WeightedAverageShares contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact002895" unitRef="Shares">133842894</ifrs-full:WeightedAverageShares> <aau:DisclosureOfSupplementalCashFlowInformationTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002897">&lt;p id="xdx_80F_ecustom--DisclosureOfSupplementalCashFlowInformationTextBlock_zEBqDYXP7D0j" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -0.55pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;13.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82E_zdOwWLDXTqv"&gt;Supplemental cash flow information&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Supplemental information regarding non-cash transactions is as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfSupplementalCashFlowTextBlock_z9vhYLYoUUse" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Supplemental cash flow information (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B0_zBA6AIWcNPRj" style="display: none"&gt;Schedule of supplemental information&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20230101__20231231_zj2zG1BDhWG5" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220101__20221231_zzXYhrDcPbz3" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20210101__20211231_zzmEIxrQ7sJf" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Investing and financing activities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40A_ecustom--ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables_zSQaHysGa6Id" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Exploration and evaluation assets expenditures included in trade and other payables&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2901"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;90,850&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;89,203&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_400_ecustom--IncreaseDecreaseInRightOfUseAssets_pp0p0_zcmaBKZJke5b" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Right-of-use assets&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2906"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(508,799&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_406_ecustom--IncreaseDecreaseInWarrantLiability_pp0p0_znMLYWh8CjQa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2910"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,371,174&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_401_ecustom--FairValueOfFindersWarrants_zCxTdiCRv7F8" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Fair value of finders&#x2019; warrants&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2913"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2914"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;130,731&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_409_ecustom--IncreaseDecreaseInLeaseLiabilities_zpRdZ6fMAiT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2918"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;508,799&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_403_ecustom--FairValueOfCashStockOptionsTransferredToShareCapitalOnExerciseOfOptions_zQJUVj8gbtw4" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Fair value of cash stock options transferred to share capital on exercise of options&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2921"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2922"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;177,250&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8AE_zNaHT6le2afl" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Supplemental information regarding the split between cash and cash equivalents is as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.75in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zdGAcFqHiHj5" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Supplemental cash flow information (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BB_z39dSc3e8Kx3" style="display: none"&gt;Schedule of supplemental information of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20231231_zW8uRG6riDY4" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20221231_zmoku9h1ctNf" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_407_eifrs-full--Cash_iI_pp0p0_maCACEzF3o_zu1JFfQC8pQk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;1,658,863&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;1,542,956&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_402_eifrs-full--ShorttermDepositsClassifiedAsCashEquivalents_iI_pp0p0_maCACEzF3o_zKK9Le8EMvX1" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Term Deposits&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;2,587,120&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;5,115,120&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_407_eifrs-full--CashEquivalents_iTI_pp0p0_mtCACEzF3o_zUTEZo910vJ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&#160;&lt;b style="display: none"&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;4,245,983&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;6,658,076&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8A1_zPzbG9qjlHNe" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </aau:DisclosureOfSupplementalCashFlowInformationTextBlock> <aau:DisclosureOfSupplementalCashFlowTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002899">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfSupplementalCashFlowTextBlock_z9vhYLYoUUse" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Supplemental cash flow information (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B0_zBA6AIWcNPRj" style="display: none"&gt;Schedule of supplemental information&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49A_20230101__20231231_zj2zG1BDhWG5" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49C_20220101__20221231_zzXYhrDcPbz3" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_496_20210101__20211231_zzmEIxrQ7sJf" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold"&gt;Investing and financing activities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40A_ecustom--ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables_zSQaHysGa6Id" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Exploration and evaluation assets expenditures included in trade and other payables&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2901"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;90,850&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;89,203&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_400_ecustom--IncreaseDecreaseInRightOfUseAssets_pp0p0_zcmaBKZJke5b" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Right-of-use assets&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2905"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2906"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(508,799&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_406_ecustom--IncreaseDecreaseInWarrantLiability_pp0p0_znMLYWh8CjQa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Warrant liability&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2909"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2910"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,371,174&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_401_ecustom--FairValueOfFindersWarrants_zCxTdiCRv7F8" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Fair value of finders&#x2019; warrants&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2913"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2914"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;130,731&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_409_ecustom--IncreaseDecreaseInLeaseLiabilities_zpRdZ6fMAiT1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Lease liabilities&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2917"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2918"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;508,799&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_403_ecustom--FairValueOfCashStockOptionsTransferredToShareCapitalOnExerciseOfOptions_zQJUVj8gbtw4" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Fair value of cash stock options transferred to share capital on exercise of options&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2921"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2922"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;177,250&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:DisclosureOfSupplementalCashFlowTextBlock> <aau:ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002902" unitRef="CAD">90850</aau:ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables> <aau:ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002903" unitRef="CAD">89203</aau:ExplorationAndEvaluationAssetsExpendituresIncludedInTradeAndOtherPayables> <aau:IncreaseDecreaseInRightOfUseAssets contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002907" unitRef="CAD">-508799</aau:IncreaseDecreaseInRightOfUseAssets> <aau:IncreaseDecreaseInWarrantLiability contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002911" unitRef="CAD">2371174</aau:IncreaseDecreaseInWarrantLiability> <aau:FairValueOfFindersWarrants contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002915" unitRef="CAD">130731</aau:FairValueOfFindersWarrants> <aau:IncreaseDecreaseInLeaseLiabilities contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002919" unitRef="CAD">508799</aau:IncreaseDecreaseInLeaseLiabilities> <aau:FairValueOfCashStockOptionsTransferredToShareCapitalOnExerciseOfOptions contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002923" unitRef="CAD">177250</aau:FairValueOfCashStockOptionsTransferredToShareCapitalOnExerciseOfOptions> <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002925">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfCashAndCashEquivalentsTableTextBlock_zdGAcFqHiHj5" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Supplemental cash flow information (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BB_z39dSc3e8Kx3" style="display: none"&gt;Schedule of supplemental information of cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_495_20231231_zW8uRG6riDY4" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20221231_zmoku9h1ctNf" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_407_eifrs-full--Cash_iI_pp0p0_maCACEzF3o_zu1JFfQC8pQk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;1,658,863&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;1,542,956&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_402_eifrs-full--ShorttermDepositsClassifiedAsCashEquivalents_iI_pp0p0_maCACEzF3o_zKK9Le8EMvX1" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 1pt"&gt;Term Deposits&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;2,587,120&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;5,115,120&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_407_eifrs-full--CashEquivalents_iTI_pp0p0_mtCACEzF3o_zUTEZo910vJ4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&#160;&lt;b style="display: none"&gt;Total cash and cash equivalents&lt;/b&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;4,245,983&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;6,658,076&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock> <ifrs-full:Cash contextRef="AsOf2023-12-31" decimals="0" id="Fact002927" unitRef="CAD">1658863</ifrs-full:Cash> <ifrs-full:Cash contextRef="AsOf2022-12-31" decimals="0" id="Fact002928" unitRef="CAD">1542956</ifrs-full:Cash> <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2023-12-31" decimals="0" id="Fact002930" unitRef="CAD">2587120</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents> <ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents contextRef="AsOf2022-12-31" decimals="0" id="Fact002931" unitRef="CAD">5115120</ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents> <ifrs-full:CashEquivalents contextRef="AsOf2023-12-31" decimals="0" id="Fact002933" unitRef="CAD">4245983</ifrs-full:CashEquivalents> <ifrs-full:CashEquivalents contextRef="AsOf2022-12-31" decimals="0" id="Fact002934" unitRef="CAD">6658076</ifrs-full:CashEquivalents> <aau:DisclosureOfIncomeTaxesExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact002936">&lt;p id="xdx_804_ecustom--DisclosureOfIncomeTaxesExplanatory_zo2Mgq0Z6pX8" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;14.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_821_ztUv5TkQz4Id"&gt;Income Taxes&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(a)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The provision for income taxes differs from the amounts computed by applying the Canadian statutory rates to the net loss before income taxes due to the following:&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify; text-indent: -21.25pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclsoureOfDeferredIncomeTaxesTextBlock_zfcXhKQNbAY7" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Income Taxes (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B9_zkinN0r8sQmg" style="display: none"&gt;Schedule of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20230101__20231231_z7TmYGf4Otah" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20220101__20221231_z4fF17Lbl3r7" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20210101__20211231_zaBGRFzyjBq9" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_405_eifrs-full--AccountingProfit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;(66,710,410&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;(10,505,375&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;(2,354,113&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Statutory rate&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231_zPtK6Tm3fje9" title="Statutory rate"&gt;27.00&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ApplicableTaxRate_pip0_dp_c20220101__20221231_zQmUVhbfnw8e" title="Statutory rate"&gt;27.00&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ApplicableTaxRate_pip0_dp_c20210101__20211231_zTvD8l0BYSti" title="Statutory rate"&gt;27.00&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40C_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_maDTEIzo6v_zpNdXcXx3RTb" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected income tax&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;(18,011,811&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,836,451&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(635,611&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40A_eifrs-full--TaxEffectOfForeignTaxRates_maDTEIzo6v_zcNukH2mVZm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of different tax rates in foreign jurisdictions&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;(2,005,959&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(83,891&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;5,281&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_407_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_maDTEIzo6v_zlBYtRyGm5y8" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Non-deductible share-based payments&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;218,741&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;399,087&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;505,116&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_402_ecustom--TaxEffectOfOtherPermanentItems_maDTEIzo6v_zHdvUiB22fc4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Other permanent items&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;2,484,720&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,838,169&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(620,413&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_401_ecustom--TaxEffectOfChangesInTaxAssetsNotRecognized_maDTEIzo6v_zQRDxse3o8na" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Change in deferred tax assets not recognized&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;15,403,428&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,471,723&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;733,447&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_407_ecustom--TaxEffectFromShareIssuanceCosts_maDTEIzo6v_zyrW9qZHwt8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Share issuance costs&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2975"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(331,660&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40E_ecustom--TaxEffectOfTrueupsAndOther_maDTEIzo6v_zG9k8y3J2Pbe" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;True-ups and other&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;(1,179,327&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(447,452&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;657,981&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_403_eifrs-full--DeferredTaxExpenseIncome_iT_pp0p0_mtDTEIzo6v_z1YtpUTgDepl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Deferred income tax (recovery) expense&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;(3,090,208&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;1,341,185&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;314,141&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8AC_zuXRoH7HUVJk" style="margin: 0pt 0 0pt 28.35pt; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;&lt;i&gt;(b)&lt;/i&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;The Company&#x2019;s deferred income tax liability relates to the Mexican income tax and Special Mining Duty (&#x201c;SMD&#x201d;) associated with the Tuligtic project.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 56.7pt; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 22.7pt; font-size: 10pt; text-align: justify; text-indent: 11.35pt"&gt;The significant components of deferred income tax assets (liabilities) are as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 22.7pt; font-size: 10pt; text-align: justify; text-indent: 11.35pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDeferredTaxAssetsAndLiabilitiesTextBlock_zq6kIYRkK1Gk" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Income Taxes (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zHCnGDCAXTUf" style="display: none"&gt;Schedule of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-left: 10pt; width: 70%; font-size: 10pt; text-align: left"&gt;Non-capital losses&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--DeferredTaxAssetsNonCapitalLosses_iI_pp0p0_c20231231_zEL581R35CXe" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Non-capital losses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DeferredTaxAssetsNonCapitalLosses_iI_pp0p0_c20221231_zJJE4IIj5jk8" style="width: 12%; font-size: 10pt; text-align: right" title="Non-capital losses"&gt;2,477,570&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DeferredTaxAssetsExplorationAndEvaluation_iI_pp0p0_c20231231_z2WUaiastuZj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exploration and evaluation assets, deferred tax assets"&gt;1,434,880&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--DeferredTaxAssetsExplorationAndEvaluation_iI_pp0p0_c20221231_znWvOMAfSxvi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exploration and evaluation assets, deferred tax assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2994"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DeferredTaxAssets_pp0p0_c20231231_zRHGjZKIKLqd" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deferred tax assets"&gt;1,434,880&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DeferredTaxAssets_pp0p0_c20221231_zDXapkt8r3ui" style="font-size: 10pt; text-align: right" title="Deferred tax assets"&gt;2,477,570&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DeferredTaxLiabilitiesExplorationAndEvaluation_iI_pp0p0_c20231231_z7rCzpSXrjQe" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exploration and evaluation assets, deferred tax liabilities"&gt;(1,434,880&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DeferredTaxLiabilitiesExplorationAndEvaluation_pp0p0_c20221231_z8Sk92QtJnj9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exploration and evaluation assets, deferred tax liabilities"&gt;(5,567,778&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Net deferred tax liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NetDeferredTaxLiabilities_pp0p0_c20231231_zB4rnhvHw3g" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Net deferred tax liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3004"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NetDeferredTaxLiabilities_pp0p0_c20221231_zJ1er1kjWk3l" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Net deferred tax liabilities"&gt;(3,090,208&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8AF_zScX1bAg2NC6" style="margin: 0pt 0 0pt 56.7pt; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(c)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;Deductible temporary differences, unused tax losses and unused tax credits for which no deferred tax assets have been recognized are attributable to the following:&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 42.55pt; font-size: 10pt; text-align: justify; text-indent: -28.35pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTextBlock_zup3ETUWOwFd" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Income Taxes (Details 2)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zQflVNKHkqb" style="display: none"&gt;Schedule of deductible temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: left"&gt;Non-capital loss carry forwards&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--NoncapitalLossCarryForwardsMember_zyr9Ewm2qaL2" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;32,616,394&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--NoncapitalLossCarryForwardsMember_zBprbV94Um8e" style="width: 12%; font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;25,487,951&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Capital loss carry forwards&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CapitalLossCarryForwardsMember_zP3srwQoieV" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;23,360,422&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CapitalLossCarryForwardsMember_z0majAz5sgNg" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;24,538,993&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_iI_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ExplorationAndEvaluationAssetsDeductibleDifferencesMember_zQNDT6cCtyIb" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;39,102,815&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ExplorationAndEvaluationAssetsDeductibleDifferencesMember_z2w09QXKY8Xa" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;8,188,922&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Share issue costs&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ShareIssueCostsMember_zG0t3vbR4ZHh" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;551,134&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ShareIssueCostsMember_zAo8kQDXXiNh" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;858,548&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Property, plant and equipment&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_iI_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember_zQ0n28f7s8P6" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;7,748,032&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pdp0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember_zx5zdC5hz0Ba" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;7,782,024&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Donations&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DonationsMember_z5bw8MNkmSX2" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;32,960&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DonationsMember_zURuT0296X8h" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;32,960&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Investment tax credit&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InvestmentTaxCreditMember_zyjFvbzxoMhl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;223,873&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InvestmentTaxCreditMember_zpx9nUJ9LUL2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;223,873&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231_z0SqmA1rUJ4i" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;103,635,630&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231_zrpMhwK0ezd5" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;67,113,271&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8AD_z9777ltbaXjb" style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;At December 31, 2023, the Company had operating loss carry forwards available for tax purposes in Canada of $&lt;span id="xdx_901_ecustom--OperatingLossCarryforward_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--CountryOfCanadaMember_zyVAdbg6NRnh" title="Operating loss carryforwards"&gt;27,592,166&lt;/span&gt; (2022 - $&lt;span id="xdx_908_ecustom--OperatingLossCarryforward_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--CountryOfCanadaMember_zbdVKHjfTOV6" title="Operating loss carryforwards"&gt;25,487,951&lt;/span&gt;) which expire between 2032 and 2043 and in Mexico of $&lt;span id="xdx_907_ecustom--OperatingLossCarryforward_iI_c20231231__srt--StatementGeographicalAxis__custom--CountryOfMexicoMember_zVIBB9hHbyG3" title="Operating loss carryforwards"&gt;4,588,699&lt;/span&gt; (2022 - $Nil&lt;span id="xdx_90A_ecustom--OperatingLossCarryforward_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--CountryOfMexicoMember_zuVVRqDGPYDh" style="display: none" title="Operating loss carryforwards"&gt;0&lt;/span&gt;) which expire between 2024 and 2026.&lt;/p&gt; </aau:DisclosureOfIncomeTaxesExplanatory> <aau:DisclsoureOfDeferredIncomeTaxesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002942">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclsoureOfDeferredIncomeTaxesTextBlock_zfcXhKQNbAY7" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Income Taxes (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8B9_zkinN0r8sQmg" style="display: none"&gt;Schedule of deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20230101__20231231_z7TmYGf4Otah" style="font-size: 10pt; font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_492_20220101__20221231_z4fF17Lbl3r7" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_493_20210101__20211231_zaBGRFzyjBq9" style="font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt;2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2021&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_405_eifrs-full--AccountingProfit_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 55%; font-size: 10pt; text-align: left"&gt;Loss before income taxes&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right"&gt;(66,710,410&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;(10,505,375&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;(2,354,113&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Statutory rate&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span id="xdx_909_eifrs-full--ApplicableTaxRate_pip0_dp_c20230101__20231231_zPtK6Tm3fje9" title="Statutory rate"&gt;27.00&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_905_eifrs-full--ApplicableTaxRate_pip0_dp_c20220101__20221231_zQmUVhbfnw8e" title="Statutory rate"&gt;27.00&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;&lt;span id="xdx_903_eifrs-full--ApplicableTaxRate_pip0_dp_c20210101__20211231_zTvD8l0BYSti" title="Statutory rate"&gt;27.00&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40C_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_maDTEIzo6v_zpNdXcXx3RTb" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Expected income tax&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;(18,011,811&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(2,836,451&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(635,611&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40A_eifrs-full--TaxEffectOfForeignTaxRates_maDTEIzo6v_zcNukH2mVZm9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Effect of different tax rates in foreign jurisdictions&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;(2,005,959&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(83,891&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;5,281&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_407_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_maDTEIzo6v_zlBYtRyGm5y8" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Non-deductible share-based payments&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;218,741&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;399,087&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;505,116&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_402_ecustom--TaxEffectOfOtherPermanentItems_maDTEIzo6v_zHdvUiB22fc4" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Other permanent items&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;2,484,720&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;1,838,169&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(620,413&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_401_ecustom--TaxEffectOfChangesInTaxAssetsNotRecognized_maDTEIzo6v_zQRDxse3o8na" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Change in deferred tax assets not recognized&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;15,403,428&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;2,471,723&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;733,447&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_407_ecustom--TaxEffectFromShareIssuanceCosts_maDTEIzo6v_zyrW9qZHwt8c" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt"&gt;Share issuance costs&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2974"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2975"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;(331,660&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_40E_ecustom--TaxEffectOfTrueupsAndOther_maDTEIzo6v_zG9k8y3J2Pbe" style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;True-ups and other&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;(1,179,327&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;(447,452&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;657,981&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr id="xdx_403_eifrs-full--DeferredTaxExpenseIncome_iT_pp0p0_mtDTEIzo6v_z1YtpUTgDepl" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Deferred income tax (recovery) expense&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right"&gt;(3,090,208&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;1,341,185&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"&gt;314,141&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:DisclsoureOfDeferredIncomeTaxesTextBlock> <ifrs-full:AccountingProfit contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002944" unitRef="CAD">-66710410</ifrs-full:AccountingProfit> <ifrs-full:AccountingProfit contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002945" unitRef="CAD">-10505375</ifrs-full:AccountingProfit> <ifrs-full:AccountingProfit contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002946" unitRef="CAD">-2354113</ifrs-full:AccountingProfit> <ifrs-full:ApplicableTaxRate contextRef="From2023-01-01to2023-12-31" decimals="INF" id="Fact002948" unitRef="Pure">0.2700</ifrs-full:ApplicableTaxRate> <ifrs-full:ApplicableTaxRate contextRef="From2022-01-012022-12-31" decimals="INF" id="Fact002950" unitRef="Pure">0.2700</ifrs-full:ApplicableTaxRate> <ifrs-full:ApplicableTaxRate contextRef="From2021-01-012021-12-31" decimals="INF" id="Fact002952" unitRef="Pure">0.2700</ifrs-full:ApplicableTaxRate> <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002954" unitRef="CAD">-18011811</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate> <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002955" unitRef="CAD">-2836451</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate> <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002956" unitRef="CAD">-635611</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate> <ifrs-full:TaxEffectOfForeignTaxRates contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002958" unitRef="CAD">-2005959</ifrs-full:TaxEffectOfForeignTaxRates> <ifrs-full:TaxEffectOfForeignTaxRates contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002959" unitRef="CAD">-83891</ifrs-full:TaxEffectOfForeignTaxRates> <ifrs-full:TaxEffectOfForeignTaxRates contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002960" unitRef="CAD">5281</ifrs-full:TaxEffectOfForeignTaxRates> <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002962" unitRef="CAD">218741</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss> <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002963" unitRef="CAD">399087</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss> <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002964" unitRef="CAD">505116</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss> <aau:TaxEffectOfOtherPermanentItems contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002966" unitRef="CAD">2484720</aau:TaxEffectOfOtherPermanentItems> <aau:TaxEffectOfOtherPermanentItems contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002967" unitRef="CAD">1838169</aau:TaxEffectOfOtherPermanentItems> <aau:TaxEffectOfOtherPermanentItems contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002968" unitRef="CAD">-620413</aau:TaxEffectOfOtherPermanentItems> <aau:TaxEffectOfChangesInTaxAssetsNotRecognized contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002970" unitRef="CAD">15403428</aau:TaxEffectOfChangesInTaxAssetsNotRecognized> <aau:TaxEffectOfChangesInTaxAssetsNotRecognized contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002971" unitRef="CAD">2471723</aau:TaxEffectOfChangesInTaxAssetsNotRecognized> <aau:TaxEffectOfChangesInTaxAssetsNotRecognized contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002972" unitRef="CAD">733447</aau:TaxEffectOfChangesInTaxAssetsNotRecognized> <aau:TaxEffectFromShareIssuanceCosts contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002976" unitRef="CAD">-331660</aau:TaxEffectFromShareIssuanceCosts> <aau:TaxEffectOfTrueupsAndOther contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002978" unitRef="CAD">-1179327</aau:TaxEffectOfTrueupsAndOther> <aau:TaxEffectOfTrueupsAndOther contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002979" unitRef="CAD">-447452</aau:TaxEffectOfTrueupsAndOther> <aau:TaxEffectOfTrueupsAndOther contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002980" unitRef="CAD">657981</aau:TaxEffectOfTrueupsAndOther> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact002982" unitRef="CAD">-3090208</ifrs-full:DeferredTaxExpenseIncome> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2022-01-012022-12-31" decimals="0" id="Fact002983" unitRef="CAD">1341185</ifrs-full:DeferredTaxExpenseIncome> <ifrs-full:DeferredTaxExpenseIncome contextRef="From2021-01-012021-12-31" decimals="0" id="Fact002984" unitRef="CAD">314141</ifrs-full:DeferredTaxExpenseIncome> <aau:DisclosureOfDeferredTaxAssetsAndLiabilitiesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact002986">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfDeferredTaxAssetsAndLiabilitiesTextBlock_zq6kIYRkK1Gk" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Income Taxes (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zHCnGDCAXTUf" style="display: none"&gt;Schedule of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred tax assets&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-left: 10pt; width: 70%; font-size: 10pt; text-align: left"&gt;Non-capital losses&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_ecustom--DeferredTaxAssetsNonCapitalLosses_iI_pp0p0_c20231231_zEL581R35CXe" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Non-capital losses"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_ecustom--DeferredTaxAssetsNonCapitalLosses_iI_pp0p0_c20221231_zJJE4IIj5jk8" style="width: 12%; font-size: 10pt; text-align: right" title="Non-capital losses"&gt;2,477,570&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_ecustom--DeferredTaxAssetsExplorationAndEvaluation_iI_pp0p0_c20231231_z2WUaiastuZj" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exploration and evaluation assets, deferred tax assets"&gt;1,434,880&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--DeferredTaxAssetsExplorationAndEvaluation_iI_pp0p0_c20221231_znWvOMAfSxvi" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exploration and evaluation assets, deferred tax assets"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2994"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DeferredTaxAssets_pp0p0_c20231231_zRHGjZKIKLqd" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deferred tax assets"&gt;1,434,880&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eifrs-full--DeferredTaxAssets_pp0p0_c20221231_zDXapkt8r3ui" style="font-size: 10pt; text-align: right" title="Deferred tax assets"&gt;2,477,570&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Deferred tax liabilities&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; padding-left: 10pt; font-size: 10pt; text-align: left"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DeferredTaxLiabilitiesExplorationAndEvaluation_iI_pp0p0_c20231231_z7rCzpSXrjQe" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Exploration and evaluation assets, deferred tax liabilities"&gt;(1,434,880&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_ecustom--DeferredTaxLiabilitiesExplorationAndEvaluation_pp0p0_c20221231_z8Sk92QtJnj9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Exploration and evaluation assets, deferred tax liabilities"&gt;(5,567,778&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;Net deferred tax liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NetDeferredTaxLiabilities_pp0p0_c20231231_zB4rnhvHw3g" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Net deferred tax liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3004"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--NetDeferredTaxLiabilities_pp0p0_c20221231_zJ1er1kjWk3l" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Net deferred tax liabilities"&gt;(3,090,208&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:DisclosureOfDeferredTaxAssetsAndLiabilitiesTextBlock> <aau:DeferredTaxAssetsNonCapitalLosses contextRef="AsOf2022-12-31" decimals="0" id="Fact002990" unitRef="CAD">2477570</aau:DeferredTaxAssetsNonCapitalLosses> <aau:DeferredTaxAssetsExplorationAndEvaluation contextRef="AsOf2023-12-31" decimals="0" id="Fact002992" unitRef="CAD">1434880</aau:DeferredTaxAssetsExplorationAndEvaluation> <ifrs-full:DeferredTaxAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact002996" unitRef="CAD">1434880</ifrs-full:DeferredTaxAssets> <ifrs-full:DeferredTaxAssets contextRef="AsOf2022-12-31" decimals="0" id="Fact002998" unitRef="CAD">2477570</ifrs-full:DeferredTaxAssets> <aau:DeferredTaxLiabilitiesExplorationAndEvaluation contextRef="AsOf2023-12-31" decimals="0" id="Fact003000" unitRef="CAD">-1434880</aau:DeferredTaxLiabilitiesExplorationAndEvaluation> <aau:DeferredTaxLiabilitiesExplorationAndEvaluation contextRef="AsOf2022-12-31" decimals="0" id="Fact003002" unitRef="CAD">-5567778</aau:DeferredTaxLiabilitiesExplorationAndEvaluation> <ifrs-full:NetDeferredTaxLiabilities contextRef="AsOf2022-12-31" decimals="0" id="Fact003006" unitRef="CAD">-3090208</ifrs-full:NetDeferredTaxLiabilities> <aau:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003008">&lt;table cellpadding="0" cellspacing="0" id="xdx_89D_ecustom--DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTextBlock_zup3ETUWOwFd" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Income Taxes (Details 2)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span id="xdx_8BA_zQflVNKHkqb" style="display: none"&gt;Schedule of deductible temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt; 2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="white-space: nowrap; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: left"&gt;Non-capital loss carry forwards&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--NoncapitalLossCarryForwardsMember_zyr9Ewm2qaL2" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;32,616,394&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--NoncapitalLossCarryForwardsMember_zBprbV94Um8e" style="width: 12%; font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;25,487,951&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Capital loss carry forwards&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CapitalLossCarryForwardsMember_zP3srwQoieV" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;23,360,422&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--CapitalLossCarryForwardsMember_z0majAz5sgNg" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;24,538,993&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Exploration and evaluation assets&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_iI_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ExplorationAndEvaluationAssetsDeductibleDifferencesMember_zQNDT6cCtyIb" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;39,102,815&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ExplorationAndEvaluationAssetsDeductibleDifferencesMember_z2w09QXKY8Xa" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;8,188,922&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Share issue costs&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ShareIssueCostsMember_zG0t3vbR4ZHh" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;551,134&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--ShareIssueCostsMember_zAo8kQDXXiNh" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;858,548&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;Property, plant and equipment&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_iI_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember_zQ0n28f7s8P6" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;7,748,032&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pdp0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember_zx5zdC5hz0Ba" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;7,782,024&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt"&gt;Donations&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DonationsMember_z5bw8MNkmSX2" style="font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;32,960&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--DonationsMember_zURuT0296X8h" style="font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;32,960&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;Investment tax credit&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InvestmentTaxCreditMember_zyjFvbzxoMhl" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;223,873&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231__ifrs-full--TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis__custom--InvestmentTaxCreditMember_zpx9nUJ9LUL2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;223,873&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20231231_z0SqmA1rUJ4i" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Deductible temporary differences"&gt;103,635,630&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised_pp0p0_c20221231_zrpMhwK0ezd5" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Deductible temporary differences"&gt;67,113,271&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTextBlock> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2023-12-31_custom_NoncapitalLossCarryForwardsMember" decimals="0" id="Fact003010" unitRef="CAD">32616394</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2022-12-31_custom_NoncapitalLossCarryForwardsMember" decimals="0" id="Fact003012" unitRef="CAD">25487951</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2023-12-31_custom_CapitalLossCarryForwardsMember" decimals="0" id="Fact003014" unitRef="CAD">23360422</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2022-12-31_custom_CapitalLossCarryForwardsMember" decimals="0" id="Fact003016" unitRef="CAD">24538993</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2023-12-31_custom_ExplorationAndEvaluationAssetsDeductibleDifferencesMember" decimals="0" id="Fact003018" unitRef="CAD">39102815</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2022-12-31_custom_ExplorationAndEvaluationAssetsDeductibleDifferencesMember" decimals="0" id="Fact003020" unitRef="CAD">8188922</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2023-12-31_custom_ShareIssueCostsMember" decimals="0" id="Fact003022" unitRef="CAD">551134</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2022-12-31_custom_ShareIssueCostsMember" decimals="0" id="Fact003024" unitRef="CAD">858548</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2023-12-31_custom_PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember" decimals="0" id="Fact003026" unitRef="CAD">7748032</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2022-12-31_custom_PropertyPlantAndEquipmentDeductibleTemporaryDifferencesMember" decimals="0" id="Fact003028" unitRef="CAD">7782024</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2023-12-31_custom_DonationsMember" decimals="0" id="Fact003030" unitRef="CAD">32960</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2022-12-31_custom_DonationsMember" decimals="0" id="Fact003032" unitRef="CAD">32960</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2023-12-31_custom_InvestmentTaxCreditMember" decimals="0" id="Fact003034" unitRef="CAD">223873</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2022-12-31_custom_InvestmentTaxCreditMember" decimals="0" id="Fact003036" unitRef="CAD">223873</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2023-12-31" decimals="0" id="Fact003038" unitRef="CAD">103635630</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised contextRef="AsOf2022-12-31" decimals="0" id="Fact003040" unitRef="CAD">67113271</ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised> <aau:OperatingLossCarryforward contextRef="AsOf2023-12-31_custom_CountryOfCanadaMember" decimals="0" id="Fact003047" unitRef="CAD">27592166</aau:OperatingLossCarryforward> <aau:OperatingLossCarryforward contextRef="AsOf2022-12-31_custom_CountryOfCanadaMember" decimals="0" id="Fact003049" unitRef="CAD">25487951</aau:OperatingLossCarryforward> <aau:OperatingLossCarryforward contextRef="AsOf2023-12-31_custom_CountryOfMexicoMember" decimals="0" id="Fact003051" unitRef="CAD">4588699</aau:OperatingLossCarryforward> <aau:OperatingLossCarryforward contextRef="AsOf2022-12-31_custom_CountryOfMexicoMember" decimals="0" id="Fact003053" unitRef="CAD">0</aau:OperatingLossCarryforward> <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003055">&lt;p id="xdx_805_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zrZUuDGFF3Xf" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;15.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82A_z474qz1Nx1h2"&gt;Financial instruments&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The fair values of the Company&#x2019;s cash and cash equivalents, accounts receivable and trade and other payables approximate their carrying values because of the short-term nature of these instruments.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;Except for warrant liability and derivative financial liabilities, the Company does not carry any financial instruments at FVTPL.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company is exposed to certain financial risks, including currency risk, credit risk, liquidity risk, interest rate risk and commodity and equity price risk.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(a)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Currency risk&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;The Company&#x2019;s property interests in Mexico make it subject to foreign currency fluctuations and inflationary pressures which may adversely affect the Company&#x2019;s financial position, results of operations and cash flows. The Company is affected by changes in exchange rates between the Canadian dollar, the US dollar and the Mexican peso. The Company does not invest in foreign currency contracts to mitigate the risks.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;As at December 31, 2023, the Company is exposed to foreign exchange risk through the following monetary assets and liabilities denominated in currencies other than the functional currency of the applicable subsidiary:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfFinancialAssetsAndLiabilitiesTextBlock_z4nK9kIcrC94" style="margin: 0pt 0 0pt 1in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Financial instruments (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span id="xdx_8B1_z1Gapd8thBQj" style="display: none"&gt;Schedule of assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;All amounts in Canadian dollars&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right; background-color: white"&gt;US dollar&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; background-color: white"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right; background-color: white"&gt;Mexican peso&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; background-color: white"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalents_iI_pp0p0_uUSD_c20231231_ze4c6BXcm6S" style="width: 12%; font-size: 10pt; text-align: right" title="Cash and cash equivalents"&gt;2,343,681&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--CashAndCashEquivalents_iI_pp0p0_uMXN_c20231231_zKssrvZ4Fdq" style="width: 12%; font-size: 10pt; text-align: right" title="Cash and cash equivalents"&gt;458,149&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Accounts receivable and prepaid expenses&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccountsReceivableAndPrepaidExpenses_iI_pp0p0_uUSD_c20231231_z6SQMSGQaOG7" style="font-size: 10pt; text-align: right" title="Accounts receivable and prepaid expenses"&gt;4,703&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccountsReceivableAndPrepaidExpenses_iI_pp0p0_uMXN_c20231231_z0p2hbMMMFSb" style="font-size: 10pt; text-align: right" title="Accounts receivable and prepaid expenses"&gt;113&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Gold in trust&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--GoldInTrust_iI_pp0p0_uUSD_c20231231_zCFKsjkwteUl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gold in trust"&gt;1,082,801&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--GoldInTrust_iI_pp0p0_uMXN_c20231231_zj2civNNOuu9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gold in trust"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3069"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Total assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--FinancialAssets_iI_pp0p0_uUSD_c20231231_zMJ0sS9j0b0d" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total assets"&gt;3,431,185&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--FinancialAssets_iI_pp0p0_uMXN_c20231231_zQ86f89Jj7we" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total assets"&gt;458,262&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Trade and other payables&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--TradeAndOtherCurrentPayables_iI_pp0p0_uUSD_c20231231_zPFnlDB4WAye" style="font-size: 10pt; text-align: right" title="Trade and other payables"&gt;53,348&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--TradeAndOtherCurrentPayables_iI_pp0p0_uMXN_c20231231_zitNJ43KUwy8" style="font-size: 10pt; text-align: right" title="Trade and other payables"&gt;14,087&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Gold loan payable&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--GoldLoanPayable_iI_pp0p0_uUSD_c20231231_zgHkz0Q5ggic" style="font-size: 10pt; text-align: right" title="Gold loan payable"&gt;4,371,546&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--GoldLoanPayable_iI_pp0p0_uMXN_c20231231_z2lWio3VseL1" style="font-size: 10pt; text-align: right" title="Gold loan payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3081"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--DerivativesFinancialLiabilities_iI_pp0p0_uUSD_c20231231_zFqgkorzVaR3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Derivatives financial liabilities"&gt;108,830&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DerivativesFinancialLiabilities_iI_pp0p0_uMXN_c20231231_zmj4XF8AvXua" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Derivatives financial liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3085"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Total liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pp0p0_uUSD_c20231231_zh27rECidqak" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total liabilities"&gt;4,533,724&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pp0p0_uMXN_c20231231_zKbL5LGntUMl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total liabilities"&gt;14,087&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: justify"&gt;Net assets&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NetAssetsLiabilities_iI_pp0p0_uUSD_c20231231_zp34tFaP1OVb" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Net assets"&gt;(1,102,539&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NetAssetsLiabilities_iI_pp0p0_uMXN_c20231231_zrFevODUL8E2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Net assets"&gt;444,175&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8AA_zIGY9Xy2m7e1" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify; background-color: white"&gt;A 10% change in the US dollar exchange rate relative to the Canadian dollar would change the Company&#x2019;s net loss by $&lt;span id="xdx_90E_ecustom--PossibleEffectOf10ChangeInExchangeRateRegardingTheUSDToTheNetIncomeLoss_pp0p0_c20230101__20231231_zhAjnedAr28i" title="Possible effect of 10% change in exchange rate regarding the USD to the net income (loss)"&gt;110,000&lt;/span&gt;.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify; background-color: white"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;A 10% change in the Mexican peso relative to the Canadian dollar would change the Company&#x2019;s net loss by $&lt;span id="xdx_90B_ecustom--PossibleEffectOf10ChangeInExchangeRateRegardingTheMxnToTheNetIncomeLoss_c20230101__20231231_zN2E10GzqHO1" title="Possible effect of 10% change in exchange rate regarding the MXN to the net income (loss)"&gt;44,000&lt;/span&gt;.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(b)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Credit risk&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;The Company&#x2019;s cash and cash equivalents are held in large financial institutions, located in both Canada and Mexico. Cash equivalents mature at less than ninety days during the twelve months following the statement of financial position date. The Company&#x2019;s accounts receivable consist of amounts due from related parties which are subsequently collected.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;To mitigate exposure to credit risk on cash and cash equivalents, the Company has established policies to limit the concentration of credit risk with any given banking institution where the funds are held, to ensure counterparties demonstrate minimum acceptable credit risk worthiness and ensure liquidity of available funds.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;As at December 31, 2023, the Company&#x2019;s maximum exposure to credit risk is the carrying value of its cash and cash equivalents, and accounts receivable.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(c)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Liquidity risk&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company manages liquidity risk through the management of its capital structure. Liquidity risk is considered low as the Company has sufficient cash and cash equivalent to meet its current liabilities.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;Trade and other payables are due within twelve months of the statement of financial position date.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(d)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Interest rate risk&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to varying interest rates on cash and cash equivalents. The Company has no debt bearing variable interest rate.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;A 1% change in the interest rate would change the Company&#x2019;s net loss by $&lt;span id="xdx_90D_ecustom--PossibleEffectOf1ChangeInTheInterestRateToTheNetIncomeLoss_pp0p0_c20230101__20231231_zp9FWFBf4lJa" title="Possible effect of 1% change in the interest rate to the net income (loss)"&gt;42,000&lt;/span&gt;.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(e)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Commodity and equity price risk&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;The ability of the Company to explore its exploration and evaluation assets and the future profitability of the Company are directly related to the market price of gold and other precious metals. The Company monitors gold prices to determine the appropriate course of action to be taken by the Company. Equity price risk is defined as the potential adverse impact on the Company&#x2019;s performance due to movements in individual equity prices or general movements in the level of the stock market.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;A 1% change in the commodity price would change the Company&#x2019;s net loss by $&lt;span id="xdx_902_ecustom--PossibleEffectOf1ChangeInTheCommodityPriceToTheNetIncomeLoss_pp0p0_c20230101__20231231_zX0aU2uxB41i" title="Possible effect of 1% change in the commodity price to the net income (loss)"&gt;11,000&lt;/span&gt;.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0.5in; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;(f)&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;Classification of financial instruments&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;IFRS 13 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value as follows:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;Level 1 &#x2013; quoted prices (unadjusted) in active markets for identical assets or liabilities;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;Level 2 &#x2013; inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 1in; font-size: 10pt; text-align: justify"&gt;Level 3 &#x2013; inputs for the asset or liability that are not based on observable market data (unobservable inputs).&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The following table sets forth the Company&#x2019;s financial assets and liabilities measured at fair value by level within the fair value hierarchy.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_899_eifrs-full--DisclosureOfFairValueOfFinancialInstrumentsExplanatory_zIZ7ynsrJn2j" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Financial instruments (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_8B2_zIOVLgkjNLDi" style="display: none"&gt;Schedule of assets and liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Level 1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Level 2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Level 3&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 48%; font-size: 10pt; text-align: left"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentDerivativeFinancialLiabilities_pdp0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zWzwU2Hi0ma" style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right" title="Derivative financial liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3117"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NoncurrentDerivativeFinancialLiabilities_pp0p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z03A2sRjWd5j" style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right" title="Derivative financial liabilities"&gt;108,830&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentDerivativeFinancialLiabilities_pdp0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zyHI4EPvT6C" style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right" title="Derivative financial liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3121"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NoncurrentDerivativeFinancialLiabilities_pp0p0_c20231231_zZhgezKHICae" style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right" title="Derivative financial liabilities"&gt;108,830&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8A3_zafWKHmCrEDa" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt; </ifrs-full:DisclosureOfFinancialInstrumentsExplanatory> <aau:DisclosureOfFinancialAssetsAndLiabilitiesTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003057">&lt;table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--DisclosureOfFinancialAssetsAndLiabilitiesTextBlock_z4nK9kIcrC94" style="margin: 0pt 0 0pt 1in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Financial instruments (Details)"&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span id="xdx_8B1_z1Gapd8thBQj" style="display: none"&gt;Schedule of assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;All amounts in Canadian dollars&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right; background-color: white"&gt;US dollar&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; background-color: white"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right; background-color: white"&gt;Mexican peso&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; background-color: white"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: justify"&gt;Cash and cash equivalents&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalents_iI_pp0p0_uUSD_c20231231_ze4c6BXcm6S" style="width: 12%; font-size: 10pt; text-align: right" title="Cash and cash equivalents"&gt;2,343,681&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--CashAndCashEquivalents_iI_pp0p0_uMXN_c20231231_zKssrvZ4Fdq" style="width: 12%; font-size: 10pt; text-align: right" title="Cash and cash equivalents"&gt;458,149&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Accounts receivable and prepaid expenses&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--AccountsReceivableAndPrepaidExpenses_iI_pp0p0_uUSD_c20231231_z6SQMSGQaOG7" style="font-size: 10pt; text-align: right" title="Accounts receivable and prepaid expenses"&gt;4,703&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccountsReceivableAndPrepaidExpenses_iI_pp0p0_uMXN_c20231231_z0p2hbMMMFSb" style="font-size: 10pt; text-align: right" title="Accounts receivable and prepaid expenses"&gt;113&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Gold in trust&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_ecustom--GoldInTrust_iI_pp0p0_uUSD_c20231231_zCFKsjkwteUl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gold in trust"&gt;1,082,801&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--GoldInTrust_iI_pp0p0_uMXN_c20231231_zj2civNNOuu9" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Gold in trust"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3069"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Total assets&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--FinancialAssets_iI_pp0p0_uUSD_c20231231_zMJ0sS9j0b0d" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total assets"&gt;3,431,185&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eifrs-full--FinancialAssets_iI_pp0p0_uMXN_c20231231_zQ86f89Jj7we" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total assets"&gt;458,262&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Trade and other payables&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eifrs-full--TradeAndOtherCurrentPayables_iI_pp0p0_uUSD_c20231231_zPFnlDB4WAye" style="font-size: 10pt; text-align: right" title="Trade and other payables"&gt;53,348&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--TradeAndOtherCurrentPayables_iI_pp0p0_uMXN_c20231231_zitNJ43KUwy8" style="font-size: 10pt; text-align: right" title="Trade and other payables"&gt;14,087&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;Gold loan payable&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--GoldLoanPayable_iI_pp0p0_uUSD_c20231231_zgHkz0Q5ggic" style="font-size: 10pt; text-align: right" title="Gold loan payable"&gt;4,371,546&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--GoldLoanPayable_iI_pp0p0_uMXN_c20231231_z2lWio3VseL1" style="font-size: 10pt; text-align: right" title="Gold loan payable"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3081"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--DerivativesFinancialLiabilities_iI_pp0p0_uUSD_c20231231_zFqgkorzVaR3" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Derivatives financial liabilities"&gt;108,830&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_ecustom--DerivativesFinancialLiabilities_iI_pp0p0_uMXN_c20231231_zmj4XF8AvXua" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Derivatives financial liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3085"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Total liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--FinancialLiabilities_iI_pp0p0_uUSD_c20231231_zh27rECidqak" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total liabilities"&gt;4,533,724&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_pp0p0_uMXN_c20231231_zKbL5LGntUMl" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Total liabilities"&gt;14,087&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: justify"&gt;Net assets&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eifrs-full--NetAssetsLiabilities_iI_pp0p0_uUSD_c20231231_zp34tFaP1OVb" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Net assets"&gt;(1,102,539&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NetAssetsLiabilities_iI_pp0p0_uMXN_c20231231_zrFevODUL8E2" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Net assets"&gt;444,175&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:DisclosureOfFinancialAssetsAndLiabilitiesTextBlock> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2023-12-31" decimals="0" id="Fact003059" unitRef="USD">2343681</ifrs-full:CashAndCashEquivalents> <ifrs-full:CashAndCashEquivalents contextRef="AsOf2023-12-31" decimals="0" id="Fact003061" unitRef="MXN">458149</ifrs-full:CashAndCashEquivalents> <aau:AccountsReceivableAndPrepaidExpenses contextRef="AsOf2023-12-31" decimals="0" id="Fact003063" unitRef="USD">4703</aau:AccountsReceivableAndPrepaidExpenses> <aau:AccountsReceivableAndPrepaidExpenses contextRef="AsOf2023-12-31" decimals="0" id="Fact003065" unitRef="MXN">113</aau:AccountsReceivableAndPrepaidExpenses> <aau:GoldInTrust contextRef="AsOf2023-12-31" decimals="0" id="Fact003067" unitRef="USD">1082801</aau:GoldInTrust> <ifrs-full:FinancialAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact003071" unitRef="USD">3431185</ifrs-full:FinancialAssets> <ifrs-full:FinancialAssets contextRef="AsOf2023-12-31" decimals="0" id="Fact003073" unitRef="MXN">458262</ifrs-full:FinancialAssets> <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2023-12-31" decimals="0" id="Fact003075" unitRef="USD">53348</ifrs-full:TradeAndOtherCurrentPayables> <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2023-12-31" decimals="0" id="Fact003077" unitRef="MXN">14087</ifrs-full:TradeAndOtherCurrentPayables> <aau:GoldLoanPayable contextRef="AsOf2023-12-31" decimals="0" id="Fact003079" unitRef="USD">4371546</aau:GoldLoanPayable> <aau:DerivativesFinancialLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact003083" unitRef="USD">108830</aau:DerivativesFinancialLiabilities> <ifrs-full:FinancialLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact003087" unitRef="USD">4533724</ifrs-full:FinancialLiabilities> <ifrs-full:FinancialLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact003089" unitRef="MXN">14087</ifrs-full:FinancialLiabilities> <ifrs-full:NetAssetsLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact003091" unitRef="USD">-1102539</ifrs-full:NetAssetsLiabilities> <ifrs-full:NetAssetsLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact003093" unitRef="MXN">444175</ifrs-full:NetAssetsLiabilities> <aau:PossibleEffectOf10ChangeInExchangeRateRegardingTheUSDToTheNetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact003095" unitRef="CAD">110000</aau:PossibleEffectOf10ChangeInExchangeRateRegardingTheUSDToTheNetIncomeLoss> <aau:PossibleEffectOf10ChangeInExchangeRateRegardingTheMxnToTheNetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact003103" unitRef="CAD">44000</aau:PossibleEffectOf10ChangeInExchangeRateRegardingTheMxnToTheNetIncomeLoss> <aau:PossibleEffectOf1ChangeInTheInterestRateToTheNetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact003105" unitRef="CAD">42000</aau:PossibleEffectOf1ChangeInTheInterestRateToTheNetIncomeLoss> <aau:PossibleEffectOf1ChangeInTheCommodityPriceToTheNetIncomeLoss contextRef="From2023-01-01to2023-12-31" decimals="0" id="Fact003113" unitRef="CAD">11000</aau:PossibleEffectOf1ChangeInTheCommodityPriceToTheNetIncomeLoss> <ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003115">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eifrs-full--DisclosureOfFairValueOfFinancialInstrumentsExplanatory_zIZ7ynsrJn2j" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Financial instruments (Details 1)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&lt;span id="xdx_8B2_zIOVLgkjNLDi" style="display: none"&gt;Schedule of assets and liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Level 1&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Level 2&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Level 3&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;Total&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 48%; font-size: 10pt; text-align: left"&gt;Derivative financial liabilities&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentDerivativeFinancialLiabilities_pdp0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level1OfFairValueHierarchyMember_zWzwU2Hi0ma" style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right" title="Derivative financial liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3117"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eifrs-full--NoncurrentDerivativeFinancialLiabilities_pp0p0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z03A2sRjWd5j" style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right" title="Derivative financial liabilities"&gt;108,830&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentDerivativeFinancialLiabilities_pdp0_c20231231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zyHI4EPvT6C" style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right" title="Derivative financial liabilities"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3121"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eifrs-full--NoncurrentDerivativeFinancialLiabilities_pp0p0_c20231231_zZhgezKHICae" style="border-bottom: Black 1.5pt solid; width: 10%; font-size: 10pt; text-align: right" title="Derivative financial liabilities"&gt;108,830&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory> <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="AsOf2023-12-31_ifrs-full_Level2OfFairValueHierarchyMember" decimals="0" id="Fact003119" unitRef="CAD">108830</ifrs-full:NoncurrentDerivativeFinancialLiabilities> <ifrs-full:NoncurrentDerivativeFinancialLiabilities contextRef="AsOf2023-12-31" decimals="0" id="Fact003123" unitRef="CAD">108830</ifrs-full:NoncurrentDerivativeFinancialLiabilities> <ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003125">&lt;p id="xdx_803_eifrs-full--DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory_zVSOB0Od4GY5" style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;16.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_82A_zHxvrGH8Rq7a"&gt;Management of capital&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 16.55pt; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company considers its capital to consist of components of equity. The Company&#x2019;s objectives when managing capital are to safeguard the Company&#x2019;s ability to continue as a going concern in order to pursue the exploration of its exploration and evaluation assets and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk.&lt;/p&gt; &lt;p style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company considers its capital to consist of components of equity. The Company&#x2019;s objectives when managing capital are to safeguard the Company&#x2019;s ability to continue as a going concern in order to pursue the exploration of its exploration and evaluation assets and to maintain a flexible capital structure which optimizes the costs of capital at an acceptable risk.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company manages the capital structure and makes adjustments to it in light of changes in economic conditions and the risk characteristics of the underlying assets. To maintain or adjust the capital structure, the Company may attempt to issue new shares and, acquire or dispose of assets.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;In order to maximize ongoing exploration efforts, the Company does not pay out dividends. The Company&#x2019;s investment policy is to invest its short-term excess cash in highly liquid short-term interest-bearing investments with short term maturities, selected with regards to the expected timing of expenditures from continuing operations.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company expects its current capital resources will be sufficient to carry its exploration plans and operations for the foreseeable future. There were no changes to the Company&#x2019;s approach to the management of capital during the period. The Company has no externally imposed capital requirements.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DisclosureOfObjectivesPoliciesAndProcessesForManagingCapitalExplanatory> <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003131">&lt;p id="xdx_80B_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zR6Cek6Xy0Nj" style="margin: 0pt 0; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;17.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_829_zqVg2iky6Av"&gt;Segmented information&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;The Company operates in one reportable operating segment, being the acquisition and exploration of mineral resource properties.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;The Company&#x2019;s non-current assets are located in the following geographic locations:&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfSegmentReportingInformationBySegmentTextBlock_zdOPG1FR9Y8k" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Segmented information (Details)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span id="xdx_8BE_z3iqeZPPPom1" style="display: none"&gt;Schedule of non-current Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: justify"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--CountryOfCanadaMember_zWetkJSqRGA9" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Non-current assets"&gt;361,967&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--CountryOfCanadaMember_z8zmHZmQTzJb" style="width: 12%; font-size: 10pt; text-align: right" title="Non-current assets"&gt;472,435&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;United States&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--CountryOfUnitedStatesMember_ziLw17ug1Sgj" style="font-size: 10pt; font-weight: bold; text-align: right" title="Non-current assets"&gt;6,568,840&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--CountryOfUnitedStatesMember_zbrpLrbYXI78" style="font-size: 10pt; text-align: right" title="Non-current assets"&gt;6,568,840&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Mexico&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--CountryOfMexicoMember_z0k0DpvVn5Ld" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Non-current assets"&gt;1,533&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--CountryOfMexicoMember_zeEiMHPMGy45" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Non-current assets"&gt;63,116,991&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_pp0p0_c20231231_zYBRh5iazuWa" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Non-current assets"&gt;6,932,340&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_pp0p0_c20221231_z4f4mwLl8Mf1" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Non-current assets"&gt;70,158,266&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; &lt;p id="xdx_8A4_zSv2XHnxOwoa" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DisclosureOfOperatingSegmentsExplanatory> <aau:DisclosureOfSegmentReportingInformationBySegmentTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact003133">&lt;table cellpadding="0" cellspacing="0" id="xdx_89B_ecustom--DisclosureOfSegmentReportingInformationBySegmentTextBlock_zdOPG1FR9Y8k" style="margin: 0pt 0 0pt 0.5in; border-collapse: collapse; width: 80%" summary="xdx: Disclosure - Segmented information (Details)"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;&lt;span id="xdx_8BE_z3iqeZPPPom1" style="display: none"&gt;Schedule of non-current Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: right"&gt;December 31, &lt;br/&gt;2023&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: right"&gt;December 31, &lt;br/&gt; 2022&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 70%; font-size: 10pt; text-align: justify"&gt;Canada&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--CountryOfCanadaMember_zWetkJSqRGA9" style="width: 12%; font-size: 10pt; font-weight: bold; text-align: right" title="Non-current assets"&gt;361,967&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--CountryOfCanadaMember_z8zmHZmQTzJb" style="width: 12%; font-size: 10pt; text-align: right" title="Non-current assets"&gt;472,435&lt;/td&gt;&lt;td style="white-space: nowrap; width: 1%; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="font-size: 10pt; text-align: justify"&gt;United States&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--CountryOfUnitedStatesMember_ziLw17ug1Sgj" style="font-size: 10pt; font-weight: bold; text-align: right" title="Non-current assets"&gt;6,568,840&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--CountryOfUnitedStatesMember_zbrpLrbYXI78" style="font-size: 10pt; text-align: right" title="Non-current assets"&gt;6,568,840&lt;/td&gt;&lt;td style="white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: justify"&gt;Mexico&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20231231__srt--StatementGeographicalAxis__custom--CountryOfMexicoMember_z0k0DpvVn5Ld" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Non-current assets"&gt;1,533&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--CountryOfMexicoMember_zeEiMHPMGy45" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right" title="Non-current assets"&gt;63,116,991&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_pp0p0_c20231231_zYBRh5iazuWa" style="border-bottom: Black 1.5pt solid; font-size: 10pt; font-weight: bold; text-align: right" title="Non-current assets"&gt;6,932,340&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eifrs-full--NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts_pp0p0_c20221231_z4f4mwLl8Mf1" style="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right" title="Non-current assets"&gt;70,158,266&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-size: 10pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt; </aau:DisclosureOfSegmentReportingInformationBySegmentTextBlock> <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="AsOf2023-12-31_custom_CountryOfCanadaMember" decimals="0" id="Fact003135" unitRef="CAD">361967</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts> <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="AsOf2022-12-31_custom_CountryOfCanadaMember" decimals="0" id="Fact003137" unitRef="CAD">472435</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts> <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="AsOf2023-12-31_custom_CountryOfUnitedStatesMember" decimals="0" id="Fact003139" unitRef="CAD">6568840</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts> <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="AsOf2022-12-31_custom_CountryOfUnitedStatesMember" decimals="0" id="Fact003141" unitRef="CAD">6568840</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts> <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="AsOf2023-12-31_custom_CountryOfMexicoMember" decimals="0" id="Fact003143" unitRef="CAD">1533</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts> <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="AsOf2022-12-31_custom_CountryOfMexicoMember" decimals="0" id="Fact003145" unitRef="CAD">63116991</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts> <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="AsOf2023-12-31" decimals="0" id="Fact003147" unitRef="CAD">6932340</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts> <ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts contextRef="AsOf2022-12-31" decimals="0" id="Fact003149" unitRef="CAD">70158266</ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts> <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="From2023-01-01to2023-12-31" id="Fact003151">&lt;p id="xdx_80F_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zAKrpVbatZDc" style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="width: 0; text-align: right"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;&lt;b&gt;18.&lt;/b&gt;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&lt;b&gt;&lt;span id="xdx_820_zdIIhaSsyCR"&gt;Subsequent event&lt;/span&gt;&lt;/b&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/table&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;On March 12, 2024, the Company provided notice to Almadex that it is extending the maturity date from March 31, 2024 to March 31, 2026 pursuant to the Gold Loan.&lt;/p&gt; &lt;p style="margin: 0pt 0 0pt 0.5in; font-size: 10pt; text-align: justify"&gt;&#160;&lt;/p&gt; </ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory> <link:footnoteLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended"> <link:loc xlink:href="#Fact002828" xlink:label="Fact002828" xlink:type="locator"/> <link:footnote id="Footnote002847" xlink:label="Footnote002847" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As at December 31, 2021, the Company owed $256,000 to the Chair as a result of the Chair deferring his salary from May 1, 2019 to December 31, 2021. On September 1, 2022, the Chair agreed to forfeit $177,200 of the unpaid balance of the deferred salary and recorded as a gain on debt forgiveness on the statement of comprehensive loss. The new amount owed of $78,800 was paid on December 15, 2022.</link:footnote> <link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact002828" xlink:to="Footnote002847" xlink:type="arc"/> <link:loc xlink:href="#Fact002826" xlink:label="Fact002826" xlink:type="locator"/> <link:footnote id="Footnote002848" xlink:label="Footnote002848" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As at December 31, 2022, the Company accrued cash bonuses to related parties of $104,263 that is included in trade and other payables.</link:footnote> <link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact002826" xlink:to="Footnote002848" xlink:type="arc"/> <link:loc xlink:href="#Fact002824" xlink:label="Fact002824" xlink:type="locator"/> <link:footnote id="Footnote002849" xlink:label="Footnote002849" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As at December 31, 2023, the Company accrued cash bonuses to related parties of $112,894 that is included in trade and other payables.</link:footnote> <link:footnoteArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Fact002824" xlink:to="Footnote002849" xlink:type="arc"/> </link:footnoteLink> </xbrl> </XML> </TEXT> </DOCUMENT> </SEC-DOCUMENT>

    IYF'51[&)L2H/:PMXRCNL(Y]A^ML\U'>E]CGH M-&/34*N$-R+$Z%+&93;WK#M+GU:IY>/^ZHBK34OYW6BB4Z .4]_H!TN1=@IF M-C8YT$=/>GT*MCV%01"% NT#]"1I7=N]+)DD]J=*0)_RMKCA"MV57?;O@(TR MC",L]-=ICO9@ZJYI2 KX22,*C25OKHDT=PBF#C7C'AL-*QN@0S])R/V-#N3J M4"G%:PR:E3HIXM"FDZ*%9Q!D"J\#4RD3TUY' M]?F2QJ=!#JE"*\#A+6B#F%%^&^XYR!/$E;"HSUX8L@1,.9!S&.^26IWY+2U2 M 7R3X]RA5!$#M<#-K"/ID(6'Q:WM8!A'&?::AM^0[4L;,=;W8G9RHU MRQ6,1)%A&XPL=F1HP/(UZZ G^A_2>!A059"I@"IY$4KX,'BMY?S<4%S+E!#. MT"WDO)72=9T@37-AZLAG2416R<(((XRFS-0C[0 C6)3WVZKS?O0IJV"#)/:!.5,:+@DGCJFQMD6\"X2KN/6C<@,CQ3(=G7A@ M$J(**8H5.4T,4*6Z!LYQZ%[IC!8L ",E"]\^BQ@SNI0KJ:,$AZR$-UE?T6). M/Y/?9V-CNK^([$Z(J/JLY6&Q $"Y*_45;GPN.Y6B7&7@*-8E-5@98E'!K\[A M8'"=GX7N";%BIM_RZ7FV5W0M^J9?W GD/3^Z@S@<+3DWW]49MKE*Z58V_;X^ MF)@?WJ9!3_H5R]LB$M\:):JRAZM3P/V25"/AO\JJBJ8B&U22J=[/+&T_ )4E M]RT+DG6<3Q50E)CMFFJXL9$CK8YS*Z*X-LS5'A ([E.I1/9)K[F,JFEZRTD$ M^L1(#&4'G!\1=T,PD5V#EL;X_8XNGY!9,[#7&9-U($PX62F=/G"-O^)$ZGJ& M1# B%7,5XQ@5;Q=)K-U\8YF,]!M0N PQ.3NA'SZ-H0@W$E#(_^Z&:U)\V?*% MK39Y)@XU7M1'9@L*\+^,,.'.0R283[!8KFA3/6PHW>RP"'"Q/&$ MOSDQN+41[D=:=/\]=O41#5'/,H/&\99\#R3ZSE65LS9#'%\@[%H%S_,F+-\Q90;3.J6NF(MR,R!@ 2"#U%1KW,.2M,(+%TP)'3>U-D( M$[OYQK MXH-3XH(M/!Q=E&,\8G.^,7+=N*#?>W^ [N,K%E'/JS MU0)<]I10T8#D48I4(8?D.G*,J MO%PFGM6,)Z6TS#%-W+%%N(QK0^B%$G99!RC%H.NCQ<=:NH2\OE=6GC01;*Y.Q35?971B M$B<6@'C#/8ON:?^IW01THDZ2GR&>U1THR Z*BUL_"(E7SW%HW8D!UW-G[MW= M7<,/$2P[0L4>M.FT 9>Q<@'I7G'B$F?;* M%N*.YNW3F;?/WB/VF0 'ZC1II_UUV>O_S]Z;;;>-)>G"]W@*+'=6EW06S!(U M6%)E_;F6+-M9RDJGW9:SNL_562 )2BB# !L ):N>_H]Q#Q@H4:)L.JV^Z$I3 M)+"'V+%C^.*+]8O!JIFUW:?,VC>86=O]7C)KCZ,GQ1L-NE4*Q7/N$E_JB"9% MW E]BB[-K!6VVI([E4,F-B*&." X3&@68NQV!%8"ARHDCF&21J ;P5#$C%*B M85K43^(F8\HGY38^)O(1L0\-M[5C,LW$=(<9,%:#C8^8,3!"O48%XC0LKX>L MTT6$'FN:)8SFM-^' N$=;*]1? G<8FR MJUUMW"?[#Z1+SGD2NI5.+>LH(1=R+% X^&<9TT7AI#U6XC- M;K7HQ;\&'\$AE'5<65K3!9KH67'-XT[;"=!&(S'T! (>A1ENRWT@Z[4U./[5 M7]=GBS=Z-!$*[!U1BA#L5 MN&0J7FK:V0QTQ>:+49:.6?!RM=KI#UC%"<:N]$Z_*(O%O!J$YY<"YFMM /[( MZ1>Y0! 23"BA[C,YBVIIR!_X^\C31$>06B MB_)$&^SX/?A:^"X]%_[WG\Y4\$^T,,-=7ICEYOD]=NC1]ETT[I\9L3WZBW'TM2E[^'=> M<-IB6]:N#K<$U%_^_3T^YQQ.\J6&DYVTC-+_!%KR$C6ILF%(?Q<2QG.&>.'V MO;; KH@^P&QV;7\V"-\654UX! S"1.';'D.$UR(,#W/[?O)^>/ MFER_,_QJVN0:I>;\_$/XEI?F+!_SJH"?Q!?'Z_.?.3)3FV1013!$"@U+K/%G M7M_F]X)7U""+=>/6SZ&=,Y\GG/+Y&9:3 MUC9@1QS.['_^Q^[^\$?X_WN'/\:X_# 14.AU!A_M'OR8@ZP,3@8O!V ]A*># M?P["K;=P&8Z+[6_G6#5%R/#!P/$@0 M%-N;_40:>4ZL8%F]R=>"HPB,@O8Z^)!Q(=R#,,M/V-;.JHS(PGX#-;?X;%1: M@;F)KM]7-K3)$@E<2P2-W$49;NUO4YS4W'T.L'USG.EU(%4>950:21>NNN61 M](T:?(?[92=SI[3 '9TSN3P; .%_EO#&YYX]V$-O0"<&$C -?]"C<*%SQ: M%"YL1^&:/0AHK5XM\#_OMRM<=G2?>%[?>X*>$-^2H?>&,Q\8Y@M,F.^^>( _ MO+('G>3FZ8)O1OET9Q=7U#(M1%'_@]O*)&@K$Y;&>X:@I(HF%?)=\S(%%//P MFL7+M %LW9GDV3YMKU"+XF, 9_C6=I0(99;*_ MMPFFO].**?9X$SXDL+IQMG%RIUR!Z M272_RHZ*9@C/+>&;H\TBRFOY$ @UC'#5;$Y\KJQ MFO&] )J##U[35[B2.$UAH*G_78 B\0MB-VHN'XD)"\R0P.*MZNLBO';'W4Q? MJ.@X/.][>X.]/W74OZH4(R4FX4+H5& \S<"+8"5OM&B9DAJ:CA'J6+==GL^% MQX.TF.HM_)7DLEZEV!P H^FT5S<*S>5A-?]*N!3%RA@X:>!C(.%-^BMO0PF5 M%3M$6C%-PP7/AZ-%38>8SB3[+D@3AGC'&/G!DAICBJD$9YF:E/"-\L9!X!6, M75\F2*6.]4?JT;A$N_,"PZ#H$.)%I#DE>.>_BM0=N<##FOOK4_2[B$R"[YCU MJ!VUH:H%C48,U&GD3OB(+5?XLKI K.3U%.#2N05 MH(05?1OD5=T=-['WA)OX!G$3>T^XB?4!&W;X4SF!ER@Z+7*!] M=H0H;S6:P[/V#7ENF&#?"P/_1LWX_:*L%HP^"+KT?O.R/C>2>MKF_9T"BGQ7@A)1()11E:3B!V)L=Z MLU%<<7(='\<%DKI]B/G6BSNP \.B+#0R,VHV/)72KA[K 6LMF-?\CV3%MT]* M^#/>ZKHM2\Z+K5G3G/,)LU8QMN@^')W?Y*E(NTWY%IN^A1\$=S\[).ZQ75<$ M"+5Y^E MP%PV:@6Z(CFFGQ561(0U+8936W.':P@KU/)EAZW)Q3>Z05 DN)$HW0&*<4]4 M"%&9GR0DU @'(9ZGEIV3.F'O'73XDENN+<84?J.'<3-OL\=*UE/\(;CO,=RH MZ9Q4 DT,;%LT$' O\Q-1H*J';L<)"O7'J9H_0EH!\\-MII"C*R]/@IZ?='2C MH3[3N -/,GM[^!\4')6,!1]\UB&TTHA/::-&[,3@.$A95(GA36(._AD\#[5W M%E^;LN@KBP07BD>W S?YI,;!9.T MLDC,DM!DH&Y);;KDB%UO0D,2-*Q-F6IE_90*_#!PDIK&:_!V,+JISP%/%IZ( M<28D,BBF0??YD&:A5- (ATCYM3;G<&Q84NR4:"*07B7P5(I39M^4)[=GD/FU M54@]JLMV8K-]CZO%"'8SC4LLR=^8)?F*?*Y">.H3ZZ1:*ANX%A+.J) MBOU<$LH@RXF1CBV*P:=36S4;@K#5QS]VNWXV'A)<%XL,CZW3](,+;QJT="O5 MQG_Y:NYU7%0/>ONIUW.+UNA,^A>#V2$D-1MU)S4=%DT[QV%C+FXH SK+BN[EO*\V4TP!^BVY34-%&3UKOVCSIEHIS*L!(XFSP2 M@D?7SS.$T=HKRNTI_0?H<7Z'Y1VMM+S(D)Q(^0US)A/N"3M=4QHS)>8PY!W- M"LHU%B-X!N_ ][&>XQ76\^2J2">5]K:[2KR%F]J&598=^_M8P\D*:_B^+&HB MKF(V]>1*"F.I23O!GT.,[B"EC+>XAF#-Y1X7&L IAW;]/WX?2Y^LL/2,=$RJ M;AO:\,U+M,4U"!=RP=YC2TQOQ^]N:Z8K;,V;HC+TSE.8:9;6M%--CGLI@<55 M K>\DE:6W\%B7JQR[5%?9$KES$ Z7UFA?:>.)/@4ETDVUQ)*J>PO,/A%3@<2 M5P\>W'ARP_S'QXDBC>'#"4IHX('56^9ZBZ!32P^QKV7'%FE?"LY?(ZZ9 TJ6 MQ1"<28JT)51@;CX.S,>JC+#[!H<>)EC[RD<)M-MLCB#!T4WG^]?3\>$/+P+( M-L!=F(.72CA_RNV8OQGGDH)^87/X7%R.<^.L\"L;B!=D)OY2T9A1UY/DU^;[ M[UZ^-M\/8I?.]2.WP=:SPE0B[[DEMGPX$*[:Q HV!CR)#P%EVP1#<7:,U<8: M?LMOBP%5&WZ!LT2\)>A!80@X'F$41FD^8*0#9\;X_!$Q3\(WBQ$5;QO>.+.6 M;B1O@S"*JS(\[3\A%;]!I.+^$U+QBR(5'R59FF56Z42!N8M)$QOEI^KTS)+T M&[IJ-"E0$QM>#6+,4/WK?FI_4G/&H$9.;Z(E0O(DH]V"#H4N4']]KGSJP_-; M/0F)<^B_N(KU2T/K*F$WB?4?>"DW ''4P7)57 @,I1T@VEA()?-CB7 M[ )9OJ9XEB('"I%NT9/8\>,V!QD:7,:,LS_G^PA^@A86UM#[Q#_\(&(^3[#U M5^U1LW8\AB:M+T9HA'WD,,%EQL+-.%MO"@(LJ]3HE_2GAS;HMC$"K\U"6EDV,+;#Q<2 FQX7;<'P M'-@TD PX(-HA*+UFR:I=@N[")K.2K7 ?]]TS(^[@R_<,NL^+[[KF;_/Y$50Q M8,&^J^>/SHA>$^:7X4-<^.XX,$GL*W!0J4YJCW@C=O?4*L<(>V+;A"$GTKQ, MLW#W!7UOWR_\X92UJBNBUP756,PSDE*B2HXCF]::DD^,>![; (*XMFR_2&Y1 M)C7Y<'XSN67M=T@3MND?OWWG1Z5UZL?%8J9A.^N M<^;X>L0#\Y'VY#>0GQ=@8U184,@-4)L'HP>M:1 @ 5HIHR1/X)_,[HE$\XXP M_KD*KXI:6*;4N=["@!3(/TVXVC8*/)XAMV:?.+>? ^\B@>8&0K<,E=UP(D!\ MA OA7H]2IPRQT79''FH[.$\U4;A4FBN_\A:IA=FL.L^M>TZ;Y[@K7+W$-VXI M#CZM?4W9Z=AW=&3O/-4ZAJ83ZZYR6B,O_+3W:#[@O7M'OE/^P$>S@C-/WWW1 MXYJ/?CJA4\,[^EM<\V>JM_A_V@S?"6I>[9 MUM,LKJK;9KS*FQCU',\X>FC4&^OFM;U(U[9[/9NO]:Z$QWTUK>?_N=,VWGF; M6.5W#KYS _SN97?ZW9))[4BX=X++^K146"SF/^T-=S>&NYL@WNXF-M0 MS,/>OS?8V_O3UUO,1M^WA\[F(-K9&49'QWMW6_!2[NR ;-YI*??7O90'1U]Q*9LTD5]P M(0_^4 O9Y/;]8LOXX@LLXTI@D#NNYD__0(Z\CV6:+&[U=F5LPVAW]R :[N_? M95T.[[ NG?,_.OZ*8O2J6%R$;\>OD,#[P5($ZW6X#U?$\"[K=;1N.3K>O7T= MUV;-+UGG>]GQOQ27>7B"\;5B%G=KQ37:SGMW/^['=]BF-8YL9[![[VV\U0.^ M)=&\EK>P_U[4L9.1_,L[)[9#D9T5':2[>+[=+M+P('IQO!<='^Y_N5<.![NH MTII>V1\38=AWAHZ<1+YX:ZO=#Z8#C*S1\Y([Z V/L O +2]^1Z')*F'86Q4. MH_TA>D,[MEC?:2\JZ2UJ!!3*_U5U 6)0<+/+@3OHIPU5A_$K;NA>M+N_\X - M#8_VHA?PZZ+Q7(SL4W,3S(&B^D(V1$E(_:.X3&=Q^#XF2@;NJ8'E3GBC<1S-O->EY/;G&0MU_Q-AL9!;? M:*/KRT4U(C#(%$0&!-.$*YZ$ID-H[A(-V$RA^2ZV<^]@L']PZ[JZ&WJ7J,3M MN+@U[=QWN&.K'L"[A#^>#N WLYVK1FWN=_R&T7#_3N9WTTH[C YV=LQVWN6Z M%O#V1[C_!_=1P/?;?T13I$+:0!R/$?4107@M MP5"Q=#ZS1KI&_[X+ 5G]@KY+ .SA&F+OZ8)>5YSE+DG?C/'Z M6"+7U8G"$<.MU]*L9X\!RTW"-FW58TXTMNS9CD(?1$ (F48JW&/VI] M0%)[E!2$4"G^;%Y<)]*0EOSR;K#:F.+8UF!@:MDB]PK8;4>VAXP-U4W5\B0H_)[,UHXB[" M2,+&"\Z\61J*'41A"-,474@+OSZ_@>7BMC2O$4Y:%GDZ=HLW84)G3"=KJT3. M7[\ZLT5W.B3&U9KE*_+G2.L5A:.RN*XPBDITD%CGEDK+8ZHTX 'A76 MX:DPV)8D&Q0<=H'RL# I$FX@?5$JO;(-IM ,J%QD@CTODXN%T/-$6G'/]2EQ M':(H%@K/(00EMUL5 ="-OXP1? ^W0VYZ9B>P9W\B8'!%XH5SHMH&'C:\81"^ MQ%G;:RKG+_"LFSLM+4B)_1*&EM/CETJG#.XV;;=&>J3FX?\_+Y7E<[AW&(%( M1/L[1[IF6+V'/=QIAZG=F8].Y9(#5V_3)]>P&E2#Z:IWZ3'_8B>RP/> MK%X>\,HC>XF1,IO*3?+:5CR9E@(?$JKW %L"+N4$KCLP,DXP4)Q,O+:(CUAD M\'!\O'G4;T7M4*T\U7,]3 J'(H-\-:<3T$'_;V<#5.;4LOVL"^=<;K4M3*%KUAE%_D?LX/BE%?C?0TCL]\: MA!\+X5M%"XM9"JZ7+5_C21D-_$HHCSW_Z+ID%5VVX(*LYYG&-# M]VI*C Z7%GU1-5618]UN5T5XTV]%\YR:99/3<=#K<]Q:!G:?HL.6.;&^.JS# MQZS#:A5WA%^I\FJEH-(MM4,ZE-W'*\!2&_[P0;566LQT]&5JJAY:.W6?/>K% M##Y""=7C5$M]@:JH5:N?^C:"7W!_!/4=:IW64-.T*BYF6>G2JBMQ.Q9R+6!@ M^\"[U3RM-JQ[5C_=9=WO-9".,JCO/4?QA 7]8VWH$Q;T"0OZ$/FY)Q;T*6?Y MA\Q98NHQ>E"JT1G.VE*.#TTUFC&M+^5XEU3CG3*-W6/[BAG'1V[X\YTG.!^Y MDPX!C#YZY$*^S./-FE;5(ID$*4;F,$%"I%=(/6YHAK@'#3M\+ ME\2;9%0NXO(FW#UV:=HN0-KRB'9E^0$>!,/#/6OI];R!!)0HW$S4.-(8ZMY1M'^\%QWL'>OCO?:2 MNT=&Q[*$0MD2/O1T?Y!M'?8O4C[*P[HT13A=YJ&>KEZ&DJS@W/*#M9K MS@YV3EL^!.\+Q(:4SD%7X^PUR,2I-/DK7.)DFPIJTJPB R3RW]K^BM:^)?O M9F'(GN54EOL(8M)7%X1?AQRYF#T:)::W.QZ,&EXW^W/U'.S#BYI(, MA'\'A4FW% U._Q!(MU#S@?2/S),+<#9H+_M:A=$;W*Q42G8JYI02(N>ESNV- M7I1]RQ4%/:2P^&1W5VXW;&*._5OZ$^J ]&LK@$WUMG>'$C4A=D_J M)*?4GBN<TUB7A MNXS3DE.D[XUW2_TN7[^3;[R1_[#LBO]$1]+_.G[!_SB"_RRHP>8K.'59,2@W-)[N'?R(B]98K'G@C(T/ZY-^+L5C,+UXT M'[U_W'STWG'/H\..1Y/G^_FOJV:,[XS&?/&$QOP&T9@OO@\TI@%>/H+XW':3 M]"7XP!2I$W+D$FP><5W&\U7OS8XKI?< N]^%>: 5__\]VVW.=4DZ;?7QBF"^ MC4LP8I!B_&^C\B\_H6-ZSXS>G2:WWJ=]V:7R"-EUM?:>5FN%U=I]6JT55FOX M"/-[ .A!U.K^49=5?T<+%6S":5*AZQ)GX93:*'1,415XU^V_9.?[?]9E%/RP M]!F=KDO'QCWO?DJ7'*PVO'O-<^.6YV G.C@Z>EJC96OT@DGVGM9H$];H ?KQ MOCIQ.>[J/,YBTVR44U]U%=X='[3*SCY,G.ZRCX<[T>[AP=WW<:TC^LISWSL^ MBO9V#A]C\@UPR,8OQ?[1?K2_]RART,!9;?Y2X!798QBOX4A\!7U&U0$".YG' MU!NVV\S;K(U8P9+[(VFEPYW=U:[6/]+DA]'N4\G<[_8.#871T\&C3?W3M MH[A8]8:'YIN>2C(4RP*FZ'<]'QYIZ/7#5]S !SU=38Z]Z+!G=V][_",(_XHS M^L;7?KC?[[,\+?ZC+_[!T^)_M<4'D^+@ZRW^IEPZ:S(#5H[WWCT*\\!'F^W> MCW9VNYVYQPB9WU.&OU@^X;%'VV?)'N]$1\=/V_"5M^%X9Q@=]H0VGK;A"VW# M;C1\L1\='=XWW[C.6^@VN!>B3>\-]%3JFW4TJ_ZJL+W# =RB2Z![1X.]V_E8 M'U0U2WW7X[K5=WWHDY<0ZOZ'W8,75$E9%Q9&QQV9RZ1:9+;I,_UADDR3LD1$ M-Q8]51C1OS&E1(0 >QO?A/2ZX3$^LS4&JC,[3^8U?\R?[D;NRQ&_.L$?3XMR MFJ1U^,/P\##:-06;X2)'A%TX@M!?I59)CT53!T-BJCFO&Z0FTMTPND[Q"Z%M65!5C__+DVO3%QI6$K_YP M>!0=P3"OX2TT0GB>+H 9%9;5X90'WWX]Z!I%_9[UQ'VBONN+>CP>EUAU,(ZK M2S"9\T655"A@I8-Q3YF%Z :/8(2 M:RV>K<^N'A-K_FB$9P+7)MHSK-AE.'U)\'&&2Y-H9? ?>85,9 B<3KBR,1! M]MRM7L_#6U MUR.P.JYOW:DLY_;%CSI7/W QZ_=??L2=LG&+^6I16/ DQ3*@'PX/HJ.#/:XA")Z#ICTZB'9>'/W()03PP3ZJWN'N MME=Z@.4/L;^^IAH"$QI&0:-B9G4,GQ2S1(TY>?LPVMM_$>V#9NYL_-B.YPLDE:ER ][L(H[^P?.2@_AY_O[[M=E::G$F^D2\# 992?G M-*5+]5M8PRY[XX??TLPNPM%.=+A[N*W60@#3=04,IIX5):\$E1B6*75[%#-S,89$H]9U]HP.,;W+G][1\>Z7%+IZCSW05RX2VS KZ"_DQF(Y4TR ML5ZWX069Q M8^T1TM/K0:$1C>3"9/\E-3:'*)' 0=4%SKA*( S\/6HC?67$[,<$>4*N/["#X/1AA'H.UIZ M9):*88944)L7GI1A@2U,>(X_"=P_1%)(3+^<@8R63/ 33Z?)N&9N6:K,;?W- M9ZG-E5LWMU6[4;N>+\+G64Z2@"O_<>\MC:S#*-.F.##MGPJ7SBC%$U;-X:WX M+KX8KO!;U;Q IPW9;JMBC!7*M!0P@S3C?UW&58!T.3I/6@@[BY#DB:=N.+O@ M/Y"]H*H'X0D+JMT(IP)SE&1I?3'"PG-D/L$;KLQZ%W4W$[NHS2=MD#-VX: 9[F[\B M02B2EXR3A!H4:%K^E4Z*\&,"=SML7"H\N[-%CEU= M+Y!I$;,_] E,,X9/P _(@PSVLM+N'A1: 2WW,\:=\IF2O%Q?@J\5\C==SE98 M-W[KK_@G7"K#WHH/ !-C#N\TA$85F#B7Z O L]W(,WP8-#GO"CCH*0X4'-ZD MA/\=%W A4P$Q>$#@ Q I6G@"ORH+BMF%&9'#@N]0HE,3OE\DHRSF)>,8?# X_9/T(LF1"A6_ ML8,NZS%-5%G@=-4U=Z>7M@]W7+(>D#I7<"_8%'?^?4J)YC-RL07-V0J'D'"/> M3.<#]RP1H=CG=,8*=V]O![QDV"]*14WCTC]BXZ+,$T,HW#E,"BK!K%%JG9F; M*('XZ?ZH-TY_GU^",J%@3IV4SO[0UK*N2%5G6H79J2\"TA!Z#9#U_3O5/3"=5%^8MKJFE2I*+]JV=X$'(22S;=:U!65 M3=L(U5)UDE.KF2O9#E>:14?>(F)!\Q# ?^#/=#DZ- 5VDT(VX?PJ+0M2=$@4 MC&>";!T0\Y@HKD$TQK71&<3;ER6!C5@K+GR!'&OZ8+ZM3C/!%O@HFE4_,$ZA;M05S">#].TBE% MZNIP4L+U@,[C**Y(H<5YI^K-/3T.6Y!4 6Y"+H"SNHQA2"C3J'.;&XUVHBS? MYJL08U,)-.!XB8Y@FX+HSB==]D3@W^_]]@1O5IONU^IGC*7JBXB=,LV(QSX* M1PN^WO5=Y!A5*A,8=44CG7YOE!D]@2BU,;6@!V !=DG&G)9UBCGCBH+#7?8- M!V9'S-^7)2#V&[>1OY/OHG=_%E\S[>#1\(6RC+J2T#@;C[L 1'( MXVE28YI.E:'D1%LUSO.$\[_4=P[,14S"3TFUXZX*\%*'PC+^:@,&'?MDZQ-]X%ZJ=MC+/"Z/"4JFWDQV!0%<_Q'08Q"F66X9"I :'"V3:7( MLT+]I?56S5UF79N&G;5I0F:UQ7X75!C$ )SCL6H'_I/NF6R9TKO#F363+AJB MB:=.79:T)OU+ER!E1FH"U:*F(-2N[-$-8?H6V)PN=Z6!5&'6;^&6."/GI[_\9GR/3=N;LQS$OH1Y65PKCM=5 MU^YQ\'4UDNVFK/2LFHX"5K;P2SX=:8PL["9'9;*OG /V-.8*/@]_L6%^4AL#]$L!^*0#I-5?07N;0[ M2:C%!$(68#VP1Q-))=G&JCK4I)BR>F\)[$U(T9")1H_<$ >NB"=G]J:%,U", MA4(9K?-9@BT_+F @LQ0&&\E1Q!- \]6NL+R $_?M(?+= MNFII[CF8'3:[V3YCFY-Q04+_7*^'+Z>5E^7(CYYRY-]@COSH^\B1]^6( MUJ2.;3N@W4[8;(].EBYPX"/.4HH-J"FX[&JKDN23:%70-7Q)8Q#>UWZ>/N.@ M(RG<*=5%T(OA@E>%!>_8W=G9):4(_W$4N.F+Z_'UN]8 M;5@GX\L_PLCN]ODM%D#,BY' M*4XDA=NX:T^7C))NHQAO1_IC7V!'[P>QY B9:MU2>^\/8"M!/KS?7EM/B.": MUTF&80]Z&!SB2S>_)^U3RA*3QXJ$9%M2>E5LH@DEOOZ>'E@]"]QNT!7F):%6$/226CY>F(-JA[QQ M$F+B8%@S58PI6=V0:LE"5KJ?&7CZ>G MJE\5\PQ;\&Y<%XAA1QE%4#4N%Z8,LTS74-_*@Y&S_EX*/W'T(">@]6>(J_8E ME&(B*)NH:(QP]JH)FZ-\>\1D)%E=Q=/D JR)24_&G);D$06$PJ=;S/I=#=@)J(9- K^3GT)??/+R<9&"&&"%5FOM1H* M=LJ^-89@^A1#*[NYUQ8'I^YI B)&$@9Y_ MA5?SO^"[\FRO(*PY0C[Q2HJP=ISW1ZY;PAQV^?2UHC# M #*6I)I2N&AGI?F"T@/P7^-T'HLWG1'RWP,M#(_"&7S_DBVBHHZSC1.0=[E3 M];O79:9/DBR]TJ2:1,?C\ -*E33R/'5,I*JOQ=NI1Y:!8O2^+"@[@_^VI;/X MP(]8=/%<&ZJCUM86REL6CG7Z_N/[]QX0RPFM!!3&PZZN7(^;5MCNE4>C7:WU M+J.X&@ZQ=TYVYD:&?DY8AAS0$"H5!M;IC_/Q38 /H]*!/!9DU4>B$]CZ6\J4 MG6.%YYAG3A)]0E'"W_8.?XS#7Q;RGQ.05?[&#%L)%_KP,3T<<7R;IX4^>GJF M J5,Z?F):N<:3]9EC/U^RY0.=+%P&I ;6TZP WB:T+WFA%]*#H?9:CA_=<*Z MI1C!.&0'&>=)@HARX_:-W4*IP!=FZ4Q0+-L/:U.V<267O9!C)>WHAX3O#W:[ M23VF\0QL[K^&YS>S49'1"ASM_;@RHT?+R>54CMP(>I=(>+0OJ$I.?%=RIY>G MZFF+'K!%\2-,JG"( _1?K5<^]7OF/!8'1A 8-RD('@#W?EJSSP9_THOATJ=>0-UA M,9-M6S)&I@PS($SA+.:2 ;G%*/\1G_\D? \7/M<>5_0&V*B$W[#P-]K-W^)Z M41+TO@(+?9P8)FR\:_6W>J&"60//G< %>C(;H=PE9I]OX GC15D5E3XR(8!\ MY(#!SU^_/?GPV\E'SP"!9\:$FS4)/9+AK":#$,M'%Q7# D202+D8_CF20EW M$ WX;8RY2NQ+;P8&U_X9I2W-H.7&-^=,LDES SU;A2B'_O_^+K56ONV*>[A! MT&]M)3G1*S730^J=:(R0,_,,3L!T]8S+'C'#660+!W'OFW^N0#E <>FW3&9% M,N%8+M;?FASOD@'KR*H <\R?GY/1WP!'(*#);[,L+D843C@!:UI#TXKG0C'8N&\V''Q4'PC'SM.P[]S MN\BI9[,Z2\XX#RX;,;@G\0L\VS^PMC^:7 )9ID)^#.)1"E5S_+5XJ!3TKSER MSK!*^V+B!S3."M/JH+.B/LGX4UY<9\GD(A$B&,RB(5X<9J][1S%9+OQ6J!'' M=*7*GIA[JBYTRRQA;@*);>?(J,#@508H,D;6I%=I[EJZST^-@@SCE'(-J4PN M8N$L C_L]X9# MAD.NRQ0T=>YJ-')*4:M)8$L46\RJS<0Q3O%?QG[P]5U3N;K9Q]_H3?K#KIC+ M"9X".'G'@^'Q8,]PM:(FQLL-;@A^!D%@;(S'27_6Q45"T%Q^GG 72=U#%?Y: MPRWIQ&/D"ZY!%"$WQBBYC+.I#&!6)=E5HC@3) !IE2ZMB>=B&5O]XP@1W*X7 ML%M,"$8XKXI%1Q8:E&9%@0W"P($5MXBS8 1:]8)2A$UCQ4$?4[J-(DM8Q6!2 M DS#BQ<*B1&_S,"-*V_/0P>\3S&8D1@(Y"(%_+@L3:985P7JB0V@23R#H]L& M+;EI(!4,&@.3L8P86H9X;X[SP_[^?OX#\O3.D.4*([MRC\87%YB6J]?"G?:H M>\Y6J^SE"B9JV#91@\_ MAM]L7C[I#%C%!'#!S MZ2# LD ,>&)-KFA= (=$F?BB2#J8D%N A%R\IJ(JR#EQ[@K+.$9)FQ&7 ". M1G^2? )[/:.$-=8X\HE -25*SN,X]:+4#<[S1B8@'LN6%)*UJOQ=QZ@#P2;[ M/:HQ,P@A@=3+ C8C.(=5RS)D8/ MRHZ5)A+V"G'YK@R5B45N;MR)_UOJ!Y3H2Q-D:J<%^RN'\T'S)<]^^GM:U469 MCN4"^J"L<^'K*>PND@9+Q"E=#[!M_4059[F4ZK*'#%YBR<5(([46M$Q&-1N" M+H2'C-UQ*MP,KD +Y36#I\9H"F:-A.0A$?I?QFJB=A7CNJD1NJ&QF-0K6_?* M/%$J*Y(N\Z? ,#.PU:&C9D\;M0(=!3Q M)ZUZ^R:CQ3OY)IF0]CE>3%.LPSQL"U>F$^M^#*M!RT?FUB$U:NVD1(QM&+AI M6W7[4O1'.CH>P4<2]M6B\NX1T&T8\V7URR(GSPQ.VJ%3/6\BM6@;"?:(@A ; M)U)G.<\!)]!#@\)@M-D\PYIGJKSRM =AH8)87 G]8NWH&6?^J(8FCLG?V)9( MD2 &Y,NM/8X\O)Y"F[R1U5R?%G1,P2D,UN\2KP'Z1^*JV'2]H(H, !;?> FZ M4]^WN065-HCI+5H/IH"(2/2$Q(ZQ&9CT://,4#X4XURAYK8Y-1J90O=.921I M5+:3X/*4! ;_MJD\3/L2(C<_91C@V-!$;2PDR@6F,^)%*^"7KK\)D40B<4&? MQ$5&-6,D$LO-,*3L5;@NWP'"Q'FE.-T;;+3P)JXQZ:KACJYO\PYWF&H8JBG: MWQX-D*K DRHY_A;1)O./7<>KL5"-GD*[+_H8#R@WQQ@GW%$'0\HEL2[F;5\? M$H>78$V;9]CV1(U';.+^6-0713EW>$F\^%@9M"HJ5_,B?N!MF"L\K'DA730S"B7J,BX M&\,-*MF@ 0)Q20UGB5_B%PG/&*X3J>BN\^WZHL1R=4MER, M ('3^!B7Q9(4V-'.4PKLVTN!'>T\I<#6X$N,W:NULGZX>RD*,8H#-MMB,7/8H[=<7.=^(FUK.57?MC'*[VK&LV>]Y#I#A1]@ M =PXKA,3+N]?1[,(:6D7YIIBH(:HA[)6M#[M*/L2ZB/,SL@O\90C@E<]5YLMD,H?Y5@: MA/]M*F"6[0RA"/PF-G>U&79"!5@S[O_36PCOU&)D-Q)ZEX K9@!&"6 M7-07&XB;B=2-$+(LO/AN@HF.4>I8\?_-;5& MLA:_,UI4*'9^#<8=PZ90/E$7L(K!?KTVS,Y;*'J;$% M(F=;#&!Y&IO.IB0\F!5536ADS+,L)H1'Z6Q*8')\:.K3>7I@+X'O66:[&YGL M^8U,CE<7YW>(""'-\RLX"P*\.L=B$;(]OY1H?U=[J?KGKO>N=D-9L<[HSL]O MR\ KO+JRJOG:1^B1^#\\')H.-MVJ/BY'?WE:>_GY^]#_]C!TS[ MH[WASN$@E.4UQ#EL]^][]DV#&B&MR0O ?"(Q"%.?[_9,JKH8?P+CAF^:R)0K M^@LZ F^-&]23,N(E>??Q]+]>(HC]4U+/LYB,.OH#3C>24NC61$_>R%37U$KS M3L*B@NH*Z9-V6W*R7SZR=GN?490 /+F*\).VZ]/75VQ=PO(EWMMJJ_BE!_!T M2E8\):>/?$I8MW[I&]_6BF!ZL"C_BI&;.GGVTWF2L(B(70M7VG/^P!@K0<-8 M>3SG^$M,V-RWN]T-V?7P=J!2<3C6@QMMK(\K^[?OKKZ<^8L?4%$A0-3](Q:5DTD3'3&$34C9KPVA=0RD8*W%WF,*V0SG(A=: MQQR3EK1/E?C/'(1G>:CY! RP6#QD4ZQ@TR^Y_H8R,@%+%&CU-)/.$R3^W @= M,?.U)ZV%!Y=F6[]/U_@VOL MFT92EM#%!4,RAD<(Y-@!2\&U>;2Y%E48SLN4&:X4&4;.A;;GH"?72.JI=&T& M*=S#%OKR].7I2<0E]6,TI#F;EB\(7D%H$->HL :UDU06#,N_V1X3QBULZ(V= M@9#J$?[0]T I0)0BR@X#,5 Y8*,-2>?"' Q+\S%B'.)/"<*%P*2+F=V[3$/QQS^SA$,]%2\YD&=R')[CH MN< -$WV4(7V-G8=M'.KC(PV8@5]VY[G@//E\F8Y2 \G!D^(G;JE,#E80_O3\ M3<"80Y<75RFHS=;N4=G,S@NVH7E_!2_4HXU"T_VW]\%PCJF)^L[NQJTNHV7, M7-;:C-X%P' M85X"ZMG*:FJABTEBMQ^I.-K>/\ MZ%PSIIE.CL*-F2MAP9#X@HF(N(N-G(?CN"QO@@ULM/&[.716TM(IM;9FB"6A M^6(BK\F*BJQYM\UV+'2YXQI;QI'@Q+A8676HPNP4S MC,"AF6)$A\-YXW')LDD1*GU>@RQ%H^(=(]$&C3*%!?/24!,F#+LFA&N?>$\( M&T_ \S*GT.NDSY)LF5P!JT$ZSMXR8" 1"=OJ3"-X-;66)=8W^9Y#@6QJ(+B3 M'@Z"%Z9OL#)=;E(2N(LF4?_^W5SV7*+28E5"/6]-$Q2BLS1O0&G7&9$$V!EL MG/"?V'W!8:.V9X8;1*\CU73(]Q=;U-.T]JP>UJ34:5[;3%@J4GW$U+R"C2Q0 M'.:=%59_$"=U6OTO7%I<9L%E3FFICZ!HKNX)\;/+X.6("$C M%,TR'M>FS?:4D>"(*8S1':]O3"6#2U\=MY[?%E1ZOIF1RG= 5L!LD0NXA7ACY(X-HM;A)(;#S]U08U$3-J=:K'1(J577>XI@)CL!B(0U(><4K MVUG(O(>D@G:"?]&C0$G^DS\GJF*Y(\P-37(]G8()WBP#IS^9?N!>%_#D,_;"$.5'JS_'RADU ML;CY?-UL5JR_PETD?>RG=/@R8_X]N]-BU=X^__@FPM]8-1N%:!;6S*D!-T:! M]"9%3LLS0_(R-.:P6".A3A>519C2C+B]%GU9&FWQ\H!&&A63&ZFVQD&F^:<0 ME2*5;\:4?B**1;8C;_AQYF7>>FE4HHA+/%^!_0<_"#'05-Q1$JA_7*:CS9-- MSS+4=FPFE_:_BZ($[]E6/*EF=>]J,15L)FW:WEZBN4P_MY4 "W$Z)9FK"OF2 MT<'8X?)?++K-QTKK>DYI6T4 ?PE(GN"!>,L0J(!)".%2C]%[N9'(BT@#$Q-\N-=%4#H4&PBRBKZMRKF%RE!MN9 M76)X'K%L$^O(4S&-.'D?&?U!VC4]-6WZHR"A:."*#0G"3@K6$NI5'UT_\&GM=<7+4G9 M\A,WO;6LDWU(O7$9:,/RK(G_:X(=O\,^+F-II M)I) F\//>%F6- ME.,1%H^6%]RC[@)C\+SJ5GE*T/KZ$DG%-/0:ER:>BLD.F#D?LXK;"OB&K]DZ M:DJNY=>H!J0L>[7&4%^M_I8=]Q!M&LI]N$GC"N44@_X."6@);H"DE,GJSY_; M3P+7M]@XG]4)LN5((JB1*C^^Y>WRQLVAT]HS'0 1!P_30R-BDLQRB\2G:B/C M,[[C&&(5!0PZT* B&PRNN) M(>,A%B * 05-M:CTG^$%!7.JF@'2M;1NJUN1(ER5YI1-MM!?&4>?(QE^7G': M$2/\P711XBAB*2S'](A?]("P][BLI0^%_[Y8V^L*T1>%?) ?"K9H$6>5'RRM M)#76J%9 E@;PGT%["07]# EZ,>N6(KT\C4QW6P*E-!.0DI1 \-QI8"/%EEGQ M(U252$N.5"R"O7"2B7%=8SL#5C?4*V&O!\^ M)NQJ(*%(OKM(L#ET)IE']XO-@+1]=X5I=18'.K'4;(2IEZ(0SL:G,/E?::I! M_#Z&=B7"K!S*%$=@V5BGHT)5 *PMY)I'?D\&/K0!:V7B)2\QKDSI/CR1)*N\ M: RJF HA5D#DH)D0VYF"("+)(W=-5)D;&%]A$)(ET+O#YI,QQI:_B-.,D#RI,6(FO72CP M)=[[.^Y;EH*=-!':9%@H2]A7!M%N%OA0["EL8)IYG#3CBFM#?;P]R8 MF.XT:T."9G^.S33)X*8N"U@%ACZLTU4G+QJH1PR0TZ_8D3+7'_[)I9]&5$59 M8IT4QZFK-*>^/MYO4#@-9**6,T M^<:1)MUXHAM20OZE^<=D%ZC5(N:,G-1H(*E1;-N.?ZH$(NB<3=\4JRQ78IK; MS3]JX*I_*YQ=-,WIA&"_TH2HXUP'JEK,A4\"2A>[D[MW%&4LED+KAPS:H5^B M19+8-)HS)(0Z(&:3=85^;W03Z I4"8S.Q]9_1^)S@A%C HXV4WV:3@T$)HI- M^4"CH]^2)5AR'=X@"3]V/L:31S;%%GO5^'-*N%-U[? @I+[(E7 U.KWI0]@\ M;:3'Z58:B@[! F-)VH)<$_GTW!?Z6+)MT&"Q#YJ"Z0(/HA$FN0NQ)8H\AP)? MEOSC^?_<;<&V":7,\"C7SC*EJ6)7O?)3SJ_\5(QB":H$4]QUQ-=E+G#WNHS- M&6YL"QC.C6\T<[1D#Y!B9"1N/W)/]+?)F\L8VE,($<0EZ?;>+T6!K$7S&\Y8 MR&EHJ!:K3+Z?4^<93N0\R2U(/@%J2='+Z&A%X3HTJ,&Y4=6VIL/&/PH"-4?DDBV_H:IA01Q#Z3T:87:'3 M2:P=EKB;,+=%UHR&?U^.52D=5HVEC%T'RNHRG6-I4U*A%1/$(P2E"P8R=[YB M./X)I(Z^S:2%#D6_SDPP^S$)^XG#G3^U?XGV:)]?4+#K1$#%W1*^D MZ*WCHB>^OS3.'1;-\-?XFDW^T8T^0"WG5N'B M;?6%;N'BAI@!7RX"?NYDZ3ZP;81,>E^/]]OPNTB+NV'4)15!.[QJ*@;CL&=2 MX8EFD[R",><;IGGH**FO,5[71''C?R\PXDSAG3/J7UV4P;G4', GXT&XY=0^ MFB_;OJ25CNGD0J-]WBBE?8DTB\MN;*501U"[<6J"V"M:U$)%MWCQK3B!Y'YR M"=V1KC0&UZG5]YU>INP]\-O]QAN#M^HT*5,^1T+LX^UO#YNCU1'V_F1WI^SM#%XV9NZ96I9W17F/$R9?>VODOLOF+.A%' Z0EV!;S1NW9S<\ MKB)_GRITW1=&DO>=.L23$50V_1+0.RBEU*\4_A1WR>6T*XSG&0HVL49#I7GOQ_!]]%YIHSP,^TXSH MY\9*3EX)DYZO7YU\Z*<12T9@::T);_XM7(0G2'W$RO> MO6'E#E=W"Q(CW&;MPSHYH M^KZ9IVUL%CEIW /(P9)ER5D2BW9C-%)O'*;-Q123@MMQ4:B.Z M-+7D57+Y>SM)XY)SH,&";EG7R]W^E4EF^,*FW G8&L3JL7$[?<83HZILAJ(T M$@B-=8RZUR!05YO$'H/$B<7K'C<8M\N2O8?#&" MX0S; OG75?[ M8-EJ\YXC-<<]I(0]KL:L54PV;+_N;-6>B W2::7 Y@5=$1WK%=XSHL/40L.C MAS4?^G+VY]M%5J=S,,W_R:@Z61ZX'X+?BSH(IM;?JM+ MPN0)[;06=$NW2"*E$?0A..T3S'3P';N8\R9VA_B\0TW^(T=;81TR!'=99KG( M80 B@Y;=G,.(S& 1M+=:I>PM9: WLK$IO9K=J>#N[5++^9-$\_*'ZVW$:Q1Q MO9G_.'VM!^(#--(I!E]3&CR8CPN _Q5P2VQU/ %YCVNM%JY[(4DHP MGC%.DDG5^8P 4983?=*4F3?P(6RUT ,H]I:WR[=)$%IT/)-%=L/35(X+VW=X M+&1C"$VXABUE;@6XG2E+#A.=S9()\F!E;65J52.W\:W&Y:+&X;FL-JHD",1- M*QB%Q/]=AMB0#'F''+.K%$( ZUH$IY=Q:BH52/"10426IWLK=<5F29QS8%I% MBQT;?]EE35G4FOP]#,HO W/]]-25CQ)=88_*8:EP1EYP)\ML)(?Y/JC5 MGF M9E'XU%XRQ/83D:8($B/6^9'M3X>F%@:F9$[5*V7"V$:"*-AE]JGAC\6VZM]K M&S\*7/V@'8MG3I"0!RHC:+XW'A$R"8_"7!AJ/2=4F![MZL!1GLTI[BH7-8-V MX5(FA__*;V/C#[D@& MP6\.]\_U9<&\")8II"W^[KKPHEG -GDG9!CYG 1"J5$[YHS[F%0X/R9(N4=+ M$3?^+O-WZDOPB8QO=("P#(!WM(0'G'-E&,UD6"_J6GXCE%U(,:^$$@NX>S*. MG-5I-SE>CO9)-T"+,KC$:R1,)S'QYIF%QGAH*M Y?2,NOAF?60\ZL$@R7S?N M1&/I-6E;N'P%9?E6V]?=D#(Q]X=IRAW$#EF-N1#4BTXX,^E/I+;IU<*V4U^U M[D4-&K6C/$K,9?B6_2=\RS>(;]G_/O M*M5KI'A=V8'J<1%:'M37])Z6G/WO ME+G]'LV'WZ*=E')O=6+I6PMI>ZO!YN-)L#'J4F*Z6\PX'SMEYW&FTU,2PBAP M@O/Z8162+B/T36TZ=1O\[KA8E'Y\AM*,?"=>F_)S)1_CDX0]N>8\*"HYC2R' MUG5!J.8JL&!GWR)=;U?C>:^@WVF=5?SE;<]^^AFI)G\M/)##)!9'#,9/SC(U MT1D>*[HA<,-A;DJ(J5.2TF(6#('T9^^+OY*%:0G9E62: IG,OT(@PN M1_78+N1QL!&$W<<,/IK]M0OFX<18OZ0[B449/>,46X.%$[S52\I$LQG'\\>V M2\)EJO85F%T((L,0/HI+A.;:>)'12A-L'@,6PDTRC]-)^+\+$#3*T*-$$O7L M1,-<&>Z7U&U^E']'X3Q;5%1=I-\>4?Z>GJ8DDA'[VXG"E[B;W O!OYL)6$"X M.KY^+%36S:C]X:XV52JD?994%]6\-RA1 Y1_J?,- [)&RTU%(8T, MCXB'+6W23(KVG,(XBCX\LC<4/C@@!U5?7)DP ]O6%3).V+I*/>\\/_3C"6# M/&_#830\W(U>' Y[1TA)1:R+H2N+R^GDU0%QM\+ P6=B8(W=$\5YA+'MAL), M0[Q9\ AAR*4U&L"J:P7]>X\4!2XP>SYX/5W?KN"C2T4>)CJ-86BC85$2NWQK M\-MSG:1QALX^UV#^PQ *\L5&"2@6[GZ%-),Q><23!?EA+*?&0E%@39?V216_ M$'=C]BR(IVVCA'^L[8AJ0K6"^OI9&:XIT?K^-,UZ9] M"1OG-<624+!1Y2R8RA\!QBUB"\I+77.Y/>ET QN>)A.*.A2BI',Z:5E\3118 MH,>2BH-I%XM,<]X,M>"@B.#5^.24V,A1 NSC>)[6<:9PC90;<28P)]/B+M"= MB9AD"=/<#&KG>Q/K4Y5OR6HW6P=OV$=,)32<:@R1FMEU8S":;=4'P@AT3 MV\0EP>=(@W6_IO81HOQPI1D>Z /_JI0A$V]0=*H"6Z.Q9M(.>!T M,VW6@G/X,#04@.#D,/J3=)V,S?2MX7]OTQTG6EL3 U..[! SMP&\$XHEX&@] M)CGB\)D[TF7Y%HY>T'$0+PD /41X809@7B&]-B60"WDTW=!W-24.D_)N^%M\NZII$VLB.(A MXK)?@S4A\*V)\IJ$F6 )M!^**700RZ."03!A*G4H)< M39,(M 8V:JCCS\PKP"'E*K!:P>8&60,259H^V'?JRF2:44N"KC10,8>;4+V: MYOMI&B \3_8( +ZNA@'F]A:14$1Q@W=!I<&N6B(EULB$AM MZ(JC55+0QO?+OT"]5Q-.C@5.VPG[BK1RLVNU"(YD':G,7I/4WF^,NB+\@5GR MJ#DS\R-3DN.L4RO!2H/A[>?6-[I]Q+(N=ACW/2BD0Y?5FCAB[J=,-9AY0K4& MB:3Q?=T:!9,$O6[L\S4S^YPE^05I&6< 9WXM@ U C0V/+!NH!^<$".,KL16^A]#)H+A,PD%8H MZM4KSWR&ZDS^=O;QQ(O_&Q.;QMTS*125@Z FRBMIY[CW-@C38W]L&/[VV4^O8U-;81"8,%YL8$>8G^N< MYA!/0(X0(82WG]I*8IWP5(.6Z>/]%OV@)A_)*IEJV1^4:, M3.W\ZPAI=)/+$&,3Q'VQ9K5J%I$0<]$DFV(46%"+>D M!%#,-UPA@(>]VJ6E-MS"N)^MV;C;11W$79XT->R1YHGF;VJS^4:3AK"H(59! M\KJ,I;3#!D/WEA:+^^'8WS0T6=_!=ZPF=\HXPN4FDO;=C56WF>A"D%1XSZ75 M)>HLQ816:;V(I1>V#5T*F7U%1,?SA(+*EM596]=UOE8Z-L74B4[_G+: 9,8< M5VE(_2IV6!0#H>:BWIPS:99?V<9-O)EQ*S@=1-NJY_NK=7L%/3L4WG)K4>^' MG(N-T350[+%& ^]\%81\%41\38+BKWS-3^7='),=FU(]]OYFB7OQN8-OA.:I MB*0CNOHFS360KJ:V61"Z_Y@0>Q">U:$)'L5@MW.K9[XI'7B?Z0>%B%'LS\YC MU+PA;C!'#W&E$$,99Q@3!@%"-OI*V:['<1[ TS#\FAOO0JX&V5A'=<&_%"-) M[IJ4%--Q(J8"#!$*8Z\KUWCQ:+_)N$M&\3:QP2I\+*D,Y]+:O#OE8Z=IUA9N M9/^T[K>CP(DI(.6R=W;X]"P[L!0;..6SJV;4FNJQUYPCXVB630_EH4>L33O[ MCL26;]VUO=8BX)L;$$DLNN.^LN*,,&O>(]P,\PBJJE R191%R8N)O;I[8',) MN9,5(X &0OM-SL#R_M+?Q)(2+#:%RS7I>(:Z^(G9> M8L!5[9,SDDD6GO%B;!OJ!N5D:ZF4ETBWG!RT2BZ3B9($C3REW'?@,0&/=QAS MCW>MDZ!F!ZV MX06?4[,$RU[\&7G"A>W5O-JYL!H:3C*UF'@J%E445I@TKM%XBH(L17Y@C%!B M>TY-1N(A \%(.00G:7O3H)BB[/ZGZ..P3<&P/;3]2RF4LG[MP4V'FO7Z[WT("F)1-^7+M0;*.K[ M7M!R%U>F?(-N/K_/Q1>Y?6%%0+\XQI[JJ OTQXF&GOX=9$55J9$XL0-G!;K4 M04PK1T5:OG[+.V$KGPS@DPKJ[$L8[&:;WW1Q47)' M8GB,\_1X@HN">KC W*P4L)M[3)BL4/72$3 ] M)65Y*3J&A4\58V2O$XSLXN$!5P!CGAWC(V,=!1QCU.I?IU(.APQ1I:U$IP;# MJO8I5V'SS3I<'":J/QQV57N;+NM&];>44#=$THA@1((N%C3OV[ U&;'VMSG/]!9#J ZA4JY0ZP4$%=>, MNB5K$TRPV]Y!XD\>"7S:)#JP=6_.J[]P'N;%4Q[F&\S#O'C*PWPM)[+#D@S$ M8L-L.XFYJP4M[)V5$0:>BFOO>ZQ$(ZN0F)[&OQ2?Z=/-<#4Z.G@F-WW0 VO3 MXF\)V/0^2)P71PT2$Y(3^"=T4MM7PY3XQ'YXAR0XX9+PYJZYQ2X]5^H),+#' MFM:E!V@4Z#B+LWOPIR8(D9M;..MANV*@]Y10Q-?H8]X%STDTZ+8$6]';'E7Z M'F4KHQN'ZXOPDBY3TR'>=65M$S\A=+R^Q/Y1C46\V[$R72P6U2-FU!D!*4 M(AAX.7MF)=$AZ[Q,]@@Q@+@XDJ9 56+.M20G N?T^9%&!DH[=)VXL.A%X3_! M>K3=.F/(O=0#X!SN M[FBCE,FBY+S;C5BT&!B /U.N;KRHK1XSNHLO U?IR4-P!,.=96HO:ND]#<$ M@'T%A-*P[@4&M6@X;O48;F&-3C+E!D)P@U]O._K>O^';>2^3-";N77;U,-P: M@9TVIKA6H)4U&X\5\5??3^XU@$>5PS#&L"/B:LX,M.:TF-!%-#P^>N&QS"KQ M.:_JQ'">1^%'C'XLRAL$^FC2-&)"/%!(D]8[0F%4-X\\^W!N($3E(B/&T<#^ MOID-=H-?-(.$DGB9(RQ/ @#DN,M39$Y36[(;,N MGF!?1LJI4Y'5)%(>\1LV.LJD+HN8N .*^<[;&MG.X--)6G3ZWB"KI0Y;0&U%GS&8H5!6P&35%3(;^?+O+OM&5>]NIF.Z*(4]TM!;HS; M;L#<*JS$7/!E+G=(Y*EMMKQ$<;>1;UC>S8U/F0OJ.E\94K5QRA^N?'?YUW:E MGU3L[V/ .,6R?D^J';IP"RSK7+! (&:Q*> JRNX$C'N?<[JEXV8Q737W=H:# MP\.=(5KV$JOU*D=,X!]&>6Z-MR2@OL/(R&2;488=*N8A)K0ACQ M798PJYS#MA+;XF#^F[O"MD%I0,L8;V_M#;>W3K;M_J$E4%*ZIQ3*[G\Y"E$[ M<52+.=[G:NG%<@\[!K5)KSE-LD24BX21$(P*7"-JE)B4NB6T=H64KH4 [H\6_2W*"\2(Q3#2CJ#CL5G+1I M].<+X3!Q_NC\?%06GY+R.4::A.[;"8K"$!.WEJFR2X.1 SP\J5X2A(@Q3MET MD8^5DE%R6.J0.2)JQ(-96J)&6Y3+H@M*BLTPP3D,!(51PGZC00>VXH5M62N- MM#F_%7-40@DE_3<(<%5KA>0E"LXDF,-G),O@A([).4LDDYAWB'S3%OV6=J#V@NW?C M((LM&($"GDM@PV),]#U=49"F45OD+&'92@3C ^]E.;3#IQS:-YA#._P^FW_5P676=[A\794&I++K648'W1:Y,M0(^ MF']E4(*!0._ZS28".'TGX1LNJ:(5@?;<\7+Y2P B:59PT_ U8 MOGX7-!,3M6C"RE1B,9G98B9F0Q(3Y-P Y*8IFA5*2%(F$O,W!.5=.#,E,P\H M?=&>X" \7XPO?72<_D:]3["A)RG%+3HP& Z_3&2 *F:%_^Y#T_&SH&,K;#$4&"# MQ)1Z(U8\A6]I$=22XK G& +MS6T('4.A;MGAP-GA%DM.C;W7M5;!M,0CPHJ8 M077UHLP=EB)A!.Q;&H-;PI6GZ)+D:H.&M<<)$'@AT6? NPC70X)$(-91X8_<-;ILO>Z4:%PZW+[:WA<-NR*:ELF56+ M/S.M'>M(P=F6! SU(]V&"E-D9=.B#HUV+NIG&K0:JW!UG,UZ-(A)T/1(#, 5 M?I/.4\Y6J2TLY(T]^J\9E:!U%C>D*57M,1I%C-).*L%7Q)VO'(0_>]@]5@K8 M^>J"G'H.M<6,:>EB LA&IB;EQ# ,F!0[%H^TP'P12,'938TXPIT(224^.I/50 MX,=\8+,C[=@HC_+P%A'- +VJ+!$L]>'.GYSQNK$=SK&'R.R6:K^2UE15R06& MR75AU9A^INJJXL.F25%P$M$F4N%J.?_JCD=A.X^6BA'B!;*OP$?,L^>S1REF& MC5%R4VC:?%S,+9)>PJ=6( +)IO&J18TKET7./L"< MS7(@6>@4+1'P[N[O<4DC!P+3FEI*-!5++ M_(B:S:3\3#@QUA4TP55C']>\_7J)NSL;J',C&.7KHLPFX/"RX5DF%]*.-\9B ME#*M"\J6\^?^L#24'#O0;2Y#(2X8^BNW:J1"$N2>A6'IJ .%.6?82X,-DO9$ MK!DX"#U P=]]@?1"PHC8]T>D39[I:FR8OP&2YL+OX+#IL>GQ-;Z!#$S;0E]? M'J9Q,Q58V551^@)]-N,DD5QY&FB[Z8D%ZE4U?I&MHH$CK$3EPY]UL M?Y?R/T2:"8N?>P>6 1MG[,YQ;!3O&A=NH<50.CL)=9H63)(^Y2PUPJF>CVZ> M4TD FWQ"C)FE$I?$(C=S#ZJ[EU3!%F>1&28*WUXP*ZI^8YL',N)LD;?4V\WY MNA@O'(G46G"Q,+P8BZABH3WIN+T"N;T:Q$]-GTFN250N69S./!UO%W40OEF4 MN/+H7$9.'LA9=]Q0R1?3HY EX#+)@T:>K^JY=#K,L;[KO&N$EMB3W1Y7B-Q5 M$1-2?X2@1=#JMJ1?R2:DN=QJB><&KTI/RAF+@H@;+> O.&25&X*V;9:%X3P? M-USW1CT1-P#6Z8U9Z]Y>!&[U4V"A2>0F]>V5%S73(B-L$6 *P[CO0;AU)N5< MIE(7G-1+(MYG6<1.<##I3TEMC5+,4QMHH4HVIXNHY7,#.FK.H^=D7B(^1AJG MX;6U#(GF%8!I>$"+YKP_IEW$AX1J\I)!ZN6"K3*I.M0QW.-N5=2U-(?*Y?R# M34RI2/(@X%R4]7,LB@UH%/D%_:-5Y$?CZRBGU8P2XV4[!_->@,,$JDT?D GEDN,@C#]U_Y(]DW6O#]#MN907,E"^'5ZHUI3ME4K>J[7R6"?<.<33D M(#!GL;TF'&8QF5X\1XN<4!V.(T"7;_/])N9*O#D3FJ:#.*+KDAO^R8S@(%-# MMNZGI<+^,L*2Y,N8XGX1DPO9;3-7$K<:'6'^S%^30;ADLF)>!IY_M>4UG]$( M@;.LYXL1V/=SG,JY!RZ(F)V&9GO;ZM!0N8J0L=UH(7 ;!_PVD__F$_-]V/%K M;';G%,&8<*;]!2]W,9UB%_/NVLN[K7E@UOQA?6V694>/GK*CWV!V].B[R8ZN MR='[#4Z9P_T._M[CI$![6"U0032&8*']PC&+E"H.4-,++VG=ONFTJOE-9CLP MI.T6OV2"DI%%A[ J<_00!M.,46S>067FF%(34ILXW!L<&>Z6WFEHV!CCG 9Y MDO(5Z1'4XP\BA:)T4*F@G5=,.)%CDDU>6E=+S'6-B,^96O8XW1O<%&N*+&D9 MD\T@];,/?6UB?;V_L;,1^,Z&YVC _IK^LFKV]:\2<^Z1O93JV#;/->D_2) :;NK0*(IP$+)S!@&LP&99HK=A;ZE=LVUI[ MK7?P-S8J%#<_RO5>4@H:[7*;8*S9P3RIG*C%V*2,:B\E4?DM>;B:P6V#,4H" M#\#[_LW9:=27O=W%OG76 !ST_D5^K0]4;+##7B493BEDDU8:BH*-#%!" Z), M+"&QLBUP-P_]6F=T)CV]E5;-+(^7GU:R<0O2!M?Q@O./00T6067#7%:MNTV M2,,;=HM<0N]E<2.E D5I_6+E(1'%#O])M0=M/WL+016LUP)=+@:&=R5)+%4^ ML3HZ#=BYM*&%'@"+7=9*/&+:"JY)Y9:19<)D4IHTZ#U/1,&$;'$ MBI\8:P6:,>9&4;8AN6HH0CI-J@VQ]XL'U- &>XIK#EDOS.".NJ78":C M\6*@%W> 7;CG(##F#_)=77"VU>8,)07HI&>;JT7A>JR;PLXW&+R.6W@3$7&\ M-Q;Y1&7/1+UI3>0W>++ P'[.)ZSU519QY.11_ N*B/ZYTB@MS[JU_PS09^56 M)DZHW?D21MQ=]@.M#U-HO?>\1J25>S5X=3WPG0)?46D)6N+;0[BBUWB@K1;0 MR)_-5+OCD5>B]I 6(,C!1OW2\$.NMH(?FB4S)\4O&6:0LX'8#F9>K!,YT+E1B<0J=Q2F+N MDP96@L:+#X*KX#DH!)%P!T(FK>WP5G[FAEA0T3WC'#1Z$16=&?R"B5PVR+XP M@(9_M\%5+URSK9=V RM6]<5?Q1OL6D4GB$,(.SQTDF MS5X;]R *I!_OWVH20[HD0F3*@/%TD73^>-NM','7_RBV&XV)*DCP>T%+YIO; M;S5NOU1BC#*)*>;?D DCE/!J30MC+6K8O%>#AO?$5@%W6@+SL[A(V$ZN$L]; M*Z;-)PF8*5(C,B0>:NI*:R^16Z#$ 5U"4]L.DQ)*@J+ES'&1VT5L*PYYH=FO MYJ(R!Z8NE3F+SCG#+$U@S1IL!7"-**A(V#4;L]ZX.^;CI;3DGF"K03]%2-2' ME T7[R[-]7(V]XQ[_)BOEE-.(=6T)Q+?EP,OZ^\"!2@00#!E529M==/(6'E7 MQZGKJM M'IQ-NRT\<55\C9&*O6K' !=@!2<"YUV. Z+H]3;\S>)5 M"7KV0U;%IS)PUR>R(%+*GA+I"];JX0?(S*VD29,"+%0'&CB7=I%7W :..6D% MQT7,H6$QJBE)@_P42%'#+:XW[GR>3;N,ODMA(!!/Q95$C]EH*^;^GNJY!)XU M)R)KN$85/<>^*B^F$V89>F$6)\*I%RJM9_/NU$&C8O2(\B.Y<+<[KYN MC?FD5\(S,9<\?-4S11$JRWAXDH<=7V2N=;TT6,Q=Q]8@:5Q0HE=\F>LEB!6G M/84\WB,UL(WG%')VO":;.AM"V MW25RJH.^J*5BI>A!Y$8S$X\UH987DE$H;+GDD(M+PT&WPTG@&D^CL!55%X5V M4O$).SN'!OIL+"6'<66*3.P/D9*/6JH@-MR-J>%EWO5$=,^]R7 K86UX34=QIK1*N#:* W-B M+=X-W2RD[ BBB*?BBJ1S)(/"-R,BH;9JS4G?!$]=D*/1*HW&-97A;Z9U.FZZ M8)TI-#VHRC#?-DL] Y>2^ZQW',_*YAJ93AE^S'4*33(@&D;G4NHS$VK A2DI M3@A2S 0CY3<<%15^3_8IFX+!N9VRX85 M A.^LRX-6^4VI\$9S0C.I3>SIB%[ SFIHWB2_:W:7MSY*#+V+?@J2H9G(:N _[8<3S:F:S.\#AZ M2^(I^=Z[NIF;>:Z6!C",N^>FM-WYZ1>"K720#"*1+H[:H^U M5@4L/:V-(-NV\4'-T()&T(3F(UM.V^J@=#!GN*C1O?=:2'98"NVL CZ6)SA* M4&4[[1<'?M47]1_)D1DK[B2ZZZXX8-RYUCHTJ>PD4(;H87+4)6SF[MW&B=WO MTO[1)5$-6R8GZ^=7S3G6"D/22IQ!L,"$0,0_:A?/-K+44GC30/;UA$FP MFL.-D304-+Y#HFT"KN@9NSF=U)VN3Z4[9]?:LG+B>FQX&YQP+E(EEZ,AM_2J M$VZ?^/V,FF6T0H'-1KRF:_3:[RIFL]4]XE*X)Y'$BK6<[G_72M%(G5RCDV>PB>!N-'XG%APY"S:%I2>9=HQ.&,O^R^AFT^'[>F8ABD8L"G8 M/&Z]9F'$>Z*L^XT128$+57XJV1Z8&$1M;\3(X0"H[/H$9GT:G TK2$L'#\7( M::-%9O.4+PX++#;;1VY=X+><4K20]);#:YWNH1[U@D/OTSQ.U:I(9D<>W-4S M@;&YN-NFN,G& /9!AFWZ"+-PLCS4/T <'GN[4LY7+1%.DC.P0P'8 68YR$+) MF:RO3*X*OZ[33K\#&'UW>TAP)]8 :E[##RMR>3@!_U+.B/5!G*>,#Z6XUH%E MWJ@+3"V;:C:/B .%$MU:K/?CDT"W=N"6^,(/; .<[H?[5U)70YV4X4\3O,S! M!ZTS:GNL_]TVY!#2&?@*A.28X!IPP+ HM]\,9.(1OS?0/98!'P%/"CJ?9$M% M.W_I3U^)[7%<[JPL9[ZG@4SDS]'BBO-;3B!B&%5+M5M/WYSJAY)>6XRHD\8; M']Q,5:A:^"GGE <*;@FI(XLD5G\#F9!M\>GRN-0NF M."'Z$+RQT =?H9E@!Z[PTBEE>6&&D44?RWQ)@QGTA,?VXY2UA%H'H[6^D0!2 M+K)BQ!&_."?^(;BCKI]S?$3>KGOZ\]FO'\^VN>'\5GJUS1T7$W HJ68@S=/9 M8L;Z2XQ5O+QT,*U%HBNU6DR1QA\7AG'>0C9EV-<_*>\)\2\3,]SZZ4L3SY^ ":E.I4R6!3+5A M)3;SN_M'K@Q&=^!QDSN)'!:/BZB;I-W0)&G EC@DZ%IN+'Q?=QZLR&0B"?%Q MI+:9$:M=HVP'M:IAWYR*_8->;MAX#6HK#>(2P,UUH.@9K> M*'&RUHMSTPC.64,Q;IZDFGVB G['-=#/T=L#1 M+B]&Y8L_&?-ZNR42@_!E,HX7E8>*!6M2B(&,?8=%!SX++E*4)=?RLTJS-2A! M#6*_H(/8;]-"WN 2GCG]CSXD=)=)*>A+T/N+>?C?2"W%P=5UUL"*:!NWWS>B MN.NI$/3.$@5(+3 M07.'N\^4=!JEOC[@#N_&>\L79-R+LV$_1WN3&Y!PCCBR#^>M0JTP72"N6NTR M;BUK>D%(<5_DMIOU"ZH#\T@7S.T@4?PAN8*!J,D;XRL9CC6;E1ZUE])))XS< MD&& X3=V4,'-4/=T ;9[=2D)! .I&3&L#R0GR^-D*GE=E&7PG3%7@0IGF4-!U'T\OTC,S..X<.*. M??-:RHZ@LN#Y@4$CZ,XH#K(8N,U(+13,&/['=>*W.FP(NDSQY!_AK;BO\T.$ASNM5>#_BN LNX^=W^ MKA)NA?G[F%J'GUS@@IMGD96-0Q=#NW>YZ?_O'N*T[W(CRH=ICFKSK^%S_.4J M/5C7\KK?!&/ :G&Y.#W:_/Y@O/(I?XO57$\[;GOC(%6TAMG5;S++YQWS3Z*?Q+N/PI)Q*CC3,:$OZ? MXZ.8(:]Z(+Z"=X7&HX)CS;IX-744P<;B?C 5T:WD#AP$9^%*5;3X@X8WH1AS M^.9P;V\O_*6X!",2VR#599+4$7BO8.^'N\.=*/QGC, N N"\+&%9JTMX3 ;6 M>!I'INOZ/U_\/=S[<+P.[[1QSG90&-=:KPG^] F7K;*S:F!YS90Q-QS&-.#OR23B[C\ M2Y7$Y?B2_UL")/S1X+*>9> KL*<8F2Q#H[MPRE&/6#@'@JY1N][X*;HQF8!X M, H_*ZI:YR6UNS/8< %!P6@7I3;-HQP7A4[RJR*[$E_!LG5,)?D)UFM /@U\ M^,L"K-?=(V2AW]WC()B=B.GZV)R2<49\\];,R/[0E"*RA?7VU7_&L_F/)SJ] MP)E>IND][N.C3R!8_9.9:\V+O]_#O%B,JG1";4T]M;KA!D;'QJYB+MRQQ^(7 MGNJR+,WP*4OS#69IAG_(+,V*!^">#1^;/_N#Z>JSU76U;^D@([3>\5Y']0U6 MVX_G%W['CF'/H>N3P"[MUBNO0Y%6]M'2">BC_[V$<$6W>^9>SIA[3Z9%X5WM_9>T#SBK^E/[U6 M0,T'#-;RF-+UM;3]V&$V:P=[#"EC_#_Y/,\T72T(L52(^,4?Q/CRV^1S.B[( M%8EMAYVQMLD\R1"-FYN74/<)J:[D9WU*YK6\.^6$\I-R^&*TH$1W1[[-,$GY18<[%N2"<0T2 4:I M_>/7O+(?%!;H]A\?$*;H?>#[DP\?P[.S>[I)3]+>EO;#AK3OW4?:IS$7$V@V M&%Q]\,>Q,IJCEJ^2+,W)J_^6Q?Q)AGIDZ*@A0_NKR]!;[#V%=_9;:O QMMUT M\?;[@*.J&JK45.(C035C$M\+UNQ)Q/YH(G;<$+&#U45,RO@$J:+\I6N2%;9[ M=>?N8^OJ,ZQ7'_:.^'[/7S,%K.W2D4OI+)9L8EF=7R2JV.M,GH046C+OKLL M^=/7[^A9IV_>#8*7U)I(^BYZ8XIN^[&ANI>R9DQD1GU3[GZ:7?F@;^6I0LG" MZ1T\*W-Q#Z25LZ,9B>+5^T+3;/;OS3XF&2O2 7#ETIB.L"._6ZDA7 MTR7'\Q+D'/0[QI3!!#7Q>/NY'0 #D,0R-<4+OH(S0;U1@7U#76A)Y"ZP90J=W#A_%]C;N1*'0'G^6+5 8-<'BJ;,>%:,/@%QC?+8%K& MBXG;"1YV] K#)Q-NTE2S+!9.$0,QJB!/:U70I?DOIW\>Y2ON9M$UUR?H/94P M7HG]ZWW;:(Q,0DO)!J7"_O_9>]?FM)%M ?2[?X5.SIYSDRKAZ(D@F9TJ_,HX M\6MLYWGK%B508Y2 1"1A&__ZVZM;$@(D)#428*-S9L_8!K6ZUUJ]WH]0?M(Q MO7XSS9"9=*8HI+*,T",H<*8_],%VIHL9"%K*^17GV$Z;4BQ%UP *]X/1CX&D MAA>3:@63-")=<_&Q5*6U/,.T%NE%IK6LM?@X1?T@35O<($\SCBW-B]OL>D>2 ML0@=,?P^1<1$HWN@NG"#UX>7-Y1NHEO1'[ ;3&P,(1:"Q:*KN93=5L^,1;/EI M$\]MTSY(V)Y:U98=E5X,A]Z+R%@0=G;7[P\=:8<2#-%"QB*DIX6Q@;:!U0/= MUU_]MF"ZK_/[6N'W@]J# M=I@1P#@S@#D,AVO/QU=2CTG MM C:+R^Z17H2TL32P2A#"N!9S(!>G M((^#\5P8TL=)BR$/?0S=*J8J]90[T_KD\JHQF0H)ZF3\< ^C, 22_.P-E*2P#O2;*P[V8E:@F9\*J# MECQ5.<*FU".8=(%Y.^WJ3(,DX3QC\A9_?D7T+=Z#'?^&O2%QC4?'LL\>F/0[ MIA,RJ! K7Q8^;8ZZ%U1R2BWJ&52YXPXV'MXHQ5\9$ MMV?,#R06?G# DG] G;K'6-!W&8I06&+SNF&/P/0/:+R+]^#ZGF6(;D>=U3H7 M[/# OU1[=*M\S$>@>9*<;?H5$A4XFD8P=,+W:-B0^ RNP*TZH?6Q%C?/&K%J MZWA0;DW;?%(O[[3:.#:R^( ZT;)CG6;I^YG_[CZ^3D&8UD"11CR1FO$P,&KY MIZG"-DES8>V1[7K3XNPDS23M\@#!].#6?A[SC:J!89S,JR#<,2 <@)/@.6H*A MF=NQ!U(AN"$!'GRGQ>7!,5!Q)-WL%G-KN"912N:N(.L<_T;_B+GV<#2P)\A/ M>_0[(.G!//+0DB#2@HU1>/E( XMF0[,+/PU"+-T_"M=_<@ M< PL;:;E&7%U4&-N0G-OP!]*4RHH3_0I97ZVAV4$J3H0?0IX![E]_A,03!T, M@FZ-0;I)].U[O;%#E EL.5OV QE]&W3M'4"# W#LA7QD>I9I@P%]:$*9#GP[ M&E^F8WH&YGTD)#9]/!P0Z??JVHLX9,) ==# FK0(-E',+L)EZ/ __\6D"WRX M'!U! >.N45\?]#@R?S[H\P$7B8PM)&PQ:/4QG5[HI^0DP#<&GO0)$E@-P(A1 M=6_:@S#R&4402!/2L=[TQIBG4M^%2WQ.YG"(##*&VQV[4-#EAWH-TP6YH \* MM:573SM,6/@8FO6'^BLM>T'=("0?!W:CY"6OBR.P?$'8#PBIVNZE)UU=2AQ,TR\7Q)-@^^XOT$B M4K1%_2$C9VS0WO0!Y>WY'?&#%4V_SL^AZFNT!:)_@(6T!L(_#P\.6XE-5%J@ MC YR]Y9;-4@L5T'B9Q@DEJL@<;'NCN=DB>9+@I?DN23X^F%^*Q145C]CS0]2 MZ=#P*5!9;R 3KHM*-$^92\KGC,;_!Y+R4$T?@94$J6A!XLYLCFVACK!YNS6H MT?93_8CJ[OKI4!&/#3SE=SPE/Q-[-BZYCCJ3Z)$0F<#FN\=<'RT\_;T6Z%C3 MOT-3T^"WB#(6_BGL.(5%]I&.?\1"@H/,L699JOYAP]-E7F0AP,\26Y::"Q1G6[^R]!I"UR2 MGI^[["\>]CSN(7]JV0Q4][)#E3)=/T>-M-Z*YLE-=U<4GRNFH')*TX177MC[ M7 /K_*[GE_S?W4$&*8PD!_ATS&!843C"";Y%Y_T^V)B078QLOY4]G>MF]Q!Q M@0!Q!Z!RX#8XJ;3T^NJP=7G G1YQFBR^24O&U4,6Q@>)PGOTQL3G_P0=X&(S M6^T(8B,D#3.&Z839\"X0*$VY9TP,D6K%MC/9H_KR'6340S?VH*/>C*D?C!J$ M"884G/Y(O.VBFT@A;H1R"ELU:IDG&/6T"#A)@LUTYYQ3!J+"?UXYF).]1"-= MHKDN""=V%: QJZ'.?RM691?W56C]CL6=$:HBJEC00J(6K]L6LK::>VW_R>:< M(A_H)/0_Y(G\.YSN+Q9C!:Y'O^@3 5F+Z:+XX(KF;1$R+V152 "C*O_N'%A: M.' "E25=[9ES)A"AK[?V"']*4=3]K?VG+O"J(&3^NJ)"_X_U'"14/?,<2&MJ M6;^J\$U!+/THMUBORW. &ML72]AZ5JY+O=A474T\:3KKS@R+ I:*A=::ZO83 M5*<3JHR%O7VGOTN^94949'HG J>FKV-&]="]>3T4O,< %GVV5V_4%,R2SYXC M#QIJO&;&,$UCF/O?\2 I+ MQL-1?E_3,4G0I?.^@X&."\DHQ/29,]Q+=#\5F1M5(*-9L6O(2Z%,E84R&<;6 M7(V=;E_W)SXO-.(*3/Q3DBY+>$BK!X8[82S!LRR-9,OQBV^H5TO0P89Q:;F\O]Q<4=-T>&VTNPM)&-(Q#?ZR'=I(P)\#&).*W4&< M/]D^$H0B?Q'?SV4/+QXC<,5_'$.N&6FLM,\=3MOZZM&("LE.VXL,A0Q;VOH. M;U)\'PMFNF_2:MA/_*A'.V#@WVDJJ$* $K0D#EO=+!YPWS_AWBG%CCTRK9A> M3+$H#V_!77@+N)$#*4A@;1@VB6L9)K;'')(1 B$R3%\DRF5Y'-3 ^OHM./ # MO$%:DM^3>(@P'78CF/91'T=).RN&&RQ,CV&6"W<.%0DW>@_ABS3MMK8Y6;L- MZMNRQ"*E2BQZAHE%RFXD%N6WE9XAI\Q343CME#GED@Q35")M**_#=E(G_J3[ M3]A0=@W3;Q1$8N57M-$0=VJ1I&7XH!".NO%VUB_-N) %%CG[*3\%G5*=;;9P MPMRVU+*,(P:" HIE)2%48R5DAX+:GCW/_XY?#]*CI>\F6]2A&9KB8G/U*]%N_=ZJ-NW M[(%]APW@";9@AY1!08,G*%/ZAJBCPH30WY"V'02;UT%]OUR[&T4H;?(W[0X5 M[;<'91\6T3YFPJ PKFEVC:AQ[_J@)YN*V/+3IK^DT'IA#Y&MDSH@<]HS*V;# MTS="RQ$;6SD.B;I"MB[1\D<.E);,?=<'V-:QYRB=3*O8Z;Y=D&"R80'"W'F7Y$B2Y: MP P/3V7H'J88PW;"2DP/-H)_GVW>/"8#MX!*.Y#)'63OSKYV:%N0P.TWK\14 M.K2]R$71'_"IPB8$?L?-\.,]2%8T:$@_W"M/I Z,;)NV&>5AJ ]IST:6P>?# MOQ@D"=NSNZ0+:.@2_'IU 6%Y>*=/@8:.F:&.ZOI Y[J"T%CS^]S&M\0158>5UP*\ ML7"!2 .\L!\^V>(TDR-L9[HY-!"9-Q\IV)B$NP10+G1/CFM)#3MV$2+MQ8'= MAR6J&$TSN(9) -'>)"ZRH-H@PL4]I _G._QBT][FDJCSO M4\KLSJCPFW;*QN^!LEJZ2\KQ GJEX^,H"XHE4,+8)J1O^A@3UY\QZ:F R2]4 M<.?+(_RN B'=]Z!0$I+3J<"$" CFH908]TSRY?@ZBP=:?XG"QF\T.$$[/-(. M[S%+!JE"BS&,;9\_Q32 :KN5_P+Z7LT9"2Q]5;3\-L+TIMV$R7.;G/\S[SD( MZT9B:TY&8\>%&:]P%R@(&M14QFQLFI]7D=IR4I,92*WQW$DM1\.NU&Q3PIZQ M&D4M1 =Y]A[ML(FU6=>?*!(&=X_\.;2O#X\N_O.&ZHM.,#P S1?-^S-$9AJM M+XX&(.E6Y8P'V 'Z9TGH;++DWO.]<).9Q)Y*<^I.?![]'/J#M6(NY8 M2<;]5V[28VZ>;\ MP3+V\ \B8P!T6T1G^QZ9-T!C. PT".83%.- M9.WEW@M:4RQOB2]@SO7H7&GW5.?*MH=7'\3]K"_%-TOG^@[J_?<5>NRWQ?V^ M-\3$&G9*(RZCUE ?W.D!QO5Y33#KKO*! VLND==R+1CA!%=F32^O89(+TT2) MP8*!!'/"NF'!V[S-1:QWMBAU6.#L1ZO%+-'J"2=JY-O2_IJ DE*1GT*3(@-1 M]CUO].[M6^CWZJ+N_IU]_[:%U4*L/;EOD7&G.V\A#/)6%$2UKFAO!0PZ4=9$ M313J^&>MKKSULPKPWREM![W:0D*>%I>_;)IBR8!8-U7E?YF4@]6=6J[GC/TY M>I 3'PY,#*>-]_T1XY"<0Y4#,D6O$T;W2+$8#2R$EL_:6-(UD$M$"I)V+.*S MP).< T^YVSVLR# $J2XIHH)_5@4!&(9,6<57&]2A<#>8=ERL)P6"R(\KTR]Q MM^3#4$IQ5-$+=3>?4S0MB6CP:ZQ;UJIW;,)8KW!#D46$BM1QUJD-?LCD.!R%(?;F4'TZ;(7UUK3#6X.>Z1&$>L<^]!J<\R?X31561I"9WL'^X3SY[P\U$5"D/ M;[#P\%E4,-E%\4T.B\$!P'X!#=CL%B1!U7PT^#KZ1WM@<&>V;L5P\GR GU=2 MB,*I_.V.1Q^\_M]OX;_+:;X;0_.2%K64)6$%@+-:H@P %Q1-J3@"Z,AU&Q$%4KWW.S/3#78U6==-CY.8P5[<-N5(\W+$H5S]"2J5PF*SS!!L?[B$A1CV@EM1^K9FKE0WI=-L\Y)B-BT M3(^D8-.D<1M:[=$Q.;UHJL4S$TNBD(,WP^ MRX92^9GQFM""$2-? 4A'4:CJ)#R%>0^^*&L]K$("YQ0>?2!6W_PQ/& MM'N= J)V-/:"--_KH$[9')#.*ZN 9%T1^ 20^#&#.0]U<.:9@YH1QRN-/WJK M*8+X].L*C2><7@E.;Y#K4CKBO,G'!$->6(A[9E8,V68-2? MS TB)RPV7^WPZXK_)AR^'E+W<&R97;]6/S@Z;:VUV@'7%69-.*"?W['8-ZS0 M0[)&-0LZI&^&?NMCZVF .@/[ 3GSYV)WD^'SL<83"SJ?GPURY9CW>G=2W,G6 MD'+]S+*M,:YSA#57]6XSD8<( 2%)K+\-X\I!+$AW$,VX#O=U35.Q26KA3$8% M*7L2:6&$/J3 #UJ,6#W3&<+OI \)R7<(T/B1=E?GSA$*M"-:#ASSE"3X3X6[ MF7NZY*3:T+&>P5_L1V+%_0*\ZJ#%EAF6C0F--S!!R J-R0)]1!(0 .7&/6BJ MX8DNJ)7D]XV<2TEJT)2D&<(@,=AH(EZFJQA$QE>XBJ5&6]/A*,["\=R?'A " MTD]6]P$9F)-!JU._*T/,A &_WDB+ ?5RE9@,/X(F M::'*SG?%'QY?0C O=--&5*#C1UJVRK6Z'D^G-&"6J-=$A7 T437(CY$T$A^G M<^N15\F"%'9GU9V.CI7GVN7C $U@=?@$:LI64:\D)A.0 D=* L[)RP#.>LE4 M9B=3.2N9QH.*A\9&, WC<#^$K2BK6-MI94-$4ZB72Z4R.Y7*6:GTF<)FO43* M7BW#'M17FY)*I:82T#FVHR&VA:'W"5H@31&A._B#3'K$#<(H(W4 5"V19%8_ MKR%((4*193>(&:Z4B_D8(E%MHF K[" RE2%L!TMKIT=.[.@=I=K4;G$S \L/IQ8TQ^&^'UR?P?P"VAKYR.Z. MPPISIO?<'/Z3_)Y;_=&V[.$$BRL/&L# *;M]--3#%[OL;SYLG>5ZOV"[!;OY-=,7LKCB=L=B7:''0Z?):T..Q,\)K$;@EZ])L>-T0(6B<. M!H$"YZ'%][/K.67WL]6T';X>.RB08 MA:93M!,W_!3301%> 4-N.JBO#WIKZJ>X_4]E[_A(RE2LV3(5QE:/4]+99M"L MUOV5KL+=FD-\'R[0 W=M#V%:*_D##Q5:9F]ITM8JS6"I*$S0CE18\ C^X M[.BG^>3UH&]F:I=8";_D8!+[C5@-1,3 (KWLPI-+*E[BK?MVKKYRZ4OG17TF M_789[.*TS=B_S>V2!X=6XE.KZ*/;>V7*G]11+;4^%.?(HFYD-S24Z34O7C?= M7F4XY=K2?^^KII5$*"9IC/R.?BD3QJLUJS6K-:LUU[KFC#X9?4)::%<JIXJ[ZE] M"3.2G5E@F774K*RC#*&"Y>0LD2$Y4>2!$B2*B2E(TG..R$F"5#$7.E&_X\:C$7*P\$7$W)]:*9'IP7O7:=.#LSL$EH AZ<@+9XQ2 M=/0/A).]XZ2FN*_$3P3'QK)?[#6M::>-=2)%M+U2-Y#@4%GMC4+\NS+"D_X! M/GS'F1XFGJ[_MP=$E^]@0+'NX7)D6GZU$*T?BHU8SI#H 'F8V&J^(^ =5Q/V M13(2-6TB=D%@@Y1G,P2>&9NNG"7[*/7]ZGY#3:*3;XCKZ]AS.ALF/\41WG<:U@82LPEX7VDQX8DOG\#Y5]07YXX'=.XA_H(#7\4?0VMU=WZ)*"9G.M[GP)$['E!#IR?5-5%[@6VP9NF.XL'73=<>84OR6!J3@B;; Q2>.?89T M/4CGEQE9&LNE70NO+7!C![IK4GQF8K(^O\[*81G97A+7RPC%@M]ZV\=W,O:Z M\HDIAMZ!!X MRY@%[YP3-H# ME!D:\!W@,$0>N/LO:'U(DZD%R8^40=%G=I[Y'T^'YMKWT38'7ZM M8Y!:WG!G4&7/]9!!VOA$&HL.] /Q7!Q\'OPN?"5EW^&:3#_U3\7MP2G(J*E$Q&(GX&I! MG&,/.%+*.SV!0XPK:%#%M5QLG5-#*X*'![1PM7QHX5?1JBP .JGOZH6OVTM[ M'=?!0(4C!D)]-'9&@$+HL4^9$>VY-<>/IDV#H&]C<+LP>#$O"_NP9=[%/N$W MI&$YZ#T 4Y\16C;GCKO]X.UE7<\@,LQ=V;E%O!1^_L_!;@:E-I9E"6#O1#MK*_=P/(BWPY M/ YZU(=D?#2#,3;P7=FP:IR)UM8Z\/0211UFZ8;A?;"?Z:B<>B MHI:"<@_;-79D _?Z8$S[[0;VDR_P1@[^DCD"*1*604*A(VD3@\&(=VH"@%T. MC";HN365[:2QU@/"6CO^[]PK@/JQ/A^H^7I498_?/&;*'30PT;W/0"/\ ,,4 MH(0A%^&6G5"?BQ@DMS2/#;WKION:G_\]%X;#<%I8U5,K-6:U'( M0I%]NPN6'PQ&:K?A)Q'_TWYZ.CNK7WT[NU9O!J\X+!_@)?Y#I#0?O\%\?&?9 MUL5XB)E6E^:J/'K7$& X<>PA+%431/R/9Y.?1:DFBZ_(7D[TKB?@_ZO+KS@+ M+_;?5WA3[R)[>O7AJ/7U].CF\H+[/WTX>L\=7IY?M2Y^<&=G5W^_G7GQAYD2 M]&W">_Q2)72%6#4M)J:O1&S?B#E:.IREI3.;MN.*IZ?'XW]^#(R?-]=- M@B>+H2DUAJ:F;_B*&;8]QA#BN4/,_PT]D9QB.UK$9!!E:;>2.:G';XT/?GG' M[B%BVTP])_I"KZ+4,%UB07LB3P#W_ZD1C\7?O[R/3P^WXVL1+6 1GN-.CT+: MQ<(>VPV3=U@;M IB%UH,:NEV7WW09#$1E?DB4>>T+:80%')G"7]<9XP"S=>2 MD$J2:"RJY\W$HN;I2&R,'M]S?=^U) K-T>.KMQE#-*OL,7L057S/78Z(]?X. MBOK]SGEAQQVQQ!CK3C3<.:FQ=,\14YKG9&[=,Y\^\1P[[N2\#XS==Y9H:$H0 ME)J)3DMA=+KH^K<<-8?IV9"%[J !'[X^IGX#.MJ,B&43VI##A73<-T74Q65C M#8%,E(4CZ.K2>=8"W9IIT7RE7?3DDRNQN6"8'[E+E6U>X]M MR.[O.P?K"$;-I^YO?=-#BSI?'+M?N /^ZS4AD4LE/2(N[SZ7(6TJ?B%8(\". MTA0B*LGEV>'GKG'_\_113DXOCSMU\"(IF14#"(F)B4"+>7#T4:;\\>0C; 7T M#@!Z$H7>%_=R=-GO?CSL=;<<>D3C9;-S4KOI9-AITBG3UHZ/%T9C@_$HQ[<8 MN-Y_7TGS_&*E8Z3&)GTQ/Q,9_KOCO/T0#LDM[_#L*Z\9AED!)A5YK.*R53.S MI8RTFOGQ..68=2OY?&)!&M!_9K0H%H95W*%6X_69(9<;3/]9"3[+]QFAX5 @ M@2/)[#ENK3<>#&JU%E8$/;?5@?9W7:]M'K2??IP>?WJTOKF"J+_*KPDY=YW7 MDJ#PDMS@)55]DR&;.X;P6S8>-I4]AACX/QXZ#E: 8 M,C6&US?BX:E\_W' 0*8)"CL; _(W2<*,@<]PIQ"Y4X>-I=KF+-7J;K]E&?"? MXS]C\UX?@(7:-@7QM#W4#Y\:WZ7VT^%7XG=F6F(\)FIWFC M:+IM[C64S7"B_":[FSZO-I-KI>R$,K6;F'5SWY-^0CK)VY;O$@]Q_2X>U:]F M7.XM][*7Y&;7U%<0C1[J'E[UT7MGC8>&[1FH:PYUS-C\'USB,1E;)EWPL'7T MZ@/&O:+RS88<>.*#/6;3)4H&.5OH)E/-.!.VRT6M%(O:.BMJZWQ=;?!X@>)1 MR\#;#MJH.W8Q'ZK5;AW\ Q7&Y\C#FY_C:<<_!T?2P]/OW\+O$H7RXAE@ @M) MU@A#$P#WJ4^[AZ\DPZ1A=HR["++4S0"[FL5<.&NFFM44P^#D#9.:J?RZ:#T@/!LF:Y&0^;U(6>%-9 MKLW"EL]^2XI^5^K%RDQ7V7EB0V16RU29KRM"ZH5;BX.Y0#052UZET=(:"2>6 M4SG8],,DSTS9O,;_V*+\&OGU^[;6?1I_J/]#GH?&I M>U><-E@$=R%_NM<=4X><&QE"7.>GDYN[%1\/-7L MBA)6#HZML%X\E=>P%JM ]EG%L[>:9^KC\S)Y9BE;$FNX]%EGA9;&[.J7D\ MPUBN'.@&XTVN!MB>;%D&1(M&D)0\QV$F7]'7K[W!E]^?&FN-C@3[XTEO 8\X M)E&P1Y_!U'>0P23B+0>GD5>(\0DBKRE2Q6M*0E@\TV%V$V"$B0+?R."A6U-N MU*UNW9F= 3I^' W\&:D $[^B'O\2I^5:%8G MTJH@2N$L,1M-Y>"/S#D0ZW*$5]ZXU?GR"E03SZ0U9B8M\Z*H9DJ=V5@PV_X/[>H*]:XN1NH: MM6286K :F_J[\^'V\K9UQ@4%-%G9;[Y7,UR9U<^6YQZM\K:,ERLGZQ4%YL00 M4>(U4>&U.FOL,0J-#7'?)0@IFIA*I)QBR22>\S([E+0&+Z@"+XFL(CH_F907 MI,[F[-QZAU85W"O/&78T(\7/3)VTB3;1;%#:[M05Z>;RV]G3FJ)Z,<+R[+1U M<'IV>GMZ7)6TOO##QE*J%II^/KLHIW,AP.+); M$D:P2>_FD;_3H*I5Y%[K;W8P]KD,B]F-&I$YA-]017 45,'/\C 6:U^(S&:H MK B\*FPPZ4*,%:-(=U%$ELYQH$;GXU"]^/[E,\1]-U:"D"Q:27=_VN-\ ">) MRMK$U*_*@UY0C<$\\>1@?,QI!** KY%<13>?CQL]#['$\USFJH,&UGR:ZO9Z MTM,LF]"K#LP8F+(K?VX_W7CR%V?R[_#Q]U;4\V:N^IJQ@ZK 9GELF8DC,^<, M-+$J6F^D*S851]XVCLS$C)F[72A2@V\(S[\ K/*M/S_C<$NJOI*-_/UHL9E817O:T*K#*A[DSAXVE:#6)HA/]!X_.N/WT\>.M^^"<];\A8ZTE M&V>V=5?SD#-D\Q"\?/]E,@:SJXP2S* *5-Y+1GS%JFX2L]-%QOBJ MR^F&=)F^RZ +UH'M./:#:=WY7<"FD)GC/2>?FI/&QT]_ZE=H4]$3TE=O8.M6 M$#?9R=YZR1C+P6N8"R$47M9$7E48FT'N$+=AP%4\GV%V)J=G9;9M6#S)-]UQ](AF/O%Y2_,E\I;H#(":B[HU M\['6-PT#X>]@O$GF8\<98,IKOOI0JR8FI.@2<42=_7;+S+GMHB#Q6F.#O30/ M$XR8(^28]SJ,&L]PW\^;=D/_^?O+[R%+*5$A:L5TOY&178MVS>YH&7%Z\G*D M9M<\9/;$(\_3'!=5%K/KZEJ<;R6JR M;E2%YK8E-)=XS7.P/&936>:%IL!+0GI:X<8R)D[2(RMAT@3PPS!I8G*D7OU2 MGO[\>\CBB5Y_TD2T&+Q*G%A;13B;BL@>$^.51E46_GQ8='9BB6?/S#T$ M-+XAJ+PFK2O59N7>''%,&9@Q,.5_)F?M)TW0CD\\?3SY8VY7A_/XTG#"F"MF M7#(S9F+!"G,E!;Y10I,7ZU4"V_-AP4R,5V%VY&"=3U9X54X?%;?MN6M5\_(J MZ2>[-&_-2'/H%HF-T6C>VOB;T7GXJGS3_V4)L3,7V[[Z;II(>-8=RQ(G9OC(M]TX^KAE]W[ M;;),=2XA]'"$>F;7]"K755Z>]3IUFL<<)>1@6SD2%5R\I_^^JBU(5U7CY:;( MJXWTH0AK]&6M&M-_OFZL8L@EGGWFR.5/()>FS&N:B$7>NH)/B:01RV*5&.<# M,%8_C@"<-8PCC$_NO[:NOGZJ?V/I4K?6. (-(B!RG(H!%ZTT4C+)P7691[I*Q3D5V]]37MZ4U]QESKXHA;TE&TZN]=)">>I:<[Z- M'03U[C#LC

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

  •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end GRAPHIC 18 orgchart.jpg GRAPHIC begin 644 orgchart.jpg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end XML 20 R1.htm IDEA: XBRL DOCUMENT v3.24.1.u1
    Cover
    12 Months Ended
    Dec. 31, 2023
    shares
    Entity Addresses [Line Items]  
    Document Type 20-F
    Amendment Flag false
    Document Registration Statement false
    Document Annual Report true
    Document Transition Report false
    Document Shell Company Report false
    Document Period End Date Dec. 31, 2023
    Document Fiscal Period Focus FY
    Document Fiscal Year Focus 2023
    Current Fiscal Year End Date --12-31
    Entity File Number 001-32702
    Entity Registrant Name ALMADEN MINERALS LTD.
    Entity Central Index Key 0001015647
    Entity Incorporation, State or Country Code A1
    Entity Address, Address Line One 1333 Johnston Street
    Entity Address, Address Line Two #210
    Entity Address, City or Town Vancouver
    Entity Address, State or Province BC
    Entity Address, Country CA
    Entity Address, Postal Zip Code V6H 3R9
    Title of 12(b) Security Common shares without Par Value
    Trading Symbol AAUAF
    Entity Well-known Seasoned Issuer No
    Entity Voluntary Filers No
    Entity Current Reporting Status Yes
    Entity Interactive Data Current Yes
    Entity Filer Category Non-accelerated Filer
    Entity Emerging Growth Company true
    Elected Not To Use the Extended Transition Period false
    Document Accounting Standard International Financial Reporting Standards
    Entity Shell Company false
    Entity Common Stock, Shares Outstanding 137,221,408
    ICFR Auditor Attestation Flag false
    Document Financial Statement Error Correction [Flag] false
    Auditor Name DAVIDSON & COMPANY LLP
    Auditor Location Vancouver, Canada
    Auditor Firm ID 731
    Business Contact [Member]  
    Entity Addresses [Line Items]  
    Entity Address, Address Line One 1333 Johnston Street
    Entity Address, Address Line Two #210
    Entity Address, City or Town Vancouver
    Entity Address, State or Province BC
    Entity Address, Postal Zip Code V6H 3R9
    Contact Personnel Name Korm Trieu
    Contact Personnel Email Address ktrieu@almadenminerals.com